data_2l90_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l90 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 t . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.63 134.64 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.489 1.516 . . . . 0.0 108.946 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.28 122.01 13.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 107.972 173.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.43 -26.12 62.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.702 1.201 . . . . 0.0 111.94 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -68.81 -32.11 71.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.904 2.882 . . . . 0.0 113.07 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -91.46 -14.54 30.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.886 1.674 . . . . 0.0 111.053 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.12 155.71 4.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.915 1.286 . . . . 0.0 111.744 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.55 0.978 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.938 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 pt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.01 165.48 32.47 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.814 1.676 . . . . 0.0 109.612 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.78 -172.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 125.289 1.436 . . . . 0.0 109.863 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 t -55.24 92.23 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.839 2.055 . . . . 0.0 109.235 165.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.4 89.08 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.836 1.254 . . . . 0.0 110.567 -169.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -81.68 117.21 21.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.087 0.955 . . . . 0.0 108.46 165.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -50.58 115.77 1.63 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.434 2.694 . . . . 0.0 110.521 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -63.27 -25.11 68.16 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.497 1.499 . . . . 0.0 112.985 -170.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.24 -46.31 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.664 1.185 . . . . 0.0 109.994 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.8 m -99.07 -46.9 5.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.881 0.872 . . . . 0.0 111.71 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 -4.62 36.18 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.567 2.032 . . . . 0.0 112.928 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -81.22 -98.36 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.173 1.789 . . . . 0.0 112.487 -172.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 ttm-85 -153.84 153.99 33.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.495 1.518 . . . . 0.0 110.502 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -128.24 11.33 6.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.448 2.699 . . . . 0.0 111.443 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 m -139.5 159.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 119.914 -1.741 . . . . 0.0 107.486 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.72 147.61 70.71 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.371 1.068 . . . . 0.0 111.487 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.31 144.96 79.21 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 119.725 0.938 . . . . 0.0 111.782 2.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -87.57 141.22 31.99 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -52.85 143.47 48.24 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.012 3.142 . . . . 0.0 112.838 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -62.12 133.71 55.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.75 0.82 . . . . 0.0 110.028 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 30.22 30.97 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.9 p -111.49 139.86 46.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 163.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -105.11 157.97 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 165.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.3 143.75 38.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.009 1.723 . . . . 0.0 107.426 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.69 172.69 12.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.019 2.128 . . . . 0.0 106.789 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 50.0 t -133.42 123.47 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -134.75 128.77 33.52 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.996 1.718 . . . . 0.0 109.067 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.11 134.73 10.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 126.552 2.025 . . . . 0.0 108.407 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.4 ptp -128.3 -121.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 105.85 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.51 -154.78 29.78 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 171.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 t -44.06 117.35 1.19 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.769 2.028 . . . . 0.0 111.456 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.289 0.0 OUTLIER -51.93 -11.59 0.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -176.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -53.66 -69.32 0.12 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.898 2.479 . . . . 0.0 114.111 165.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 -15.91 66.46 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.087 -1.008 . . . . 0.0 111.553 -171.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.5 70.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.979 1.711 . . . . 0.0 111.105 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.24 -40.65 81.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.402 1.881 . . . . 0.0 111.817 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -51.28 -52.49 44.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.893 2.077 . . . . 0.0 113.355 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.26 -3.18 12.8 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.777 1.231 . . . . 0.0 114.316 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -102.44 -27.83 12.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.825 -1.083 . . . . 0.0 112.241 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -80.87 -19.57 44.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 121.413 1.915 . . . . 0.0 111.795 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -79.56 -0.21 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 125.703 1.601 . . . . 0.0 112.281 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.9 152.34 22.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.147 1.779 . . . . 0.0 108.948 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -89.97 134.59 34.14 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.9 -13.54 45.52 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.01 0.814 . . . . 0.0 112.514 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 p -72.23 132.09 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 169.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.09 -51.09 11.65 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.1 p -161.48 171.58 17.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.314 1.845 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 p -128.45 153.97 46.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 107.885 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -145.43 160.37 41.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.009 2.124 . . . . 0.0 109.54 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.96 154.16 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.14 1.376 . . . . 0.0 111.103 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.86 176.55 40.63 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-O 122.237 0.91 . . . . 0.0 111.519 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.83 136.71 32.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.37 165.38 28.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.778 1.631 . . . . 0.0 107.871 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.34 2.45 79.9 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 119.747 -1.846 . . . . 0.0 114.867 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -115.16 -173.62 17.78 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.753 1.644 . . . . 0.0 110.923 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . 0.261 0.0 OUTLIER -145.42 60.76 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.325 1.45 . . . . 0.0 110.561 -167.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.52 142.35 27.95 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 129.29 3.036 . . . . 0.0 104.887 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -67.18 -55.56 13.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.297 0.953 . . . . 0.0 112.429 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.273 43.2 m-80 -137.69 70.24 51.77 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 120.314 1.416 . . . . 0.0 112.619 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.79 152.0 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.124 1.883 . . . . 0.0 108.444 171.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.47 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 34.1 p -108.03 175.25 5.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.168 1.387 . . . . 0.0 107.617 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -53.26 -44.75 68.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 111.862 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -72.94 -30.01 63.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.958 1.303 . . . . 0.0 111.395 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.47 ' HB2' ' H ' ' A' ' 102' ' ' THR . 9.6 mm-40 -77.08 -45.89 25.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.167 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.48 HG12 ' HG1' ' A' ' 111' ' ' THR . 15.3 m -62.01 -25.92 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.257 1.39 . . . . 0.0 112.769 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.5 t -56.67 -29.67 62.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.511 1.925 . . . . 0.0 113.262 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.0 p -68.04 -13.44 62.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.618 1.167 . . . . 0.0 112.963 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 79.15 -23.21 0.25 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 130.237 3.415 . . . . 0.0 112.224 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -54.38 -22.73 13.1 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 127.06 2.144 . . . . 0.0 114.629 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.48 ' HG1' HG12 ' A' ' 106' ' ' VAL . 51.0 p -76.41 -29.83 57.21 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.317 -1.49 . . . . 0.0 111.525 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.19 85.08 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.909 1.718 . . . . 0.0 112.325 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.29 152.11 41.98 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.299 1.549 . . . . 0.0 112.4 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -110.29 129.53 55.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.656 2.382 . . . . 0.0 105.523 165.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -74.11 132.64 42.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.15 151.69 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.704 1.602 . . . . 0.0 110.187 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.2 128.84 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 127.602 2.361 . . . . 0.0 106.159 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -107.44 95.18 5.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.778 2.431 . . . . 0.0 104.652 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.85 126.71 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.56 142.34 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -134.0 158.31 43.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.727 1.211 . . . . 0.0 110.086 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -103.97 106.24 52.13 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.876 1.271 . . . . 0.0 108.158 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -35.23 -42.57 0.41 Allowed 'Trans proline' 0 C--N 1.361 1.217 1 C-N-CA 127.391 5.394 . . . . 0.0 118.652 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.83 -25.39 56.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.342 1.857 . . . . 0.0 113.658 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -120.68 -16.02 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.973 1.309 . . . . 0.0 113.341 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.033 1.733 . . . . 0.0 107.681 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.2 p -83.78 169.62 15.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.358 1.435 . . . . 0.0 111.369 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.01 -32.46 72.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.008 1.323 . . . . 0.0 112.028 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -56.54 -27.14 56.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.013 2.125 . . . . 0.0 112.717 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.38 -44.41 65.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.313 1.445 . . . . 0.0 111.373 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.0 mt -67.33 -42.51 83.46 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.961 0.8 . . . . 0.0 110.398 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.28 -52.96 63.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.654 1.581 . . . . 0.0 110.334 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -52.1 -55.53 20.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.039 1.736 . . . . 0.0 112.805 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.05 -42.02 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.875 0.87 . . . . 0.0 110.927 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -56.08 -56.34 21.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.333 0.969 . . . . 0.0 112.244 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -63.28 -45.11 92.96 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.89 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.66 -24.02 63.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.958 2.103 . . . . 0.0 114.77 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.442 12.6 p30 -130.01 47.09 2.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.691 1.196 . . . . 0.0 114.2 -176.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -153.76 158.01 40.31 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.164 -1.398 . . . . 0.0 110.481 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -90.81 115.88 65.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.976 1.716 . . . . 0.0 107.363 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.58 -6.9 11.69 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.416 2.077 . . . . 0.0 114.495 -170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.2 p -109.45 9.73 25.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.197 1.799 . . . . 0.0 112.128 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -110.57 108.43 18.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.58 -56.58 1.24 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -166.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -90.92 19.01 5.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.409 1.105 . . . . 0.0 112.657 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.0 ttm105 -167.5 148.4 5.45 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.912 2.085 . . . . 0.0 107.302 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -139.44 114.06 9.22 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.546 1.539 . . . . 0.0 107.651 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 45.8 -109.5 0.34 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.7 2.095 . . . . 0.0 113.124 -167.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -85.8 -16.91 37.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.645 1.578 . . . . 0.0 112.112 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.98 122.34 33.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.941 1.296 . . . . 0.0 107.58 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -115.83 139.59 50.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.337 1.455 . . . . 0.0 110.578 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.99 157.04 9.36 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.033 1.778 . . . . 0.0 112.024 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.6 t -58.58 -15.83 13.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.226 2.611 . . . . 0.0 114.618 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -80.46 -18.34 49.01 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.02 -1.05 . . . . 0.0 112.3 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -111.16 66.85 0.63 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -109.95 152.04 26.36 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.63 1.172 . . . . 0.0 108.123 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 p -60.28 118.41 6.37 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.593 1.157 . . . . 0.0 109.093 156.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.18 116.98 6.69 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.528 1.131 . . . . 0.0 110.869 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 76.2 t -111.13 121.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -115.27 114.1 43.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.52 155.67 45.24 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 123.151 2.567 . . . . 0.0 111.412 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.2 m -79.69 -32.67 41.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.037 0.935 . . . . 0.0 111.859 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 87.9 p -171.6 -167.56 0.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.21 1.804 . . . . 0.0 108.954 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.1 -21.96 25.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.105 . . . . 0.0 113.797 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -52.44 -56.67 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.933 2.493 . . . . 0.0 110.899 169.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -86.77 -18.96 29.82 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.915 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.6 ttt -54.89 -36.02 64.72 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.557 1.543 . . . . 0.0 113.303 175.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -67.98 -38.01 82.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.889 0.876 . . . . 0.0 112.142 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.07 -38.98 12.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.678 1.191 . . . . 0.0 111.356 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.47 74.7 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.004 1.722 . . . . 0.0 111.057 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.29 -34.76 79.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.24 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -69.35 -46.89 65.93 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.724 0.809 . . . . 0.0 110.007 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.8 p -59.42 -40.65 87.37 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.252 1.421 . . . . 0.0 112.06 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.07 -63.67 1.11 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.109 2.164 . . . . 0.0 110.596 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.51 -34.75 78.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.597 1.159 . . . . 0.0 113.736 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.03 -48.12 83.02 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.438 1.895 . . . . 0.0 111.714 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -76.68 -25.82 54.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -60.46 -44.06 96.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.734 0.697 . . . . 0.0 110.94 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -64.69 -42.14 95.53 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.744 1.218 . . . . 0.0 112.671 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.26 -42.36 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 119.028 0.831 . . . . 0.0 110.565 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -83.01 -23.61 33.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.432 1.015 . . . . 0.0 113.184 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.5 t -56.86 -33.91 67.3 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.839 1.2 . . . . 0.0 111.351 167.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -79.46 -17.61 53.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -91.95 12.11 22.85 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.481 1.512 . . . . 0.0 111.721 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 76.94 28.89 0.63 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.625 1.97 . . . . 0.0 111.049 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -98.69 169.23 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -103.65 -160.6 24.9 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.441 1.019 . . . . 0.0 110.904 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.24 21.67 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 124.094 3.196 . . . . 0.0 111.903 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.64 149.55 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.845 0.831 . . . . 0.0 109.627 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.6 p -112.59 21.52 15.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.175 1.79 . . . . 0.0 109.951 -171.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -66.72 106.44 1.84 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -69.82 124.59 24.38 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.719 1.208 . . . . 0.0 108.268 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.89 114.66 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -144.92 160.86 40.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 129.212 3.005 . . . . 0.0 106.484 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 161.82 20.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.624 1.969 . . . . 0.0 108.733 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.24 61.9 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.813 -0.555 . . . . 0.0 111.911 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -76.49 120.19 21.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.981 0.912 . . . . 0.0 109.134 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 p -59.92 134.88 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.141 1.777 . . . . 0.0 108.866 168.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -101.01 129.47 46.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -122.18 115.64 22.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -57.39 130.43 46.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.414 1.085 . . . . 0.0 110.294 171.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -76.88 173.5 11.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.136 0.974 . . . . 0.0 109.372 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.66 160.7 22.13 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.772 1.629 . . . . 0.0 110.798 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -55.57 -37.94 68.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.373 2.269 . . . . 0.0 111.976 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -18.89 22.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.262 2.225 . . . . 0.0 114.123 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -105.28 -6.47 19.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.366 1.467 . . . . 0.0 111.442 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -94.91 -130.75 0.15 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.194 2.198 . . . . 0.0 108.952 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -68.79 14.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 132.02 4.128 . . . . 0.0 112.797 -173.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -51.56 -39.43 57.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.118 2.567 . . . . 0.0 112.463 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.1 mp -84.33 0.45 49.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.68 0.792 . . . . 0.0 112.021 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -76.21 -38.18 56.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.889 -1.132 . . . . 0.0 108.01 166.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -77.51 -34.9 53.93 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.525 1.53 . . . . 0.0 110.107 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -117.7 77.65 11.4 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.246 1.818 . . . . 0.0 109.246 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.37 1.91 4.38 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.605 2.87 . . . . 0.0 114.268 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -39.53 -38.88 0.64 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.46 3.104 . . . . 0.0 113.362 163.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.67 44.1 11.02 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 162.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -36.97 109.84 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.58 2.752 . . . . 0.0 115.413 -161.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 12.1 t 81.92 -65.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.455 2.302 . . . . 0.0 114.704 161.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.25 151.44 46.93 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.648 0.619 . . . . 0.0 114.648 -147.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.02 171.69 14.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.919 1.287 . . . . 0.0 109.576 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -88.58 -164.46 40.33 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 160.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -117.29 -141.04 6.81 Favored Glycine 0 CA--C 1.519 0.319 0 O-C-N 121.375 -1.074 . . . . 0.0 114.855 -159.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.702 1 C-N-CA 136.037 5.735 . . . . 0.0 119.923 163.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.61 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.788 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.61 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -41.34 177.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.76 -178.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -107.67 125.64 51.61 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.509 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.679 ' CB ' ' ND1' ' A' ' 97' ' ' HIS . . . -54.01 -17.93 3.08 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.427 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.566 ' OE1' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -82.98 -9.52 59.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.974 -1.079 . . . . 0.0 110.12 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 34' ' ' ALA . 9.4 tp10 -112.32 -28.11 8.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 110.384 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -30.57 148.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.157 -0.965 . . . . 0.0 110.389 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.016 0.436 . . . . 0.0 110.413 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 42' ' ' ILE . 76.6 Cg_exo -48.34 -165.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.787 2.325 . . . . 0.0 111.435 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -160.9 -171.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.891 -1.131 . . . . 0.0 110.281 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -33.9 83.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.554 0.692 . . . . 0.0 111.334 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -64.4 -20.13 65.95 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.441 -0.787 . . . . 0.0 110.271 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -88.49 100.45 13.07 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 116.384 -2.126 . . . . 0.0 107.786 178.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.682 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 6.1 t-80 -30.18 141.21 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.0 -6.96 57.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.461 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 46.9 t -95.43 -63.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -80.55 -44.69 18.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.927 . . . . 0.0 110.214 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.22 55.6 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 33.4 p30 -82.75 -114.87 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 57' ' ' GLU . 1.2 ttm-85 -128.06 170.57 12.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.978 1.37 . . . . 0.0 108.434 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 3.0 p -132.22 17.33 4.52 Favored 'General case' 0 C--N 1.263 -3.169 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.968 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.519 ' O ' ' C ' ' A' ' 57' ' ' GLU . 3.4 m -151.55 -168.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.098 -1.001 . . . . 0.0 109.117 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 23.7 mm-40 -34.08 153.77 0.05 OUTLIER Pre-proline 0 C--N 1.293 -1.854 0 CA-C-O 121.494 0.664 . . . . 0.0 110.296 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -87.79 155.29 41.94 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.03 -1.654 . . . . 0.0 110.889 0.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-85 -117.53 66.68 5.0 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.28 -176.42 0.84 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.821 2.347 . . . . 0.0 113.049 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.39 158.55 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.94 -41.37 2.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.491 ' CG2' ' CG2' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -97.72 144.2 27.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -1.04 . . . . 0.0 109.231 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.691 HE21 HE21 ' A' ' 166' ' ' GLN . 29.4 tp60 -107.79 147.77 30.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.704 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -122.18 128.85 51.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.33 -167.38 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.2 t -141.98 140.69 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.081 -1.637 . . . . 0.0 109.379 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 42.0 m-85 -127.92 131.91 49.33 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.561 ' O ' ' CD2' ' A' ' 139' ' ' HIS . . . -135.89 136.15 8.27 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.233 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -126.25 -94.29 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.514 -0.992 . . . . 0.0 108.998 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.691 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -142.46 71.28 0.4 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.4 t 113.05 149.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.087 0.955 . . . . 0.0 108.776 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.701 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -101.6 20.26 16.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.2 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.706 ' CG ' ' OH ' ' A' ' 209' ' ' TYR . 17.8 m0 -101.56 -65.98 0.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.748 -1.22 . . . . 0.0 109.395 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.523 ' N ' ' OH ' ' A' ' 217' ' ' TYR . . . -68.32 -16.12 68.77 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -75.29 -58.27 3.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.409 -1.054 . . . . 0.0 110.591 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.544 ' CD ' ' O ' ' A' ' 77' ' ' GLU . 10.5 tp10 -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.253 -0.904 . . . . 0.0 111.473 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.406 HH11 ' HG3' ' A' ' 78' ' ' ARG . 13.9 tpt85 -56.52 -53.98 51.23 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.874 -1.142 . . . . 0.0 110.787 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -83.42 18.32 1.86 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.329 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.714 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 4.9 m-85 -103.95 -40.05 6.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.776 -1.203 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.581 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -81.91 -4.36 56.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.848 -1.158 . . . . 0.0 110.108 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -90.4 21.11 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 0.0 109.786 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.6 mt -111.1 165.92 11.5 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.794 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 169.85 10.93 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.16 3.64 38.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.89 115.91 40.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.559 -0.965 . . . . 0.0 109.615 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.0 OUTLIER -73.53 -46.64 46.44 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 6.9 t -164.37 157.65 17.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.542 -0.724 . . . . 0.0 109.554 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.682 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.1 p -117.26 154.05 31.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.645 ' NE2' ' C ' ' A' ' 89' ' ' THR . 10.9 mp0 -149.24 146.95 27.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.773 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 206' ' ' HIS . 20.6 m -140.56 177.7 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 110.124 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . 156.48 -118.9 0.87 Allowed Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.209 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.438 ' CZ ' ' HB1' ' A' ' 202' ' ' ALA . 5.0 m-85 -125.13 167.78 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.937 . . . . 0.0 109.814 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.673 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.76 -179.62 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.884 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.61 6.61 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -121.95 -170.56 13.81 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.679 ' ND1' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -144.05 78.55 1.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.548 -0.972 . . . . 0.0 109.917 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.52 145.1 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 3.5 ttm-85 -55.17 -80.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.427 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 99' ' ' ARG . 44.5 m-80 -122.83 75.25 47.54 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.054 -1.029 . . . . 0.0 109.668 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.78 151.48 31.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.827 2.351 . . . . 0.0 112.05 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 106' ' ' VAL . 19.1 p -122.0 164.22 18.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.055 -1.028 . . . . 0.0 109.393 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.453 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 14.5 t80 -51.1 -44.35 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.614 -0.678 . . . . 0.0 110.016 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -27.03 62.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.009 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 0.6 OUTLIER -80.98 -38.06 28.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.074 -1.016 . . . . 0.0 110.375 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 109' ' ' GLU . 15.3 m -69.42 -24.03 27.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 120.866 -1.146 . . . . 0.0 110.161 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.655 ' C ' ' H ' ' A' ' 109' ' ' GLU . 94.5 m -45.76 -45.21 14.46 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.603 ' C ' ' H ' ' A' ' 110' ' ' LYS . 29.6 t -60.52 5.5 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.85 . . . . 0.0 108.965 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.655 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.9 mt-10 54.82 -0.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.456 -0.778 . . . . 0.0 109.659 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.603 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 mmtp -63.84 -19.5 65.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.058 -1.026 . . . . 0.0 109.044 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.538 ' O ' ' C ' ' A' ' 112' ' ' GLY . 31.7 p -98.34 0.72 46.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.418 -0.801 . . . . 0.0 109.373 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 30.99 47.81 0.17 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -84.79 174.7 9.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.709 -1.465 . . . . 0.0 108.367 178.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -125.52 114.52 18.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.131 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.701 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.1 mm-40 -62.52 111.53 2.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -140.16 -171.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.095 -1.003 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.5 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.1 m -130.32 128.18 63.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.468 0.652 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.602 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -97.95 97.3 8.82 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -105.8 129.72 58.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.509 -179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 63' ' ' THR . 0.2 OUTLIER -108.25 132.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.658 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -139.06 156.71 46.98 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.544 0.688 . . . . 0.0 109.695 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.471 ' HE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -95.92 108.28 39.72 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.66 -0.65 . . . . 0.0 110.633 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -41.62 -67.47 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.713 2.276 . . . . 0.0 113.169 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.656 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 18.4 mp0 -49.64 -21.3 0.99 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.258 -0.901 . . . . 0.0 109.746 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.562 ' N ' ' HD1' ' A' ' 125' ' ' HIS . 1.1 m80 -92.37 -33.82 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -0.981 . . . . 0.0 108.981 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.462 ' CG1' ' HG2' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -148.18 141.04 18.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.14 140.81 57.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.955 -1.091 . . . . 0.0 110.088 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 132' ' ' LEU . 21.9 t80 -69.42 -33.28 72.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -14.01 61.47 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.543 ' CD ' ' C ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -74.98 -45.33 42.81 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.473 -0.767 . . . . 0.0 110.454 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.565 ' CD1' ' CG ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -71.67 -31.02 66.35 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 119.361 -2.087 . . . . 0.0 107.492 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.569 ' CD1' ' CE2' ' A' ' 128' ' ' PHE . 1.1 mt -57.01 -21.77 33.31 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -70.34 -52.89 19.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.411 -0.805 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -49.93 -34.82 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.713 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 13.6 t80 -69.01 -53.22 21.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.481 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 50.6 m95 -70.44 -55.61 8.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.583 -1.323 . . . . 0.0 109.129 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.517 ' OE2' ' O ' ' A' ' 137' ' ' GLU . 2.2 tm-20 -37.53 -40.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.68 -0.637 . . . . 0.0 111.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 14.0 p30 -125.4 72.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.972 -1.08 . . . . 0.0 110.784 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.713 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 8.4 m80 -157.62 142.18 16.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.122 -0.986 . . . . 0.0 110.593 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.74 ' CG ' HE21 ' A' ' 143' ' ' GLN . 0.7 OUTLIER -105.21 73.02 0.24 Allowed Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.483 ' CD ' ' O ' ' A' ' 139' ' ' HIS . 17.7 Cg_endo -59.53 23.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.736 1.624 . . . . 0.0 112.587 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.599 ' H ' ' C ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -121.95 1.6 9.86 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.135 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.74 HE21 ' CG ' ' A' ' 140' ' ' ASP . 46.2 mt-30 -106.79 92.35 4.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.951 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.594 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -37.97 -113.3 0.0 OUTLIER Glycine 0 N--CA 1.495 2.603 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.331 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.649 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 22.2 ptt? -66.05 41.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.84 0.829 . . . . 0.0 110.963 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.755 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 178.37 145.49 0.13 Allowed 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.897 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 1.3 mt-30 -152.13 155.48 37.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 119.782 -1.824 . . . . 0.0 110.215 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.58 -126.25 3.63 Favored Glycine 0 C--N 1.302 -1.309 0 CA-C-O 122.898 1.277 . . . . 0.0 110.438 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.472 ' HB2' ' H ' ' A' ' 220' ' ' LEU . 0.7 OUTLIER -81.85 -34.57 30.05 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.16 -1.02 . . . . 0.0 112.129 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.452 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -91.84 126.26 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.314 -1.491 . . . . 0.0 108.862 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CA ' ' HB2' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -105.81 154.62 20.26 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.054 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.755 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 123.92 172.89 13.78 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.353 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -75.56 -28.15 58.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.285 -1.126 . . . . 0.0 109.82 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.785 ' NE2' ' HH ' ' A' ' 155' ' ' TYR . 4.3 pt20 -69.98 -5.74 28.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.885 -1.134 . . . . 0.0 109.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.785 ' HH ' ' NE2' ' A' ' 154' ' ' GLN . 23.4 m-85 -131.4 52.08 2.09 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.078 -1.014 . . . . 0.0 109.351 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.77 HH22 HH22 ' A' ' 194' ' ' ARG . 6.8 mtp180 -90.96 176.18 6.7 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.582 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 192' ' ' ASP . 0.2 OUTLIER -91.08 117.66 29.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 175.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -136.99 128.75 28.92 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.99 -175.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.4 t -115.89 115.52 49.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -113.2 121.15 38.66 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.7 170.11 13.02 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.575 2.183 . . . . 0.0 112.28 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -90.15 -29.23 18.42 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 120.916 -1.115 . . . . 0.0 109.369 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.48 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 178.48 -162.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.58 -15.83 2.03 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.993 1.378 . . . . 0.0 108.648 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.48 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.8 t -55.92 -64.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.691 HE21 HE21 ' A' ' 64' ' ' GLN . 22.3 mt-30 -79.56 -19.59 49.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.596 -0.69 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.93 -34.87 43.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.26 -28.56 63.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.746 -1.221 . . . . 0.0 109.431 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.76 -45.13 8.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.65 -56.09 17.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 mt -52.87 -37.16 60.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.218 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.481 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -55.84 -36.5 67.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.539 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.494 ' HZ2' ' CD1' ' A' ' 189' ' ' ILE . 8.8 tttm -72.84 -57.81 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.595 ' CG ' ' N ' ' A' ' 176' ' ' GLU . 6.4 pt-20 -63.46 -47.09 83.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.595 ' N ' ' CG ' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -53.08 -31.98 44.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 109.655 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.6 OUTLIER -78.92 -14.92 58.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.527 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.496 ' C ' ' CD ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -74.89 -38.79 61.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.182 -0.949 . . . . 0.0 109.299 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.466 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -78.02 -23.17 48.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.651 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.59 -54.56 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.466 HD22 ' CE2' ' A' ' 177' ' ' TYR . 4.6 mm? -68.96 -36.46 77.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.629 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.3 p -56.03 -27.8 54.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -88.11 -3.03 58.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.42 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.444 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 11.9 m170 -107.59 35.88 2.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.86 61.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.493 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -152.19 175.04 13.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.9 -141.49 5.01 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.51 105.82 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.239 1.96 . . . . 0.0 111.196 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.494 ' CD1' ' HZ2' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -53.24 177.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 2.7 p -143.89 70.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.647 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.411 ' HA ' ' HG ' ' A' ' 157' ' ' SER . 61.2 m -100.47 160.24 14.51 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH2' ' A' ' 156' ' ' ARG . 21.2 t0 -105.91 106.38 16.86 Favored 'General case' 0 C--N 1.265 -3.067 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.93 114.07 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.415 -0.803 . . . . 0.0 109.054 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.77 HH22 HH22 ' A' ' 156' ' ' ARG . 1.0 OUTLIER -154.68 -170.46 3.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 109.178 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.408 ' HA ' HE22 ' A' ' 197' ' ' GLN . 86.3 mt-10 -119.67 -179.22 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 56.37 54.08 38.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.427 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.85 92.48 6.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.454 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.42 156.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 118' ' ' ARG . 63.2 t80 -126.05 140.24 52.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.235 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 10.2 m-85 -139.67 103.89 4.79 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.052 -1.03 . . . . 0.0 109.975 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -52.4 132.58 34.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 111.219 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 93' ' ' PHE . . . -88.37 -171.26 3.28 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.662 ' CD ' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.44 174.94 8.22 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.662 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.4 OUTLIER -60.92 -50.49 73.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.733 -1.229 . . . . 0.0 108.088 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.641 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.53 -8.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 109.77 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.574 ' H ' ' C ' ' A' ' 204' ' ' ASP . 8.7 m-70 -103.55 13.62 32.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.066 -1.021 . . . . 0.0 111.446 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.774 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -138.6 -148.0 0.25 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.684 -1.26 . . . . 0.0 111.197 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.668 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 18.7 mp0 -33.49 -3.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.606 -1.179 . . . . 0.0 114.049 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.774 ' N ' ' O ' ' A' ' 207' ' ' GLN . 14.3 p90 -44.83 -33.63 2.0 Favored 'General case' 0 N--CA 1.518 2.941 0 C-N-CA 116.429 -2.108 . . . . 0.0 108.738 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 209' ' ' TYR . 0.4 OUTLIER -51.13 -20.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.769 -1.207 . . . . 0.0 109.947 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 16.2 t -59.88 -35.83 75.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.058 -1.026 . . . . 0.0 108.683 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 214' ' ' PRO . 5.8 mmmt -88.29 -29.8 20.1 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.468 -0.77 . . . . 0.0 109.67 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.7 OUTLIER -119.6 51.07 1.67 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 213' ' ' ASN . 12.0 Cg_endo -60.41 8.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.095 2.53 . . . . 0.0 112.406 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.0 t70 -63.58 -12.48 33.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 110.36 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 62.56 86.67 0.05 OUTLIER Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.657 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.61 ' O ' ' O ' ' A' ' 216' ' ' GLY . 1.5 p90 -44.61 179.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.385 2.093 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.452 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER -72.84 76.71 1.15 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.041 -1.037 . . . . 0.0 108.765 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.36 150.42 17.24 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.472 ' H ' ' HB2' ' A' ' 149' ' ' ASN . 7.6 mt -84.67 -173.38 4.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 165.2 110.48 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 154.0 139.09 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.195 -1.179 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.628 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.789 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -41.18 176.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 122.828 1.299 . . . . 0.0 109.669 -178.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.469 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -105.27 123.26 47.54 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.423 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.601 ' CB ' ' HD1' ' A' ' 97' ' ' HIS . . . -47.04 -36.18 7.7 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.697 -0.627 . . . . 0.0 109.531 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -54.0 -38.0 64.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.81 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' C ' ' A' ' 34' ' ' ALA . 24.3 tp10 -91.19 -27.87 18.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.573 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -28.24 126.38 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 110.371 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.635 ' O ' ' CG2' ' A' ' 98' ' ' THR . 4.5 mp . . . . . 0 C--N 1.304 -1.412 0 O-C-N 121.567 -0.708 . . . . 0.0 109.715 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.032 0.444 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.535 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 83.7 Cg_endo -85.0 162.6 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.144 2.563 . . . . 0.0 112.504 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.654 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 15.7 m -160.7 -176.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.238 -0.914 . . . . 0.0 109.628 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.6 100.12 12.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.598 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.45 -61.31 2.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.261 -0.9 . . . . 0.0 111.414 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.553 ' O ' ' C ' ' A' ' 48' ' ' HIS . 17.3 mttm -70.82 100.76 1.98 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 115.579 -2.448 . . . . 0.0 108.423 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.553 ' C ' ' O ' ' A' ' 47' ' ' LYS . 5.9 t-80 -32.34 122.88 0.33 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.06 -28.94 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 0.0 111.012 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 41.8 t -69.25 -43.78 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.143 . . . . 0.0 110.001 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -106.57 -44.16 4.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 110.306 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.22 2.76 51.25 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 43.9 p30 -79.44 -121.01 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.6 mmt180 -127.81 172.03 11.21 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 123.061 1.41 . . . . 0.0 109.784 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 37.0 p -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.985 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.537 ' O ' ' C ' ' A' ' 57' ' ' GLU . 11.6 m -145.62 132.76 15.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.415 -1.428 . . . . 0.0 109.809 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.6 mm-40 -32.73 149.36 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.504 0 CA-C-O 121.75 0.786 . . . . 0.0 110.538 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.34 166.21 80.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.961 -2.1 . . . . 0.0 111.831 -0.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.33 151.68 39.15 Favored Pre-proline 0 C--N 1.269 -2.934 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.289 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.57 ' O ' ' OG1' ' A' ' 63' ' ' THR . 23.9 Cg_endo -64.61 122.94 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.747 2.298 . . . . 0.0 112.162 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLU . 2.4 pp20? -43.48 143.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 32.41 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -154.77 137.15 14.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.603 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.794 HE21 ' H ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -108.11 171.08 7.61 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.464 ' O ' ' CG2' ' A' ' 162' ' ' THR . 7.4 mtm -128.07 132.54 49.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.99 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.91 -170.75 2.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.683 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 62.0 t -143.58 151.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 119.906 -1.746 . . . . 0.0 109.749 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 36.6 m-85 -147.07 125.93 12.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.982 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -105.68 89.26 0.61 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.541 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -85.89 -75.2 0.38 Allowed 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.626 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -165.74 -161.03 13.85 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.728 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -28.77 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.289 1.045 . . . . 0.0 108.611 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.78 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -59.3 7.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.016 . . . . 0.0 111.183 -177.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.556 ' H ' ' C ' ' A' ' 72' ' ' CYS . 6.3 m0 -69.35 -60.83 2.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.0 108.856 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.69 -10.01 58.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.7 -58.61 7.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 8.8 pt-20 -76.12 -12.57 60.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.132 -0.98 . . . . 0.0 110.757 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -56.79 -54.97 40.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.603 -1.31 . . . . 0.0 109.623 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.452 ' HE3' ' ND2' ' A' ' 138' ' ' ASN . 0.1 OUTLIER -56.43 -0.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 0.0 110.69 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 78' ' ' ARG . 19.8 m-85 -94.32 -39.57 10.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.744 -1.223 . . . . 0.0 109.851 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.464 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -77.01 16.74 0.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.85 -1.156 . . . . 0.0 109.318 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 80' ' ' PHE . 1.2 m -117.11 19.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 pp -135.67 161.31 35.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.11 -0.994 . . . . 0.0 109.466 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 150.3 20.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.686 . . . . 0.0 109.984 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 110.44 -29.0 9.48 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.472 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -84.36 132.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.791 -0.829 . . . . 0.0 110.143 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.693 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.85 -43.04 31.56 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' CG ' ' A' ' 48' ' ' HIS . 5.5 t -162.25 -165.19 1.16 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.483 0.659 . . . . 0.0 109.796 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.492 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 74.1 p -154.16 143.47 21.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 118' ' ' ARG . 6.7 mp0 -144.64 145.88 31.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 109.854 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.476 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.1 OUTLIER -128.99 156.6 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.037 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.28 172.84 45.84 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.471 ' CE2' ' HA ' ' A' ' 102' ' ' THR . 3.7 m-85 -79.99 138.37 37.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -1.058 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.672 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -157.72 -170.16 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.926 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.513 ' O ' ' NH2' ' A' ' 194' ' ' ARG . . . 40.83 38.05 1.51 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.568 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -117.71 -154.27 9.83 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.757 -1.437 . . . . 0.0 109.751 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.601 ' HD1' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -151.8 64.68 0.86 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.325 -1.103 . . . . 0.0 109.166 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.635 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.31 -178.48 7.38 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.027 -1.045 . . . . 0.0 108.636 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 14.3 tpp85 -75.12 -107.59 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.449 -0.782 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' CG ' ' A' ' 99' ' ' ARG . 1.2 m-80 -104.9 72.69 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 38.3 Cg_endo -65.59 157.72 56.99 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.824 2.35 . . . . 0.0 112.521 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . 23.2 p -122.94 170.43 10.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.407 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 4.3 t80 -55.48 -45.76 76.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -25.89 61.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 0.0 110.033 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.581 ' O ' ' OG ' ' A' ' 108' ' ' SER . 3.5 mm-40 -81.89 -37.66 26.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 102' ' ' THR . 13.5 m -66.31 -23.83 32.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 O-C-N 120.594 -1.317 . . . . 0.0 109.663 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.665 ' C ' ' H ' ' A' ' 109' ' ' GLU . 3.7 t -52.72 -38.93 61.55 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.634 ' C ' ' H ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -52.86 -1.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.23 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.665 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.4 tt0 59.65 -6.59 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.253 -0.905 . . . . 0.0 109.65 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.634 ' H ' ' C ' ' A' ' 108' ' ' SER . 1.6 mmtt -75.98 -24.46 55.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 110.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 112' ' ' GLY . 31.1 p -84.15 -10.56 57.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 109.378 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 43.26 39.5 4.14 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.672 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -82.42 162.6 22.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.225 . . . . 0.0 109.16 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.661 ' CB ' HH12 ' A' ' 156' ' ' ARG . . . -124.37 113.85 18.74 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.376 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.689 ' OE1' ' CD1' ' A' ' 73' ' ' PHE . 2.4 mm-40 -54.27 116.31 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.503 ' CG1' ' CE1' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -124.66 175.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.03 -1.044 . . . . 0.0 110.88 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.594 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 3.6 m -133.01 114.92 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -95.87 98.68 10.6 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.474 HG22 ' CD2' ' A' ' 80' ' ' PHE . 14.0 m -118.96 122.43 69.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.5 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -83.6 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.794 ' H ' HE21 ' A' ' 64' ' ' GLN . 4.7 m-85 -130.18 160.71 32.99 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.845 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 50.6 mtp85 -101.3 105.44 39.64 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.52 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 125' ' ' HIS . 9.4 Cg_exo -40.58 -66.84 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 123.203 2.602 . . . . 0.0 113.877 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.5 tt0 -42.82 -19.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.997 -1.064 . . . . 0.0 109.938 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' A' ' 123' ' ' PRO . 67.5 m-70 -109.97 -7.78 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.999 -1.063 . . . . 0.0 109.852 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 121' ' ' TYR . 1.2 pt -152.19 -176.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.389 1.09 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.498 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 43.7 t -130.37 152.32 49.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 25.4 t80 -48.33 -19.16 0.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.514 -1.367 . . . . 0.0 109.382 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' C ' ' A' ' 127' ' ' SER . 9.1 mp0 -70.48 -24.54 62.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.352 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.591 ' O ' ' C ' ' A' ' 131' ' ' LEU . 7.1 mt-10 -68.87 -71.77 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.0 109.999 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.666 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 1.2 mp -35.86 -43.55 0.31 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.326 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.605 ' CD1' ' CE1' ' A' ' 128' ' ' PHE . 7.5 mp -73.94 -44.98 53.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.446 -0.784 . . . . 0.0 111.519 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -52.26 -53.19 47.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.795 -1.19 . . . . 0.0 110.343 -178.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.676 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 2.0 t -50.28 -50.64 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CZ ' ' CE1' ' A' ' 139' ' ' HIS . 22.5 t80 -58.0 -44.39 87.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.775 -1.203 . . . . 0.0 111.589 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.559 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 67.7 m95 -70.74 -36.09 72.98 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.772 -1.205 . . . . 0.0 111.702 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 133' ' ' LYS . 21.7 mt-10 -79.21 -13.38 59.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.938 -1.101 . . . . 0.0 112.974 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.0 OUTLIER -133.99 59.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.11 -1.619 . . . . 0.0 112.087 -178.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.798 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 p-80 177.58 134.25 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.027 -1.045 . . . . 0.0 109.833 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.658 ' OD2' ' NE2' ' A' ' 143' ' ' GLN . 1.2 t0 -48.96 107.36 0.75 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.33 -0.857 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -85.98 -2.07 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.735 2.29 . . . . 0.0 113.038 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.55 ' C ' ' OG1' ' A' ' 190' ' ' THR . 40.2 p -121.72 20.55 10.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 110.261 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.69 ' N ' ' OG1' ' A' ' 190' ' ' THR . 7.7 mt-30 -130.94 101.25 5.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.022 -1.049 . . . . 0.0 109.15 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.677 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -96.86 18.74 56.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -18.35 12.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.979 -1.306 . . . . 0.0 109.8 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.649 ' CD ' ' C ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.54 164.59 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.001 -1.062 . . . . 0.0 109.87 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.571 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -99.34 108.36 20.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.589 -1.32 . . . . 0.0 109.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.91 -122.15 28.46 Favored Glycine 0 C--N 1.301 -1.366 0 CA-C-O 123.211 1.451 . . . . 0.0 110.461 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.05 -32.96 39.37 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.461 -1.37 . . . . 0.0 111.964 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.571 ' OD2' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.31 101.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.171 -1.581 . . . . 0.0 108.885 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.691 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 6.5 p90 -82.43 118.44 23.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.554 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 166.15 144.19 4.0 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.531 ' O ' ' OG1' ' A' ' 153' ' ' THR . 0.5 OUTLIER -70.97 14.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -1.23 . . . . 0.0 109.047 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.668 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 9.3 pt20 -102.79 -1.65 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.668 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 22.4 m-85 -132.38 53.09 2.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.815 -1.178 . . . . 0.0 109.633 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.661 HH12 ' CB ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -100.02 177.41 5.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 110.331 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' OG1' ' A' ' 191' ' ' THR . 11.5 p -92.98 71.41 4.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.548 ' CB ' ' OH ' ' A' ' 160' ' ' TYR . . . -97.38 129.57 44.61 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.631 0.729 . . . . 0.0 110.912 -176.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.414 ' CG2' HD12 ' A' ' 193' ' ' ILE . 19.9 m -102.11 146.35 10.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.548 ' OH ' ' CB ' ' A' ' 158' ' ' ALA . 22.2 m-85 -139.89 115.89 8.07 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 72.3 Cg_endo -77.57 167.37 24.33 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.344 2.029 . . . . 0.0 113.349 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -93.5 -41.73 9.62 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.282 -0.886 . . . . 0.0 109.392 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -171.8 -172.15 0.98 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 109.994 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.8 -25.53 4.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.074 1.416 . . . . 0.0 108.529 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.426 ' N ' ' C ' ' A' ' 163' ' ' SER . 2.5 t -56.01 -58.8 3.82 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.12 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.25 -25.66 46.94 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.086 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -38.6 56.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 0.0 110.657 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.13 -61.62 1.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 110.826 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.86 -16.93 23.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.85 -1.156 . . . . 0.0 112.341 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -52.33 -65.67 0.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.429 -1.419 . . . . 0.0 110.357 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.413 ' CD2' ' C ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.13 -21.42 61.58 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.875 -1.141 . . . . 0.0 108.247 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.51 -27.98 58.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.438 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.559 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 97.3 p -56.29 -26.91 53.67 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HB2' ' NZ ' ' A' ' 174' ' ' LYS . 14.4 mtmm -67.73 -58.48 4.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.55 8.56 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.019 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.57 -75.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 110.102 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.16 -32.31 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -52.79 -17.97 1.63 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 0.0 109.652 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -68.04 -39.29 83.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.686 ' O ' ' CE1' ' A' ' 184' ' ' HIS . 15.8 m -87.45 -30.88 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.108 -0.995 . . . . 0.0 109.898 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 186' ' ' PHE . 40.1 mt -75.29 -38.51 60.32 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.133 -0.979 . . . . 0.0 109.62 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.9 t -56.56 -24.78 49.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -75.69 -29.84 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.686 ' CE1' ' O ' ' A' ' 180' ' ' VAL . 0.6 OUTLIER -86.0 6.39 28.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.366 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.74 68.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.554 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.419 ' CD2' HD22 ' A' ' 181' ' ' LEU . 9.2 m-85 -115.78 162.62 17.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.82 178.23 48.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.5 157.86 29.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.708 2.272 . . . . 0.0 112.075 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.05 125.29 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.166 -0.959 . . . . 0.0 108.686 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.69 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 6.8 p -110.59 54.1 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.548 ' OG1' ' O ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -100.68 159.53 15.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.662 ' CG ' HH12 ' A' ' 194' ' ' ARG . 10.7 t0 -109.29 145.28 36.23 Favored 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.321 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.414 HD12 ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -123.73 156.41 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.662 HH12 ' CG ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -146.82 -166.91 2.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.821 -1.174 . . . . 0.0 111.276 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.807 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.46 159.62 14.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 1.24 ' O ' ' NE2' ' A' ' 197' ' ' GLN . . . 10.97 -79.69 0.0 OUTLIER Glycine 0 C--O 1.17 -3.858 0 N-CA-C 105.261 -3.135 . . . . 0.0 105.261 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 1.24 ' NE2' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 151.15 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 124.048 0.939 . . . . 0.0 110.172 175.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 197' ' ' GLN . 10.0 p -45.78 117.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 117.47 -1.692 . . . . 0.0 106.511 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.503 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 18.6 t80 -102.52 147.53 26.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 111.578 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 7.7 m-85 -153.39 100.75 2.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.451 ' CZ ' HG11 ' A' ' 56' ' ' VAL . 25.6 m-85 -53.08 135.43 37.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.787 -1.196 . . . . 0.0 109.65 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.654 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -86.87 -170.56 3.12 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.257 -0.902 . . . . 0.0 108.9 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -74.39 155.06 38.5 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -50.6 -43.22 56.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.557 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -54.07 -15.14 1.3 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.624 . . . . 0.0 109.74 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.78 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 8.2 m-70 -100.69 9.35 42.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.605 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.832 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.5 mm-40 -127.98 -145.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.092 0.949 . . . . 0.0 110.119 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.673 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.86 -3.72 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.953 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.832 ' N ' ' O ' ' A' ' 207' ' ' GLN . 86.8 t80 -41.02 -43.22 2.1 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 120.524 -1.36 . . . . 0.0 110.837 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.472 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.8 OUTLIER -65.36 -13.14 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.378 -1.452 . . . . 0.0 109.903 -178.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 212' ' ' LYS . 94.6 p -55.96 -31.09 62.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.08 -1.012 . . . . 0.0 108.656 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.435 ' N ' ' HG ' ' A' ' 211' ' ' SER . 11.9 mmtp -85.62 -36.39 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.456 -0.778 . . . . 0.0 109.0 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.626 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -131.98 68.41 80.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' LEU . 52.5 Cg_exo -49.94 8.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.072 2.514 . . . . 0.0 113.298 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 213' ' ' ASN . 0.0 OUTLIER -61.34 -24.8 66.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.49 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 58.88 83.84 0.05 OUTLIER Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.21 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -70.5 88.2 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.902 2.351 . . . . 0.0 108.575 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.587 ' O ' ' O ' ' A' ' 219' ' ' GLY . 18.1 t -169.74 114.32 0.52 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.863 -1.148 . . . . 0.0 109.387 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -39.89 170.09 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 221' ' ' GLY . 2.5 pp -61.93 -174.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.343 -1.093 . . . . 0.0 110.131 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.575 ' O ' ' C ' ' A' ' 222' ' ' GLY . . . -155.04 -80.88 0.03 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 221' ' ' GLY . . . -27.95 105.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 CA-C-O 123.051 1.362 . . . . 0.0 109.954 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.27 -2.855 0 CA-C-N 113.896 -1.152 . . . . 0.0 109.308 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.716 ' O ' ' O ' ' A' ' 29' ' ' ILE . 47.5 t . . . . . 0 CA--C 1.502 -0.902 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.716 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -36.58 176.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-O 123.141 1.448 . . . . 0.0 110.14 -178.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.427 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.7 124.45 26.03 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.249 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.43 80.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.755 -0.591 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.17 0.88 3.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 mm-40 -107.27 -35.93 6.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 108.963 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.78 -170.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.665 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 35' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 108.973 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.717 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.923 0.392 . . . . 0.0 110.143 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.717 ' CD ' ' N ' ' A' ' 42' ' ' ILE . 27.2 Cg_endo -64.34 165.91 18.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.636 2.224 . . . . 0.0 111.862 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.626 ' O ' ' C ' ' A' ' 45' ' ' THR . 2.3 m -172.95 172.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.38 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.626 ' C ' ' O ' ' A' ' 44' ' ' VAL . 7.3 t 9.98 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.509 0.671 . . . . 0.0 110.823 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -69.24 -52.68 25.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 111.394 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.557 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.63 99.66 10.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 115.746 -2.382 . . . . 0.0 108.765 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.775 ' NE2' ' NE2' ' A' ' 208' ' ' GLN . 8.5 t-80 -31.67 141.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.472 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.9 t60 -80.44 -42.51 22.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 110.572 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 211' ' ' SER . 25.8 t -58.1 -37.56 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 110.179 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 t -109.4 -48.69 3.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 110.507 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.04 4.63 55.35 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.6 p30 -81.81 -110.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.743 ' CB ' ' HH ' ' A' ' 87' ' ' TYR . 10.1 mtm-85 -129.24 174.88 9.19 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 123.519 1.628 . . . . 0.0 109.855 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 46' ' ' ALA . 63.3 p -132.51 0.35 3.64 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.397 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' GLU . 1.1 m -145.11 132.09 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.507 -1.37 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt-10 -34.03 154.8 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 CA-C-O 121.881 0.848 . . . . 0.0 110.845 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.53 166.05 78.82 Favored 'Cis proline' 0 C--N 1.301 -1.969 0 C-N-CA 121.479 -2.301 . . . . 0.0 111.633 -0.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.473 ' CE2' HG23 ' A' ' 120' ' ' VAL . 35.6 m-85 -111.15 148.92 39.71 Favored Pre-proline 0 C--N 1.266 -3.035 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.0 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.573 ' O ' ' OG1' ' A' ' 63' ' ' THR . 8.3 Cg_endo -53.28 139.47 63.75 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.929 2.42 . . . . 0.0 112.618 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -45.5 158.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 42.78 66.82 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 1.2 p -136.7 147.38 46.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.622 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.583 ' OE1' ' CG ' ' A' ' 123' ' ' PRO . 2.1 mp0 -116.79 173.47 6.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.41 -0.806 . . . . 0.0 108.839 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.751 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -154.22 128.67 9.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.983 -1.073 . . . . 0.0 109.841 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.01 -167.6 2.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.1 t -143.22 137.6 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.087 -1.633 . . . . 0.0 109.983 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 54.5 m-85 -131.76 137.89 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.059 -1.026 . . . . 0.0 110.144 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 157' ' ' SER . . . -122.78 110.26 1.52 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 105.715 -2.954 . . . . 0.0 105.715 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.482 ' HA ' ' CD2' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -107.14 -87.62 0.48 Allowed 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.214 -1.168 . . . . 0.0 110.413 -177.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.717 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.75 74.76 0.2 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.717 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 51.1 t 111.41 82.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.68 ' N ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -55.72 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.623 -1.298 . . . . 0.0 110.734 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.659 ' H ' ' C ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -91.41 -44.41 9.15 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.068 -1.02 . . . . 0.0 109.363 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.51 -3.95 49.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.695 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.24 -35.41 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 109.733 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.628 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 29.4 tt0 -68.17 -15.17 63.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.28 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 80' ' ' PHE . 11.5 ttt180 -60.16 -54.39 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.504 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' H ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -73.38 25.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.941 -1.099 . . . . 0.0 110.165 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.7 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 6.8 m-85 -126.78 -39.01 2.01 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.482 -0.761 . . . . 0.0 110.125 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.693 ' CE2' ' OG ' ' A' ' 211' ' ' SER . 1.2 p90 -84.74 1.71 45.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.703 -1.248 . . . . 0.0 109.72 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' CD1' ' A' ' 81' ' ' TRP . 2.2 m -104.84 11.66 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.0 mt -99.04 149.49 22.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.07 0.938 . . . . 0.0 109.116 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HZ3' ' HA ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -85.82 136.7 33.21 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 107.53 -26.51 17.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.3 138.67 21.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.128 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.743 ' HH ' ' CB ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -78.42 -41.38 33.11 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -175.56 -169.81 0.38 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.685 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 30.6 p -146.55 167.0 24.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.914 -1.116 . . . . 0.0 110.214 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.628 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -168.66 -178.75 3.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.671 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 1.6 m -156.82 161.03 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.665 -1.272 . . . . 0.0 108.504 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 201' ' ' TYR . . . -167.46 -172.42 34.57 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.199 -1.477 . . . . 0.0 111.934 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 202' ' ' ALA . 1.6 m-85 -104.44 150.29 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.852 -0.793 . . . . 0.0 109.511 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -177.0 154.22 1.07 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.31 38.56 7.16 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.497 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -129.5 -152.01 7.47 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.038 -1.272 . . . . 0.0 110.111 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.48 55.1 1.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 109.474 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -157.07 141.62 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.682 ' O ' ' CE2' ' A' ' 200' ' ' TYR . 0.0 OUTLIER -48.96 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 109.438 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -122.84 86.27 50.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.517 ' CG ' ' NE2' ' A' ' 113' ' ' HIS . 59.4 Cg_endo -78.41 -171.62 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.657 2.238 . . . . 0.0 111.811 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.633 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 23.1 p -121.69 170.5 9.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.048 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.53 -59.09 5.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.39 -0.819 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -61.22 -23.22 65.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 108.822 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.633 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.1 mm-40 -67.81 -60.07 2.81 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.66 0.743 . . . . 0.0 110.322 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.658 ' C ' ' H ' ' A' ' 108' ' ' SER . 17.8 m -64.37 -24.49 35.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.663 -0.648 . . . . 0.0 111.635 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.7 t -53.7 -0.5 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.261 -0.9 . . . . 0.0 109.363 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.66 ' C ' ' H ' ' A' ' 110' ' ' LYS . 22.6 p -99.8 11.17 39.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.404 ' HG2' ' CG2' ' A' ' 153' ' ' THR . 2.5 tt0 59.08 -5.58 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.071 -1.018 . . . . 0.0 109.512 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.66 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.4 OUTLIER -70.67 -30.97 67.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 110.371 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.605 ' OG1' ' CG1' ' A' ' 106' ' ' VAL . 26.7 p -84.98 -18.34 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.929 -1.107 . . . . 0.0 110.28 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.06 14.61 47.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.517 ' NE2' ' CG ' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -58.32 158.22 7.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.029 -1.277 . . . . 0.0 109.711 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -120.36 113.83 20.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.68 ' OE1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.95 135.23 15.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.483 -179.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -151.68 178.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.989 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 34.5 m -138.97 147.89 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.201 -0.937 . . . . 0.0 110.688 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.793 ' NH1' ' CZ ' ' A' ' 201' ' ' TYR . 8.9 ptm180 -115.49 95.71 5.29 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.731 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 4.0 m -109.52 113.82 45.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.17 -1.581 . . . . 0.0 108.815 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.473 HG23 ' CE2' ' A' ' 59' ' ' PHE . 3.0 t -74.49 156.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.731 ' CE1' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -136.9 160.35 39.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.887 -1.133 . . . . 0.0 110.156 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 59.8 mtp180 -119.46 100.4 49.61 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 125' ' ' HIS . 13.5 Cg_exo -41.71 -61.05 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.235 2.623 . . . . 0.0 113.276 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -38.37 -14.59 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.603 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.695 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -143.8 15.53 1.76 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.718 -1.239 . . . . 0.0 109.49 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.422 HD11 ' CB ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -155.19 146.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.869 . . . . 0.0 109.419 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.475 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -107.8 166.79 10.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.244 -0.91 . . . . 0.0 109.37 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 37.9 t80 -64.82 -38.83 92.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 133' ' ' LYS . 36.7 mm-40 -53.71 -27.39 27.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 109.086 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 1.0 OUTLIER -66.69 -68.82 0.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.094 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.799 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -33.89 -47.55 0.26 Allowed 'General case' 0 C--N 1.316 -0.859 0 O-C-N 120.95 -1.094 . . . . 0.0 108.493 178.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.469 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 11.2 mp -76.1 -41.24 50.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.581 ' O ' ' OE2' ' A' ' 137' ' ' GLU . 2.8 tmmm? -52.56 -39.59 61.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.098 -1.001 . . . . 0.0 111.44 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.7 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.1 t -74.84 -39.44 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.722 -1.236 . . . . 0.0 110.098 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 8.0 t80 -65.32 -48.22 73.83 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.375 -0.828 . . . . 0.0 111.211 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.49 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 61.4 m95 -67.04 -34.11 76.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.784 -1.198 . . . . 0.0 111.363 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.672 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -76.95 -33.21 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 113.23 -176.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 41.9 m-80 -96.12 36.09 1.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.323 -1.486 . . . . 0.0 114.483 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.799 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 6.6 p-80 178.53 175.95 0.54 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.393 -1.442 . . . . 0.0 111.981 176.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.85 107.92 57.84 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.401 ' O ' ' N ' ' A' ' 190' ' ' THR . 74.1 Cg_endo -78.48 20.38 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.187 1.925 . . . . 0.0 112.299 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.7 3.18 13.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.753 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.536 ' O ' ' O ' ' A' ' 146' ' ' ARG . 18.1 mt-30 -101.88 78.26 1.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.069 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.782 ' N ' ' HG1' ' A' ' 190' ' ' THR . . . -39.4 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.499 2.855 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.466 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.471 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -66.97 40.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.936 0.874 . . . . 0.0 110.39 -176.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.652 ' CZ ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -161.65 152.54 18.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' A' ' 143' ' ' GLN . 21.0 mm100 -154.92 74.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.281 -1.512 . . . . 0.0 110.05 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.652 ' O ' ' CZ ' ' A' ' 146' ' ' ARG . . . 78.11 -115.71 4.27 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -79.52 -33.45 42.01 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-N 114.517 -0.842 . . . . 0.0 111.624 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -85.36 129.49 34.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.283 -1.511 . . . . 0.0 109.015 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.449 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 17.6 p90 -127.64 138.39 52.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 154' ' ' GLN . . . 138.58 167.08 10.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -72.32 15.16 0.18 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.001 -1.294 . . . . 0.0 108.9 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.598 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 1.4 pt20 -114.32 17.58 17.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 44.2 m-85 -155.48 65.63 0.62 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.682 HH22 ' CG ' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -118.54 -176.03 3.0 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.384 -0.822 . . . . 0.0 109.389 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.6 t -92.11 140.56 29.51 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.434 ' HB3' ' CE1' ' A' ' 160' ' ' TYR . . . -162.14 118.95 2.06 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.603 -2.039 . . . . 0.0 112.115 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.541 ' O ' ' CG2' ' A' ' 159' ' ' VAL . 2.2 m -115.72 126.2 73.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.154 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 158' ' ' ALA . 4.8 m-30 -113.9 119.99 39.87 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.41 170.43 19.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.564 2.176 . . . . 0.0 112.53 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.16 -40.4 8.82 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.209 -0.932 . . . . 0.0 109.592 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 165' ' ' VAL . 43.3 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.114 -0.991 . . . . 0.0 109.923 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 123.154 1.454 . . . . 0.0 108.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 163' ' ' SER . 2.5 t -56.06 -56.46 12.83 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.987 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.227 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.45 HE21 ' HB2' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -78.03 -36.82 48.13 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.965 -178.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.5 mtm -52.46 -35.41 52.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 110.815 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -48.29 -55.0 11.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 109.962 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.13 -30.84 15.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.017 -1.052 . . . . 0.0 110.582 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.509 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -52.54 -62.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.047 . . . . 0.0 110.014 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mt -52.66 -33.87 49.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 109.642 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -56.43 -34.27 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.912 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -72.18 -46.79 54.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.96 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -72.22 -39.67 68.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.045 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.59 -29.45 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.089 -1.007 . . . . 0.0 109.92 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -79.54 -44.15 21.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.886 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 187' ' ' GLY . 35.8 tp60 -62.19 -5.34 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.592 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -49.64 13.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.89 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.35 -51.81 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.72 -40.82 66.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.835 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 51.0 p -56.38 -27.27 55.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.441 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.439 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -88.03 6.34 36.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.554 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.428 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 1.7 m-70 -108.22 35.82 3.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 69.88 36.07 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.48 175.61 5.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.402 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.625 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -133.47 -145.62 5.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 189' ' ' ILE . 30.0 Cg_exo -58.73 106.03 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.402 2.068 . . . . 0.0 111.248 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.58 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.4 OUTLIER -48.45 -172.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.782 ' HG1' ' N ' ' A' ' 144' ' ' GLY . 21.4 p -151.43 58.57 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.568 -0.707 . . . . 0.0 109.813 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.7 m -99.76 128.7 45.84 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.682 ' CG ' HH22 ' A' ' 156' ' ' ARG . 4.9 t70 -75.97 119.42 19.91 Favored 'General case' 0 C--N 1.272 -2.793 0 C-N-CA 119.569 -0.853 . . . . 0.0 109.419 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.421 ' C ' ' CG ' ' A' ' 194' ' ' ARG . 0.6 OUTLIER -119.77 103.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.386 -0.925 . . . . 0.0 109.643 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.661 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -165.33 141.92 5.58 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.654 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -114.95 -177.67 3.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 109.843 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.77 29.75 60.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 198' ' ' VAL . 16.2 mm-40 -104.0 103.64 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.302 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -33.6 154.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.183 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.56 ' CE1' ' HD2' ' A' ' 118' ' ' ARG . 7.7 t80 -128.75 120.23 26.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.682 ' CE2' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.97 126.77 40.29 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.793 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.53 -176.53 3.4 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 116.329 -2.148 . . . . 0.0 114.642 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . . . -95.71 -179.58 4.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 112.185 -2.279 . . . . 0.0 111.478 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.556 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 1.3 pt-20 -73.57 -168.16 0.53 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.429 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.74 -14.38 54.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.866 -1.146 . . . . 0.0 110.527 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.556 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -78.53 -14.17 59.48 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.881 -1.137 . . . . 0.0 109.382 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 74' ' ' TRP . 74.2 m-70 -104.68 2.88 30.91 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.109 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.841 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.2 mm-40 -120.51 -138.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.237 1.018 . . . . 0.0 109.938 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.775 ' NE2' ' NE2' ' A' ' 48' ' ' HIS . 1.4 mp0 -34.73 -5.56 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.634 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.841 ' N ' ' O ' ' A' ' 207' ' ' GLN . 64.2 t80 -41.88 -47.48 4.25 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 120.464 -1.398 . . . . 0.0 109.298 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.565 ' CD2' ' SG ' ' A' ' 218' ' ' CYS . 0.9 OUTLIER -70.63 -28.68 65.01 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.532 -1.355 . . . . 0.0 110.219 -179.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.693 ' OG ' ' CE2' ' A' ' 81' ' ' TRP . 0.1 OUTLIER -69.01 -41.83 77.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.923 -1.11 . . . . 0.0 108.22 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.472 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -88.91 -19.17 26.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.535 -0.728 . . . . 0.0 109.672 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.766 ' ND2' ' CD1' ' A' ' 209' ' ' TYR . 34.7 m-80 -116.0 89.89 26.27 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.036 . . . . 0.0 110.265 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.1 11.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.249 2.632 . . . . 0.0 112.205 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.656 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.1 t0 -61.94 -4.73 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.275 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.617 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 64.05 -44.32 0.09 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.996 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.617 ' C ' ' O ' ' A' ' 216' ' ' GLY . 40.6 m-85 -23.33 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 CA-C-N 119.408 1.604 . . . . 0.0 110.529 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.611 ' SG ' ' O ' ' A' ' 216' ' ' GLY . 69.1 m -137.42 -126.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -151.92 -154.84 6.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.4 mt -82.82 -175.84 6.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.664 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.13 125.85 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 139' ' ' HIS . . . 140.28 167.67 11.1 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 11.7 p . . . . . 0 C--N 1.27 -2.889 0 CA-C-N 114.388 -0.906 . . . . 0.0 108.672 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.644 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.799 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.644 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -39.82 175.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.328 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.488 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -99.59 126.97 45.66 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.634 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -47.04 -62.11 1.56 Allowed 'General case' 0 C--N 1.285 -2.233 0 CA-C-O 121.258 0.551 . . . . 0.0 109.904 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -54.72 -3.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' ALA . 3.0 tt0 -108.97 -23.69 11.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.928 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.6 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.98 -167.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.904 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 98' ' ' THR . 1.7 mm? . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.47 167.93 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.909 2.406 . . . . 0.0 112.31 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' ALA . 28.8 m -128.68 -171.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.613 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 44' ' ' VAL . 1.3 t -39.2 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.623 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.72 -27.18 58.65 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.192 -0.943 . . . . 0.0 111.313 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 7.8 ptpt -91.96 98.9 11.86 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 116.243 -2.183 . . . . 0.0 107.873 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.693 ' CG ' ' OG ' ' A' ' 88' ' ' SER . 6.1 t-80 -32.43 121.78 0.33 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -67.09 -34.91 78.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.347 -0.846 . . . . 0.0 111.276 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.5 -34.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.887 -1.133 . . . . 0.0 109.725 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -107.73 -42.45 4.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 92.46 0.42 70.03 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.699 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 34.5 p30 -78.17 -119.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.699 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttt-85 -126.3 170.74 11.59 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 123.246 1.498 . . . . 0.0 108.736 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.623 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 1.3 p -131.95 23.26 4.57 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.566 ' O ' ' O ' ' A' ' 57' ' ' GLU . 5.6 m -162.11 138.03 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.652 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.3 156.83 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.025 0.917 . . . . 0.0 110.795 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -80.07 166.18 77.2 Favored 'Cis proline' 0 C--N 1.301 -1.953 0 C-N-CA 121.471 -2.304 . . . . 0.0 112.157 -0.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.473 ' CE1' HG11 ' A' ' 120' ' ' VAL . 27.2 m-85 -103.27 147.91 34.88 Favored Pre-proline 0 C--N 1.27 -2.89 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.078 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.574 ' O ' ' OG1' ' A' ' 63' ' ' THR . 38.9 Cg_endo -70.29 142.89 46.73 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.827 2.351 . . . . 0.0 112.368 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -46.43 158.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.467 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.26 62.65 5.42 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -146.02 139.41 26.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -1.116 . . . . 0.0 109.569 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.628 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 1.6 mp0 -109.15 123.58 49.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.649 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -111.78 139.49 47.21 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.08 -169.38 2.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 72.2 t -143.94 140.79 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.105 -1.622 . . . . 0.0 109.743 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' CB ' ' A' ' 135' ' ' PHE . 97.3 m-85 -123.19 155.2 37.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -153.32 94.67 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 118.564 -1.779 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.588 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -92.87 -87.01 0.24 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.621 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -134.97 -158.01 8.22 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.769 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.85 102.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -1.019 . . . . 0.0 108.317 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.657 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -51.95 7.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 111.698 -177.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.769 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 4.7 m0 -69.22 -73.39 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.604 -1.31 . . . . 0.0 109.027 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.9 -14.52 63.37 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB3' ' SD ' ' A' ' 70' ' ' MET . . . -77.03 -53.88 7.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -1.143 . . . . 0.0 110.858 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.557 ' OE2' ' C ' ' A' ' 90' ' ' GLN . 7.8 tp10 -48.42 -36.56 15.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.298 -0.876 . . . . 0.0 111.379 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.685 ' O ' ' N ' ' A' ' 80' ' ' PHE . 1.5 tmt_? -66.36 -57.95 6.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 0.0 109.941 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -41.18 -10.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.527 -0.733 . . . . 0.0 111.366 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.685 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.7 m-85 -101.91 -40.69 6.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.583 -1.323 . . . . 0.0 111.256 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.567 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -86.69 1.83 50.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.48 -1.387 . . . . 0.0 110.906 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 78' ' ' ARG . 1.2 m -83.52 19.99 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.134 . . . . 0.0 109.636 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.595 ' C ' ' HZ3' ' A' ' 84' ' ' LYS . 0.6 OUTLIER -129.97 158.57 39.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.708 ' N ' ' HZ2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -91.48 153.43 19.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.576 -0.702 . . . . 0.0 109.742 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -26.63 19.09 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.438 HG23 ' CD2' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -75.34 138.06 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.712 -0.875 . . . . 0.0 109.76 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.691 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -82.74 -41.52 19.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.693 ' OG ' ' CG ' ' A' ' 48' ' ' HIS . 11.8 t -156.98 -163.66 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.662 0.744 . . . . 0.0 110.066 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.672 ' O ' ' NE2' ' A' ' 48' ' ' HIS . 3.7 p -168.72 121.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.557 ' C ' ' OE2' ' A' ' 77' ' ' GLU . 5.5 mp0 -136.39 173.63 11.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.963 -1.086 . . . . 0.0 110.707 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.598 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -146.39 157.93 11.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.584 0.707 . . . . 0.0 109.62 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.43 174.5 46.08 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.627 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -85.39 156.13 20.99 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.374 -1.074 . . . . 0.0 109.547 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.538 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -172.72 -170.73 0.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 109.72 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 59.27 21.77 54.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.754 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -160.41 -156.08 8.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.697 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 40.4 p-80 178.91 109.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.416 -1.049 . . . . 0.0 108.983 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 99' ' ' ARG . 13.9 m -144.45 144.79 31.55 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.612 ' C ' ' O ' ' A' ' 98' ' ' THR . 17.6 mtm-85 -19.83 -85.39 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.747 0.784 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -117.19 90.83 34.97 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 2.8 Cg_exo -73.35 111.1 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.566 2.178 . . . . 0.0 113.329 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.6 p -123.05 163.3 20.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.635 ' O ' ' CD1' ' A' ' 103' ' ' TYR . 0.5 OUTLIER -50.05 -35.95 27.1 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.381 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.66 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 3.9 ttmt -73.7 -31.93 63.67 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.693 -0.63 . . . . 0.0 110.956 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.2 mm-40 -80.99 -47.08 14.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.424 HG11 ' CB ' ' A' ' 111' ' ' THR . 30.2 m -67.6 -25.03 32.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 120.608 -1.308 . . . . 0.0 110.342 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 14.5 p -53.89 -40.62 66.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.673 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 58.1 m -48.51 -66.52 0.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.673 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.6 mt-10 137.82 -25.25 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.259 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.06 3.87 1.02 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.542 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.67 ' HG1' ' H ' ' A' ' 113' ' ' HIS . 71.0 p -99.91 -25.15 14.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.77 -1.206 . . . . 0.0 109.33 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 66.07 13.26 59.47 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.428 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.754 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.55 159.07 28.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.494 -1.592 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.499 ' CB ' ' NH2' ' A' ' 156' ' ' ARG . . . -126.31 117.79 23.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.657 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.5 mm-40 -49.46 112.61 0.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.76 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.474 HG12 ' CE2' ' A' ' 160' ' ' TYR . 0.2 OUTLIER -124.54 175.29 7.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.382 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.7 m -132.45 148.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.15 -0.969 . . . . 0.0 110.158 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.502 ' C ' ' CD ' ' A' ' 118' ' ' ARG . 2.0 tpp180 -110.69 107.81 17.49 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.409 ' HB ' ' HH ' ' A' ' 121' ' ' TYR . 7.5 m -133.66 116.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 108.805 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.538 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.0 OUTLIER -96.95 158.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 131' ' ' LEU . 3.0 m-85 -134.45 155.45 50.32 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.885 -1.134 . . . . 0.0 109.543 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.624 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 1.4 ptm180 -110.37 112.31 57.05 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 125' ' ' HIS . 34.1 Cg_exo -44.48 -63.6 0.32 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 123.177 2.584 . . . . 0.0 113.383 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.653 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 16.9 mp0 -33.17 -21.9 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.737 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.688 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -137.99 6.46 2.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.433 -1.417 . . . . 0.0 110.502 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -155.82 150.41 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 110.043 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.507 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 37.6 t -97.81 147.6 24.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CD2' HD12 ' A' ' 132' ' ' LEU . 50.8 t80 -62.51 -21.16 65.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.28 -7.57 47.9 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.507 ' HG3' ' H ' ' A' ' 127' ' ' SER . 9.1 mm-40 -74.46 -70.31 0.41 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.757 -0.59 . . . . 0.0 110.358 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.737 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -51.95 -29.79 21.91 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 120.495 -1.378 . . . . 0.0 108.236 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.47 ' O ' ' CD1' ' A' ' 136' ' ' TRP . 47.3 mt -63.68 -57.05 11.23 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.524 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -39.61 94.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.745 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.759 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 3.8 t -50.27 -62.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 109.515 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 6.0 t80 -54.63 -39.09 67.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.457 -1.402 . . . . 0.0 110.078 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.537 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 51.5 m95 -70.75 -36.35 73.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.973 -1.079 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.77 -4.95 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 113.577 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.759 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -122.74 41.71 3.37 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.06 -1.65 . . . . 0.0 111.422 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.623 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER 173.55 -168.41 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.849 0.833 . . . . 0.0 108.752 177.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -118.25 138.57 25.74 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.449 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 93.3 Cg_endo -81.21 0.99 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.614 2.21 . . . . 0.0 113.285 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 142' ' ' THR . 0.1 OUTLIER -121.8 47.25 1.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.858 -1.151 . . . . 0.0 110.196 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.574 ' O ' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER -129.9 70.32 1.43 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.129 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -51.59 -118.71 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.626 ' SD ' ' C ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -70.56 40.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.444 -1.033 . . . . 0.0 109.736 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 144' ' ' GLY . 9.4 ttt180 -165.64 85.29 0.35 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.558 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.588 ' OE1' ' O ' ' A' ' 70' ' ' MET . 5.7 tp60 -86.23 117.16 24.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.428 -1.42 . . . . 0.0 109.79 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 46.58 -114.31 1.44 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.533 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 12.8 t30 -92.77 16.71 11.75 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 114.329 -0.936 . . . . 0.0 110.282 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 147' ' ' GLN . 0.7 OUTLIER -107.19 147.15 30.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.114 . . . . 0.0 109.201 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 151' ' ' PHE . 20.2 p90 -130.07 129.42 43.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.435 ' HA3' ' NE2' ' A' ' 154' ' ' GLN . . . 147.16 155.06 6.4 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.675 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.1 OUTLIER -79.3 5.1 13.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.361 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.651 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 15.1 pm0 -97.48 -5.75 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.474 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 23.0 m-85 -122.45 61.82 0.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.122 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.675 ' NH1' ' O ' ' A' ' 153' ' ' THR . 8.9 ptt-85 -112.23 175.91 5.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -0.842 . . . . 0.0 109.125 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.605 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -89.44 121.0 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -137.18 128.88 28.75 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 118.291 -1.363 . . . . 0.0 110.986 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.582 ' O ' ' CG2' ' A' ' 159' ' ' VAL . 1.1 m -126.77 120.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.26 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CE2' HG12 ' A' ' 116' ' ' VAL . 6.2 m-30 -109.86 126.13 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.14 174.66 9.84 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 123.012 2.474 . . . . 0.0 112.999 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.603 ' HG1' ' NE2' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -99.3 -40.33 7.98 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.469 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -172.97 -162.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 0.0 109.722 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -53.57 -16.64 1.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.921 1.343 . . . . 0.0 108.959 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.469 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.9 t -59.2 -57.54 10.97 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.246 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.603 ' NE2' ' HG1' ' A' ' 162' ' ' THR . 1.3 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.749 -0.594 . . . . 0.0 110.392 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtp -50.92 -44.33 60.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.658 -1.276 . . . . 0.0 109.498 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.69 -19.23 59.27 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.034 -1.041 . . . . 0.0 109.12 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.58 -57.65 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.85 . . . . 0.0 110.616 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.64 -65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.068 -1.02 . . . . 0.0 110.035 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -33.53 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.24 -45.92 44.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.537 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 83.0 p -56.23 -49.45 74.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.388 -0.82 . . . . 0.0 109.826 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.456 ' HZ1' HD11 ' A' ' 189' ' ' ILE . 12.8 tttm -61.8 -53.59 53.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.741 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.02 -6.75 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.849 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.15 -52.17 9.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 110.464 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -11.79 59.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.028 -1.045 . . . . 0.0 110.28 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.517 ' OE1' ' CB ' ' A' ' 182' ' ' SER . 0.2 OUTLIER -70.8 -41.07 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.561 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -77.05 -16.04 59.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.49 -54.62 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 0.0 109.911 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.468 HD22 ' CE1' ' A' ' 186' ' ' PHE . 37.2 mt -75.4 -43.68 48.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 110.174 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.517 ' CB ' ' OE1' ' A' ' 178' ' ' GLN . 12.7 t -55.35 -22.1 17.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -88.18 -9.94 51.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 109.008 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.419 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 22.5 m170 -108.28 34.58 3.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.5 OUTLIER 69.79 68.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.965 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.468 ' CE1' HD22 ' A' ' 181' ' ' LEU . 2.8 m-85 -134.73 173.15 12.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -110.75 -168.74 19.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 189' ' ' ILE . 11.1 Cg_endo -58.84 115.1 2.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.761 1.641 . . . . 0.0 110.812 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.3 OUTLIER -47.8 179.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.0 110.06 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.605 ' O ' ' OG ' ' A' ' 157' ' ' SER . 39.9 p -140.01 59.75 1.57 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.1 m -98.04 115.81 28.97 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 194' ' ' ARG . 6.3 t0 -84.72 125.28 32.4 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.953 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.44 148.33 19.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.65 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 3.6 mtm180 -165.44 169.81 15.19 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.522 -0.736 . . . . 0.0 109.128 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.697 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -123.86 170.6 10.41 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.994 -1.067 . . . . 0.0 110.808 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 195' ' ' GLU . . . 22.72 38.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.697 ' N ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -65.32 132.76 49.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.832 -1.393 . . . . 0.0 109.862 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.84 163.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -127.05 141.69 51.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.365 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' A' ' 93' ' ' PHE . 1.6 m-85 -142.56 97.91 3.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.922 . . . . 0.0 109.608 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -54.24 134.64 44.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.38 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.93 -173.16 4.58 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.646 ' CD ' ' H ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -75.33 168.06 20.71 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.636 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.04 -48.97 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.863 -1.148 . . . . 0.0 108.51 179.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.646 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.48 -23.04 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 110.054 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.48 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 9.5 m-70 -92.3 6.79 45.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.048 -1.032 . . . . 0.0 110.022 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.827 ' O ' ' N ' ' A' ' 209' ' ' TYR . 6.0 mm-40 -122.56 -138.66 0.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.776 1.274 . . . . 0.0 111.024 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.668 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.3 OUTLIER -34.21 -3.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.44 -179.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.827 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.0 t80 -42.68 -43.08 3.72 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 120.563 -1.336 . . . . 0.0 110.464 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 74' ' ' TRP . 2.9 mp -61.17 -12.37 12.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.525 -1.36 . . . . 0.0 109.867 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.5 t -55.78 -29.76 60.2 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 108.545 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -83.92 -35.16 24.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.423 -0.798 . . . . 0.0 108.867 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -136.35 130.65 18.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.589 ' C ' ' H ' ' A' ' 216' ' ' GLY . 30.2 Cg_endo -65.37 -56.84 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.921 1.747 . . . . 0.0 113.287 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.617 ' O ' ' N ' ' A' ' 217' ' ' TYR . 0.8 OUTLIER -64.11 2.37 0.56 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.689 -1.257 . . . . 0.0 107.926 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 61.95 -68.43 0.02 OUTLIER Glycine 0 N--CA 1.479 1.507 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' A' ' 215' ' ' ASP . 9.2 t80 -145.95 -150.85 0.35 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.475 -1.015 . . . . 0.0 108.737 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' A' ' 218' ' ' CYS . 23.8 p -90.3 77.96 6.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.089 -1.007 . . . . 0.0 108.991 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -135.73 -152.05 6.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 221' ' ' GLY . 0.6 OUTLIER -169.66 -178.71 3.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -1.208 . . . . 0.0 109.75 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.403 ' N ' ' HG ' ' A' ' 220' ' ' LEU . . . -104.57 -143.74 12.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -154.45 -141.94 3.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.579 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.421 -1.046 . . . . 0.0 109.662 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.629 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.762 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.629 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -42.68 176.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.759 1.266 . . . . 0.0 108.775 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.487 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -94.02 128.66 40.5 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.16 179.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.472 ' HB3' ' CG ' ' A' ' 97' ' ' HIS . . . -47.34 -38.5 13.0 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.24 -10.66 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.632 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 34' ' ' ALA . 4.6 tt0 -81.87 -46.48 14.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.604 ' CB ' ' HG1' ' A' ' 98' ' ' THR . . . -37.07 137.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.935 -1.103 . . . . 0.0 112.28 -179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.635 ' CG1' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.15 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.2 m -148.88 -179.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.577 ' OG1' ' OD1' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -47.9 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.129 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.41 -28.09 58.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.424 -0.797 . . . . 0.0 111.39 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.84 99.27 11.7 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 115.958 -2.297 . . . . 0.0 108.581 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.688 ' HE2' HE21 ' A' ' 208' ' ' GLN . 4.6 t-80 -32.25 126.43 0.27 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.474 ' CD2' ' OG ' ' A' ' 211' ' ' SER . 1.9 t60 -71.41 -29.4 64.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.697 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.501 ' CG2' ' CD2' ' A' ' 81' ' ' TRP . 21.5 t -69.25 -40.58 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.977 -1.077 . . . . 0.0 110.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -109.37 -42.69 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.158 -0.963 . . . . 0.0 110.335 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.26 3.59 56.58 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 38.4 p30 -79.21 -116.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.0 ttt180 -129.43 169.95 14.3 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 123.221 1.486 . . . . 0.0 108.992 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 3.3 p -133.7 34.0 3.45 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.025 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' O ' ' A' ' 57' ' ' GLU . 4.5 m -163.86 150.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.3 pm0 -32.2 153.89 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.72 0 CA-C-O 121.932 0.872 . . . . 0.0 110.909 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 98.6 Cg_endo -78.73 166.07 80.52 Favored 'Cis proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.568 -2.263 . . . . 0.0 111.862 0.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.783 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 1.9 m-30 -115.48 132.45 23.11 Favored Pre-proline 0 C--N 1.269 -2.892 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.977 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.581 ' O ' ' OG1' ' A' ' 63' ' ' THR . 47.1 Cg_exo -49.48 115.57 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.002 1.801 . . . . 0.0 112.049 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -43.31 152.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.644 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.583 ' O ' ' CD ' ' A' ' 123' ' ' PRO . . . 79.38 4.38 89.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.581 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 1.2 p -90.8 143.51 26.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -1.146 . . . . 0.0 109.694 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mp0 -121.71 125.62 47.03 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.676 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -116.92 115.12 24.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 0.0 110.114 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HA ' HE22 ' A' ' 166' ' ' GLN . . . -88.4 -175.98 5.18 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.3 t -146.06 113.83 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 119.724 -1.86 . . . . 0.0 110.11 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.605 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.4 p90 -162.71 155.19 19.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.722 -1.236 . . . . 0.0 109.387 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.04 133.59 6.71 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.297 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.612 ' CG ' ' N ' ' A' ' 71' ' ' GLY . 8.0 ptm -85.05 -50.71 7.21 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -1.013 . . . . 0.0 108.537 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.612 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.58 -154.15 8.2 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.662 ' N ' ' OD2' ' A' ' 150' ' ' ASP . 40.9 t -35.49 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -1.062 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -58.84 25.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.97 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.745 ' NE1' ' CE1' ' A' ' 209' ' ' TYR . 9.6 t90 -77.9 -60.29 2.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.9 -1.125 . . . . 0.0 108.91 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.67 -3.91 43.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.78 69.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.004 -1.292 . . . . 0.0 109.475 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.664 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 6.7 tt0 -73.63 -13.74 61.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 80' ' ' PHE . 11.1 ttp85 -60.53 -71.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 110.288 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 78' ' ' ARG . 14.7 mtmt -36.32 -22.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.212 -0.93 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.674 ' N ' ' O ' ' A' ' 78' ' ' ARG . 84.3 m-85 -77.98 -41.81 34.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 0.0 110.803 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.557 ' HZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -76.83 8.59 3.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.55 -1.344 . . . . 0.0 109.518 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -102.13 19.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.0 109.851 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 mt -110.97 154.22 24.44 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.029 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -92.67 132.28 37.04 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -27.36 13.46 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.18 136.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.378 -1.072 . . . . 0.0 109.309 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.683 ' CE2' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -76.96 -51.49 11.07 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.585 -0.697 . . . . 0.0 109.455 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.683 ' OG ' ' CE2' ' A' ' 87' ' ' TYR . 2.0 p -160.04 -160.49 0.8 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.183 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.677 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -164.11 155.48 16.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.664 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.46 171.69 10.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.989 -1.069 . . . . 0.0 109.737 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.458 ' CG2' ' OE1' ' A' ' 207' ' ' GLN . 1.8 m -142.98 166.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.955 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.91 173.76 45.15 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 200' ' ' TYR . 5.5 m-85 -80.73 163.27 23.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.271 -1.135 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.631 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.94 139.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.993 -1.067 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 94.66 23.92 19.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.642 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -108.15 178.92 21.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.472 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 1.6 m170 -120.59 58.63 0.93 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.286 -1.126 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.604 ' HG1' ' CB ' ' A' ' 34' ' ' ALA . 2.3 m -157.51 -178.41 7.32 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.88 -1.137 . . . . 0.0 108.724 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.687 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 34.9 mtt180 -76.66 -89.36 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.934 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -113.43 96.52 40.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.965 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 11.5 Cg_endo -79.93 159.97 24.18 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.257 . . . . 0.0 112.21 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.63 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 9.9 p -114.78 172.51 6.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.19 -0.944 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.603 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -63.88 -59.65 4.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 2.0 mttm -59.3 -22.95 61.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.094 . . . . 0.0 108.528 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.63 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 8.3 mm-40 -69.78 -56.67 6.52 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.533 0.683 . . . . 0.0 110.471 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.6 m -66.17 -24.74 34.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.498 -0.752 . . . . 0.0 111.368 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.631 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.8 p -57.36 -41.93 81.06 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 35.5 p -51.91 -66.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.3 mt-10 138.62 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -46.8 -27.44 1.22 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.415 -0.803 . . . . 0.0 111.767 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.1 p -90.84 -32.6 16.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.564 -1.335 . . . . 0.0 109.941 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 65.76 44.32 92.47 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.642 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 1.2 m-70 -86.2 173.74 9.59 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.674 -1.486 . . . . 0.0 108.778 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -132.38 114.19 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.609 ' OE2' ' CE1' ' A' ' 73' ' ' PHE . 17.0 mt-10 -56.05 123.16 13.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.478 HG12 ' CE2' ' A' ' 160' ' ' TYR . 11.8 m -127.31 150.82 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.416 -0.802 . . . . 0.0 108.979 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 3.6 m -111.31 135.31 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.783 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -98.52 98.51 9.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.532 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.559 ' CG2' ' CD2' ' A' ' 80' ' ' PHE . 49.0 t -103.38 120.75 53.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.449 -0.782 . . . . 0.0 109.222 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.438 HG13 ' CE2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -118.07 144.2 26.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 8.8 p90 -141.39 174.31 10.67 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.087 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -116.03 117.93 38.8 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' HIS . 28.2 Cg_exo -42.09 -62.38 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.879 2.386 . . . . 0.0 113.318 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.657 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 27.3 mp0 -38.94 -14.34 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.153 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' PRO . 11.8 m-70 -133.38 -10.8 2.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.527 -1.358 . . . . 0.0 111.578 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.64 158.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 120.565 -1.335 . . . . 0.0 110.656 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.448 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 1.1 p -109.76 169.53 8.66 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.795 0.807 . . . . 0.0 111.375 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.55 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 41.2 t80 -69.32 -27.85 65.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 22.4 mt-10 -66.4 -8.74 27.67 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 127' ' ' SER . 7.2 mm-40 -72.36 -66.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.827 . . . . 0.0 110.797 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.684 ' CD1' ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -57.29 -35.65 70.06 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.61 -1.306 . . . . 0.0 107.98 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.55 ' CD1' ' CE1' ' A' ' 128' ' ' PHE . 9.3 mp -74.73 -50.4 17.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 3.8 tttt -52.66 -41.37 63.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.865 -1.147 . . . . 0.0 110.272 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.638 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -72.15 -28.5 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.952 -1.093 . . . . 0.0 109.501 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.801 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.3 t80 -71.41 -50.8 28.36 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.732 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.497 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 76.9 m95 -72.03 -46.6 56.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.207 -1.558 . . . . 0.0 110.527 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.56 -42.78 55.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.14 -0.975 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.711 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -119.43 74.3 0.99 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 110.433 -178.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.801 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 12.0 m80 -156.75 -179.92 8.66 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.149 0.976 . . . . 0.0 110.299 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.505 ' HB3' HE21 ' A' ' 143' ' ' GLN . 1.0 OUTLIER -144.26 67.77 15.08 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 140' ' ' ASP . 16.4 Cg_exo -63.51 12.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.681 2.921 . . . . 0.0 113.998 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.0 OUTLIER -121.95 29.15 7.21 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.046 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.667 ' CG ' ' O ' ' A' ' 143' ' ' GLN . 4.8 pt20 -155.61 77.69 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.841 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.471 ' N ' HG21 ' A' ' 190' ' ' THR . . . -70.38 14.71 1.25 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -108.27 1.46 21.99 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.146 -1.208 . . . . 0.0 108.223 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.447 ' CB ' ' HA ' ' A' ' 151' ' ' PHE . 11.5 ptt180 178.59 -174.18 0.17 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.718 0.771 . . . . 0.0 109.314 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -175.1 118.93 0.18 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.721 0.772 . . . . 0.0 109.255 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.88 -120.38 10.53 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.439 ' ND2' ' HA3' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -80.94 -34.02 33.6 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.321 -0.939 . . . . 0.0 112.176 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.662 ' OD2' ' N ' ' A' ' 72' ' ' CYS . 1.5 m-20 -82.48 144.21 30.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.398 -1.439 . . . . 0.0 109.23 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.447 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 38.5 p90 -136.36 144.57 44.66 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.05 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.66 -174.18 18.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.13 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.671 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -74.83 -19.72 60.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.695 -0.886 . . . . 0.0 110.367 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 155' ' ' TYR . 17.5 pm0 -86.52 7.51 25.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.156 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 154' ' ' GLN . 16.3 m-85 -139.65 50.84 1.75 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 0.0 109.59 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 153' ' ' THR . 38.4 mtm-85 -93.52 173.21 7.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.28 -0.888 . . . . 0.0 108.676 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.679 ' HG ' ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -94.28 109.26 21.09 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' A' ' 160' ' ' TYR . . . -133.33 119.28 19.53 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.396 -1.322 . . . . 0.0 109.947 -177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 t -114.5 125.43 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.982 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.72 ' HH ' HH21 ' A' ' 194' ' ' ARG . 3.3 m-85 -119.57 133.51 23.82 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.23 169.03 22.09 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.564 2.176 . . . . 0.0 111.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -19.69 20.17 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 120.729 -1.232 . . . . 0.0 109.146 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 p 177.44 -163.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.74 23.68 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.033 1.397 . . . . 0.0 108.471 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.15 -62.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.496 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 170' ' ' ALA . 17.8 mt-30 -77.81 -11.42 59.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 0.0 111.298 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.42 -45.57 62.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.569 -1.332 . . . . 0.0 109.248 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.71 -17.75 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.87 -55.88 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.0 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.34 -53.77 40.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 70.0 mt -52.66 -39.1 61.5 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 108.906 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -58.26 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.429 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.497 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 4.0 p -56.67 -36.23 69.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.253 -0.904 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.46 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 4.2 ttpt -72.61 -46.41 54.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 109.383 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.411 ' N ' ' HE2' ' A' ' 174' ' ' LYS . 1.5 tt0 -71.63 -30.23 65.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 4.1 pt-20 -53.25 -34.02 55.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.526 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.456 ' CD2' HD11 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.28 -30.83 43.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.579 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.4 OUTLIER -66.61 -38.12 86.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 109.466 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -28.28 59.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.1 t -87.48 -54.22 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 181' ' ' LEU . 3.7 mt -63.97 -45.26 89.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.027 -1.045 . . . . 0.0 109.92 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.579 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 87.8 p -54.97 -23.75 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -88.38 -3.56 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.46 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.7 m-70 -108.18 30.82 6.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.1 OUTLIER 72.3 29.74 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 110.25 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -103.54 175.16 5.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.032 -1.042 . . . . 0.0 108.99 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.93 -152.05 8.45 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' A' ' 189' ' ' ILE . 28.0 Cg_exo -58.69 105.74 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.639 2.226 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.508 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.2 OUTLIER -48.8 -178.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.265 -0.897 . . . . 0.0 110.01 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.679 ' CG2' ' HG ' ' A' ' 157' ' ' SER . 1.7 t -130.76 -2.04 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.777 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.511 ' C ' ' O ' ' A' ' 190' ' ' THR . 3.9 m -42.07 113.43 0.44 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.657 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -80.79 114.53 19.74 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.341 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.21 111.93 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.72 HH21 ' HH ' ' A' ' 160' ' ' TYR . 55.6 mtm-85 -115.18 -173.23 2.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.02 164.12 33.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.42 23.36 1.98 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.66 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -83.68 173.23 11.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.62 -1.518 . . . . 0.0 108.919 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.743 ' CG1' ' CE2' ' A' ' 200' ' ' TYR . 1.0 OUTLIER -118.72 160.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.08 . . . . 0.0 110.379 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.487 ' CZ ' ' HG3' ' A' ' 118' ' ' ARG . 47.1 t80 -91.04 149.88 21.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 109.314 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.743 ' CE2' ' CG1' ' A' ' 198' ' ' VAL . 18.6 m-85 -143.83 100.43 3.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 109.8 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -58.54 146.49 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 109.225 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -90.07 -167.22 1.78 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.101 -0.999 . . . . 0.0 108.985 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.719 ' OE2' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -73.84 176.82 6.0 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 109.267 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.719 ' N ' ' OE2' ' A' ' 203' ' ' GLU . 0.3 OUTLIER -61.03 -61.02 2.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.711 ' CD1' ' OE2' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.43 8.62 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.774 -1.204 . . . . 0.0 111.039 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.603 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 6.5 m-70 -104.0 14.8 29.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.766 -1.209 . . . . 0.0 111.04 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.803 ' O ' ' N ' ' A' ' 209' ' ' TYR . 20.0 mm-40 -129.05 -168.35 1.91 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 110.495 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.79 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -38.64 1.15 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.803 ' N ' ' O ' ' A' ' 207' ' ' GLN . 21.1 p90 -38.35 -24.03 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 O-C-N 120.788 -1.195 . . . . 0.0 110.965 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.672 ' CB ' ' HE1' ' A' ' 74' ' ' TRP . 0.2 OUTLIER -79.38 -10.42 59.8 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.267 -1.521 . . . . 0.0 111.81 -176.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.474 ' OG ' ' CD2' ' A' ' 49' ' ' HIS . 83.3 p -54.06 -24.63 17.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.152 -0.968 . . . . 0.0 108.757 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.464 ' CG ' ' CE1' ' A' ' 49' ' ' HIS . 6.4 mmmt -68.39 -18.41 64.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.0 OUTLIER -140.23 73.05 32.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.71 4.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 123.037 2.491 . . . . 0.0 113.079 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.623 ' OD2' ' CE1' ' A' ' 217' ' ' TYR . 38.0 t0 -63.02 -19.5 64.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 110.053 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.56 85.25 0.04 OUTLIER Glycine 0 N--CA 1.504 3.214 0 C-N-CA 120.067 -1.064 . . . . 0.0 111.757 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.623 ' CE1' ' OD2' ' A' ' 215' ' ' ASP . 66.5 m-85 -91.81 81.13 5.21 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 121.002 2.401 . . . . 0.0 109.602 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.572 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.5 OUTLIER -170.83 112.12 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 109.447 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.572 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -37.87 161.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 218' ' ' CYS . 4.6 mp -143.54 -177.97 5.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.12 -1.224 . . . . 0.0 109.775 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 108.47 158.74 19.53 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -123.79 -167.31 12.74 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 222' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.914 0 CA-C-N 114.511 -0.844 . . . . 0.0 109.219 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 29' ' ' ILE . 36.0 t . . . . . 0 C--O 1.215 -0.742 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -40.08 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.984 1.373 . . . . 0.0 109.773 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.461 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -111.25 125.97 54.38 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HA ' ' ND1' ' A' ' 97' ' ' HIS . . . -46.47 -22.39 0.26 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.25 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 22.3 mp0 -83.97 -7.58 59.37 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.082 -1.011 . . . . 0.0 110.391 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.7 pt-20 -106.3 -14.6 15.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 109.578 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.644 ' CB ' ' CD2' ' A' ' 97' ' ' HIS . . . -45.48 -170.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.597 0.713 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 110' ' ' LYS . 4.1 mm? . . . . . 0 C--N 1.307 -1.262 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.174 0.511 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.534 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 72.0 Cg_endo -82.38 169.59 13.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.054 2.503 . . . . 0.0 112.334 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 5.1 m -162.34 -166.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.575 ' CG2' ' O ' ' A' ' 45' ' ' THR . 14.1 t -82.31 95.16 7.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.73 -27.59 59.51 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.26 -0.9 . . . . 0.0 111.424 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.587 ' O ' ' C ' ' A' ' 48' ' ' HIS . 4.5 ptpt -95.42 99.03 11.0 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.588 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.35 114.34 0.13 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -27.81 69.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.0 111.134 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 15.8 t -71.27 -38.98 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.326 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -109.94 -42.74 4.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 110.239 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.14 0.9 55.92 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 24.4 p30 -76.24 -117.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.633 ' C ' ' HH ' ' A' ' 87' ' ' TYR . 41.8 mtm-85 -126.16 174.01 8.82 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.323 1.535 . . . . 0.0 110.121 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.602 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 2.9 p -147.11 30.78 0.94 Allowed 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.293 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.537 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -171.34 134.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.064 -1.023 . . . . 0.0 109.484 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.595 ' OE1' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.28 144.96 0.1 Allowed Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.395 -0.816 . . . . 0.0 110.534 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.17 166.66 81.71 Favored 'Cis proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.132 -2.028 . . . . 0.0 111.825 -0.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.786 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 92.8 m-85 -106.85 153.31 40.89 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.351 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.545 ' O ' ' OG1' ' A' ' 63' ' ' THR . 32.3 Cg_exo -50.3 161.03 1.25 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.318 2.012 . . . . 0.0 112.22 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.189 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.96 61.53 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -144.9 137.68 26.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -1.117 . . . . 0.0 109.413 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.657 ' CD ' ' H ' ' A' ' 65' ' ' MET . 13.3 tp60 -106.29 157.53 17.53 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 108.811 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.772 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -126.85 137.81 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.424 ' CB ' HD11 ' A' ' 131' ' ' LEU . . . -130.07 -171.03 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.5 t -144.49 150.11 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.156 -1.59 . . . . 0.0 110.093 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 67.1 m-85 -143.21 141.62 31.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.29 -0.881 . . . . 0.0 108.824 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 158' ' ' ALA . . . -137.1 101.61 0.35 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.716 ' SD ' ' N ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -109.18 -89.73 0.47 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.46 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.649 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -141.09 -166.46 10.73 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.792 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 1.1 t -25.79 107.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.833 -0.804 . . . . 0.0 109.026 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.798 ' CZ ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.1 6.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 111.893 -177.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.792 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 32.0 m0 -71.66 -40.79 69.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.215 -1.553 . . . . 0.0 107.899 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.8 -23.34 30.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.71 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.0 -21.8 54.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 110.662 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.598 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -84.89 -41.91 15.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.64 -1.288 . . . . 0.0 111.486 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.668 ' C ' ' H ' ' A' ' 80' ' ' PHE . 3.9 ttt180 -56.69 -57.84 10.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.758 -1.214 . . . . 0.0 111.309 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.0 25.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.978 -1.076 . . . . 0.0 110.953 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 19.6 m-85 -128.26 -41.78 1.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.94 -1.1 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.538 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -91.63 -2.7 56.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.645 -1.284 . . . . 0.0 110.341 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 m -83.87 13.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.085 -1.009 . . . . 0.0 109.14 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.3 mt -111.68 152.91 27.17 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.915 0.864 . . . . 0.0 109.408 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 136.41 34.17 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.41 -31.43 6.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.96 137.65 23.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.554 -0.968 . . . . 0.0 109.118 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.675 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -72.4 -42.42 65.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.673 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -177.67 -171.2 0.3 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.444 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.496 ' OG1' ' CD ' ' A' ' 77' ' ' GLU . 1.1 p -151.44 156.73 41.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.673 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 9.0 mp0 -149.64 158.55 44.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.415 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.598 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.6 OUTLIER -135.85 150.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 108.829 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.23 174.35 42.44 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.646 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.3 m-85 -79.06 146.46 33.26 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.306 -1.114 . . . . 0.0 108.464 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.69 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -145.12 -175.55 4.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.288 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 49.76 21.62 3.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.538 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -91.0 178.31 42.03 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.644 ' CD2' ' CB ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -137.47 5.28 2.69 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.285 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.719 ' C ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -160.08 147.38 16.36 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 119.918 -1.738 . . . . 0.0 110.899 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.661 ' C ' ' ND2' ' A' ' 100' ' ' ASN . 4.3 mtp85 -72.3 61.51 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.82 HD21 ' N ' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -123.58 -136.2 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 -176.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 100' ' ' ASN . 74.4 Cg_exo -40.42 169.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.137 0 CA-C-N 122.486 1.924 . . . . 0.0 114.562 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.581 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 8.9 p -123.72 -175.1 3.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.605 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.706 ' CD1' ' CE1' ' A' ' 206' ' ' HIS . 0.3 OUTLIER -47.59 -38.73 15.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 0.0 110.38 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -74.34 -49.46 22.78 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.932 -1.105 . . . . 0.0 111.636 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' C ' ' N ' ' A' ' 107' ' ' CYS . 9.5 mm-40 -84.28 -25.34 29.42 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.038 -1.039 . . . . 0.0 111.24 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.701 ' O ' ' N ' ' A' ' 108' ' ' SER . 29.7 m -54.48 -21.52 6.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.494 ' C ' ' O ' ' A' ' 106' ' ' VAL . 1.2 p -37.32 -20.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.869 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 106' ' ' VAL . 79.3 p -75.49 3.36 9.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 108.859 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.65 ' N ' ' O ' ' A' ' 106' ' ' VAL . 16.2 mt-10 55.39 3.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.65 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.616 ' O ' ' NE2' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -77.51 -19.69 55.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 110.829 -178.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.491 ' C ' ' CE1' ' A' ' 97' ' ' HIS . 67.8 p -86.22 -6.27 59.02 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.679 -1.263 . . . . 0.0 110.393 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 51.16 16.8 2.18 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.489 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.69 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -73.86 161.55 30.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -1.173 . . . . 0.0 110.763 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -138.74 114.28 9.76 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.688 ' OE1' ' CE1' ' A' ' 155' ' ' TYR . 6.3 mp0 -55.17 130.87 43.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.5 m -142.19 -171.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 110.978 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.9 t -131.1 118.86 42.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.685 -0.634 . . . . 0.0 110.33 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.786 ' NH1' ' CZ ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.31 103.29 15.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.69 142.86 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.743 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.651 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.8 m -107.95 163.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.651 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 3.6 m-85 -141.93 151.55 42.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.906 -1.122 . . . . 0.0 109.412 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HB3' ' HD1' ' A' ' 125' ' ' HIS . 51.5 mtt180 -102.02 105.94 44.93 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.877 . . . . 0.0 109.923 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.04 -23.93 10.03 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.595 2.196 . . . . 0.0 112.345 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -83.61 -21.54 32.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.922 . . . . 0.0 110.317 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.423 ' HD1' ' HB3' ' A' ' 122' ' ' ARG . 16.2 m80 -116.29 -12.17 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.427 ' CD1' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.47 163.61 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.8 t -110.6 170.84 7.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.626 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 7.9 t80 -69.54 -19.99 63.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -71.18 -17.45 62.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.581 -1.325 . . . . 0.0 108.171 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.506 ' CD ' ' C ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -76.39 -42.35 44.77 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.567 -0.708 . . . . 0.0 110.803 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 1.2 pp -65.53 -48.95 70.72 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.254 -1.529 . . . . 0.0 108.813 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.596 ' C ' ' CD1' ' A' ' 132' ' ' LEU . 2.4 pp -71.39 -18.8 62.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.929 -1.107 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.481 ' N ' HD11 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.01 -42.62 66.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.735 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -67.04 -38.72 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.147 -0.971 . . . . 0.0 110.321 -178.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.792 ' CE1' ' CE1' ' A' ' 139' ' ' HIS . 5.3 t80 -61.62 -48.49 80.66 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.4 -0.813 . . . . 0.0 110.389 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.731 ' CG ' ' CZ ' ' A' ' 177' ' ' TYR . 90.3 m95 -70.47 -32.44 69.98 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 120.863 -1.148 . . . . 0.0 110.66 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.26 -43.62 41.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 112.562 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -111.48 65.05 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.588 -1.32 . . . . 0.0 112.581 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.792 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.1 OUTLIER 175.67 134.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.195 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.659 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -73.88 114.55 33.66 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.394 -0.816 . . . . 0.0 109.167 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 190' ' ' THR . 72.9 Cg_endo -81.43 -26.79 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.501 2.134 . . . . 0.0 113.053 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.428 ' C ' ' HG1' ' A' ' 190' ' ' THR . 0.7 OUTLIER -89.13 34.07 0.8 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.904 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.787 ' N ' ' HG1' ' A' ' 190' ' ' THR . 29.7 mt-30 -129.84 90.79 3.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.081 -1.012 . . . . 0.0 110.808 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 146' ' ' ARG . . . -63.57 -117.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 40.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.949 . . . . 0.0 109.846 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 144' ' ' GLY . 13.5 ttt-85 -163.58 84.66 0.48 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.288 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.581 ' OE1' ' OE1' ' A' ' 143' ' ' GLN . 6.2 tp-100 -76.53 63.64 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.481 -1.387 . . . . 0.0 109.866 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.72 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 91.6 -121.3 6.31 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -80.52 10.33 4.88 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.217 -0.992 . . . . 0.0 109.515 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.16 154.65 20.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 108.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -136.46 125.42 24.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.984 -1.072 . . . . 0.0 110.477 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' C ' ' H ' ' A' ' 154' ' ' GLN . . . 156.46 142.04 3.33 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.12 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 153' ' ' THR . 0.1 OUTLIER -72.62 5.0 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -1.102 . . . . 0.0 109.014 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.623 ' NE2' ' CZ ' ' A' ' 155' ' ' TYR . 7.2 pt20 -95.18 -1.47 51.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.199 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.688 ' CE1' ' OE1' ' A' ' 115' ' ' GLU . 38.8 m-85 -129.82 61.11 1.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.326 -0.859 . . . . 0.0 108.993 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.79 ' NH2' HH22 ' A' ' 194' ' ' ARG . 5.8 mtm180 -111.6 177.92 4.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 109.83 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -92.48 119.39 31.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 176.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 160' ' ' TYR . . . -140.4 129.33 23.31 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 118.191 -1.403 . . . . 0.0 111.189 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 192' ' ' ASP . 3.1 m -107.4 127.85 62.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.706 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.577 ' CB ' ' NE2' ' A' ' 197' ' ' GLN . 10.9 m-85 -124.86 107.73 28.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.3 176.08 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.359 2.039 . . . . 0.0 112.802 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.2 -34.2 11.2 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.458 -0.776 . . . . 0.0 109.46 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 p -173.96 -163.21 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.165 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.99 -17.8 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.972 1.368 . . . . 0.0 108.764 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.21 -61.0 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.758 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 166' ' ' GLN . 1.3 tt0 -76.88 -25.75 53.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.69 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.4 ' SD ' ' CD1' ' A' ' 171' ' ' LEU . 1.7 mtt -52.3 -14.47 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.004 -1.06 . . . . 0.0 110.627 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -75.9 -45.55 34.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.754 -1.216 . . . . 0.0 109.638 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -93.03 -47.45 6.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.517 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.71 -65.92 0.47 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.192 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.4 ' CD1' ' SD ' ' A' ' 167' ' ' MET . 0.6 OUTLIER -54.94 -47.59 74.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.521 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -61.25 -38.18 85.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.614 ' OG ' ' NE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -56.33 -32.6 64.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 109.281 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -72.6 -55.99 6.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 110.203 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -70.68 -47.64 58.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.463 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -53.11 -32.89 49.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.025 . . . . 0.0 109.824 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.731 ' CZ ' ' CG ' ' A' ' 136' ' ' TRP . 1.5 m-85 -74.08 -30.58 62.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.538 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.6 mm100 -52.92 -60.77 2.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.961 -1.087 . . . . 0.0 109.478 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -47.79 -22.31 0.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.959 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.25 -53.2 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 109.605 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.1 mt -74.68 -44.88 47.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.873 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.2 t -55.63 -30.85 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.018 -1.051 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -88.34 -3.33 58.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.305 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 43.3 m170 -108.25 35.86 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 186' ' ' PHE . 0.5 OUTLIER 68.23 66.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 185' ' ' ASN . 65.4 m-85 -158.13 168.57 26.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.054 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.2 -158.73 18.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -58.76 107.33 0.33 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.483 2.122 . . . . 0.0 111.193 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.538 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -46.9 169.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.444 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.787 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 79.2 p -114.67 58.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.562 0.696 . . . . 0.0 109.446 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.411 ' CG2' HG11 ' A' ' 159' ' ' VAL . 39.8 m -94.45 116.65 29.04 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.608 ' CG ' HH22 ' A' ' 156' ' ' ARG . 32.9 t70 -93.98 138.18 32.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 121.582 0.706 . . . . 0.0 110.505 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.437 HD11 ' CG2' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -111.62 159.73 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.79 HH22 ' NH2' ' A' ' 156' ' ' ARG . 1.5 ttm180 -162.31 -167.65 1.66 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.887 -1.133 . . . . 0.0 110.465 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -103.11 140.37 37.41 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.997 ' O ' ' NE2' ' A' ' 197' ' ' GLN . . . 14.38 -81.21 0.0 OUTLIER Glycine 0 C--O 1.185 -2.964 0 N-CA-C 104.069 -3.613 . . . . 0.0 104.069 -177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.997 ' NE2' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 145.13 115.07 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.127 0.464 . . . . 0.0 111.616 172.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 198' ' ' VAL . 7.7 p -61.12 82.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 119.963 -1.711 . . . . 0.0 106.732 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.677 ' N ' ' O ' ' A' ' 197' ' ' GLN . 11.7 t80 -49.76 147.88 3.41 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.088 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.6 m-85 -151.05 97.31 2.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.492 ' CZ ' ' CG1' ' A' ' 56' ' ' VAL . 25.0 m-85 -53.78 147.84 11.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.994 -1.066 . . . . 0.0 110.76 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.543 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -99.31 177.72 5.11 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.535 ' OE2' ' CD2' ' A' ' 206' ' ' HIS . 1.3 pm0 -74.17 163.12 28.24 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.035 -1.041 . . . . 0.0 109.056 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -49.56 -51.87 33.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.912 -1.118 . . . . 0.0 108.522 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -46.85 -15.97 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.757 . . . . 0.0 110.189 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.798 ' ND1' ' CZ ' ' A' ' 73' ' ' PHE . 4.7 m-70 -100.75 13.49 34.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 110.684 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.847 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.6 mm-40 -131.87 -138.98 0.2 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.478 1.132 . . . . 0.0 109.989 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.68 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -32.86 -3.65 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.858 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.847 ' N ' ' O ' ' A' ' 207' ' ' GLN . 9.4 t80 -41.7 -43.27 2.81 Favored 'General case' 0 N--CA 1.511 2.624 0 O-C-N 120.171 -1.581 . . . . 0.0 108.699 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.631 ' O ' ' N ' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -53.29 -25.18 13.71 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.627 -1.296 . . . . 0.0 109.538 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 208' ' ' GLN . 29.0 t -55.71 -51.1 68.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.909 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -67.46 -33.45 75.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.197 -0.939 . . . . 0.0 108.506 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 215' ' ' ASP . 24.8 m120 -136.47 76.03 50.06 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.631 ' N ' ' O ' ' A' ' 210' ' ' LEU . 76.8 Cg_exo -45.35 -0.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.942 2.428 . . . . 0.0 112.532 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 213' ' ' ASN . 4.9 t70 -63.95 -16.1 60.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.046 -1.034 . . . . 0.0 110.025 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.56 -66.68 0.02 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 215' ' ' ASP . 24.8 t80 -159.91 -150.68 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -1.013 . . . . 0.0 109.237 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 8.6 t -79.87 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.105 -0.997 . . . . 0.0 109.685 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 220' ' ' LEU . . . -90.03 -144.05 11.12 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 1.4 tp 76.75 139.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.793 -0.828 . . . . 0.0 109.755 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.31 115.64 0.34 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 148.66 141.64 3.5 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.581 ' OG1' ' O ' ' A' ' 139' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.285 . . . . 0.0 109.819 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.936 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.205 -1.25 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.936 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 15.4 -179.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-O 123.375 1.559 . . . . 0.0 113.565 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.21 119.89 15.08 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.721 -1.237 . . . . 0.0 110.685 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -59.31 -46.15 89.35 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.596 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.694 ' OE2' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -53.33 -12.73 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 108.994 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.694 ' N ' ' OE2' ' A' ' 32' ' ' GLU . 3.3 tt0 -113.72 -48.42 2.93 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . . . -47.72 163.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.228 -0.92 . . . . 0.0 108.814 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.494 ' N ' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.585 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.476 ' CG2' ' OD1' ' A' ' 100' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.39 175.28 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.661 2.241 . . . . 0.0 112.569 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 11.4 m -143.22 -166.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.958 . . . . 0.0 109.677 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -49.21 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.582 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.09 -65.05 0.67 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 111.184 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.97 99.67 1.83 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.622 -2.431 . . . . 0.0 108.48 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.685 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.55 122.32 0.34 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.7 -31.58 71.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.381 -0.824 . . . . 0.0 110.716 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 47.1 t -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.925 -1.11 . . . . 0.0 109.637 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.41 -45.1 4.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.19 4.55 55.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.602 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.2 p30 -82.03 -121.57 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.602 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 mtm-85 -123.19 167.37 13.79 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.371 1.082 . . . . 0.0 108.572 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.6 p -124.09 -17.41 6.22 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.255 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 m -151.76 -167.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.574 -1.328 . . . . 0.0 109.521 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 56' ' ' VAL . 4.6 mt-10 -32.36 120.23 0.41 Allowed Pre-proline 0 C--N 1.295 -1.782 0 O-C-N 121.91 -0.494 . . . . 0.0 110.176 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' VAL . 98.3 Cg_endo -75.57 172.28 63.85 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.87 0.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -116.91 129.78 25.06 Favored Pre-proline 0 C--N 1.28 -2.419 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' O ' ' OG1' ' A' ' 63' ' ' THR . 37.5 Cg_exo -49.67 140.27 29.55 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.057 1.838 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.86 155.86 27.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.34 -9.73 25.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -95.66 135.88 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -1.199 . . . . 0.0 109.91 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -108.61 167.12 10.28 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.729 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -149.35 156.42 42.04 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.386 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.454 ' CB ' HE22 ' A' ' 166' ' ' GLN . . . -141.22 -174.65 4.07 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.58 127.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 119.803 -1.811 . . . . 0.0 109.666 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.667 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.6 OUTLIER -156.72 153.85 29.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.701 -1.25 . . . . 0.0 109.853 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.36 -170.08 25.53 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.333 -1.413 . . . . 0.0 112.993 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.776 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -133.65 -93.04 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.906 0.86 . . . . 0.0 110.264 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.702 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -132.46 65.37 0.59 Allowed Glycine 0 N--CA 1.498 2.811 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.702 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.5 t 120.75 170.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 124.16 0.984 . . . . 0.0 109.499 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.562 ' N ' ' SG ' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -120.58 30.13 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.242 -0.911 . . . . 0.0 111.341 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -88.79 -87.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.404 -1.435 . . . . 0.0 109.005 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -7.37 29.96 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -76.13 -47.54 23.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -1.169 . . . . 0.0 110.28 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.571 ' CD ' ' O ' ' A' ' 77' ' ' GLU . 7.2 tp10 -78.67 -27.8 45.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 31.4 ttt-85 -56.23 -34.55 66.44 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.942 -1.098 . . . . 0.0 109.925 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -75.7 17.82 0.28 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 110.294 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.603 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 81.3 m-85 -126.35 -41.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.847 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.535 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -74.36 8.77 2.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 109.793 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 80' ' ' PHE . 2.0 m -109.54 15.8 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 109.365 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.72 156.83 24.08 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.808 0.813 . . . . 0.0 109.018 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -89.98 140.11 29.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.337 0.589 . . . . 0.0 109.61 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.46 -29.36 8.32 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.43 123.51 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.401 -1.058 . . . . 0.0 109.301 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.598 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.327 -0.858 . . . . 0.0 108.988 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.532 ' OG ' ' CE1' ' A' ' 87' ' ' TYR . 6.4 p -158.43 -162.14 1.08 Allowed 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.596 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.685 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.7 p -160.99 128.36 4.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 108.817 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.598 ' OE1' ' O ' ' A' ' 89' ' ' THR . 4.1 mp0 -130.95 145.78 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.415 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.54 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 1.1 m -126.76 156.56 37.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 202' ' ' ALA . . . -172.09 -128.96 1.09 Allowed Glycine 0 C--N 1.293 -1.831 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.28 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 200' ' ' TYR . 83.1 m-85 -143.24 160.64 40.09 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.876 -0.779 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -168.71 148.41 4.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.365 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 87.37 30.8 18.25 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.643 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -142.97 173.28 24.17 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.733 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 29.0 p-80 -135.88 85.34 2.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -1.204 . . . . 0.0 110.22 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.489 ' HG1' HD22 ' A' ' 35' ' ' LEU . 96.4 m -150.02 163.48 38.03 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.057 -1.027 . . . . 0.0 108.393 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -65.18 -76.8 0.07 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.718 0.771 . . . . 0.0 111.423 -177.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.476 ' OD1' ' CG2' ' A' ' 42' ' ' ILE . 6.3 m-80 -121.46 83.17 40.43 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-O 121.504 0.668 . . . . 0.0 110.09 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HA ' ' CD ' ' A' ' 105' ' ' GLU . 23.1 Cg_exo -63.15 117.24 4.17 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 123.34 2.693 . . . . 0.0 113.023 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.621 ' H ' ' HG2' ' A' ' 105' ' ' GLU . 4.1 p -109.16 149.77 28.87 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 120.569 -1.332 . . . . 0.0 107.617 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.694 ' CE2' ' OH ' ' A' ' 155' ' ' TYR . 2.8 t80 -47.68 -34.37 8.06 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.398 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.581 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -73.28 -26.49 61.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 110.443 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.621 ' HG2' ' H ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -83.53 -57.33 3.28 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 120.565 -1.334 . . . . 0.0 110.142 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.611 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 11.5 m -61.93 -20.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.471 -0.768 . . . . 0.0 111.843 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 9.3 p -33.85 -37.84 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.438 -0.789 . . . . 0.0 109.66 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 106' ' ' VAL . 27.0 t -103.97 -115.53 0.22 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.653 -1.28 . . . . 0.0 109.791 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.458 ' N ' ' OG ' ' A' ' 108' ' ' SER . 1.5 mp0 -120.4 9.86 11.06 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.347 0.594 . . . . 0.0 110.236 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.419 ' CA ' HD23 ' A' ' 35' ' ' LEU . 5.4 mttt -43.0 -50.96 5.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -122.51 14.13 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.747 -1.221 . . . . 0.0 110.512 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.544 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 37.2 35.02 0.14 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.643 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.09 168.93 19.1 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.038 -1.272 . . . . 0.0 109.801 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -119.12 114.11 21.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.538 ' CD ' ' O ' ' A' ' 115' ' ' GLU . 1.9 pp20? -72.86 130.05 39.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.269 -0.895 . . . . 0.0 109.906 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -179.39 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.146 -0.971 . . . . 0.0 110.507 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.591 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.3 m -115.94 117.8 56.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.808 0.813 . . . . 0.0 110.2 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.871 HH22 ' N ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -98.24 101.68 13.21 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.646 ' C ' HH22 ' A' ' 118' ' ' ARG . 31.0 m -126.63 123.65 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.871 ' N ' HH22 ' A' ' 118' ' ' ARG . 0.7 OUTLIER -78.27 171.57 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.55 ' CG ' ' CD1' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -158.08 155.58 29.49 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.356 -1.338 . . . . 0.0 110.957 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -103.4 102.63 30.54 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.822 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' O ' ' A' ' 126' ' ' ILE . 31.7 Cg_exo -43.7 -64.24 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.968 2.445 . . . . 0.0 112.754 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -44.43 -29.96 0.78 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.811 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -92.92 -46.32 7.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 109.769 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.559 ' O ' ' O ' ' A' ' 123' ' ' PRO . 2.6 tt -126.07 166.99 21.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.048 -1.032 . . . . 0.0 108.255 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.53 ' N ' ' CG1' ' A' ' 126' ' ' ILE . 6.1 m -99.96 159.33 15.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.66 -1.275 . . . . 0.0 110.721 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.544 ' CE2' ' CD1' ' A' ' 132' ' ' LEU . 17.4 t80 -66.43 -27.46 67.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.585 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -69.67 -16.74 63.41 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.579 ' O ' ' C ' ' A' ' 131' ' ' LEU . 2.8 mt-10 -73.57 -72.33 0.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 108.992 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.781 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -39.2 -35.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 178.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.544 ' CD1' ' CE2' ' A' ' 128' ' ' PHE . 44.4 mt -76.28 -44.75 35.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' GLU . 2.6 mttm -52.28 -53.56 42.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.94 -1.1 . . . . 0.0 110.117 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.656 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 41.3 t -57.85 -30.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.797 -1.19 . . . . 0.0 108.45 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.709 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 3.0 t80 -73.1 -56.74 4.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.143 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 177' ' ' TYR . 37.7 m95 -71.57 -54.08 11.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.384 -1.448 . . . . 0.0 110.021 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 20.8 tt0 -37.08 -56.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.717 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 8.3 p30 -103.25 63.8 0.82 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.061 -1.025 . . . . 0.0 109.949 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.776 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 22.5 m80 -158.28 177.21 11.53 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.286 1.041 . . . . 0.0 110.072 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' THR . 1.6 t0 -145.22 80.23 11.18 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 190' ' ' THR . 13.0 Cg_exo -48.09 13.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.545 2.163 . . . . 0.0 113.592 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 140' ' ' ASP . 0.4 OUTLIER -122.15 43.29 2.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.808 -1.182 . . . . 0.0 110.318 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.587 ' O ' ' O ' ' A' ' 144' ' ' GLY . 5.3 mt-30 -130.72 78.61 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 109.325 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.43 -116.26 0.0 OUTLIER Glycine 0 N--CA 1.493 2.473 0 CA-C-O 121.905 0.725 . . . . 0.0 112.513 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.97 42.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.795 -0.827 . . . . 0.0 110.353 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.9 OUTLIER -170.9 139.62 1.48 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.24 177.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.548 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -146.93 91.46 2.01 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.128 -1.607 . . . . 0.0 108.424 176.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.46 -129.47 9.83 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -94.69 12.9 26.14 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.652 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.675 ' OD1' ' CE2' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -109.05 112.91 25.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.649 -1.282 . . . . 0.0 109.488 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.469 ' CE2' ' HG3' ' A' ' 146' ' ' ARG . 6.2 m-85 -104.22 113.48 27.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.53 149.42 7.87 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.43 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.598 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -48.87 -45.98 41.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.51 -0.994 . . . . 0.0 109.393 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.814 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 2.1 pm0 -75.38 1.53 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 111.177 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.814 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 21.1 m-85 -102.99 41.58 1.24 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.443 -1.411 . . . . 0.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.618 ' O ' ' O ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -103.45 174.91 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 108.969 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.4 129.37 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 68' ' ' PHE . . . -143.74 117.82 9.48 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 115.94 -2.304 . . . . 0.0 112.444 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.483 HG21 ' CE2' ' A' ' 135' ' ' PHE . 16.1 t -111.98 133.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.214 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.507 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 53.7 m-85 -130.5 94.41 29.68 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.0 109.192 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.9 170.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.773 2.315 . . . . 0.0 112.063 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.0 -21.13 16.99 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 120.941 -1.099 . . . . 0.0 109.633 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 165' ' ' VAL . 4.1 p 173.54 -178.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.086 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.07 -15.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.009 1.385 . . . . 0.0 108.6 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.6 t -55.69 -64.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.672 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 170' ' ' ALA . 17.1 mt-30 -79.54 -19.32 49.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.682 -0.636 . . . . 0.0 110.932 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -31.23 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.869 -1.145 . . . . 0.0 110.632 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -71.98 -43.06 65.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.681 -1.262 . . . . 0.0 109.979 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.44 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.92 -42.94 9.2 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.136 -0.977 . . . . 0.0 110.409 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.11 -57.79 8.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.855 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.63 -35.76 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.026 -1.046 . . . . 0.0 109.048 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 -74.51 -45.38 46.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.468 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -56.21 -31.15 63.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -72.17 -52.15 17.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.824 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -73.0 -26.1 61.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 110.317 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 6.2 pt-20 -52.97 -34.53 56.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.687 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.475 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -79.65 -28.94 40.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.077 -1.014 . . . . 0.0 109.454 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.515 ' OE1' ' CG2' ' A' ' 189' ' ' ILE . 15.5 tp60 -74.91 -7.66 54.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -75.49 -41.93 54.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 0.0 108.907 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.6 t -88.52 -43.66 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.315 -0.865 . . . . 0.0 109.859 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' CD2' ' A' ' 186' ' ' PHE . 38.2 mt -56.55 -49.17 75.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.058 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.1 t -55.24 -30.33 59.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.35 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -88.26 -6.76 57.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.229 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.417 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.9 m170 -108.43 29.32 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.77 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.5 OUTLIER 69.67 68.93 0.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.473 ' CD2' HD23 ' A' ' 181' ' ' LEU . 23.4 m-85 -137.14 169.99 16.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.935 . . . . 0.0 109.0 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -119.82 -159.8 11.04 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -58.62 105.77 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.204 1.936 . . . . 0.0 110.774 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.515 ' CG2' ' OE1' ' A' ' 178' ' ' GLN . 0.2 OUTLIER -51.19 174.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.175 -0.953 . . . . 0.0 110.048 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.562 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 4.8 p -137.32 67.73 1.43 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.232 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.9 m -100.6 125.2 46.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.692 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -76.32 113.77 14.26 Favored 'General case' 0 C--N 1.278 -2.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.205 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.47 108.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.87 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.692 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.4 OUTLIER -147.4 153.36 39.52 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -104.16 164.9 11.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.01 39.07 94.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.539 ' O ' ' C ' ' A' ' 198' ' ' VAL . 55.6 mm-40 -96.41 90.99 5.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.68 -1.482 . . . . 0.0 108.974 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.539 ' C ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -32.11 150.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.554 -0.716 . . . . 0.0 109.97 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.502 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 38.3 t80 -96.11 140.02 31.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.458 -0.776 . . . . 0.0 109.325 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 93' ' ' PHE . 7.0 m-85 -130.86 94.81 3.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.351 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -54.12 136.44 42.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 110.428 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.602 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -84.46 -174.94 5.55 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.13 161.12 30.98 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 122.264 1.03 . . . . 0.0 110.059 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -43.31 74.27 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.459 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -60.82 -7.85 2.64 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.425 -0.797 . . . . 0.0 110.119 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.622 ' CE1' ' CB ' ' A' ' 103' ' ' TYR . 50.4 m-70 -104.4 4.01 32.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.985 -1.072 . . . . 0.0 110.65 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.849 ' O ' ' N ' ' A' ' 209' ' ' TYR . 16.7 mm-40 -109.89 -143.83 0.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.144 0.973 . . . . 0.0 110.19 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.677 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -35.49 -4.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.845 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.849 ' N ' ' O ' ' A' ' 207' ' ' GLN . 59.4 t80 -39.75 -42.14 1.21 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 120.757 -1.214 . . . . 0.0 111.015 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.08 -20.75 62.32 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.68 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 208' ' ' GLN . 8.1 t -73.25 -49.07 29.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 0.0 108.946 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.1 0.92 56.31 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.264 -0.897 . . . . 0.0 110.264 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.788 ' ND2' ' CD2' ' A' ' 209' ' ' TYR . 36.3 m-80 -132.65 133.42 23.46 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 109.686 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.1 2.1 5.26 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.698 2.266 . . . . 0.0 113.663 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 217' ' ' TYR . 2.9 t0 -62.74 -17.43 60.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.23 . . . . 0.0 109.864 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.421 ' C ' ' CD2' ' A' ' 217' ' ' TYR . . . 63.88 -62.75 0.05 OUTLIER Glycine 0 C--N 1.296 -1.684 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 215' ' ' ASP . 2.8 p90 171.31 -156.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 109.569 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 217' ' ' TYR . 3.6 t -159.94 79.51 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.006 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 161.24 174.28 30.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.41 -165.16 1.29 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.234 -1.157 . . . . 0.0 109.858 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.04 -107.87 2.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -128.06 -168.44 12.45 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.27 -2.89 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.603 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.72 ' O ' ' O ' ' A' ' 29' ' ' ILE . 44.6 t . . . . . 0 C--O 1.214 -0.805 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.72 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -33.95 177.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 123.225 1.488 . . . . 0.0 110.852 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -103.92 121.3 42.82 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.952 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -49.35 -15.59 0.14 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 30' ' ' SER . 11.4 mm-40 -62.17 -62.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.855 . . . . 0.0 109.793 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' ' C ' ' A' ' 34' ' ' ALA . 28.5 tt0 -75.19 -28.39 60.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.707 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -30.97 152.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.781 . . . . 0.0 110.203 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.472 ' N ' HD11 ' A' ' 35' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.26 175.51 11.24 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.608 2.205 . . . . 0.0 112.318 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -147.43 -167.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.583 ' CG2' ' O ' ' A' ' 45' ' ' THR . 15.1 t -49.21 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.617 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.39 -50.32 71.94 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.173 -0.954 . . . . 0.0 111.068 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 48' ' ' HIS . 27.7 mttm -84.34 99.17 10.45 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.614 -2.434 . . . . 0.0 108.419 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.6 t-80 -32.11 117.88 0.23 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -64.59 -32.46 74.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.318 -0.864 . . . . 0.0 110.665 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 25.9 t -63.43 -44.1 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 109.379 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -106.37 -45.09 4.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.39 4.53 54.96 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.687 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 27.3 p30 -82.04 -112.71 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.673 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.4 mtt180 -130.09 174.36 9.87 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.653 1.692 . . . . 0.0 110.423 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.617 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.8 p -137.95 8.35 2.75 Favored 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.892 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 57' ' ' GLU . 10.9 m -144.98 132.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.687 -1.258 . . . . 0.0 109.519 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.4 pm0 -32.86 151.81 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 CA-C-O 121.809 0.814 . . . . 0.0 110.849 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.88 166.28 79.76 Favored 'Cis proline' 0 C--N 1.303 -1.844 0 C-N-CA 121.808 -2.163 . . . . 0.0 111.716 -0.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CZ ' HG12 ' A' ' 120' ' ' VAL . 31.8 m-85 -110.26 154.56 42.82 Favored Pre-proline 0 C--N 1.269 -2.907 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.118 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.574 ' O ' ' OG1' ' A' ' 63' ' ' THR . 44.1 Cg_exo -50.15 132.5 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.3 2.0 . . . . 0.0 112.1 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -48.65 146.69 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.84 46.52 23.17 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -128.93 137.54 51.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -1.121 . . . . 0.0 109.674 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.87 149.51 25.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.721 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -138.86 113.11 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.533 ' CB ' HE22 ' A' ' 166' ' ' GLN . . . -112.09 -167.69 1.22 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 t -141.96 132.06 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.07 -1.644 . . . . 0.0 108.998 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 135' ' ' PHE . 91.3 m-85 -123.04 156.16 35.42 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.193 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 157' ' ' SER . . . -140.44 114.71 0.98 Allowed Glycine 0 C--O 1.207 -1.571 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CD1' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -125.31 -82.47 0.63 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.485 -1.009 . . . . 0.0 109.31 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.624 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -153.27 -163.55 11.84 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.699 ' C ' ' H ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -29.67 104.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.903 . . . . 0.0 108.582 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.786 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -49.44 6.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.787 . . . . 0.0 111.4 -178.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.699 ' H ' ' C ' ' A' ' 72' ' ' CYS . 14.5 m0 -72.04 -47.58 50.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.614 -1.304 . . . . 0.0 108.799 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.58 -22.93 27.53 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.721 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.35 -26.87 56.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 90' ' ' GLN . 8.9 tp10 -84.59 -36.66 21.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.693 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 80' ' ' PHE . 1.7 ttt85 -59.28 -59.17 5.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.606 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.477 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 18.0 mmtm -56.43 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.944 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.721 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.0 m-85 -120.88 -40.93 2.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.824 -1.173 . . . . 0.0 110.315 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.542 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -87.96 3.74 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.84 -1.163 . . . . 0.0 109.981 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -94.62 13.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -106.56 152.76 23.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.96 0.886 . . . . 0.0 109.135 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.527 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 8.8 pttm -88.96 145.79 25.3 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.15 -25.37 28.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.593 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -73.29 137.78 22.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.97 . . . . 0.0 108.807 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.687 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -81.41 -41.06 22.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 108.744 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.509 ' O ' ' CG2' ' A' ' 89' ' ' THR . 1.1 p -173.51 -163.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 88' ' ' SER . 60.3 p -158.82 170.78 21.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.581 ' O ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.96 176.49 6.15 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.619 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -152.35 162.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.821 -1.174 . . . . 0.0 109.853 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.15 171.22 44.08 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 200' ' ' TYR . 4.1 m-85 -87.55 155.84 19.79 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.473 -1.016 . . . . 0.0 109.499 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -178.96 155.47 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.391 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.8 22.26 14.16 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -154.49 -151.62 5.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.519 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 47.9 p-80 -178.37 107.09 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.691 ' O ' ' O ' ' A' ' 99' ' ' ARG . 1.1 m -152.26 156.04 38.9 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.777 ' NE ' HD21 ' A' ' 100' ' ' ASN . 7.8 ttp180 -40.27 169.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.777 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -30.71 89.96 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.71 ' N ' ' O ' ' A' ' 99' ' ' ARG . 1.3 Cg_endo -77.15 141.78 21.07 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.052 2.501 . . . . 0.0 112.963 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 105' ' ' GLU . 24.6 p -124.06 170.69 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.116 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.783 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 1.2 t80 -56.92 -43.36 81.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.798 . . . . 0.0 109.325 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -73.35 -27.54 61.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.356 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.43 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.4 mm-40 -80.88 -41.37 23.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.777 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.458 HG12 ' HG1' ' A' ' 111' ' ' THR . 5.4 m -55.73 -23.99 15.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 120.421 -1.425 . . . . 0.0 108.634 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.673 ' C ' ' H ' ' A' ' 109' ' ' GLU . 23.2 m -59.27 -36.3 75.29 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 110' ' ' LYS . 9.1 m -46.95 -9.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.673 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.8 mt-10 65.3 -12.25 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.679 -0.638 . . . . 0.0 109.944 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 108' ' ' SER . 23.8 mttp -77.56 -15.05 59.49 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.063 -1.023 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' GLY . 4.7 p -91.19 -6.61 53.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 109.665 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 36.28 37.28 0.18 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.102 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.491 ' ND1' ' CA ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -82.04 158.13 23.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.596 -1.532 . . . . 0.0 109.974 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -120.83 112.67 19.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.448 -0.783 . . . . 0.0 109.118 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.682 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 74.4 mt-10 -61.54 117.44 5.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.29 -176.11 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.7 t -132.68 120.74 42.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.734 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.587 ' HD2' ' CZ ' ' A' ' 199' ' ' PHE . 9.9 ptm180 -97.81 120.95 39.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.419 ' O ' ' CG2' ' A' ' 119' ' ' VAL . 2.6 m -133.87 129.91 55.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 O-C-N 120.72 -1.237 . . . . 0.0 109.645 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 59' ' ' PHE . 0.8 OUTLIER -92.32 145.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.593 ' CE1' ' CG2' ' A' ' 86' ' ' VAL . 4.1 m-85 -129.21 161.16 30.79 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.182 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -121.62 105.19 38.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.591 -0.693 . . . . 0.0 110.382 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 124' ' ' GLU . 18.7 Cg_exo -43.64 -61.2 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.538 2.825 . . . . 0.0 114.229 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.2 tt0 -26.9 -52.69 0.06 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.361 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 21.05 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 0.0 109.756 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -157.6 162.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.28 -0.888 . . . . 0.0 109.618 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.482 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -128.72 148.3 50.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.894 -1.129 . . . . 0.0 109.653 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.473 ' CD2' HD12 ' A' ' 132' ' ' LEU . 72.8 t80 -54.43 -38.86 66.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.222 -0.924 . . . . 0.0 109.613 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -51.08 -14.36 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.07 -1.019 . . . . 0.0 108.84 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.482 ' HG3' ' H ' ' A' ' 127' ' ' SER . 6.5 mm-40 -73.77 -62.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.882 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.776 ' CD1' ' H ' ' A' ' 131' ' ' LEU . 2.9 mp -51.69 -34.12 37.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.976 -1.077 . . . . 0.0 108.184 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 128' ' ' PHE . 39.0 mt -68.67 -50.16 53.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 110.255 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.21 -30.01 70.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.084 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.2 t -74.04 -40.06 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.884 -1.135 . . . . 0.0 109.633 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.683 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 24.3 t80 -69.26 -43.41 74.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.63 -0.669 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.636 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 82.3 m95 -71.73 -39.69 69.93 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.699 -1.251 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.85 -37.12 59.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 112.88 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 25.3 m-80 -97.78 36.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.639 -1.288 . . . . 0.0 113.27 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.683 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER 177.97 130.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.56 -1.338 . . . . 0.0 110.733 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.606 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -61.54 112.04 5.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -74.68 -11.01 22.05 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.161 1.907 . . . . 0.0 112.569 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 71.4 p -101.2 46.62 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.021 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.645 ' C ' ' HG1' ' A' ' 190' ' ' THR . 2.6 pt20 -114.08 107.29 15.45 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.81 0.814 . . . . 0.0 110.552 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.622 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.06 -118.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.578 0 CA-C-O 121.482 0.49 . . . . 0.0 112.157 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.578 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -99.48 44.62 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.258 . . . . 0.0 111.822 -177.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.417 ' HB3' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -174.29 159.61 3.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.701 -1.25 . . . . 0.0 109.329 178.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.596 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -122.85 145.14 48.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.428 -1.42 . . . . 0.0 110.536 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.85 -124.19 25.73 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -111.7 26.7 10.37 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.76 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -107.88 167.13 10.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.124 . . . . 0.0 108.42 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 151' ' ' PHE . 33.5 m-85 -132.35 111.54 11.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.824 -1.173 . . . . 0.0 109.912 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 172.38 143.61 4.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.55 6.2 4.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -1.219 . . . . 0.0 109.147 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.667 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 6.8 pt20 -88.87 -1.22 57.98 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.667 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 29.7 m-85 -136.75 62.55 1.6 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.745 HH22 ' CB ' ' A' ' 192' ' ' ASP . 10.4 mtm105 -107.96 174.74 5.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.673 ' OG ' ' NE2' ' A' ' 139' ' ' HIS . 6.2 t -93.2 107.26 19.1 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 160' ' ' TYR . . . -138.42 123.08 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 118.182 -1.407 . . . . 0.0 111.473 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 192' ' ' ASP . 11.2 t -112.04 127.66 69.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.249 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.472 ' CG ' ' HG3' ' A' ' 197' ' ' GLN . 7.6 m-85 -119.81 89.24 41.47 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.78 174.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.237 2.625 . . . . 0.0 112.608 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.47 ' H ' ' HG1' ' A' ' 162' ' ' THR . 0.0 OUTLIER -96.24 -33.85 11.85 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.559 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 12.3 t -176.64 -162.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.374 -0.828 . . . . 0.0 109.054 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.559 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -56.93 -15.46 4.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.988 1.375 . . . . 0.0 108.614 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.559 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 3.7 t -55.82 -64.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.749 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.533 HE22 ' CB ' ' A' ' 66' ' ' ALA . 14.1 mt-30 -79.32 -17.76 53.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.618 -0.676 . . . . 0.0 111.061 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.1 ttm -52.36 -38.05 57.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.761 -1.212 . . . . 0.0 110.218 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.37 -23.49 57.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.862 -1.149 . . . . 0.0 109.688 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.667 ' N ' ' OE2' ' A' ' 168' ' ' GLU . . . -92.88 -42.17 9.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.46 -55.17 23.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.677 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 172' ' ' ARG . 2.5 pp -52.65 -35.55 55.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.055 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.577 ' O ' ' OE2' ' A' ' 176' ' ' GLU . 4.2 mtm180 -74.82 -46.45 36.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.886 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.636 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 70.2 m -56.54 -41.33 76.6 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.446 -0.784 . . . . 0.0 109.546 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 25.1 ttpp -72.4 -49.99 29.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.63 -25.52 68.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' O ' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -64.74 -53.36 48.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -78.9 -21.4 47.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.737 -179.669 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.628 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 38.8 tp60 -62.14 -41.0 97.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 0.0 109.656 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -16.0 58.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.939 . . . . 0.0 109.619 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 49.7 t -81.55 -54.71 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -75.72 -30.96 59.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 14.5 t -56.89 -38.0 72.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.599 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -79.35 0.77 27.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -108.15 23.81 13.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.15 62.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.639 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -134.74 168.07 19.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -94.84 -150.58 27.28 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.04 136.72 11.84 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.755 2.303 . . . . 0.0 112.099 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.628 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 2.6 mm -59.14 123.16 10.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.645 ' HG1' ' C ' ' A' ' 143' ' ' GLN . 53.2 p -79.41 5.1 13.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.995 . . . . 0.0 110.744 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.516 ' OG1' ' CG2' ' A' ' 189' ' ' ILE . 31.3 m -43.81 110.94 0.24 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.745 ' CB ' HH22 ' A' ' 156' ' ' ARG . 4.0 t0 -77.14 117.74 18.99 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.945 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.17 123.62 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.68 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -163.54 155.96 17.92 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.366 -0.834 . . . . 0.0 109.089 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.74 167.32 9.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 62.75 66.2 2.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.472 ' HG3' ' CG ' ' A' ' 160' ' ' TYR . 78.5 mm-40 -111.3 102.87 11.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -1.199 . . . . 0.0 109.429 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 197' ' ' GLN . 61.9 t -41.67 155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.424 -0.798 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.587 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 22.1 t80 -117.64 151.52 37.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.865 . . . . 0.0 109.505 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -152.01 98.33 2.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.506 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 19.6 m-85 -54.0 136.13 41.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 110.554 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.451 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -87.27 -177.97 6.09 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.8 pt-20 -75.29 175.56 8.24 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.381 -0.825 . . . . 0.0 109.478 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -52.04 67.03 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.477 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.13 -19.25 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.601 -0.687 . . . . 0.0 109.874 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.786 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 7.2 m-70 -96.99 7.84 45.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 110.327 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.829 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.0 mm-40 -127.0 -142.04 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.308 1.052 . . . . 0.0 110.491 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.615 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -35.46 -3.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.352 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.829 ' N ' ' O ' ' A' ' 207' ' ' GLN . 88.2 t80 -40.85 -43.45 2.05 Favored 'General case' 0 N--CA 1.514 2.761 0 O-C-N 120.431 -1.418 . . . . 0.0 110.431 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.427 ' H ' HD12 ' A' ' 210' ' ' LEU . 4.5 mp -75.87 -13.44 60.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.425 -1.422 . . . . 0.0 110.085 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 208' ' ' GLN . 79.8 p -57.88 -44.2 86.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 -9.01 54.45 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.538 -0.726 . . . . 0.0 109.498 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.441 ' N ' ' HD3' ' A' ' 214' ' ' PRO . 10.3 m120 -137.13 66.8 54.38 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 213' ' ' ASN . 12.3 Cg_exo -67.29 9.59 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.013 2.476 . . . . 0.0 112.237 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.497 ' OD1' ' C ' ' A' ' 215' ' ' ASP . 1.1 p30 -63.07 -18.92 63.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.537 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.62 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.71 85.35 0.05 OUTLIER Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.157 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 87.2 t80 -48.91 -171.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.314 2.057 . . . . 0.0 109.052 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.661 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 13.2 m -72.29 76.65 1.0 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.661 -1.275 . . . . 0.0 108.852 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.94 17.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.25 -177.54 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -1.212 . . . . 0.0 109.777 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.96 90.61 0.08 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.59 171.22 14.32 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.574 ' OG1' ' OD1' ' A' ' 140' ' ' ASP . 1.6 t . . . . . 0 C--N 1.27 -2.851 0 CA-C-N 114.919 -0.64 . . . . 0.0 109.713 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.661 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.214 -0.795 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -36.22 166.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.736 1.255 . . . . 0.0 109.189 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.05 124.66 28.11 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.617 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.28 60.28 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.506 -0.746 . . . . 0.0 109.183 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -81.64 -4.67 56.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' LEU . 5.7 mt-10 -98.02 -36.23 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 35' ' ' LEU . . . -35.59 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.653 ' O ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 pt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -39.85 164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.92 2.413 . . . . 0.0 112.554 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.87 -154.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.573 ' O ' ' OG1' ' A' ' 55' ' ' THR . 9.9 t -80.09 86.79 5.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.231 -0.918 . . . . 0.0 110.14 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.612 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.41 -37.65 70.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.383 -0.823 . . . . 0.0 111.016 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.8 mtmt -93.24 98.86 11.55 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 116.33 -2.148 . . . . 0.0 108.15 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.661 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.14 107.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -30.45 64.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.807 . . . . 0.0 111.133 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 13.2 t -66.65 -43.59 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.788 -1.195 . . . . 0.0 109.554 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.38 -42.17 4.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.135 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.06 0.97 48.33 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -72.14 -119.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -127.92 174.17 9.39 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 123.506 1.622 . . . . 0.0 110.103 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 10.3 p -150.89 22.13 0.78 Allowed 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.134 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.578 ' CG1' ' O ' ' A' ' 55' ' ' THR . 2.5 m -167.79 143.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.918 -1.114 . . . . 0.0 109.542 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' A' ' 56' ' ' VAL . 32.6 mt-10 -32.46 142.76 0.16 Allowed Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.442 -0.786 . . . . 0.0 110.462 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.52 167.1 80.02 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.224 -1.99 . . . . 0.0 111.661 0.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -100.39 132.69 22.12 Favored Pre-proline 0 C--N 1.271 -2.835 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.905 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.526 ' O ' ' OG1' ' A' ' 63' ' ' THR . 45.5 Cg_exo -49.51 114.61 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.999 1.799 . . . . 0.0 112.199 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.71 118.39 3.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -8.26 20.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -83.12 137.13 34.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.107 . . . . 0.0 109.795 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.77 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.1 tp60 -103.66 155.33 18.64 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.374 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.734 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -161.79 137.27 7.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.276 -1.515 . . . . 0.0 112.434 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.28 -168.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.96 115.02 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.785 -1.822 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 1.5 p90 -163.29 156.04 18.61 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 109.719 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.92 164.16 30.31 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' ' OD1' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -114.8 -88.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -1.111 . . . . 0.0 109.052 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . -125.07 -152.14 8.2 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.681 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.4 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.412 -1.052 . . . . 0.0 108.193 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.729 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -49.45 5.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.361 -0.837 . . . . 0.0 111.665 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.783 ' CZ2' ' CE1' ' A' ' 206' ' ' HIS . 5.1 m0 -69.52 -49.84 50.76 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.277 -1.514 . . . . 0.0 108.549 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.52 -49.65 76.31 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.13 -27.52 57.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.964 -1.315 . . . . 0.0 110.202 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.57 ' OE2' ' O ' ' A' ' 77' ' ' GLU . 6.9 tp10 -52.1 -34.85 45.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.907 -1.12 . . . . 0.0 110.153 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 21.7 ttt-85 -106.52 -56.69 2.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.979 -1.076 . . . . 0.0 111.36 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -38.69 -17.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 110.262 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 11.6 m-85 -91.52 -42.7 10.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.702 -1.249 . . . . 0.0 110.953 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.531 ' CE3' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -70.91 -4.61 25.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.745 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -83.62 14.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.752 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.69 164.0 14.3 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -93.19 138.12 31.88 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.451 0.643 . . . . 0.0 110.359 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 123' ' ' PRO . . . 89.65 -19.12 42.67 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.22 137.91 18.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.945 -1.326 . . . . 0.0 109.775 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.571 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -76.73 -40.89 47.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.676 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 177.12 -160.38 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.079 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.553 ' N ' ' OG ' ' A' ' 88' ' ' SER . 70.2 p -160.33 150.97 18.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.676 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 8.6 mp0 -144.68 164.43 30.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.554 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.2 OUTLIER -144.53 156.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.061 -1.024 . . . . 0.0 110.008 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 176.29 45.93 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 1.4 m-85 -88.77 164.78 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.356 -1.085 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.677 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.73 174.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.144 -0.973 . . . . 0.0 109.642 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 53.17 46.96 62.03 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.511 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -135.87 -152.38 6.36 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 120.945 -1.326 . . . . 0.0 110.381 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 2.5 t-160 -153.29 63.63 0.76 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.535 -0.979 . . . . 0.0 108.856 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.653 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.95 142.37 16.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 101' ' ' PRO . 31.0 mtp180 -49.26 177.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 108.548 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.567 ' C ' ' O ' ' A' ' 99' ' ' ARG . 2.6 m-80 -33.84 94.92 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.332 -0.855 . . . . 0.0 109.111 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 60.9 Cg_endo -85.62 163.07 10.82 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.81 2.34 . . . . 0.0 112.503 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.589 ' OG1' ' OE1' ' A' ' 105' ' ' GLU . 21.5 p -121.02 170.78 9.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.692 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.777 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 13.6 t80 -60.37 -59.56 5.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.0 110.295 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -55.48 -36.73 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 108.309 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.589 ' OE1' ' OG1' ' A' ' 102' ' ' THR . 0.1 OUTLIER -58.27 -62.01 2.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.258 0.552 . . . . 0.0 110.345 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.686 ' O ' ' N ' ' A' ' 109' ' ' GLU . 27.1 m -65.04 -23.98 34.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.264 -0.897 . . . . 0.0 110.856 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.604 ' C ' ' H ' ' A' ' 109' ' ' GLU . 42.9 t -42.13 -44.18 3.57 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.79 ' C ' ' H ' ' A' ' 110' ' ' LYS . 33.2 t -69.42 13.23 0.13 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.24 -0.912 . . . . 0.0 108.735 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER 51.95 -16.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.514 0.726 . . . . 0.0 110.755 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.79 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -45.88 -30.43 1.73 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.67 -0.644 . . . . 0.0 110.186 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.63 ' OG1' ' CG1' ' A' ' 106' ' ' VAL . 48.7 p -84.53 11.77 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.129 . . . . 0.0 109.073 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 24.72 44.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.677 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 2.6 m-70 -83.91 170.83 13.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.492 -1.593 . . . . 0.0 109.214 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 158' ' ' ALA . . . -118.55 114.21 22.46 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.693 ' OE2' ' CG ' ' A' ' 73' ' ' PHE . 1.9 mm-40 -51.19 118.25 3.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.407 ' CG1' ' CE2' ' A' ' 160' ' ' TYR . 0.8 OUTLIER -125.21 136.18 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.05 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -116.85 125.01 73.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 118' ' ' ARG . 2.7 ptm180 -104.7 116.37 31.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 110.723 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.57 114.25 39.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.445 ' CA ' ' O ' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -95.43 159.51 2.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.041 -1.037 . . . . 0.0 111.698 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.77 ' O ' ' N ' ' A' ' 64' ' ' GLN . 5.7 p90 -138.95 136.61 35.61 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 123.518 1.628 . . . . 0.0 111.592 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.967 ' N ' ' CD ' ' A' ' 123' ' ' PRO . 6.9 ptt-85 -137.16 -1.09 0.03 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.621 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.967 ' CD ' ' N ' ' A' ' 122' ' ' ARG . 56.2 Cg_endo -71.53 -27.75 18.45 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 124.288 3.325 . . . . 0.0 116.838 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 5.1 tt0 72.79 -5.18 1.94 Allowed 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.698 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -105.51 -25.07 12.47 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.756 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -128.4 124.13 61.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.467 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -132.22 -170.73 2.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.885 -1.135 . . . . 0.0 112.698 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.733 ' N ' ' CE2' ' A' ' 121' ' ' TYR . 60.5 t80 -58.08 -45.39 87.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.569 -0.707 . . . . 0.0 110.497 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 78.0 mt-10 -46.73 -35.02 5.67 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 131' ' ' LEU . 17.4 mm-40 -73.77 -63.54 1.19 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.689 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 13.2 mt -34.22 -57.83 0.48 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -76.84 -42.17 41.24 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.403 -1.435 . . . . 0.0 110.996 -178.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.69 ' CB ' ' HZ3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -52.15 -63.07 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.771 -1.205 . . . . 0.0 109.167 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.8 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 t -50.14 -40.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' CZ3' ' A' ' 136' ' ' TRP . 15.8 t80 -56.45 -45.46 80.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.188 -1.57 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.479 ' HB3' ' CE1' ' A' ' 177' ' ' TYR . 29.4 m95 -73.49 -41.57 62.93 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.642 -1.286 . . . . 0.0 111.102 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -67.5 -2.45 6.51 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.8 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -133.76 48.0 2.4 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.937 -1.727 . . . . 0.0 112.096 -178.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.667 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER 176.21 -164.79 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.646 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -129.49 117.63 18.75 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 190' ' ' THR . 10.7 Cg_endo -67.12 -4.11 10.98 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.554 1.503 . . . . 0.0 111.615 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -101.3 -13.76 17.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.196 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -68.02 70.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.633 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -52.05 -118.26 0.01 OUTLIER Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.659 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.62 39.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -1.041 . . . . 0.0 109.334 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.612 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -156.52 164.83 37.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.681 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -155.52 89.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.566 -1.334 . . . . 0.0 109.44 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.599 ' H ' ' CD ' ' A' ' 143' ' ' GLN . . . 51.72 -113.65 2.56 Favored Glycine 0 N--CA 1.478 1.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -80.48 3.83 20.24 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.434 -0.883 . . . . 0.0 110.236 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -108.28 146.34 33.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.915 -1.116 . . . . 0.0 108.934 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.61 130.42 32.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.053 -1.029 . . . . 0.0 109.961 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.01 163.34 9.48 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.421 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.501 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 44.8 p -73.72 -10.62 59.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.523 -0.986 . . . . 0.0 109.896 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 16.2 pm0 -87.47 -7.08 58.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 32.2 m-85 -124.41 60.43 1.15 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.082 -1.011 . . . . 0.0 108.772 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.472 HH12 ' HB ' ' A' ' 153' ' ' THR . 5.4 ptt-85 -112.96 173.67 6.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 118.57 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -139.62 116.36 10.83 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' A' ' 192' ' ' ASP . 48.4 t -102.19 148.34 7.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.609 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.412 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 91.0 m-85 -139.23 87.36 13.82 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.776 -1.203 . . . . 0.0 108.554 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -46.02 163.15 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.881 2.387 . . . . 0.0 112.243 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.566 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.14 -21.54 13.24 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 120.635 -1.29 . . . . 0.0 110.553 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 162' ' ' THR . 0.8 OUTLIER -176.48 178.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 0.0 108.929 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.31 -16.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 123.007 1.384 . . . . 0.0 108.484 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.558 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.3 t -59.26 -62.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.812 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.925 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.576 ' O ' ' CB ' ' A' ' 170' ' ' ALA . 4.5 mp0 -77.74 -19.4 55.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 110.381 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.5 ttt -54.09 -54.66 36.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.954 -1.092 . . . . 0.0 109.534 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -54.58 -66.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 109.77 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -57.5 -39.33 76.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.869 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.44 -58.54 6.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.6 mp -53.04 -49.5 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -60.87 -48.55 81.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 109.466 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.473 ' HB2' ' NE1' ' A' ' 136' ' ' TRP . 1.0 OUTLIER -55.97 -40.15 72.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.66 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.554 ' NZ ' ' OG1' ' A' ' 191' ' ' THR . 0.0 OUTLIER -73.04 -58.2 3.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.607 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.97 -44.56 92.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.913 . . . . 0.0 110.81 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 74.8 mt-10 -53.1 -20.21 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.031 . . . . 0.0 110.451 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.479 ' CD2' ' HG3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -79.49 -40.08 30.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.821 -1.174 . . . . 0.0 110.556 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -44.8 65.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.835 -1.166 . . . . 0.0 108.502 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -30.59 5.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 109.286 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.7 t -87.9 -54.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.278 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.477 HD22 ' CG ' ' A' ' 186' ' ' PHE . 25.3 mt -58.99 -45.55 90.34 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.387 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -23.57 22.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.972 -1.08 . . . . 0.0 109.023 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -88.43 -13.84 39.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.338 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 2.9 m-70 -99.85 11.76 38.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 72.0 55.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.73 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.477 ' CG ' HD22 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -119.31 -176.58 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 108.972 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -119.55 -158.13 10.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.561 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.4 Cg_exo -58.63 116.47 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.325 2.017 . . . . 0.0 110.771 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.2 OUTLIER -47.91 -175.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.005 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.633 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 26.8 p -154.67 55.34 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.654 -0.653 . . . . 0.0 110.384 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.554 ' OG1' ' NZ ' ' A' ' 174' ' ' LYS . 32.9 m -99.93 119.05 37.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 17.2 t0 -75.9 111.06 10.88 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.389 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 1.0 OUTLIER -117.33 114.82 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 110.466 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.799 ' HE ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -165.0 -170.16 1.87 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.539 ' OE2' ' C ' ' A' ' 194' ' ' ARG . 9.4 mp0 -145.82 178.66 8.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.309 . . . . 0.0 110.389 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.23 14.91 67.88 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.077 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.799 ' NE2' ' HE ' ' A' ' 194' ' ' ARG . 1.2 mp0 -89.35 126.47 35.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.502 -1.587 . . . . 0.0 109.784 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.31 154.87 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.468 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 6.7 t80 -92.82 124.79 37.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.13 95.09 5.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.285 -0.884 . . . . 0.0 108.975 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.46 ' CE1' HG13 ' A' ' 56' ' ' VAL . 22.8 m-85 -54.41 133.87 45.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.322 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.476 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -84.58 -175.75 5.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.722 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.2 pm0 -74.89 171.5 13.92 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -58.52 -53.84 53.74 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.66 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -51.35 -11.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.016 -1.052 . . . . 0.0 111.118 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.783 ' CE1' ' CZ2' ' A' ' 74' ' ' TRP . 12.2 m-70 -101.49 10.27 40.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.709 -1.245 . . . . 0.0 110.335 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.0 mm-40 -131.12 -146.46 0.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.233 1.015 . . . . 0.0 110.009 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.631 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 12.8 mp0 -33.87 -8.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.444 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 11.3 t80 -44.95 -40.52 6.45 Favored 'General case' 0 N--CA 1.515 2.815 0 O-C-N 120.146 -1.596 . . . . 0.0 109.343 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -52.61 -18.43 1.76 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 120.868 -1.145 . . . . 0.0 110.47 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 p -61.39 -39.7 91.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -71.02 -33.07 70.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.306 -0.871 . . . . 0.0 109.687 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 215' ' ' ASP . 5.6 m-80 -134.27 70.0 73.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.441 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.449 ' HB3' ' NE ' ' A' ' 78' ' ' ARG . 24.3 Cg_exo -60.76 8.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.039 2.492 . . . . 0.0 112.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 213' ' ' ASN . 10.1 t0 -63.37 -18.97 64.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.524 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.79 85.32 0.05 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.512 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.74 92.97 9.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.598 2.199 . . . . 0.0 109.388 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.727 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -169.72 112.74 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 109.491 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -0.33 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.505 3.294 0 CA-C-O 122.464 1.036 . . . . 0.0 112.711 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.78 -173.71 2.76 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.676 -0.896 . . . . 0.0 109.69 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -82.73 -149.04 7.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -153.64 -136.66 2.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 O-C-N 121.286 -1.126 . . . . 0.0 109.131 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.635 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.213 -0.822 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.635 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.75 168.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.744 1.259 . . . . 0.0 109.539 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.09 124.47 31.8 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.68 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -55.9 -46.01 78.49 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.761 -0.587 . . . . 0.0 109.576 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 3.1 pm0 -78.46 15.77 0.93 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.569 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.582 ' O ' ' C ' ' A' ' 34' ' ' ALA . 10.1 tp10 -116.07 -40.6 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.6 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -29.0 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.766 . . . . 0.0 110.108 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.21 168.19 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.595 2.197 . . . . 0.0 112.209 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.448 HG11 ' N ' ' A' ' 204' ' ' ASP . 12.5 m -139.39 170.4 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.167 -0.958 . . . . 0.0 109.675 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 45' ' ' THR . 13.4 t -58.82 103.77 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.356 -0.84 . . . . 0.0 110.231 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.572 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.92 -50.13 73.51 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.359 -0.838 . . . . 0.0 111.479 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.4 pttt -70.74 100.62 1.92 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 115.846 -2.342 . . . . 0.0 108.168 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.591 ' NE2' ' CD ' ' A' ' 208' ' ' GLN . 6.3 t-80 -31.95 125.02 0.28 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.003 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -66.65 -8.08 25.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 110.848 -178.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.459 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 18.9 t -92.98 -63.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.161 . . . . 0.0 109.805 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -83.56 -42.76 16.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.0 5.5 54.82 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.3 p30 -81.52 -119.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.689 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttp180 -129.54 168.67 16.04 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.989 1.376 . . . . 0.0 108.418 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.572 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 20.8 p -128.38 30.68 5.14 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.94 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 55' ' ' THR . 7.0 m -161.29 132.58 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-10 -33.78 154.41 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.314 0 CA-C-O 121.899 0.857 . . . . 0.0 110.852 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD2' ' NH2' ' A' ' 54' ' ' ARG . 96.5 Cg_endo -79.44 166.28 78.52 Favored 'Cis proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.48 -2.3 . . . . 0.0 111.756 -0.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.469 ' CE1' HG13 ' A' ' 120' ' ' VAL . 32.6 m-85 -108.37 154.51 41.39 Favored Pre-proline 0 C--N 1.267 -3.005 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.041 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.445 ' O ' ' OG1' ' A' ' 63' ' ' THR . 51.3 Cg_exo -49.51 148.88 10.63 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.33 2.02 . . . . 0.0 112.468 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -55.95 132.79 50.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.84 53.91 2.6 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -136.23 137.1 40.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -1.051 . . . . 0.0 109.44 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.532 ' OE1' ' CA ' ' A' ' 64' ' ' GLN . 1.6 tp60 -123.85 125.43 44.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.688 ' SD ' ' NH2' ' A' ' 118' ' ' ARG . 3.5 ptt? -109.63 141.28 42.39 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.621 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.43 -167.29 1.87 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.0 129.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.081 -1.637 . . . . 0.0 109.446 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.483 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 59.1 m-85 -117.82 125.75 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.116 -0.99 . . . . 0.0 108.61 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 157' ' ' SER . . . -113.13 105.81 1.72 Allowed Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.023 -1.56 . . . . 0.0 110.146 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.723 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -107.86 -88.79 0.47 Allowed 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.449 -1.03 . . . . 0.0 108.666 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.635 ' N ' ' OE2' ' A' ' 115' ' ' GLU . . . -146.92 -152.73 5.71 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.812 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -36.42 106.05 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 108.956 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.85 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.419 -0.801 . . . . 0.0 112.307 -178.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.812 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 21.1 m0 -67.48 -48.73 66.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.076 -1.64 . . . . 0.0 109.412 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.43 5.42 57.21 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.55 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.726 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.42 -41.86 38.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.276 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 90' ' ' GLN . 2.6 tp10 -83.39 -14.82 51.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.15 -0.969 . . . . 0.0 111.786 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.598 ' C ' ' H ' ' A' ' 80' ' ' PHE . 15.0 ttp85 -57.52 -73.13 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.807 -1.183 . . . . 0.0 110.965 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 11.9 mttt -61.71 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.726 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.5 m-85 -115.87 -29.95 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.757 -1.215 . . . . 0.0 110.602 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.0 OUTLIER -104.26 -0.75 27.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.723 -1.236 . . . . 0.0 109.571 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.3 8.51 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 109.105 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.626 ' C ' ' CD1' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -103.3 -179.03 3.84 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -96.72 156.51 16.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.639 -1.288 . . . . 0.0 111.209 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.72 79.88 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.557 -0.714 . . . . 0.0 111.906 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 t -99.79 129.52 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 120.387 -1.654 . . . . 0.0 110.791 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.588 ' HH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -77.68 -43.8 30.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.53 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t -169.62 -176.74 2.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.434 ' HB ' ' CG ' ' A' ' 77' ' ' GLU . 7.7 p -148.31 149.53 32.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.097 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.576 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 8.8 mp0 -146.71 170.51 16.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.41 -0.806 . . . . 0.0 109.455 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 207' ' ' GLN . 0.1 OUTLIER -146.66 167.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . 178.06 156.02 15.61 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -80.01 160.71 25.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.604 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.648 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.56 -170.11 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 0.0 109.875 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.35 22.41 63.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.745 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -128.44 -164.06 11.46 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -145.57 78.5 1.54 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.38 -1.07 . . . . 0.0 109.708 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.498 ' O ' ' C ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -147.36 135.18 21.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.616 ' C ' HD21 ' A' ' 100' ' ' ASN . 5.9 mtt180 -38.84 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.616 HD21 ' C ' ' A' ' 99' ' ' ARG . 1.1 m-80 -122.47 89.5 49.47 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 109.668 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -70.87 132.81 22.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.834 2.356 . . . . 0.0 110.848 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 21.1 p -124.21 159.43 30.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.845 -1.159 . . . . 0.0 110.614 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 102' ' ' THR . 6.0 t80 -48.41 -38.85 20.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 108.834 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -40.46 64.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.79 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.421 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.0 mm-40 -81.75 -30.99 32.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -80.98 -29.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 108.833 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -28.97 64.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.508 -0.745 . . . . 0.0 109.496 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.677 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 51.6 p -62.67 -70.46 0.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.677 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.9 mt-10 140.4 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -48.22 1.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 110.939 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' GLU . 14.4 p -108.25 -7.47 15.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.814 -1.179 . . . . 0.0 109.55 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 43.03 51.0 6.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.745 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 15.4 m-70 -97.27 169.19 9.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.295 . . . . 0.0 108.929 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.2 113.08 17.82 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.665 ' OE2' ' N ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -51.7 114.67 1.34 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.959 . . . . 0.0 108.939 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.479 HG12 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -125.34 157.66 34.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 20.6 m -130.14 131.96 65.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.688 ' NH2' ' SD ' ' A' ' 65' ' ' MET . 10.6 ptm180 -103.68 130.34 51.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.738 -1.226 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.484 ' CG1' ' OE2' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -132.86 138.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.61 122.0 63.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -125.41 166.88 15.79 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.472 -177.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.471 ' HG2' ' H ' ' A' ' 125' ' ' HIS . 4.5 ttm180 -99.26 114.1 65.29 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.668 -0.645 . . . . 0.0 110.534 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.85 -42.37 51.78 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.406 2.07 . . . . 0.0 111.785 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -57.28 -23.09 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.299 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.471 ' H ' ' HG2' ' A' ' 122' ' ' ARG . 1.1 m-70 -104.86 -56.02 2.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 108.849 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.42 ' CD1' ' HG3' ' A' ' 130' ' ' GLU . 3.3 tp -130.25 133.43 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.541 ' H ' ' HG ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -78.47 168.53 19.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.16 -0.963 . . . . 0.0 110.42 -178.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' CE2' HD13 ' A' ' 132' ' ' LEU . 4.0 t80 -69.56 -44.87 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 130' ' ' GLU . 1.3 pt-20 -47.95 -31.06 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 11.8 mm-40 -57.38 -70.02 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 111.216 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.514 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 8.5 mp -56.31 -27.13 54.55 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.133 -1.604 . . . . 0.0 110.078 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.488 HD13 ' CE2' ' A' ' 128' ' ' PHE . 5.0 mt -55.91 -30.54 61.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.382 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.441 ' HB2' ' HZ1' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -70.63 -52.0 24.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.686 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 9.2 t -49.91 -30.7 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 108.461 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 51.3 t80 -70.79 -46.6 62.58 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.028 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.475 ' HB3' ' CD1' ' A' ' 177' ' ' TYR . 58.2 m95 -72.68 -60.94 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.396 -1.44 . . . . 0.0 110.719 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 14.8 tm-20 -37.93 -56.98 1.07 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.311 -0.868 . . . . 0.0 111.789 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.743 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 4.6 p30 -96.55 61.55 1.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.011 -1.056 . . . . 0.0 110.681 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.765 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 13.4 m80 -152.99 -161.81 1.36 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.669 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -121.24 178.06 1.31 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' CD ' ' OD2' ' A' ' 140' ' ' ASP . 9.7 Cg_exo -69.09 -83.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.257 1.971 . . . . 0.0 112.005 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -124.83 13.44 8.55 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.378 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 140' ' ' ASP . 2.6 mt-30 -55.45 70.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.008 -1.058 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.79 13.67 51.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.41 2.42 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -1.083 . . . . 0.0 109.296 179.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.478 ' NE ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER 174.98 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.245 -0.909 . . . . 0.0 109.223 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.92 103.11 11.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 119.581 -1.949 . . . . 0.0 108.822 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' NE ' ' A' ' 146' ' ' ARG . . . 67.21 -118.74 10.55 Favored Glycine 0 C--N 1.301 -1.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.79 -33.17 30.99 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-N 114.381 -0.909 . . . . 0.0 112.377 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.632 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 4.5 m-20 -72.19 99.1 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.229 -1.544 . . . . 0.0 110.415 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.655 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 10.5 p90 -92.92 128.83 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.82 177.58 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.21 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.87 -0.49 48.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -1.135 . . . . 0.0 109.602 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.413 ' HG3' ' CE1' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -100.81 4.33 42.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.113 -0.992 . . . . 0.0 109.308 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.541 ' CG ' ' CB ' ' A' ' 150' ' ' ASP . 29.4 m-85 -124.65 58.41 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 108.74 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -110.18 -177.09 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.514 -0.741 . . . . 0.0 109.347 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 31.1 t -90.66 128.39 36.61 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.45 ' HB2' ' CE1' ' A' ' 160' ' ' TYR . . . -151.01 113.19 4.56 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.715 -1.594 . . . . 0.0 111.553 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.434 ' CG2' ' CG2' ' A' ' 191' ' ' THR . 5.8 t -113.71 122.33 67.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.479 ' CE2' HG12 ' A' ' 116' ' ' VAL . 11.0 m-30 -111.03 124.64 32.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 O-C-N 121.583 -0.698 . . . . 0.0 109.328 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.26 176.53 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.767 2.311 . . . . 0.0 112.193 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.96 -23.54 19.54 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 174.33 -162.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.6 -15.57 7.83 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 123.039 1.4 . . . . 0.0 108.549 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.3 t -55.82 -63.46 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.817 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.321 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.495 HE22 ' NE2' ' A' ' 64' ' ' GLN . 16.8 mt-30 -78.56 -12.59 60.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.707 . . . . 0.0 111.375 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 6.0 ttm -52.6 -44.89 66.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.685 -1.26 . . . . 0.0 109.915 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -75.63 -20.35 58.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 109.759 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.61 -52.78 4.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.006 . . . . 0.0 110.0 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.53 -42.0 63.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.73 -31.02 35.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.334 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -74.41 -35.56 63.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.469 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 76.8 p -56.68 -46.11 81.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 109.781 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -70.21 -44.36 68.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -72.16 -15.85 61.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 109.876 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.37 -57.75 3.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.26 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 136' ' ' TRP . 7.7 t80 -67.21 -37.26 83.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 187' ' ' GLY . 14.2 tp60 -62.21 -10.96 12.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -37.89 65.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.57 -37.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.028 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.65 ' C ' ' H ' ' A' ' 183' ' ' LYS . 4.2 mm? -67.58 -48.52 66.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.089 -1.007 . . . . 0.0 109.733 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t -56.04 1.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.965 -1.084 . . . . 0.0 109.213 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 181' ' ' LEU . 21.8 ttpt -78.1 -53.48 7.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 108.971 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.743 ' CD2' ' CE2' ' A' ' 186' ' ' PHE . 0.0 OUTLIER -75.64 7.2 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.4 OUTLIER 73.29 64.07 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 109.8 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.743 ' CE2' ' CD2' ' A' ' 184' ' ' HIS . 21.4 m-85 -99.27 174.38 6.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.21 -0.931 . . . . 0.0 108.723 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -77.1 175.6 53.87 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.599 ' O ' ' OG1' ' A' ' 142' ' ' THR . 26.6 Cg_exo -58.95 -175.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.497 2.131 . . . . 0.0 111.617 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 191' ' ' THR . 1.1 mm -89.41 112.23 24.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.058 -1.027 . . . . 0.0 109.675 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.559 ' N ' ' HG1' ' A' ' 142' ' ' THR . 2.3 t -78.33 -3.07 41.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 109.444 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.486 ' H ' HG22 ' A' ' 189' ' ' ILE . 20.6 m -42.95 114.46 0.61 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.601 1.191 . . . . 0.0 108.101 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.664 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 4.1 t70 -76.14 116.94 17.32 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.962 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.81 100.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.851 . . . . 0.0 109.297 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.664 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -154.45 151.74 29.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 109.026 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.661 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -109.55 -175.7 2.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.71 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.06 34.06 48.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -106.95 118.79 37.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.4 p -57.04 159.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.529 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 13.5 t80 -113.7 126.6 55.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.576 ' OH ' ' O ' ' A' ' 99' ' ' ARG . 6.9 m-85 -127.86 103.12 7.09 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.17 -0.956 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -54.32 137.62 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 111.191 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.491 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . . . -88.34 179.59 6.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 3.4 pt-20 -74.56 171.75 13.25 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.417 -0.802 . . . . 0.0 109.302 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.448 ' N ' HG11 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.99 -47.45 85.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.036 -1.04 . . . . 0.0 108.478 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.478 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -50.08 -25.44 3.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 109.826 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.663 ' ND1' ' CD1' ' A' ' 73' ' ' PHE . 14.5 m-70 -92.67 8.28 39.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.98 . . . . 0.0 109.839 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -127.91 -136.77 0.24 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.834 1.302 . . . . 0.0 110.177 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.591 ' CD ' ' NE2' ' A' ' 48' ' ' HIS . 1.4 mp0 -35.01 -4.64 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.196 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.825 ' N ' ' O ' ' A' ' 207' ' ' GLN . 87.6 t80 -41.96 -48.72 4.57 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.616 -1.302 . . . . 0.0 110.537 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.637 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 2.9 mt -50.23 -12.53 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.512 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 209' ' ' TYR . 32.4 t -67.32 -40.36 85.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.219 -0.926 . . . . 0.0 108.921 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.69 -39.7 30.7 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.27 -0.894 . . . . 0.0 109.196 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -119.47 120.37 30.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 216' ' ' GLY . 58.3 Cg_endo -72.68 -50.48 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.074 1.849 . . . . 0.0 112.672 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 217' ' ' TYR . 5.7 p-10 -62.81 -3.52 1.61 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.048 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 61.31 -66.68 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 215' ' ' ASP . 38.2 p90 -177.98 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 108.325 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.506 ' N ' ' CD2' ' A' ' 217' ' ' TYR . 10.2 t -73.71 -124.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.039 -1.038 . . . . 0.0 108.676 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 74.53 -164.8 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.2 mp -151.33 -175.17 5.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -73.61 -110.78 0.07 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -135.81 -141.11 4.28 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 119.562 -1.304 . . . . 0.0 109.893 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 139' ' ' HIS . 50.5 p . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.329 -1.101 . . . . 0.0 109.177 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.213 -0.824 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.733 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.29 174.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.359 1.552 . . . . 0.0 109.65 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 124.7 25.39 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.112 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.9 86.8 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.24 0.543 . . . . 0.0 109.553 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.565 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.14 0.67 5.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 tt0 -99.41 -48.47 4.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 108.964 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -30.68 152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.547 0.689 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.652 ' O ' ' CG2' ' A' ' 98' ' ' THR . 4.2 mm? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 42' ' ' ILE . 82.9 Cg_exo -44.19 -170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.799 2.333 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.562 ' CG1' ' O ' ' A' ' 43' ' ' PRO . 31.2 m -162.23 161.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.275 -0.891 . . . . 0.0 110.112 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER 25.55 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.693 -0.629 . . . . 0.0 111.195 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.619 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -87.47 -45.42 10.52 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.099 -1.0 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.5 98.99 10.42 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 115.737 -2.385 . . . . 0.0 108.155 179.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.677 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.9 t-80 -32.73 115.89 0.2 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.96 -40.88 90.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 0.0 110.501 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 48.5 t -56.67 -49.69 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 109.867 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -99.59 -46.1 5.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.86 4.06 55.77 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.89 -118.7 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 ttt180 -125.36 171.56 10.33 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.097 1.427 . . . . 0.0 108.689 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.619 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.3 p -131.22 12.06 5.05 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.163 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.564 ' CG1' ' CZ ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -144.78 131.03 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.057 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' VAL . 17.4 mt-10 -34.63 156.51 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 CA-C-O 121.979 0.895 . . . . 0.0 110.818 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -81.44 165.36 74.9 Favored 'Cis proline' 0 C--N 1.3 -1.981 0 C-N-CA 121.466 -2.306 . . . . 0.0 111.992 -0.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CE2' ' CG2' ' A' ' 120' ' ' VAL . 28.6 m-85 -112.42 149.61 41.33 Favored Pre-proline 0 C--N 1.267 -3.004 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.765 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' GLU . 10.0 Cg_endo -54.47 140.27 74.46 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.732 2.288 . . . . 0.0 112.195 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 60' ' ' PRO . 4.4 mt-10 -43.47 157.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.23 47.77 42.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.538 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -133.32 135.63 44.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.736 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.538 ' OE1' ' C ' ' A' ' 63' ' ' THR . 3.8 mp0 -123.63 145.82 48.65 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 3.2 ttp -139.57 145.42 38.58 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 109.793 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.61 -170.61 2.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 160' ' ' TYR . 22.9 t -144.17 107.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 119.967 -1.708 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.53 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.2 OUTLIER -162.63 162.8 27.24 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.763 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.21 148.15 19.24 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.287 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.701 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 0.8 OUTLIER -85.73 -84.55 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 0.0 108.358 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.715 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.94 75.85 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.715 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 48.3 t 111.13 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -52.58 5.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.574 -1.329 . . . . 0.0 110.797 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.674 ' H ' ' C ' ' A' ' 72' ' ' CYS . 32.6 m0 -89.14 -90.96 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.698 -1.251 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.18 -6.09 1.85 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 74' ' ' TRP . . . -76.48 -70.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -1.13 . . . . 0.0 110.953 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.592 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 13.8 tp10 -51.03 -14.71 0.24 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.682 ' O ' ' N ' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -64.0 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.168 . . . . 0.0 110.341 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' A' ' 78' ' ' ARG . 3.9 mmtt -30.62 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 111.349 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.682 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.3 m-85 -76.25 -42.16 46.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.801 -1.187 . . . . 0.0 111.734 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -85.56 2.29 45.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.486 -1.383 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.423 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -97.4 22.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.978 -1.076 . . . . 0.0 109.526 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 mt -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 108.993 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -92.91 142.94 26.76 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.364 0.602 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.488 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 101.75 -26.91 22.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.74 136.55 26.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.628 -0.925 . . . . 0.0 109.573 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.602 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.61 -44.33 17.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.527 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.1 p -170.8 -169.58 0.79 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 88' ' ' SER . 75.2 p -158.55 165.48 34.42 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.301 -0.875 . . . . 0.0 109.317 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.592 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.51 169.78 11.8 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.363 -0.836 . . . . 0.0 109.021 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' CG2' ' CD ' ' A' ' 207' ' ' GLN . 4.1 m -129.18 -173.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.47 160.7 19.53 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.943 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 202' ' ' ALA . 7.7 m-85 -97.51 154.21 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.956 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . . . -178.6 179.28 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.35 93.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.502 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -136.6 -151.31 6.01 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.0 61.28 1.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 0.0 109.344 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.652 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.47 176.89 12.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CE1' ' A' ' 200' ' ' TYR . 99.5 mtt180 -100.83 -77.49 0.54 Allowed 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -117.28 70.77 6.04 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.377 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HG3' ' NE2' ' A' ' 113' ' ' HIS . 44.0 Cg_endo -71.87 170.53 18.58 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.746 2.297 . . . . 0.0 112.057 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.638 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.4 p -121.06 171.36 8.72 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.562 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -63.52 -59.33 4.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.631 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -58.42 -23.0 56.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 108.392 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.638 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.0 mm-40 -73.02 -56.45 5.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.397 0.618 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.401 ' CG1' ' OG1' ' A' ' 111' ' ' THR . 17.3 m -65.47 -24.67 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.288 -0.883 . . . . 0.0 111.421 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.631 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 12.5 p -55.61 -23.44 27.53 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.639 ' C ' ' H ' ' A' ' 110' ' ' LYS . 21.4 t -69.62 5.38 1.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.227 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 107' ' ' CYS . 1.9 tt0 59.61 -6.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.272 -0.893 . . . . 0.0 109.483 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.639 ' H ' ' C ' ' A' ' 108' ' ' SER . 18.0 mttt -72.52 -29.37 63.53 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 110.713 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.529 ' O ' ' C ' ' A' ' 112' ' ' GLY . 68.7 p -87.47 -6.59 58.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.878 -1.139 . . . . 0.0 110.541 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 35.31 43.84 0.53 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.439 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.502 ' ND1' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.1 163.17 26.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.393 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -113.49 113.41 25.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 0.0 108.972 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.658 ' CD ' ' N ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -50.12 127.02 15.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.48 HG13 ' CE2' ' A' ' 160' ' ' TYR . 2.6 m -151.1 165.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 2.5 m -143.96 149.4 17.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.195 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.766 ' CD ' ' CZ ' ' A' ' 199' ' ' PHE . 10.1 ptm180 -116.84 95.05 4.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.6 m -97.06 126.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.927 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.508 ' CG2' ' CE2' ' A' ' 59' ' ' PHE . 3.9 t -80.63 140.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.568 ' CD2' ' CD2' ' A' ' 131' ' ' LEU . 4.5 m-85 -132.05 161.0 34.27 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.079 -1.013 . . . . 0.0 109.224 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.638 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -125.07 109.72 27.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.506 -0.746 . . . . 0.0 110.384 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 124' ' ' GLU . 24.1 Cg_exo -44.43 -61.44 0.58 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.401 2.734 . . . . 0.0 114.493 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 123' ' ' PRO . 38.6 tt0 -25.98 -57.32 0.07 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.402 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.6 22.68 13.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.733 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -157.87 162.94 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.382 -0.824 . . . . 0.0 108.962 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.488 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -125.94 165.61 18.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.44 -1.412 . . . . 0.0 110.942 -179.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.567 ' CZ ' ' CD2' ' A' ' 132' ' ' LEU . 38.6 t80 -70.61 -43.8 68.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 108.988 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 5.0 mp0 -48.02 -14.6 0.05 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.891 -1.131 . . . . 0.0 108.086 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -73.67 -69.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.806 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -40.98 -38.7 1.02 Allowed 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.606 -1.308 . . . . 0.0 108.296 179.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.567 ' CD2' ' CZ ' ' A' ' 128' ' ' PHE . 4.2 mm? -75.42 -35.13 61.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.525 -0.734 . . . . 0.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 130' ' ' GLU . 0.5 OUTLIER -70.28 -57.68 4.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.964 -1.085 . . . . 0.0 111.256 -178.41 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.682 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.6 OUTLIER -50.42 -35.49 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.081 -1.012 . . . . 0.0 109.767 -178.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 50.7 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.526 -0.734 . . . . 0.0 110.485 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.613 ' O ' ' CG2' ' A' ' 223' ' ' THR . 90.5 m95 -72.8 -33.19 66.08 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.866 -1.146 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -79.43 -21.52 45.43 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.2 m-80 -121.28 53.69 1.15 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.102 -1.624 . . . . 0.0 113.443 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.786 ' NE2' ' CZ ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER 172.51 -175.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.186 0.993 . . . . 0.0 110.13 176.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 142' ' ' THR . 3.5 t70 -128.3 134.98 26.85 Favored Pre-proline 0 C--N 1.291 -1.959 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.429 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 190' ' ' THR . 72.0 Cg_endo -80.31 -11.15 13.36 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.353 2.035 . . . . 0.0 112.854 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.615 ' N ' ' OD1' ' A' ' 140' ' ' ASP . 1.9 p -104.04 50.23 0.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 109.362 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.796 ' N ' ' HG1' ' A' ' 190' ' ' THR . 5.6 mm100 -114.64 83.63 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -38.55 -117.53 0.0 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.922 0.734 . . . . 0.0 112.499 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.671 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 11.0 ptt? -92.87 53.5 2.02 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -1.02 . . . . 0.0 109.507 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' C ' ' O ' ' A' ' 155' ' ' TYR . 28.4 ptt-85 -178.56 154.71 0.79 Allowed 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.701 ' NE2' ' O ' ' A' ' 70' ' ' MET . 6.4 mt-30 -157.18 149.17 22.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.344 -1.473 . . . . 0.0 110.718 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.52 -124.62 3.21 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-O 122.986 1.326 . . . . 0.0 110.66 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -81.54 -35.32 30.43 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.049 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.654 ' OD2' ' SG ' ' A' ' 72' ' ' CYS . 0.0 OUTLIER -87.19 152.2 22.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.316 -1.49 . . . . 0.0 107.92 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.461 ' CB ' ' HB2' ' A' ' 146' ' ' ARG . 8.9 p90 -136.58 154.49 50.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.47 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.671 ' CA ' ' O ' ' A' ' 145' ' ' MET . . . 126.6 178.64 15.4 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 118.48 -1.819 . . . . 0.0 111.642 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -66.76 0.86 2.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.638 -0.919 . . . . 0.0 110.584 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 14.8 pm0 -112.38 16.5 19.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.75 -1.219 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.692 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 28.2 m-85 -146.69 59.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.576 ' O ' ' OE2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -114.81 177.05 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.591 ' OG ' ' O ' ' A' ' 190' ' ' THR . 1.0 OUTLIER -90.44 124.36 34.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 119.867 -1.77 . . . . 0.0 106.455 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.68 111.48 6.35 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.084 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.566 ' O ' ' CG2' ' A' ' 159' ' ' VAL . 1.3 m -113.41 123.98 69.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.253 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.48 ' CE2' HG13 ' A' ' 116' ' ' VAL . 2.4 m-30 -112.7 126.16 28.76 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.75 170.67 17.2 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.146 1.898 . . . . 0.0 112.228 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.498 ' HB ' HE22 ' A' ' 166' ' ' GLN . 0.7 OUTLIER -102.9 -22.19 13.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 120.923 -1.111 . . . . 0.0 110.22 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -176.92 174.59 1.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 108.972 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.49 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 123.081 1.42 . . . . 0.0 108.181 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 163' ' ' SER . 4.9 t -58.06 -62.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.836 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.498 HE22 ' HB ' ' A' ' 162' ' ' THR . 4.6 mp0 -76.68 -12.9 60.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.492 -0.755 . . . . 0.0 110.123 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' MET . . . . . 0.438 ' SD ' ' HA ' ' A' ' 164' ' ' ALA . 32.3 mtt -53.99 -47.97 70.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 109.971 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.047 -1.033 . . . . 0.0 110.161 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.48 -58.82 2.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 0.0 109.866 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.79 -48.55 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.955 . . . . 0.0 109.852 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -42.43 65.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.542 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -68.3 -45.04 74.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.163 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.59 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 8.7 p -56.32 -53.48 56.81 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -55.91 -58.2 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.453 ' N ' ' HD3' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -60.61 -11.4 7.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.539 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.18 -50.45 16.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 110.007 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 181' ' ' LEU . 1.1 m-85 -79.41 -31.16 42.67 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.062 -1.024 . . . . 0.0 109.797 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -63.08 -40.79 98.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -77.82 -26.36 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.29 -54.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.021 -1.049 . . . . 0.0 110.058 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.511 ' CD2' ' CD2' ' A' ' 177' ' ' TYR . 4.4 mm? -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.4 t -56.22 -35.64 67.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -88.49 9.09 24.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.855 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.462 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 38.5 m-70 -108.41 29.32 7.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.057 -1.027 . . . . 0.0 109.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.92 16.26 5.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -104.53 174.92 5.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.172 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -125.62 -149.02 7.36 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.75 106.64 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.379 2.053 . . . . 0.0 110.709 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -48.08 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 110.409 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.796 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 79.4 p -119.95 47.38 1.75 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.396 0.617 . . . . 0.0 109.746 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.422 ' CG2' HG12 ' A' ' 159' ' ' VAL . 54.2 m -97.94 118.67 35.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.4 t70 -76.08 140.76 42.02 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.42 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.56 93.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.977 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -157.15 153.18 27.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.642 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -119.67 -173.41 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.02 20.76 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 198' ' ' VAL . 61.1 mm-40 -91.63 101.81 14.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.273 . . . . 0.0 109.531 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.527 ' C ' ' O ' ' A' ' 197' ' ' GLN . 3.0 p -35.95 153.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.766 ' CZ ' ' CD ' ' A' ' 118' ' ' ARG . 68.9 t80 -111.13 131.25 55.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CE1' ' O ' ' A' ' 99' ' ' ARG . 42.1 m-85 -127.26 112.65 15.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 0.0 109.419 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.569 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 16.5 m-85 -53.74 142.69 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.075 . . . . 0.0 110.614 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 44' ' ' VAL . . . -90.77 178.18 6.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.575 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 3.0 mt-10 -73.67 161.13 30.62 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.557 1.17 . . . . 0.0 110.364 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -56.36 -49.72 73.57 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.531 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.575 ' OH ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -59.47 -3.75 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.087 -1.008 . . . . 0.0 110.777 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.562 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 14.6 m-70 -101.29 -20.91 15.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.823 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -101.2 -134.36 0.3 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.705 1.24 . . . . 0.0 110.504 -178.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 211' ' ' SER . 1.3 mp0 -34.88 -2.93 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.442 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.823 ' N ' ' O ' ' A' ' 207' ' ' GLN . 75.9 t80 -41.34 -46.38 3.27 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.191 -1.568 . . . . 0.0 109.952 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.619 ' CD1' ' C ' ' A' ' 74' ' ' TRP . 0.7 OUTLIER -71.34 -13.21 61.8 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.573 -1.329 . . . . 0.0 110.441 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 208' ' ' GLN . 36.9 t -63.38 -38.68 92.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 108.985 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -72.78 -38.73 67.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.357 -0.84 . . . . 0.0 109.35 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.57 77.42 76.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.063 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.675 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 12.7 Cg_exo -66.73 5.08 0.84 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.99 2.46 . . . . 0.0 112.683 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.95 -19.99 64.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.11 84.46 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.829 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 217' ' ' TYR . 78.8 t80 -70.53 83.94 0.6 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 121.108 2.454 . . . . 0.0 109.268 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 43.1 t -168.84 -124.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.966 -1.084 . . . . 0.0 108.803 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.529 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 134.69 153.4 6.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.478 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 75.62 143.15 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -1.106 . . . . 0.0 110.06 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -134.27 -144.43 5.07 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -152.0 -144.3 3.89 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.643 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 O-C-N 121.494 -1.004 . . . . 0.0 109.032 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.721 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.213 -0.84 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.721 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.14 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 123.068 1.413 . . . . 0.0 110.029 -177.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -94.9 123.86 38.61 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.344 179.49 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -56.74 -57.87 10.57 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.156 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' OE1' ' O ' ' A' ' 32' ' ' GLU . 1.5 pp20? -53.05 -6.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.952 . . . . 0.0 109.915 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.0 tt0 -112.46 -35.99 5.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.613 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -44.88 -179.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.285 -0.884 . . . . 0.0 109.552 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.428 ' HB2' ' HG1' ' A' ' 98' ' ' THR . 4.2 mm? . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 43' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 42' ' ' ILE . 74.0 Cg_exo -46.27 -166.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.321 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.1 m -150.56 -179.16 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.592 ' O ' ' OG1' ' A' ' 55' ' ' THR . 9.6 t -34.19 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.773 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.646 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -55.86 -38.75 70.51 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.344 -0.847 . . . . 0.0 111.196 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttp -91.46 98.7 11.84 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 116.15 -2.22 . . . . 0.0 108.678 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.675 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.7 t-80 -31.73 110.95 0.08 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -59.82 -30.79 69.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 110.807 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.468 HG23 ' CE1' ' A' ' 48' ' ' HIS . 3.4 t -64.6 -43.4 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.934 -1.104 . . . . 0.0 109.524 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.86 -44.49 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.941 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 104.1 1.73 45.03 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.5 p30 -76.15 -112.05 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.607 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -130.68 175.25 9.17 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 123.806 1.765 . . . . 0.0 110.811 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.611 ' HG1' ' C ' ' A' ' 46' ' ' ALA . 6.9 p -149.33 23.35 0.92 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 112.425 -2.17 . . . . 0.0 110.088 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -157.27 132.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 56' ' ' VAL . 12.7 mt-10 -41.48 156.03 0.22 Allowed Pre-proline 0 C--N 1.304 -1.397 0 CA-C-O 121.855 0.836 . . . . 0.0 110.199 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.24 157.12 62.87 Favored 'Cis proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.494 0.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.769 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 18.7 m-85 -104.15 147.91 35.08 Favored Pre-proline 0 C--N 1.279 -2.496 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 11.7 Cg_endo -57.47 134.21 61.94 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.843 2.362 . . . . 0.0 112.423 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -49.34 158.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 64' ' ' GLN . . . 93.91 -35.88 3.98 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -83.03 134.06 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.784 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 6.2 mp0 -114.98 -175.93 2.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.451 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 2.2 ttp -161.35 149.37 15.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.642 -1.286 . . . . 0.0 110.826 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.71 -174.37 2.67 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.23 106.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.686 -1.884 . . . . 0.0 109.96 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.704 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -140.82 156.39 46.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.963 -1.495 . . . . 0.0 110.359 177.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' CA ' ' OE2' ' A' ' 115' ' ' GLU . . . -132.15 154.18 20.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.746 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -122.81 -91.85 0.55 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.746 ' H ' ' CG ' ' A' ' 70' ' ' MET . . . -134.84 63.76 0.6 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.767 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 48.5 t 109.13 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -81.43 25.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.363 -1.46 . . . . 0.0 110.873 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.767 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 8.3 m0 -91.6 -72.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.567 -1.333 . . . . 0.0 109.573 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.26 -3.51 65.76 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.712 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.09 -32.89 56.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.198 -1.178 . . . . 0.0 109.473 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.629 ' OE2' ' CA ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -83.69 -15.79 47.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.016 -1.052 . . . . 0.0 110.154 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.699 ' C ' ' H ' ' A' ' 80' ' ' PHE . 28.0 ttt180 -79.46 -67.6 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 110.027 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 14.2 mttp -54.89 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.613 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.712 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 19.1 m-85 -120.72 -39.7 2.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.879 -1.138 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.675 ' CZ2' ' OG ' ' A' ' 211' ' ' SER . 0.9 OUTLIER -82.28 -3.98 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.764 -1.21 . . . . 0.0 110.03 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.3 m -83.94 17.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.034 -1.041 . . . . 0.0 109.334 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.71 154.53 22.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 137.26 32.51 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.55 -31.89 5.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.72 136.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.57 -0.959 . . . . 0.0 109.549 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.668 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -71.15 -39.91 71.64 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.915 0.864 . . . . 0.0 108.828 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.697 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 179.63 -160.57 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.546 ' N ' ' OG ' ' A' ' 88' ' ' SER . 63.6 p -157.51 151.16 24.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.033 -1.042 . . . . 0.0 109.801 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.697 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 5.1 mp0 -147.32 167.75 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.753 . . . . 0.0 109.028 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.551 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -142.96 168.65 13.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.026 -1.046 . . . . 0.0 109.878 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.37 164.07 30.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -80.11 174.29 11.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -1.078 . . . . 0.0 109.192 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.728 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -175.2 177.04 1.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 50.9 22.13 5.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.518 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -134.64 -164.1 10.43 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 57.3 p-80 -173.75 105.34 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.398 -1.06 . . . . 0.0 108.904 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.607 ' O ' ' C ' ' A' ' 99' ' ' ARG . 1.6 m -137.72 148.0 45.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.607 ' C ' ' O ' ' A' ' 98' ' ' THR . 19.6 tpt180 -33.21 -68.75 0.1 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.486 ' ND2' ' HG3' ' A' ' 99' ' ' ARG . 50.5 m-80 -124.3 95.88 42.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.44 106.0 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.481 2.121 . . . . 0.0 113.224 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 22.0 p -122.08 170.81 9.48 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.94 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.481 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 2.1 t80 -63.45 -58.95 5.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.217 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.663 ' HZ1' ' CB ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -61.58 -22.86 65.57 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.113 -0.992 . . . . 0.0 108.816 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.653 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.1 mm-40 -66.28 -57.54 7.3 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.459 0.647 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 18.7 m -65.45 -24.78 35.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.844 . . . . 0.0 110.808 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.408 ' C ' ' H ' ' A' ' 109' ' ' GLU . 24.0 t -64.56 -28.47 69.66 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.653 ' C ' ' H ' ' A' ' 110' ' ' LYS . 2.5 t -70.91 2.09 4.75 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 111' ' ' THR . 4.8 mp0 58.54 -21.6 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.452 -0.78 . . . . 0.0 110.953 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.653 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -65.75 2.25 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 109' ' ' GLU . 3.1 p -107.73 -29.41 9.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.091 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 62.13 49.06 78.64 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.728 ' ND1' ' N ' ' A' ' 94' ' ' ALA . 1.5 m-70 -97.24 173.5 7.19 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.783 -1.422 . . . . 0.0 109.784 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.37 116.63 18.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.533 ' C ' ' CD ' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -62.36 123.79 19.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.991 -1.068 . . . . 0.0 109.296 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.466 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -128.09 140.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.1 -1.0 . . . . 0.0 109.308 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.423 HG21 ' CG1' ' A' ' 91' ' ' VAL . 2.0 t -103.78 107.32 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.792 ' NH1' ' HH ' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -96.58 96.98 9.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.637 1.208 . . . . 0.0 110.386 -177.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 20.4 m -112.12 128.03 68.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.903 -1.123 . . . . 0.0 108.675 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.434 HG23 ' CD1' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -80.29 169.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -156.56 156.27 33.34 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.806 -1.558 . . . . 0.0 111.599 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.67 110.62 35.2 Favored Pre-proline 0 C--N 1.291 -1.958 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.937 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.541 ' O ' ' C ' ' A' ' 124' ' ' GLU . 39.3 Cg_exo -45.32 -63.76 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.068 2.512 . . . . 0.0 113.23 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.2 tp10 -25.69 -43.7 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -127.82 3.76 6.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.707 -1.246 . . . . 0.0 109.898 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' A' ' 126' ' ' ILE . 0.1 OUTLIER -155.15 104.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.05 0.929 . . . . 0.0 108.964 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.3 m -69.81 169.64 12.64 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.774 0.797 . . . . 0.0 111.871 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.559 ' CZ ' ' CD1' ' A' ' 132' ' ' LEU . 36.9 t80 -69.39 -27.92 65.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 109.43 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 133' ' ' LYS . 2.5 mt-10 -62.69 -19.77 64.2 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.517 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 131' ' ' LEU . 3.2 mm-40 -66.63 -72.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.042 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.778 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -42.05 -40.05 2.13 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.559 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 mp -75.68 -34.89 60.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.77 . . . . 0.0 111.611 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -58.54 -68.91 0.21 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.504 -1.372 . . . . 0.0 110.085 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.556 ' CG1' ' CE1' ' A' ' 80' ' ' PHE . 58.5 t -51.3 -22.19 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.253 -0.904 . . . . 0.0 109.208 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 34.7 t80 -73.41 -52.18 14.65 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 111.147 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.466 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 58.8 m95 -70.22 -38.72 75.32 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.069 -1.644 . . . . 0.0 111.569 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.48 -43.46 73.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.831 -1.168 . . . . 0.0 111.641 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.486 ' ND2' ' CG1' ' A' ' 134' ' ' VAL . 67.8 m-80 -81.56 59.27 4.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 112.296 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.765 ' CE1' ' O ' ' A' ' 135' ' ' PHE . 46.8 m80 -153.76 -166.59 2.43 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.003 0.906 . . . . 0.0 109.293 176.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -132.87 171.61 8.86 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 140' ' ' ASP . 30.8 Cg_exo -33.5 -103.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.039 1.826 . . . . 0.0 113.334 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.68 ' CG2' ' O ' ' A' ' 142' ' ' THR . 1.5 t -128.45 57.14 1.6 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.041 -1.037 . . . . 0.0 111.428 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.737 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -75.93 84.42 2.85 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.218 -1.551 . . . . 0.0 110.882 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.39 -115.85 0.0 OUTLIER Glycine 0 N--CA 1.491 2.345 0 CA-C-O 122.097 0.832 . . . . 0.0 111.723 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.739 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.27 25.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.743 -0.857 . . . . 0.0 111.691 -176.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.536 ' NH2' ' OD1' ' A' ' 149' ' ' ASN . 10.6 ttt-85 -159.54 88.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 119.218 -2.176 . . . . 0.0 112.115 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.692 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -57.66 122.19 12.19 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.992 -1.692 . . . . 0.0 108.954 178.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.607 ' H ' ' HG3' ' A' ' 143' ' ' GLN . . . 43.14 -114.96 0.93 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 122.932 1.296 . . . . 0.0 110.197 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.536 ' OD1' ' NH2' ' A' ' 146' ' ' ARG . 3.0 t-20 -95.98 15.81 19.55 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.084 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 8.7 m-20 -101.7 93.39 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.903 -1.123 . . . . 0.0 108.457 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.454 ' HB3' ' HE ' ' A' ' 146' ' ' ARG . 4.8 p90 -75.47 121.83 22.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.381 -0.824 . . . . 0.0 110.875 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 167.13 140.34 2.88 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.119 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -4.02 47.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -1.197 . . . . 0.0 108.729 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.64 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -96.58 -13.2 23.1 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.352 -0.843 . . . . 0.0 110.486 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.611 ' O ' ' O ' ' A' ' 70' ' ' MET . 13.2 m-85 -100.16 -4.72 29.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.864 -1.148 . . . . 0.0 110.98 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.61 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -42.69 177.58 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.842 -1.161 . . . . 0.0 109.492 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.1 t -91.55 124.87 36.04 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' PHE . . . -145.55 127.82 15.8 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 116.468 -2.093 . . . . 0.0 112.705 -176.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.513 ' CG2' ' CZ ' ' A' ' 135' ' ' PHE . 5.2 t -117.9 129.46 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.097 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.466 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -122.27 95.59 47.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.336 -0.852 . . . . 0.0 108.814 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.6 170.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.633 2.222 . . . . 0.0 112.044 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.56 -29.64 14.25 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 120.911 -1.118 . . . . 0.0 109.632 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 165' ' ' VAL . 2.0 m -179.52 -162.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.93 -15.55 9.18 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 123.021 1.391 . . . . 0.0 108.599 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.425 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.7 t -55.77 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.883 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.759 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 16.4 mt-30 -78.86 -19.13 52.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 ttp -52.44 -36.19 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.705 -1.247 . . . . 0.0 110.394 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -75.58 -32.55 60.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.795 -1.19 . . . . 0.0 110.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.58 -43.28 9.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.077 -1.014 . . . . 0.0 110.134 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.45 -51.79 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' A' ' 171' ' ' LEU . 1.3 pp -52.85 -33.52 50.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.004 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -74.6 -55.54 5.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.466 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.82 -39.02 73.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.373 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -65.07 -58.36 6.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 175' ' ' GLU . 0.9 OUTLIER -70.58 -24.19 62.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.933 . . . . 0.0 109.908 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 5.8 mm-40 -53.26 -30.87 40.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -0.91 . . . . 0.0 109.931 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.591 ' CD1' ' CD1' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.47 -45.36 19.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.907 -1.121 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.68 HE22 ' C ' ' A' ' 187' ' ' GLY . 1.2 tp60 -54.26 -30.83 51.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -61.83 -44.27 97.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.319 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 181' ' ' LEU . 9.2 p -87.31 -42.2 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.387 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 177' ' ' TYR . 31.8 mt -65.24 -39.4 92.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.111 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 21.6 p -56.07 -26.56 49.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.987 -1.071 . . . . 0.0 109.401 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -88.3 -9.66 52.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.737 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -108.33 34.93 3.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.873 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.36 68.65 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.937 . . . . 0.0 109.799 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.472 ' CD2' HD21 ' A' ' 181' ' ' LEU . 37.4 m-85 -148.08 174.55 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.68 ' C ' HE22 ' A' ' 178' ' ' GLN . . . -126.22 -162.24 11.19 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 189' ' ' ILE . 32.0 Cg_exo -58.07 105.56 0.21 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.993 1.795 . . . . 0.0 110.274 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.412 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 0.9 OUTLIER -47.68 155.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.585 -178.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.66 ' N ' ' OG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -88.57 44.73 1.23 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.338 0.589 . . . . 0.0 111.571 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 19.4 m -84.57 113.78 21.49 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.494 ' OD2' ' CZ ' ' A' ' 194' ' ' ARG . 9.1 t0 -75.54 114.98 14.72 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.986 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.76 97.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 121.925 0.869 . . . . 0.0 109.45 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.675 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -152.62 152.29 31.62 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.644 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 1.0 OUTLIER -111.74 -176.95 3.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 110.197 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.55 30.37 66.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.675 ' NE2' ' O ' ' A' ' 194' ' ' ARG . 1.8 mp0 -95.85 95.16 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.239 . . . . 0.0 109.882 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 197' ' ' GLN . 8.3 p -32.6 154.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 109.711 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.514 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 65.0 t80 -120.63 137.23 54.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.633 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.9 m-85 -139.54 112.84 8.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.167 -0.958 . . . . 0.0 109.787 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.792 ' HH ' ' NH1' ' A' ' 118' ' ' ARG . 23.3 m-85 -54.12 141.67 28.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 110.108 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.484 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -90.46 -174.64 4.2 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.03 165.05 25.82 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.749 -0.594 . . . . 0.0 109.704 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.445 ' N ' HG11 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -57.95 -45.14 87.13 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.537 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -55.05 -13.53 1.19 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.567 ' CE1' ' CZ2' ' A' ' 74' ' ' TRP . 14.3 m-70 -100.99 5.38 43.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.83 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.3 mm-40 -124.57 -144.18 0.32 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.238 1.018 . . . . 0.0 110.143 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.651 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 11.7 mp0 -34.4 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.188 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.83 ' N ' ' O ' ' A' ' 207' ' ' GLN . 79.5 t80 -43.7 -45.58 7.09 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 120.495 -1.378 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -55.21 -17.3 4.18 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.648 -1.283 . . . . 0.0 110.068 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.675 ' OG ' ' CZ2' ' A' ' 81' ' ' TRP . 13.4 m -73.17 -26.51 61.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.109 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -87.75 -38.92 15.36 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.338 -0.851 . . . . 0.0 109.487 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.476 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.4 m-80 -123.42 79.66 53.92 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.63 8.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.954 2.436 . . . . 0.0 112.598 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 213' ' ' ASN . 1.5 t70 -63.44 -19.09 64.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.023 -1.048 . . . . 0.0 110.356 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.98 84.97 0.05 OUTLIER Glycine 0 N--CA 1.503 3.104 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.693 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -83.38 92.68 7.6 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.652 2.226 . . . . 0.0 109.297 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 49.1 t -168.74 -124.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 O-C-N 120.994 -1.066 . . . . 0.0 108.962 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 153.8 151.8 5.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 2.5 tp 75.47 162.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.734 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 157.16 81.59 0.04 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.42 140.83 3.66 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.277 179.817 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.738 ' O ' ' O ' ' A' ' 29' ' ' ILE . 41.9 t . . . . . 0 CA--C 1.501 -0.942 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.738 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -35.3 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 123.198 1.475 . . . . 0.0 110.038 -178.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.63 124.25 26.34 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.966 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HA ' ' HD1' ' A' ' 97' ' ' HIS . . . -64.76 -40.06 94.65 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.83 -0.544 . . . . 0.0 109.692 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.654 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -80.65 12.77 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' ' C ' ' A' ' 34' ' ' ALA . 1.6 tt0 -116.67 -43.25 2.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 109.648 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -33.08 152.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.586 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.644 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 42' ' ' ILE . 35.6 Cg_endo -66.97 164.09 31.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.747 2.298 . . . . 0.0 112.261 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 46' ' ' ALA . 7.0 m -161.2 172.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.227 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.71 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 109.681 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.27 -40.38 74.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 110.911 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.574 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.62 99.72 11.93 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.002 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.643 ' O ' ' N ' ' A' ' 52' ' ' GLY . 6.7 t-80 -31.16 104.19 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -53.97 -26.17 24.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.654 -0.654 . . . . 0.0 110.965 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.486 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 2.6 t -70.09 -48.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.84 -1.163 . . . . 0.0 109.448 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -103.56 -41.1 6.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.54 1.98 53.27 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -75.41 -116.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.578 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -131.55 174.39 10.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.657 1.694 . . . . 0.0 110.217 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 16.0 p -145.56 18.98 1.51 Allowed 'General case' 0 C--N 1.264 -3.118 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -165.62 149.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.037 -1.04 . . . . 0.0 109.05 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.55 ' O ' ' O ' ' A' ' 56' ' ' VAL . 16.0 mt-10 -32.33 154.92 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.675 0 CA-C-O 121.885 0.85 . . . . 0.0 110.731 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.3 165.51 80.62 Favored 'Cis proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.689 -2.213 . . . . 0.0 112.126 -0.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.526 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-30 -115.98 85.68 15.35 Favored Pre-proline 0 C--N 1.27 -2.871 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.16 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.96 170.18 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.974 2.45 . . . . 0.0 112.549 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -75.98 158.32 32.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.4 -38.42 3.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.03 135.04 50.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.602 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 14.9 mp0 -113.32 171.65 7.43 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.735 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -156.9 145.48 19.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.58 -1.325 . . . . 0.0 110.896 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.1 -169.36 1.78 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 160' ' ' TYR . 2.7 t -143.02 101.6 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.024 -1.672 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 2.4 p90 -148.38 149.37 31.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.922 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.74 156.25 17.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.579 ' SD ' ' CB ' ' A' ' 157' ' ' SER . 1.7 mtt -145.68 30.72 1.08 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.347 -1.09 . . . . 0.0 108.339 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.588 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -166.6 155.63 26.94 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.924 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.769 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -35.97 116.76 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -45.26 7.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.869 -178.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.769 ' N ' ' O ' ' A' ' 72' ' ' CYS . 24.9 m0 -82.34 -64.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.3 -1.5 . . . . 0.0 109.84 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.09 -26.82 74.38 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.024 -1.047 . . . . 0.0 111.335 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.757 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.94 -29.25 55.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.343 . . . . 0.0 111.526 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' ' CE3' ' A' ' 81' ' ' TRP . 28.2 tt0 -83.88 -13.86 52.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.277 -1.515 . . . . 0.0 110.757 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.665 ' C ' ' H ' ' A' ' 80' ' ' PHE . 15.9 ttt180 -69.29 -81.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.132 -0.98 . . . . 0.0 111.137 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 25.2 mtmt -58.76 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.211 -0.931 . . . . 0.0 110.628 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.757 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.1 m-85 -97.9 -38.72 9.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.911 -1.118 . . . . 0.0 109.026 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.566 ' CE3' ' OE1' ' A' ' 208' ' ' GLN . 1.5 p90 -85.17 8.48 18.09 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.36 18.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.329 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.97 167.68 9.62 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.28 162.72 14.5 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.536 -0.727 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.4 5.61 50.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.78 117.45 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -1.063 . . . . 0.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.578 ' OH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -68.45 -36.29 78.81 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.218 1.009 . . . . 0.0 108.753 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.538 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER 177.83 -164.03 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.293 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.648 ' C ' HE21 ' A' ' 90' ' ' GLN . 71.3 p -156.25 144.76 20.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.648 HE21 ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -141.86 166.34 24.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.612 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 3.0 m -152.41 160.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.22 -174.54 45.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -86.32 169.41 12.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.307 -1.114 . . . . 0.0 109.554 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.651 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.58 149.09 0.36 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.005 -1.059 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 76.86 22.24 72.34 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.639 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -100.44 -165.04 28.45 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.69 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 1.7 t-160 -140.85 72.02 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.78 175.99 13.17 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.448 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.0 mmp_? -76.26 -78.28 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.422 -0.799 . . . . 0.0 109.047 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -116.18 66.43 3.1 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.636 ' CG ' ' HE2' ' A' ' 113' ' ' HIS . 1.1 Cg_endo -48.88 149.95 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.307 2.004 . . . . 0.0 111.674 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.636 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 17.4 p -120.85 172.62 7.77 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.221 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.712 ' CG ' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -66.41 -59.23 3.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.069 -1.019 . . . . 0.0 109.958 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.712 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -57.93 -23.52 53.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.636 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.2 mm-40 -67.25 -64.95 0.75 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.601 0.715 . . . . 0.0 109.936 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.752 ' CG1' ' HG1' ' A' ' 111' ' ' THR . 34.4 m -71.39 -24.37 23.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.479 -0.763 . . . . 0.0 111.098 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.512 ' C ' ' O ' ' A' ' 106' ' ' VAL . 11.9 t -38.38 -22.9 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.67 ' N ' ' O ' ' A' ' 106' ' ' VAL . 80.2 p -77.8 -80.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.682 ' O ' ' N ' ' A' ' 111' ' ' THR . 0.0 OUTLIER 158.7 -39.62 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.642 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 1.6 ttmt -46.29 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.911 -0.493 . . . . 0.0 112.215 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.752 ' HG1' ' CG1' ' A' ' 106' ' ' VAL . 11.1 p -101.33 -19.68 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.449 -1.407 . . . . 0.0 109.193 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 67.16 21.63 72.04 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.075 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.651 ' ND1' ' C ' ' A' ' 94' ' ' ALA . 1.4 m-70 -80.15 172.46 13.74 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.258 -1.731 . . . . 0.0 108.174 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.44 112.92 13.69 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.079 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.684 ' OE1' ' CE2' ' A' ' 73' ' ' PHE . 20.8 mm-40 -51.04 112.1 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.5 m -123.34 138.37 53.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 108.937 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.407 HG13 ' CD2' ' A' ' 80' ' ' PHE . 2.5 t -103.78 113.11 39.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.526 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -96.92 113.84 25.41 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 m -132.02 126.57 56.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.46 HG13 ' CE2' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -86.2 169.41 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.435 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.552 ' CD1' ' CD1' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -157.4 156.62 32.56 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.651 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -106.66 99.28 24.24 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.918 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 Cg_exo -43.55 -63.91 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.032 2.488 . . . . 0.0 112.917 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.663 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 22.5 mp0 -49.91 -13.14 0.09 Allowed 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.586 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 123' ' ' PRO . 22.1 m-70 -110.86 -46.85 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.448 ' CD1' ' HG3' ' A' ' 130' ' ' GLU . 5.3 tp -128.73 144.18 38.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -75.11 153.1 38.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.864 -1.148 . . . . 0.0 111.192 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.489 ' CE2' ' CD1' ' A' ' 132' ' ' LEU . 41.4 t80 -63.9 -28.7 70.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -52.88 -32.13 43.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 6.5 mm-40 -62.39 -67.85 0.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.642 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 17.0 mt -34.05 -49.07 0.34 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.199 -0.938 . . . . 0.0 108.711 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.489 ' CD1' ' CE2' ' A' ' 128' ' ' PHE . 64.0 mt -76.61 -34.54 58.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 110.69 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' GLU . 31.7 ttmt -57.71 -68.37 0.25 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.885 -1.134 . . . . 0.0 110.449 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.752 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -49.28 -34.17 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 108.985 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.533 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 26.4 t80 -57.92 -52.67 64.53 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.014 -1.054 . . . . 0.0 111.072 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.58 ' O ' ' CG2' ' A' ' 223' ' ' THR . 85.6 m95 -74.8 -47.45 30.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.159 -1.588 . . . . 0.0 111.236 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.582 ' O ' ' O ' ' A' ' 222' ' ' GLY . 1.3 mm-40 -45.23 -48.83 12.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 111.334 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.752 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.5 p30 -98.51 38.22 1.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 112.554 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 223' ' ' THR . 20.6 m80 -155.44 -155.77 0.59 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.714 -1.241 . . . . 0.0 109.342 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 70' ' ' MET . 2.7 t0 -147.33 132.01 8.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.445 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 68.9 Cg_endo -73.81 -13.81 24.26 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 121.931 1.754 . . . . 0.0 113.142 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 142' ' ' THR . 3.3 p -122.32 56.63 1.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.743 -1.223 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.812 ' NE2' ' NE2' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -122.39 77.59 1.42 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.713 -1.242 . . . . 0.0 110.889 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -47.34 -117.64 0.0 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -85.19 47.02 1.35 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.338 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 150' ' ' ASP . 1.6 ttm180 -162.16 87.23 0.63 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.583 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.812 ' NE2' ' NE2' ' A' ' 143' ' ' GLN . 2.1 tp-100 -84.09 119.94 25.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.181 -1.575 . . . . 0.0 109.381 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . 53.26 -113.45 2.97 Favored Glycine 0 C--N 1.293 -1.844 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.622 ' OD1' ' N ' ' A' ' 149' ' ' ASN . 1.8 p-10 -101.12 22.77 11.8 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 114.18 -1.01 . . . . 0.0 110.023 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -107.61 161.12 15.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.0 109.426 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 151' ' ' PHE . 35.0 p90 -136.79 127.07 26.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.1 149.43 5.05 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.956 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 1.2 p -56.06 -52.68 63.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.596 -0.943 . . . . 0.0 109.407 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.636 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 8.9 pm0 -56.55 -11.04 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.669 . . . . 0.0 110.857 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -101.63 49.64 0.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.804 -1.185 . . . . 0.0 109.348 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.672 ' NH1' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -116.54 165.06 13.68 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.62 ' OG ' ' O ' ' A' ' 190' ' ' THR . 44.9 p -77.02 128.22 34.09 Favored 'General case' 0 CA--C 1.467 -2.237 0 CA-C-O 122.442 1.115 . . . . 0.0 108.25 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -137.31 129.49 29.38 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.282 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.625 ' CG1' ' CG2' ' A' ' 191' ' ' THR . 0.2 OUTLIER -139.41 108.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.011 177.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 160' ' ' TYR . 1.1 m-30 -107.08 134.32 19.93 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.56 168.96 17.49 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.364 2.043 . . . . 0.0 111.835 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -19.59 20.59 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.907 -1.12 . . . . 0.0 108.939 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER 179.57 -164.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.7 -15.6 20.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 123.005 1.383 . . . . 0.0 108.421 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.6 t -56.05 -64.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 23.6 mt-30 -79.6 -17.12 54.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.675 -0.641 . . . . 0.0 110.9 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.92 -44.09 66.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.847 -1.158 . . . . 0.0 110.04 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.23 -20.76 59.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.8 -54.3 3.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.76 -44.54 66.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.4 mt -52.88 -39.65 62.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.642 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -74.52 -51.35 14.96 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 0.0 109.527 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.487 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.8 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.699 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.461 ' NZ ' HD13 ' A' ' 189' ' ' ILE . 6.8 tttp -73.05 -58.16 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.0 110.326 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.35 -27.86 61.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.916 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mm-40 -53.06 -31.32 40.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.961 -1.087 . . . . 0.0 110.129 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.439 ' CD1' ' HG3' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -80.22 -33.26 38.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 110.079 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 182' ' ' SER . 0.8 OUTLIER -52.8 -31.96 41.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.013 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.16 -20.39 52.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.804 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.74 -55.88 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.828 -1.17 . . . . 0.0 110.872 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . 7.3 mt -76.22 -19.88 57.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.052 -1.03 . . . . 0.0 110.737 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 2.2 t -55.01 -33.68 62.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.865 -1.147 . . . . 0.0 109.16 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -88.2 1.0 55.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -108.29 32.42 4.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.79 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.31 59.49 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 109.939 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 181' ' ' LEU . 38.4 m-85 -133.81 168.98 17.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.002 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -128.76 -149.0 6.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.65 119.65 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.358 2.039 . . . . 0.0 110.99 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.461 HD13 ' NZ ' ' A' ' 174' ' ' LYS . 1.1 pt -57.55 179.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.317 1.056 . . . . 0.0 111.097 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.672 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 1.5 p -139.46 58.39 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.816 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.625 ' CG2' ' CG1' ' A' ' 159' ' ' VAL . 21.7 m -99.55 120.44 39.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.649 ' OD1' ' NE ' ' A' ' 194' ' ' ARG . 15.0 t0 -77.93 122.45 25.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.448 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.403 ' CD1' ' HD3' ' A' ' 174' ' ' LYS . 0.8 OUTLIER -131.45 100.64 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.649 ' NE ' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -151.39 178.38 9.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -129.93 166.28 20.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.13 49.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.513 ' NE2' ' CD2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -89.84 93.97 9.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.079 -1.248 . . . . 0.0 109.425 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 197' ' ' GLN . 7.4 p -41.11 122.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 109.597 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.481 ' CE1' ' HD3' ' A' ' 118' ' ' ARG . 25.4 t80 -77.79 150.39 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.299 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.448 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 6.8 m-85 -149.19 100.53 3.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -53.84 144.07 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -92.02 -170.83 2.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.359 -0.838 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.47 167.3 20.87 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-O 122.801 1.286 . . . . 0.0 110.309 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -53.8 -43.61 69.48 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.719 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.736 ' CD1' ' O ' ' A' ' 205' ' ' TYR . 0.2 OUTLIER -81.14 13.32 2.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.582 -1.324 . . . . 0.0 109.496 -178.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.549 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 22.7 m-70 -102.71 6.41 39.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.747 -1.221 . . . . 0.0 109.706 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.837 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.4 mm-40 -127.61 -138.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.43 1.11 . . . . 0.0 109.772 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.566 ' OE1' ' CE3' ' A' ' 81' ' ' TRP . 18.8 mm-40 -34.15 -4.75 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.936 -1.484 . . . . 0.0 112.282 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.837 ' N ' ' O ' ' A' ' 207' ' ' GLN . 82.0 t80 -42.74 -46.32 5.09 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 120.398 -1.439 . . . . 0.0 109.896 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.649 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.6 OUTLIER -60.43 -17.14 42.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.57 -1.331 . . . . 0.0 110.109 -178.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.681 ' HG ' ' N ' ' A' ' 212' ' ' LYS . 36.6 p -70.53 -47.43 60.43 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 108.643 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.681 ' N ' ' HG ' ' A' ' 211' ' ' SER . 9.0 mmmt -88.85 -7.77 55.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.352 -0.842 . . . . 0.0 110.121 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.66 ' CG ' ' CZ ' ' A' ' 209' ' ' TYR . 5.4 m-80 -129.19 77.15 78.15 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.0 110.102 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.57 10.82 0.92 Allowed 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.511 2.808 . . . . 0.0 112.46 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -61.75 -21.2 64.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.349 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.57 85.81 0.05 OUTLIER Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.46 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 216' ' ' GLY . 9.7 m-85 -47.21 -170.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 120.314 2.057 . . . . 0.0 109.67 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.43 78.32 4.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.914 -1.116 . . . . 0.0 109.745 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 220' ' ' LEU . . . -174.14 143.66 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.594 ' CD1' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 161.19 167.89 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 110.4 131.2 5.97 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.639 ' CA ' ' O ' ' A' ' 139' ' ' HIS . . . -173.43 140.52 5.62 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 139' ' ' HIS . 29.5 p . . . . . 0 C--N 1.295 -1.798 0 O-C-N 121.466 -1.02 . . . . 0.0 108.271 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.615 ' CG1' ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.212 -0.899 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' VAL . 1.1 tp -38.6 132.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 122.057 0.932 . . . . 0.0 113.009 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.91 121.43 21.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 122.144 0.973 . . . . 0.0 110.203 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -51.7 -55.36 20.01 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.65 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -53.92 -8.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 2.5 mm-40 -110.61 -36.23 5.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.427 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.91 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 0.0 109.265 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.484 ' N ' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 O-C-N 121.207 -0.933 . . . . 0.0 109.141 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.34 -176.27 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.073 2.515 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 15.8 m -147.95 -176.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.927 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.571 ' CG2' ' O ' ' A' ' 45' ' ' THR . 14.7 t -79.84 104.28 10.31 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.095 -1.003 . . . . 0.0 110.305 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.606 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.94 -29.77 63.42 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.305 -0.872 . . . . 0.0 111.496 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 5.5 pttt -88.52 100.04 12.77 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 115.93 -2.308 . . . . 0.0 108.113 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' A' ' 52' ' ' GLY . 7.2 t-80 -31.64 112.25 0.1 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.784 ' CD2' ' HZ3' ' A' ' 212' ' ' LYS . 13.9 t-80 -50.78 -37.46 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 110.625 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 18.0 t -72.15 -61.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -77.13 -36.08 55.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.567 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 83.61 0.11 89.79 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 40.5 p30 -78.72 -119.63 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.651 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 29.5 mtt180 -126.46 174.52 8.57 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 123.275 1.512 . . . . 0.0 109.59 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 11.7 p -143.42 35.77 1.32 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.87 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -176.56 152.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 0.0 109.098 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -31.67 149.5 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.518 -0.739 . . . . 0.0 110.547 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD2' ' NH1' ' A' ' 54' ' ' ARG . 88.4 Cg_endo -79.3 165.94 79.62 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.013 -2.078 . . . . 0.0 112.158 0.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.59 129.56 24.25 Favored Pre-proline 0 C--N 1.27 -2.857 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.557 ' O ' ' CG2' ' A' ' 63' ' ' THR . 46.2 Cg_exo -49.65 148.39 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.083 1.855 . . . . 0.0 112.064 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 158.18 10.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.585 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.55 39.63 75.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.557 ' CG2' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -90.2 132.3 35.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -1.147 . . . . 0.0 110.649 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.772 ' NE2' ' CD1' ' A' ' 128' ' ' PHE . 36.7 tp60 -106.16 142.75 35.33 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -161.37 161.81 30.53 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.994 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.77 -167.11 1.77 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 74.5 t -141.78 127.85 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.158 -1.589 . . . . 0.0 108.607 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 28.1 m-85 -114.87 135.16 54.5 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.835 -1.166 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 157' ' ' SER . . . -134.38 83.25 0.29 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.635 ' O ' ' O ' ' A' ' 155' ' ' TYR . 2.2 ptp -86.32 -80.99 0.22 Allowed 'General case' 0 C--N 1.282 -2.357 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.843 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 73' ' ' PHE . . . -139.36 -152.2 5.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.785 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -33.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.686 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -53.51 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 112.039 -177.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.785 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 10.9 m0 -70.3 -65.94 0.66 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.742 -1.224 . . . . 0.0 108.562 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.46 -12.07 82.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.68 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.26 -33.88 59.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 109.733 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.566 ' OE2' ' OE1' ' A' ' 208' ' ' GLN . 1.1 tt0 -83.36 -17.09 43.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -85.93 -52.04 5.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 110.227 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 9.4 mttp -47.91 -4.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.181 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.68 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.3 m-85 -104.5 -35.39 7.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.0 110.354 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.569 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -88.96 -0.62 57.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.747 -1.22 . . . . 0.0 110.426 -178.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.421 ' CG1' ' HG2' ' A' ' 78' ' ' ARG . 2.3 m -88.32 5.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.003 -1.061 . . . . 0.0 110.145 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.611 ' C ' ' CD1' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -116.95 179.33 4.05 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 109.664 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 137.46 37.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.929 -1.107 . . . . 0.0 111.529 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 123' ' ' PRO . . . 124.26 -50.1 0.87 Allowed Glycine 0 C--O 1.202 -1.859 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.763 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.469 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -53.91 136.85 15.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.715 -1.462 . . . . 0.0 111.582 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.69 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -75.13 -40.76 59.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.694 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 2.0 p -171.92 -174.84 1.38 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 88' ' ' SER . 62.6 p -160.15 128.79 4.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.068 -1.02 . . . . 0.0 109.534 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.694 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 3.0 mp0 -138.46 172.03 13.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.009 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.671 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -132.59 168.19 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.45 168.26 38.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -80.0 153.09 29.09 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.351 -1.088 . . . . 0.0 109.138 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.673 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -166.55 175.47 8.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.496 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 53.86 22.4 19.12 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.496 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -102.08 -151.43 23.99 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.516 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 3.7 m-70 -109.81 -41.15 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 109.768 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.545 ' HB ' HD22 ' A' ' 100' ' ' ASN . 0.6 OUTLIER -154.94 172.83 17.42 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.661 ' C ' HD21 ' A' ' 100' ' ' ASN . 0.3 OUTLIER -81.84 78.3 8.57 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.771 HD21 ' N ' ' A' ' 100' ' ' ASN . 1.1 m-80 -115.13 -130.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.324 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.644 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.3 Cg_exo -45.39 -156.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 123.672 2.347 . . . . 0.0 115.092 -175.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 106' ' ' VAL . 29.6 p -126.53 170.66 11.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.231 -0.918 . . . . 0.0 112.046 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.668 ' CD1' ' OE2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -50.21 -43.46 52.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.346 0.594 . . . . 0.0 110.016 179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.562 ' CD ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.05 -34.89 64.22 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.821 -1.174 . . . . 0.0 109.487 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 107' ' ' CYS . 1.7 mm-40 -83.56 -43.7 15.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.81 . . . . 0.0 110.749 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.703 ' O ' ' N ' ' A' ' 108' ' ' SER . 34.5 m -46.33 -21.66 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 120.881 -1.137 . . . . 0.0 109.439 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.487 ' C ' ' O ' ' A' ' 106' ' ' VAL . 10.2 t -36.84 -20.67 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.631 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -79.82 3.91 18.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.062 -1.024 . . . . 0.0 108.865 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.1 mt-10 64.76 3.8 2.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.648 ' CD ' ' OG ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -72.93 -9.94 59.25 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.025 -1.672 . . . . 0.0 110.467 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.442 ' CG2' ' CG1' ' A' ' 106' ' ' VAL . 1.7 p -105.01 -8.34 18.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.653 -1.279 . . . . 0.0 109.705 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 44.36 30.72 2.09 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 7.1 m-70 -81.68 170.01 16.3 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.908 -1.348 . . . . 0.0 109.386 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 115' ' ' GLU . . . -129.03 114.33 16.27 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.668 ' OE2' ' CD1' ' A' ' 103' ' ' TYR . 1.6 mm-40 -40.19 120.94 1.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 108.934 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.473 HG13 ' CE2' ' A' ' 160' ' ' TYR . 0.3 OUTLIER -140.55 162.77 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 110.262 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 35.4 m -130.63 127.4 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.484 -0.76 . . . . 0.0 109.216 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -98.38 124.85 43.27 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 m -133.85 125.88 49.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.018 -1.051 . . . . 0.0 108.723 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 87' ' ' TYR . 1.8 m -96.39 146.55 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.717 -1.239 . . . . 0.0 107.971 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.621 ' CE2' HD21 ' A' ' 131' ' ' LEU . 2.9 m-30 -129.99 147.5 51.74 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.054 0.93 . . . . 0.0 108.661 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.976 ' H ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -179.31 27.21 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.976 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 37.9 Cg_exo -73.79 -13.46 24.35 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 N-CA-C 119.436 2.821 . . . . 0.0 119.436 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.87 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.837 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -123.76 2.1 8.81 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.573 ' CG2' ' CD2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -153.85 132.93 3.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.547 -0.721 . . . . 0.0 109.834 -178.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.574 ' OG ' ' N ' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -103.0 -177.89 3.5 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.04 0.924 . . . . 0.0 112.775 -177.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.772 ' CD1' ' NE2' ' A' ' 64' ' ' GLN . 35.7 t80 -69.82 -40.56 75.82 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.191 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.89 -14.49 47.03 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.805 -1.184 . . . . 0.0 108.809 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.516 ' CB ' ' CD1' ' A' ' 126' ' ' ILE . 0.4 OUTLIER -74.58 -55.94 5.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 111.377 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.86 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -59.99 -34.46 73.36 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 120.597 -1.314 . . . . 0.0 107.862 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.492 HD23 ' CZ ' ' A' ' 128' ' ' PHE . 1.5 mm? -66.12 -32.49 73.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -70.51 -62.53 1.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.38 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.716 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 25.5 t -49.37 -27.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.16 -0.963 . . . . 0.0 108.979 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.474 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 6.7 t80 -71.73 -50.74 27.39 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.794 -1.191 . . . . 0.0 109.889 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.463 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 55.1 m95 -72.4 -37.9 68.57 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.616 -1.303 . . . . 0.0 110.299 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -20.8 64.65 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.9 OUTLIER -131.56 59.48 1.69 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.161 -1.587 . . . . 0.0 111.768 -178.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.608 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER 170.26 136.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.375 -0.828 . . . . 0.0 109.256 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.28 135.4 72.9 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.451 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 73.8 Cg_endo -75.58 -8.66 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.576 2.184 . . . . 0.0 112.558 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 142' ' ' THR . 0.6 OUTLIER -118.04 56.0 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.228 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 144' ' ' GLY . 6.0 mm100 -118.73 62.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 108.739 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -45.27 -119.29 0.0 OUTLIER Glycine 0 N--CA 1.492 2.422 0 CA-C-O 121.81 0.672 . . . . 0.0 112.414 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.666 ' O ' ' SD ' ' A' ' 145' ' ' MET . 1.5 tmt? -69.84 35.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.507 -0.996 . . . . 0.0 110.648 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.502 ' H ' ' C ' ' A' ' 144' ' ' GLY . 4.1 ttm180 -166.32 152.73 9.04 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.023 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.481 HE21 ' HG3' ' A' ' 143' ' ' GLN . 1.2 mm-40 -146.92 100.7 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.439 -1.413 . . . . 0.0 108.39 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 52.03 -119.6 9.23 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.453 ' H ' HD23 ' A' ' 220' ' ' LEU . 1.6 t-20 -81.72 8.86 8.95 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.744 -1.228 . . . . 0.0 110.13 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.36 147.85 29.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.99 -1.069 . . . . 0.0 109.409 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.1 p90 -136.67 129.63 30.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.144 -0.973 . . . . 0.0 110.088 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.5 158.59 7.75 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.415 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.12 -4.6 48.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -1.146 . . . . 0.0 109.65 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.584 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 15.3 pm0 -88.38 3.06 51.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.029 -1.044 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.635 ' O ' ' O ' ' A' ' 70' ' ' MET . 93.2 m-85 -114.9 -12.56 12.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 111.053 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -39.62 172.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.571 -1.331 . . . . 0.0 110.195 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.474 ' OG ' ' CG2' ' A' ' 190' ' ' THR . 31.5 p -89.11 132.82 34.63 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -147.64 123.08 10.36 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 117.68 -1.608 . . . . 0.0 111.58 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 135' ' ' PHE . 2.8 m -119.85 130.55 74.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.766 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.473 ' CE2' HG13 ' A' ' 116' ' ' VAL . 10.1 m-30 -112.85 131.66 22.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.105 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.35 169.38 20.17 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.86 2.373 . . . . 0.0 112.624 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.4 OUTLIER -103.14 -6.64 22.0 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.039 -1.038 . . . . 0.0 109.498 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.635 ' C ' ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 166.44 173.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 108.813 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -47.07 -14.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.989 1.376 . . . . 0.0 108.231 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.635 ' H ' ' C ' ' A' ' 163' ' ' SER . 3.3 t -55.54 -61.3 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 170' ' ' ALA . 1.2 mp0 -60.88 -11.62 8.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.557 -0.714 . . . . 0.0 110.378 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttt -51.87 -43.61 63.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 109.919 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.673 ' O ' ' NH1' ' A' ' 172' ' ' ARG . 2.6 tm-20 -75.66 -22.68 56.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.452 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -93.06 -56.32 3.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.421 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.96 -58.97 4.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 109.683 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.2 mt -52.24 -35.68 50.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.08 -1.013 . . . . 0.0 109.244 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.673 ' NH1' ' O ' ' A' ' 168' ' ' GLU . 13.4 ttp-105 -74.52 -55.92 5.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.463 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -56.54 -37.08 70.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.481 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -68.09 -53.15 27.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -73.0 2.21 7.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.66 -56.52 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -27.37 65.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 109.941 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.679 ' NE2' ' OG ' ' A' ' 182' ' ' SER . 0.5 OUTLIER -53.24 -53.85 44.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.171 -0.955 . . . . 0.0 109.666 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -15.55 63.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.89 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.7 t -87.22 -54.2 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 183' ' ' LYS . 35.2 mt -75.26 -45.93 36.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.164 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.679 ' OG ' ' NE2' ' A' ' 178' ' ' GLN . 61.1 m -56.23 -3.05 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 0.0 109.685 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -88.02 -21.29 24.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.306 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.459 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 14.1 m-70 -107.99 14.4 25.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.92 68.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.21 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.42 173.55 52.99 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.64 174.27 11.99 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.825 2.35 . . . . 0.0 112.245 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 141' ' ' PRO . 0.8 OUTLIER -80.99 116.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.006 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.474 ' CG2' ' OG ' ' A' ' 157' ' ' SER . 5.2 t -100.37 -5.21 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.002 -1.061 . . . . 0.0 109.544 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 190' ' ' THR . 47.0 m -43.6 112.65 0.41 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 7.2 t0 -77.17 132.93 39.03 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.924 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 194' ' ' ARG . 0.8 OUTLIER -133.41 125.66 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.418 -0.801 . . . . 0.0 108.909 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 69.7 mtm-85 -157.11 152.19 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 109.307 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.8 OUTLIER -115.36 -174.51 2.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.53 56.48 8.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -116.25 148.04 40.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -1.213 . . . . 0.0 109.573 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.595 ' CG1' ' CE2' ' A' ' 200' ' ' TYR . 1.3 p -87.7 165.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 55.2 t80 -125.56 132.3 52.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 109.964 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.595 ' CE2' ' CG1' ' A' ' 198' ' ' VAL . 35.0 m-85 -128.32 104.39 7.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.822 . . . . 0.0 109.109 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.8 m-85 -54.98 141.48 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 110.572 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.555 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -85.0 -169.3 2.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -76.0 153.26 36.63 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.547 ' N ' ' HG3' ' A' ' 203' ' ' GLU . 0.7 OUTLIER -56.54 -37.89 71.12 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.083 -1.01 . . . . 0.0 108.318 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.503 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -60.85 -14.55 22.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.635 -0.665 . . . . 0.0 110.635 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -99.02 -4.05 33.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.856 -1.152 . . . . 0.0 110.118 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.855 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.1 mt-30 -110.41 -133.07 0.33 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 122.752 1.263 . . . . 0.0 110.568 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -33.63 -5.06 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.887 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.855 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.2 t80 -42.56 -44.43 4.15 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.673 -1.267 . . . . 0.0 109.936 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.625 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -59.23 -17.23 26.34 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.439 -1.413 . . . . 0.0 110.016 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 208' ' ' GLN . 71.1 p -73.26 -31.31 64.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.784 ' HZ3' ' CD2' ' A' ' 49' ' ' HIS . 10.9 mmtm -87.72 -33.91 18.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.866 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.689 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 26.2 m120 -121.71 82.42 41.52 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.46 9.88 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.206 2.604 . . . . 0.0 112.164 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -63.52 -11.92 28.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.13 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.31 85.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.766 -1.206 . . . . 0.0 111.449 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.601 ' O ' ' O ' ' A' ' 216' ' ' GLY . 33.1 t80 -52.31 -158.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.6 2.2 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.581 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 18.1 m -90.3 78.08 6.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.852 -1.155 . . . . 0.0 109.378 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.479 ' O ' ' CD1' ' A' ' 220' ' ' LEU . . . -88.62 -169.27 44.74 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.479 ' CD1' ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -152.41 178.96 8.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -1.223 . . . . 0.0 109.673 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -153.98 -162.33 11.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -170.85 -136.53 2.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 47.4 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.342 -1.093 . . . . 0.0 109.436 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.18 132.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 122.315 1.055 . . . . 0.0 113.77 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.87 125.55 29.3 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.282 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.631 ' CB ' ' HD1' ' A' ' 97' ' ' HIS . . . -50.41 -27.21 6.0 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.15 3.37 31.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.29 4.55 13.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.617 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.32 178.96 8.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.399 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 168.37 23.3 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.737 2.291 . . . . 0.0 112.217 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -148.67 -166.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.005 . . . . 0.0 109.586 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.631 ' CG2' ' O ' ' A' ' 45' ' ' THR . 13.5 t -93.46 94.0 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.02 -45.41 79.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.282 -0.886 . . . . 0.0 111.016 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -83.43 99.94 10.4 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 115.775 -2.37 . . . . 0.0 108.597 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.661 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 15.1 t-80 -30.97 137.01 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.28 -7.47 56.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.267 -0.896 . . . . 0.0 111.139 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.464 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 55.1 t -95.51 -55.31 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.828 -1.17 . . . . 0.0 109.967 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -89.98 -43.95 10.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.97 5.37 53.51 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.695 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.37 -117.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.695 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.8 ttp180 -129.2 170.35 13.68 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 123.223 1.487 . . . . 0.0 108.84 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.6 p -133.56 32.39 3.61 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.544 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -164.71 133.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.214 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.8 pm0 -33.08 148.87 0.06 OUTLIER Pre-proline 0 C--N 1.305 -1.348 0 O-C-N 121.436 -0.79 . . . . 0.0 110.574 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.03 166.4 80.9 Favored 'Cis proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.866 -2.139 . . . . 0.0 111.545 -0.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CE1' HG12 ' A' ' 120' ' ' VAL . 28.6 m-85 -106.32 156.47 36.88 Favored Pre-proline 0 C--N 1.268 -2.973 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.86 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.591 ' CG ' ' CD2' ' A' ' 87' ' ' TYR . 47.8 Cg_exo -49.62 129.28 23.15 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.24 1.96 . . . . 0.0 112.147 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.626 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 1.9 pm0 -43.35 144.31 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.85 . . . . 0.0 109.134 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.34 1.11 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 137.13 28.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -1.06 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.9 tt0 -106.51 136.37 46.41 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.741 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.85 127.9 27.75 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.85 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 -168.79 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -143.57 98.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 119.9 -1.75 . . . . 0.0 110.599 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -137.52 164.35 28.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.545 178.135 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.58 162.64 33.56 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.971 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.596 ' O ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -115.71 -86.01 0.61 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -132.42 -151.41 6.74 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.784 ' SG ' ' CZ3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -28.58 114.4 0.08 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.521 -0.988 . . . . 0.0 108.992 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -53.0 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.769 -0.582 . . . . 0.0 111.75 -178.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.784 ' CZ3' ' SG ' ' A' ' 72' ' ' CYS . 16.1 m0 -84.59 -63.34 1.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.487 -1.383 . . . . 0.0 109.646 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.24 74.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.745 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.04 -38.17 57.48 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.247 -1.149 . . . . 0.0 109.76 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.544 ' CD ' ' NE2' ' A' ' 208' ' ' GLN . 3.6 tt0 -84.5 -14.82 48.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.907 -1.121 . . . . 0.0 110.554 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.663 ' C ' ' H ' ' A' ' 80' ' ' PHE . 13.1 ttp180 -76.25 -74.2 0.24 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.025 -1.047 . . . . 0.0 110.556 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -48.39 -2.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.955 -1.09 . . . . 0.0 110.26 -179.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.8 m-85 -108.64 -24.18 11.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.649 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -104.63 -2.89 24.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.719 -1.238 . . . . 0.0 111.122 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.465 HG11 ' CD1' ' A' ' 81' ' ' TRP . 1.1 m -97.76 11.54 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.686 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.621 ' C ' ' CD1' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -112.0 178.7 4.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.117 -0.989 . . . . 0.0 109.325 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -98.83 137.53 37.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.0 111.536 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.28 -33.25 3.88 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -78.61 135.86 25.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.448 -1.031 . . . . 0.0 111.049 -178.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.655 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -75.81 -40.24 55.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.685 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.9 OUTLIER -174.43 -173.62 0.78 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.555 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 39.7 p -144.12 163.01 34.83 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.685 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 12.7 mp0 -154.89 140.03 17.49 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 3.2 m -127.21 162.79 31.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.951 -1.093 . . . . 0.0 109.521 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.94 177.69 48.13 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.501 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -102.64 168.46 9.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 110.046 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.707 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.19 -170.37 0.17 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 51.25 40.78 45.85 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.738 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -106.05 -158.02 22.15 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.631 ' HD1' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -149.68 58.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.986 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -178.86 7.66 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.02 -1.05 . . . . 0.0 108.335 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.648 ' C ' HD21 ' A' ' 100' ' ' ASN . 9.3 mmt180 -52.76 -93.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.387 -0.821 . . . . 0.0 108.79 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.648 HD21 ' C ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -123.06 71.99 44.57 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.911 . . . . 0.0 109.286 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.481 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 52.0 Cg_exo -48.85 131.9 25.71 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.495 2.13 . . . . 0.0 111.633 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.47 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . 1.8 t -121.25 171.3 8.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' ' CB ' ' A' ' 107' ' ' CYS . 40.8 t80 -49.23 -43.71 42.9 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -42.46 92.0 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.599 -0.688 . . . . 0.0 109.399 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -74.77 -54.61 7.03 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.812 -1.18 . . . . 0.0 110.933 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.69 ' O ' ' N ' ' A' ' 108' ' ' SER . 17.0 m -73.09 -25.17 21.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.028 -1.045 . . . . 0.0 111.354 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -38.78 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.69 ' N ' ' O ' ' A' ' 106' ' ' VAL . 84.2 p -76.94 -81.1 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.568 ' H ' ' HG ' ' A' ' 108' ' ' SER . 0.0 OUTLIER 156.85 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -53.55 2.79 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 -177.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.641 ' OG1' ' CG1' ' A' ' 106' ' ' VAL . 32.2 p -96.53 -6.14 37.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.25 -1.531 . . . . 0.0 108.961 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 52.92 25.54 23.84 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.829 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.738 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -69.77 159.64 33.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.281 -1.717 . . . . 0.0 109.168 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -112.38 112.45 24.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.335 -0.853 . . . . 0.0 109.062 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.679 ' OE1' ' N ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -48.84 109.0 0.21 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.415 -0.803 . . . . 0.0 108.986 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 160' ' ' TYR . 16.0 m -124.71 137.4 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.79 123.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.443 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -97.82 116.18 29.52 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.313 -0.867 . . . . 0.0 109.342 -179.007 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.8 140.81 47.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.451 -0.781 . . . . 0.0 108.909 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.648 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m -107.26 158.77 7.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.322 -0.862 . . . . 0.0 108.808 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.648 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 4.4 m-85 -141.91 155.84 45.5 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.826 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -101.04 106.13 42.79 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.405 -0.81 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -47.75 -26.46 6.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.685 2.256 . . . . 0.0 112.5 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.15 -18.6 52.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -121.06 -7.62 9.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.647 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 127' ' ' SER . 0.1 OUTLIER -154.1 156.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 110.488 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 126' ' ' ILE . 33.0 t -108.17 147.68 30.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.715 . . . . 0.0 109.73 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 2.1 t80 -49.79 -21.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.442 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -63.62 -23.44 67.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.147 -0.97 . . . . 0.0 109.128 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 131' ' ' LEU . 2.5 mt-10 -71.41 -71.53 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.875 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -35.3 -47.87 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.088 -1.007 . . . . 0.0 109.579 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.539 ' C ' ' CD1' ' A' ' 132' ' ' LEU . 2.8 pp -75.82 -28.93 58.49 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.095 -1.003 . . . . 0.0 111.385 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 130' ' ' GLU . 4.3 mtmt -70.41 -58.16 4.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.671 -1.268 . . . . 0.0 110.312 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.714 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -48.76 -28.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 108.897 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.704 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 38.5 t80 -65.25 -54.8 23.93 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.815 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 86.8 m95 -71.78 -42.54 67.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.356 -1.465 . . . . 0.0 109.79 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.8 -35.37 22.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.0 111.021 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.714 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 11.4 p30 -127.83 72.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.946 -1.096 . . . . 0.0 111.275 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.704 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 6.3 m80 -150.6 151.62 32.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.612 ' OD1' ' NE2' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.38 177.77 0.33 Allowed Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' ' 142' ' ' THR . 3.4 Cg_endo -79.87 -91.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.16 1.907 . . . . 0.0 111.405 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' A' ' 189' ' ' ILE . 32.9 p -123.89 54.96 1.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.42 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.64 ' C ' ' H ' ' A' ' 145' ' ' MET . 3.7 mt-30 -101.68 51.46 0.84 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.837 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.569 ' CA ' ' HG1' ' A' ' 190' ' ' THR . . . -61.07 10.13 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.177 -1.487 . . . . 0.0 109.729 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.64 ' H ' ' C ' ' A' ' 143' ' ' GLN . 2.3 ptt? -117.13 13.23 14.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.028 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' GLN . 4.9 tmm_? -178.32 152.68 0.7 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.001 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.612 ' NE2' ' OD1' ' A' ' 140' ' ' ASP . 0.6 OUTLIER -134.53 76.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.409 -1.432 . . . . 0.0 108.8 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.76 -110.37 3.44 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.05 -32.84 39.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 114.453 -0.874 . . . . 0.0 111.901 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 148.39 22.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 109.339 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.91 156.84 47.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.912 -1.118 . . . . 0.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.94 179.47 16.23 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -18.62 37.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -1.184 . . . . 0.0 109.352 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 5.9 pt20 -88.61 4.25 47.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.123 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 67.7 m-85 -122.06 52.37 1.28 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.633 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 70' ' ' MET . 2.4 mtm105 -108.43 -170.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.504 -0.748 . . . . 0.0 109.152 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.72 126.14 35.9 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' PHE . . . -133.52 131.84 40.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.443 -1.703 . . . . 0.0 111.104 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.583 ' O ' ' CG2' ' A' ' 159' ' ' VAL . 1.2 m -135.55 119.0 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.562 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 2.8 m-30 -116.02 129.76 24.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.73 168.34 22.57 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.381 2.054 . . . . 0.0 112.131 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -20.49 20.09 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.907 -1.121 . . . . 0.0 109.222 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 177.18 -171.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 168' ' ' GLU . . . -53.12 -15.25 0.8 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.995 1.379 . . . . 0.0 108.52 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.52 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.6 t -55.75 -64.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.891 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 18.1 mt-30 -78.74 -20.92 48.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.556 -0.715 . . . . 0.0 110.651 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 12.4 ttp -52.2 -31.96 34.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.54 ' OE1' ' O ' ' A' ' 164' ' ' ALA . 2.8 mp0 -75.35 -36.25 61.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.772 -1.205 . . . . 0.0 109.79 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.578 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.77 -47.33 7.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.086 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.75 -63.15 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.07 -34.69 44.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.974 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -74.93 -35.33 62.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.192 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -59.18 -46.18 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -72.39 -25.23 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.005 . . . . 0.0 109.744 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 69.5 mt-10 -73.19 -56.82 4.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.664 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.571 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 15.7 pt-20 -53.25 -45.55 68.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.571 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -68.17 -20.54 64.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.631 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.456 HE21 ' HB2' ' A' ' 182' ' ' SER . 43.3 tp60 -74.64 -38.19 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -29.79 52.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.674 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.38 -54.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.724 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 183' ' ' LYS . 4.5 mm? -64.31 -42.31 96.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.737 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.456 ' HB2' HE21 ' A' ' 178' ' ' GLN . 23.0 t -56.38 -6.22 0.26 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 181' ' ' LEU . 3.8 tttp -88.09 -10.55 49.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.605 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.747 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.4 OUTLIER -108.4 35.96 2.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.702 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 184' ' ' HIS . 0.0 OUTLIER 72.96 31.01 1.58 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.525 -0.734 . . . . 0.0 110.004 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -105.19 174.65 5.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.18 -147.17 6.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 189' ' ' ILE . 29.6 Cg_exo -58.79 106.29 0.27 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.542 2.161 . . . . 0.0 111.451 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.526 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.2 OUTLIER -48.34 -177.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.834 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.569 ' HG1' ' CA ' ' A' ' 144' ' ' GLY . 1.8 p -133.91 68.68 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.691 0.758 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.411 ' CG2' ' CG1' ' A' ' 159' ' ' VAL . 24.5 m -98.39 119.88 37.84 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.627 ' OD1' ' CZ ' ' A' ' 194' ' ' ARG . 2.0 t70 -75.36 121.04 21.64 Favored 'General case' 0 C--N 1.279 -2.485 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.492 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.55 109.57 14.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.627 ' CZ ' ' OD1' ' A' ' 192' ' ' ASP . 1.9 ptp180 -166.75 120.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.652 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 1.9 pm0 -80.81 -179.32 7.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.529 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.49 22.75 61.78 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.474 ' HG3' ' CE2' ' A' ' 160' ' ' TYR . 53.0 mm-40 -93.31 98.29 11.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.612 -1.522 . . . . 0.0 109.516 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 197' ' ' GLN . 1.4 p -42.98 161.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.468 -0.77 . . . . 0.0 109.794 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 41.3 t80 -109.31 131.43 55.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.505 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -127.54 98.65 5.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.67 131.52 39.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.982 -1.074 . . . . 0.0 110.584 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -83.58 179.14 7.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.0 OUTLIER -74.64 170.57 15.54 Favored 'General case' 0 C--N 1.286 -2.153 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 179.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -63.93 -13.43 45.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.897 . . . . 0.0 109.841 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -76.77 -15.75 59.66 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.912 -1.118 . . . . 0.0 110.182 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.41 ' CD2' ' OE2' ' A' ' 203' ' ' GLU . 63.5 m-70 -107.35 8.89 29.94 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.677 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.751 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.7 mm-40 -119.88 -149.98 0.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.822 -1.174 . . . . 0.0 112.087 -177.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.661 ' CG ' ' NE2' ' A' ' 48' ' ' HIS . 12.2 mp0 -36.25 -2.49 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.73 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.751 ' N ' ' O ' ' A' ' 207' ' ' GLN . 10.6 p90 -46.79 -34.75 5.54 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 117.373 -1.731 . . . . 0.0 110.705 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 209' ' ' TYR . 1.7 mt -49.44 -10.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.403 -1.436 . . . . 0.0 110.042 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 209' ' ' TYR . 11.4 p -53.21 -37.02 61.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -84.75 -36.74 21.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.1 66.79 3.09 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.594 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 10.0 Cg_endo -54.9 -39.76 88.77 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.997 2.465 . . . . 0.0 113.16 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.584 ' C ' HH12 ' A' ' 78' ' ' ARG . 29.6 p30 -61.23 -5.6 1.66 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.787 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 218' ' ' CYS . . . 58.99 84.41 0.04 OUTLIER Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.561 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.637 ' OH ' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -48.82 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 121.017 2.408 . . . . 0.0 109.452 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 216' ' ' GLY . 31.4 p -166.12 -125.15 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.769 -1.207 . . . . 0.0 109.143 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.631 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -128.04 -149.94 7.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 0.1 OUTLIER -114.23 -175.02 2.59 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.36 -1.083 . . . . 0.0 109.641 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.86 -139.28 0.05 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -153.42 -142.02 3.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.63 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.521 -0.987 . . . . 0.0 109.455 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 CA--C 1.505 -0.77 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.82 135.78 25.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -173.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.53 ' H ' ' HG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -82.23 131.28 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.151 0.977 . . . . 0.0 110.243 -179.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 97' ' ' HIS . . . -45.9 -55.68 6.41 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.494 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -85.03 8.28 18.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.765 -1.209 . . . . 0.0 111.73 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.472 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 3.2 tt0 -117.59 -14.3 10.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.444 -1.41 . . . . 0.0 111.501 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HB3' ' CD2' ' A' ' 97' ' ' HIS . . . -67.39 -169.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.541 -1.35 . . . . 0.0 109.45 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.69 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.591 ' CG2' ' O ' ' A' ' 201' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.497 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 71.5 Cg_endo -81.37 149.86 17.06 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.06 2.507 . . . . 0.0 112.751 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 43' ' ' PRO . 3.2 m -163.37 158.92 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.416 -0.802 . . . . 0.0 109.493 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.599 ' CG2' ' O ' ' A' ' 45' ' ' THR . 15.2 t -59.43 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.908 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.587 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.91 -21.79 22.38 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.235 -0.916 . . . . 0.0 110.759 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.6 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.8 OUTLIER -90.93 100.15 13.06 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 116.344 -2.143 . . . . 0.0 108.03 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.652 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 7.8 t-80 -31.48 132.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.486 ' CE1' ' HE2' ' A' ' 212' ' ' LYS . 0.1 OUTLIER -82.72 -11.43 58.32 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.104 -0.998 . . . . 0.0 111.234 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 48' ' ' HIS . 21.9 t -85.6 -36.34 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 108.207 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -45.14 3.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.011 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.11 54.27 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -76.32 -116.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.688 ' CB ' ' HH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.89 174.06 10.1 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 123.497 1.617 . . . . 0.0 109.606 177.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 6.9 p -142.34 38.57 1.56 Allowed 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.07 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 55' ' ' THR . 4.6 m -163.89 138.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.995 -1.066 . . . . 0.0 109.795 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.451 ' HB3' ' CE2' ' A' ' 59' ' ' PHE . 8.1 pt-20 -71.78 177.33 1.71 Allowed Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 2.9 Cg_exo -49.26 143.62 6.21 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 N-CA-C 116.067 1.526 . . . . 0.0 116.067 -0.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 37.6 m-85 -94.56 110.44 49.04 Favored Pre-proline 0 C--N 1.272 -2.768 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.577 ' O ' ' OG1' ' A' ' 63' ' ' THR . 50.1 Cg_exo -50.38 133.45 36.88 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.331 2.021 . . . . 0.0 112.387 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 60' ' ' PRO . 50.8 mt-10 -43.59 157.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.14 32.0 27.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -158.71 137.93 11.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -1.174 . . . . 0.0 109.474 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.663 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 20.6 mp0 -111.55 156.67 21.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.123 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.742 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -140.78 114.62 8.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.965 . . . . 0.0 109.904 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.64 -170.71 1.69 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.93 . . . . 0.0 108.802 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.14 133.55 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.049 -1.657 . . . . 0.0 109.518 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.713 ' CE2' ' O ' ' A' ' 131' ' ' LEU . 25.9 m-85 -126.41 145.22 50.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.828 -1.17 . . . . 0.0 109.293 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.03 108.93 1.72 Allowed Glycine 0 N--CA 1.482 1.715 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.601 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -114.3 -87.84 0.57 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.403 -1.057 . . . . 0.0 108.502 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.569 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -148.19 -152.19 5.63 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.703 ' C ' ' H ' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -36.18 104.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.78 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -50.67 7.28 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.703 ' H ' ' C ' ' A' ' 72' ' ' CYS . 37.9 m0 -75.27 -52.23 11.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.656 -1.278 . . . . 0.0 109.417 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 218' ' ' CYS . . . -88.8 -26.96 25.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -64.85 -45.2 87.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.105 -1.233 . . . . 0.0 110.173 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 4.2 tt0 -83.03 -14.77 53.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.126 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 80' ' ' PHE . 51.4 ttp85 -68.6 -36.12 78.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.0 110.067 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -70.49 15.76 0.09 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.0 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 93.2 m-85 -123.73 -42.25 2.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 110.644 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -68.77 6.88 0.76 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.553 -1.342 . . . . 0.0 109.268 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 80' ' ' PHE . 1.5 m -109.53 15.97 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 109.369 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.9 mt -110.84 154.64 23.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.98 138.42 31.5 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.353 0.596 . . . . 0.0 109.561 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.84 -27.35 14.96 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.26 137.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.53 -0.982 . . . . 0.0 108.999 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.688 ' HH ' ' CB ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -79.94 -46.69 16.27 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.672 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 1.4 p -165.7 -170.21 1.74 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.652 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 41.4 p -151.16 146.42 26.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 108.989 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.672 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 6.8 mp0 -144.59 155.8 43.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 110.13 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.464 ' CG2' ' OE1' ' A' ' 207' ' ' GLN . 0.1 OUTLIER -141.05 151.95 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.2 42.82 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.374 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.2 m-85 -80.1 171.68 14.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.951 . . . . 0.0 109.252 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -176.95 168.73 2.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 109.667 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 64.64 20.88 66.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -93.83 173.72 33.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.634 ' CD2' ' O ' ' A' ' 31' ' ' ALA . 1.2 m-70 -91.66 -111.83 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.544 -1.563 . . . . 0.0 111.404 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.748 ' HG1' ' H ' ' A' ' 99' ' ' ARG . 5.9 t -75.98 -172.88 2.12 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.748 ' H ' ' HG1' ' A' ' 98' ' ' THR . 0.1 OUTLIER -37.81 139.26 0.32 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.937 ' H ' ' ND2' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -128.38 144.87 53.54 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -172.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 100' ' ' ASN . 73.5 Cg_exo -45.68 -147.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 124.133 3.222 . . . . 0.0 112.214 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 106' ' ' VAL . 1.5 t -125.53 176.1 7.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.971 -1.08 . . . . 0.0 111.514 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.786 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -50.81 -41.1 57.09 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.531 0.682 . . . . 0.0 110.397 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 12.7 tttp -72.59 -33.44 66.72 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.146 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.658 ' C ' ' HZ2' ' A' ' 110' ' ' LYS . 1.9 mm-40 -81.71 -41.2 21.65 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 110.47 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 108' ' ' SER . 28.3 m -56.29 -23.32 16.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.061 -1.024 . . . . 0.0 109.85 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' A' ' 106' ' ' VAL . 69.0 m -41.66 -15.48 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.691 ' C ' ' H ' ' A' ' 110' ' ' LYS . 35.6 m -102.67 19.81 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 110.006 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER 60.08 -9.38 0.05 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.92 -1.112 . . . . 0.0 109.647 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.691 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -44.67 -14.32 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.739 -0.6 . . . . 0.0 111.691 -178.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -122.09 -10.0 8.63 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.554 -1.342 . . . . 0.0 111.481 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 60.74 24.87 62.84 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 118.527 -1.796 . . . . 0.0 109.771 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.655 ' HE2' ' CG ' ' A' ' 100' ' ' ASN . 1.8 m-70 -78.83 172.41 13.8 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.992 -1.299 . . . . 0.0 109.274 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -137.25 125.26 22.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.674 ' OE2' ' CZ ' ' A' ' 73' ' ' PHE . 3.5 mt-10 -66.33 119.7 12.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.232 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -125.05 169.74 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.13 128.22 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.376 -0.827 . . . . 0.0 109.519 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.711 HH11 ' HH ' ' A' ' 201' ' ' TYR . 8.9 ttm180 -103.48 111.83 24.46 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.551 -0.718 . . . . 0.0 109.886 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.72 112.89 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.49 160.72 3.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 108.94 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 10.5 p90 -141.23 169.5 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.581 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.513 ' C ' ' OE2' ' A' ' 124' ' ' GLU . 60.7 mtp180 -110.05 114.1 56.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' HIS . 38.3 Cg_exo -42.94 -63.97 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.927 2.418 . . . . 0.0 113.022 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.683 ' OE2' ' N ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -46.45 -10.67 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 -179.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' PRO . 36.1 m80 -126.13 -18.86 4.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.617 -1.302 . . . . 0.0 110.716 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.482 HG21 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.59 158.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.873 -1.142 . . . . 0.0 110.212 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 126' ' ' ILE . 88.5 p -108.8 153.19 23.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.825 . . . . 0.0 110.369 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' C ' ' N ' ' A' ' 130' ' ' GLU . 25.1 t80 -53.63 -30.1 41.19 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 3.0 mp0 -47.35 -19.26 0.15 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 128' ' ' PHE . 1.5 mm-40 -73.84 -63.02 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.827 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.713 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 7.2 mt -44.74 -45.74 10.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.253 -0.904 . . . . 0.0 108.785 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.599 ' C ' ' CD1' ' A' ' 132' ' ' LEU . 2.5 pp -75.04 -21.96 58.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.495 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.446 ' N ' HD11 ' A' ' 132' ' ' LEU . 0.4 OUTLIER -69.94 -68.13 0.44 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.736 -1.227 . . . . 0.0 110.057 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.727 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 38.9 t -58.3 -17.22 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.58 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 7.2 t80 -72.45 -60.27 2.31 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.844 -1.16 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.658 ' CB ' ' CE2' ' A' ' 177' ' ' TYR . 94.1 m95 -72.06 -52.84 14.94 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.468 -1.395 . . . . 0.0 110.348 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 136' ' ' TRP . 4.1 tt0 -36.84 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.557 -0.714 . . . . 0.0 111.86 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.727 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.7 p30 -124.0 64.76 1.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.609 -1.307 . . . . 0.0 111.734 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 223' ' ' THR . 13.0 m80 -147.95 161.25 41.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.201 -0.937 . . . . 0.0 109.056 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.65 ' CG ' HE22 ' A' ' 143' ' ' GLN . 0.9 OUTLIER -91.77 160.32 36.46 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 186' ' ' PHE . 79.8 Cg_exo -32.62 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.572 2.181 . . . . 0.0 111.792 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.707 ' OG1' ' N ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -122.21 14.77 10.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.793 -1.192 . . . . 0.0 109.005 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.65 HE22 ' CG ' ' A' ' 140' ' ' ASP . 3.5 mt-30 -55.4 71.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.61 10.17 62.84 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.97 15.53 15.14 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 148' ' ' GLY . 4.3 ttm180 179.3 133.62 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.326 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 70' ' ' MET . 2.0 tp60 -109.54 63.67 0.6 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 119.731 -1.856 . . . . 0.0 107.894 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' CD ' ' A' ' 146' ' ' ARG . . . 91.96 -118.07 5.41 Favored Glycine 0 C--N 1.301 -1.413 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -32.75 47.54 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.458 -0.871 . . . . 0.0 111.434 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.95 117.46 18.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.28 -1.513 . . . . 0.0 109.304 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 35.6 p90 -109.21 131.89 54.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.928 . . . . 0.0 110.716 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.06 164.51 25.9 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.023 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.574 ' OG1' ' OE2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -72.13 -23.42 61.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.589 -0.948 . . . . 0.0 109.629 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.631 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 7.2 pm0 -89.17 3.7 51.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.453 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 22.5 m-85 -112.59 50.03 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 109.37 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 144' ' ' GLY . 1.6 mtm180 -97.37 -178.65 4.23 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 109.236 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 192' ' ' ASP . 3.8 t -93.9 112.95 24.87 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -145.17 123.18 12.06 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 117.866 -1.533 . . . . 0.0 112.036 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.478 HG21 ' CE2' ' A' ' 135' ' ' PHE . 4.5 t -112.26 127.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.689 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.5 m-85 -112.88 93.02 22.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.323 -0.86 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -49.12 172.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.838 2.358 . . . . 0.0 112.186 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.44 HG23 ' SD ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -107.44 -44.24 4.35 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.191 -0.943 . . . . 0.0 109.698 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.509 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER -175.12 -178.02 1.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.12 -0.988 . . . . 0.0 109.902 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.18 -24.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 123.252 1.501 . . . . 0.0 108.255 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.649 ' O ' ' CG ' ' A' ' 168' ' ' GLU . 2.5 t -56.43 -53.81 35.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.38 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 168' ' ' GLU . 0.4 OUTLIER -78.51 -20.92 49.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.336 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 22.8 ttm -52.95 -4.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER -73.58 -68.48 0.5 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.845 -1.159 . . . . 0.0 110.583 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -92.74 -42.92 9.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -0.987 . . . . 0.0 111.175 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -51.68 -65.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.968 -1.082 . . . . 0.0 110.169 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.458 ' HG ' ' NZ ' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -55.04 -40.14 69.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.045 -1.034 . . . . 0.0 109.431 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -74.26 -24.17 59.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.648 ' N ' ' O ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -67.23 -32.31 73.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.583 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.595 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 8.1 pttm -72.36 -47.14 51.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.997 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CG ' ' A' ' 174' ' ' LYS . 15.3 tt0 -72.86 -30.38 63.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.518 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.639 ' OE2' ' CD2' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -73.22 -40.79 64.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.0 -1.062 . . . . 0.0 110.819 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.658 ' CE2' ' CB ' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -80.12 -25.61 39.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.748 -1.22 . . . . 0.0 110.238 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -74.76 -26.44 59.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 109.912 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 1.4 ttpm? -77.89 -20.04 53.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.22 -54.11 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.76 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.1 mt -66.38 -13.09 60.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.963 . . . . 0.0 109.75 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.43 ' HG ' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -59.48 -40.66 87.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -88.04 10.61 18.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.95 . . . . 0.0 109.659 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.516 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 14.3 m170 -104.49 35.11 2.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.31 48.55 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.543 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 141' ' ' PRO . 71.7 m-85 -152.5 168.61 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.31 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -117.83 -144.42 7.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -58.66 105.85 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.24 1.96 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.544 ' C ' ' OG1' ' A' ' 142' ' ' THR . 0.5 OUTLIER -47.47 166.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -178.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.707 ' N ' ' OG1' ' A' ' 142' ' ' THR . 0.8 OUTLIER -95.06 0.48 54.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.827 -0.546 . . . . 0.0 111.199 -179.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.496 ' C ' ' O ' ' A' ' 190' ' ' THR . 27.2 m -42.87 108.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.69 -1.256 . . . . 0.0 108.401 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.663 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 2.2 t70 -76.91 131.8 38.75 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.84 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 193' ' ' ILE . 7.7 mm -131.97 101.38 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.402 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.663 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -143.35 153.54 42.83 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.669 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -107.02 171.21 7.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.976 -1.077 . . . . 0.0 110.01 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.544 ' C ' ' OE1' ' A' ' 197' ' ' GLN . . . 75.37 43.94 23.5 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.591 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 3.6 mm100 -97.41 97.6 9.24 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.318 -1.107 . . . . 0.0 109.539 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.5 t -48.3 153.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.69 131.88 54.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.407 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' PHE . 4.4 m-85 -131.79 98.35 4.44 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.711 ' HH ' HH11 ' A' ' 118' ' ' ARG . 16.0 m-85 -54.02 141.49 28.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 110.462 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.461 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -92.87 -176.08 4.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.701 ' OE1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.45 175.11 8.04 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.441 -0.787 . . . . 0.0 109.064 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.701 ' N ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -60.42 -54.83 40.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.867 -1.146 . . . . 0.0 108.77 179.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -46.89 -11.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.052 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.786 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 9.1 m-70 -100.75 9.84 41.9 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.12 -0.987 . . . . 0.0 110.777 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.9 mm-40 -130.51 -143.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.402 1.096 . . . . 0.0 110.688 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.651 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 16.4 mp0 -36.59 -2.76 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.072 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 60.3 t80 -41.01 -50.69 3.32 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 120.865 -1.147 . . . . 0.0 112.083 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 63.9 mt -65.97 -25.23 67.01 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.115 -1.615 . . . . 0.0 111.221 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.91 -52.06 65.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 108.608 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.636 ' NZ ' ' CB ' ' A' ' 212' ' ' LYS . 7.4 mtmp? -90.34 -12.49 37.54 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 111.096 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.693 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 2.0 m-80 -115.0 95.18 41.08 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.669 -1.269 . . . . 0.0 111.082 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.68 12.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.326 2.684 . . . . 0.0 111.899 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.603 ' H ' ' C ' ' A' ' 213' ' ' ASN . 8.1 t0 -60.74 -5.42 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.44 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.33 -47.41 0.13 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.592 -1.289 . . . . 0.0 112.492 177.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.615 ' C ' ' O ' ' A' ' 216' ' ' GLY . 25.9 m-85 -27.22 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 119.382 1.591 . . . . 0.0 109.641 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.759 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 16.6 p -142.24 -127.62 0.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.337 -0.852 . . . . 0.0 109.564 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.759 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -152.66 151.0 22.89 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 mt -104.65 146.25 29.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -1.138 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.4 -162.63 5.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -155.51 -141.77 3.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 139' ' ' HIS . 1.2 p . . . . . 0 C--N 1.304 -1.376 0 O-C-N 121.47 -1.017 . . . . 0.0 110.082 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.553 ' CG1' ' O ' ' A' ' 28' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.473 -2.005 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.444 HG21 ' NE2' ' A' ' 97' ' ' HIS . 0.2 OUTLIER -40.41 120.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 109.219 -3.628 . . . . 0.0 115.301 -169.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.96 121.17 9.92 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.874 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -52.79 -24.7 9.4 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.827 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -73.5 -14.56 61.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.793 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.6 -14.03 14.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.26 146.09 12.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 110.314 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.43 ' N ' ' HD3' ' A' ' 110' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 mm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.38 168.01 16.91 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.829 2.353 . . . . 0.0 112.174 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 29.7 m -129.39 -163.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.14 -0.975 . . . . 0.0 109.68 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.666 ' N ' ' OD2' ' A' ' 204' ' ' ASP . 13.2 t -90.66 102.39 15.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.595 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.89 -57.8 10.56 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.367 -0.833 . . . . 0.0 110.915 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -71.23 100.8 2.17 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 115.62 -2.432 . . . . 0.0 108.061 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.757 ' HE2' ' NE2' ' A' ' 208' ' ' GLN . 11.4 t-80 -31.63 136.53 0.06 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.454 ' NE2' ' HD2' ' A' ' 212' ' ' LYS . 37.4 t-80 -74.81 -32.32 61.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 111.09 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG21 ' CD2' ' A' ' 81' ' ' TRP . 64.2 t -70.27 -47.58 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.892 -1.13 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -99.34 -42.72 6.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.062 -1.024 . . . . 0.0 110.789 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.03 2.51 58.17 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -75.61 -115.66 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.587 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -134.23 173.44 11.6 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 123.613 1.673 . . . . 0.0 110.106 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 41.3 p -143.72 17.38 1.81 Allowed 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 112.601 -2.091 . . . . 0.0 110.061 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 57' ' ' GLU . 8.6 m -151.96 136.81 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 109.368 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' A' ' 56' ' ' VAL . 8.2 mt-10 -32.4 155.28 0.04 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.971 0.891 . . . . 0.0 110.816 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.26 165.83 79.98 Favored 'Cis proline' 0 C--N 1.303 -1.865 0 C-N-CA 121.606 -2.248 . . . . 0.0 112.045 -0.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.796 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 2.2 m-30 -112.24 150.31 42.32 Favored Pre-proline 0 C--N 1.269 -2.91 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.21 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.573 ' O ' ' OG1' ' A' ' 63' ' ' THR . 36.2 Cg_endo -68.01 109.98 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.727 2.285 . . . . 0.0 112.331 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.84 143.42 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.11 -19.0 50.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -82.78 149.1 27.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -1.134 . . . . 0.0 109.533 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.678 ' OE1' ' N ' ' A' ' 65' ' ' MET . 5.6 tm0? -99.47 146.98 25.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.752 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -139.36 114.27 9.42 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.093 -1.004 . . . . 0.0 109.647 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.98 -167.98 1.63 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 t -142.35 138.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.126 -1.609 . . . . 0.0 109.47 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.694 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 32.9 m-85 -134.63 136.74 43.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.06 111.12 2.21 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.672 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 2.9 mmm -100.01 -89.76 0.33 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.429 -1.042 . . . . 0.0 108.519 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.721 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -161.3 72.49 0.21 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.216 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.721 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 49.0 t 110.52 110.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.561 0.744 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.6 ' CD1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -63.99 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.505 -1.372 . . . . 0.0 110.61 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.688 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 9.0 m0 -94.89 -70.52 0.71 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.565 -1.334 . . . . 0.0 109.553 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -2.43 65.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.34 -37.62 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -1.164 . . . . 0.0 109.796 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.671 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 2.1 pm0 -82.74 -25.75 32.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.267 -0.896 . . . . 0.0 110.479 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 6.4 tmm_? -57.94 -56.79 17.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.075 -1.016 . . . . 0.0 110.076 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.455 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 13.0 mttp -43.53 -25.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.484 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 94.6 m-85 -84.96 -41.75 15.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 111.406 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 81' ' ' TRP . 0.7 OUTLIER -69.55 -5.18 22.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.318 -1.489 . . . . 0.0 109.259 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 81' ' ' TRP . 0.9 OUTLIER -97.74 18.58 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.234 -0.916 . . . . 0.0 109.365 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.29 152.2 21.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.972 0.892 . . . . 0.0 109.402 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -90.0 143.27 26.93 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 95.66 -21.44 44.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.53 138.02 21.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.838 . . . . 0.0 109.529 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.587 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.8 -47.56 12.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.525 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 1.5 t -167.65 -175.13 2.69 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.631 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 81' ' ' TRP . 20.2 p -149.29 164.38 35.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.803 . . . . 0.0 109.285 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.85 162.59 13.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 206' ' ' HIS . 0.9 OUTLIER -126.67 176.91 6.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.274 -0.891 . . . . 0.0 109.365 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.53 169.27 37.04 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 202' ' ' ALA . 3.4 m-85 -89.1 161.59 16.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.984 . . . . 0.0 109.99 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.688 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.06 -171.37 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.433 -0.792 . . . . 0.0 109.104 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 54.61 32.1 53.38 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.616 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -139.47 -159.61 8.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.477 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 4.2 p80 -148.77 78.58 1.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.313 -1.11 . . . . 0.0 109.909 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.581 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.86 149.33 21.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.262 -0.898 . . . . 0.0 109.009 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.706 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.1 mmt180 -48.83 -106.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.24 83.82 5.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.46 171.18 18.06 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.481 2.121 . . . . 0.0 112.265 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.487 ' OG1' ' HB3' ' A' ' 105' ' ' GLU . 21.2 p -122.27 167.31 13.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.025 -1.047 . . . . 0.0 110.077 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.732 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 2.1 t80 -57.79 -59.33 5.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.586 -0.696 . . . . 0.0 110.144 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -22.06 41.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 108.78 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.487 ' HB3' ' OG1' ' A' ' 102' ' ' THR . 0.8 OUTLIER -79.06 -61.46 2.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.653 -0.655 . . . . 0.0 110.596 -179.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.48 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 15.3 m -52.13 -24.68 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.128 -0.982 . . . . 0.0 110.533 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.2 p -52.97 -45.32 67.72 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.695 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 13.6 t -52.23 -6.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.639 ' H ' ' C ' ' A' ' 107' ' ' CYS . 1.9 tt0 65.13 -6.01 0.38 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.585 -0.697 . . . . 0.0 110.359 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 108' ' ' SER . 7.2 tttt -60.98 -23.01 65.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.106 -0.996 . . . . 0.0 109.206 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.475 ' O ' ' C ' ' A' ' 112' ' ' GLY . 25.3 p -94.87 -5.63 44.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.281 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 39.41 47.62 2.85 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.688 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 5.6 m-70 -92.26 170.05 10.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.782 -1.422 . . . . 0.0 109.064 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -123.59 116.1 22.57 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.546 ' C ' ' OE2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -53.41 143.4 19.25 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.583 -178.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -151.8 174.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.125 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 33.9 m -135.32 121.62 32.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.796 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 8.1 ptm180 -96.98 96.9 8.82 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.442 1.115 . . . . 0.0 108.7 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.469 ' CG2' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -103.82 147.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.664 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -114.31 157.25 15.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.664 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 2.8 m-85 -141.89 157.33 45.11 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.243 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.42 ' CD ' ' CG2' ' A' ' 63' ' ' THR . 7.7 mmm180 -109.98 99.55 39.52 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.513 -0.742 . . . . 0.0 109.252 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 125' ' ' HIS . 10.9 Cg_exo -40.32 -67.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.111 2.541 . . . . 0.0 113.906 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -40.94 -12.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.204 -0.935 . . . . 0.0 110.711 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.692 ' N ' ' O ' ' A' ' 123' ' ' PRO . 5.8 m-70 -135.41 6.77 3.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.614 -1.303 . . . . 0.0 109.69 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.582 ' CD1' ' CD ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -156.28 148.31 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.594 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 126' ' ' ILE . 4.6 t -99.47 151.09 21.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.481 ' CZ ' ' CD2' ' A' ' 132' ' ' LEU . 41.9 t80 -61.72 -19.88 62.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -61.88 -22.56 65.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 131' ' ' LEU . 3.0 mt-10 -70.15 -70.65 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 110.147 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.7 ' CD1' ' H ' ' A' ' 131' ' ' LEU . 0.8 OUTLIER -35.19 -50.12 0.51 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 128' ' ' PHE . 4.5 mm? -68.05 -54.47 18.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 0.0 111.503 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.421 ' NZ ' ' OE2' ' A' ' 137' ' ' GLU . 3.8 tttm -52.04 -57.66 8.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.081 -1.012 . . . . 0.0 111.276 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.484 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 78.8 t -49.83 -33.77 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.132 . . . . 0.0 110.22 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.701 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 23.2 t80 -71.72 -52.33 18.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.831 -1.168 . . . . 0.0 109.923 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 177' ' ' TYR . 87.5 m95 -70.42 -32.13 69.6 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.906 -1.121 . . . . 0.0 110.348 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.597 ' O ' ' OG1' ' A' ' 223' ' ' THR . 7.8 tt0 -72.35 -34.83 68.31 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 112.259 -177.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.37 73.72 1.56 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.44 -1.412 . . . . 0.0 112.361 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.701 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 2.0 p-80 178.15 129.59 0.06 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.81 -1.181 . . . . 0.0 110.518 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 221' ' ' GLY . 4.8 m-20 -69.09 111.3 8.08 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.453 ' HB3' ' CE1' ' A' ' 139' ' ' HIS . 66.5 Cg_endo -91.34 5.69 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 0.0 113.081 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 142' ' ' THR . 0.1 OUTLIER -123.14 46.23 2.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 111.049 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.596 ' C ' ' H ' ' A' ' 145' ' ' MET . 23.5 mt-30 -140.39 67.92 1.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 108.999 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.08 13.0 0.23 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.596 ' H ' ' C ' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -115.08 -20.02 10.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.033 -1.275 . . . . 0.0 109.057 178.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.518 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 176.85 163.94 0.47 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.672 ' NE2' ' O ' ' A' ' 70' ' ' MET . 15.3 mt-30 -141.44 159.66 41.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.551 -1.343 . . . . 0.0 110.191 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 147' ' ' GLN . . . 44.23 -120.55 3.44 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 36.9 t30 -111.05 26.11 11.05 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.34 -0.93 . . . . 0.0 110.542 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.573 ' OD2' ' CD1' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -108.18 91.48 3.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.855 -1.153 . . . . 0.0 109.221 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' HD2' ' A' ' 146' ' ' ARG . 3.7 m-85 -69.14 118.62 12.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 149.8 168.39 15.04 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.138 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 153' ' ' THR . 0.4 OUTLIER -94.18 9.41 38.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.416 -1.049 . . . . 0.0 109.154 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.682 ' OE1' ' CE2' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -93.25 -1.16 56.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.694 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.682 ' CE2' ' OE1' ' A' ' 154' ' ' GLN . 3.3 m-85 -129.99 57.99 1.67 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.024 -1.048 . . . . 0.0 109.879 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.557 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.6 OUTLIER -91.51 -175.63 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 108.913 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.567 ' N ' ' OE1' ' A' ' 147' ' ' GLN . 13.1 p -94.08 118.89 32.17 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -147.06 110.72 4.95 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.501 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 192' ' ' ASP . 8.3 t -98.38 131.28 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.739 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.451 ' CE2' HG13 ' A' ' 116' ' ' VAL . 7.8 m-85 -114.01 120.53 38.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.51 173.72 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.574 2.183 . . . . 0.0 113.038 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -94.62 -19.61 20.31 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.227 -0.921 . . . . 0.0 109.215 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 162' ' ' THR . 0.4 OUTLIER 167.69 -163.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.453 -0.779 . . . . 0.0 109.084 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.68 -15.39 11.65 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.952 1.358 . . . . 0.0 108.743 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.76 -62.7 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.638 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.651 HE22 ' NE2' ' A' ' 64' ' ' GLN . 1.4 mp0 -61.44 -12.06 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.524 -0.735 . . . . 0.0 109.823 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.0 ttm -51.94 -34.09 40.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.913 -1.117 . . . . 0.0 110.533 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.37 -38.67 59.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.829 -1.169 . . . . 0.0 110.388 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.558 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.78 -41.52 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.021 -1.049 . . . . 0.0 110.462 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.18 -62.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.91 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . 0.419 HD21 ' N ' ' A' ' 171' ' ' LEU . 1.7 mm? -53.04 -36.81 60.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -74.33 -24.06 59.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.92 . . . . 0.0 109.98 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.558 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.62 -50.11 16.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.937 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -36.26 73.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.015 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.05 -49.95 25.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 110.094 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 17.8 pt-20 -59.27 -43.05 92.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.5 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 1.1 m-85 -79.29 -12.2 59.94 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.998 -1.064 . . . . 0.0 109.61 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -74.57 -55.13 6.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.544 ' O ' ' OG ' ' A' ' 182' ' ' SER . 5.7 ttpm? -73.1 -29.49 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.9 -54.37 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.98 . . . . 0.0 109.853 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.412 HD12 ' CG2' ' A' ' 189' ' ' ILE . 37.2 mt -68.17 -5.35 17.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.768 ' HG ' ' H ' ' A' ' 183' ' ' LYS . 81.4 p -61.62 -67.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.07 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.768 ' H ' ' HG ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -88.64 13.26 12.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.738 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -94.83 32.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 0.0 109.542 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.738 ' ND2' ' O ' ' A' ' 184' ' ' HIS . 0.0 OUTLIER 72.87 29.75 1.82 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.669 -0.645 . . . . 0.0 110.324 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.603 ' CD2' ' ND2' ' A' ' 185' ' ' ASN . 7.1 m-85 -137.13 170.9 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.134 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -114.08 -136.76 6.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 189' ' ' ILE . 56.7 Cg_endo -77.45 107.14 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.293 1.995 . . . . 0.0 111.718 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.2 OUTLIER -48.05 178.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 143' ' ' GLN . 6.8 t -128.69 -2.27 5.39 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.121 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 190' ' ' THR . 56.8 m -42.91 114.48 0.61 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.659 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 7.0 t0 -87.45 136.34 32.98 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.615 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 4.5 mp -135.53 92.15 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 118.116 -1.434 . . . . 0.0 110.63 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.659 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -134.37 -179.51 5.62 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 4.3 pt-20 -139.11 -173.04 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.719 -1.238 . . . . 0.0 110.855 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.61 72.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 1.3 mp0 -79.89 128.02 32.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.87 -1.371 . . . . 0.0 109.885 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.7 p -60.55 153.65 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.188 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.595 ' CZ ' ' CD ' ' A' ' 118' ' ' ARG . 66.7 t80 -117.84 130.29 56.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 109.769 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.706 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 21.0 m-85 -132.29 109.83 10.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.482 -0.761 . . . . 0.0 109.187 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.776 ' HH ' ' NH1' ' A' ' 118' ' ' ARG . 20.1 m-85 -53.69 131.32 38.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.03 -1.044 . . . . 0.0 111.116 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -82.8 179.28 7.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 203' ' ' GLU . 8.5 pm0 -75.08 158.68 32.74 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.486 -0.759 . . . . 0.0 108.96 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.666 ' OD2' ' N ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -55.4 -39.66 70.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.952 -1.092 . . . . 0.0 108.145 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.51 ' CE1' ' CE2' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -48.83 -19.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.577 -0.702 . . . . 0.0 110.304 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.732 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 10.5 m-70 -100.78 -17.7 16.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.811 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -106.44 -148.49 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.846 0.832 . . . . 0.0 110.357 -177.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.757 ' NE2' ' HE2' ' A' ' 48' ' ' HIS . 18.5 mp0 -35.53 -9.32 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.269 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.811 ' N ' ' O ' ' A' ' 207' ' ' GLN . 1.3 t80 -43.14 -41.87 3.86 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 120.8 -1.188 . . . . 0.0 110.915 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.475 ' CD2' ' O ' ' A' ' 74' ' ' TRP . 3.7 pp -79.98 -11.92 59.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.693 -1.603 . . . . 0.0 109.6 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 208' ' ' GLN . 91.7 p -55.8 -43.61 77.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 108.843 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.454 ' HD2' ' NE2' ' A' ' 49' ' ' HIS . 6.8 mtmm -65.49 -18.34 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.671 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.9 m-20 -128.24 71.9 79.68 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.004 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.47 9.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.274 2.649 . . . . 0.0 112.704 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.671 ' H ' ' C ' ' A' ' 213' ' ' ASN . 7.3 p30 -63.2 -18.51 63.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.012 -1.055 . . . . 0.0 110.657 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.73 85.47 0.05 OUTLIER Glycine 0 N--CA 1.498 2.79 0 C-N-CA 119.345 -1.407 . . . . 0.0 111.036 178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.737 ' CD2' ' N ' ' A' ' 218' ' ' CYS . 71.4 t80 -45.11 -177.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.321 2.06 . . . . 0.0 109.778 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.737 ' N ' ' CD2' ' A' ' 217' ' ' TYR . 0.7 OUTLIER -72.99 76.86 1.19 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.98 -1.075 . . . . 0.0 109.339 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.4 149.13 17.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.09 -171.78 4.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -1.101 . . . . 0.0 110.0 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 140' ' ' ASP . . . -142.5 -126.99 2.14 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.589 ' O ' ' OG1' ' A' ' 223' ' ' THR . . . -176.8 -134.94 2.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.645 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 10.5 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.428 -1.043 . . . . 0.0 109.398 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 32.1 t . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.92 133.05 21.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.262 1.03 . . . . 0.0 113.544 -175.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.426 ' HG ' ' CB ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -70.12 125.41 26.7 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.718 -179.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.568 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -48.13 -43.19 30.93 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.654 -0.654 . . . . 0.0 109.433 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -73.34 4.32 4.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' ALA . 15.7 tt0 -111.55 -1.97 15.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -49.66 -168.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 0.0 109.686 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.558 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' ILE . 54.2 Cg_exo -48.46 -168.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.719 2.279 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.456 HG11 ' N ' ' A' ' 204' ' ' ASP . 26.9 m -136.05 -161.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 45' ' ' THR . 11.8 t -72.75 99.47 2.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.564 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.19 -49.07 75.09 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.145 -0.972 . . . . 0.0 111.277 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 mttm -75.35 99.51 4.14 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 115.84 -2.344 . . . . 0.0 108.682 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.649 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.7 t-80 -33.03 113.38 0.14 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.454 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.1 t-80 -61.3 -30.86 70.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.365 -0.834 . . . . 0.0 110.83 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.491 ' CG2' ' OG ' ' A' ' 211' ' ' SER . 26.1 t -65.17 -45.4 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.898 -1.126 . . . . 0.0 109.521 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.03 -45.86 4.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.906 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.53 2.74 47.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.7 p30 -79.33 -116.32 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.1 ttp180 -130.5 170.83 13.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 123.23 1.491 . . . . 0.0 109.057 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 21.6 p -134.14 26.84 3.87 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.747 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 57' ' ' GLU . 2.9 m -163.48 138.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.796 . . . . 0.0 109.695 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.3 pm0 -33.01 152.3 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.311 -0.868 . . . . 0.0 110.642 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.28 166.16 79.17 Favored 'Cis proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.7 -0.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -104.02 149.1 36.87 Favored Pre-proline 0 C--N 1.268 -2.965 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.576 ' O ' ' OG1' ' A' ' 63' ' ' THR . 9.6 Cg_endo -54.83 119.47 6.53 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.637 2.225 . . . . 0.0 112.089 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' PRO . 25.1 mt-10 -43.35 117.91 1.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.18 23.94 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -132.93 137.02 46.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.884 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' OE1' ' SD ' ' A' ' 65' ' ' MET . 5.6 mm-40 -104.93 -176.89 3.21 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.761 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -145.11 128.21 16.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.88 -1.138 . . . . 0.0 110.433 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.57 -170.74 2.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.87 146.04 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.146 -1.596 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 70.5 m-85 -140.84 126.84 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.671 -1.268 . . . . 0.0 109.961 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.38 107.06 2.76 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.532 ' SD ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.74 -89.14 0.5 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.515 -0.991 . . . . 0.0 109.715 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.716 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -147.89 167.47 28.81 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.716 ' C ' ' O ' ' A' ' 71' ' ' GLY . 2.1 t -5.82 115.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 117.651 0.725 . . . . 0.0 109.818 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.657 ' CD1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.52 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.22 -0.925 . . . . 0.0 110.764 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.687 ' H ' ' C ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -89.77 -55.61 3.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.752 -1.217 . . . . 0.0 109.153 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' A' ' 217' ' ' TYR . . . -105.22 2.75 40.41 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.532 ' CB ' ' SD ' ' A' ' 70' ' ' MET . . . -76.75 -39.93 50.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.288 . . . . 0.0 110.525 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.671 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 4.6 tt0 -82.65 -14.34 54.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.965 -1.085 . . . . 0.0 110.806 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 20.5 ttt180 -57.91 -72.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.894 -1.129 . . . . 0.0 110.207 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.451 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 12.1 mmtt -44.11 -5.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.748 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 46.7 m-85 -94.43 -41.34 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.734 -1.229 . . . . 0.0 110.978 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.527 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -84.99 -0.68 55.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.672 -1.267 . . . . 0.0 110.646 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.17 19.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.977 -1.077 . . . . 0.0 110.051 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -119.73 157.24 28.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.245 -0.91 . . . . 0.0 109.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -93.25 141.59 28.26 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.839 -0.538 . . . . 0.0 109.549 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.04 -29.09 8.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.9 138.61 20.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.468 -1.019 . . . . 0.0 109.865 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.673 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.53 -44.62 28.04 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 89' ' ' THR . 1.1 p -168.17 -162.97 0.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.488 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.626 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 14.1 p -163.82 160.0 21.82 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.394 -0.816 . . . . 0.0 109.126 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.671 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -164.87 171.15 14.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.119 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.498 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -141.88 171.84 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.39 -175.95 44.78 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' TYR . 2.0 m-85 -96.17 164.88 12.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -1.044 . . . . 0.0 109.614 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -179.31 147.13 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.96 . . . . 0.0 109.936 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 88.86 29.02 19.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.752 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -112.18 -156.72 13.26 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.568 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -138.98 54.1 1.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -1.173 . . . . 0.0 109.892 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.731 ' CG2' ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.5 177.15 11.74 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.043 . . . . 0.0 108.262 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.735 ' HE ' ' H ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -72.98 -86.64 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.384 -0.822 . . . . 0.0 109.851 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.735 ' H ' ' HE ' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -122.79 79.91 49.11 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.869 -1.144 . . . . 0.0 110.051 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.457 ' HG2' ' CD2' ' A' ' 113' ' ' HIS . 11.4 Cg_exo -67.38 169.28 15.86 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.743 2.295 . . . . 0.0 111.675 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.625 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 16.4 p -117.56 171.11 8.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 109.852 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.618 ' C ' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -63.47 -58.89 5.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 0.0 110.354 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.601 ' CD ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -59.22 -22.46 61.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.919 -1.113 . . . . 0.0 108.254 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.625 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.8 mm-40 -72.89 -60.67 2.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.394 0.616 . . . . 0.0 110.977 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.416 HG12 ' CB ' ' A' ' 111' ' ' THR . 11.4 m -56.56 -24.66 19.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.402 -0.811 . . . . 0.0 110.997 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.494 ' C ' ' H ' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -49.81 -33.85 17.86 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.253 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.65 ' C ' ' H ' ' A' ' 110' ' ' LYS . 1.4 t -63.52 0.12 0.8 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.198 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.494 ' H ' ' C ' ' A' ' 107' ' ' CYS . 0.8 OUTLIER 63.97 -21.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.251 -0.906 . . . . 0.0 109.87 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 tttt -57.82 -10.66 1.79 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.278 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.416 ' CB ' HG12 ' A' ' 106' ' ' VAL . 41.3 p -94.08 -38.67 11.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.96 -1.087 . . . . 0.0 110.515 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 72.63 21.2 79.72 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -75.17 161.32 29.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.112 -1.228 . . . . 0.0 110.315 -179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.8 113.32 17.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' GLN . 1.9 pp20? -57.26 119.43 6.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.724 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.14 170.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.244 -0.91 . . . . 0.0 109.965 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 68' ' ' PHE . 6.1 m -130.36 125.46 59.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.496 ' HG3' ' CE1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -96.89 114.49 26.12 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 119' ' ' VAL . 34.9 m -131.78 109.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -75.66 176.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.611 ' CG ' ' CD2' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -159.94 152.8 21.51 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.38 -1.328 . . . . 0.0 110.391 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.469 HH21 ' CG ' ' A' ' 125' ' ' HIS . 1.9 mtp180 -108.7 102.12 46.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.804 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 126' ' ' ILE . 18.3 Cg_exo -41.88 -68.04 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.114 2.542 . . . . 0.0 113.942 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 123' ' ' PRO . 13.3 tt0 -37.97 -33.37 0.08 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.165 -0.96 . . . . 0.0 111.277 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.469 ' CG ' HH21 ' A' ' 122' ' ' ARG . 32.2 m80 -108.39 -0.2 20.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.704 -1.248 . . . . 0.0 109.537 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -155.84 165.55 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.188 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.4 m -114.03 170.07 8.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.817 -1.177 . . . . 0.0 111.218 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.508 ' CZ ' HD23 ' A' ' 132' ' ' LEU . 37.5 t80 -69.23 -24.75 64.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.579 -0.701 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.86 -13.02 60.27 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.564 ' CD ' ' C ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -75.62 -45.55 36.78 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.804 ' CD1' ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -77.13 -27.62 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 119.964 -1.71 . . . . 0.0 108.296 178.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.508 HD23 ' CZ ' ' A' ' 128' ' ' PHE . 1.1 mm? -72.62 -57.46 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 110.12 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -52.55 -45.0 66.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 13.3 t -50.1 -37.17 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 0.0 109.29 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.807 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 28.1 t80 -71.44 -47.29 56.74 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.925 -1.109 . . . . 0.0 110.653 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.488 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 83.4 m95 -72.18 -14.37 61.79 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.568 -1.332 . . . . 0.0 110.877 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.62 -17.25 19.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.865 -1.147 . . . . 0.0 113.15 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.6 p30 -133.33 63.13 1.64 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 119.983 -1.698 . . . . 0.0 112.861 -177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.807 ' NE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 p-80 173.17 177.93 0.1 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.615 1.197 . . . . 0.0 110.643 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.631 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -111.56 90.16 11.99 Favored Pre-proline 0 C--N 1.286 -2.154 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.289 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.596 ' O ' ' OG1' ' A' ' 190' ' ' THR . 33.9 Cg_endo -74.39 -17.39 21.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.501 2.134 . . . . 0.0 112.535 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.3 29.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.8 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.736 ' N ' ' HG1' ' A' ' 190' ' ' THR . 30.9 mt-30 -129.96 82.64 2.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -37.7 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.496 2.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.28 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.661 ' O ' ' SD ' ' A' ' 145' ' ' MET . 1.8 ppp? -67.25 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -1.142 . . . . 0.0 110.876 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.597 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -152.6 160.43 43.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.057 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.585 ' OE1' ' O ' ' A' ' 146' ' ' ARG . 14.3 mm100 -153.38 96.52 2.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.413 -1.429 . . . . 0.0 109.044 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.86 -113.94 2.82 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.454 ' H ' HD13 ' A' ' 220' ' ' LEU . 1.8 m-20 -79.29 -32.41 43.54 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.361 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.469 ' HB3' ' CD1' ' A' ' 155' ' ' TYR . 3.6 m-20 -82.63 130.38 35.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.217 -1.552 . . . . 0.0 109.123 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 p90 -128.89 145.62 51.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 0.0 110.028 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 140.41 -165.29 26.1 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -22.43 22.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.447 -1.031 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.577 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 8.7 pm0 -91.83 -5.39 53.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.109 -0.994 . . . . 0.0 108.9 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 103' ' ' TYR . 47.6 m-85 -113.01 61.89 0.64 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.533 HH11 ' CA ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -124.03 168.59 12.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 67.5 p -92.05 141.62 28.41 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.456 ' HA ' ' N ' ' A' ' 192' ' ' ASP . . . -168.17 111.31 0.6 Allowed 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 116.981 -1.888 . . . . 0.0 111.512 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.612 ' N ' ' O ' ' A' ' 192' ' ' ASP . 60.2 t -92.41 143.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.051 -1.059 . . . . 0.0 109.18 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -136.14 107.85 9.6 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.05 173.82 12.96 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.556 2.171 . . . . 0.0 112.289 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.6 OUTLIER -89.97 -19.66 24.22 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.184 -0.948 . . . . 0.0 109.009 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.607 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER 167.33 -173.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.329 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.607 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -47.75 -15.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.978 1.371 . . . . 0.0 108.588 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 163' ' ' SER . 3.7 t -55.17 -65.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.156 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 170' ' ' ALA . 20.2 mt-30 -78.63 -24.74 45.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.8 ttp -53.51 -41.96 66.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.994 -1.066 . . . . 0.0 110.497 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.26 8.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 110.221 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.07 -36.88 34.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.85 -51.83 59.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.74 -34.96 55.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.942 . . . . 0.0 109.562 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -34.34 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.425 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -75.41 -36.82 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -67.53 -57.04 7.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.9 . . . . 0.0 110.048 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.91 2.68 6.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.536 ' CA ' ' OE1' ' A' ' 176' ' ' GLU . 0.3 OUTLIER -75.87 -52.35 10.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 109.847 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.439 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 4.0 m-85 -79.47 -7.46 58.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.502 ' C ' ' CD ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -70.69 -53.92 13.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 179' ' ' LYS . 23.4 tttm -73.22 -15.41 61.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.432 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.9 t -82.28 -55.5 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 110.274 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.449 ' N ' HD22 ' A' ' 181' ' ' LEU . 4.4 mt -76.37 -27.26 56.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.996 -1.065 . . . . 0.0 109.983 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.4 p -55.99 -14.0 2.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 109.551 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -88.27 -1.04 57.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.446 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 37.3 m-70 -108.26 4.28 24.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.754 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.77 8.42 6.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.441 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.36 164.43 19.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 108.868 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.794 ' N ' ' CD ' ' A' ' 188' ' ' PRO . . . 92.7 24.64 22.86 Favored Glycine 0 C--N 1.302 -1.324 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.794 ' CD ' ' N ' ' A' ' 187' ' ' GLY . 27.7 Cg_endo -66.06 104.67 0.74 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.64 -1.331 . . . . 0.0 108.64 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 188' ' ' PRO . 1.7 pp -47.01 143.86 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 123.019 1.39 . . . . 0.0 111.386 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.736 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 69.5 p -121.54 4.75 10.13 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.005 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 190' ' ' THR . 72.4 m -42.79 115.45 0.73 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 159' ' ' VAL . 4.0 t0 -75.43 125.13 28.39 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.51 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.21 110.52 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.654 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.524 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 64.8 mtm-85 -146.24 -170.56 3.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.775 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.503 ' HA ' HE22 ' A' ' 197' ' ' GLN . 27.6 mt-10 -142.84 166.55 24.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.685 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.47 70.19 1.35 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -139.16 146.9 41.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.909 -1.348 . . . . 0.0 109.708 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.464 HG22 ' CE2' ' A' ' 200' ' ' TYR . 0.7 OUTLIER -98.32 -176.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.087 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.496 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 46.8 t80 -125.35 130.7 52.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -1.0 . . . . 0.0 109.894 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.702 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 19.9 m-85 -126.67 100.19 6.1 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.331 -0.856 . . . . 0.0 109.212 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . 0.454 ' OH ' ' O ' ' A' ' 55' ' ' THR . 22.7 m-85 -54.27 136.38 43.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.922 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -87.69 -169.67 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.7 pt-20 -75.18 167.81 21.2 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 108.915 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -59.27 -48.82 80.19 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.987 -1.071 . . . . 0.0 108.692 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.451 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.44 -22.65 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.657 ' ND1' ' CD1' ' A' ' 73' ' ' PHE . 11.8 m-70 -94.0 13.16 23.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.989 -1.069 . . . . 0.0 110.537 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.6 mm-40 -130.32 -141.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.694 1.235 . . . . 0.0 110.899 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.664 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.03 -2.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.51 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 28.6 t80 -38.41 -42.8 0.77 Allowed 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.595 -1.315 . . . . 0.0 110.496 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 9.5 mt -70.47 -25.05 63.0 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.316 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 208' ' ' GLN . 8.0 t -73.47 -40.5 64.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.077 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.454 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 2.0 mtmm -88.25 -38.05 15.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.318 -0.864 . . . . 0.0 110.034 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.629 ' C ' ' H ' ' A' ' 215' ' ' ASP . 1.2 m-80 -101.03 107.65 50.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.14 6.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.766 2.31 . . . . 0.0 113.05 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.629 ' H ' ' C ' ' A' ' 213' ' ' ASN . 1.9 t70 -63.14 -16.71 60.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.735 -1.228 . . . . 0.0 109.851 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.459 ' O ' ' CD2' ' A' ' 210' ' ' LEU . . . 65.59 -68.45 0.11 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.788 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 53.2 t80 171.94 -175.87 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -1.111 . . . . 0.0 109.256 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.788 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 4.5 m -93.08 -125.65 0.1 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.152 -0.968 . . . . 0.0 109.004 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.629 ' O ' ' CG ' ' A' ' 220' ' ' LEU . . . -127.19 148.0 17.21 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.629 ' CG ' ' O ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER 146.92 160.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.47 116.87 1.22 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 139' ' ' HIS . . . 158.03 131.86 1.35 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' THR . . . . . 0.515 ' HG1' ' CD ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.501 -1.0 . . . . 0.0 110.028 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.9 t . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.65 132.07 19.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.765 -175.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.19 124.72 25.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.762 0.791 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -56.06 -22.75 29.43 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.616 -0.678 . . . . 0.0 109.758 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -83.87 -0.76 52.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.559 ' O ' ' NZ ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -112.65 -4.62 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.68 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 97' ' ' HIS . . . -61.66 -171.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.808 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.449 ' N ' HD22 ' A' ' 35' ' ' LEU . 4.5 mm? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.633 ' CG1' ' O ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.22 175.24 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.908 2.406 . . . . 0.0 112.558 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 204' ' ' ASP . 16.2 m -138.87 -174.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.668 ' OG1' ' NE2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -59.9 97.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 109.513 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -55.99 -49.19 74.31 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.261 -0.899 . . . . 0.0 111.426 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.534 ' O ' ' C ' ' A' ' 48' ' ' HIS . 20.3 mttm -71.03 99.91 1.9 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.906 -2.317 . . . . 0.0 108.241 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.749 ' HE2' ' HG1' ' A' ' 89' ' ' THR . 5.0 t-80 -33.45 101.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.788 ' ND1' ' N ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -53.24 -12.34 0.38 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.341 -0.849 . . . . 0.0 112.077 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.507 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 88.2 t -82.49 -50.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.455 -1.403 . . . . 0.0 108.482 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -99.56 -40.41 7.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.523 -0.736 . . . . 0.0 109.768 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.04 2.42 51.76 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 30.2 p30 -77.83 -120.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.715 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 ttm-85 -131.76 167.87 18.78 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 123.286 1.517 . . . . 0.0 109.481 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.572 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 66.7 p -134.77 34.34 3.17 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.071 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.572 ' CG1' ' O ' ' A' ' 55' ' ' THR . 2.0 m -168.82 147.21 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 109.49 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 7.6 pt-20 -33.73 145.25 0.15 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 110.057 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.19 161.52 84.8 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.741 -1.774 . . . . 0.0 110.363 0.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 70.8 m-85 -102.37 151.57 38.18 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 59' ' ' PHE . 51.9 Cg_exo -47.6 -178.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.26 1.973 . . . . 0.0 111.983 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.634 ' O ' ' NE ' ' A' ' 122' ' ' ARG . 88.7 mt-10 -79.23 133.73 36.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.68 ' O ' ' NE ' ' A' ' 122' ' ' ARG . . . 49.88 72.01 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.591 ' O ' ' SD ' ' A' ' 65' ' ' MET . 0.8 OUTLIER -90.97 134.36 34.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -1.208 . . . . 0.0 110.105 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.802 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.5 tp60 -97.94 120.41 38.29 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.759 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -133.72 158.59 42.89 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.908 -177.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.63 -166.02 2.38 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.82 115.63 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.084 -1.635 . . . . 0.0 108.595 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 132' ' ' LEU . 72.9 m-85 -111.6 148.66 32.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 110.489 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.79 99.31 0.61 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 2.1 ttt -98.08 -91.07 0.27 Allowed 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.648 -0.913 . . . . 0.0 109.179 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.667 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.4 -149.53 5.99 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.74 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -35.12 104.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.038 . . . . 0.0 108.368 179.103 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CZ ' ' CD ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -54.97 7.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.842 -1.161 . . . . 0.0 111.426 -177.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.625 ' H ' ' C ' ' A' ' 72' ' ' CYS . 5.9 m0 -74.38 -40.41 62.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.568 -1.332 . . . . 0.0 108.694 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.6 -14.29 25.84 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.814 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.693 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -66.31 -53.5 35.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.668 -1.49 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.635 ' OE2' ' NE2' ' A' ' 208' ' ' GLN . 1.3 tm-20 -82.64 -14.63 54.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.929 . . . . 0.0 110.77 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -58.02 -68.12 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.787 -1.196 . . . . 0.0 109.653 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -53.36 -5.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.157 -0.965 . . . . 0.0 110.511 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.693 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 11.3 m-85 -90.82 -42.02 10.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.784 -1.197 . . . . 0.0 110.196 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.499 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -68.84 -4.79 17.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.712 -1.242 . . . . 0.0 109.323 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.461 HG13 ' CD1' ' A' ' 81' ' ' TRP . 2.5 m -97.39 6.74 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.3 mt -85.12 142.41 29.53 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.244 1.021 . . . . 0.0 108.999 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -79.77 131.64 35.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.078 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.495 ' C ' ' HG3' ' A' ' 123' ' ' PRO . . . 101.36 -29.19 13.05 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.9 132.97 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.225 -1.162 . . . . 0.0 110.231 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.702 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -79.93 -53.67 6.53 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.516 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 2.3 p -151.73 -176.26 5.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 109.347 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.749 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 82.4 p -157.49 128.6 6.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.38 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.576 ' CD ' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.2 153.03 49.88 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.445 ' CG2' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.94 175.54 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 108.903 179.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.403 ' HA2' ' N ' ' A' ' 202' ' ' ALA . . . 167.88 177.59 39.29 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.022 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.634 ' N ' ' O ' ' A' ' 200' ' ' TYR . 28.0 m-85 -82.28 166.45 19.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.965 . . . . 0.0 109.395 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.681 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -177.41 -179.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 109.765 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.17 27.37 10.73 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.471 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -123.35 -176.82 14.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.466 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -135.63 78.16 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.101 . . . . 0.0 109.837 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.407 ' HG1' ' HB ' ' A' ' 111' ' ' THR . 21.4 m -157.07 142.67 17.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 109.196 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -54.06 -84.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.854 . . . . 0.0 109.576 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.459 ' ND2' ' HG2' ' A' ' 99' ' ' ARG . 55.9 m-80 -118.86 82.69 21.24 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.71 161.83 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.847 2.365 . . . . 0.0 112.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 106' ' ' VAL . 21.7 p -121.33 169.93 10.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.164 -0.96 . . . . 0.0 109.803 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.47 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 7.8 t80 -56.26 -58.84 6.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -27.05 65.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 109.02 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -75.4 -53.27 8.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.726 -0.609 . . . . 0.0 111.159 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 102' ' ' THR . 12.7 m -61.24 -24.3 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.646 ' C ' ' H ' ' A' ' 109' ' ' GLU . 90.7 m -64.65 -38.31 90.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 109.382 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 110' ' ' LYS . 89.3 p -53.8 -0.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.316 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.646 ' H ' ' C ' ' A' ' 107' ' ' CYS . 28.8 mt-10 64.89 -5.27 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.559 ' NZ ' ' O ' ' A' ' 33' ' ' GLU . 1.5 mmpt? -66.97 -32.76 74.23 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.178 -0.951 . . . . 0.0 109.67 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' GLY . 3.7 p -93.51 -0.34 56.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 109.764 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 34.25 55.6 0.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.681 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 1.5 m-70 -93.35 174.54 7.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.907 -1.349 . . . . 0.0 108.813 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.754 ' CB ' HH12 ' A' ' 156' ' ' ARG . . . -129.72 114.97 16.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.66 ' CD ' ' CZ ' ' A' ' 73' ' ' PHE . 3.8 mt-10 -56.44 105.83 0.24 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.68 159.03 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.134 -0.979 . . . . 0.0 110.499 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -116.49 122.53 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.645 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.09 97.12 9.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.93 129.4 51.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.78 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.79 126.27 47.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.802 ' O ' ' N ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -157.18 142.05 16.89 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.535 -1.266 . . . . 0.0 111.725 -178.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . 0.978 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -165.67 17.15 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 123.612 0.765 . . . . 0.0 110.294 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.978 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 7.1 Cg_endo -50.88 -15.68 1.97 Allowed 'Trans proline' 0 C--N 1.294 -2.292 0 C-N-CA 124.189 3.259 . . . . 0.0 115.79 -176.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 1.7 tm-20 70.54 -6.62 1.17 Allowed 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.757 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -111.7 -12.98 13.81 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.33 1.062 . . . . 0.0 108.329 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.534 ' N ' ' HG2' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -152.8 118.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -129.76 -175.4 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.526 -1.359 . . . . 0.0 112.559 -177.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -48.28 -46.54 36.04 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.673 ' O ' ' CD2' ' A' ' 132' ' ' LEU . 6.0 pt-20 -59.66 -26.57 65.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 127' ' ' SER . 9.0 mm-40 -75.31 -66.25 0.79 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.304 -0.872 . . . . 0.0 111.558 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 131' ' ' LEU . 9.8 mp -57.41 -23.75 51.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.838 -1.164 . . . . 0.0 113.873 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -75.73 -17.9 59.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 119.843 -1.785 . . . . 0.0 109.556 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -70.44 -54.54 11.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.697 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 6.6 t -49.66 -40.29 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.349 -0.844 . . . . 0.0 109.046 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.631 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 21.2 t80 -61.08 -41.99 97.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.793 -1.192 . . . . 0.0 110.63 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.71 ' CZ2' ' CA ' ' A' ' 173' ' ' SER . 45.4 m0 -71.51 -50.47 31.04 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.75 -1.219 . . . . 0.0 111.735 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.02 -57.46 12.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 111.73 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.6 OUTLIER -83.3 54.23 2.74 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 112.113 -177.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.764 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 20.7 m80 -161.11 176.91 10.81 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 142' ' ' THR . 0.3 OUTLIER -129.16 70.22 81.54 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 190' ' ' THR . 80.4 Cg_exo -39.39 -0.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.427 2.752 . . . . 0.0 113.627 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -105.88 22.7 15.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.671 -1.268 . . . . 0.0 110.814 -179.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.812 ' N ' ' HG1' ' A' ' 190' ' ' THR . 33.4 mt-30 -134.04 78.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.411 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -75.47 12.66 7.34 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.159 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.642 ' O ' ' O ' ' A' ' 152' ' ' GLY . 2.2 ptt? -118.0 -21.82 8.13 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.305 . . . . 0.0 109.911 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' CD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -152.31 168.88 23.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 111.053 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.58 ' OE1' ' O ' ' A' ' 155' ' ' TYR . 5.2 mm100 -120.21 58.77 0.91 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.08 -113.84 3.73 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.64 ' H ' ' CD1' ' A' ' 220' ' ' LEU . 12.6 t-20 -81.21 11.41 4.28 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 114.771 -0.715 . . . . 0.0 110.874 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.478 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -107.3 87.81 2.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.769 -1.207 . . . . 0.0 109.146 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.419 ' HA ' ' CG ' ' A' ' 146' ' ' ARG . 3.4 m-85 -65.49 115.87 6.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.411 -0.805 . . . . 0.0 110.674 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 166.62 150.78 6.52 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 117.687 -2.197 . . . . 0.0 111.777 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.1 p -74.26 -20.23 60.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.701 -0.882 . . . . 0.0 109.325 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 7.3 pm0 -87.15 -6.69 58.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.58 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 26.4 m-85 -97.11 57.27 1.46 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.754 HH12 ' CB ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -117.63 165.72 13.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.725 -0.61 . . . . 0.0 109.66 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 191' ' ' THR . 0.0 OUTLIER -89.85 106.03 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 177.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.479 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -125.21 124.09 40.97 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.06 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.6 t -113.48 123.27 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.3 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.517 ' CG ' ' NE2' ' A' ' 197' ' ' GLN . 3.9 m-30 -118.51 121.53 30.87 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.73 166.25 23.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.462 2.108 . . . . 0.0 112.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.87 1.82 27.14 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 120.796 -1.19 . . . . 0.0 108.793 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER 167.76 170.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 0.0 108.862 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.62 -15.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.04 1.4 . . . . 0.0 108.361 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.5 t -56.05 -64.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 33.8 mt-30 -78.94 -18.39 53.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.719 -0.613 . . . . 0.0 110.9 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 14.3 ttm -53.16 -46.85 69.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.24 -16.93 60.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 0.0 109.617 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.77 -57.29 2.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.838 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 172' ' ' ARG . . . -52.13 -43.52 64.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.135 -0.978 . . . . 0.0 109.457 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -11.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.246 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 170' ' ' ALA . 75.9 mtt180 -74.78 -39.52 61.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.335 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.71 ' CA ' ' CZ2' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -54.48 -33.1 59.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.055 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.431 ' HZ3' HD11 ' A' ' 189' ' ' ILE . 0.4 OUTLIER -72.56 -57.44 4.15 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 113.199 -1.819 . . . . 0.0 110.21 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.17 -52.48 12.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 0.0 111.894 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.576 ' O ' ' OE1' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -55.19 -50.64 68.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.921 -1.112 . . . . 0.0 110.742 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.487 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 0.1 OUTLIER -70.99 -13.74 62.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.157 . . . . 0.0 109.907 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.57 ' O ' ' OG ' ' A' ' 182' ' ' SER . 22.0 tp60 -75.01 -48.31 24.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 109.757 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -19.17 55.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . 0.563 ' O ' ' CD2' ' A' ' 184' ' ' HIS . 92.7 t -87.23 -52.64 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 181' ' ' LEU . 4.0 mm? -71.95 -44.53 63.43 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.116 -0.99 . . . . 0.0 109.586 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 86.3 p -55.79 -26.59 46.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.016 . . . . 0.0 109.002 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.06 -27.93 21.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.108 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 180' ' ' VAL . 12.5 m170 -80.78 15.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.875 . . . . 0.0 109.388 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.3 OUTLIER 72.37 48.93 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.937 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.451 ' CG ' HD13 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -114.25 -176.72 2.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.0 108.933 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -104.21 -168.94 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.3 Cg_exo -58.81 116.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.519 2.146 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 190' ' ' THR . 0.3 OUTLIER -48.01 176.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 110.145 -179.306 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.812 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 71.2 p -156.98 76.23 0.85 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.597 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 157' ' ' SER . 8.1 m -101.53 122.83 44.54 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.64 ' CG ' HH21 ' A' ' 194' ' ' ARG . 2.1 t0 -81.11 115.98 20.81 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.951 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.69 128.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.386 -0.821 . . . . 0.0 109.396 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.64 HH21 ' CG ' ' A' ' 192' ' ' ASP . 4.7 ptt180 -165.36 173.03 11.58 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.646 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -120.49 -178.66 3.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.909 -1.119 . . . . 0.0 110.431 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 54.89 35.87 59.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.573 ' O ' ' O ' ' A' ' 198' ' ' VAL . 1.8 mp0 -84.11 80.44 9.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.866 -1.373 . . . . 0.0 109.243 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 197' ' ' GLN . 9.8 p -33.31 156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 110.198 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 65.0 t80 -117.95 138.77 51.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 109.054 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 1.7 m-85 -140.34 113.94 8.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.096 -1.003 . . . . 0.0 109.819 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.66 142.99 21.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.403 ' N ' ' HA2' ' A' ' 92' ' ' GLY . . . -91.26 -168.1 1.97 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.444 -0.785 . . . . 0.0 109.104 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.58 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 2.9 mt-10 -73.38 163.85 27.49 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-O 122.469 1.128 . . . . 0.0 110.372 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.511 ' OD1' ' OG1' ' A' ' 45' ' ' THR . 0.5 OUTLIER -54.67 -44.26 73.17 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -70.63 4.17 2.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.304 -0.873 . . . . 0.0 110.576 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.5 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 9.4 m-70 -102.99 14.75 31.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.0 OUTLIER -135.74 -150.08 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.971 -1.081 . . . . 0.0 110.178 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.686 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -36.55 -7.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.138 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 2.2 t80 -43.9 -47.09 8.31 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 120.762 -1.211 . . . . 0.0 111.361 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.451 ' CD2' ' O ' ' A' ' 74' ' ' TRP . 3.6 pp -82.64 -12.26 57.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.0 -1.687 . . . . 0.0 109.947 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 213' ' ' ASN . 37.3 t -55.83 -50.86 69.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.496 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.469 ' HE2' HD22 ' A' ' 213' ' ' ASN . 1.2 pttm -70.19 4.9 1.91 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.685 ' C ' ' H ' ' A' ' 215' ' ' ASP . 75.9 m-20 -142.52 68.01 20.13 Favored Pre-proline 0 N--CA 1.487 1.413 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -48.53 11.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.571 2.848 . . . . 0.0 112.702 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.685 ' H ' ' C ' ' A' ' 213' ' ' ASN . 33.9 t70 -61.88 -20.29 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.664 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 60.69 86.15 0.04 OUTLIER Glycine 0 CA--C 1.552 2.371 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.17 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.664 ' O ' ' O ' ' A' ' 216' ' ' GLY . 39.1 t80 -52.11 -150.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 120.538 2.169 . . . . 0.0 109.308 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 49.4 m -71.75 -124.28 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.002 -1.686 . . . . 0.0 109.419 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . 58.72 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.64 ' CD1' ' H ' ' A' ' 149' ' ' ASN . 0.4 OUTLIER -109.06 -155.74 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.212 . . . . 0.0 109.978 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 138' ' ' ASN . . . -118.73 -73.99 0.44 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.444 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . -175.02 134.05 2.63 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.471 -1.017 . . . . 0.0 109.631 179.956 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 40.0 t . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.37 128.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 122.256 1.027 . . . . 0.0 113.128 -175.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.05 124.27 30.91 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.908 0.861 . . . . 0.0 110.126 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . . . -49.05 -26.41 2.61 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.14 -22.77 62.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.115 -0.991 . . . . 0.0 110.251 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -116.69 6.95 13.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.2 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -83.17 -165.06 0.98 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.491 -179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.503 HD22 ' HG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.093 -1.004 . . . . 0.0 108.913 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 42' ' ' ILE . 2.8 mm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.93 172.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.803 2.335 . . . . 0.0 112.231 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 17.2 m -151.64 -178.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.49 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.246 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.07 -40.61 73.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.482 -0.761 . . . . 0.0 111.052 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttt -74.04 99.23 3.26 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 115.877 -2.329 . . . . 0.0 108.055 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.684 ' CE1' ' OG1' ' A' ' 89' ' ' THR . 4.4 t-80 -34.11 114.07 0.19 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' HIS . . . . . 0.634 ' CG ' ' CE ' ' A' ' 212' ' ' LYS . 63.7 t60 -63.05 -31.81 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.657 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 48' ' ' HIS . 5.3 t -66.71 -38.33 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.936 -1.103 . . . . 0.0 109.484 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -111.08 -44.28 3.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.91 -0.1 51.84 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.74 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 31.9 p30 -77.22 -121.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.74 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.6 ttt180 -131.15 166.88 20.13 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.056 1.408 . . . . 0.0 108.68 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 46' ' ' ALA . 30.5 p -129.03 34.35 4.46 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.528 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -172.63 149.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.037 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -31.63 139.37 0.19 Allowed Pre-proline 0 C--N 1.299 -1.603 0 CA-C-O 121.266 0.555 . . . . 0.0 110.152 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.36 167.26 79.86 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.479 -1.884 . . . . 0.0 111.783 0.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.43 147.3 35.76 Favored Pre-proline 0 C--N 1.271 -2.837 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.34 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' O ' ' OG1' ' A' ' 63' ' ' THR . 51.5 Cg_exo -49.39 120.64 5.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.593 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' PRO . 20.3 mm-40 -42.73 118.3 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.799 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.5 44.51 3.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -121.11 142.56 49.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.799 -1.412 . . . . 0.0 110.093 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 65' ' ' MET . 2.2 tm0? -108.53 143.93 36.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.75 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.8 103.86 5.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.905 -1.122 . . . . 0.0 110.163 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.08 -169.36 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 2.2 t -143.62 144.2 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 119.913 -1.742 . . . . 0.0 109.218 179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 22.1 m-85 -135.79 143.71 45.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.431 178.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -134.82 90.34 0.24 Allowed Glycine 0 N--CA 1.482 1.761 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.174 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' MET . . . . . 0.641 ' SD ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.93 -74.53 0.61 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -163.59 -156.09 8.53 Favored Glycine 0 C--N 1.3 -1.444 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' CYS . . . . . 0.637 ' C ' ' H ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -23.36 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 122.144 -0.621 . . . . 0.0 109.763 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -53.77 7.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.313 -0.867 . . . . 0.0 111.178 -178.497 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' TRP . . . . . 0.637 ' H ' ' C ' ' A' ' 72' ' ' CYS . 35.9 m0 -68.98 -44.56 72.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.596 -1.315 . . . . 0.0 108.21 179.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . 0.455 ' CA ' ' SG ' ' A' ' 218' ' ' CYS . . . -98.87 -15.64 33.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.641 ' CB ' ' SD ' ' A' ' 70' ' ' MET . . . -68.45 -45.07 73.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.939 -1.33 . . . . 0.0 109.85 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . 0.586 ' OE2' ' OE1' ' A' ' 208' ' ' GLN . 23.5 tt0 -82.66 -20.38 36.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' PHE . 11.7 ttt-85 -60.54 -46.38 90.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.867 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.45 12.58 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.003 -1.06 . . . . 0.0 110.355 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.591 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 37.0 m-85 -124.16 -11.27 7.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 111.136 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' TRP . . . . . 0.518 ' CE2' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -106.83 13.18 28.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.579 -1.326 . . . . 0.0 109.414 179.25 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.26 8.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.089 -1.007 . . . . 0.0 111.238 -178.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.517 ' N ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -118.69 166.1 13.17 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.87 -1.144 . . . . 0.0 108.789 179.298 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.541 ' C ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -93.96 144.16 25.71 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 109.459 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.13 -33.69 4.92 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.73 133.77 31.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.639 -0.918 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.698 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -83.38 -45.68 13.43 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 108.747 -179.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.516 ' C ' ' HG1' ' A' ' 89' ' ' THR . 22.9 t -150.01 -166.56 2.58 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.053 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.688 ' O ' ' NE2' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -169.92 113.7 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.57 ' OE1' ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -126.68 163.79 22.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 109.913 -178.218 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.577 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 1.3 m -143.36 150.38 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.069 -1.02 . . . . 0.0 110.457 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . -160.14 178.04 36.36 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 5.4 m-85 -78.73 177.84 8.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.156 -1.202 . . . . 0.0 108.427 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . 0.642 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -174.39 159.33 3.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.193 -1.567 . . . . 0.0 113.063 -178.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.46 20.1 60.83 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.51 -0.744 . . . . 0.0 111.432 178.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.656 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -139.0 175.08 21.78 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.662 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -158.87 95.88 1.32 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.117 -1.226 . . . . 0.0 110.648 -178.631 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' THR . . . . . 0.646 ' O ' ' C ' ' A' ' 99' ' ' ARG . 21.0 m -142.3 122.57 13.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 109.681 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ARG . . . . . 0.646 ' C ' ' O ' ' A' ' 98' ' ' THR . 1.2 mtp180 10.79 -89.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.862 0.839 . . . . 0.0 109.873 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.569 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m-80 -120.9 90.31 46.64 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 8.8 Cg_exo -68.86 114.66 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.667 2.245 . . . . 0.0 113.358 -177.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.474 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . 19.2 p -121.35 158.9 27.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.639 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' TYR . . . . . 0.628 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.1 OUTLIER -49.77 -42.13 45.81 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.51 -179.069 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 5.1 tttt -73.06 -27.56 61.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.93 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE1' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -83.14 -41.43 18.52 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.974 -1.079 . . . . 0.0 110.412 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 102' ' ' THR . 6.8 m -57.4 -23.97 20.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.676 -1.265 . . . . 0.0 109.54 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 109' ' ' GLU . 5.8 m -52.92 -43.84 66.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.627 ' C ' ' H ' ' A' ' 110' ' ' LYS . 39.3 m -46.53 -8.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.896 . . . . 0.0 108.83 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.66 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.1 tt0 60.24 -7.78 0.07 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.438 -0.789 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' LYS . . . . . 0.627 ' H ' ' C ' ' A' ' 108' ' ' SER . 1.1 tttp -79.39 -12.98 59.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.128 -0.983 . . . . 0.0 109.185 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' THR . . . . . 0.518 HG21 ' HG1' ' A' ' 98' ' ' THR . 4.7 p -89.6 -19.27 25.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.921 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 55.29 52.43 47.52 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' HIS . . . . . 0.656 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 2.4 m-70 -109.09 171.99 7.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.528 -1.572 . . . . 0.0 109.65 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -139.0 111.98 7.9 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLU . . . . . 0.698 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 mt-10 -54.35 131.48 42.1 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.02 -170.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 111.804 -178.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.2 m -147.5 151.09 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.459 ' HD3' ' CD1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -121.22 98.4 5.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 108.681 178.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 80' ' ' PHE . 14.4 t -88.05 120.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.86 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 125.75 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 2.5 p90 -130.14 169.88 14.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.582 -1.324 . . . . 0.0 111.065 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -117.43 118.23 35.63 Favored Pre-proline 0 N--CA 1.487 1.398 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.701 ' O ' ' N ' ' A' ' 125' ' ' HIS . 18.4 Cg_exo -42.08 -61.88 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.998 2.465 . . . . 0.0 113.602 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.687 ' OE2' ' CD2' ' A' ' 125' ' ' HIS . 6.8 tm-20 -34.92 -19.36 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.368 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' HIS . . . . . 0.701 ' N ' ' O ' ' A' ' 123' ' ' PRO . 4.2 m170 -134.34 -2.39 2.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.402 -1.436 . . . . 0.0 111.42 -179.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.494 HG21 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.35 158.74 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' SER . . . . . 0.747 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -111.65 170.67 7.98 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.537 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -70.16 -18.72 63.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 24.6 mt-10 -65.15 -23.68 67.18 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.488 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.747 ' CD ' ' H ' ' A' ' 127' ' ' SER . 1.2 pm0 -73.38 -45.28 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.416 -1.714 . . . . 0.0 110.492 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' LEU . . . . . 0.483 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 6.7 mt -64.35 -44.14 92.37 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.884 -1.76 . . . . 0.0 108.941 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.511 ' C ' ' CD1' ' A' ' 132' ' ' LEU . 0.6 OUTLIER -75.27 -27.16 59.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.042 . . . . 0.0 110.527 -179.233 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 1.4 tmtp? -70.31 -65.68 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.987 -1.071 . . . . 0.0 109.799 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.69 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 37.3 t -49.95 -22.52 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.0 t80 -72.23 -49.91 31.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.197 -0.94 . . . . 0.0 110.593 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.615 ' CG ' ' CE2' ' A' ' 177' ' ' TYR . 66.2 m95 -74.77 -60.56 2.23 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.027 -1.67 . . . . 0.0 110.967 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 136' ' ' TRP . 11.7 tt0 -36.33 -32.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 111.138 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 12.0 p30 -131.31 69.66 1.47 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.886 -1.134 . . . . 0.0 110.088 -178.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.811 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 4.8 m80 -153.6 142.04 20.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.982 -1.073 . . . . 0.0 110.876 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' ASP . . . . . 0.574 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -106.9 72.18 0.3 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 190' ' ' THR . 57.7 Cg_endo -69.09 -9.14 25.51 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.984 2.456 . . . . 0.0 115.543 -177.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.99 16.6 8.01 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.242 -1.536 . . . . 0.0 111.18 -178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' GLN . . . . . 0.574 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -131.06 89.21 2.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.948 -1.095 . . . . 0.0 108.937 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . 0.678 ' O ' ' NH1' ' A' ' 156' ' ' ARG . . . -83.81 20.67 11.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.805 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -113.76 -15.93 12.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.745 -1.444 . . . . 0.0 109.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' ARG . . . . . 0.493 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 177.6 164.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.407 -0.808 . . . . 0.0 108.857 -179.389 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLN . . . . . 0.566 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 3.3 tp-100 -111.8 132.71 54.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.558 -1.339 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 43.98 -123.59 4.8 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-O 123.317 1.509 . . . . 0.0 111.122 178.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' ASN . . . . . 0.426 ' H ' ' CD2' ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.9 -32.92 40.23 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 113.388 -1.406 . . . . 0.0 112.023 -177.58 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 147' ' ' GLN . 42.4 p30 -52.46 164.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.209 -1.557 . . . . 0.0 108.564 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.5 p90 -136.72 119.72 16.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.927 -1.108 . . . . 0.0 109.98 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 153.7 165.88 14.13 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.527 -1.321 . . . . 0.0 109.992 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.476 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.4 OUTLIER -91.03 2.4 56.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -1.125 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' GLN . . . . . 0.631 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 12.2 pm0 -90.2 -0.1 57.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.125 -0.984 . . . . 0.0 108.354 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.47 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 36.7 m-85 -123.26 57.16 1.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.436 -0.79 . . . . 0.0 109.768 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.678 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -99.39 -178.58 3.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 108.956 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' SER . . . . . 0.583 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -93.61 107.75 19.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 176.306 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -137.29 114.85 11.15 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 117.899 -1.521 . . . . 0.0 111.092 -176.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 192' ' ' ASP . 39.6 t -101.4 137.76 27.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.12 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' TYR . . . . . 0.554 ' CG ' ' CG2' ' A' ' 198' ' ' VAL . 84.4 m-85 -127.15 86.05 59.66 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 108.216 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 160' ' ' TYR . 52.0 Cg_exo -38.35 168.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.089 2.526 . . . . 0.0 112.972 -178.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' THR . . . . . 0.446 ' C ' ' OG ' ' A' ' 163' ' ' SER . 0.1 OUTLIER -102.69 -40.65 6.52 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.144 -0.972 . . . . 0.0 109.534 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.9 OUTLIER -173.25 178.52 2.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 0.0 109.798 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.8 -23.84 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.11 1.433 . . . . 0.0 108.076 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 163' ' ' SER . 2.5 t -56.09 -56.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.863 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.08 -36.29 48.41 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.483 -178.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.4 ttp -52.67 -11.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 110.782 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -75.57 -53.8 8.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.758 -1.214 . . . . 0.0 110.034 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . 0.588 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.73 -47.93 6.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' ALA . . . . . 0.471 ' HA ' ' HG ' ' A' ' 173' ' ' SER . . . -50.97 -55.72 15.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -0.917 . . . . 0.0 110.083 -179.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.52 -41.23 63.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.051 . . . . 0.0 109.331 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.43 -37.34 63.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' SER . . . . . 0.588 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.7 OUTLIER -56.51 -39.13 72.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' LYS . . . . . 0.786 ' HZ2' ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -72.59 -58.27 3.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.003 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.786 ' N ' ' HZ2' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -57.22 -50.3 73.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.265 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.497 ' CD ' ' C ' ' A' ' 176' ' ' GLU . 0.9 OUTLIER -53.39 -34.99 59.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.976 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' TYR . . . . . 0.615 ' CE2' ' CG ' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -79.75 -35.01 39.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.023 -1.048 . . . . 0.0 109.638 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . 0.594 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.5 tp60 -75.13 -33.79 61.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.329 -0.857 . . . . 0.0 109.621 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -73.54 -31.25 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.332 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.06 -51.75 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.09 -39.69 66.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.988 . . . . 0.0 109.574 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 t -56.32 -32.13 64.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -88.01 0.8 55.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 184' ' ' HIS . . . . . 0.532 ' O ' ' CE2' ' A' ' 186' ' ' PHE . 10.0 m-70 -108.33 35.97 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.677 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.61 58.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.58 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 186' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 184' ' ' HIS . 86.3 m-85 -151.8 168.5 24.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.85 -167.44 19.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 188' ' ' PRO . . . . . 0.464 ' HA ' ' NE2' ' A' ' 178' ' ' GLN . 10.8 Cg_endo -58.57 107.69 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.644 1.563 . . . . 0.0 110.53 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 189' ' ' ILE . . . . . 0.594 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -47.22 168.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 122.21 1.005 . . . . 0.0 110.603 -178.228 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 190' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 141' ' ' PRO . 27.1 p -120.33 58.65 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.485 -179.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 191' ' ' THR . . . . . 0.406 ' CG2' HG23 ' A' ' 159' ' ' VAL . 45.6 m -100.12 116.11 31.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 192' ' ' ASP . . . . . 0.654 ' CG ' ' NH1' ' A' ' 194' ' ' ARG . 4.0 t0 -76.51 128.24 34.38 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.551 -178.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -125.32 99.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -179.364 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 194' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 9.8 mtm-85 -135.4 152.57 51.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 195' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 195' ' ' GLU . 1.4 mp0 -129.48 163.77 25.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.504 -1.372 . . . . 0.0 110.752 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 104.65 -22.01 35.15 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' GLN . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' VAL . 0.9 OUTLIER -142.45 -173.9 3.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.054 -1.262 . . . . 0.0 111.747 -178.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' VAL . . . . . 0.641 ' CB ' ' O ' ' A' ' 197' ' ' GLN . 91.1 t 109.2 74.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.921 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 174.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . 0.459 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 3.0 t80 -165.5 126.57 1.92 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 111.134 172.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -156.47 94.9 1.52 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.475 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -49.19 125.85 11.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.783 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' ALA . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.2 -168.69 2.26 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' GLU . . . . . 0.65 ' OE2' ' CE2' ' A' ' 205' ' ' TYR . 1.4 pt-20 -75.81 -176.51 3.39 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.0 -1.062 . . . . 0.0 108.766 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -50.06 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.831 -1.168 . . . . 0.0 110.662 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' TYR . . . . . 0.788 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -62.66 1.95 0.33 Allowed 'General case' 0 C--N 1.307 -1.283 0 O-C-N 120.877 -1.139 . . . . 0.0 112.144 -178.307 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.71 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 5.0 m-70 -102.04 11.6 38.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.434 -1.416 . . . . 0.0 110.942 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' GLN . . . . . 0.853 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.7 mm-40 -129.53 -141.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.641 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 89' ' ' THR . 1.0 OUTLIER -37.01 -1.36 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.389 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' TYR . . . . . 0.853 ' N ' ' O ' ' A' ' 207' ' ' GLN . 80.1 t80 -38.45 -42.26 0.73 Allowed 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.014 -1.054 . . . . 0.0 111.457 -178.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.9 OUTLIER -62.21 -47.68 83.37 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.553 -178.467 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.3 t -56.11 -38.24 70.5 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.061 -1.024 . . . . 0.0 108.873 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.634 ' CE ' ' CG ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -88.28 -21.24 24.56 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 215' ' ' ASP . 1.4 m-80 -133.4 89.11 33.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.541 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 216' ' ' GLY . 31.7 Cg_exo -56.92 13.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 123.525 2.817 . . . . 0.0 112.08 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.623 ' H ' ' C ' ' A' ' 213' ' ' ASN . 38.0 t0 -60.92 20.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.937 . . . . 0.0 111.112 -177.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 65.52 -51.47 0.14 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.868 -1.158 . . . . 0.0 112.199 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' TYR . . . . . 0.605 ' C ' ' O ' ' A' ' 216' ' ' GLY . 27.0 m-85 -22.32 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.905 0 CA-C-N 118.892 1.346 . . . . 0.0 110.121 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER -151.18 103.01 2.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.441 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 218' ' ' CYS . . . -36.33 151.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' LEU . . . . . 0.426 ' CD2' ' H ' ' A' ' 149' ' ' ASN . 0.4 OUTLIER -63.41 -175.67 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -1.142 . . . . 0.0 109.52 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.65 -67.62 0.8 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' GLY . . . . . 0.498 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . 156.85 147.05 4.65 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.724 0 O-C-N 121.495 -1.003 . . . . 0.0 109.114 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 58.14 39.87 25.6 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.0 1.9 . . . . 0.0 109.321 -163.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 t -57.37 -38.25 73.91 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.143 2.177 . . . . 0.0 111.306 -162.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -33.95 -42.7 0.13 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.129 2.971 . . . . 0.0 116.16 161.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -76.95 -20.19 56.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.309 1.044 . . . . 0.0 111.848 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -37.22 8.53 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.361 0.982 . . . . 0.0 110.57 171.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.78 51.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.847 1.659 . . . . 0.0 107.378 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -57.63 134.64 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.489 1.516 . . . . 0.0 108.946 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.28 122.01 13.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 107.972 173.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.43 -26.12 62.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.702 1.201 . . . . 0.0 111.94 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -68.81 -32.11 71.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.904 2.882 . . . . 0.0 113.07 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -91.46 -14.54 30.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.886 1.674 . . . . 0.0 111.053 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -55.12 155.71 4.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.915 1.286 . . . . 0.0 111.744 174.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.08 150.9 13.9 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.938 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.28 -35.8 44.98 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.221 2.614 . . . . 0.0 114.612 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' HA3' ' H ' ' A' ' 99' ' ' ARG . . . 104.65 130.3 6.77 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 105.707 -2.957 . . . . 0.0 105.707 -168.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -90.08 157.62 17.69 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 m -109.93 16.63 21.82 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 120.111 -1.618 . . . . 0.0 109.656 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -98.16 102.07 12.93 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.498 1.919 . . . . 0.0 107.439 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.19 161.93 34.66 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.987 1.791 . . . . 0.0 109.42 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 pt -130.75 94.14 29.67 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.01 165.48 32.47 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.814 1.676 . . . . 0.0 109.612 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.78 -172.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 125.289 1.436 . . . . 0.0 109.863 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 t -55.24 92.23 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.839 2.055 . . . . 0.0 109.235 165.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.4 89.08 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.836 1.254 . . . . 0.0 110.567 -169.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -81.68 117.21 21.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.087 0.955 . . . . 0.0 108.46 165.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -50.58 115.77 1.63 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.434 2.694 . . . . 0.0 110.521 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -63.27 -25.11 68.16 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.497 1.499 . . . . 0.0 112.985 -170.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.24 -46.31 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.664 1.185 . . . . 0.0 109.994 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.8 m -99.07 -46.9 5.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.881 0.872 . . . . 0.0 111.71 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 -4.62 36.18 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.567 2.032 . . . . 0.0 112.928 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -81.22 -98.36 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.173 1.789 . . . . 0.0 112.487 -172.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 24.1 ttm-85 -153.84 153.99 33.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.495 1.518 . . . . 0.0 110.502 -175.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -128.24 11.33 6.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.448 2.699 . . . . 0.0 111.443 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 8.1 m -139.5 159.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 119.914 -1.741 . . . . 0.0 107.486 -176.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.72 147.61 70.71 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.371 1.068 . . . . 0.0 111.487 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.31 144.96 79.21 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 119.725 0.938 . . . . 0.0 111.782 2.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -87.57 141.22 31.99 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -52.85 143.47 48.24 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.012 3.142 . . . . 0.0 112.838 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -62.12 133.71 55.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.75 0.82 . . . . 0.0 110.028 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 30.22 30.97 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.9 p -111.49 139.86 46.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 163.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -105.11 157.97 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 165.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.3 143.75 38.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.009 1.723 . . . . 0.0 107.426 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.69 172.69 12.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.019 2.128 . . . . 0.0 106.789 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 50.0 t -133.42 123.47 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -134.75 128.77 33.52 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.996 1.718 . . . . 0.0 109.067 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.11 134.73 10.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 126.552 2.025 . . . . 0.0 108.407 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.4 ptp -128.3 -121.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 105.85 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.51 -154.78 29.78 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 171.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 t -44.06 117.35 1.19 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.769 2.028 . . . . 0.0 111.456 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . 0.289 0.0 OUTLIER -51.93 -11.59 0.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -176.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -53.66 -69.32 0.12 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.898 2.479 . . . . 0.0 114.111 165.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 -15.91 66.46 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.087 -1.008 . . . . 0.0 111.553 -171.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.5 70.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.979 1.711 . . . . 0.0 111.105 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.24 -40.65 81.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.402 1.881 . . . . 0.0 111.817 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -51.28 -52.49 44.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.893 2.077 . . . . 0.0 113.355 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.26 -3.18 12.8 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.777 1.231 . . . . 0.0 114.316 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -102.44 -27.83 12.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.825 -1.083 . . . . 0.0 112.241 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -80.87 -19.57 44.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 121.413 1.915 . . . . 0.0 111.795 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -79.56 -0.21 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 125.703 1.601 . . . . 0.0 112.281 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.9 152.34 22.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.147 1.779 . . . . 0.0 108.948 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -89.97 134.59 34.14 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.9 -13.54 45.52 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.01 0.814 . . . . 0.0 112.514 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 p -72.23 132.09 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 169.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.09 -51.09 11.65 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.1 p -161.48 171.58 17.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.314 1.845 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 p -128.45 153.97 46.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 107.885 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -145.43 160.37 41.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.009 2.124 . . . . 0.0 109.54 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.96 154.16 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.14 1.376 . . . . 0.0 111.103 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.86 176.55 40.63 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-O 122.237 0.91 . . . . 0.0 111.519 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.83 136.71 32.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.37 165.38 28.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.778 1.631 . . . . 0.0 107.871 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.34 2.45 79.9 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 119.747 -1.846 . . . . 0.0 114.867 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -115.16 -173.62 17.78 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.753 1.644 . . . . 0.0 110.923 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . 0.261 0.0 OUTLIER -145.42 60.76 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.325 1.45 . . . . 0.0 110.561 -167.132 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.52 142.35 27.95 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 129.29 3.036 . . . . 0.0 104.887 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.419 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 37.8 mtm180 -67.18 -55.56 13.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.297 0.953 . . . . 0.0 112.429 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.273 43.2 m-80 -137.69 70.24 51.77 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 120.314 1.416 . . . . 0.0 112.619 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.79 152.0 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.124 1.883 . . . . 0.0 108.444 171.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.47 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 34.1 p -108.03 175.25 5.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.168 1.387 . . . . 0.0 107.617 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -53.26 -44.75 68.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 111.862 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -72.94 -30.01 63.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.958 1.303 . . . . 0.0 111.395 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.47 ' HB2' ' H ' ' A' ' 102' ' ' THR . 9.6 mm-40 -77.08 -45.89 25.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.167 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.48 HG12 ' HG1' ' A' ' 111' ' ' THR . 15.3 m -62.01 -25.92 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.257 1.39 . . . . 0.0 112.769 176.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.5 t -56.67 -29.67 62.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.511 1.925 . . . . 0.0 113.262 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.0 p -68.04 -13.44 62.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.618 1.167 . . . . 0.0 112.963 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 79.15 -23.21 0.25 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 130.237 3.415 . . . . 0.0 112.224 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -54.38 -22.73 13.1 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 127.06 2.144 . . . . 0.0 114.629 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.48 ' HG1' HG12 ' A' ' 106' ' ' VAL . 51.0 p -76.41 -29.83 57.21 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.317 -1.49 . . . . 0.0 111.525 176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.19 85.08 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.909 1.718 . . . . 0.0 112.325 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.29 152.11 41.98 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.299 1.549 . . . . 0.0 112.4 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -110.29 129.53 55.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.656 2.382 . . . . 0.0 105.523 165.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -74.11 132.64 42.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.15 151.69 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.704 1.602 . . . . 0.0 110.187 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.3 m -105.2 128.84 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 127.602 2.361 . . . . 0.0 106.159 171.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -107.44 95.18 5.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.778 2.431 . . . . 0.0 104.652 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.6 m -108.85 126.71 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 -174.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.56 142.34 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 34.3 p90 -134.0 158.31 43.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.727 1.211 . . . . 0.0 110.086 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -103.97 106.24 52.13 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.876 1.271 . . . . 0.0 108.158 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -35.23 -42.57 0.41 Allowed 'Trans proline' 0 C--N 1.361 1.217 1 C-N-CA 127.391 5.394 . . . . 0.0 118.652 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.83 -25.39 56.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.342 1.857 . . . . 0.0 113.658 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -120.68 -16.02 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.973 1.309 . . . . 0.0 113.341 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.033 1.733 . . . . 0.0 107.681 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.2 p -83.78 169.62 15.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.358 1.435 . . . . 0.0 111.369 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.01 -32.46 72.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.008 1.323 . . . . 0.0 112.028 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -56.54 -27.14 56.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.013 2.125 . . . . 0.0 112.717 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.38 -44.41 65.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.313 1.445 . . . . 0.0 111.373 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 36.0 mt -67.33 -42.51 83.46 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.961 0.8 . . . . 0.0 110.398 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.28 -52.96 63.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.654 1.581 . . . . 0.0 110.334 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -52.1 -55.53 20.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.039 1.736 . . . . 0.0 112.805 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.05 -42.02 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.875 0.87 . . . . 0.0 110.927 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -56.08 -56.34 21.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.333 0.969 . . . . 0.0 112.244 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -63.28 -45.11 92.96 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.89 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.66 -24.02 63.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.958 2.103 . . . . 0.0 114.77 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.442 12.6 p30 -130.01 47.09 2.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.691 1.196 . . . . 0.0 114.2 -176.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -153.76 158.01 40.31 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.164 -1.398 . . . . 0.0 110.481 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -90.81 115.88 65.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.976 1.716 . . . . 0.0 107.363 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -82.58 -6.9 11.69 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.416 2.077 . . . . 0.0 114.495 -170.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.2 p -109.45 9.73 25.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.197 1.799 . . . . 0.0 112.128 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -110.57 108.43 18.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.58 -56.58 1.24 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -166.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -90.92 19.01 5.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.409 1.105 . . . . 0.0 112.657 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.0 ttm105 -167.5 148.4 5.45 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.912 2.085 . . . . 0.0 107.302 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -139.44 114.06 9.22 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.546 1.539 . . . . 0.0 107.651 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 45.8 -109.5 0.34 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.7 2.095 . . . . 0.0 113.124 -167.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -85.8 -16.91 37.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.645 1.578 . . . . 0.0 112.112 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.98 122.34 33.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.941 1.296 . . . . 0.0 107.58 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -115.83 139.59 50.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.337 1.455 . . . . 0.0 110.578 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.99 157.04 9.36 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.033 1.778 . . . . 0.0 112.024 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.6 t -58.58 -15.83 13.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.226 2.611 . . . . 0.0 114.618 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -80.46 -18.34 49.01 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.02 -1.05 . . . . 0.0 112.3 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -111.16 66.85 0.63 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -109.95 152.04 26.36 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.63 1.172 . . . . 0.0 108.123 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 p -60.28 118.41 6.37 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.593 1.157 . . . . 0.0 109.093 156.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.18 116.98 6.69 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.528 1.131 . . . . 0.0 110.869 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 76.2 t -111.13 121.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -115.27 114.1 43.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.52 155.67 45.24 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 123.151 2.567 . . . . 0.0 111.412 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.2 m -79.69 -32.67 41.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.037 0.935 . . . . 0.0 111.859 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 87.9 p -171.6 -167.56 0.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.21 1.804 . . . . 0.0 108.954 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.1 -21.96 25.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.105 . . . . 0.0 113.797 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -52.44 -56.67 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.933 2.493 . . . . 0.0 110.899 169.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -86.77 -18.96 29.82 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.915 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.6 ttt -54.89 -36.02 64.72 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.557 1.543 . . . . 0.0 113.303 175.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -67.98 -38.01 82.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.889 0.876 . . . . 0.0 112.142 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.07 -38.98 12.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.678 1.191 . . . . 0.0 111.356 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.47 74.7 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.004 1.722 . . . . 0.0 111.057 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.29 -34.76 79.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.24 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -69.35 -46.89 65.93 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.724 0.809 . . . . 0.0 110.007 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.8 p -59.42 -40.65 87.37 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.252 1.421 . . . . 0.0 112.06 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.07 -63.67 1.11 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.109 2.164 . . . . 0.0 110.596 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.51 -34.75 78.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.597 1.159 . . . . 0.0 113.736 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.03 -48.12 83.02 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.438 1.895 . . . . 0.0 111.714 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -76.68 -25.82 54.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -60.46 -44.06 96.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.734 0.697 . . . . 0.0 110.94 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -64.69 -42.14 95.53 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.744 1.218 . . . . 0.0 112.671 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.26 -42.36 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 119.028 0.831 . . . . 0.0 110.565 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -83.01 -23.61 33.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.432 1.015 . . . . 0.0 113.184 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.5 t -56.86 -33.91 67.3 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.839 1.2 . . . . 0.0 111.351 167.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -79.46 -17.61 53.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -91.95 12.11 22.85 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.481 1.512 . . . . 0.0 111.721 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 76.94 28.89 0.63 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.625 1.97 . . . . 0.0 111.049 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -98.69 169.23 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -103.65 -160.6 24.9 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.441 1.019 . . . . 0.0 110.904 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.24 21.67 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 124.094 3.196 . . . . 0.0 111.903 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.64 149.55 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.845 0.831 . . . . 0.0 109.627 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.6 p -112.59 21.52 15.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.175 1.79 . . . . 0.0 109.951 -171.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -66.72 106.44 1.84 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -69.82 124.59 24.38 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.719 1.208 . . . . 0.0 108.268 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.89 114.66 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -144.92 160.86 40.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 129.212 3.005 . . . . 0.0 106.484 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 161.82 20.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.624 1.969 . . . . 0.0 108.733 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.24 61.9 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.813 -0.555 . . . . 0.0 111.911 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -76.49 120.19 21.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.981 0.912 . . . . 0.0 109.134 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 p -59.92 134.88 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.141 1.777 . . . . 0.0 108.866 168.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -101.01 129.47 46.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -122.18 115.64 22.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -57.39 130.43 46.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.414 1.085 . . . . 0.0 110.294 171.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -76.88 173.5 11.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.136 0.974 . . . . 0.0 109.372 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.66 160.7 22.13 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.772 1.629 . . . . 0.0 110.798 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -55.57 -37.94 68.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.373 2.269 . . . . 0.0 111.976 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -18.89 22.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.262 2.225 . . . . 0.0 114.123 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -105.28 -6.47 19.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.366 1.467 . . . . 0.0 111.442 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . . . . . . . . . 76.8 mm-40 -94.91 -130.75 0.15 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.194 2.198 . . . . 0.0 108.952 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -68.79 14.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 132.02 4.128 . . . . 0.0 112.797 -173.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -51.56 -39.43 57.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.118 2.567 . . . . 0.0 112.463 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 3.1 mp -84.33 0.45 49.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.68 0.792 . . . . 0.0 112.021 -179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -76.21 -38.18 56.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.889 -1.132 . . . . 0.0 108.01 166.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -77.51 -34.9 53.93 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.525 1.53 . . . . 0.0 110.107 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -117.7 77.65 11.4 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.246 1.818 . . . . 0.0 109.246 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.37 1.91 4.38 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.605 2.87 . . . . 0.0 114.268 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -39.53 -38.88 0.64 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.46 3.104 . . . . 0.0 113.362 163.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.67 44.1 11.02 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 162.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -36.97 109.84 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.58 2.752 . . . . 0.0 115.413 -161.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 12.1 t 81.92 -65.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.455 2.302 . . . . 0.0 114.704 161.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.25 151.44 46.93 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.648 0.619 . . . . 0.0 114.648 -147.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.02 171.69 14.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.919 1.287 . . . . 0.0 109.576 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -88.58 -164.46 40.33 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 160.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -117.29 -141.04 6.81 Favored Glycine 0 CA--C 1.519 0.319 0 O-C-N 121.375 -1.074 . . . . 0.0 114.855 -159.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 0.56 -35.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 1 C-N-CA 136.037 5.735 . . . . 0.0 119.923 163.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -77.41 0.71 68.12 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.788 2.137 . . . . 0.0 112.436 -155.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.9 m -49.28 71.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 127.048 2.139 . . . . 0.0 113.274 141.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 66.4 m -78.83 151.5 31.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 127.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . 1.058 27.4 p 98.07 -109.78 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.89 1 C-N-CA 135.798 5.639 . . . . 0.0 113.74 -12.629 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -50.63 -19.76 5.5 Favored 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 124.251 3.301 . . . . 0.0 118.112 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' MET . . . . . . . . . . . . . 60.2 ttp -143.36 148.05 35.62 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.397 2.279 . . . . 0.0 107.635 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . 0.265 . . 85.59 -14.23 0.57 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 128.8 2.84 . . . . 0.0 115.098 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.2 132.81 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 127.623 2.369 . . . . 0.0 106.051 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . 0.256 36.4 ttmt 72.88 -113.28 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.552 1 C-N-CA 132.517 4.327 . . . . 0.0 112.026 -9.558 . . . . . . . . 3 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.4 2.777 0 CA-C-N 113.195 -1.82 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 22' ' ' GLY . 39.3 m-20 36.0 -89.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -1.164 . . . . 0.0 109.317 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.677 ' C ' ' H ' ' A' ' 26' ' ' SER . 1.6 m -50.62 -18.23 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.031 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.625 ' C ' ' H ' ' A' ' 27' ' ' LYS . . . -49.95 -7.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 123.011 1.386 . . . . 0.0 109.751 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.677 ' H ' ' C ' ' A' ' 24' ' ' SER . 40.9 t -46.37 -9.26 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.445 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 25' ' ' ALA . 1.8 pttt -114.91 54.88 0.77 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 123.416 1.579 . . . . 0.0 108.753 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.61 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -155.55 21.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.259 -3.362 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -178.488 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.61 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -41.34 177.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.76 -178.074 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.475 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -107.67 125.64 51.61 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.509 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.679 ' CB ' ' ND1' ' A' ' 97' ' ' HIS . . . -54.01 -17.93 3.08 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.427 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.566 ' OE1' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -82.98 -9.52 59.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.974 -1.079 . . . . 0.0 110.12 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 34' ' ' ALA . 9.4 tp10 -112.32 -28.11 8.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 110.384 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -30.57 148.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.157 -0.965 . . . . 0.0 110.389 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -37.78 161.39 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.18 -41.81 48.22 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.026 1.817 . . . . 0.0 111.747 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.1 137.11 4.58 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.16 165.78 12.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -1.124 . . . . 0.0 109.435 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.42 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 2.2 m -124.94 33.55 5.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 109.706 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -118.05 74.24 10.13 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.013 -1.054 . . . . 0.0 110.11 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.09 130.94 11.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.907 2.404 . . . . 0.0 111.581 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -139.27 92.23 10.72 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.947 -1.096 . . . . 0.0 110.413 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 42' ' ' ILE . 76.6 Cg_exo -48.34 -165.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.787 2.325 . . . . 0.0 111.435 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -160.9 -171.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.891 -1.131 . . . . 0.0 110.281 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -33.9 83.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.554 0.692 . . . . 0.0 111.334 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -64.4 -20.13 65.95 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.441 -0.787 . . . . 0.0 110.271 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -88.49 100.45 13.07 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 116.384 -2.126 . . . . 0.0 107.786 178.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.682 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 6.1 t-80 -30.18 141.21 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.0 -6.96 57.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.461 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 46.9 t -95.43 -63.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -80.55 -44.69 18.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.927 . . . . 0.0 110.214 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.22 55.6 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 33.4 p30 -82.75 -114.87 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 57' ' ' GLU . 1.2 ttm-85 -128.06 170.57 12.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.978 1.37 . . . . 0.0 108.434 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 3.0 p -132.22 17.33 4.52 Favored 'General case' 0 C--N 1.263 -3.169 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.968 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.519 ' O ' ' C ' ' A' ' 57' ' ' GLU . 3.4 m -151.55 -168.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.098 -1.001 . . . . 0.0 109.117 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 23.7 mm-40 -34.08 153.77 0.05 OUTLIER Pre-proline 0 C--N 1.293 -1.854 0 CA-C-O 121.494 0.664 . . . . 0.0 110.296 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -87.79 155.29 41.94 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.03 -1.654 . . . . 0.0 110.889 0.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-85 -117.53 66.68 5.0 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.28 -176.42 0.84 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.821 2.347 . . . . 0.0 113.049 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.39 158.55 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.94 -41.37 2.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.491 ' CG2' ' CG2' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -97.72 144.2 27.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -1.04 . . . . 0.0 109.231 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.691 HE21 HE21 ' A' ' 166' ' ' GLN . 29.4 tp60 -107.79 147.77 30.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.704 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -122.18 128.85 51.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.33 -167.38 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.2 t -141.98 140.69 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.081 -1.637 . . . . 0.0 109.379 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 42.0 m-85 -127.92 131.91 49.33 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.561 ' O ' ' CD2' ' A' ' 139' ' ' HIS . . . -135.89 136.15 8.27 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.233 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -126.25 -94.29 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.514 -0.992 . . . . 0.0 108.998 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.691 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -142.46 71.28 0.4 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.4 t 113.05 149.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.087 0.955 . . . . 0.0 108.776 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.701 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -101.6 20.26 16.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.2 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.706 ' CG ' ' OH ' ' A' ' 209' ' ' TYR . 17.8 m0 -101.56 -65.98 0.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.748 -1.22 . . . . 0.0 109.395 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.523 ' N ' ' OH ' ' A' ' 217' ' ' TYR . . . -68.32 -16.12 68.77 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -75.29 -58.27 3.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.409 -1.054 . . . . 0.0 110.591 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.544 ' CD ' ' O ' ' A' ' 77' ' ' GLU . 10.5 tp10 -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.253 -0.904 . . . . 0.0 111.473 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.406 HH11 ' HG3' ' A' ' 78' ' ' ARG . 13.9 tpt85 -56.52 -53.98 51.23 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.874 -1.142 . . . . 0.0 110.787 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -83.42 18.32 1.86 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.329 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.714 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 4.9 m-85 -103.95 -40.05 6.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.776 -1.203 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.581 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -81.91 -4.36 56.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.848 -1.158 . . . . 0.0 110.108 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.425 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -90.4 21.11 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 0.0 109.786 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 60.6 mt -111.1 165.92 11.5 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.794 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 169.85 10.93 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.16 3.64 38.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -98.89 115.91 40.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.559 -0.965 . . . . 0.0 109.615 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.483 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.0 OUTLIER -73.53 -46.64 46.44 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.483 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 6.9 t -164.37 157.65 17.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.542 -0.724 . . . . 0.0 109.554 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.682 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.1 p -117.26 154.05 31.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.645 ' NE2' ' C ' ' A' ' 89' ' ' THR . 10.9 mp0 -149.24 146.95 27.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.773 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 206' ' ' HIS . 20.6 m -140.56 177.7 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 110.124 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . 156.48 -118.9 0.87 Allowed Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.209 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' CZ ' ' HB1' ' A' ' 202' ' ' ALA . 5.0 m-85 -125.13 167.78 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.937 . . . . 0.0 109.814 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.673 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.76 -179.62 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.884 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.61 6.61 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -121.95 -170.56 13.81 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.679 ' ND1' ' CB ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -144.05 78.55 1.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.548 -0.972 . . . . 0.0 109.917 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.52 145.1 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 109.238 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 3.5 ttm-85 -55.17 -80.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.427 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.463 ' ND2' ' HG2' ' A' ' 99' ' ' ARG . 44.5 m-80 -122.83 75.25 47.54 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.054 -1.029 . . . . 0.0 109.668 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.78 151.48 31.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.827 2.351 . . . . 0.0 112.05 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.42 ' O ' HG23 ' A' ' 106' ' ' VAL . 19.1 p -122.0 164.22 18.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.055 -1.028 . . . . 0.0 109.393 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.453 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 14.5 t80 -51.1 -44.35 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.614 -0.678 . . . . 0.0 110.016 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -27.03 62.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.009 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.411 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 0.6 OUTLIER -80.98 -38.06 28.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.074 -1.016 . . . . 0.0 110.375 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 109' ' ' GLU . 15.3 m -69.42 -24.03 27.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 120.866 -1.146 . . . . 0.0 110.161 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.655 ' C ' ' H ' ' A' ' 109' ' ' GLU . 94.5 m -45.76 -45.21 14.46 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.603 ' C ' ' H ' ' A' ' 110' ' ' LYS . 29.6 t -60.52 5.5 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.85 . . . . 0.0 108.965 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.655 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.9 mt-10 54.82 -0.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.456 -0.778 . . . . 0.0 109.659 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.603 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 mmtp -63.84 -19.5 65.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.058 -1.026 . . . . 0.0 109.044 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.538 ' O ' ' C ' ' A' ' 112' ' ' GLY . 31.7 p -98.34 0.72 46.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.418 -0.801 . . . . 0.0 109.373 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 30.99 47.81 0.17 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -84.79 174.7 9.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.709 -1.465 . . . . 0.0 108.367 178.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.476 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -125.52 114.52 18.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.131 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.701 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.1 mm-40 -62.52 111.53 2.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -140.16 -171.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.095 -1.003 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.5 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.1 m -130.32 128.18 63.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.468 0.652 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.602 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -97.95 97.3 8.82 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.413 HG23 ' CD1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -105.8 129.72 58.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.509 -179.057 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.491 ' CG2' ' CG2' ' A' ' 63' ' ' THR . 0.2 OUTLIER -108.25 132.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.343 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.658 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -139.06 156.71 46.98 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.544 0.688 . . . . 0.0 109.695 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.471 ' HE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -95.92 108.28 39.72 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.66 -0.65 . . . . 0.0 110.633 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -41.62 -67.47 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.713 2.276 . . . . 0.0 113.169 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.656 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 18.4 mp0 -49.64 -21.3 0.99 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.258 -0.901 . . . . 0.0 109.746 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.562 ' N ' ' HD1' ' A' ' 125' ' ' HIS . 1.1 m80 -92.37 -33.82 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -0.981 . . . . 0.0 108.981 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.462 ' CG1' ' HG2' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -148.18 141.04 18.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.14 140.81 57.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.955 -1.091 . . . . 0.0 110.088 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.569 ' CE2' ' CD1' ' A' ' 132' ' ' LEU . 21.9 t80 -69.42 -33.28 72.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -14.01 61.47 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.543 ' CD ' ' C ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -74.98 -45.33 42.81 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.473 -0.767 . . . . 0.0 110.454 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.565 ' CD1' ' CG ' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -71.67 -31.02 66.35 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 119.361 -2.087 . . . . 0.0 107.492 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.569 ' CD1' ' CE2' ' A' ' 128' ' ' PHE . 1.1 mt -57.01 -21.77 33.31 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -70.34 -52.89 19.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.411 -0.805 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -49.93 -34.82 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.713 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 13.6 t80 -69.01 -53.22 21.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.481 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 50.6 m95 -70.44 -55.61 8.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.583 -1.323 . . . . 0.0 109.129 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.517 ' OE2' ' O ' ' A' ' 137' ' ' GLU . 2.2 tm-20 -37.53 -40.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.68 -0.637 . . . . 0.0 111.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 14.0 p30 -125.4 72.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.972 -1.08 . . . . 0.0 110.784 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.713 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 8.4 m80 -157.62 142.18 16.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.122 -0.986 . . . . 0.0 110.593 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.74 ' CG ' HE21 ' A' ' 143' ' ' GLN . 0.7 OUTLIER -105.21 73.02 0.24 Allowed Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.636 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.483 ' CD ' ' O ' ' A' ' 139' ' ' HIS . 17.7 Cg_endo -59.53 23.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.736 1.624 . . . . 0.0 112.587 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.599 ' H ' ' C ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -121.95 1.6 9.86 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.135 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.74 HE21 ' CG ' ' A' ' 140' ' ' ASP . 46.2 mt-30 -106.79 92.35 4.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.951 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.594 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -37.97 -113.3 0.0 OUTLIER Glycine 0 N--CA 1.495 2.603 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.331 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.649 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 22.2 ptt? -66.05 41.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.84 0.829 . . . . 0.0 110.963 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.755 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 178.37 145.49 0.13 Allowed 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.897 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 1.3 mt-30 -152.13 155.48 37.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 119.782 -1.824 . . . . 0.0 110.215 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.58 -126.25 3.63 Favored Glycine 0 C--N 1.302 -1.309 0 CA-C-O 122.898 1.277 . . . . 0.0 110.438 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.472 ' HB2' ' H ' ' A' ' 220' ' ' LEU . 0.7 OUTLIER -81.85 -34.57 30.05 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.16 -1.02 . . . . 0.0 112.129 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.452 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -91.84 126.26 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.314 -1.491 . . . . 0.0 108.862 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.415 ' CA ' ' HB2' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -105.81 154.62 20.26 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.054 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.755 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 123.92 172.89 13.78 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.353 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -75.56 -28.15 58.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.285 -1.126 . . . . 0.0 109.82 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.785 ' NE2' ' HH ' ' A' ' 155' ' ' TYR . 4.3 pt20 -69.98 -5.74 28.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.885 -1.134 . . . . 0.0 109.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.785 ' HH ' ' NE2' ' A' ' 154' ' ' GLN . 23.4 m-85 -131.4 52.08 2.09 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.078 -1.014 . . . . 0.0 109.351 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.77 HH22 HH22 ' A' ' 194' ' ' ARG . 6.8 mtp180 -90.96 176.18 6.7 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.582 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.618 ' O ' ' N ' ' A' ' 192' ' ' ASP . 0.2 OUTLIER -91.08 117.66 29.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 175.733 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.451 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -136.99 128.75 28.92 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.99 -175.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 1.4 t -115.89 115.52 49.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -113.2 121.15 38.66 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.7 170.11 13.02 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.575 2.183 . . . . 0.0 112.28 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -90.15 -29.23 18.42 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 120.916 -1.115 . . . . 0.0 109.369 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.48 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 178.48 -162.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.58 -15.83 2.03 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.993 1.378 . . . . 0.0 108.648 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.48 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.8 t -55.92 -64.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.691 HE21 HE21 ' A' ' 64' ' ' GLN . 22.3 mt-30 -79.56 -19.59 49.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.596 -0.69 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.93 -34.87 43.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.26 -28.56 63.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.746 -1.221 . . . . 0.0 109.431 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.76 -45.13 8.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.65 -56.09 17.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 mt -52.87 -37.16 60.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.218 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.481 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -55.84 -36.5 67.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.539 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.494 ' HZ2' ' CD1' ' A' ' 189' ' ' ILE . 8.8 tttm -72.84 -57.81 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.595 ' CG ' ' N ' ' A' ' 176' ' ' GLU . 6.4 pt-20 -63.46 -47.09 83.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.595 ' N ' ' CG ' ' A' ' 175' ' ' GLU . 0.3 OUTLIER -53.08 -31.98 44.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 109.655 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.478 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.6 OUTLIER -78.92 -14.92 58.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.527 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.496 ' C ' ' CD ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -74.89 -38.79 61.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.182 -0.949 . . . . 0.0 109.299 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.466 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -78.02 -23.17 48.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.651 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 60.3 t -75.59 -54.56 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.466 HD22 ' CE2' ' A' ' 177' ' ' TYR . 4.6 mm? -68.96 -36.46 77.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.629 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.3 p -56.03 -27.8 54.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -88.11 -3.03 58.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.42 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.444 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 11.9 m170 -107.59 35.88 2.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.86 61.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.493 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -152.19 175.04 13.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.9 -141.49 5.01 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.51 105.82 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.239 1.96 . . . . 0.0 111.196 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.494 ' CD1' ' HZ2' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -53.24 177.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 2.7 p -143.89 70.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.647 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.411 ' HA ' ' HG ' ' A' ' 157' ' ' SER . 61.2 m -100.47 160.24 14.51 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH2' ' A' ' 156' ' ' ARG . 21.2 t0 -105.91 106.38 16.86 Favored 'General case' 0 C--N 1.265 -3.067 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.93 114.07 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.415 -0.803 . . . . 0.0 109.054 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.77 HH22 HH22 ' A' ' 156' ' ' ARG . 1.0 OUTLIER -154.68 -170.46 3.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 109.178 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.408 ' HA ' HE22 ' A' ' 197' ' ' GLN . 86.3 mt-10 -119.67 -179.22 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 56.37 54.08 38.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.427 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.85 92.48 6.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.454 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.42 156.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.506 ' CE1' ' HB2' ' A' ' 118' ' ' ARG . 63.2 t80 -126.05 140.24 52.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.235 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 10.2 m-85 -139.67 103.89 4.79 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.052 -1.03 . . . . 0.0 109.975 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -52.4 132.58 34.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 111.219 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.438 ' HB1' ' CZ ' ' A' ' 93' ' ' PHE . . . -88.37 -171.26 3.28 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.662 ' CD ' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.44 174.94 8.22 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.662 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.4 OUTLIER -60.92 -50.49 73.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.733 -1.229 . . . . 0.0 108.088 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.641 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.53 -8.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 109.77 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.574 ' H ' ' C ' ' A' ' 204' ' ' ASP . 8.7 m-70 -103.55 13.62 32.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.066 -1.021 . . . . 0.0 111.446 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.774 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -138.6 -148.0 0.25 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.684 -1.26 . . . . 0.0 111.197 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.668 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 18.7 mp0 -33.49 -3.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.606 -1.179 . . . . 0.0 114.049 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.774 ' N ' ' O ' ' A' ' 207' ' ' GLN . 14.3 p90 -44.83 -33.63 2.0 Favored 'General case' 0 N--CA 1.518 2.941 0 C-N-CA 116.429 -2.108 . . . . 0.0 108.738 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 209' ' ' TYR . 0.4 OUTLIER -51.13 -20.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.769 -1.207 . . . . 0.0 109.947 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 16.2 t -59.88 -35.83 75.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.058 -1.026 . . . . 0.0 108.683 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 214' ' ' PRO . 5.8 mmmt -88.29 -29.8 20.1 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.468 -0.77 . . . . 0.0 109.67 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.527 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.7 OUTLIER -119.6 51.07 1.67 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 213' ' ' ASN . 12.0 Cg_endo -60.41 8.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.095 2.53 . . . . 0.0 112.406 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.527 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.0 t70 -63.58 -12.48 33.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 110.36 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 62.56 86.67 0.05 OUTLIER Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.657 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.61 ' O ' ' O ' ' A' ' 216' ' ' GLY . 1.5 p90 -44.61 179.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.385 2.093 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.452 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER -72.84 76.71 1.15 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.041 -1.037 . . . . 0.0 108.765 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.36 150.42 17.24 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.472 ' H ' ' HB2' ' A' ' 149' ' ' ASN . 7.6 mt -84.67 -173.38 4.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 165.2 110.48 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 154.0 139.09 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.45 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER -81.33 37.06 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -1.179 . . . . 0.0 109.45 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 72.25 13.67 76.74 Favored Glycine 0 C--N 1.302 -1.312 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.637 ' CG1' ' O ' ' A' ' 225' ' ' VAL . 0.8 OUTLIER -49.89 101.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.746 -0.855 . . . . 0.0 109.061 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.689 ' O ' ' SD ' ' A' ' 229' ' ' MET . 47.9 t -99.76 -153.11 0.43 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 120.729 -1.232 . . . . 0.0 110.429 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.586 ' O ' ' SD ' ' A' ' 229' ' ' MET . 0.0 OUTLIER -76.59 -55.88 1.52 Allowed Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.991 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.471 ' HD3' ' SG ' ' A' ' 227' ' ' CYS . 84.3 Cg_exo -50.37 -24.74 12.5 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.413 2.075 . . . . 0.0 109.477 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.708 ' O ' ' SD ' ' A' ' 229' ' ' MET . 0.0 OUTLIER -51.63 161.19 0.54 Allowed 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.351 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.555 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.3 130.25 0.08 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.967 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.445 HG12 ' SD ' ' A' ' 229' ' ' MET . 1.5 mm -142.58 114.43 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.205 -0.934 . . . . 0.0 109.39 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.13 136.1 37.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.491 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.346 0 O-C-N 121.271 -0.893 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.459 H112 ' NH1' ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 59.38 -69.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -1.112 . . . . 0.0 109.445 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.655 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -50.79 -18.58 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.367 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.672 ' N ' ' O1 ' ' A' ' 21' ' ' MYR . . . -49.89 -9.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 123.018 1.39 . . . . 0.0 109.53 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.655 ' H ' ' C ' ' A' ' 24' ' ' SER . 2.3 p -47.46 -6.29 0.01 OUTLIER 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.595 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.658 ' H ' ' C ' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -122.3 40.38 3.67 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.984 1.373 . . . . 0.0 109.561 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.628 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -161.51 22.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.256 -3.469 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -41.18 176.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 122.828 1.299 . . . . 0.0 109.669 -178.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.469 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -105.27 123.26 47.54 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.423 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.601 ' CB ' ' HD1' ' A' ' 97' ' ' HIS . . . -47.04 -36.18 7.7 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.697 -0.627 . . . . 0.0 109.531 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -54.0 -38.0 64.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.81 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' C ' ' A' ' 34' ' ' ALA . 24.3 tp10 -91.19 -27.87 18.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.573 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -28.24 126.38 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 110.371 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.635 ' O ' ' CG2' ' A' ' 98' ' ' THR . 4.5 mp -41.61 171.95 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.567 -0.708 . . . . 0.0 109.715 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.48 -50.06 6.32 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.267 1.978 . . . . 0.0 111.114 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' PRO . . . 112.39 -64.38 0.27 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.741 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.457 ' HD2' ' N ' ' A' ' 39' ' ' THR . 5.4 tmm_? -64.79 122.54 17.14 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.57 -1.547 . . . . 0.0 109.973 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -126.66 -12.21 6.07 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.254 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 39' ' ' THR . 2.9 mt-10 156.87 165.67 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.66 170.91 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.632 2.222 . . . . 0.0 112.281 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.55 78.18 27.09 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.023 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.535 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 83.7 Cg_endo -85.0 162.6 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.144 2.563 . . . . 0.0 112.504 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.654 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 15.7 m -160.7 -176.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.238 -0.914 . . . . 0.0 109.628 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.6 100.12 12.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.598 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.45 -61.31 2.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.261 -0.9 . . . . 0.0 111.414 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.553 ' O ' ' C ' ' A' ' 48' ' ' HIS . 17.3 mttm -70.82 100.76 1.98 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 115.579 -2.448 . . . . 0.0 108.423 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.553 ' C ' ' O ' ' A' ' 47' ' ' LYS . 5.9 t-80 -32.34 122.88 0.33 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.06 -28.94 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 0.0 111.012 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.442 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 41.8 t -69.25 -43.78 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.143 . . . . 0.0 110.001 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -106.57 -44.16 4.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 110.306 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.22 2.76 51.25 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 43.9 p30 -79.44 -121.01 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.6 mmt180 -127.81 172.03 11.21 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 123.061 1.41 . . . . 0.0 109.784 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 37.0 p -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.985 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.537 ' O ' ' C ' ' A' ' 57' ' ' GLU . 11.6 m -145.62 132.76 15.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.415 -1.428 . . . . 0.0 109.809 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.6 mm-40 -32.73 149.36 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.504 0 CA-C-O 121.75 0.786 . . . . 0.0 110.538 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -78.34 166.21 80.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.961 -2.1 . . . . 0.0 111.831 -0.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.33 151.68 39.15 Favored Pre-proline 0 C--N 1.269 -2.934 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.289 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.57 ' O ' ' OG1' ' A' ' 63' ' ' THR . 23.9 Cg_endo -64.61 122.94 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.747 2.298 . . . . 0.0 112.162 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLU . 2.4 pp20? -43.48 143.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 32.41 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -154.77 137.15 14.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.603 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.794 HE21 ' H ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -108.11 171.08 7.61 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.464 ' O ' ' CG2' ' A' ' 162' ' ' THR . 7.4 mtm -128.07 132.54 49.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.99 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.91 -170.75 2.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.683 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 62.0 t -143.58 151.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 119.906 -1.746 . . . . 0.0 109.749 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 36.6 m-85 -147.07 125.93 12.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.982 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -105.68 89.26 0.61 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.541 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -85.89 -75.2 0.38 Allowed 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.626 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -165.74 -161.03 13.85 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.728 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -28.77 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.289 1.045 . . . . 0.0 108.611 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.78 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -59.3 7.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.016 . . . . 0.0 111.183 -177.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.556 ' H ' ' C ' ' A' ' 72' ' ' CYS . 6.3 m0 -69.35 -60.83 2.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.0 108.856 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.69 -10.01 58.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.7 -58.61 7.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.469 ' HA ' ' CD1' ' A' ' 80' ' ' PHE . 8.8 pt-20 -76.12 -12.57 60.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.132 -0.98 . . . . 0.0 110.757 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.501 ' C ' ' H ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -56.79 -54.97 40.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.603 -1.31 . . . . 0.0 109.623 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.452 ' HE3' ' ND2' ' A' ' 138' ' ' ASN . 0.1 OUTLIER -56.43 -0.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 0.0 110.69 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.501 ' H ' ' C ' ' A' ' 78' ' ' ARG . 19.8 m-85 -94.32 -39.57 10.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.744 -1.223 . . . . 0.0 109.851 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.464 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -77.01 16.74 0.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.85 -1.156 . . . . 0.0 109.318 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.45 ' H ' ' C ' ' A' ' 80' ' ' PHE . 1.2 m -117.11 19.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 pp -135.67 161.31 35.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.11 -0.994 . . . . 0.0 109.466 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 150.3 20.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.686 . . . . 0.0 109.984 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 110.44 -29.0 9.48 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.472 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -84.36 132.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.791 -0.829 . . . . 0.0 110.143 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.693 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.85 -43.04 31.56 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' CG ' ' A' ' 48' ' ' HIS . 5.5 t -162.25 -165.19 1.16 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.483 0.659 . . . . 0.0 109.796 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.492 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 74.1 p -154.16 143.47 21.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 118' ' ' ARG . 6.7 mp0 -144.64 145.88 31.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 109.854 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.476 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.1 OUTLIER -128.99 156.6 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.037 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.28 172.84 45.84 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.471 ' CE2' ' HA ' ' A' ' 102' ' ' THR . 3.7 m-85 -79.99 138.37 37.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -1.058 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.672 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -157.72 -170.16 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.926 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.513 ' O ' ' NH2' ' A' ' 194' ' ' ARG . . . 40.83 38.05 1.51 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.568 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -117.71 -154.27 9.83 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.757 -1.437 . . . . 0.0 109.751 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.601 ' HD1' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -151.8 64.68 0.86 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.325 -1.103 . . . . 0.0 109.166 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.635 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.31 -178.48 7.38 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.027 -1.045 . . . . 0.0 108.636 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 14.3 tpp85 -75.12 -107.59 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.449 -0.782 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' CG ' ' A' ' 99' ' ' ARG . 1.2 m-80 -104.9 72.69 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.574 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 38.3 Cg_endo -65.59 157.72 56.99 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.824 2.35 . . . . 0.0 112.521 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.471 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . 23.2 p -122.94 170.43 10.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.407 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 4.3 t80 -55.48 -45.76 76.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -25.89 61.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 0.0 110.033 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.581 ' O ' ' OG ' ' A' ' 108' ' ' SER . 3.5 mm-40 -81.89 -37.66 26.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 102' ' ' THR . 13.5 m -66.31 -23.83 32.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 O-C-N 120.594 -1.317 . . . . 0.0 109.663 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.665 ' C ' ' H ' ' A' ' 109' ' ' GLU . 3.7 t -52.72 -38.93 61.55 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.634 ' C ' ' H ' ' A' ' 110' ' ' LYS . 0.1 OUTLIER -52.86 -1.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.23 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.665 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.4 tt0 59.65 -6.59 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.253 -0.905 . . . . 0.0 109.65 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.634 ' H ' ' C ' ' A' ' 108' ' ' SER . 1.6 mmtt -75.98 -24.46 55.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 110.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 112' ' ' GLY . 31.1 p -84.15 -10.56 57.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 109.378 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 43.26 39.5 4.14 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.672 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -82.42 162.6 22.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.225 . . . . 0.0 109.16 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.661 ' CB ' HH12 ' A' ' 156' ' ' ARG . . . -124.37 113.85 18.74 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.376 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.689 ' OE1' ' CD1' ' A' ' 73' ' ' PHE . 2.4 mm-40 -54.27 116.31 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.503 ' CG1' ' CE1' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -124.66 175.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.03 -1.044 . . . . 0.0 110.88 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.594 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 3.6 m -133.01 114.92 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -95.87 98.68 10.6 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.474 HG22 ' CD2' ' A' ' 80' ' ' PHE . 14.0 m -118.96 122.43 69.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.5 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -83.6 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.794 ' H ' HE21 ' A' ' 64' ' ' GLN . 4.7 m-85 -130.18 160.71 32.99 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.845 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 50.6 mtp85 -101.3 105.44 39.64 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.52 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 125' ' ' HIS . 9.4 Cg_exo -40.58 -66.84 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 123.203 2.602 . . . . 0.0 113.877 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.5 tt0 -42.82 -19.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.997 -1.064 . . . . 0.0 109.938 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' A' ' 123' ' ' PRO . 67.5 m-70 -109.97 -7.78 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.999 -1.063 . . . . 0.0 109.852 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 121' ' ' TYR . 1.2 pt -152.19 -176.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.389 1.09 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.498 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 43.7 t -130.37 152.32 49.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.605 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 25.4 t80 -48.33 -19.16 0.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.514 -1.367 . . . . 0.0 109.382 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' C ' ' A' ' 127' ' ' SER . 9.1 mp0 -70.48 -24.54 62.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.352 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.591 ' O ' ' C ' ' A' ' 131' ' ' LEU . 7.1 mt-10 -68.87 -71.77 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.0 109.999 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.666 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 1.2 mp -35.86 -43.55 0.31 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.326 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.605 ' CD1' ' CE1' ' A' ' 128' ' ' PHE . 7.5 mp -73.94 -44.98 53.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.446 -0.784 . . . . 0.0 111.519 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -52.26 -53.19 47.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.795 -1.19 . . . . 0.0 110.343 -178.612 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.676 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 2.0 t -50.28 -50.64 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CZ ' ' CE1' ' A' ' 139' ' ' HIS . 22.5 t80 -58.0 -44.39 87.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.775 -1.203 . . . . 0.0 111.589 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.559 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 67.7 m95 -70.74 -36.09 72.98 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.772 -1.205 . . . . 0.0 111.702 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 133' ' ' LYS . 21.7 mt-10 -79.21 -13.38 59.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.938 -1.101 . . . . 0.0 112.974 -177.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.0 OUTLIER -133.99 59.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.11 -1.619 . . . . 0.0 112.087 -178.31 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.798 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 p-80 177.58 134.25 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.027 -1.045 . . . . 0.0 109.833 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.658 ' OD2' ' NE2' ' A' ' 143' ' ' GLN . 1.2 t0 -48.96 107.36 0.75 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.33 -0.857 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -85.98 -2.07 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.735 2.29 . . . . 0.0 113.038 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.55 ' C ' ' OG1' ' A' ' 190' ' ' THR . 40.2 p -121.72 20.55 10.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 110.261 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.69 ' N ' ' OG1' ' A' ' 190' ' ' THR . 7.7 mt-30 -130.94 101.25 5.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.022 -1.049 . . . . 0.0 109.15 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.677 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -96.86 18.74 56.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -18.35 12.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.979 -1.306 . . . . 0.0 109.8 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.649 ' CD ' ' C ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.54 164.59 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.001 -1.062 . . . . 0.0 109.87 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.571 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -99.34 108.36 20.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.589 -1.32 . . . . 0.0 109.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.91 -122.15 28.46 Favored Glycine 0 C--N 1.301 -1.366 0 CA-C-O 123.211 1.451 . . . . 0.0 110.461 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.05 -32.96 39.37 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.461 -1.37 . . . . 0.0 111.964 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.571 ' OD2' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.31 101.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.171 -1.581 . . . . 0.0 108.885 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.691 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 6.5 p90 -82.43 118.44 23.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.554 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 166.15 144.19 4.0 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.531 ' O ' ' OG1' ' A' ' 153' ' ' THR . 0.5 OUTLIER -70.97 14.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -1.23 . . . . 0.0 109.047 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.668 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 9.3 pt20 -102.79 -1.65 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.668 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 22.4 m-85 -132.38 53.09 2.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.815 -1.178 . . . . 0.0 109.633 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.661 HH12 ' CB ' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -100.02 177.41 5.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 110.331 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' OG1' ' A' ' 191' ' ' THR . 11.5 p -92.98 71.41 4.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.548 ' CB ' ' OH ' ' A' ' 160' ' ' TYR . . . -97.38 129.57 44.61 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.631 0.729 . . . . 0.0 110.912 -176.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.414 ' CG2' HD12 ' A' ' 193' ' ' ILE . 19.9 m -102.11 146.35 10.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.548 ' OH ' ' CB ' ' A' ' 158' ' ' ALA . 22.2 m-85 -139.89 115.89 8.07 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 72.3 Cg_endo -77.57 167.37 24.33 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.344 2.029 . . . . 0.0 113.349 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.464 ' CG2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -93.5 -41.73 9.62 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.282 -0.886 . . . . 0.0 109.392 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -171.8 -172.15 0.98 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 109.994 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.8 -25.53 4.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.074 1.416 . . . . 0.0 108.529 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.426 ' N ' ' C ' ' A' ' 163' ' ' SER . 2.5 t -56.01 -58.8 3.82 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.12 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -78.25 -25.66 46.94 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.086 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -38.6 56.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 0.0 110.657 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.13 -61.62 1.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 110.826 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.86 -16.93 23.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.85 -1.156 . . . . 0.0 112.341 -178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -52.33 -65.67 0.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.429 -1.419 . . . . 0.0 110.357 -178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.413 ' CD2' ' C ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.13 -21.42 61.58 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.875 -1.141 . . . . 0.0 108.247 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -75.51 -27.98 58.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.438 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.559 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 97.3 p -56.29 -26.91 53.67 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.426 ' HB2' ' NZ ' ' A' ' 174' ' ' LYS . 14.4 mtmm -67.73 -58.48 4.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.55 8.56 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.019 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.57 -75.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 110.102 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -58.16 -32.31 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -52.79 -17.97 1.63 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 0.0 109.652 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -68.04 -39.29 83.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.686 ' O ' ' CE1' ' A' ' 184' ' ' HIS . 15.8 m -87.45 -30.88 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.108 -0.995 . . . . 0.0 109.898 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.419 HD22 ' CD2' ' A' ' 186' ' ' PHE . 40.1 mt -75.29 -38.51 60.32 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.133 -0.979 . . . . 0.0 109.62 -179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.9 t -56.56 -24.78 49.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -75.69 -29.84 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.708 ' CD2' ' SD ' ' A' ' 229' ' ' MET . 0.6 OUTLIER -86.0 6.39 28.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.366 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.74 68.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.554 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.419 ' CD2' HD22 ' A' ' 181' ' ' LEU . 9.2 m-85 -115.78 162.62 17.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.82 178.23 48.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.5 157.86 29.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.708 2.272 . . . . 0.0 112.075 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -64.05 125.29 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.166 -0.959 . . . . 0.0 108.686 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.69 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 6.8 p -110.59 54.1 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.548 ' OG1' ' O ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -100.68 159.53 15.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.662 ' CG ' HH12 ' A' ' 194' ' ' ARG . 10.7 t0 -109.29 145.28 36.23 Favored 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.321 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.414 HD12 ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -123.73 156.41 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.662 HH12 ' CG ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -146.82 -166.91 2.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.821 -1.174 . . . . 0.0 111.276 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.807 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.46 159.62 14.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 1.24 ' O ' ' NE2' ' A' ' 197' ' ' GLN . . . 10.97 -79.69 0.0 OUTLIER Glycine 0 C--O 1.17 -3.858 0 N-CA-C 105.261 -3.135 . . . . 0.0 105.261 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 1.24 ' NE2' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 151.15 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 124.048 0.939 . . . . 0.0 110.172 175.625 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.548 ' C ' ' O ' ' A' ' 197' ' ' GLN . 10.0 p -45.78 117.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 117.47 -1.692 . . . . 0.0 106.511 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.503 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 18.6 t80 -102.52 147.53 26.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 111.578 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 7.7 m-85 -153.39 100.75 2.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.451 ' CZ ' HG11 ' A' ' 56' ' ' VAL . 25.6 m-85 -53.08 135.43 37.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.787 -1.196 . . . . 0.0 109.65 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.654 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -86.87 -170.56 3.12 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.257 -0.902 . . . . 0.0 108.9 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -74.39 155.06 38.5 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.447 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -50.6 -43.22 56.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.557 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -54.07 -15.14 1.3 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.624 . . . . 0.0 109.74 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.78 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 8.2 m-70 -100.69 9.35 42.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.605 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.832 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.5 mm-40 -127.98 -145.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.092 0.949 . . . . 0.0 110.119 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.673 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.86 -3.72 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.953 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.832 ' N ' ' O ' ' A' ' 207' ' ' GLN . 86.8 t80 -41.02 -43.22 2.1 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 120.524 -1.36 . . . . 0.0 110.837 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.472 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.8 OUTLIER -65.36 -13.14 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.378 -1.452 . . . . 0.0 109.903 -178.234 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 212' ' ' LYS . 94.6 p -55.96 -31.09 62.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.08 -1.012 . . . . 0.0 108.656 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.435 ' N ' ' HG ' ' A' ' 211' ' ' SER . 11.9 mmtp -85.62 -36.39 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.456 -0.778 . . . . 0.0 109.0 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.626 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -131.98 68.41 80.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' LEU . 52.5 Cg_exo -49.94 8.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.072 2.514 . . . . 0.0 113.298 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.626 ' H ' ' C ' ' A' ' 213' ' ' ASN . 0.0 OUTLIER -61.34 -24.8 66.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.49 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 58.88 83.84 0.05 OUTLIER Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.21 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -70.5 88.2 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.902 2.351 . . . . 0.0 108.575 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.587 ' O ' ' O ' ' A' ' 219' ' ' GLY . 18.1 t -169.74 114.32 0.52 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.863 -1.148 . . . . 0.0 109.387 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -39.89 170.09 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.428 HD12 ' N ' ' A' ' 221' ' ' GLY . 2.5 pp -61.93 -174.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.343 -1.093 . . . . 0.0 110.131 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.575 ' O ' ' C ' ' A' ' 222' ' ' GLY . . . -155.04 -80.88 0.03 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 221' ' ' GLY . . . -27.95 105.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 CA-C-O 123.051 1.362 . . . . 0.0 109.954 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.636 ' C ' ' H ' ' A' ' 225' ' ' VAL . 0.8 OUTLIER -126.91 21.19 6.93 Favored 'General case' 0 C--N 1.27 -2.855 0 CA-C-N 113.896 -1.152 . . . . 0.0 109.308 179.76 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -69.33 14.29 0.95 Allowed Glycine 0 N--CA 1.474 1.198 0 N-CA-C 108.506 -1.837 . . . . 0.0 108.506 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.636 ' H ' ' C ' ' A' ' 223' ' ' THR . 1.5 t -100.86 120.77 50.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.887 -0.772 . . . . 0.0 109.575 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.605 ' H ' ' CB ' ' A' ' 229' ' ' MET . 0.7 OUTLIER -98.62 -153.66 0.44 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.061 0.934 . . . . 0.0 109.776 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.575 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -72.53 -63.9 1.06 Allowed Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.568 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.575 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 56.5 Cg_endo -70.55 -36.65 8.38 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.37 2.047 . . . . 0.0 109.447 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.708 ' SD ' ' CD2' ' A' ' 184' ' ' HIS . 0.0 OUTLIER -53.7 153.61 4.35 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.756 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.568 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.29 130.85 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.139 0.495 . . . . 0.0 109.989 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.6 mm -138.33 112.47 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -71.54 110.76 6.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.375 0 O-C-N 121.268 -0.895 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.672 ' O1 ' ' N ' ' A' ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.587 ' O ' ' O ' ' A' ' 22' ' ' GLY . 8.4 t0 43.79 100.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -1.118 . . . . 0.0 109.185 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 p -66.78 -27.01 67.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 29' ' ' ILE . . . -77.63 -12.42 59.97 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.895 1.331 . . . . 0.0 109.931 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 153' ' ' THR . 29.8 t -49.46 -48.87 47.31 Favored 'General case' 0 C--N 1.261 -3.281 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.695 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.585 ' O ' ' C14' ' A' ' 21' ' ' MYR . 0.0 OUTLIER -115.95 27.5 9.24 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.446 1.594 . . . . 0.0 109.796 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.716 ' O ' ' O ' ' A' ' 29' ' ' ILE . 47.5 t -152.19 22.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.557 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.716 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -36.58 176.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-O 123.141 1.448 . . . . 0.0 110.14 -178.341 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.427 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.7 124.45 26.03 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.249 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.43 80.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.755 -0.591 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.17 0.88 3.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 mm-40 -107.27 -35.93 6.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 108.963 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.78 -170.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.665 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.447 ' N ' HD22 ' A' ' 35' ' ' LEU . 4.2 mm? -82.68 165.76 39.98 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 108.973 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -62.59 -45.29 14.6 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.129 1.886 . . . . 0.0 111.987 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.09 153.86 8.51 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -147.41 149.52 32.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -1.106 . . . . 0.0 109.469 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.464 ' HA ' HD21 ' A' ' 100' ' ' ASN . 13.6 p -122.72 -13.4 7.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 0.0 109.398 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -49.61 149.46 4.26 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.86 151.74 84.66 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.855 2.37 . . . . 0.0 112.13 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.717 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -137.83 35.59 0.26 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.164 -0.96 . . . . 0.0 110.143 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.717 ' CD ' ' N ' ' A' ' 42' ' ' ILE . 27.2 Cg_endo -64.34 165.91 18.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.636 2.224 . . . . 0.0 111.862 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.626 ' O ' ' C ' ' A' ' 45' ' ' THR . 2.3 m -172.95 172.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.38 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.626 ' C ' ' O ' ' A' ' 44' ' ' VAL . 7.3 t 9.98 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.509 0.671 . . . . 0.0 110.823 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.498 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -69.24 -52.68 25.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 111.394 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.557 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.63 99.66 10.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 115.746 -2.382 . . . . 0.0 108.765 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.775 ' NE2' ' NE2' ' A' ' 208' ' ' GLN . 8.5 t-80 -31.67 141.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.472 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.9 t60 -80.44 -42.51 22.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 110.572 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 211' ' ' SER . 25.8 t -58.1 -37.56 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 110.179 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 t -109.4 -48.69 3.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 110.507 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.04 4.63 55.35 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.6 p30 -81.81 -110.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.743 ' CB ' ' HH ' ' A' ' 87' ' ' TYR . 10.1 mtm-85 -129.24 174.88 9.19 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 123.519 1.628 . . . . 0.0 109.855 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.498 ' OG1' ' HA ' ' A' ' 46' ' ' ALA . 63.3 p -132.51 0.35 3.64 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.397 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' GLU . 1.1 m -145.11 132.09 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.507 -1.37 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt-10 -34.03 154.8 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 CA-C-O 121.881 0.848 . . . . 0.0 110.845 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -79.53 166.05 78.82 Favored 'Cis proline' 0 C--N 1.301 -1.969 0 C-N-CA 121.479 -2.301 . . . . 0.0 111.633 -0.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.473 ' CE2' HG23 ' A' ' 120' ' ' VAL . 35.6 m-85 -111.15 148.92 39.71 Favored Pre-proline 0 C--N 1.266 -3.035 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.0 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.573 ' O ' ' OG1' ' A' ' 63' ' ' THR . 8.3 Cg_endo -53.28 139.47 63.75 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.929 2.42 . . . . 0.0 112.618 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -45.5 158.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 42.78 66.82 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 1.2 p -136.7 147.38 46.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.622 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.583 ' OE1' ' CG ' ' A' ' 123' ' ' PRO . 2.1 mp0 -116.79 173.47 6.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.41 -0.806 . . . . 0.0 108.839 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.751 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -154.22 128.67 9.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.983 -1.073 . . . . 0.0 109.841 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.01 -167.6 2.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.1 t -143.22 137.6 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.087 -1.633 . . . . 0.0 109.983 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.547 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 54.5 m-85 -131.76 137.89 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.059 -1.026 . . . . 0.0 110.144 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 157' ' ' SER . . . -122.78 110.26 1.52 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 105.715 -2.954 . . . . 0.0 105.715 176.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.482 ' HA ' ' CD2' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -107.14 -87.62 0.48 Allowed 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.214 -1.168 . . . . 0.0 110.413 -177.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.717 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.75 74.76 0.2 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.717 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 51.1 t 111.41 82.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.68 ' N ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -55.72 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.623 -1.298 . . . . 0.0 110.734 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.659 ' H ' ' C ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -91.41 -44.41 9.15 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.068 -1.02 . . . . 0.0 109.363 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.51 -3.95 49.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.695 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.24 -35.41 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 109.733 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.628 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 29.4 tt0 -68.17 -15.17 63.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.28 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.54 ' C ' ' H ' ' A' ' 80' ' ' PHE . 11.5 ttt180 -60.16 -54.39 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.504 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.465 ' HE2' ' H ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -73.38 25.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.941 -1.099 . . . . 0.0 110.165 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.7 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 6.8 m-85 -126.78 -39.01 2.01 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.482 -0.761 . . . . 0.0 110.125 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.693 ' CE2' ' OG ' ' A' ' 211' ' ' SER . 1.2 p90 -84.74 1.71 45.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.703 -1.248 . . . . 0.0 109.72 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.459 HG11 ' CD1' ' A' ' 81' ' ' TRP . 2.2 m -104.84 11.66 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.0 mt -99.04 149.49 22.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.07 0.938 . . . . 0.0 109.116 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.477 ' HZ3' ' HA ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -85.82 136.7 33.21 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 107.53 -26.51 17.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.3 138.67 21.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.128 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.743 ' HH ' ' CB ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -78.42 -41.38 33.11 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -175.56 -169.81 0.38 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.985 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.685 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 30.6 p -146.55 167.0 24.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.914 -1.116 . . . . 0.0 110.214 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.628 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -168.66 -178.75 3.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.671 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 1.6 m -156.82 161.03 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.665 -1.272 . . . . 0.0 108.504 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' HA3' ' HA ' ' A' ' 201' ' ' TYR . . . -167.46 -172.42 34.57 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.199 -1.477 . . . . 0.0 111.934 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 202' ' ' ALA . 1.6 m-85 -104.44 150.29 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.852 -0.793 . . . . 0.0 109.511 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.42 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -177.0 154.22 1.07 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.31 38.56 7.16 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.497 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -129.5 -152.01 7.47 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.038 -1.272 . . . . 0.0 110.111 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.48 55.1 1.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 109.474 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -157.07 141.62 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.682 ' O ' ' CE2' ' A' ' 200' ' ' TYR . 0.0 OUTLIER -48.96 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 109.438 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.464 HD21 ' HA ' ' A' ' 39' ' ' THR . 10.8 m-20 -122.84 86.27 50.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.517 ' CG ' ' NE2' ' A' ' 113' ' ' HIS . 59.4 Cg_endo -78.41 -171.62 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.657 2.238 . . . . 0.0 111.811 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.633 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 23.1 p -121.69 170.5 9.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.048 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.53 -59.09 5.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.39 -0.819 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -61.22 -23.22 65.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 108.822 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.633 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.1 mm-40 -67.81 -60.07 2.81 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.66 0.743 . . . . 0.0 110.322 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.658 ' C ' ' H ' ' A' ' 108' ' ' SER . 17.8 m -64.37 -24.49 35.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.663 -0.648 . . . . 0.0 111.635 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.7 t -53.7 -0.5 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.261 -0.9 . . . . 0.0 109.363 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.66 ' C ' ' H ' ' A' ' 110' ' ' LYS . 22.6 p -99.8 11.17 39.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.404 ' HG2' ' CG2' ' A' ' 153' ' ' THR . 2.5 tt0 59.08 -5.58 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.071 -1.018 . . . . 0.0 109.512 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.66 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.4 OUTLIER -70.67 -30.97 67.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 110.371 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.605 ' OG1' ' CG1' ' A' ' 106' ' ' VAL . 26.7 p -84.98 -18.34 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.929 -1.107 . . . . 0.0 110.28 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.06 14.61 47.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.517 ' NE2' ' CG ' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -58.32 158.22 7.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.029 -1.277 . . . . 0.0 109.711 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.42 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -120.36 113.83 20.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.68 ' OE1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.95 135.23 15.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.483 -179.28 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.414 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -151.68 178.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.989 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 34.5 m -138.97 147.89 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.201 -0.937 . . . . 0.0 110.688 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.793 ' NH1' ' CZ ' ' A' ' 201' ' ' TYR . 8.9 ptm180 -115.49 95.71 5.29 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.731 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 4.0 m -109.52 113.82 45.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.17 -1.581 . . . . 0.0 108.815 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.473 HG23 ' CE2' ' A' ' 59' ' ' PHE . 3.0 t -74.49 156.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.731 ' CE1' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -136.9 160.35 39.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.887 -1.133 . . . . 0.0 110.156 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 59.8 mtp180 -119.46 100.4 49.61 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 125' ' ' HIS . 13.5 Cg_exo -41.71 -61.05 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.235 2.623 . . . . 0.0 113.276 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -38.37 -14.59 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.603 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.695 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -143.8 15.53 1.76 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.718 -1.239 . . . . 0.0 109.49 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.422 HD11 ' CB ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -155.19 146.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.869 . . . . 0.0 109.419 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.475 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -107.8 166.79 10.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.244 -0.91 . . . . 0.0 109.37 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 37.9 t80 -64.82 -38.83 92.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.404 ' O ' ' N ' ' A' ' 133' ' ' LYS . 36.7 mm-40 -53.71 -27.39 27.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 109.086 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 1.0 OUTLIER -66.69 -68.82 0.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.094 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.799 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -33.89 -47.55 0.26 Allowed 'General case' 0 C--N 1.316 -0.859 0 O-C-N 120.95 -1.094 . . . . 0.0 108.493 178.932 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.469 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 11.2 mp -76.1 -41.24 50.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.581 ' O ' ' OE2' ' A' ' 137' ' ' GLU . 2.8 tmmm? -52.56 -39.59 61.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.098 -1.001 . . . . 0.0 111.44 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.7 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.1 t -74.84 -39.44 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.722 -1.236 . . . . 0.0 110.098 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 8.0 t80 -65.32 -48.22 73.83 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.375 -0.828 . . . . 0.0 111.211 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.49 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 61.4 m95 -67.04 -34.11 76.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.784 -1.198 . . . . 0.0 111.363 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.672 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -76.95 -33.21 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 113.23 -176.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 41.9 m-80 -96.12 36.09 1.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.323 -1.486 . . . . 0.0 114.483 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.799 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 6.6 p-80 178.53 175.95 0.54 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.393 -1.442 . . . . 0.0 111.981 176.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.85 107.92 57.84 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.401 ' O ' ' N ' ' A' ' 190' ' ' THR . 74.1 Cg_endo -78.48 20.38 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.187 1.925 . . . . 0.0 112.299 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -115.7 3.18 13.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.753 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.536 ' O ' ' O ' ' A' ' 146' ' ' ARG . 18.1 mt-30 -101.88 78.26 1.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.069 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.782 ' N ' ' HG1' ' A' ' 190' ' ' THR . . . -39.4 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.499 2.855 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.466 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.471 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -66.97 40.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.936 0.874 . . . . 0.0 110.39 -176.67 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.652 ' CZ ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -161.65 152.54 18.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' A' ' 143' ' ' GLN . 21.0 mm100 -154.92 74.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.281 -1.512 . . . . 0.0 110.05 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.652 ' O ' ' CZ ' ' A' ' 146' ' ' ARG . . . 78.11 -115.71 4.27 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -79.52 -33.45 42.01 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-N 114.517 -0.842 . . . . 0.0 111.624 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.474 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -85.36 129.49 34.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.283 -1.511 . . . . 0.0 109.015 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.449 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 17.6 p90 -127.64 138.39 52.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.564 ' C ' ' H ' ' A' ' 154' ' ' GLN . . . 138.58 167.08 10.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -72.32 15.16 0.18 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.001 -1.294 . . . . 0.0 108.9 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.598 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 1.4 pt20 -114.32 17.58 17.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 44.2 m-85 -155.48 65.63 0.62 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.682 HH22 ' CG ' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -118.54 -176.03 3.0 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.384 -0.822 . . . . 0.0 109.389 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 2.6 t -92.11 140.56 29.51 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.434 ' HB3' ' CE1' ' A' ' 160' ' ' TYR . . . -162.14 118.95 2.06 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.603 -2.039 . . . . 0.0 112.115 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.541 ' O ' ' CG2' ' A' ' 159' ' ' VAL . 2.2 m -115.72 126.2 73.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.154 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 158' ' ' ALA . 4.8 m-30 -113.9 119.99 39.87 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.41 170.43 19.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.564 2.176 . . . . 0.0 112.53 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.16 -40.4 8.82 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.209 -0.932 . . . . 0.0 109.592 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 165' ' ' VAL . 43.3 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.114 -0.991 . . . . 0.0 109.923 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 123.154 1.454 . . . . 0.0 108.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 163' ' ' SER . 2.5 t -56.06 -56.46 12.83 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.987 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.227 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.45 HE21 ' HB2' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -78.03 -36.82 48.13 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.965 -178.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.5 mtm -52.46 -35.41 52.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 110.815 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -48.29 -55.0 11.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 109.962 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.13 -30.84 15.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.017 -1.052 . . . . 0.0 110.582 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.509 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -52.54 -62.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.047 . . . . 0.0 110.014 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mt -52.66 -33.87 49.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 109.642 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.509 ' OG ' ' O ' ' A' ' 170' ' ' ALA . 0.1 OUTLIER -56.43 -34.27 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.912 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -72.18 -46.79 54.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.96 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -72.22 -39.67 68.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.045 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.59 -29.45 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.089 -1.007 . . . . 0.0 109.92 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.473 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -79.54 -44.15 21.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.886 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.625 ' NE2' ' O ' ' A' ' 187' ' ' GLY . 35.8 tp60 -62.19 -5.34 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.592 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -49.64 13.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.89 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.35 -51.81 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -53.72 -40.82 66.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.835 -179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 51.0 p -56.38 -27.27 55.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.441 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.439 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -88.03 6.34 36.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.554 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.428 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 1.7 m-70 -108.22 35.82 3.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 69.88 36.07 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.48 175.61 5.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.402 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.625 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -133.47 -145.62 5.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 189' ' ' ILE . 30.0 Cg_exo -58.73 106.03 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.402 2.068 . . . . 0.0 111.248 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.58 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.4 OUTLIER -48.45 -172.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.782 ' HG1' ' N ' ' A' ' 144' ' ' GLY . 21.4 p -151.43 58.57 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.568 -0.707 . . . . 0.0 109.813 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.7 m -99.76 128.7 45.84 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.682 ' CG ' HH22 ' A' ' 156' ' ' ARG . 4.9 t70 -75.97 119.42 19.91 Favored 'General case' 0 C--N 1.272 -2.793 0 C-N-CA 119.569 -0.853 . . . . 0.0 109.419 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.421 ' C ' ' CG ' ' A' ' 194' ' ' ARG . 0.6 OUTLIER -119.77 103.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.386 -0.925 . . . . 0.0 109.643 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.661 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -165.33 141.92 5.58 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.654 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -114.95 -177.67 3.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 109.843 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.77 29.75 60.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 198' ' ' VAL . 16.2 mm-40 -104.0 103.64 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.302 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -33.6 154.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.183 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.56 ' CE1' ' HD2' ' A' ' 118' ' ' ARG . 7.7 t80 -128.75 120.23 26.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.682 ' CE2' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.97 126.77 40.29 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.793 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.53 -176.53 3.4 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 116.329 -2.148 . . . . 0.0 114.642 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . . . -95.71 -179.58 4.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 112.185 -2.279 . . . . 0.0 111.478 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.556 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 1.3 pt-20 -73.57 -168.16 0.53 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.429 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.74 -14.38 54.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.866 -1.146 . . . . 0.0 110.527 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.556 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -78.53 -14.17 59.48 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.881 -1.137 . . . . 0.0 109.382 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.445 ' HA ' ' CD1' ' A' ' 74' ' ' TRP . 74.2 m-70 -104.68 2.88 30.91 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.109 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.841 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.2 mm-40 -120.51 -138.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.237 1.018 . . . . 0.0 109.938 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.775 ' NE2' ' NE2' ' A' ' 48' ' ' HIS . 1.4 mp0 -34.73 -5.56 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.634 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.841 ' N ' ' O ' ' A' ' 207' ' ' GLN . 64.2 t80 -41.88 -47.48 4.25 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 120.464 -1.398 . . . . 0.0 109.298 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.565 ' CD2' ' SG ' ' A' ' 218' ' ' CYS . 0.9 OUTLIER -70.63 -28.68 65.01 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.532 -1.355 . . . . 0.0 110.219 -179.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.693 ' OG ' ' CE2' ' A' ' 81' ' ' TRP . 0.1 OUTLIER -69.01 -41.83 77.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.923 -1.11 . . . . 0.0 108.22 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.472 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -88.91 -19.17 26.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.535 -0.728 . . . . 0.0 109.672 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.766 ' ND2' ' CD1' ' A' ' 209' ' ' TYR . 34.7 m-80 -116.0 89.89 26.27 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.036 . . . . 0.0 110.265 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.1 11.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.249 2.632 . . . . 0.0 112.205 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.656 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.1 t0 -61.94 -4.73 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.275 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.617 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 64.05 -44.32 0.09 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.996 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.617 ' C ' ' O ' ' A' ' 216' ' ' GLY . 40.6 m-85 -23.33 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 CA-C-N 119.408 1.604 . . . . 0.0 110.529 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.611 ' SG ' ' O ' ' A' ' 216' ' ' GLY . 69.1 m -137.42 -126.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -151.92 -154.84 6.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 20.4 mt -82.82 -175.84 6.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.664 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.13 125.85 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.486 ' H ' ' HA ' ' A' ' 139' ' ' HIS . . . 140.28 167.67 11.1 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 11.7 p -101.34 -21.29 14.89 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 114.388 -0.906 . . . . 0.0 108.672 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 173.85 -53.69 0.15 Allowed Glycine 0 C--N 1.303 -1.269 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 226' ' ' SER . 68.6 t -72.23 166.15 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.476 -1.014 . . . . 0.0 109.191 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.422 ' N ' ' CG1' ' A' ' 225' ' ' VAL . 0.2 OUTLIER -98.54 107.58 20.07 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.248 1.023 . . . . 0.0 109.265 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.489 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.07 -57.47 2.32 Favored Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.342 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.55 ' CD ' ' H ' ' A' ' 229' ' ' MET . 42.9 Cg_endo -94.23 -33.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.885 2.39 . . . . 0.0 110.116 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.561 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.8 OUTLIER -55.28 154.91 5.45 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.784 0.802 . . . . 0.0 109.854 179.66 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.87 128.27 0.14 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.137 0.494 . . . . 0.0 109.811 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.664 ' O ' ' N ' ' A' ' 233' ' ' LYS . 3.4 tp -157.58 122.1 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.106 -0.996 . . . . 0.0 109.346 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 231' ' ' ILE . 4.2 ttpm? -42.61 86.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.664 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.369 0 O-C-N 121.201 -0.937 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.585 ' C14' ' O ' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.57 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 22' ' ' GLY . 2.0 t70 -45.08 -53.55 7.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -1.233 . . . . 0.0 109.176 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.676 ' C ' ' H ' ' A' ' 26' ' ' SER . 3.5 m -50.94 -18.42 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.312 -0.868 . . . . 0.0 109.191 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.61 ' C ' ' H ' ' A' ' 27' ' ' LYS . . . -49.62 -9.5 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 123.037 1.399 . . . . 0.0 109.482 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.676 ' H ' ' C ' ' A' ' 24' ' ' SER . 1.9 t -47.63 -8.92 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.638 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' H ' ' C ' ' A' ' 25' ' ' ALA . 1.2 ptpp? -124.08 41.25 3.54 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 123.051 1.405 . . . . 0.0 109.472 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.644 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -160.19 21.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.258 -3.376 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 -178.218 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.644 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -39.82 175.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.328 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.488 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -99.59 126.97 45.66 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.634 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -47.04 -62.11 1.56 Allowed 'General case' 0 C--N 1.285 -2.233 0 CA-C-O 121.258 0.551 . . . . 0.0 109.904 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -54.72 -3.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' ALA . 3.0 tt0 -108.97 -23.69 11.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.928 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.6 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.98 -167.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.904 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 98' ' ' THR . 1.7 mm? -72.24 174.51 4.12 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.421 ' CD ' ' HB3' ' A' ' 35' ' ' LEU . 18.8 Cg_exo -66.91 -46.39 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.796 2.33 . . . . 0.0 114.279 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.435 ' HA2' ' C ' ' A' ' 98' ' ' THR . . . 101.4 106.25 2.91 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 118.855 -1.64 . . . . 0.0 110.409 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.527 ' N ' ' HA ' ' A' ' 99' ' ' ARG . 4.4 tpt180 -99.12 157.55 16.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.266 . . . . 0.0 109.325 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.512 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -84.84 -28.66 25.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.559 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 39' ' ' THR . 1.9 tt0 -36.46 100.53 0.2 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.574 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' THR . 69.7 Cg_endo -80.66 160.76 21.91 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.574 2.183 . . . . 0.0 112.265 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.96 84.02 17.71 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.47 167.93 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.909 2.406 . . . . 0.0 112.31 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' ALA . 28.8 m -128.68 -171.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.613 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 44' ' ' VAL . 1.3 t -39.2 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.623 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.72 -27.18 58.65 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.192 -0.943 . . . . 0.0 111.313 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 7.8 ptpt -91.96 98.9 11.86 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 116.243 -2.183 . . . . 0.0 107.873 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.693 ' CG ' ' OG ' ' A' ' 88' ' ' SER . 6.1 t-80 -32.43 121.78 0.33 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -67.09 -34.91 78.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.347 -0.846 . . . . 0.0 111.276 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.5 -34.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.887 -1.133 . . . . 0.0 109.725 -179.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -107.73 -42.45 4.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 92.46 0.42 70.03 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.699 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 34.5 p30 -78.17 -119.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.699 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttt-85 -126.3 170.74 11.59 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 123.246 1.498 . . . . 0.0 108.736 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.623 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 1.3 p -131.95 23.26 4.57 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.566 ' O ' ' O ' ' A' ' 57' ' ' GLU . 5.6 m -162.11 138.03 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.652 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.3 156.83 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.025 0.917 . . . . 0.0 110.795 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -80.07 166.18 77.2 Favored 'Cis proline' 0 C--N 1.301 -1.953 0 C-N-CA 121.471 -2.304 . . . . 0.0 112.157 -0.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.473 ' CE1' HG11 ' A' ' 120' ' ' VAL . 27.2 m-85 -103.27 147.91 34.88 Favored Pre-proline 0 C--N 1.27 -2.89 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.078 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.574 ' O ' ' OG1' ' A' ' 63' ' ' THR . 38.9 Cg_endo -70.29 142.89 46.73 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.827 2.351 . . . . 0.0 112.368 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -46.43 158.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.467 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.26 62.65 5.42 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -146.02 139.41 26.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -1.116 . . . . 0.0 109.569 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.628 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 1.6 mp0 -109.15 123.58 49.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.649 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -111.78 139.49 47.21 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.08 -169.38 2.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 72.2 t -143.94 140.79 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.105 -1.622 . . . . 0.0 109.743 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.516 ' CD2' ' CB ' ' A' ' 135' ' ' PHE . 97.3 m-85 -123.19 155.2 37.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -153.32 94.67 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 118.564 -1.779 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.588 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -92.87 -87.01 0.24 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.621 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -134.97 -158.01 8.22 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.769 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.85 102.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -1.019 . . . . 0.0 108.317 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.657 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -51.95 7.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 111.698 -177.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.769 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 4.7 m0 -69.22 -73.39 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.604 -1.31 . . . . 0.0 109.027 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.9 -14.52 63.37 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.46 ' HB3' ' SD ' ' A' ' 70' ' ' MET . . . -77.03 -53.88 7.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -1.143 . . . . 0.0 110.858 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.557 ' OE2' ' C ' ' A' ' 90' ' ' GLN . 7.8 tp10 -48.42 -36.56 15.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.298 -0.876 . . . . 0.0 111.379 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.685 ' O ' ' N ' ' A' ' 80' ' ' PHE . 1.5 tmt_? -66.36 -57.95 6.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 0.0 109.941 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.477 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -41.18 -10.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.527 -0.733 . . . . 0.0 111.366 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.685 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.7 m-85 -101.91 -40.69 6.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.583 -1.323 . . . . 0.0 111.256 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.567 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -86.69 1.83 50.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.48 -1.387 . . . . 0.0 110.906 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.468 ' CG1' ' O ' ' A' ' 78' ' ' ARG . 1.2 m -83.52 19.99 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.134 . . . . 0.0 109.636 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.595 ' C ' ' HZ3' ' A' ' 84' ' ' LYS . 0.6 OUTLIER -129.97 158.57 39.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.708 ' N ' ' HZ2' ' A' ' 84' ' ' LYS . 0.1 OUTLIER -91.48 153.43 19.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.576 -0.702 . . . . 0.0 109.742 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -26.63 19.09 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.438 HG23 ' CD2' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -75.34 138.06 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.712 -0.875 . . . . 0.0 109.76 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.691 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -82.74 -41.52 19.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.693 ' OG ' ' CG ' ' A' ' 48' ' ' HIS . 11.8 t -156.98 -163.66 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.662 0.744 . . . . 0.0 110.066 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.672 ' O ' ' NE2' ' A' ' 48' ' ' HIS . 3.7 p -168.72 121.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' C ' ' OE2' ' A' ' 77' ' ' GLU . 5.5 mp0 -136.39 173.63 11.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.963 -1.086 . . . . 0.0 110.707 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.598 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -146.39 157.93 11.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.584 0.707 . . . . 0.0 109.62 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.43 174.5 46.08 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.627 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -85.39 156.13 20.99 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.374 -1.074 . . . . 0.0 109.547 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.538 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -172.72 -170.73 0.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 109.72 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 59.27 21.77 54.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.754 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -160.41 -156.08 8.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.697 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 40.4 p-80 178.91 109.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.416 -1.049 . . . . 0.0 108.983 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.612 ' O ' ' C ' ' A' ' 99' ' ' ARG . 13.9 m -144.45 144.79 31.55 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.612 ' C ' ' O ' ' A' ' 98' ' ' THR . 17.6 mtm-85 -19.83 -85.39 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.747 0.784 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -117.19 90.83 34.97 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 2.8 Cg_exo -73.35 111.1 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.566 2.178 . . . . 0.0 113.329 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.6 p -123.05 163.3 20.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.635 ' O ' ' CD1' ' A' ' 103' ' ' TYR . 0.5 OUTLIER -50.05 -35.95 27.1 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.381 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.66 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 3.9 ttmt -73.7 -31.93 63.67 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.693 -0.63 . . . . 0.0 110.956 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.2 mm-40 -80.99 -47.08 14.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.424 HG11 ' CB ' ' A' ' 111' ' ' THR . 30.2 m -67.6 -25.03 32.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 120.608 -1.308 . . . . 0.0 110.342 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.66 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 14.5 p -53.89 -40.62 66.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.673 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 58.1 m -48.51 -66.52 0.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.673 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.6 mt-10 137.82 -25.25 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.259 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -67.06 3.87 1.02 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.542 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.67 ' HG1' ' H ' ' A' ' 113' ' ' HIS . 71.0 p -99.91 -25.15 14.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.77 -1.206 . . . . 0.0 109.33 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 66.07 13.26 59.47 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.428 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.754 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.55 159.07 28.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.494 -1.592 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.499 ' CB ' ' NH2' ' A' ' 156' ' ' ARG . . . -126.31 117.79 23.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.657 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.5 mm-40 -49.46 112.61 0.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.76 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.474 HG12 ' CE2' ' A' ' 160' ' ' TYR . 0.2 OUTLIER -124.54 175.29 7.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.382 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.516 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.7 m -132.45 148.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.15 -0.969 . . . . 0.0 110.158 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.502 ' C ' ' CD ' ' A' ' 118' ' ' ARG . 2.0 tpp180 -110.69 107.81 17.49 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.409 ' HB ' ' HH ' ' A' ' 121' ' ' TYR . 7.5 m -133.66 116.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 108.805 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.538 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.0 OUTLIER -96.95 158.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 131' ' ' LEU . 3.0 m-85 -134.45 155.45 50.32 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.885 -1.134 . . . . 0.0 109.543 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.624 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 1.4 ptm180 -110.37 112.31 57.05 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 125' ' ' HIS . 34.1 Cg_exo -44.48 -63.6 0.32 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 123.177 2.584 . . . . 0.0 113.383 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.653 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 16.9 mp0 -33.17 -21.9 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.737 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.688 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -137.99 6.46 2.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.433 -1.417 . . . . 0.0 110.502 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -155.82 150.41 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 110.043 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.507 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 37.6 t -97.81 147.6 24.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.469 ' CD2' HD12 ' A' ' 132' ' ' LEU . 50.8 t80 -62.51 -21.16 65.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.28 -7.57 47.9 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.507 ' HG3' ' H ' ' A' ' 127' ' ' SER . 9.1 mm-40 -74.46 -70.31 0.41 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.757 -0.59 . . . . 0.0 110.358 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.737 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.7 OUTLIER -51.95 -29.79 21.91 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 120.495 -1.378 . . . . 0.0 108.236 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.47 ' O ' ' CD1' ' A' ' 136' ' ' TRP . 47.3 mt -63.68 -57.05 11.23 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.524 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -39.61 94.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.745 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.759 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 3.8 t -50.27 -62.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 109.515 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 6.0 t80 -54.63 -39.09 67.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.457 -1.402 . . . . 0.0 110.078 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.537 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 51.5 m95 -70.75 -36.35 73.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.973 -1.079 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.77 -4.95 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 113.577 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.759 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -122.74 41.71 3.37 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.06 -1.65 . . . . 0.0 111.422 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.623 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 0.0 OUTLIER 173.55 -168.41 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.849 0.833 . . . . 0.0 108.752 177.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -118.25 138.57 25.74 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.449 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 93.3 Cg_endo -81.21 0.99 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.614 2.21 . . . . 0.0 113.285 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 142' ' ' THR . 0.1 OUTLIER -121.8 47.25 1.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.858 -1.151 . . . . 0.0 110.196 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.574 ' O ' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER -129.9 70.32 1.43 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.129 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -51.59 -118.71 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.626 ' SD ' ' C ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -70.56 40.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.444 -1.033 . . . . 0.0 109.736 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.531 ' H ' ' C ' ' A' ' 144' ' ' GLY . 9.4 ttt180 -165.64 85.29 0.35 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.558 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.588 ' OE1' ' O ' ' A' ' 70' ' ' MET . 5.7 tp60 -86.23 117.16 24.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.428 -1.42 . . . . 0.0 109.79 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 46.58 -114.31 1.44 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.533 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 12.8 t30 -92.77 16.71 11.75 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 114.329 -0.936 . . . . 0.0 110.282 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 147' ' ' GLN . 0.7 OUTLIER -107.19 147.15 30.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.114 . . . . 0.0 109.201 179.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 151' ' ' PHE . 20.2 p90 -130.07 129.42 43.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.435 ' HA3' ' NE2' ' A' ' 154' ' ' GLN . . . 147.16 155.06 6.4 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.675 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.1 OUTLIER -79.3 5.1 13.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.361 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.651 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 15.1 pm0 -97.48 -5.75 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.474 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 23.0 m-85 -122.45 61.82 0.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.122 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.675 ' NH1' ' O ' ' A' ' 153' ' ' THR . 8.9 ptt-85 -112.23 175.91 5.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -0.842 . . . . 0.0 109.125 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.605 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -89.44 121.0 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -137.18 128.88 28.75 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 118.291 -1.363 . . . . 0.0 110.986 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.582 ' O ' ' CG2' ' A' ' 159' ' ' VAL . 1.1 m -126.77 120.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.26 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CE2' HG12 ' A' ' 116' ' ' VAL . 6.2 m-30 -109.86 126.13 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.14 174.66 9.84 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 123.012 2.474 . . . . 0.0 112.999 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.603 ' HG1' ' NE2' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -99.3 -40.33 7.98 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.469 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -172.97 -162.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 0.0 109.722 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -53.57 -16.64 1.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.921 1.343 . . . . 0.0 108.959 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.469 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.9 t -59.2 -57.54 10.97 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.246 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.603 ' NE2' ' HG1' ' A' ' 162' ' ' THR . 1.3 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.749 -0.594 . . . . 0.0 110.392 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtp -50.92 -44.33 60.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.658 -1.276 . . . . 0.0 109.498 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.69 -19.23 59.27 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.034 -1.041 . . . . 0.0 109.12 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.58 -57.65 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.85 . . . . 0.0 110.616 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.64 -65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.068 -1.02 . . . . 0.0 110.035 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -33.53 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.24 -45.92 44.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.537 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 83.0 p -56.23 -49.45 74.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.388 -0.82 . . . . 0.0 109.826 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.456 ' HZ1' HD11 ' A' ' 189' ' ' ILE . 12.8 tttm -61.8 -53.59 53.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.741 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.02 -6.75 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.849 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.15 -52.17 9.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 110.464 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -11.79 59.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.028 -1.045 . . . . 0.0 110.28 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.517 ' OE1' ' CB ' ' A' ' 182' ' ' SER . 0.2 OUTLIER -70.8 -41.07 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.561 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -77.05 -16.04 59.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.49 -54.62 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 0.0 109.911 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.468 HD22 ' CE1' ' A' ' 186' ' ' PHE . 37.2 mt -75.4 -43.68 48.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 110.174 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.517 ' CB ' ' OE1' ' A' ' 178' ' ' GLN . 12.7 t -55.35 -22.1 17.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -88.18 -9.94 51.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 109.008 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.419 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 22.5 m170 -108.28 34.58 3.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.5 OUTLIER 69.79 68.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.965 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.468 ' CE1' HD22 ' A' ' 181' ' ' LEU . 2.8 m-85 -134.73 173.15 12.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -110.75 -168.74 19.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 189' ' ' ILE . 11.1 Cg_endo -58.84 115.1 2.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.761 1.641 . . . . 0.0 110.812 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.513 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.3 OUTLIER -47.8 179.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.0 110.06 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.605 ' O ' ' OG ' ' A' ' 157' ' ' SER . 39.9 p -140.01 59.75 1.57 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 27.1 m -98.04 115.81 28.97 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 194' ' ' ARG . 6.3 t0 -84.72 125.28 32.4 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.953 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.44 148.33 19.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.65 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 3.6 mtm180 -165.44 169.81 15.19 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.522 -0.736 . . . . 0.0 109.128 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.697 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -123.86 170.6 10.41 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.994 -1.067 . . . . 0.0 110.808 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 195' ' ' GLU . . . 22.72 38.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.697 ' N ' ' O ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -65.32 132.76 49.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.832 -1.393 . . . . 0.0 109.862 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.84 163.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -127.05 141.69 51.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.365 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' A' ' 93' ' ' PHE . 1.6 m-85 -142.56 97.91 3.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.922 . . . . 0.0 109.608 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -54.24 134.64 44.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.38 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.93 -173.16 4.58 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.646 ' CD ' ' H ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -75.33 168.06 20.71 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.636 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.04 -48.97 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.863 -1.148 . . . . 0.0 108.51 179.135 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.646 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.48 -23.04 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 110.054 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.48 ' O ' ' CG2' ' A' ' 91' ' ' VAL . 9.5 m-70 -92.3 6.79 45.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.048 -1.032 . . . . 0.0 110.022 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.827 ' O ' ' N ' ' A' ' 209' ' ' TYR . 6.0 mm-40 -122.56 -138.66 0.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.776 1.274 . . . . 0.0 111.024 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.668 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.3 OUTLIER -34.21 -3.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.44 -179.072 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.827 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.0 t80 -42.68 -43.08 3.72 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 120.563 -1.336 . . . . 0.0 110.464 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 74' ' ' TRP . 2.9 mp -61.17 -12.37 12.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.525 -1.36 . . . . 0.0 109.867 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.5 t -55.78 -29.76 60.2 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 108.545 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -83.92 -35.16 24.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.423 -0.798 . . . . 0.0 108.867 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -136.35 130.65 18.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.589 ' C ' ' H ' ' A' ' 216' ' ' GLY . 30.2 Cg_endo -65.37 -56.84 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.921 1.747 . . . . 0.0 113.287 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.617 ' O ' ' N ' ' A' ' 217' ' ' TYR . 0.8 OUTLIER -64.11 2.37 0.56 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.689 -1.257 . . . . 0.0 107.926 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.589 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 61.95 -68.43 0.02 OUTLIER Glycine 0 N--CA 1.479 1.507 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' A' ' 215' ' ' ASP . 9.2 t80 -145.95 -150.85 0.35 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.475 -1.015 . . . . 0.0 108.737 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.646 ' SG ' ' O ' ' A' ' 218' ' ' CYS . 23.8 p -90.3 77.96 6.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.089 -1.007 . . . . 0.0 108.991 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -135.73 -152.05 6.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.403 ' HG ' ' N ' ' A' ' 221' ' ' GLY . 0.6 OUTLIER -169.66 -178.71 3.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -1.208 . . . . 0.0 109.75 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.403 ' N ' ' HG ' ' A' ' 220' ' ' LEU . . . -104.57 -143.74 12.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.687 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -154.45 -141.94 3.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.579 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.2 OUTLIER 40.88 15.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.421 -1.046 . . . . 0.0 109.662 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -86.87 14.22 57.19 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.63 ' CG1' ' O ' ' A' ' 225' ' ' VAL . 9.2 p -111.59 97.42 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.333 -1.099 . . . . 0.0 109.825 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.586 ' H ' ' CB ' ' A' ' 229' ' ' MET . 3.0 p -98.63 -153.9 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.183 -0.948 . . . . 0.0 109.496 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.512 ' CB ' ' CD ' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -72.47 -67.72 0.47 Allowed Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.525 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 34.9 Cg_endo -65.21 -37.42 31.91 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.308 2.005 . . . . 0.0 109.532 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.586 ' CB ' ' H ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -53.6 152.75 4.83 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.717 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.12 133.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.303 0.573 . . . . 0.0 110.125 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 2.7 mm -129.96 108.46 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.254 -0.904 . . . . 0.0 109.246 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.452 ' HD2' ' N ' ' A' ' 233' ' ' LYS . 0.0 OUTLIER -89.75 -152.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 109.39 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.452 ' N ' ' HD2' ' A' ' 232' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.307 0 O-C-N 121.143 -0.973 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.453 H121 ' NH1' ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.71 61.57 0.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -1.155 . . . . 0.0 109.381 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.5 m -50.56 -18.51 0.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 109.555 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -70.02 -93.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 123.366 1.555 . . . . 0.0 111.069 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.423 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 19.0 m -46.42 -11.49 0.02 OUTLIER 'General case' 0 C--N 1.256 -3.483 0 CA-C-N 113.329 -1.76 . . . . 0.0 111.619 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.687 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.7 ttpt -106.12 25.03 11.5 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 124.595 2.141 . . . . 0.0 109.492 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.629 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -157.45 21.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.253 -3.59 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.629 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -42.68 176.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.759 1.266 . . . . 0.0 108.775 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.487 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -94.02 128.66 40.5 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.16 179.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.472 ' HB3' ' CG ' ' A' ' 97' ' ' HIS . . . -47.34 -38.5 13.0 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.24 -10.66 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.632 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 34' ' ' ALA . 4.6 tt0 -81.87 -46.48 14.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.604 ' CB ' ' HG1' ' A' ' 98' ' ' THR . . . -37.07 137.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.777 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -131.88 14.03 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 120.935 -1.103 . . . . 0.0 112.28 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.777 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 11.0 Cg_endo -64.97 -28.7 57.86 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.329 1.353 . . . . 0.0 111.745 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . 17.31 89.42 0.01 OUTLIER Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.419 ' HG3' HH11 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -116.6 177.7 4.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -1.188 . . . . 0.0 109.503 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.98 -21.75 5.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.526 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -148.25 149.36 31.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.488 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.47 -178.2 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.771 2.314 . . . . 0.0 112.194 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.635 ' CG1' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -135.54 97.9 12.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.431 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.15 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.2 m -148.88 -179.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.577 ' OG1' ' OD1' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -47.9 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.129 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.41 -28.09 58.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.424 -0.797 . . . . 0.0 111.39 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.84 99.27 11.7 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 115.958 -2.297 . . . . 0.0 108.581 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.688 ' HE2' HE21 ' A' ' 208' ' ' GLN . 4.6 t-80 -32.25 126.43 0.27 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.474 ' CD2' ' OG ' ' A' ' 211' ' ' SER . 1.9 t60 -71.41 -29.4 64.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.697 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.501 ' CG2' ' CD2' ' A' ' 81' ' ' TRP . 21.5 t -69.25 -40.58 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.977 -1.077 . . . . 0.0 110.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -109.37 -42.69 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.158 -0.963 . . . . 0.0 110.335 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.26 3.59 56.58 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 38.4 p30 -79.21 -116.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.0 ttt180 -129.43 169.95 14.3 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 123.221 1.486 . . . . 0.0 108.992 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 3.3 p -133.7 34.0 3.45 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.025 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.54 ' O ' ' O ' ' A' ' 57' ' ' GLU . 4.5 m -163.86 150.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.614 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.3 pm0 -32.2 153.89 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.72 0 CA-C-O 121.932 0.872 . . . . 0.0 110.909 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 98.6 Cg_endo -78.73 166.07 80.52 Favored 'Cis proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.568 -2.263 . . . . 0.0 111.862 0.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.783 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 1.9 m-30 -115.48 132.45 23.11 Favored Pre-proline 0 C--N 1.269 -2.892 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.977 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.581 ' O ' ' OG1' ' A' ' 63' ' ' THR . 47.1 Cg_exo -49.48 115.57 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.002 1.801 . . . . 0.0 112.049 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -43.31 152.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.644 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.583 ' O ' ' CD ' ' A' ' 123' ' ' PRO . . . 79.38 4.38 89.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.581 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 1.2 p -90.8 143.51 26.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -1.146 . . . . 0.0 109.694 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mp0 -121.71 125.62 47.03 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.676 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -116.92 115.12 24.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 0.0 110.114 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HA ' HE22 ' A' ' 166' ' ' GLN . . . -88.4 -175.98 5.18 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.3 t -146.06 113.83 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 119.724 -1.86 . . . . 0.0 110.11 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.605 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.4 p90 -162.71 155.19 19.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.722 -1.236 . . . . 0.0 109.387 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -136.04 133.59 6.71 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.297 -179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.612 ' CG ' ' N ' ' A' ' 71' ' ' GLY . 8.0 ptm -85.05 -50.71 7.21 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -1.013 . . . . 0.0 108.537 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.612 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.58 -154.15 8.2 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.662 ' N ' ' OD2' ' A' ' 150' ' ' ASP . 40.9 t -35.49 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -1.062 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.658 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -58.84 25.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.97 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.745 ' NE1' ' CE1' ' A' ' 209' ' ' TYR . 9.6 t90 -77.9 -60.29 2.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.9 -1.125 . . . . 0.0 108.91 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.67 -3.91 43.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.78 69.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.004 -1.292 . . . . 0.0 109.475 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.664 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 6.7 tt0 -73.63 -13.74 61.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 80' ' ' PHE . 11.1 ttp85 -60.53 -71.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 110.288 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.483 ' C ' ' O ' ' A' ' 78' ' ' ARG . 14.7 mtmt -36.32 -22.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.212 -0.93 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.674 ' N ' ' O ' ' A' ' 78' ' ' ARG . 84.3 m-85 -77.98 -41.81 34.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 0.0 110.803 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.557 ' HZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -76.83 8.59 3.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.55 -1.344 . . . . 0.0 109.518 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.41 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -102.13 19.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.0 109.851 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 mt -110.97 154.22 24.44 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.029 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -92.67 132.28 37.04 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -27.36 13.46 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.18 136.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.378 -1.072 . . . . 0.0 109.309 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.683 ' CE2' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -76.96 -51.49 11.07 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.585 -0.697 . . . . 0.0 109.455 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.683 ' OG ' ' CE2' ' A' ' 87' ' ' TYR . 2.0 p -160.04 -160.49 0.8 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.183 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.677 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -164.11 155.48 16.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.664 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.46 171.69 10.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.989 -1.069 . . . . 0.0 109.737 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.458 ' CG2' ' OE1' ' A' ' 207' ' ' GLN . 1.8 m -142.98 166.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.955 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.91 173.76 45.15 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 200' ' ' TYR . 5.5 m-85 -80.73 163.27 23.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.271 -1.135 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.631 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.94 139.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.993 -1.067 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 94.66 23.92 19.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.642 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -108.15 178.92 21.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.472 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 1.6 m170 -120.59 58.63 0.93 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.286 -1.126 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.604 ' HG1' ' CB ' ' A' ' 34' ' ' ALA . 2.3 m -157.51 -178.41 7.32 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.88 -1.137 . . . . 0.0 108.724 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.687 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 34.9 mtt180 -76.66 -89.36 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.934 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -113.43 96.52 40.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.965 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 11.5 Cg_endo -79.93 159.97 24.18 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.257 . . . . 0.0 112.21 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.63 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 9.9 p -114.78 172.51 6.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.19 -0.944 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.603 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -63.88 -59.65 4.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.501 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 2.0 mttm -59.3 -22.95 61.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.094 . . . . 0.0 108.528 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.63 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 8.3 mm-40 -69.78 -56.67 6.52 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.533 0.683 . . . . 0.0 110.471 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 16.6 m -66.17 -24.74 34.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.498 -0.752 . . . . 0.0 111.368 -178.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.631 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.8 p -57.36 -41.93 81.06 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 35.5 p -51.91 -66.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.3 mt-10 138.62 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -46.8 -27.44 1.22 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.415 -0.803 . . . . 0.0 111.767 -178.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 11.1 p -90.84 -32.6 16.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.564 -1.335 . . . . 0.0 109.941 -179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 65.76 44.32 92.47 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.642 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 1.2 m-70 -86.2 173.74 9.59 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.674 -1.486 . . . . 0.0 108.778 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -132.38 114.19 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.609 ' OE2' ' CE1' ' A' ' 73' ' ' PHE . 17.0 mt-10 -56.05 123.16 13.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.478 HG12 ' CE2' ' A' ' 160' ' ' TYR . 11.8 m -127.31 150.82 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.416 -0.802 . . . . 0.0 108.979 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 3.6 m -111.31 135.31 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.783 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -98.52 98.51 9.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.532 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.559 ' CG2' ' CD2' ' A' ' 80' ' ' PHE . 49.0 t -103.38 120.75 53.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.449 -0.782 . . . . 0.0 109.222 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.438 HG13 ' CE2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -118.07 144.2 26.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.553 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 8.8 p90 -141.39 174.31 10.67 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.087 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -116.03 117.93 38.8 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' HIS . 28.2 Cg_exo -42.09 -62.38 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.879 2.386 . . . . 0.0 113.318 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.657 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 27.3 mp0 -38.94 -14.34 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.153 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' PRO . 11.8 m-70 -133.38 -10.8 2.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.527 -1.358 . . . . 0.0 111.578 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.513 HG23 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.64 158.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 120.565 -1.335 . . . . 0.0 110.656 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.448 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 1.1 p -109.76 169.53 8.66 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.795 0.807 . . . . 0.0 111.375 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.55 ' CE1' ' CD1' ' A' ' 132' ' ' LEU . 41.2 t80 -69.32 -27.85 65.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 22.4 mt-10 -66.4 -8.74 27.67 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.448 ' HG3' ' H ' ' A' ' 127' ' ' SER . 7.2 mm-40 -72.36 -66.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.827 . . . . 0.0 110.797 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.684 ' CD1' ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -57.29 -35.65 70.06 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.61 -1.306 . . . . 0.0 107.98 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.55 ' CD1' ' CE1' ' A' ' 128' ' ' PHE . 9.3 mp -74.73 -50.4 17.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 3.8 tttt -52.66 -41.37 63.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.865 -1.147 . . . . 0.0 110.272 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.638 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -72.15 -28.5 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.952 -1.093 . . . . 0.0 109.501 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.801 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.3 t80 -71.41 -50.8 28.36 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.732 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.497 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 76.9 m95 -72.03 -46.6 56.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.207 -1.558 . . . . 0.0 110.527 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.56 -42.78 55.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.14 -0.975 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.711 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -119.43 74.3 0.99 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 110.433 -178.215 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.801 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 12.0 m80 -156.75 -179.92 8.66 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.149 0.976 . . . . 0.0 110.299 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.505 ' HB3' HE21 ' A' ' 143' ' ' GLN . 1.0 OUTLIER -144.26 67.77 15.08 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' HD3' ' N ' ' A' ' 140' ' ' ASP . 16.4 Cg_exo -63.51 12.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.681 2.921 . . . . 0.0 113.998 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.409 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.0 OUTLIER -121.95 29.15 7.21 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.046 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.667 ' CG ' ' O ' ' A' ' 143' ' ' GLN . 4.8 pt20 -155.61 77.69 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.841 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.471 ' N ' HG21 ' A' ' 190' ' ' THR . . . -70.38 14.71 1.25 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -108.27 1.46 21.99 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.146 -1.208 . . . . 0.0 108.223 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.447 ' CB ' ' HA ' ' A' ' 151' ' ' PHE . 11.5 ptt180 178.59 -174.18 0.17 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.718 0.771 . . . . 0.0 109.314 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.426 ' CG ' ' O ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -175.1 118.93 0.18 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.721 0.772 . . . . 0.0 109.255 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.88 -120.38 10.53 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.439 ' ND2' ' HA3' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -80.94 -34.02 33.6 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.321 -0.939 . . . . 0.0 112.176 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.662 ' OD2' ' N ' ' A' ' 72' ' ' CYS . 1.5 m-20 -82.48 144.21 30.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.398 -1.439 . . . . 0.0 109.23 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.447 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 38.5 p90 -136.36 144.57 44.66 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.05 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.66 -174.18 18.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.13 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.671 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -74.83 -19.72 60.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.695 -0.886 . . . . 0.0 110.367 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 155' ' ' TYR . 17.5 pm0 -86.52 7.51 25.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.156 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 154' ' ' GLN . 16.3 m-85 -139.65 50.84 1.75 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 0.0 109.59 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 153' ' ' THR . 38.4 mtm-85 -93.52 173.21 7.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.28 -0.888 . . . . 0.0 108.676 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.679 ' HG ' ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -94.28 109.26 21.09 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.271 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.466 ' HB2' ' CE1' ' A' ' 160' ' ' TYR . . . -133.33 119.28 19.53 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.396 -1.322 . . . . 0.0 109.947 -177.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 7.9 t -114.5 125.43 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.982 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.72 ' HH ' HH21 ' A' ' 194' ' ' ARG . 3.3 m-85 -119.57 133.51 23.82 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.23 169.03 22.09 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.564 2.176 . . . . 0.0 111.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -19.69 20.17 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 120.729 -1.232 . . . . 0.0 109.146 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 p 177.44 -163.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.74 23.68 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.033 1.397 . . . . 0.0 108.471 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.4 t -56.15 -62.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.496 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 170' ' ' ALA . 17.8 mt-30 -77.81 -11.42 59.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 0.0 111.298 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.42 -45.57 62.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.569 -1.332 . . . . 0.0 109.248 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.71 -17.75 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.87 -55.88 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.0 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.34 -53.77 40.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 70.0 mt -52.66 -39.1 61.5 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 108.906 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -58.26 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.429 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.497 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 4.0 p -56.67 -36.23 69.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.253 -0.904 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.46 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 4.2 ttpt -72.61 -46.41 54.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 109.383 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.411 ' N ' ' HE2' ' A' ' 174' ' ' LYS . 1.5 tt0 -71.63 -30.23 65.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.437 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 4.1 pt-20 -53.25 -34.02 55.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.526 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.456 ' CD2' HD11 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.28 -30.83 43.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.579 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.4 OUTLIER -66.61 -38.12 86.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 109.466 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -28.28 59.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.1 t -87.48 -54.22 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.473 ' N ' HD23 ' A' ' 181' ' ' LEU . 3.7 mt -63.97 -45.26 89.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.027 -1.045 . . . . 0.0 109.92 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.579 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 87.8 p -54.97 -23.75 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -88.38 -3.56 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.46 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.7 m-70 -108.18 30.82 6.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.1 OUTLIER 72.3 29.74 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 110.25 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -103.54 175.16 5.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.032 -1.042 . . . . 0.0 108.99 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.93 -152.05 8.45 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' A' ' 189' ' ' ILE . 28.0 Cg_exo -58.69 105.74 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.639 2.226 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.508 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.2 OUTLIER -48.8 -178.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.265 -0.897 . . . . 0.0 110.01 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.679 ' CG2' ' HG ' ' A' ' 157' ' ' SER . 1.7 t -130.76 -2.04 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.777 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.511 ' C ' ' O ' ' A' ' 190' ' ' THR . 3.9 m -42.07 113.43 0.44 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.657 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -80.79 114.53 19.74 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.341 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.21 111.93 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.72 HH21 ' HH ' ' A' ' 160' ' ' TYR . 55.6 mtm-85 -115.18 -173.23 2.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.02 164.12 33.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.42 23.36 1.98 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.66 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -83.68 173.23 11.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.62 -1.518 . . . . 0.0 108.919 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.743 ' CG1' ' CE2' ' A' ' 200' ' ' TYR . 1.0 OUTLIER -118.72 160.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.08 . . . . 0.0 110.379 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.487 ' CZ ' ' HG3' ' A' ' 118' ' ' ARG . 47.1 t80 -91.04 149.88 21.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 109.314 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.743 ' CE2' ' CG1' ' A' ' 198' ' ' VAL . 18.6 m-85 -143.83 100.43 3.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 109.8 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -58.54 146.49 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 109.225 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -90.07 -167.22 1.78 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.101 -0.999 . . . . 0.0 108.985 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.719 ' OE2' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -73.84 176.82 6.0 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 109.267 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.719 ' N ' ' OE2' ' A' ' 203' ' ' GLU . 0.3 OUTLIER -61.03 -61.02 2.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.711 ' CD1' ' OE2' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.43 8.62 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.774 -1.204 . . . . 0.0 111.039 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.603 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 6.5 m-70 -104.0 14.8 29.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.766 -1.209 . . . . 0.0 111.04 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.803 ' O ' ' N ' ' A' ' 209' ' ' TYR . 20.0 mm-40 -129.05 -168.35 1.91 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 110.495 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.79 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -38.64 1.15 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.803 ' N ' ' O ' ' A' ' 207' ' ' GLN . 21.1 p90 -38.35 -24.03 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 O-C-N 120.788 -1.195 . . . . 0.0 110.965 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.672 ' CB ' ' HE1' ' A' ' 74' ' ' TRP . 0.2 OUTLIER -79.38 -10.42 59.8 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.267 -1.521 . . . . 0.0 111.81 -176.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.474 ' OG ' ' CD2' ' A' ' 49' ' ' HIS . 83.3 p -54.06 -24.63 17.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.152 -0.968 . . . . 0.0 108.757 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.464 ' CG ' ' CE1' ' A' ' 49' ' ' HIS . 6.4 mmmt -68.39 -18.41 64.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.556 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.0 OUTLIER -140.23 73.05 32.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.71 4.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 123.037 2.491 . . . . 0.0 113.079 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.623 ' OD2' ' CE1' ' A' ' 217' ' ' TYR . 38.0 t0 -63.02 -19.5 64.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 110.053 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.56 85.25 0.04 OUTLIER Glycine 0 N--CA 1.504 3.214 0 C-N-CA 120.067 -1.064 . . . . 0.0 111.757 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.623 ' CE1' ' OD2' ' A' ' 215' ' ' ASP . 66.5 m-85 -91.81 81.13 5.21 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 121.002 2.401 . . . . 0.0 109.602 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.572 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.5 OUTLIER -170.83 112.12 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 109.447 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.572 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -37.87 161.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 218' ' ' CYS . 4.6 mp -143.54 -177.97 5.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.12 -1.224 . . . . 0.0 109.775 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 108.47 158.74 19.53 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.667 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -123.79 -167.31 12.74 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 222' ' ' GLY . 0.0 OUTLIER -34.95 -25.74 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.914 0 CA-C-N 114.511 -0.844 . . . . 0.0 109.219 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . 79.59 17.03 76.54 Favored Glycine 0 C--N 1.305 -1.158 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.675 ' C ' ' H ' ' A' ' 227' ' ' CYS . 3.2 p -53.58 166.16 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.809 -0.819 . . . . 0.0 109.627 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.508 ' H ' HG22 ' A' ' 225' ' ' VAL . 5.6 m -66.94 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.312 1.053 . . . . 0.0 111.437 -178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.675 ' H ' ' C ' ' A' ' 225' ' ' VAL . 1.3 m -69.87 -71.29 0.29 Allowed Pre-proline 0 C--N 1.259 -3.368 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.867 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 21.7 Cg_endo -62.78 -0.51 2.06 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.833 1.689 . . . . 0.0 110.074 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.66 ' SD ' ' O ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -58.0 155.52 10.71 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.8 0.81 . . . . 0.0 110.262 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.66 ' O ' ' SD ' ' A' ' 229' ' ' MET . . . -30.43 136.01 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.792 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.582 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 2.5 tp -147.3 117.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.208 -0.932 . . . . 0.0 109.394 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -69.76 -26.84 64.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.195 -0.941 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.597 ' O1 ' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 25' ' ' ALA . . . . . . . . 0 N--CA 1.493 2.495 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' CG ' ' N ' ' A' ' 24' ' ' SER . 3.5 p-10 -48.11 -45.03 32.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.082 -1.246 . . . . 0.0 108.666 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.677 ' C ' ' H ' ' A' ' 26' ' ' SER . 2.5 m -50.81 -15.97 0.35 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -47.74 -9.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.852 1.31 . . . . 0.0 109.935 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.677 ' H ' ' C ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -47.19 -17.05 0.05 Allowed 'General case' 0 C--N 1.262 -3.237 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.103 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.641 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -109.34 24.9 12.45 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 124.15 1.929 . . . . 0.0 109.2 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 29' ' ' ILE . 36.0 t -155.68 21.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -40.08 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.984 1.373 . . . . 0.0 109.773 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.461 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -111.25 125.97 54.38 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HA ' ' ND1' ' A' ' 97' ' ' HIS . . . -46.47 -22.39 0.26 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.25 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 22.3 mp0 -83.97 -7.58 59.37 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.082 -1.011 . . . . 0.0 110.391 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.7 pt-20 -106.3 -14.6 15.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 109.578 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.644 ' CB ' ' CD2' ' A' ' 97' ' ' HIS . . . -45.48 -170.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.597 0.713 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.452 ' CD2' ' HB3' ' A' ' 110' ' ' LYS . 4.1 mm? -70.34 165.06 48.08 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -66.85 -56.07 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.256 1.971 . . . . 0.0 112.404 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' N ' ' OD1' ' A' ' 100' ' ' ASN . . . 160.07 143.0 3.53 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.621 ' C ' ' H ' ' A' ' 40' ' ' GLU . 9.2 ttm180 -149.83 128.21 12.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.358 -1.084 . . . . 0.0 109.267 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.7 m -66.33 35.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.017 . . . . 0.0 109.301 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 38' ' ' ARG . 1.6 tt0 -63.12 112.57 7.14 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.11 -0.994 . . . . 0.0 110.128 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.33 143.66 7.73 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.806 2.337 . . . . 0.0 112.187 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mt -129.86 84.08 61.97 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.093 -1.004 . . . . 0.0 109.865 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.534 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 72.0 Cg_endo -82.38 169.59 13.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.054 2.503 . . . . 0.0 112.334 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 5.1 m -162.34 -166.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.575 ' CG2' ' O ' ' A' ' 45' ' ' THR . 14.1 t -82.31 95.16 7.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.73 -27.59 59.51 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.26 -0.9 . . . . 0.0 111.424 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.587 ' O ' ' C ' ' A' ' 48' ' ' HIS . 4.5 ptpt -95.42 99.03 11.0 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.588 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.35 114.34 0.13 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -27.81 69.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.0 111.134 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 15.8 t -71.27 -38.98 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.326 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -109.94 -42.74 4.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 110.239 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.14 0.9 55.92 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 24.4 p30 -76.24 -117.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.633 ' C ' ' HH ' ' A' ' 87' ' ' TYR . 41.8 mtm-85 -126.16 174.01 8.82 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.323 1.535 . . . . 0.0 110.121 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.602 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 2.9 p -147.11 30.78 0.94 Allowed 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.293 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.537 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -171.34 134.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.064 -1.023 . . . . 0.0 109.484 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.595 ' OE1' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.28 144.96 0.1 Allowed Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.395 -0.816 . . . . 0.0 110.534 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.17 166.66 81.71 Favored 'Cis proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.132 -2.028 . . . . 0.0 111.825 -0.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.786 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 92.8 m-85 -106.85 153.31 40.89 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.351 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.545 ' O ' ' OG1' ' A' ' 63' ' ' THR . 32.3 Cg_exo -50.3 161.03 1.25 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.318 2.012 . . . . 0.0 112.22 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.189 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.96 61.53 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -144.9 137.68 26.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -1.117 . . . . 0.0 109.413 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.657 ' CD ' ' H ' ' A' ' 65' ' ' MET . 13.3 tp60 -106.29 157.53 17.53 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 108.811 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.772 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -126.85 137.81 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.424 ' CB ' HD11 ' A' ' 131' ' ' LEU . . . -130.07 -171.03 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 96.5 t -144.49 150.11 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.156 -1.59 . . . . 0.0 110.093 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 67.1 m-85 -143.21 141.62 31.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.29 -0.881 . . . . 0.0 108.824 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.482 ' O ' ' N ' ' A' ' 158' ' ' ALA . . . -137.1 101.61 0.35 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.716 ' SD ' ' N ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -109.18 -89.73 0.47 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.46 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.649 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -141.09 -166.46 10.73 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.792 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 1.1 t -25.79 107.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.833 -0.804 . . . . 0.0 109.026 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.798 ' CZ ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.1 6.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 111.893 -177.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.792 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 32.0 m0 -71.66 -40.79 69.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.215 -1.553 . . . . 0.0 107.899 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.8 -23.34 30.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.71 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.0 -21.8 54.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 110.662 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.598 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -84.89 -41.91 15.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.64 -1.288 . . . . 0.0 111.486 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.668 ' C ' ' H ' ' A' ' 80' ' ' PHE . 3.9 ttt180 -56.69 -57.84 10.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.758 -1.214 . . . . 0.0 111.309 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.0 25.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.978 -1.076 . . . . 0.0 110.953 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 19.6 m-85 -128.26 -41.78 1.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.94 -1.1 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.538 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -91.63 -2.7 56.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.645 -1.284 . . . . 0.0 110.341 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.4 m -83.87 13.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.085 -1.009 . . . . 0.0 109.14 179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 43.3 mt -111.68 152.91 27.17 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.915 0.864 . . . . 0.0 109.408 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 136.41 34.17 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.41 -31.43 6.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.96 137.65 23.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.554 -0.968 . . . . 0.0 109.118 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.675 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -72.4 -42.42 65.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.673 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -177.67 -171.2 0.3 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.444 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.496 ' OG1' ' CD ' ' A' ' 77' ' ' GLU . 1.1 p -151.44 156.73 41.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.673 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 9.0 mp0 -149.64 158.55 44.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.415 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.598 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.6 OUTLIER -135.85 150.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 108.829 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.23 174.35 42.44 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.646 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.3 m-85 -79.06 146.46 33.26 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.306 -1.114 . . . . 0.0 108.464 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.69 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -145.12 -175.55 4.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.288 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 49.76 21.62 3.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.538 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -91.0 178.31 42.03 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.644 ' CD2' ' CB ' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -137.47 5.28 2.69 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.285 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.719 ' C ' HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -160.08 147.38 16.36 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 119.918 -1.738 . . . . 0.0 110.899 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.661 ' C ' ' ND2' ' A' ' 100' ' ' ASN . 4.3 mtp85 -72.3 61.51 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.82 HD21 ' N ' ' A' ' 100' ' ' ASN . 0.5 OUTLIER -123.58 -136.2 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 -176.931 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 100' ' ' ASN . 74.4 Cg_exo -40.42 169.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.137 0 CA-C-N 122.486 1.924 . . . . 0.0 114.562 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.581 ' O ' ' CG1' ' A' ' 106' ' ' VAL . 8.9 p -123.72 -175.1 3.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.605 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.706 ' CD1' ' CE1' ' A' ' 206' ' ' HIS . 0.3 OUTLIER -47.59 -38.73 15.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 0.0 110.38 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -74.34 -49.46 22.78 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.932 -1.105 . . . . 0.0 111.636 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' C ' ' N ' ' A' ' 107' ' ' CYS . 9.5 mm-40 -84.28 -25.34 29.42 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.038 -1.039 . . . . 0.0 111.24 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.701 ' O ' ' N ' ' A' ' 108' ' ' SER . 29.7 m -54.48 -21.52 6.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.494 ' C ' ' O ' ' A' ' 106' ' ' VAL . 1.2 p -37.32 -20.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.869 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 106' ' ' VAL . 79.3 p -75.49 3.36 9.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 108.859 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.65 ' N ' ' O ' ' A' ' 106' ' ' VAL . 16.2 mt-10 55.39 3.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.65 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.616 ' O ' ' NE2' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -77.51 -19.69 55.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 110.829 -178.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.491 ' C ' ' CE1' ' A' ' 97' ' ' HIS . 67.8 p -86.22 -6.27 59.02 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.679 -1.263 . . . . 0.0 110.393 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 51.16 16.8 2.18 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.489 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.69 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -73.86 161.55 30.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -1.173 . . . . 0.0 110.763 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.491 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -138.74 114.28 9.76 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.688 ' OE1' ' CE1' ' A' ' 155' ' ' TYR . 6.3 mp0 -55.17 130.87 43.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.5 m -142.19 -171.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 110.978 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 2.9 t -131.1 118.86 42.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.685 -0.634 . . . . 0.0 110.33 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.786 ' NH1' ' CZ ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.31 103.29 15.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 t -120.69 142.86 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.743 -177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.651 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.8 m -107.95 163.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.651 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 3.6 m-85 -141.93 151.55 42.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.906 -1.122 . . . . 0.0 109.412 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.423 ' HB3' ' HD1' ' A' ' 125' ' ' HIS . 51.5 mtt180 -102.02 105.94 44.93 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.877 . . . . 0.0 109.923 -179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -50.04 -23.93 10.03 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.595 2.196 . . . . 0.0 112.345 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -83.61 -21.54 32.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.922 . . . . 0.0 110.317 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.423 ' HD1' ' HB3' ' A' ' 122' ' ' ARG . 16.2 m80 -116.29 -12.17 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 -179.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.427 ' CD1' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.47 163.61 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 32.8 t -110.6 170.84 7.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -178.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.626 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 7.9 t80 -69.54 -19.99 63.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -71.18 -17.45 62.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.581 -1.325 . . . . 0.0 108.171 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.506 ' CD ' ' C ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -76.39 -42.35 44.77 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.567 -0.708 . . . . 0.0 110.803 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 121' ' ' TYR . 1.2 pp -65.53 -48.95 70.72 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.254 -1.529 . . . . 0.0 108.813 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.596 ' C ' ' CD1' ' A' ' 132' ' ' LEU . 2.4 pp -71.39 -18.8 62.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.929 -1.107 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.481 ' N ' HD11 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.01 -42.62 66.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.735 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -67.04 -38.72 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.147 -0.971 . . . . 0.0 110.321 -178.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.792 ' CE1' ' CE1' ' A' ' 139' ' ' HIS . 5.3 t80 -61.62 -48.49 80.66 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.4 -0.813 . . . . 0.0 110.389 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.731 ' CG ' ' CZ ' ' A' ' 177' ' ' TYR . 90.3 m95 -70.47 -32.44 69.98 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 120.863 -1.148 . . . . 0.0 110.66 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.26 -43.62 41.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 112.562 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -111.48 65.05 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.588 -1.32 . . . . 0.0 112.581 -176.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.792 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.1 OUTLIER 175.67 134.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.195 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.659 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -73.88 114.55 33.66 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.394 -0.816 . . . . 0.0 109.167 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 190' ' ' THR . 72.9 Cg_endo -81.43 -26.79 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.501 2.134 . . . . 0.0 113.053 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.428 ' C ' ' HG1' ' A' ' 190' ' ' THR . 0.7 OUTLIER -89.13 34.07 0.8 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.904 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.787 ' N ' ' HG1' ' A' ' 190' ' ' THR . 29.7 mt-30 -129.84 90.79 3.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.081 -1.012 . . . . 0.0 110.808 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.537 ' C ' ' H ' ' A' ' 146' ' ' ARG . . . -63.57 -117.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.466 ' SD ' ' C9 ' ' A' ' 21' ' ' MYR . 0.0 OUTLIER -69.67 40.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.949 . . . . 0.0 109.846 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.537 ' H ' ' C ' ' A' ' 144' ' ' GLY . 13.5 ttt-85 -163.58 84.66 0.48 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.288 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.581 ' OE1' ' OE1' ' A' ' 143' ' ' GLN . 6.2 tp-100 -76.53 63.64 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.481 -1.387 . . . . 0.0 109.866 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.72 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 91.6 -121.3 6.31 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -80.52 10.33 4.88 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.217 -0.992 . . . . 0.0 109.515 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.16 154.65 20.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 108.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -136.46 125.42 24.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.984 -1.072 . . . . 0.0 110.477 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.481 ' CA ' ' HZ1' ' A' ' 27' ' ' LYS . . . 156.46 142.04 3.33 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.12 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.603 ' N ' ' NZ ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -72.62 5.0 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -1.102 . . . . 0.0 109.014 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.623 ' NE2' ' CZ ' ' A' ' 155' ' ' TYR . 7.2 pt20 -95.18 -1.47 51.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.199 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.688 ' CE1' ' OE1' ' A' ' 115' ' ' GLU . 38.8 m-85 -129.82 61.11 1.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.326 -0.859 . . . . 0.0 108.993 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.79 ' NH2' HH22 ' A' ' 194' ' ' ARG . 5.8 mtm180 -111.6 177.92 4.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 109.83 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.593 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -92.48 119.39 31.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 176.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.484 ' HB2' ' CE1' ' A' ' 160' ' ' TYR . . . -140.4 129.33 23.31 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 118.191 -1.403 . . . . 0.0 111.189 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.537 ' N ' ' O ' ' A' ' 192' ' ' ASP . 3.1 m -107.4 127.85 62.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.706 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.577 ' CB ' ' NE2' ' A' ' 197' ' ' GLN . 10.9 m-85 -124.86 107.73 28.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.3 176.08 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.359 2.039 . . . . 0.0 112.802 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.2 -34.2 11.2 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.458 -0.776 . . . . 0.0 109.46 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 p -173.96 -163.21 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.165 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.99 -17.8 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.972 1.368 . . . . 0.0 108.764 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.21 -61.0 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.758 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.407 HE21 ' HB2' ' A' ' 166' ' ' GLN . 1.3 tt0 -76.88 -25.75 53.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.69 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.4 ' SD ' ' CD1' ' A' ' 171' ' ' LEU . 1.7 mtt -52.3 -14.47 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.004 -1.06 . . . . 0.0 110.627 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -75.9 -45.55 34.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.754 -1.216 . . . . 0.0 109.638 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -93.03 -47.45 6.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.517 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.71 -65.92 0.47 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.192 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.4 ' CD1' ' SD ' ' A' ' 167' ' ' MET . 0.6 OUTLIER -54.94 -47.59 74.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.521 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -61.25 -38.18 85.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.614 ' OG ' ' NE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -56.33 -32.6 64.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 109.281 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -72.6 -55.99 6.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 110.203 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -70.68 -47.64 58.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.463 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -53.11 -32.89 49.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.025 . . . . 0.0 109.824 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.731 ' CZ ' ' CG ' ' A' ' 136' ' ' TRP . 1.5 m-85 -74.08 -30.58 62.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.538 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.6 mm100 -52.92 -60.77 2.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.961 -1.087 . . . . 0.0 109.478 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -47.79 -22.31 0.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.959 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.25 -53.2 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 109.605 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.1 mt -74.68 -44.88 47.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.873 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.2 t -55.63 -30.85 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.018 -1.051 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -88.34 -3.33 58.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.305 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 43.3 m170 -108.25 35.86 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 186' ' ' PHE . 0.5 OUTLIER 68.23 66.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 185' ' ' ASN . 65.4 m-85 -158.13 168.57 26.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.054 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.2 -158.73 18.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -58.76 107.33 0.33 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.483 2.122 . . . . 0.0 111.193 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.538 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -46.9 169.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.444 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.787 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 79.2 p -114.67 58.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.562 0.696 . . . . 0.0 109.446 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.411 ' CG2' HG11 ' A' ' 159' ' ' VAL . 39.8 m -94.45 116.65 29.04 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.608 ' CG ' HH22 ' A' ' 156' ' ' ARG . 32.9 t70 -93.98 138.18 32.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 121.582 0.706 . . . . 0.0 110.505 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.437 HD11 ' CG2' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -111.62 159.73 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.79 HH22 ' NH2' ' A' ' 156' ' ' ARG . 1.5 ttm180 -162.31 -167.65 1.66 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.887 -1.133 . . . . 0.0 110.465 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -103.11 140.37 37.41 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.997 ' O ' ' NE2' ' A' ' 197' ' ' GLN . . . 14.38 -81.21 0.0 OUTLIER Glycine 0 C--O 1.185 -2.964 0 N-CA-C 104.069 -3.613 . . . . 0.0 104.069 -177.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.997 ' NE2' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 145.13 115.07 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.127 0.464 . . . . 0.0 111.616 172.606 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.465 ' O ' ' CG1' ' A' ' 198' ' ' VAL . 7.7 p -61.12 82.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 119.963 -1.711 . . . . 0.0 106.732 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.677 ' N ' ' O ' ' A' ' 197' ' ' GLN . 11.7 t80 -49.76 147.88 3.41 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.088 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.6 m-85 -151.05 97.31 2.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.492 ' CZ ' ' CG1' ' A' ' 56' ' ' VAL . 25.0 m-85 -53.78 147.84 11.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.994 -1.066 . . . . 0.0 110.76 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.543 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -99.31 177.72 5.11 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.535 ' OE2' ' CD2' ' A' ' 206' ' ' HIS . 1.3 pm0 -74.17 163.12 28.24 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.035 -1.041 . . . . 0.0 109.056 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -49.56 -51.87 33.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.912 -1.118 . . . . 0.0 108.522 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -46.85 -15.97 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.757 . . . . 0.0 110.189 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.798 ' ND1' ' CZ ' ' A' ' 73' ' ' PHE . 4.7 m-70 -100.75 13.49 34.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 110.684 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.847 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.6 mm-40 -131.87 -138.98 0.2 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.478 1.132 . . . . 0.0 109.989 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.68 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -32.86 -3.65 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.858 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.847 ' N ' ' O ' ' A' ' 207' ' ' GLN . 9.4 t80 -41.7 -43.27 2.81 Favored 'General case' 0 N--CA 1.511 2.624 0 O-C-N 120.171 -1.581 . . . . 0.0 108.699 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.631 ' O ' ' N ' ' A' ' 214' ' ' PRO . 0.2 OUTLIER -53.29 -25.18 13.71 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.627 -1.296 . . . . 0.0 109.538 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 208' ' ' GLN . 29.0 t -55.71 -51.1 68.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.909 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -67.46 -33.45 75.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.197 -0.939 . . . . 0.0 108.506 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 215' ' ' ASP . 24.8 m120 -136.47 76.03 50.06 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.631 ' N ' ' O ' ' A' ' 210' ' ' LEU . 76.8 Cg_exo -45.35 -0.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.942 2.428 . . . . 0.0 112.532 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 213' ' ' ASN . 4.9 t70 -63.95 -16.1 60.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.046 -1.034 . . . . 0.0 110.025 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 62.56 -66.68 0.02 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 215' ' ' ASP . 24.8 t80 -159.91 -150.68 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -1.013 . . . . 0.0 109.237 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 8.6 t -79.87 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.105 -0.997 . . . . 0.0 109.685 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 220' ' ' LEU . . . -90.03 -144.05 11.12 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 1.4 tp 76.75 139.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.793 -0.828 . . . . 0.0 109.755 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.31 115.64 0.34 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 148.66 141.64 3.5 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.581 ' OG1' ' O ' ' A' ' 139' ' ' HIS . 0.4 OUTLIER -103.98 -19.96 14.04 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.285 . . . . 0.0 109.819 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 176.98 49.18 0.06 OUTLIER Glycine 0 C--N 1.305 -1.18 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.425 ' O ' ' CG1' ' A' ' 225' ' ' VAL . 2.2 t -55.24 97.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -1.127 . . . . 0.0 109.078 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.628 ' O ' ' CG1' ' A' ' 231' ' ' ILE . 1.3 p -98.5 -152.48 0.41 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.965 0.888 . . . . 0.0 109.835 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.538 ' N ' ' OG ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -71.3 -70.11 0.33 Allowed Pre-proline 0 N--CA 1.504 2.231 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 30.4 Cg_endo -64.52 -40.07 25.4 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.1 1.866 . . . . 0.0 109.412 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.574 ' CB ' ' H ' ' A' ' 226' ' ' SER . 2.9 mmm -54.12 151.78 6.7 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.56 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.565 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.85 129.52 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.903 -0.498 . . . . 0.0 109.882 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.628 ' CG1' ' O ' ' A' ' 226' ' ' SER . 1.7 mm -142.8 114.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.115 -0.991 . . . . 0.0 109.446 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -93.14 10.86 29.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.341 0 O-C-N 121.246 -0.909 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.478 ' C13' ' OG1' ' A' ' 153' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.737 ' H ' ' C1 ' ' A' ' 21' ' ' MYR . 11.4 p30 -162.24 83.23 0.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -1.143 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.651 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -51.01 -24.28 3.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.315 -0.866 . . . . 0.0 109.378 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.598 ' C ' ' H ' ' A' ' 27' ' ' LYS . . . -55.49 -6.89 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 123.106 1.431 . . . . 0.0 109.057 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.651 ' H ' ' C ' ' A' ' 24' ' ' SER . 14.9 t -46.74 -9.18 0.02 OUTLIER 'General case' 0 C--N 1.262 -3.23 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.004 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.598 ' H ' ' C ' ' A' ' 25' ' ' ALA . 7.9 pttm -83.48 24.84 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 124.033 1.873 . . . . 0.0 108.58 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.936 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -164.55 13.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.253 -3.611 0 CA-C-N 112.037 -2.347 . . . . 0.0 105.842 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.936 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 15.4 -179.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-O 123.375 1.559 . . . . 0.0 113.565 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.21 119.89 15.08 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.721 -1.237 . . . . 0.0 110.685 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -59.31 -46.15 89.35 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.596 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.694 ' OE2' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -53.33 -12.73 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 108.994 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.694 ' N ' ' OE2' ' A' ' 32' ' ' GLU . 3.3 tt0 -113.72 -48.42 2.93 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.423 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . . . -47.72 163.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.228 -0.92 . . . . 0.0 108.814 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.494 ' N ' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -85.68 173.95 6.29 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.585 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 35' ' ' LEU . 5.9 Cg_exo -77.59 -63.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.156 2.57 . . . . 0.0 114.924 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' HA2' ' N ' ' A' ' 99' ' ' ARG . . . 119.22 110.37 2.37 Favored Glycine 0 N--CA 1.498 2.787 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.722 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.533 ' H ' ' HA ' ' A' ' 99' ' ' ARG . 1.5 ttm180 -106.72 169.9 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.813 -1.404 . . . . 0.0 109.152 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.467 ' H ' ' HG2' ' A' ' 38' ' ' ARG . 75.0 p -89.72 32.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.547 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.463 ' HB3' HD22 ' A' ' 100' ' ' ASN . 1.2 tt0 -108.32 109.35 61.66 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.779 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.39 172.3 13.78 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.609 2.206 . . . . 0.0 112.289 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.476 ' CG2' ' OD1' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -139.04 105.21 7.31 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.892 . . . . 0.0 109.604 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.39 175.28 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.661 2.241 . . . . 0.0 112.569 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 11.4 m -143.22 -166.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.958 . . . . 0.0 109.677 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -49.21 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.582 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.09 -65.05 0.67 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 111.184 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.97 99.67 1.83 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.622 -2.431 . . . . 0.0 108.48 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.685 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.55 122.32 0.34 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.7 -31.58 71.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.381 -0.824 . . . . 0.0 110.716 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 47.1 t -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.925 -1.11 . . . . 0.0 109.637 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.41 -45.1 4.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.19 4.55 55.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.602 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.2 p30 -82.03 -121.57 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.602 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 mtm-85 -123.19 167.37 13.79 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.371 1.082 . . . . 0.0 108.572 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.582 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.6 p -124.09 -17.41 6.22 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.255 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 m -151.76 -167.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.574 -1.328 . . . . 0.0 109.521 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 56' ' ' VAL . 4.6 mt-10 -32.36 120.23 0.41 Allowed Pre-proline 0 C--N 1.295 -1.782 0 O-C-N 121.91 -0.494 . . . . 0.0 110.176 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' VAL . 98.3 Cg_endo -75.57 172.28 63.85 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.87 0.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -116.91 129.78 25.06 Favored Pre-proline 0 C--N 1.28 -2.419 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' O ' ' OG1' ' A' ' 63' ' ' THR . 37.5 Cg_exo -49.67 140.27 29.55 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.057 1.838 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.86 155.86 27.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.34 -9.73 25.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -95.66 135.88 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -1.199 . . . . 0.0 109.91 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -108.61 167.12 10.28 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.729 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -149.35 156.42 42.04 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.386 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.454 ' CB ' HE22 ' A' ' 166' ' ' GLN . . . -141.22 -174.65 4.07 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -144.58 127.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 119.803 -1.811 . . . . 0.0 109.666 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.667 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.6 OUTLIER -156.72 153.85 29.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.701 -1.25 . . . . 0.0 109.853 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -161.36 -170.08 25.53 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.333 -1.413 . . . . 0.0 112.993 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.776 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -133.65 -93.04 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.906 0.86 . . . . 0.0 110.264 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.702 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -132.46 65.37 0.59 Allowed Glycine 0 N--CA 1.498 2.811 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.702 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.5 t 120.75 170.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 124.16 0.984 . . . . 0.0 109.499 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.562 ' N ' ' SG ' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -120.58 30.13 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.242 -0.911 . . . . 0.0 111.341 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 7.2 m0 -88.79 -87.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.404 -1.435 . . . . 0.0 109.005 179.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -7.37 29.96 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -76.13 -47.54 23.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -1.169 . . . . 0.0 110.28 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.571 ' CD ' ' O ' ' A' ' 77' ' ' GLU . 7.2 tp10 -78.67 -27.8 45.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.492 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 31.4 ttt-85 -56.23 -34.55 66.44 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.942 -1.098 . . . . 0.0 109.925 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -75.7 17.82 0.28 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 110.294 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.603 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 81.3 m-85 -126.35 -41.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.847 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.535 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -74.36 8.77 2.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 109.793 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.406 ' H ' ' C ' ' A' ' 80' ' ' PHE . 2.0 m -109.54 15.8 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 109.365 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.72 156.83 24.08 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.808 0.813 . . . . 0.0 109.018 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -89.98 140.11 29.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.337 0.589 . . . . 0.0 109.61 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.46 -29.36 8.32 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.2 t -77.43 123.51 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.401 -1.058 . . . . 0.0 109.301 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.598 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.327 -0.858 . . . . 0.0 108.988 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.532 ' OG ' ' CE1' ' A' ' 87' ' ' TYR . 6.4 p -158.43 -162.14 1.08 Allowed 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.596 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.685 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.7 p -160.99 128.36 4.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 108.817 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.598 ' OE1' ' O ' ' A' ' 89' ' ' THR . 4.1 mp0 -130.95 145.78 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.415 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.54 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 1.1 m -126.76 156.56 37.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.44 ' HA2' ' N ' ' A' ' 202' ' ' ALA . . . -172.09 -128.96 1.09 Allowed Glycine 0 C--N 1.293 -1.831 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.28 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.566 ' N ' ' O ' ' A' ' 200' ' ' TYR . 83.1 m-85 -143.24 160.64 40.09 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.876 -0.779 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -168.71 148.41 4.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.365 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 87.37 30.8 18.25 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.643 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -142.97 173.28 24.17 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.733 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 29.0 p-80 -135.88 85.34 2.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -1.204 . . . . 0.0 110.22 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.489 ' HG1' HD22 ' A' ' 35' ' ' LEU . 96.4 m -150.02 163.48 38.03 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.057 -1.027 . . . . 0.0 108.393 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.565 ' N ' ' HA2' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -65.18 -76.8 0.07 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.718 0.771 . . . . 0.0 111.423 -177.604 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.476 ' OD1' ' CG2' ' A' ' 42' ' ' ILE . 6.3 m-80 -121.46 83.17 40.43 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-O 121.504 0.668 . . . . 0.0 110.09 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.416 ' HA ' ' CD ' ' A' ' 105' ' ' GLU . 23.1 Cg_exo -63.15 117.24 4.17 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 123.34 2.693 . . . . 0.0 113.023 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.621 ' H ' ' HG2' ' A' ' 105' ' ' GLU . 4.1 p -109.16 149.77 28.87 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 120.569 -1.332 . . . . 0.0 107.617 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.694 ' CE2' ' OH ' ' A' ' 155' ' ' TYR . 2.8 t80 -47.68 -34.37 8.06 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.398 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.581 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -73.28 -26.49 61.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 110.443 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.621 ' HG2' ' H ' ' A' ' 102' ' ' THR . 0.0 OUTLIER -83.53 -57.33 3.28 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 120.565 -1.334 . . . . 0.0 110.142 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.611 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 11.5 m -61.93 -20.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.471 -0.768 . . . . 0.0 111.843 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.581 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 9.3 p -33.85 -37.84 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.438 -0.789 . . . . 0.0 109.66 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 106' ' ' VAL . 27.0 t -103.97 -115.53 0.22 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.653 -1.28 . . . . 0.0 109.791 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.458 ' N ' ' OG ' ' A' ' 108' ' ' SER . 1.5 mp0 -120.4 9.86 11.06 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.347 0.594 . . . . 0.0 110.236 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.419 ' CA ' HD23 ' A' ' 35' ' ' LEU . 5.4 mttt -43.0 -50.96 5.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -122.51 14.13 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.747 -1.221 . . . . 0.0 110.512 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.632 ' O ' ' C14' ' A' ' 21' ' ' MYR . . . 37.2 35.02 0.14 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.643 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.09 168.93 19.1 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.038 -1.272 . . . . 0.0 109.801 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -119.12 114.11 21.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.538 ' CD ' ' O ' ' A' ' 115' ' ' GLU . 1.9 pp20? -72.86 130.05 39.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.269 -0.895 . . . . 0.0 109.906 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -153.41 -179.39 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.146 -0.971 . . . . 0.0 110.507 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.591 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.3 m -115.94 117.8 56.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.808 0.813 . . . . 0.0 110.2 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.871 HH22 ' N ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -98.24 101.68 13.21 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.646 ' C ' HH22 ' A' ' 118' ' ' ARG . 31.0 m -126.63 123.65 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.871 ' N ' HH22 ' A' ' 118' ' ' ARG . 0.7 OUTLIER -78.27 171.57 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.55 ' CG ' ' CD1' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -158.08 155.58 29.49 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.356 -1.338 . . . . 0.0 110.957 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -103.4 102.63 30.54 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.822 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' O ' ' A' ' 126' ' ' ILE . 31.7 Cg_exo -43.7 -64.24 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.968 2.445 . . . . 0.0 112.754 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -44.43 -29.96 0.78 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.811 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -92.92 -46.32 7.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 109.769 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.559 ' O ' ' O ' ' A' ' 123' ' ' PRO . 2.6 tt -126.07 166.99 21.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.048 -1.032 . . . . 0.0 108.255 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.53 ' N ' ' CG1' ' A' ' 126' ' ' ILE . 6.1 m -99.96 159.33 15.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.66 -1.275 . . . . 0.0 110.721 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.544 ' CE2' ' CD1' ' A' ' 132' ' ' LEU . 17.4 t80 -66.43 -27.46 67.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.585 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -69.67 -16.74 63.41 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.579 ' O ' ' C ' ' A' ' 131' ' ' LEU . 2.8 mt-10 -73.57 -72.33 0.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 108.992 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.781 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -39.2 -35.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 178.504 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.544 ' CD1' ' CE2' ' A' ' 128' ' ' PHE . 44.4 mt -76.28 -44.75 35.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' GLU . 2.6 mttm -52.28 -53.56 42.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.94 -1.1 . . . . 0.0 110.117 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.656 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 41.3 t -57.85 -30.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.797 -1.19 . . . . 0.0 108.45 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.709 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 3.0 t80 -73.1 -56.74 4.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.143 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.475 ' HB3' ' CE1' ' A' ' 177' ' ' TYR . 37.7 m95 -71.57 -54.08 11.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.384 -1.448 . . . . 0.0 110.021 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 20.8 tt0 -37.08 -56.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.717 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 8.3 p30 -103.25 63.8 0.82 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.061 -1.025 . . . . 0.0 109.949 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.776 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 22.5 m80 -158.28 177.21 11.53 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.286 1.041 . . . . 0.0 110.072 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' THR . 1.6 t0 -145.22 80.23 11.18 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.493 ' O ' ' N ' ' A' ' 190' ' ' THR . 13.0 Cg_exo -48.09 13.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.545 2.163 . . . . 0.0 113.592 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.685 ' N ' ' O ' ' A' ' 140' ' ' ASP . 0.4 OUTLIER -122.15 43.29 2.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.808 -1.182 . . . . 0.0 110.318 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.587 ' O ' ' O ' ' A' ' 144' ' ' GLY . 5.3 mt-30 -130.72 78.61 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 109.325 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.43 -116.26 0.0 OUTLIER Glycine 0 N--CA 1.493 2.473 0 CA-C-O 121.905 0.725 . . . . 0.0 112.513 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.97 42.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.795 -0.827 . . . . 0.0 110.353 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.509 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.9 OUTLIER -170.9 139.62 1.48 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.24 177.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.548 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -146.93 91.46 2.01 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.128 -1.607 . . . . 0.0 108.424 176.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.46 -129.47 9.83 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -94.69 12.9 26.14 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.652 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.675 ' OD1' ' CE2' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -109.05 112.91 25.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.649 -1.282 . . . . 0.0 109.488 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.469 ' CE2' ' HG3' ' A' ' 146' ' ' ARG . 6.2 m-85 -104.22 113.48 27.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.53 149.42 7.87 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.43 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.598 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -48.87 -45.98 41.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.51 -0.994 . . . . 0.0 109.393 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.814 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 2.1 pm0 -75.38 1.53 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 111.177 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.814 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 21.1 m-85 -102.99 41.58 1.24 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.443 -1.411 . . . . 0.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.618 ' O ' ' O ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -103.45 174.91 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 108.969 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.4 129.37 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 68' ' ' PHE . . . -143.74 117.82 9.48 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 115.94 -2.304 . . . . 0.0 112.444 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.483 HG21 ' CE2' ' A' ' 135' ' ' PHE . 16.1 t -111.98 133.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.214 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.507 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 53.7 m-85 -130.5 94.41 29.68 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.0 109.192 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.9 170.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.773 2.315 . . . . 0.0 112.063 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.0 -21.13 16.99 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 120.941 -1.099 . . . . 0.0 109.633 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 165' ' ' VAL . 4.1 p 173.54 -178.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.086 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.07 -15.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.009 1.385 . . . . 0.0 108.6 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.6 t -55.69 -64.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.672 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.501 ' O ' ' N ' ' A' ' 170' ' ' ALA . 17.1 mt-30 -79.54 -19.32 49.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.682 -0.636 . . . . 0.0 110.932 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.15 -31.23 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.869 -1.145 . . . . 0.0 110.632 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.425 ' HG3' ' H ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -71.98 -43.06 65.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.681 -1.262 . . . . 0.0 109.979 -179.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.44 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.92 -42.94 9.2 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.136 -0.977 . . . . 0.0 110.409 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.11 -57.79 8.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.855 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 1.2 mp -52.63 -35.76 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.026 -1.046 . . . . 0.0 109.048 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 -74.51 -45.38 46.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.468 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -56.21 -31.15 63.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -72.17 -52.15 17.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.824 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -73.0 -26.1 61.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 110.317 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 6.2 pt-20 -52.97 -34.53 56.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.687 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.481 ' OH ' ' CG2' ' A' ' 225' ' ' VAL . 0.2 OUTLIER -79.65 -28.94 40.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.077 -1.014 . . . . 0.0 109.454 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.515 ' OE1' ' CG2' ' A' ' 189' ' ' ILE . 15.5 tp60 -74.91 -7.66 54.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -75.49 -41.93 54.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 0.0 108.907 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 73.6 t -88.52 -43.66 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.315 -0.865 . . . . 0.0 109.859 179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.473 HD23 ' CD2' ' A' ' 186' ' ' PHE . 38.2 mt -56.55 -49.17 75.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.058 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.1 t -55.24 -30.33 59.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.35 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.9 pttt -88.26 -6.76 57.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.229 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.417 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.9 m170 -108.43 29.32 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.77 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.5 OUTLIER 69.67 68.93 0.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.473 ' CD2' HD23 ' A' ' 181' ' ' LEU . 23.4 m-85 -137.14 169.99 16.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.935 . . . . 0.0 109.0 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -119.82 -159.8 11.04 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -58.62 105.77 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.204 1.936 . . . . 0.0 110.774 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.515 ' CG2' ' OE1' ' A' ' 178' ' ' GLN . 0.2 OUTLIER -51.19 174.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.175 -0.953 . . . . 0.0 110.048 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.562 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 4.8 p -137.32 67.73 1.43 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.232 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.9 m -100.6 125.2 46.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.692 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -76.32 113.77 14.26 Favored 'General case' 0 C--N 1.278 -2.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.205 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.47 108.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.87 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.692 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.4 OUTLIER -147.4 153.36 39.52 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -104.16 164.9 11.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.01 39.07 94.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.539 ' O ' ' C ' ' A' ' 198' ' ' VAL . 55.6 mm-40 -96.41 90.99 5.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.68 -1.482 . . . . 0.0 108.974 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.539 ' C ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -32.11 150.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.554 -0.716 . . . . 0.0 109.97 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.502 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 38.3 t80 -96.11 140.02 31.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.458 -0.776 . . . . 0.0 109.325 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 93' ' ' PHE . 7.0 m-85 -130.86 94.81 3.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.351 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -54.12 136.44 42.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 110.428 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.602 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -84.46 -174.94 5.55 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.13 161.12 30.98 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 122.264 1.03 . . . . 0.0 110.059 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -43.31 74.27 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.459 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -60.82 -7.85 2.64 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.425 -0.797 . . . . 0.0 110.119 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.622 ' CE1' ' CB ' ' A' ' 103' ' ' TYR . 50.4 m-70 -104.4 4.01 32.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.985 -1.072 . . . . 0.0 110.65 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.849 ' O ' ' N ' ' A' ' 209' ' ' TYR . 16.7 mm-40 -109.89 -143.83 0.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.144 0.973 . . . . 0.0 110.19 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.677 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -35.49 -4.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.845 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.849 ' N ' ' O ' ' A' ' 207' ' ' GLN . 59.4 t80 -39.75 -42.14 1.21 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 120.757 -1.214 . . . . 0.0 111.015 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 6.6 mt -71.08 -20.75 62.32 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.68 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.517 ' N ' ' O ' ' A' ' 208' ' ' GLN . 8.1 t -73.25 -49.07 29.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 0.0 108.946 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.1 0.92 56.31 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.264 -0.897 . . . . 0.0 110.264 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.788 ' ND2' ' CD2' ' A' ' 209' ' ' TYR . 36.3 m-80 -132.65 133.42 23.46 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 109.686 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.1 2.1 5.26 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.698 2.266 . . . . 0.0 113.663 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.518 ' O ' ' N ' ' A' ' 217' ' ' TYR . 2.9 t0 -62.74 -17.43 60.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.23 . . . . 0.0 109.864 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.421 ' C ' ' CD2' ' A' ' 217' ' ' TYR . . . 63.88 -62.75 0.05 OUTLIER Glycine 0 C--N 1.296 -1.684 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.518 ' N ' ' O ' ' A' ' 215' ' ' ASP . 2.8 p90 171.31 -156.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 109.569 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.44 ' H ' ' HB2' ' A' ' 217' ' ' TYR . 3.6 t -159.94 79.51 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.006 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 161.24 174.28 30.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.41 -165.16 1.29 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.234 -1.157 . . . . 0.0 109.858 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.04 -107.87 2.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -128.06 -168.44 12.45 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.605 ' C ' ' H ' ' A' ' 225' ' ' VAL . 6.8 t -165.1 -7.63 0.03 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.603 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -67.49 7.27 2.07 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.605 ' H ' ' C ' ' A' ' 223' ' ' THR . 2.3 t -111.41 165.74 6.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.883 -0.775 . . . . 0.0 109.546 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.558 ' N ' ' CG1' ' A' ' 225' ' ' VAL . 0.3 OUTLIER -44.99 103.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.695 1.236 . . . . 0.0 109.228 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.481 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -73.76 -55.82 3.16 Favored Pre-proline 0 C--N 1.274 -2.693 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.126 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.583 ' CD ' ' H ' ' A' ' 229' ' ' MET . 40.8 Cg_endo -94.08 -36.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.068 2.512 . . . . 0.0 109.834 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.583 ' H ' ' CD ' ' A' ' 228' ' ' PRO . 5.0 mtt -54.77 154.14 5.37 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.969 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.554 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.45 134.3 0.06 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.319 0.581 . . . . 0.0 109.966 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.8 mm -133.51 109.93 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.261 -0.899 . . . . 0.0 109.316 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -68.14 117.8 10.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.36 0 O-C-N 121.228 -0.92 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.737 ' C1 ' ' H ' ' A' ' 23' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 22' ' ' GLY . 54.4 m-20 36.07 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -1.146 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.669 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.1 OUTLIER -50.86 -18.96 0.85 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.255 -0.903 . . . . 0.0 109.236 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.414 ' HB1' ' C1 ' ' A' ' 21' ' ' MYR . . . -50.41 -8.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 123.028 1.394 . . . . 0.0 109.624 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.669 ' H ' ' C ' ' A' ' 24' ' ' SER . 22.9 t -46.52 -27.25 1.06 Allowed 'General case' 0 C--N 1.261 -3.282 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.427 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.444 ' HE2' ' SD ' ' A' ' 145' ' ' MET . 0.9 OUTLIER -97.23 45.07 1.04 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 123.274 1.511 . . . . 0.0 109.888 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.72 ' O ' ' O ' ' A' ' 29' ' ' ILE . 44.6 t -151.99 25.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.263 -3.161 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.72 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -33.95 177.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 123.225 1.488 . . . . 0.0 110.852 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -103.92 121.3 42.82 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.952 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -49.35 -15.59 0.14 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 30' ' ' SER . 11.4 mm-40 -62.17 -62.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.855 . . . . 0.0 109.793 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' ' C ' ' A' ' 34' ' ' ALA . 28.5 tt0 -75.19 -28.39 60.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.707 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -30.97 152.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.781 . . . . 0.0 110.203 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.472 ' N ' HD11 ' A' ' 35' ' ' LEU . 0.2 OUTLIER -50.2 173.0 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.434 ' CD ' ' HB3' ' A' ' 35' ' ' LEU . 12.8 Cg_exo -70.27 -40.44 4.52 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 123.125 2.55 . . . . 0.0 115.726 -176.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA2' ' C ' ' A' ' 98' ' ' THR . . . 93.28 94.75 1.49 Allowed Glycine 0 N--CA 1.501 2.979 0 C-N-CA 118.115 -1.993 . . . . 0.0 110.319 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.532 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 5.2 mmt85 -96.23 -172.61 2.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.703 -1.469 . . . . 0.0 109.343 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 p -124.4 37.22 4.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.93 . . . . 0.0 109.911 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.74 92.95 18.54 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.9 -1.125 . . . . 0.0 109.943 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.82 -178.1 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.936 2.424 . . . . 0.0 112.216 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.67 133.96 18.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.26 175.51 11.24 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.608 2.205 . . . . 0.0 112.318 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -147.43 -167.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.583 ' CG2' ' O ' ' A' ' 45' ' ' THR . 15.1 t -49.21 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.617 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.39 -50.32 71.94 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.173 -0.954 . . . . 0.0 111.068 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 48' ' ' HIS . 27.7 mttm -84.34 99.17 10.45 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.614 -2.434 . . . . 0.0 108.419 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.6 t-80 -32.11 117.88 0.23 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -64.59 -32.46 74.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.318 -0.864 . . . . 0.0 110.665 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 25.9 t -63.43 -44.1 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 109.379 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -106.37 -45.09 4.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.39 4.53 54.96 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.687 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 27.3 p30 -82.04 -112.71 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.673 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.4 mtt180 -130.09 174.36 9.87 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.653 1.692 . . . . 0.0 110.423 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.617 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.8 p -137.95 8.35 2.75 Favored 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.892 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 57' ' ' GLU . 10.9 m -144.98 132.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.687 -1.258 . . . . 0.0 109.519 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.608 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.4 pm0 -32.86 151.81 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 CA-C-O 121.809 0.814 . . . . 0.0 110.849 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -78.88 166.28 79.76 Favored 'Cis proline' 0 C--N 1.303 -1.844 0 C-N-CA 121.808 -2.163 . . . . 0.0 111.716 -0.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CZ ' HG12 ' A' ' 120' ' ' VAL . 31.8 m-85 -110.26 154.56 42.82 Favored Pre-proline 0 C--N 1.269 -2.907 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.118 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.574 ' O ' ' OG1' ' A' ' 63' ' ' THR . 44.1 Cg_exo -50.15 132.5 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.3 2.0 . . . . 0.0 112.1 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -48.65 146.69 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.84 46.52 23.17 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -128.93 137.54 51.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -1.121 . . . . 0.0 109.674 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.87 149.51 25.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.721 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -138.86 113.11 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.533 ' CB ' HE22 ' A' ' 166' ' ' GLN . . . -112.09 -167.69 1.22 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.2 t -141.96 132.06 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.07 -1.644 . . . . 0.0 108.998 179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 135' ' ' PHE . 91.3 m-85 -123.04 156.16 35.42 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.193 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 157' ' ' SER . . . -140.44 114.71 0.98 Allowed Glycine 0 C--O 1.207 -1.571 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CD1' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -125.31 -82.47 0.63 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.485 -1.009 . . . . 0.0 109.31 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.624 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -153.27 -163.55 11.84 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.699 ' C ' ' H ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -29.67 104.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.903 . . . . 0.0 108.582 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.786 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -49.44 6.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.787 . . . . 0.0 111.4 -178.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.699 ' H ' ' C ' ' A' ' 72' ' ' CYS . 14.5 m0 -72.04 -47.58 50.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.614 -1.304 . . . . 0.0 108.799 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.58 -22.93 27.53 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.721 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.35 -26.87 56.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.581 ' OE2' ' O ' ' A' ' 90' ' ' GLN . 8.9 tp10 -84.59 -36.66 21.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.693 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.68 ' C ' ' H ' ' A' ' 80' ' ' PHE . 1.7 ttt85 -59.28 -59.17 5.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.606 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.477 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 18.0 mmtm -56.43 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.944 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.721 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.0 m-85 -120.88 -40.93 2.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.824 -1.173 . . . . 0.0 110.315 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.542 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -87.96 3.74 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.84 -1.163 . . . . 0.0 109.981 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.5 m -94.62 13.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 75.7 mt -106.56 152.76 23.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.96 0.886 . . . . 0.0 109.135 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 8.8 pttm -88.96 145.79 25.3 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.15 -25.37 28.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.593 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -73.29 137.78 22.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.97 . . . . 0.0 108.807 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.687 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -81.41 -41.06 22.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 108.744 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.509 ' O ' ' CG2' ' A' ' 89' ' ' THR . 1.1 p -173.51 -163.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 88' ' ' SER . 60.3 p -158.82 170.78 21.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.581 ' O ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.96 176.49 6.15 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.619 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -152.35 162.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.821 -1.174 . . . . 0.0 109.853 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.15 171.22 44.08 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 200' ' ' TYR . 4.1 m-85 -87.55 155.84 19.79 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.473 -1.016 . . . . 0.0 109.499 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -178.96 155.47 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.391 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.8 22.26 14.16 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -154.49 -151.62 5.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.519 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 47.9 p-80 -178.37 107.09 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.691 ' O ' ' O ' ' A' ' 99' ' ' ARG . 1.1 m -152.26 156.04 38.9 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.777 ' NE ' HD21 ' A' ' 100' ' ' ASN . 7.8 ttp180 -40.27 169.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.777 HD21 ' NE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -30.71 89.96 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.71 ' N ' ' O ' ' A' ' 99' ' ' ARG . 1.3 Cg_endo -77.15 141.78 21.07 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.052 2.501 . . . . 0.0 112.963 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.43 ' OG1' ' HB2' ' A' ' 105' ' ' GLU . 24.6 p -124.06 170.69 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.116 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.783 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 1.2 t80 -56.92 -43.36 81.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.798 . . . . 0.0 109.325 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -73.35 -27.54 61.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.356 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.43 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.4 mm-40 -80.88 -41.37 23.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.777 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.458 HG12 ' HG1' ' A' ' 111' ' ' THR . 5.4 m -55.73 -23.99 15.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 120.421 -1.425 . . . . 0.0 108.634 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.673 ' C ' ' H ' ' A' ' 109' ' ' GLU . 23.2 m -59.27 -36.3 75.29 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.577 ' C ' ' H ' ' A' ' 110' ' ' LYS . 9.1 m -46.95 -9.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.673 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.8 mt-10 65.3 -12.25 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.679 -0.638 . . . . 0.0 109.944 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.577 ' H ' ' C ' ' A' ' 108' ' ' SER . 23.8 mttp -77.56 -15.05 59.49 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.063 -1.023 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' GLY . 4.7 p -91.19 -6.61 53.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 109.665 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 36.28 37.28 0.18 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.102 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.491 ' ND1' ' CA ' ' A' ' 96' ' ' GLY . 0.3 OUTLIER -82.04 158.13 23.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.596 -1.532 . . . . 0.0 109.974 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -120.83 112.67 19.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.448 -0.783 . . . . 0.0 109.118 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.682 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 74.4 mt-10 -61.54 117.44 5.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -125.29 -176.11 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -179.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 6.7 t -132.68 120.74 42.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.734 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.587 ' HD2' ' CZ ' ' A' ' 199' ' ' PHE . 9.9 ptm180 -97.81 120.95 39.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.419 ' O ' ' CG2' ' A' ' 119' ' ' VAL . 2.6 m -133.87 129.91 55.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 O-C-N 120.72 -1.237 . . . . 0.0 109.645 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 59' ' ' PHE . 0.8 OUTLIER -92.32 145.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.593 ' CE1' ' CG2' ' A' ' 86' ' ' VAL . 4.1 m-85 -129.21 161.16 30.79 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.182 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -121.62 105.19 38.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.591 -0.693 . . . . 0.0 110.382 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.503 ' O ' ' C ' ' A' ' 124' ' ' GLU . 18.7 Cg_exo -43.64 -61.2 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.538 2.825 . . . . 0.0 114.229 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.2 tt0 -26.9 -52.69 0.06 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.361 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 21.05 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 0.0 109.756 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -157.6 162.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.28 -0.888 . . . . 0.0 109.618 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.482 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -128.72 148.3 50.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.894 -1.129 . . . . 0.0 109.653 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.473 ' CD2' HD12 ' A' ' 132' ' ' LEU . 72.8 t80 -54.43 -38.86 66.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.222 -0.924 . . . . 0.0 109.613 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -51.08 -14.36 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.07 -1.019 . . . . 0.0 108.84 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.482 ' HG3' ' H ' ' A' ' 127' ' ' SER . 6.5 mm-40 -73.77 -62.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.882 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.776 ' CD1' ' H ' ' A' ' 131' ' ' LEU . 2.9 mp -51.69 -34.12 37.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.976 -1.077 . . . . 0.0 108.184 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.473 HD12 ' CD2' ' A' ' 128' ' ' PHE . 39.0 mt -68.67 -50.16 53.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 110.255 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.21 -30.01 70.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.084 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.549 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.2 t -74.04 -40.06 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.884 -1.135 . . . . 0.0 109.633 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.683 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 24.3 t80 -69.26 -43.41 74.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.63 -0.669 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.636 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 82.3 m95 -71.73 -39.69 69.93 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.699 -1.251 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.85 -37.12 59.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 112.88 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.546 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 25.3 m-80 -97.78 36.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.639 -1.288 . . . . 0.0 113.27 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.683 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER 177.97 130.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.56 -1.338 . . . . 0.0 110.733 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.606 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -61.54 112.04 5.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -74.68 -11.01 22.05 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.161 1.907 . . . . 0.0 112.569 -179.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 71.4 p -101.2 46.62 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.021 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.645 ' C ' ' HG1' ' A' ' 190' ' ' THR . 2.6 pt20 -114.08 107.29 15.45 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.81 0.814 . . . . 0.0 110.552 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.622 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.06 -118.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.578 0 CA-C-O 121.482 0.49 . . . . 0.0 112.157 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.578 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -99.48 44.62 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.258 . . . . 0.0 111.822 -177.135 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.417 ' HB3' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -174.29 159.61 3.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.701 -1.25 . . . . 0.0 109.329 178.421 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.596 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -122.85 145.14 48.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.428 -1.42 . . . . 0.0 110.536 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 65.85 -124.19 25.73 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -111.7 26.7 10.37 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.76 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -107.88 167.13 10.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.124 . . . . 0.0 108.42 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 151' ' ' PHE . 33.5 m-85 -132.35 111.54 11.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.824 -1.173 . . . . 0.0 109.912 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 172.38 143.61 4.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.55 6.2 4.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -1.219 . . . . 0.0 109.147 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.667 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 6.8 pt20 -88.87 -1.22 57.98 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.667 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 29.7 m-85 -136.75 62.55 1.6 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.745 HH22 ' CB ' ' A' ' 192' ' ' ASP . 10.4 mtm105 -107.96 174.74 5.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.673 ' OG ' ' NE2' ' A' ' 139' ' ' HIS . 6.2 t -93.2 107.26 19.1 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.47 ' HB2' ' CE1' ' A' ' 160' ' ' TYR . . . -138.42 123.08 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 118.182 -1.407 . . . . 0.0 111.473 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.447 ' N ' ' O ' ' A' ' 192' ' ' ASP . 11.2 t -112.04 127.66 69.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.249 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.472 ' CG ' ' HG3' ' A' ' 197' ' ' GLN . 7.6 m-85 -119.81 89.24 41.47 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.78 174.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.237 2.625 . . . . 0.0 112.608 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.47 ' H ' ' HG1' ' A' ' 162' ' ' THR . 0.0 OUTLIER -96.24 -33.85 11.85 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.559 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 12.3 t -176.64 -162.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.374 -0.828 . . . . 0.0 109.054 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.559 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -56.93 -15.46 4.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.988 1.375 . . . . 0.0 108.614 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.559 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 3.7 t -55.82 -64.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.749 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.533 HE22 ' CB ' ' A' ' 66' ' ' ALA . 14.1 mt-30 -79.32 -17.76 53.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.618 -0.676 . . . . 0.0 111.061 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.1 ttm -52.36 -38.05 57.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.761 -1.212 . . . . 0.0 110.218 -179.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.37 -23.49 57.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.862 -1.149 . . . . 0.0 109.688 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.667 ' N ' ' OE2' ' A' ' 168' ' ' GLU . . . -92.88 -42.17 9.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.46 -55.17 23.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.677 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.462 ' HG ' ' N ' ' A' ' 172' ' ' ARG . 2.5 pp -52.65 -35.55 55.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.055 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.577 ' O ' ' OE2' ' A' ' 176' ' ' GLU . 4.2 mtm180 -74.82 -46.45 36.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.886 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.636 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 70.2 m -56.54 -41.33 76.6 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.446 -0.784 . . . . 0.0 109.546 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 25.1 ttpp -72.4 -49.99 29.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.63 -25.52 68.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' O ' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -64.74 -53.36 48.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.464 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -78.9 -21.4 47.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.737 -179.669 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.628 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 38.8 tp60 -62.14 -41.0 97.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 0.0 109.656 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -16.0 58.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.939 . . . . 0.0 109.619 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 49.7 t -81.55 -54.71 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -75.72 -30.96 59.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 14.5 t -56.89 -38.0 72.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.599 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -79.35 0.77 27.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -108.15 23.81 13.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.15 62.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.639 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.456 ' CZ ' ' HD2' ' A' ' 228' ' ' PRO . 20.1 m-85 -134.74 168.07 19.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -94.84 -150.58 27.28 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.04 136.72 11.84 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.755 2.303 . . . . 0.0 112.099 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.628 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 2.6 mm -59.14 123.16 10.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.645 ' HG1' ' C ' ' A' ' 143' ' ' GLN . 53.2 p -79.41 5.1 13.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.995 . . . . 0.0 110.744 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.516 ' OG1' ' CG2' ' A' ' 189' ' ' ILE . 31.3 m -43.81 110.94 0.24 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.745 ' CB ' HH22 ' A' ' 156' ' ' ARG . 4.0 t0 -77.14 117.74 18.99 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.945 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.17 123.62 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.68 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -163.54 155.96 17.92 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.366 -0.834 . . . . 0.0 109.089 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.74 167.32 9.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 62.75 66.2 2.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.472 ' HG3' ' CG ' ' A' ' 160' ' ' TYR . 78.5 mm-40 -111.3 102.87 11.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -1.199 . . . . 0.0 109.429 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 197' ' ' GLN . 61.9 t -41.67 155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.424 -0.798 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.587 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 22.1 t80 -117.64 151.52 37.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.865 . . . . 0.0 109.505 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -152.01 98.33 2.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.506 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 19.6 m-85 -54.0 136.13 41.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 110.554 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.451 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -87.27 -177.97 6.09 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.8 pt-20 -75.29 175.56 8.24 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.381 -0.825 . . . . 0.0 109.478 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -52.04 67.03 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.477 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.13 -19.25 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.601 -0.687 . . . . 0.0 109.874 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.786 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 7.2 m-70 -96.99 7.84 45.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 110.327 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.829 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.0 mm-40 -127.0 -142.04 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.308 1.052 . . . . 0.0 110.491 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.615 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -35.46 -3.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.352 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.829 ' N ' ' O ' ' A' ' 207' ' ' GLN . 88.2 t80 -40.85 -43.45 2.05 Favored 'General case' 0 N--CA 1.514 2.761 0 O-C-N 120.431 -1.418 . . . . 0.0 110.431 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.427 ' H ' HD12 ' A' ' 210' ' ' LEU . 4.5 mp -75.87 -13.44 60.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.425 -1.422 . . . . 0.0 110.085 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.576 ' OG ' ' O ' ' A' ' 208' ' ' GLN . 79.8 p -57.88 -44.2 86.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 -9.01 54.45 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.538 -0.726 . . . . 0.0 109.498 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.441 ' N ' ' HD3' ' A' ' 214' ' ' PRO . 10.3 m120 -137.13 66.8 54.38 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.441 ' HD3' ' N ' ' A' ' 213' ' ' ASN . 12.3 Cg_exo -67.29 9.59 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.013 2.476 . . . . 0.0 112.237 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.497 ' OD1' ' C ' ' A' ' 215' ' ' ASP . 1.1 p30 -63.07 -18.92 63.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.537 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.62 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.71 85.35 0.05 OUTLIER Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.157 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.661 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 87.2 t80 -48.91 -171.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.314 2.057 . . . . 0.0 109.052 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.661 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 13.2 m -72.29 76.65 1.0 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.661 -1.275 . . . . 0.0 108.852 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.94 17.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 4.8 mp -85.25 -177.54 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -1.212 . . . . 0.0 109.777 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.96 90.61 0.08 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.59 171.22 14.32 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.59 ' C ' ' H ' ' A' ' 225' ' ' VAL . 1.6 t -143.5 8.31 1.55 Allowed 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 114.919 -0.64 . . . . 0.0 109.713 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -73.5 23.57 0.99 Allowed Glycine 0 C--N 1.303 -1.294 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.59 ' H ' ' C ' ' A' ' 223' ' ' THR . 4.0 p -111.53 163.69 8.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.715 -0.873 . . . . 0.0 109.954 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.52 110.06 22.55 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 122.167 0.984 . . . . 0.0 109.054 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.566 ' CB ' ' CD ' ' A' ' 228' ' ' PRO . 1.3 m -72.37 -72.32 0.21 Allowed Pre-proline 0 C--N 1.279 -2.48 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 72.8 Cg_endo -74.39 -40.7 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.192 1.928 . . . . 0.0 109.828 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.544 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -54.66 153.08 6.22 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.873 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.52 138.23 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.32 0.581 . . . . 0.0 109.789 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.558 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -149.78 118.8 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -68.99 42.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 0.0 109.472 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 121.218 -0.926 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.433 ' H72' ' SD ' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.541 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.57 ' O ' ' OG ' ' A' ' 26' ' ' SER . 4.6 m-20 -35.53 107.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -1.112 . . . . 0.0 109.365 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.5 m -67.93 -33.39 74.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 110.078 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -72.96 -10.24 59.58 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 123.282 1.515 . . . . 0.0 109.505 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 23' ' ' ASP . 95.3 p -49.4 -65.26 0.6 Allowed 'General case' 0 C--N 1.26 -3.285 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.645 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.664 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -103.81 45.94 0.94 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.63 1.205 . . . . 0.0 111.278 -178.097 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.661 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -143.91 12.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.607 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 179.061 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -36.22 166.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.736 1.255 . . . . 0.0 109.189 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.05 124.66 28.11 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.617 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.28 60.28 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.506 -0.746 . . . . 0.0 109.183 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -81.64 -4.67 56.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' LEU . 5.7 mt-10 -98.02 -36.23 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 35' ' ' LEU . . . -35.59 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.653 ' O ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER -40.48 162.41 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.506 ' C ' ' H ' ' A' ' 38' ' ' ARG . 60.5 Cg_exo -50.76 -30.67 30.14 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.971 1.781 . . . . 0.0 110.911 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.538 ' O ' ' O ' ' A' ' 100' ' ' ASN . . . 65.2 -38.8 0.11 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.506 ' H ' ' C ' ' A' ' 36' ' ' PRO . 7.9 ttt180 -53.38 121.54 7.83 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.737 -1.449 . . . . 0.0 109.315 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 41' ' ' PRO . 4.4 m -127.89 31.87 5.04 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.656 ' C ' ' O ' ' A' ' 39' ' ' THR . 3.1 tm-20 -8.17 75.44 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.142 0 CA-C-O 121.41 0.624 . . . . 0.0 110.679 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.673 ' N ' ' O ' ' A' ' 39' ' ' THR . 72.2 Cg_endo -90.97 -177.3 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.695 2.93 . . . . 0.0 112.511 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.8 pt -102.08 149.75 36.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 109.023 179.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -39.85 164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.92 2.413 . . . . 0.0 112.554 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.2 m -106.87 -154.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.573 ' O ' ' OG1' ' A' ' 55' ' ' THR . 9.9 t -80.09 86.79 5.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.231 -0.918 . . . . 0.0 110.14 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.612 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.41 -37.65 70.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.383 -0.823 . . . . 0.0 111.016 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.8 mtmt -93.24 98.86 11.55 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 116.33 -2.148 . . . . 0.0 108.15 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.661 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.14 107.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -30.45 64.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.807 . . . . 0.0 111.133 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.48 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 13.2 t -66.65 -43.59 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.788 -1.195 . . . . 0.0 109.554 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.38 -42.17 4.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.135 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.06 0.97 48.33 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 46.4 m-20 -72.14 -119.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -127.92 174.17 9.39 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 123.506 1.622 . . . . 0.0 110.103 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.612 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 10.3 p -150.89 22.13 0.78 Allowed 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.134 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.578 ' CG1' ' O ' ' A' ' 55' ' ' THR . 2.5 m -167.79 143.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.918 -1.114 . . . . 0.0 109.542 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' A' ' 56' ' ' VAL . 32.6 mt-10 -32.46 142.76 0.16 Allowed Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.442 -0.786 . . . . 0.0 110.462 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -77.52 167.1 80.02 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.224 -1.99 . . . . 0.0 111.661 0.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -100.39 132.69 22.12 Favored Pre-proline 0 C--N 1.271 -2.835 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.905 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.526 ' O ' ' OG1' ' A' ' 63' ' ' THR . 45.5 Cg_exo -49.51 114.61 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.999 1.799 . . . . 0.0 112.199 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.71 118.39 3.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -8.26 20.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.526 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -83.12 137.13 34.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.107 . . . . 0.0 109.795 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.77 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.1 tp60 -103.66 155.33 18.64 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.374 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.734 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -161.79 137.27 7.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.276 -1.515 . . . . 0.0 112.434 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.28 -168.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.96 115.02 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.785 -1.822 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 1.5 p90 -163.29 156.04 18.61 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 109.719 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.92 164.16 30.31 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' ' OD1' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -114.8 -88.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -1.111 . . . . 0.0 109.052 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . -125.07 -152.14 8.2 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.681 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.4 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.412 -1.052 . . . . 0.0 108.193 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.729 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -49.45 5.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.361 -0.837 . . . . 0.0 111.665 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.783 ' CZ2' ' CE1' ' A' ' 206' ' ' HIS . 5.1 m0 -69.52 -49.84 50.76 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.277 -1.514 . . . . 0.0 108.549 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.52 -49.65 76.31 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.13 -27.52 57.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.964 -1.315 . . . . 0.0 110.202 -179.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.57 ' OE2' ' O ' ' A' ' 77' ' ' GLU . 6.9 tp10 -52.1 -34.85 45.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.907 -1.12 . . . . 0.0 110.153 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 21.7 ttt-85 -106.52 -56.69 2.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.979 -1.076 . . . . 0.0 111.36 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' C ' ' O ' ' A' ' 78' ' ' ARG . 0.3 OUTLIER -38.69 -17.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 110.262 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 11.6 m-85 -91.52 -42.7 10.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.702 -1.249 . . . . 0.0 110.953 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.531 ' CE3' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -70.91 -4.61 25.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.745 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -83.62 14.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.752 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 96.4 mt -90.69 164.0 14.3 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -93.19 138.12 31.88 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.451 0.643 . . . . 0.0 110.359 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.44 ' CA ' ' HB3' ' A' ' 123' ' ' PRO . . . 89.65 -19.12 42.67 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.22 137.91 18.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.945 -1.326 . . . . 0.0 109.775 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.571 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -76.73 -40.89 47.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.676 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 177.12 -160.38 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.079 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.553 ' N ' ' OG ' ' A' ' 88' ' ' SER . 70.2 p -160.33 150.97 18.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.676 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 8.6 mp0 -144.68 164.43 30.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.554 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.2 OUTLIER -144.53 156.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.061 -1.024 . . . . 0.0 110.008 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 176.29 45.93 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 1.4 m-85 -88.77 164.78 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.356 -1.085 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.677 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.73 174.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.144 -0.973 . . . . 0.0 109.642 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 53.17 46.96 62.03 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.511 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -135.87 -152.38 6.36 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 120.945 -1.326 . . . . 0.0 110.381 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 2.5 t-160 -153.29 63.63 0.76 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.535 -0.979 . . . . 0.0 108.856 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.653 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.95 142.37 16.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 101' ' ' PRO . 31.0 mtp180 -49.26 177.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 108.548 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.567 ' C ' ' O ' ' A' ' 99' ' ' ARG . 2.6 m-80 -33.84 94.92 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.332 -0.855 . . . . 0.0 109.111 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 60.9 Cg_endo -85.62 163.07 10.82 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.81 2.34 . . . . 0.0 112.503 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.589 ' OG1' ' OE1' ' A' ' 105' ' ' GLU . 21.5 p -121.02 170.78 9.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.692 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.777 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 13.6 t80 -60.37 -59.56 5.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.0 110.295 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -55.48 -36.73 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 108.309 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.589 ' OE1' ' OG1' ' A' ' 102' ' ' THR . 0.1 OUTLIER -58.27 -62.01 2.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.258 0.552 . . . . 0.0 110.345 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.686 ' O ' ' N ' ' A' ' 109' ' ' GLU . 27.1 m -65.04 -23.98 34.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.264 -0.897 . . . . 0.0 110.856 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.604 ' C ' ' H ' ' A' ' 109' ' ' GLU . 42.9 t -42.13 -44.18 3.57 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.79 ' C ' ' H ' ' A' ' 110' ' ' LYS . 33.2 t -69.42 13.23 0.13 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.24 -0.912 . . . . 0.0 108.735 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER 51.95 -16.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.514 0.726 . . . . 0.0 110.755 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.79 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -45.88 -30.43 1.73 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.67 -0.644 . . . . 0.0 110.186 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.63 ' OG1' ' CG1' ' A' ' 106' ' ' VAL . 48.7 p -84.53 11.77 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.129 . . . . 0.0 109.073 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 24.72 44.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.677 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 2.6 m-70 -83.91 170.83 13.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.492 -1.593 . . . . 0.0 109.214 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.42 ' HB2' ' CB ' ' A' ' 158' ' ' ALA . . . -118.55 114.21 22.46 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.693 ' OE2' ' CG ' ' A' ' 73' ' ' PHE . 1.9 mm-40 -51.19 118.25 3.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.407 ' CG1' ' CE2' ' A' ' 160' ' ' TYR . 0.8 OUTLIER -125.21 136.18 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.05 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.406 ' N ' ' O ' ' A' ' 68' ' ' PHE . 0.9 OUTLIER -116.85 125.01 73.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 118' ' ' ARG . 2.7 ptm180 -104.7 116.37 31.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 110.723 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -124.57 114.25 39.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.445 ' CA ' ' O ' ' A' ' 64' ' ' GLN . 0.7 OUTLIER -95.43 159.51 2.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.041 -1.037 . . . . 0.0 111.698 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.77 ' O ' ' N ' ' A' ' 64' ' ' GLN . 5.7 p90 -138.95 136.61 35.61 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 123.518 1.628 . . . . 0.0 111.592 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.967 ' N ' ' CD ' ' A' ' 123' ' ' PRO . 6.9 ptt-85 -137.16 -1.09 0.03 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.621 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.967 ' CD ' ' N ' ' A' ' 122' ' ' ARG . 56.2 Cg_endo -71.53 -27.75 18.45 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 124.288 3.325 . . . . 0.0 116.838 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 5.1 tt0 72.79 -5.18 1.94 Allowed 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.698 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -105.51 -25.07 12.47 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.756 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -128.4 124.13 61.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.332 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.467 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -132.22 -170.73 2.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.885 -1.135 . . . . 0.0 112.698 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.733 ' N ' ' CE2' ' A' ' 121' ' ' TYR . 60.5 t80 -58.08 -45.39 87.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.569 -0.707 . . . . 0.0 110.497 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.523 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 78.0 mt-10 -46.73 -35.02 5.67 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.523 ' O ' ' C ' ' A' ' 131' ' ' LEU . 17.4 mm-40 -73.77 -63.54 1.19 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.689 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 13.2 mt -34.22 -57.83 0.48 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -76.84 -42.17 41.24 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.403 -1.435 . . . . 0.0 110.996 -178.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.69 ' CB ' ' HZ3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -52.15 -63.07 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.771 -1.205 . . . . 0.0 109.167 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.8 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 t -50.14 -40.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' CZ3' ' A' ' 136' ' ' TRP . 15.8 t80 -56.45 -45.46 80.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.188 -1.57 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.479 ' HB3' ' CE1' ' A' ' 177' ' ' TYR . 29.4 m95 -73.49 -41.57 62.93 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.642 -1.286 . . . . 0.0 111.102 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -67.5 -2.45 6.51 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.749 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.8 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -133.76 48.0 2.4 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.937 -1.727 . . . . 0.0 112.096 -178.939 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.667 ' C ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER 176.21 -164.79 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.646 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -129.49 117.63 18.75 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.572 ' O ' ' N ' ' A' ' 190' ' ' THR . 10.7 Cg_endo -67.12 -4.11 10.98 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.554 1.503 . . . . 0.0 111.615 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -101.3 -13.76 17.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.196 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.599 ' CD ' ' H ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -68.02 70.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.633 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -52.05 -118.26 0.01 OUTLIER Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.659 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.62 39.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -1.041 . . . . 0.0 109.334 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.612 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -156.52 164.83 37.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.681 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -155.52 89.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.566 -1.334 . . . . 0.0 109.44 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.599 ' H ' ' CD ' ' A' ' 143' ' ' GLN . . . 51.72 -113.65 2.56 Favored Glycine 0 N--CA 1.478 1.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -80.48 3.83 20.24 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.434 -0.883 . . . . 0.0 110.236 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -108.28 146.34 33.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.915 -1.116 . . . . 0.0 108.934 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.61 130.42 32.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.053 -1.029 . . . . 0.0 109.961 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.01 163.34 9.48 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.421 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.501 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 44.8 p -73.72 -10.62 59.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.523 -0.986 . . . . 0.0 109.896 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 16.2 pm0 -87.47 -7.08 58.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 32.2 m-85 -124.41 60.43 1.15 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.082 -1.011 . . . . 0.0 108.772 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.472 HH12 ' HB ' ' A' ' 153' ' ' THR . 5.4 ptt-85 -112.96 173.67 6.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 118.57 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.431 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -139.62 116.36 10.83 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' A' ' 192' ' ' ASP . 48.4 t -102.19 148.34 7.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.609 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.412 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 91.0 m-85 -139.23 87.36 13.82 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.776 -1.203 . . . . 0.0 108.554 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -46.02 163.15 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.881 2.387 . . . . 0.0 112.243 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.566 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.14 -21.54 13.24 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 120.635 -1.29 . . . . 0.0 110.553 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 162' ' ' THR . 0.8 OUTLIER -176.48 178.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 0.0 108.929 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.31 -16.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 123.007 1.384 . . . . 0.0 108.484 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.558 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.3 t -59.26 -62.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.812 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.925 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.576 ' O ' ' CB ' ' A' ' 170' ' ' ALA . 4.5 mp0 -77.74 -19.4 55.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 110.381 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.5 ttt -54.09 -54.66 36.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.954 -1.092 . . . . 0.0 109.534 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -54.58 -66.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 109.77 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -57.5 -39.33 76.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.869 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.44 -58.54 6.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.6 mp -53.04 -49.5 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -60.87 -48.55 81.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 109.466 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.473 ' HB2' ' NE1' ' A' ' 136' ' ' TRP . 1.0 OUTLIER -55.97 -40.15 72.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.66 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.554 ' NZ ' ' OG1' ' A' ' 191' ' ' THR . 0.0 OUTLIER -73.04 -58.2 3.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.607 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.97 -44.56 92.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.913 . . . . 0.0 110.81 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 74.8 mt-10 -53.1 -20.21 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.031 . . . . 0.0 110.451 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.479 ' CD2' ' HG3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -79.49 -40.08 30.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.821 -1.174 . . . . 0.0 110.556 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -44.8 65.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.835 -1.166 . . . . 0.0 108.502 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -30.59 5.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 109.286 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.7 t -87.9 -54.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.278 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.477 HD22 ' CG ' ' A' ' 186' ' ' PHE . 25.3 mt -58.99 -45.55 90.34 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.387 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -23.57 22.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.972 -1.08 . . . . 0.0 109.023 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -88.43 -13.84 39.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.338 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 2.9 m-70 -99.85 11.76 38.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 72.0 55.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.73 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.477 ' CG ' HD22 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -119.31 -176.58 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 108.972 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -119.55 -158.13 10.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.561 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.4 Cg_exo -58.63 116.47 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.325 2.017 . . . . 0.0 110.771 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.561 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.2 OUTLIER -47.91 -175.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.005 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.633 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 26.8 p -154.67 55.34 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.654 -0.653 . . . . 0.0 110.384 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.554 ' OG1' ' NZ ' ' A' ' 174' ' ' LYS . 32.9 m -99.93 119.05 37.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 17.2 t0 -75.9 111.06 10.88 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.389 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.449 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 1.0 OUTLIER -117.33 114.82 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 110.466 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.799 ' HE ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -165.0 -170.16 1.87 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.539 ' OE2' ' C ' ' A' ' 194' ' ' ARG . 9.4 mp0 -145.82 178.66 8.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.309 . . . . 0.0 110.389 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.23 14.91 67.88 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.077 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.799 ' NE2' ' HE ' ' A' ' 194' ' ' ARG . 1.2 mp0 -89.35 126.47 35.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.502 -1.587 . . . . 0.0 109.784 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.31 154.87 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.468 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 6.7 t80 -92.82 124.79 37.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.13 95.09 5.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.285 -0.884 . . . . 0.0 108.975 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.46 ' CE1' HG13 ' A' ' 56' ' ' VAL . 22.8 m-85 -54.41 133.87 45.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.322 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.476 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -84.58 -175.75 5.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.722 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.2 pm0 -74.89 171.5 13.92 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -58.52 -53.84 53.74 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.66 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -51.35 -11.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.016 -1.052 . . . . 0.0 111.118 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.783 ' CE1' ' CZ2' ' A' ' 74' ' ' TRP . 12.2 m-70 -101.49 10.27 40.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.709 -1.245 . . . . 0.0 110.335 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.0 mm-40 -131.12 -146.46 0.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.233 1.015 . . . . 0.0 110.009 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.631 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 12.8 mp0 -33.87 -8.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.444 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 11.3 t80 -44.95 -40.52 6.45 Favored 'General case' 0 N--CA 1.515 2.815 0 O-C-N 120.146 -1.596 . . . . 0.0 109.343 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -52.61 -18.43 1.76 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 120.868 -1.145 . . . . 0.0 110.47 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 p -61.39 -39.7 91.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -71.02 -33.07 70.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.306 -0.871 . . . . 0.0 109.687 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 215' ' ' ASP . 5.6 m-80 -134.27 70.0 73.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.441 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.449 ' HB3' ' NE ' ' A' ' 78' ' ' ARG . 24.3 Cg_exo -60.76 8.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.039 2.492 . . . . 0.0 112.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.487 ' H ' ' C ' ' A' ' 213' ' ' ASN . 10.1 t0 -63.37 -18.97 64.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.524 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.79 85.32 0.05 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.512 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.74 92.97 9.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.598 2.199 . . . . 0.0 109.388 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.727 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -169.72 112.74 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 109.491 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -0.33 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.505 3.294 0 CA-C-O 122.464 1.036 . . . . 0.0 112.711 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.78 -173.71 2.76 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.676 -0.896 . . . . 0.0 109.69 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -82.73 -149.04 7.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -153.64 -136.66 2.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.515 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER 45.26 25.0 0.17 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.286 -1.126 . . . . 0.0 109.131 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -163.12 40.26 0.34 Allowed Glycine 0 C--N 1.302 -1.355 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.404 ' O ' ' CG1' ' A' ' 225' ' ' VAL . 2.7 t -66.74 96.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -1.159 . . . . 0.0 109.133 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.56 ' H ' ' CB ' ' A' ' 229' ' ' MET . 0.3 OUTLIER -98.41 -153.0 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.11 0.957 . . . . 0.0 109.507 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.574 ' CB ' ' CD ' ' A' ' 228' ' ' PRO . 1.2 m -71.24 -68.27 0.49 Allowed Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 45.9 Cg_endo -68.6 -39.42 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.427 2.084 . . . . 0.0 109.51 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.56 ' CB ' ' H ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -54.35 151.06 7.95 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.745 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -32.77 131.77 0.16 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.188 0.518 . . . . 0.0 109.817 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.2 mm -128.0 103.99 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.2 -0.937 . . . . 0.0 109.396 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -23.18 55.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.427 -0.795 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.357 0 O-C-N 121.287 -0.883 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.464 H112 HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.508 ' OD2' ' OG ' ' A' ' 26' ' ' SER . 19.0 t70 -65.27 65.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -1.189 . . . . 0.0 109.393 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 22' ' ' GLY . 4.4 t -50.85 -19.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.758 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -62.32 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 123.265 1.507 . . . . 0.0 110.694 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.508 ' OG ' ' OD2' ' A' ' 23' ' ' ASP . 59.5 p -47.3 -7.09 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.967 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.674 ' NZ ' ' CB ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -105.46 23.14 14.26 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 124.305 2.002 . . . . 0.0 109.538 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.635 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -156.74 21.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.257 -3.433 0 CA-C-N 112.845 -1.98 . . . . 0.0 105.717 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.635 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.75 168.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.744 1.259 . . . . 0.0 109.539 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.09 124.47 31.8 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.68 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -55.9 -46.01 78.49 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.761 -0.587 . . . . 0.0 109.576 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.57 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 3.1 pm0 -78.46 15.77 0.93 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.569 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.582 ' O ' ' C ' ' A' ' 34' ' ' ALA . 10.1 tp10 -116.07 -40.6 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.6 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -29.0 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.766 . . . . 0.0 110.108 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -37.58 161.26 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -59.73 -41.98 50.41 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.064 1.842 . . . . 0.0 111.676 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.93 134.54 4.41 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.542 ' CG ' ' H ' ' A' ' 39' ' ' THR . 14.5 ttp180 -110.75 177.78 4.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -1.112 . . . . 0.0 109.518 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.542 ' H ' ' CG ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -124.57 33.52 5.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.586 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.83 98.88 27.2 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.009 . . . . 0.0 109.65 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.78 170.78 15.14 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.726 2.284 . . . . 0.0 112.211 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.06 100.56 7.88 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.938 . . . . 0.0 109.639 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.21 168.19 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.595 2.197 . . . . 0.0 112.209 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.448 HG11 ' N ' ' A' ' 204' ' ' ASP . 12.5 m -139.39 170.4 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.167 -0.958 . . . . 0.0 109.675 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.538 ' CG2' ' O ' ' A' ' 45' ' ' THR . 13.4 t -58.82 103.77 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.356 -0.84 . . . . 0.0 110.231 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.572 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.92 -50.13 73.51 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.359 -0.838 . . . . 0.0 111.479 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.4 pttt -70.74 100.62 1.92 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 115.846 -2.342 . . . . 0.0 108.168 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.591 ' NE2' ' CD ' ' A' ' 208' ' ' GLN . 6.3 t-80 -31.95 125.02 0.28 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.003 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -66.65 -8.08 25.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 110.848 -178.733 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.459 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 18.9 t -92.98 -63.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.161 . . . . 0.0 109.805 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -83.56 -42.76 16.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.0 5.5 54.82 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.3 p30 -81.52 -119.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.689 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttp180 -129.54 168.67 16.04 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.989 1.376 . . . . 0.0 108.418 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.572 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 20.8 p -128.38 30.68 5.14 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.94 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 55' ' ' THR . 7.0 m -161.29 132.58 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-10 -33.78 154.41 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.314 0 CA-C-O 121.899 0.857 . . . . 0.0 110.852 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.442 ' HD2' ' NH2' ' A' ' 54' ' ' ARG . 96.5 Cg_endo -79.44 166.28 78.52 Favored 'Cis proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.48 -2.3 . . . . 0.0 111.756 -0.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.469 ' CE1' HG13 ' A' ' 120' ' ' VAL . 32.6 m-85 -108.37 154.51 41.39 Favored Pre-proline 0 C--N 1.267 -3.005 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.041 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.445 ' O ' ' OG1' ' A' ' 63' ' ' THR . 51.3 Cg_exo -49.51 148.88 10.63 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.33 2.02 . . . . 0.0 112.468 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -55.95 132.79 50.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.84 53.91 2.6 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -136.23 137.1 40.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -1.051 . . . . 0.0 109.44 -179.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' OE1' ' CA ' ' A' ' 64' ' ' GLN . 1.6 tp60 -123.85 125.43 44.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.688 ' SD ' ' NH2' ' A' ' 118' ' ' ARG . 3.5 ptt? -109.63 141.28 42.39 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.621 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.43 -167.29 1.87 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.0 129.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.081 -1.637 . . . . 0.0 109.446 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.483 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 59.1 m-85 -117.82 125.75 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.116 -0.99 . . . . 0.0 108.61 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 157' ' ' SER . . . -113.13 105.81 1.72 Allowed Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.023 -1.56 . . . . 0.0 110.146 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.723 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -107.86 -88.79 0.47 Allowed 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.449 -1.03 . . . . 0.0 108.666 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' N ' ' OE2' ' A' ' 115' ' ' GLU . . . -146.92 -152.73 5.71 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.812 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -36.42 106.05 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 108.956 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.85 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.419 -0.801 . . . . 0.0 112.307 -178.225 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.812 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 21.1 m0 -67.48 -48.73 66.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.076 -1.64 . . . . 0.0 109.412 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.43 5.42 57.21 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.55 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.726 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.42 -41.86 38.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.276 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 90' ' ' GLN . 2.6 tp10 -83.39 -14.82 51.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.15 -0.969 . . . . 0.0 111.786 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.598 ' C ' ' H ' ' A' ' 80' ' ' PHE . 15.0 ttp85 -57.52 -73.13 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.807 -1.183 . . . . 0.0 110.965 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 11.9 mttt -61.71 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.726 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.5 m-85 -115.87 -29.95 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.757 -1.215 . . . . 0.0 110.602 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.565 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.0 OUTLIER -104.26 -0.75 27.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.723 -1.236 . . . . 0.0 109.571 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -93.3 8.51 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 109.105 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.626 ' C ' ' CD1' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -103.3 -179.03 3.84 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -96.72 156.51 16.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.639 -1.288 . . . . 0.0 111.209 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.72 79.88 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.557 -0.714 . . . . 0.0 111.906 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 1.1 t -99.79 129.52 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 120.387 -1.654 . . . . 0.0 110.791 -179.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.588 ' HH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -77.68 -43.8 30.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.53 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t -169.62 -176.74 2.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.434 ' HB ' ' CG ' ' A' ' 77' ' ' GLU . 7.7 p -148.31 149.53 32.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.097 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.576 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 8.8 mp0 -146.71 170.51 16.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.41 -0.806 . . . . 0.0 109.455 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.435 ' CG2' ' HA ' ' A' ' 207' ' ' GLN . 0.1 OUTLIER -146.66 167.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . 178.06 156.02 15.61 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.529 ' N ' ' O ' ' A' ' 200' ' ' TYR . 0.5 OUTLIER -80.01 160.71 25.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.604 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.648 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.56 -170.11 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 0.0 109.875 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.35 22.41 63.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.745 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -128.44 -164.06 11.46 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -145.57 78.5 1.54 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.38 -1.07 . . . . 0.0 109.708 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.498 ' O ' ' C ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -147.36 135.18 21.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.616 ' C ' HD21 ' A' ' 100' ' ' ASN . 5.9 mtt180 -38.84 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.616 HD21 ' C ' ' A' ' 99' ' ' ARG . 1.1 m-80 -122.47 89.5 49.47 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 109.668 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -70.87 132.81 22.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.834 2.356 . . . . 0.0 110.848 179.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.472 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 21.1 p -124.21 159.43 30.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.845 -1.159 . . . . 0.0 110.614 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 102' ' ' THR . 6.0 t80 -48.41 -38.85 20.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 108.834 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -40.46 64.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.79 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.421 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.0 mm-40 -81.75 -30.99 32.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.472 ' HB ' ' O ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -80.98 -29.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 108.833 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -28.97 64.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.508 -0.745 . . . . 0.0 109.496 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.677 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 51.6 p -62.67 -70.46 0.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.677 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.9 mt-10 140.4 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -48.22 1.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 110.939 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' GLU . 14.4 p -108.25 -7.47 15.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.814 -1.179 . . . . 0.0 109.55 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 43.03 51.0 6.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.745 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 15.4 m-70 -97.27 169.19 9.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.295 . . . . 0.0 108.929 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.2 113.08 17.82 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.665 ' OE2' ' N ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -51.7 114.67 1.34 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.959 . . . . 0.0 108.939 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.479 HG12 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -125.34 157.66 34.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.483 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 20.6 m -130.14 131.96 65.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.688 ' NH2' ' SD ' ' A' ' 65' ' ' MET . 10.6 ptm180 -103.68 130.34 51.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.738 -1.226 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.484 ' CG1' ' OE2' ' A' ' 77' ' ' GLU . 0.2 OUTLIER -132.86 138.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.469 HG13 ' CE1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.61 122.0 63.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.713 ' N ' ' CD1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -125.41 166.88 15.79 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.472 -177.767 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.471 ' HG2' ' H ' ' A' ' 125' ' ' HIS . 4.5 ttm180 -99.26 114.1 65.29 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.668 -0.645 . . . . 0.0 110.534 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -50.85 -42.37 51.78 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.406 2.07 . . . . 0.0 111.785 178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -57.28 -23.09 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.299 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.471 ' H ' ' HG2' ' A' ' 122' ' ' ARG . 1.1 m-70 -104.86 -56.02 2.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 108.849 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.42 ' CD1' ' HG3' ' A' ' 130' ' ' GLU . 3.3 tp -130.25 133.43 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.541 ' H ' ' HG ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -78.47 168.53 19.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.16 -0.963 . . . . 0.0 110.42 -178.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' CE2' HD13 ' A' ' 132' ' ' LEU . 4.0 t80 -69.56 -44.87 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.464 ' HG3' ' N ' ' A' ' 130' ' ' GLU . 1.3 pt-20 -47.95 -31.06 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.464 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 11.8 mm-40 -57.38 -70.02 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 111.216 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.514 ' N ' ' CD1' ' A' ' 131' ' ' LEU . 8.5 mp -56.31 -27.13 54.55 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.133 -1.604 . . . . 0.0 110.078 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.488 HD13 ' CE2' ' A' ' 128' ' ' PHE . 5.0 mt -55.91 -30.54 61.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.382 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.441 ' HB2' ' HZ1' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -70.63 -52.0 24.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.686 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 9.2 t -49.91 -30.7 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 108.461 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 51.3 t80 -70.79 -46.6 62.58 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.028 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.475 ' HB3' ' CD1' ' A' ' 177' ' ' TYR . 58.2 m95 -72.68 -60.94 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.396 -1.44 . . . . 0.0 110.719 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 14.8 tm-20 -37.93 -56.98 1.07 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.311 -0.868 . . . . 0.0 111.789 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.743 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 4.6 p30 -96.55 61.55 1.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.011 -1.056 . . . . 0.0 110.681 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.765 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 13.4 m80 -152.99 -161.81 1.36 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.669 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -121.24 178.06 1.31 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' CD ' ' OD2' ' A' ' 140' ' ' ASP . 9.7 Cg_exo -69.09 -83.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.257 1.971 . . . . 0.0 112.005 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -124.83 13.44 8.55 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.378 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 140' ' ' ASP . 2.6 mt-30 -55.45 70.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.008 -1.058 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.79 13.67 51.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.674 ' CB ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -115.41 2.42 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -1.083 . . . . 0.0 109.296 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' NE ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER 174.98 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.245 -0.909 . . . . 0.0 109.223 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.92 103.11 11.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 119.581 -1.949 . . . . 0.0 108.822 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' NE ' ' A' ' 146' ' ' ARG . . . 67.21 -118.74 10.55 Favored Glycine 0 C--N 1.301 -1.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.79 -33.17 30.99 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-N 114.381 -0.909 . . . . 0.0 112.377 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.632 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 4.5 m-20 -72.19 99.1 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.229 -1.544 . . . . 0.0 110.415 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.655 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 10.5 p90 -92.92 128.83 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.82 177.58 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.21 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -82.87 -0.49 48.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -1.135 . . . . 0.0 109.602 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.413 ' HG3' ' CE1' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -100.81 4.33 42.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.113 -0.992 . . . . 0.0 109.308 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.541 ' CG ' ' CB ' ' A' ' 150' ' ' ASP . 29.4 m-85 -124.65 58.41 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 108.74 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -110.18 -177.09 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.514 -0.741 . . . . 0.0 109.347 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 69' ' ' GLY . 31.1 t -90.66 128.39 36.61 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.45 ' HB2' ' CE1' ' A' ' 160' ' ' TYR . . . -151.01 113.19 4.56 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.715 -1.594 . . . . 0.0 111.553 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.434 ' CG2' ' CG2' ' A' ' 191' ' ' THR . 5.8 t -113.71 122.33 67.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.479 ' CE2' HG12 ' A' ' 116' ' ' VAL . 11.0 m-30 -111.03 124.64 32.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 O-C-N 121.583 -0.698 . . . . 0.0 109.328 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.26 176.53 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.767 2.311 . . . . 0.0 112.193 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.96 -23.54 19.54 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 174.33 -162.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.6 -15.57 7.83 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 123.039 1.4 . . . . 0.0 108.549 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.418 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.3 t -55.82 -63.46 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.817 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.321 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.495 HE22 ' NE2' ' A' ' 64' ' ' GLN . 16.8 mt-30 -78.56 -12.59 60.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.707 . . . . 0.0 111.375 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 6.0 ttm -52.6 -44.89 66.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.685 -1.26 . . . . 0.0 109.915 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -75.63 -20.35 58.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 109.759 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.61 -52.78 4.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.006 . . . . 0.0 110.0 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.53 -42.0 63.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.73 -31.02 35.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.334 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -74.41 -35.56 63.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.469 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 76.8 p -56.68 -46.11 81.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 109.781 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -70.21 -44.36 68.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -72.16 -15.85 61.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 109.876 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.37 -57.75 3.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.26 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.475 ' CD1' ' HB3' ' A' ' 136' ' ' TRP . 7.7 t80 -67.21 -37.26 83.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 187' ' ' GLY . 14.2 tp60 -62.21 -10.96 12.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -37.89 65.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.57 -37.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.028 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.65 ' C ' ' H ' ' A' ' 183' ' ' LYS . 4.2 mm? -67.58 -48.52 66.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.089 -1.007 . . . . 0.0 109.733 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t -56.04 1.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.965 -1.084 . . . . 0.0 109.213 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 181' ' ' LEU . 21.8 ttpt -78.1 -53.48 7.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 108.971 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.743 ' CD2' ' CE2' ' A' ' 186' ' ' PHE . 0.0 OUTLIER -75.64 7.2 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.4 OUTLIER 73.29 64.07 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 109.8 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.743 ' CE2' ' CD2' ' A' ' 184' ' ' HIS . 21.4 m-85 -99.27 174.38 6.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.21 -0.931 . . . . 0.0 108.723 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -77.1 175.6 53.87 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.599 ' O ' ' OG1' ' A' ' 142' ' ' THR . 26.6 Cg_exo -58.95 -175.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.497 2.131 . . . . 0.0 111.617 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.486 HG22 ' H ' ' A' ' 191' ' ' THR . 1.1 mm -89.41 112.23 24.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.058 -1.027 . . . . 0.0 109.675 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.559 ' N ' ' HG1' ' A' ' 142' ' ' THR . 2.3 t -78.33 -3.07 41.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 109.444 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.486 ' H ' HG22 ' A' ' 189' ' ' ILE . 20.6 m -42.95 114.46 0.61 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.601 1.191 . . . . 0.0 108.101 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.664 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 4.1 t70 -76.14 116.94 17.32 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.962 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.81 100.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.851 . . . . 0.0 109.297 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.664 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -154.45 151.74 29.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 109.026 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.661 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -109.55 -175.7 2.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.71 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.06 34.06 48.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -106.95 118.79 37.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 5.4 p -57.04 159.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.529 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 13.5 t80 -113.7 126.6 55.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.576 ' OH ' ' O ' ' A' ' 99' ' ' ARG . 6.9 m-85 -127.86 103.12 7.09 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.17 -0.956 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -54.32 137.62 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 111.191 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.491 ' CB ' ' CE1' ' A' ' 93' ' ' PHE . . . -88.34 179.59 6.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 3.4 pt-20 -74.56 171.75 13.25 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.417 -0.802 . . . . 0.0 109.302 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.448 ' N ' HG11 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.99 -47.45 85.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.036 -1.04 . . . . 0.0 108.478 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.478 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -50.08 -25.44 3.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 109.826 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.663 ' ND1' ' CD1' ' A' ' 73' ' ' PHE . 14.5 m-70 -92.67 8.28 39.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.98 . . . . 0.0 109.839 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -127.91 -136.77 0.24 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.834 1.302 . . . . 0.0 110.177 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.591 ' CD ' ' NE2' ' A' ' 48' ' ' HIS . 1.4 mp0 -35.01 -4.64 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.196 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.825 ' N ' ' O ' ' A' ' 207' ' ' GLN . 87.6 t80 -41.96 -48.72 4.57 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.616 -1.302 . . . . 0.0 110.537 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.637 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 2.9 mt -50.23 -12.53 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.512 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 209' ' ' TYR . 32.4 t -67.32 -40.36 85.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.219 -0.926 . . . . 0.0 108.921 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.69 -39.7 30.7 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.27 -0.894 . . . . 0.0 109.196 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -119.47 120.37 30.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.483 ' C ' ' H ' ' A' ' 216' ' ' GLY . 58.3 Cg_endo -72.68 -50.48 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.074 1.849 . . . . 0.0 112.672 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 217' ' ' TYR . 5.7 p-10 -62.81 -3.52 1.61 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.048 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.483 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 61.31 -66.68 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 215' ' ' ASP . 38.2 p90 -177.98 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 108.325 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.506 ' N ' ' CD2' ' A' ' 217' ' ' TYR . 10.2 t -73.71 -124.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.039 -1.038 . . . . 0.0 108.676 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 74.53 -164.8 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.2 mp -151.33 -175.17 5.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -73.61 -110.78 0.07 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.687 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -135.81 -141.11 4.28 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 119.562 -1.304 . . . . 0.0 109.893 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 139' ' ' HIS . 50.5 p -38.2 -20.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -1.101 . . . . 0.0 109.177 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . 55.64 7.55 1.56 Allowed Glycine 0 N--CA 1.477 1.429 0 N-CA-C 107.221 -2.351 . . . . 0.0 107.221 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.645 ' H ' ' C ' ' A' ' 223' ' ' THR . 0.5 OUTLIER -49.51 158.92 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 121.325 0.583 . . . . 0.0 110.138 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.32 108.75 21.36 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.094 0.95 . . . . 0.0 109.047 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.494 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -73.74 -57.46 2.52 Favored Pre-proline 0 C--N 1.279 -2.476 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.282 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.544 ' CD ' ' H ' ' A' ' 229' ' ' MET . 41.5 Cg_endo -94.49 -33.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.881 2.388 . . . . 0.0 110.081 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.545 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.2 OUTLIER -55.66 154.57 6.61 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.852 0.834 . . . . 0.0 110.097 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.48 148.99 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.352 0.596 . . . . 0.0 109.862 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.4 mm -131.12 108.84 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.175 -0.953 . . . . 0.0 109.273 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -68.51 150.02 48.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.86 . . . . 0.0 109.584 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.354 0 O-C-N 121.342 -0.849 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.45 H112 HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.451 ' N ' ' H52' ' A' ' 21' ' ' MYR . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -111.46 41.35 1.9 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -1.121 . . . . 0.0 109.716 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.88 -18.45 0.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.095 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -49.37 -92.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 123.221 1.486 . . . . 0.0 110.832 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.546 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 28.0 t -45.14 -11.1 0.01 OUTLIER 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.582 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.678 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -90.14 24.73 2.39 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 124.591 2.138 . . . . 0.0 107.803 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -158.41 21.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.256 -3.462 0 CA-C-N 112.902 -1.953 . . . . 0.0 106.397 -178.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.733 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.29 174.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.359 1.552 . . . . 0.0 109.65 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.8 124.7 25.39 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.112 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.9 86.8 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.24 0.543 . . . . 0.0 109.553 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.565 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.14 0.67 5.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 tt0 -99.41 -48.47 4.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 108.964 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -30.68 152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.547 0.689 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.652 ' O ' ' CG2' ' A' ' 98' ' ' THR . 4.2 mm? -79.32 169.64 19.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.643 ' C ' ' H ' ' A' ' 38' ' ' ARG . 34.5 Cg_exo -59.33 -42.15 52.05 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.093 1.862 . . . . 0.0 111.974 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 100' ' ' ASN . . . 60.56 -16.89 0.04 OUTLIER Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.028 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.674 ' C ' ' H ' ' A' ' 40' ' ' GLU . 38.8 ttt85 -30.53 154.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.188 -1.184 . . . . 0.0 110.144 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.451 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -58.88 25.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.334 -0.854 . . . . 0.0 110.847 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.674 ' H ' ' C ' ' A' ' 38' ' ' ARG . 2.1 mm-40 -44.34 -52.34 17.11 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.87 -1.144 . . . . 0.0 109.352 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.471 ' CD ' ' N ' ' A' ' 40' ' ' GLU . 64.7 Cg_endo -79.68 -178.27 4.44 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.844 2.362 . . . . 0.0 112.53 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -136.19 166.6 26.8 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' A' ' 42' ' ' ILE . 82.9 Cg_exo -44.19 -170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.799 2.333 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.562 ' CG1' ' O ' ' A' ' 43' ' ' PRO . 31.2 m -162.23 161.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.275 -0.891 . . . . 0.0 110.112 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER 25.55 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.693 -0.629 . . . . 0.0 111.195 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.619 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -87.47 -45.42 10.52 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.099 -1.0 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.5 98.99 10.42 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 115.737 -2.385 . . . . 0.0 108.155 179.332 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.677 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.9 t-80 -32.73 115.89 0.2 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.96 -40.88 90.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 0.0 110.501 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.473 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 48.5 t -56.67 -49.69 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 109.867 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -99.59 -46.1 5.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.86 4.06 55.77 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.89 -118.7 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 ttt180 -125.36 171.56 10.33 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.097 1.427 . . . . 0.0 108.689 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.619 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.3 p -131.22 12.06 5.05 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.163 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.564 ' CG1' ' CZ ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -144.78 131.03 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.057 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' VAL . 17.4 mt-10 -34.63 156.51 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 CA-C-O 121.979 0.895 . . . . 0.0 110.818 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -81.44 165.36 74.9 Favored 'Cis proline' 0 C--N 1.3 -1.981 0 C-N-CA 121.466 -2.306 . . . . 0.0 111.992 -0.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.508 ' CE2' ' CG2' ' A' ' 120' ' ' VAL . 28.6 m-85 -112.42 149.61 41.33 Favored Pre-proline 0 C--N 1.267 -3.004 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.765 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' GLU . 10.0 Cg_endo -54.47 140.27 74.46 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.732 2.288 . . . . 0.0 112.195 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 60' ' ' PRO . 4.4 mt-10 -43.47 157.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.23 47.77 42.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.538 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -133.32 135.63 44.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.736 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.538 ' OE1' ' C ' ' A' ' 63' ' ' THR . 3.8 mp0 -123.63 145.82 48.65 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.441 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 3.2 ttp -139.57 145.42 38.58 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 109.793 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.61 -170.61 2.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.44 HG11 ' CD2' ' A' ' 160' ' ' TYR . 22.9 t -144.17 107.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 119.967 -1.708 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.53 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.2 OUTLIER -162.63 162.8 27.24 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.763 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.21 148.15 19.24 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.287 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.701 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 0.8 OUTLIER -85.73 -84.55 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 0.0 108.358 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.715 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.94 75.85 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.715 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 48.3 t 111.13 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -52.58 5.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.574 -1.329 . . . . 0.0 110.797 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.674 ' H ' ' C ' ' A' ' 72' ' ' CYS . 32.6 m0 -89.14 -90.96 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.698 -1.251 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -57.18 -6.09 1.85 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 74' ' ' TRP . . . -76.48 -70.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -1.13 . . . . 0.0 110.953 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.592 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 13.8 tp10 -51.03 -14.71 0.24 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.682 ' O ' ' N ' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -64.0 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.168 . . . . 0.0 110.341 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' A' ' 78' ' ' ARG . 3.9 mmtt -30.62 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 111.349 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.682 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.3 m-85 -76.25 -42.16 46.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.801 -1.187 . . . . 0.0 111.734 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.504 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -85.56 2.29 45.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.486 -1.383 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.423 ' O ' ' CG2' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -97.4 22.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.978 -1.076 . . . . 0.0 109.526 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 34.4 mt -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 108.993 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -92.91 142.94 26.76 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.364 0.602 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.488 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 101.75 -26.91 22.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.74 136.55 26.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.628 -0.925 . . . . 0.0 109.573 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.602 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.61 -44.33 17.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.527 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.1 p -170.8 -169.58 0.79 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 88' ' ' SER . 75.2 p -158.55 165.48 34.42 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.301 -0.875 . . . . 0.0 109.317 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.592 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.51 169.78 11.8 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.363 -0.836 . . . . 0.0 109.021 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' CG2' ' CD ' ' A' ' 207' ' ' GLN . 4.1 m -129.18 -173.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 170.47 160.7 19.53 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.943 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.441 ' CE2' ' HA ' ' A' ' 202' ' ' ALA . 7.7 m-85 -97.51 154.21 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.956 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.417 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . . . -178.6 179.28 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.35 93.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.502 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -136.6 -151.31 6.01 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.0 61.28 1.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 0.0 109.344 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.652 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.47 176.89 12.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CE1' ' A' ' 200' ' ' TYR . 99.5 mtt180 -100.83 -77.49 0.54 Allowed 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 37' ' ' GLY . 39.3 m-80 -117.28 70.77 6.04 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.377 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.456 ' HG3' ' NE2' ' A' ' 113' ' ' HIS . 44.0 Cg_endo -71.87 170.53 18.58 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.746 2.297 . . . . 0.0 112.057 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.638 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.4 p -121.06 171.36 8.72 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.562 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -63.52 -59.33 4.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.631 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -58.42 -23.0 56.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 108.392 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.638 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.0 mm-40 -73.02 -56.45 5.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.397 0.618 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.401 ' CG1' ' OG1' ' A' ' 111' ' ' THR . 17.3 m -65.47 -24.67 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.288 -0.883 . . . . 0.0 111.421 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.631 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 12.5 p -55.61 -23.44 27.53 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.639 ' C ' ' H ' ' A' ' 110' ' ' LYS . 21.4 t -69.62 5.38 1.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.227 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 107' ' ' CYS . 1.9 tt0 59.61 -6.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.272 -0.893 . . . . 0.0 109.483 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.639 ' H ' ' C ' ' A' ' 108' ' ' SER . 18.0 mttt -72.52 -29.37 63.53 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 110.713 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.529 ' O ' ' C ' ' A' ' 112' ' ' GLY . 68.7 p -87.47 -6.59 58.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.878 -1.139 . . . . 0.0 110.541 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 35.31 43.84 0.53 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.439 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.502 ' ND1' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.1 163.17 26.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.393 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -113.49 113.41 25.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 0.0 108.972 179.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.658 ' CD ' ' N ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -50.12 127.02 15.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.48 HG13 ' CE2' ' A' ' 160' ' ' TYR . 2.6 m -151.1 165.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 2.5 m -143.96 149.4 17.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.195 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.766 ' CD ' ' CZ ' ' A' ' 199' ' ' PHE . 10.1 ptm180 -116.84 95.05 4.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 13.6 m -97.06 126.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.927 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.508 ' CG2' ' CE2' ' A' ' 59' ' ' PHE . 3.9 t -80.63 140.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.568 ' CD2' ' CD2' ' A' ' 131' ' ' LEU . 4.5 m-85 -132.05 161.0 34.27 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.079 -1.013 . . . . 0.0 109.224 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.638 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -125.07 109.72 27.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.506 -0.746 . . . . 0.0 110.384 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 124' ' ' GLU . 24.1 Cg_exo -44.43 -61.44 0.58 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.401 2.734 . . . . 0.0 114.493 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 123' ' ' PRO . 38.6 tt0 -25.98 -57.32 0.07 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.402 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.6 22.68 13.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.733 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.492 ' O ' ' O ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -157.87 162.94 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.382 -0.824 . . . . 0.0 108.962 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.488 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -125.94 165.61 18.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.44 -1.412 . . . . 0.0 110.942 -179.096 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.567 ' CZ ' ' CD2' ' A' ' 132' ' ' LEU . 38.6 t80 -70.61 -43.8 68.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 108.988 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.434 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 5.0 mp0 -48.02 -14.6 0.05 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.891 -1.131 . . . . 0.0 108.086 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.558 ' N ' ' O ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -73.67 -69.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.806 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -40.98 -38.7 1.02 Allowed 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.606 -1.308 . . . . 0.0 108.296 179.398 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.567 ' CD2' ' CZ ' ' A' ' 128' ' ' PHE . 4.2 mm? -75.42 -35.13 61.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.525 -0.734 . . . . 0.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 130' ' ' GLU . 0.5 OUTLIER -70.28 -57.68 4.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.964 -1.085 . . . . 0.0 111.256 -178.41 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.682 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.6 OUTLIER -50.42 -35.49 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.081 -1.012 . . . . 0.0 109.767 -178.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 50.7 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.526 -0.734 . . . . 0.0 110.485 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.613 ' O ' ' CG2' ' A' ' 223' ' ' THR . 90.5 m95 -72.8 -33.19 66.08 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.866 -1.146 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -79.43 -21.52 45.43 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.2 m-80 -121.28 53.69 1.15 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.102 -1.624 . . . . 0.0 113.443 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.786 ' NE2' ' CZ ' ' A' ' 135' ' ' PHE . 0.2 OUTLIER 172.51 -175.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.186 0.993 . . . . 0.0 110.13 176.564 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 142' ' ' THR . 3.5 t70 -128.3 134.98 26.85 Favored Pre-proline 0 C--N 1.291 -1.959 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.429 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.566 ' O ' ' N ' ' A' ' 190' ' ' THR . 72.0 Cg_endo -80.31 -11.15 13.36 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.353 2.035 . . . . 0.0 112.854 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.615 ' N ' ' OD1' ' A' ' 140' ' ' ASP . 1.9 p -104.04 50.23 0.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 109.362 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.796 ' N ' ' HG1' ' A' ' 190' ' ' THR . 5.6 mm100 -114.64 83.63 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -38.55 -117.53 0.0 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.922 0.734 . . . . 0.0 112.499 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.671 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 11.0 ptt? -92.87 53.5 2.02 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -1.02 . . . . 0.0 109.507 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' C ' ' O ' ' A' ' 155' ' ' TYR . 28.4 ptt-85 -178.56 154.71 0.79 Allowed 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.701 ' NE2' ' O ' ' A' ' 70' ' ' MET . 6.4 mt-30 -157.18 149.17 22.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.344 -1.473 . . . . 0.0 110.718 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.52 -124.62 3.21 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-O 122.986 1.326 . . . . 0.0 110.66 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -81.54 -35.32 30.43 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.049 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.654 ' OD2' ' SG ' ' A' ' 72' ' ' CYS . 0.0 OUTLIER -87.19 152.2 22.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.316 -1.49 . . . . 0.0 107.92 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.461 ' CB ' ' HB2' ' A' ' 146' ' ' ARG . 8.9 p90 -136.58 154.49 50.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.47 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.671 ' CA ' ' O ' ' A' ' 145' ' ' MET . . . 126.6 178.64 15.4 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 118.48 -1.819 . . . . 0.0 111.642 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.48 ' CG2' ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -66.76 0.86 2.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.638 -0.919 . . . . 0.0 110.584 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 14.8 pm0 -112.38 16.5 19.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.75 -1.219 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.692 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 28.2 m-85 -146.69 59.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.576 ' O ' ' OE2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -114.81 177.05 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.591 ' OG ' ' O ' ' A' ' 190' ' ' THR . 1.0 OUTLIER -90.44 124.36 34.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 119.867 -1.77 . . . . 0.0 106.455 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -142.68 111.48 6.35 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.084 -178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.566 ' O ' ' CG2' ' A' ' 159' ' ' VAL . 1.3 m -113.41 123.98 69.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.253 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.48 ' CE2' HG13 ' A' ' 116' ' ' VAL . 2.4 m-30 -112.7 126.16 28.76 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.75 170.67 17.2 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.146 1.898 . . . . 0.0 112.228 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.498 ' HB ' HE22 ' A' ' 166' ' ' GLN . 0.7 OUTLIER -102.9 -22.19 13.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 120.923 -1.111 . . . . 0.0 110.22 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -176.92 174.59 1.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 108.972 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.49 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 123.081 1.42 . . . . 0.0 108.181 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 163' ' ' SER . 4.9 t -58.06 -62.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.836 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.498 HE22 ' HB ' ' A' ' 162' ' ' THR . 4.6 mp0 -76.68 -12.9 60.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.492 -0.755 . . . . 0.0 110.123 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' MET . . . . . 0.438 ' SD ' ' HA ' ' A' ' 164' ' ' ALA . 32.3 mtt -53.99 -47.97 70.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 109.971 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.047 -1.033 . . . . 0.0 110.161 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.48 -58.82 2.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 0.0 109.866 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.79 -48.55 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.955 . . . . 0.0 109.852 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.06 -42.43 65.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.542 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -68.3 -45.04 74.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.163 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.59 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 8.7 p -56.32 -53.48 56.81 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.453 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -55.91 -58.2 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.453 ' N ' ' HD3' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -60.61 -11.4 7.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.539 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -75.18 -50.45 16.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 110.007 -179.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 181' ' ' LEU . 1.1 m-85 -79.41 -31.16 42.67 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.062 -1.024 . . . . 0.0 109.797 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -63.08 -40.79 98.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -77.82 -26.36 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 98.0 t -87.29 -54.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.021 -1.049 . . . . 0.0 110.058 -179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.511 ' CD2' ' CD2' ' A' ' 177' ' ' TYR . 4.4 mm? -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.4 t -56.22 -35.64 67.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -88.49 9.09 24.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.855 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.462 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 38.5 m-70 -108.41 29.32 7.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.057 -1.027 . . . . 0.0 109.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.92 16.26 5.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -104.53 174.92 5.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.172 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -125.62 -149.02 7.36 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -58.75 106.64 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.379 2.053 . . . . 0.0 110.709 179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -48.08 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 110.409 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.796 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 79.4 p -119.95 47.38 1.75 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.396 0.617 . . . . 0.0 109.746 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.422 ' CG2' HG12 ' A' ' 159' ' ' VAL . 54.2 m -97.94 118.67 35.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 178.017 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.4 t70 -76.08 140.76 42.02 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.42 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.56 93.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.977 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -157.15 153.18 27.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.642 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -119.67 -173.41 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.02 20.76 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 198' ' ' VAL . 61.1 mm-40 -91.63 101.81 14.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.273 . . . . 0.0 109.531 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.527 ' C ' ' O ' ' A' ' 197' ' ' GLN . 3.0 p -35.95 153.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.766 ' CZ ' ' CD ' ' A' ' 118' ' ' ARG . 68.9 t80 -111.13 131.25 55.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CE1' ' O ' ' A' ' 99' ' ' ARG . 42.1 m-85 -127.26 112.65 15.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 0.0 109.419 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.569 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 16.5 m-85 -53.74 142.69 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.075 . . . . 0.0 110.614 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.481 ' O ' ' CG2' ' A' ' 44' ' ' VAL . . . -90.77 178.18 6.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.575 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 3.0 mt-10 -73.67 161.13 30.62 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.557 1.17 . . . . 0.0 110.364 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.413 ' C ' ' H ' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -56.36 -49.72 73.57 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.531 -179.762 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.575 ' OH ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -59.47 -3.75 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.087 -1.008 . . . . 0.0 110.777 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.562 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 14.6 m-70 -101.29 -20.91 15.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.823 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -101.2 -134.36 0.3 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.705 1.24 . . . . 0.0 110.504 -178.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.532 ' O ' ' N ' ' A' ' 211' ' ' SER . 1.3 mp0 -34.88 -2.93 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.442 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.823 ' N ' ' O ' ' A' ' 207' ' ' GLN . 75.9 t80 -41.34 -46.38 3.27 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.191 -1.568 . . . . 0.0 109.952 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.619 ' CD1' ' C ' ' A' ' 74' ' ' TRP . 0.7 OUTLIER -71.34 -13.21 61.8 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.573 -1.329 . . . . 0.0 110.441 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 208' ' ' GLN . 36.9 t -63.38 -38.68 92.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 108.985 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -72.78 -38.73 67.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.357 -0.84 . . . . 0.0 109.35 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.57 77.42 76.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.063 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.675 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 12.7 Cg_exo -66.73 5.08 0.84 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.99 2.46 . . . . 0.0 112.683 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.95 -19.99 64.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.11 84.46 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.829 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 217' ' ' TYR . 78.8 t80 -70.53 83.94 0.6 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 121.108 2.454 . . . . 0.0 109.268 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 43.1 t -168.84 -124.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.966 -1.084 . . . . 0.0 108.803 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.529 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 134.69 153.4 6.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.478 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 75.62 143.15 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -1.106 . . . . 0.0 110.06 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -134.27 -144.43 5.07 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -152.0 -144.3 3.89 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.643 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.3 OUTLIER 41.33 24.34 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.494 -1.004 . . . . 0.0 109.032 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -158.2 37.78 0.52 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.81 98.63 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -1.173 . . . . 0.0 109.141 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.0 107.43 19.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.278 1.037 . . . . 0.0 109.433 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.491 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.43 -57.65 2.07 Favored Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.576 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.527 ' CD ' ' H ' ' A' ' 229' ' ' MET . 41.3 Cg_endo -95.2 -29.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.918 2.412 . . . . 0.0 110.636 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.612 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.5 OUTLIER -55.11 157.18 3.53 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.623 0.725 . . . . 0.0 109.957 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.612 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -18.44 136.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.551 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 233' ' ' LYS . 3.0 tp -153.86 121.46 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.31 -0.869 . . . . 0.0 109.139 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 231' ' ' ILE . 4.5 ttmm -33.75 -32.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.357 -0.84 . . . . 0.0 109.708 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 121.293 -0.879 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.486 ' H52' ' H ' ' A' ' 23' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.676 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.658 ' C ' ' NZ ' ' A' ' 27' ' ' LYS . 1.1 t0 -46.5 84.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -1.189 . . . . 0.0 109.415 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.661 ' N ' ' O ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -50.68 -33.51 22.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.94 -93.89 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 123.403 1.573 . . . . 0.0 111.116 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 m -47.16 -18.38 0.09 Allowed 'General case' 0 C--N 1.257 -3.445 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.793 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.681 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -102.53 22.7 13.09 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 124.412 2.053 . . . . 0.0 109.86 -178.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.721 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -168.16 28.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.665 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -178.788 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.721 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.14 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 123.068 1.413 . . . . 0.0 110.029 -177.812 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.439 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -94.9 123.86 38.61 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.344 179.49 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.537 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -56.74 -57.87 10.57 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.156 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' OE1' ' O ' ' A' ' 32' ' ' GLU . 1.5 pp20? -53.05 -6.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.952 . . . . 0.0 109.915 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.0 tt0 -112.46 -35.99 5.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.613 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -44.88 -179.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.285 -0.884 . . . . 0.0 109.552 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.428 ' HB2' ' HG1' ' A' ' 98' ' ' THR . 4.2 mm? -55.24 169.54 0.45 Allowed Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.29 -49.33 3.67 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.791 2.327 . . . . 0.0 113.221 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.57 ' H ' ' N ' ' A' ' 99' ' ' ARG . . . 100.34 87.75 1.97 Allowed Glycine 0 N--CA 1.5 2.932 0 C-N-CA 118.928 -1.605 . . . . 0.0 111.191 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.666 ' NH2' ' OE2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -101.26 -179.27 3.99 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.421 -1.635 . . . . 0.0 109.233 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.2 p -124.16 32.63 5.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.652 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.666 ' OE2' ' NH2' ' A' ' 38' ' ' ARG . 9.1 tt0 -118.52 75.21 12.27 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.155 -0.966 . . . . 0.0 109.48 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.11 -178.45 4.59 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.87 2.38 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -131.8 103.01 14.64 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 42' ' ' ILE . 74.0 Cg_exo -46.27 -166.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.321 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.1 m -150.56 -179.16 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.592 ' O ' ' OG1' ' A' ' 55' ' ' THR . 9.6 t -34.19 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.773 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.646 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -55.86 -38.75 70.51 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.344 -0.847 . . . . 0.0 111.196 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttp -91.46 98.7 11.84 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 116.15 -2.22 . . . . 0.0 108.678 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.675 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.7 t-80 -31.73 110.95 0.08 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -59.82 -30.79 69.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 110.807 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.468 HG23 ' CE1' ' A' ' 48' ' ' HIS . 3.4 t -64.6 -43.4 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.934 -1.104 . . . . 0.0 109.524 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.86 -44.49 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.941 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.675 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 104.1 1.73 45.03 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.5 p30 -76.15 -112.05 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.607 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -130.68 175.25 9.17 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 123.806 1.765 . . . . 0.0 110.811 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.611 ' HG1' ' C ' ' A' ' 46' ' ' ALA . 6.9 p -149.33 23.35 0.92 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 112.425 -2.17 . . . . 0.0 110.088 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.44 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -157.27 132.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 56' ' ' VAL . 12.7 mt-10 -41.48 156.03 0.22 Allowed Pre-proline 0 C--N 1.304 -1.397 0 CA-C-O 121.855 0.836 . . . . 0.0 110.199 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.24 157.12 62.87 Favored 'Cis proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.494 0.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.769 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 18.7 m-85 -104.15 147.91 35.08 Favored Pre-proline 0 C--N 1.279 -2.496 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 11.7 Cg_endo -57.47 134.21 61.94 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.843 2.362 . . . . 0.0 112.423 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -49.34 158.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 64' ' ' GLN . . . 93.91 -35.88 3.98 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -83.03 134.06 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.784 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 6.2 mp0 -114.98 -175.93 2.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.451 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 2.2 ttp -161.35 149.37 15.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.642 -1.286 . . . . 0.0 110.826 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.71 -174.37 2.67 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 t -146.23 106.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.686 -1.884 . . . . 0.0 109.96 179.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.704 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -140.82 156.39 46.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.963 -1.495 . . . . 0.0 110.359 177.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' CA ' ' OE2' ' A' ' 115' ' ' GLU . . . -132.15 154.18 20.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.746 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -122.81 -91.85 0.55 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.746 ' H ' ' CG ' ' A' ' 70' ' ' MET . . . -134.84 63.76 0.6 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.767 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 48.5 t 109.13 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.505 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -81.43 25.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.363 -1.46 . . . . 0.0 110.873 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.767 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 8.3 m0 -91.6 -72.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.567 -1.333 . . . . 0.0 109.573 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.26 -3.51 65.76 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.712 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.09 -32.89 56.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.198 -1.178 . . . . 0.0 109.473 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.629 ' OE2' ' CA ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -83.69 -15.79 47.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.016 -1.052 . . . . 0.0 110.154 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.699 ' C ' ' H ' ' A' ' 80' ' ' PHE . 28.0 ttt180 -79.46 -67.6 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 110.027 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.459 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 14.2 mttp -54.89 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.613 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.712 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 19.1 m-85 -120.72 -39.7 2.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.879 -1.138 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.675 ' CZ2' ' OG ' ' A' ' 211' ' ' SER . 0.9 OUTLIER -82.28 -3.98 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.764 -1.21 . . . . 0.0 110.03 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.3 m -83.94 17.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.034 -1.041 . . . . 0.0 109.334 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.71 154.53 22.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 137.26 32.51 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.55 -31.89 5.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.72 136.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.57 -0.959 . . . . 0.0 109.549 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.668 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -71.15 -39.91 71.64 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.915 0.864 . . . . 0.0 108.828 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.697 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 179.63 -160.57 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.546 ' N ' ' OG ' ' A' ' 88' ' ' SER . 63.6 p -157.51 151.16 24.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.033 -1.042 . . . . 0.0 109.801 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.697 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 5.1 mp0 -147.32 167.75 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.753 . . . . 0.0 109.028 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.551 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -142.96 168.65 13.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.026 -1.046 . . . . 0.0 109.878 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 177.37 164.07 30.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.484 ' CE2' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -80.11 174.29 11.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -1.078 . . . . 0.0 109.192 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.728 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -175.2 177.04 1.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 50.9 22.13 5.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.518 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -134.64 -164.1 10.43 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.546 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 57.3 p-80 -173.75 105.34 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.398 -1.06 . . . . 0.0 108.904 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.607 ' O ' ' C ' ' A' ' 99' ' ' ARG . 1.6 m -137.72 148.0 45.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.611 ' O ' ' CB ' ' A' ' 38' ' ' ARG . 19.6 tpt180 -33.21 -68.75 0.1 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.486 ' ND2' ' HG3' ' A' ' 99' ' ' ARG . 50.5 m-80 -124.3 95.88 42.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.44 106.0 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.481 2.121 . . . . 0.0 113.224 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 22.0 p -122.08 170.81 9.48 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.94 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.481 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 2.1 t80 -63.45 -58.95 5.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.217 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.663 ' HZ1' ' CB ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -61.58 -22.86 65.57 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.113 -0.992 . . . . 0.0 108.816 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.653 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.1 mm-40 -66.28 -57.54 7.3 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.459 0.647 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.435 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 18.7 m -65.45 -24.78 35.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.844 . . . . 0.0 110.808 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.408 ' C ' ' H ' ' A' ' 109' ' ' GLU . 24.0 t -64.56 -28.47 69.66 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.653 ' C ' ' H ' ' A' ' 110' ' ' LYS . 2.5 t -70.91 2.09 4.75 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' A' ' 111' ' ' THR . 4.8 mp0 58.54 -21.6 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.452 -0.78 . . . . 0.0 110.953 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.653 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -65.75 2.25 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.472 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.478 ' H ' ' C ' ' A' ' 109' ' ' GLU . 3.1 p -107.73 -29.41 9.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.091 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 62.13 49.06 78.64 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.728 ' ND1' ' N ' ' A' ' 94' ' ' ALA . 1.5 m-70 -97.24 173.5 7.19 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.783 -1.422 . . . . 0.0 109.784 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.545 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.37 116.63 18.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.533 ' C ' ' CD ' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -62.36 123.79 19.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.991 -1.068 . . . . 0.0 109.296 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.466 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -128.09 140.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.1 -1.0 . . . . 0.0 109.308 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.423 HG21 ' CG1' ' A' ' 91' ' ' VAL . 2.0 t -103.78 107.32 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.792 ' NH1' ' HH ' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -96.58 96.98 9.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.637 1.208 . . . . 0.0 110.386 -177.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 20.4 m -112.12 128.03 68.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.903 -1.123 . . . . 0.0 108.675 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.434 HG23 ' CD1' ' A' ' 87' ' ' TYR . 0.6 OUTLIER -80.29 169.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.879 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.484 ' CE2' ' HA ' ' A' ' 128' ' ' PHE . 0.4 OUTLIER -156.56 156.27 33.34 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.806 -1.558 . . . . 0.0 111.599 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.67 110.62 35.2 Favored Pre-proline 0 C--N 1.291 -1.958 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.937 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.541 ' O ' ' C ' ' A' ' 124' ' ' GLU . 39.3 Cg_exo -45.32 -63.76 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.068 2.512 . . . . 0.0 113.23 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.2 tp10 -25.69 -43.7 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -127.82 3.76 6.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.707 -1.246 . . . . 0.0 109.898 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.453 ' O ' ' CG2' ' A' ' 126' ' ' ILE . 0.1 OUTLIER -155.15 104.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.05 0.929 . . . . 0.0 108.964 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.3 m -69.81 169.64 12.64 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.774 0.797 . . . . 0.0 111.871 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.559 ' CZ ' ' CD1' ' A' ' 132' ' ' LEU . 36.9 t80 -69.39 -27.92 65.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 109.43 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 133' ' ' LYS . 2.5 mt-10 -62.69 -19.77 64.2 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.517 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.55 ' O ' ' C ' ' A' ' 131' ' ' LEU . 3.2 mm-40 -66.63 -72.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.042 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.778 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -42.05 -40.05 2.13 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.559 ' CD1' ' CZ ' ' A' ' 128' ' ' PHE . 8.3 mp -75.68 -34.89 60.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.77 . . . . 0.0 111.611 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -58.54 -68.91 0.21 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.504 -1.372 . . . . 0.0 110.085 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.556 ' CG1' ' CE1' ' A' ' 80' ' ' PHE . 58.5 t -51.3 -22.19 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.253 -0.904 . . . . 0.0 109.208 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 34.7 t80 -73.41 -52.18 14.65 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 111.147 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.466 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 58.8 m95 -70.22 -38.72 75.32 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.069 -1.644 . . . . 0.0 111.569 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.48 -43.46 73.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.831 -1.168 . . . . 0.0 111.641 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.486 ' ND2' ' CG1' ' A' ' 134' ' ' VAL . 67.8 m-80 -81.56 59.27 4.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 112.296 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.765 ' CE1' ' O ' ' A' ' 135' ' ' PHE . 46.8 m80 -153.76 -166.59 2.43 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.003 0.906 . . . . 0.0 109.293 176.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -132.87 171.61 8.86 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 140' ' ' ASP . 30.8 Cg_exo -33.5 -103.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.039 1.826 . . . . 0.0 113.334 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.68 ' CG2' ' O ' ' A' ' 142' ' ' THR . 1.5 t -128.45 57.14 1.6 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.041 -1.037 . . . . 0.0 111.428 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.737 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -75.93 84.42 2.85 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.218 -1.551 . . . . 0.0 110.882 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.607 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.39 -115.85 0.0 OUTLIER Glycine 0 N--CA 1.491 2.345 0 CA-C-O 122.097 0.832 . . . . 0.0 111.723 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.739 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.27 25.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.743 -0.857 . . . . 0.0 111.691 -176.873 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.536 ' NH2' ' OD1' ' A' ' 149' ' ' ASN . 10.6 ttt-85 -159.54 88.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 119.218 -2.176 . . . . 0.0 112.115 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.692 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -57.66 122.19 12.19 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.992 -1.692 . . . . 0.0 108.954 178.635 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.607 ' H ' ' HG3' ' A' ' 143' ' ' GLN . . . 43.14 -114.96 0.93 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 122.932 1.296 . . . . 0.0 110.197 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.536 ' OD1' ' NH2' ' A' ' 146' ' ' ARG . 3.0 t-20 -95.98 15.81 19.55 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.084 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 8.7 m-20 -101.7 93.39 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.903 -1.123 . . . . 0.0 108.457 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.454 ' HB3' ' HE ' ' A' ' 146' ' ' ARG . 4.8 p90 -75.47 121.83 22.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.381 -0.824 . . . . 0.0 110.875 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 167.13 140.34 2.88 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.119 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -4.02 47.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -1.197 . . . . 0.0 108.729 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.64 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -96.58 -13.2 23.1 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.352 -0.843 . . . . 0.0 110.486 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.611 ' O ' ' O ' ' A' ' 70' ' ' MET . 13.2 m-85 -100.16 -4.72 29.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.864 -1.148 . . . . 0.0 110.98 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.61 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -42.69 177.58 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.842 -1.161 . . . . 0.0 109.492 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.1 t -91.55 124.87 36.04 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 68' ' ' PHE . . . -145.55 127.82 15.8 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 116.468 -2.093 . . . . 0.0 112.705 -176.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.513 ' CG2' ' CZ ' ' A' ' 135' ' ' PHE . 5.2 t -117.9 129.46 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.097 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.466 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -122.27 95.59 47.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.336 -0.852 . . . . 0.0 108.814 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.6 170.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.633 2.222 . . . . 0.0 112.044 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.56 -29.64 14.25 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 120.911 -1.118 . . . . 0.0 109.632 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 165' ' ' VAL . 2.0 m -179.52 -162.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.93 -15.55 9.18 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 123.021 1.391 . . . . 0.0 108.599 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.425 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.7 t -55.77 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.883 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.759 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.461 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 16.4 mt-30 -78.86 -19.13 52.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 ttp -52.44 -36.19 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.705 -1.247 . . . . 0.0 110.394 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -75.58 -32.55 60.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.795 -1.19 . . . . 0.0 110.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.58 -43.28 9.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.077 -1.014 . . . . 0.0 110.134 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.45 -51.79 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' A' ' 171' ' ' LEU . 1.3 pp -52.85 -33.52 50.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.004 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -74.6 -55.54 5.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.466 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.82 -39.02 73.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.373 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.437 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -65.07 -58.36 6.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 175' ' ' GLU . 0.9 OUTLIER -70.58 -24.19 62.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.933 . . . . 0.0 109.908 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 5.8 mm-40 -53.26 -30.87 40.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -0.91 . . . . 0.0 109.931 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.591 ' CD1' ' CD1' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.47 -45.36 19.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.907 -1.121 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.68 HE22 ' C ' ' A' ' 187' ' ' GLY . 1.2 tp60 -54.26 -30.83 51.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -61.83 -44.27 97.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.319 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 181' ' ' LEU . 9.2 p -87.31 -42.2 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.387 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 177' ' ' TYR . 31.8 mt -65.24 -39.4 92.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.111 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 21.6 p -56.07 -26.56 49.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.987 -1.071 . . . . 0.0 109.401 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -88.3 -9.66 52.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.737 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -108.33 34.93 3.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.873 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.36 68.65 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.937 . . . . 0.0 109.799 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.472 ' CD2' HD21 ' A' ' 181' ' ' LEU . 37.4 m-85 -148.08 174.55 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.68 ' C ' HE22 ' A' ' 178' ' ' GLN . . . -126.22 -162.24 11.19 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 189' ' ' ILE . 32.0 Cg_exo -58.07 105.56 0.21 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.993 1.795 . . . . 0.0 110.274 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.412 ' HA ' ' OG1' ' A' ' 142' ' ' THR . 0.9 OUTLIER -47.68 155.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.585 -178.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.66 ' N ' ' OG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -88.57 44.73 1.23 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.338 0.589 . . . . 0.0 111.571 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 19.4 m -84.57 113.78 21.49 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.494 ' OD2' ' CZ ' ' A' ' 194' ' ' ARG . 9.1 t0 -75.54 114.98 14.72 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.986 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.76 97.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 121.925 0.869 . . . . 0.0 109.45 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.675 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -152.62 152.29 31.62 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.644 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 1.0 OUTLIER -111.74 -176.95 3.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 110.197 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.55 30.37 66.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.675 ' NE2' ' O ' ' A' ' 194' ' ' ARG . 1.8 mp0 -95.85 95.16 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.239 . . . . 0.0 109.882 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 197' ' ' GLN . 8.3 p -32.6 154.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 109.711 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.514 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 65.0 t80 -120.63 137.23 54.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.633 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.9 m-85 -139.54 112.84 8.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.167 -0.958 . . . . 0.0 109.787 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.792 ' HH ' ' NH1' ' A' ' 118' ' ' ARG . 23.3 m-85 -54.12 141.67 28.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 110.108 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.484 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -90.46 -174.64 4.2 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.03 165.05 25.82 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.749 -0.594 . . . . 0.0 109.704 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.445 ' N ' HG11 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -57.95 -45.14 87.13 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.537 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -55.05 -13.53 1.19 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.567 ' CE1' ' CZ2' ' A' ' 74' ' ' TRP . 14.3 m-70 -100.99 5.38 43.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.83 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.3 mm-40 -124.57 -144.18 0.32 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.238 1.018 . . . . 0.0 110.143 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.651 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 11.7 mp0 -34.4 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.188 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.83 ' N ' ' O ' ' A' ' 207' ' ' GLN . 79.5 t80 -43.7 -45.58 7.09 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 120.495 -1.378 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -55.21 -17.3 4.18 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.648 -1.283 . . . . 0.0 110.068 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.675 ' OG ' ' CZ2' ' A' ' 81' ' ' TRP . 13.4 m -73.17 -26.51 61.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.109 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -87.75 -38.92 15.36 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.338 -0.851 . . . . 0.0 109.487 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.476 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.4 m-80 -123.42 79.66 53.92 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.63 8.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.954 2.436 . . . . 0.0 112.598 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' A' ' 213' ' ' ASN . 1.5 t70 -63.44 -19.09 64.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.023 -1.048 . . . . 0.0 110.356 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.98 84.97 0.05 OUTLIER Glycine 0 N--CA 1.503 3.104 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.693 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -83.38 92.68 7.6 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.652 2.226 . . . . 0.0 109.297 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 49.1 t -168.74 -124.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 O-C-N 120.994 -1.066 . . . . 0.0 108.962 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 153.8 151.8 5.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 2.5 tp 75.47 162.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.734 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 157.16 81.59 0.04 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.42 140.83 3.66 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.2 p -75.64 -42.66 50.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.277 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 94.37 -4.13 69.77 Favored Glycine 0 C--N 1.305 -1.194 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.28 115.4 11.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.546 -0.973 . . . . 0.0 109.508 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.0 m -99.02 107.8 20.31 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.094 -1.004 . . . . 0.0 109.571 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.49 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.87 -56.41 2.13 Favored Pre-proline 0 C--N 1.276 -2.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.829 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.597 ' CD ' ' H ' ' A' ' 229' ' ' MET . 27.2 Cg_endo -95.7 -35.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.269 2.646 . . . . 0.0 110.307 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.597 ' H ' ' CD ' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -54.27 156.13 3.38 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.057 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.569 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -24.74 135.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.423 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.544 ' O ' ' C ' ' A' ' 232' ' ' LYS . 1.0 OUTLIER -133.98 110.72 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.345 -0.847 . . . . 0.0 109.13 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 231' ' ' ILE . 10.1 tttt -34.57 99.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.805 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.333 0 O-C-N 121.344 -0.847 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.478 H122 HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' C ' ' O1 ' ' A' ' 21' ' ' MYR . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.1 m-20 -86.06 134.49 33.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -1.18 . . . . 0.0 109.364 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.79 -32.47 73.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 109.552 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' ILE . . . -75.65 -7.12 53.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 123.222 1.487 . . . . 0.0 109.078 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 23' ' ' ASP . 34.9 t -47.01 -29.84 2.3 Favored 'General case' 0 C--N 1.263 -3.178 0 CA-C-N 113.606 -1.633 . . . . 0.0 110.106 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HD3' ' C6 ' ' A' ' 21' ' ' MYR . 0.0 OUTLIER -108.6 26.74 10.16 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 123.424 1.583 . . . . 0.0 109.069 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.738 ' O ' ' O ' ' A' ' 29' ' ' ILE . 41.9 t -156.95 24.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.556 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.738 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -35.3 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 123.198 1.475 . . . . 0.0 110.038 -178.049 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.63 124.25 26.34 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.966 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HA ' ' HD1' ' A' ' 97' ' ' HIS . . . -64.76 -40.06 94.65 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.83 -0.544 . . . . 0.0 109.692 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.654 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -80.65 12.77 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' ' C ' ' A' ' 34' ' ' ALA . 1.6 tt0 -116.67 -43.25 2.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 109.648 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -33.08 152.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.586 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -37.12 160.56 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.23 -39.02 82.23 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.061 1.84 . . . . 0.0 111.966 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.5 155.51 9.77 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.574 ' NH2' ' OE1' ' A' ' 40' ' ' GLU . 43.0 mmm-85 -120.72 154.72 35.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 109.595 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.453 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 6.6 m -124.37 32.13 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.574 ' OE1' ' NH2' ' A' ' 38' ' ' ARG . 2.5 mt-10 -103.25 142.84 25.4 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.37 166.79 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.283 1.988 . . . . 0.0 112.181 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.644 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.4 OUTLIER -138.99 41.96 0.52 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.693 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.644 ' CD ' ' N ' ' A' ' 42' ' ' ILE . 35.6 Cg_endo -66.97 164.09 31.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.747 2.298 . . . . 0.0 112.261 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.625 ' O ' ' N ' ' A' ' 46' ' ' ALA . 7.0 m -161.2 172.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.227 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.71 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 109.681 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.27 -40.38 74.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 110.911 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.574 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.62 99.72 11.93 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.002 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.643 ' O ' ' N ' ' A' ' 52' ' ' GLY . 6.7 t-80 -31.16 104.19 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -53.97 -26.17 24.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.654 -0.654 . . . . 0.0 110.965 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.486 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 2.6 t -70.09 -48.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.84 -1.163 . . . . 0.0 109.448 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -103.56 -41.1 6.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.54 1.98 53.27 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.2 m-20 -75.41 -116.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.578 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -131.55 174.39 10.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.657 1.694 . . . . 0.0 110.217 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 16.0 p -145.56 18.98 1.51 Allowed 'General case' 0 C--N 1.264 -3.118 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -165.62 149.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.037 -1.04 . . . . 0.0 109.05 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.55 ' O ' ' O ' ' A' ' 56' ' ' VAL . 16.0 mt-10 -32.33 154.92 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.675 0 CA-C-O 121.885 0.85 . . . . 0.0 110.731 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.3 165.51 80.62 Favored 'Cis proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.689 -2.213 . . . . 0.0 112.126 -0.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.526 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-30 -115.98 85.68 15.35 Favored Pre-proline 0 C--N 1.27 -2.871 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.16 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.96 170.18 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.974 2.45 . . . . 0.0 112.549 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -75.98 158.32 32.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.4 -38.42 3.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.03 135.04 50.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.602 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 14.9 mp0 -113.32 171.65 7.43 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.735 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -156.9 145.48 19.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.58 -1.325 . . . . 0.0 110.896 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -120.1 -169.36 1.78 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.475 HG13 ' CD2' ' A' ' 160' ' ' TYR . 2.7 t -143.02 101.6 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.024 -1.672 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 2.4 p90 -148.38 149.37 31.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.922 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 179.74 156.25 17.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.579 ' SD ' ' CB ' ' A' ' 157' ' ' SER . 1.7 mtt -145.68 30.72 1.08 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.347 -1.09 . . . . 0.0 108.339 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.588 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -166.6 155.63 26.94 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.924 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.769 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -35.97 116.76 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -45.26 7.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.869 -178.108 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.769 ' N ' ' O ' ' A' ' 72' ' ' CYS . 24.9 m0 -82.34 -64.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.3 -1.5 . . . . 0.0 109.84 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.09 -26.82 74.38 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.024 -1.047 . . . . 0.0 111.335 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.757 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.94 -29.25 55.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.343 . . . . 0.0 111.526 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.427 ' O ' ' CE3' ' A' ' 81' ' ' TRP . 28.2 tt0 -83.88 -13.86 52.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.277 -1.515 . . . . 0.0 110.757 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.665 ' C ' ' H ' ' A' ' 80' ' ' PHE . 15.9 ttt180 -69.29 -81.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.132 -0.98 . . . . 0.0 111.137 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 25.2 mtmt -58.76 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.211 -0.931 . . . . 0.0 110.628 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.757 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.1 m-85 -97.9 -38.72 9.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.911 -1.118 . . . . 0.0 109.026 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.566 ' CE3' ' OE1' ' A' ' 208' ' ' GLN . 1.5 p90 -85.17 8.48 18.09 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 1.2 m -99.36 18.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.329 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.97 167.68 9.62 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.28 162.72 14.5 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.536 -0.727 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.4 5.61 50.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -90.78 117.45 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -1.063 . . . . 0.0 109.436 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.578 ' OH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -68.45 -36.29 78.81 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.218 1.009 . . . . 0.0 108.753 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.538 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER 177.83 -164.03 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.293 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.648 ' C ' HE21 ' A' ' 90' ' ' GLN . 71.3 p -156.25 144.76 20.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.648 HE21 ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -141.86 166.34 24.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.612 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 3.0 m -152.41 160.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.22 -174.54 45.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -86.32 169.41 12.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.307 -1.114 . . . . 0.0 109.554 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.651 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.58 149.09 0.36 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.005 -1.059 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 76.86 22.24 72.34 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.639 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -100.44 -165.04 28.45 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.69 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 1.7 t-160 -140.85 72.02 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.78 175.99 13.17 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.448 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.0 mmp_? -76.26 -78.28 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.422 -0.799 . . . . 0.0 109.047 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.453 ' ND2' ' HA ' ' A' ' 39' ' ' THR . 26.3 m-80 -116.18 66.43 3.1 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.636 ' CG ' ' HE2' ' A' ' 113' ' ' HIS . 1.1 Cg_endo -48.88 149.95 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.307 2.004 . . . . 0.0 111.674 -179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.636 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 17.4 p -120.85 172.62 7.77 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.221 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.712 ' CG ' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -66.41 -59.23 3.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.069 -1.019 . . . . 0.0 109.958 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.712 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -57.93 -23.52 53.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.636 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.2 mm-40 -67.25 -64.95 0.75 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.601 0.715 . . . . 0.0 109.936 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.752 ' CG1' ' HG1' ' A' ' 111' ' ' THR . 34.4 m -71.39 -24.37 23.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.479 -0.763 . . . . 0.0 111.098 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.512 ' C ' ' O ' ' A' ' 106' ' ' VAL . 11.9 t -38.38 -22.9 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.67 ' N ' ' O ' ' A' ' 106' ' ' VAL . 80.2 p -77.8 -80.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.682 ' O ' ' N ' ' A' ' 111' ' ' THR . 0.0 OUTLIER 158.7 -39.62 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.642 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 1.6 ttmt -46.29 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.911 -0.493 . . . . 0.0 112.215 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.752 ' HG1' ' CG1' ' A' ' 106' ' ' VAL . 11.1 p -101.33 -19.68 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.449 -1.407 . . . . 0.0 109.193 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 67.16 21.63 72.04 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.075 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.651 ' ND1' ' C ' ' A' ' 94' ' ' ALA . 1.4 m-70 -80.15 172.46 13.74 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.258 -1.731 . . . . 0.0 108.174 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.44 112.92 13.69 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.079 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.684 ' OE1' ' CE2' ' A' ' 73' ' ' PHE . 20.8 mm-40 -51.04 112.1 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 1.5 m -123.34 138.37 53.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 108.937 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.407 HG13 ' CD2' ' A' ' 80' ' ' PHE . 2.5 t -103.78 113.11 39.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.526 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -96.92 113.84 25.41 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 6.0 m -132.02 126.57 56.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.46 HG13 ' CE2' ' A' ' 59' ' ' PHE . 0.7 OUTLIER -86.2 169.41 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.435 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.552 ' CD1' ' CD1' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -157.4 156.62 32.56 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.651 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -106.66 99.28 24.24 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.918 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.473 ' HG3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 Cg_exo -43.55 -63.91 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.032 2.488 . . . . 0.0 112.917 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.663 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 22.5 mp0 -49.91 -13.14 0.09 Allowed 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.586 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.448 ' H ' ' C ' ' A' ' 123' ' ' PRO . 22.1 m-70 -110.86 -46.85 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.448 ' CD1' ' HG3' ' A' ' 130' ' ' GLU . 5.3 tp -128.73 144.18 38.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -75.11 153.1 38.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.864 -1.148 . . . . 0.0 111.192 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.489 ' CE2' ' CD1' ' A' ' 132' ' ' LEU . 41.4 t80 -63.9 -28.7 70.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -52.88 -32.13 43.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 6.5 mm-40 -62.39 -67.85 0.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.642 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 17.0 mt -34.05 -49.07 0.34 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.199 -0.938 . . . . 0.0 108.711 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.489 ' CD1' ' CE2' ' A' ' 128' ' ' PHE . 64.0 mt -76.61 -34.54 58.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 110.69 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' GLU . 31.7 ttmt -57.71 -68.37 0.25 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.885 -1.134 . . . . 0.0 110.449 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.752 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -49.28 -34.17 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 108.985 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.533 ' HB2' ' CE1' ' A' ' 68' ' ' PHE . 26.4 t80 -57.92 -52.67 64.53 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.014 -1.054 . . . . 0.0 111.072 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.58 ' O ' ' CG2' ' A' ' 223' ' ' THR . 85.6 m95 -74.8 -47.45 30.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.159 -1.588 . . . . 0.0 111.236 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.582 ' O ' ' O ' ' A' ' 222' ' ' GLY . 1.3 mm-40 -45.23 -48.83 12.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 111.334 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.752 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.5 p30 -98.51 38.22 1.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 112.554 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 223' ' ' THR . 20.6 m80 -155.44 -155.77 0.59 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.714 -1.241 . . . . 0.0 109.342 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 70' ' ' MET . 2.7 t0 -147.33 132.01 8.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.445 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 68.9 Cg_endo -73.81 -13.81 24.26 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 121.931 1.754 . . . . 0.0 113.142 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 142' ' ' THR . 3.3 p -122.32 56.63 1.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.743 -1.223 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.812 ' NE2' ' NE2' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -122.39 77.59 1.42 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.713 -1.242 . . . . 0.0 110.889 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -47.34 -117.64 0.0 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -85.19 47.02 1.35 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.338 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 150' ' ' ASP . 1.6 ttm180 -162.16 87.23 0.63 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.583 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.812 ' NE2' ' NE2' ' A' ' 143' ' ' GLN . 2.1 tp-100 -84.09 119.94 25.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.181 -1.575 . . . . 0.0 109.381 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . 53.26 -113.45 2.97 Favored Glycine 0 C--N 1.293 -1.844 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.622 ' OD1' ' N ' ' A' ' 149' ' ' ASN . 1.8 p-10 -101.12 22.77 11.8 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 114.18 -1.01 . . . . 0.0 110.023 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -107.61 161.12 15.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.0 109.426 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 151' ' ' PHE . 35.0 p90 -136.79 127.07 26.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.1 149.43 5.05 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.956 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.496 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 1.2 p -56.06 -52.68 63.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.596 -0.943 . . . . 0.0 109.407 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.636 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 8.9 pm0 -56.55 -11.04 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.669 . . . . 0.0 110.857 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -101.63 49.64 0.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.804 -1.185 . . . . 0.0 109.348 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.672 ' NH1' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -116.54 165.06 13.68 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.62 ' OG ' ' O ' ' A' ' 190' ' ' THR . 44.9 p -77.02 128.22 34.09 Favored 'General case' 0 CA--C 1.467 -2.237 0 CA-C-O 122.442 1.115 . . . . 0.0 108.25 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.483 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -137.31 129.49 29.38 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.282 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.625 ' CG1' ' CG2' ' A' ' 191' ' ' THR . 0.2 OUTLIER -139.41 108.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.011 177.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 160' ' ' TYR . 1.1 m-30 -107.08 134.32 19.93 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.56 168.96 17.49 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.364 2.043 . . . . 0.0 111.835 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -19.59 20.59 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.907 -1.12 . . . . 0.0 108.939 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER 179.57 -164.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.7 -15.6 20.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 123.005 1.383 . . . . 0.0 108.421 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.416 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.6 t -56.05 -64.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.436 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 23.6 mt-30 -79.6 -17.12 54.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.675 -0.641 . . . . 0.0 110.9 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.92 -44.09 66.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.847 -1.158 . . . . 0.0 110.04 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.23 -20.76 59.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.8 -54.3 3.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.434 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.76 -44.54 66.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 52.4 mt -52.88 -39.65 62.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.642 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -74.52 -51.35 14.96 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 0.0 109.527 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.487 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.8 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.699 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' NZ ' HD13 ' A' ' 189' ' ' ILE . 6.8 tttp -73.05 -58.16 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.0 110.326 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.35 -27.86 61.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.916 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mm-40 -53.06 -31.32 40.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.961 -1.087 . . . . 0.0 110.129 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.439 ' CD1' ' HG3' ' A' ' 141' ' ' PRO . 0.7 OUTLIER -80.22 -33.26 38.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 110.079 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 182' ' ' SER . 0.8 OUTLIER -52.8 -31.96 41.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.013 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.16 -20.39 52.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.804 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.74 -55.88 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.828 -1.17 . . . . 0.0 110.872 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . 7.3 mt -76.22 -19.88 57.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.052 -1.03 . . . . 0.0 110.737 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 2.2 t -55.01 -33.68 62.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.865 -1.147 . . . . 0.0 109.16 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -88.2 1.0 55.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -108.29 32.42 4.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.79 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.31 59.49 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 109.939 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.449 ' CD1' ' HB3' ' A' ' 181' ' ' LEU . 38.4 m-85 -133.81 168.98 17.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.002 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -128.76 -149.0 6.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.65 119.65 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.358 2.039 . . . . 0.0 110.99 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.461 HD13 ' NZ ' ' A' ' 174' ' ' LYS . 1.1 pt -57.55 179.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.317 1.056 . . . . 0.0 111.097 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.672 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 1.5 p -139.46 58.39 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.816 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.625 ' CG2' ' CG1' ' A' ' 159' ' ' VAL . 21.7 m -99.55 120.44 39.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.649 ' OD1' ' NE ' ' A' ' 194' ' ' ARG . 15.0 t0 -77.93 122.45 25.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.448 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.403 ' CD1' ' HD3' ' A' ' 174' ' ' LYS . 0.8 OUTLIER -131.45 100.64 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.649 ' NE ' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -151.39 178.38 9.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -129.93 166.28 20.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.13 49.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.513 ' NE2' ' CD2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -89.84 93.97 9.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.079 -1.248 . . . . 0.0 109.425 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.445 ' C ' ' O ' ' A' ' 197' ' ' GLN . 7.4 p -41.11 122.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 109.597 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.481 ' CE1' ' HD3' ' A' ' 118' ' ' ARG . 25.4 t80 -77.79 150.39 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.299 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.448 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 6.8 m-85 -149.19 100.53 3.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -53.84 144.07 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.418 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -92.02 -170.83 2.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.359 -0.838 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.47 167.3 20.87 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-O 122.801 1.286 . . . . 0.0 110.309 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -53.8 -43.61 69.48 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.719 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.736 ' CD1' ' O ' ' A' ' 205' ' ' TYR . 0.2 OUTLIER -81.14 13.32 2.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.582 -1.324 . . . . 0.0 109.496 -178.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.549 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 22.7 m-70 -102.71 6.41 39.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.747 -1.221 . . . . 0.0 109.706 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.837 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.4 mm-40 -127.61 -138.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.43 1.11 . . . . 0.0 109.772 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.566 ' OE1' ' CE3' ' A' ' 81' ' ' TRP . 18.8 mm-40 -34.15 -4.75 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.936 -1.484 . . . . 0.0 112.282 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.837 ' N ' ' O ' ' A' ' 207' ' ' GLN . 82.0 t80 -42.74 -46.32 5.09 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 120.398 -1.439 . . . . 0.0 109.896 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.649 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.6 OUTLIER -60.43 -17.14 42.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.57 -1.331 . . . . 0.0 110.109 -178.813 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.681 ' HG ' ' N ' ' A' ' 212' ' ' LYS . 36.6 p -70.53 -47.43 60.43 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 108.643 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.681 ' N ' ' HG ' ' A' ' 211' ' ' SER . 9.0 mmmt -88.85 -7.77 55.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.352 -0.842 . . . . 0.0 110.121 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.66 ' CG ' ' CZ ' ' A' ' 209' ' ' TYR . 5.4 m-80 -129.19 77.15 78.15 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.0 110.102 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.57 10.82 0.92 Allowed 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.511 2.808 . . . . 0.0 112.46 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -61.75 -21.2 64.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.349 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.57 85.81 0.05 OUTLIER Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.46 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 216' ' ' GLY . 9.7 m-85 -47.21 -170.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 120.314 2.057 . . . . 0.0 109.67 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.43 78.32 4.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.914 -1.116 . . . . 0.0 109.745 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 220' ' ' LEU . . . -174.14 143.66 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.594 ' CD1' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 161.19 167.89 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 110.4 131.2 5.97 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.639 ' CA ' ' O ' ' A' ' 139' ' ' HIS . . . -173.43 140.52 5.62 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 139' ' ' HIS . 29.5 p 51.31 15.91 0.35 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.466 -1.02 . . . . 0.0 108.271 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.465 ' N ' ' C ' ' A' ' 222' ' ' GLY . . . -160.73 44.52 0.41 Allowed Glycine 0 C--N 1.303 -1.299 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.517 ' CG1' ' SG ' ' A' ' 227' ' ' CYS . 91.7 t -83.24 80.85 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.583 -0.951 . . . . 0.0 109.167 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.671 ' O ' ' SD ' ' A' ' 229' ' ' MET . 4.7 m -100.09 23.84 9.4 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.708 1.242 . . . . 0.0 110.223 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.562 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -70.92 -63.28 1.59 Allowed Pre-proline 0 C--N 1.26 -3.299 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.88 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.562 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 42.0 Cg_endo -68.02 -3.24 10.24 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.248 1.965 . . . . 0.0 109.707 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.672 ' O ' ' SD ' ' A' ' 229' ' ' MET . 0.0 OUTLIER -55.37 157.29 3.8 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.916 0.865 . . . . 0.0 110.332 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.86 145.39 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.727 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 2.5 mm -127.97 107.16 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.198 -0.939 . . . . 0.0 109.553 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -112.96 97.27 6.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.39 0 O-C-N 121.178 -0.951 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.481 ' O1 ' ' C ' ' A' ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 22' ' ' GLY . 2.8 t70 36.16 62.5 0.68 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -1.218 . . . . 0.0 109.367 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.76 -19.8 18.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.33 -0.856 . . . . 0.0 109.865 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.645 ' C ' ' H ' ' A' ' 27' ' ' LYS . . . -55.86 -94.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.224 1.488 . . . . 0.0 110.243 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.576 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -47.66 -3.29 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.409 -178.748 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.671 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -104.21 21.77 15.94 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 124.474 2.083 . . . . 0.0 108.468 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.615 ' CG1' ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -152.71 34.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.256 -3.466 0 CA-C-N 112.725 -2.034 . . . . 0.0 107.208 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' VAL . 1.1 tp -38.6 132.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 122.057 0.932 . . . . 0.0 113.009 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.91 121.43 21.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 122.144 0.973 . . . . 0.0 110.203 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -51.7 -55.36 20.01 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.65 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -53.92 -8.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 2.5 mm-40 -110.61 -36.23 5.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.427 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.91 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 0.0 109.265 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.484 ' N ' HD11 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -81.3 135.09 50.83 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.207 -0.933 . . . . 0.0 109.141 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -71.76 -26.38 19.31 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.821 2.347 . . . . 0.0 114.242 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' ' OD1' ' A' ' 100' ' ' ASN . . . -179.19 158.43 22.48 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.64 HH21 ' C ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -49.56 151.73 1.56 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.031 0.92 . . . . 0.0 111.646 -178.927 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.64 ' C ' HH21 ' A' ' 38' ' ' ARG . 0.2 OUTLIER -124.63 -6.98 7.43 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -171.42 119.15 0.46 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.625 -0.672 . . . . 0.0 109.214 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.432 ' HB3' ' NH1' ' A' ' 99' ' ' ARG . 74.1 Cg_endo -79.84 148.61 20.01 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.632 2.221 . . . . 0.0 112.777 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.44 87.71 13.23 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.315 -0.866 . . . . 0.0 109.617 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.34 -176.27 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.073 2.515 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.555 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 15.8 m -147.95 -176.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.927 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.571 ' CG2' ' O ' ' A' ' 45' ' ' THR . 14.7 t -79.84 104.28 10.31 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.095 -1.003 . . . . 0.0 110.305 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.606 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.94 -29.77 63.42 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.305 -0.872 . . . . 0.0 111.496 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 5.5 pttt -88.52 100.04 12.77 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 115.93 -2.308 . . . . 0.0 108.113 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' A' ' 52' ' ' GLY . 7.2 t-80 -31.64 112.25 0.1 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.784 ' CD2' ' HZ3' ' A' ' 212' ' ' LYS . 13.9 t-80 -50.78 -37.46 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 110.625 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 18.0 t -72.15 -61.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -77.13 -36.08 55.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.567 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 83.61 0.11 89.79 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 40.5 p30 -78.72 -119.63 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.651 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 29.5 mtt180 -126.46 174.52 8.57 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 123.275 1.512 . . . . 0.0 109.59 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.606 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 11.7 p -143.42 35.77 1.32 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.87 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.544 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -176.56 152.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 0.0 109.098 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -31.67 149.5 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.518 -0.739 . . . . 0.0 110.547 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.424 ' HD2' ' NH1' ' A' ' 54' ' ' ARG . 88.4 Cg_endo -79.3 165.94 79.62 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.013 -2.078 . . . . 0.0 112.158 0.065 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.59 129.56 24.25 Favored Pre-proline 0 C--N 1.27 -2.857 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.557 ' O ' ' CG2' ' A' ' 63' ' ' THR . 46.2 Cg_exo -49.65 148.39 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.083 1.855 . . . . 0.0 112.064 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 158.18 10.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.585 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.55 39.63 75.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.557 ' CG2' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -90.2 132.3 35.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -1.147 . . . . 0.0 110.649 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.772 ' NE2' ' CD1' ' A' ' 128' ' ' PHE . 36.7 tp60 -106.16 142.75 35.33 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -161.37 161.81 30.53 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.994 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.77 -167.11 1.77 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.427 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 74.5 t -141.78 127.85 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.158 -1.589 . . . . 0.0 108.607 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.512 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 28.1 m-85 -114.87 135.16 54.5 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.835 -1.166 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 157' ' ' SER . . . -134.38 83.25 0.29 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.474 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.635 ' O ' ' O ' ' A' ' 155' ' ' TYR . 2.2 ptp -86.32 -80.99 0.22 Allowed 'General case' 0 C--N 1.282 -2.357 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.843 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 73' ' ' PHE . . . -139.36 -152.2 5.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.785 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -33.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.046 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.686 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -53.51 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 112.039 -177.488 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.785 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 10.9 m0 -70.3 -65.94 0.66 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.742 -1.224 . . . . 0.0 108.562 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.46 -12.07 82.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.68 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.26 -33.88 59.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 109.733 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.566 ' OE2' ' OE1' ' A' ' 208' ' ' GLN . 1.1 tt0 -83.36 -17.09 43.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.643 ' O ' ' N ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -85.93 -52.04 5.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 110.227 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.42 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 9.4 mttp -47.91 -4.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.181 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.68 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.3 m-85 -104.5 -35.39 7.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.0 110.354 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.569 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -88.96 -0.62 57.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.747 -1.22 . . . . 0.0 110.426 -178.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.421 ' CG1' ' HG2' ' A' ' 78' ' ' ARG . 2.3 m -88.32 5.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.003 -1.061 . . . . 0.0 110.145 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.611 ' C ' ' CD1' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -116.95 179.33 4.05 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 109.664 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 137.46 37.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.929 -1.107 . . . . 0.0 111.529 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 123' ' ' PRO . . . 124.26 -50.1 0.87 Allowed Glycine 0 C--O 1.202 -1.859 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.763 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.469 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -53.91 136.85 15.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.715 -1.462 . . . . 0.0 111.582 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.69 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -75.13 -40.76 59.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.694 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 2.0 p -171.92 -174.84 1.38 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 88' ' ' SER . 62.6 p -160.15 128.79 4.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.068 -1.02 . . . . 0.0 109.534 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.694 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 3.0 mp0 -138.46 172.03 13.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.009 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.671 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -132.59 168.19 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -179.45 168.26 38.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -80.0 153.09 29.09 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.351 -1.088 . . . . 0.0 109.138 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.673 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -166.55 175.47 8.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.496 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 53.86 22.4 19.12 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.496 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -102.08 -151.43 23.99 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.516 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 3.7 m-70 -109.81 -41.15 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 109.768 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.545 ' HB ' HD22 ' A' ' 100' ' ' ASN . 0.6 OUTLIER -154.94 172.83 17.42 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.661 ' C ' HD21 ' A' ' 100' ' ' ASN . 0.3 OUTLIER -81.84 78.3 8.57 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.771 HD21 ' N ' ' A' ' 100' ' ' ASN . 1.1 m-80 -115.13 -130.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.324 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.644 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.3 Cg_exo -45.39 -156.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 123.672 2.347 . . . . 0.0 115.092 -175.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.429 ' O ' HG21 ' A' ' 106' ' ' VAL . 29.6 p -126.53 170.66 11.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.231 -0.918 . . . . 0.0 112.046 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.668 ' CD1' ' OE2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -50.21 -43.46 52.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.346 0.594 . . . . 0.0 110.016 179.134 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.562 ' CD ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.05 -34.89 64.22 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.821 -1.174 . . . . 0.0 109.487 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 107' ' ' CYS . 1.7 mm-40 -83.56 -43.7 15.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.81 . . . . 0.0 110.749 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.703 ' O ' ' N ' ' A' ' 108' ' ' SER . 34.5 m -46.33 -21.66 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 120.881 -1.137 . . . . 0.0 109.439 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.487 ' C ' ' O ' ' A' ' 106' ' ' VAL . 10.2 t -36.84 -20.67 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.631 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -79.82 3.91 18.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.062 -1.024 . . . . 0.0 108.865 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.1 mt-10 64.76 3.8 2.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.648 ' CD ' ' OG ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -72.93 -9.94 59.25 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.025 -1.672 . . . . 0.0 110.467 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.442 ' CG2' ' CG1' ' A' ' 106' ' ' VAL . 1.7 p -105.01 -8.34 18.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.653 -1.279 . . . . 0.0 109.705 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 44.36 30.72 2.09 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 7.1 m-70 -81.68 170.01 16.3 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.908 -1.348 . . . . 0.0 109.386 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.491 ' O ' ' C ' ' A' ' 115' ' ' GLU . . . -129.03 114.33 16.27 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.668 ' OE2' ' CD1' ' A' ' 103' ' ' TYR . 1.6 mm-40 -40.19 120.94 1.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 108.934 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.473 HG13 ' CE2' ' A' ' 160' ' ' TYR . 0.3 OUTLIER -140.55 162.77 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 110.262 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 35.4 m -130.63 127.4 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.484 -0.76 . . . . 0.0 109.216 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -98.38 124.85 43.27 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.2 m -133.85 125.88 49.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.018 -1.051 . . . . 0.0 108.723 178.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.469 HG22 ' CD1' ' A' ' 87' ' ' TYR . 1.8 m -96.39 146.55 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.717 -1.239 . . . . 0.0 107.971 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.621 ' CE2' HD21 ' A' ' 131' ' ' LEU . 2.9 m-30 -129.99 147.5 51.74 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.054 0.93 . . . . 0.0 108.661 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.976 ' H ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -179.31 27.21 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.976 ' HD3' ' H ' ' A' ' 122' ' ' ARG . 37.9 Cg_exo -73.79 -13.46 24.35 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 N-CA-C 119.436 2.821 . . . . 0.0 119.436 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.87 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.837 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -123.76 2.1 8.81 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.573 ' CG2' ' CD2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -153.85 132.93 3.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.547 -0.721 . . . . 0.0 109.834 -178.937 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.574 ' OG ' ' N ' ' A' ' 128' ' ' PHE . 0.2 OUTLIER -103.0 -177.89 3.5 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.04 0.924 . . . . 0.0 112.775 -177.546 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.772 ' CD1' ' NE2' ' A' ' 64' ' ' GLN . 35.7 t80 -69.82 -40.56 75.82 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.191 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.89 -14.49 47.03 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.805 -1.184 . . . . 0.0 108.809 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.516 ' CB ' ' CD1' ' A' ' 126' ' ' ILE . 0.4 OUTLIER -74.58 -55.94 5.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 111.377 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.86 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.2 OUTLIER -59.99 -34.46 73.36 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 120.597 -1.314 . . . . 0.0 107.862 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.492 HD23 ' CZ ' ' A' ' 128' ' ' PHE . 1.5 mm? -66.12 -32.49 73.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -70.51 -62.53 1.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.38 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.716 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 25.5 t -49.37 -27.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.16 -0.963 . . . . 0.0 108.979 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.474 ' HB2' ' CD1' ' A' ' 68' ' ' PHE . 6.7 t80 -71.73 -50.74 27.39 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.794 -1.191 . . . . 0.0 109.889 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.463 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 55.1 m95 -72.4 -37.9 68.57 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.616 -1.303 . . . . 0.0 110.299 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -20.8 64.65 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.9 OUTLIER -131.56 59.48 1.69 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.161 -1.587 . . . . 0.0 111.768 -178.191 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.608 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER 170.26 136.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.375 -0.828 . . . . 0.0 109.256 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.28 135.4 72.9 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.451 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 73.8 Cg_endo -75.58 -8.66 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.576 2.184 . . . . 0.0 112.558 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.54 ' OG1' ' O ' ' A' ' 142' ' ' THR . 0.6 OUTLIER -118.04 56.0 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.228 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 144' ' ' GLY . 6.0 mm100 -118.73 62.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 108.739 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -45.27 -119.29 0.0 OUTLIER Glycine 0 N--CA 1.492 2.422 0 CA-C-O 121.81 0.672 . . . . 0.0 112.414 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.666 ' O ' ' SD ' ' A' ' 145' ' ' MET . 1.5 tmt? -69.84 35.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.507 -0.996 . . . . 0.0 110.648 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.502 ' H ' ' C ' ' A' ' 144' ' ' GLY . 4.1 ttm180 -166.32 152.73 9.04 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.023 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.481 HE21 ' HG3' ' A' ' 143' ' ' GLN . 1.2 mm-40 -146.92 100.7 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.439 -1.413 . . . . 0.0 108.39 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 52.03 -119.6 9.23 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.453 ' H ' HD23 ' A' ' 220' ' ' LEU . 1.6 t-20 -81.72 8.86 8.95 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.744 -1.228 . . . . 0.0 110.13 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.36 147.85 29.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.99 -1.069 . . . . 0.0 109.409 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.1 p90 -136.67 129.63 30.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.144 -0.973 . . . . 0.0 110.088 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.5 158.59 7.75 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.415 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.12 -4.6 48.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -1.146 . . . . 0.0 109.65 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.584 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 15.3 pm0 -88.38 3.06 51.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.029 -1.044 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.635 ' O ' ' O ' ' A' ' 70' ' ' MET . 93.2 m-85 -114.9 -12.56 12.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 111.053 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -39.62 172.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.571 -1.331 . . . . 0.0 110.195 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.474 ' OG ' ' CG2' ' A' ' 190' ' ' THR . 31.5 p -89.11 132.82 34.63 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.419 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -147.64 123.08 10.36 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 117.68 -1.608 . . . . 0.0 111.58 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 135' ' ' PHE . 2.8 m -119.85 130.55 74.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.766 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.473 ' CE2' HG13 ' A' ' 116' ' ' VAL . 10.1 m-30 -112.85 131.66 22.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.105 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.35 169.38 20.17 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.86 2.373 . . . . 0.0 112.624 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.4 OUTLIER -103.14 -6.64 22.0 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.039 -1.038 . . . . 0.0 109.498 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.635 ' C ' ' H ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 166.44 173.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 108.813 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -47.07 -14.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.989 1.376 . . . . 0.0 108.231 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.635 ' H ' ' C ' ' A' ' 163' ' ' SER . 3.3 t -55.54 -61.3 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 170' ' ' ALA . 1.2 mp0 -60.88 -11.62 8.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.557 -0.714 . . . . 0.0 110.378 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttt -51.87 -43.61 63.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 109.919 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.673 ' O ' ' NH1' ' A' ' 172' ' ' ARG . 2.6 tm-20 -75.66 -22.68 56.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.452 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -93.06 -56.32 3.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.421 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.96 -58.97 4.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 109.683 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 63.2 mt -52.24 -35.68 50.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.08 -1.013 . . . . 0.0 109.244 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.673 ' NH1' ' O ' ' A' ' 168' ' ' GLU . 13.4 ttp-105 -74.52 -55.92 5.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.463 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -56.54 -37.08 70.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.481 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -68.09 -53.15 27.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -73.0 2.21 7.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.66 -56.52 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -27.37 65.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 109.941 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.679 ' NE2' ' OG ' ' A' ' 182' ' ' SER . 0.5 OUTLIER -53.24 -53.85 44.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.171 -0.955 . . . . 0.0 109.666 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -15.55 63.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.89 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.7 t -87.22 -54.2 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.529 ' C ' ' H ' ' A' ' 183' ' ' LYS . 35.2 mt -75.26 -45.93 36.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.164 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.679 ' OG ' ' NE2' ' A' ' 178' ' ' GLN . 61.1 m -56.23 -3.05 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 0.0 109.685 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.529 ' H ' ' C ' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -88.02 -21.29 24.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.306 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.459 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 14.1 m-70 -107.99 14.4 25.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.92 68.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.21 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.42 173.55 52.99 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.64 174.27 11.99 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.825 2.35 . . . . 0.0 112.245 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.424 ' CD1' ' HB2' ' A' ' 141' ' ' PRO . 0.8 OUTLIER -80.99 116.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.006 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.474 ' CG2' ' OG ' ' A' ' 157' ' ' SER . 5.2 t -100.37 -5.21 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.002 -1.061 . . . . 0.0 109.544 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.455 ' C ' ' O ' ' A' ' 190' ' ' THR . 47.0 m -43.6 112.65 0.41 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 7.2 t0 -77.17 132.93 39.03 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.924 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 194' ' ' ARG . 0.8 OUTLIER -133.41 125.66 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.418 -0.801 . . . . 0.0 108.909 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 69.7 mtm-85 -157.11 152.19 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 109.307 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.8 OUTLIER -115.36 -174.51 2.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.53 56.48 8.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -116.25 148.04 40.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -1.213 . . . . 0.0 109.573 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.595 ' CG1' ' CE2' ' A' ' 200' ' ' TYR . 1.3 p -87.7 165.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.437 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 55.2 t80 -125.56 132.3 52.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 109.964 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.595 ' CE2' ' CG1' ' A' ' 198' ' ' VAL . 35.0 m-85 -128.32 104.39 7.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.822 . . . . 0.0 109.109 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.8 m-85 -54.98 141.48 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 110.572 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.555 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -85.0 -169.3 2.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.547 ' HG3' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -76.0 153.26 36.63 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.547 ' N ' ' HG3' ' A' ' 203' ' ' GLU . 0.7 OUTLIER -56.54 -37.89 71.12 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.083 -1.01 . . . . 0.0 108.318 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.503 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -60.85 -14.55 22.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.635 -0.665 . . . . 0.0 110.635 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 20.2 m-70 -99.02 -4.05 33.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.856 -1.152 . . . . 0.0 110.118 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.855 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.1 mt-30 -110.41 -133.07 0.33 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 122.752 1.263 . . . . 0.0 110.568 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -33.63 -5.06 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.887 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.855 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.2 t80 -42.56 -44.43 4.15 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.673 -1.267 . . . . 0.0 109.936 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.625 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -59.23 -17.23 26.34 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.439 -1.413 . . . . 0.0 110.016 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.466 ' N ' ' O ' ' A' ' 208' ' ' GLN . 71.1 p -73.26 -31.31 64.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.784 ' HZ3' ' CD2' ' A' ' 49' ' ' HIS . 10.9 mmtm -87.72 -33.91 18.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.866 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.689 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 26.2 m120 -121.71 82.42 41.52 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.46 9.88 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.206 2.604 . . . . 0.0 112.164 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -63.52 -11.92 28.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.13 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.31 85.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.766 -1.206 . . . . 0.0 111.449 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.601 ' O ' ' O ' ' A' ' 216' ' ' GLY . 33.1 t80 -52.31 -158.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.6 2.2 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.581 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 18.1 m -90.3 78.08 6.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.852 -1.155 . . . . 0.0 109.378 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.479 ' O ' ' CD1' ' A' ' 220' ' ' LEU . . . -88.62 -169.27 44.74 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.479 ' CD1' ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -152.41 178.96 8.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -1.223 . . . . 0.0 109.673 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -153.98 -162.33 11.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -170.85 -136.53 2.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 47.4 p 46.01 21.24 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -1.093 . . . . 0.0 109.436 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -168.12 43.0 0.23 Allowed Glycine 0 C--N 1.3 -1.433 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 2.6 p -111.16 81.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -1.158 . . . . 0.0 109.495 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.51 ' H ' ' HG ' ' A' ' 226' ' ' SER . 0.2 OUTLIER -99.57 107.59 19.78 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.163 -0.961 . . . . 0.0 109.27 179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.487 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.18 -57.49 2.25 Favored Pre-proline 0 C--N 1.28 -2.448 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.549 ' CD ' ' H ' ' A' ' 229' ' ' MET . 40.0 Cg_endo -95.32 -30.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.866 2.377 . . . . 0.0 110.445 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.552 ' O ' ' C ' ' A' ' 230' ' ' ALA . 4.0 mmm -55.28 155.52 4.95 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.916 0.865 . . . . 0.0 110.216 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.23 142.56 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.307 0.575 . . . . 0.0 109.989 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.562 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -150.11 118.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.3 -0.875 . . . . 0.0 109.228 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -94.73 154.58 17.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.152 -0.967 . . . . 0.0 109.564 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.252 -0.905 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.486 ' H42' ' H ' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 57.3 151.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -1.181 . . . . 0.0 109.431 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 28' ' ' VAL . 15.5 t -50.37 -18.42 0.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.495 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.55 -93.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.351 1.548 . . . . 0.0 110.94 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.616 ' C ' ' H ' ' A' ' 28' ' ' VAL . 6.3 m -46.59 -30.53 2.33 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.638 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.639 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -80.91 22.67 0.6 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 124.221 1.962 . . . . 0.0 109.003 -179.16 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.616 ' H ' ' C ' ' A' ' 26' ' ' SER . 29.0 t -148.76 46.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.26 -3.315 0 CA-C-N 112.626 -2.079 . . . . 0.0 106.285 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.18 132.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 122.315 1.055 . . . . 0.0 113.77 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.87 125.55 29.3 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.282 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.631 ' CB ' ' HD1' ' A' ' 97' ' ' HIS . . . -50.41 -27.21 6.0 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.15 3.37 31.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.29 4.55 13.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.617 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.32 178.96 8.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -54.07 169.3 0.37 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.01 -44.45 15.73 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.123 1.882 . . . . 0.0 112.361 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.3 155.35 7.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.78 145.57 34.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -1.113 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 33.85 5.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.651 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -132.07 94.79 23.22 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.017 . . . . 0.0 109.871 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -53.52 179.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.796 2.331 . . . . 0.0 112.087 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.08 138.5 21.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.157 -0.964 . . . . 0.0 109.706 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 168.37 23.3 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.737 2.291 . . . . 0.0 112.217 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -148.67 -166.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.005 . . . . 0.0 109.586 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.631 ' CG2' ' O ' ' A' ' 45' ' ' THR . 13.5 t -93.46 94.0 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.02 -45.41 79.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.282 -0.886 . . . . 0.0 111.016 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -83.43 99.94 10.4 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 115.775 -2.37 . . . . 0.0 108.597 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.661 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 15.1 t-80 -30.97 137.01 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.28 -7.47 56.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.267 -0.896 . . . . 0.0 111.139 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.464 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 55.1 t -95.51 -55.31 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.828 -1.17 . . . . 0.0 109.967 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -89.98 -43.95 10.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.97 5.37 53.51 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.695 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.37 -117.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.695 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.8 ttp180 -129.2 170.35 13.68 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 123.223 1.487 . . . . 0.0 108.84 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.6 p -133.56 32.39 3.61 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.544 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.539 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -164.71 133.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.214 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.8 pm0 -33.08 148.87 0.06 OUTLIER Pre-proline 0 C--N 1.305 -1.348 0 O-C-N 121.436 -0.79 . . . . 0.0 110.574 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.03 166.4 80.9 Favored 'Cis proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.866 -2.139 . . . . 0.0 111.545 -0.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.471 ' CE1' HG12 ' A' ' 120' ' ' VAL . 28.6 m-85 -106.32 156.47 36.88 Favored Pre-proline 0 C--N 1.268 -2.973 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.86 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.591 ' CG ' ' CD2' ' A' ' 87' ' ' TYR . 47.8 Cg_exo -49.62 129.28 23.15 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.24 1.96 . . . . 0.0 112.147 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.626 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 1.9 pm0 -43.35 144.31 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.85 . . . . 0.0 109.134 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.34 1.11 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 137.13 28.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -1.06 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.9 tt0 -106.51 136.37 46.41 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.741 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.85 127.9 27.75 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.85 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 -168.79 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 43.9 t -143.57 98.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 119.9 -1.75 . . . . 0.0 110.599 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -137.52 164.35 28.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.545 178.135 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.58 162.64 33.56 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.971 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.596 ' O ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -115.71 -86.01 0.61 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -132.42 -151.41 6.74 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.784 ' SG ' ' CZ3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -28.58 114.4 0.08 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.521 -0.988 . . . . 0.0 108.992 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -53.0 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.769 -0.582 . . . . 0.0 111.75 -178.316 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.784 ' CZ3' ' SG ' ' A' ' 72' ' ' CYS . 16.1 m0 -84.59 -63.34 1.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.487 -1.383 . . . . 0.0 109.646 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.24 74.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.745 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.04 -38.17 57.48 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.247 -1.149 . . . . 0.0 109.76 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.544 ' CD ' ' NE2' ' A' ' 208' ' ' GLN . 3.6 tt0 -84.5 -14.82 48.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.907 -1.121 . . . . 0.0 110.554 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.663 ' C ' ' H ' ' A' ' 80' ' ' PHE . 13.1 ttp180 -76.25 -74.2 0.24 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.025 -1.047 . . . . 0.0 110.556 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -48.39 -2.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.955 -1.09 . . . . 0.0 110.26 -179.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.8 m-85 -108.64 -24.18 11.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.649 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -104.63 -2.89 24.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.719 -1.238 . . . . 0.0 111.122 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.465 HG11 ' CD1' ' A' ' 81' ' ' TRP . 1.1 m -97.76 11.54 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.686 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.621 ' C ' ' CD1' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -112.0 178.7 4.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.117 -0.989 . . . . 0.0 109.325 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -98.83 137.53 37.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.0 111.536 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 124.28 -33.25 3.88 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.42 ' CG2' ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -78.61 135.86 25.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.448 -1.031 . . . . 0.0 111.049 -178.783 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.655 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -75.81 -40.24 55.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.71 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.685 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.9 OUTLIER -174.43 -173.62 0.78 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.555 ' O ' ' NE2' ' A' ' 90' ' ' GLN . 39.7 p -144.12 163.01 34.83 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.685 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 12.7 mp0 -154.89 140.03 17.49 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.465 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 3.2 m -127.21 162.79 31.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.951 -1.093 . . . . 0.0 109.521 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.94 177.69 48.13 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.501 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -102.64 168.46 9.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 110.046 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.707 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.19 -170.37 0.17 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 51.25 40.78 45.85 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.738 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -106.05 -158.02 22.15 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.631 ' HD1' ' CB ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -149.68 58.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.986 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -178.86 7.66 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.02 -1.05 . . . . 0.0 108.335 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.648 ' C ' HD21 ' A' ' 100' ' ' ASN . 9.3 mmt180 -52.76 -93.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.387 -0.821 . . . . 0.0 108.79 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.648 HD21 ' C ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -123.06 71.99 44.57 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.911 . . . . 0.0 109.286 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.481 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 52.0 Cg_exo -48.85 131.9 25.71 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.495 2.13 . . . . 0.0 111.633 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.47 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . 1.8 t -121.25 171.3 8.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' ' CB ' ' A' ' 107' ' ' CYS . 40.8 t80 -49.23 -43.71 42.9 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -42.46 92.0 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.599 -0.688 . . . . 0.0 109.399 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -74.77 -54.61 7.03 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.812 -1.18 . . . . 0.0 110.933 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.69 ' O ' ' N ' ' A' ' 108' ' ' SER . 17.0 m -73.09 -25.17 21.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.028 -1.045 . . . . 0.0 111.354 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -38.78 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.69 ' N ' ' O ' ' A' ' 106' ' ' VAL . 84.2 p -76.94 -81.1 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.568 ' H ' ' HG ' ' A' ' 108' ' ' SER . 0.0 OUTLIER 156.85 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.443 ' N ' ' HG2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -53.55 2.79 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 -177.077 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.641 ' OG1' ' CG1' ' A' ' 106' ' ' VAL . 32.2 p -96.53 -6.14 37.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.25 -1.531 . . . . 0.0 108.961 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 52.92 25.54 23.84 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.829 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.738 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -69.77 159.64 33.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.281 -1.717 . . . . 0.0 109.168 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -112.38 112.45 24.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.335 -0.853 . . . . 0.0 109.062 179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.679 ' OE1' ' N ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -48.84 109.0 0.21 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.415 -0.803 . . . . 0.0 108.986 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.467 HG11 ' CE2' ' A' ' 160' ' ' TYR . 16.0 m -124.71 137.4 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.5 t -113.79 123.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.443 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -97.82 116.18 29.52 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.313 -0.867 . . . . 0.0 109.342 -179.007 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.415 HG12 ' CG2' ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.8 140.81 47.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.451 -0.781 . . . . 0.0 108.909 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.648 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m -107.26 158.77 7.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.322 -0.862 . . . . 0.0 108.808 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.648 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 4.4 m-85 -141.91 155.84 45.5 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.826 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -101.04 106.13 42.79 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.405 -0.81 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_exo -47.75 -26.46 6.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.685 2.256 . . . . 0.0 112.5 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.15 -18.6 52.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -121.06 -7.62 9.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.647 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.438 HG22 ' N ' ' A' ' 127' ' ' SER . 0.1 OUTLIER -154.1 156.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 110.488 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.438 ' N ' HG22 ' A' ' 126' ' ' ILE . 33.0 t -108.17 147.68 30.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.715 . . . . 0.0 109.73 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 2.1 t80 -49.79 -21.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.442 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -63.62 -23.44 67.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.147 -0.97 . . . . 0.0 109.128 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 131' ' ' LEU . 2.5 mt-10 -71.41 -71.53 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.875 ' H ' ' CD2' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -35.3 -47.87 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.088 -1.007 . . . . 0.0 109.579 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.539 ' C ' ' CD1' ' A' ' 132' ' ' LEU . 2.8 pp -75.82 -28.93 58.49 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.095 -1.003 . . . . 0.0 111.385 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 130' ' ' GLU . 4.3 mtmt -70.41 -58.16 4.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.671 -1.268 . . . . 0.0 110.312 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.714 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -48.76 -28.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 108.897 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.704 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 38.5 t80 -65.25 -54.8 23.93 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.815 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.5 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 86.8 m95 -71.78 -42.54 67.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.356 -1.465 . . . . 0.0 109.79 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.8 -35.37 22.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.0 111.021 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.714 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 11.4 p30 -127.83 72.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.946 -1.096 . . . . 0.0 111.275 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.704 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 6.3 m80 -150.6 151.62 32.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.612 ' OD1' ' NE2' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.38 177.77 0.33 Allowed Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.746 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.406 ' HB2' ' H ' ' A' ' 142' ' ' THR . 3.4 Cg_endo -79.87 -91.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.16 1.907 . . . . 0.0 111.405 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.417 ' CG2' ' HA ' ' A' ' 189' ' ' ILE . 32.9 p -123.89 54.96 1.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.42 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.64 ' C ' ' H ' ' A' ' 145' ' ' MET . 3.7 mt-30 -101.68 51.46 0.84 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.837 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.569 ' CA ' ' HG1' ' A' ' 190' ' ' THR . . . -61.07 10.13 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.177 -1.487 . . . . 0.0 109.729 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.64 ' H ' ' C ' ' A' ' 143' ' ' GLN . 2.3 ptt? -117.13 13.23 14.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.028 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' GLN . 4.9 tmm_? -178.32 152.68 0.7 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.001 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.612 ' NE2' ' OD1' ' A' ' 140' ' ' ASP . 0.6 OUTLIER -134.53 76.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.409 -1.432 . . . . 0.0 108.8 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.76 -110.37 3.44 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.05 -32.84 39.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 114.453 -0.874 . . . . 0.0 111.901 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 148.39 22.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 109.339 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.91 156.84 47.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.912 -1.118 . . . . 0.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.94 179.47 16.23 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.465 ' HB ' ' H1 ' ' A' ' 22' ' ' GLY . 0.0 OUTLIER -83.7 -18.62 37.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -1.184 . . . . 0.0 109.352 179.889 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 5.9 pt20 -88.61 4.25 47.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.123 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 67.7 m-85 -122.06 52.37 1.28 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.633 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 70' ' ' MET . 2.4 mtm105 -108.43 -170.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.504 -0.748 . . . . 0.0 109.152 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.72 126.14 35.9 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 68' ' ' PHE . . . -133.52 131.84 40.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.443 -1.703 . . . . 0.0 111.104 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.583 ' O ' ' CG2' ' A' ' 159' ' ' VAL . 1.2 m -135.55 119.0 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.562 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 2.8 m-30 -116.02 129.76 24.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.73 168.34 22.57 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.381 2.054 . . . . 0.0 112.131 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -20.49 20.09 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.907 -1.121 . . . . 0.0 109.222 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 177.18 -171.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 168' ' ' GLU . . . -53.12 -15.25 0.8 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.995 1.379 . . . . 0.0 108.52 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.52 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.6 t -55.75 -64.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.891 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.454 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 18.1 mt-30 -78.74 -20.92 48.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.556 -0.715 . . . . 0.0 110.651 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 12.4 ttp -52.2 -31.96 34.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.54 ' OE1' ' O ' ' A' ' 164' ' ' ALA . 2.8 mp0 -75.35 -36.25 61.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.772 -1.205 . . . . 0.0 109.79 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.578 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.77 -47.33 7.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.086 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.75 -63.15 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.07 -34.69 44.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.974 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -74.93 -35.33 62.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.192 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -59.18 -46.18 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -72.39 -25.23 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.005 . . . . 0.0 109.744 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.461 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 69.5 mt-10 -73.19 -56.82 4.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.664 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.571 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 15.7 pt-20 -53.25 -45.55 68.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.571 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -68.17 -20.54 64.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.631 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.456 HE21 ' HB2' ' A' ' 182' ' ' SER . 43.3 tp60 -74.64 -38.19 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -29.79 52.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.674 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.2 t -74.38 -54.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.724 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.473 ' C ' ' H ' ' A' ' 183' ' ' LYS . 4.5 mm? -64.31 -42.31 96.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.737 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.456 ' HB2' HE21 ' A' ' 178' ' ' GLN . 23.0 t -56.38 -6.22 0.26 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.473 ' H ' ' C ' ' A' ' 181' ' ' LEU . 3.8 tttp -88.09 -10.55 49.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.605 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.747 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.4 OUTLIER -108.4 35.96 2.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.702 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 184' ' ' HIS . 0.0 OUTLIER 72.96 31.01 1.58 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.525 -0.734 . . . . 0.0 110.004 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -105.19 174.65 5.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.18 -147.17 6.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 189' ' ' ILE . 29.6 Cg_exo -58.79 106.29 0.27 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.542 2.161 . . . . 0.0 111.451 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.526 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.2 OUTLIER -48.34 -177.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.834 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.569 ' HG1' ' CA ' ' A' ' 144' ' ' GLY . 1.8 p -133.91 68.68 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.691 0.758 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.411 ' CG2' ' CG1' ' A' ' 159' ' ' VAL . 24.5 m -98.39 119.88 37.84 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.627 ' OD1' ' CZ ' ' A' ' 194' ' ' ARG . 2.0 t70 -75.36 121.04 21.64 Favored 'General case' 0 C--N 1.279 -2.485 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.492 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.55 109.57 14.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.659 HH12 ' C10' ' A' ' 21' ' ' MYR . 1.9 ptp180 -166.75 120.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.652 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 1.9 pm0 -80.81 -179.32 7.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.529 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.49 22.75 61.78 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.474 ' HG3' ' CE2' ' A' ' 160' ' ' TYR . 53.0 mm-40 -93.31 98.29 11.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.612 -1.522 . . . . 0.0 109.516 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.411 ' C ' ' O ' ' A' ' 197' ' ' GLN . 1.4 p -42.98 161.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.468 -0.77 . . . . 0.0 109.794 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.43 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 41.3 t80 -109.31 131.43 55.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.505 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -127.54 98.65 5.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 -179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.67 131.52 39.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.982 -1.074 . . . . 0.0 110.584 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -83.58 179.14 7.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.541 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.0 OUTLIER -74.64 170.57 15.54 Favored 'General case' 0 C--N 1.286 -2.153 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 179.514 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -63.93 -13.43 45.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.897 . . . . 0.0 109.841 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -76.77 -15.75 59.66 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.912 -1.118 . . . . 0.0 110.182 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.41 ' CD2' ' OE2' ' A' ' 203' ' ' GLU . 63.5 m-70 -107.35 8.89 29.94 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.677 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.751 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.7 mm-40 -119.88 -149.98 0.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.822 -1.174 . . . . 0.0 112.087 -177.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.661 ' CG ' ' NE2' ' A' ' 48' ' ' HIS . 12.2 mp0 -36.25 -2.49 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.73 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.751 ' N ' ' O ' ' A' ' 207' ' ' GLN . 10.6 p90 -46.79 -34.75 5.54 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 117.373 -1.731 . . . . 0.0 110.705 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.591 ' N ' ' CD1' ' A' ' 209' ' ' TYR . 1.7 mt -49.44 -10.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.403 -1.436 . . . . 0.0 110.042 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 209' ' ' TYR . 11.4 p -53.21 -37.02 61.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -84.75 -36.74 21.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.1 66.79 3.09 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.594 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 10.0 Cg_endo -54.9 -39.76 88.77 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.997 2.465 . . . . 0.0 113.16 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.584 ' C ' HH12 ' A' ' 78' ' ' ARG . 29.6 p30 -61.23 -5.6 1.66 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.787 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 218' ' ' CYS . . . 58.99 84.41 0.04 OUTLIER Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.561 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.637 ' OH ' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -48.82 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 121.017 2.408 . . . . 0.0 109.452 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 216' ' ' GLY . 31.4 p -166.12 -125.15 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.769 -1.207 . . . . 0.0 109.143 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.631 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -128.04 -149.94 7.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.419 ' CD2' ' N ' ' A' ' 220' ' ' LEU . 0.1 OUTLIER -114.23 -175.02 2.59 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.36 -1.083 . . . . 0.0 109.641 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.86 -139.28 0.05 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -153.42 -142.02 3.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.63 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER 33.72 27.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.521 -0.987 . . . . 0.0 109.455 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -79.47 -8.4 87.79 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 226' ' ' SER . 1.3 t -49.55 161.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.847 -0.796 . . . . 0.0 109.507 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.467 ' N ' ' CG1' ' A' ' 225' ' ' VAL . 0.1 OUTLIER -99.14 108.95 21.69 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.273 1.035 . . . . 0.0 109.202 179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.592 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.1 OUTLIER -73.17 -68.84 0.35 Allowed Pre-proline 0 C--N 1.279 -2.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.154 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.592 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 94.9 Cg_endo -79.65 -35.75 0.73 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.026 1.817 . . . . 0.0 110.122 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.565 ' O ' ' C ' ' A' ' 230' ' ' ALA . 3.9 mmm -55.34 154.16 6.4 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.794 0.807 . . . . 0.0 109.949 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.565 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.31 138.81 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.217 0.532 . . . . 0.0 109.868 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.563 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 2.9 tp -151.52 119.48 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.311 -0.868 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 231' ' ' ILE . 0.2 OUTLIER -35.41 110.74 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 109.551 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.301 0 O-C-N 121.227 -0.921 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.659 ' C10' HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.526 ' C ' ' O ' ' A' ' 22' ' ' GLY . 0.6 OUTLIER 35.96 83.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -1.123 . . . . 0.0 109.275 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.677 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 25.3 m -50.64 -19.42 0.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.077 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.714 ' C ' ' H ' ' A' ' 27' ' ' LYS . . . -78.04 -94.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 123.199 1.476 . . . . 0.0 110.435 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.658 ' C ' ' H ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER -49.1 9.11 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.517 -178.721 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.714 ' H ' ' C ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -80.09 21.85 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 124.084 1.897 . . . . 0.0 108.768 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.658 ' H ' ' C ' ' A' ' 26' ' ' SER . 20.1 t -154.13 55.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.261 -3.27 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.82 135.78 25.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -173.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.53 ' H ' ' HG ' ' A' ' 30' ' ' SER . 0.1 OUTLIER -82.23 131.28 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.151 0.977 . . . . 0.0 110.243 -179.172 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 97' ' ' HIS . . . -45.9 -55.68 6.41 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.494 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -85.03 8.28 18.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.765 -1.209 . . . . 0.0 111.73 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.472 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 3.2 tt0 -117.59 -14.3 10.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.444 -1.41 . . . . 0.0 111.501 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HB3' ' CD2' ' A' ' 97' ' ' HIS . . . -67.39 -169.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.541 -1.35 . . . . 0.0 109.45 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.69 ' N ' ' CD1' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -138.11 61.31 26.67 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.738 ' O ' ' N ' ' A' ' 38' ' ' ARG . 44.3 Cg_endo -89.2 -27.12 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 123.191 2.594 . . . . 0.0 113.198 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . -26.1 81.37 0.0 OUTLIER Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.738 ' N ' ' O ' ' A' ' 36' ' ' PRO . 1.1 ttt85 -139.78 124.88 18.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.048 -1.266 . . . . 0.0 109.548 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -88.13 37.78 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.224 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.08 113.28 29.17 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.935 -1.103 . . . . 0.0 109.707 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -57.7 169.75 2.32 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.167 1.911 . . . . 0.0 112.416 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.591 ' CG2' ' O ' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -139.05 71.34 41.15 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.312 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.497 ' O ' ' CG1' ' A' ' 44' ' ' VAL . 71.5 Cg_endo -81.37 149.86 17.06 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.06 2.507 . . . . 0.0 112.751 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.497 ' CG1' ' O ' ' A' ' 43' ' ' PRO . 3.2 m -163.37 158.92 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.416 -0.802 . . . . 0.0 109.493 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.599 ' CG2' ' O ' ' A' ' 45' ' ' THR . 15.2 t -59.43 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.908 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.587 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.91 -21.79 22.38 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.235 -0.916 . . . . 0.0 110.759 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.6 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.8 OUTLIER -90.93 100.15 13.06 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 116.344 -2.143 . . . . 0.0 108.03 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.652 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 7.8 t-80 -31.48 132.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.486 ' CE1' ' HE2' ' A' ' 212' ' ' LYS . 0.1 OUTLIER -82.72 -11.43 58.32 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.104 -0.998 . . . . 0.0 111.234 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.477 HG21 ' CE1' ' A' ' 48' ' ' HIS . 21.9 t -85.6 -36.34 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 108.207 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -45.14 3.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.011 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.11 54.27 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 -76.32 -116.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.243 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.688 ' CB ' ' HH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.89 174.06 10.1 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 123.497 1.617 . . . . 0.0 109.606 177.563 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.587 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 6.9 p -142.34 38.57 1.56 Allowed 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.07 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.547 ' CG1' ' O ' ' A' ' 55' ' ' THR . 4.6 m -163.89 138.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.995 -1.066 . . . . 0.0 109.795 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.451 ' HB3' ' CE2' ' A' ' 59' ' ' PHE . 8.1 pt-20 -71.78 177.33 1.71 Allowed Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.445 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 2.9 Cg_exo -49.26 143.62 6.21 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 N-CA-C 116.067 1.526 . . . . 0.0 116.067 -0.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 37.6 m-85 -94.56 110.44 49.04 Favored Pre-proline 0 C--N 1.272 -2.768 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.577 ' O ' ' OG1' ' A' ' 63' ' ' THR . 50.1 Cg_exo -50.38 133.45 36.88 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.331 2.021 . . . . 0.0 112.387 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 60' ' ' PRO . 50.8 mt-10 -43.59 157.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.14 32.0 27.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -158.71 137.93 11.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -1.174 . . . . 0.0 109.474 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.663 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 20.6 mp0 -111.55 156.67 21.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.123 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.742 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -140.78 114.62 8.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.965 . . . . 0.0 109.904 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.64 -170.71 1.69 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.93 . . . . 0.0 108.802 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.14 133.55 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.049 -1.657 . . . . 0.0 109.518 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.713 ' CE2' ' O ' ' A' ' 131' ' ' LEU . 25.9 m-85 -126.41 145.22 50.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.828 -1.17 . . . . 0.0 109.293 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.03 108.93 1.72 Allowed Glycine 0 N--CA 1.482 1.715 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.601 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -114.3 -87.84 0.57 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.403 -1.057 . . . . 0.0 108.502 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.569 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -148.19 -152.19 5.63 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.703 ' C ' ' H ' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -36.18 104.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.78 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -50.67 7.28 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.703 ' H ' ' C ' ' A' ' 72' ' ' CYS . 37.9 m0 -75.27 -52.23 11.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.656 -1.278 . . . . 0.0 109.417 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' CA ' ' HB2' ' A' ' 218' ' ' CYS . . . -88.8 -26.96 25.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -64.85 -45.2 87.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.105 -1.233 . . . . 0.0 110.173 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.425 ' O ' ' CG ' ' A' ' 77' ' ' GLU . 4.2 tt0 -83.03 -14.77 53.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.126 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 80' ' ' PHE . 51.4 ttp85 -68.6 -36.12 78.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.0 110.067 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -70.49 15.76 0.09 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.0 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 93.2 m-85 -123.73 -42.25 2.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 110.644 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -68.77 6.88 0.76 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.553 -1.342 . . . . 0.0 109.268 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.515 ' H ' ' C ' ' A' ' 80' ' ' PHE . 1.5 m -109.53 15.97 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 109.369 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.9 mt -110.84 154.64 23.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.98 138.42 31.5 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.353 0.596 . . . . 0.0 109.561 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.84 -27.35 14.96 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.26 137.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.53 -0.982 . . . . 0.0 108.999 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.688 ' HH ' ' CB ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -79.94 -46.69 16.27 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.672 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 1.4 p -165.7 -170.21 1.74 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.652 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 41.4 p -151.16 146.42 26.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 108.989 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.672 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 6.8 mp0 -144.59 155.8 43.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 110.13 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.464 ' CG2' ' OE1' ' A' ' 207' ' ' GLN . 0.1 OUTLIER -141.05 151.95 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.2 42.82 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.374 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.2 m-85 -80.1 171.68 14.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.951 . . . . 0.0 109.252 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -176.95 168.73 2.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 109.667 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 64.64 20.88 66.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -93.83 173.72 33.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.634 ' CD2' ' O ' ' A' ' 31' ' ' ALA . 1.2 m-70 -91.66 -111.83 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.544 -1.563 . . . . 0.0 111.404 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.748 ' HG1' ' H ' ' A' ' 99' ' ' ARG . 5.9 t -75.98 -172.88 2.12 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.748 ' H ' ' HG1' ' A' ' 98' ' ' THR . 0.1 OUTLIER -37.81 139.26 0.32 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.937 ' H ' ' ND2' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -128.38 144.87 53.54 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -172.414 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 100' ' ' ASN . 73.5 Cg_exo -45.68 -147.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 124.133 3.222 . . . . 0.0 112.214 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.417 ' O ' HG22 ' A' ' 106' ' ' VAL . 1.5 t -125.53 176.1 7.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.971 -1.08 . . . . 0.0 111.514 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.786 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -50.81 -41.1 57.09 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.531 0.682 . . . . 0.0 110.397 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 12.7 tttp -72.59 -33.44 66.72 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.146 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.658 ' C ' ' HZ2' ' A' ' 110' ' ' LYS . 1.9 mm-40 -81.71 -41.2 21.65 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 110.47 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.687 ' O ' ' N ' ' A' ' 108' ' ' SER . 28.3 m -56.29 -23.32 16.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.061 -1.024 . . . . 0.0 109.85 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' A' ' 106' ' ' VAL . 69.0 m -41.66 -15.48 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.691 ' C ' ' H ' ' A' ' 110' ' ' LYS . 35.6 m -102.67 19.81 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 110.006 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER 60.08 -9.38 0.05 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.92 -1.112 . . . . 0.0 109.647 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.691 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -44.67 -14.32 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.739 -0.6 . . . . 0.0 111.691 -178.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.487 ' N ' ' O ' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -122.09 -10.0 8.63 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.554 -1.342 . . . . 0.0 111.481 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 60.74 24.87 62.84 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 118.527 -1.796 . . . . 0.0 109.771 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.655 ' HE2' ' CG ' ' A' ' 100' ' ' ASN . 1.8 m-70 -78.83 172.41 13.8 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.992 -1.299 . . . . 0.0 109.274 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -137.25 125.26 22.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.674 ' OE2' ' CZ ' ' A' ' 73' ' ' PHE . 3.5 mt-10 -66.33 119.7 12.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.232 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -125.05 169.74 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 15.8 m -127.13 128.22 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.376 -0.827 . . . . 0.0 109.519 179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.711 HH11 ' HH ' ' A' ' 201' ' ' TYR . 8.9 ttm180 -103.48 111.83 24.46 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.551 -0.718 . . . . 0.0 109.886 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.72 112.89 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -98.49 160.72 3.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 108.94 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 10.5 p90 -141.23 169.5 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.581 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.513 ' C ' ' OE2' ' A' ' 124' ' ' GLU . 60.7 mtp180 -110.05 114.1 56.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' HIS . 38.3 Cg_exo -42.94 -63.97 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.927 2.418 . . . . 0.0 113.022 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.683 ' OE2' ' N ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -46.45 -10.67 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 -179.175 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' PRO . 36.1 m80 -126.13 -18.86 4.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.617 -1.302 . . . . 0.0 110.716 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.482 HG21 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.59 158.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.873 -1.142 . . . . 0.0 110.212 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 126' ' ' ILE . 88.5 p -108.8 153.19 23.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.825 . . . . 0.0 110.369 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' C ' ' N ' ' A' ' 130' ' ' GLU . 25.1 t80 -53.63 -30.1 41.19 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 3.0 mp0 -47.35 -19.26 0.15 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 128' ' ' PHE . 1.5 mm-40 -73.84 -63.02 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.827 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.713 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 7.2 mt -44.74 -45.74 10.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.253 -0.904 . . . . 0.0 108.785 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.599 ' C ' ' CD1' ' A' ' 132' ' ' LEU . 2.5 pp -75.04 -21.96 58.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.495 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.446 ' N ' HD11 ' A' ' 132' ' ' LEU . 0.4 OUTLIER -69.94 -68.13 0.44 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.736 -1.227 . . . . 0.0 110.057 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.727 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 38.9 t -58.3 -17.22 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.58 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 7.2 t80 -72.45 -60.27 2.31 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.844 -1.16 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.658 ' CB ' ' CE2' ' A' ' 177' ' ' TYR . 94.1 m95 -72.06 -52.84 14.94 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.468 -1.395 . . . . 0.0 110.348 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 136' ' ' TRP . 4.1 tt0 -36.84 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.557 -0.714 . . . . 0.0 111.86 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.727 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.7 p30 -124.0 64.76 1.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.609 -1.307 . . . . 0.0 111.734 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 223' ' ' THR . 13.0 m80 -147.95 161.25 41.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.201 -0.937 . . . . 0.0 109.056 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.65 ' CG ' HE22 ' A' ' 143' ' ' GLN . 0.9 OUTLIER -91.77 160.32 36.46 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.086 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 186' ' ' PHE . 79.8 Cg_exo -32.62 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.572 2.181 . . . . 0.0 111.792 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.707 ' OG1' ' N ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -122.21 14.77 10.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.793 -1.192 . . . . 0.0 109.005 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.65 HE22 ' CG ' ' A' ' 140' ' ' ASP . 3.5 mt-30 -55.4 71.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.61 10.17 62.84 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.97 15.53 15.14 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 148' ' ' GLY . 4.3 ttm180 179.3 133.62 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.326 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 70' ' ' MET . 2.0 tp60 -109.54 63.67 0.6 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 119.731 -1.856 . . . . 0.0 107.894 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' CD ' ' A' ' 146' ' ' ARG . . . 91.96 -118.07 5.41 Favored Glycine 0 C--N 1.301 -1.413 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -32.75 47.54 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.458 -0.871 . . . . 0.0 111.434 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.95 117.46 18.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.28 -1.513 . . . . 0.0 109.304 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 35.6 p90 -109.21 131.89 54.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.928 . . . . 0.0 110.716 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.06 164.51 25.9 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.023 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.574 ' OG1' ' OE2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -72.13 -23.42 61.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.589 -0.948 . . . . 0.0 109.629 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.631 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 7.2 pm0 -89.17 3.7 51.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.453 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 22.5 m-85 -112.59 50.03 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 109.37 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 144' ' ' GLY . 1.6 mtm180 -97.37 -178.65 4.23 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 109.236 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 192' ' ' ASP . 3.8 t -93.9 112.95 24.87 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.436 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -145.17 123.18 12.06 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 117.866 -1.533 . . . . 0.0 112.036 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.478 HG21 ' CE2' ' A' ' 135' ' ' PHE . 4.5 t -112.26 127.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.689 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.474 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.5 m-85 -112.88 93.02 22.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.323 -0.86 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -49.12 172.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.838 2.358 . . . . 0.0 112.186 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.44 HG23 ' SD ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -107.44 -44.24 4.35 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.191 -0.943 . . . . 0.0 109.698 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.509 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER -175.12 -178.02 1.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.12 -0.988 . . . . 0.0 109.902 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.18 -24.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 123.252 1.501 . . . . 0.0 108.255 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.649 ' O ' ' CG ' ' A' ' 168' ' ' GLU . 2.5 t -56.43 -53.81 35.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.38 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.506 ' C ' ' H ' ' A' ' 168' ' ' GLU . 0.4 OUTLIER -78.51 -20.92 49.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.336 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 22.8 ttm -52.95 -4.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER -73.58 -68.48 0.5 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.845 -1.159 . . . . 0.0 110.583 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -92.74 -42.92 9.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -0.987 . . . . 0.0 111.175 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -51.68 -65.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.968 -1.082 . . . . 0.0 110.169 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.458 ' HG ' ' NZ ' ' A' ' 174' ' ' LYS . 0.4 OUTLIER -55.04 -40.14 69.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.045 -1.034 . . . . 0.0 109.431 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -74.26 -24.17 59.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.648 ' N ' ' O ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -67.23 -32.31 73.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.583 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.595 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 8.1 pttm -72.36 -47.14 51.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.997 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CG ' ' A' ' 174' ' ' LYS . 15.3 tt0 -72.86 -30.38 63.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.518 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.639 ' OE2' ' CD2' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -73.22 -40.79 64.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.0 -1.062 . . . . 0.0 110.819 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.658 ' CE2' ' CB ' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -80.12 -25.61 39.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.748 -1.22 . . . . 0.0 110.238 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -74.76 -26.44 59.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 109.912 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 1.4 ttpm? -77.89 -20.04 53.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.22 -54.11 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.76 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.1 mt -66.38 -13.09 60.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.963 . . . . 0.0 109.75 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.43 ' HG ' ' HA ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -59.48 -40.66 87.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -88.04 10.61 18.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.95 . . . . 0.0 109.659 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.516 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 14.3 m170 -104.49 35.11 2.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.31 48.55 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.543 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 141' ' ' PRO . 71.7 m-85 -152.5 168.61 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.31 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -117.83 -144.42 7.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -58.66 105.85 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.24 1.96 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.544 ' C ' ' OG1' ' A' ' 142' ' ' THR . 0.5 OUTLIER -47.47 166.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -178.746 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.707 ' N ' ' OG1' ' A' ' 142' ' ' THR . 0.8 OUTLIER -95.06 0.48 54.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.827 -0.546 . . . . 0.0 111.199 -179.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.496 ' C ' ' O ' ' A' ' 190' ' ' THR . 27.2 m -42.87 108.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.69 -1.256 . . . . 0.0 108.401 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.663 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 2.2 t70 -76.91 131.8 38.75 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.84 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.421 HG23 HD12 ' A' ' 193' ' ' ILE . 7.7 mm -131.97 101.38 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.402 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.663 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -143.35 153.54 42.83 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.669 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -107.02 171.21 7.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.976 -1.077 . . . . 0.0 110.01 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.544 ' C ' ' OE1' ' A' ' 197' ' ' GLN . . . 75.37 43.94 23.5 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.591 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 3.6 mm100 -97.41 97.6 9.24 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.318 -1.107 . . . . 0.0 109.539 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.5 t -48.3 153.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.69 131.88 54.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.407 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' PHE . 4.4 m-85 -131.79 98.35 4.44 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.711 ' HH ' HH11 ' A' ' 118' ' ' ARG . 16.0 m-85 -54.02 141.49 28.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 110.462 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.461 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -92.87 -176.08 4.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.701 ' OE1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.45 175.11 8.04 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.441 -0.787 . . . . 0.0 109.064 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.701 ' N ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -60.42 -54.83 40.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.867 -1.146 . . . . 0.0 108.77 179.433 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -46.89 -11.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.052 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.786 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 9.1 m-70 -100.75 9.84 41.9 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.12 -0.987 . . . . 0.0 110.777 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.9 mm-40 -130.51 -143.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.402 1.096 . . . . 0.0 110.688 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.651 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 16.4 mp0 -36.59 -2.76 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.072 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 60.3 t80 -41.01 -50.69 3.32 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 120.865 -1.147 . . . . 0.0 112.083 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . . . . . . . . . 63.9 mt -65.97 -25.23 67.01 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.115 -1.615 . . . . 0.0 111.221 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.91 -52.06 65.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 108.608 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.636 ' NZ ' ' CB ' ' A' ' 212' ' ' LYS . 7.4 mtmp? -90.34 -12.49 37.54 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 111.096 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.693 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 2.0 m-80 -115.0 95.18 41.08 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.669 -1.269 . . . . 0.0 111.082 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.68 12.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.326 2.684 . . . . 0.0 111.899 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.603 ' H ' ' C ' ' A' ' 213' ' ' ASN . 8.1 t0 -60.74 -5.42 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.44 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.33 -47.41 0.13 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.592 -1.289 . . . . 0.0 112.492 177.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.615 ' C ' ' O ' ' A' ' 216' ' ' GLY . 25.9 m-85 -27.22 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 119.382 1.591 . . . . 0.0 109.641 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.759 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 16.6 p -142.24 -127.62 0.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.337 -0.852 . . . . 0.0 109.564 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.759 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -152.66 151.0 22.89 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 mt -104.65 146.25 29.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -1.138 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.4 -162.63 5.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.677 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -155.51 -141.77 3.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 139' ' ' HIS . 1.2 p 47.81 1.39 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.47 -1.017 . . . . 0.0 110.082 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -80.54 11.5 38.83 Favored Glycine 0 C--N 1.306 -1.119 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.561 ' CG1' ' O ' ' A' ' 225' ' ' VAL . 3.8 p -98.17 119.52 46.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.404 -1.057 . . . . 0.0 109.889 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.443 ' O ' ' SD ' ' A' ' 229' ' ' MET . 23.5 m -99.41 111.53 23.87 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.609 1.195 . . . . 0.0 108.61 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.627 ' C ' ' H ' ' A' ' 229' ' ' MET . 1.3 m -75.13 -72.4 0.18 Allowed Pre-proline 0 C--N 1.284 -2.276 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.16 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.581 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 19.3 Cg_endo -60.0 2.19 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.221 1.948 . . . . 0.0 109.971 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.627 ' H ' ' C ' ' A' ' 227' ' ' CYS . 0.0 OUTLIER -55.35 157.99 3.42 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.758 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.532 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.97 131.85 0.13 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.711 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 2.0 mm -133.86 110.13 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.27 -0.894 . . . . 0.0 109.284 179.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.66 -169.95 1.87 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 121.313 -0.867 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.508 ' C8 ' ' NH1' ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -106.44 -141.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -60.89 -34.07 74.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.867 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -65.5 -94.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.915 1.341 . . . . 0.0 110.124 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.664 ' C ' ' H ' ' A' ' 28' ' ' VAL . 37.1 t -56.92 32.28 0.0 OUTLIER 'General case' 0 C--N 1.259 -3.333 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.939 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.671 ' NZ ' ' OG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -70.39 35.12 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 123.269 1.509 . . . . 0.0 110.773 -178.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.664 ' H ' ' C ' ' A' ' 26' ' ' SER . 0.9 OUTLIER 48.47 70.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 -179.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.444 HG21 ' NE2' ' A' ' 97' ' ' HIS . 0.2 OUTLIER -40.41 120.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 109.219 -3.628 . . . . 0.0 115.301 -169.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.671 ' OG ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.96 121.17 9.92 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.874 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.477 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -52.79 -24.7 9.4 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.827 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -73.5 -14.56 61.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.793 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.6 -14.03 14.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -53.26 146.09 12.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 110.314 -179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.594 ' CD1' ' H ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -65.66 166.65 13.88 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.72 -24.14 9.37 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.157 1.905 . . . . 0.0 111.206 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.594 ' H ' ' CD1' ' A' ' 35' ' ' LEU . . . 95.59 -62.67 1.39 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.675 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.477 ' HB2' HD21 ' A' ' 100' ' ' ASN . 0.0 OUTLIER -81.25 125.21 30.04 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.954 -1.321 . . . . 0.0 109.903 -179.191 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 3.6 m -124.73 -5.59 7.52 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 39' ' ' THR . 2.5 mt-10 158.55 151.35 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.2 134.16 18.89 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.867 2.378 . . . . 0.0 112.187 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.7 mm -138.12 95.84 10.44 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.146 -0.971 . . . . 0.0 109.729 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.38 168.01 16.91 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.829 2.353 . . . . 0.0 112.174 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.477 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 29.7 m -129.39 -163.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.14 -0.975 . . . . 0.0 109.68 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.666 ' N ' ' OD2' ' A' ' 204' ' ' ASP . 13.2 t -90.66 102.39 15.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.595 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.89 -57.8 10.56 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.367 -0.833 . . . . 0.0 110.915 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -71.23 100.8 2.17 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 115.62 -2.432 . . . . 0.0 108.061 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.757 ' HE2' ' NE2' ' A' ' 208' ' ' GLN . 11.4 t-80 -31.63 136.53 0.06 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.454 ' NE2' ' HD2' ' A' ' 212' ' ' LYS . 37.4 t-80 -74.81 -32.32 61.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 111.09 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG21 ' CD2' ' A' ' 81' ' ' TRP . 64.2 t -70.27 -47.58 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.892 -1.13 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -99.34 -42.72 6.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.062 -1.024 . . . . 0.0 110.789 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.03 2.51 58.17 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -75.61 -115.66 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.587 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -134.23 173.44 11.6 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 123.613 1.673 . . . . 0.0 110.106 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.595 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 41.3 p -143.72 17.38 1.81 Allowed 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 112.601 -2.091 . . . . 0.0 110.061 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 57' ' ' GLU . 8.6 m -151.96 136.81 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 109.368 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' A' ' 56' ' ' VAL . 8.2 mt-10 -32.4 155.28 0.04 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.971 0.891 . . . . 0.0 110.816 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -79.26 165.83 79.98 Favored 'Cis proline' 0 C--N 1.303 -1.865 0 C-N-CA 121.606 -2.248 . . . . 0.0 112.045 -0.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.796 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 2.2 m-30 -112.24 150.31 42.32 Favored Pre-proline 0 C--N 1.269 -2.91 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.21 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.573 ' O ' ' OG1' ' A' ' 63' ' ' THR . 36.2 Cg_endo -68.01 109.98 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.727 2.285 . . . . 0.0 112.331 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.84 143.42 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.11 -19.0 50.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.573 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -82.78 149.1 27.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -1.134 . . . . 0.0 109.533 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.678 ' OE1' ' N ' ' A' ' 65' ' ' MET . 5.6 tm0? -99.47 146.98 25.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.752 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -139.36 114.27 9.42 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.093 -1.004 . . . . 0.0 109.647 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.98 -167.98 1.63 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 t -142.35 138.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.126 -1.609 . . . . 0.0 109.47 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.694 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 32.9 m-85 -134.63 136.74 43.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.06 111.12 2.21 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.672 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 2.9 mmm -100.01 -89.76 0.33 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.429 -1.042 . . . . 0.0 108.519 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.721 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -161.3 72.49 0.21 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.216 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.721 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 49.0 t 110.52 110.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.561 0.744 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.6 ' CD1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -63.99 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.505 -1.372 . . . . 0.0 110.61 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.688 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 9.0 m0 -94.89 -70.52 0.71 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.565 -1.334 . . . . 0.0 109.553 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -2.43 65.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -76.34 -37.62 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -1.164 . . . . 0.0 109.796 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.671 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 2.1 pm0 -82.74 -25.75 32.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.267 -0.896 . . . . 0.0 110.479 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.633 ' N ' ' CD ' ' A' ' 77' ' ' GLU . 6.4 tmm_? -57.94 -56.79 17.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.075 -1.016 . . . . 0.0 110.076 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.455 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 13.0 mttp -43.53 -25.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.484 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 94.6 m-85 -84.96 -41.75 15.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 111.406 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 81' ' ' TRP . 0.7 OUTLIER -69.55 -5.18 22.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.318 -1.489 . . . . 0.0 109.259 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 81' ' ' TRP . 0.9 OUTLIER -97.74 18.58 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.234 -0.916 . . . . 0.0 109.365 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.29 152.2 21.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.972 0.892 . . . . 0.0 109.402 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -90.0 143.27 26.93 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 95.66 -21.44 44.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -75.53 138.02 21.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.838 . . . . 0.0 109.529 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.587 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.8 -47.56 12.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.525 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 1.5 t -167.65 -175.13 2.69 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.631 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 81' ' ' TRP . 20.2 p -149.29 164.38 35.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.803 . . . . 0.0 109.285 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.85 162.59 13.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 206' ' ' HIS . 0.9 OUTLIER -126.67 176.91 6.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.274 -0.891 . . . . 0.0 109.365 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.53 169.27 37.04 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.488 ' CZ ' ' HA ' ' A' ' 202' ' ' ALA . 3.4 m-85 -89.1 161.59 16.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.984 . . . . 0.0 109.99 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.688 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.06 -171.37 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.433 -0.792 . . . . 0.0 109.104 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 54.61 32.1 53.38 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.616 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -139.47 -159.61 8.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.477 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 4.2 p80 -148.77 78.58 1.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.313 -1.11 . . . . 0.0 109.909 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.581 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.86 149.33 21.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.262 -0.898 . . . . 0.0 109.009 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.706 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.1 mmt180 -48.83 -106.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.477 HD21 ' HB2' ' A' ' 38' ' ' ARG . 0.6 OUTLIER -112.24 83.82 5.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.46 171.18 18.06 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.481 2.121 . . . . 0.0 112.265 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.487 ' OG1' ' HB3' ' A' ' 105' ' ' GLU . 21.2 p -122.27 167.31 13.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.025 -1.047 . . . . 0.0 110.077 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.732 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 2.1 t80 -57.79 -59.33 5.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.586 -0.696 . . . . 0.0 110.144 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -22.06 41.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 108.78 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.487 ' HB3' ' OG1' ' A' ' 102' ' ' THR . 0.8 OUTLIER -79.06 -61.46 2.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.653 -0.655 . . . . 0.0 110.596 -179.188 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.48 ' N ' ' CG ' ' A' ' 105' ' ' GLU . 15.3 m -52.13 -24.68 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.128 -0.982 . . . . 0.0 110.533 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.2 p -52.97 -45.32 67.72 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.695 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 13.6 t -52.23 -6.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.664 ' OE1' ' N ' ' A' ' 26' ' ' SER . 1.9 tt0 65.13 -6.01 0.38 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.585 -0.697 . . . . 0.0 110.359 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.471 ' H ' ' C ' ' A' ' 108' ' ' SER . 7.2 tttt -60.98 -23.01 65.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.106 -0.996 . . . . 0.0 109.206 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.475 ' O ' ' C ' ' A' ' 112' ' ' GLY . 25.3 p -94.87 -5.63 44.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.281 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 39.41 47.62 2.85 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.688 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 5.6 m-70 -92.26 170.05 10.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.782 -1.422 . . . . 0.0 109.064 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -123.59 116.1 22.57 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.546 ' C ' ' OE2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -53.41 143.4 19.25 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.583 -178.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.451 HG13 ' CE2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -151.8 174.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.125 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 68' ' ' PHE . 33.9 m -135.32 121.62 32.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.796 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 8.1 ptm180 -96.98 96.9 8.82 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.442 1.115 . . . . 0.0 108.7 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.469 ' CG2' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -103.82 147.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.664 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -114.31 157.25 15.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.664 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 2.8 m-85 -141.89 157.33 45.11 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.243 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.42 ' CD ' ' CG2' ' A' ' 63' ' ' THR . 7.7 mmm180 -109.98 99.55 39.52 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.513 -0.742 . . . . 0.0 109.252 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 125' ' ' HIS . 10.9 Cg_exo -40.32 -67.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.111 2.541 . . . . 0.0 113.906 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -40.94 -12.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.204 -0.935 . . . . 0.0 110.711 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.692 ' N ' ' O ' ' A' ' 123' ' ' PRO . 5.8 m-70 -135.41 6.77 3.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.614 -1.303 . . . . 0.0 109.69 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.582 ' CD1' ' CD ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -156.28 148.31 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.594 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.431 ' N ' HG22 ' A' ' 126' ' ' ILE . 4.6 t -99.47 151.09 21.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.481 ' CZ ' ' CD2' ' A' ' 132' ' ' LEU . 41.9 t80 -61.72 -19.88 62.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -61.88 -22.56 65.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 131' ' ' LEU . 3.0 mt-10 -70.15 -70.65 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 110.147 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.7 ' CD1' ' H ' ' A' ' 131' ' ' LEU . 0.8 OUTLIER -35.19 -50.12 0.51 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.481 ' CD2' ' CZ ' ' A' ' 128' ' ' PHE . 4.5 mm? -68.05 -54.47 18.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 0.0 111.503 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.421 ' NZ ' ' OE2' ' A' ' 137' ' ' GLU . 3.8 tttm -52.04 -57.66 8.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.081 -1.012 . . . . 0.0 111.276 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.484 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 78.8 t -49.83 -33.77 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.132 . . . . 0.0 110.22 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.701 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 23.2 t80 -71.72 -52.33 18.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.831 -1.168 . . . . 0.0 109.923 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.468 ' HB3' ' CZ ' ' A' ' 177' ' ' TYR . 87.5 m95 -70.42 -32.13 69.6 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.906 -1.121 . . . . 0.0 110.348 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.597 ' O ' ' OG1' ' A' ' 223' ' ' THR . 7.8 tt0 -72.35 -34.83 68.31 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 112.259 -177.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.37 73.72 1.56 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.44 -1.412 . . . . 0.0 112.361 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.701 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 2.0 p-80 178.15 129.59 0.06 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.81 -1.181 . . . . 0.0 110.518 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 221' ' ' GLY . 4.8 m-20 -69.09 111.3 8.08 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.453 ' HB3' ' CE1' ' A' ' 139' ' ' HIS . 66.5 Cg_endo -91.34 5.69 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 0.0 113.081 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.584 ' OG1' ' O ' ' A' ' 142' ' ' THR . 0.1 OUTLIER -123.14 46.23 2.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 111.049 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.596 ' C ' ' H ' ' A' ' 145' ' ' MET . 23.5 mt-30 -140.39 67.92 1.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 108.999 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -65.08 13.0 0.23 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.596 ' H ' ' C ' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -115.08 -20.02 10.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.033 -1.275 . . . . 0.0 109.057 178.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.518 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 176.85 163.94 0.47 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.672 ' NE2' ' O ' ' A' ' 70' ' ' MET . 15.3 mt-30 -141.44 159.66 41.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.551 -1.343 . . . . 0.0 110.191 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 147' ' ' GLN . . . 44.23 -120.55 3.44 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 36.9 t30 -111.05 26.11 11.05 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.34 -0.93 . . . . 0.0 110.542 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.573 ' OD2' ' CD1' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -108.18 91.48 3.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.855 -1.153 . . . . 0.0 109.221 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.459 ' CD1' ' HD2' ' A' ' 146' ' ' ARG . 3.7 m-85 -69.14 118.62 12.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 149.8 168.39 15.04 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.138 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.486 ' CB ' ' OG ' ' A' ' 26' ' ' SER . 0.4 OUTLIER -94.18 9.41 38.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.416 -1.049 . . . . 0.0 109.154 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.682 ' OE1' ' CE2' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -93.25 -1.16 56.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.694 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.682 ' CE2' ' OE1' ' A' ' 154' ' ' GLN . 3.3 m-85 -129.99 57.99 1.67 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.024 -1.048 . . . . 0.0 109.879 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.557 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.6 OUTLIER -91.51 -175.63 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 108.913 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.567 ' N ' ' OE1' ' A' ' 147' ' ' GLN . 13.1 p -94.08 118.89 32.17 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.409 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -147.06 110.72 4.95 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.501 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 192' ' ' ASP . 8.3 t -98.38 131.28 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.739 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.451 ' CE2' HG13 ' A' ' 116' ' ' VAL . 7.8 m-85 -114.01 120.53 38.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.51 173.72 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.574 2.183 . . . . 0.0 113.038 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -94.62 -19.61 20.31 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.227 -0.921 . . . . 0.0 109.215 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 162' ' ' THR . 0.4 OUTLIER 167.69 -163.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.453 -0.779 . . . . 0.0 109.084 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.68 -15.39 11.65 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.952 1.358 . . . . 0.0 108.743 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.76 -62.7 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.638 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.651 HE22 ' NE2' ' A' ' 64' ' ' GLN . 1.4 mp0 -61.44 -12.06 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.524 -0.735 . . . . 0.0 109.823 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.0 ttm -51.94 -34.09 40.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.913 -1.117 . . . . 0.0 110.533 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.37 -38.67 59.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.829 -1.169 . . . . 0.0 110.388 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.558 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.78 -41.52 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.021 -1.049 . . . . 0.0 110.462 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.505 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.18 -62.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.91 -179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . 0.419 HD21 ' N ' ' A' ' 171' ' ' LEU . 1.7 mm? -53.04 -36.81 60.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -74.33 -24.06 59.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.92 . . . . 0.0 109.98 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.558 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.62 -50.11 16.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.937 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -36.26 73.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.015 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.05 -49.95 25.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 110.094 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 17.8 pt-20 -59.27 -43.05 92.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.5 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 1.1 m-85 -79.29 -12.2 59.94 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.998 -1.064 . . . . 0.0 109.61 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -74.57 -55.13 6.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.594 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.544 ' O ' ' OG ' ' A' ' 182' ' ' SER . 5.7 ttpm? -73.1 -29.49 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.9 -54.37 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.98 . . . . 0.0 109.853 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.412 HD12 ' CG2' ' A' ' 189' ' ' ILE . 37.2 mt -68.17 -5.35 17.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.768 ' HG ' ' H ' ' A' ' 183' ' ' LYS . 81.4 p -61.62 -67.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.07 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.768 ' H ' ' HG ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -88.64 13.26 12.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.738 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -94.83 32.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 0.0 109.542 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.738 ' ND2' ' O ' ' A' ' 184' ' ' HIS . 0.0 OUTLIER 72.87 29.75 1.82 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.669 -0.645 . . . . 0.0 110.324 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.603 ' CD2' ' ND2' ' A' ' 185' ' ' ASN . 7.1 m-85 -137.13 170.9 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.134 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -114.08 -136.76 6.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 189' ' ' ILE . 56.7 Cg_endo -77.45 107.14 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.293 1.995 . . . . 0.0 111.718 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.475 ' O ' ' O ' ' A' ' 188' ' ' PRO . 0.2 OUTLIER -48.05 178.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 143' ' ' GLN . 6.8 t -128.69 -2.27 5.39 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.121 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.434 ' C ' ' O ' ' A' ' 190' ' ' THR . 56.8 m -42.91 114.48 0.61 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.659 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 7.0 t0 -87.45 136.34 32.98 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.615 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 4.5 mp -135.53 92.15 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 118.116 -1.434 . . . . 0.0 110.63 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.659 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -134.37 -179.51 5.62 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.634 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 4.3 pt-20 -139.11 -173.04 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.719 -1.238 . . . . 0.0 110.855 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.61 72.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 1.3 mp0 -79.89 128.02 32.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.87 -1.371 . . . . 0.0 109.885 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 6.7 p -60.55 153.65 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.188 179.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.595 ' CZ ' ' CD ' ' A' ' 118' ' ' ARG . 66.7 t80 -117.84 130.29 56.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 109.769 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.706 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 21.0 m-85 -132.29 109.83 10.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.482 -0.761 . . . . 0.0 109.187 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.776 ' HH ' ' NH1' ' A' ' 118' ' ' ARG . 20.1 m-85 -53.69 131.32 38.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.03 -1.044 . . . . 0.0 111.116 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.488 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -82.8 179.28 7.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.516 ' OE1' ' N ' ' A' ' 203' ' ' GLU . 8.5 pm0 -75.08 158.68 32.74 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.486 -0.759 . . . . 0.0 108.96 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.666 ' OD2' ' N ' ' A' ' 45' ' ' THR . 0.4 OUTLIER -55.4 -39.66 70.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.952 -1.092 . . . . 0.0 108.145 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.51 ' CE1' ' CE2' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -48.83 -19.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.577 -0.702 . . . . 0.0 110.304 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.732 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 10.5 m-70 -100.78 -17.7 16.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.811 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -106.44 -148.49 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.846 0.832 . . . . 0.0 110.357 -177.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.757 ' NE2' ' HE2' ' A' ' 48' ' ' HIS . 18.5 mp0 -35.53 -9.32 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.269 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.811 ' N ' ' O ' ' A' ' 207' ' ' GLN . 1.3 t80 -43.14 -41.87 3.86 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 120.8 -1.188 . . . . 0.0 110.915 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.475 ' CD2' ' O ' ' A' ' 74' ' ' TRP . 3.7 pp -79.98 -11.92 59.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.693 -1.603 . . . . 0.0 109.6 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 208' ' ' GLN . 91.7 p -55.8 -43.61 77.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 108.843 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.454 ' HD2' ' NE2' ' A' ' 49' ' ' HIS . 6.8 mtmm -65.49 -18.34 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.671 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.9 m-20 -128.24 71.9 79.68 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.004 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.47 9.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.274 2.649 . . . . 0.0 112.704 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.671 ' H ' ' C ' ' A' ' 213' ' ' ASN . 7.3 p30 -63.2 -18.51 63.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.012 -1.055 . . . . 0.0 110.657 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.73 85.47 0.05 OUTLIER Glycine 0 N--CA 1.498 2.79 0 C-N-CA 119.345 -1.407 . . . . 0.0 111.036 178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.737 ' CD2' ' N ' ' A' ' 218' ' ' CYS . 71.4 t80 -45.11 -177.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.321 2.06 . . . . 0.0 109.778 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.737 ' N ' ' CD2' ' A' ' 217' ' ' TYR . 0.7 OUTLIER -72.99 76.86 1.19 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.98 -1.075 . . . . 0.0 109.339 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.4 149.13 17.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.09 -171.78 4.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -1.101 . . . . 0.0 110.0 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 140' ' ' ASP . . . -142.5 -126.99 2.14 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.589 ' O ' ' OG1' ' A' ' 223' ' ' THR . . . -176.8 -134.94 2.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.645 ' CG2' ' O ' ' A' ' 139' ' ' HIS . 10.5 p 62.3 38.25 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -1.043 . . . . 0.0 109.398 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.647 ' O ' ' SD ' ' A' ' 229' ' ' MET . . . -160.59 38.74 0.44 Allowed Glycine 0 C--N 1.301 -1.368 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.85 81.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -1.165 . . . . 0.0 109.211 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.587 ' H ' ' CB ' ' A' ' 229' ' ' MET . 19.6 p -98.45 -154.45 0.46 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.109 0.957 . . . . 0.0 109.807 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.574 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.1 OUTLIER -73.11 -65.55 0.67 Allowed Pre-proline 0 C--N 1.291 -1.97 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.395 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.574 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 42.8 Cg_endo -68.15 -2.22 8.51 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.108 1.872 . . . . 0.0 110.082 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.647 ' SD ' ' O ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -81.01 155.87 26.17 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.877 0.846 . . . . 0.0 109.992 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.22 131.12 0.11 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.209 0.528 . . . . 0.0 109.667 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -152.08 119.43 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.157 -0.964 . . . . 0.0 109.45 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -56.01 -174.26 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.167 -0.958 . . . . 0.0 109.406 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.382 0 O-C-N 121.266 -0.896 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.453 ' H71' HH22 ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -36.15 134.6 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -1.111 . . . . 0.0 109.167 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 p -68.41 -47.24 67.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 111.192 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.0 -13.09 60.0 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.839 1.304 . . . . 0.0 110.795 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.571 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 2.4 t -63.67 -58.96 5.28 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.831 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.651 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -92.24 25.8 2.79 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 124.152 1.929 . . . . 0.0 109.302 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.423 ' H ' ' C ' ' A' ' 26' ' ' SER . 32.1 t -145.61 43.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.258 -3.391 0 CA-C-N 112.883 -1.962 . . . . 0.0 106.331 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.92 133.05 21.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.262 1.03 . . . . 0.0 113.544 -175.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.426 ' HG ' ' CB ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -70.12 125.41 26.7 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.718 -179.434 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.568 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -48.13 -43.19 30.93 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.654 -0.654 . . . . 0.0 109.433 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -73.34 4.32 4.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' ALA . 15.7 tt0 -111.55 -1.97 15.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -49.66 -168.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 0.0 109.686 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.14 165.63 39.9 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.78 -30.82 93.72 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.237 1.958 . . . . 0.0 112.6 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.48 ' HA2' HH11 ' A' ' 99' ' ' ARG . . . 135.42 143.77 4.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' H ' ' NE ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -69.23 172.83 6.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.12 . . . . 0.0 109.36 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.19 -12.27 7.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.164 -0.96 . . . . 0.0 109.591 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 174.88 115.99 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.132 -0.98 . . . . 0.0 109.435 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.61 163.2 29.6 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.43 2.087 . . . . 0.0 112.299 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.5 OUTLIER -137.57 94.11 12.1 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.474 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' ILE . 54.2 Cg_exo -48.46 -168.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.719 2.279 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.456 HG11 ' N ' ' A' ' 204' ' ' ASP . 26.9 m -136.05 -161.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.547 ' CG2' ' O ' ' A' ' 45' ' ' THR . 11.8 t -72.75 99.47 2.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.564 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.19 -49.07 75.09 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.145 -0.972 . . . . 0.0 111.277 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.554 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 mttm -75.35 99.51 4.14 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 115.84 -2.344 . . . . 0.0 108.682 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.649 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.7 t-80 -33.03 113.38 0.14 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.454 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.1 t-80 -61.3 -30.86 70.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.365 -0.834 . . . . 0.0 110.83 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.491 ' CG2' ' OG ' ' A' ' 211' ' ' SER . 26.1 t -65.17 -45.4 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.898 -1.126 . . . . 0.0 109.521 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.03 -45.86 4.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.906 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.53 2.74 47.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.7 p30 -79.33 -116.32 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.1 ttp180 -130.5 170.83 13.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 123.23 1.491 . . . . 0.0 109.057 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.564 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 21.6 p -134.14 26.84 3.87 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.747 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 57' ' ' GLU . 2.9 m -163.48 138.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.796 . . . . 0.0 109.695 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.58 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.3 pm0 -33.01 152.3 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.311 -0.868 . . . . 0.0 110.642 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -79.28 166.16 79.17 Favored 'Cis proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.7 -0.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -104.02 149.1 36.87 Favored Pre-proline 0 C--N 1.268 -2.965 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.576 ' O ' ' OG1' ' A' ' 63' ' ' THR . 9.6 Cg_endo -54.83 119.47 6.53 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.637 2.225 . . . . 0.0 112.089 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' PRO . 25.1 mt-10 -43.35 117.91 1.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.18 23.94 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.576 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -132.93 137.02 46.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.884 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' OE1' ' SD ' ' A' ' 65' ' ' MET . 5.6 mm-40 -104.93 -176.89 3.21 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.761 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -145.11 128.21 16.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.88 -1.138 . . . . 0.0 110.433 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.57 -170.74 2.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.87 146.04 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.146 -1.596 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.673 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 70.5 m-85 -140.84 126.84 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.671 -1.268 . . . . 0.0 109.961 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.38 107.06 2.76 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.532 ' SD ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.74 -89.14 0.5 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.515 -0.991 . . . . 0.0 109.715 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.716 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -147.89 167.47 28.81 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.716 ' C ' ' O ' ' A' ' 71' ' ' GLY . 2.1 t -5.82 115.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 117.651 0.725 . . . . 0.0 109.818 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.657 ' CD1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.52 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.22 -0.925 . . . . 0.0 110.764 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.687 ' H ' ' C ' ' A' ' 72' ' ' CYS . 0.2 OUTLIER -89.77 -55.61 3.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.752 -1.217 . . . . 0.0 109.153 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.421 ' HA3' ' CD1' ' A' ' 217' ' ' TYR . . . -105.22 2.75 40.41 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.532 ' CB ' ' SD ' ' A' ' 70' ' ' MET . . . -76.75 -39.93 50.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.288 . . . . 0.0 110.525 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.671 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 4.6 tt0 -82.65 -14.34 54.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.965 -1.085 . . . . 0.0 110.806 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 20.5 ttt180 -57.91 -72.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.894 -1.129 . . . . 0.0 110.207 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.451 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 12.1 mmtt -44.11 -5.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.748 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 46.7 m-85 -94.43 -41.34 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.734 -1.229 . . . . 0.0 110.978 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.527 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -84.99 -0.68 55.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.672 -1.267 . . . . 0.0 110.646 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -92.17 19.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.977 -1.077 . . . . 0.0 110.051 -179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -119.73 157.24 28.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.245 -0.91 . . . . 0.0 109.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -93.25 141.59 28.26 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.839 -0.538 . . . . 0.0 109.549 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.04 -29.09 8.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.9 138.61 20.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.468 -1.019 . . . . 0.0 109.865 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.673 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.53 -44.62 28.04 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.544 ' O ' ' CG2' ' A' ' 89' ' ' THR . 1.1 p -168.17 -162.97 0.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.488 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.626 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 14.1 p -163.82 160.0 21.82 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.394 -0.816 . . . . 0.0 109.126 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.671 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -164.87 171.15 14.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.119 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.498 ' N ' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -141.88 171.84 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 171.39 -175.95 44.78 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' TYR . 2.0 m-85 -96.17 164.88 12.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -1.044 . . . . 0.0 109.614 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -179.31 147.13 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.96 . . . . 0.0 109.936 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 88.86 29.02 19.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.752 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -112.18 -156.72 13.26 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.568 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -138.98 54.1 1.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -1.173 . . . . 0.0 109.892 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.731 ' CG2' ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.5 177.15 11.74 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.043 . . . . 0.0 108.262 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.735 ' HE ' ' H ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -72.98 -86.64 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.384 -0.822 . . . . 0.0 109.851 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.735 ' H ' ' HE ' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -122.79 79.91 49.11 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.869 -1.144 . . . . 0.0 110.051 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.457 ' HG2' ' CD2' ' A' ' 113' ' ' HIS . 11.4 Cg_exo -67.38 169.28 15.86 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.743 2.295 . . . . 0.0 111.675 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.625 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 16.4 p -117.56 171.11 8.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 109.852 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.618 ' C ' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -63.47 -58.89 5.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 0.0 110.354 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.601 ' CD ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -59.22 -22.46 61.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.919 -1.113 . . . . 0.0 108.254 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.625 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.8 mm-40 -72.89 -60.67 2.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.394 0.616 . . . . 0.0 110.977 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.416 HG12 ' CB ' ' A' ' 111' ' ' THR . 11.4 m -56.56 -24.66 19.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.402 -0.811 . . . . 0.0 110.997 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.494 ' C ' ' H ' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -49.81 -33.85 17.86 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.253 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.65 ' C ' ' H ' ' A' ' 110' ' ' LYS . 1.4 t -63.52 0.12 0.8 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.198 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.571 ' OE2' ' OG ' ' A' ' 26' ' ' SER . 0.8 OUTLIER 63.97 -21.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.251 -0.906 . . . . 0.0 109.87 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.65 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 tttt -57.82 -10.66 1.79 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.278 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.416 ' CB ' HG12 ' A' ' 106' ' ' VAL . 41.3 p -94.08 -38.67 11.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.96 -1.087 . . . . 0.0 110.515 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 72.63 21.2 79.72 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -75.17 161.32 29.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.112 -1.228 . . . . 0.0 110.315 -179.62 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -124.8 113.32 17.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' GLN . 1.9 pp20? -57.26 119.43 6.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.724 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.14 170.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.244 -0.91 . . . . 0.0 109.965 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.421 ' CG2' ' HB2' ' A' ' 68' ' ' PHE . 6.1 m -130.36 125.46 59.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.496 ' HG3' ' CE1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -96.89 114.49 26.12 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 119' ' ' VAL . 34.9 m -131.78 109.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -75.66 176.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.611 ' CG ' ' CD2' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -159.94 152.8 21.51 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.38 -1.328 . . . . 0.0 110.391 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.469 HH21 ' CG ' ' A' ' 125' ' ' HIS . 1.9 mtp180 -108.7 102.12 46.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.804 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 126' ' ' ILE . 18.3 Cg_exo -41.88 -68.04 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.114 2.542 . . . . 0.0 113.942 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 123' ' ' PRO . 13.3 tt0 -37.97 -33.37 0.08 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.165 -0.96 . . . . 0.0 111.277 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.469 ' CG ' HH21 ' A' ' 122' ' ' ARG . 32.2 m80 -108.39 -0.2 20.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.704 -1.248 . . . . 0.0 109.537 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -155.84 165.55 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.188 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 1.4 m -114.03 170.07 8.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.817 -1.177 . . . . 0.0 111.218 -178.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.508 ' CZ ' HD23 ' A' ' 132' ' ' LEU . 37.5 t80 -69.23 -24.75 64.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.579 -0.701 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.86 -13.02 60.27 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.564 ' CD ' ' C ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -75.62 -45.55 36.78 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.804 ' CD1' ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -77.13 -27.62 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 119.964 -1.71 . . . . 0.0 108.296 178.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.508 HD23 ' CZ ' ' A' ' 128' ' ' PHE . 1.1 mm? -72.62 -57.46 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 110.12 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -52.55 -45.0 66.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 13.3 t -50.1 -37.17 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 0.0 109.29 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.807 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 28.1 t80 -71.44 -47.29 56.74 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.925 -1.109 . . . . 0.0 110.653 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.488 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 83.4 m95 -72.18 -14.37 61.79 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.568 -1.332 . . . . 0.0 110.877 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.62 -17.25 19.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.865 -1.147 . . . . 0.0 113.15 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.6 p30 -133.33 63.13 1.64 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 119.983 -1.698 . . . . 0.0 112.861 -177.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.807 ' NE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 p-80 173.17 177.93 0.1 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.615 1.197 . . . . 0.0 110.643 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.631 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -111.56 90.16 11.99 Favored Pre-proline 0 C--N 1.286 -2.154 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.289 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.596 ' O ' ' OG1' ' A' ' 190' ' ' THR . 33.9 Cg_endo -74.39 -17.39 21.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.501 2.134 . . . . 0.0 112.535 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.3 29.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.8 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.736 ' N ' ' HG1' ' A' ' 190' ' ' THR . 30.9 mt-30 -129.96 82.64 2.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -37.7 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.496 2.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.28 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.661 ' O ' ' SD ' ' A' ' 145' ' ' MET . 1.8 ppp? -67.25 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -1.142 . . . . 0.0 110.876 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.597 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -152.6 160.43 43.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.057 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.585 ' OE1' ' O ' ' A' ' 146' ' ' ARG . 14.3 mm100 -153.38 96.52 2.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.413 -1.429 . . . . 0.0 109.044 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.86 -113.94 2.82 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.454 ' H ' HD13 ' A' ' 220' ' ' LEU . 1.8 m-20 -79.29 -32.41 43.54 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.361 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.469 ' HB3' ' CD1' ' A' ' 155' ' ' TYR . 3.6 m-20 -82.63 130.38 35.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.217 -1.552 . . . . 0.0 109.123 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 p90 -128.89 145.62 51.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 0.0 110.028 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 140.41 -165.29 26.1 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -22.43 22.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.447 -1.031 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.577 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 8.7 pm0 -91.83 -5.39 53.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.109 -0.994 . . . . 0.0 108.9 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 103' ' ' TYR . 47.6 m-85 -113.01 61.89 0.64 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.533 HH11 ' CA ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -124.03 168.59 12.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 67.5 p -92.05 141.62 28.41 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.456 ' HA ' ' N ' ' A' ' 192' ' ' ASP . . . -168.17 111.31 0.6 Allowed 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 116.981 -1.888 . . . . 0.0 111.512 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.612 ' N ' ' O ' ' A' ' 192' ' ' ASP . 60.2 t -92.41 143.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.051 -1.059 . . . . 0.0 109.18 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -136.14 107.85 9.6 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.05 173.82 12.96 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.556 2.171 . . . . 0.0 112.289 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.6 OUTLIER -89.97 -19.66 24.22 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.184 -0.948 . . . . 0.0 109.009 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.607 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER 167.33 -173.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.329 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.607 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -47.75 -15.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.978 1.371 . . . . 0.0 108.588 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 163' ' ' SER . 3.7 t -55.17 -65.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.156 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 170' ' ' ALA . 20.2 mt-30 -78.63 -24.74 45.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.8 ttp -53.51 -41.96 66.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.994 -1.066 . . . . 0.0 110.497 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.26 8.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 110.221 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.07 -36.88 34.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.85 -51.83 59.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.74 -34.96 55.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.942 . . . . 0.0 109.562 -179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -34.34 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.425 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -75.41 -36.82 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -67.53 -57.04 7.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.9 . . . . 0.0 110.048 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.91 2.68 6.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.536 ' CA ' ' OE1' ' A' ' 176' ' ' GLU . 0.3 OUTLIER -75.87 -52.35 10.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 109.847 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.439 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 4.0 m-85 -79.47 -7.46 58.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.502 ' C ' ' CD ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -70.69 -53.92 13.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 179' ' ' LYS . 23.4 tttm -73.22 -15.41 61.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.432 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 44.9 t -82.28 -55.5 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 110.274 -179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.449 ' N ' HD22 ' A' ' 181' ' ' LEU . 4.4 mt -76.37 -27.26 56.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.996 -1.065 . . . . 0.0 109.983 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.4 p -55.99 -14.0 2.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 109.551 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -88.27 -1.04 57.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.446 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 37.3 m-70 -108.26 4.28 24.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.754 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.77 8.42 6.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.441 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.468 ' CD1' ' HE2' ' A' ' 229' ' ' MET . 0.9 OUTLIER -165.36 164.43 19.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 108.868 179.767 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.794 ' N ' ' CD ' ' A' ' 188' ' ' PRO . . . 92.7 24.64 22.86 Favored Glycine 0 C--N 1.302 -1.324 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.794 ' CD ' ' N ' ' A' ' 187' ' ' GLY . 27.7 Cg_endo -66.06 104.67 0.74 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.64 -1.331 . . . . 0.0 108.64 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.41 ' C ' ' O ' ' A' ' 188' ' ' PRO . 1.7 pp -47.01 143.86 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 123.019 1.39 . . . . 0.0 111.386 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.736 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 69.5 p -121.54 4.75 10.13 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.005 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.454 ' C ' ' O ' ' A' ' 190' ' ' THR . 72.4 m -42.79 115.45 0.73 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.612 ' O ' ' N ' ' A' ' 159' ' ' VAL . 4.0 t0 -75.43 125.13 28.39 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.51 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.21 110.52 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.654 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.524 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 64.8 mtm-85 -146.24 -170.56 3.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.775 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.503 ' HA ' HE22 ' A' ' 197' ' ' GLN . 27.6 mt-10 -142.84 166.55 24.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.685 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.47 70.19 1.35 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -139.16 146.9 41.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.909 -1.348 . . . . 0.0 109.708 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.464 HG22 ' CE2' ' A' ' 200' ' ' TYR . 0.7 OUTLIER -98.32 -176.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.087 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.496 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 46.8 t80 -125.35 130.7 52.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -1.0 . . . . 0.0 109.894 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.702 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 19.9 m-85 -126.67 100.19 6.1 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.331 -0.856 . . . . 0.0 109.212 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . 0.454 ' OH ' ' O ' ' A' ' 55' ' ' THR . 22.7 m-85 -54.27 136.38 43.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.922 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -87.69 -169.67 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.7 pt-20 -75.18 167.81 21.2 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 108.915 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.551 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -59.27 -48.82 80.19 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.987 -1.071 . . . . 0.0 108.692 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.451 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.44 -22.65 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.657 ' ND1' ' CD1' ' A' ' 73' ' ' PHE . 11.8 m-70 -94.0 13.16 23.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.989 -1.069 . . . . 0.0 110.537 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.6 mm-40 -130.32 -141.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.694 1.235 . . . . 0.0 110.899 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.664 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.03 -2.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.51 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 28.6 t80 -38.41 -42.8 0.77 Allowed 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.595 -1.315 . . . . 0.0 110.496 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 9.5 mt -70.47 -25.05 63.0 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.316 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.584 ' N ' ' O ' ' A' ' 208' ' ' GLN . 8.0 t -73.47 -40.5 64.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.077 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.454 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 2.0 mtmm -88.25 -38.05 15.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.318 -0.864 . . . . 0.0 110.034 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.629 ' C ' ' H ' ' A' ' 215' ' ' ASP . 1.2 m-80 -101.03 107.65 50.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.14 6.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.766 2.31 . . . . 0.0 113.05 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.629 ' H ' ' C ' ' A' ' 213' ' ' ASN . 1.9 t70 -63.14 -16.71 60.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.735 -1.228 . . . . 0.0 109.851 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.459 ' O ' ' CD2' ' A' ' 210' ' ' LEU . . . 65.59 -68.45 0.11 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.788 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 53.2 t80 171.94 -175.87 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -1.111 . . . . 0.0 109.256 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.788 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 4.5 m -93.08 -125.65 0.1 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.152 -0.968 . . . . 0.0 109.004 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.629 ' O ' ' CG ' ' A' ' 220' ' ' LEU . . . -127.19 148.0 17.21 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.629 ' CG ' ' O ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER 146.92 160.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.47 116.87 1.22 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 139' ' ' HIS . . . 158.03 131.86 1.35 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.515 ' HG1' ' CD ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -115.32 -14.24 11.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.501 -1.0 . . . . 0.0 110.028 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 171.09 54.28 0.04 OUTLIER Glycine 0 C--N 1.306 -1.119 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.607 ' C ' ' H ' ' A' ' 227' ' ' CYS . 96.2 t -82.66 135.86 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.355 -1.085 . . . . 0.0 109.346 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.8 t -77.35 23.21 0.21 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.933 1.349 . . . . 0.0 109.409 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.607 ' H ' ' C ' ' A' ' 225' ' ' VAL . 0.0 OUTLIER -71.21 -67.53 0.57 Allowed Pre-proline 0 C--N 1.262 -3.207 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.58 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 34.1 Cg_endo -64.51 -6.58 12.32 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.052 1.835 . . . . 0.0 110.184 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.536 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -67.02 154.53 40.95 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.034 0.921 . . . . 0.0 110.155 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -33.67 149.3 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.322 0.582 . . . . 0.0 109.759 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 2.4 mm -135.67 111.16 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.245 -0.91 . . . . 0.0 109.302 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -78.47 158.38 28.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 121.324 -0.86 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 0.462 ' H41' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.632 ' OD1' ' N ' ' A' ' 24' ' ' SER . 45.0 p-10 -46.23 -35.78 5.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -1.193 . . . . 0.0 109.049 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.643 ' C ' ' H ' ' A' ' 26' ' ' SER . 1.8 t -51.09 -18.18 0.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -49.54 -9.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 123.056 1.408 . . . . 0.0 109.523 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.643 ' H ' ' C ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -47.19 -17.91 0.08 Allowed 'General case' 0 C--N 1.262 -3.236 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.127 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.839 ' O ' H122 ' A' ' 21' ' ' MYR . 0.1 OUTLIER -103.14 25.39 9.52 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 123.959 1.838 . . . . 0.0 108.071 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 25' ' ' ALA . 47.9 t -139.66 36.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.19 0 CA-C-N 112.107 -2.315 . . . . 0.0 105.382 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.65 132.07 19.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.765 -175.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.19 124.72 25.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.762 0.791 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.464 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -56.06 -22.75 29.43 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.616 -0.678 . . . . 0.0 109.758 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -83.87 -0.76 52.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.559 ' O ' ' NZ ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -112.65 -4.62 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.68 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 97' ' ' HIS . . . -61.66 -171.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.808 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.449 ' N ' HD22 ' A' ' 35' ' ' LEU . 4.5 mm? -77.33 165.38 52.21 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.44 -44.17 19.41 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.077 1.851 . . . . 0.0 112.15 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' NE ' ' A' ' 38' ' ' ARG . . . 120.48 142.19 6.48 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.702 ' CD ' ' N ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -109.09 -179.4 3.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -1.162 . . . . 0.0 109.468 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -124.33 0.77 8.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.636 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -97.9 126.4 40.74 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.518 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.97 169.24 20.84 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.492 2.128 . . . . 0.0 112.371 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.633 ' CG1' ' O ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -139.26 89.72 12.14 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 109.454 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.22 175.24 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.908 2.406 . . . . 0.0 112.558 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.455 HG12 ' N ' ' A' ' 204' ' ' ASP . 16.2 m -138.87 -174.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.668 ' OG1' ' NE2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -59.9 97.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 109.513 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.436 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -55.99 -49.19 74.31 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.261 -0.899 . . . . 0.0 111.426 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' O ' ' C ' ' A' ' 48' ' ' HIS . 20.3 mttm -71.03 99.91 1.9 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.906 -2.317 . . . . 0.0 108.241 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.749 ' HE2' ' HG1' ' A' ' 89' ' ' THR . 5.0 t-80 -33.45 101.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.788 ' ND1' ' N ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -53.24 -12.34 0.38 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.341 -0.849 . . . . 0.0 112.077 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.507 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 88.2 t -82.49 -50.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.455 -1.403 . . . . 0.0 108.482 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -99.56 -40.41 7.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.523 -0.736 . . . . 0.0 109.768 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.04 2.42 51.76 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 30.2 p30 -77.83 -120.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.715 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 ttm-85 -131.76 167.87 18.78 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 123.286 1.517 . . . . 0.0 109.481 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.572 ' O ' ' CG1' ' A' ' 56' ' ' VAL . 66.7 p -134.77 34.34 3.17 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.071 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.572 ' CG1' ' O ' ' A' ' 55' ' ' THR . 2.0 m -168.82 147.21 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 109.49 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 7.6 pt-20 -33.73 145.25 0.15 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 110.057 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.19 161.52 84.8 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.741 -1.774 . . . . 0.0 110.363 0.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 70.8 m-85 -102.37 151.57 38.18 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 59' ' ' PHE . 51.9 Cg_exo -47.6 -178.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.26 1.973 . . . . 0.0 111.983 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.634 ' O ' ' NE ' ' A' ' 122' ' ' ARG . 88.7 mt-10 -79.23 133.73 36.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.68 ' O ' ' NE ' ' A' ' 122' ' ' ARG . . . 49.88 72.01 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.591 ' O ' ' SD ' ' A' ' 65' ' ' MET . 0.8 OUTLIER -90.97 134.36 34.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -1.208 . . . . 0.0 110.105 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.802 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.5 tp60 -97.94 120.41 38.29 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.759 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -133.72 158.59 42.89 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.908 -177.488 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.63 -166.02 2.38 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 44.5 t -140.82 115.63 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.084 -1.635 . . . . 0.0 108.595 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.456 ' CE1' ' HA ' ' A' ' 132' ' ' LEU . 72.9 m-85 -111.6 148.66 32.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 110.489 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.79 99.31 0.61 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 2.1 ttt -98.08 -91.07 0.27 Allowed 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.648 -0.913 . . . . 0.0 109.179 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.667 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.4 -149.53 5.99 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.74 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -35.12 104.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.038 . . . . 0.0 108.368 179.103 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CZ ' ' CD ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -54.97 7.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.842 -1.161 . . . . 0.0 111.426 -177.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.625 ' H ' ' C ' ' A' ' 72' ' ' CYS . 5.9 m0 -74.38 -40.41 62.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.568 -1.332 . . . . 0.0 108.694 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.6 -14.29 25.84 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.814 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.693 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -66.31 -53.5 35.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.668 -1.49 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.635 ' OE2' ' NE2' ' A' ' 208' ' ' GLN . 1.3 tm-20 -82.64 -14.63 54.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.929 . . . . 0.0 110.77 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.488 ' C ' ' H ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -58.02 -68.12 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.787 -1.196 . . . . 0.0 109.653 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 49.5 mttt -53.36 -5.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.157 -0.965 . . . . 0.0 110.511 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.693 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 11.3 m-85 -90.82 -42.02 10.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.784 -1.197 . . . . 0.0 110.196 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.499 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -68.84 -4.79 17.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.712 -1.242 . . . . 0.0 109.323 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.461 HG13 ' CD1' ' A' ' 81' ' ' TRP . 2.5 m -97.39 6.74 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 31.3 mt -85.12 142.41 29.53 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.244 1.021 . . . . 0.0 108.999 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -79.77 131.64 35.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.078 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.495 ' C ' ' HG3' ' A' ' 123' ' ' PRO . . . 101.36 -29.19 13.05 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.9 132.97 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.225 -1.162 . . . . 0.0 110.231 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.702 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -79.93 -53.67 6.53 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.516 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 2.3 p -151.73 -176.26 5.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 109.347 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.749 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 82.4 p -157.49 128.6 6.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.38 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.576 ' CD ' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.2 153.03 49.88 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.445 ' CG2' ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.94 175.54 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 108.903 179.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.403 ' HA2' ' N ' ' A' ' 202' ' ' ALA . . . 167.88 177.59 39.29 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.022 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.634 ' N ' ' O ' ' A' ' 200' ' ' TYR . 28.0 m-85 -82.28 166.45 19.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.965 . . . . 0.0 109.395 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.681 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -177.41 -179.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 109.765 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.17 27.37 10.73 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.471 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -123.35 -176.82 14.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.466 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -135.63 78.16 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.101 . . . . 0.0 109.837 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.407 ' HG1' ' HB ' ' A' ' 111' ' ' THR . 21.4 m -157.07 142.67 17.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 109.196 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -54.06 -84.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.854 . . . . 0.0 109.576 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.459 ' O ' ' CG ' ' A' ' 38' ' ' ARG . 55.9 m-80 -118.86 82.69 21.24 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -79.71 161.83 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.847 2.365 . . . . 0.0 112.105 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.435 ' O ' HG22 ' A' ' 106' ' ' VAL . 21.7 p -121.33 169.93 10.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.164 -0.96 . . . . 0.0 109.803 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.47 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 7.8 t80 -56.26 -58.84 6.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -27.05 65.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 109.02 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -75.4 -53.27 8.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.726 -0.609 . . . . 0.0 111.159 -179.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 102' ' ' THR . 12.7 m -61.24 -24.3 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.646 ' C ' ' H ' ' A' ' 109' ' ' GLU . 90.7 m -64.65 -38.31 90.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 109.382 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.507 ' C ' ' H ' ' A' ' 110' ' ' LYS . 89.3 p -53.8 -0.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.316 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.646 ' H ' ' C ' ' A' ' 107' ' ' CYS . 28.8 mt-10 64.89 -5.27 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.559 ' NZ ' ' O ' ' A' ' 33' ' ' GLU . 1.5 mmpt? -66.97 -32.76 74.23 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.178 -0.951 . . . . 0.0 109.67 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.549 ' O ' ' C ' ' A' ' 112' ' ' GLY . 3.7 p -93.51 -0.34 56.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 109.764 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 34.25 55.6 0.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.681 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 1.5 m-70 -93.35 174.54 7.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.907 -1.349 . . . . 0.0 108.813 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.754 ' CB ' HH12 ' A' ' 156' ' ' ARG . . . -129.72 114.97 16.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.66 ' CD ' ' CZ ' ' A' ' 73' ' ' PHE . 3.8 mt-10 -56.44 105.83 0.24 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 4.4 m -124.68 159.03 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.134 -0.979 . . . . 0.0 110.499 -178.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -116.49 122.53 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.645 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.09 97.12 9.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.93 129.4 51.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.78 -178.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 55.1 t -94.79 126.27 47.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.802 ' O ' ' N ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -157.18 142.05 16.89 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.535 -1.266 . . . . 0.0 111.725 -178.784 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . 0.978 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -165.67 17.15 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 123.612 0.765 . . . . 0.0 110.294 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.978 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 7.1 Cg_endo -50.88 -15.68 1.97 Allowed 'Trans proline' 0 C--N 1.294 -2.292 0 C-N-CA 124.189 3.259 . . . . 0.0 115.79 -176.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 1.7 tm-20 70.54 -6.62 1.17 Allowed 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.757 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -111.7 -12.98 13.81 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.33 1.062 . . . . 0.0 108.329 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.534 ' N ' ' HG2' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -152.8 118.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -129.76 -175.4 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.526 -1.359 . . . . 0.0 112.559 -177.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -48.28 -46.54 36.04 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.628 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.673 ' O ' ' CD2' ' A' ' 132' ' ' LEU . 6.0 pt-20 -59.66 -26.57 65.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.478 ' HG3' ' H ' ' A' ' 127' ' ' SER . 9.0 mm-40 -75.31 -66.25 0.79 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.304 -0.872 . . . . 0.0 111.558 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.53 HD12 ' H ' ' A' ' 131' ' ' LEU . 9.8 mp -57.41 -23.75 51.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.838 -1.164 . . . . 0.0 113.873 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -75.73 -17.9 59.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 119.843 -1.785 . . . . 0.0 109.556 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.6 mptt -70.44 -54.54 11.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 179.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.697 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 6.6 t -49.66 -40.29 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.349 -0.844 . . . . 0.0 109.046 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.631 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 21.2 t80 -61.08 -41.99 97.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.793 -1.192 . . . . 0.0 110.63 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.71 ' CZ2' ' CA ' ' A' ' 173' ' ' SER . 45.4 m0 -71.51 -50.47 31.04 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.75 -1.219 . . . . 0.0 111.735 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.02 -57.46 12.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 111.73 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.6 OUTLIER -83.3 54.23 2.74 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 112.113 -177.378 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.764 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 20.7 m80 -161.11 176.91 10.81 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 142' ' ' THR . 0.3 OUTLIER -129.16 70.22 81.54 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 190' ' ' THR . 80.4 Cg_exo -39.39 -0.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.427 2.752 . . . . 0.0 113.627 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -105.88 22.7 15.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.671 -1.268 . . . . 0.0 110.814 -179.639 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.812 ' N ' ' HG1' ' A' ' 190' ' ' THR . 33.4 mt-30 -134.04 78.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.411 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -75.47 12.66 7.34 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.159 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.642 ' O ' ' O ' ' A' ' 152' ' ' GLY . 2.2 ptt? -118.0 -21.82 8.13 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.305 . . . . 0.0 109.911 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' CD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -152.31 168.88 23.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 111.053 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.58 ' OE1' ' O ' ' A' ' 155' ' ' TYR . 5.2 mm100 -120.21 58.77 0.91 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.08 -113.84 3.73 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.64 ' H ' ' CD1' ' A' ' 220' ' ' LEU . 12.6 t-20 -81.21 11.41 4.28 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 114.771 -0.715 . . . . 0.0 110.874 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.478 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -107.3 87.81 2.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.769 -1.207 . . . . 0.0 109.146 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.419 ' HA ' ' CG ' ' A' ' 146' ' ' ARG . 3.4 m-85 -65.49 115.87 6.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.411 -0.805 . . . . 0.0 110.674 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 166.62 150.78 6.52 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 117.687 -2.197 . . . . 0.0 111.777 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.1 p -74.26 -20.23 60.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.701 -0.882 . . . . 0.0 109.325 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.652 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 7.3 pm0 -87.15 -6.69 58.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.58 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 26.4 m-85 -97.11 57.27 1.46 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.089 HH21 ' C13' ' A' ' 21' ' ' MYR . 0.0 OUTLIER -117.63 165.72 13.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.725 -0.61 . . . . 0.0 109.66 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 191' ' ' THR . 0.0 OUTLIER -89.85 106.03 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 177.913 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.479 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -125.21 124.09 40.97 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.06 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.6 t -113.48 123.27 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.3 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.517 ' CG ' ' NE2' ' A' ' 197' ' ' GLN . 3.9 m-30 -118.51 121.53 30.87 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.73 166.25 23.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.462 2.108 . . . . 0.0 112.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.87 1.82 27.14 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 120.796 -1.19 . . . . 0.0 108.793 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER 167.76 170.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 0.0 108.862 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.62 -15.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.04 1.4 . . . . 0.0 108.361 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.5 t -56.05 -64.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 33.8 mt-30 -78.94 -18.39 53.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.719 -0.613 . . . . 0.0 110.9 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 14.3 ttm -53.16 -46.85 69.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.24 -16.93 60.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 0.0 109.617 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.77 -57.29 2.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.838 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 172' ' ' ARG . . . -52.13 -43.52 64.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.135 -0.978 . . . . 0.0 109.457 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -11.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.246 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . 0.435 ' H ' ' C ' ' A' ' 170' ' ' ALA . 75.9 mtt180 -74.78 -39.52 61.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.335 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.71 ' CA ' ' CZ2' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -54.48 -33.1 59.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.055 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.431 ' HZ3' HD11 ' A' ' 189' ' ' ILE . 0.4 OUTLIER -72.56 -57.44 4.15 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 113.199 -1.819 . . . . 0.0 110.21 -179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.17 -52.48 12.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 0.0 111.894 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.576 ' O ' ' OE1' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -55.19 -50.64 68.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.921 -1.112 . . . . 0.0 110.742 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.487 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 0.1 OUTLIER -70.99 -13.74 62.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.157 . . . . 0.0 109.907 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.57 ' O ' ' OG ' ' A' ' 182' ' ' SER . 22.0 tp60 -75.01 -48.31 24.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 109.757 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -19.17 55.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . 0.563 ' O ' ' CD2' ' A' ' 184' ' ' HIS . 92.7 t -87.23 -52.64 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.516 ' N ' ' CD2' ' A' ' 181' ' ' LEU . 4.0 mm? -71.95 -44.53 63.43 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.116 -0.99 . . . . 0.0 109.586 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 86.3 p -55.79 -26.59 46.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.016 . . . . 0.0 109.002 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.06 -27.93 21.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.108 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 180' ' ' VAL . 12.5 m170 -80.78 15.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.875 . . . . 0.0 109.388 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.3 OUTLIER 72.37 48.93 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.937 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.451 ' CG ' HD13 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -114.25 -176.72 2.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.0 108.933 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -104.21 -168.94 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.3 Cg_exo -58.81 116.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.519 2.146 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.47 ' O ' ' CG2' ' A' ' 190' ' ' THR . 0.3 OUTLIER -48.01 176.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 110.145 -179.306 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.812 ' HG1' ' N ' ' A' ' 143' ' ' GLN . 71.2 p -156.98 76.23 0.85 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.597 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 157' ' ' SER . 8.1 m -101.53 122.83 44.54 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.64 ' CG ' HH21 ' A' ' 194' ' ' ARG . 2.1 t0 -81.11 115.98 20.81 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.951 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.69 128.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.386 -0.821 . . . . 0.0 109.396 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.64 HH21 ' CG ' ' A' ' 192' ' ' ASP . 4.7 ptt180 -165.36 173.03 11.58 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.646 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -120.49 -178.66 3.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.909 -1.119 . . . . 0.0 110.431 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 54.89 35.87 59.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.573 ' O ' ' O ' ' A' ' 198' ' ' VAL . 1.8 mp0 -84.11 80.44 9.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.866 -1.373 . . . . 0.0 109.243 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 197' ' ' GLN . 9.8 p -33.31 156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 110.198 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.511 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 65.0 t80 -117.95 138.77 51.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 109.054 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 1.7 m-85 -140.34 113.94 8.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.096 -1.003 . . . . 0.0 109.819 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.66 142.99 21.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.403 ' N ' ' HA2' ' A' ' 92' ' ' GLY . . . -91.26 -168.1 1.97 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.444 -0.785 . . . . 0.0 109.104 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.58 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 2.9 mt-10 -73.38 163.85 27.49 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-O 122.469 1.128 . . . . 0.0 110.372 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.511 ' OD1' ' OG1' ' A' ' 45' ' ' THR . 0.5 OUTLIER -54.67 -44.26 73.17 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -70.63 4.17 2.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.304 -0.873 . . . . 0.0 110.576 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.5 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 9.4 m-70 -102.99 14.75 31.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.0 OUTLIER -135.74 -150.08 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.971 -1.081 . . . . 0.0 110.178 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.686 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -36.55 -7.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.138 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 2.2 t80 -43.9 -47.09 8.31 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 120.762 -1.211 . . . . 0.0 111.361 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.451 ' CD2' ' O ' ' A' ' 74' ' ' TRP . 3.6 pp -82.64 -12.26 57.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.0 -1.687 . . . . 0.0 109.947 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.504 ' C ' ' H ' ' A' ' 213' ' ' ASN . 37.3 t -55.83 -50.86 69.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.496 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.469 ' HE2' HD22 ' A' ' 213' ' ' ASN . 1.2 pttm -70.19 4.9 1.91 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.685 ' C ' ' H ' ' A' ' 215' ' ' ASP . 75.9 m-20 -142.52 68.01 20.13 Favored Pre-proline 0 N--CA 1.487 1.413 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -48.53 11.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.571 2.848 . . . . 0.0 112.702 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.685 ' H ' ' C ' ' A' ' 213' ' ' ASN . 33.9 t70 -61.88 -20.29 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.664 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 60.69 86.15 0.04 OUTLIER Glycine 0 CA--C 1.552 2.371 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.17 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.664 ' O ' ' O ' ' A' ' 216' ' ' GLY . 39.1 t80 -52.11 -150.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 120.538 2.169 . . . . 0.0 109.308 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 49.4 m -71.75 -124.28 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.002 -1.686 . . . . 0.0 109.419 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . 58.72 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.64 ' CD1' ' H ' ' A' ' 149' ' ' ASN . 0.4 OUTLIER -109.06 -155.74 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.212 . . . . 0.0 109.978 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 138' ' ' ASN . . . -118.73 -73.99 0.44 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.444 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . -175.02 134.05 2.63 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.1 t -111.84 7.04 19.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -1.017 . . . . 0.0 109.631 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -75.58 -8.52 84.2 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 226' ' ' SER . 3.2 p -60.37 165.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.827 -0.808 . . . . 0.0 109.852 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 229' ' ' MET . 14.8 m -44.9 106.56 0.08 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 123.173 1.464 . . . . 0.0 109.24 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.58 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.1 OUTLIER -76.32 -66.1 0.39 Allowed Pre-proline 0 C--N 1.278 -2.54 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.994 -179.385 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.58 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 28.0 Cg_endo -64.25 1.29 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.273 1.982 . . . . 0.0 109.779 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.563 ' H ' ' C ' ' A' ' 227' ' ' CYS . 2.2 ptm -54.99 158.63 2.72 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.726 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.83 130.42 0.08 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.0 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . 0.669 ' O ' ' N ' ' A' ' 233' ' ' LYS . 2.0 mm -144.5 115.52 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.193 -0.942 . . . . 0.0 109.273 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 231' ' ' ILE . 4.4 ttpm? -44.51 85.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.517 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.353 0 O-C-N 121.226 -0.921 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 1.089 ' C13' HH21 ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 1.229 ' O ' ' O1 ' ' A' ' 21' ' ' MYR . . . . . . . . 0 N--CA 1.493 2.442 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . 0.438 ' C ' ' N ' ' A' ' 25' ' ' ALA . 17.8 t70 49.03 -80.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -1.13 . . . . 0.0 109.279 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 22' ' ' GLY . 4.8 p -50.24 -16.75 0.35 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 108.917 179.255 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -48.6 -9.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.991 1.377 . . . . 0.0 109.649 -179.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.647 ' H ' ' C ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -47.24 -31.98 4.17 Favored 'General case' 0 C--N 1.259 -3.364 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.346 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.967 ' NZ ' ' H51' ' A' ' 21' ' ' MYR . 0.1 OUTLIER -95.66 25.83 4.34 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 124.305 2.002 . . . . 0.0 108.062 179.491 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 25' ' ' ALA . 40.0 t -142.58 47.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 CA-C-N 112.427 -2.17 . . . . 0.0 105.984 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -64.37 128.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 122.256 1.027 . . . . 0.0 113.128 -175.311 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.05 124.27 30.91 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.908 0.861 . . . . 0.0 110.126 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . . . -49.05 -26.41 2.61 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.14 -22.77 62.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.115 -0.991 . . . . 0.0 110.251 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -116.69 6.95 13.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.2 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -83.17 -165.06 0.98 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.491 -179.665 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.503 HD22 ' HG1' ' A' ' 98' ' ' THR . 0.4 OUTLIER -84.62 171.25 11.45 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.093 -1.004 . . . . 0.0 108.913 -179.528 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.6 -49.4 0.82 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.651 2.234 . . . . 0.0 113.864 -178.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.459 ' HA2' ' N ' ' A' ' 99' ' ' ARG . . . 92.26 114.14 2.07 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.938 -179.443 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' C ' ' H ' ' A' ' 40' ' ' GLU . 77.0 mtt180 -100.08 143.56 30.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.875 -1.367 . . . . 0.0 109.445 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.574 ' OG1' ' O ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -75.36 34.07 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 0.0 109.698 -179.854 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.474 ' H ' ' C ' ' A' ' 38' ' ' ARG . 27.5 tp10 -110.68 94.58 20.04 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -80.83 -178.46 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.802 2.335 . . . . 0.0 112.311 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.433 HG21 HD12 ' A' ' 42' ' ' ILE . 2.8 mm -132.45 90.71 32.91 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.623 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.93 172.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.803 2.335 . . . . 0.0 112.231 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 17.2 m -151.64 -178.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.49 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.246 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.07 -40.61 73.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.482 -0.761 . . . . 0.0 111.052 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttt -74.04 99.23 3.26 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 115.877 -2.329 . . . . 0.0 108.055 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.684 ' CE1' ' OG1' ' A' ' 89' ' ' THR . 4.4 t-80 -34.11 114.07 0.19 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . 0.634 ' CG ' ' CE ' ' A' ' 212' ' ' LYS . 63.7 t60 -63.05 -31.81 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.657 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.471 HG21 ' CE1' ' A' ' 48' ' ' HIS . 5.3 t -66.71 -38.33 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.936 -1.103 . . . . 0.0 109.484 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -111.08 -44.28 3.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.91 -0.1 51.84 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.74 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 31.9 p30 -77.22 -121.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.74 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.6 ttt180 -131.15 166.88 20.13 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.056 1.408 . . . . 0.0 108.68 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 46' ' ' ALA . 30.5 p -129.03 34.35 4.46 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.528 ' O ' ' C ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -172.63 149.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.037 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -31.63 139.37 0.19 Allowed Pre-proline 0 C--N 1.299 -1.603 0 CA-C-O 121.266 0.555 . . . . 0.0 110.152 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.36 167.26 79.86 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.479 -1.884 . . . . 0.0 111.783 0.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.43 147.3 35.76 Favored Pre-proline 0 C--N 1.271 -2.837 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.34 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' O ' ' OG1' ' A' ' 63' ' ' THR . 51.5 Cg_exo -49.39 120.64 5.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.593 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' PRO . 20.3 mm-40 -42.73 118.3 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.799 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.5 44.51 3.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.883 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -121.11 142.56 49.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.799 -1.412 . . . . 0.0 110.093 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 65' ' ' MET . 2.2 tm0? -108.53 143.93 36.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.75 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.8 103.86 5.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.905 -1.122 . . . . 0.0 110.163 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.08 -169.36 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.027 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 2.2 t -143.62 144.2 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 119.913 -1.742 . . . . 0.0 109.218 179.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 22.1 m-85 -135.79 143.71 45.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.431 178.797 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.592 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -134.82 90.34 0.24 Allowed Glycine 0 N--CA 1.482 1.761 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.174 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' MET . . . . . 0.641 ' SD ' ' CB ' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.93 -74.53 0.61 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -163.59 -156.09 8.53 Favored Glycine 0 C--N 1.3 -1.444 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' CYS . . . . . 0.637 ' C ' ' H ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -23.36 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 122.144 -0.621 . . . . 0.0 109.763 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -53.77 7.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.313 -0.867 . . . . 0.0 111.178 -178.497 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' TRP . . . . . 0.637 ' H ' ' C ' ' A' ' 72' ' ' CYS . 35.9 m0 -68.98 -44.56 72.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.596 -1.315 . . . . 0.0 108.21 179.014 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.455 ' CA ' ' SG ' ' A' ' 218' ' ' CYS . . . -98.87 -15.64 33.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.641 ' CB ' ' SD ' ' A' ' 70' ' ' MET . . . -68.45 -45.07 73.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.939 -1.33 . . . . 0.0 109.85 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.586 ' OE2' ' OE1' ' A' ' 208' ' ' GLN . 23.5 tt0 -82.66 -20.38 36.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.521 ' C ' ' H ' ' A' ' 80' ' ' PHE . 11.7 ttt-85 -60.54 -46.38 90.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.867 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.45 12.58 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.003 -1.06 . . . . 0.0 110.355 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.591 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 37.0 m-85 -124.16 -11.27 7.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 111.136 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' TRP . . . . . 0.518 ' CE2' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -106.83 13.18 28.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.579 -1.326 . . . . 0.0 109.414 179.25 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.8 m -109.26 8.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.089 -1.007 . . . . 0.0 111.238 -178.119 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.517 ' N ' ' CD1' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -118.69 166.1 13.17 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.87 -1.144 . . . . 0.0 108.789 179.298 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.541 ' C ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -93.96 144.16 25.71 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 109.459 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.13 -33.69 4.92 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.73 133.77 31.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.639 -0.918 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.698 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -83.38 -45.68 13.43 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 108.747 -179.844 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.516 ' C ' ' HG1' ' A' ' 89' ' ' THR . 22.9 t -150.01 -166.56 2.58 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.053 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.688 ' O ' ' NE2' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -169.92 113.7 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.57 ' OE1' ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -126.68 163.79 22.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 109.913 -178.218 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.577 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 1.3 m -143.36 150.38 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.069 -1.02 . . . . 0.0 110.457 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . -160.14 178.04 36.36 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 5.4 m-85 -78.73 177.84 8.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.156 -1.202 . . . . 0.0 108.427 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . 0.642 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -174.39 159.33 3.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.193 -1.567 . . . . 0.0 113.063 -178.053 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.46 20.1 60.83 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.51 -0.744 . . . . 0.0 111.432 178.01 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.656 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -139.0 175.08 21.78 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.662 ' N ' ' ND1' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -158.87 95.88 1.32 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.117 -1.226 . . . . 0.0 110.648 -178.631 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.646 ' O ' ' C ' ' A' ' 99' ' ' ARG . 21.0 m -142.3 122.57 13.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 109.681 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.646 ' C ' ' O ' ' A' ' 98' ' ' THR . 1.2 mtp180 10.79 -89.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.862 0.839 . . . . 0.0 109.873 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.569 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m-80 -120.9 90.31 46.64 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 8.8 Cg_exo -68.86 114.66 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.667 2.245 . . . . 0.0 113.358 -177.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.474 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . 19.2 p -121.35 158.9 27.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.639 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.628 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.1 OUTLIER -49.77 -42.13 45.81 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.51 -179.069 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 5.1 tttt -73.06 -27.56 61.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.93 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE1' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -83.14 -41.43 18.52 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.974 -1.079 . . . . 0.0 110.412 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 102' ' ' THR . 6.8 m -57.4 -23.97 20.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.676 -1.265 . . . . 0.0 109.54 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 109' ' ' GLU . 5.8 m -52.92 -43.84 66.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.627 ' C ' ' H ' ' A' ' 110' ' ' LYS . 39.3 m -46.53 -8.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.896 . . . . 0.0 108.83 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.66 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.1 tt0 60.24 -7.78 0.07 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.438 -0.789 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' LYS . . . . . 0.627 ' H ' ' C ' ' A' ' 108' ' ' SER . 1.1 tttp -79.39 -12.98 59.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.128 -0.983 . . . . 0.0 109.185 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' THR . . . . . 0.518 HG21 ' HG1' ' A' ' 98' ' ' THR . 4.7 p -89.6 -19.27 25.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.921 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 55.29 52.43 47.52 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' HIS . . . . . 0.656 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 2.4 m-70 -109.09 171.99 7.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.528 -1.572 . . . . 0.0 109.65 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -139.0 111.98 7.9 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . 0.698 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 mt-10 -54.35 131.48 42.1 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -143.02 -170.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 111.804 -178.664 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 1.2 m -147.5 151.09 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 -179.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.459 ' HD3' ' CD1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -121.22 98.4 5.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 108.681 178.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 80' ' ' PHE . 14.4 t -88.05 120.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.86 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 125.75 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 2.5 p90 -130.14 169.88 14.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.582 -1.324 . . . . 0.0 111.065 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -117.43 118.23 35.63 Favored Pre-proline 0 N--CA 1.487 1.398 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.701 ' O ' ' N ' ' A' ' 125' ' ' HIS . 18.4 Cg_exo -42.08 -61.88 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.998 2.465 . . . . 0.0 113.602 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.687 ' OE2' ' CD2' ' A' ' 125' ' ' HIS . 6.8 tm-20 -34.92 -19.36 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.368 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' HIS . . . . . 0.701 ' N ' ' O ' ' A' ' 123' ' ' PRO . 4.2 m170 -134.34 -2.39 2.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.402 -1.436 . . . . 0.0 111.42 -179.024 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.494 HG21 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.35 158.74 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.747 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -111.65 170.67 7.98 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.537 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -70.16 -18.72 63.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 24.6 mt-10 -65.15 -23.68 67.18 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.488 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.747 ' CD ' ' H ' ' A' ' 127' ' ' SER . 1.2 pm0 -73.38 -45.28 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.416 -1.714 . . . . 0.0 110.492 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.483 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 6.7 mt -64.35 -44.14 92.37 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.884 -1.76 . . . . 0.0 108.941 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.511 ' C ' ' CD1' ' A' ' 132' ' ' LEU . 0.6 OUTLIER -75.27 -27.16 59.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.042 . . . . 0.0 110.527 -179.233 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 1.4 tmtp? -70.31 -65.68 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.987 -1.071 . . . . 0.0 109.799 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.69 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 37.3 t -49.95 -22.52 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.0 t80 -72.23 -49.91 31.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.197 -0.94 . . . . 0.0 110.593 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.615 ' CG ' ' CE2' ' A' ' 177' ' ' TYR . 66.2 m95 -74.77 -60.56 2.23 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.027 -1.67 . . . . 0.0 110.967 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 136' ' ' TRP . 11.7 tt0 -36.33 -32.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 111.138 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 12.0 p30 -131.31 69.66 1.47 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.886 -1.134 . . . . 0.0 110.088 -178.799 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.811 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 4.8 m80 -153.6 142.04 20.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.982 -1.073 . . . . 0.0 110.876 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . 0.574 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -106.9 72.18 0.3 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 190' ' ' THR . 57.7 Cg_endo -69.09 -9.14 25.51 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.984 2.456 . . . . 0.0 115.543 -177.434 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -89.99 16.6 8.01 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.242 -1.536 . . . . 0.0 111.18 -178.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' GLN . . . . . 0.574 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -131.06 89.21 2.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.948 -1.095 . . . . 0.0 108.937 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . 0.678 ' O ' ' NH1' ' A' ' 156' ' ' ARG . . . -83.81 20.67 11.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.805 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -113.76 -15.93 12.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.745 -1.444 . . . . 0.0 109.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . 0.493 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 177.6 164.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.407 -0.808 . . . . 0.0 108.857 -179.389 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLN . . . . . 0.566 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 3.3 tp-100 -111.8 132.71 54.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.558 -1.339 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 43.98 -123.59 4.8 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-O 123.317 1.509 . . . . 0.0 111.122 178.8 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' ASN . . . . . 0.426 ' H ' ' CD2' ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.9 -32.92 40.23 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 113.388 -1.406 . . . . 0.0 112.023 -177.58 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 147' ' ' GLN . 42.4 p30 -52.46 164.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.209 -1.557 . . . . 0.0 108.564 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.5 p90 -136.72 119.72 16.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.927 -1.108 . . . . 0.0 109.98 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 153.7 165.88 14.13 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.527 -1.321 . . . . 0.0 109.992 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.476 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.4 OUTLIER -91.03 2.4 56.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -1.125 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' GLN . . . . . 0.631 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 12.2 pm0 -90.2 -0.1 57.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.125 -0.984 . . . . 0.0 108.354 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.47 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 36.7 m-85 -123.26 57.16 1.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.436 -0.79 . . . . 0.0 109.768 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.678 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -99.39 -178.58 3.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 108.956 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.583 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -93.61 107.75 19.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 176.306 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.44 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -137.29 114.85 11.15 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 117.899 -1.521 . . . . 0.0 111.092 -176.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 192' ' ' ASP . 39.6 t -101.4 137.76 27.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.12 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' TYR . . . . . 0.554 ' CG ' ' CG2' ' A' ' 198' ' ' VAL . 84.4 m-85 -127.15 86.05 59.66 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 108.216 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 160' ' ' TYR . 52.0 Cg_exo -38.35 168.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.089 2.526 . . . . 0.0 112.972 -178.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' THR . . . . . 0.446 ' C ' ' OG ' ' A' ' 163' ' ' SER . 0.1 OUTLIER -102.69 -40.65 6.52 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.144 -0.972 . . . . 0.0 109.534 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.9 OUTLIER -173.25 178.52 2.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 0.0 109.798 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.8 -23.84 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.11 1.433 . . . . 0.0 108.076 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 163' ' ' SER . 2.5 t -56.09 -56.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.863 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.08 -36.29 48.41 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.483 -178.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.4 ttp -52.67 -11.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 110.782 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -75.57 -53.8 8.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.758 -1.214 . . . . 0.0 110.034 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . 0.588 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.73 -47.93 6.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' ALA . . . . . 0.471 ' HA ' ' HG ' ' A' ' 173' ' ' SER . . . -50.97 -55.72 15.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -0.917 . . . . 0.0 110.083 -179.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.52 -41.23 63.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.051 . . . . 0.0 109.331 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.43 -37.34 63.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.588 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.7 OUTLIER -56.51 -39.13 72.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' LYS . . . . . 0.786 ' HZ2' ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -72.59 -58.27 3.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.003 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.786 ' N ' ' HZ2' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -57.22 -50.3 73.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.265 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.497 ' CD ' ' C ' ' A' ' 176' ' ' GLU . 0.9 OUTLIER -53.39 -34.99 59.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.976 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' TYR . . . . . 0.615 ' CE2' ' CG ' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -79.75 -35.01 39.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.023 -1.048 . . . . 0.0 109.638 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . 0.594 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.5 tp60 -75.13 -33.79 61.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.329 -0.857 . . . . 0.0 109.621 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -73.54 -31.25 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.332 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.06 -51.75 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.09 -39.69 66.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.988 . . . . 0.0 109.574 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 t -56.32 -32.13 64.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -88.01 0.8 55.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . 0.762 ' ND1' ' SG ' ' A' ' 227' ' ' CYS . 10.0 m-70 -108.33 35.97 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.677 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.61 58.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.58 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 186' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 184' ' ' HIS . 86.3 m-85 -151.8 168.5 24.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.85 -167.44 19.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' PRO . . . . . 0.464 ' HA ' ' NE2' ' A' ' 178' ' ' GLN . 10.8 Cg_endo -58.57 107.69 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.644 1.563 . . . . 0.0 110.53 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . 0.594 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -47.22 168.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 122.21 1.005 . . . . 0.0 110.603 -178.228 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 141' ' ' PRO . 27.1 p -120.33 58.65 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.485 -179.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' THR . . . . . 0.406 ' CG2' HG23 ' A' ' 159' ' ' VAL . 45.6 m -100.12 116.11 31.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.137 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.654 ' CG ' ' NH1' ' A' ' 194' ' ' ARG . 4.0 t0 -76.51 128.24 34.38 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.551 -178.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -125.32 99.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -179.364 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 9.8 mtm-85 -135.4 152.57 51.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 195' ' ' GLU . 1.4 mp0 -129.48 163.77 25.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.504 -1.372 . . . . 0.0 110.752 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 104.65 -22.01 35.15 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' GLN . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' VAL . 0.9 OUTLIER -142.45 -173.9 3.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.054 -1.262 . . . . 0.0 111.747 -178.691 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' VAL . . . . . 0.641 ' CB ' ' O ' ' A' ' 197' ' ' GLN . 91.1 t 109.2 74.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.921 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 174.708 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . 0.459 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 3.0 t80 -165.5 126.57 1.92 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 111.134 172.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -156.47 94.9 1.52 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.475 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -49.19 125.85 11.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.783 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' ALA . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.2 -168.69 2.26 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' GLU . . . . . 0.65 ' OE2' ' CE2' ' A' ' 205' ' ' TYR . 1.4 pt-20 -75.81 -176.51 3.39 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.0 -1.062 . . . . 0.0 108.766 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -50.06 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.831 -1.168 . . . . 0.0 110.662 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' TYR . . . . . 0.788 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -62.66 1.95 0.33 Allowed 'General case' 0 C--N 1.307 -1.283 0 O-C-N 120.877 -1.139 . . . . 0.0 112.144 -178.307 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.71 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 5.0 m-70 -102.04 11.6 38.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.434 -1.416 . . . . 0.0 110.942 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' GLN . . . . . 0.853 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.7 mm-40 -129.53 -141.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.641 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 89' ' ' THR . 1.0 OUTLIER -37.01 -1.36 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.389 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' TYR . . . . . 0.853 ' N ' ' O ' ' A' ' 207' ' ' GLN . 80.1 t80 -38.45 -42.26 0.73 Allowed 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.014 -1.054 . . . . 0.0 111.457 -178.103 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.9 OUTLIER -62.21 -47.68 83.37 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.553 -178.467 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.3 t -56.11 -38.24 70.5 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.061 -1.024 . . . . 0.0 108.873 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.634 ' CE ' ' CG ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -88.28 -21.24 24.56 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' ASN . . . . . 0.623 ' C ' ' H ' ' A' ' 215' ' ' ASP . 1.4 m-80 -133.4 89.11 33.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.541 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' PRO . . . . . 0.646 ' C ' ' H ' ' A' ' 216' ' ' GLY . 31.7 Cg_exo -56.92 13.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 123.525 2.817 . . . . 0.0 112.08 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.623 ' H ' ' C ' ' A' ' 213' ' ' ASN . 38.0 t0 -60.92 20.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.937 . . . . 0.0 111.112 -177.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' GLY . . . . . 0.646 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 65.52 -51.47 0.14 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.868 -1.158 . . . . 0.0 112.199 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' TYR . . . . . 0.605 ' C ' ' O ' ' A' ' 216' ' ' GLY . 27.0 m-85 -22.32 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.905 0 CA-C-N 118.892 1.346 . . . . 0.0 110.121 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER -151.18 103.01 2.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.441 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 218' ' ' CYS . . . -36.33 151.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' LEU . . . . . 0.426 ' CD2' ' H ' ' A' ' 149' ' ' ASN . 0.4 OUTLIER -63.41 -175.67 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -1.142 . . . . 0.0 109.52 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.65 -67.62 0.8 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' GLY . . . . . 0.498 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . 156.85 147.05 4.65 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' THR . . . . . 0.574 ' C ' ' N ' ' A' ' 225' ' ' VAL . 0.1 OUTLIER -70.29 -48.62 55.88 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.495 -1.003 . . . . 0.0 109.114 179.974 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 223' ' ' THR . . . 45.9 21.73 0.66 Allowed Glycine 0 N--CA 1.481 1.666 0 N-CA-C 105.716 -2.953 . . . . 0.0 105.716 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' VAL . . . . . 0.574 ' N ' ' C ' ' A' ' 223' ' ' THR . 0.4 OUTLIER -90.17 131.59 37.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.228 -0.986 . . . . 0.0 110.519 -178.272 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' SER . . . . . 0.641 ' OG ' ' CG ' ' A' ' 184' ' ' HIS . 48.4 t -98.48 -155.67 0.51 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.236 -0.915 . . . . 0.0 109.186 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' CYS . . . . . 0.762 ' SG ' ' ND1' ' A' ' 184' ' ' HIS . 0.1 OUTLIER -73.8 -66.64 0.49 Allowed Pre-proline 0 C--N 1.291 -1.944 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.382 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' PRO . . . . . 0.583 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 57.4 Cg_endo -70.37 -15.29 34.76 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.263 1.975 . . . . 0.0 110.322 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' MET . . . . . 0.631 ' CB ' ' H ' ' A' ' 226' ' ' SER . 2.8 mmm -55.27 154.76 5.6 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.973 0.892 . . . . 0.0 110.047 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -32.91 130.24 0.2 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.848 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.8 mm -139.66 103.19 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.216 -0.927 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.41 -78.51 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.472 -0.767 . . . . 0.0 109.428 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.347 0 O-C-N 121.259 -0.901 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' MYR . . . . . 1.229 ' O1 ' ' O ' ' A' ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 t . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -57.63 134.64 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.489 1.516 . . . . 0.0 108.946 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.28 122.01 13.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 107.972 173.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.43 -26.12 62.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.702 1.201 . . . . 0.0 111.94 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -68.81 -32.11 71.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.904 2.882 . . . . 0.0 113.07 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -91.46 -14.54 30.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.886 1.674 . . . . 0.0 111.053 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -55.12 155.71 4.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.915 1.286 . . . . 0.0 111.744 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.55 0.978 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.938 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 pt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.01 165.48 32.47 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.814 1.676 . . . . 0.0 109.612 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.78 -172.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 125.289 1.436 . . . . 0.0 109.863 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 t -55.24 92.23 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.839 2.055 . . . . 0.0 109.235 165.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.4 89.08 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.836 1.254 . . . . 0.0 110.567 -169.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -81.68 117.21 21.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.087 0.955 . . . . 0.0 108.46 165.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -50.58 115.77 1.63 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.434 2.694 . . . . 0.0 110.521 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -63.27 -25.11 68.16 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.497 1.499 . . . . 0.0 112.985 -170.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.24 -46.31 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.664 1.185 . . . . 0.0 109.994 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.8 m -99.07 -46.9 5.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.881 0.872 . . . . 0.0 111.71 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 -4.62 36.18 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.567 2.032 . . . . 0.0 112.928 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -81.22 -98.36 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.173 1.789 . . . . 0.0 112.487 -172.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 56' ' ' VAL . 24.1 ttm-85 -153.84 153.99 33.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.495 1.518 . . . . 0.0 110.502 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -128.24 11.33 6.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.448 2.699 . . . . 0.0 111.443 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 m -139.5 159.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 119.914 -1.741 . . . . 0.0 107.486 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.72 147.61 70.71 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.371 1.068 . . . . 0.0 111.487 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.31 144.96 79.21 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 119.725 0.938 . . . . 0.0 111.782 2.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -87.57 141.22 31.99 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -52.85 143.47 48.24 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.012 3.142 . . . . 0.0 112.838 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -62.12 133.71 55.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.75 0.82 . . . . 0.0 110.028 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 30.22 30.97 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.9 p -111.49 139.86 46.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 163.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -105.11 157.97 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 165.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.3 143.75 38.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.009 1.723 . . . . 0.0 107.426 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.69 172.69 12.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.019 2.128 . . . . 0.0 106.789 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 50.0 t -133.42 123.47 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -134.75 128.77 33.52 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.996 1.718 . . . . 0.0 109.067 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.11 134.73 10.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 126.552 2.025 . . . . 0.0 108.407 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.4 ptp -128.3 -121.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 105.85 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.51 -154.78 29.78 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 171.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 t -44.06 117.35 1.19 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.769 2.028 . . . . 0.0 111.456 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.436 ' HB2' HG11 ' A' ' 91' ' ' VAL 0.289 0.0 OUTLIER -51.93 -11.59 0.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -176.695 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -53.66 -69.32 0.12 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.898 2.479 . . . . 0.0 114.111 165.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 -15.91 66.46 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.087 -1.008 . . . . 0.0 111.553 -171.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.5 70.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.979 1.711 . . . . 0.0 111.105 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.24 -40.65 81.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.402 1.881 . . . . 0.0 111.817 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -51.28 -52.49 44.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.893 2.077 . . . . 0.0 113.355 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.26 -3.18 12.8 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.777 1.231 . . . . 0.0 114.316 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -102.44 -27.83 12.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.825 -1.083 . . . . 0.0 112.241 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -80.87 -19.57 44.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 121.413 1.915 . . . . 0.0 111.795 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -79.56 -0.21 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 125.703 1.601 . . . . 0.0 112.281 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.9 152.34 22.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.147 1.779 . . . . 0.0 108.948 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -89.97 134.59 34.14 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.9 -13.54 45.52 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.01 0.814 . . . . 0.0 112.514 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 p -72.23 132.09 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 169.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.09 -51.09 11.65 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.1 p -161.48 171.58 17.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.314 1.845 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 p -128.45 153.97 46.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 107.885 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -145.43 160.37 41.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.009 2.124 . . . . 0.0 109.54 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -138.96 154.16 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.14 1.376 . . . . 0.0 111.103 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.86 176.55 40.63 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-O 122.237 0.91 . . . . 0.0 111.519 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.83 136.71 32.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.37 165.38 28.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.778 1.631 . . . . 0.0 107.871 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.34 2.45 79.9 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 119.747 -1.846 . . . . 0.0 114.867 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -115.16 -173.62 17.78 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.753 1.644 . . . . 0.0 110.923 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . 0.261 0.0 OUTLIER -145.42 60.76 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.325 1.45 . . . . 0.0 110.561 -167.132 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.52 142.35 27.95 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 129.29 3.036 . . . . 0.0 104.887 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -67.18 -55.56 13.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.297 0.953 . . . . 0.0 112.429 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.273 43.2 m-80 -137.69 70.24 51.77 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 120.314 1.416 . . . . 0.0 112.619 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.79 152.0 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.124 1.883 . . . . 0.0 108.444 171.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.418 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 34.1 p -108.03 175.25 5.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.168 1.387 . . . . 0.0 107.617 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -53.26 -44.75 68.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 111.862 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -72.94 -30.01 63.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.958 1.303 . . . . 0.0 111.395 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 102' ' ' THR . 9.6 mm-40 -77.08 -45.89 25.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.167 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.01 -25.92 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.257 1.39 . . . . 0.0 112.769 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.5 t -56.67 -29.67 62.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.511 1.925 . . . . 0.0 113.262 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.0 p -68.04 -13.44 62.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.618 1.167 . . . . 0.0 112.963 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 79.15 -23.21 0.25 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 130.237 3.415 . . . . 0.0 112.224 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -54.38 -22.73 13.1 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 127.06 2.144 . . . . 0.0 114.629 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.0 p -76.41 -29.83 57.21 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.317 -1.49 . . . . 0.0 111.525 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.19 85.08 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.909 1.718 . . . . 0.0 112.325 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.29 152.11 41.98 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.299 1.549 . . . . 0.0 112.4 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -110.29 129.53 55.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.656 2.382 . . . . 0.0 105.523 165.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -74.11 132.64 42.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.15 151.69 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.704 1.602 . . . . 0.0 110.187 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.3 m -105.2 128.84 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 127.602 2.361 . . . . 0.0 106.159 171.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -107.44 95.18 5.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.778 2.431 . . . . 0.0 104.652 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 131' ' ' LEU . 3.6 m -108.85 126.71 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.56 142.34 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.462 ' HD1' HD11 ' A' ' 131' ' ' LEU . 34.3 p90 -134.0 158.31 43.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.727 1.211 . . . . 0.0 110.086 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -103.97 106.24 52.13 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.876 1.271 . . . . 0.0 108.158 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -35.23 -42.57 0.41 Allowed 'Trans proline' 0 C--N 1.361 1.217 1 C-N-CA 127.391 5.394 . . . . 0.0 118.652 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.83 -25.39 56.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.342 1.857 . . . . 0.0 113.658 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -120.68 -16.02 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.973 1.309 . . . . 0.0 113.341 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.033 1.733 . . . . 0.0 107.681 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.2 p -83.78 169.62 15.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.358 1.435 . . . . 0.0 111.369 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.01 -32.46 72.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.008 1.323 . . . . 0.0 112.028 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -56.54 -27.14 56.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.013 2.125 . . . . 0.0 112.717 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.38 -44.41 65.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.313 1.445 . . . . 0.0 111.373 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 119' ' ' VAL . 36.0 mt -67.33 -42.51 83.46 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.961 0.8 . . . . 0.0 110.398 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.28 -52.96 63.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.654 1.581 . . . . 0.0 110.334 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -52.1 -55.53 20.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.039 1.736 . . . . 0.0 112.805 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.05 -42.02 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.875 0.87 . . . . 0.0 110.927 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -56.08 -56.34 21.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.333 0.969 . . . . 0.0 112.244 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -63.28 -45.11 92.96 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.89 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.66 -24.02 63.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.958 2.103 . . . . 0.0 114.77 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.442 0.9 OUTLIER -130.01 47.09 2.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.691 1.196 . . . . 0.0 114.2 -176.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -153.76 158.01 40.31 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.164 -1.398 . . . . 0.0 110.481 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -90.81 115.88 65.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.976 1.716 . . . . 0.0 107.363 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.721 ' HD3' HG23 ' A' ' 223' ' ' THR . 62.7 Cg_endo -82.58 -6.9 11.69 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.416 2.077 . . . . 0.0 114.495 -170.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.2 p -109.45 9.73 25.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.197 1.799 . . . . 0.0 112.128 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -110.57 108.43 18.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.58 -56.58 1.24 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -166.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -90.92 19.01 5.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.409 1.105 . . . . 0.0 112.657 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.0 ttm105 -167.5 148.4 5.45 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.912 2.085 . . . . 0.0 107.302 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -139.44 114.06 9.22 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.546 1.539 . . . . 0.0 107.651 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 45.8 -109.5 0.34 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.7 2.095 . . . . 0.0 113.124 -167.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -85.8 -16.91 37.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.645 1.578 . . . . 0.0 112.112 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.98 122.34 33.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.941 1.296 . . . . 0.0 107.58 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -115.83 139.59 50.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.337 1.455 . . . . 0.0 110.578 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.99 157.04 9.36 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.033 1.778 . . . . 0.0 112.024 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.6 t -58.58 -15.83 13.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.226 2.611 . . . . 0.0 114.618 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -80.46 -18.34 49.01 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.02 -1.05 . . . . 0.0 112.3 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -111.16 66.85 0.63 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -109.95 152.04 26.36 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.63 1.172 . . . . 0.0 108.123 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 p -60.28 118.41 6.37 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.593 1.157 . . . . 0.0 109.093 156.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.18 116.98 6.69 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.528 1.131 . . . . 0.0 110.869 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 76.2 t -111.13 121.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -115.27 114.1 43.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.52 155.67 45.24 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 123.151 2.567 . . . . 0.0 111.412 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.2 m -79.69 -32.67 41.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.037 0.935 . . . . 0.0 111.859 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 87.9 p -171.6 -167.56 0.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.21 1.804 . . . . 0.0 108.954 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.1 -21.96 25.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.105 . . . . 0.0 113.797 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -52.44 -56.67 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.933 2.493 . . . . 0.0 110.899 169.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -86.77 -18.96 29.82 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.915 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.6 ttt -54.89 -36.02 64.72 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.557 1.543 . . . . 0.0 113.303 175.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -67.98 -38.01 82.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.889 0.876 . . . . 0.0 112.142 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.07 -38.98 12.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.678 1.191 . . . . 0.0 111.356 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.47 74.7 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.004 1.722 . . . . 0.0 111.057 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.29 -34.76 79.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.24 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -69.35 -46.89 65.93 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.724 0.809 . . . . 0.0 110.007 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.8 p -59.42 -40.65 87.37 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.252 1.421 . . . . 0.0 112.06 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.07 -63.67 1.11 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.109 2.164 . . . . 0.0 110.596 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.51 -34.75 78.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.597 1.159 . . . . 0.0 113.736 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.03 -48.12 83.02 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.438 1.895 . . . . 0.0 111.714 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -76.68 -25.82 54.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -60.46 -44.06 96.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.734 0.697 . . . . 0.0 110.94 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -64.69 -42.14 95.53 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.744 1.218 . . . . 0.0 112.671 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.26 -42.36 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 119.028 0.831 . . . . 0.0 110.565 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -83.01 -23.61 33.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.432 1.015 . . . . 0.0 113.184 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.5 t -56.86 -33.91 67.3 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.839 1.2 . . . . 0.0 111.351 167.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -79.46 -17.61 53.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -91.95 12.11 22.85 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.481 1.512 . . . . 0.0 111.721 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 76.94 28.89 0.63 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.625 1.97 . . . . 0.0 111.049 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -98.69 169.23 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -103.65 -160.6 24.9 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.441 1.019 . . . . 0.0 110.904 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.24 21.67 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 124.094 3.196 . . . . 0.0 111.903 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.64 149.55 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.845 0.831 . . . . 0.0 109.627 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.6 p -112.59 21.52 15.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.175 1.79 . . . . 0.0 109.951 -171.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -66.72 106.44 1.84 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -69.82 124.59 24.38 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.719 1.208 . . . . 0.0 108.268 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.89 114.66 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -144.92 160.86 40.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 129.212 3.005 . . . . 0.0 106.484 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 161.82 20.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.624 1.969 . . . . 0.0 108.733 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.24 61.9 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.813 -0.555 . . . . 0.0 111.911 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -76.49 120.19 21.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.981 0.912 . . . . 0.0 109.134 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 p -59.92 134.88 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.141 1.777 . . . . 0.0 108.866 168.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -101.01 129.47 46.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -122.18 115.64 22.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -57.39 130.43 46.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.414 1.085 . . . . 0.0 110.294 171.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -76.88 173.5 11.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.136 0.974 . . . . 0.0 109.372 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.66 160.7 22.13 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.772 1.629 . . . . 0.0 110.798 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -55.57 -37.94 68.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.373 2.269 . . . . 0.0 111.976 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -18.89 22.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.262 2.225 . . . . 0.0 114.123 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.405 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 74.9 m-70 -105.28 -6.47 19.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.366 1.467 . . . . 0.0 111.442 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.41 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 76.8 mm-40 -94.91 -130.75 0.15 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.194 2.198 . . . . 0.0 108.952 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -68.79 14.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 132.02 4.128 . . . . 0.0 112.797 -173.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -51.56 -39.43 57.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.118 2.567 . . . . 0.0 112.463 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 210' ' ' LEU . 3.1 mp -84.33 0.45 49.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.68 0.792 . . . . 0.0 112.021 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -76.21 -38.18 56.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.889 -1.132 . . . . 0.0 108.01 166.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -77.51 -34.9 53.93 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.525 1.53 . . . . 0.0 110.107 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -117.7 77.65 11.4 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.246 1.818 . . . . 0.0 109.246 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.37 1.91 4.38 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.605 2.87 . . . . 0.0 114.268 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -39.53 -38.88 0.64 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.46 3.104 . . . . 0.0 113.362 163.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.67 44.1 11.02 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 162.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -36.97 109.84 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.58 2.752 . . . . 0.0 115.413 -161.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 12.1 t 81.92 -65.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.455 2.302 . . . . 0.0 114.704 161.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.25 151.44 46.93 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.648 0.619 . . . . 0.0 114.648 -147.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.02 171.69 14.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.919 1.287 . . . . 0.0 109.576 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -88.58 -164.46 40.33 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 160.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -117.29 -141.04 6.81 Favored Glycine 0 CA--C 1.519 0.319 0 O-C-N 121.375 -1.074 . . . . 0.0 114.855 -159.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.721 HG23 ' HD3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.702 1 C-N-CA 136.037 5.735 . . . . 0.0 119.923 163.188 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.695 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.788 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.61 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -41.34 177.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.76 -178.074 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -107.67 125.64 51.61 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.509 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -54.01 -17.93 3.08 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.427 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.566 ' OE1' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -82.98 -9.52 59.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.974 -1.079 . . . . 0.0 110.12 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 34' ' ' ALA . 9.4 tp10 -112.32 -28.11 8.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 110.384 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -30.57 148.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.157 -0.965 . . . . 0.0 110.389 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.016 0.436 . . . . 0.0 110.413 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 42' ' ' ILE . 76.6 Cg_exo -48.34 -165.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.787 2.325 . . . . 0.0 111.435 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -160.9 -171.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.891 -1.131 . . . . 0.0 110.281 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -33.9 83.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.554 0.692 . . . . 0.0 111.334 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -64.4 -20.13 65.95 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.441 -0.787 . . . . 0.0 110.271 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -88.49 100.45 13.07 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 116.384 -2.126 . . . . 0.0 107.786 178.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.657 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 6.1 t-80 -30.18 141.21 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.0 -6.96 57.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.468 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 46.9 t -95.43 -63.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -80.55 -44.69 18.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.927 . . . . 0.0 110.214 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.22 55.6 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 33.4 p30 -82.75 -114.87 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 57' ' ' GLU . 1.2 ttm-85 -128.06 170.57 12.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.978 1.37 . . . . 0.0 108.434 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 3.0 p -132.22 17.33 4.52 Favored 'General case' 0 C--N 1.263 -3.169 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.968 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.519 ' O ' ' C ' ' A' ' 57' ' ' GLU . 3.4 m -151.55 -168.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.098 -1.001 . . . . 0.0 109.117 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 23.7 mm-40 -34.08 153.77 0.05 OUTLIER Pre-proline 0 C--N 1.293 -1.854 0 CA-C-O 121.494 0.664 . . . . 0.0 110.296 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -87.79 155.29 41.94 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.03 -1.654 . . . . 0.0 110.889 0.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-85 -117.53 66.68 5.0 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.28 -176.42 0.84 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.821 2.347 . . . . 0.0 113.049 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.39 158.55 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.94 -41.37 2.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.511 HG23 ' HE ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -97.72 144.2 27.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -1.04 . . . . 0.0 109.231 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 29.4 tp60 -107.79 147.77 30.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -122.18 128.85 51.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.33 -167.38 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.2 t -141.98 140.69 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.081 -1.637 . . . . 0.0 109.379 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 42.0 m-85 -127.92 131.91 49.33 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.668 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -135.89 136.15 8.27 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.233 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -126.25 -94.29 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.514 -0.992 . . . . 0.0 108.998 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.691 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -142.46 71.28 0.4 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.4 t 113.05 149.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.087 0.955 . . . . 0.0 108.776 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.701 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -101.6 20.26 16.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.2 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.698 ' CG ' ' OH ' ' A' ' 209' ' ' TYR . 17.8 m0 -101.56 -65.98 0.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.748 -1.22 . . . . 0.0 109.395 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.523 ' N ' ' OH ' ' A' ' 217' ' ' TYR . . . -68.32 -16.12 68.77 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -75.29 -58.27 3.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.409 -1.054 . . . . 0.0 110.591 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.544 ' CD ' ' O ' ' A' ' 77' ' ' GLU . 10.5 tp10 -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.253 -0.904 . . . . 0.0 111.473 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 78' ' ' ARG . 13.9 tpt85 -56.52 -53.98 51.23 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.874 -1.142 . . . . 0.0 110.787 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -83.42 18.32 1.86 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.329 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.714 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 4.9 m-85 -103.95 -40.05 6.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.776 -1.203 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.596 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -81.91 -4.36 56.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.848 -1.158 . . . . 0.0 110.108 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -90.4 21.11 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 0.0 109.786 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.662 HD12 HD21 ' A' ' 131' ' ' LEU . 60.6 mt -111.1 165.92 11.5 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.794 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 169.85 10.93 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.16 3.64 38.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -98.89 115.91 40.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.559 -0.965 . . . . 0.0 109.615 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.0 OUTLIER -73.53 -46.64 46.44 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.51 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 6.9 t -164.37 157.65 17.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.542 -0.724 . . . . 0.0 109.554 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.657 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.1 p -117.26 154.05 31.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.636 HE21 HH21 ' A' ' 118' ' ' ARG . 1.7 mp0 -149.24 146.95 27.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.773 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 117' ' ' VAL . 20.6 m -140.56 177.7 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 110.124 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . 156.48 -118.9 0.87 Allowed Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.209 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 5.0 m-85 -125.13 167.78 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.937 . . . . 0.0 109.814 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.673 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.76 -179.62 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.884 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.61 6.61 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -121.95 -170.56 13.81 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.682 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -144.05 78.55 1.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.548 -0.972 . . . . 0.0 109.917 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.471 HG21 HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -157.52 145.1 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 109.238 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 3.5 ttm-85 -55.17 -80.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.427 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -122.83 75.25 47.54 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.054 -1.029 . . . . 0.0 109.668 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.78 151.48 31.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.827 2.351 . . . . 0.0 112.05 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 106' ' ' VAL . 19.1 p -122.0 164.22 18.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.055 -1.028 . . . . 0.0 109.393 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -51.1 -44.35 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.614 -0.678 . . . . 0.0 110.016 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -27.03 62.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.009 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 0.6 OUTLIER -80.98 -38.06 28.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.074 -1.016 . . . . 0.0 110.375 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.9 HG12 ' OG1' ' A' ' 111' ' ' THR . 15.3 m -69.42 -24.03 27.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 120.866 -1.146 . . . . 0.0 110.161 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.624 ' C ' ' H ' ' A' ' 109' ' ' GLU . 94.5 m -45.76 -45.21 14.46 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 110' ' ' LYS . 29.6 t -60.52 5.5 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.85 . . . . 0.0 108.965 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.624 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.9 mt-10 54.82 -0.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.456 -0.778 . . . . 0.0 109.659 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 mmtp -63.84 -19.5 65.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.058 -1.026 . . . . 0.0 109.044 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.9 ' OG1' HG12 ' A' ' 106' ' ' VAL . 31.7 p -98.34 0.72 46.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.418 -0.801 . . . . 0.0 109.373 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 30.99 47.81 0.17 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -84.79 174.7 9.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.709 -1.465 . . . . 0.0 108.367 178.665 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.765 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -125.52 114.52 18.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.131 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.701 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.1 mm-40 -62.52 111.53 2.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -140.16 -171.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.095 -1.003 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.843 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.1 m -130.32 128.18 63.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.468 0.652 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.636 HH21 HE21 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -97.95 97.3 8.82 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.485 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -105.8 129.72 58.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.509 -179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.25 132.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.343 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.742 ' CD2' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -139.06 156.71 46.98 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.544 0.688 . . . . 0.0 109.695 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.511 ' HE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -95.92 108.28 39.72 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.66 -0.65 . . . . 0.0 110.633 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 15.2 Cg_exo -41.62 -67.47 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.713 2.276 . . . . 0.0 113.169 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.748 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 18.4 mp0 -49.64 -21.3 0.99 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.258 -0.901 . . . . 0.0 109.746 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 122' ' ' ARG . 1.1 m80 -92.37 -33.82 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -0.981 . . . . 0.0 108.981 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.673 HD11 ' CG ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -148.18 141.04 18.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.14 140.81 57.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.955 -1.091 . . . . 0.0 110.088 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.911 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 21.9 t80 -69.42 -33.28 72.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -14.01 61.47 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.673 ' CG ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -74.98 -45.33 42.81 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.473 -0.767 . . . . 0.0 110.454 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.742 HD12 ' CD2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -71.67 -31.02 66.35 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 119.361 -2.087 . . . . 0.0 107.492 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.911 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 1.1 mt -57.01 -21.77 33.31 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -70.34 -52.89 19.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.411 -0.805 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -49.93 -34.82 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.713 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 13.6 t80 -69.01 -53.22 21.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 50.6 m95 -70.44 -55.61 8.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.583 -1.323 . . . . 0.0 109.129 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.517 ' OE2' ' O ' ' A' ' 137' ' ' GLU . 2.2 tm-20 -37.53 -40.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.68 -0.637 . . . . 0.0 111.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 14.0 p30 -125.4 72.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.972 -1.08 . . . . 0.0 110.784 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.713 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 8.4 m80 -157.62 142.18 16.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.122 -0.986 . . . . 0.0 110.593 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.597 ' OD2' ' O ' ' A' ' 140' ' ' ASP . 0.7 OUTLIER -105.21 73.02 0.24 Allowed Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.636 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.483 ' CD ' ' O ' ' A' ' 139' ' ' HIS . 17.7 Cg_endo -59.53 23.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.736 1.624 . . . . 0.0 112.587 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 189' ' ' ILE . 0.2 OUTLIER -121.95 1.6 9.86 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.135 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.611 ' O ' ' O ' ' A' ' 146' ' ' ARG . 47.8 mt-30 -106.79 92.35 4.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.951 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.594 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -37.97 -113.3 0.0 OUTLIER Glycine 0 N--CA 1.495 2.603 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.331 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.649 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 22.2 ptt? -66.05 41.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.84 0.829 . . . . 0.0 110.963 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.708 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 178.37 145.49 0.13 Allowed 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.897 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 1.3 mt-30 -152.13 155.48 37.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 119.782 -1.824 . . . . 0.0 110.215 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.58 -126.25 3.63 Favored Glycine 0 C--N 1.302 -1.309 0 CA-C-O 122.898 1.277 . . . . 0.0 110.438 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.47 ' HB2' ' H ' ' A' ' 220' ' ' LEU . 0.7 OUTLIER -81.85 -34.57 30.05 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.16 -1.02 . . . . 0.0 112.129 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.475 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -91.84 126.26 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.314 -1.491 . . . . 0.0 108.862 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.43 ' CA ' ' HB2' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -105.81 154.62 20.26 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.054 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.708 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 123.92 172.89 13.78 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.353 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -75.56 -28.15 58.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.285 -1.126 . . . . 0.0 109.82 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.653 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -69.98 -5.74 28.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.885 -1.134 . . . . 0.0 109.448 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.653 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 23.4 m-85 -131.4 52.08 2.09 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.078 -1.014 . . . . 0.0 109.351 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.801 HH22 HH22 ' A' ' 194' ' ' ARG . 6.8 mtp180 -90.96 176.18 6.7 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.582 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.694 ' OG ' HG23 ' A' ' 191' ' ' THR . 0.2 OUTLIER -91.08 117.66 29.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 175.733 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -136.99 128.75 28.92 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.99 -175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.578 HG22 ' CZ ' ' A' ' 135' ' ' PHE . 1.4 t -115.89 115.52 49.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -113.2 121.15 38.66 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.524 ' HA ' ' NE2' ' A' ' 166' ' ' GLN . 85.7 Cg_endo -82.7 170.11 13.02 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.575 2.183 . . . . 0.0 112.28 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.716 HG23 ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -90.15 -29.23 18.42 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 120.916 -1.115 . . . . 0.0 109.369 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.48 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 178.48 -162.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.58 -15.83 2.03 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.993 1.378 . . . . 0.0 108.648 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.48 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.8 t -55.92 -64.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 161' ' ' PRO . 13.3 mt-30 -79.56 -19.59 49.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.596 -0.69 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.93 -34.87 43.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.26 -28.56 63.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.746 -1.221 . . . . 0.0 109.431 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.76 -45.13 8.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.65 -56.09 17.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 mt -52.87 -37.16 60.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.218 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -55.84 -36.5 67.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.539 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -72.84 -57.81 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.595 ' CG ' ' N ' ' A' ' 176' ' ' GLU . 6.4 pt-20 -63.46 -47.09 83.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.635 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -53.08 -31.98 44.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 109.655 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.506 ' CE2' HD21 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -78.92 -14.92 58.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.527 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.496 ' C ' ' CD ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -74.89 -38.79 61.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.182 -0.949 . . . . 0.0 109.299 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.456 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -78.02 -23.17 48.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.651 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 176' ' ' GLU . 60.3 t -75.59 -54.56 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' HB ' ' A' ' 223' ' ' THR . 4.6 mm? -68.96 -36.46 77.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.629 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.3 p -56.03 -27.8 54.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -88.11 -3.03 58.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.42 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.444 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 11.9 m170 -107.59 35.88 2.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 7.2 t-20 71.86 61.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.493 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -152.19 175.04 13.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.9 -141.49 5.01 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.51 105.82 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.239 1.96 . . . . 0.0 111.196 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.714 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -53.24 177.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 2.7 p -143.89 70.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.647 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.694 HG23 ' OG ' ' A' ' 157' ' ' SER . 61.2 m -100.47 160.24 14.51 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH2' ' A' ' 156' ' ' ARG . 21.2 t0 -105.91 106.38 16.86 Favored 'General case' 0 C--N 1.265 -3.067 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.93 114.07 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.415 -0.803 . . . . 0.0 109.054 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.801 HH22 HH22 ' A' ' 156' ' ' ARG . 1.0 OUTLIER -154.68 -170.46 3.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 109.178 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -119.67 -179.22 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 56.37 54.08 38.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 1.0 OUTLIER -95.85 92.48 6.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.454 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.42 156.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 118' ' ' ARG . 63.2 t80 -126.05 140.24 52.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.235 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 10.2 m-85 -139.67 103.89 4.79 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.052 -1.03 . . . . 0.0 109.975 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -52.4 132.58 34.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 111.219 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.427 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -88.37 -171.26 3.28 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.662 ' CD ' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.44 174.94 8.22 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.662 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.4 OUTLIER -60.92 -50.49 73.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.733 -1.229 . . . . 0.0 108.088 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.659 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.53 -8.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 109.77 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.571 ' N ' ' O ' ' A' ' 204' ' ' ASP . 8.7 m-70 -103.55 13.62 32.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.066 -1.021 . . . . 0.0 111.446 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.774 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -138.6 -148.0 0.25 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.684 -1.26 . . . . 0.0 111.197 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.753 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 4.0 mp0 -33.49 -3.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.606 -1.179 . . . . 0.0 114.049 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.774 ' N ' ' O ' ' A' ' 207' ' ' GLN . 14.3 p90 -44.83 -33.63 2.0 Favored 'General case' 0 N--CA 1.518 2.941 0 C-N-CA 116.429 -2.108 . . . . 0.0 108.738 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 209' ' ' TYR . 0.4 OUTLIER -51.13 -20.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.769 -1.207 . . . . 0.0 109.947 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 16.2 t -59.88 -35.83 75.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.058 -1.026 . . . . 0.0 108.683 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 214' ' ' PRO . 5.8 mmmt -88.29 -29.8 20.1 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.468 -0.77 . . . . 0.0 109.67 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -119.6 51.07 1.67 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 213' ' ' ASN . 12.0 Cg_endo -60.41 8.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.095 2.53 . . . . 0.0 112.406 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.0 t70 -63.58 -12.48 33.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 110.36 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 62.56 86.67 0.05 OUTLIER Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.657 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.61 ' O ' ' O ' ' A' ' 216' ' ' GLY . 1.5 p90 -44.61 179.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.385 2.093 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.452 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER -72.84 76.71 1.15 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.041 -1.037 . . . . 0.0 108.765 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.36 150.42 17.24 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.47 ' H ' ' HB2' ' A' ' 149' ' ' ASN . 7.6 mt -84.67 -173.38 4.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 165.2 110.48 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 154.0 139.09 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.508 ' HB ' HD11 ' A' ' 181' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.195 -1.179 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.789 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -41.18 176.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 122.828 1.299 . . . . 0.0 109.669 -178.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -105.27 123.26 47.54 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.423 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.851 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -47.04 -36.18 7.7 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.697 -0.627 . . . . 0.0 109.531 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -54.0 -38.0 64.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.81 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' C ' ' A' ' 34' ' ' ALA . 24.3 tp10 -91.19 -27.87 18.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.573 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -28.24 126.38 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 110.371 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.923 HD23 ' OE1' ' A' ' 105' ' ' GLU . 4.5 mp . . . . . 0 C--N 1.304 -1.412 0 O-C-N 121.567 -0.708 . . . . 0.0 109.715 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.032 0.444 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' HG13 ' A' ' 44' ' ' VAL . 83.7 Cg_endo -85.0 162.6 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.144 2.563 . . . . 0.0 112.504 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 43' ' ' PRO . 15.7 m -160.7 -176.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.238 -0.914 . . . . 0.0 109.628 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.6 100.12 12.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.598 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.45 -61.31 2.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.261 -0.9 . . . . 0.0 111.414 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.553 ' O ' ' C ' ' A' ' 48' ' ' HIS . 17.3 mttm -70.82 100.76 1.98 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 115.579 -2.448 . . . . 0.0 108.423 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.635 ' HE2' ' HG1' ' A' ' 89' ' ' THR . 5.9 t-80 -32.34 122.88 0.33 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.06 -28.94 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 0.0 111.012 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' ' 81' ' ' TRP . 41.8 t -69.25 -43.78 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.143 . . . . 0.0 110.001 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -106.57 -44.16 4.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 110.306 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.22 2.76 51.25 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 43.9 p30 -79.44 -121.01 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.6 mmt180 -127.81 172.03 11.21 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 123.061 1.41 . . . . 0.0 109.784 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 37.0 p -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.985 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.537 ' O ' ' C ' ' A' ' 57' ' ' GLU . 11.6 m -145.62 132.76 15.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.415 -1.428 . . . . 0.0 109.809 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.6 mm-40 -32.73 149.36 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.504 0 CA-C-O 121.75 0.786 . . . . 0.0 110.538 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.3 Cg_endo -78.34 166.21 80.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.961 -2.1 . . . . 0.0 111.831 -0.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.33 151.68 39.15 Favored Pre-proline 0 C--N 1.269 -2.934 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.289 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.57 ' O ' ' OG1' ' A' ' 63' ' ' THR . 23.9 Cg_endo -64.61 122.94 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.747 2.298 . . . . 0.0 112.162 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLU . 2.4 pp20? -43.48 143.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 32.41 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -154.77 137.15 14.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.603 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.509 ' OE1' ' N ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -108.11 171.08 7.61 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.582 ' O ' HG21 ' A' ' 162' ' ' THR . 7.4 mtm -128.07 132.54 49.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.99 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.91 -170.75 2.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.683 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 62.0 t -143.58 151.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 119.906 -1.746 . . . . 0.0 109.749 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 36.6 m-85 -147.07 125.93 12.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.982 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -105.68 89.26 0.61 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.541 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -85.89 -75.2 0.38 Allowed 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.626 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -165.74 -161.03 13.85 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.728 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -28.77 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.289 1.045 . . . . 0.0 108.611 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.78 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -59.3 7.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.016 . . . . 0.0 111.183 -177.435 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.675 ' O ' HD11 ' A' ' 210' ' ' LEU . 6.3 m0 -69.35 -60.83 2.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.0 108.856 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.69 -10.01 58.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . . . -59.7 -58.61 7.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.694 ' OE1' HG13 ' A' ' 91' ' ' VAL . 8.8 pt-20 -76.12 -12.57 60.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.132 -0.98 . . . . 0.0 110.757 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -56.79 -54.97 40.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.603 -1.31 . . . . 0.0 109.623 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HZ3' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -56.43 -0.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 0.0 110.69 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.537 ' CE2' HG11 ' A' ' 134' ' ' VAL . 19.8 m-85 -94.32 -39.57 10.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.744 -1.223 . . . . 0.0 109.851 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.72 ' HB2' HG11 ' A' ' 50' ' ' VAL . 1.3 p90 -77.01 16.74 0.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.85 -1.156 . . . . 0.0 109.318 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 82' ' ' VAL . 1.2 m -117.11 19.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 83' ' ' LEU . 3.9 pp -135.67 161.31 35.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.11 -0.994 . . . . 0.0 109.466 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 150.3 20.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.686 . . . . 0.0 109.984 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 110.44 -29.0 9.48 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -84.36 132.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.791 -0.829 . . . . 0.0 110.143 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.693 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.85 -43.04 31.56 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' CG ' ' A' ' 48' ' ' HIS . 5.5 t -162.25 -165.19 1.16 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.483 0.659 . . . . 0.0 109.796 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.635 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 74.1 p -154.16 143.47 21.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -144.64 145.88 31.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 109.854 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.694 HG13 ' OE1' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -128.99 156.6 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.037 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.28 172.84 45.84 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 102' ' ' THR . 3.7 m-85 -79.99 138.37 37.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -1.058 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.779 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -157.72 -170.16 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.926 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.513 ' O ' ' NH2' ' A' ' 194' ' ' ARG . . . 40.83 38.05 1.51 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.581 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -117.71 -154.27 9.83 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.757 -1.437 . . . . 0.0 109.751 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.851 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -151.8 64.68 0.86 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.325 -1.103 . . . . 0.0 109.166 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.635 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.31 -178.48 7.38 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.027 -1.045 . . . . 0.0 108.636 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 14.3 tpp85 -75.12 -107.59 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.449 -0.782 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.771 HD21 ' HE1' ' A' ' 200' ' ' TYR . 1.5 m120 -104.9 72.69 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 38.3 Cg_endo -65.59 157.72 56.99 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.824 2.35 . . . . 0.0 112.521 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 106' ' ' VAL . 23.2 p -122.94 170.43 10.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.414 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 4.3 t80 -55.48 -45.76 76.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -25.89 61.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 0.0 110.033 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.923 ' OE1' HD23 ' A' ' 35' ' ' LEU . 3.5 mm-40 -81.89 -37.66 26.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 102' ' ' THR . 13.5 m -66.31 -23.83 32.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 O-C-N 120.594 -1.317 . . . . 0.0 109.663 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.614 ' C ' ' H ' ' A' ' 109' ' ' GLU . 3.7 t -52.72 -38.93 61.55 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.648 ' OG ' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -52.86 -1.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.23 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.4 tt0 59.65 -6.59 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.253 -0.905 . . . . 0.0 109.65 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.718 ' CB ' HD13 ' A' ' 35' ' ' LEU . 1.6 mmtt -75.98 -24.46 55.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 110.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.448 ' OG1' HG12 ' A' ' 106' ' ' VAL . 31.1 p -84.15 -10.56 57.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 109.378 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 43.26 39.5 4.14 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.672 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -82.42 162.6 22.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.225 . . . . 0.0 109.16 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.869 ' HB2' HH12 ' A' ' 156' ' ' ARG . . . -124.37 113.85 18.74 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.376 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.689 ' OE1' ' CD1' ' A' ' 73' ' ' PHE . 2.4 mm-40 -54.27 116.31 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.779 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -124.66 175.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.03 -1.044 . . . . 0.0 110.88 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.738 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.6 m -133.01 114.92 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -95.87 98.68 10.6 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 80' ' ' PHE . 14.0 m -118.96 122.43 69.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.5 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -83.6 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.69 ' HB2' HD21 ' A' ' 131' ' ' LEU . 4.7 m-85 -130.18 160.71 32.99 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.845 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 50.6 mtp85 -101.3 105.44 39.64 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.52 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 125' ' ' HIS . 9.4 Cg_exo -40.58 -66.84 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 123.203 2.602 . . . . 0.0 113.877 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.5 tt0 -42.82 -19.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.997 -1.064 . . . . 0.0 109.938 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' A' ' 123' ' ' PRO . 67.5 m-70 -109.97 -7.78 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.999 -1.063 . . . . 0.0 109.852 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.687 HG22 ' CD ' ' A' ' 130' ' ' GLU . 1.2 pt -152.19 -176.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.389 1.09 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.545 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 43.7 t -130.37 152.32 49.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 25.4 t80 -48.33 -19.16 0.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.514 -1.367 . . . . 0.0 109.382 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' C ' ' A' ' 127' ' ' SER . 9.1 mp0 -70.48 -24.54 62.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.352 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.687 ' CD ' HG22 ' A' ' 126' ' ' ILE . 7.1 mt-10 -68.87 -71.77 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.0 109.999 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 121' ' ' TYR . 1.2 mp -35.86 -43.55 0.31 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.326 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 7.5 mp -73.94 -44.98 53.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.446 -0.784 . . . . 0.0 111.519 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -53.19 47.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.795 -1.19 . . . . 0.0 110.343 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.676 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 2.0 t -50.28 -50.64 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CZ ' ' CE1' ' A' ' 139' ' ' HIS . 22.5 t80 -58.0 -44.39 87.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.775 -1.203 . . . . 0.0 111.589 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.583 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 67.7 m95 -70.74 -36.09 72.98 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.772 -1.205 . . . . 0.0 111.702 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -79.21 -13.38 59.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.938 -1.101 . . . . 0.0 112.974 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.0 OUTLIER -133.99 59.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.11 -1.619 . . . . 0.0 112.087 -178.31 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.798 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 p-80 177.58 134.25 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.027 -1.045 . . . . 0.0 109.833 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.658 ' OD2' ' NE2' ' A' ' 143' ' ' GLN . 1.2 t0 -48.96 107.36 0.75 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.33 -0.857 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -85.98 -2.07 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.735 2.29 . . . . 0.0 113.038 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.55 ' C ' ' OG1' ' A' ' 190' ' ' THR . 40.2 p -121.72 20.55 10.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 110.261 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.69 ' N ' ' OG1' ' A' ' 190' ' ' THR . 7.7 mt-30 -130.94 101.25 5.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.022 -1.049 . . . . 0.0 109.15 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.677 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -96.86 18.74 56.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -18.35 12.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.979 -1.306 . . . . 0.0 109.8 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.649 ' CD ' ' C ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.54 164.59 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.001 -1.062 . . . . 0.0 109.87 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.571 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -99.34 108.36 20.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.589 -1.32 . . . . 0.0 109.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.91 -122.15 28.46 Favored Glycine 0 C--N 1.301 -1.366 0 CA-C-O 123.211 1.451 . . . . 0.0 110.461 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.05 -32.96 39.37 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.461 -1.37 . . . . 0.0 111.964 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.571 ' OD2' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.31 101.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.171 -1.581 . . . . 0.0 108.885 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.691 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 6.5 p90 -82.43 118.44 23.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.578 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 166.15 144.19 4.0 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.531 ' O ' ' OG1' ' A' ' 153' ' ' THR . 0.5 OUTLIER -70.97 14.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -1.23 . . . . 0.0 109.047 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.668 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -102.79 -1.65 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.668 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 22.4 m-85 -132.38 53.09 2.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.815 -1.178 . . . . 0.0 109.633 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.869 HH12 ' HB2' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -100.02 177.41 5.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 110.331 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' OG1' ' A' ' 191' ' ' THR . 11.5 p -92.98 71.41 4.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.548 ' CB ' ' OH ' ' A' ' 160' ' ' TYR . . . -97.38 129.57 44.61 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.631 0.729 . . . . 0.0 110.912 -176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 HG21 ' A' ' 191' ' ' THR . 19.9 m -102.11 146.35 10.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.566 ' CE1' HG11 ' A' ' 116' ' ' VAL . 22.2 m-85 -139.89 115.89 8.07 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.422 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 72.3 Cg_endo -77.57 167.37 24.33 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.344 2.029 . . . . 0.0 113.349 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -93.5 -41.73 9.62 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.282 -0.886 . . . . 0.0 109.392 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -171.8 -172.15 0.98 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 109.994 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.8 -25.53 4.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.074 1.416 . . . . 0.0 108.529 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 166' ' ' GLN . 2.5 t -56.01 -58.8 3.82 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.12 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.435 ' N ' HG12 ' A' ' 165' ' ' VAL . 5.5 tt0 -78.25 -25.66 46.94 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.086 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -38.6 56.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 0.0 110.657 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.13 -61.62 1.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 110.826 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . . . -93.86 -16.93 23.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.85 -1.156 . . . . 0.0 112.341 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.33 -65.67 0.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.429 -1.419 . . . . 0.0 110.357 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.13 -21.42 61.58 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.875 -1.141 . . . . 0.0 108.247 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.556 ' N ' HD23 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -75.51 -27.98 58.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.438 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.583 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 97.3 p -56.29 -26.91 53.67 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 174' ' ' LYS . 14.4 mtmm -67.73 -58.48 4.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.55 8.56 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.019 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.57 -75.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 110.102 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -58.16 -32.31 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -52.79 -17.97 1.63 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 0.0 109.652 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -68.04 -39.29 83.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.686 ' O ' ' CE1' ' A' ' 184' ' ' HIS . 15.8 m -87.45 -30.88 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.108 -0.995 . . . . 0.0 109.898 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.29 -38.51 60.32 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.133 -0.979 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.9 t -56.56 -24.78 49.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -75.69 -29.84 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.686 ' CE1' ' O ' ' A' ' 180' ' ' VAL . 0.6 OUTLIER -86.0 6.39 28.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.366 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 10.8 t-20 71.74 68.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.554 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -115.78 162.62 17.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.82 178.23 48.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.5 157.86 29.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.708 2.272 . . . . 0.0 112.075 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -64.05 125.29 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.166 -0.959 . . . . 0.0 108.686 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.69 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 6.8 p -110.59 54.1 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.548 ' OG1' ' O ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -100.68 159.53 15.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.671 ' CG ' HH12 ' A' ' 194' ' ' ARG . 10.7 t0 -109.29 145.28 36.23 Favored 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.321 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.405 HD13 ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -123.73 156.41 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.671 HH12 ' CG ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -146.82 -166.91 2.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.821 -1.174 . . . . 0.0 111.276 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.807 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.46 159.62 14.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 1.102 ' O ' ' OE1' ' A' ' 197' ' ' GLN . . . 10.97 -79.69 0.0 OUTLIER Glycine 0 C--O 1.17 -3.858 0 N-CA-C 105.261 -3.135 . . . . 0.0 105.261 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 1.102 ' OE1' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 151.15 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 124.048 0.939 . . . . 0.0 110.172 175.625 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 198' ' ' VAL . 10.0 p -45.78 117.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 117.47 -1.692 . . . . 0.0 106.511 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.51 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 18.6 t80 -102.52 147.53 26.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 111.578 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.771 ' HE1' HD21 ' A' ' 100' ' ' ASN . 7.7 m-85 -153.39 100.75 2.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.482 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 25.6 m-85 -53.08 135.43 37.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.787 -1.196 . . . . 0.0 109.65 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.654 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -86.87 -170.56 3.12 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.257 -0.902 . . . . 0.0 108.9 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -74.39 155.06 38.5 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.473 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -50.6 -43.22 56.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.557 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -54.07 -15.14 1.3 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.624 . . . . 0.0 109.74 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.78 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 8.2 m-70 -100.69 9.35 42.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.605 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.832 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.5 mm-40 -127.98 -145.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.092 0.949 . . . . 0.0 110.119 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.684 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.86 -3.72 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.953 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.832 ' N ' ' O ' ' A' ' 207' ' ' GLN . 86.8 t80 -41.02 -43.22 2.1 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 120.524 -1.36 . . . . 0.0 110.837 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.675 HD11 ' O ' ' A' ' 74' ' ' TRP . 0.8 OUTLIER -65.36 -13.14 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.378 -1.452 . . . . 0.0 109.903 -178.234 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 208' ' ' GLN . 94.6 p -55.96 -31.09 62.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.08 -1.012 . . . . 0.0 108.656 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -85.62 -36.39 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.456 -0.778 . . . . 0.0 109.0 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -131.98 68.41 80.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' LEU . 52.5 Cg_exo -49.94 8.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.072 2.514 . . . . 0.0 113.298 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 213' ' ' ASN . 0.0 OUTLIER -61.34 -24.8 66.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.49 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 58.88 83.84 0.05 OUTLIER Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.21 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -70.5 88.2 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.902 2.351 . . . . 0.0 108.575 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.587 ' O ' ' O ' ' A' ' 219' ' ' GLY . 18.1 t -169.74 114.32 0.52 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.863 -1.148 . . . . 0.0 109.387 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -39.89 170.09 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.93 -174.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.343 -1.093 . . . . 0.0 110.131 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.575 ' O ' ' C ' ' A' ' 222' ' ' GLY . . . -155.04 -80.88 0.03 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 221' ' ' GLY . . . -27.95 105.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 CA-C-O 123.051 1.362 . . . . 0.0 109.954 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.27 -2.855 0 CA-C-N 113.896 -1.152 . . . . 0.0 109.308 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.716 ' O ' ' O ' ' A' ' 29' ' ' ILE . 47.5 t . . . . . 0 CA--C 1.502 -0.902 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.716 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -36.58 176.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-O 123.141 1.448 . . . . 0.0 110.14 -178.341 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.434 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.7 124.45 26.03 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.249 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.43 80.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.755 -0.591 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.17 0.88 3.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 mm-40 -107.27 -35.93 6.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 108.963 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.78 -170.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.665 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 35' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 108.973 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.717 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.923 0.392 . . . . 0.0 110.143 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.922 ' O ' HG13 ' A' ' 44' ' ' VAL . 27.2 Cg_endo -64.34 165.91 18.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.636 2.224 . . . . 0.0 111.862 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 43' ' ' PRO . 2.3 m -172.95 172.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.38 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 45' ' ' THR . 7.3 t 9.98 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.509 0.671 . . . . 0.0 110.823 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.703 ' O ' HG23 ' A' ' 55' ' ' THR . . . -69.24 -52.68 25.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 111.394 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.557 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.63 99.66 10.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 115.746 -2.382 . . . . 0.0 108.765 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.632 ' NE2' ' OE1' ' A' ' 208' ' ' GLN . 8.5 t-80 -31.67 141.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.492 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 9.1 t-80 -80.44 -42.51 22.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 110.572 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 211' ' ' SER . 25.8 t -58.1 -37.56 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 110.179 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 t -109.4 -48.69 3.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 110.507 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.04 4.63 55.35 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.6 p30 -81.81 -110.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.68 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 10.1 mtm-85 -129.24 174.88 9.19 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 123.519 1.628 . . . . 0.0 109.855 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 46' ' ' ALA . 63.3 p -132.51 0.35 3.64 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.397 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' GLU . 1.1 m -145.11 132.09 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.507 -1.37 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt-10 -34.03 154.8 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 CA-C-O 121.881 0.848 . . . . 0.0 110.845 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.8 Cg_endo -79.53 166.05 78.82 Favored 'Cis proline' 0 C--N 1.301 -1.969 0 C-N-CA 121.479 -2.301 . . . . 0.0 111.633 -0.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.402 ' CZ ' HG21 ' A' ' 120' ' ' VAL . 35.6 m-85 -111.15 148.92 39.71 Favored Pre-proline 0 C--N 1.266 -3.035 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.0 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 63' ' ' THR . 8.3 Cg_endo -53.28 139.47 63.75 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.929 2.42 . . . . 0.0 112.618 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -45.5 158.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 42.78 66.82 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.544 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 1.2 p -136.7 147.38 46.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.622 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.583 ' OE1' ' CG ' ' A' ' 123' ' ' PRO . 2.1 mp0 -116.79 173.47 6.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.41 -0.806 . . . . 0.0 108.839 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.751 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -154.22 128.67 9.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.983 -1.073 . . . . 0.0 109.841 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.01 -167.6 2.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.1 t -143.22 137.6 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.087 -1.633 . . . . 0.0 109.983 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 1.045 ' O ' HG22 ' A' ' 117' ' ' VAL . 54.5 m-85 -131.76 137.89 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.059 -1.026 . . . . 0.0 110.144 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -122.78 110.26 1.52 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 105.715 -2.954 . . . . 0.0 105.715 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.556 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -107.14 -87.62 0.48 Allowed 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.214 -1.168 . . . . 0.0 110.413 -177.49 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.717 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.75 74.76 0.2 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.717 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 51.1 t 111.41 82.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.68 ' N ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -55.72 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.623 -1.298 . . . . 0.0 110.734 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.643 ' H ' ' C ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -91.41 -44.41 9.15 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.068 -1.02 . . . . 0.0 109.363 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.51 -3.95 49.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.695 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.24 -35.41 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 109.733 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.79 ' CD ' HE22 ' A' ' 208' ' ' GLN . 29.4 tt0 -68.17 -15.17 63.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.28 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.593 ' O ' HG13 ' A' ' 82' ' ' VAL . 11.5 ttt180 -60.16 -54.39 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.504 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.507 ' HE2' ' H ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -73.38 25.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.941 -1.099 . . . . 0.0 110.165 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.7 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 6.8 m-85 -126.78 -39.01 2.01 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.482 -0.761 . . . . 0.0 110.125 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.693 ' CE2' ' OG ' ' A' ' 211' ' ' SER . 1.2 p90 -84.74 1.71 45.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.703 -1.248 . . . . 0.0 109.72 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.2 m -104.84 11.66 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.829 HD11 HG21 ' A' ' 134' ' ' VAL . 96.0 mt -99.04 149.49 22.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.07 0.938 . . . . 0.0 109.116 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.579 ' HZ3' ' HA ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -85.82 136.7 33.21 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 107.53 -26.51 17.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -72.3 138.67 21.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.128 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.692 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -78.42 -41.38 33.11 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -175.56 -169.81 0.38 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.985 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.542 ' C ' ' OE2' ' A' ' 77' ' ' GLU . 30.6 p -146.55 167.0 24.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.914 -1.116 . . . . 0.0 110.214 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.628 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -168.66 -178.75 3.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.921 HG12 HG12 ' A' ' 117' ' ' VAL . 1.6 m -156.82 161.03 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.665 -1.272 . . . . 0.0 108.504 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 201' ' ' TYR . . . -167.46 -172.42 34.57 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.199 -1.477 . . . . 0.0 111.934 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 202' ' ' ALA . 1.6 m-85 -104.44 150.29 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.852 -0.793 . . . . 0.0 109.511 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.656 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -177.0 154.22 1.07 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.31 38.56 7.16 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.498 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -129.5 -152.01 7.47 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.038 -1.272 . . . . 0.0 110.111 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.48 55.1 1.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 109.474 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -157.07 141.62 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.682 ' O ' ' CE2' ' A' ' 200' ' ' TYR . 0.0 OUTLIER -48.96 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 109.438 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -122.84 86.27 50.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.517 ' CG ' ' NE2' ' A' ' 113' ' ' HIS . 59.4 Cg_endo -78.41 -171.62 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.657 2.238 . . . . 0.0 111.811 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.633 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 23.1 p -121.69 170.5 9.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.048 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.53 -59.09 5.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.39 -0.819 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -61.22 -23.22 65.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 108.822 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.633 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.1 mm-40 -67.81 -60.07 2.81 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.66 0.743 . . . . 0.0 110.322 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.918 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.8 m -64.37 -24.49 35.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.663 -0.648 . . . . 0.0 111.635 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.7 t -53.7 -0.5 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.261 -0.9 . . . . 0.0 109.363 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 110' ' ' LYS . 22.6 p -99.8 11.17 39.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.453 ' O ' HG21 ' A' ' 29' ' ' ILE . 2.5 tt0 59.08 -5.58 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.071 -1.018 . . . . 0.0 109.512 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.4 OUTLIER -70.67 -30.97 67.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 110.371 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.918 ' OG1' HG12 ' A' ' 106' ' ' VAL . 26.7 p -84.98 -18.34 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.929 -1.107 . . . . 0.0 110.28 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.06 14.61 47.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.652 ' CD2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -58.32 158.22 7.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.029 -1.277 . . . . 0.0 109.711 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.542 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -120.36 113.83 20.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.68 ' OE1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.95 135.23 15.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.483 -179.28 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -151.68 178.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.989 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.045 HG22 ' O ' ' A' ' 68' ' ' PHE . 34.5 m -138.97 147.89 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.201 -0.937 . . . . 0.0 110.688 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.793 ' NH1' ' CZ ' ' A' ' 201' ' ' TYR . 8.9 ptm180 -115.49 95.71 5.29 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.731 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 4.0 m -109.52 113.82 45.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.17 -1.581 . . . . 0.0 108.815 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.0 t -74.49 156.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.161 ' CD2' HD22 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -136.9 160.35 39.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.887 -1.133 . . . . 0.0 110.156 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 59.8 mtp180 -119.46 100.4 49.61 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 125' ' ' HIS . 13.5 Cg_exo -41.71 -61.05 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.235 2.623 . . . . 0.0 113.276 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -38.37 -14.59 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.603 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.695 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -143.8 15.53 1.76 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.718 -1.239 . . . . 0.0 109.49 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -155.19 146.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.869 . . . . 0.0 109.419 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.572 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -107.8 166.79 10.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.244 -0.91 . . . . 0.0 109.37 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 169' ' ' ALA . 37.9 t80 -64.82 -38.83 92.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 133' ' ' LYS . 36.7 mm-40 -53.71 -27.39 27.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 109.086 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 1.0 OUTLIER -66.69 -68.82 0.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.094 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.161 HD22 ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -33.89 -47.55 0.26 Allowed 'General case' 0 C--N 1.316 -0.859 0 O-C-N 120.95 -1.094 . . . . 0.0 108.493 178.932 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 173' ' ' SER . 11.2 mp -76.1 -41.24 50.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.581 ' O ' ' OE2' ' A' ' 137' ' ' GLU . 2.8 tmmm? -52.56 -39.59 61.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.098 -1.001 . . . . 0.0 111.44 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.829 HG21 HD11 ' A' ' 83' ' ' LEU . 1.1 t -74.84 -39.44 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.722 -1.236 . . . . 0.0 110.098 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 8.0 t80 -65.32 -48.22 73.83 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.375 -0.828 . . . . 0.0 111.211 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.52 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 61.4 m95 -67.04 -34.11 76.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.784 -1.198 . . . . 0.0 111.363 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.672 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -76.95 -33.21 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 113.23 -176.844 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 41.9 m-80 -96.12 36.09 1.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.323 -1.486 . . . . 0.0 114.483 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.799 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 6.6 p-80 178.53 175.95 0.54 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.393 -1.442 . . . . 0.0 111.981 176.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.85 107.92 57.84 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 20.38 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.187 1.925 . . . . 0.0 112.299 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.73 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -115.7 3.18 13.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.753 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.536 ' O ' ' O ' ' A' ' 146' ' ' ARG . 18.1 mt-30 -101.88 78.26 1.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.069 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 146' ' ' ARG . . . -39.4 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.499 2.855 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.466 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.471 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -66.97 40.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.936 0.874 . . . . 0.0 110.39 -176.67 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.652 ' CZ ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -161.65 152.54 18.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' A' ' 143' ' ' GLN . 21.0 mm100 -154.92 74.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.281 -1.512 . . . . 0.0 110.05 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 220' ' ' LEU . . . 78.11 -115.71 4.27 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -79.52 -33.45 42.01 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-N 114.517 -0.842 . . . . 0.0 111.624 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.497 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -85.36 129.49 34.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.283 -1.511 . . . . 0.0 109.015 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.446 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 17.6 p90 -127.64 138.39 52.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 154' ' ' GLN . . . 138.58 167.08 10.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -72.32 15.16 0.18 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.001 -1.294 . . . . 0.0 108.9 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.598 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 1.4 pt20 -114.32 17.58 17.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 44.2 m-85 -155.48 65.63 0.62 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.703 HH22 ' CG ' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -118.54 -176.03 3.0 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.384 -0.822 . . . . 0.0 109.389 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 t -92.11 140.56 29.51 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.461 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -162.14 118.95 2.06 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.603 -2.039 . . . . 0.0 112.115 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.72 HG13 ' CG2' ' A' ' 191' ' ' THR . 2.2 m -115.72 126.2 73.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.154 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.484 ' CE2' HG11 ' A' ' 116' ' ' VAL . 4.8 m-30 -113.9 119.99 39.87 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.41 170.43 19.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.564 2.176 . . . . 0.0 112.53 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.16 -40.4 8.82 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.209 -0.932 . . . . 0.0 109.592 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 165' ' ' VAL . 43.3 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.114 -0.991 . . . . 0.0 109.923 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 123.154 1.454 . . . . 0.0 108.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 163' ' ' SER . 2.5 t -56.06 -56.46 12.83 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.987 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.227 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.03 -36.82 48.13 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.965 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 1.5 mtm -52.46 -35.41 52.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 110.815 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -48.29 -55.0 11.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 109.962 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . . . -93.13 -30.84 15.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.017 -1.052 . . . . 0.0 110.582 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.468 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -52.54 -62.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.047 . . . . 0.0 110.014 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mt -52.66 -33.87 49.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 109.642 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.739 ' HB3' HD23 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -56.43 -34.27 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.912 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -72.18 -46.79 54.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.96 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -72.22 -39.67 68.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.045 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.59 -29.45 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.089 -1.007 . . . . 0.0 109.92 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -79.54 -44.15 21.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.886 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.767 ' OE1' HG23 ' A' ' 189' ' ' ILE . 35.8 tp60 -62.19 -5.34 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.592 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -49.64 13.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.89 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.35 -51.81 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 181' ' ' LEU . 4.5 mm? -53.72 -40.82 66.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.835 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 51.0 p -56.38 -27.27 55.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.441 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -88.03 6.34 36.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.554 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.428 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 1.7 m-70 -108.22 35.82 3.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 9.3 t-20 69.88 36.07 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.48 175.61 5.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.402 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.625 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -133.47 -145.62 5.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 189' ' ' ILE . 30.0 Cg_exo -58.73 106.03 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.402 2.068 . . . . 0.0 111.248 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.767 HG23 ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -48.45 -172.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 21.4 p -151.43 58.57 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.568 -0.707 . . . . 0.0 109.813 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.72 ' CG2' HG13 ' A' ' 159' ' ' VAL . 45.7 m -99.76 128.7 45.84 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.703 ' CG ' HH22 ' A' ' 156' ' ' ARG . 4.9 t70 -75.97 119.42 19.91 Favored 'General case' 0 C--N 1.272 -2.793 0 C-N-CA 119.569 -0.853 . . . . 0.0 109.419 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.421 ' C ' ' CG ' ' A' ' 194' ' ' ARG . 0.6 OUTLIER -119.77 103.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.386 -0.925 . . . . 0.0 109.643 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.661 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -165.33 141.92 5.58 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.654 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -114.95 -177.67 3.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 109.843 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.77 29.75 60.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 198' ' ' VAL . 16.2 mm-40 -104.0 103.64 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.302 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -33.6 154.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.183 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.576 ' CE1' ' HD2' ' A' ' 118' ' ' ARG . 7.7 t80 -128.75 120.23 26.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.682 ' CE2' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.97 126.77 40.29 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.793 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.53 -176.53 3.4 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 116.329 -2.148 . . . . 0.0 114.642 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . . . -95.71 -179.58 4.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 112.185 -2.279 . . . . 0.0 111.478 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.698 ' HA ' HG11 ' A' ' 44' ' ' VAL . 1.3 pt-20 -73.57 -168.16 0.53 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.429 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.74 -14.38 54.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.866 -1.146 . . . . 0.0 110.527 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.651 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -78.53 -14.17 59.48 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.881 -1.137 . . . . 0.0 109.382 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 74' ' ' TRP . 53.7 m80 -104.68 2.88 30.91 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.109 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.841 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.2 mm-40 -120.51 -138.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.237 1.018 . . . . 0.0 109.938 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.79 HE22 ' CD ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -34.73 -5.56 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.634 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.841 ' N ' ' O ' ' A' ' 207' ' ' GLN . 64.2 t80 -41.88 -47.48 4.25 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 120.464 -1.398 . . . . 0.0 109.298 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.72 HD22 ' SG ' ' A' ' 218' ' ' CYS . 0.9 OUTLIER -70.63 -28.68 65.01 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.532 -1.355 . . . . 0.0 110.219 -179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.693 ' OG ' ' CE2' ' A' ' 81' ' ' TRP . 0.1 OUTLIER -69.01 -41.83 77.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.923 -1.11 . . . . 0.0 108.22 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -88.91 -19.17 26.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.535 -0.728 . . . . 0.0 109.672 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 215' ' ' ASP . 22.9 m120 -116.0 89.89 26.27 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.036 . . . . 0.0 110.265 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.1 11.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.249 2.632 . . . . 0.0 112.205 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.1 t0 -61.94 -4.73 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.275 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.617 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 64.05 -44.32 0.09 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.996 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.617 ' C ' ' O ' ' A' ' 216' ' ' GLY . 40.6 m-85 -23.33 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 CA-C-N 119.408 1.604 . . . . 0.0 110.529 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.72 ' SG ' HD22 ' A' ' 210' ' ' LEU . 69.1 m -137.42 -126.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -151.92 -154.84 6.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.715 HD12 ' HA3' ' A' ' 148' ' ' GLY . 20.4 mt -82.82 -175.84 6.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.664 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.13 125.85 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.591 ' H ' ' HA ' ' A' ' 139' ' ' HIS . . . 140.28 167.67 11.1 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 139' ' ' HIS . 11.7 p . . . . . 0 C--N 1.27 -2.889 0 CA-C-N 114.388 -0.906 . . . . 0.0 108.672 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.799 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.644 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -39.82 175.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.328 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.497 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -99.59 126.97 45.66 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.634 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -47.04 -62.11 1.56 Allowed 'General case' 0 C--N 1.285 -2.233 0 CA-C-O 121.258 0.551 . . . . 0.0 109.904 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -54.72 -3.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' ALA . 3.0 tt0 -108.97 -23.69 11.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.928 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . . . -48.98 -167.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.904 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.826 ' CB ' HG23 ' A' ' 98' ' ' THR . 1.7 mm? . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.47 167.93 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.909 2.406 . . . . 0.0 112.31 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' ALA . 28.8 m -128.68 -171.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.613 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 44' ' ' VAL . 1.3 t -39.2 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.591 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.72 -27.18 58.65 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.192 -0.943 . . . . 0.0 111.313 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 7.8 ptpt -91.96 98.9 11.86 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 116.243 -2.183 . . . . 0.0 107.873 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.693 ' CG ' ' OG ' ' A' ' 88' ' ' SER . 6.1 t-80 -32.43 121.78 0.33 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -67.09 -34.91 78.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.347 -0.846 . . . . 0.0 111.276 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.601 HG23 ' HG3' ' A' ' 208' ' ' GLN . 21.7 t -70.5 -34.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.887 -1.133 . . . . 0.0 109.725 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -107.73 -42.45 4.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 92.46 0.42 70.03 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.699 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 34.5 p30 -78.17 -119.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.699 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttt-85 -126.3 170.74 11.59 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 123.246 1.498 . . . . 0.0 108.736 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.729 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.3 p -131.95 23.26 4.57 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 55' ' ' THR . 5.6 m -162.11 138.03 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.74 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.3 156.83 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.025 0.917 . . . . 0.0 110.795 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 81.3 Cg_endo -80.07 166.18 77.2 Favored 'Cis proline' 0 C--N 1.301 -1.953 0 C-N-CA 121.471 -2.304 . . . . 0.0 112.157 -0.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.521 ' CE1' HG11 ' A' ' 120' ' ' VAL . 27.2 m-85 -103.27 147.91 34.88 Favored Pre-proline 0 C--N 1.27 -2.89 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.078 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' O ' ' OG1' ' A' ' 63' ' ' THR . 38.9 Cg_endo -70.29 142.89 46.73 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.827 2.351 . . . . 0.0 112.368 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -46.43 158.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.467 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.26 62.65 5.42 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.54 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.5 OUTLIER -146.02 139.41 26.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -1.116 . . . . 0.0 109.569 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.628 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 1.6 mp0 -109.15 123.58 49.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.649 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -111.78 139.49 47.21 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.08 -169.38 2.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 117' ' ' VAL . 72.2 t -143.94 140.79 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.105 -1.622 . . . . 0.0 109.743 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.896 ' O ' HG22 ' A' ' 117' ' ' VAL . 97.3 m-85 -123.19 155.2 37.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -153.32 94.67 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 118.564 -1.779 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.588 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -92.87 -87.01 0.24 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.621 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -134.97 -158.01 8.22 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.769 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.85 102.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -1.019 . . . . 0.0 108.317 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.657 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -51.95 7.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 111.698 -177.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.769 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 4.7 m0 -69.22 -73.39 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.604 -1.31 . . . . 0.0 109.027 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.9 -14.52 63.37 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . . . -77.03 -53.88 7.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -1.143 . . . . 0.0 110.858 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.71 ' OE2' HG13 ' A' ' 91' ' ' VAL . 7.8 tp10 -48.42 -36.56 15.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.298 -0.876 . . . . 0.0 111.379 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.899 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.5 tmt_? -66.36 -57.95 6.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 0.0 109.941 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -41.18 -10.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.527 -0.733 . . . . 0.0 111.366 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.685 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.7 m-85 -101.91 -40.69 6.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.583 -1.323 . . . . 0.0 111.256 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.622 ' HB3' HG21 ' A' ' 89' ' ' THR . 1.1 p90 -86.69 1.83 50.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.48 -1.387 . . . . 0.0 110.906 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.2 m -83.52 19.99 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.134 . . . . 0.0 109.636 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -129.97 158.57 39.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.662 ' HZ1' ' C ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -91.48 153.43 19.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.576 -0.702 . . . . 0.0 109.742 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -26.63 19.09 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG23 ' CD2' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -75.34 138.06 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.712 -0.875 . . . . 0.0 109.76 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.691 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -82.74 -41.52 19.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 89' ' ' THR . 11.8 t -156.98 -163.66 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.662 0.744 . . . . 0.0 110.066 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 88' ' ' SER . 3.7 p -168.72 121.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.557 ' C ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -136.39 173.63 11.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.963 -1.086 . . . . 0.0 110.707 -178.291 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.782 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -146.39 157.93 11.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.584 0.707 . . . . 0.0 109.62 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.43 174.5 46.08 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.627 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -85.39 156.13 20.99 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.374 -1.074 . . . . 0.0 109.547 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.8 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -172.72 -170.73 0.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 109.72 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 59.27 21.77 54.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.754 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -160.41 -156.08 8.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.742 ' CE1' ' HB3' ' A' ' 34' ' ' ALA . 30.9 p80 178.91 109.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.416 -1.049 . . . . 0.0 108.983 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.826 HG23 ' CB ' ' A' ' 35' ' ' LEU . 13.9 m -144.45 144.79 31.55 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.612 ' C ' ' O ' ' A' ' 98' ' ' THR . 17.6 mtm-85 -19.83 -85.39 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.747 0.784 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -117.19 90.83 34.97 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 2.8 Cg_exo -73.35 111.1 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.566 2.178 . . . . 0.0 113.329 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.6 p -123.05 163.3 20.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.635 ' O ' ' CD1' ' A' ' 103' ' ' TYR . 0.5 OUTLIER -50.05 -35.95 27.1 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.381 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.629 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 3.9 ttmt -73.7 -31.93 63.67 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.693 -0.63 . . . . 0.0 110.956 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.2 mm-40 -80.99 -47.08 14.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 102' ' ' THR . 30.2 m -67.6 -25.03 32.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 120.608 -1.308 . . . . 0.0 110.342 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.629 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 14.5 p -53.89 -40.62 66.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.673 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 58.1 m -48.51 -66.52 0.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.673 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.6 mt-10 137.82 -25.25 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.259 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' HD22 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -67.06 3.87 1.02 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.542 -177.532 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.439 ' OG1' HG12 ' A' ' 106' ' ' VAL . 71.0 p -99.91 -25.15 14.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.77 -1.206 . . . . 0.0 109.33 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 66.07 13.26 59.47 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.428 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.754 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.55 159.07 28.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.494 -1.592 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 1.041 ' HB2' ' NH2' ' A' ' 156' ' ' ARG . . . -126.31 117.79 23.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.657 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.5 mm-40 -49.46 112.61 0.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.76 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -124.54 175.29 7.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.382 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 68' ' ' PHE . 33.7 m -132.45 148.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.15 -0.969 . . . . 0.0 110.158 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HG3' ' NE2' ' A' ' 90' ' ' GLN . 2.0 tpp180 -110.69 107.81 17.49 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.685 HG12 HG22 ' A' ' 89' ' ' THR . 7.5 m -133.66 116.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 108.805 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.538 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.0 OUTLIER -96.95 158.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 131' ' ' LEU . 3.0 m-85 -134.45 155.45 50.32 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.885 -1.134 . . . . 0.0 109.543 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.624 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 1.4 ptm180 -110.37 112.31 57.05 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 125' ' ' HIS . 34.1 Cg_exo -44.48 -63.6 0.32 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 123.177 2.584 . . . . 0.0 113.383 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.755 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 16.9 mp0 -33.17 -21.9 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.737 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.688 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -137.99 6.46 2.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.433 -1.417 . . . . 0.0 110.502 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -155.82 150.41 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 110.043 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.568 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 37.6 t -97.81 147.6 24.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.96 ' CE2' HD11 ' A' ' 132' ' ' LEU . 50.8 t80 -62.51 -21.16 65.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.28 -7.57 47.9 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.568 ' HG3' ' H ' ' A' ' 127' ' ' SER . 9.1 mm-40 -74.46 -70.31 0.41 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.757 -0.59 . . . . 0.0 110.358 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.044 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -51.95 -29.79 21.91 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 120.495 -1.378 . . . . 0.0 108.236 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.96 HD11 ' CE2' ' A' ' 128' ' ' PHE . 47.3 mt -63.68 -57.05 11.23 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.524 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -39.61 94.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.745 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.759 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 3.8 t -50.27 -62.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 109.515 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 6.0 t80 -54.63 -39.09 67.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.457 -1.402 . . . . 0.0 110.078 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.56 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 51.5 m95 -70.75 -36.35 73.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.973 -1.079 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.77 -4.95 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 113.577 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.759 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -122.74 41.71 3.37 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.06 -1.65 . . . . 0.0 111.422 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 173.55 -168.41 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.849 0.833 . . . . 0.0 108.752 177.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -118.25 138.57 25.74 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.449 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 93.3 Cg_endo -81.21 0.99 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.614 2.21 . . . . 0.0 113.285 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.571 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -121.8 47.25 1.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.858 -1.151 . . . . 0.0 110.196 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.574 ' O ' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER -129.9 70.32 1.43 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.129 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.72 ' H ' HG21 ' A' ' 190' ' ' THR . . . -51.59 -118.71 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.626 ' SD ' ' C ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -70.56 40.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.444 -1.033 . . . . 0.0 109.736 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 144' ' ' GLY . 9.4 ttt180 -165.64 85.29 0.35 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.558 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.588 ' OE1' ' O ' ' A' ' 70' ' ' MET . 5.7 tp60 -86.23 117.16 24.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.428 -1.42 . . . . 0.0 109.79 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 46.58 -114.31 1.44 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.533 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 12.8 t30 -92.77 16.71 11.75 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 114.329 -0.936 . . . . 0.0 110.282 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.19 147.15 30.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.114 . . . . 0.0 109.201 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 151' ' ' PHE . 20.2 p90 -130.07 129.42 43.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' NE2' ' A' ' 154' ' ' GLN . . . 147.16 155.06 6.4 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.675 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.1 OUTLIER -79.3 5.1 13.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.361 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.651 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 15.1 pm0 -97.48 -5.75 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.474 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 23.0 m-85 -122.45 61.82 0.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.122 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.041 ' NH2' ' HB2' ' A' ' 114' ' ' ALA . 8.9 ptt-85 -112.23 175.91 5.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -0.842 . . . . 0.0 109.125 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.639 ' HB3' ' HE2' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -89.44 121.0 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -137.18 128.88 28.75 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 118.291 -1.363 . . . . 0.0 110.986 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.781 HG13 ' CG2' ' A' ' 191' ' ' THR . 1.1 m -126.77 120.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.26 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.518 ' CE2' HG11 ' A' ' 116' ' ' VAL . 6.2 m-30 -109.86 126.13 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.14 174.66 9.84 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 123.012 2.474 . . . . 0.0 112.999 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.556 ' OG1' ' OE1' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -99.3 -40.33 7.98 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.469 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -172.97 -162.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 0.0 109.722 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -53.57 -16.64 1.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.921 1.343 . . . . 0.0 108.959 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.469 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.9 t -59.2 -57.54 10.97 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.246 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.556 ' OE1' ' OG1' ' A' ' 162' ' ' THR . 1.3 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.749 -0.594 . . . . 0.0 110.392 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtp -50.92 -44.33 60.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.658 -1.276 . . . . 0.0 109.498 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.69 -19.23 59.27 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.034 -1.041 . . . . 0.0 109.12 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.58 -57.65 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.85 . . . . 0.0 110.616 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.64 -65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.068 -1.02 . . . . 0.0 110.035 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -33.53 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.24 -45.92 44.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.56 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 83.0 p -56.23 -49.45 74.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.388 -0.82 . . . . 0.0 109.826 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.536 ' HZ3' HD12 ' A' ' 189' ' ' ILE . 12.8 tttm -61.8 -53.59 53.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.741 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.02 -6.75 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.849 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.15 -52.17 9.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 110.464 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -11.79 59.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.028 -1.045 . . . . 0.0 110.28 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.517 ' OE1' ' CB ' ' A' ' 182' ' ' SER . 0.2 OUTLIER -70.8 -41.07 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.561 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -77.05 -16.04 59.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.49 -54.62 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 0.0 109.911 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.449 ' CD1' ' CG ' ' A' ' 141' ' ' PRO . 37.2 mt -75.4 -43.68 48.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 110.174 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.517 ' CB ' ' OE1' ' A' ' 178' ' ' GLN . 12.7 t -55.35 -22.1 17.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -88.18 -9.94 51.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 109.008 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.419 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 22.5 m170 -108.28 34.58 3.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 28.0 t-20 69.79 68.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.965 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -134.73 173.15 12.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -110.75 -168.74 19.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 189' ' ' ILE . 11.1 Cg_endo -58.84 115.1 2.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.761 1.641 . . . . 0.0 110.812 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.571 HG22 HG22 ' A' ' 142' ' ' THR . 0.3 OUTLIER -47.8 179.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.0 110.06 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.72 HG21 ' H ' ' A' ' 144' ' ' GLY . 39.9 p -140.01 59.75 1.57 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.781 ' CG2' HG13 ' A' ' 159' ' ' VAL . 27.1 m -98.04 115.81 28.97 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 194' ' ' ARG . 6.3 t0 -84.72 125.28 32.4 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.953 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.44 148.33 19.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.65 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 3.6 mtm180 -165.44 169.81 15.19 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.522 -0.736 . . . . 0.0 109.128 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.697 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -123.86 170.6 10.41 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.994 -1.067 . . . . 0.0 110.808 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 195' ' ' GLU . . . 22.72 38.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.753 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -65.32 132.76 49.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.832 -1.393 . . . . 0.0 109.862 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.84 163.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -127.05 141.69 51.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.365 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' A' ' 93' ' ' PHE . 1.6 m-85 -142.56 97.91 3.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.922 . . . . 0.0 109.608 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -54.24 134.64 44.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.38 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.93 -173.16 4.58 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.669 ' CD ' ' H ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -75.33 168.06 20.71 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.636 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.04 -48.97 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.863 -1.148 . . . . 0.0 108.51 179.135 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.669 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.48 -23.04 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 110.054 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.651 ' O ' HG21 ' A' ' 91' ' ' VAL . 9.5 m-70 -92.3 6.79 45.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.048 -1.032 . . . . 0.0 110.022 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.827 ' O ' ' N ' ' A' ' 209' ' ' TYR . 6.0 mm-40 -122.56 -138.66 0.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.776 1.274 . . . . 0.0 111.024 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.699 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.3 OUTLIER -34.21 -3.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.44 -179.072 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.827 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.0 t80 -42.68 -43.08 3.72 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 120.563 -1.336 . . . . 0.0 110.464 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.625 HD21 ' O ' ' A' ' 74' ' ' TRP . 2.9 mp -61.17 -12.37 12.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.525 -1.36 . . . . 0.0 109.867 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.5 t -55.78 -29.76 60.2 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 108.545 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -83.92 -35.16 24.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.423 -0.798 . . . . 0.0 108.867 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -136.35 130.65 18.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 216' ' ' GLY . 30.2 Cg_endo -65.37 -56.84 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.921 1.747 . . . . 0.0 113.287 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.617 ' O ' ' N ' ' A' ' 217' ' ' TYR . 0.8 OUTLIER -64.11 2.37 0.56 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.689 -1.257 . . . . 0.0 107.926 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 61.95 -68.43 0.02 OUTLIER Glycine 0 N--CA 1.479 1.507 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' A' ' 215' ' ' ASP . 9.2 t80 -145.95 -150.85 0.35 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.475 -1.015 . . . . 0.0 108.737 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 218' ' ' CYS . 23.8 p -90.3 77.96 6.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.089 -1.007 . . . . 0.0 108.991 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -135.73 -152.05 6.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -169.66 -178.71 3.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -1.208 . . . . 0.0 109.75 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 220' ' ' LEU . . . -104.57 -143.74 12.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -154.45 -141.94 3.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.421 -1.046 . . . . 0.0 109.662 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.762 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.652 HG21 ' O ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -42.68 176.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.759 1.266 . . . . 0.0 108.775 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -94.02 128.66 40.5 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.16 179.451 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 97' ' ' HIS . . . -47.34 -38.5 13.0 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.24 -10.66 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.632 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 34' ' ' ALA . 4.6 tt0 -81.87 -46.48 14.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 111' ' ' THR . . . -37.07 137.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.483 ' N ' HD23 ' A' ' 35' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.935 -1.103 . . . . 0.0 112.28 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.635 ' CG1' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.15 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.2 m -148.88 -179.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.542 ' OG1' ' OD1' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -47.9 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.129 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.41 -28.09 58.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.424 -0.797 . . . . 0.0 111.39 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.84 99.27 11.7 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 115.958 -2.297 . . . . 0.0 108.581 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.941 ' CE1' ' HG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.25 126.43 0.27 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.656 ' HE1' ' HD3' ' A' ' 212' ' ' LYS . 8.7 t-80 -71.41 -29.4 64.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.697 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.855 HG21 ' CG ' ' A' ' 81' ' ' TRP . 21.5 t -69.25 -40.58 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.977 -1.077 . . . . 0.0 110.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -109.37 -42.69 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.158 -0.963 . . . . 0.0 110.335 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.26 3.59 56.58 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 38.4 p30 -79.21 -116.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.0 ttt180 -129.43 169.95 14.3 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 123.221 1.486 . . . . 0.0 108.992 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.75 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.3 p -133.7 34.0 3.45 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.025 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 55' ' ' THR . 4.5 m -163.86 150.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.71 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.3 pm0 -32.2 153.89 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.72 0 CA-C-O 121.932 0.872 . . . . 0.0 110.909 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 98.6 Cg_endo -78.73 166.07 80.52 Favored 'Cis proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.568 -2.263 . . . . 0.0 111.862 0.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.783 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 1.9 m-30 -115.48 132.45 23.11 Favored Pre-proline 0 C--N 1.269 -2.892 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.977 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.536 ' O ' ' OG1' ' A' ' 63' ' ' THR . 47.1 Cg_exo -49.48 115.57 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.002 1.801 . . . . 0.0 112.049 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -43.31 152.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.644 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.583 ' O ' ' CD ' ' A' ' 123' ' ' PRO . . . 79.38 4.38 89.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 1.2 p -90.8 143.51 26.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -1.146 . . . . 0.0 109.694 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mp0 -121.71 125.62 47.03 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.674 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -116.92 115.12 24.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 0.0 110.114 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' ' HE1' ' A' ' 128' ' ' PHE . . . -88.4 -175.98 5.18 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.3 t -146.06 113.83 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 119.724 -1.86 . . . . 0.0 110.11 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 1.107 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.4 p90 -162.71 155.19 19.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.722 -1.236 . . . . 0.0 109.387 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.628 ' HA2' HG13 ' A' ' 117' ' ' VAL . . . -136.04 133.59 6.71 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.297 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.612 ' CG ' ' N ' ' A' ' 71' ' ' GLY . 8.0 ptm -85.05 -50.71 7.21 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -1.013 . . . . 0.0 108.537 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.612 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.58 -154.15 8.2 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.697 ' H ' ' CG ' ' A' ' 150' ' ' ASP . 40.9 t -35.49 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -1.062 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.84 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -58.84 25.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.97 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.745 ' NE1' ' CE1' ' A' ' 209' ' ' TYR . 9.6 t90 -77.9 -60.29 2.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.9 -1.125 . . . . 0.0 108.91 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.67 -3.91 43.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.78 69.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.004 -1.292 . . . . 0.0 109.475 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.664 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 6.7 tt0 -73.63 -13.74 61.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 80' ' ' PHE . 11.1 ttp85 -60.53 -71.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 110.288 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.676 ' O ' HG22 ' A' ' 82' ' ' VAL . 14.7 mtmt -36.32 -22.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.212 -0.93 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.943 ' CD2' HG21 ' A' ' 119' ' ' VAL . 84.3 m-85 -77.98 -41.81 34.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 0.0 110.803 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.855 ' CG ' HG21 ' A' ' 50' ' ' VAL . 1.2 p90 -76.83 8.59 3.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.55 -1.344 . . . . 0.0 109.518 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -102.13 19.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.0 109.851 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 126' ' ' ILE . 45.6 mt -110.97 154.22 24.44 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.029 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -92.67 132.28 37.04 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -27.36 13.46 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -67.18 136.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.378 -1.072 . . . . 0.0 109.309 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.683 ' CE2' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -76.96 -51.49 11.07 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.585 -0.697 . . . . 0.0 109.455 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.683 ' OG ' ' CE2' ' A' ' 87' ' ' TYR . 2.0 p -160.04 -160.49 0.8 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.183 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.941 ' HG1' ' CE1' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -164.11 155.48 16.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.664 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.46 171.69 10.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.989 -1.069 . . . . 0.0 109.737 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.84 HG11 ' HB2' ' A' ' 73' ' ' PHE . 1.8 m -142.98 166.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.955 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.91 173.76 45.15 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 200' ' ' TYR . 5.5 m-85 -80.73 163.27 23.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.271 -1.135 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.631 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.94 139.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.993 -1.067 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 94.66 23.92 19.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.698 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -108.15 178.92 21.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.429 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 1.6 m170 -120.59 58.63 0.93 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.286 -1.126 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.714 HG22 ' H ' ' A' ' 99' ' ' ARG . 2.3 m -157.51 -178.41 7.32 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.88 -1.137 . . . . 0.0 108.724 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.714 ' H ' HG22 ' A' ' 98' ' ' THR . 34.9 mtt180 -76.66 -89.36 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.934 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.43 96.52 40.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.965 -179.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 11.5 Cg_endo -79.93 159.97 24.18 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.257 . . . . 0.0 112.21 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.63 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 9.9 p -114.78 172.51 6.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.19 -0.944 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.603 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -63.88 -59.65 4.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -59.3 -22.95 61.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.094 . . . . 0.0 108.528 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.63 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 8.3 mm-40 -69.78 -56.67 6.52 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.533 0.683 . . . . 0.0 110.471 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 102' ' ' THR . 16.6 m -66.17 -24.74 34.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.498 -0.752 . . . . 0.0 111.368 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.631 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.8 p -57.36 -41.93 81.06 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 35.5 p -51.91 -66.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.3 mt-10 138.62 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -46.8 -27.44 1.22 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.415 -0.803 . . . . 0.0 111.767 -178.612 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 11.1 p -90.84 -32.6 16.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.564 -1.335 . . . . 0.0 109.941 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 65.76 44.32 92.47 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.698 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 1.2 m-70 -86.2 173.74 9.59 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.674 -1.486 . . . . 0.0 108.778 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -132.38 114.19 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.609 ' OE2' ' CE1' ' A' ' 73' ' ' PHE . 17.0 mt-10 -56.05 123.16 13.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.813 HG11 ' CE2' ' A' ' 160' ' ' TYR . 11.8 m -127.31 150.82 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.416 -0.802 . . . . 0.0 108.979 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.107 HG22 ' O ' ' A' ' 68' ' ' PHE . 3.6 m -111.31 135.31 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.783 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -98.52 98.51 9.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.532 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.943 HG21 ' CD2' ' A' ' 80' ' ' PHE . 49.0 t -103.38 120.75 53.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.449 -0.782 . . . . 0.0 109.222 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.508 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -118.07 144.2 26.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.699 ' CE2' HD11 ' A' ' 131' ' ' LEU . 8.8 p90 -141.39 174.31 10.67 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.087 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -116.03 117.93 38.8 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' HIS . 28.2 Cg_exo -42.09 -62.38 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.879 2.386 . . . . 0.0 113.318 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.759 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 27.3 mp0 -38.94 -14.34 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.153 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' PRO . 11.8 m-70 -133.38 -10.8 2.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.527 -1.358 . . . . 0.0 111.578 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.64 158.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 120.565 -1.335 . . . . 0.0 110.656 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.515 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 1.1 p -109.76 169.53 8.66 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.795 0.807 . . . . 0.0 111.375 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.57 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 41.2 t80 -69.32 -27.85 65.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 22.4 mt-10 -66.4 -8.74 27.67 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 127' ' ' SER . 7.2 mm-40 -72.36 -66.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.827 . . . . 0.0 110.797 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.901 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -57.29 -35.65 70.06 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.61 -1.306 . . . . 0.0 107.98 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 9.3 mp -74.73 -50.4 17.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 3.8 tttt -52.66 -41.37 63.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.865 -1.147 . . . . 0.0 110.272 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.638 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -72.15 -28.5 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.952 -1.093 . . . . 0.0 109.501 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.801 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.3 t80 -71.41 -50.8 28.36 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.732 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.52 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 76.9 m95 -72.03 -46.6 56.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.207 -1.558 . . . . 0.0 110.527 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.56 -42.78 55.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.14 -0.975 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.711 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 0.3 OUTLIER -119.43 74.3 0.99 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 110.433 -178.215 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.801 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 12.0 m80 -156.75 -179.92 8.66 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.149 0.976 . . . . 0.0 110.299 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.481 ' N ' ' HD3' ' A' ' 141' ' ' PRO . 1.0 OUTLIER -144.26 67.77 15.08 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 140' ' ' ASP . 16.4 Cg_exo -63.51 12.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.681 2.921 . . . . 0.0 113.998 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.607 HG22 HG22 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -121.95 29.15 7.21 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.046 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.667 ' CG ' ' O ' ' A' ' 143' ' ' GLN . 1.2 pt20 -155.61 77.69 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.841 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.699 ' N ' HG21 ' A' ' 190' ' ' THR . . . -70.38 14.71 1.25 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -108.27 1.46 21.99 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.146 -1.208 . . . . 0.0 108.223 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.461 ' CB ' ' HA ' ' A' ' 151' ' ' PHE . 11.5 ptt180 178.59 -174.18 0.17 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.718 0.771 . . . . 0.0 109.314 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.454 HE22 ' HA ' ' A' ' 139' ' ' HIS . 0.4 OUTLIER -175.1 118.93 0.18 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.721 0.772 . . . . 0.0 109.255 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.88 -120.38 10.53 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.448 ' ND2' ' HA3' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -80.94 -34.02 33.6 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.321 -0.939 . . . . 0.0 112.176 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.697 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 1.5 m-20 -82.48 144.21 30.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.398 -1.439 . . . . 0.0 109.23 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.461 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 38.5 p90 -136.36 144.57 44.66 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.05 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.66 -174.18 18.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.13 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.671 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -74.83 -19.72 60.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.695 -0.886 . . . . 0.0 110.367 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 155' ' ' TYR . 17.5 pm0 -86.52 7.51 25.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.156 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 154' ' ' GLN . 16.3 m-85 -139.65 50.84 1.75 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 0.0 109.59 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 153' ' ' THR . 38.4 mtm-85 -93.52 173.21 7.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.28 -0.888 . . . . 0.0 108.676 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.605 ' OG ' ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -94.28 109.26 21.09 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.271 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -133.33 119.28 19.53 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.396 -1.322 . . . . 0.0 109.947 -177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.693 HG23 ' CG2' ' A' ' 191' ' ' THR . 7.9 t -114.5 125.43 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.813 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -119.57 133.51 23.82 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.23 169.03 22.09 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.564 2.176 . . . . 0.0 111.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -19.69 20.17 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 120.729 -1.232 . . . . 0.0 109.146 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 p 177.44 -163.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.74 23.68 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.033 1.397 . . . . 0.0 108.471 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.4 t -56.15 -62.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.496 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 170' ' ' ALA . 12.7 mt-30 -77.81 -11.42 59.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 0.0 111.298 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.42 -45.57 62.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.569 -1.332 . . . . 0.0 109.248 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.71 -17.75 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.87 -55.88 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.0 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.34 -53.77 40.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 171' ' ' LEU . 70.0 mt -52.66 -39.1 61.5 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 108.906 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -58.26 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.429 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.52 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 4.0 p -56.67 -36.23 69.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.253 -0.904 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.471 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 4.2 ttpt -72.61 -46.41 54.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 109.383 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.423 ' N ' ' HE2' ' A' ' 174' ' ' LYS . 1.5 tt0 -71.63 -30.23 65.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 4.1 pt-20 -53.25 -34.02 55.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.526 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.618 ' CD2' HD11 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.28 -30.83 43.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.499 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.4 OUTLIER -66.61 -38.12 86.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 109.466 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -28.28 59.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.1 t -87.48 -54.22 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.618 HD11 ' CD2' ' A' ' 177' ' ' TYR . 3.7 mt -63.97 -45.26 89.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.027 -1.045 . . . . 0.0 109.92 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 87.8 p -54.97 -23.75 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -88.38 -3.56 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.46 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.7 m-70 -108.18 30.82 6.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 4.4 t-20 72.3 29.74 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 110.25 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -103.54 175.16 5.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.032 -1.042 . . . . 0.0 108.99 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.93 -152.05 8.45 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' A' ' 189' ' ' ILE . 28.0 Cg_exo -58.69 105.74 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.639 2.226 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.607 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.8 -178.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.265 -0.897 . . . . 0.0 110.01 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.699 HG21 ' N ' ' A' ' 144' ' ' GLY . 1.7 t -130.76 -2.04 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.777 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.693 ' CG2' HG23 ' A' ' 159' ' ' VAL . 3.9 m -42.07 113.43 0.44 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.657 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -80.79 114.53 19.74 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.341 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.21 111.93 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.672 ' NH2' ' OH ' ' A' ' 160' ' ' TYR . 55.6 mtm-85 -115.18 -173.23 2.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.02 164.12 33.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.42 23.36 1.98 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.754 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -83.68 173.23 11.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.62 -1.518 . . . . 0.0 108.919 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.743 ' CG1' ' CE2' ' A' ' 200' ' ' TYR . 1.0 OUTLIER -118.72 160.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.08 . . . . 0.0 110.379 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.511 ' CZ ' ' HG3' ' A' ' 118' ' ' ARG . 47.1 t80 -91.04 149.88 21.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 109.314 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.743 ' CE2' ' CG1' ' A' ' 198' ' ' VAL . 18.6 m-85 -143.83 100.43 3.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 109.8 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -58.54 146.49 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 109.225 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -90.07 -167.22 1.78 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.101 -0.999 . . . . 0.0 108.985 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.719 ' OE2' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -73.84 176.82 6.0 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 109.267 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.719 ' N ' ' OE2' ' A' ' 203' ' ' GLU . 0.3 OUTLIER -61.03 -61.02 2.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.711 ' CD1' ' OE2' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.43 8.62 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.774 -1.204 . . . . 0.0 111.039 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.603 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 6.5 m-70 -104.0 14.8 29.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.766 -1.209 . . . . 0.0 111.04 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.803 ' O ' ' N ' ' A' ' 209' ' ' TYR . 20.0 mm-40 -129.05 -168.35 1.91 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 110.495 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.824 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -38.64 1.15 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.803 ' N ' ' O ' ' A' ' 207' ' ' GLN . 21.1 p90 -38.35 -24.03 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 O-C-N 120.788 -1.195 . . . . 0.0 110.965 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.714 ' CB ' ' HE1' ' A' ' 74' ' ' TRP . 0.2 OUTLIER -79.38 -10.42 59.8 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.267 -1.521 . . . . 0.0 111.81 -176.056 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.442 ' OG ' ' CG ' ' A' ' 49' ' ' HIS . 83.3 p -54.06 -24.63 17.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.152 -0.968 . . . . 0.0 108.757 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.656 ' HD3' ' HE1' ' A' ' 49' ' ' HIS . 6.4 mmmt -68.39 -18.41 64.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.0 OUTLIER -140.23 73.05 32.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.71 4.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 123.037 2.491 . . . . 0.0 113.079 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.623 ' OD2' ' CE1' ' A' ' 217' ' ' TYR . 38.0 t0 -63.02 -19.5 64.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 110.053 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.56 85.25 0.04 OUTLIER Glycine 0 N--CA 1.504 3.214 0 C-N-CA 120.067 -1.064 . . . . 0.0 111.757 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.623 ' CE1' ' OD2' ' A' ' 215' ' ' ASP . 66.5 m-85 -91.81 81.13 5.21 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 121.002 2.401 . . . . 0.0 109.602 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.572 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.5 OUTLIER -170.83 112.12 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 109.447 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.572 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -37.87 161.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 218' ' ' CYS . 4.6 mp -143.54 -177.97 5.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.12 -1.224 . . . . 0.0 109.775 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 108.47 158.74 19.53 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -123.79 -167.31 12.74 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 222' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.914 0 CA-C-N 114.511 -0.844 . . . . 0.0 109.219 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 29' ' ' ILE . 36.0 t . . . . . 0 C--O 1.215 -0.742 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -40.08 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.984 1.373 . . . . 0.0 109.773 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.471 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -111.25 125.97 54.38 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HA ' ' ND1' ' A' ' 97' ' ' HIS . . . -46.47 -22.39 0.26 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.25 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 22.3 mp0 -83.97 -7.58 59.37 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.082 -1.011 . . . . 0.0 110.391 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.7 pt-20 -106.3 -14.6 15.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 109.578 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.833 ' HB2' ' NE2' ' A' ' 97' ' ' HIS . . . -45.48 -170.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.597 0.713 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.552 ' HB3' HD21 ' A' ' 100' ' ' ASN . 4.1 mm? . . . . . 0 C--N 1.307 -1.262 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.174 0.511 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.736 ' O ' HG13 ' A' ' 44' ' ' VAL . 72.0 Cg_endo -82.38 169.59 13.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.054 2.503 . . . . 0.0 112.334 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' ' 43' ' ' PRO . 5.1 m -162.34 -166.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 45' ' ' THR . 14.1 t -82.31 95.16 7.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.73 -27.59 59.51 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.26 -0.9 . . . . 0.0 111.424 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.587 ' O ' ' C ' ' A' ' 48' ' ' HIS . 4.5 ptpt -95.42 99.03 11.0 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.588 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' A' ' 52' ' ' GLY . 27.5 t60 -31.35 114.34 0.13 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -27.81 69.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.0 111.134 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.621 HG11 ' CD1' ' A' ' 81' ' ' TRP . 15.8 t -71.27 -38.98 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.326 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -109.94 -42.74 4.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 110.239 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.14 0.9 55.92 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 24.4 p30 -76.24 -117.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.589 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 41.8 mtm-85 -126.16 174.01 8.82 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.323 1.535 . . . . 0.0 110.121 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.642 ' C ' HG22 ' A' ' 56' ' ' VAL . 2.9 p -147.11 30.78 0.94 Allowed 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.293 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.642 HG22 ' C ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -171.34 134.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.064 -1.023 . . . . 0.0 109.484 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.595 ' OE1' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.28 144.96 0.1 Allowed Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.395 -0.816 . . . . 0.0 110.534 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 90.1 Cg_endo -77.17 166.66 81.71 Favored 'Cis proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.132 -2.028 . . . . 0.0 111.825 -0.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.786 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 92.8 m-85 -106.85 153.31 40.89 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.351 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.545 ' O ' ' OG1' ' A' ' 63' ' ' THR . 32.3 Cg_exo -50.3 161.03 1.25 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.318 2.012 . . . . 0.0 112.22 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.189 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.96 61.53 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -144.9 137.68 26.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -1.117 . . . . 0.0 109.413 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.637 ' CD ' ' H ' ' A' ' 65' ' ' MET . 13.3 tp60 -106.29 157.53 17.53 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 108.811 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.772 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -126.85 137.81 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.618 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -130.07 -171.03 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.53 HG21 ' NE2' ' A' ' 197' ' ' GLN . 96.5 t -144.49 150.11 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.156 -1.59 . . . . 0.0 110.093 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 67.1 m-85 -143.21 141.62 31.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.29 -0.881 . . . . 0.0 108.824 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.742 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -137.1 101.61 0.35 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.716 ' SD ' ' N ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -109.18 -89.73 0.47 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.46 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.649 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -141.09 -166.46 10.73 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.788 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 1.1 t -25.79 107.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.833 -0.804 . . . . 0.0 109.026 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.798 ' CZ ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.1 6.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 111.893 -177.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.788 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 32.0 m0 -71.66 -40.79 69.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.215 -1.553 . . . . 0.0 107.899 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.8 -23.34 30.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.71 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.0 -21.8 54.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 110.662 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.598 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -84.89 -41.91 15.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.64 -1.288 . . . . 0.0 111.486 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.699 ' O ' HG13 ' A' ' 82' ' ' VAL . 3.9 ttt180 -56.69 -57.84 10.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.758 -1.214 . . . . 0.0 111.309 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' O ' HG21 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -60.0 25.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.978 -1.076 . . . . 0.0 110.953 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 19.6 m-85 -128.26 -41.78 1.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.94 -1.1 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.621 ' CD1' HG11 ' A' ' 50' ' ' VAL . 1.2 p90 -91.63 -2.7 56.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.645 -1.284 . . . . 0.0 110.341 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 78' ' ' ARG . 3.4 m -83.87 13.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.085 -1.009 . . . . 0.0 109.14 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.404 HD13 ' OE1' ' A' ' 130' ' ' GLU . 43.3 mt -111.68 152.91 27.17 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.915 0.864 . . . . 0.0 109.408 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 136.41 34.17 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.41 -31.43 6.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -72.96 137.65 23.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.554 -0.968 . . . . 0.0 109.118 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.675 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -72.4 -42.42 65.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.576 ' OG ' ' CE1' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -177.67 -171.2 0.3 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.444 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.496 ' OG1' ' CD ' ' A' ' 77' ' ' GLU . 1.1 p -151.44 156.73 41.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.533 ' OE1' ' OG ' ' A' ' 88' ' ' SER . 1.1 mp0 -149.64 158.55 44.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.415 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.598 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.6 OUTLIER -135.85 150.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 108.829 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.23 174.35 42.44 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.646 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.3 m-85 -79.06 146.46 33.26 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.306 -1.114 . . . . 0.0 108.464 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.679 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -145.12 -175.55 4.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.288 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 49.76 21.62 3.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.555 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -91.0 178.31 42.03 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.833 ' NE2' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -137.47 5.28 2.69 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.285 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.699 HG22 ' OD1' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -160.08 147.38 16.36 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 119.918 -1.738 . . . . 0.0 110.899 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.534 ' CG ' ' OH ' ' A' ' 200' ' ' TYR . 4.3 mtp85 -72.3 61.51 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.699 ' OD1' HG22 ' A' ' 98' ' ' THR . 2.7 m120 -123.58 -136.2 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 100' ' ' ASN . 74.4 Cg_exo -40.42 169.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.137 0 CA-C-N 122.486 1.924 . . . . 0.0 114.562 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.967 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.9 p -123.72 -175.1 3.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.605 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.706 ' CD1' ' CE1' ' A' ' 206' ' ' HIS . 0.3 OUTLIER -47.59 -38.73 15.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 0.0 110.38 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -74.34 -49.46 22.78 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.932 -1.105 . . . . 0.0 111.636 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' C ' ' N ' ' A' ' 107' ' ' CYS . 9.5 mm-40 -84.28 -25.34 29.42 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.038 -1.039 . . . . 0.0 111.24 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 102' ' ' THR . 29.7 m -54.48 -21.52 6.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.494 ' C ' ' O ' ' A' ' 106' ' ' VAL . 1.2 p -37.32 -20.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.869 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 106' ' ' VAL . 79.3 p -75.49 3.36 9.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 108.859 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 106' ' ' VAL . 16.2 mt-10 55.39 3.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.65 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.55 ' O ' ' NE2' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -77.51 -19.69 55.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 110.829 -178.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.745 HG21 HG12 ' A' ' 106' ' ' VAL . 67.8 p -86.22 -6.27 59.02 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.679 -1.263 . . . . 0.0 110.393 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 51.16 16.8 2.18 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.489 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.679 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -73.86 161.55 30.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -1.173 . . . . 0.0 110.763 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -138.74 114.28 9.76 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.688 ' OE1' ' CE1' ' A' ' 155' ' ' TYR . 6.3 mp0 -55.17 130.87 43.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.742 HG12 ' CA ' ' A' ' 69' ' ' GLY . 10.5 m -142.19 -171.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.581 ' HA ' HG12 ' A' ' 91' ' ' VAL . 2.9 t -131.1 118.86 42.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.685 -0.634 . . . . 0.0 110.33 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.786 ' NH1' ' CZ ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.31 103.29 15.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 117' ' ' VAL . 2.1 t -120.69 142.86 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.743 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.682 HG12 ' NH2' ' A' ' 118' ' ' ARG . 1.8 m -107.95 163.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.651 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 3.6 m-85 -141.93 151.55 42.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.906 -1.122 . . . . 0.0 109.412 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -102.02 105.94 44.93 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.877 . . . . 0.0 109.923 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 52.5 Cg_exo -50.04 -23.93 10.03 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.595 2.196 . . . . 0.0 112.345 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -83.61 -21.54 32.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.922 . . . . 0.0 110.317 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -116.29 -12.17 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.781 HD13 ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.47 163.61 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 126' ' ' ILE . 32.8 t -110.6 170.84 7.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.626 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 7.9 t80 -69.54 -19.99 63.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -71.18 -17.45 62.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.581 -1.325 . . . . 0.0 108.171 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.781 ' HG2' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -76.39 -42.35 44.77 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.567 -0.708 . . . . 0.0 110.803 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.618 HD13 ' CB ' ' A' ' 66' ' ' ALA . 1.2 pp -65.53 -48.95 70.72 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.254 -1.529 . . . . 0.0 108.813 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.883 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.4 pp -71.39 -18.8 62.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.929 -1.107 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.736 ' N ' HD12 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.01 -42.62 66.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.735 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -67.04 -38.72 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.147 -0.971 . . . . 0.0 110.321 -178.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.792 ' CE1' ' CE1' ' A' ' 139' ' ' HIS . 5.3 t80 -61.62 -48.49 80.66 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.4 -0.813 . . . . 0.0 110.389 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.731 ' CG ' ' CZ ' ' A' ' 177' ' ' TYR . 90.3 m95 -70.47 -32.44 69.98 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 120.863 -1.148 . . . . 0.0 110.66 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.26 -43.62 41.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 112.562 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 2.2 m120 -111.48 65.05 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.588 -1.32 . . . . 0.0 112.581 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.792 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.1 OUTLIER 175.67 134.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.195 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.659 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -73.88 114.55 33.66 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.394 -0.816 . . . . 0.0 109.167 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 190' ' ' THR . 72.9 Cg_endo -81.43 -26.79 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.501 2.134 . . . . 0.0 113.053 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.694 HG22 HG22 ' A' ' 189' ' ' ILE . 0.7 OUTLIER -89.13 34.07 0.8 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.904 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.72 ' OE1' ' N ' ' A' ' 148' ' ' GLY . 29.7 mt-30 -129.84 90.79 3.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.081 -1.012 . . . . 0.0 110.808 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.678 ' H ' HG21 ' A' ' 190' ' ' THR . . . -63.57 -117.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 40.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.949 . . . . 0.0 109.846 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 144' ' ' GLY . 13.5 ttt-85 -163.58 84.66 0.48 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.288 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.581 ' OE1' ' OE1' ' A' ' 143' ' ' GLN . 6.2 tp-100 -76.53 63.64 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.481 -1.387 . . . . 0.0 109.866 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.72 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 91.6 -121.3 6.31 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.52 10.33 4.88 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.217 -0.992 . . . . 0.0 109.515 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.16 154.65 20.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 108.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -136.46 125.42 24.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.984 -1.072 . . . . 0.0 110.477 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 156.46 142.04 3.33 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.12 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 153' ' ' THR . 0.1 OUTLIER -72.62 5.0 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -1.102 . . . . 0.0 109.014 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.562 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -95.18 -1.47 51.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.199 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.688 ' CE1' ' OE1' ' A' ' 115' ' ' GLU . 38.8 m-85 -129.82 61.11 1.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.326 -0.859 . . . . 0.0 108.993 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.799 ' NH2' HH22 ' A' ' 194' ' ' ARG . 5.8 mtm180 -111.6 177.92 4.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 109.83 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -92.48 119.39 31.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 176.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.627 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -140.4 129.33 23.31 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 118.191 -1.403 . . . . 0.0 111.189 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.741 HG13 ' CG2' ' A' ' 191' ' ' THR . 3.1 m -107.4 127.85 62.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.706 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.627 ' CE1' ' HB1' ' A' ' 158' ' ' ALA . 10.9 m-85 -124.86 107.73 28.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.3 176.08 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.359 2.039 . . . . 0.0 112.802 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.2 -34.2 11.2 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.458 -0.776 . . . . 0.0 109.46 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 p -173.96 -163.21 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.165 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.99 -17.8 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.972 1.368 . . . . 0.0 108.764 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.21 -61.0 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.758 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 170' ' ' ALA . 1.3 tt0 -76.88 -25.75 53.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.69 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.4 ' SD ' ' CD1' ' A' ' 171' ' ' LEU . 1.7 mtt -52.3 -14.47 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.004 -1.06 . . . . 0.0 110.627 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -75.9 -45.55 34.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.754 -1.216 . . . . 0.0 109.638 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -93.03 -47.45 6.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.517 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 166' ' ' GLN . . . -52.71 -65.92 0.47 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.192 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.4 ' CD1' ' SD ' ' A' ' 167' ' ' MET . 0.6 OUTLIER -54.94 -47.59 74.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.521 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -61.25 -38.18 85.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.614 ' OG ' ' NE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -56.33 -32.6 64.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 109.281 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -72.6 -55.99 6.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 110.203 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -70.68 -47.64 58.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.463 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -53.11 -32.89 49.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.025 . . . . 0.0 109.824 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.731 ' CZ ' ' CG ' ' A' ' 136' ' ' TRP . 1.5 m-85 -74.08 -30.58 62.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.538 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.6 mm100 -52.92 -60.77 2.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.961 -1.087 . . . . 0.0 109.478 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -47.79 -22.31 0.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.959 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.25 -53.2 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 109.605 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.1 mt -74.68 -44.88 47.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.873 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.2 t -55.63 -30.85 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.018 -1.051 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -88.34 -3.33 58.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.305 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 2.0 m-70 -108.25 35.86 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 186' ' ' PHE . 28.7 t-20 68.23 66.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 185' ' ' ASN . 65.4 m-85 -158.13 168.57 26.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.054 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.2 -158.73 18.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -58.76 107.33 0.33 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.483 2.122 . . . . 0.0 111.193 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.694 HG22 HG22 ' A' ' 142' ' ' THR . 0.4 OUTLIER -46.9 169.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.444 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.678 HG21 ' H ' ' A' ' 144' ' ' GLY . 79.2 p -114.67 58.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.562 0.696 . . . . 0.0 109.446 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.741 ' CG2' HG13 ' A' ' 159' ' ' VAL . 39.8 m -94.45 116.65 29.04 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.628 ' CG ' HH22 ' A' ' 156' ' ' ARG . 32.9 t70 -93.98 138.18 32.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 121.582 0.706 . . . . 0.0 110.505 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.493 HD13 ' CG2' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -111.62 159.73 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.799 HH22 ' NH2' ' A' ' 156' ' ' ARG . 1.5 ttm180 -162.31 -167.65 1.66 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.887 -1.133 . . . . 0.0 110.465 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -103.11 140.37 37.41 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.841 ' O ' ' OE1' ' A' ' 197' ' ' GLN . . . 14.38 -81.21 0.0 OUTLIER Glycine 0 C--O 1.185 -2.964 0 N-CA-C 104.069 -3.613 . . . . 0.0 104.069 -177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.841 ' OE1' ' O ' ' A' ' 196' ' ' GLY . 0.3 OUTLIER 145.13 115.07 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.127 0.464 . . . . 0.0 111.616 172.606 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 198' ' ' VAL . 7.7 p -61.12 82.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 119.963 -1.711 . . . . 0.0 106.732 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.677 ' N ' ' O ' ' A' ' 197' ' ' GLN . 11.7 t80 -49.76 147.88 3.41 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.088 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.6 m-85 -151.05 97.31 2.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.492 ' CZ ' ' CG1' ' A' ' 56' ' ' VAL . 25.0 m-85 -53.78 147.84 11.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.994 -1.066 . . . . 0.0 110.76 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.543 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -99.31 177.72 5.11 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.535 ' OE2' ' CD2' ' A' ' 206' ' ' HIS . 1.3 pm0 -74.17 163.12 28.24 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.035 -1.041 . . . . 0.0 109.056 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.646 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -49.56 -51.87 33.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.912 -1.118 . . . . 0.0 108.522 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -46.85 -15.97 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.757 . . . . 0.0 110.189 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.798 ' ND1' ' CZ ' ' A' ' 73' ' ' PHE . 4.7 m-70 -100.75 13.49 34.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 110.684 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.847 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.6 mm-40 -131.87 -138.98 0.2 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.478 1.132 . . . . 0.0 109.989 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.68 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -32.86 -3.65 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.858 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.847 ' N ' ' O ' ' A' ' 207' ' ' GLN . 9.4 t80 -41.7 -43.27 2.81 Favored 'General case' 0 N--CA 1.511 2.624 0 O-C-N 120.171 -1.581 . . . . 0.0 108.699 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.678 HD22 ' HA2' ' A' ' 216' ' ' GLY . 0.2 OUTLIER -53.29 -25.18 13.71 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.627 -1.296 . . . . 0.0 109.538 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 208' ' ' GLN . 29.0 t -55.71 -51.1 68.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.909 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -67.46 -33.45 75.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.197 -0.939 . . . . 0.0 108.506 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 215' ' ' ASP . 68.8 m-20 -136.47 76.03 50.06 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.631 ' N ' ' O ' ' A' ' 210' ' ' LEU . 76.8 Cg_exo -45.35 -0.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.942 2.428 . . . . 0.0 112.532 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 213' ' ' ASN . 4.9 t70 -63.95 -16.1 60.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.046 -1.034 . . . . 0.0 110.025 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.678 ' HA2' HD22 ' A' ' 210' ' ' LEU . . . 62.56 -66.68 0.02 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 215' ' ' ASP . 24.8 t80 -159.91 -150.68 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -1.013 . . . . 0.0 109.237 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 8.6 t -79.87 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.105 -0.997 . . . . 0.0 109.685 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 220' ' ' LEU . . . -90.03 -144.05 11.12 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 1.4 tp 76.75 139.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.793 -0.828 . . . . 0.0 109.755 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.31 115.64 0.34 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 148.66 141.64 3.5 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 136' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.285 . . . . 0.0 109.819 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.936 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.205 -1.25 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.936 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 15.4 -179.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-O 123.375 1.559 . . . . 0.0 113.565 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.21 119.89 15.08 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.721 -1.237 . . . . 0.0 110.685 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' A' ' 33' ' ' GLU . . . -59.31 -46.15 89.35 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.596 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.694 ' OE2' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -53.33 -12.73 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 108.994 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.694 ' N ' ' OE2' ' A' ' 32' ' ' GLU . 3.3 tt0 -113.72 -48.42 2.93 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -47.72 163.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.228 -0.92 . . . . 0.0 108.814 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.895 HD22 ' O ' ' A' ' 110' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.585 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.639 HG23 ' OD1' ' A' ' 100' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.39 175.28 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.661 2.241 . . . . 0.0 112.569 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 11.4 m -143.22 -166.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.958 . . . . 0.0 109.677 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -49.21 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.09 -65.05 0.67 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 111.184 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.97 99.67 1.83 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.622 -2.431 . . . . 0.0 108.48 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.685 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.55 122.32 0.34 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.7 -31.58 71.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.381 -0.824 . . . . 0.0 110.716 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.696 HG22 ' OG ' ' A' ' 211' ' ' SER . 47.1 t -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.925 -1.11 . . . . 0.0 109.637 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.41 -45.1 4.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.19 4.55 55.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.602 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.2 p30 -82.03 -121.57 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.602 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 mtm-85 -123.19 167.37 13.79 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.371 1.082 . . . . 0.0 108.572 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.6 p -124.09 -17.41 6.22 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.255 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 m -151.76 -167.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.574 -1.328 . . . . 0.0 109.521 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.557 ' N ' HG23 ' A' ' 56' ' ' VAL . 4.6 mt-10 -32.36 120.23 0.41 Allowed Pre-proline 0 C--N 1.295 -1.782 0 O-C-N 121.91 -0.494 . . . . 0.0 110.176 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' VAL . 98.3 Cg_endo -75.57 172.28 63.85 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.87 0.032 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -116.91 129.78 25.06 Favored Pre-proline 0 C--N 1.28 -2.419 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' O ' ' OG1' ' A' ' 63' ' ' THR . 37.5 Cg_exo -49.67 140.27 29.55 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.057 1.838 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.86 155.86 27.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.34 -9.73 25.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -95.66 135.88 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -1.199 . . . . 0.0 109.91 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -108.61 167.12 10.28 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.729 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -149.35 156.42 42.04 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.386 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.67 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -141.22 -174.65 4.07 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 118' ' ' ARG . 2.5 t -144.58 127.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 119.803 -1.811 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.667 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.6 OUTLIER -156.72 153.85 29.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.701 -1.25 . . . . 0.0 109.853 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.612 ' N ' HG12 ' A' ' 116' ' ' VAL . . . -161.36 -170.08 25.53 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.333 -1.413 . . . . 0.0 112.993 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.776 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -133.65 -93.04 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.906 0.86 . . . . 0.0 110.264 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.702 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -132.46 65.37 0.59 Allowed Glycine 0 N--CA 1.498 2.811 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.702 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.5 t 120.75 170.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 124.16 0.984 . . . . 0.0 109.499 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.562 ' N ' ' SG ' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -120.58 30.13 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.242 -0.911 . . . . 0.0 111.341 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.51 ' C ' HD11 ' A' ' 210' ' ' LEU . 7.2 m0 -88.79 -87.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.404 -1.435 . . . . 0.0 109.005 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -7.37 29.96 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -76.13 -47.54 23.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -1.169 . . . . 0.0 110.28 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.571 ' CD ' ' O ' ' A' ' 77' ' ' GLU . 7.2 tp10 -78.67 -27.8 45.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 82' ' ' VAL . 31.4 ttt-85 -56.23 -34.55 66.44 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.942 -1.098 . . . . 0.0 109.925 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -75.7 17.82 0.28 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 110.294 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 81.3 m-85 -126.35 -41.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.847 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.57 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -74.36 8.77 2.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 109.793 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.0 m -109.54 15.8 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 109.365 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.72 156.83 24.08 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.808 0.813 . . . . 0.0 109.018 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -89.98 140.11 29.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.337 0.589 . . . . 0.0 109.61 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.46 -29.36 8.32 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 120' ' ' VAL . 1.2 t -77.43 123.51 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.401 -1.058 . . . . 0.0 109.301 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.598 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.327 -0.858 . . . . 0.0 108.988 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 89' ' ' THR . 6.4 p -158.43 -162.14 1.08 Allowed 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.596 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.685 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.7 p -160.99 128.36 4.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 108.817 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.598 ' OE1' ' O ' ' A' ' 89' ' ' THR . 4.1 mp0 -130.95 145.78 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.415 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 117' ' ' VAL . 1.1 m -126.76 156.56 37.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -172.09 -128.96 1.09 Allowed Glycine 0 C--N 1.293 -1.831 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.28 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE1' HG21 ' A' ' 106' ' ' VAL . 83.1 m-85 -143.24 160.64 40.09 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.876 -0.779 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -168.71 148.41 4.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.365 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 87.37 30.8 18.25 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.643 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -142.97 173.28 24.17 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 22.8 p80 -135.88 85.34 2.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -1.204 . . . . 0.0 110.22 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 35' ' ' LEU . 96.4 m -150.02 163.48 38.03 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.057 -1.027 . . . . 0.0 108.393 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.548 ' N ' HG22 ' A' ' 98' ' ' THR . 0.1 OUTLIER -65.18 -76.8 0.07 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.718 0.771 . . . . 0.0 111.423 -177.604 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.639 ' OD1' HG23 ' A' ' 42' ' ' ILE . 6.3 m-80 -121.46 83.17 40.43 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-O 121.504 0.668 . . . . 0.0 110.09 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.46 ' HA ' ' CD ' ' A' ' 105' ' ' GLU . 23.1 Cg_exo -63.15 117.24 4.17 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 123.34 2.693 . . . . 0.0 113.023 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.593 ' H ' ' HG2' ' A' ' 105' ' ' GLU . 4.1 p -109.16 149.77 28.87 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 120.569 -1.332 . . . . 0.0 107.617 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.687 ' CZ ' ' OH ' ' A' ' 155' ' ' TYR . 2.8 t80 -47.68 -34.37 8.06 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.398 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -73.28 -26.49 61.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 110.443 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.643 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -83.53 -57.33 3.28 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 120.565 -1.334 . . . . 0.0 110.142 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.643 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 11.5 m -61.93 -20.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.471 -0.768 . . . . 0.0 111.843 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.565 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.3 p -33.85 -37.84 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.438 -0.789 . . . . 0.0 109.66 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 106' ' ' VAL . 27.0 t -103.97 -115.53 0.22 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.653 -1.28 . . . . 0.0 109.791 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.458 ' N ' ' OG ' ' A' ' 108' ' ' SER . 1.5 mp0 -120.4 9.86 11.06 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.347 0.594 . . . . 0.0 110.236 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.895 ' O ' HD22 ' A' ' 35' ' ' LEU . 5.4 mttt -43.0 -50.96 5.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -122.51 14.13 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.747 -1.221 . . . . 0.0 110.512 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.544 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 37.2 35.02 0.14 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.643 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.09 168.93 19.1 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.038 -1.272 . . . . 0.0 109.801 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -119.12 114.11 21.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 72' ' ' CYS . 1.9 pp20? -72.86 130.05 39.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.269 -0.895 . . . . 0.0 109.906 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -153.41 -179.39 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.146 -0.971 . . . . 0.0 110.507 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.658 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.3 m -115.94 117.8 56.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.808 0.813 . . . . 0.0 110.2 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.896 HH22 ' N ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -98.24 101.68 13.21 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.664 ' C ' HH22 ' A' ' 118' ' ' ARG . 31.0 m -126.63 123.65 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.896 ' N ' HH22 ' A' ' 118' ' ' ARG . 0.7 OUTLIER -78.27 171.57 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.894 ' CD2' HD21 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -158.08 155.58 29.49 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.356 -1.338 . . . . 0.0 110.957 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -103.4 102.63 30.54 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.822 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' O ' ' A' ' 126' ' ' ILE . 31.7 Cg_exo -43.7 -64.24 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.968 2.445 . . . . 0.0 112.754 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -44.43 -29.96 0.78 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.811 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -92.92 -46.32 7.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 109.769 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 130' ' ' GLU . 2.6 tt -126.07 166.99 21.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.048 -1.032 . . . . 0.0 108.255 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.53 ' N ' ' CG1' ' A' ' 126' ' ' ILE . 6.1 m -99.96 159.33 15.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.66 -1.275 . . . . 0.0 110.721 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 1.077 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 17.4 t80 -66.43 -27.46 67.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.585 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -69.67 -16.74 63.41 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' A' ' 126' ' ' ILE . 2.8 mt-10 -73.57 -72.33 0.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 108.992 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.99 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -39.2 -35.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 178.504 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 1.077 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 44.4 mt -76.28 -44.75 35.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' GLU . 2.6 mttm -52.28 -53.56 42.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.94 -1.1 . . . . 0.0 110.117 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.751 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 41.3 t -57.85 -30.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.797 -1.19 . . . . 0.0 108.45 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.709 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 3.0 t80 -73.1 -56.74 4.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.143 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 37.7 m95 -71.57 -54.08 11.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.384 -1.448 . . . . 0.0 110.021 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 20.8 tt0 -37.08 -56.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.751 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -103.25 63.8 0.82 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.061 -1.025 . . . . 0.0 109.949 -178.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.776 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 22.5 m80 -158.28 177.21 11.53 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.286 1.041 . . . . 0.0 110.072 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' THR . 1.6 t0 -145.22 80.23 11.18 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 190' ' ' THR . 13.0 Cg_exo -48.09 13.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.545 2.163 . . . . 0.0 113.592 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . 1.049 HG22 HG22 ' A' ' 189' ' ' ILE . 0.4 OUTLIER -122.15 43.29 2.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.808 -1.182 . . . . 0.0 110.318 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.587 ' O ' ' O ' ' A' ' 144' ' ' GLY . 5.3 mt-30 -130.72 78.61 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 109.325 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.43 -116.26 0.0 OUTLIER Glycine 0 N--CA 1.493 2.473 0 CA-C-O 121.905 0.725 . . . . 0.0 112.513 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.97 42.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.795 -0.827 . . . . 0.0 110.353 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -170.9 139.62 1.48 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.24 177.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.615 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -146.93 91.46 2.01 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.128 -1.607 . . . . 0.0 108.424 176.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.46 -129.47 9.83 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -94.69 12.9 26.14 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.652 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.675 ' OD1' ' CE2' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -109.05 112.91 25.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.649 -1.282 . . . . 0.0 109.488 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.483 ' CE2' ' HG3' ' A' ' 146' ' ' ARG . 6.2 m-85 -104.22 113.48 27.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.53 149.42 7.87 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.43 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.598 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -48.87 -45.98 41.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.51 -0.994 . . . . 0.0 109.393 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.814 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 2.1 pm0 -75.38 1.53 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 111.177 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.814 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 21.1 m-85 -102.99 41.58 1.24 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.443 -1.411 . . . . 0.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.618 ' O ' ' O ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -103.45 174.91 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 108.969 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.4 129.37 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -143.74 117.82 9.48 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 115.94 -2.304 . . . . 0.0 112.444 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' ASP . 16.1 t -111.98 133.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.214 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.507 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 53.7 m-85 -130.5 94.41 29.68 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.0 109.192 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.9 170.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.773 2.315 . . . . 0.0 112.063 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.458 HG22 ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -98.0 -21.13 16.99 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 120.941 -1.099 . . . . 0.0 109.633 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 165' ' ' VAL . 4.1 p 173.54 -178.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.086 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.07 -15.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.009 1.385 . . . . 0.0 108.6 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.6 t -55.69 -64.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.672 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.67 HE22 ' HB2' ' A' ' 66' ' ' ALA . 17.1 mt-30 -79.54 -19.32 49.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.682 -0.636 . . . . 0.0 110.932 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.4 ' HG2' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -52.15 -31.23 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.869 -1.145 . . . . 0.0 110.632 -178.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.06 65.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.681 -1.262 . . . . 0.0 109.979 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.433 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.92 -42.94 9.2 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.136 -0.977 . . . . 0.0 110.409 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.11 -57.79 8.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.855 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.4 HD13 ' HG2' ' A' ' 167' ' ' MET . 1.2 mp -52.63 -35.76 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.026 -1.046 . . . . 0.0 109.048 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 -74.51 -45.38 46.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.526 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -56.21 -31.15 63.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -72.17 -52.15 17.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.824 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -73.0 -26.1 61.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 110.317 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 6.2 pt-20 -52.97 -34.53 56.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.687 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -79.65 -28.94 40.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.077 -1.014 . . . . 0.0 109.454 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.704 ' OE1' HG23 ' A' ' 189' ' ' ILE . 15.5 tp60 -74.91 -7.66 54.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -75.49 -41.93 54.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 0.0 108.907 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.454 HG13 ' HE2' ' A' ' 183' ' ' LYS . 73.6 t -88.52 -43.66 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.315 -0.865 . . . . 0.0 109.859 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 186' ' ' PHE . 38.2 mt -56.55 -49.17 75.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.058 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.1 t -55.24 -30.33 59.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.35 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.454 ' HE2' HG13 ' A' ' 180' ' ' VAL . 13.9 pttt -88.26 -6.76 57.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.229 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.417 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.9 m170 -108.43 29.32 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.77 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 27.9 t-20 69.67 68.93 0.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 181' ' ' LEU . 23.4 m-85 -137.14 169.99 16.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.935 . . . . 0.0 109.0 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -119.82 -159.8 11.04 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -58.62 105.77 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.204 1.936 . . . . 0.0 110.774 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 1.049 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -51.19 174.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.175 -0.953 . . . . 0.0 110.048 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 141' ' ' PRO . 4.8 p -137.32 67.73 1.43 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.232 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.9 m -100.6 125.2 46.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.692 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -76.32 113.77 14.26 Favored 'General case' 0 C--N 1.278 -2.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.205 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.47 108.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.87 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.692 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.4 OUTLIER -147.4 153.36 39.52 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -104.16 164.9 11.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.01 39.07 94.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.539 ' O ' ' C ' ' A' ' 198' ' ' VAL . 55.6 mm-40 -96.41 90.99 5.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.68 -1.482 . . . . 0.0 108.974 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.539 ' C ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -32.11 150.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.554 -0.716 . . . . 0.0 109.97 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.491 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 38.3 t80 -96.11 140.02 31.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.458 -0.776 . . . . 0.0 109.325 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 93' ' ' PHE . 7.0 m-85 -130.86 94.81 3.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.351 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -54.12 136.44 42.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 110.428 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.602 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -84.46 -174.94 5.55 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.13 161.12 30.98 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 122.264 1.03 . . . . 0.0 110.059 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -43.31 74.27 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.459 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -60.82 -7.85 2.64 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.425 -0.797 . . . . 0.0 110.119 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.622 ' CE1' ' CB ' ' A' ' 103' ' ' TYR . 50.4 m-70 -104.4 4.01 32.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.985 -1.072 . . . . 0.0 110.65 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.849 ' O ' ' N ' ' A' ' 209' ' ' TYR . 16.7 mm-40 -109.89 -143.83 0.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.144 0.973 . . . . 0.0 110.19 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.677 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -35.49 -4.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.845 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.849 ' N ' ' O ' ' A' ' 207' ' ' GLN . 59.4 t80 -39.75 -42.14 1.21 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 120.757 -1.214 . . . . 0.0 111.015 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 216' ' ' GLY . 6.6 mt -71.08 -20.75 62.32 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.68 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.696 ' OG ' HG22 ' A' ' 50' ' ' VAL . 8.1 t -73.25 -49.07 29.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 0.0 108.946 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.1 0.92 56.31 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.264 -0.897 . . . . 0.0 110.264 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.634 ' OD1' ' CD2' ' A' ' 209' ' ' TYR . 20.8 m120 -132.65 133.42 23.46 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 109.686 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.1 2.1 5.26 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.698 2.266 . . . . 0.0 113.663 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 217' ' ' TYR . 2.9 t0 -62.74 -17.43 60.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.23 . . . . 0.0 109.864 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.673 ' O ' HD13 ' A' ' 210' ' ' LEU . . . 63.88 -62.75 0.05 OUTLIER Glycine 0 C--N 1.296 -1.684 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 215' ' ' ASP . 2.8 p90 171.31 -156.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 109.569 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 3.6 t -159.94 79.51 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.006 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 161.24 174.28 30.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.41 -165.16 1.29 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.234 -1.157 . . . . 0.0 109.858 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.04 -107.87 2.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -128.06 -168.44 12.45 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.27 -2.89 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.603 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.72 ' O ' ' O ' ' A' ' 29' ' ' ILE . 44.6 t . . . . . 0 C--O 1.214 -0.805 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.72 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -33.95 177.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 123.225 1.488 . . . . 0.0 110.852 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -103.92 121.3 42.82 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.952 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -49.35 -15.59 0.14 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 30' ' ' SER . 11.4 mm-40 -62.17 -62.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.855 . . . . 0.0 109.793 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' ' C ' ' A' ' 34' ' ' ALA . 28.5 tt0 -75.19 -28.39 60.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.707 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -30.97 152.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.781 . . . . 0.0 110.203 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 98' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.26 175.51 11.24 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.608 2.205 . . . . 0.0 112.318 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -147.43 -167.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 45' ' ' THR . 15.1 t -49.21 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.616 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.39 -50.32 71.94 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.173 -0.954 . . . . 0.0 111.068 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 48' ' ' HIS . 27.7 mttm -84.34 99.17 10.45 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.614 -2.434 . . . . 0.0 108.419 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.6 t-80 -32.11 117.88 0.23 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.59 -32.46 74.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.318 -0.864 . . . . 0.0 110.665 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 211' ' ' SER . 25.9 t -63.43 -44.1 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 109.379 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -106.37 -45.09 4.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.39 4.53 54.96 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.687 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 27.3 p30 -82.04 -112.71 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.673 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.4 mtt180 -130.09 174.36 9.87 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.653 1.692 . . . . 0.0 110.423 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.8 p -137.95 8.35 2.75 Favored 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.892 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 57' ' ' GLU . 10.9 m -144.98 132.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.687 -1.258 . . . . 0.0 109.519 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.691 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.4 pm0 -32.86 151.81 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 CA-C-O 121.809 0.814 . . . . 0.0 110.849 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.4 Cg_endo -78.88 166.28 79.76 Favored 'Cis proline' 0 C--N 1.303 -1.844 0 C-N-CA 121.808 -2.163 . . . . 0.0 111.716 -0.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CE1' HG11 ' A' ' 120' ' ' VAL . 31.8 m-85 -110.26 154.56 42.82 Favored Pre-proline 0 C--N 1.269 -2.907 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.118 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 63' ' ' THR . 44.1 Cg_exo -50.15 132.5 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.3 2.0 . . . . 0.0 112.1 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -48.65 146.69 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.84 46.52 23.17 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -128.93 137.54 51.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -1.121 . . . . 0.0 109.674 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.87 149.51 25.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.702 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -138.86 113.11 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.446 ' HB1' HE22 ' A' ' 166' ' ' GLN . . . -112.09 -167.69 1.22 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG11 ' HD2' ' A' ' 160' ' ' TYR . 7.2 t -141.96 132.06 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.07 -1.644 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 131' ' ' LEU . 91.3 m-85 -123.04 156.16 35.42 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.193 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.674 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -140.44 114.71 0.98 Allowed Glycine 0 C--O 1.207 -1.571 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CD1' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -125.31 -82.47 0.63 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.485 -1.009 . . . . 0.0 109.31 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.624 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -153.27 -163.55 11.84 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.693 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -29.67 104.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.903 . . . . 0.0 108.582 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.786 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -49.44 6.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.787 . . . . 0.0 111.4 -178.189 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.693 ' N ' ' O ' ' A' ' 72' ' ' CYS . 14.5 m0 -72.04 -47.58 50.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.614 -1.304 . . . . 0.0 108.799 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.58 -22.93 27.53 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.721 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.35 -26.87 56.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.618 ' OE2' HG13 ' A' ' 91' ' ' VAL . 8.9 tp10 -84.59 -36.66 21.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.693 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.799 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.7 ttt85 -59.28 -59.17 5.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.606 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.608 ' O ' HG21 ' A' ' 134' ' ' VAL . 18.0 mmtm -56.43 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.944 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.721 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.0 m-85 -120.88 -40.93 2.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.824 -1.173 . . . . 0.0 110.315 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.577 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -87.96 3.74 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.84 -1.163 . . . . 0.0 109.981 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.5 m -94.62 13.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.514 HD11 HG21 ' A' ' 134' ' ' VAL . 75.7 mt -106.56 152.76 23.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.96 0.886 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.527 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 8.8 pttm -88.96 145.79 25.3 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.15 -25.37 28.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.593 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -73.29 137.78 22.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.97 . . . . 0.0 108.807 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.687 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -81.41 -41.06 22.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 108.744 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.534 ' HB3' HD21 ' A' ' 53' ' ' ASN . 1.1 p -173.51 -163.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 88' ' ' SER . 60.3 p -158.82 170.78 21.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.581 ' O ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.96 176.49 6.15 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -152.35 162.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.821 -1.174 . . . . 0.0 109.853 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.15 171.22 44.08 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 200' ' ' TYR . 4.1 m-85 -87.55 155.84 19.79 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.473 -1.016 . . . . 0.0 109.499 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -178.96 155.47 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.391 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.8 22.26 14.16 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -154.49 -151.62 5.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.519 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 47.9 p-80 -178.37 107.09 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.691 ' O ' ' O ' ' A' ' 99' ' ' ARG . 1.1 m -152.26 156.04 38.9 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.71 ' O ' ' N ' ' A' ' 101' ' ' PRO . 7.8 ttp180 -40.27 169.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.628 ' C ' ' O ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -30.71 89.96 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.71 ' N ' ' O ' ' A' ' 99' ' ' ARG . 1.3 Cg_endo -77.15 141.78 21.07 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.052 2.501 . . . . 0.0 112.963 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.549 ' O ' HG22 ' A' ' 106' ' ' VAL . 24.6 p -124.06 170.69 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.116 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.783 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 1.2 t80 -56.92 -43.36 81.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.798 . . . . 0.0 109.325 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -73.35 -27.54 61.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.356 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.4 mm-40 -80.88 -41.37 23.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.777 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 102' ' ' THR . 5.4 m -55.73 -23.99 15.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 120.421 -1.425 . . . . 0.0 108.634 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.667 ' O ' ' N ' ' A' ' 109' ' ' GLU . 23.2 m -59.27 -36.3 75.29 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 110' ' ' LYS . 9.1 m -46.95 -9.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.8 mt-10 65.3 -12.25 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.679 -0.638 . . . . 0.0 109.944 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 108' ' ' SER . 23.8 mttp -77.56 -15.05 59.49 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.063 -1.023 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' GLY . 4.7 p -91.19 -6.61 53.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 109.665 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 36.28 37.28 0.18 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.102 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.58 ' HE2' ' HG2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -82.04 158.13 23.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.596 -1.532 . . . . 0.0 109.974 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -120.83 112.67 19.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.448 -0.783 . . . . 0.0 109.118 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.682 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 74.4 mt-10 -61.54 117.44 5.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.674 HG12 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -125.29 -176.11 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 91' ' ' VAL . 6.7 t -132.68 120.74 42.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.734 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.609 ' HD2' ' CZ ' ' A' ' 199' ' ' PHE . 9.9 ptm180 -97.81 120.95 39.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 119' ' ' VAL . 2.6 m -133.87 129.91 55.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 O-C-N 120.72 -1.237 . . . . 0.0 109.645 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.552 HG11 ' CE1' ' A' ' 59' ' ' PHE . 0.8 OUTLIER -92.32 145.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.717 ' CD2' HD11 ' A' ' 131' ' ' LEU . 4.1 m-85 -129.21 161.16 30.79 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.182 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -121.62 105.19 38.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.591 -0.693 . . . . 0.0 110.382 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 18.7 Cg_exo -43.64 -61.2 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.538 2.825 . . . . 0.0 114.229 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.2 tt0 -26.9 -52.69 0.06 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.361 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 21.05 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 0.0 109.756 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -157.6 162.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.28 -0.888 . . . . 0.0 109.618 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.57 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -128.72 148.3 50.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.894 -1.129 . . . . 0.0 109.653 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.765 ' CE2' HD11 ' A' ' 132' ' ' LEU . 72.8 t80 -54.43 -38.86 66.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.222 -0.924 . . . . 0.0 109.613 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -51.08 -14.36 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.07 -1.019 . . . . 0.0 108.84 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.57 ' HG3' ' H ' ' A' ' 127' ' ' SER . 6.5 mm-40 -73.77 -62.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.882 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.048 HD12 ' H ' ' A' ' 131' ' ' LEU . 2.9 mp -51.69 -34.12 37.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.976 -1.077 . . . . 0.0 108.184 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.765 HD11 ' CE2' ' A' ' 128' ' ' PHE . 39.0 mt -68.67 -50.16 53.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 110.255 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.21 -30.01 70.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.084 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 79' ' ' LYS . 1.2 t -74.04 -40.06 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.884 -1.135 . . . . 0.0 109.633 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.683 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 24.3 t80 -69.26 -43.41 74.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.63 -0.669 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.649 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 82.3 m95 -71.73 -39.69 69.93 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.699 -1.251 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.85 -37.12 59.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 112.88 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 25.3 m-80 -97.78 36.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.639 -1.288 . . . . 0.0 113.27 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.683 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER 177.97 130.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.56 -1.338 . . . . 0.0 110.733 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.606 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -61.54 112.04 5.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.428 ' HB2' HD12 ' A' ' 189' ' ' ILE . 45.6 Cg_endo -74.68 -11.01 22.05 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.161 1.907 . . . . 0.0 112.569 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.494 HG22 HD13 ' A' ' 189' ' ' ILE . 71.4 p -101.2 46.62 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.021 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.622 ' O ' ' O ' ' A' ' 144' ' ' GLY . 2.6 pt20 -114.08 107.29 15.45 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.81 0.814 . . . . 0.0 110.552 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.668 ' HA2' HG21 ' A' ' 190' ' ' THR . . . -39.06 -118.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.578 0 CA-C-O 121.482 0.49 . . . . 0.0 112.157 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.578 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -99.48 44.62 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.258 . . . . 0.0 111.822 -177.135 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.438 ' HB3' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -174.29 159.61 3.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.701 -1.25 . . . . 0.0 109.329 178.421 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.596 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -122.85 145.14 48.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.428 -1.42 . . . . 0.0 110.536 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.543 ' CA ' HD22 ' A' ' 220' ' ' LEU . . . 65.85 -124.19 25.73 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -111.7 26.7 10.37 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.76 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -107.88 167.13 10.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.124 . . . . 0.0 108.42 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 151' ' ' PHE . 33.5 m-85 -132.35 111.54 11.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.824 -1.173 . . . . 0.0 109.912 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 172.38 143.61 4.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 153' ' ' THR . 0.1 OUTLIER -74.55 6.2 4.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -1.219 . . . . 0.0 109.147 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.606 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -88.87 -1.22 57.98 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.606 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 29.7 m-85 -136.75 62.55 1.6 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.763 HH22 ' CB ' ' A' ' 192' ' ' ASP . 10.4 mtm105 -107.96 174.74 5.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.599 ' OG ' ' NE2' ' A' ' 139' ' ' HIS . 6.2 t -93.2 107.26 19.1 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.464 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -138.42 123.08 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 118.182 -1.407 . . . . 0.0 111.473 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.693 HG23 ' CG2' ' A' ' 191' ' ' THR . 11.2 t -112.04 127.66 69.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.249 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.494 ' CG ' ' HG3' ' A' ' 197' ' ' GLN . 7.6 m-85 -119.81 89.24 41.47 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.78 174.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.237 2.625 . . . . 0.0 112.608 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -96.24 -33.85 11.85 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.559 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 12.3 t -176.64 -162.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.374 -0.828 . . . . 0.0 109.054 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.559 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -56.93 -15.46 4.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.988 1.375 . . . . 0.0 108.614 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.559 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 3.7 t -55.82 -64.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.749 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 11.6 mt-30 -79.32 -17.76 53.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.618 -0.676 . . . . 0.0 111.061 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' HD23 ' A' ' 171' ' ' LEU . 3.1 ttm -52.36 -38.05 57.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.761 -1.212 . . . . 0.0 110.218 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.37 -23.49 57.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.862 -1.149 . . . . 0.0 109.688 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.667 ' N ' ' OE2' ' A' ' 168' ' ' GLU . . . -92.88 -42.17 9.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.46 -55.17 23.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.677 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 172' ' ' ARG . 2.5 pp -52.65 -35.55 55.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.055 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.577 ' O ' ' OE2' ' A' ' 176' ' ' GLU . 4.2 mtm180 -74.82 -46.45 36.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.886 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.649 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 70.2 m -56.54 -41.33 76.6 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.446 -0.784 . . . . 0.0 109.546 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.476 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 25.1 ttpp -72.4 -49.99 29.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.63 -25.52 68.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' O ' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -64.74 -53.36 48.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.497 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -78.9 -21.4 47.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.737 -179.669 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.628 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 38.8 tp60 -62.14 -41.0 97.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 0.0 109.656 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -16.0 58.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.939 . . . . 0.0 109.619 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 176' ' ' GLU . 49.7 t -81.55 -54.71 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -75.72 -30.96 59.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 14.5 t -56.89 -38.0 72.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.599 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -79.35 0.77 27.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -108.15 23.81 13.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 70.15 62.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -134.74 168.07 19.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -94.84 -150.58 27.28 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.04 136.72 11.84 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.755 2.303 . . . . 0.0 112.099 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.673 HG22 ' H ' ' A' ' 191' ' ' THR . 2.6 mm -59.14 123.16 10.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.668 HG21 ' HA2' ' A' ' 144' ' ' GLY . 53.2 p -79.41 5.1 13.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.995 . . . . 0.0 110.744 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.693 ' CG2' HG23 ' A' ' 159' ' ' VAL . 31.3 m -43.81 110.94 0.24 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.763 ' CB ' HH22 ' A' ' 156' ' ' ARG . 4.0 t0 -77.14 117.74 18.99 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.945 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.17 123.62 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.68 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -163.54 155.96 17.92 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.366 -0.834 . . . . 0.0 109.089 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.74 167.32 9.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 62.75 66.2 2.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.494 ' HG3' ' CG ' ' A' ' 160' ' ' TYR . 78.5 mm-40 -111.3 102.87 11.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -1.199 . . . . 0.0 109.429 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 197' ' ' GLN . 61.9 t -41.67 155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.424 -0.798 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.609 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 22.1 t80 -117.64 151.52 37.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.865 . . . . 0.0 109.505 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -152.01 98.33 2.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.506 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 19.6 m-85 -54.0 136.13 41.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 110.554 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HB1' ' CB ' ' A' ' 206' ' ' HIS . . . -87.27 -177.97 6.09 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.8 pt-20 -75.29 175.56 8.24 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.381 -0.825 . . . . 0.0 109.478 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -52.04 67.03 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.512 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.13 -19.25 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.601 -0.687 . . . . 0.0 109.874 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.786 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 7.2 m-70 -96.99 7.84 45.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 110.327 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.829 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.0 mm-40 -127.0 -142.04 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.308 1.052 . . . . 0.0 110.491 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.615 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -35.46 -3.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.352 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.829 ' N ' ' O ' ' A' ' 207' ' ' GLN . 88.2 t80 -40.85 -43.45 2.05 Favored 'General case' 0 N--CA 1.514 2.761 0 O-C-N 120.431 -1.418 . . . . 0.0 110.431 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.463 ' H ' HD12 ' A' ' 210' ' ' LEU . 4.5 mp -75.87 -13.44 60.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.425 -1.422 . . . . 0.0 110.085 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.737 ' HB2' HG22 ' A' ' 50' ' ' VAL . 79.8 p -57.88 -44.2 86.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 -9.01 54.45 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.538 -0.726 . . . . 0.0 109.498 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 214' ' ' PRO . 12.6 m-80 -137.13 66.8 54.38 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 213' ' ' ASN . 12.3 Cg_exo -67.29 9.59 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.013 2.476 . . . . 0.0 112.237 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.497 ' OD1' ' C ' ' A' ' 215' ' ' ASP . 1.1 p30 -63.07 -18.92 63.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.537 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.62 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.71 85.35 0.05 OUTLIER Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.157 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.703 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 87.2 t80 -48.91 -171.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.314 2.057 . . . . 0.0 109.052 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.703 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 13.2 m -72.29 76.65 1.0 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.661 -1.275 . . . . 0.0 108.852 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.94 17.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.543 HD22 ' CA ' ' A' ' 148' ' ' GLY . 4.8 mp -85.25 -177.54 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -1.212 . . . . 0.0 109.777 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.96 90.61 0.08 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.59 171.22 14.32 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.574 ' OG1' ' OD1' ' A' ' 140' ' ' ASP . 1.6 t . . . . . 0 C--N 1.27 -2.851 0 CA-C-N 114.919 -0.64 . . . . 0.0 109.713 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.661 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.214 -0.795 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -36.22 166.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.736 1.255 . . . . 0.0 109.189 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.05 124.66 28.11 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.617 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.28 60.28 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.506 -0.746 . . . . 0.0 109.183 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -81.64 -4.67 56.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' LEU . 5.7 mt-10 -98.02 -36.23 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 35' ' ' LEU . . . -35.59 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.653 ' O ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 42' ' ' ILE . 6.8 pt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -39.85 164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.92 2.413 . . . . 0.0 112.554 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 202' ' ' ALA . 27.2 m -106.87 -154.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 45' ' ' THR . 9.9 t -80.09 86.79 5.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.231 -0.918 . . . . 0.0 110.14 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.612 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.41 -37.65 70.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.383 -0.823 . . . . 0.0 111.016 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.8 mtmt -93.24 98.86 11.55 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 116.33 -2.148 . . . . 0.0 108.15 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.661 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.14 107.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -30.45 64.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.807 . . . . 0.0 111.133 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 81' ' ' TRP . 13.2 t -66.65 -43.59 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.788 -1.195 . . . . 0.0 109.554 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.38 -42.17 4.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.135 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.06 0.97 48.33 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 46.4 m-20 -72.14 -119.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -127.92 174.17 9.39 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 123.506 1.622 . . . . 0.0 110.103 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.859 ' O ' HG13 ' A' ' 56' ' ' VAL . 10.3 p -150.89 22.13 0.78 Allowed 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.134 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 55' ' ' THR . 2.5 m -167.79 143.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.918 -1.114 . . . . 0.0 109.542 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' A' ' 56' ' ' VAL . 32.6 mt-10 -32.46 142.76 0.16 Allowed Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.442 -0.786 . . . . 0.0 110.462 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 88.4 Cg_endo -77.52 167.1 80.02 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.224 -1.99 . . . . 0.0 111.661 0.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -100.39 132.69 22.12 Favored Pre-proline 0 C--N 1.271 -2.835 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.905 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.524 ' O ' ' OG1' ' A' ' 63' ' ' THR . 45.5 Cg_exo -49.51 114.61 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.999 1.799 . . . . 0.0 112.199 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.71 118.39 3.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -8.26 20.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.611 HG22 ' HB3' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -83.12 137.13 34.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.107 . . . . 0.0 109.795 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.77 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.1 tp60 -103.66 155.33 18.64 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.374 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.734 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -161.79 137.27 7.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.276 -1.515 . . . . 0.0 112.434 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.28 -168.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.96 115.02 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.785 -1.822 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 1.5 p90 -163.29 156.04 18.61 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 109.719 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.92 164.16 30.31 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' ' OD1' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -114.8 -88.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -1.111 . . . . 0.0 109.052 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . -125.07 -152.14 8.2 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.681 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.4 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.412 -1.052 . . . . 0.0 108.193 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.729 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -49.45 5.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.361 -0.837 . . . . 0.0 111.665 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.783 ' CZ2' ' CE1' ' A' ' 206' ' ' HIS . 5.1 m0 -69.52 -49.84 50.76 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.277 -1.514 . . . . 0.0 108.549 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.52 -49.65 76.31 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB3' HG21 ' A' ' 117' ' ' VAL . . . -76.13 -27.52 57.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.964 -1.315 . . . . 0.0 110.202 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.575 ' OE1' HG22 ' A' ' 91' ' ' VAL . 6.9 tp10 -52.1 -34.85 45.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.907 -1.12 . . . . 0.0 110.153 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 21.7 ttt-85 -106.52 -56.69 2.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.979 -1.076 . . . . 0.0 111.36 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.655 ' O ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -38.69 -17.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 110.262 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 11.6 m-85 -91.52 -42.7 10.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.702 -1.249 . . . . 0.0 110.953 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.54 ' CE3' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -70.91 -4.61 25.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.745 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 79' ' ' LYS . 3.7 m -83.62 14.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.752 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 134' ' ' VAL . 96.4 mt -90.69 164.0 14.3 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -93.19 138.12 31.88 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.451 0.643 . . . . 0.0 110.359 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 123' ' ' PRO . . . 89.65 -19.12 42.67 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.22 137.91 18.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.945 -1.326 . . . . 0.0 109.775 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.571 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -76.73 -40.89 47.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.563 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.3 OUTLIER 177.12 -160.38 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.079 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.553 ' N ' ' OG ' ' A' ' 88' ' ' SER . 70.2 p -160.33 150.97 18.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.547 HE21 ' HD3' ' A' ' 118' ' ' ARG . 1.1 mp0 -144.68 164.43 30.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.583 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.2 OUTLIER -144.53 156.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.061 -1.024 . . . . 0.0 110.008 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 176.29 45.93 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 1.4 m-85 -88.77 164.78 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.356 -1.085 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.677 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.73 174.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.144 -0.973 . . . . 0.0 109.642 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 53.17 46.96 62.03 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -135.87 -152.38 6.36 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 120.945 -1.326 . . . . 0.0 110.381 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 0.2 OUTLIER -153.29 63.63 0.76 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.535 -0.979 . . . . 0.0 108.856 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.653 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.95 142.37 16.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 101' ' ' PRO . 31.0 mtp180 -49.26 177.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 108.548 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.567 ' C ' ' O ' ' A' ' 99' ' ' ARG . 2.6 m-80 -33.84 94.92 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.332 -0.855 . . . . 0.0 109.111 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 60.9 Cg_endo -85.62 163.07 10.82 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.81 2.34 . . . . 0.0 112.503 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.589 ' OG1' ' OE1' ' A' ' 105' ' ' GLU . 21.5 p -121.02 170.78 9.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.692 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.777 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 13.6 t80 -60.37 -59.56 5.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.0 110.295 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -55.48 -36.73 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 108.309 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.589 ' OE1' ' OG1' ' A' ' 102' ' ' THR . 0.1 OUTLIER -58.27 -62.01 2.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.258 0.552 . . . . 0.0 110.345 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.033 HG12 ' OG1' ' A' ' 111' ' ' THR . 27.1 m -65.04 -23.98 34.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.264 -0.897 . . . . 0.0 110.856 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.594 ' C ' ' H ' ' A' ' 109' ' ' GLU . 42.9 t -42.13 -44.18 3.57 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.74 ' C ' ' H ' ' A' ' 110' ' ' LYS . 33.2 t -69.42 13.23 0.13 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.24 -0.912 . . . . 0.0 108.735 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER 51.95 -16.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.514 0.726 . . . . 0.0 110.755 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.74 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -45.88 -30.43 1.73 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.67 -0.644 . . . . 0.0 110.186 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 1.033 ' OG1' HG12 ' A' ' 106' ' ' VAL . 48.7 p -84.53 11.77 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.129 . . . . 0.0 109.073 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 24.72 44.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.677 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 2.6 m-70 -83.91 170.83 13.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.492 -1.593 . . . . 0.0 109.214 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB1' ' CB ' ' A' ' 158' ' ' ALA . . . -118.55 114.21 22.46 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.693 ' OE2' ' CG ' ' A' ' 73' ' ' PHE . 1.9 mm-40 -51.19 118.25 3.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -125.21 136.18 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.05 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.561 HG22 ' CG1' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -116.85 125.01 73.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 118' ' ' ARG . 2.7 ptm180 -104.7 116.37 31.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 110.723 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.603 HG13 HD22 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -124.57 114.25 39.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.466 HG12 ' HB3' ' A' ' 65' ' ' MET . 0.7 OUTLIER -95.43 159.51 2.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.041 -1.037 . . . . 0.0 111.698 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.82 ' HB2' HG22 ' A' ' 126' ' ' ILE . 5.7 p90 -138.95 136.61 35.61 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 123.518 1.628 . . . . 0.0 111.592 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.969 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 6.9 ptt-85 -137.16 -1.09 0.03 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.621 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.969 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 56.2 Cg_endo -71.53 -27.75 18.45 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 124.288 3.325 . . . . 0.0 116.838 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 5.1 tt0 72.79 -5.18 1.94 Allowed 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.651 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -105.51 -25.07 12.47 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.892 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -128.4 124.13 61.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.332 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.519 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -132.22 -170.73 2.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.885 -1.135 . . . . 0.0 112.698 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.733 ' N ' ' CE2' ' A' ' 121' ' ' TYR . 60.5 t80 -58.08 -45.39 87.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.569 -0.707 . . . . 0.0 110.497 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' O ' HD23 ' A' ' 132' ' ' LEU . 78.0 mt-10 -46.73 -35.02 5.67 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.73 ' HG3' HD13 ' A' ' 126' ' ' ILE . 17.4 mm-40 -73.77 -63.54 1.19 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.689 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 13.2 mt -34.22 -57.83 0.48 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.786 HD23 ' H ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -76.84 -42.17 41.24 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.403 -1.435 . . . . 0.0 110.996 -178.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.786 ' H ' HD23 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -52.15 -63.07 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.771 -1.205 . . . . 0.0 109.167 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.8 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 t -50.14 -40.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' CZ3' ' A' ' 136' ' ' TRP . 15.8 t80 -56.45 -45.46 80.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.188 -1.57 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.514 ' O ' HG21 ' A' ' 223' ' ' THR . 29.4 m95 -73.49 -41.57 62.93 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.642 -1.286 . . . . 0.0 111.102 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -67.5 -2.45 6.51 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.749 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.8 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -133.76 48.0 2.4 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.937 -1.727 . . . . 0.0 112.096 -178.939 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 1.025 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 176.21 -164.79 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.646 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -129.49 117.63 18.75 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.509 ' HG3' ' CD2' ' A' ' 177' ' ' TYR . 10.7 Cg_endo -67.12 -4.11 10.98 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.554 1.503 . . . . 0.0 111.615 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.608 HG22 HD13 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -101.3 -13.76 17.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.196 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.645 ' CD ' ' H ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -68.02 70.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.633 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -52.05 -118.26 0.01 OUTLIER Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.659 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.62 39.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -1.041 . . . . 0.0 109.334 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -156.52 164.83 37.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.681 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -155.52 89.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.566 -1.334 . . . . 0.0 109.44 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.645 ' H ' ' CD ' ' A' ' 143' ' ' GLN . . . 51.72 -113.65 2.56 Favored Glycine 0 N--CA 1.478 1.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -80.48 3.83 20.24 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.434 -0.883 . . . . 0.0 110.236 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -108.28 146.34 33.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.915 -1.116 . . . . 0.0 108.934 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.61 130.42 32.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.053 -1.029 . . . . 0.0 109.961 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.01 163.34 9.48 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.421 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.575 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 44.8 p -73.72 -10.62 59.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.523 -0.986 . . . . 0.0 109.896 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 16.2 pm0 -87.47 -7.08 58.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.446 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 32.2 m-85 -124.41 60.43 1.15 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.082 -1.011 . . . . 0.0 108.772 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.5 HH12 ' HB ' ' A' ' 153' ' ' THR . 5.4 ptt-85 -112.96 173.67 6.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 118.57 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.468 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . . . -139.62 116.36 10.83 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' A' ' 192' ' ' ASP . 48.4 t -102.19 148.34 7.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.609 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.412 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 91.0 m-85 -139.23 87.36 13.82 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.776 -1.203 . . . . 0.0 108.554 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -46.02 163.15 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.881 2.387 . . . . 0.0 112.243 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.566 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.14 -21.54 13.24 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 120.635 -1.29 . . . . 0.0 110.553 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 162' ' ' THR . 0.8 OUTLIER -176.48 178.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 0.0 108.929 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.31 -16.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 123.007 1.384 . . . . 0.0 108.484 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.558 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.3 t -59.26 -62.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.812 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.925 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.576 ' O ' ' CB ' ' A' ' 170' ' ' ALA . 4.5 mp0 -77.74 -19.4 55.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 110.381 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.5 ttt -54.09 -54.66 36.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.954 -1.092 . . . . 0.0 109.534 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -54.58 -66.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 109.77 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -57.5 -39.33 76.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.869 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.44 -58.54 6.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.6 mp -53.04 -49.5 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -60.87 -48.55 81.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 109.466 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.498 ' HB2' ' NE1' ' A' ' 136' ' ' TRP . 1.0 OUTLIER -55.97 -40.15 72.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.66 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.636 ' HZ2' HD12 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -73.04 -58.2 3.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.607 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.97 -44.56 92.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.913 . . . . 0.0 110.81 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 74.8 mt-10 -53.1 -20.21 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.031 . . . . 0.0 110.451 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.509 ' CD2' ' HG3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -79.49 -40.08 30.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.821 -1.174 . . . . 0.0 110.556 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -52.25 -44.8 65.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.835 -1.166 . . . . 0.0 108.502 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -30.59 5.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 109.286 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.7 t -87.9 -54.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.278 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.608 HD13 HG22 ' A' ' 142' ' ' THR . 25.3 mt -58.99 -45.55 90.34 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.387 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -23.57 22.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.972 -1.08 . . . . 0.0 109.023 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -88.43 -13.84 39.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.338 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 2.9 m-70 -99.85 11.76 38.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 10.0 t-20 72.0 55.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.73 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.487 ' HE2' ' HG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -119.31 -176.58 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 108.972 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -119.55 -158.13 10.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.561 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.4 Cg_exo -58.63 116.47 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.325 2.017 . . . . 0.0 110.771 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.636 HD12 ' HZ2' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -47.91 -175.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.005 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.633 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 26.8 p -154.67 55.34 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.654 -0.653 . . . . 0.0 110.384 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.614 ' CG2' HG23 ' A' ' 159' ' ' VAL . 32.9 m -99.93 119.05 37.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 17.2 t0 -75.9 111.06 10.88 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.389 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 1.0 OUTLIER -117.33 114.82 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 110.466 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.81 ' HE ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -165.0 -170.16 1.87 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.539 ' OE2' ' C ' ' A' ' 194' ' ' ARG . 9.4 mp0 -145.82 178.66 8.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.309 . . . . 0.0 110.389 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.23 14.91 67.88 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.077 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.81 ' NE2' ' HE ' ' A' ' 194' ' ' ARG . 1.2 mp0 -89.35 126.47 35.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.502 -1.587 . . . . 0.0 109.784 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.31 154.87 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.464 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 6.7 t80 -92.82 124.79 37.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.13 95.09 5.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.285 -0.884 . . . . 0.0 108.975 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -54.41 133.87 45.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.322 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.525 ' O ' HG11 ' A' ' 44' ' ' VAL . . . -84.58 -175.75 5.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.808 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.2 pm0 -74.89 171.5 13.92 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -58.52 -53.84 53.74 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -51.35 -11.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.016 -1.052 . . . . 0.0 111.118 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.783 ' CE1' ' CZ2' ' A' ' 74' ' ' TRP . 12.2 m-70 -101.49 10.27 40.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.709 -1.245 . . . . 0.0 110.335 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.0 mm-40 -131.12 -146.46 0.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.233 1.015 . . . . 0.0 110.009 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.696 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 12.8 mp0 -33.87 -8.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.444 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 11.3 t80 -44.95 -40.52 6.45 Favored 'General case' 0 N--CA 1.515 2.815 0 O-C-N 120.146 -1.596 . . . . 0.0 109.343 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -52.61 -18.43 1.76 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 120.868 -1.145 . . . . 0.0 110.47 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 p -61.39 -39.7 91.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -71.02 -33.07 70.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.306 -0.871 . . . . 0.0 109.687 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 215' ' ' ASP . 5.6 m-80 -134.27 70.0 73.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.441 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HB3' ' NE ' ' A' ' 78' ' ' ARG . 24.3 Cg_exo -60.76 8.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.039 2.492 . . . . 0.0 112.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 213' ' ' ASN . 10.1 t0 -63.37 -18.97 64.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.524 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.79 85.32 0.05 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.512 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.74 92.97 9.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.598 2.199 . . . . 0.0 109.388 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.727 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -169.72 112.74 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 109.491 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -0.33 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.505 3.294 0 CA-C-O 122.464 1.036 . . . . 0.0 112.711 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.78 -173.71 2.76 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.676 -0.896 . . . . 0.0 109.69 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -82.73 -149.04 7.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -153.64 -136.66 2.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' THR . . . . . 1.025 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 O-C-N 121.286 -1.126 . . . . 0.0 109.131 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.213 -0.822 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.635 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.75 168.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.744 1.259 . . . . 0.0 109.539 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.09 124.47 31.8 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.68 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.9 -46.01 78.49 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.761 -0.587 . . . . 0.0 109.576 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 3.1 pm0 -78.46 15.77 0.93 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.569 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.582 ' O ' ' C ' ' A' ' 34' ' ' ALA . 10.1 tp10 -116.07 -40.6 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.6 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -29.0 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.766 . . . . 0.0 110.108 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.43 HD11 ' HE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.21 168.19 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.595 2.197 . . . . 0.0 112.209 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 204' ' ' ASP . 12.5 m -139.39 170.4 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.167 -0.958 . . . . 0.0 109.675 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 45' ' ' THR . 13.4 t -58.82 103.77 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.356 -0.84 . . . . 0.0 110.231 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.572 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.92 -50.13 73.51 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.359 -0.838 . . . . 0.0 111.479 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.4 pttt -70.74 100.62 1.92 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 115.846 -2.342 . . . . 0.0 108.168 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.604 ' HD1' ' HB ' ' A' ' 50' ' ' VAL . 6.3 t-80 -31.95 125.02 0.28 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.003 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -66.65 -8.08 25.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 110.848 -178.733 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HD1' ' A' ' 48' ' ' HIS . 18.9 t -92.98 -63.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.161 . . . . 0.0 109.805 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -83.56 -42.76 16.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.0 5.5 54.82 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.3 p30 -81.52 -119.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.689 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttp180 -129.54 168.67 16.04 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.989 1.376 . . . . 0.0 108.418 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.685 ' O ' HG13 ' A' ' 56' ' ' VAL . 20.8 p -128.38 30.68 5.14 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.94 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 55' ' ' THR . 7.0 m -161.29 132.58 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-10 -33.78 154.41 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.314 0 CA-C-O 121.899 0.857 . . . . 0.0 110.852 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HD2' ' NH2' ' A' ' 54' ' ' ARG . 96.5 Cg_endo -79.44 166.28 78.52 Favored 'Cis proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.48 -2.3 . . . . 0.0 111.756 -0.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.484 ' CE1' HG11 ' A' ' 120' ' ' VAL . 32.6 m-85 -108.37 154.51 41.39 Favored Pre-proline 0 C--N 1.267 -3.005 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.041 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.51 148.88 10.63 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.33 2.02 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -55.95 132.79 50.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.84 53.91 2.6 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.23 137.1 40.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -1.051 . . . . 0.0 109.44 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.532 ' OE1' ' CA ' ' A' ' 64' ' ' GLN . 1.6 tp60 -123.85 125.43 44.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.688 ' SD ' ' NH2' ' A' ' 118' ' ' ARG . 3.5 ptt? -109.63 141.28 42.39 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.621 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.43 -167.29 1.87 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.0 129.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.081 -1.637 . . . . 0.0 109.446 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 1.025 ' O ' HG22 ' A' ' 117' ' ' VAL . 59.1 m-85 -117.82 125.75 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.116 -0.99 . . . . 0.0 108.61 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.13 105.81 1.72 Allowed Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.023 -1.56 . . . . 0.0 110.146 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.723 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -107.86 -88.79 0.47 Allowed 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.449 -1.03 . . . . 0.0 108.666 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.635 ' N ' ' OE2' ' A' ' 115' ' ' GLU . . . -146.92 -152.73 5.71 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.812 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -36.42 106.05 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 108.956 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.85 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.419 -0.801 . . . . 0.0 112.307 -178.225 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 1.0 ' O ' HD11 ' A' ' 210' ' ' LEU . 21.1 m0 -67.48 -48.73 66.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.076 -1.64 . . . . 0.0 109.412 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.43 5.42 57.21 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.55 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.726 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.42 -41.86 38.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.276 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.727 ' OE2' HG13 ' A' ' 119' ' ' VAL . 2.6 tp10 -83.39 -14.82 51.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.15 -0.969 . . . . 0.0 111.786 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.842 ' CB ' HD13 ' A' ' 210' ' ' LEU . 15.0 ttp85 -57.52 -73.13 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.807 -1.183 . . . . 0.0 110.965 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 11.9 mttt -61.71 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.726 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.5 m-85 -115.87 -29.95 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.757 -1.215 . . . . 0.0 110.602 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.613 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.0 OUTLIER -104.26 -0.75 27.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.723 -1.236 . . . . 0.0 109.571 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 78' ' ' ARG . 3.7 m -93.3 8.51 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 109.105 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -103.3 -179.03 3.84 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -96.72 156.51 16.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.639 -1.288 . . . . 0.0 111.209 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.72 79.88 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.557 -0.714 . . . . 0.0 111.906 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 86' ' ' VAL . 1.1 t -99.79 129.52 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 120.387 -1.654 . . . . 0.0 110.791 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.584 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.68 -43.8 30.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.53 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t -169.62 -176.74 2.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 1.113 HG22 HG12 ' A' ' 119' ' ' VAL . 7.7 p -148.31 149.53 32.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.097 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.576 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -146.71 170.51 16.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.41 -0.806 . . . . 0.0 109.455 -179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.815 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -146.66 167.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . 178.06 156.02 15.61 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 202' ' ' ALA . 0.5 OUTLIER -80.01 160.71 25.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.604 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.648 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.56 -170.11 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 0.0 109.875 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.35 22.41 63.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.745 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -128.44 -164.06 11.46 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 1.9 p80 -145.57 78.5 1.54 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.38 -1.07 . . . . 0.0 109.708 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.498 ' O ' ' C ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -147.36 135.18 21.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 98' ' ' THR . 5.9 mtt180 -38.84 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.47 89.5 49.47 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 109.668 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.461 ' HG3' ' HE2' ' A' ' 113' ' ' HIS . 5.1 Cg_exo -70.87 132.81 22.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.834 2.356 . . . . 0.0 110.848 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 21.1 p -124.21 159.43 30.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.845 -1.159 . . . . 0.0 110.614 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 102' ' ' THR . 6.0 t80 -48.41 -38.85 20.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 108.834 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -40.46 64.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.79 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.0 mm-40 -81.75 -30.99 32.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -80.98 -29.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 108.833 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -28.97 64.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.508 -0.745 . . . . 0.0 109.496 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.677 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 51.6 p -62.67 -70.46 0.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.677 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.9 mt-10 140.4 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -48.22 1.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 110.939 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' GLU . 14.4 p -108.25 -7.47 15.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.814 -1.179 . . . . 0.0 109.55 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 43.03 51.0 6.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.745 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 15.4 m-70 -97.27 169.19 9.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.295 . . . . 0.0 108.929 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -124.2 113.08 17.82 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.665 ' OE2' ' N ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -51.7 114.67 1.34 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.959 . . . . 0.0 108.939 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -125.34 157.66 34.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.025 HG22 ' O ' ' A' ' 68' ' ' PHE . 20.6 m -130.14 131.96 65.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.688 ' NH2' ' SD ' ' A' ' 65' ' ' MET . 10.6 ptm180 -103.68 130.34 51.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.738 -1.226 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 1.113 HG12 HG22 ' A' ' 89' ' ' THR . 0.2 OUTLIER -132.86 138.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.61 122.0 63.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.953 ' CZ ' HD22 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -125.41 166.88 15.79 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.472 -177.767 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.505 ' HG2' ' H ' ' A' ' 125' ' ' HIS . 4.5 ttm180 -99.26 114.1 65.29 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.668 -0.645 . . . . 0.0 110.534 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 51.2 Cg_exo -50.85 -42.37 51.78 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.406 2.07 . . . . 0.0 111.785 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -57.28 -23.09 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.299 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.505 ' H ' ' HG2' ' A' ' 122' ' ' ARG . 1.1 m-70 -104.86 -56.02 2.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 108.849 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 3.3 tp -130.25 133.43 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.47 168.53 19.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.16 -0.963 . . . . 0.0 110.42 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.824 ' CE2' HD11 ' A' ' 132' ' ' LEU . 4.0 t80 -69.56 -44.87 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.568 ' HA ' HD12 ' A' ' 132' ' ' LEU . 1.3 pt-20 -47.95 -31.06 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 11.8 mm-40 -57.38 -70.02 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 111.216 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.953 HD22 ' CZ ' ' A' ' 121' ' ' TYR . 8.5 mp -56.31 -27.13 54.55 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.133 -1.604 . . . . 0.0 110.078 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.824 HD11 ' CE2' ' A' ' 128' ' ' PHE . 5.0 mt -55.91 -30.54 61.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.382 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -70.63 -52.0 24.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.747 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 9.2 t -49.91 -30.7 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 108.461 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 51.3 t80 -70.79 -46.6 62.58 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.028 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 177' ' ' TYR . 58.2 m95 -72.68 -60.94 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.396 -1.44 . . . . 0.0 110.719 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 14.8 tm-20 -37.93 -56.98 1.07 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.311 -0.868 . . . . 0.0 111.789 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -96.55 61.55 1.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.011 -1.056 . . . . 0.0 110.681 -178.128 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.765 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 13.4 m80 -152.99 -161.81 1.36 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.729 ' OD2' ' NE2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -121.24 178.06 1.31 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' CD ' ' OD2' ' A' ' 140' ' ' ASP . 9.7 Cg_exo -69.09 -83.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.257 1.971 . . . . 0.0 112.005 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -124.83 13.44 8.55 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.378 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.729 ' NE2' ' OD2' ' A' ' 140' ' ' ASP . 2.1 mt-30 -55.45 70.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.008 -1.058 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.79 13.67 51.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.458 ' H ' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -115.41 2.42 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -1.083 . . . . 0.0 109.296 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.478 ' NE ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER 174.98 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.245 -0.909 . . . . 0.0 109.223 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.92 103.11 11.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 119.581 -1.949 . . . . 0.0 108.822 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' NE ' ' A' ' 146' ' ' ARG . . . 67.21 -118.74 10.55 Favored Glycine 0 C--N 1.301 -1.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.79 -33.17 30.99 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-N 114.381 -0.909 . . . . 0.0 112.377 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.705 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 4.5 m-20 -72.19 99.1 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.229 -1.544 . . . . 0.0 110.415 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.655 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 10.5 p90 -92.92 128.83 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.82 177.58 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.21 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 153' ' ' THR . 0.1 OUTLIER -82.87 -0.49 48.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -1.135 . . . . 0.0 109.602 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -100.81 4.33 42.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.113 -0.992 . . . . 0.0 109.308 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.541 ' CG ' ' CB ' ' A' ' 150' ' ' ASP . 29.4 m-85 -124.65 58.41 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 108.74 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -110.18 -177.09 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.514 -0.741 . . . . 0.0 109.347 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 190' ' ' THR . 31.1 t -90.66 128.39 36.61 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -151.01 113.19 4.56 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.715 -1.594 . . . . 0.0 111.553 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.83 HG23 ' CG2' ' A' ' 191' ' ' THR . 5.8 t -113.71 122.33 67.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.0 m-30 -111.03 124.64 32.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 O-C-N 121.583 -0.698 . . . . 0.0 109.328 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.26 176.53 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.767 2.311 . . . . 0.0 112.193 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.96 -23.54 19.54 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 174.33 -162.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.6 -15.57 7.83 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 123.039 1.4 . . . . 0.0 108.549 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.3 t -55.82 -63.46 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.817 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.321 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.441 ' N ' HG12 ' A' ' 165' ' ' VAL . 12.0 mt-30 -78.56 -12.59 60.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.707 . . . . 0.0 111.375 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.676 ' O ' HD12 ' A' ' 171' ' ' LEU . 6.0 ttm -52.6 -44.89 66.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.685 -1.26 . . . . 0.0 109.915 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -75.63 -20.35 58.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 109.759 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.61 -52.78 4.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.006 . . . . 0.0 110.0 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.53 -42.0 63.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 167' ' ' MET . 0.8 OUTLIER -52.73 -31.02 35.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.334 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -74.41 -35.56 63.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 76.8 p -56.68 -46.11 81.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 109.781 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -70.21 -44.36 68.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -72.16 -15.85 61.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 109.876 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 0.9 OUTLIER -78.37 -57.75 3.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.26 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 136' ' ' TRP . 7.7 t80 -67.21 -37.26 83.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 187' ' ' GLY . 14.2 tp60 -62.21 -10.96 12.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -37.89 65.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.57 -37.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.028 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.608 ' C ' ' H ' ' A' ' 183' ' ' LYS . 4.2 mm? -67.58 -48.52 66.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.089 -1.007 . . . . 0.0 109.733 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t -56.04 1.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.965 -1.084 . . . . 0.0 109.213 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 181' ' ' LEU . 21.8 ttpt -78.1 -53.48 7.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 108.971 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.707 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 0.0 OUTLIER -75.64 7.2 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 18.8 t-20 73.29 64.07 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 109.8 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.707 ' CE1' ' CE1' ' A' ' 184' ' ' HIS . 21.4 m-85 -99.27 174.38 6.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.21 -0.931 . . . . 0.0 108.723 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -77.1 175.6 53.87 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.599 ' O ' ' OG1' ' A' ' 142' ' ' THR . 26.6 Cg_exo -58.95 -175.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.497 2.131 . . . . 0.0 111.617 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 189' ' ' ILE . 1.1 mm -89.41 112.23 24.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.058 -1.027 . . . . 0.0 109.675 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 142' ' ' THR . 2.3 t -78.33 -3.07 41.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 109.444 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.83 ' CG2' HG23 ' A' ' 159' ' ' VAL . 20.6 m -42.95 114.46 0.61 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.601 1.191 . . . . 0.0 108.101 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.664 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 4.1 t70 -76.14 116.94 17.32 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.962 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.81 100.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.851 . . . . 0.0 109.297 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.664 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -154.45 151.74 29.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 109.026 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.755 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -109.55 -175.7 2.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.71 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.06 34.06 48.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -106.95 118.79 37.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.451 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 5.4 p -57.04 159.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.54 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 13.5 t80 -113.7 126.6 55.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' PHE . 6.9 m-85 -127.86 103.12 7.09 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.17 -0.956 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -54.32 137.62 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 111.191 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -88.34 179.59 6.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.533 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 3.4 pt-20 -74.56 171.75 13.25 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.417 -0.802 . . . . 0.0 109.302 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.576 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.99 -47.45 85.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.036 -1.04 . . . . 0.0 108.478 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.533 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -50.08 -25.44 3.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 109.826 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.68 ' O ' HG21 ' A' ' 91' ' ' VAL . 14.5 m-70 -92.67 8.28 39.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.98 . . . . 0.0 109.839 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -127.91 -136.77 0.24 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.834 1.302 . . . . 0.0 110.177 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.613 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 1.4 mp0 -35.01 -4.64 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.196 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.825 ' N ' ' O ' ' A' ' 207' ' ' GLN . 87.6 t80 -41.96 -48.72 4.57 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.616 -1.302 . . . . 0.0 110.537 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 1.0 HD11 ' O ' ' A' ' 74' ' ' TRP . 2.9 mt -50.23 -12.53 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.512 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 209' ' ' TYR . 32.4 t -67.32 -40.36 85.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.219 -0.926 . . . . 0.0 108.921 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.69 -39.7 30.7 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.27 -0.894 . . . . 0.0 109.196 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -119.47 120.37 30.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 216' ' ' GLY . 58.3 Cg_endo -72.68 -50.48 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.074 1.849 . . . . 0.0 112.672 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 217' ' ' TYR . 5.7 p-10 -62.81 -3.52 1.61 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.048 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.499 ' CA ' HD23 ' A' ' 210' ' ' LEU . . . 61.31 -66.68 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 215' ' ' ASP . 38.2 p90 -177.98 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 108.325 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.506 ' N ' ' CD2' ' A' ' 217' ' ' TYR . 10.2 t -73.71 -124.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.039 -1.038 . . . . 0.0 108.676 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.712 ' C ' HD12 ' A' ' 220' ' ' LEU . . . 74.53 -164.8 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 219' ' ' GLY . 5.2 mp -151.33 -175.17 5.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -73.61 -110.78 0.07 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -135.81 -141.11 4.28 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 119.562 -1.304 . . . . 0.0 109.893 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 139' ' ' HIS . 50.5 p . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.329 -1.101 . . . . 0.0 109.177 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.213 -0.824 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.733 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.29 174.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.359 1.552 . . . . 0.0 109.65 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.409 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.8 124.7 25.39 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.112 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.9 86.8 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.24 0.543 . . . . 0.0 109.553 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.565 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.14 0.67 5.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 tt0 -99.41 -48.47 4.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 108.964 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -30.68 152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.547 0.689 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.652 ' O ' ' CG2' ' A' ' 98' ' ' THR . 4.2 mm? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.626 ' O ' HG13 ' A' ' 44' ' ' VAL . 82.9 Cg_exo -44.19 -170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.799 2.333 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 43' ' ' PRO . 31.2 m -162.23 161.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.275 -0.891 . . . . 0.0 110.112 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER 25.55 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.693 -0.629 . . . . 0.0 111.195 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.619 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -87.47 -45.42 10.52 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.099 -1.0 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.5 98.99 10.42 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 115.737 -2.385 . . . . 0.0 108.155 179.332 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.677 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.9 t-80 -32.73 115.89 0.2 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.96 -40.88 90.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 0.0 110.501 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.663 HG22 ' OG ' ' A' ' 211' ' ' SER . 48.5 t -56.67 -49.69 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 109.867 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -99.59 -46.1 5.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.86 4.06 55.77 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.89 -118.7 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 ttt180 -125.36 171.56 10.33 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.097 1.427 . . . . 0.0 108.689 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.619 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.3 p -131.22 12.06 5.05 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.163 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.763 HG12 ' CZ ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -144.78 131.03 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.057 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' VAL . 17.4 mt-10 -34.63 156.51 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 CA-C-O 121.979 0.895 . . . . 0.0 110.818 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -81.44 165.36 74.9 Favored 'Cis proline' 0 C--N 1.3 -1.981 0 C-N-CA 121.466 -2.306 . . . . 0.0 111.992 -0.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 120' ' ' VAL . 28.6 m-85 -112.42 149.61 41.33 Favored Pre-proline 0 C--N 1.267 -3.004 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.765 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' GLU . 10.0 Cg_endo -54.47 140.27 74.46 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.732 2.288 . . . . 0.0 112.195 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 60' ' ' PRO . 4.4 mt-10 -43.47 157.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.23 47.77 42.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.538 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -133.32 135.63 44.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.736 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.538 ' OE1' ' C ' ' A' ' 63' ' ' THR . 3.8 mp0 -123.63 145.82 48.65 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 3.2 ttp -139.57 145.42 38.58 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 109.793 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.61 -170.61 2.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 160' ' ' TYR . 22.9 t -144.17 107.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 119.967 -1.708 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 1.085 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -162.63 162.8 27.24 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.763 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.21 148.15 19.24 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.287 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.701 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 0.8 OUTLIER -85.73 -84.55 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 0.0 108.358 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.715 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.94 75.85 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.715 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 48.3 t 111.13 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -52.58 5.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.574 -1.329 . . . . 0.0 110.797 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.648 ' H ' ' C ' ' A' ' 72' ' ' CYS . 32.6 m0 -89.14 -90.96 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.698 -1.251 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA2' HD13 ' A' ' 210' ' ' LEU . . . -57.18 -6.09 1.85 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.547 ' HB1' ' HG3' ' A' ' 70' ' ' MET . . . -76.48 -70.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -1.13 . . . . 0.0 110.953 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.592 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 13.8 tp10 -51.03 -14.71 0.24 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.682 ' O ' ' N ' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -64.0 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.168 . . . . 0.0 110.341 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' A' ' 78' ' ' ARG . 3.9 mmtt -30.62 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 111.349 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.682 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.3 m-85 -76.25 -42.16 46.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.801 -1.187 . . . . 0.0 111.734 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.538 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -85.56 2.29 45.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.486 -1.383 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -97.4 22.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.978 -1.076 . . . . 0.0 109.526 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.503 HD12 ' OH ' ' A' ' 121' ' ' TYR . 34.4 mt -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 108.993 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -92.91 142.94 26.76 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.364 0.602 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.488 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 101.75 -26.91 22.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -68.74 136.55 26.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.628 -0.925 . . . . 0.0 109.573 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.602 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.61 -44.33 17.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.532 ' HB3' HD21 ' A' ' 53' ' ' ASN . 1.1 p -170.8 -169.58 0.79 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 88' ' ' SER . 75.2 p -158.55 165.48 34.42 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.301 -0.875 . . . . 0.0 109.317 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.592 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.51 169.78 11.8 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.363 -0.836 . . . . 0.0 109.021 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' CG2' ' CD ' ' A' ' 207' ' ' GLN . 4.1 m -129.18 -173.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 170.47 160.7 19.53 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.502 ' CZ ' ' HB1' ' A' ' 202' ' ' ALA . 7.7 m-85 -97.51 154.21 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.956 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . . . -178.6 179.28 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.35 93.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -136.6 -151.31 6.01 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.0 61.28 1.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 0.0 109.344 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.652 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.47 176.89 12.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CE1' ' A' ' 200' ' ' TYR . 99.5 mtt180 -100.83 -77.49 0.54 Allowed 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -117.28 70.77 6.04 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.377 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HG3' ' NE2' ' A' ' 113' ' ' HIS . 44.0 Cg_endo -71.87 170.53 18.58 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.746 2.297 . . . . 0.0 112.057 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.638 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.4 p -121.06 171.36 8.72 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.562 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -63.52 -59.33 4.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.56 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -58.42 -23.0 56.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 108.392 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.638 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.0 mm-40 -73.02 -56.45 5.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.397 0.618 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.763 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.3 m -65.47 -24.67 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.288 -0.883 . . . . 0.0 111.421 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 12.5 p -55.61 -23.44 27.53 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 110' ' ' LYS . 21.4 t -69.62 5.38 1.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.227 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 107' ' ' CYS . 1.9 tt0 59.61 -6.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.272 -0.893 . . . . 0.0 109.483 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' A' ' 108' ' ' SER . 18.0 mttt -72.52 -29.37 63.53 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 110.713 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.763 ' OG1' HG12 ' A' ' 106' ' ' VAL . 68.7 p -87.47 -6.59 58.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.878 -1.139 . . . . 0.0 110.541 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 35.31 43.84 0.53 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.439 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.5 ' ND1' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.1 163.17 26.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.393 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.444 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . . . -113.49 113.41 25.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 0.0 108.972 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.658 ' CD ' ' N ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -50.12 127.02 15.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.667 HG11 ' CE2' ' A' ' 160' ' ' TYR . 2.6 m -151.1 165.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.085 HG22 ' O ' ' A' ' 68' ' ' PHE . 2.5 m -143.96 149.4 17.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.195 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.766 ' CD ' ' CZ ' ' A' ' 199' ' ' PHE . 10.1 ptm180 -116.84 95.05 4.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.572 HG11 ' CG ' ' A' ' 80' ' ' PHE . 13.6 m -97.06 126.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.927 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.9 t -80.63 140.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.616 ' CG ' HD22 ' A' ' 131' ' ' LEU . 4.5 m-85 -132.05 161.0 34.27 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.079 -1.013 . . . . 0.0 109.224 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.638 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -125.07 109.72 27.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.506 -0.746 . . . . 0.0 110.384 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 124' ' ' GLU . 24.1 Cg_exo -44.43 -61.44 0.58 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.401 2.734 . . . . 0.0 114.493 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 123' ' ' PRO . 38.6 tt0 -25.98 -57.32 0.07 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.402 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.6 22.68 13.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.733 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -157.87 162.94 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.382 -0.824 . . . . 0.0 108.962 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.598 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -125.94 165.61 18.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.44 -1.412 . . . . 0.0 110.942 -179.096 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.567 ' CZ ' ' CD2' ' A' ' 132' ' ' LEU . 38.6 t80 -70.61 -43.8 68.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 108.988 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 5.0 mp0 -48.02 -14.6 0.05 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.891 -1.131 . . . . 0.0 108.086 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -73.67 -69.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.984 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -40.98 -38.7 1.02 Allowed 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.606 -1.308 . . . . 0.0 108.296 179.398 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.567 ' CD2' ' CZ ' ' A' ' 128' ' ' PHE . 4.2 mm? -75.42 -35.13 61.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.525 -0.734 . . . . 0.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 130' ' ' GLU . 0.5 OUTLIER -70.28 -57.68 4.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.964 -1.085 . . . . 0.0 111.256 -178.41 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.682 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.6 OUTLIER -50.42 -35.49 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.081 -1.012 . . . . 0.0 109.767 -178.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 50.7 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.526 -0.734 . . . . 0.0 110.485 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.817 ' O ' HG21 ' A' ' 223' ' ' THR . 90.5 m95 -72.8 -33.19 66.08 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.866 -1.146 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -79.43 -21.52 45.43 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.2 m-80 -121.28 53.69 1.15 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.102 -1.624 . . . . 0.0 113.443 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 223' ' ' THR . 0.2 OUTLIER 172.51 -175.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.186 0.993 . . . . 0.0 110.13 176.564 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 142' ' ' THR . 3.5 t70 -128.3 134.98 26.85 Favored Pre-proline 0 C--N 1.291 -1.959 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.429 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 190' ' ' THR . 72.0 Cg_endo -80.31 -11.15 13.36 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.353 2.035 . . . . 0.0 112.854 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.828 HG22 HG22 ' A' ' 189' ' ' ILE . 1.9 p -104.04 50.23 0.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 109.362 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 190' ' ' THR . 5.6 mm100 -114.64 83.63 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.621 ' CA ' HG21 ' A' ' 190' ' ' THR . . . -38.55 -117.53 0.0 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.922 0.734 . . . . 0.0 112.499 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.671 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 11.0 ptt? -92.87 53.5 2.02 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -1.02 . . . . 0.0 109.507 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' C ' ' O ' ' A' ' 155' ' ' TYR . 28.4 ptt-85 -178.56 154.71 0.79 Allowed 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.701 ' NE2' ' O ' ' A' ' 70' ' ' MET . 6.4 mt-30 -157.18 149.17 22.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.344 -1.473 . . . . 0.0 110.718 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.52 -124.62 3.21 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-O 122.986 1.326 . . . . 0.0 110.66 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -81.54 -35.32 30.43 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.049 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.654 ' OD2' ' SG ' ' A' ' 72' ' ' CYS . 0.0 OUTLIER -87.19 152.2 22.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.316 -1.49 . . . . 0.0 107.92 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.498 ' CB ' ' HB2' ' A' ' 146' ' ' ARG . 8.9 p90 -136.58 154.49 50.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.47 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.671 ' CA ' ' O ' ' A' ' 145' ' ' MET . . . 126.6 178.64 15.4 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 118.48 -1.819 . . . . 0.0 111.642 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -66.76 0.86 2.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.638 -0.919 . . . . 0.0 110.584 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 14.8 pm0 -112.38 16.5 19.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.75 -1.219 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.692 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 28.2 m-85 -146.69 59.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.742 ' HD2' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -114.81 177.05 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 190' ' ' THR . 1.0 OUTLIER -90.44 124.36 34.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 119.867 -1.77 . . . . 0.0 106.455 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.742 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -142.68 111.48 6.35 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.084 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.3 m -113.41 123.98 69.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.253 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.667 ' CE2' HG11 ' A' ' 116' ' ' VAL . 2.4 m-30 -112.7 126.16 28.76 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.75 170.67 17.2 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.146 1.898 . . . . 0.0 112.228 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.541 ' HB ' HE22 ' A' ' 166' ' ' GLN . 0.7 OUTLIER -102.9 -22.19 13.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 120.923 -1.111 . . . . 0.0 110.22 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -176.92 174.59 1.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 108.972 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' ' SD ' ' A' ' 167' ' ' MET . . . -45.49 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 123.081 1.42 . . . . 0.0 108.181 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 163' ' ' SER . 4.9 t -58.06 -62.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.836 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.541 HE22 ' HB ' ' A' ' 162' ' ' THR . 4.6 mp0 -76.68 -12.9 60.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.492 -0.755 . . . . 0.0 110.123 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' A' ' 164' ' ' ALA . 32.3 mtt -53.99 -47.97 70.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 109.971 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.047 -1.033 . . . . 0.0 110.161 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.48 -58.82 2.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 0.0 109.866 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.79 -48.55 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.955 . . . . 0.0 109.852 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -53.06 -42.43 65.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.542 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -68.3 -45.04 74.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.163 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.619 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 8.7 p -56.32 -53.48 56.81 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -55.91 -58.2 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.461 ' N ' ' HD3' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -60.61 -11.4 7.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.539 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 180' ' ' VAL . 1.6 tt0 -75.18 -50.45 16.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 110.007 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 181' ' ' LEU . 1.1 m-85 -79.41 -31.16 42.67 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.062 -1.024 . . . . 0.0 109.797 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 188' ' ' PRO . 21.9 tp60 -63.08 -40.79 98.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -77.82 -26.36 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 176' ' ' GLU . 98.0 t -87.29 -54.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.021 -1.049 . . . . 0.0 110.058 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.511 ' CD2' ' CD2' ' A' ' 177' ' ' TYR . 4.4 mm? -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.4 t -56.22 -35.64 67.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -88.49 9.09 24.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.855 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.462 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 38.5 m-70 -108.41 29.32 7.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.057 -1.027 . . . . 0.0 109.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 5.1 t-20 71.92 16.26 5.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -104.53 174.92 5.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.172 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -125.62 -149.02 7.36 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 178' ' ' GLN . 27.6 Cg_exo -58.75 106.64 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.379 2.053 . . . . 0.0 110.709 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.828 HG22 HG22 ' A' ' 142' ' ' THR . 0.3 OUTLIER -48.08 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 110.409 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 79.4 p -119.95 47.38 1.75 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.396 0.617 . . . . 0.0 109.746 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.2 m -97.94 118.67 35.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.4 t70 -76.08 140.76 42.02 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.42 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.56 93.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.977 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -157.15 153.18 27.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.642 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -119.67 -173.41 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.02 20.76 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 198' ' ' VAL . 61.1 mm-40 -91.63 101.81 14.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.273 . . . . 0.0 109.531 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.611 HG21 ' CZ ' ' A' ' 200' ' ' TYR . 3.0 p -35.95 153.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.766 ' CZ ' ' CD ' ' A' ' 118' ' ' ARG . 68.9 t80 -111.13 131.25 55.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CE1' ' O ' ' A' ' 99' ' ' ARG . 42.1 m-85 -127.26 112.65 15.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 0.0 109.419 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.763 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 16.5 m-85 -53.74 142.69 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.075 . . . . 0.0 110.614 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.515 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -90.77 178.18 6.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.575 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 3.0 mt-10 -73.67 161.13 30.62 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.557 1.17 . . . . 0.0 110.364 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -49.72 73.57 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.531 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.575 ' OH ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -59.47 -3.75 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.087 -1.008 . . . . 0.0 110.777 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.562 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 14.6 m-70 -101.29 -20.91 15.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.823 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -101.2 -134.36 0.3 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.705 1.24 . . . . 0.0 110.504 -178.201 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.538 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 1.3 mp0 -34.88 -2.93 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.442 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.823 ' N ' ' O ' ' A' ' 207' ' ' GLN . 75.9 t80 -41.34 -46.38 3.27 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.191 -1.568 . . . . 0.0 109.952 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.619 ' CD1' ' C ' ' A' ' 74' ' ' TRP . 0.7 OUTLIER -71.34 -13.21 61.8 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.573 -1.329 . . . . 0.0 110.441 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.663 ' OG ' HG22 ' A' ' 50' ' ' VAL . 36.9 t -63.38 -38.68 92.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 108.985 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -72.78 -38.73 67.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.357 -0.84 . . . . 0.0 109.35 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.57 77.42 76.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.063 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.675 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 12.7 Cg_exo -66.73 5.08 0.84 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.99 2.46 . . . . 0.0 112.683 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.95 -19.99 64.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.11 84.46 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.829 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 217' ' ' TYR . 78.8 t80 -70.53 83.94 0.6 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 121.108 2.454 . . . . 0.0 109.268 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 43.1 t -168.84 -124.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.966 -1.084 . . . . 0.0 108.803 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.529 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 134.69 153.4 6.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.478 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 75.62 143.15 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -1.106 . . . . 0.0 110.06 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -134.27 -144.43 5.07 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -152.0 -144.3 3.89 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.864 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 O-C-N 121.494 -1.004 . . . . 0.0 109.032 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.213 -0.84 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.721 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.14 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 123.068 1.413 . . . . 0.0 110.029 -177.812 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -94.9 123.86 38.61 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.344 179.49 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -56.74 -57.87 10.57 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.156 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' OE1' ' O ' ' A' ' 32' ' ' GLU . 1.5 pp20? -53.05 -6.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.952 . . . . 0.0 109.915 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.0 tt0 -112.46 -35.99 5.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.813 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . . . -44.88 -179.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.285 -0.884 . . . . 0.0 109.552 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 mm? . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 43' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 42' ' ' ILE . 74.0 Cg_exo -46.27 -166.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.321 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.1 m -150.56 -179.16 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 45' ' ' THR . 9.6 t -34.19 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.773 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.646 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -55.86 -38.75 70.51 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.344 -0.847 . . . . 0.0 111.196 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttp -91.46 98.7 11.84 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 116.15 -2.22 . . . . 0.0 108.678 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.7 t-80 -31.73 110.95 0.08 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -59.82 -30.79 69.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 110.807 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 3.4 t -64.6 -43.4 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.934 -1.104 . . . . 0.0 109.524 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.86 -44.49 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.941 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 104.1 1.73 45.03 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.5 p30 -76.15 -112.05 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.607 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -130.68 175.25 9.17 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 123.806 1.765 . . . . 0.0 110.811 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 6.9 p -149.33 23.35 0.92 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 112.425 -2.17 . . . . 0.0 110.088 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.497 HG22 ' C ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -157.27 132.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 56' ' ' VAL . 12.7 mt-10 -41.48 156.03 0.22 Allowed Pre-proline 0 C--N 1.304 -1.397 0 CA-C-O 121.855 0.836 . . . . 0.0 110.199 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.24 157.12 62.87 Favored 'Cis proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.494 0.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.769 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 18.7 m-85 -104.15 147.91 35.08 Favored Pre-proline 0 C--N 1.279 -2.496 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 11.7 Cg_endo -57.47 134.21 61.94 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.843 2.362 . . . . 0.0 112.423 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -49.34 158.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 64' ' ' GLN . . . 93.91 -35.88 3.98 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -83.03 134.06 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.784 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 6.2 mp0 -114.98 -175.93 2.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 2.2 ttp -161.35 149.37 15.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.642 -1.286 . . . . 0.0 110.826 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.71 -174.37 2.67 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG12 ' CG1' ' A' ' 116' ' ' VAL . 1.4 t -146.23 106.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.686 -1.884 . . . . 0.0 109.96 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.704 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -140.82 156.39 46.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.963 -1.495 . . . . 0.0 110.359 177.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' CA ' ' OE2' ' A' ' 115' ' ' GLU . . . -132.15 154.18 20.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.738 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -122.81 -91.85 0.55 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.738 ' H ' ' CG ' ' A' ' 70' ' ' MET . . . -134.84 63.76 0.6 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.767 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 48.5 t 109.13 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.575 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -81.43 25.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.363 -1.46 . . . . 0.0 110.873 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.767 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 8.3 m0 -91.6 -72.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.567 -1.333 . . . . 0.0 109.573 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.26 -3.51 65.76 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 117' ' ' VAL . . . -77.09 -32.89 56.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.198 -1.178 . . . . 0.0 109.473 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.629 ' OE2' ' CA ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -83.69 -15.79 47.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.016 -1.052 . . . . 0.0 110.154 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.794 ' O ' HG13 ' A' ' 82' ' ' VAL . 28.0 ttt180 -79.46 -67.6 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 110.027 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.452 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 14.2 mttp -54.89 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.613 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.712 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 19.1 m-85 -120.72 -39.7 2.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.879 -1.138 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.632 ' CZ2' ' OG ' ' A' ' 211' ' ' SER . 0.9 OUTLIER -82.28 -3.98 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.764 -1.21 . . . . 0.0 110.03 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.3 m -83.94 17.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.034 -1.041 . . . . 0.0 109.334 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.71 154.53 22.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 137.26 32.51 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.55 -31.89 5.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.72 136.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.57 -0.959 . . . . 0.0 109.549 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.668 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -71.15 -39.91 71.64 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.915 0.864 . . . . 0.0 108.828 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.697 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 179.63 -160.57 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.608 ' HB ' HG12 ' A' ' 119' ' ' VAL . 63.6 p -157.51 151.16 24.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.033 -1.042 . . . . 0.0 109.801 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.697 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 5.1 mp0 -147.32 167.75 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.753 . . . . 0.0 109.028 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -142.96 168.65 13.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.026 -1.046 . . . . 0.0 109.878 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.414 ' HA2' ' N ' ' A' ' 202' ' ' ALA . . . 177.37 164.07 30.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -80.11 174.29 11.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -1.078 . . . . 0.0 109.192 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.728 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -175.2 177.04 1.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 50.9 22.13 5.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -134.64 -164.1 10.43 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.813 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 57.3 p-80 -173.75 105.34 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.398 -1.06 . . . . 0.0 108.904 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.607 ' O ' ' C ' ' A' ' 99' ' ' ARG . 1.6 m -137.72 148.0 45.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.607 ' C ' ' O ' ' A' ' 98' ' ' THR . 19.6 tpt180 -33.21 -68.75 0.1 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.3 95.88 42.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.44 106.0 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.481 2.121 . . . . 0.0 113.224 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 22.0 p -122.08 170.81 9.48 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.94 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.483 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 2.1 t80 -63.45 -58.95 5.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.217 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.544 ' HZ3' ' HB3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -61.58 -22.86 65.57 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.113 -0.992 . . . . 0.0 108.816 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.653 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.1 mm-40 -66.28 -57.54 7.3 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.459 0.647 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 18.7 m -65.45 -24.78 35.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.844 . . . . 0.0 110.808 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.401 ' O ' ' OE1' ' A' ' 109' ' ' GLU . 24.0 t -64.56 -28.47 69.66 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.656 ' C ' ' H ' ' A' ' 110' ' ' LYS . 2.5 t -70.91 2.09 4.75 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.707 ' O ' HG21 ' A' ' 29' ' ' ILE . 4.8 mp0 58.54 -21.6 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.452 -0.78 . . . . 0.0 110.953 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.768 ' O ' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.75 2.25 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.472 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.522 HG22 ' OG1' ' A' ' 98' ' ' THR . 3.1 p -107.73 -29.41 9.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.091 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 62.13 49.06 78.64 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.728 ' ND1' ' N ' ' A' ' 94' ' ' ALA . 1.5 m-70 -97.24 173.5 7.19 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.783 -1.422 . . . . 0.0 109.784 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.37 116.63 18.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.533 ' C ' ' CD ' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -62.36 123.79 19.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.991 -1.068 . . . . 0.0 109.296 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -128.09 140.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.1 -1.0 . . . . 0.0 109.308 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.737 HG21 ' CB ' ' A' ' 76' ' ' ALA . 2.0 t -103.78 107.32 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.769 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -96.58 96.98 9.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.637 1.208 . . . . 0.0 110.386 -177.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.608 HG12 ' HB ' ' A' ' 89' ' ' THR . 20.4 m -112.12 128.03 68.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.903 -1.123 . . . . 0.0 108.675 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -80.29 169.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.879 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.967 ' CD2' HD21 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -156.56 156.27 33.34 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.806 -1.558 . . . . 0.0 111.599 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.67 110.62 35.2 Favored Pre-proline 0 C--N 1.291 -1.958 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.937 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.541 ' O ' ' C ' ' A' ' 124' ' ' GLU . 39.3 Cg_exo -45.32 -63.76 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.068 2.512 . . . . 0.0 113.23 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.2 tp10 -25.69 -43.7 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -127.82 3.76 6.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.707 -1.246 . . . . 0.0 109.898 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 126' ' ' ILE . 0.1 OUTLIER -155.15 104.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.05 0.929 . . . . 0.0 108.964 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.3 m -69.81 169.64 12.64 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.774 0.797 . . . . 0.0 111.871 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.702 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 36.9 t80 -69.39 -27.92 65.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 109.43 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 133' ' ' LYS . 2.5 mt-10 -62.69 -19.77 64.2 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.517 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.59 ' CG ' HD13 ' A' ' 126' ' ' ILE . 3.2 mm-40 -66.63 -72.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.042 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.009 ' H ' HD22 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -42.05 -40.05 2.13 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.702 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 8.3 mp -75.68 -34.89 60.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.77 . . . . 0.0 111.611 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -58.54 -68.91 0.21 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.504 -1.372 . . . . 0.0 110.085 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.618 HG12 ' CZ ' ' A' ' 80' ' ' PHE . 58.5 t -51.3 -22.19 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.253 -0.904 . . . . 0.0 109.208 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 34.7 t80 -73.41 -52.18 14.65 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 111.147 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 58.8 m95 -70.22 -38.72 75.32 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.069 -1.644 . . . . 0.0 111.569 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.48 -43.46 73.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.831 -1.168 . . . . 0.0 111.641 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.477 ' OD1' HG13 ' A' ' 134' ' ' VAL . 31.9 m120 -81.56 59.27 4.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 112.296 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.765 ' CE1' ' O ' ' A' ' 135' ' ' PHE . 46.8 m80 -153.76 -166.59 2.43 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.003 0.906 . . . . 0.0 109.293 176.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -132.87 171.61 8.86 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 140' ' ' ASP . 30.8 Cg_exo -33.5 -103.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.039 1.826 . . . . 0.0 113.334 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 142' ' ' THR . 1.5 t -128.45 57.14 1.6 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.041 -1.037 . . . . 0.0 111.428 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.737 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -75.93 84.42 2.85 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.218 -1.551 . . . . 0.0 110.882 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.728 ' CA ' HG21 ' A' ' 190' ' ' THR . . . -39.39 -115.85 0.0 OUTLIER Glycine 0 N--CA 1.491 2.345 0 CA-C-O 122.097 0.832 . . . . 0.0 111.723 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.739 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.27 25.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.743 -0.857 . . . . 0.0 111.691 -176.873 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.536 ' NH2' ' OD1' ' A' ' 149' ' ' ASN . 10.6 ttt-85 -159.54 88.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 119.218 -2.176 . . . . 0.0 112.115 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.692 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -57.66 122.19 12.19 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.992 -1.692 . . . . 0.0 108.954 178.635 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.663 ' H ' ' HG3' ' A' ' 143' ' ' GLN . . . 43.14 -114.96 0.93 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 122.932 1.296 . . . . 0.0 110.197 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.536 ' OD1' ' NH2' ' A' ' 146' ' ' ARG . 3.0 t-20 -95.98 15.81 19.55 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.084 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 8.7 m-20 -101.7 93.39 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.903 -1.123 . . . . 0.0 108.457 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.45 ' HB3' ' HE ' ' A' ' 146' ' ' ARG . 4.8 p90 -75.47 121.83 22.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.381 -0.824 . . . . 0.0 110.875 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 167.13 140.34 2.88 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.119 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -4.02 47.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -1.197 . . . . 0.0 108.729 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.726 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -96.58 -13.2 23.1 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.352 -0.843 . . . . 0.0 110.486 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.611 ' O ' ' O ' ' A' ' 70' ' ' MET . 13.2 m-85 -100.16 -4.72 29.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.864 -1.148 . . . . 0.0 110.98 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.61 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -42.69 177.58 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.842 -1.161 . . . . 0.0 109.492 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.1 t -91.55 124.87 36.04 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -145.55 127.82 15.8 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 116.468 -2.093 . . . . 0.0 112.705 -176.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.551 HG23 ' CG2' ' A' ' 191' ' ' THR . 5.2 t -117.9 129.46 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.097 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -122.27 95.59 47.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.336 -0.852 . . . . 0.0 108.814 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.6 170.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.633 2.222 . . . . 0.0 112.044 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.56 -29.64 14.25 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 120.911 -1.118 . . . . 0.0 109.632 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 165' ' ' VAL . 2.0 m -179.52 -162.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.93 -15.55 9.18 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 123.021 1.391 . . . . 0.0 108.599 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.7 t -55.77 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.883 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.759 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 13.1 mt-30 -78.86 -19.13 52.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 ttp -52.44 -36.19 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.705 -1.247 . . . . 0.0 110.394 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -75.58 -32.55 60.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.795 -1.19 . . . . 0.0 110.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.58 -43.28 9.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.077 -1.014 . . . . 0.0 110.134 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.79 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.697 ' C ' HD12 ' A' ' 171' ' ' LEU . 1.3 pp -52.85 -33.52 50.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.004 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -74.6 -55.54 5.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.82 -39.02 73.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.373 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -65.07 -58.36 6.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 175' ' ' GLU . 0.9 OUTLIER -70.58 -24.19 62.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.933 . . . . 0.0 109.908 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 5.8 mm-40 -53.26 -30.87 40.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -0.91 . . . . 0.0 109.931 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.591 ' CD1' ' CD1' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.47 -45.36 19.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.907 -1.121 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.553 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.5 OUTLIER -54.26 -30.83 51.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -61.83 -44.27 97.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.319 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 181' ' ' LEU . 9.2 p -87.31 -42.2 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.387 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 177' ' ' TYR . 31.8 mt -65.24 -39.4 92.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.111 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.553 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 21.6 p -56.07 -26.56 49.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.987 -1.071 . . . . 0.0 109.401 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -88.3 -9.66 52.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.737 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -108.33 34.93 3.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.873 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 63.36 68.65 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.937 . . . . 0.0 109.799 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -148.08 174.55 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -126.22 -162.24 11.19 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.518 ' HA ' HE22 ' A' ' 178' ' ' GLN . 32.0 Cg_exo -58.07 105.56 0.21 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.993 1.795 . . . . 0.0 110.274 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -47.68 155.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.585 -178.129 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.728 HG21 ' CA ' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -88.57 44.73 1.23 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.338 0.589 . . . . 0.0 111.571 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.551 ' CG2' HG23 ' A' ' 159' ' ' VAL . 19.4 m -84.57 113.78 21.49 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.494 ' OD2' ' CZ ' ' A' ' 194' ' ' ARG . 9.1 t0 -75.54 114.98 14.72 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.986 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.76 97.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 121.925 0.869 . . . . 0.0 109.45 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.669 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -152.62 152.29 31.62 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.644 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 1.0 OUTLIER -111.74 -176.95 3.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 110.197 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.55 30.37 66.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.669 ' NE2' ' O ' ' A' ' 194' ' ' ARG . 1.8 mp0 -95.85 95.16 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.239 . . . . 0.0 109.882 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 197' ' ' GLN . 8.3 p -32.6 154.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 109.711 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.545 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 65.0 t80 -120.63 137.23 54.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.633 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.9 m-85 -139.54 112.84 8.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.167 -0.958 . . . . 0.0 109.787 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.582 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.3 m-85 -54.12 141.67 28.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 110.108 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -90.46 -174.64 4.2 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.03 165.05 25.82 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.749 -0.594 . . . . 0.0 109.704 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.454 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -57.95 -45.14 87.13 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.537 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -55.05 -13.53 1.19 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.697 ' O ' HG21 ' A' ' 91' ' ' VAL . 14.3 m-70 -100.99 5.38 43.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.83 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.3 mm-40 -124.57 -144.18 0.32 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.238 1.018 . . . . 0.0 110.143 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.719 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 11.7 mp0 -34.4 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.188 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.83 ' N ' ' O ' ' A' ' 207' ' ' GLN . 79.5 t80 -43.7 -45.58 7.09 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 120.495 -1.378 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -55.21 -17.3 4.18 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.648 -1.283 . . . . 0.0 110.068 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.632 ' OG ' ' CZ2' ' A' ' 81' ' ' TRP . 13.4 m -73.17 -26.51 61.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.109 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -87.75 -38.92 15.36 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.338 -0.851 . . . . 0.0 109.487 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.4 m-80 -123.42 79.66 53.92 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.63 8.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.954 2.436 . . . . 0.0 112.598 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 213' ' ' ASN . 1.5 t70 -63.44 -19.09 64.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.023 -1.048 . . . . 0.0 110.356 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.98 84.97 0.05 OUTLIER Glycine 0 N--CA 1.503 3.104 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.693 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -83.38 92.68 7.6 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.652 2.226 . . . . 0.0 109.297 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 49.1 t -168.74 -124.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 O-C-N 120.994 -1.066 . . . . 0.0 108.962 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 153.8 151.8 5.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 2.5 tp 75.47 162.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.734 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 157.16 81.59 0.04 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.42 140.83 3.66 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.277 179.817 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.738 ' O ' ' O ' ' A' ' 29' ' ' ILE . 41.9 t . . . . . 0 CA--C 1.501 -0.942 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.738 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -35.3 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 123.198 1.475 . . . . 0.0 110.038 -178.049 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -74.63 124.25 26.34 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.966 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HB1' ' NE2' ' A' ' 97' ' ' HIS . . . -64.76 -40.06 94.65 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.83 -0.544 . . . . 0.0 109.692 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.654 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -80.65 12.77 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' ' C ' ' A' ' 34' ' ' ALA . 1.6 tt0 -116.67 -43.25 2.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 109.648 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -33.08 152.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.586 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.644 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.69 ' O ' HG13 ' A' ' 44' ' ' VAL . 35.6 Cg_endo -66.97 164.09 31.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.747 2.298 . . . . 0.0 112.261 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 43' ' ' PRO . 7.0 m -161.2 172.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.227 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.71 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 109.681 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.27 -40.38 74.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 110.911 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.574 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.62 99.72 11.93 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.002 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.643 ' O ' ' N ' ' A' ' 52' ' ' GLY . 6.7 t-80 -31.16 104.19 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -53.97 -26.17 24.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.654 -0.654 . . . . 0.0 110.965 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 2.6 t -70.09 -48.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.84 -1.163 . . . . 0.0 109.448 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -103.56 -41.1 6.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.54 1.98 53.27 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 66.2 m-20 -75.41 -116.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.578 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -131.55 174.39 10.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.657 1.694 . . . . 0.0 110.217 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 16.0 p -145.56 18.98 1.51 Allowed 'General case' 0 C--N 1.264 -3.118 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -165.62 149.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.037 -1.04 . . . . 0.0 109.05 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.55 ' O ' ' O ' ' A' ' 56' ' ' VAL . 16.0 mt-10 -32.33 154.92 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.675 0 CA-C-O 121.885 0.85 . . . . 0.0 110.731 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 84.4 Cg_endo -79.3 165.51 80.62 Favored 'Cis proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.689 -2.213 . . . . 0.0 112.126 -0.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.526 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-30 -115.98 85.68 15.35 Favored Pre-proline 0 C--N 1.27 -2.871 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.16 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.96 170.18 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.974 2.45 . . . . 0.0 112.549 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -75.98 158.32 32.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.4 -38.42 3.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.03 135.04 50.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.602 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 14.9 mp0 -113.32 171.65 7.43 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.735 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -156.9 145.48 19.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.58 -1.325 . . . . 0.0 110.896 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -120.1 -169.36 1.78 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 67' ' ' VAL . 2.7 t -143.02 101.6 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.024 -1.672 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 2.4 p90 -148.38 149.37 31.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.922 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 158' ' ' ALA . . . 179.74 156.25 17.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.613 ' HE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 mtt -145.68 30.72 1.08 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.347 -1.09 . . . . 0.0 108.339 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.588 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -166.6 155.63 26.94 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.924 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.769 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -35.97 116.76 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -45.26 7.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.869 -178.108 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.769 ' N ' ' O ' ' A' ' 72' ' ' CYS . 24.9 m0 -82.34 -64.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.3 -1.5 . . . . 0.0 109.84 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.09 -26.82 74.38 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.024 -1.047 . . . . 0.0 111.335 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.761 ' CB ' HG21 ' A' ' 117' ' ' VAL . . . -76.94 -29.25 55.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.343 . . . . 0.0 111.526 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.557 ' HB2' HG11 ' A' ' 91' ' ' VAL . 28.2 tt0 -83.88 -13.86 52.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.277 -1.515 . . . . 0.0 110.757 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 80' ' ' PHE . 15.9 ttt180 -69.29 -81.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.132 -0.98 . . . . 0.0 111.137 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 25.2 mtmt -58.76 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.211 -0.931 . . . . 0.0 110.628 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.757 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.1 m-85 -97.9 -38.72 9.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.911 -1.118 . . . . 0.0 109.026 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.593 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.5 p90 -85.17 8.48 18.09 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 82' ' ' VAL . 1.2 m -99.36 18.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.97 167.68 9.62 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.28 162.72 14.5 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.536 -0.727 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.4 5.61 50.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -90.78 117.45 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -1.063 . . . . 0.0 109.436 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.578 ' OH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -68.45 -36.29 78.81 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.218 1.009 . . . . 0.0 108.753 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.538 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER 177.83 -164.03 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.293 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.663 ' C ' HE21 ' A' ' 90' ' ' GLN . 71.3 p -156.25 144.76 20.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.663 HE21 ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -141.86 166.34 24.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 117' ' ' VAL . 3.0 m -152.41 160.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -179.22 -174.54 45.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 1.6 m-85 -86.32 169.41 12.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.307 -1.114 . . . . 0.0 109.554 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 1.034 ' C ' ' HD1' ' A' ' 113' ' ' HIS . . . -179.58 149.09 0.36 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.005 -1.059 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 76.86 22.24 72.34 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.709 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -100.44 -165.04 28.45 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.69 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 0.1 OUTLIER -140.85 72.02 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.571 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.78 175.99 13.17 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.448 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.0 mmp_? -76.26 -78.28 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.422 -0.799 . . . . 0.0 109.047 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -116.18 66.43 3.1 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.88 149.95 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.307 2.004 . . . . 0.0 111.674 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.636 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 17.4 p -120.85 172.62 7.77 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.221 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.712 ' CG ' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -66.41 -59.23 3.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.069 -1.019 . . . . 0.0 109.958 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.712 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -57.93 -23.52 53.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.636 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.2 mm-40 -67.25 -64.95 0.75 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.601 0.715 . . . . 0.0 109.936 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.729 HG12 ' CB ' ' A' ' 111' ' ' THR . 34.4 m -71.39 -24.37 23.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.479 -0.763 . . . . 0.0 111.098 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.512 ' C ' ' O ' ' A' ' 106' ' ' VAL . 11.9 t -38.38 -22.9 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.67 ' N ' ' O ' ' A' ' 106' ' ' VAL . 80.2 p -77.8 -80.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.682 ' O ' ' N ' ' A' ' 111' ' ' THR . 0.0 OUTLIER 158.7 -39.62 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.507 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.642 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 1.6 ttmt -46.29 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.911 -0.493 . . . . 0.0 112.215 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.729 ' CB ' HG12 ' A' ' 106' ' ' VAL . 11.1 p -101.33 -19.68 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.449 -1.407 . . . . 0.0 109.193 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 67.16 21.63 72.04 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.075 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 1.034 ' HD1' ' C ' ' A' ' 94' ' ' ALA . 1.4 m-70 -80.15 172.46 13.74 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.258 -1.731 . . . . 0.0 108.174 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.44 112.92 13.69 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.079 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.684 ' OE1' ' CE2' ' A' ' 73' ' ' PHE . 20.8 mm-40 -51.04 112.1 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 94' ' ' ALA . 1.5 m -123.34 138.37 53.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 108.937 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.761 HG21 ' CB ' ' A' ' 76' ' ' ALA . 2.5 t -103.78 113.11 39.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.526 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -96.92 113.84 25.41 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 89' ' ' THR . 6.0 m -132.02 126.57 56.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -86.2 169.41 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.435 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.761 ' CD1' HD11 ' A' ' 131' ' ' LEU . 0.2 OUTLIER -157.4 156.62 32.56 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.651 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -106.66 99.28 24.24 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.918 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 Cg_exo -43.55 -63.91 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.032 2.488 . . . . 0.0 112.917 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.753 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 22.5 mp0 -49.91 -13.14 0.09 Allowed 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.586 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 123' ' ' PRO . 22.1 m-70 -110.86 -46.85 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 130' ' ' GLU . 5.3 tp -128.73 144.18 38.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -75.11 153.1 38.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.864 -1.148 . . . . 0.0 111.192 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 132' ' ' LEU . 41.4 t80 -63.9 -28.7 70.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -52.88 -32.13 43.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 6.5 mm-40 -62.39 -67.85 0.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.761 HD11 ' CD1' ' A' ' 121' ' ' TYR . 17.0 mt -34.05 -49.07 0.34 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.199 -0.938 . . . . 0.0 108.711 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.573 HD11 ' CE2' ' A' ' 128' ' ' PHE . 64.0 mt -76.61 -34.54 58.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 110.69 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' GLU . 31.7 ttmt -57.71 -68.37 0.25 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.885 -1.134 . . . . 0.0 110.449 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.752 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -49.28 -34.17 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 108.985 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.613 ' CZ ' ' HE2' ' A' ' 70' ' ' MET . 26.4 t80 -57.92 -52.67 64.53 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.014 -1.054 . . . . 0.0 111.072 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.58 ' O ' ' CG2' ' A' ' 223' ' ' THR . 85.6 m95 -74.8 -47.45 30.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.159 -1.588 . . . . 0.0 111.236 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.582 ' O ' ' O ' ' A' ' 222' ' ' GLY . 1.3 mm-40 -45.23 -48.83 12.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 111.334 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.752 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.5 p30 -98.51 38.22 1.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 112.554 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 223' ' ' THR . 20.6 m80 -155.44 -155.77 0.59 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.714 -1.241 . . . . 0.0 109.342 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 70' ' ' MET . 2.7 t0 -147.33 132.01 8.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 177' ' ' TYR . 68.9 Cg_endo -73.81 -13.81 24.26 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 121.931 1.754 . . . . 0.0 113.142 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.844 HG22 HG22 ' A' ' 189' ' ' ILE . 3.3 p -122.32 56.63 1.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.743 -1.223 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.662 ' OE1' ' NE2' ' A' ' 147' ' ' GLN . 1.3 pt20 -122.39 77.59 1.42 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.713 -1.242 . . . . 0.0 110.889 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -47.34 -117.64 0.0 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -85.19 47.02 1.35 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.338 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 150' ' ' ASP . 1.6 ttm180 -162.16 87.23 0.63 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.583 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.681 ' OE1' ' N ' ' A' ' 148' ' ' GLY . 2.1 tp-100 -84.09 119.94 25.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.181 -1.575 . . . . 0.0 109.381 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . 53.26 -113.45 2.97 Favored Glycine 0 C--N 1.293 -1.844 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.622 ' OD1' ' N ' ' A' ' 149' ' ' ASN . 1.8 p-10 -101.12 22.77 11.8 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 114.18 -1.01 . . . . 0.0 110.023 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -107.61 161.12 15.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.0 109.426 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 151' ' ' PHE . 35.0 p90 -136.79 127.07 26.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.1 149.43 5.05 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.956 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 1.2 p -56.06 -52.68 63.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.596 -0.943 . . . . 0.0 109.407 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.636 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 8.9 pm0 -56.55 -11.04 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.669 . . . . 0.0 110.857 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -101.63 49.64 0.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.804 -1.185 . . . . 0.0 109.348 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.672 ' NH1' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -116.54 165.06 13.68 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.635 ' N ' HE21 ' A' ' 143' ' ' GLN . 44.9 p -77.02 128.22 34.09 Favored 'General case' 0 CA--C 1.467 -2.237 0 CA-C-O 122.442 1.115 . . . . 0.0 108.25 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.493 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -137.31 129.49 29.38 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.282 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.625 ' CG1' ' CG2' ' A' ' 191' ' ' THR . 0.2 OUTLIER -139.41 108.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.011 177.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 160' ' ' TYR . 1.1 m-30 -107.08 134.32 19.93 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.56 168.96 17.49 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.364 2.043 . . . . 0.0 111.835 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -19.59 20.59 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.907 -1.12 . . . . 0.0 108.939 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER 179.57 -164.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.7 -15.6 20.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 123.005 1.383 . . . . 0.0 108.421 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.6 t -56.05 -64.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.541 HE22 ' HB2' ' A' ' 66' ' ' ALA . 23.6 mt-30 -79.6 -17.12 54.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.675 -0.641 . . . . 0.0 110.9 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.92 -44.09 66.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.847 -1.158 . . . . 0.0 110.04 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.23 -20.76 59.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.8 -54.3 3.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.76 -44.54 66.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 171' ' ' LEU . 52.4 mt -52.88 -39.65 62.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.642 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -74.52 -51.35 14.96 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 0.0 109.527 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.549 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.8 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.699 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.499 ' HZ3' HD11 ' A' ' 189' ' ' ILE . 6.8 tttp -73.05 -58.16 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.0 110.326 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.35 -27.86 61.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.916 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mm-40 -53.06 -31.32 40.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.961 -1.087 . . . . 0.0 110.129 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -80.22 -33.26 38.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 110.079 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 182' ' ' SER . 0.8 OUTLIER -52.8 -31.96 41.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.013 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.16 -20.39 52.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.804 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.74 -55.88 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.828 -1.17 . . . . 0.0 110.872 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . 7.3 mt -76.22 -19.88 57.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.052 -1.03 . . . . 0.0 110.737 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 2.2 t -55.01 -33.68 62.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.865 -1.147 . . . . 0.0 109.16 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -88.2 1.0 55.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -108.29 32.42 4.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.79 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 69.31 59.49 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 109.939 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 181' ' ' LEU . 38.4 m-85 -133.81 168.98 17.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.002 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -128.76 -149.0 6.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.65 119.65 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.358 2.039 . . . . 0.0 110.99 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.844 HG22 HG22 ' A' ' 142' ' ' THR . 1.1 pt -57.55 179.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.317 1.056 . . . . 0.0 111.097 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.672 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 1.5 p -139.46 58.39 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.816 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.625 ' CG2' ' CG1' ' A' ' 159' ' ' VAL . 21.7 m -99.55 120.44 39.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.649 ' OD1' ' NE ' ' A' ' 194' ' ' ARG . 15.0 t0 -77.93 122.45 25.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.448 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.426 ' CD1' ' HD3' ' A' ' 174' ' ' LYS . 0.8 OUTLIER -131.45 100.64 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.649 ' NE ' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -151.39 178.38 9.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -129.93 166.28 20.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.13 49.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 198' ' ' VAL . 0.4 OUTLIER -89.84 93.97 9.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.079 -1.248 . . . . 0.0 109.425 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 198' ' ' VAL . 7.4 p -41.11 122.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 109.597 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.489 ' CE1' ' HD3' ' A' ' 118' ' ' ARG . 25.4 t80 -77.79 150.39 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.299 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.448 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 6.8 m-85 -149.19 100.53 3.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -53.84 144.07 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -92.02 -170.83 2.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.359 -0.838 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.47 167.3 20.87 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-O 122.801 1.286 . . . . 0.0 110.309 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.612 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -53.8 -43.61 69.48 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.719 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.736 ' CD1' ' O ' ' A' ' 205' ' ' TYR . 0.2 OUTLIER -81.14 13.32 2.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.582 -1.324 . . . . 0.0 109.496 -178.233 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -102.71 6.41 39.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.747 -1.221 . . . . 0.0 109.706 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.837 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.4 mm-40 -127.61 -138.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.43 1.11 . . . . 0.0 109.772 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.593 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 18.8 mm-40 -34.15 -4.75 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.936 -1.484 . . . . 0.0 112.282 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.837 ' N ' ' O ' ' A' ' 207' ' ' GLN . 82.0 t80 -42.74 -46.32 5.09 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 120.398 -1.439 . . . . 0.0 109.896 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.649 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.6 OUTLIER -60.43 -17.14 42.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.57 -1.331 . . . . 0.0 110.109 -178.813 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 208' ' ' GLN . 36.6 p -70.53 -47.43 60.43 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 108.643 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -88.85 -7.77 55.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.352 -0.842 . . . . 0.0 110.121 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.66 ' CG ' ' CZ ' ' A' ' 209' ' ' TYR . 5.4 m-80 -129.19 77.15 78.15 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.0 110.102 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.57 10.82 0.92 Allowed 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.511 2.808 . . . . 0.0 112.46 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -61.75 -21.2 64.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.349 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.57 85.81 0.05 OUTLIER Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.46 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 216' ' ' GLY . 9.7 m-85 -47.21 -170.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 120.314 2.057 . . . . 0.0 109.67 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.43 78.32 4.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.914 -1.116 . . . . 0.0 109.745 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 220' ' ' LEU . . . -174.14 143.66 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.594 ' CD1' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 161.19 167.89 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 110.4 131.2 5.97 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.639 ' CA ' ' O ' ' A' ' 139' ' ' HIS . . . -173.43 140.52 5.62 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 139' ' ' HIS . 29.5 p . . . . . 0 C--N 1.295 -1.798 0 O-C-N 121.466 -1.02 . . . . 0.0 108.271 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.802 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.212 -0.899 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' VAL . 1.1 tp -38.6 132.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 122.057 0.932 . . . . 0.0 113.009 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.91 121.43 21.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 122.144 0.973 . . . . 0.0 110.203 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -51.7 -55.36 20.01 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.65 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -53.92 -8.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 2.5 mm-40 -110.61 -36.23 5.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.427 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.91 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 0.0 109.265 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.89 HD21 ' CG ' ' A' ' 110' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 O-C-N 121.207 -0.933 . . . . 0.0 109.141 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.34 -176.27 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.073 2.515 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 204' ' ' ASP . 15.8 m -147.95 -176.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.927 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 45' ' ' THR . 14.7 t -79.84 104.28 10.31 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.095 -1.003 . . . . 0.0 110.305 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.606 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.94 -29.77 63.42 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.305 -0.872 . . . . 0.0 111.496 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 5.5 pttt -88.52 100.04 12.77 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 115.93 -2.308 . . . . 0.0 108.113 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' A' ' 52' ' ' GLY . 7.2 t-80 -31.64 112.25 0.1 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.796 ' CD2' ' HZ2' ' A' ' 212' ' ' LYS . 13.9 t-80 -50.78 -37.46 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 110.625 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' HG3' ' A' ' 208' ' ' GLN . 18.0 t -72.15 -61.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -77.13 -36.08 55.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.567 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 83.61 0.11 89.79 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 40.5 p30 -78.72 -119.63 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.651 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 29.5 mtt180 -126.46 174.52 8.57 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 123.275 1.512 . . . . 0.0 109.59 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.692 ' C ' HG22 ' A' ' 56' ' ' VAL . 11.7 p -143.42 35.77 1.32 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.87 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.692 HG22 ' C ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -176.56 152.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 0.0 109.098 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -31.67 149.5 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.518 -0.739 . . . . 0.0 110.547 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' NH1' ' A' ' 54' ' ' ARG . 88.4 Cg_endo -79.3 165.94 79.62 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.013 -2.078 . . . . 0.0 112.158 0.065 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.59 129.56 24.25 Favored Pre-proline 0 C--N 1.27 -2.857 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 63' ' ' THR . 46.2 Cg_exo -49.65 148.39 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.083 1.855 . . . . 0.0 112.064 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 158.18 10.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.585 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.55 39.63 75.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -90.2 132.3 35.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -1.147 . . . . 0.0 110.649 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.772 ' NE2' ' CD1' ' A' ' 128' ' ' PHE . 36.7 tp60 -106.16 142.75 35.33 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -161.37 161.81 30.53 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.994 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.77 -167.11 1.77 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 74.5 t -141.78 127.85 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.158 -1.589 . . . . 0.0 108.607 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 1.046 ' O ' HG22 ' A' ' 117' ' ' VAL . 28.1 m-85 -114.87 135.16 54.5 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.835 -1.166 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.38 83.25 0.29 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.635 ' O ' ' O ' ' A' ' 155' ' ' TYR . 2.2 ptp -86.32 -80.99 0.22 Allowed 'General case' 0 C--N 1.282 -2.357 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.843 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 73' ' ' PHE . . . -139.36 -152.2 5.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.781 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -33.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.046 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.686 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -53.51 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 112.039 -177.488 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.781 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 10.9 m0 -70.3 -65.94 0.66 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.742 -1.224 . . . . 0.0 108.562 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.46 -12.07 82.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.68 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.26 -33.88 59.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 109.733 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.566 ' OE2' ' OE1' ' A' ' 208' ' ' GLN . 1.1 tt0 -83.36 -17.09 43.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.832 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -85.93 -52.04 5.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 110.227 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 9.4 mttp -47.91 -4.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.181 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 10.3 m-85 -104.5 -35.39 7.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.0 110.354 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.611 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -88.96 -0.62 57.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.747 -1.22 . . . . 0.0 110.426 -178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.3 m -88.32 5.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.003 -1.061 . . . . 0.0 110.145 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -116.95 179.33 4.05 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 109.664 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 137.46 37.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.929 -1.107 . . . . 0.0 111.529 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 123' ' ' PRO . . . 124.26 -50.1 0.87 Allowed Glycine 0 C--O 1.202 -1.859 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.763 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.562 HG23 ' CZ ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -53.91 136.85 15.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.715 -1.462 . . . . 0.0 111.582 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.718 ' CD1' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -75.13 -40.76 59.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.957 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.694 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 2.0 p -171.92 -174.84 1.38 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 88' ' ' SER . 62.6 p -160.15 128.79 4.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.068 -1.02 . . . . 0.0 109.534 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.694 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 3.0 mp0 -138.46 172.03 13.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.009 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.785 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -132.59 168.19 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -179.45 168.26 38.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -80.0 153.09 29.09 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.351 -1.088 . . . . 0.0 109.138 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.797 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -166.55 175.47 8.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.496 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 53.86 22.4 19.12 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.496 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -102.08 -151.43 23.99 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.516 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 3.7 m-70 -109.81 -41.15 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 109.768 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.94 172.83 17.42 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.478 ' HB2' ' CE1' ' A' ' 200' ' ' TYR . 0.3 OUTLIER -81.84 78.3 8.57 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.644 ' O ' ' O ' ' A' ' 101' ' ' PRO . 3.2 m120 -115.13 -130.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.324 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.644 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.3 Cg_exo -45.39 -156.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 123.672 2.347 . . . . 0.0 115.092 -175.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.767 ' O ' HG13 ' A' ' 106' ' ' VAL . 29.6 p -126.53 170.66 11.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.231 -0.918 . . . . 0.0 112.046 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.668 ' CD1' ' OE2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -50.21 -43.46 52.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.346 0.594 . . . . 0.0 110.016 179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.562 ' CD ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.05 -34.89 64.22 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.821 -1.174 . . . . 0.0 109.487 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 107' ' ' CYS . 1.7 mm-40 -83.56 -43.7 15.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.81 . . . . 0.0 110.749 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 1.091 HG12 HG21 ' A' ' 111' ' ' THR . 34.5 m -46.33 -21.66 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 120.881 -1.137 . . . . 0.0 109.439 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.487 ' C ' ' O ' ' A' ' 106' ' ' VAL . 10.2 t -36.84 -20.67 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.631 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -79.82 3.91 18.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.062 -1.024 . . . . 0.0 108.865 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.1 mt-10 64.76 3.8 2.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.89 ' CG ' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -72.93 -9.94 59.25 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.025 -1.672 . . . . 0.0 110.467 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . 1.091 HG21 HG12 ' A' ' 106' ' ' VAL . 1.7 p -105.01 -8.34 18.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.653 -1.279 . . . . 0.0 109.705 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 44.36 30.72 2.09 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 7.1 m-70 -81.68 170.01 16.3 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.908 -1.348 . . . . 0.0 109.386 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -129.03 114.33 16.27 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.668 ' OE2' ' CD1' ' A' ' 103' ' ' TYR . 1.6 mm-40 -40.19 120.94 1.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 108.934 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -140.55 162.77 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 110.262 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.046 HG22 ' O ' ' A' ' 68' ' ' PHE . 35.4 m -130.63 127.4 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.484 -0.76 . . . . 0.0 109.216 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -98.38 124.85 43.27 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 119' ' ' VAL . 4.2 m -133.85 125.88 49.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.018 -1.051 . . . . 0.0 108.723 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.718 HG22 ' CD1' ' A' ' 87' ' ' TYR . 1.8 m -96.39 146.55 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.717 -1.239 . . . . 0.0 107.971 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.858 ' CD2' HD22 ' A' ' 131' ' ' LEU . 2.9 m-30 -129.99 147.5 51.74 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.054 0.93 . . . . 0.0 108.661 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.985 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -179.31 27.21 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.985 ' HD3' ' N ' ' A' ' 122' ' ' ARG . 37.9 Cg_exo -73.79 -13.46 24.35 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 N-CA-C 119.436 2.821 . . . . 0.0 119.436 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.87 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.849 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -123.76 2.1 8.81 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.625 HD13 ' CG ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -153.85 132.93 3.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.547 -0.721 . . . . 0.0 109.834 -178.937 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.609 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -103.0 -177.89 3.5 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.04 0.924 . . . . 0.0 112.775 -177.546 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.912 ' HA ' HD21 ' A' ' 131' ' ' LEU . 35.7 t80 -69.82 -40.56 75.82 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.191 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.89 -14.49 47.03 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.805 -1.184 . . . . 0.0 108.809 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.625 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -74.58 -55.94 5.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 111.377 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.963 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.2 OUTLIER -59.99 -34.46 73.36 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 120.597 -1.314 . . . . 0.0 107.862 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 132' ' ' LEU . 1.5 mm? -66.12 -32.49 73.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -70.51 -62.53 1.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.38 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.716 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 25.5 t -49.37 -27.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.16 -0.963 . . . . 0.0 108.979 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.488 ' CE2' HG11 ' A' ' 159' ' ' VAL . 6.7 t80 -71.73 -50.74 27.39 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.794 -1.191 . . . . 0.0 109.889 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.947 ' O ' HG21 ' A' ' 223' ' ' THR . 55.1 m95 -72.4 -37.9 68.57 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.616 -1.303 . . . . 0.0 110.299 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -20.8 64.65 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.9 OUTLIER -131.56 59.48 1.69 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.161 -1.587 . . . . 0.0 111.768 -178.191 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.65 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 170.26 136.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.375 -0.828 . . . . 0.0 109.256 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.28 135.4 72.9 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.451 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 73.8 Cg_endo -75.58 -8.66 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.576 2.184 . . . . 0.0 112.558 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -118.04 56.0 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.228 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 144' ' ' GLY . 6.0 mm100 -118.73 62.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 108.739 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -45.27 -119.29 0.0 OUTLIER Glycine 0 N--CA 1.492 2.422 0 CA-C-O 121.81 0.672 . . . . 0.0 112.414 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.666 ' O ' ' SD ' ' A' ' 145' ' ' MET . 1.5 tmt? -69.84 35.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.507 -0.996 . . . . 0.0 110.648 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 144' ' ' GLY . 4.1 ttm180 -166.32 152.73 9.04 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.023 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.507 HE21 ' HG3' ' A' ' 143' ' ' GLN . 1.2 mm-40 -146.92 100.7 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.439 -1.413 . . . . 0.0 108.39 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 52.03 -119.6 9.23 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.499 ' H ' HD22 ' A' ' 220' ' ' LEU . 1.6 t-20 -81.72 8.86 8.95 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.744 -1.228 . . . . 0.0 110.13 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.36 147.85 29.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.99 -1.069 . . . . 0.0 109.409 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.1 p90 -136.67 129.63 30.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.144 -0.973 . . . . 0.0 110.088 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.5 158.59 7.75 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.415 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 153' ' ' THR . 0.1 OUTLIER -78.12 -4.6 48.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -1.146 . . . . 0.0 109.65 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.584 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 15.3 pm0 -88.38 3.06 51.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.029 -1.044 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.635 ' O ' ' O ' ' A' ' 70' ' ' MET . 93.2 m-85 -114.9 -12.56 12.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 111.053 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -39.62 172.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.571 -1.331 . . . . 0.0 110.195 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.707 ' OG ' HG23 ' A' ' 190' ' ' THR . 31.5 p -89.11 132.82 34.63 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.456 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -147.64 123.08 10.36 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 117.68 -1.608 . . . . 0.0 111.58 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.677 HG13 ' CG2' ' A' ' 191' ' ' THR . 2.8 m -119.85 130.55 74.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.766 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.483 ' CE2' HG11 ' A' ' 116' ' ' VAL . 10.1 m-30 -112.85 131.66 22.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.105 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.35 169.38 20.17 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.86 2.373 . . . . 0.0 112.624 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.4 OUTLIER -103.14 -6.64 22.0 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.039 -1.038 . . . . 0.0 109.498 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.622 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 166.44 173.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 108.813 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -47.07 -14.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.989 1.376 . . . . 0.0 108.231 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.622 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.3 t -55.54 -61.3 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 170' ' ' ALA . 1.2 mp0 -60.88 -11.62 8.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.557 -0.714 . . . . 0.0 110.378 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttt -51.87 -43.61 63.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 109.919 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.673 ' O ' ' NH1' ' A' ' 172' ' ' ARG . 2.6 tm-20 -75.66 -22.68 56.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -93.06 -56.32 3.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.421 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.96 -58.97 4.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 109.683 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 171' ' ' LEU . 63.2 mt -52.24 -35.68 50.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.08 -1.013 . . . . 0.0 109.244 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.673 ' NH1' ' O ' ' A' ' 168' ' ' GLU . 13.4 ttp-105 -74.52 -55.92 5.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.524 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -56.54 -37.08 70.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.481 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -68.09 -53.15 27.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -73.0 2.21 7.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.66 -56.52 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -27.37 65.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 109.941 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.679 ' NE2' ' OG ' ' A' ' 182' ' ' SER . 0.5 OUTLIER -53.24 -53.85 44.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.171 -0.955 . . . . 0.0 109.666 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -15.55 63.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.89 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.7 t -87.22 -54.2 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 183' ' ' LYS . 35.2 mt -75.26 -45.93 36.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.164 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.679 ' OG ' ' NE2' ' A' ' 178' ' ' GLN . 61.1 m -56.23 -3.05 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 0.0 109.685 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -88.02 -21.29 24.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.306 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.459 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 14.1 m-70 -107.99 14.4 25.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 8.2 t-20 71.92 68.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.21 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.42 173.55 52.99 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.64 174.27 11.99 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.825 2.35 . . . . 0.0 112.245 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 189' ' ' ILE . 0.8 OUTLIER -80.99 116.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.006 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.707 HG23 ' OG ' ' A' ' 157' ' ' SER . 5.2 t -100.37 -5.21 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.002 -1.061 . . . . 0.0 109.544 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.677 ' CG2' HG13 ' A' ' 159' ' ' VAL . 47.0 m -43.6 112.65 0.41 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 7.2 t0 -77.17 132.93 39.03 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.924 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 194' ' ' ARG . 0.8 OUTLIER -133.41 125.66 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.418 -0.801 . . . . 0.0 108.909 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 69.7 mtm-85 -157.11 152.19 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 109.307 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.8 OUTLIER -115.36 -174.51 2.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.53 56.48 8.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -116.25 148.04 40.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -1.213 . . . . 0.0 109.573 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 200' ' ' TYR . 1.3 p -87.7 165.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 55.2 t80 -125.56 132.3 52.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 109.964 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.772 ' CZ ' HG11 ' A' ' 198' ' ' VAL . 35.0 m-85 -128.32 104.39 7.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.822 . . . . 0.0 109.109 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.8 m-85 -54.98 141.48 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 110.572 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.555 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -85.0 -169.3 2.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.574 ' HG3' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -76.0 153.26 36.63 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -56.54 -37.89 71.12 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.083 -1.01 . . . . 0.0 108.318 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.563 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -60.85 -14.55 22.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.635 -0.665 . . . . 0.0 110.635 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.494 ' O ' HG21 ' A' ' 91' ' ' VAL . 20.2 m-70 -99.02 -4.05 33.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.856 -1.152 . . . . 0.0 110.118 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.855 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.1 mt-30 -110.41 -133.07 0.33 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 122.752 1.263 . . . . 0.0 110.568 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -33.63 -5.06 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.887 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.855 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.2 t80 -42.56 -44.43 4.15 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.673 -1.267 . . . . 0.0 109.936 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.625 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -59.23 -17.23 26.34 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.439 -1.413 . . . . 0.0 110.016 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.466 ' OG ' ' ND1' ' A' ' 49' ' ' HIS . 71.1 p -73.26 -31.31 64.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.796 ' HZ2' ' CD2' ' A' ' 49' ' ' HIS . 10.9 mmtm -87.72 -33.91 18.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.866 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.689 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 26.2 m120 -121.71 82.42 41.52 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.46 9.88 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.206 2.604 . . . . 0.0 112.164 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -63.52 -11.92 28.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.13 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.31 85.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.766 -1.206 . . . . 0.0 111.449 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.601 ' O ' ' O ' ' A' ' 216' ' ' GLY . 33.1 t80 -52.31 -158.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.6 2.2 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.581 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 18.1 m -90.3 78.08 6.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.852 -1.155 . . . . 0.0 109.378 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.89 ' O ' HD12 ' A' ' 220' ' ' LEU . . . -88.62 -169.27 44.74 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -152.41 178.96 8.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -1.223 . . . . 0.0 109.673 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -153.98 -162.33 11.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -170.85 -136.53 2.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.947 HG21 ' O ' ' A' ' 136' ' ' TRP . 47.4 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.342 -1.093 . . . . 0.0 109.436 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.18 132.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 122.315 1.055 . . . . 0.0 113.77 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.87 125.55 29.3 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.282 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.961 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -50.41 -27.21 6.0 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.15 3.37 31.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.29 4.55 13.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.617 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.32 178.96 8.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.399 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 168.37 23.3 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.737 2.291 . . . . 0.0 112.217 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -148.67 -166.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.005 . . . . 0.0 109.586 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 45' ' ' THR . 13.5 t -93.46 94.0 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.02 -45.41 79.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.282 -0.886 . . . . 0.0 111.016 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -83.43 99.94 10.4 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 115.775 -2.37 . . . . 0.0 108.597 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.661 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 15.1 t-80 -30.97 137.01 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.28 -7.47 56.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.267 -0.896 . . . . 0.0 111.139 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 55.1 t -95.51 -55.31 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.828 -1.17 . . . . 0.0 109.967 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -89.98 -43.95 10.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.97 5.37 53.51 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.695 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.37 -117.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.695 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.8 ttp180 -129.2 170.35 13.68 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 123.223 1.487 . . . . 0.0 108.84 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.6 p -133.56 32.39 3.61 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.544 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.569 HG22 ' C ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -164.71 133.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.214 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.8 pm0 -33.08 148.87 0.06 OUTLIER Pre-proline 0 C--N 1.305 -1.348 0 O-C-N 121.436 -0.79 . . . . 0.0 110.574 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 92.3 Cg_endo -78.03 166.4 80.9 Favored 'Cis proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.866 -2.139 . . . . 0.0 111.545 -0.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.522 ' CE1' HG11 ' A' ' 120' ' ' VAL . 28.6 m-85 -106.32 156.47 36.88 Favored Pre-proline 0 C--N 1.268 -2.973 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.86 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.591 ' CG ' ' CD2' ' A' ' 87' ' ' TYR . 47.8 Cg_exo -49.62 129.28 23.15 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.24 1.96 . . . . 0.0 112.147 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.687 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 1.9 pm0 -43.35 144.31 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.85 . . . . 0.0 109.134 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.34 1.11 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 137.13 28.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -1.06 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.9 tt0 -106.51 136.37 46.41 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.731 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.85 127.9 27.75 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.85 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 -168.79 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 67' ' ' VAL . 43.9 t -143.57 98.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 119.9 -1.75 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -137.52 164.35 28.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.545 178.135 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.58 162.64 33.56 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.971 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.596 ' O ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -115.71 -86.01 0.61 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -132.42 -151.41 6.74 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.784 ' SG ' ' CZ3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -28.58 114.4 0.08 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.521 -0.988 . . . . 0.0 108.992 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -53.0 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.769 -0.582 . . . . 0.0 111.75 -178.316 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.784 ' CZ3' ' SG ' ' A' ' 72' ' ' CYS . 16.1 m0 -84.59 -63.34 1.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.487 -1.383 . . . . 0.0 109.646 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.24 74.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.745 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.04 -38.17 57.48 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.247 -1.149 . . . . 0.0 109.76 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.418 ' OE2' ' CA ' ' A' ' 90' ' ' GLN . 3.6 tt0 -84.5 -14.82 48.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.907 -1.121 . . . . 0.0 110.554 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.71 ' O ' HG13 ' A' ' 82' ' ' VAL . 13.1 ttp180 -76.25 -74.2 0.24 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.025 -1.047 . . . . 0.0 110.556 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.484 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -48.39 -2.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.955 -1.09 . . . . 0.0 110.26 -179.275 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.8 m-85 -108.64 -24.18 11.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.756 ' CH2' HD12 ' A' ' 210' ' ' LEU . 0.1 OUTLIER -104.63 -2.89 24.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.719 -1.238 . . . . 0.0 111.122 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.1 m -97.76 11.54 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.686 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -112.0 178.7 4.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.117 -0.989 . . . . 0.0 109.325 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -98.83 137.53 37.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.0 111.536 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.511 ' HA3' HD12 ' A' ' 126' ' ' ILE . . . 124.28 -33.25 3.88 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -78.61 135.86 25.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.448 -1.031 . . . . 0.0 111.049 -178.783 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.655 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -75.81 -40.24 55.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.71 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.532 ' HB3' HD21 ' A' ' 53' ' ' ASN . 0.9 OUTLIER -174.43 -173.62 0.78 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.593 HG21 ' HB3' ' A' ' 81' ' ' TRP . 39.7 p -144.12 163.01 34.83 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.521 ' OE1' ' OG ' ' A' ' 88' ' ' SER . 1.3 mp0 -154.89 140.03 17.49 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.092 HG12 HG22 ' A' ' 117' ' ' VAL . 3.2 m -127.21 162.79 31.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.951 -1.093 . . . . 0.0 109.521 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.94 177.69 48.13 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.522 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -102.64 168.46 9.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 110.046 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.707 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.19 -170.37 0.17 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 51.25 40.78 45.85 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.738 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -106.05 -158.02 22.15 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.961 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -149.68 58.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.986 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -178.86 7.66 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.02 -1.05 . . . . 0.0 108.335 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -52.76 -93.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.387 -0.821 . . . . 0.0 108.79 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -123.06 71.99 44.57 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.911 . . . . 0.0 109.286 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 52.0 Cg_exo -48.85 131.9 25.71 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.495 2.13 . . . . 0.0 111.633 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.64 HG22 ' HG3' ' A' ' 105' ' ' GLU . 1.8 t -121.25 171.3 8.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' ' CB ' ' A' ' 107' ' ' CYS . 40.8 t80 -49.23 -43.71 42.9 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -42.46 92.0 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.599 -0.688 . . . . 0.0 109.399 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.64 ' HG3' HG22 ' A' ' 102' ' ' THR . 2.0 mm-40 -74.77 -54.61 7.03 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.812 -1.18 . . . . 0.0 110.933 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.993 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.0 m -73.09 -25.17 21.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.028 -1.045 . . . . 0.0 111.354 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -38.78 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.69 ' N ' ' O ' ' A' ' 106' ' ' VAL . 84.2 p -76.94 -81.1 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 108' ' ' SER . 0.0 OUTLIER 156.85 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' N ' ' HG2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -53.55 2.79 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 -177.077 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.993 ' OG1' HG12 ' A' ' 106' ' ' VAL . 32.2 p -96.53 -6.14 37.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.25 -1.531 . . . . 0.0 108.961 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 52.92 25.54 23.84 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.829 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.738 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -69.77 159.64 33.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.281 -1.717 . . . . 0.0 109.168 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.642 ' O ' HG13 ' A' ' 116' ' ' VAL . . . -112.38 112.45 24.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.335 -0.853 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.667 ' OE1' ' N ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -48.84 109.0 0.21 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.415 -0.803 . . . . 0.0 108.986 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 114' ' ' ALA . 16.0 m -124.71 137.4 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 91' ' ' VAL . 1.5 t -113.79 123.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.506 HH21 HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -97.82 116.18 29.52 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.313 -0.867 . . . . 0.0 109.342 -179.007 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.8 140.81 47.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.451 -0.781 . . . . 0.0 108.909 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.648 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m -107.26 158.77 7.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.322 -0.862 . . . . 0.0 108.808 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.926 ' CG ' HD22 ' A' ' 131' ' ' LEU . 4.4 m-85 -141.91 155.84 45.5 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.826 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -101.04 106.13 42.79 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.405 -0.81 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 55.3 Cg_exo -47.75 -26.46 6.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.685 2.256 . . . . 0.0 112.5 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.15 -18.6 52.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -121.06 -7.62 9.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.647 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.511 HD12 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -154.1 156.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 110.488 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -108.17 147.68 30.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.715 . . . . 0.0 109.73 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.723 ' CZ ' HD23 ' A' ' 132' ' ' LEU . 2.1 t80 -49.79 -21.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.442 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -63.62 -23.44 67.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.147 -0.97 . . . . 0.0 109.128 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 131' ' ' LEU . 2.5 mt-10 -71.41 -71.53 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.995 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -35.3 -47.87 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.088 -1.007 . . . . 0.0 109.579 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.824 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.8 pp -75.82 -28.93 58.49 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.095 -1.003 . . . . 0.0 111.385 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.729 ' N ' HD12 ' A' ' 132' ' ' LEU . 4.3 mtmt -70.41 -58.16 4.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.671 -1.268 . . . . 0.0 110.312 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.647 ' CG1' ' CE2' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -48.76 -28.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 108.897 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.704 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 38.5 t80 -65.25 -54.8 23.93 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.815 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.557 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 86.8 m95 -71.78 -42.54 67.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.356 -1.465 . . . . 0.0 109.79 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.8 -35.37 22.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.0 111.021 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -127.83 72.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.946 -1.096 . . . . 0.0 111.275 -178.242 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 223' ' ' THR . 6.3 m80 -150.6 151.62 32.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.612 ' OD1' ' NE2' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.38 177.77 0.33 Allowed Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.746 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HB3' HD12 ' A' ' 181' ' ' LEU . 3.4 Cg_endo -79.87 -91.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.16 1.907 . . . . 0.0 111.405 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.686 HG22 ' HA ' ' A' ' 189' ' ' ILE . 32.9 p -123.89 54.96 1.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.42 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.597 ' C ' ' H ' ' A' ' 145' ' ' MET . 3.7 mt-30 -101.68 51.46 0.84 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.837 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.685 ' H ' HG21 ' A' ' 190' ' ' THR . . . -61.07 10.13 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.177 -1.487 . . . . 0.0 109.729 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.597 ' H ' ' C ' ' A' ' 143' ' ' GLN . 2.3 ptt? -117.13 13.23 14.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.028 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' GLN . 4.9 tmm_? -178.32 152.68 0.7 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.001 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.612 ' NE2' ' OD1' ' A' ' 140' ' ' ASP . 0.6 OUTLIER -134.53 76.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.409 -1.432 . . . . 0.0 108.8 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.76 -110.37 3.44 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.05 -32.84 39.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 114.453 -0.874 . . . . 0.0 111.901 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 148.39 22.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 109.339 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.91 156.84 47.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.912 -1.118 . . . . 0.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.94 179.47 16.23 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -18.62 37.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -1.184 . . . . 0.0 109.352 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 5.9 pt20 -88.61 4.25 47.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.123 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 67.7 m-85 -122.06 52.37 1.28 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.633 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 70' ' ' MET . 2.4 mtm105 -108.43 -170.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.504 -0.748 . . . . 0.0 109.152 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.72 126.14 35.9 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -133.52 131.84 40.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.443 -1.703 . . . . 0.0 111.104 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.769 HG13 ' CG2' ' A' ' 191' ' ' THR . 1.2 m -135.55 119.0 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.562 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.491 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 2.8 m-30 -116.02 129.76 24.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.73 168.34 22.57 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.381 2.054 . . . . 0.0 112.131 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -20.49 20.09 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.907 -1.121 . . . . 0.0 109.222 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 177.18 -171.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 168' ' ' GLU . . . -53.12 -15.25 0.8 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.995 1.379 . . . . 0.0 108.52 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.52 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.6 t -55.75 -64.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.891 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 18.1 mt-30 -78.74 -20.92 48.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.556 -0.715 . . . . 0.0 110.651 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 12.4 ttp -52.2 -31.96 34.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.54 ' OE1' ' O ' ' A' ' 164' ' ' ALA . 2.8 mp0 -75.35 -36.25 61.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.772 -1.205 . . . . 0.0 109.79 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.566 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.77 -47.33 7.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.086 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.75 -63.15 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.07 -34.69 44.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.974 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -74.93 -35.33 62.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.192 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -59.18 -46.18 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.475 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -72.39 -25.23 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.005 . . . . 0.0 109.744 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 69.5 mt-10 -73.19 -56.82 4.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.664 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.571 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 15.7 pt-20 -53.25 -45.55 68.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.571 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -68.17 -20.54 64.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.631 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.501 HE21 ' HB2' ' A' ' 182' ' ' SER . 43.3 tp60 -74.64 -38.19 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -29.79 52.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.674 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 176' ' ' GLU . 99.2 t -74.38 -54.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.724 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 141' ' ' PRO . 4.5 mm? -64.31 -42.31 96.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.737 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.501 ' HB2' HE21 ' A' ' 178' ' ' GLN . 23.0 t -56.38 -6.22 0.26 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 181' ' ' LEU . 3.8 tttp -88.09 -10.55 49.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.605 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.597 ' O ' ' OD1' ' A' ' 185' ' ' ASN . 0.4 OUTLIER -108.4 35.96 2.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.702 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.597 ' OD1' ' O ' ' A' ' 184' ' ' HIS . 1.0 OUTLIER 72.96 31.01 1.58 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.525 -0.734 . . . . 0.0 110.004 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -105.19 174.65 5.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.18 -147.17 6.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 189' ' ' ILE . 29.6 Cg_exo -58.79 106.29 0.27 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.542 2.161 . . . . 0.0 111.451 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.686 ' HA ' HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.34 -177.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.834 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.685 HG21 ' H ' ' A' ' 144' ' ' GLY . 1.8 p -133.91 68.68 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.691 0.758 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.769 ' CG2' HG13 ' A' ' 159' ' ' VAL . 24.5 m -98.39 119.88 37.84 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.627 ' OD1' ' CZ ' ' A' ' 194' ' ' ARG . 2.0 t70 -75.36 121.04 21.64 Favored 'General case' 0 C--N 1.279 -2.485 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.492 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.55 109.57 14.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.627 ' CZ ' ' OD1' ' A' ' 192' ' ' ASP . 1.9 ptp180 -166.75 120.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.709 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 1.9 pm0 -80.81 -179.32 7.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.529 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.49 22.75 61.78 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.491 ' HG3' ' CE2' ' A' ' 160' ' ' TYR . 53.0 mm-40 -93.31 98.29 11.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.612 -1.522 . . . . 0.0 109.516 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.58 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.4 p -42.98 161.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.468 -0.77 . . . . 0.0 109.794 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 41.3 t80 -109.31 131.43 55.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.505 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.408 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 6.8 m-85 -127.54 98.65 5.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.67 131.52 39.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.982 -1.074 . . . . 0.0 110.584 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -83.58 179.14 7.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.0 OUTLIER -74.64 170.57 15.54 Favored 'General case' 0 C--N 1.286 -2.153 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 179.514 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -63.93 -13.43 45.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.897 . . . . 0.0 109.841 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -76.77 -15.75 59.66 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.912 -1.118 . . . . 0.0 110.182 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 74' ' ' TRP . 63.5 m-70 -107.35 8.89 29.94 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.677 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.751 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.7 mm-40 -119.88 -149.98 0.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.822 -1.174 . . . . 0.0 112.087 -177.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.691 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 2.5 mp0 -36.25 -2.49 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.73 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.751 ' N ' ' O ' ' A' ' 207' ' ' GLN . 10.6 p90 -46.79 -34.75 5.54 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 117.373 -1.731 . . . . 0.0 110.705 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.756 HD12 ' CH2' ' A' ' 81' ' ' TRP . 1.7 mt -49.44 -10.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.403 -1.436 . . . . 0.0 110.042 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 209' ' ' TYR . 11.4 p -53.21 -37.02 61.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -84.75 -36.74 21.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.1 66.79 3.09 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.594 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 10.0 Cg_endo -54.9 -39.76 88.77 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.997 2.465 . . . . 0.0 113.16 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.596 ' C ' HH12 ' A' ' 78' ' ' ARG . 29.6 p30 -61.23 -5.6 1.66 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.787 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 218' ' ' CYS . . . 58.99 84.41 0.04 OUTLIER Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.561 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.626 ' OH ' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -48.82 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 121.017 2.408 . . . . 0.0 109.452 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 216' ' ' GLY . 31.4 p -166.12 -125.15 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.769 -1.207 . . . . 0.0 109.143 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.631 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -128.04 -149.94 7.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.564 ' N ' HD23 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -114.23 -175.02 2.59 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.36 -1.083 . . . . 0.0 109.641 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.86 -139.28 0.05 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -153.42 -142.02 3.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.847 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.521 -0.987 . . . . 0.0 109.455 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 CA--C 1.505 -0.77 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.452 HG12 ' HB2' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -76.82 135.78 25.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -173.623 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -82.23 131.28 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.151 0.977 . . . . 0.0 110.243 -179.172 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 97' ' ' HIS . . . -45.9 -55.68 6.41 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.494 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -85.03 8.28 18.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.765 -1.209 . . . . 0.0 111.73 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.472 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 3.2 tt0 -117.59 -14.3 10.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.444 -1.41 . . . . 0.0 111.501 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.812 ' C ' HD13 ' A' ' 35' ' ' LEU . . . -67.39 -169.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.541 -1.35 . . . . 0.0 109.45 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.997 ' N ' HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.591 ' CG2' ' O ' ' A' ' 201' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.75 ' O ' HG13 ' A' ' 44' ' ' VAL . 71.5 Cg_endo -81.37 149.86 17.06 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.06 2.507 . . . . 0.0 112.751 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 43' ' ' PRO . 3.2 m -163.37 158.92 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.416 -0.802 . . . . 0.0 109.493 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.851 HG23 ' O ' ' A' ' 45' ' ' THR . 15.2 t -59.43 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.908 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.586 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.91 -21.79 22.38 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.235 -0.916 . . . . 0.0 110.759 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.6 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.8 OUTLIER -90.93 100.15 13.06 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 116.344 -2.143 . . . . 0.0 108.03 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.631 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 7.8 t-80 -31.48 132.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.633 ' CD2' ' HE2' ' A' ' 212' ' ' LYS . 0.3 OUTLIER -82.72 -11.43 58.32 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.104 -0.998 . . . . 0.0 111.234 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.648 HG22 ' OG ' ' A' ' 211' ' ' SER . 21.9 t -85.6 -36.34 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 108.207 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -45.14 3.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.011 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.11 54.27 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 66.7 m-20 -76.32 -116.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.547 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.89 174.06 10.1 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 123.497 1.617 . . . . 0.0 109.606 177.563 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.762 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.9 p -142.34 38.57 1.56 Allowed 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.07 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 55' ' ' THR . 4.6 m -163.89 138.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.995 -1.066 . . . . 0.0 109.795 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 8.1 pt-20 -71.78 177.33 1.71 Allowed Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 2.9 Cg_exo -49.26 143.62 6.21 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 N-CA-C 116.067 1.526 . . . . 0.0 116.067 -0.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 37.6 m-85 -94.56 110.44 49.04 Favored Pre-proline 0 C--N 1.272 -2.768 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.577 ' O ' ' OG1' ' A' ' 63' ' ' THR . 50.1 Cg_exo -50.38 133.45 36.88 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.331 2.021 . . . . 0.0 112.387 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 60' ' ' PRO . 50.8 mt-10 -43.59 157.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 63' ' ' THR . . . 83.14 32.0 27.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -158.71 137.93 11.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -1.174 . . . . 0.0 109.474 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.663 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 20.6 mp0 -111.55 156.67 21.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.123 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.742 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -140.78 114.62 8.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.965 . . . . 0.0 109.904 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.64 -170.71 1.69 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.93 . . . . 0.0 108.802 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.14 133.55 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.049 -1.657 . . . . 0.0 109.518 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.713 ' CE2' ' O ' ' A' ' 131' ' ' LEU . 25.9 m-85 -126.41 145.22 50.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.828 -1.17 . . . . 0.0 109.293 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.03 108.93 1.72 Allowed Glycine 0 N--CA 1.482 1.715 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.62 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -114.3 -87.84 0.57 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.403 -1.057 . . . . 0.0 108.502 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.569 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -148.19 -152.19 5.63 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.671 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -36.18 104.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.779 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -50.67 7.28 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.679 ' HB3' HD11 ' A' ' 210' ' ' LEU . 37.9 m0 -75.27 -52.23 11.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.656 -1.278 . . . . 0.0 109.417 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' A' ' 218' ' ' CYS . . . -88.8 -26.96 25.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.62 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . -64.85 -45.2 87.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.105 -1.233 . . . . 0.0 110.173 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.486 ' OE1' HG13 ' A' ' 91' ' ' VAL . 4.2 tt0 -83.03 -14.77 53.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.126 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.536 ' O ' HG13 ' A' ' 82' ' ' VAL . 51.4 ttp85 -68.6 -36.12 78.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.0 110.067 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -70.49 15.76 0.09 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.0 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 93.2 m-85 -123.73 -42.25 2.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 110.644 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.601 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -68.77 6.88 0.76 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.553 -1.342 . . . . 0.0 109.268 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.5 m -109.53 15.97 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 109.369 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.9 mt -110.84 154.64 23.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.98 138.42 31.5 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.353 0.596 . . . . 0.0 109.561 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.84 -27.35 14.96 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -70.26 137.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.53 -0.982 . . . . 0.0 108.999 179.63 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.549 ' CE1' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -79.94 -46.69 16.27 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.549 ' OG ' ' CE1' ' A' ' 87' ' ' TYR . 1.4 p -165.7 -170.21 1.74 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.631 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 41.4 p -151.16 146.42 26.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 108.989 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.773 HE21 ' HD3' ' A' ' 118' ' ' ARG . 1.1 mp0 -144.59 155.8 43.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 110.13 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -141.05 151.95 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.2 42.82 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.374 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.2 m-85 -80.1 171.68 14.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.951 . . . . 0.0 109.252 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -176.95 168.73 2.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 109.667 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 64.64 20.88 66.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.564 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -93.83 173.72 33.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.731 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 1.2 m-70 -91.66 -111.83 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.544 -1.563 . . . . 0.0 111.404 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.604 ' O ' ' C ' ' A' ' 99' ' ' ARG . 5.9 t -75.98 -172.88 2.12 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.604 ' C ' ' O ' ' A' ' 98' ' ' THR . 0.1 OUTLIER -37.81 139.26 0.32 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.919 ' H ' ' ND2' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -128.38 144.87 53.54 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -172.414 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 100' ' ' ASN . 73.5 Cg_exo -45.68 -147.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 124.133 3.222 . . . . 0.0 112.214 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.543 HG22 ' HG3' ' A' ' 105' ' ' GLU . 1.5 t -125.53 176.1 7.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.971 -1.08 . . . . 0.0 111.514 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.786 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -50.81 -41.1 57.09 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.531 0.682 . . . . 0.0 110.397 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 12.7 tttp -72.59 -33.44 66.72 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.146 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.676 ' C ' ' HZ1' ' A' ' 110' ' ' LYS . 1.9 mm-40 -81.71 -41.2 21.65 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 110.47 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.919 HG12 ' CG2' ' A' ' 111' ' ' THR . 28.3 m -56.29 -23.32 16.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.061 -1.024 . . . . 0.0 109.85 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' A' ' 106' ' ' VAL . 69.0 m -41.66 -15.48 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.687 ' N ' ' O ' ' A' ' 106' ' ' VAL . 35.6 m -102.67 19.81 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 110.006 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER 60.08 -9.38 0.05 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.92 -1.112 . . . . 0.0 109.647 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.679 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -44.67 -14.32 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.739 -0.6 . . . . 0.0 111.691 -178.257 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.919 ' CG2' HG12 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -122.09 -10.0 8.63 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.554 -1.342 . . . . 0.0 111.481 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 60.74 24.87 62.84 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 118.527 -1.796 . . . . 0.0 109.771 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.71 ' HE2' ' CG ' ' A' ' 100' ' ' ASN . 1.8 m-70 -78.83 172.41 13.8 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.992 -1.299 . . . . 0.0 109.274 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -137.25 125.26 22.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.674 ' OE2' ' CZ ' ' A' ' 73' ' ' PHE . 3.5 mt-10 -66.33 119.7 12.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.232 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -125.05 169.74 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.761 ' HA ' HG12 ' A' ' 91' ' ' VAL . 15.8 m -127.13 128.22 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.376 -0.827 . . . . 0.0 109.519 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.773 ' HD3' HE21 ' A' ' 90' ' ' GLN . 8.9 ttm180 -103.48 111.83 24.46 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.551 -0.718 . . . . 0.0 109.886 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.72 112.89 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 65' ' ' MET . 0.8 OUTLIER -98.49 160.72 3.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 108.94 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 10.5 p90 -141.23 169.5 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.581 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.513 ' C ' ' OE2' ' A' ' 124' ' ' GLU . 60.7 mtp180 -110.05 114.1 56.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' HIS . 38.3 Cg_exo -42.94 -63.97 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.927 2.418 . . . . 0.0 113.022 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.692 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -46.45 -10.67 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 -179.175 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' PRO . 36.1 m80 -126.13 -18.86 4.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.617 -1.302 . . . . 0.0 110.716 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.484 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.59 158.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.873 -1.142 . . . . 0.0 110.212 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.5 p -108.8 153.19 23.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.825 . . . . 0.0 110.369 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' C ' ' N ' ' A' ' 130' ' ' GLU . 25.1 t80 -53.63 -30.1 41.19 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 3.0 mp0 -47.35 -19.26 0.15 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 128' ' ' PHE . 1.5 mm-40 -73.84 -63.02 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.827 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.713 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 7.2 mt -44.74 -45.74 10.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.253 -0.904 . . . . 0.0 108.785 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.891 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.5 pp -75.04 -21.96 58.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.495 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.675 ' N ' HD12 ' A' ' 132' ' ' LEU . 0.4 OUTLIER -69.94 -68.13 0.44 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.736 -1.227 . . . . 0.0 110.057 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.737 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 38.9 t -58.3 -17.22 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.58 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 7.2 t80 -72.45 -60.27 2.31 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.844 -1.16 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.658 ' CB ' ' CE2' ' A' ' 177' ' ' TYR . 94.1 m95 -72.06 -52.84 14.94 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.468 -1.395 . . . . 0.0 110.348 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 136' ' ' TRP . 4.1 tt0 -36.84 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.557 -0.714 . . . . 0.0 111.86 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.737 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -124.0 64.76 1.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.609 -1.307 . . . . 0.0 111.734 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.824 ' O ' HG23 ' A' ' 223' ' ' THR . 13.0 m80 -147.95 161.25 41.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.201 -0.937 . . . . 0.0 109.056 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.553 ' HA ' ' H ' ' A' ' 223' ' ' THR . 0.9 OUTLIER -91.77 160.32 36.46 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.086 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 186' ' ' PHE . 79.8 Cg_exo -32.62 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.572 2.181 . . . . 0.0 111.792 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.707 ' OG1' ' N ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -122.21 14.77 10.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.793 -1.192 . . . . 0.0 109.005 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.478 ' OE1' ' CG ' ' A' ' 140' ' ' ASP . 3.5 mt-30 -55.4 71.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.61 10.17 62.84 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.97 15.53 15.14 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 148' ' ' GLY . 4.3 ttm180 179.3 133.62 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.326 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 70' ' ' MET . 2.0 tp60 -109.54 63.67 0.6 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 119.731 -1.856 . . . . 0.0 107.894 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' CD ' ' A' ' 146' ' ' ARG . . . 91.96 -118.07 5.41 Favored Glycine 0 C--N 1.301 -1.413 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -32.75 47.54 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.458 -0.871 . . . . 0.0 111.434 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -76.95 117.46 18.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.28 -1.513 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 35.6 p90 -109.21 131.89 54.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.928 . . . . 0.0 110.716 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.06 164.51 25.9 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.023 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.574 ' OG1' ' OE2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -72.13 -23.42 61.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.589 -0.948 . . . . 0.0 109.629 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.718 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 7.2 pm0 -89.17 3.7 51.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.453 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 22.5 m-85 -112.59 50.03 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 109.37 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 144' ' ' GLY . 1.6 mtm180 -97.37 -178.65 4.23 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 109.236 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 192' ' ' ASP . 3.8 t -93.9 112.95 24.87 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -145.17 123.18 12.06 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 117.866 -1.533 . . . . 0.0 112.036 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 191' ' ' THR . 4.5 t -112.26 127.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.689 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.615 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.5 m-85 -112.88 93.02 22.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.323 -0.86 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -49.12 172.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.838 2.358 . . . . 0.0 112.186 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.516 HG21 ' SD ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -107.44 -44.24 4.35 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.191 -0.943 . . . . 0.0 109.698 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.509 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER -175.12 -178.02 1.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.12 -0.988 . . . . 0.0 109.902 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.18 -24.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 123.252 1.501 . . . . 0.0 108.255 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.649 ' O ' ' CG ' ' A' ' 168' ' ' GLU . 2.5 t -56.43 -53.81 35.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.38 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.472 ' C ' ' H ' ' A' ' 168' ' ' GLU . 3.6 tt0 -78.51 -20.92 49.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.336 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' MET . . . . . 0.674 ' CG ' HD22 ' A' ' 171' ' ' LEU . 22.8 ttm -52.95 -4.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER -73.58 -68.48 0.5 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.845 -1.159 . . . . 0.0 110.583 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -92.74 -42.92 9.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -0.987 . . . . 0.0 111.175 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -51.68 -65.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.968 -1.082 . . . . 0.0 110.169 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.674 HD22 ' CG ' ' A' ' 167' ' ' MET . 0.4 OUTLIER -55.04 -40.14 69.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.045 -1.034 . . . . 0.0 109.431 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -74.26 -24.17 59.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.648 ' N ' ' O ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -67.23 -32.31 73.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.583 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.595 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 8.1 pttm -72.36 -47.14 51.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.997 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CG ' ' A' ' 174' ' ' LYS . 15.3 tt0 -72.86 -30.38 63.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.518 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.639 ' OE2' ' CD2' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -73.22 -40.79 64.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.0 -1.062 . . . . 0.0 110.819 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.658 ' CE2' ' CB ' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -80.12 -25.61 39.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.748 -1.22 . . . . 0.0 110.238 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -74.76 -26.44 59.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 109.912 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 1.4 ttpm? -77.89 -20.04 53.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.22 -54.11 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.76 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.1 mt -66.38 -13.09 60.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.963 . . . . 0.0 109.75 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -59.48 -40.66 87.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -88.04 10.61 18.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.95 . . . . 0.0 109.659 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.516 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 14.3 m170 -104.49 35.11 2.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 68.31 48.55 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 141' ' ' PRO . 71.7 m-85 -152.5 168.61 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.31 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -117.83 -144.42 7.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -58.66 105.85 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.24 1.96 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.544 ' C ' ' OG1' ' A' ' 142' ' ' THR . 0.5 OUTLIER -47.47 166.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -178.746 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.707 ' N ' ' OG1' ' A' ' 142' ' ' THR . 0.8 OUTLIER -95.06 0.48 54.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.827 -0.546 . . . . 0.0 111.199 -179.117 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.714 HG22 HD11 ' A' ' 193' ' ' ILE . 27.2 m -42.87 108.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.69 -1.256 . . . . 0.0 108.401 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.772 ' O ' HD13 ' A' ' 193' ' ' ILE . 2.2 t70 -76.91 131.8 38.75 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.84 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 192' ' ' ASP . 7.7 mm -131.97 101.38 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.402 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.663 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -143.35 153.54 42.83 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.762 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -107.02 171.21 7.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.976 -1.077 . . . . 0.0 110.01 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.544 ' C ' ' OE1' ' A' ' 197' ' ' GLN . . . 75.37 43.94 23.5 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.591 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 3.6 mm100 -97.41 97.6 9.24 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.318 -1.107 . . . . 0.0 109.539 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.5 t -48.3 153.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.69 131.88 54.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.407 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' PHE . 4.4 m-85 -131.79 98.35 4.44 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.591 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 16.0 m-85 -54.02 141.49 28.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 110.462 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.559 ' O ' HG11 ' A' ' 44' ' ' VAL . . . -92.87 -176.08 4.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.701 ' OE1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.45 175.11 8.04 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.441 -0.787 . . . . 0.0 109.064 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.701 ' N ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -60.42 -54.83 40.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.867 -1.146 . . . . 0.0 108.77 179.433 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -46.89 -11.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.052 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.786 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 9.1 m-70 -100.75 9.84 41.9 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.12 -0.987 . . . . 0.0 110.777 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.9 mm-40 -130.51 -143.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.402 1.096 . . . . 0.0 110.688 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.754 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 4.4 mp0 -36.59 -2.76 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.072 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 60.3 t80 -41.01 -50.69 3.32 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 120.865 -1.147 . . . . 0.0 112.083 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 74' ' ' TRP . 63.9 mt -65.97 -25.23 67.01 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.115 -1.615 . . . . 0.0 111.221 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.91 -52.06 65.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 108.608 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.636 ' NZ ' ' CB ' ' A' ' 212' ' ' LYS . 7.4 mtmp? -90.34 -12.49 37.54 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 111.096 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.693 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 2.0 m-80 -115.0 95.18 41.08 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.669 -1.269 . . . . 0.0 111.082 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.68 12.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.326 2.684 . . . . 0.0 111.899 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 213' ' ' ASN . 8.1 t0 -60.74 -5.42 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.44 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.33 -47.41 0.13 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.592 -1.289 . . . . 0.0 112.492 177.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.615 ' C ' ' O ' ' A' ' 216' ' ' GLY . 25.9 m-85 -27.22 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 119.382 1.591 . . . . 0.0 109.641 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.759 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 16.6 p -142.24 -127.62 0.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.337 -0.852 . . . . 0.0 109.564 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.759 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -152.66 151.0 22.89 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 mt -104.65 146.25 29.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -1.138 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.4 -162.63 5.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -155.51 -141.77 3.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 139' ' ' HIS . 1.2 p . . . . . 0 C--N 1.304 -1.376 0 O-C-N 121.47 -1.017 . . . . 0.0 110.082 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 28' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.473 -2.005 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.486 HG21 ' C ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -40.41 120.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 109.219 -3.628 . . . . 0.0 115.301 -169.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.96 121.17 9.92 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.874 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -52.79 -24.7 9.4 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.827 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -73.5 -14.56 61.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.793 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.6 -14.03 14.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.79 ' HB2' ' CE1' ' A' ' 97' ' ' HIS . . . -53.26 146.09 12.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 110.314 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.556 HD11 ' OE2' ' A' ' 105' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.491 HG21 ' HB3' ' A' ' 203' ' ' GLU . 14.7 mm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.38 168.01 16.91 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.829 2.353 . . . . 0.0 112.174 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' ' 204' ' ' ASP . 29.7 m -129.39 -163.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.14 -0.975 . . . . 0.0 109.68 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 45' ' ' THR . 13.2 t -90.66 102.39 15.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.89 -57.8 10.56 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.367 -0.833 . . . . 0.0 110.915 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -71.23 100.8 2.17 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 115.62 -2.432 . . . . 0.0 108.061 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.711 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 11.4 t-80 -31.63 136.53 0.06 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.478 ' NE2' ' HD2' ' A' ' 212' ' ' LYS . 37.4 t-80 -74.81 -32.32 61.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 111.09 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.482 HG21 ' CG ' ' A' ' 81' ' ' TRP . 64.2 t -70.27 -47.58 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.892 -1.13 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -99.34 -42.72 6.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.062 -1.024 . . . . 0.0 110.789 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.03 2.51 58.17 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 9.9 m120 -75.61 -115.66 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.587 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -134.23 173.44 11.6 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 123.613 1.673 . . . . 0.0 110.106 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 41.3 p -143.72 17.38 1.81 Allowed 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 112.601 -2.091 . . . . 0.0 110.061 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 57' ' ' GLU . 8.6 m -151.96 136.81 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 109.368 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' A' ' 56' ' ' VAL . 8.2 mt-10 -32.4 155.28 0.04 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.971 0.891 . . . . 0.0 110.816 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 89.3 Cg_endo -79.26 165.83 79.98 Favored 'Cis proline' 0 C--N 1.303 -1.865 0 C-N-CA 121.606 -2.248 . . . . 0.0 112.045 -0.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.796 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 2.2 m-30 -112.24 150.31 42.32 Favored Pre-proline 0 C--N 1.269 -2.91 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.21 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' O ' ' OG1' ' A' ' 63' ' ' THR . 36.2 Cg_endo -68.01 109.98 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.727 2.285 . . . . 0.0 112.331 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.84 143.42 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.11 -19.0 50.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -82.78 149.1 27.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -1.134 . . . . 0.0 109.533 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.678 ' OE1' ' N ' ' A' ' 65' ' ' MET . 5.6 tm0? -99.47 146.98 25.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.752 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -139.36 114.27 9.42 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.093 -1.004 . . . . 0.0 109.647 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.98 -167.98 1.63 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 t -142.35 138.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.126 -1.609 . . . . 0.0 109.47 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 1.058 ' O ' HG22 ' A' ' 117' ' ' VAL . 32.9 m-85 -134.63 136.74 43.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.06 111.12 2.21 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.672 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 2.9 mmm -100.01 -89.76 0.33 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.429 -1.042 . . . . 0.0 108.519 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.721 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -161.3 72.49 0.21 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.216 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.721 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 49.0 t 110.52 110.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.561 0.744 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.709 ' HD1' ' HD1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -63.99 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.505 -1.372 . . . . 0.0 110.61 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.796 ' O ' HD21 ' A' ' 210' ' ' LEU . 9.0 m0 -94.89 -70.52 0.71 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.565 -1.334 . . . . 0.0 109.553 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -2.43 65.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB1' ' CG ' ' A' ' 70' ' ' MET . . . -76.34 -37.62 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -1.164 . . . . 0.0 109.796 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.671 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 2.1 pm0 -82.74 -25.75 32.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.267 -0.896 . . . . 0.0 110.479 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.758 ' O ' HG13 ' A' ' 82' ' ' VAL . 6.4 tmm_? -57.94 -56.79 17.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.075 -1.016 . . . . 0.0 110.076 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.0 mttp -43.53 -25.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' CB ' HG11 ' A' ' 119' ' ' VAL . 94.6 m-85 -84.96 -41.75 15.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 111.406 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 81' ' ' TRP . 0.7 OUTLIER -69.55 -5.18 22.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.318 -1.489 . . . . 0.0 109.259 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -97.74 18.58 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.234 -0.916 . . . . 0.0 109.365 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.29 152.2 21.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.972 0.892 . . . . 0.0 109.402 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -90.0 143.27 26.93 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 95.66 -21.44 44.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -75.53 138.02 21.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.838 . . . . 0.0 109.529 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.587 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.8 -47.56 12.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.525 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 1.5 t -167.65 -175.13 2.69 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.631 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.476 HG21 ' N ' ' A' ' 81' ' ' TRP . 20.2 p -149.29 164.38 35.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.803 . . . . 0.0 109.285 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.4 ' HG3' ' NE ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -167.85 162.59 13.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.746 HG12 HG12 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -126.67 176.91 6.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.274 -0.891 . . . . 0.0 109.365 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.53 169.27 37.04 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 202' ' ' ALA . 3.4 m-85 -89.1 161.59 16.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.984 . . . . 0.0 109.99 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.688 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.06 -171.37 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.433 -0.792 . . . . 0.0 109.104 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 54.61 32.1 53.38 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.616 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -139.47 -159.61 8.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.79 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 4.2 p80 -148.77 78.58 1.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.313 -1.11 . . . . 0.0 109.909 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.581 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.86 149.33 21.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.262 -0.898 . . . . 0.0 109.009 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.706 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.1 mmt180 -48.83 -106.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.24 83.82 5.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.46 171.18 18.06 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.481 2.121 . . . . 0.0 112.265 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.536 ' OG1' ' HB3' ' A' ' 105' ' ' GLU . 21.2 p -122.27 167.31 13.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.025 -1.047 . . . . 0.0 110.077 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.72 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 2.1 t80 -57.79 -59.33 5.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.586 -0.696 . . . . 0.0 110.144 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -22.06 41.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 108.78 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.556 ' OE2' HD11 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -79.06 -61.46 2.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.653 -0.655 . . . . 0.0 110.596 -179.188 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.702 HG12 ' OG1' ' A' ' 111' ' ' THR . 15.3 m -52.13 -24.68 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.128 -0.982 . . . . 0.0 110.533 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.2 p -52.97 -45.32 67.72 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.695 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 13.6 t -52.23 -6.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.596 ' H ' ' C ' ' A' ' 107' ' ' CYS . 1.9 tt0 65.13 -6.01 0.38 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.585 -0.697 . . . . 0.0 110.359 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' C ' HG21 ' A' ' 29' ' ' ILE . 7.2 tttt -60.98 -23.01 65.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.106 -0.996 . . . . 0.0 109.206 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.702 ' OG1' HG12 ' A' ' 106' ' ' VAL . 25.3 p -94.87 -5.63 44.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.281 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 39.41 47.62 2.85 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.688 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 5.6 m-70 -92.26 170.05 10.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.782 -1.422 . . . . 0.0 109.064 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -123.59 116.1 22.57 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.546 ' C ' ' OE2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -53.41 143.4 19.25 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.583 -178.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -151.8 174.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.125 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 1.058 HG22 ' O ' ' A' ' 68' ' ' PHE . 33.9 m -135.32 121.62 32.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.796 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 8.1 ptm180 -96.98 96.9 8.82 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.442 1.115 . . . . 0.0 108.7 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.688 HG11 ' CB ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -103.82 147.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.664 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -114.31 157.25 15.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.664 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 2.8 m-85 -141.89 157.33 45.11 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.243 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.42 ' CD ' ' CG2' ' A' ' 63' ' ' THR . 7.7 mmm180 -109.98 99.55 39.52 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.513 -0.742 . . . . 0.0 109.252 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 125' ' ' HIS . 10.9 Cg_exo -40.32 -67.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.111 2.541 . . . . 0.0 113.906 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -40.94 -12.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.204 -0.935 . . . . 0.0 110.711 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.692 ' N ' ' O ' ' A' ' 123' ' ' PRO . 5.8 m-70 -135.41 6.77 3.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.614 -1.303 . . . . 0.0 109.69 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.582 ' CD1' ' CD ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -156.28 148.31 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.594 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -99.47 151.09 21.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.585 ' CZ ' HD21 ' A' ' 132' ' ' LEU . 41.9 t80 -61.72 -19.88 62.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -61.88 -22.56 65.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 131' ' ' LEU . 3.0 mt-10 -70.15 -70.65 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 110.147 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.025 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.8 OUTLIER -35.19 -50.12 0.51 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.585 HD21 ' CZ ' ' A' ' 128' ' ' PHE . 4.5 mm? -68.05 -54.47 18.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 0.0 111.503 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 137' ' ' GLU . 3.8 tttm -52.04 -57.66 8.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.081 -1.012 . . . . 0.0 111.276 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.555 HG12 ' CZ ' ' A' ' 80' ' ' PHE . 78.8 t -49.83 -33.77 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.132 . . . . 0.0 110.22 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.701 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 23.2 t80 -71.72 -52.33 18.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.831 -1.168 . . . . 0.0 109.923 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.513 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 87.5 m95 -70.42 -32.13 69.6 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.906 -1.121 . . . . 0.0 110.348 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.597 ' O ' ' OG1' ' A' ' 223' ' ' THR . 7.8 tt0 -72.35 -34.83 68.31 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 112.259 -177.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.37 73.72 1.56 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.44 -1.412 . . . . 0.0 112.361 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.701 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 2.0 p-80 178.15 129.59 0.06 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.81 -1.181 . . . . 0.0 110.518 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 221' ' ' GLY . 4.8 m-20 -69.09 111.3 8.08 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.451 ' HB3' ' CE1' ' A' ' 139' ' ' HIS . 66.5 Cg_endo -91.34 5.69 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 0.0 113.081 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.814 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -123.14 46.23 2.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 111.049 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.547 ' C ' ' H ' ' A' ' 145' ' ' MET . 44.0 mt-30 -140.39 67.92 1.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 108.999 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' HG21 ' A' ' 190' ' ' THR . . . -65.08 13.0 0.23 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.591 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -115.08 -20.02 10.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.033 -1.275 . . . . 0.0 109.057 178.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.544 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 176.85 163.94 0.47 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.672 ' NE2' ' O ' ' A' ' 70' ' ' MET . 15.3 mt-30 -141.44 159.66 41.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.551 -1.343 . . . . 0.0 110.191 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 147' ' ' GLN . . . 44.23 -120.55 3.44 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 36.9 t30 -111.05 26.11 11.05 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.34 -0.93 . . . . 0.0 110.542 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.573 ' OD2' ' CD1' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -108.18 91.48 3.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.855 -1.153 . . . . 0.0 109.221 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 146' ' ' ARG . 3.7 m-85 -69.14 118.62 12.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 149.8 168.39 15.04 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.138 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER -94.18 9.41 38.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.416 -1.049 . . . . 0.0 109.154 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.725 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 0.7 OUTLIER -93.25 -1.16 56.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.694 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.682 ' CE2' ' OE1' ' A' ' 154' ' ' GLN . 3.3 m-85 -129.99 57.99 1.67 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.024 -1.048 . . . . 0.0 109.879 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.557 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.6 OUTLIER -91.51 -175.63 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 108.913 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.737 ' OG ' HG23 ' A' ' 190' ' ' THR . 13.1 p -94.08 118.89 32.17 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.479 ' HB1' ' NH1' ' A' ' 194' ' ' ARG . . . -147.06 110.72 4.95 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.501 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 192' ' ' ASP . 8.3 t -98.38 131.28 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.739 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.555 ' CE2' HG11 ' A' ' 116' ' ' VAL . 7.8 m-85 -114.01 120.53 38.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.51 173.72 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.574 2.183 . . . . 0.0 113.038 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -94.62 -19.61 20.31 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.227 -0.921 . . . . 0.0 109.215 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 162' ' ' THR . 0.4 OUTLIER 167.69 -163.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.453 -0.779 . . . . 0.0 109.084 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.68 -15.39 11.65 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.952 1.358 . . . . 0.0 108.743 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.76 -62.7 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.638 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.677 HE22 ' NE2' ' A' ' 64' ' ' GLN . 1.4 mp0 -61.44 -12.06 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.524 -0.735 . . . . 0.0 109.823 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.0 ttm -51.94 -34.09 40.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.913 -1.117 . . . . 0.0 110.533 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.37 -38.67 59.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.829 -1.169 . . . . 0.0 110.388 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.552 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.78 -41.52 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.021 -1.049 . . . . 0.0 110.462 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.91 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 171' ' ' LEU . 1.7 mm? -53.04 -36.81 60.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -74.33 -24.06 59.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.92 . . . . 0.0 109.98 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.552 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.62 -50.11 16.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.937 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -36.26 73.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.015 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.05 -49.95 25.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 110.094 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 17.8 pt-20 -59.27 -43.05 92.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.5 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 1.1 m-85 -79.29 -12.2 59.94 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.998 -1.064 . . . . 0.0 109.61 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 178' ' ' GLN . 6.7 tp60 -74.57 -55.13 6.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.594 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.522 ' O ' ' OG ' ' A' ' 182' ' ' SER . 5.7 ttpm? -73.1 -29.49 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.9 -54.37 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.98 . . . . 0.0 109.853 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.17 -5.35 17.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 179' ' ' LYS . 81.4 p -61.62 -67.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.07 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.452 ' N ' ' OG ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -88.64 13.26 12.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.588 ' O ' ' OD1' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -94.83 32.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 0.0 109.542 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.588 ' OD1' ' O ' ' A' ' 184' ' ' HIS . 1.0 OUTLIER 72.87 29.75 1.82 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.669 -0.645 . . . . 0.0 110.324 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.457 ' CD2' ' OD1' ' A' ' 185' ' ' ASN . 7.1 m-85 -137.13 170.9 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.134 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -114.08 -136.76 6.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 189' ' ' ILE . 56.7 Cg_endo -77.45 107.14 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.293 1.995 . . . . 0.0 111.718 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.814 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.05 178.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.737 HG23 ' OG ' ' A' ' 157' ' ' SER . 6.8 t -128.69 -2.27 5.39 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.121 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.601 HG22 HD11 ' A' ' 193' ' ' ILE . 56.8 m -42.91 114.48 0.61 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.659 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 7.0 t0 -87.45 136.34 32.98 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.615 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.601 HD11 HG22 ' A' ' 191' ' ' THR . 4.5 mp -135.53 92.15 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 118.116 -1.434 . . . . 0.0 110.63 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.659 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -134.37 -179.51 5.62 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.634 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 4.3 pt-20 -139.11 -173.04 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.719 -1.238 . . . . 0.0 110.855 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.61 72.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 1.3 mp0 -79.89 128.02 32.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.87 -1.371 . . . . 0.0 109.885 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' A' ' 200' ' ' TYR . 6.7 p -60.55 153.65 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.188 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.619 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 66.7 t80 -117.84 130.29 56.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 109.769 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.706 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 21.0 m-85 -132.29 109.83 10.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.482 -0.761 . . . . 0.0 109.187 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' TYR . . . . . 0.471 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 20.1 m-85 -53.69 131.32 38.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.03 -1.044 . . . . 0.0 111.116 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -82.8 179.28 7.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.491 ' HB3' HG21 ' A' ' 42' ' ' ILE . 8.5 pm0 -75.08 158.68 32.74 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.486 -0.759 . . . . 0.0 108.96 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.781 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -55.4 -39.66 70.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.952 -1.092 . . . . 0.0 108.145 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.51 ' CE1' ' CE2' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -48.83 -19.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.577 -0.702 . . . . 0.0 110.304 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.72 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 10.5 m-70 -100.78 -17.7 16.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.811 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -106.44 -148.49 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.846 0.832 . . . . 0.0 110.357 -177.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.711 ' CG ' ' NE2' ' A' ' 48' ' ' HIS . 4.0 mp0 -35.53 -9.32 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.269 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.811 ' N ' ' O ' ' A' ' 207' ' ' GLN . 1.3 t80 -43.14 -41.87 3.86 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 120.8 -1.188 . . . . 0.0 110.915 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.796 HD21 ' O ' ' A' ' 74' ' ' TRP . 3.7 pp -79.98 -11.92 59.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.693 -1.603 . . . . 0.0 109.6 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 208' ' ' GLN . 91.7 p -55.8 -43.61 77.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 108.843 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.478 ' HD2' ' NE2' ' A' ' 49' ' ' HIS . 6.8 mtmm -65.49 -18.34 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.636 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.9 m-20 -128.24 71.9 79.68 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.004 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.47 9.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.274 2.649 . . . . 0.0 112.704 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.636 ' H ' ' C ' ' A' ' 213' ' ' ASN . 7.3 p30 -63.2 -18.51 63.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.012 -1.055 . . . . 0.0 110.657 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.73 85.47 0.05 OUTLIER Glycine 0 N--CA 1.498 2.79 0 C-N-CA 119.345 -1.407 . . . . 0.0 111.036 178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.743 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 71.4 t80 -45.11 -177.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.321 2.06 . . . . 0.0 109.778 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.743 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 0.7 OUTLIER -72.99 76.86 1.19 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.98 -1.075 . . . . 0.0 109.339 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.4 149.13 17.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.09 -171.78 4.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -1.101 . . . . 0.0 110.0 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 140' ' ' ASP . . . -142.5 -126.99 2.14 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.483 ' O ' ' OG1' ' A' ' 223' ' ' THR . . . -176.8 -134.94 2.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.664 ' CG2' ' H ' ' A' ' 139' ' ' HIS . 10.5 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.428 -1.043 . . . . 0.0 109.398 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 28' ' ' VAL . 32.1 t . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.92 133.05 21.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.262 1.03 . . . . 0.0 113.544 -175.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.12 125.41 26.7 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.638 ' HB2' ' CE1' ' A' ' 97' ' ' HIS . . . -48.13 -43.19 30.93 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.654 -0.654 . . . . 0.0 109.433 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -73.34 4.32 4.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' ALA . 15.7 tt0 -111.55 -1.97 15.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -49.66 -168.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 0.0 109.686 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.563 HD13 ' OE1' ' A' ' 105' ' ' GLU . 86.9 mt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' ILE . 54.2 Cg_exo -48.46 -168.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.719 2.279 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.705 HG12 ' N ' ' A' ' 204' ' ' ASP . 26.9 m -136.05 -161.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 45' ' ' THR . 11.8 t -72.75 99.47 2.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -56.19 -49.07 75.09 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.145 -0.972 . . . . 0.0 111.277 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 mttm -75.35 99.51 4.14 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 115.84 -2.344 . . . . 0.0 108.682 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.7 t-80 -33.03 113.38 0.14 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.477 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.1 t-80 -61.3 -30.86 70.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.365 -0.834 . . . . 0.0 110.83 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.004 HG22 ' OG ' ' A' ' 211' ' ' SER . 26.1 t -65.17 -45.4 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.898 -1.126 . . . . 0.0 109.521 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.03 -45.86 4.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.906 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.53 2.74 47.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.7 p30 -79.33 -116.32 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.1 ttp180 -130.5 170.83 13.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 123.23 1.491 . . . . 0.0 109.057 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.733 ' O ' HG13 ' A' ' 56' ' ' VAL . 21.6 p -134.14 26.84 3.87 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.747 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 55' ' ' THR . 2.9 m -163.48 138.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.796 . . . . 0.0 109.695 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.664 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.3 pm0 -33.01 152.3 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.311 -0.868 . . . . 0.0 110.642 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 96.5 Cg_endo -79.28 166.16 79.17 Favored 'Cis proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.7 -0.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -104.02 149.1 36.87 Favored Pre-proline 0 C--N 1.268 -2.965 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 9.6 Cg_endo -54.83 119.47 6.53 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.637 2.225 . . . . 0.0 112.089 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' PRO . 25.1 mt-10 -43.35 117.91 1.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.18 23.94 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -132.93 137.02 46.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.884 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' OE1' ' SD ' ' A' ' 65' ' ' MET . 5.6 mm-40 -104.93 -176.89 3.21 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.761 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -145.11 128.21 16.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.88 -1.138 . . . . 0.0 110.433 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.57 -170.74 2.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.87 146.04 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.146 -1.596 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.739 ' O ' HG22 ' A' ' 117' ' ' VAL . 70.5 m-85 -140.84 126.84 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.671 -1.268 . . . . 0.0 109.961 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.38 107.06 2.76 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.869 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.74 -89.14 0.5 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.515 -0.991 . . . . 0.0 109.715 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.716 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -147.89 167.47 28.81 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.716 ' C ' ' O ' ' A' ' 71' ' ' GLY . 2.1 t -5.82 115.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 117.651 0.725 . . . . 0.0 109.818 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.68 ' HD1' ' HD1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.52 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.22 -0.925 . . . . 0.0 110.764 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.877 ' O ' HD11 ' A' ' 210' ' ' LEU . 0.2 OUTLIER -89.77 -55.61 3.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.752 -1.217 . . . . 0.0 109.153 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 217' ' ' TYR . . . -105.22 2.75 40.41 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.869 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . -76.75 -39.93 50.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.288 . . . . 0.0 110.525 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.671 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 4.6 tt0 -82.65 -14.34 54.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.965 -1.085 . . . . 0.0 110.806 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 20.5 ttt180 -57.91 -72.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.894 -1.129 . . . . 0.0 110.207 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.458 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 12.1 mmtt -44.11 -5.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.748 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 46.7 m-85 -94.43 -41.34 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.734 -1.229 . . . . 0.0 110.978 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -84.99 -0.68 55.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.672 -1.267 . . . . 0.0 110.646 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.17 19.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.977 -1.077 . . . . 0.0 110.051 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -119.73 157.24 28.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.245 -0.91 . . . . 0.0 109.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -93.25 141.59 28.26 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.839 -0.538 . . . . 0.0 109.549 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.04 -29.09 8.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.9 138.61 20.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.468 -1.019 . . . . 0.0 109.865 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.673 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.53 -44.62 28.04 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 89' ' ' THR . 1.1 p -168.17 -162.97 0.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.488 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 88' ' ' SER . 14.1 p -163.82 160.0 21.82 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.394 -0.816 . . . . 0.0 109.126 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.671 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -164.87 171.15 14.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.119 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.66 HG21 ' O ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -141.88 171.84 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 171.39 -175.95 44.78 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' TYR . 2.0 m-85 -96.17 164.88 12.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -1.044 . . . . 0.0 109.614 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -179.31 147.13 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.96 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 88.86 29.02 19.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.752 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -112.18 -156.72 13.26 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.638 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -138.98 54.1 1.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -1.173 . . . . 0.0 109.892 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.731 ' CG2' ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.5 177.15 11.74 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.043 . . . . 0.0 108.262 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.801 ' CD ' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -72.98 -86.64 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.384 -0.822 . . . . 0.0 109.851 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.79 ' H ' ' HE ' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -122.79 79.91 49.11 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.869 -1.144 . . . . 0.0 110.051 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HG2' ' CD2' ' A' ' 113' ' ' HIS . 11.4 Cg_exo -67.38 169.28 15.86 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.743 2.295 . . . . 0.0 111.675 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.625 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 16.4 p -117.56 171.11 8.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 109.852 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.618 ' C ' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -63.47 -58.89 5.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 0.0 110.354 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.601 ' CD ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -59.22 -22.46 61.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.919 -1.113 . . . . 0.0 108.254 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.625 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.8 mm-40 -72.89 -60.67 2.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.394 0.616 . . . . 0.0 110.977 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 102' ' ' THR . 11.4 m -56.56 -24.66 19.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.402 -0.811 . . . . 0.0 110.997 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.459 ' C ' ' H ' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -49.81 -33.85 17.86 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.253 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 110' ' ' LYS . 1.4 t -63.52 0.12 0.8 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.198 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' A' ' 107' ' ' CYS . 0.8 OUTLIER 63.97 -21.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.251 -0.906 . . . . 0.0 109.87 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.629 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 tttt -57.82 -10.66 1.79 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.278 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.532 ' CB ' HG12 ' A' ' 106' ' ' VAL . 41.3 p -94.08 -38.67 11.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.96 -1.087 . . . . 0.0 110.515 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 72.63 21.2 79.72 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -75.17 161.32 29.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.112 -1.228 . . . . 0.0 110.315 -179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -124.8 113.32 17.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' GLN . 1.9 pp20? -57.26 119.43 6.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.724 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -127.14 170.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.244 -0.91 . . . . 0.0 109.965 179.687 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 68' ' ' PHE . 6.1 m -130.36 125.46 59.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HG3' ' CE1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -96.89 114.49 26.12 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 119' ' ' VAL . 34.9 m -131.78 109.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -75.66 176.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.904 ' CG ' HD21 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -159.94 152.8 21.51 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.38 -1.328 . . . . 0.0 110.391 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 0.485 HH21 ' CG ' ' A' ' 125' ' ' HIS . 1.9 mtp180 -108.7 102.12 46.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.804 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 126' ' ' ILE . 18.3 Cg_exo -41.88 -68.04 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.114 2.542 . . . . 0.0 113.942 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 123' ' ' PRO . 13.3 tt0 -37.97 -33.37 0.08 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.165 -0.96 . . . . 0.0 111.277 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.485 ' CG ' HH21 ' A' ' 122' ' ' ARG . 32.2 m80 -108.39 -0.2 20.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.704 -1.248 . . . . 0.0 109.537 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -155.84 165.55 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.188 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 126' ' ' ILE . 1.4 m -114.03 170.07 8.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.817 -1.177 . . . . 0.0 111.218 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 131' ' ' LEU . 37.5 t80 -69.23 -24.75 64.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.579 -0.701 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.86 -13.02 60.27 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.587 ' HG2' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -75.62 -45.55 36.78 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -77.13 -27.62 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 119.964 -1.71 . . . . 0.0 108.296 178.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.452 HD22 ' CZ ' ' A' ' 68' ' ' PHE . 1.1 mm? -72.62 -57.46 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 110.12 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -52.55 -45.0 66.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 13.3 t -50.1 -37.17 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 0.0 109.29 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.807 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 28.1 t80 -71.44 -47.29 56.74 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.925 -1.109 . . . . 0.0 110.653 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 83.4 m95 -72.18 -14.37 61.79 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.568 -1.332 . . . . 0.0 110.877 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.62 -17.25 19.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.865 -1.147 . . . . 0.0 113.15 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.6 p30 -133.33 63.13 1.64 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 119.983 -1.698 . . . . 0.0 112.861 -177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.807 ' NE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 p-80 173.17 177.93 0.1 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.615 1.197 . . . . 0.0 110.643 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.631 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -111.56 90.16 11.99 Favored Pre-proline 0 C--N 1.286 -2.154 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.289 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 190' ' ' THR . 33.9 Cg_endo -74.39 -17.39 21.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.501 2.134 . . . . 0.0 112.535 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 190' ' ' THR . 0.3 OUTLIER -89.3 29.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.8 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.631 ' NE2' ' CG ' ' A' ' 140' ' ' ASP . 30.9 mt-30 -129.96 82.64 2.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -37.7 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.496 2.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.28 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.661 ' O ' ' SD ' ' A' ' 145' ' ' MET . 1.8 ppp? -67.25 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -1.142 . . . . 0.0 110.876 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.695 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -152.6 160.43 43.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.057 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.695 ' NE2' ' O ' ' A' ' 146' ' ' ARG . 26.6 mm-40 -153.38 96.52 2.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.413 -1.429 . . . . 0.0 109.044 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.86 -113.94 2.82 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.56 ' H ' HD11 ' A' ' 220' ' ' LEU . 1.8 m-20 -79.29 -32.41 43.54 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.361 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.493 ' HB3' ' CD1' ' A' ' 155' ' ' TYR . 3.6 m-20 -82.63 130.38 35.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.217 -1.552 . . . . 0.0 109.123 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 p90 -128.89 145.62 51.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 0.0 110.028 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 140.41 -165.29 26.1 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -22.43 22.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.447 -1.031 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.596 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 8.7 pm0 -91.83 -5.39 53.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.109 -0.994 . . . . 0.0 108.9 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 103' ' ' TYR . 47.6 m-85 -113.01 61.89 0.64 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.546 HH11 ' CA ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -124.03 168.59 12.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 67.5 p -92.05 141.62 28.41 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.47 ' HA ' ' N ' ' A' ' 192' ' ' ASP . . . -168.17 111.31 0.6 Allowed 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 116.981 -1.888 . . . . 0.0 111.512 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.786 HG23 ' CG2' ' A' ' 191' ' ' THR . 60.2 t -92.41 143.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.051 -1.059 . . . . 0.0 109.18 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -136.14 107.85 9.6 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.05 173.82 12.96 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.556 2.171 . . . . 0.0 112.289 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.6 OUTLIER -89.97 -19.66 24.22 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.184 -0.948 . . . . 0.0 109.009 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.607 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER 167.33 -173.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.329 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.607 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -47.75 -15.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.978 1.371 . . . . 0.0 108.588 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.59 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.7 t -55.17 -65.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.156 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 20.2 mt-30 -78.63 -24.74 45.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.8 ttp -53.51 -41.96 66.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.994 -1.066 . . . . 0.0 110.497 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.26 8.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 110.221 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.07 -36.88 34.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.85 -51.83 59.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LEU . . . . . 0.495 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -52.74 -34.96 55.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.942 . . . . 0.0 109.562 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -34.34 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.425 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -75.41 -36.82 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -67.53 -57.04 7.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.9 . . . . 0.0 110.048 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.91 2.68 6.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -75.87 -52.35 10.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 109.847 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 4.0 m-85 -79.47 -7.46 58.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.502 ' C ' ' CD ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -70.69 -53.92 13.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 179' ' ' LYS . 23.4 tttm -73.22 -15.41 61.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.432 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 176' ' ' GLU . 44.9 t -82.28 -55.5 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 110.274 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 181' ' ' LEU . 4.4 mt -76.37 -27.26 56.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.996 -1.065 . . . . 0.0 109.983 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.4 p -55.99 -14.0 2.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 109.551 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -88.27 -1.04 57.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.446 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 37.3 m-70 -108.26 4.28 24.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.754 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 5.3 t-20 71.77 8.42 6.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.441 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.36 164.43 19.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 108.868 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.794 ' N ' ' CD ' ' A' ' 188' ' ' PRO . . . 92.7 24.64 22.86 Favored Glycine 0 C--N 1.302 -1.324 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.794 ' CD ' ' N ' ' A' ' 187' ' ' GLY . 27.7 Cg_endo -66.06 104.67 0.74 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.64 -1.331 . . . . 0.0 108.64 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.638 ' O ' HD12 ' A' ' 189' ' ' ILE . 1.7 pp -47.01 143.86 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 123.019 1.39 . . . . 0.0 111.386 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 141' ' ' PRO . 69.5 p -121.54 4.75 10.13 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.005 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.786 ' CG2' HG23 ' A' ' 159' ' ' VAL . 72.4 m -42.79 115.45 0.73 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 159' ' ' VAL . 4.0 t0 -75.43 125.13 28.39 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.51 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.21 110.52 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.654 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.524 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 64.8 mtm-85 -146.24 -170.56 3.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.775 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -142.84 166.55 24.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.685 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.47 70.19 1.35 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.431 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 4.3 pm0 -139.16 146.9 41.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.909 -1.348 . . . . 0.0 109.708 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.636 HG23 ' N ' ' A' ' 199' ' ' PHE . 0.7 OUTLIER -98.32 -176.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.087 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.636 ' N ' HG23 ' A' ' 198' ' ' VAL . 46.8 t80 -125.35 130.7 52.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -1.0 . . . . 0.0 109.894 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.702 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 19.9 m-85 -126.67 100.19 6.1 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.331 -0.856 . . . . 0.0 109.212 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.27 136.38 43.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.922 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.462 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -87.69 -169.67 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.7 pt-20 -75.18 167.81 21.2 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 108.915 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.705 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.27 -48.82 80.19 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.987 -1.071 . . . . 0.0 108.692 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.49 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.44 -22.65 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.68 ' HD1' ' HD1' ' A' ' 73' ' ' PHE . 11.8 m-70 -94.0 13.16 23.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.989 -1.069 . . . . 0.0 110.537 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.6 mm-40 -130.32 -141.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.694 1.235 . . . . 0.0 110.899 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.664 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.03 -2.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.51 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 28.6 t80 -38.41 -42.8 0.77 Allowed 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.595 -1.315 . . . . 0.0 110.496 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 74' ' ' TRP . 9.5 mt -70.47 -25.05 63.0 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.316 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' SER . . . . . 1.004 ' OG ' HG22 ' A' ' 50' ' ' VAL . 8.0 t -73.47 -40.5 64.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.077 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.477 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 2.0 mtmm -88.25 -38.05 15.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.318 -0.864 . . . . 0.0 110.034 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 215' ' ' ASP . 1.2 m-80 -101.03 107.65 50.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.14 6.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.766 2.31 . . . . 0.0 113.05 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 213' ' ' ASN . 1.9 t70 -63.14 -16.71 60.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.735 -1.228 . . . . 0.0 109.851 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.84 ' O ' HD22 ' A' ' 210' ' ' LEU . . . 65.59 -68.45 0.11 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.788 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 53.2 t80 171.94 -175.87 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -1.111 . . . . 0.0 109.256 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.788 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 4.5 m -93.08 -125.65 0.1 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.152 -0.968 . . . . 0.0 109.004 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.629 ' O ' ' CG ' ' A' ' 220' ' ' LEU . . . -127.19 148.0 17.21 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.629 ' CG ' ' O ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER 146.92 160.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.47 116.87 1.22 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 139' ' ' HIS . . . 158.03 131.86 1.35 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.434 ' OG1' ' CD ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.501 -1.0 . . . . 0.0 110.028 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.534 HG12 ' O ' ' A' ' 28' ' ' VAL . 47.9 t . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.65 132.07 19.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.765 -175.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.19 124.72 25.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.762 0.791 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -56.06 -22.75 29.43 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.616 -0.678 . . . . 0.0 109.758 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -83.87 -0.76 52.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.559 ' O ' ' NZ ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -112.65 -4.62 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.68 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . . . -61.66 -171.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.808 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.5 mm? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.633 ' CG1' ' O ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.22 175.24 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.908 2.406 . . . . 0.0 112.558 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 204' ' ' ASP . 16.2 m -138.87 -174.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.668 ' OG1' ' NE2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -59.9 97.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 109.513 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -55.99 -49.19 74.31 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.261 -0.899 . . . . 0.0 111.426 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.534 ' O ' ' C ' ' A' ' 48' ' ' HIS . 20.3 mttm -71.03 99.91 1.9 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.906 -2.317 . . . . 0.0 108.241 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.67 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 5.0 t-80 -33.45 101.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.788 ' ND1' ' N ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -53.24 -12.34 0.38 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.341 -0.849 . . . . 0.0 112.077 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 88.2 t -82.49 -50.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.455 -1.403 . . . . 0.0 108.482 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -99.56 -40.41 7.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.523 -0.736 . . . . 0.0 109.768 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.04 2.42 51.76 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 30.2 p30 -77.83 -120.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.715 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 ttm-85 -131.76 167.87 18.78 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 123.286 1.517 . . . . 0.0 109.481 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.886 ' O ' HG13 ' A' ' 56' ' ' VAL . 66.7 p -134.77 34.34 3.17 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.071 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 55' ' ' THR . 2.0 m -168.82 147.21 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 109.49 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 7.6 pt-20 -33.73 145.25 0.15 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 110.057 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.19 161.52 84.8 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.741 -1.774 . . . . 0.0 110.363 0.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 70.8 m-85 -102.37 151.57 38.18 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 59' ' ' PHE . 51.9 Cg_exo -47.6 -178.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.26 1.973 . . . . 0.0 111.983 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.634 ' O ' ' NE ' ' A' ' 122' ' ' ARG . 88.7 mt-10 -79.23 133.73 36.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.68 ' O ' ' NE ' ' A' ' 122' ' ' ARG . . . 49.88 72.01 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.591 ' O ' ' SD ' ' A' ' 65' ' ' MET . 0.8 OUTLIER -90.97 134.36 34.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -1.208 . . . . 0.0 110.105 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.802 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.5 tp60 -97.94 120.41 38.29 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.759 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -133.72 158.59 42.89 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.908 -177.488 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.63 -166.02 2.38 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG11 ' HD2' ' A' ' 160' ' ' TYR . 44.5 t -140.82 115.63 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.084 -1.635 . . . . 0.0 108.595 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 132' ' ' LEU . 72.9 m-85 -111.6 148.66 32.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 110.489 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.79 99.31 0.61 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 2.1 ttt -98.08 -91.07 0.27 Allowed 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.648 -0.913 . . . . 0.0 109.179 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.667 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.4 -149.53 5.99 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.74 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -35.12 104.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.038 . . . . 0.0 108.368 179.103 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CZ ' ' CD ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -54.97 7.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.842 -1.161 . . . . 0.0 111.426 -177.259 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.967 ' O ' HD21 ' A' ' 210' ' ' LEU . 5.9 m0 -74.38 -40.41 62.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.568 -1.332 . . . . 0.0 108.694 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.6 -14.29 25.84 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.814 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.693 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -66.31 -53.5 35.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.668 -1.49 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.635 ' OE2' ' NE2' ' A' ' 208' ' ' GLN . 1.3 tm-20 -82.64 -14.63 54.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.929 . . . . 0.0 110.77 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -58.02 -68.12 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.787 -1.196 . . . . 0.0 109.653 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 82' ' ' VAL . 49.5 mttt -53.36 -5.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.157 -0.965 . . . . 0.0 110.511 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.693 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 11.3 m-85 -90.82 -42.02 10.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.784 -1.197 . . . . 0.0 110.196 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -68.84 -4.79 17.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.712 -1.242 . . . . 0.0 109.323 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 79' ' ' LYS . 2.5 m -97.39 6.74 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.44 HD13 HD11 ' A' ' 126' ' ' ILE . 31.3 mt -85.12 142.41 29.53 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.244 1.021 . . . . 0.0 108.999 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -79.77 131.64 35.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.078 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' C ' ' HG3' ' A' ' 123' ' ' PRO . . . 101.36 -29.19 13.05 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.9 132.97 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.225 -1.162 . . . . 0.0 110.231 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.702 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -79.93 -53.67 6.53 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.516 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 2.3 p -151.73 -176.26 5.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 109.347 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.67 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 82.4 p -157.49 128.6 6.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.38 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.576 ' CD ' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.2 153.03 49.88 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.664 HG23 ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.94 175.54 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 108.903 179.494 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 167.88 177.59 39.29 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.022 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.634 ' N ' ' O ' ' A' ' 200' ' ' TYR . 28.0 m-85 -82.28 166.45 19.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.965 . . . . 0.0 109.395 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.681 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -177.41 -179.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 109.765 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.17 27.37 10.73 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -123.35 -176.82 14.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -135.63 78.16 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.101 . . . . 0.0 109.837 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.4 m -157.07 142.67 17.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 109.196 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -54.06 -84.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.854 . . . . 0.0 109.576 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -118.86 82.69 21.24 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.665 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HB2' HG13 ' A' ' 106' ' ' VAL . 72.0 Cg_endo -79.71 161.83 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.847 2.365 . . . . 0.0 112.105 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 106' ' ' VAL . 21.7 p -121.33 169.93 10.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.164 -0.96 . . . . 0.0 109.803 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.47 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 7.8 t80 -56.26 -58.84 6.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -27.05 65.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 109.02 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 102' ' ' THR . 2.0 mt-10 -75.4 -53.27 8.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.726 -0.609 . . . . 0.0 111.159 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 102' ' ' THR . 12.7 m -61.24 -24.3 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.621 ' C ' ' H ' ' A' ' 109' ' ' GLU . 90.7 m -64.65 -38.31 90.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 109.382 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 110' ' ' LYS . 89.3 p -53.8 -0.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.316 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 107' ' ' CYS . 28.8 mt-10 64.89 -5.27 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.559 ' NZ ' ' O ' ' A' ' 33' ' ' GLU . 1.5 mmpt? -66.97 -32.76 74.23 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.178 -0.951 . . . . 0.0 109.67 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.57 ' OG1' HG12 ' A' ' 106' ' ' VAL . 3.7 p -93.51 -0.34 56.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 109.764 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 34.25 55.6 0.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.681 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 1.5 m-70 -93.35 174.54 7.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.907 -1.349 . . . . 0.0 108.813 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.769 ' CB ' HH12 ' A' ' 156' ' ' ARG . . . -129.72 114.97 16.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.66 ' CD ' ' CZ ' ' A' ' 73' ' ' PHE . 3.8 mt-10 -56.44 105.83 0.24 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 94' ' ' ALA . 4.4 m -124.68 159.03 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.134 -0.979 . . . . 0.0 110.499 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -116.49 122.53 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.645 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.09 97.12 9.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.811 HG21 HD23 ' A' ' 131' ' ' LEU . 1.7 m -100.93 129.4 51.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.78 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.533 HG23 ' OE1' ' A' ' 90' ' ' GLN . 55.1 t -94.79 126.27 47.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.802 ' O ' ' N ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -157.18 142.05 16.89 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.535 -1.266 . . . . 0.0 111.725 -178.784 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ARG . . . . . 1.033 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -165.67 17.15 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 123.612 0.765 . . . . 0.0 110.294 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 1.033 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 7.1 Cg_endo -50.88 -15.68 1.97 Allowed 'Trans proline' 0 C--N 1.294 -2.292 0 C-N-CA 124.189 3.259 . . . . 0.0 115.79 -176.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 1.7 tm-20 70.54 -6.62 1.17 Allowed 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.703 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -111.7 -12.98 13.81 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.33 1.062 . . . . 0.0 108.329 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -152.8 118.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -129.76 -175.4 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.526 -1.359 . . . . 0.0 112.559 -177.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -48.28 -46.54 36.04 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.628 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.673 ' O ' ' CD2' ' A' ' 132' ' ' LEU . 6.0 pt-20 -59.66 -26.57 65.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.502 ' CB ' HD13 ' A' ' 126' ' ' ILE . 9.0 mm-40 -75.31 -66.25 0.79 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.304 -0.872 . . . . 0.0 111.558 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.811 HD23 HG21 ' A' ' 119' ' ' VAL . 9.8 mp -57.41 -23.75 51.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.838 -1.164 . . . . 0.0 113.873 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -75.73 -17.9 59.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 119.843 -1.785 . . . . 0.0 109.556 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.478 ' N ' HD23 ' A' ' 132' ' ' LEU . 7.6 mptt -70.44 -54.54 11.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.697 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 6.6 t -49.66 -40.29 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.349 -0.844 . . . . 0.0 109.046 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.631 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 21.2 t80 -61.08 -41.99 97.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.793 -1.192 . . . . 0.0 110.63 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.71 ' CZ2' ' CA ' ' A' ' 173' ' ' SER . 45.4 m0 -71.51 -50.47 31.04 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.75 -1.219 . . . . 0.0 111.735 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.02 -57.46 12.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 111.73 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.6 OUTLIER -83.3 54.23 2.74 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 112.113 -177.378 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.764 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 20.7 m80 -161.11 176.91 10.81 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 142' ' ' THR . 0.3 OUTLIER -129.16 70.22 81.54 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 190' ' ' THR . 80.4 Cg_exo -39.39 -0.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.427 2.752 . . . . 0.0 113.627 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -105.88 22.7 15.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.671 -1.268 . . . . 0.0 110.814 -179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.681 ' N ' ' OG1' ' A' ' 190' ' ' THR . 40.3 mt-30 -134.04 78.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 156' ' ' ARG . . . -75.47 12.66 7.34 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.159 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.642 ' O ' ' O ' ' A' ' 152' ' ' GLY . 2.2 ptt? -118.0 -21.82 8.13 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.305 . . . . 0.0 109.911 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' CD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -152.31 168.88 23.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 111.053 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.58 ' OE1' ' O ' ' A' ' 155' ' ' TYR . 5.2 mm100 -120.21 58.77 0.91 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.08 -113.84 3.73 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.823 ' H ' HD11 ' A' ' 220' ' ' LEU . 12.6 t-20 -81.21 11.41 4.28 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 114.771 -0.715 . . . . 0.0 110.874 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.489 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -107.3 87.81 2.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.769 -1.207 . . . . 0.0 109.146 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.453 ' HA ' ' CG ' ' A' ' 146' ' ' ARG . 3.4 m-85 -65.49 115.87 6.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.411 -0.805 . . . . 0.0 110.674 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 166.62 150.78 6.52 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 117.687 -2.197 . . . . 0.0 111.777 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.1 p -74.26 -20.23 60.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.701 -0.882 . . . . 0.0 109.325 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.737 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 7.3 pm0 -87.15 -6.69 58.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.58 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 26.4 m-85 -97.11 57.27 1.46 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.769 HH12 ' CB ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -117.63 165.72 13.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.725 -0.61 . . . . 0.0 109.66 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.85 106.03 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -125.21 124.09 40.97 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.06 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.725 HG23 ' CG2' ' A' ' 191' ' ' THR . 10.6 t -113.48 123.27 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.3 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 0.517 ' CG ' ' NE2' ' A' ' 197' ' ' GLN . 3.9 m-30 -118.51 121.53 30.87 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.73 166.25 23.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.462 2.108 . . . . 0.0 112.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.87 1.82 27.14 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 120.796 -1.19 . . . . 0.0 108.793 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER 167.76 170.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 0.0 108.862 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.62 -15.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.04 1.4 . . . . 0.0 108.361 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.5 t -56.05 -64.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.496 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 33.8 mt-30 -78.94 -18.39 53.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.719 -0.613 . . . . 0.0 110.9 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 14.3 ttm -53.16 -46.85 69.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.24 -16.93 60.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 0.0 109.617 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.77 -57.29 2.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.838 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 172' ' ' ARG . . . -52.13 -43.52 64.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.135 -0.978 . . . . 0.0 109.457 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -11.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.246 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 170' ' ' ALA . 75.9 mtt180 -74.78 -39.52 61.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.335 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.71 ' CA ' ' CZ2' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -54.48 -33.1 59.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.055 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.56 -57.44 4.15 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 113.199 -1.819 . . . . 0.0 110.21 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.17 -52.48 12.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 0.0 111.894 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.576 ' O ' ' OE1' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -55.19 -50.64 68.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.921 -1.112 . . . . 0.0 110.742 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.477 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 0.1 OUTLIER -70.99 -13.74 62.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.157 . . . . 0.0 109.907 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.57 ' O ' ' OG ' ' A' ' 182' ' ' SER . 22.0 tp60 -75.01 -48.31 24.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 109.757 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -19.17 55.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 92.7 t -87.23 -52.64 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 181' ' ' LEU . 4.0 mm? -71.95 -44.53 63.43 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.116 -0.99 . . . . 0.0 109.586 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 86.3 p -55.79 -26.59 46.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.016 . . . . 0.0 109.002 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.06 -27.93 21.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.108 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.461 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 1.4 m80 -80.78 15.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.875 . . . . 0.0 109.388 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 17.7 t-20 72.37 48.93 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.937 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.4 ' CG ' HD12 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -114.25 -176.72 2.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.0 108.933 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -104.21 -168.94 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.3 Cg_exo -58.81 116.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.519 2.146 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.477 ' C ' HG23 ' A' ' 190' ' ' THR . 0.3 OUTLIER -48.01 176.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 110.145 -179.306 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.681 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 71.2 p -156.98 76.23 0.85 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.597 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' THR . . . . . 0.725 ' CG2' HG23 ' A' ' 159' ' ' VAL . 8.1 m -101.53 122.83 44.54 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.65 ' CG ' HH21 ' A' ' 194' ' ' ARG . 2.1 t0 -81.11 115.98 20.81 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.951 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.69 128.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.386 -0.821 . . . . 0.0 109.396 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.65 HH21 ' CG ' ' A' ' 192' ' ' ASP . 4.7 ptt180 -165.36 173.03 11.58 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.646 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -120.49 -178.66 3.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.909 -1.119 . . . . 0.0 110.431 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 54.89 35.87 59.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.573 ' O ' ' O ' ' A' ' 198' ' ' VAL . 1.8 mp0 -84.11 80.44 9.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.866 -1.373 . . . . 0.0 109.243 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 197' ' ' GLN . 9.8 p -33.31 156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 110.198 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.525 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 65.0 t80 -117.95 138.77 51.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 109.054 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 1.7 m-85 -140.34 113.94 8.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.096 -1.003 . . . . 0.0 109.819 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.66 142.99 21.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -91.26 -168.1 1.97 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.444 -0.785 . . . . 0.0 109.104 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.58 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 2.9 mt-10 -73.38 163.85 27.49 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-O 122.469 1.128 . . . . 0.0 110.372 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.71 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -54.67 -44.26 73.17 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -70.63 4.17 2.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.304 -0.873 . . . . 0.0 110.576 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.499 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 9.4 m-70 -102.99 14.75 31.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.0 OUTLIER -135.74 -150.08 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.971 -1.081 . . . . 0.0 110.178 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.76 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -36.55 -7.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.138 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 2.2 t80 -43.9 -47.09 8.31 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 120.762 -1.211 . . . . 0.0 111.361 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.967 HD21 ' O ' ' A' ' 74' ' ' TRP . 3.6 pp -82.64 -12.26 57.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.0 -1.687 . . . . 0.0 109.947 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.493 ' OG ' HG22 ' A' ' 50' ' ' VAL . 37.3 t -55.83 -50.86 69.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.496 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -70.19 4.9 1.91 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 215' ' ' ASP . 34.6 m120 -142.52 68.01 20.13 Favored Pre-proline 0 N--CA 1.487 1.413 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -48.53 11.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.571 2.848 . . . . 0.0 112.702 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 213' ' ' ASN . 33.9 t70 -61.88 -20.29 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.664 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 60.69 86.15 0.04 OUTLIER Glycine 0 CA--C 1.552 2.371 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.17 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.664 ' O ' ' O ' ' A' ' 216' ' ' GLY . 39.1 t80 -52.11 -150.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 120.538 2.169 . . . . 0.0 109.308 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 49.4 m -71.75 -124.28 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.002 -1.686 . . . . 0.0 109.419 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . 58.72 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.823 HD11 ' H ' ' A' ' 149' ' ' ASN . 0.4 OUTLIER -109.06 -155.74 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.212 . . . . 0.0 109.978 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 138' ' ' ASN . . . -118.73 -73.99 0.44 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . -175.02 134.05 2.63 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.471 -1.017 . . . . 0.0 109.631 179.956 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.424 HG12 ' O ' ' A' ' 28' ' ' VAL . 40.0 t . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -64.37 128.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 122.256 1.027 . . . . 0.0 113.128 -175.311 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.05 124.27 30.91 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.908 0.861 . . . . 0.0 110.126 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' CB ' ' NE2' ' A' ' 97' ' ' HIS . . . -49.05 -26.41 2.61 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.14 -22.77 62.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.115 -0.991 . . . . 0.0 110.251 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -116.69 6.95 13.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.2 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -83.17 -165.06 0.98 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.491 -179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.819 ' CB ' HG23 ' A' ' 98' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.093 -1.004 . . . . 0.0 108.913 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.93 172.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.803 2.335 . . . . 0.0 112.231 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 17.2 m -151.64 -178.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.49 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.246 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.907 ' O ' HG23 ' A' ' 55' ' ' THR . . . -56.07 -40.61 73.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.482 -0.761 . . . . 0.0 111.052 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttt -74.04 99.23 3.26 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 115.877 -2.329 . . . . 0.0 108.055 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.918 ' CE1' ' HG1' ' A' ' 89' ' ' THR . 4.4 t-80 -34.11 114.07 0.19 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' HIS . . . . . 0.639 ' CD2' ' HE3' ' A' ' 212' ' ' LYS . 20.9 t-80 -63.05 -31.81 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.657 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.563 HG23 ' HG3' ' A' ' 208' ' ' GLN . 5.3 t -66.71 -38.33 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.936 -1.103 . . . . 0.0 109.484 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -111.08 -44.28 3.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.91 -0.1 51.84 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.74 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 31.9 p30 -77.22 -121.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.74 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.6 ttt180 -131.15 166.88 20.13 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.056 1.408 . . . . 0.0 108.68 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 46' ' ' ALA . 30.5 p -129.03 34.35 4.46 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.421 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' ' 55' ' ' THR . 0.2 OUTLIER -172.63 149.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.037 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -31.63 139.37 0.19 Allowed Pre-proline 0 C--N 1.299 -1.603 0 CA-C-O 121.266 0.555 . . . . 0.0 110.152 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.36 167.26 79.86 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.479 -1.884 . . . . 0.0 111.783 0.084 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.43 147.3 35.76 Favored Pre-proline 0 C--N 1.271 -2.837 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.34 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 63' ' ' THR . 51.5 Cg_exo -49.39 120.64 5.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.593 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' PRO . 20.3 mm-40 -42.73 118.3 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.799 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 123' ' ' PRO . . . 92.5 44.51 3.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -121.11 142.56 49.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.799 -1.412 . . . . 0.0 110.093 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 65' ' ' MET . 2.2 tm0? -108.53 143.93 36.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.03 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.75 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.8 103.86 5.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.905 -1.122 . . . . 0.0 110.163 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.522 ' HB1' HE22 ' A' ' 166' ' ' GLN . . . -93.08 -169.36 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.027 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 2.2 t -143.62 144.2 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 119.913 -1.742 . . . . 0.0 109.218 179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.495 ' O ' HG12 ' A' ' 116' ' ' VAL . 22.1 m-85 -135.79 143.71 45.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.431 178.797 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.8 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -134.82 90.34 0.24 Allowed Glycine 0 N--CA 1.482 1.761 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.174 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' MET . . . . . 0.918 ' SD ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.93 -74.53 0.61 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -163.59 -156.09 8.53 Favored Glycine 0 C--N 1.3 -1.444 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' CYS . . . . . 0.632 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -23.36 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 122.144 -0.621 . . . . 0.0 109.763 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -53.77 7.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.313 -0.867 . . . . 0.0 111.178 -178.497 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' TRP . . . . . 0.603 ' H ' ' C ' ' A' ' 72' ' ' CYS . 35.9 m0 -68.98 -44.56 72.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.596 -1.315 . . . . 0.0 108.21 179.014 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' SG ' ' A' ' 218' ' ' CYS . . . -98.87 -15.64 33.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.918 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -68.45 -45.07 73.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.939 -1.33 . . . . 0.0 109.85 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' GLU . . . . . 0.766 ' OE1' HG13 ' A' ' 91' ' ' VAL . 23.5 tt0 -82.66 -20.38 36.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 11.7 ttt-85 -60.54 -46.38 90.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.867 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.45 12.58 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.003 -1.06 . . . . 0.0 110.355 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 37.0 m-85 -124.16 -11.27 7.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 111.136 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' TRP . . . . . 0.521 ' CE2' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -106.83 13.18 28.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.579 -1.326 . . . . 0.0 109.414 179.25 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.8 m -109.26 8.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.089 -1.007 . . . . 0.0 111.238 -178.119 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.764 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -118.69 166.1 13.17 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.87 -1.144 . . . . 0.0 108.789 179.298 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.541 ' C ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -93.96 144.16 25.71 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 109.459 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.13 -33.69 4.92 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.73 133.77 31.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.639 -0.918 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.698 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -83.38 -45.68 13.43 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 108.747 -179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 55' ' ' THR . 22.9 t -150.01 -166.56 2.58 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.053 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.918 ' HG1' ' CE1' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -169.92 113.7 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.57 ' OE1' ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -126.68 163.79 22.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 109.913 -178.218 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.766 HG13 ' OE1' ' A' ' 77' ' ' GLU . 1.3 m -143.36 150.38 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.069 -1.02 . . . . 0.0 110.457 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . -160.14 178.04 36.36 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 5.4 m-85 -78.73 177.84 8.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.156 -1.202 . . . . 0.0 108.427 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.88 ' HB1' HG13 ' A' ' 198' ' ' VAL . . . -174.39 159.33 3.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.193 -1.567 . . . . 0.0 113.063 -178.053 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.46 20.1 60.83 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.51 -0.744 . . . . 0.0 111.432 178.01 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.736 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -139.0 175.08 21.78 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' HIS . . . . . 0.708 ' H ' ' HD1' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -158.87 95.88 1.32 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.117 -1.226 . . . . 0.0 110.648 -178.631 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 98' ' ' THR . . . . . 0.819 HG23 ' CB ' ' A' ' 35' ' ' LEU . 21.0 m -142.3 122.57 13.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 109.681 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ARG . . . . . 0.646 ' C ' ' O ' ' A' ' 98' ' ' THR . 1.2 mtp180 10.79 -89.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.862 0.839 . . . . 0.0 109.873 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.569 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m-80 -120.9 90.31 46.64 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 8.8 Cg_exo -68.86 114.66 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.667 2.245 . . . . 0.0 113.358 -177.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.566 ' O ' HG22 ' A' ' 106' ' ' VAL . 19.2 p -121.35 158.9 27.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.639 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' TYR . . . . . 0.628 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.1 OUTLIER -49.77 -42.13 45.81 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.51 -179.069 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 5.1 tttt -73.06 -27.56 61.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.93 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE1' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -83.14 -41.43 18.52 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.974 -1.079 . . . . 0.0 110.412 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 102' ' ' THR . 6.8 m -57.4 -23.97 20.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.676 -1.265 . . . . 0.0 109.54 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 109' ' ' GLU . 5.8 m -52.92 -43.84 66.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.602 ' C ' ' H ' ' A' ' 110' ' ' LYS . 39.3 m -46.53 -8.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.896 . . . . 0.0 108.83 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.66 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.1 tt0 60.24 -7.78 0.07 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.438 -0.789 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' LYS . . . . . 0.79 ' HB3' HD21 ' A' ' 35' ' ' LEU . 1.1 tttp -79.39 -12.98 59.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.128 -0.983 . . . . 0.0 109.185 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 p -89.6 -19.27 25.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.921 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 55.29 52.43 47.52 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' HIS . . . . . 0.736 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 2.4 m-70 -109.09 171.99 7.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.528 -1.572 . . . . 0.0 109.65 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -139.0 111.98 7.9 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLU . . . . . 0.698 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 mt-10 -54.35 131.48 42.1 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.8 HG12 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -143.02 -170.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 111.804 -178.664 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.2 m -147.5 151.09 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HD3' ' CD1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -121.22 98.4 5.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 108.681 178.57 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.66 HG21 ' CD2' ' A' ' 80' ' ' PHE . 14.4 t -88.05 120.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.86 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 125.75 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 2.5 p90 -130.14 169.88 14.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.582 -1.324 . . . . 0.0 111.065 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -117.43 118.23 35.63 Favored Pre-proline 0 N--CA 1.487 1.398 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.701 ' O ' ' N ' ' A' ' 125' ' ' HIS . 18.4 Cg_exo -42.08 -61.88 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.998 2.465 . . . . 0.0 113.602 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.687 ' OE2' ' CD2' ' A' ' 125' ' ' HIS . 6.8 tm-20 -34.92 -19.36 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.368 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' HIS . . . . . 0.701 ' N ' ' O ' ' A' ' 123' ' ' PRO . 4.2 m170 -134.34 -2.39 2.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.402 -1.436 . . . . 0.0 111.42 -179.024 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.567 HG23 ' CG ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.35 158.74 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 127' ' ' SER . . . . . 0.819 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -111.65 170.67 7.98 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.537 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -70.16 -18.72 63.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 24.6 mt-10 -65.15 -23.68 67.18 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.488 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.819 ' CD ' ' H ' ' A' ' 127' ' ' SER . 1.2 pm0 -73.38 -45.28 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.416 -1.714 . . . . 0.0 110.492 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' LEU . . . . . 0.573 HD13 ' HB ' ' A' ' 119' ' ' VAL . 6.7 mt -64.35 -44.14 92.37 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.884 -1.76 . . . . 0.0 108.941 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 132' ' ' LEU . 0.6 OUTLIER -75.27 -27.16 59.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.042 . . . . 0.0 110.527 -179.233 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 1.4 tmtp? -70.31 -65.68 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.987 -1.071 . . . . 0.0 109.799 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.762 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 37.3 t -49.95 -22.52 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.0 t80 -72.23 -49.91 31.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.197 -0.94 . . . . 0.0 110.593 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.615 ' CG ' ' CE2' ' A' ' 177' ' ' TYR . 66.2 m95 -74.77 -60.56 2.23 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.027 -1.67 . . . . 0.0 110.967 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 136' ' ' TRP . 11.7 tt0 -36.33 -32.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 111.138 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.762 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -131.31 69.66 1.47 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.886 -1.134 . . . . 0.0 110.088 -178.799 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.811 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 4.8 m80 -153.6 142.04 20.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.982 -1.073 . . . . 0.0 110.876 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' ASP . . . . . 0.574 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -106.9 72.18 0.3 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 190' ' ' THR . 57.7 Cg_endo -69.09 -9.14 25.51 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.984 2.456 . . . . 0.0 115.543 -177.434 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.57 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -89.99 16.6 8.01 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.242 -1.536 . . . . 0.0 111.18 -178.668 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 143' ' ' GLN . . . . . 0.574 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -131.06 89.21 2.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.948 -1.095 . . . . 0.0 108.937 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . 0.678 ' O ' ' NH1' ' A' ' 156' ' ' ARG . . . -83.81 20.67 11.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.805 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -113.76 -15.93 12.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.745 -1.444 . . . . 0.0 109.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 146' ' ' ARG . . . . . 0.509 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 177.6 164.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.407 -0.808 . . . . 0.0 108.857 -179.389 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLN . . . . . 0.566 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 3.3 tp-100 -111.8 132.71 54.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.558 -1.339 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' A' ' 220' ' ' LEU . . . 43.98 -123.59 4.8 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-O 123.317 1.509 . . . . 0.0 111.122 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' ASN . . . . . 0.484 ' H ' HD21 ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.9 -32.92 40.23 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 113.388 -1.406 . . . . 0.0 112.023 -177.58 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 147' ' ' GLN . 42.4 p30 -52.46 164.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.209 -1.557 . . . . 0.0 108.564 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.5 p90 -136.72 119.72 16.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.927 -1.108 . . . . 0.0 109.98 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 153.7 165.88 14.13 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.527 -1.321 . . . . 0.0 109.992 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER -91.03 2.4 56.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -1.125 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 154' ' ' GLN . . . . . 0.631 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 12.2 pm0 -90.2 -0.1 57.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.125 -0.984 . . . . 0.0 108.354 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 36.7 m-85 -123.26 57.16 1.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.436 -0.79 . . . . 0.0 109.768 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.678 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -99.39 -178.58 3.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 108.956 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 157' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -93.61 107.75 19.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 176.306 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 158' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -137.29 114.85 11.15 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 117.899 -1.521 . . . . 0.0 111.092 -176.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 192' ' ' ASP . 39.6 t -101.4 137.76 27.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.12 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' TYR . . . . . 1.101 ' CG ' HG21 ' A' ' 198' ' ' VAL . 84.4 m-85 -127.15 86.05 59.66 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 108.216 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 160' ' ' TYR . 52.0 Cg_exo -38.35 168.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.089 2.526 . . . . 0.0 112.972 -178.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -102.69 -40.65 6.52 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.144 -0.972 . . . . 0.0 109.534 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.9 OUTLIER -173.25 178.52 2.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 0.0 109.798 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.8 -23.84 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.11 1.433 . . . . 0.0 108.076 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 163' ' ' SER . 2.5 t -56.09 -56.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.863 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 166' ' ' GLN . . . . . 0.522 HE22 ' HB1' ' A' ' 66' ' ' ALA . 2.7 tt0 -78.08 -36.29 48.41 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.483 -178.945 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.4 ttp -52.67 -11.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 110.782 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -75.57 -53.8 8.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.758 -1.214 . . . . 0.0 110.034 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 169' ' ' ALA . . . . . 0.588 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.73 -47.93 6.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -50.97 -55.72 15.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -0.917 . . . . 0.0 110.083 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.52 -41.23 63.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.051 . . . . 0.0 109.331 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.43 -37.34 63.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' SER . . . . . 0.601 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.51 -39.13 72.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 174' ' ' LYS . . . . . 0.793 ' HZ3' ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -72.59 -58.27 3.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.003 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.793 ' N ' ' HZ3' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -57.22 -50.3 73.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.265 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.497 ' CD ' ' C ' ' A' ' 176' ' ' GLU . 0.9 OUTLIER -53.39 -34.99 59.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.976 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 177' ' ' TYR . . . . . 0.615 ' CE2' ' CG ' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -79.75 -35.01 39.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.023 -1.048 . . . . 0.0 109.638 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 178' ' ' GLN . . . . . 0.594 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.5 tp60 -75.13 -33.79 61.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.329 -0.857 . . . . 0.0 109.621 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -73.54 -31.25 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.332 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.06 -51.75 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.09 -39.69 66.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.988 . . . . 0.0 109.574 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 t -56.32 -32.13 64.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -88.01 0.8 55.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 184' ' ' HIS . . . . . 0.532 ' O ' ' CE2' ' A' ' 186' ' ' PHE . 10.0 m-70 -108.33 35.97 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.677 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 68.61 58.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.58 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 186' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 184' ' ' HIS . 86.3 m-85 -151.8 168.5 24.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.85 -167.44 19.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HA ' ' NE2' ' A' ' 178' ' ' GLN . 10.8 Cg_endo -58.57 107.69 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.644 1.563 . . . . 0.0 110.53 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 189' ' ' ILE . . . . . 0.594 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -47.22 168.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 122.21 1.005 . . . . 0.0 110.603 -178.228 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 190' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 141' ' ' PRO . 27.1 p -120.33 58.65 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.485 -179.348 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -100.12 116.11 31.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 192' ' ' ASP . . . . . 0.654 ' CG ' ' NH1' ' A' ' 194' ' ' ARG . 4.0 t0 -76.51 128.24 34.38 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.551 -178.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 193' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -125.32 99.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -179.364 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 194' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 9.8 mtm-85 -135.4 152.57 51.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 195' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 195' ' ' GLU . 1.4 mp0 -129.48 163.77 25.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.504 -1.372 . . . . 0.0 110.752 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 104.65 -22.01 35.15 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 197' ' ' GLN . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' VAL . 0.9 OUTLIER -142.45 -173.9 3.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.054 -1.262 . . . . 0.0 111.747 -178.691 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 198' ' ' VAL . . . . . 1.101 HG21 ' CG ' ' A' ' 160' ' ' TYR . 91.1 t 109.2 74.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.921 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 174.708 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.457 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 3.0 t80 -165.5 126.57 1.92 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 111.134 172.171 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -156.47 94.9 1.52 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.475 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -49.19 125.85 11.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.783 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 202' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.2 -168.69 2.26 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' GLU . . . . . 0.65 ' OE2' ' CE2' ' A' ' 205' ' ' TYR . 1.4 pt-20 -75.81 -176.51 3.39 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.0 -1.062 . . . . 0.0 108.766 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -50.06 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.831 -1.168 . . . . 0.0 110.662 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 205' ' ' TYR . . . . . 0.788 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -62.66 1.95 0.33 Allowed 'General case' 0 C--N 1.307 -1.283 0 O-C-N 120.877 -1.139 . . . . 0.0 112.144 -178.307 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.71 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 5.0 m-70 -102.04 11.6 38.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.434 -1.416 . . . . 0.0 110.942 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' GLN . . . . . 0.853 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.7 mm-40 -129.53 -141.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.641 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 208' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 89' ' ' THR . 1.0 OUTLIER -37.01 -1.36 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.389 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 209' ' ' TYR . . . . . 0.853 ' N ' ' O ' ' A' ' 207' ' ' GLN . 80.1 t80 -38.45 -42.26 0.73 Allowed 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.014 -1.054 . . . . 0.0 111.457 -178.103 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 210' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.9 OUTLIER -62.21 -47.68 83.37 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.553 -178.467 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.3 t -56.11 -38.24 70.5 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.061 -1.024 . . . . 0.0 108.873 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.639 ' HE3' ' CD2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -88.28 -21.24 24.56 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 213' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 209' ' ' TYR . 1.4 m-80 -133.4 89.11 33.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.541 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 214' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 216' ' ' GLY . 31.7 Cg_exo -56.92 13.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 123.525 2.817 . . . . 0.0 112.08 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.592 ' H ' ' C ' ' A' ' 213' ' ' ASN . 38.0 t0 -60.92 20.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.937 . . . . 0.0 111.112 -177.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 216' ' ' GLY . . . . . 0.605 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.52 -51.47 0.14 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.868 -1.158 . . . . 0.0 112.199 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 217' ' ' TYR . . . . . 0.605 ' C ' ' O ' ' A' ' 216' ' ' GLY . 27.0 m-85 -22.32 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.905 0 CA-C-N 118.892 1.346 . . . . 0.0 110.121 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 218' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER -151.18 103.01 2.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.441 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 219' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 218' ' ' CYS . . . -36.33 151.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 220' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' A' ' 148' ' ' GLY . 0.4 OUTLIER -63.41 -175.67 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -1.142 . . . . 0.0 109.52 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.65 -67.62 0.8 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 222' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . 156.85 147.05 4.65 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 223' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 223' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.724 0 O-C-N 121.495 -1.003 . . . . 0.0 109.114 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 58.14 39.87 25.6 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.0 1.9 . . . . 0.0 109.321 -163.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 t -57.37 -38.25 73.91 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.143 2.177 . . . . 0.0 111.306 -162.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -33.95 -42.7 0.13 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.129 2.971 . . . . 0.0 116.16 161.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -76.95 -20.19 56.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.309 1.044 . . . . 0.0 111.848 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -37.22 8.53 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.361 0.982 . . . . 0.0 110.57 171.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.78 51.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.847 1.659 . . . . 0.0 107.378 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -57.63 134.64 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.489 1.516 . . . . 0.0 108.946 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.28 122.01 13.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 107.972 173.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.43 -26.12 62.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.702 1.201 . . . . 0.0 111.94 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -68.81 -32.11 71.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.904 2.882 . . . . 0.0 113.07 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -91.46 -14.54 30.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.886 1.674 . . . . 0.0 111.053 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -55.12 155.71 4.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.915 1.286 . . . . 0.0 111.744 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.08 150.9 13.9 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.938 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.28 -35.8 44.98 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.221 2.614 . . . . 0.0 114.612 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' H ' ' A' ' 99' ' ' ARG . . . 104.65 130.3 6.77 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 105.707 -2.957 . . . . 0.0 105.707 -168.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -90.08 157.62 17.69 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 m -109.93 16.63 21.82 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 120.111 -1.618 . . . . 0.0 109.656 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -98.16 102.07 12.93 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.498 1.919 . . . . 0.0 107.439 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.19 161.93 34.66 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.987 1.791 . . . . 0.0 109.42 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 pt -130.75 94.14 29.67 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.01 165.48 32.47 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.814 1.676 . . . . 0.0 109.612 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.78 -172.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 125.289 1.436 . . . . 0.0 109.863 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 t -55.24 92.23 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.839 2.055 . . . . 0.0 109.235 165.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.4 89.08 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.836 1.254 . . . . 0.0 110.567 -169.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -81.68 117.21 21.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.087 0.955 . . . . 0.0 108.46 165.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -50.58 115.77 1.63 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.434 2.694 . . . . 0.0 110.521 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -63.27 -25.11 68.16 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.497 1.499 . . . . 0.0 112.985 -170.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.24 -46.31 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.664 1.185 . . . . 0.0 109.994 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.8 m -99.07 -46.9 5.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.881 0.872 . . . . 0.0 111.71 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 -4.62 36.18 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.567 2.032 . . . . 0.0 112.928 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -81.22 -98.36 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.173 1.789 . . . . 0.0 112.487 -172.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 56' ' ' VAL . 24.1 ttm-85 -153.84 153.99 33.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.495 1.518 . . . . 0.0 110.502 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -128.24 11.33 6.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.448 2.699 . . . . 0.0 111.443 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 m -139.5 159.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 119.914 -1.741 . . . . 0.0 107.486 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.72 147.61 70.71 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.371 1.068 . . . . 0.0 111.487 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.31 144.96 79.21 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 119.725 0.938 . . . . 0.0 111.782 2.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -87.57 141.22 31.99 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -52.85 143.47 48.24 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.012 3.142 . . . . 0.0 112.838 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -62.12 133.71 55.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.75 0.82 . . . . 0.0 110.028 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 30.22 30.97 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.9 p -111.49 139.86 46.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 163.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -105.11 157.97 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 165.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.3 143.75 38.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.009 1.723 . . . . 0.0 107.426 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.69 172.69 12.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.019 2.128 . . . . 0.0 106.789 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 50.0 t -133.42 123.47 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -134.75 128.77 33.52 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.996 1.718 . . . . 0.0 109.067 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.11 134.73 10.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 126.552 2.025 . . . . 0.0 108.407 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.4 ptp -128.3 -121.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 105.85 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.51 -154.78 29.78 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 171.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 t -44.06 117.35 1.19 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.769 2.028 . . . . 0.0 111.456 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.436 ' HB2' HG11 ' A' ' 91' ' ' VAL 0.289 0.0 OUTLIER -51.93 -11.59 0.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -176.695 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -53.66 -69.32 0.12 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.898 2.479 . . . . 0.0 114.111 165.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 -15.91 66.46 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.087 -1.008 . . . . 0.0 111.553 -171.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.5 70.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.979 1.711 . . . . 0.0 111.105 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.24 -40.65 81.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.402 1.881 . . . . 0.0 111.817 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -51.28 -52.49 44.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.893 2.077 . . . . 0.0 113.355 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.26 -3.18 12.8 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.777 1.231 . . . . 0.0 114.316 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -102.44 -27.83 12.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.825 -1.083 . . . . 0.0 112.241 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -80.87 -19.57 44.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 121.413 1.915 . . . . 0.0 111.795 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -79.56 -0.21 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 125.703 1.601 . . . . 0.0 112.281 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.9 152.34 22.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.147 1.779 . . . . 0.0 108.948 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -89.97 134.59 34.14 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.9 -13.54 45.52 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.01 0.814 . . . . 0.0 112.514 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 p -72.23 132.09 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 169.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.09 -51.09 11.65 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.1 p -161.48 171.58 17.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.314 1.845 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 p -128.45 153.97 46.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 107.885 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -145.43 160.37 41.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.009 2.124 . . . . 0.0 109.54 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -138.96 154.16 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.14 1.376 . . . . 0.0 111.103 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.86 176.55 40.63 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-O 122.237 0.91 . . . . 0.0 111.519 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.83 136.71 32.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.37 165.38 28.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.778 1.631 . . . . 0.0 107.871 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.34 2.45 79.9 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 119.747 -1.846 . . . . 0.0 114.867 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -115.16 -173.62 17.78 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.753 1.644 . . . . 0.0 110.923 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . 0.261 0.0 OUTLIER -145.42 60.76 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.325 1.45 . . . . 0.0 110.561 -167.132 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.52 142.35 27.95 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 129.29 3.036 . . . . 0.0 104.887 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.484 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 37.8 mtm180 -67.18 -55.56 13.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.297 0.953 . . . . 0.0 112.429 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.273 43.2 m-80 -137.69 70.24 51.77 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 120.314 1.416 . . . . 0.0 112.619 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.79 152.0 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.124 1.883 . . . . 0.0 108.444 171.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.418 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 34.1 p -108.03 175.25 5.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.168 1.387 . . . . 0.0 107.617 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -53.26 -44.75 68.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 111.862 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -72.94 -30.01 63.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.958 1.303 . . . . 0.0 111.395 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 102' ' ' THR . 9.6 mm-40 -77.08 -45.89 25.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.167 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.01 -25.92 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.257 1.39 . . . . 0.0 112.769 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.5 t -56.67 -29.67 62.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.511 1.925 . . . . 0.0 113.262 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.0 p -68.04 -13.44 62.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.618 1.167 . . . . 0.0 112.963 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 79.15 -23.21 0.25 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 130.237 3.415 . . . . 0.0 112.224 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -54.38 -22.73 13.1 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 127.06 2.144 . . . . 0.0 114.629 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.0 p -76.41 -29.83 57.21 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.317 -1.49 . . . . 0.0 111.525 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.19 85.08 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.909 1.718 . . . . 0.0 112.325 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.29 152.11 41.98 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.299 1.549 . . . . 0.0 112.4 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -110.29 129.53 55.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.656 2.382 . . . . 0.0 105.523 165.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -74.11 132.64 42.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.15 151.69 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.704 1.602 . . . . 0.0 110.187 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.3 m -105.2 128.84 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 127.602 2.361 . . . . 0.0 106.159 171.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -107.44 95.18 5.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.778 2.431 . . . . 0.0 104.652 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 131' ' ' LEU . 3.6 m -108.85 126.71 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.56 142.34 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.462 ' HD1' HD11 ' A' ' 131' ' ' LEU . 34.3 p90 -134.0 158.31 43.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.727 1.211 . . . . 0.0 110.086 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -103.97 106.24 52.13 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.876 1.271 . . . . 0.0 108.158 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -35.23 -42.57 0.41 Allowed 'Trans proline' 0 C--N 1.361 1.217 1 C-N-CA 127.391 5.394 . . . . 0.0 118.652 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.83 -25.39 56.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.342 1.857 . . . . 0.0 113.658 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -120.68 -16.02 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.973 1.309 . . . . 0.0 113.341 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.033 1.733 . . . . 0.0 107.681 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.2 p -83.78 169.62 15.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.358 1.435 . . . . 0.0 111.369 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.01 -32.46 72.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.008 1.323 . . . . 0.0 112.028 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -56.54 -27.14 56.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.013 2.125 . . . . 0.0 112.717 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.38 -44.41 65.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.313 1.445 . . . . 0.0 111.373 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 119' ' ' VAL . 36.0 mt -67.33 -42.51 83.46 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.961 0.8 . . . . 0.0 110.398 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.28 -52.96 63.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.654 1.581 . . . . 0.0 110.334 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -52.1 -55.53 20.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.039 1.736 . . . . 0.0 112.805 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . . . . . . . . . 96.2 t -60.05 -42.02 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.875 0.87 . . . . 0.0 110.927 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -56.08 -56.34 21.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.333 0.969 . . . . 0.0 112.244 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -63.28 -45.11 92.96 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.89 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.66 -24.02 63.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.958 2.103 . . . . 0.0 114.77 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . 0.442 0.9 OUTLIER -130.01 47.09 2.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.691 1.196 . . . . 0.0 114.2 -176.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -153.76 158.01 40.31 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.164 -1.398 . . . . 0.0 110.481 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -90.81 115.88 65.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.976 1.716 . . . . 0.0 107.363 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.721 ' HD3' HG23 ' A' ' 223' ' ' THR . 62.7 Cg_endo -82.58 -6.9 11.69 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.416 2.077 . . . . 0.0 114.495 -170.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.2 p -109.45 9.73 25.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.197 1.799 . . . . 0.0 112.128 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -110.57 108.43 18.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.58 -56.58 1.24 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -166.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -90.92 19.01 5.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.409 1.105 . . . . 0.0 112.657 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.0 ttm105 -167.5 148.4 5.45 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.912 2.085 . . . . 0.0 107.302 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -139.44 114.06 9.22 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.546 1.539 . . . . 0.0 107.651 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 45.8 -109.5 0.34 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.7 2.095 . . . . 0.0 113.124 -167.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -85.8 -16.91 37.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.645 1.578 . . . . 0.0 112.112 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.98 122.34 33.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.941 1.296 . . . . 0.0 107.58 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -115.83 139.59 50.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.337 1.455 . . . . 0.0 110.578 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.99 157.04 9.36 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.033 1.778 . . . . 0.0 112.024 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.6 t -58.58 -15.83 13.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.226 2.611 . . . . 0.0 114.618 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -80.46 -18.34 49.01 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.02 -1.05 . . . . 0.0 112.3 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -111.16 66.85 0.63 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -109.95 152.04 26.36 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.63 1.172 . . . . 0.0 108.123 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 p -60.28 118.41 6.37 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.593 1.157 . . . . 0.0 109.093 156.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.18 116.98 6.69 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.528 1.131 . . . . 0.0 110.869 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 76.2 t -111.13 121.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -115.27 114.1 43.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.52 155.67 45.24 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 123.151 2.567 . . . . 0.0 111.412 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.2 m -79.69 -32.67 41.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.037 0.935 . . . . 0.0 111.859 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 87.9 p -171.6 -167.56 0.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.21 1.804 . . . . 0.0 108.954 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.1 -21.96 25.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.105 . . . . 0.0 113.797 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -52.44 -56.67 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.933 2.493 . . . . 0.0 110.899 169.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -86.77 -18.96 29.82 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.915 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.6 ttt -54.89 -36.02 64.72 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.557 1.543 . . . . 0.0 113.303 175.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -67.98 -38.01 82.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.889 0.876 . . . . 0.0 112.142 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.07 -38.98 12.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.678 1.191 . . . . 0.0 111.356 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.47 74.7 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.004 1.722 . . . . 0.0 111.057 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.29 -34.76 79.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.24 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -69.35 -46.89 65.93 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.724 0.809 . . . . 0.0 110.007 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.8 p -59.42 -40.65 87.37 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.252 1.421 . . . . 0.0 112.06 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.07 -63.67 1.11 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.109 2.164 . . . . 0.0 110.596 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.51 -34.75 78.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.597 1.159 . . . . 0.0 113.736 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.03 -48.12 83.02 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.438 1.895 . . . . 0.0 111.714 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -76.68 -25.82 54.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -60.46 -44.06 96.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.734 0.697 . . . . 0.0 110.94 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -64.69 -42.14 95.53 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.744 1.218 . . . . 0.0 112.671 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.26 -42.36 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 119.028 0.831 . . . . 0.0 110.565 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -83.01 -23.61 33.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.432 1.015 . . . . 0.0 113.184 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.5 t -56.86 -33.91 67.3 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.839 1.2 . . . . 0.0 111.351 167.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -79.46 -17.61 53.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -91.95 12.11 22.85 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.481 1.512 . . . . 0.0 111.721 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 76.94 28.89 0.63 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.625 1.97 . . . . 0.0 111.049 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -98.69 169.23 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -103.65 -160.6 24.9 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.441 1.019 . . . . 0.0 110.904 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.24 21.67 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 124.094 3.196 . . . . 0.0 111.903 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.64 149.55 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.845 0.831 . . . . 0.0 109.627 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.6 p -112.59 21.52 15.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.175 1.79 . . . . 0.0 109.951 -171.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -66.72 106.44 1.84 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -69.82 124.59 24.38 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.719 1.208 . . . . 0.0 108.268 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.89 114.66 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -144.92 160.86 40.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 129.212 3.005 . . . . 0.0 106.484 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 161.82 20.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.624 1.969 . . . . 0.0 108.733 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.24 61.9 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.813 -0.555 . . . . 0.0 111.911 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -76.49 120.19 21.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.981 0.912 . . . . 0.0 109.134 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 p -59.92 134.88 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.141 1.777 . . . . 0.0 108.866 168.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -101.01 129.47 46.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -122.18 115.64 22.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -57.39 130.43 46.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.414 1.085 . . . . 0.0 110.294 171.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -76.88 173.5 11.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.136 0.974 . . . . 0.0 109.372 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.66 160.7 22.13 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.772 1.629 . . . . 0.0 110.798 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -55.57 -37.94 68.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.373 2.269 . . . . 0.0 111.976 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -18.89 22.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.262 2.225 . . . . 0.0 114.123 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.405 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 74.9 m-70 -105.28 -6.47 19.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.366 1.467 . . . . 0.0 111.442 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.41 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 76.8 mm-40 -94.91 -130.75 0.15 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.194 2.198 . . . . 0.0 108.952 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -68.79 14.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 132.02 4.128 . . . . 0.0 112.797 -173.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -51.56 -39.43 57.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.118 2.567 . . . . 0.0 112.463 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.452 ' H ' HD12 ' A' ' 210' ' ' LEU . 3.1 mp -84.33 0.45 49.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.68 0.792 . . . . 0.0 112.021 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -76.21 -38.18 56.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.889 -1.132 . . . . 0.0 108.01 166.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -77.51 -34.9 53.93 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.525 1.53 . . . . 0.0 110.107 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -117.7 77.65 11.4 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.246 1.818 . . . . 0.0 109.246 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.37 1.91 4.38 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.605 2.87 . . . . 0.0 114.268 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -39.53 -38.88 0.64 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.46 3.104 . . . . 0.0 113.362 163.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.67 44.1 11.02 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 162.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -36.97 109.84 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.58 2.752 . . . . 0.0 115.413 -161.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 12.1 t 81.92 -65.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.455 2.302 . . . . 0.0 114.704 161.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.25 151.44 46.93 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.648 0.619 . . . . 0.0 114.648 -147.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.02 171.69 14.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.919 1.287 . . . . 0.0 109.576 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -88.58 -164.46 40.33 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 160.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -117.29 -141.04 6.81 Favored Glycine 0 CA--C 1.519 0.319 0 O-C-N 121.375 -1.074 . . . . 0.0 114.855 -159.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.721 HG23 ' HD3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 0.56 -35.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 1 C-N-CA 136.037 5.735 . . . . 0.0 119.923 163.188 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -77.41 0.71 68.12 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.788 2.137 . . . . 0.0 112.436 -155.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.9 m -49.28 71.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 127.048 2.139 . . . . 0.0 113.274 141.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 66.4 m -78.83 151.5 31.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 127.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . 1.058 27.4 p 98.07 -109.78 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.89 1 C-N-CA 135.798 5.639 . . . . 0.0 113.74 -12.629 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -50.63 -19.76 5.5 Favored 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 124.251 3.301 . . . . 0.0 118.112 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' MET . . . . . . . . . . . . . 60.2 ttp -143.36 148.05 35.62 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.397 2.279 . . . . 0.0 107.635 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . 0.265 . . 85.59 -14.23 0.57 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 128.8 2.84 . . . . 0.0 115.098 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.2 132.81 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 127.623 2.369 . . . . 0.0 106.051 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . 0.256 36.4 ttmt 72.88 -113.28 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.552 1 C-N-CA 132.517 4.327 . . . . 0.0 112.026 -9.558 . . . . . . . . 3 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.4 2.777 0 CA-C-N 113.195 -1.82 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 22' ' ' GLY . 39.3 m-20 36.0 -89.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -1.164 . . . . 0.0 109.317 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.676 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.6 m -50.62 -18.23 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.031 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -49.95 -7.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 123.011 1.386 . . . . 0.0 109.751 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 24' ' ' SER . 40.9 t -46.37 -9.26 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.445 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.619 ' N ' ' O ' ' A' ' 25' ' ' ALA . 1.8 pttt -114.91 54.88 0.77 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 123.416 1.579 . . . . 0.0 108.753 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.695 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -155.55 21.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.259 -3.362 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -178.488 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.61 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -41.34 177.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.76 -178.074 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -107.67 125.64 51.61 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.509 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -54.01 -17.93 3.08 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.427 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.566 ' OE1' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -82.98 -9.52 59.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.974 -1.079 . . . . 0.0 110.12 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 34' ' ' ALA . 9.4 tp10 -112.32 -28.11 8.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 110.384 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -30.57 148.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.157 -0.965 . . . . 0.0 110.389 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -37.78 161.39 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.18 -41.81 48.22 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.026 1.817 . . . . 0.0 111.747 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.1 137.11 4.58 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.16 165.78 12.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -1.124 . . . . 0.0 109.435 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.43 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 2.2 m -124.94 33.55 5.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 109.706 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -118.05 74.24 10.13 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.013 -1.054 . . . . 0.0 110.11 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.09 130.94 11.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.907 2.404 . . . . 0.0 111.581 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -139.27 92.23 10.72 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.947 -1.096 . . . . 0.0 110.413 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 42' ' ' ILE . 76.6 Cg_exo -48.34 -165.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.787 2.325 . . . . 0.0 111.435 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -160.9 -171.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.891 -1.131 . . . . 0.0 110.281 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -33.9 83.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.554 0.692 . . . . 0.0 111.334 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -64.4 -20.13 65.95 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.441 -0.787 . . . . 0.0 110.271 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -88.49 100.45 13.07 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 116.384 -2.126 . . . . 0.0 107.786 178.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.657 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 6.1 t-80 -30.18 141.21 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.0 -6.96 57.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.468 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 46.9 t -95.43 -63.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -80.55 -44.69 18.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.927 . . . . 0.0 110.214 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.22 55.6 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 33.4 p30 -82.75 -114.87 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 57' ' ' GLU . 1.2 ttm-85 -128.06 170.57 12.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.978 1.37 . . . . 0.0 108.434 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 3.0 p -132.22 17.33 4.52 Favored 'General case' 0 C--N 1.263 -3.169 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.968 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.519 ' O ' ' C ' ' A' ' 57' ' ' GLU . 3.4 m -151.55 -168.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.098 -1.001 . . . . 0.0 109.117 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 23.7 mm-40 -34.08 153.77 0.05 OUTLIER Pre-proline 0 C--N 1.293 -1.854 0 CA-C-O 121.494 0.664 . . . . 0.0 110.296 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -87.79 155.29 41.94 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.03 -1.654 . . . . 0.0 110.889 0.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-85 -117.53 66.68 5.0 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.28 -176.42 0.84 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.821 2.347 . . . . 0.0 113.049 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.39 158.55 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.94 -41.37 2.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.511 HG23 ' HE ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -97.72 144.2 27.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -1.04 . . . . 0.0 109.231 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' VAL . 29.4 tp60 -107.79 147.77 30.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -122.18 128.85 51.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.33 -167.38 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.2 t -141.98 140.69 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.081 -1.637 . . . . 0.0 109.379 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 42.0 m-85 -127.92 131.91 49.33 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.668 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -135.89 136.15 8.27 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.233 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -126.25 -94.29 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.514 -0.992 . . . . 0.0 108.998 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.691 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -142.46 71.28 0.4 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.4 t 113.05 149.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.087 0.955 . . . . 0.0 108.776 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.701 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -101.6 20.26 16.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.2 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.698 ' CG ' ' OH ' ' A' ' 209' ' ' TYR . 17.8 m0 -101.56 -65.98 0.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.748 -1.22 . . . . 0.0 109.395 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.523 ' N ' ' OH ' ' A' ' 217' ' ' TYR . . . -68.32 -16.12 68.77 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -75.29 -58.27 3.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.409 -1.054 . . . . 0.0 110.591 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.544 ' CD ' ' O ' ' A' ' 77' ' ' GLU . 10.5 tp10 -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.253 -0.904 . . . . 0.0 111.473 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 78' ' ' ARG . 13.9 tpt85 -56.52 -53.98 51.23 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.874 -1.142 . . . . 0.0 110.787 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -83.42 18.32 1.86 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.329 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.714 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 4.9 m-85 -103.95 -40.05 6.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.776 -1.203 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.596 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -81.91 -4.36 56.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.848 -1.158 . . . . 0.0 110.108 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.678 HG23 ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -90.4 21.11 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 0.0 109.786 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.662 HD12 HD21 ' A' ' 131' ' ' LEU . 60.6 mt -111.1 165.92 11.5 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.794 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 169.85 10.93 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.16 3.64 38.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -98.89 115.91 40.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.559 -0.965 . . . . 0.0 109.615 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.0 OUTLIER -73.53 -46.64 46.44 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.51 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 6.9 t -164.37 157.65 17.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.542 -0.724 . . . . 0.0 109.554 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.657 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.1 p -117.26 154.05 31.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.636 HE21 HH21 ' A' ' 118' ' ' ARG . 1.7 mp0 -149.24 146.95 27.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.773 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 117' ' ' VAL . 20.6 m -140.56 177.7 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 110.124 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . 156.48 -118.9 0.87 Allowed Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.209 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 5.0 m-85 -125.13 167.78 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.937 . . . . 0.0 109.814 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.673 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.76 -179.62 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.884 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.61 6.61 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -121.95 -170.56 13.81 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.682 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -144.05 78.55 1.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.548 -0.972 . . . . 0.0 109.917 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.471 HG21 HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -157.52 145.1 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 109.238 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 3.5 ttm-85 -55.17 -80.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.427 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.46 ' ND2' ' HG2' ' A' ' 99' ' ' ARG . 44.5 m-80 -122.83 75.25 47.54 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.054 -1.029 . . . . 0.0 109.668 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.78 151.48 31.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.827 2.351 . . . . 0.0 112.05 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 106' ' ' VAL . 19.1 p -122.0 164.22 18.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.055 -1.028 . . . . 0.0 109.393 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -51.1 -44.35 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.614 -0.678 . . . . 0.0 110.016 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -27.03 62.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.009 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 0.6 OUTLIER -80.98 -38.06 28.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.074 -1.016 . . . . 0.0 110.375 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.9 HG12 ' OG1' ' A' ' 111' ' ' THR . 15.3 m -69.42 -24.03 27.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 120.866 -1.146 . . . . 0.0 110.161 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.624 ' C ' ' H ' ' A' ' 109' ' ' GLU . 94.5 m -45.76 -45.21 14.46 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 110' ' ' LYS . 29.6 t -60.52 5.5 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.85 . . . . 0.0 108.965 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.624 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.9 mt-10 54.82 -0.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.456 -0.778 . . . . 0.0 109.659 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 mmtp -63.84 -19.5 65.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.058 -1.026 . . . . 0.0 109.044 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.9 ' OG1' HG12 ' A' ' 106' ' ' VAL . 31.7 p -98.34 0.72 46.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.418 -0.801 . . . . 0.0 109.373 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 30.99 47.81 0.17 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -84.79 174.7 9.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.709 -1.465 . . . . 0.0 108.367 178.665 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.765 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -125.52 114.52 18.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.131 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.701 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.1 mm-40 -62.52 111.53 2.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -140.16 -171.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.095 -1.003 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.843 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.1 m -130.32 128.18 63.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.468 0.652 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.636 HH21 HE21 ' A' ' 90' ' ' GLN . 0.1 OUTLIER -97.95 97.3 8.82 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.485 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -105.8 129.72 58.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.509 -179.057 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.25 132.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.343 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.742 ' CD2' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -139.06 156.71 46.98 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.544 0.688 . . . . 0.0 109.695 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.511 ' HE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -95.92 108.28 39.72 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.66 -0.65 . . . . 0.0 110.633 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 15.2 Cg_exo -41.62 -67.47 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.713 2.276 . . . . 0.0 113.169 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.748 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 18.4 mp0 -49.64 -21.3 0.99 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.258 -0.901 . . . . 0.0 109.746 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 122' ' ' ARG . 1.1 m80 -92.37 -33.82 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -0.981 . . . . 0.0 108.981 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.673 HD11 ' CG ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -148.18 141.04 18.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.14 140.81 57.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.955 -1.091 . . . . 0.0 110.088 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.911 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 21.9 t80 -69.42 -33.28 72.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -14.01 61.47 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.673 ' CG ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -74.98 -45.33 42.81 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.473 -0.767 . . . . 0.0 110.454 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.742 HD12 ' CD2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -71.67 -31.02 66.35 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 119.361 -2.087 . . . . 0.0 107.492 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.911 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 1.1 mt -57.01 -21.77 33.31 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -70.34 -52.89 19.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.411 -0.805 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -49.93 -34.82 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.713 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 13.6 t80 -69.01 -53.22 21.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 50.6 m95 -70.44 -55.61 8.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.583 -1.323 . . . . 0.0 109.129 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.517 ' OE2' ' O ' ' A' ' 137' ' ' GLU . 2.2 tm-20 -37.53 -40.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.68 -0.637 . . . . 0.0 111.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 14.0 p30 -125.4 72.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.972 -1.08 . . . . 0.0 110.784 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.713 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 8.4 m80 -157.62 142.18 16.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.122 -0.986 . . . . 0.0 110.593 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.597 ' OD2' ' O ' ' A' ' 140' ' ' ASP . 0.7 OUTLIER -105.21 73.02 0.24 Allowed Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.636 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.483 ' CD ' ' O ' ' A' ' 139' ' ' HIS . 17.7 Cg_endo -59.53 23.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.736 1.624 . . . . 0.0 112.587 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 189' ' ' ILE . 0.2 OUTLIER -121.95 1.6 9.86 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.135 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.611 ' O ' ' O ' ' A' ' 146' ' ' ARG . 47.8 mt-30 -106.79 92.35 4.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.951 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.594 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -37.97 -113.3 0.0 OUTLIER Glycine 0 N--CA 1.495 2.603 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.331 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.649 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 22.2 ptt? -66.05 41.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.84 0.829 . . . . 0.0 110.963 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.708 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 178.37 145.49 0.13 Allowed 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.897 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 1.3 mt-30 -152.13 155.48 37.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 119.782 -1.824 . . . . 0.0 110.215 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.58 -126.25 3.63 Favored Glycine 0 C--N 1.302 -1.309 0 CA-C-O 122.898 1.277 . . . . 0.0 110.438 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.47 ' HB2' ' H ' ' A' ' 220' ' ' LEU . 0.7 OUTLIER -81.85 -34.57 30.05 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.16 -1.02 . . . . 0.0 112.129 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.475 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -91.84 126.26 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.314 -1.491 . . . . 0.0 108.862 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.43 ' CA ' ' HB2' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -105.81 154.62 20.26 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.054 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.708 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 123.92 172.89 13.78 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.353 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -75.56 -28.15 58.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.285 -1.126 . . . . 0.0 109.82 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.653 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -69.98 -5.74 28.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.885 -1.134 . . . . 0.0 109.448 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.653 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 23.4 m-85 -131.4 52.08 2.09 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.078 -1.014 . . . . 0.0 109.351 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.801 HH22 HH22 ' A' ' 194' ' ' ARG . 6.8 mtp180 -90.96 176.18 6.7 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.582 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.694 ' OG ' HG23 ' A' ' 191' ' ' THR . 0.2 OUTLIER -91.08 117.66 29.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 175.733 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -136.99 128.75 28.92 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.99 -175.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.578 HG22 ' CZ ' ' A' ' 135' ' ' PHE . 1.4 t -115.89 115.52 49.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -113.2 121.15 38.66 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.524 ' HA ' ' NE2' ' A' ' 166' ' ' GLN . 85.7 Cg_endo -82.7 170.11 13.02 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.575 2.183 . . . . 0.0 112.28 179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.716 HG23 ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -90.15 -29.23 18.42 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 120.916 -1.115 . . . . 0.0 109.369 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.48 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 178.48 -162.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.58 -15.83 2.03 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.993 1.378 . . . . 0.0 108.648 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.48 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.8 t -55.92 -64.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.524 ' NE2' ' HA ' ' A' ' 161' ' ' PRO . 13.3 mt-30 -79.56 -19.59 49.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.596 -0.69 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.93 -34.87 43.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.26 -28.56 63.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.746 -1.221 . . . . 0.0 109.431 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.76 -45.13 8.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.65 -56.09 17.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 mt -52.87 -37.16 60.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.218 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -55.84 -36.5 67.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.539 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -72.84 -57.81 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.595 ' CG ' ' N ' ' A' ' 176' ' ' GLU . 6.4 pt-20 -63.46 -47.09 83.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.635 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -53.08 -31.98 44.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 109.655 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.506 ' CE2' HD21 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -78.92 -14.92 58.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.527 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.496 ' C ' ' CD ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -74.89 -38.79 61.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.182 -0.949 . . . . 0.0 109.299 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.456 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -78.02 -23.17 48.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.651 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 176' ' ' GLU . 60.3 t -75.59 -54.56 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' HB ' ' A' ' 223' ' ' THR . 4.6 mm? -68.96 -36.46 77.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.629 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.3 p -56.03 -27.8 54.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -88.11 -3.03 58.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.42 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.444 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 11.9 m170 -107.59 35.88 2.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 7.2 t-20 71.86 61.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.493 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -152.19 175.04 13.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.9 -141.49 5.01 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.51 105.82 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.239 1.96 . . . . 0.0 111.196 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.714 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -53.24 177.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 2.7 p -143.89 70.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.647 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.694 HG23 ' OG ' ' A' ' 157' ' ' SER . 61.2 m -100.47 160.24 14.51 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH2' ' A' ' 156' ' ' ARG . 21.2 t0 -105.91 106.38 16.86 Favored 'General case' 0 C--N 1.265 -3.067 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.93 114.07 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.415 -0.803 . . . . 0.0 109.054 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.801 HH22 HH22 ' A' ' 156' ' ' ARG . 1.0 OUTLIER -154.68 -170.46 3.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 109.178 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 86.3 mt-10 -119.67 -179.22 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 56.37 54.08 38.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 1.0 OUTLIER -95.85 92.48 6.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.454 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.42 156.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 118' ' ' ARG . 63.2 t80 -126.05 140.24 52.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.235 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 10.2 m-85 -139.67 103.89 4.79 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.052 -1.03 . . . . 0.0 109.975 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -52.4 132.58 34.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 111.219 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.427 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -88.37 -171.26 3.28 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.662 ' CD ' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.44 174.94 8.22 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.662 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.4 OUTLIER -60.92 -50.49 73.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.733 -1.229 . . . . 0.0 108.088 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.659 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.53 -8.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 109.77 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.571 ' N ' ' O ' ' A' ' 204' ' ' ASP . 8.7 m-70 -103.55 13.62 32.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.066 -1.021 . . . . 0.0 111.446 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.774 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -138.6 -148.0 0.25 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.684 -1.26 . . . . 0.0 111.197 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.753 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 4.0 mp0 -33.49 -3.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.606 -1.179 . . . . 0.0 114.049 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.774 ' N ' ' O ' ' A' ' 207' ' ' GLN . 14.3 p90 -44.83 -33.63 2.0 Favored 'General case' 0 N--CA 1.518 2.941 0 C-N-CA 116.429 -2.108 . . . . 0.0 108.738 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 209' ' ' TYR . 0.4 OUTLIER -51.13 -20.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.769 -1.207 . . . . 0.0 109.947 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 16.2 t -59.88 -35.83 75.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.058 -1.026 . . . . 0.0 108.683 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 214' ' ' PRO . 5.8 mmmt -88.29 -29.8 20.1 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.468 -0.77 . . . . 0.0 109.67 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -119.6 51.07 1.67 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 213' ' ' ASN . 12.0 Cg_endo -60.41 8.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.095 2.53 . . . . 0.0 112.406 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.0 t70 -63.58 -12.48 33.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 110.36 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 62.56 86.67 0.05 OUTLIER Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.657 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.61 ' O ' ' O ' ' A' ' 216' ' ' GLY . 1.5 p90 -44.61 179.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.385 2.093 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.452 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER -72.84 76.71 1.15 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.041 -1.037 . . . . 0.0 108.765 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.36 150.42 17.24 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.47 ' H ' ' HB2' ' A' ' 149' ' ' ASN . 7.6 mt -84.67 -173.38 4.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 165.2 110.48 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 154.0 139.09 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.508 ' HB ' HD11 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -81.33 37.06 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -1.179 . . . . 0.0 109.45 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 72.25 13.67 76.74 Favored Glycine 0 C--N 1.302 -1.312 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.836 HG22 ' HG3' ' A' ' 229' ' ' MET . 0.8 OUTLIER -49.89 101.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.746 -0.855 . . . . 0.0 109.061 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.689 ' O ' ' SD ' ' A' ' 229' ' ' MET . 47.9 t -99.76 -153.11 0.43 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 120.729 -1.232 . . . . 0.0 110.429 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.586 ' O ' ' SD ' ' A' ' 229' ' ' MET . 0.0 OUTLIER -76.59 -55.88 1.52 Allowed Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.473 ' HD3' ' SG ' ' A' ' 227' ' ' CYS . 84.3 Cg_exo -50.37 -24.74 12.5 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.413 2.075 . . . . 0.0 109.477 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.836 ' HG3' HG22 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -51.63 161.19 0.54 Allowed 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.351 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.555 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.3 130.25 0.08 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.967 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.463 HG12 ' SD ' ' A' ' 229' ' ' MET . 1.5 mm -142.58 114.43 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.205 -0.934 . . . . 0.0 109.39 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.13 136.1 37.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.491 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.346 0 O-C-N 121.271 -0.893 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.474 ' C1 ' ' HB2' ' A' ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 59.38 -69.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -1.112 . . . . 0.0 109.445 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.674 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -50.79 -18.58 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.367 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.672 ' N ' ' O1 ' ' A' ' 21' ' ' MYR . . . -49.89 -9.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 123.018 1.39 . . . . 0.0 109.53 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.674 ' H ' ' C ' ' A' ' 24' ' ' SER . 2.3 p -47.46 -6.29 0.01 OUTLIER 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.595 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.626 ' N ' ' O ' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -122.3 40.38 3.67 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.984 1.373 . . . . 0.0 109.561 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -161.51 22.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.256 -3.469 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -41.18 176.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 122.828 1.299 . . . . 0.0 109.669 -178.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -105.27 123.26 47.54 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.423 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.851 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -47.04 -36.18 7.7 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.697 -0.627 . . . . 0.0 109.531 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -54.0 -38.0 64.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.81 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' C ' ' A' ' 34' ' ' ALA . 24.3 tp10 -91.19 -27.87 18.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.573 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -28.24 126.38 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 110.371 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.923 HD23 ' OE1' ' A' ' 105' ' ' GLU . 4.5 mp -41.61 171.95 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.567 -0.708 . . . . 0.0 109.715 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.588 ' O ' HG22 ' A' ' 98' ' ' THR . 24.7 Cg_exo -61.48 -50.06 6.32 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.267 1.978 . . . . 0.0 111.114 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 101' ' ' PRO . . . 112.39 -64.38 0.27 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.741 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 40' ' ' GLU . 5.4 tmm_? -64.79 122.54 17.14 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.57 -1.547 . . . . 0.0 109.973 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -126.66 -12.21 6.07 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.254 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 39' ' ' THR . 2.9 mt-10 156.87 165.67 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.66 170.91 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.632 2.222 . . . . 0.0 112.281 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.55 78.18 27.09 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.023 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' HG13 ' A' ' 44' ' ' VAL . 83.7 Cg_endo -85.0 162.6 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.144 2.563 . . . . 0.0 112.504 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 43' ' ' PRO . 15.7 m -160.7 -176.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.238 -0.914 . . . . 0.0 109.628 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.6 100.12 12.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.598 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.45 -61.31 2.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.261 -0.9 . . . . 0.0 111.414 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.553 ' O ' ' C ' ' A' ' 48' ' ' HIS . 17.3 mttm -70.82 100.76 1.98 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 115.579 -2.448 . . . . 0.0 108.423 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.635 ' HE2' ' HG1' ' A' ' 89' ' ' THR . 5.9 t-80 -32.34 122.88 0.33 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.06 -28.94 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 0.0 111.012 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' ' 81' ' ' TRP . 41.8 t -69.25 -43.78 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.143 . . . . 0.0 110.001 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -106.57 -44.16 4.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 110.306 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.22 2.76 51.25 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 43.9 p30 -79.44 -121.01 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.6 mmt180 -127.81 172.03 11.21 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 123.061 1.41 . . . . 0.0 109.784 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 37.0 p -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.985 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.537 ' O ' ' C ' ' A' ' 57' ' ' GLU . 11.6 m -145.62 132.76 15.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.415 -1.428 . . . . 0.0 109.809 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.6 mm-40 -32.73 149.36 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.504 0 CA-C-O 121.75 0.786 . . . . 0.0 110.538 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.3 Cg_endo -78.34 166.21 80.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.961 -2.1 . . . . 0.0 111.831 -0.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.33 151.68 39.15 Favored Pre-proline 0 C--N 1.269 -2.934 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.289 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.57 ' O ' ' OG1' ' A' ' 63' ' ' THR . 23.9 Cg_endo -64.61 122.94 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.747 2.298 . . . . 0.0 112.162 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.536 ' CD ' ' O ' ' A' ' 61' ' ' GLU . 2.4 pp20? -43.48 143.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 32.41 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -154.77 137.15 14.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.603 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.509 ' OE1' ' N ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -108.11 171.08 7.61 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.582 ' O ' HG21 ' A' ' 162' ' ' THR . 7.4 mtm -128.07 132.54 49.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.99 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.91 -170.75 2.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.683 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 62.0 t -143.58 151.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 119.906 -1.746 . . . . 0.0 109.749 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 36.6 m-85 -147.07 125.93 12.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.982 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -105.68 89.26 0.61 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.541 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -85.89 -75.2 0.38 Allowed 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.626 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -165.74 -161.03 13.85 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.728 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -28.77 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.289 1.045 . . . . 0.0 108.611 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.78 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -59.3 7.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.016 . . . . 0.0 111.183 -177.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.675 ' O ' HD11 ' A' ' 210' ' ' LEU . 6.3 m0 -69.35 -60.83 2.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.0 108.856 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.69 -10.01 58.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . . . -59.7 -58.61 7.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.694 ' OE1' HG13 ' A' ' 91' ' ' VAL . 8.8 pt-20 -76.12 -12.57 60.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.132 -0.98 . . . . 0.0 110.757 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -56.79 -54.97 40.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.603 -1.31 . . . . 0.0 109.623 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HZ3' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -56.43 -0.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 0.0 110.69 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.537 ' CE2' HG11 ' A' ' 134' ' ' VAL . 19.8 m-85 -94.32 -39.57 10.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.744 -1.223 . . . . 0.0 109.851 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.72 ' HB2' HG11 ' A' ' 50' ' ' VAL . 1.3 p90 -77.01 16.74 0.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.85 -1.156 . . . . 0.0 109.318 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 82' ' ' VAL . 1.2 m -117.11 19.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 83' ' ' LEU . 3.9 pp -135.67 161.31 35.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.11 -0.994 . . . . 0.0 109.466 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 150.3 20.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.686 . . . . 0.0 109.984 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 110.44 -29.0 9.48 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -84.36 132.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.791 -0.829 . . . . 0.0 110.143 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.693 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.85 -43.04 31.56 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' CG ' ' A' ' 48' ' ' HIS . 5.5 t -162.25 -165.19 1.16 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.483 0.659 . . . . 0.0 109.796 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.635 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 74.1 p -154.16 143.47 21.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -144.64 145.88 31.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 109.854 -179.183 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.694 HG13 ' OE1' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -128.99 156.6 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.037 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.28 172.84 45.84 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 102' ' ' THR . 3.7 m-85 -79.99 138.37 37.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -1.058 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.779 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -157.72 -170.16 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.926 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.513 ' O ' ' NH2' ' A' ' 194' ' ' ARG . . . 40.83 38.05 1.51 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.581 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -117.71 -154.27 9.83 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.757 -1.437 . . . . 0.0 109.751 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.851 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -151.8 64.68 0.86 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.325 -1.103 . . . . 0.0 109.166 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.635 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.31 -178.48 7.38 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.027 -1.045 . . . . 0.0 108.636 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 14.3 tpp85 -75.12 -107.59 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.449 -0.782 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.771 HD21 ' HE1' ' A' ' 200' ' ' TYR . 1.5 m120 -104.9 72.69 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.574 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 38.3 Cg_endo -65.59 157.72 56.99 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.824 2.35 . . . . 0.0 112.521 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 106' ' ' VAL . 23.2 p -122.94 170.43 10.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.414 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 4.3 t80 -55.48 -45.76 76.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -25.89 61.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 0.0 110.033 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.923 ' OE1' HD23 ' A' ' 35' ' ' LEU . 3.5 mm-40 -81.89 -37.66 26.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 102' ' ' THR . 13.5 m -66.31 -23.83 32.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 O-C-N 120.594 -1.317 . . . . 0.0 109.663 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.614 ' C ' ' H ' ' A' ' 109' ' ' GLU . 3.7 t -52.72 -38.93 61.55 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.648 ' OG ' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -52.86 -1.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.23 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.4 tt0 59.65 -6.59 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.253 -0.905 . . . . 0.0 109.65 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.718 ' CB ' HD13 ' A' ' 35' ' ' LEU . 1.6 mmtt -75.98 -24.46 55.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 110.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.448 ' OG1' HG12 ' A' ' 106' ' ' VAL . 31.1 p -84.15 -10.56 57.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 109.378 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 43.26 39.5 4.14 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.672 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -82.42 162.6 22.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.225 . . . . 0.0 109.16 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.869 ' HB2' HH12 ' A' ' 156' ' ' ARG . . . -124.37 113.85 18.74 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.376 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.689 ' OE1' ' CD1' ' A' ' 73' ' ' PHE . 2.4 mm-40 -54.27 116.31 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.779 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -124.66 175.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.03 -1.044 . . . . 0.0 110.88 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.738 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.6 m -133.01 114.92 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -95.87 98.68 10.6 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 80' ' ' PHE . 14.0 m -118.96 122.43 69.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.5 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -83.6 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.69 ' HB2' HD21 ' A' ' 131' ' ' LEU . 4.7 m-85 -130.18 160.71 32.99 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.845 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 50.6 mtp85 -101.3 105.44 39.64 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.52 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 125' ' ' HIS . 9.4 Cg_exo -40.58 -66.84 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 123.203 2.602 . . . . 0.0 113.877 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.5 tt0 -42.82 -19.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.997 -1.064 . . . . 0.0 109.938 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' A' ' 123' ' ' PRO . 67.5 m-70 -109.97 -7.78 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.999 -1.063 . . . . 0.0 109.852 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.687 HG22 ' CD ' ' A' ' 130' ' ' GLU . 1.2 pt -152.19 -176.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.389 1.09 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.545 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 43.7 t -130.37 152.32 49.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 25.4 t80 -48.33 -19.16 0.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.514 -1.367 . . . . 0.0 109.382 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' C ' ' A' ' 127' ' ' SER . 9.1 mp0 -70.48 -24.54 62.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.352 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.687 ' CD ' HG22 ' A' ' 126' ' ' ILE . 7.1 mt-10 -68.87 -71.77 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.0 109.999 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 121' ' ' TYR . 1.2 mp -35.86 -43.55 0.31 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.326 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 7.5 mp -73.94 -44.98 53.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.446 -0.784 . . . . 0.0 111.519 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -53.19 47.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.795 -1.19 . . . . 0.0 110.343 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.676 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 2.0 t -50.28 -50.64 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CZ ' ' CE1' ' A' ' 139' ' ' HIS . 22.5 t80 -58.0 -44.39 87.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.775 -1.203 . . . . 0.0 111.589 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.583 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 67.7 m95 -70.74 -36.09 72.98 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.772 -1.205 . . . . 0.0 111.702 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -79.21 -13.38 59.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.938 -1.101 . . . . 0.0 112.974 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.0 OUTLIER -133.99 59.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.11 -1.619 . . . . 0.0 112.087 -178.31 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.798 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 p-80 177.58 134.25 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.027 -1.045 . . . . 0.0 109.833 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.658 ' OD2' ' NE2' ' A' ' 143' ' ' GLN . 1.2 t0 -48.96 107.36 0.75 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.33 -0.857 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -85.98 -2.07 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.735 2.29 . . . . 0.0 113.038 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.55 ' C ' ' OG1' ' A' ' 190' ' ' THR . 40.2 p -121.72 20.55 10.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 110.261 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.69 ' N ' ' OG1' ' A' ' 190' ' ' THR . 7.7 mt-30 -130.94 101.25 5.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.022 -1.049 . . . . 0.0 109.15 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.677 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -96.86 18.74 56.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -18.35 12.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.979 -1.306 . . . . 0.0 109.8 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.649 ' CD ' ' C ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.54 164.59 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.001 -1.062 . . . . 0.0 109.87 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.571 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -99.34 108.36 20.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.589 -1.32 . . . . 0.0 109.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.91 -122.15 28.46 Favored Glycine 0 C--N 1.301 -1.366 0 CA-C-O 123.211 1.451 . . . . 0.0 110.461 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.05 -32.96 39.37 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.461 -1.37 . . . . 0.0 111.964 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.571 ' OD2' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.31 101.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.171 -1.581 . . . . 0.0 108.885 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.691 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 6.5 p90 -82.43 118.44 23.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.578 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 166.15 144.19 4.0 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.531 ' O ' ' OG1' ' A' ' 153' ' ' THR . 0.5 OUTLIER -70.97 14.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -1.23 . . . . 0.0 109.047 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.668 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -102.79 -1.65 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.668 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 22.4 m-85 -132.38 53.09 2.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.815 -1.178 . . . . 0.0 109.633 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.869 HH12 ' HB2' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -100.02 177.41 5.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 110.331 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' OG1' ' A' ' 191' ' ' THR . 11.5 p -92.98 71.41 4.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.548 ' CB ' ' OH ' ' A' ' 160' ' ' TYR . . . -97.38 129.57 44.61 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.631 0.729 . . . . 0.0 110.912 -176.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 HG21 ' A' ' 191' ' ' THR . 19.9 m -102.11 146.35 10.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.566 ' CE1' HG11 ' A' ' 116' ' ' VAL . 22.2 m-85 -139.89 115.89 8.07 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.422 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 72.3 Cg_endo -77.57 167.37 24.33 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.344 2.029 . . . . 0.0 113.349 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -93.5 -41.73 9.62 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.282 -0.886 . . . . 0.0 109.392 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -171.8 -172.15 0.98 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 109.994 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.8 -25.53 4.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.074 1.416 . . . . 0.0 108.529 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 166' ' ' GLN . 2.5 t -56.01 -58.8 3.82 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.12 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.435 ' N ' HG12 ' A' ' 165' ' ' VAL . 5.5 tt0 -78.25 -25.66 46.94 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.086 -178.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -38.6 56.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 0.0 110.657 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.13 -61.62 1.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 110.826 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . . . -93.86 -16.93 23.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.85 -1.156 . . . . 0.0 112.341 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.33 -65.67 0.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.429 -1.419 . . . . 0.0 110.357 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.13 -21.42 61.58 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.875 -1.141 . . . . 0.0 108.247 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.556 ' N ' HD23 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -75.51 -27.98 58.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.438 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.583 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 97.3 p -56.29 -26.91 53.67 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 174' ' ' LYS . 14.4 mtmm -67.73 -58.48 4.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.55 8.56 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.019 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.57 -75.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 110.102 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -58.16 -32.31 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -52.79 -17.97 1.63 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 0.0 109.652 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -68.04 -39.29 83.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.686 ' O ' ' CE1' ' A' ' 184' ' ' HIS . 15.8 m -87.45 -30.88 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.108 -0.995 . . . . 0.0 109.898 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.29 -38.51 60.32 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.133 -0.979 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.9 t -56.56 -24.78 49.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -75.69 -29.84 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.708 ' CD2' ' SD ' ' A' ' 229' ' ' MET . 0.6 OUTLIER -86.0 6.39 28.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.366 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 10.8 t-20 71.74 68.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.554 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -115.78 162.62 17.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.82 178.23 48.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.5 157.86 29.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.708 2.272 . . . . 0.0 112.075 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -64.05 125.29 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.166 -0.959 . . . . 0.0 108.686 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.69 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 6.8 p -110.59 54.1 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.548 ' OG1' ' O ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -100.68 159.53 15.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.671 ' CG ' HH12 ' A' ' 194' ' ' ARG . 10.7 t0 -109.29 145.28 36.23 Favored 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.321 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.405 HD13 ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -123.73 156.41 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.671 HH12 ' CG ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -146.82 -166.91 2.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.821 -1.174 . . . . 0.0 111.276 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.807 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.46 159.62 14.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 1.102 ' O ' ' OE1' ' A' ' 197' ' ' GLN . . . 10.97 -79.69 0.0 OUTLIER Glycine 0 C--O 1.17 -3.858 0 N-CA-C 105.261 -3.135 . . . . 0.0 105.261 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 1.102 ' OE1' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 151.15 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 124.048 0.939 . . . . 0.0 110.172 175.625 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.64 ' O ' HG13 ' A' ' 198' ' ' VAL . 10.0 p -45.78 117.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 117.47 -1.692 . . . . 0.0 106.511 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.51 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 18.6 t80 -102.52 147.53 26.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 111.578 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.771 ' HE1' HD21 ' A' ' 100' ' ' ASN . 7.7 m-85 -153.39 100.75 2.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.482 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 25.6 m-85 -53.08 135.43 37.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.787 -1.196 . . . . 0.0 109.65 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.654 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -86.87 -170.56 3.12 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.257 -0.902 . . . . 0.0 108.9 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -74.39 155.06 38.5 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.473 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -50.6 -43.22 56.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.557 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -54.07 -15.14 1.3 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.624 . . . . 0.0 109.74 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.78 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 8.2 m-70 -100.69 9.35 42.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.605 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.832 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.5 mm-40 -127.98 -145.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.092 0.949 . . . . 0.0 110.119 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.684 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.86 -3.72 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.953 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.832 ' N ' ' O ' ' A' ' 207' ' ' GLN . 86.8 t80 -41.02 -43.22 2.1 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 120.524 -1.36 . . . . 0.0 110.837 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.675 HD11 ' O ' ' A' ' 74' ' ' TRP . 0.8 OUTLIER -65.36 -13.14 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.378 -1.452 . . . . 0.0 109.903 -178.234 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 208' ' ' GLN . 94.6 p -55.96 -31.09 62.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.08 -1.012 . . . . 0.0 108.656 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -85.62 -36.39 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.456 -0.778 . . . . 0.0 109.0 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -131.98 68.41 80.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' LEU . 52.5 Cg_exo -49.94 8.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.072 2.514 . . . . 0.0 113.298 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 213' ' ' ASN . 0.0 OUTLIER -61.34 -24.8 66.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.49 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 58.88 83.84 0.05 OUTLIER Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.21 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -70.5 88.2 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.902 2.351 . . . . 0.0 108.575 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.587 ' O ' ' O ' ' A' ' 219' ' ' GLY . 18.1 t -169.74 114.32 0.52 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.863 -1.148 . . . . 0.0 109.387 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -39.89 170.09 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.93 -174.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.343 -1.093 . . . . 0.0 110.131 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.575 ' O ' ' C ' ' A' ' 222' ' ' GLY . . . -155.04 -80.88 0.03 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 221' ' ' GLY . . . -27.95 105.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 CA-C-O 123.051 1.362 . . . . 0.0 109.954 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 225' ' ' VAL . 0.8 OUTLIER -126.91 21.19 6.93 Favored 'General case' 0 C--N 1.27 -2.855 0 CA-C-N 113.896 -1.152 . . . . 0.0 109.308 179.76 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -69.33 14.29 0.95 Allowed Glycine 0 N--CA 1.474 1.198 0 N-CA-C 108.506 -1.837 . . . . 0.0 108.506 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 230' ' ' ALA . 1.5 t -100.86 120.77 50.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.887 -0.772 . . . . 0.0 109.575 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.677 ' H ' ' CB ' ' A' ' 229' ' ' MET . 0.7 OUTLIER -98.62 -153.66 0.44 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.061 0.934 . . . . 0.0 109.776 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.575 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -72.53 -63.9 1.06 Allowed Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.568 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.575 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 56.5 Cg_endo -70.55 -36.65 8.38 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.37 2.047 . . . . 0.0 109.447 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.708 ' SD ' ' CD2' ' A' ' 184' ' ' HIS . 0.0 OUTLIER -53.7 153.61 4.35 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.756 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.726 ' O ' HG13 ' A' ' 225' ' ' VAL . . . -29.29 130.85 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.139 0.495 . . . . 0.0 109.989 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.6 mm -138.33 112.47 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -71.54 110.76 6.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.375 0 O-C-N 121.268 -0.895 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.672 ' O1 ' ' N ' ' A' ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.587 ' O ' ' O ' ' A' ' 22' ' ' GLY . 8.4 t0 43.79 100.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -1.118 . . . . 0.0 109.185 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 p -66.78 -27.01 67.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 29' ' ' ILE . . . -77.63 -12.42 59.97 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.895 1.331 . . . . 0.0 109.931 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.809 ' O ' HG21 ' A' ' 153' ' ' THR . 29.8 t -49.46 -48.87 47.31 Favored 'General case' 0 C--N 1.261 -3.281 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.695 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.867 ' O ' H142 ' A' ' 21' ' ' MYR . 0.0 OUTLIER -115.95 27.5 9.24 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.446 1.594 . . . . 0.0 109.796 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.716 ' O ' ' O ' ' A' ' 29' ' ' ILE . 47.5 t -152.19 22.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.557 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.716 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -36.58 176.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-O 123.141 1.448 . . . . 0.0 110.14 -178.341 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.434 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.7 124.45 26.03 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.249 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.43 80.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.755 -0.591 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.17 0.88 3.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 mm-40 -107.27 -35.93 6.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 108.963 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.78 -170.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.665 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 35' ' ' LEU . 4.2 mm? -82.68 165.76 39.98 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 108.973 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -62.59 -45.29 14.6 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.129 1.886 . . . . 0.0 111.987 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.411 ' HA2' HG22 ' A' ' 98' ' ' THR . . . 126.09 153.86 8.51 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -147.41 149.52 32.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -1.106 . . . . 0.0 109.469 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 13.6 p -122.72 -13.4 7.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 0.0 109.398 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -49.61 149.46 4.26 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.86 151.74 84.66 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.855 2.37 . . . . 0.0 112.13 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.717 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -137.83 35.59 0.26 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.164 -0.96 . . . . 0.0 110.143 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.922 ' O ' HG13 ' A' ' 44' ' ' VAL . 27.2 Cg_endo -64.34 165.91 18.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.636 2.224 . . . . 0.0 111.862 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 43' ' ' PRO . 2.3 m -172.95 172.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.38 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.642 HG23 ' O ' ' A' ' 45' ' ' THR . 7.3 t 9.98 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.509 0.671 . . . . 0.0 110.823 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.703 ' O ' HG23 ' A' ' 55' ' ' THR . . . -69.24 -52.68 25.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 111.394 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.557 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.63 99.66 10.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 115.746 -2.382 . . . . 0.0 108.765 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.632 ' NE2' ' OE1' ' A' ' 208' ' ' GLN . 8.5 t-80 -31.67 141.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.492 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 9.1 t-80 -80.44 -42.51 22.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 110.572 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 211' ' ' SER . 25.8 t -58.1 -37.56 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 110.179 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 t -109.4 -48.69 3.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 110.507 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.04 4.63 55.35 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.6 p30 -81.81 -110.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.68 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 10.1 mtm-85 -129.24 174.88 9.19 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 123.519 1.628 . . . . 0.0 109.855 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 46' ' ' ALA . 63.3 p -132.51 0.35 3.64 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.397 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' GLU . 1.1 m -145.11 132.09 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.507 -1.37 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt-10 -34.03 154.8 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 CA-C-O 121.881 0.848 . . . . 0.0 110.845 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.8 Cg_endo -79.53 166.05 78.82 Favored 'Cis proline' 0 C--N 1.301 -1.969 0 C-N-CA 121.479 -2.301 . . . . 0.0 111.633 -0.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.402 ' CZ ' HG21 ' A' ' 120' ' ' VAL . 35.6 m-85 -111.15 148.92 39.71 Favored Pre-proline 0 C--N 1.266 -3.035 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.0 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 63' ' ' THR . 8.3 Cg_endo -53.28 139.47 63.75 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.929 2.42 . . . . 0.0 112.618 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -45.5 158.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 42.78 66.82 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.544 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 1.2 p -136.7 147.38 46.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.622 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.583 ' OE1' ' CG ' ' A' ' 123' ' ' PRO . 2.1 mp0 -116.79 173.47 6.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.41 -0.806 . . . . 0.0 108.839 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.751 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -154.22 128.67 9.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.983 -1.073 . . . . 0.0 109.841 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.01 -167.6 2.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.1 t -143.22 137.6 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.087 -1.633 . . . . 0.0 109.983 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 1.045 ' O ' HG22 ' A' ' 117' ' ' VAL . 54.5 m-85 -131.76 137.89 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.059 -1.026 . . . . 0.0 110.144 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -122.78 110.26 1.52 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 105.715 -2.954 . . . . 0.0 105.715 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.556 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -107.14 -87.62 0.48 Allowed 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.214 -1.168 . . . . 0.0 110.413 -177.49 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.717 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.75 74.76 0.2 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.717 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 51.1 t 111.41 82.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.68 ' N ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -55.72 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.623 -1.298 . . . . 0.0 110.734 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.643 ' H ' ' C ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -91.41 -44.41 9.15 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.068 -1.02 . . . . 0.0 109.363 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.51 -3.95 49.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.695 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.24 -35.41 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 109.733 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.79 ' CD ' HE22 ' A' ' 208' ' ' GLN . 29.4 tt0 -68.17 -15.17 63.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.28 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.593 ' O ' HG13 ' A' ' 82' ' ' VAL . 11.5 ttt180 -60.16 -54.39 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.504 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.507 ' HE2' ' H ' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -73.38 25.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.941 -1.099 . . . . 0.0 110.165 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.7 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 6.8 m-85 -126.78 -39.01 2.01 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.482 -0.761 . . . . 0.0 110.125 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.693 ' CE2' ' OG ' ' A' ' 211' ' ' SER . 1.2 p90 -84.74 1.71 45.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.703 -1.248 . . . . 0.0 109.72 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.2 m -104.84 11.66 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.829 HD11 HG21 ' A' ' 134' ' ' VAL . 96.0 mt -99.04 149.49 22.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.07 0.938 . . . . 0.0 109.116 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.579 ' HZ3' ' HA ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -85.82 136.7 33.21 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 107.53 -26.51 17.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -72.3 138.67 21.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.128 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.692 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -78.42 -41.38 33.11 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -175.56 -169.81 0.38 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.985 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.542 ' C ' ' OE2' ' A' ' 77' ' ' GLU . 30.6 p -146.55 167.0 24.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.914 -1.116 . . . . 0.0 110.214 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.628 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -168.66 -178.75 3.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.921 HG12 HG12 ' A' ' 117' ' ' VAL . 1.6 m -156.82 161.03 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.665 -1.272 . . . . 0.0 108.504 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 201' ' ' TYR . . . -167.46 -172.42 34.57 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.199 -1.477 . . . . 0.0 111.934 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 202' ' ' ALA . 1.6 m-85 -104.44 150.29 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.852 -0.793 . . . . 0.0 109.511 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.656 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -177.0 154.22 1.07 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.31 38.56 7.16 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.498 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -129.5 -152.01 7.47 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.038 -1.272 . . . . 0.0 110.111 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.48 55.1 1.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 109.474 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 ' HA2' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -157.07 141.62 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.682 ' O ' ' CE2' ' A' ' 200' ' ' TYR . 0.0 OUTLIER -48.96 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 109.438 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -122.84 86.27 50.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.517 ' CG ' ' NE2' ' A' ' 113' ' ' HIS . 59.4 Cg_endo -78.41 -171.62 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.657 2.238 . . . . 0.0 111.811 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.633 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 23.1 p -121.69 170.5 9.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.048 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.53 -59.09 5.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.39 -0.819 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -61.22 -23.22 65.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 108.822 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.633 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.1 mm-40 -67.81 -60.07 2.81 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.66 0.743 . . . . 0.0 110.322 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.918 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.8 m -64.37 -24.49 35.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.663 -0.648 . . . . 0.0 111.635 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.7 t -53.7 -0.5 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.261 -0.9 . . . . 0.0 109.363 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 110' ' ' LYS . 22.6 p -99.8 11.17 39.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.453 ' O ' HG21 ' A' ' 29' ' ' ILE . 2.5 tt0 59.08 -5.58 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.071 -1.018 . . . . 0.0 109.512 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.4 OUTLIER -70.67 -30.97 67.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 110.371 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.918 ' OG1' HG12 ' A' ' 106' ' ' VAL . 26.7 p -84.98 -18.34 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.929 -1.107 . . . . 0.0 110.28 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.06 14.61 47.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.652 ' CD2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -58.32 158.22 7.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.029 -1.277 . . . . 0.0 109.711 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.542 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -120.36 113.83 20.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.68 ' OE1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.95 135.23 15.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.483 -179.28 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -151.68 178.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.989 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.045 HG22 ' O ' ' A' ' 68' ' ' PHE . 34.5 m -138.97 147.89 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.201 -0.937 . . . . 0.0 110.688 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.793 ' NH1' ' CZ ' ' A' ' 201' ' ' TYR . 8.9 ptm180 -115.49 95.71 5.29 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.731 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 4.0 m -109.52 113.82 45.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.17 -1.581 . . . . 0.0 108.815 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.0 t -74.49 156.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.161 ' CD2' HD22 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -136.9 160.35 39.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.887 -1.133 . . . . 0.0 110.156 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 59.8 mtp180 -119.46 100.4 49.61 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 125' ' ' HIS . 13.5 Cg_exo -41.71 -61.05 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.235 2.623 . . . . 0.0 113.276 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -38.37 -14.59 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.603 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.695 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -143.8 15.53 1.76 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.718 -1.239 . . . . 0.0 109.49 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -155.19 146.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.869 . . . . 0.0 109.419 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.572 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -107.8 166.79 10.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.244 -0.91 . . . . 0.0 109.37 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 169' ' ' ALA . 37.9 t80 -64.82 -38.83 92.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 133' ' ' LYS . 36.7 mm-40 -53.71 -27.39 27.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 109.086 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 1.0 OUTLIER -66.69 -68.82 0.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.094 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.161 HD22 ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -33.89 -47.55 0.26 Allowed 'General case' 0 C--N 1.316 -0.859 0 O-C-N 120.95 -1.094 . . . . 0.0 108.493 178.932 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 173' ' ' SER . 11.2 mp -76.1 -41.24 50.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.581 ' O ' ' OE2' ' A' ' 137' ' ' GLU . 2.8 tmmm? -52.56 -39.59 61.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.098 -1.001 . . . . 0.0 111.44 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.829 HG21 HD11 ' A' ' 83' ' ' LEU . 1.1 t -74.84 -39.44 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.722 -1.236 . . . . 0.0 110.098 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 8.0 t80 -65.32 -48.22 73.83 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.375 -0.828 . . . . 0.0 111.211 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.52 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 61.4 m95 -67.04 -34.11 76.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.784 -1.198 . . . . 0.0 111.363 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.672 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -76.95 -33.21 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 113.23 -176.844 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 41.9 m-80 -96.12 36.09 1.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.323 -1.486 . . . . 0.0 114.483 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.799 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 6.6 p-80 178.53 175.95 0.54 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.393 -1.442 . . . . 0.0 111.981 176.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.85 107.92 57.84 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 20.38 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.187 1.925 . . . . 0.0 112.299 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.73 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -115.7 3.18 13.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.753 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.536 ' O ' ' O ' ' A' ' 146' ' ' ARG . 18.1 mt-30 -101.88 78.26 1.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.069 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 146' ' ' ARG . . . -39.4 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.499 2.855 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.466 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.471 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -66.97 40.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.936 0.874 . . . . 0.0 110.39 -176.67 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.652 ' CZ ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -161.65 152.54 18.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' A' ' 143' ' ' GLN . 21.0 mm100 -154.92 74.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.281 -1.512 . . . . 0.0 110.05 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 220' ' ' LEU . . . 78.11 -115.71 4.27 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -79.52 -33.45 42.01 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-N 114.517 -0.842 . . . . 0.0 111.624 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.497 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -85.36 129.49 34.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.283 -1.511 . . . . 0.0 109.015 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.446 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 17.6 p90 -127.64 138.39 52.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 154' ' ' GLN . . . 138.58 167.08 10.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.809 HG21 ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -72.32 15.16 0.18 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.001 -1.294 . . . . 0.0 108.9 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.598 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 1.4 pt20 -114.32 17.58 17.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 44.2 m-85 -155.48 65.63 0.62 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.703 HH22 ' CG ' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -118.54 -176.03 3.0 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.384 -0.822 . . . . 0.0 109.389 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 t -92.11 140.56 29.51 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.461 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -162.14 118.95 2.06 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.603 -2.039 . . . . 0.0 112.115 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.72 HG13 ' CG2' ' A' ' 191' ' ' THR . 2.2 m -115.72 126.2 73.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.154 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.484 ' CE2' HG11 ' A' ' 116' ' ' VAL . 4.8 m-30 -113.9 119.99 39.87 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.41 170.43 19.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.564 2.176 . . . . 0.0 112.53 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.16 -40.4 8.82 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.209 -0.932 . . . . 0.0 109.592 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 165' ' ' VAL . 43.3 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.114 -0.991 . . . . 0.0 109.923 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 123.154 1.454 . . . . 0.0 108.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 163' ' ' SER . 2.5 t -56.06 -56.46 12.83 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.987 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.227 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -78.03 -36.82 48.13 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.965 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 1.5 mtm -52.46 -35.41 52.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 110.815 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -48.29 -55.0 11.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 109.962 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . . . -93.13 -30.84 15.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.017 -1.052 . . . . 0.0 110.582 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.468 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -52.54 -62.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.047 . . . . 0.0 110.014 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mt -52.66 -33.87 49.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 109.642 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.739 ' HB3' HD23 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -56.43 -34.27 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.912 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -72.18 -46.79 54.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.96 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -72.22 -39.67 68.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.045 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.59 -29.45 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.089 -1.007 . . . . 0.0 109.92 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -79.54 -44.15 21.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.886 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.767 ' OE1' HG23 ' A' ' 189' ' ' ILE . 35.8 tp60 -62.19 -5.34 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.592 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -49.64 13.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.89 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.35 -51.81 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 181' ' ' LEU . 4.5 mm? -53.72 -40.82 66.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.835 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 51.0 p -56.38 -27.27 55.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.441 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.434 ' N ' ' HD2' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -88.03 6.34 36.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.554 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.428 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 1.7 m-70 -108.22 35.82 3.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 9.3 t-20 69.88 36.07 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.48 175.61 5.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.402 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.625 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -133.47 -145.62 5.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 189' ' ' ILE . 30.0 Cg_exo -58.73 106.03 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.402 2.068 . . . . 0.0 111.248 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.767 HG23 ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -48.45 -172.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 21.4 p -151.43 58.57 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.568 -0.707 . . . . 0.0 109.813 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.72 ' CG2' HG13 ' A' ' 159' ' ' VAL . 45.7 m -99.76 128.7 45.84 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.703 ' CG ' HH22 ' A' ' 156' ' ' ARG . 4.9 t70 -75.97 119.42 19.91 Favored 'General case' 0 C--N 1.272 -2.793 0 C-N-CA 119.569 -0.853 . . . . 0.0 109.419 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.421 ' C ' ' CG ' ' A' ' 194' ' ' ARG . 0.6 OUTLIER -119.77 103.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.386 -0.925 . . . . 0.0 109.643 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.661 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -165.33 141.92 5.58 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.654 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -114.95 -177.67 3.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 109.843 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.77 29.75 60.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 198' ' ' VAL . 16.2 mm-40 -104.0 103.64 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.302 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -33.6 154.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.183 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.576 ' CE1' ' HD2' ' A' ' 118' ' ' ARG . 7.7 t80 -128.75 120.23 26.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.682 ' CE2' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.97 126.77 40.29 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.793 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.53 -176.53 3.4 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 116.329 -2.148 . . . . 0.0 114.642 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . . . -95.71 -179.58 4.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 112.185 -2.279 . . . . 0.0 111.478 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.698 ' HA ' HG11 ' A' ' 44' ' ' VAL . 1.3 pt-20 -73.57 -168.16 0.53 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.429 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.74 -14.38 54.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.866 -1.146 . . . . 0.0 110.527 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.651 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -78.53 -14.17 59.48 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.881 -1.137 . . . . 0.0 109.382 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 74' ' ' TRP . 53.7 m80 -104.68 2.88 30.91 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.109 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.841 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.2 mm-40 -120.51 -138.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.237 1.018 . . . . 0.0 109.938 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.79 HE22 ' CD ' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -34.73 -5.56 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.634 -179.763 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.841 ' N ' ' O ' ' A' ' 207' ' ' GLN . 64.2 t80 -41.88 -47.48 4.25 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 120.464 -1.398 . . . . 0.0 109.298 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.72 HD22 ' SG ' ' A' ' 218' ' ' CYS . 0.9 OUTLIER -70.63 -28.68 65.01 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.532 -1.355 . . . . 0.0 110.219 -179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.693 ' OG ' ' CE2' ' A' ' 81' ' ' TRP . 0.1 OUTLIER -69.01 -41.83 77.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.923 -1.11 . . . . 0.0 108.22 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -88.91 -19.17 26.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.535 -0.728 . . . . 0.0 109.672 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.62 ' C ' ' H ' ' A' ' 215' ' ' ASP . 22.9 m120 -116.0 89.89 26.27 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.036 . . . . 0.0 110.265 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.1 11.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.249 2.632 . . . . 0.0 112.205 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.1 t0 -61.94 -4.73 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.275 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.617 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 64.05 -44.32 0.09 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.996 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.617 ' C ' ' O ' ' A' ' 216' ' ' GLY . 40.6 m-85 -23.33 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 CA-C-N 119.408 1.604 . . . . 0.0 110.529 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.72 ' SG ' HD22 ' A' ' 210' ' ' LEU . 69.1 m -137.42 -126.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -151.92 -154.84 6.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.715 HD12 ' HA3' ' A' ' 148' ' ' GLY . 20.4 mt -82.82 -175.84 6.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.664 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.13 125.85 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.591 ' H ' ' HA ' ' A' ' 139' ' ' HIS . . . 140.28 167.67 11.1 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 139' ' ' HIS . 11.7 p -101.34 -21.29 14.89 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 114.388 -0.906 . . . . 0.0 108.672 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 173.85 -53.69 0.15 Allowed Glycine 0 C--N 1.303 -1.269 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 226' ' ' SER . 68.6 t -72.23 166.15 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.476 -1.014 . . . . 0.0 109.191 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.605 ' OG ' HD13 ' A' ' 231' ' ' ILE . 0.2 OUTLIER -98.54 107.58 20.07 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.248 1.023 . . . . 0.0 109.265 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.07 -57.47 2.32 Favored Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.342 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 229' ' ' MET . 42.9 Cg_endo -94.23 -33.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.885 2.39 . . . . 0.0 110.116 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.561 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.8 OUTLIER -55.28 154.91 5.45 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.784 0.802 . . . . 0.0 109.854 179.66 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.87 128.27 0.14 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.137 0.494 . . . . 0.0 109.811 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.664 ' O ' ' N ' ' A' ' 233' ' ' LYS . 3.4 tp -157.58 122.1 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.106 -0.996 . . . . 0.0 109.346 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 231' ' ' ILE . 4.2 ttpm? -42.61 86.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.664 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.369 0 O-C-N 121.201 -0.937 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.867 H142 ' O ' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.57 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 22' ' ' GLY . 2.0 t70 -45.08 -53.55 7.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -1.233 . . . . 0.0 109.176 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.646 ' C ' ' H ' ' A' ' 26' ' ' SER . 3.5 m -50.94 -18.42 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.312 -0.868 . . . . 0.0 109.191 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -49.62 -9.5 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 123.037 1.399 . . . . 0.0 109.482 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 24' ' ' SER . 1.9 t -47.63 -8.92 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.638 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 25' ' ' ALA . 1.2 ptpp? -124.08 41.25 3.54 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 123.051 1.405 . . . . 0.0 109.472 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -160.19 21.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.258 -3.376 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 -178.218 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.644 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -39.82 175.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.328 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.497 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -99.59 126.97 45.66 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.634 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -47.04 -62.11 1.56 Allowed 'General case' 0 C--N 1.285 -2.233 0 CA-C-O 121.258 0.551 . . . . 0.0 109.904 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -54.72 -3.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' ALA . 3.0 tt0 -108.97 -23.69 11.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.928 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.742 ' HB3' ' CE1' ' A' ' 97' ' ' HIS . . . -48.98 -167.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.904 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.826 ' CB ' HG23 ' A' ' 98' ' ' THR . 1.7 mm? -72.24 174.51 4.12 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 35' ' ' LEU . 18.8 Cg_exo -66.91 -46.39 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.796 2.33 . . . . 0.0 114.279 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA2' ' C ' ' A' ' 98' ' ' THR . . . 101.4 106.25 2.91 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 118.855 -1.64 . . . . 0.0 110.409 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' N ' ' HA ' ' A' ' 99' ' ' ARG . 4.4 tpt180 -99.12 157.55 16.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.266 . . . . 0.0 109.325 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.512 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -84.84 -28.66 25.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.559 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 39' ' ' THR . 1.9 tt0 -36.46 100.53 0.2 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.574 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' THR . 69.7 Cg_endo -80.66 160.76 21.91 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.574 2.183 . . . . 0.0 112.265 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.96 84.02 17.71 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.47 167.93 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.909 2.406 . . . . 0.0 112.31 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' ALA . 28.8 m -128.68 -171.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.613 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 44' ' ' VAL . 1.3 t -39.2 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.591 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.72 -27.18 58.65 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.192 -0.943 . . . . 0.0 111.313 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 7.8 ptpt -91.96 98.9 11.86 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 116.243 -2.183 . . . . 0.0 107.873 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.693 ' CG ' ' OG ' ' A' ' 88' ' ' SER . 6.1 t-80 -32.43 121.78 0.33 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -67.09 -34.91 78.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.347 -0.846 . . . . 0.0 111.276 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.601 HG23 ' HG3' ' A' ' 208' ' ' GLN . 21.7 t -70.5 -34.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.887 -1.133 . . . . 0.0 109.725 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -107.73 -42.45 4.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 92.46 0.42 70.03 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.699 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 34.5 p30 -78.17 -119.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.699 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttt-85 -126.3 170.74 11.59 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 123.246 1.498 . . . . 0.0 108.736 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.729 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.3 p -131.95 23.26 4.57 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 55' ' ' THR . 5.6 m -162.11 138.03 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.74 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.3 156.83 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.025 0.917 . . . . 0.0 110.795 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 81.3 Cg_endo -80.07 166.18 77.2 Favored 'Cis proline' 0 C--N 1.301 -1.953 0 C-N-CA 121.471 -2.304 . . . . 0.0 112.157 -0.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.521 ' CE1' HG11 ' A' ' 120' ' ' VAL . 27.2 m-85 -103.27 147.91 34.88 Favored Pre-proline 0 C--N 1.27 -2.89 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.078 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' O ' ' OG1' ' A' ' 63' ' ' THR . 38.9 Cg_endo -70.29 142.89 46.73 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.827 2.351 . . . . 0.0 112.368 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -46.43 158.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.467 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.26 62.65 5.42 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.54 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.5 OUTLIER -146.02 139.41 26.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -1.116 . . . . 0.0 109.569 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.628 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 1.6 mp0 -109.15 123.58 49.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.649 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -111.78 139.49 47.21 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.08 -169.38 2.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 117' ' ' VAL . 72.2 t -143.94 140.79 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.105 -1.622 . . . . 0.0 109.743 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.896 ' O ' HG22 ' A' ' 117' ' ' VAL . 97.3 m-85 -123.19 155.2 37.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -153.32 94.67 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 118.564 -1.779 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.588 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -92.87 -87.01 0.24 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.621 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -134.97 -158.01 8.22 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.769 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.85 102.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -1.019 . . . . 0.0 108.317 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.657 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -51.95 7.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 111.698 -177.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.769 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 4.7 m0 -69.22 -73.39 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.604 -1.31 . . . . 0.0 109.027 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.9 -14.52 63.37 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . . . -77.03 -53.88 7.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -1.143 . . . . 0.0 110.858 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.71 ' OE2' HG13 ' A' ' 91' ' ' VAL . 7.8 tp10 -48.42 -36.56 15.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.298 -0.876 . . . . 0.0 111.379 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.899 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.5 tmt_? -66.36 -57.95 6.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 0.0 109.941 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -41.18 -10.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.527 -0.733 . . . . 0.0 111.366 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.685 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.7 m-85 -101.91 -40.69 6.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.583 -1.323 . . . . 0.0 111.256 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.622 ' HB3' HG21 ' A' ' 89' ' ' THR . 1.1 p90 -86.69 1.83 50.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.48 -1.387 . . . . 0.0 110.906 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.2 m -83.52 19.99 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.134 . . . . 0.0 109.636 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 83' ' ' LEU . 0.6 OUTLIER -129.97 158.57 39.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.662 ' HZ1' ' C ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -91.48 153.43 19.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.576 -0.702 . . . . 0.0 109.742 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -26.63 19.09 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG23 ' CD2' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -75.34 138.06 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.712 -0.875 . . . . 0.0 109.76 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.691 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -82.74 -41.52 19.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 89' ' ' THR . 11.8 t -156.98 -163.66 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.662 0.744 . . . . 0.0 110.066 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 88' ' ' SER . 3.7 p -168.72 121.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' C ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -136.39 173.63 11.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.963 -1.086 . . . . 0.0 110.707 -178.291 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.782 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -146.39 157.93 11.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.584 0.707 . . . . 0.0 109.62 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.43 174.5 46.08 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.627 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -85.39 156.13 20.99 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.374 -1.074 . . . . 0.0 109.547 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.8 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -172.72 -170.73 0.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 109.72 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 59.27 21.77 54.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.754 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -160.41 -156.08 8.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.742 ' CE1' ' HB3' ' A' ' 34' ' ' ALA . 30.9 p80 178.91 109.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.416 -1.049 . . . . 0.0 108.983 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.826 HG23 ' CB ' ' A' ' 35' ' ' LEU . 13.9 m -144.45 144.79 31.55 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.612 ' C ' ' O ' ' A' ' 98' ' ' THR . 17.6 mtm-85 -19.83 -85.39 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.747 0.784 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -117.19 90.83 34.97 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 2.8 Cg_exo -73.35 111.1 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.566 2.178 . . . . 0.0 113.329 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.6 p -123.05 163.3 20.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.635 ' O ' ' CD1' ' A' ' 103' ' ' TYR . 0.5 OUTLIER -50.05 -35.95 27.1 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.381 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.629 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 3.9 ttmt -73.7 -31.93 63.67 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.693 -0.63 . . . . 0.0 110.956 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.2 mm-40 -80.99 -47.08 14.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 102' ' ' THR . 30.2 m -67.6 -25.03 32.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 120.608 -1.308 . . . . 0.0 110.342 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.629 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 14.5 p -53.89 -40.62 66.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.673 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 58.1 m -48.51 -66.52 0.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.673 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.6 mt-10 137.82 -25.25 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.259 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' HD22 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -67.06 3.87 1.02 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.542 -177.532 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.439 ' OG1' HG12 ' A' ' 106' ' ' VAL . 71.0 p -99.91 -25.15 14.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.77 -1.206 . . . . 0.0 109.33 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 66.07 13.26 59.47 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.428 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.754 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.55 159.07 28.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.494 -1.592 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 1.041 ' HB2' ' NH2' ' A' ' 156' ' ' ARG . . . -126.31 117.79 23.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.657 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.5 mm-40 -49.46 112.61 0.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.76 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -124.54 175.29 7.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.382 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 68' ' ' PHE . 33.7 m -132.45 148.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.15 -0.969 . . . . 0.0 110.158 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HG3' ' NE2' ' A' ' 90' ' ' GLN . 2.0 tpp180 -110.69 107.81 17.49 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.685 HG12 HG22 ' A' ' 89' ' ' THR . 7.5 m -133.66 116.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 108.805 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.538 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.0 OUTLIER -96.95 158.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 131' ' ' LEU . 3.0 m-85 -134.45 155.45 50.32 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.885 -1.134 . . . . 0.0 109.543 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.624 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 1.4 ptm180 -110.37 112.31 57.05 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 125' ' ' HIS . 34.1 Cg_exo -44.48 -63.6 0.32 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 123.177 2.584 . . . . 0.0 113.383 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.755 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 16.9 mp0 -33.17 -21.9 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.737 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.688 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -137.99 6.46 2.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.433 -1.417 . . . . 0.0 110.502 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -155.82 150.41 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 110.043 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.568 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 37.6 t -97.81 147.6 24.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.96 ' CE2' HD11 ' A' ' 132' ' ' LEU . 50.8 t80 -62.51 -21.16 65.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.28 -7.57 47.9 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.568 ' HG3' ' H ' ' A' ' 127' ' ' SER . 9.1 mm-40 -74.46 -70.31 0.41 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.757 -0.59 . . . . 0.0 110.358 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.044 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -51.95 -29.79 21.91 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 120.495 -1.378 . . . . 0.0 108.236 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.96 HD11 ' CE2' ' A' ' 128' ' ' PHE . 47.3 mt -63.68 -57.05 11.23 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.524 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -39.61 94.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.745 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.759 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 3.8 t -50.27 -62.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 109.515 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 6.0 t80 -54.63 -39.09 67.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.457 -1.402 . . . . 0.0 110.078 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.56 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 51.5 m95 -70.75 -36.35 73.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.973 -1.079 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.77 -4.95 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 113.577 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.759 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -122.74 41.71 3.37 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.06 -1.65 . . . . 0.0 111.422 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 173.55 -168.41 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.849 0.833 . . . . 0.0 108.752 177.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -118.25 138.57 25.74 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.449 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 93.3 Cg_endo -81.21 0.99 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.614 2.21 . . . . 0.0 113.285 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.571 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -121.8 47.25 1.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.858 -1.151 . . . . 0.0 110.196 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.574 ' O ' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER -129.9 70.32 1.43 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.129 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.72 ' H ' HG21 ' A' ' 190' ' ' THR . . . -51.59 -118.71 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.626 ' SD ' ' C ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -70.56 40.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.444 -1.033 . . . . 0.0 109.736 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 144' ' ' GLY . 9.4 ttt180 -165.64 85.29 0.35 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.558 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.588 ' OE1' ' O ' ' A' ' 70' ' ' MET . 5.7 tp60 -86.23 117.16 24.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.428 -1.42 . . . . 0.0 109.79 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 46.58 -114.31 1.44 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.533 ' CG ' ' O ' ' A' ' 149' ' ' ASN . 12.8 t30 -92.77 16.71 11.75 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 114.329 -0.936 . . . . 0.0 110.282 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.19 147.15 30.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.114 . . . . 0.0 109.201 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 151' ' ' PHE . 20.2 p90 -130.07 129.42 43.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' NE2' ' A' ' 154' ' ' GLN . . . 147.16 155.06 6.4 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.675 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.1 OUTLIER -79.3 5.1 13.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.361 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.651 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 15.1 pm0 -97.48 -5.75 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.474 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 23.0 m-85 -122.45 61.82 0.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.122 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.041 ' NH2' ' HB2' ' A' ' 114' ' ' ALA . 8.9 ptt-85 -112.23 175.91 5.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -0.842 . . . . 0.0 109.125 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.639 ' HB3' ' HE2' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -89.44 121.0 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -137.18 128.88 28.75 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 118.291 -1.363 . . . . 0.0 110.986 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.781 HG13 ' CG2' ' A' ' 191' ' ' THR . 1.1 m -126.77 120.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.26 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.518 ' CE2' HG11 ' A' ' 116' ' ' VAL . 6.2 m-30 -109.86 126.13 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.14 174.66 9.84 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 123.012 2.474 . . . . 0.0 112.999 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.556 ' OG1' ' OE1' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -99.3 -40.33 7.98 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.469 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -172.97 -162.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 0.0 109.722 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -53.57 -16.64 1.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.921 1.343 . . . . 0.0 108.959 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.469 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.9 t -59.2 -57.54 10.97 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.246 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.556 ' OE1' ' OG1' ' A' ' 162' ' ' THR . 1.3 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.749 -0.594 . . . . 0.0 110.392 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtp -50.92 -44.33 60.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.658 -1.276 . . . . 0.0 109.498 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.69 -19.23 59.27 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.034 -1.041 . . . . 0.0 109.12 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.58 -57.65 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.85 . . . . 0.0 110.616 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.64 -65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.068 -1.02 . . . . 0.0 110.035 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -33.53 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.24 -45.92 44.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.56 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 83.0 p -56.23 -49.45 74.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.388 -0.82 . . . . 0.0 109.826 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.536 ' HZ3' HD12 ' A' ' 189' ' ' ILE . 12.8 tttm -61.8 -53.59 53.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.741 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.02 -6.75 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.849 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.15 -52.17 9.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 110.464 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -11.79 59.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.028 -1.045 . . . . 0.0 110.28 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.517 ' OE1' ' CB ' ' A' ' 182' ' ' SER . 0.2 OUTLIER -70.8 -41.07 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.561 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -77.05 -16.04 59.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.49 -54.62 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 0.0 109.911 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.449 ' CD1' ' CG ' ' A' ' 141' ' ' PRO . 37.2 mt -75.4 -43.68 48.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 110.174 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.517 ' CB ' ' OE1' ' A' ' 178' ' ' GLN . 12.7 t -55.35 -22.1 17.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -88.18 -9.94 51.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 109.008 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.419 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 22.5 m170 -108.28 34.58 3.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 28.0 t-20 69.79 68.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.965 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -134.73 173.15 12.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -110.75 -168.74 19.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 189' ' ' ILE . 11.1 Cg_endo -58.84 115.1 2.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.761 1.641 . . . . 0.0 110.812 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.571 HG22 HG22 ' A' ' 142' ' ' THR . 0.3 OUTLIER -47.8 179.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.0 110.06 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.72 HG21 ' H ' ' A' ' 144' ' ' GLY . 39.9 p -140.01 59.75 1.57 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.781 ' CG2' HG13 ' A' ' 159' ' ' VAL . 27.1 m -98.04 115.81 28.97 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 194' ' ' ARG . 6.3 t0 -84.72 125.28 32.4 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.953 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.44 148.33 19.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.65 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 3.6 mtm180 -165.44 169.81 15.19 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.522 -0.736 . . . . 0.0 109.128 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.697 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -123.86 170.6 10.41 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.994 -1.067 . . . . 0.0 110.808 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 195' ' ' GLU . . . 22.72 38.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.753 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -65.32 132.76 49.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.832 -1.393 . . . . 0.0 109.862 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.84 163.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -127.05 141.69 51.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.365 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' A' ' 93' ' ' PHE . 1.6 m-85 -142.56 97.91 3.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.922 . . . . 0.0 109.608 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -54.24 134.64 44.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.38 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.93 -173.16 4.58 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.669 ' CD ' ' H ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -75.33 168.06 20.71 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.636 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.04 -48.97 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.863 -1.148 . . . . 0.0 108.51 179.135 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.669 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.48 -23.04 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 110.054 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.651 ' O ' HG21 ' A' ' 91' ' ' VAL . 9.5 m-70 -92.3 6.79 45.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.048 -1.032 . . . . 0.0 110.022 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.827 ' O ' ' N ' ' A' ' 209' ' ' TYR . 6.0 mm-40 -122.56 -138.66 0.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.776 1.274 . . . . 0.0 111.024 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.699 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.3 OUTLIER -34.21 -3.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.44 -179.072 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.827 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.0 t80 -42.68 -43.08 3.72 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 120.563 -1.336 . . . . 0.0 110.464 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.625 HD21 ' O ' ' A' ' 74' ' ' TRP . 2.9 mp -61.17 -12.37 12.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.525 -1.36 . . . . 0.0 109.867 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.5 t -55.78 -29.76 60.2 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 108.545 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -83.92 -35.16 24.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.423 -0.798 . . . . 0.0 108.867 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -136.35 130.65 18.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 216' ' ' GLY . 30.2 Cg_endo -65.37 -56.84 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.921 1.747 . . . . 0.0 113.287 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.617 ' O ' ' N ' ' A' ' 217' ' ' TYR . 0.8 OUTLIER -64.11 2.37 0.56 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.689 -1.257 . . . . 0.0 107.926 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 61.95 -68.43 0.02 OUTLIER Glycine 0 N--CA 1.479 1.507 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' A' ' 215' ' ' ASP . 9.2 t80 -145.95 -150.85 0.35 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.475 -1.015 . . . . 0.0 108.737 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 218' ' ' CYS . 23.8 p -90.3 77.96 6.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.089 -1.007 . . . . 0.0 108.991 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -135.73 -152.05 6.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -169.66 -178.71 3.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -1.208 . . . . 0.0 109.75 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 220' ' ' LEU . . . -104.57 -143.74 12.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.687 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -154.45 -141.94 3.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.2 OUTLIER 40.88 15.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.421 -1.046 . . . . 0.0 109.662 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -86.87 14.22 57.19 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.828 HG13 ' O ' ' A' ' 225' ' ' VAL . 9.2 p -111.59 97.42 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.333 -1.099 . . . . 0.0 109.825 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.645 ' H ' ' CB ' ' A' ' 229' ' ' MET . 3.0 p -98.63 -153.9 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.183 -0.948 . . . . 0.0 109.496 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.512 ' CB ' ' CD ' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -72.47 -67.72 0.47 Allowed Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.525 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 34.9 Cg_endo -65.21 -37.42 31.91 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.308 2.005 . . . . 0.0 109.532 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.645 ' CB ' ' H ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -53.6 152.75 4.83 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.717 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 225' ' ' VAL . . . -29.12 133.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.303 0.573 . . . . 0.0 110.125 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 231' ' ' ILE . 2.7 mm -129.96 108.46 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.254 -0.904 . . . . 0.0 109.246 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 233' ' ' LYS . 0.0 OUTLIER -89.75 -152.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 109.39 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 232' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.307 0 O-C-N 121.143 -0.973 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.479 H121 ' NH1' ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.71 61.57 0.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -1.155 . . . . 0.0 109.381 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.5 m -50.56 -18.51 0.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 109.555 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -70.02 -93.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 123.366 1.555 . . . . 0.0 111.069 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.423 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 19.0 m -46.42 -11.49 0.02 OUTLIER 'General case' 0 C--N 1.256 -3.483 0 CA-C-N 113.329 -1.76 . . . . 0.0 111.619 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.687 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.7 ttpt -106.12 25.03 11.5 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 124.595 2.141 . . . . 0.0 109.492 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -157.45 21.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.253 -3.59 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.652 HG21 ' O ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -42.68 176.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.759 1.266 . . . . 0.0 108.775 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -94.02 128.66 40.5 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.16 179.451 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 97' ' ' HIS . . . -47.34 -38.5 13.0 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.24 -10.66 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.632 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 34' ' ' ALA . 4.6 tt0 -81.87 -46.48 14.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 111' ' ' THR . . . -37.07 137.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.777 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -131.88 14.03 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 120.935 -1.103 . . . . 0.0 112.28 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.777 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 11.0 Cg_endo -64.97 -28.7 57.86 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.329 1.353 . . . . 0.0 111.745 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . 17.31 89.42 0.01 OUTLIER Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -116.6 177.7 4.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -1.188 . . . . 0.0 109.503 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.98 -21.75 5.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.526 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' N ' ' CD ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -148.25 149.36 31.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.488 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.47 -178.2 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.771 2.314 . . . . 0.0 112.194 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.635 ' CG1' ' O ' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -135.54 97.9 12.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.431 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.15 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.2 m -148.88 -179.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.542 ' OG1' ' OD1' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -47.9 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.129 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.41 -28.09 58.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.424 -0.797 . . . . 0.0 111.39 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.84 99.27 11.7 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 115.958 -2.297 . . . . 0.0 108.581 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.941 ' CE1' ' HG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.25 126.43 0.27 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.656 ' HE1' ' HD3' ' A' ' 212' ' ' LYS . 8.7 t-80 -71.41 -29.4 64.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.697 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.855 HG21 ' CG ' ' A' ' 81' ' ' TRP . 21.5 t -69.25 -40.58 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.977 -1.077 . . . . 0.0 110.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -109.37 -42.69 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.158 -0.963 . . . . 0.0 110.335 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.26 3.59 56.58 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 38.4 p30 -79.21 -116.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.0 ttt180 -129.43 169.95 14.3 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 123.221 1.486 . . . . 0.0 108.992 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.75 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.3 p -133.7 34.0 3.45 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.025 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 55' ' ' THR . 4.5 m -163.86 150.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.71 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.3 pm0 -32.2 153.89 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.72 0 CA-C-O 121.932 0.872 . . . . 0.0 110.909 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 98.6 Cg_endo -78.73 166.07 80.52 Favored 'Cis proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.568 -2.263 . . . . 0.0 111.862 0.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.783 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 1.9 m-30 -115.48 132.45 23.11 Favored Pre-proline 0 C--N 1.269 -2.892 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.977 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.536 ' O ' ' OG1' ' A' ' 63' ' ' THR . 47.1 Cg_exo -49.48 115.57 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.002 1.801 . . . . 0.0 112.049 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -43.31 152.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.644 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.583 ' O ' ' CD ' ' A' ' 123' ' ' PRO . . . 79.38 4.38 89.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 1.2 p -90.8 143.51 26.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -1.146 . . . . 0.0 109.694 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mp0 -121.71 125.62 47.03 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.674 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -116.92 115.12 24.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 0.0 110.114 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' ' HE1' ' A' ' 128' ' ' PHE . . . -88.4 -175.98 5.18 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.3 t -146.06 113.83 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 119.724 -1.86 . . . . 0.0 110.11 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 1.107 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.4 p90 -162.71 155.19 19.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.722 -1.236 . . . . 0.0 109.387 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.628 ' HA2' HG13 ' A' ' 117' ' ' VAL . . . -136.04 133.59 6.71 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.297 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.612 ' CG ' ' N ' ' A' ' 71' ' ' GLY . 8.0 ptm -85.05 -50.71 7.21 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -1.013 . . . . 0.0 108.537 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.612 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.58 -154.15 8.2 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.697 ' H ' ' CG ' ' A' ' 150' ' ' ASP . 40.9 t -35.49 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -1.062 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.84 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -58.84 25.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.97 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.745 ' NE1' ' CE1' ' A' ' 209' ' ' TYR . 9.6 t90 -77.9 -60.29 2.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.9 -1.125 . . . . 0.0 108.91 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.67 -3.91 43.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.78 69.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.004 -1.292 . . . . 0.0 109.475 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.664 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 6.7 tt0 -73.63 -13.74 61.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 80' ' ' PHE . 11.1 ttp85 -60.53 -71.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 110.288 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.676 ' O ' HG22 ' A' ' 82' ' ' VAL . 14.7 mtmt -36.32 -22.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.212 -0.93 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.943 ' CD2' HG21 ' A' ' 119' ' ' VAL . 84.3 m-85 -77.98 -41.81 34.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 0.0 110.803 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.855 ' CG ' HG21 ' A' ' 50' ' ' VAL . 1.2 p90 -76.83 8.59 3.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.55 -1.344 . . . . 0.0 109.518 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -102.13 19.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.0 109.851 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 126' ' ' ILE . 45.6 mt -110.97 154.22 24.44 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.029 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -92.67 132.28 37.04 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -27.36 13.46 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -67.18 136.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.378 -1.072 . . . . 0.0 109.309 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.683 ' CE2' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -76.96 -51.49 11.07 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.585 -0.697 . . . . 0.0 109.455 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.683 ' OG ' ' CE2' ' A' ' 87' ' ' TYR . 2.0 p -160.04 -160.49 0.8 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.183 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.941 ' HG1' ' CE1' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -164.11 155.48 16.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.664 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.46 171.69 10.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.989 -1.069 . . . . 0.0 109.737 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.84 HG11 ' HB2' ' A' ' 73' ' ' PHE . 1.8 m -142.98 166.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.955 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.91 173.76 45.15 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 200' ' ' TYR . 5.5 m-85 -80.73 163.27 23.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.271 -1.135 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.631 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.94 139.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.993 -1.067 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 94.66 23.92 19.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.698 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -108.15 178.92 21.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.429 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 1.6 m170 -120.59 58.63 0.93 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.286 -1.126 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.714 HG22 ' H ' ' A' ' 99' ' ' ARG . 2.3 m -157.51 -178.41 7.32 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.88 -1.137 . . . . 0.0 108.724 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.714 ' H ' HG22 ' A' ' 98' ' ' THR . 34.9 mtt180 -76.66 -89.36 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.934 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.516 ' ND2' ' N ' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -113.43 96.52 40.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.965 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 11.5 Cg_endo -79.93 159.97 24.18 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.257 . . . . 0.0 112.21 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.63 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 9.9 p -114.78 172.51 6.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.19 -0.944 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.603 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -63.88 -59.65 4.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -59.3 -22.95 61.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.094 . . . . 0.0 108.528 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.63 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 8.3 mm-40 -69.78 -56.67 6.52 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.533 0.683 . . . . 0.0 110.471 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 102' ' ' THR . 16.6 m -66.17 -24.74 34.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.498 -0.752 . . . . 0.0 111.368 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.631 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.8 p -57.36 -41.93 81.06 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 35.5 p -51.91 -66.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.3 mt-10 138.62 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -46.8 -27.44 1.22 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.415 -0.803 . . . . 0.0 111.767 -178.612 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 11.1 p -90.84 -32.6 16.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.564 -1.335 . . . . 0.0 109.941 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 65.76 44.32 92.47 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.698 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 1.2 m-70 -86.2 173.74 9.59 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.674 -1.486 . . . . 0.0 108.778 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -132.38 114.19 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.609 ' OE2' ' CE1' ' A' ' 73' ' ' PHE . 17.0 mt-10 -56.05 123.16 13.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.813 HG11 ' CE2' ' A' ' 160' ' ' TYR . 11.8 m -127.31 150.82 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.416 -0.802 . . . . 0.0 108.979 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.107 HG22 ' O ' ' A' ' 68' ' ' PHE . 3.6 m -111.31 135.31 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.783 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -98.52 98.51 9.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.532 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.943 HG21 ' CD2' ' A' ' 80' ' ' PHE . 49.0 t -103.38 120.75 53.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.449 -0.782 . . . . 0.0 109.222 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.508 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -118.07 144.2 26.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.699 ' CE2' HD11 ' A' ' 131' ' ' LEU . 8.8 p90 -141.39 174.31 10.67 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.087 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -116.03 117.93 38.8 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' HIS . 28.2 Cg_exo -42.09 -62.38 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.879 2.386 . . . . 0.0 113.318 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.759 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 27.3 mp0 -38.94 -14.34 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.153 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' PRO . 11.8 m-70 -133.38 -10.8 2.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.527 -1.358 . . . . 0.0 111.578 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.64 158.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 120.565 -1.335 . . . . 0.0 110.656 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.515 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 1.1 p -109.76 169.53 8.66 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.795 0.807 . . . . 0.0 111.375 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.57 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 41.2 t80 -69.32 -27.85 65.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 22.4 mt-10 -66.4 -8.74 27.67 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 127' ' ' SER . 7.2 mm-40 -72.36 -66.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.827 . . . . 0.0 110.797 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.901 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -57.29 -35.65 70.06 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.61 -1.306 . . . . 0.0 107.98 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 9.3 mp -74.73 -50.4 17.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 3.8 tttt -52.66 -41.37 63.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.865 -1.147 . . . . 0.0 110.272 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.638 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -72.15 -28.5 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.952 -1.093 . . . . 0.0 109.501 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.801 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.3 t80 -71.41 -50.8 28.36 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.732 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.52 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 76.9 m95 -72.03 -46.6 56.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.207 -1.558 . . . . 0.0 110.527 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.56 -42.78 55.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.14 -0.975 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.711 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 0.3 OUTLIER -119.43 74.3 0.99 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 110.433 -178.215 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.801 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 12.0 m80 -156.75 -179.92 8.66 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.149 0.976 . . . . 0.0 110.299 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.481 ' N ' ' HD3' ' A' ' 141' ' ' PRO . 1.0 OUTLIER -144.26 67.77 15.08 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 140' ' ' ASP . 16.4 Cg_exo -63.51 12.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.681 2.921 . . . . 0.0 113.998 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.607 HG22 HG22 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -121.95 29.15 7.21 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.046 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.667 ' CG ' ' O ' ' A' ' 143' ' ' GLN . 1.2 pt20 -155.61 77.69 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.841 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.699 ' N ' HG21 ' A' ' 190' ' ' THR . . . -70.38 14.71 1.25 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.658 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -108.27 1.46 21.99 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.146 -1.208 . . . . 0.0 108.223 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.461 ' CB ' ' HA ' ' A' ' 151' ' ' PHE . 11.5 ptt180 178.59 -174.18 0.17 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.718 0.771 . . . . 0.0 109.314 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.454 HE22 ' HA ' ' A' ' 139' ' ' HIS . 0.4 OUTLIER -175.1 118.93 0.18 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.721 0.772 . . . . 0.0 109.255 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.88 -120.38 10.53 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.448 ' ND2' ' HA3' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -80.94 -34.02 33.6 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.321 -0.939 . . . . 0.0 112.176 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.697 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 1.5 m-20 -82.48 144.21 30.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.398 -1.439 . . . . 0.0 109.23 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.461 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 38.5 p90 -136.36 144.57 44.66 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.05 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.66 -174.18 18.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.13 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.671 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -74.83 -19.72 60.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.695 -0.886 . . . . 0.0 110.367 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 155' ' ' TYR . 17.5 pm0 -86.52 7.51 25.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.156 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 154' ' ' GLN . 16.3 m-85 -139.65 50.84 1.75 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 0.0 109.59 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 153' ' ' THR . 38.4 mtm-85 -93.52 173.21 7.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.28 -0.888 . . . . 0.0 108.676 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.605 ' OG ' ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -94.28 109.26 21.09 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.271 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -133.33 119.28 19.53 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.396 -1.322 . . . . 0.0 109.947 -177.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.693 HG23 ' CG2' ' A' ' 191' ' ' THR . 7.9 t -114.5 125.43 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.813 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -119.57 133.51 23.82 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.23 169.03 22.09 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.564 2.176 . . . . 0.0 111.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -19.69 20.17 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 120.729 -1.232 . . . . 0.0 109.146 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 p 177.44 -163.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.74 23.68 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.033 1.397 . . . . 0.0 108.471 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.4 t -56.15 -62.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.496 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 170' ' ' ALA . 12.7 mt-30 -77.81 -11.42 59.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 0.0 111.298 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.42 -45.57 62.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.569 -1.332 . . . . 0.0 109.248 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.71 -17.75 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.87 -55.88 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.0 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.34 -53.77 40.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 171' ' ' LEU . 70.0 mt -52.66 -39.1 61.5 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 108.906 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -58.26 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.429 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.52 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 4.0 p -56.67 -36.23 69.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.253 -0.904 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.471 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 4.2 ttpt -72.61 -46.41 54.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 109.383 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.423 ' N ' ' HE2' ' A' ' 174' ' ' LYS . 1.5 tt0 -71.63 -30.23 65.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 4.1 pt-20 -53.25 -34.02 55.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.526 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.618 ' CD2' HD11 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.28 -30.83 43.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.499 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.4 OUTLIER -66.61 -38.12 86.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 109.466 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -28.28 59.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.1 t -87.48 -54.22 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.618 HD11 ' CD2' ' A' ' 177' ' ' TYR . 3.7 mt -63.97 -45.26 89.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.027 -1.045 . . . . 0.0 109.92 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 87.8 p -54.97 -23.75 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -88.38 -3.56 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.46 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.7 m-70 -108.18 30.82 6.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 4.4 t-20 72.3 29.74 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 110.25 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -103.54 175.16 5.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.032 -1.042 . . . . 0.0 108.99 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.93 -152.05 8.45 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' A' ' 189' ' ' ILE . 28.0 Cg_exo -58.69 105.74 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.639 2.226 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.607 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.8 -178.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.265 -0.897 . . . . 0.0 110.01 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.699 HG21 ' N ' ' A' ' 144' ' ' GLY . 1.7 t -130.76 -2.04 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.777 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.693 ' CG2' HG23 ' A' ' 159' ' ' VAL . 3.9 m -42.07 113.43 0.44 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.657 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -80.79 114.53 19.74 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.341 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.21 111.93 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.672 ' NH2' ' OH ' ' A' ' 160' ' ' TYR . 55.6 mtm-85 -115.18 -173.23 2.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.02 164.12 33.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.42 23.36 1.98 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.754 ' CD ' ' H ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -83.68 173.23 11.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.62 -1.518 . . . . 0.0 108.919 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.743 ' CG1' ' CE2' ' A' ' 200' ' ' TYR . 1.0 OUTLIER -118.72 160.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.08 . . . . 0.0 110.379 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.511 ' CZ ' ' HG3' ' A' ' 118' ' ' ARG . 47.1 t80 -91.04 149.88 21.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 109.314 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.743 ' CE2' ' CG1' ' A' ' 198' ' ' VAL . 18.6 m-85 -143.83 100.43 3.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 109.8 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -58.54 146.49 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 109.225 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -90.07 -167.22 1.78 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.101 -0.999 . . . . 0.0 108.985 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.719 ' OE2' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -73.84 176.82 6.0 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 109.267 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.719 ' N ' ' OE2' ' A' ' 203' ' ' GLU . 0.3 OUTLIER -61.03 -61.02 2.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.711 ' CD1' ' OE2' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.43 8.62 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.774 -1.204 . . . . 0.0 111.039 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.603 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 6.5 m-70 -104.0 14.8 29.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.766 -1.209 . . . . 0.0 111.04 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.803 ' O ' ' N ' ' A' ' 209' ' ' TYR . 20.0 mm-40 -129.05 -168.35 1.91 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 110.495 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.824 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -38.64 1.15 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.803 ' N ' ' O ' ' A' ' 207' ' ' GLN . 21.1 p90 -38.35 -24.03 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 O-C-N 120.788 -1.195 . . . . 0.0 110.965 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.714 ' CB ' ' HE1' ' A' ' 74' ' ' TRP . 0.2 OUTLIER -79.38 -10.42 59.8 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.267 -1.521 . . . . 0.0 111.81 -176.056 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.442 ' OG ' ' CG ' ' A' ' 49' ' ' HIS . 83.3 p -54.06 -24.63 17.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.152 -0.968 . . . . 0.0 108.757 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.656 ' HD3' ' HE1' ' A' ' 49' ' ' HIS . 6.4 mmmt -68.39 -18.41 64.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.0 OUTLIER -140.23 73.05 32.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.71 4.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 123.037 2.491 . . . . 0.0 113.079 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.623 ' OD2' ' CE1' ' A' ' 217' ' ' TYR . 38.0 t0 -63.02 -19.5 64.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 110.053 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.56 85.25 0.04 OUTLIER Glycine 0 N--CA 1.504 3.214 0 C-N-CA 120.067 -1.064 . . . . 0.0 111.757 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.623 ' CE1' ' OD2' ' A' ' 215' ' ' ASP . 66.5 m-85 -91.81 81.13 5.21 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 121.002 2.401 . . . . 0.0 109.602 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.572 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.5 OUTLIER -170.83 112.12 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 109.447 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.572 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -37.87 161.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 218' ' ' CYS . 4.6 mp -143.54 -177.97 5.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.12 -1.224 . . . . 0.0 109.775 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 108.47 158.74 19.53 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.667 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -123.79 -167.31 12.74 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 222' ' ' GLY . 0.0 OUTLIER -34.95 -25.74 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.914 0 CA-C-N 114.511 -0.844 . . . . 0.0 109.219 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . 79.59 17.03 76.54 Favored Glycine 0 C--N 1.305 -1.158 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.638 ' C ' ' H ' ' A' ' 227' ' ' CYS . 3.2 p -53.58 166.16 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.809 -0.819 . . . . 0.0 109.627 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.6 m -66.94 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.312 1.053 . . . . 0.0 111.437 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.638 ' H ' ' C ' ' A' ' 225' ' ' VAL . 1.3 m -69.87 -71.29 0.29 Allowed Pre-proline 0 C--N 1.259 -3.368 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.867 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 21.7 Cg_endo -62.78 -0.51 2.06 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.833 1.689 . . . . 0.0 110.074 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.66 ' SD ' ' O ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -58.0 155.52 10.71 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.8 0.81 . . . . 0.0 110.262 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.66 ' O ' ' SD ' ' A' ' 229' ' ' MET . . . -30.43 136.01 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.792 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.582 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 2.5 tp -147.3 117.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.208 -0.932 . . . . 0.0 109.394 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -69.76 -26.84 64.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.195 -0.941 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.597 ' O1 ' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.495 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' CG ' ' N ' ' A' ' 24' ' ' SER . 3.5 p-10 -48.11 -45.03 32.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.082 -1.246 . . . . 0.0 108.666 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.665 ' C ' ' H ' ' A' ' 26' ' ' SER . 2.5 m -50.81 -15.97 0.35 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -47.74 -9.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.852 1.31 . . . . 0.0 109.935 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.665 ' H ' ' C ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -47.19 -17.05 0.05 Allowed 'General case' 0 C--N 1.262 -3.237 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.103 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.641 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -109.34 24.9 12.45 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 124.15 1.929 . . . . 0.0 109.2 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 29' ' ' ILE . 36.0 t -155.68 21.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -40.08 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.984 1.373 . . . . 0.0 109.773 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.471 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -111.25 125.97 54.38 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HA ' ' ND1' ' A' ' 97' ' ' HIS . . . -46.47 -22.39 0.26 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.25 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.582 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 22.3 mp0 -83.97 -7.58 59.37 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.082 -1.011 . . . . 0.0 110.391 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.7 pt-20 -106.3 -14.6 15.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 109.578 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.833 ' HB2' ' NE2' ' A' ' 97' ' ' HIS . . . -45.48 -170.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.597 0.713 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.552 ' HB3' HD21 ' A' ' 100' ' ' ASN . 4.1 mm? -70.34 165.06 48.08 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -66.85 -56.07 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.256 1.971 . . . . 0.0 112.404 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.988 ' N ' HD22 ' A' ' 100' ' ' ASN . . . 160.07 143.0 3.53 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 40' ' ' GLU . 9.2 ttm180 -149.83 128.21 12.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.358 -1.084 . . . . 0.0 109.267 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 39' ' ' THR . 17.7 m -66.33 35.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.017 . . . . 0.0 109.301 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 38' ' ' ARG . 1.6 tt0 -63.12 112.57 7.14 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.11 -0.994 . . . . 0.0 110.128 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.33 143.66 7.73 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.806 2.337 . . . . 0.0 112.187 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mt -129.86 84.08 61.97 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.093 -1.004 . . . . 0.0 109.865 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.736 ' O ' HG13 ' A' ' 44' ' ' VAL . 72.0 Cg_endo -82.38 169.59 13.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.054 2.503 . . . . 0.0 112.334 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' ' 43' ' ' PRO . 5.1 m -162.34 -166.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.834 HG23 ' O ' ' A' ' 45' ' ' THR . 14.1 t -82.31 95.16 7.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.73 -27.59 59.51 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.26 -0.9 . . . . 0.0 111.424 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.587 ' O ' ' C ' ' A' ' 48' ' ' HIS . 4.5 ptpt -95.42 99.03 11.0 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.588 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' A' ' 52' ' ' GLY . 27.5 t60 -31.35 114.34 0.13 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -27.81 69.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.0 111.134 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.621 HG11 ' CD1' ' A' ' 81' ' ' TRP . 15.8 t -71.27 -38.98 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.326 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -109.94 -42.74 4.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 110.239 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.14 0.9 55.92 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 24.4 p30 -76.24 -117.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.589 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 41.8 mtm-85 -126.16 174.01 8.82 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.323 1.535 . . . . 0.0 110.121 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.642 ' C ' HG22 ' A' ' 56' ' ' VAL . 2.9 p -147.11 30.78 0.94 Allowed 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.293 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.642 HG22 ' C ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -171.34 134.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.064 -1.023 . . . . 0.0 109.484 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.595 ' OE1' ' N ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.28 144.96 0.1 Allowed Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.395 -0.816 . . . . 0.0 110.534 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 90.1 Cg_endo -77.17 166.66 81.71 Favored 'Cis proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.132 -2.028 . . . . 0.0 111.825 -0.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.786 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 92.8 m-85 -106.85 153.31 40.89 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.351 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.545 ' O ' ' OG1' ' A' ' 63' ' ' THR . 32.3 Cg_exo -50.3 161.03 1.25 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.318 2.012 . . . . 0.0 112.22 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.189 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.96 61.53 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -144.9 137.68 26.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -1.117 . . . . 0.0 109.413 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.637 ' CD ' ' H ' ' A' ' 65' ' ' MET . 13.3 tp60 -106.29 157.53 17.53 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 108.811 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.772 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -126.85 137.81 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.618 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -130.07 -171.03 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.53 HG21 ' NE2' ' A' ' 197' ' ' GLN . 96.5 t -144.49 150.11 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.156 -1.59 . . . . 0.0 110.093 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 67.1 m-85 -143.21 141.62 31.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.29 -0.881 . . . . 0.0 108.824 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.742 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -137.1 101.61 0.35 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.716 ' SD ' ' N ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -109.18 -89.73 0.47 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.46 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.649 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -141.09 -166.46 10.73 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.788 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 1.1 t -25.79 107.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.833 -0.804 . . . . 0.0 109.026 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.798 ' CZ ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.1 6.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 111.893 -177.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.788 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 32.0 m0 -71.66 -40.79 69.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.215 -1.553 . . . . 0.0 107.899 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.8 -23.34 30.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.71 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.0 -21.8 54.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 110.662 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.598 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -84.89 -41.91 15.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.64 -1.288 . . . . 0.0 111.486 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.699 ' O ' HG13 ' A' ' 82' ' ' VAL . 3.9 ttt180 -56.69 -57.84 10.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.758 -1.214 . . . . 0.0 111.309 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' O ' HG21 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -60.0 25.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.978 -1.076 . . . . 0.0 110.953 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 19.6 m-85 -128.26 -41.78 1.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.94 -1.1 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.621 ' CD1' HG11 ' A' ' 50' ' ' VAL . 1.2 p90 -91.63 -2.7 56.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.645 -1.284 . . . . 0.0 110.341 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 78' ' ' ARG . 3.4 m -83.87 13.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.085 -1.009 . . . . 0.0 109.14 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.404 HD13 ' OE1' ' A' ' 130' ' ' GLU . 43.3 mt -111.68 152.91 27.17 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.915 0.864 . . . . 0.0 109.408 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 136.41 34.17 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.41 -31.43 6.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -72.96 137.65 23.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.554 -0.968 . . . . 0.0 109.118 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.675 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -72.4 -42.42 65.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.576 ' OG ' ' CE1' ' A' ' 87' ' ' TYR . 1.0 OUTLIER -177.67 -171.2 0.3 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.444 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.496 ' OG1' ' CD ' ' A' ' 77' ' ' GLU . 1.1 p -151.44 156.73 41.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.533 ' OE1' ' OG ' ' A' ' 88' ' ' SER . 1.1 mp0 -149.64 158.55 44.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.415 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.598 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.6 OUTLIER -135.85 150.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 108.829 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.23 174.35 42.44 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.646 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.3 m-85 -79.06 146.46 33.26 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.306 -1.114 . . . . 0.0 108.464 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.679 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -145.12 -175.55 4.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.288 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 49.76 21.62 3.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.555 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -91.0 178.31 42.03 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.833 ' NE2' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -137.47 5.28 2.69 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.285 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.699 HG22 ' OD1' ' A' ' 100' ' ' ASN . 1.0 OUTLIER -160.08 147.38 16.36 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 119.918 -1.738 . . . . 0.0 110.899 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.534 ' CG ' ' OH ' ' A' ' 200' ' ' TYR . 4.3 mtp85 -72.3 61.51 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.988 HD22 ' N ' ' A' ' 37' ' ' GLY . 2.7 m120 -123.58 -136.2 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 -176.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 100' ' ' ASN . 74.4 Cg_exo -40.42 169.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.137 0 CA-C-N 122.486 1.924 . . . . 0.0 114.562 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.967 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.9 p -123.72 -175.1 3.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.605 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.706 ' CD1' ' CE1' ' A' ' 206' ' ' HIS . 0.3 OUTLIER -47.59 -38.73 15.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 0.0 110.38 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -74.34 -49.46 22.78 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.932 -1.105 . . . . 0.0 111.636 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' C ' ' N ' ' A' ' 107' ' ' CYS . 9.5 mm-40 -84.28 -25.34 29.42 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.038 -1.039 . . . . 0.0 111.24 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 102' ' ' THR . 29.7 m -54.48 -21.52 6.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.494 ' C ' ' O ' ' A' ' 106' ' ' VAL . 1.2 p -37.32 -20.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.869 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 106' ' ' VAL . 79.3 p -75.49 3.36 9.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 108.859 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 106' ' ' VAL . 16.2 mt-10 55.39 3.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.65 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.55 ' O ' ' NE2' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -77.51 -19.69 55.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 110.829 -178.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.745 HG21 HG12 ' A' ' 106' ' ' VAL . 67.8 p -86.22 -6.27 59.02 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.679 -1.263 . . . . 0.0 110.393 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 51.16 16.8 2.18 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.489 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.679 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -73.86 161.55 30.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -1.173 . . . . 0.0 110.763 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -138.74 114.28 9.76 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.688 ' OE1' ' CE1' ' A' ' 155' ' ' TYR . 6.3 mp0 -55.17 130.87 43.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.742 HG12 ' CA ' ' A' ' 69' ' ' GLY . 10.5 m -142.19 -171.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.581 ' HA ' HG12 ' A' ' 91' ' ' VAL . 2.9 t -131.1 118.86 42.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.685 -0.634 . . . . 0.0 110.33 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.786 ' NH1' ' CZ ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.31 103.29 15.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 117' ' ' VAL . 2.1 t -120.69 142.86 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.743 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.682 HG12 ' NH2' ' A' ' 118' ' ' ARG . 1.8 m -107.95 163.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.651 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 3.6 m-85 -141.93 151.55 42.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.906 -1.122 . . . . 0.0 109.412 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -102.02 105.94 44.93 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.877 . . . . 0.0 109.923 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 52.5 Cg_exo -50.04 -23.93 10.03 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.595 2.196 . . . . 0.0 112.345 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -83.61 -21.54 32.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.922 . . . . 0.0 110.317 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -116.29 -12.17 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.781 HD13 ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.47 163.61 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 126' ' ' ILE . 32.8 t -110.6 170.84 7.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.626 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 7.9 t80 -69.54 -19.99 63.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -71.18 -17.45 62.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.581 -1.325 . . . . 0.0 108.171 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.781 ' HG2' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -76.39 -42.35 44.77 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.567 -0.708 . . . . 0.0 110.803 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.618 HD13 ' CB ' ' A' ' 66' ' ' ALA . 1.2 pp -65.53 -48.95 70.72 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.254 -1.529 . . . . 0.0 108.813 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.883 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.4 pp -71.39 -18.8 62.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.929 -1.107 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.736 ' N ' HD12 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.01 -42.62 66.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.735 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -67.04 -38.72 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.147 -0.971 . . . . 0.0 110.321 -178.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.792 ' CE1' ' CE1' ' A' ' 139' ' ' HIS . 5.3 t80 -61.62 -48.49 80.66 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.4 -0.813 . . . . 0.0 110.389 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.731 ' CG ' ' CZ ' ' A' ' 177' ' ' TYR . 90.3 m95 -70.47 -32.44 69.98 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 120.863 -1.148 . . . . 0.0 110.66 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.26 -43.62 41.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 112.562 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 2.2 m120 -111.48 65.05 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.588 -1.32 . . . . 0.0 112.581 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.792 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.1 OUTLIER 175.67 134.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.195 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.659 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -73.88 114.55 33.66 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.394 -0.816 . . . . 0.0 109.167 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 190' ' ' THR . 72.9 Cg_endo -81.43 -26.79 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.501 2.134 . . . . 0.0 113.053 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.694 HG22 HG22 ' A' ' 189' ' ' ILE . 0.7 OUTLIER -89.13 34.07 0.8 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.904 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.72 ' OE1' ' N ' ' A' ' 148' ' ' GLY . 29.7 mt-30 -129.84 90.79 3.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.081 -1.012 . . . . 0.0 110.808 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.678 ' H ' HG21 ' A' ' 190' ' ' THR . . . -63.57 -117.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.472 ' SD ' ' H71' ' A' ' 21' ' ' MYR . 0.0 OUTLIER -69.67 40.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.949 . . . . 0.0 109.846 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 144' ' ' GLY . 13.5 ttt-85 -163.58 84.66 0.48 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.288 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.581 ' OE1' ' OE1' ' A' ' 143' ' ' GLN . 6.2 tp-100 -76.53 63.64 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.481 -1.387 . . . . 0.0 109.866 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.72 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 91.6 -121.3 6.31 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -80.52 10.33 4.88 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.217 -0.992 . . . . 0.0 109.515 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.16 154.65 20.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 108.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -136.46 125.42 24.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.984 -1.072 . . . . 0.0 110.477 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.58 ' HA2' ' HZ1' ' A' ' 27' ' ' LYS . . . 156.46 142.04 3.33 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.12 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.603 ' N ' ' NZ ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -72.62 5.0 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -1.102 . . . . 0.0 109.014 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.562 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -95.18 -1.47 51.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.199 -179.832 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.688 ' CE1' ' OE1' ' A' ' 115' ' ' GLU . 38.8 m-85 -129.82 61.11 1.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.326 -0.859 . . . . 0.0 108.993 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.799 ' NH2' HH22 ' A' ' 194' ' ' ARG . 5.8 mtm180 -111.6 177.92 4.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 109.83 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -92.48 119.39 31.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 176.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.627 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -140.4 129.33 23.31 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 118.191 -1.403 . . . . 0.0 111.189 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.741 HG13 ' CG2' ' A' ' 191' ' ' THR . 3.1 m -107.4 127.85 62.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.706 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.627 ' CE1' ' HB1' ' A' ' 158' ' ' ALA . 10.9 m-85 -124.86 107.73 28.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.3 176.08 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.359 2.039 . . . . 0.0 112.802 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.2 -34.2 11.2 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.458 -0.776 . . . . 0.0 109.46 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 p -173.96 -163.21 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.165 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.99 -17.8 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.972 1.368 . . . . 0.0 108.764 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.21 -61.0 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.758 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 170' ' ' ALA . 1.3 tt0 -76.88 -25.75 53.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.69 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.4 ' SD ' ' CD1' ' A' ' 171' ' ' LEU . 1.7 mtt -52.3 -14.47 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.004 -1.06 . . . . 0.0 110.627 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -75.9 -45.55 34.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.754 -1.216 . . . . 0.0 109.638 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -93.03 -47.45 6.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.517 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 166' ' ' GLN . . . -52.71 -65.92 0.47 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.192 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.4 ' CD1' ' SD ' ' A' ' 167' ' ' MET . 0.6 OUTLIER -54.94 -47.59 74.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.521 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -61.25 -38.18 85.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.614 ' OG ' ' NE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -56.33 -32.6 64.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 109.281 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -72.6 -55.99 6.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 110.203 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -70.68 -47.64 58.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.463 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -53.11 -32.89 49.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.025 . . . . 0.0 109.824 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.731 ' CZ ' ' CG ' ' A' ' 136' ' ' TRP . 1.5 m-85 -74.08 -30.58 62.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.538 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.6 mm100 -52.92 -60.77 2.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.961 -1.087 . . . . 0.0 109.478 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -47.79 -22.31 0.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.959 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.25 -53.2 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 109.605 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.1 mt -74.68 -44.88 47.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.873 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.2 t -55.63 -30.85 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.018 -1.051 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -88.34 -3.33 58.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.305 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 2.0 m-70 -108.25 35.86 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 186' ' ' PHE . 28.7 t-20 68.23 66.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 185' ' ' ASN . 65.4 m-85 -158.13 168.57 26.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.054 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.2 -158.73 18.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -58.76 107.33 0.33 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.483 2.122 . . . . 0.0 111.193 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.694 HG22 HG22 ' A' ' 142' ' ' THR . 0.4 OUTLIER -46.9 169.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.444 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.678 HG21 ' H ' ' A' ' 144' ' ' GLY . 79.2 p -114.67 58.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.562 0.696 . . . . 0.0 109.446 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.741 ' CG2' HG13 ' A' ' 159' ' ' VAL . 39.8 m -94.45 116.65 29.04 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.628 ' CG ' HH22 ' A' ' 156' ' ' ARG . 32.9 t70 -93.98 138.18 32.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 121.582 0.706 . . . . 0.0 110.505 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.493 HD13 ' CG2' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -111.62 159.73 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.799 HH22 ' NH2' ' A' ' 156' ' ' ARG . 1.5 ttm180 -162.31 -167.65 1.66 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.887 -1.133 . . . . 0.0 110.465 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -103.11 140.37 37.41 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.841 ' O ' ' OE1' ' A' ' 197' ' ' GLN . . . 14.38 -81.21 0.0 OUTLIER Glycine 0 C--O 1.185 -2.964 0 N-CA-C 104.069 -3.613 . . . . 0.0 104.069 -177.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.841 ' OE1' ' O ' ' A' ' 196' ' ' GLY . 0.3 OUTLIER 145.13 115.07 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.127 0.464 . . . . 0.0 111.616 172.606 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.707 ' O ' HG13 ' A' ' 198' ' ' VAL . 7.7 p -61.12 82.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 119.963 -1.711 . . . . 0.0 106.732 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.677 ' N ' ' O ' ' A' ' 197' ' ' GLN . 11.7 t80 -49.76 147.88 3.41 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.088 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.6 m-85 -151.05 97.31 2.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.492 ' CZ ' ' CG1' ' A' ' 56' ' ' VAL . 25.0 m-85 -53.78 147.84 11.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.994 -1.066 . . . . 0.0 110.76 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.543 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -99.31 177.72 5.11 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.535 ' OE2' ' CD2' ' A' ' 206' ' ' HIS . 1.3 pm0 -74.17 163.12 28.24 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.035 -1.041 . . . . 0.0 109.056 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.646 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -49.56 -51.87 33.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.912 -1.118 . . . . 0.0 108.522 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -46.85 -15.97 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.757 . . . . 0.0 110.189 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.798 ' ND1' ' CZ ' ' A' ' 73' ' ' PHE . 4.7 m-70 -100.75 13.49 34.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 110.684 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.847 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.6 mm-40 -131.87 -138.98 0.2 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.478 1.132 . . . . 0.0 109.989 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.68 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -32.86 -3.65 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.858 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.847 ' N ' ' O ' ' A' ' 207' ' ' GLN . 9.4 t80 -41.7 -43.27 2.81 Favored 'General case' 0 N--CA 1.511 2.624 0 O-C-N 120.171 -1.581 . . . . 0.0 108.699 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.678 HD22 ' HA2' ' A' ' 216' ' ' GLY . 0.2 OUTLIER -53.29 -25.18 13.71 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.627 -1.296 . . . . 0.0 109.538 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 208' ' ' GLN . 29.0 t -55.71 -51.1 68.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.909 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -67.46 -33.45 75.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.197 -0.939 . . . . 0.0 108.506 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 215' ' ' ASP . 68.8 m-20 -136.47 76.03 50.06 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.631 ' N ' ' O ' ' A' ' 210' ' ' LEU . 76.8 Cg_exo -45.35 -0.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.942 2.428 . . . . 0.0 112.532 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 213' ' ' ASN . 4.9 t70 -63.95 -16.1 60.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.046 -1.034 . . . . 0.0 110.025 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.678 ' HA2' HD22 ' A' ' 210' ' ' LEU . . . 62.56 -66.68 0.02 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 215' ' ' ASP . 24.8 t80 -159.91 -150.68 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -1.013 . . . . 0.0 109.237 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 8.6 t -79.87 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.105 -0.997 . . . . 0.0 109.685 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 220' ' ' LEU . . . -90.03 -144.05 11.12 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 1.4 tp 76.75 139.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.793 -0.828 . . . . 0.0 109.755 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.31 115.64 0.34 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 148.66 141.64 3.5 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 136' ' ' TRP . 0.4 OUTLIER -103.98 -19.96 14.04 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.285 . . . . 0.0 109.819 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 176.98 49.18 0.06 OUTLIER Glycine 0 C--N 1.305 -1.18 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.669 HG12 ' O ' ' A' ' 225' ' ' VAL . 2.2 t -55.24 97.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -1.127 . . . . 0.0 109.078 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.642 ' H ' ' CB ' ' A' ' 229' ' ' MET . 1.3 p -98.5 -152.48 0.41 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.965 0.888 . . . . 0.0 109.835 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.538 ' N ' ' OG ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -71.3 -70.11 0.33 Allowed Pre-proline 0 N--CA 1.504 2.231 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 30.4 Cg_endo -64.52 -40.07 25.4 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.1 1.866 . . . . 0.0 109.412 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.642 ' CB ' ' H ' ' A' ' 226' ' ' SER . 2.9 mmm -54.12 151.78 6.7 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.56 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.638 ' O ' HG13 ' A' ' 225' ' ' VAL . . . -30.85 129.52 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.903 -0.498 . . . . 0.0 109.882 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.628 ' CG1' ' O ' ' A' ' 226' ' ' SER . 1.7 mm -142.8 114.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.115 -0.991 . . . . 0.0 109.446 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -93.14 10.86 29.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.341 0 O-C-N 121.246 -0.909 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.478 ' C13' ' OG1' ' A' ' 153' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.709 ' H ' ' C1 ' ' A' ' 21' ' ' MYR . 11.4 p30 -162.24 83.23 0.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -1.143 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -51.01 -24.28 3.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.315 -0.866 . . . . 0.0 109.378 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -55.49 -6.89 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 123.106 1.431 . . . . 0.0 109.057 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.624 ' H ' ' C ' ' A' ' 24' ' ' SER . 14.9 t -46.74 -9.18 0.02 OUTLIER 'General case' 0 C--N 1.262 -3.23 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.004 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 25' ' ' ALA . 7.9 pttm -83.48 24.84 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 124.033 1.873 . . . . 0.0 108.58 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.936 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -164.55 13.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.253 -3.611 0 CA-C-N 112.037 -2.347 . . . . 0.0 105.842 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.936 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 15.4 -179.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-O 123.375 1.559 . . . . 0.0 113.565 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.21 119.89 15.08 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.721 -1.237 . . . . 0.0 110.685 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' A' ' 33' ' ' GLU . . . -59.31 -46.15 89.35 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.596 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.694 ' OE2' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -53.33 -12.73 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 108.994 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.694 ' N ' ' OE2' ' A' ' 32' ' ' GLU . 3.3 tt0 -113.72 -48.42 2.93 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -47.72 163.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.228 -0.92 . . . . 0.0 108.814 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.895 HD22 ' O ' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -85.68 173.95 6.29 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.585 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' CD ' ' HB3' ' A' ' 35' ' ' LEU . 5.9 Cg_exo -77.59 -63.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.156 2.57 . . . . 0.0 114.924 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.587 ' HA2' ' N ' ' A' ' 99' ' ' ARG . . . 119.22 110.37 2.37 Favored Glycine 0 N--CA 1.498 2.787 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.722 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' H ' ' CB ' ' A' ' 99' ' ' ARG . 1.5 ttm180 -106.72 169.9 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.813 -1.404 . . . . 0.0 109.152 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.449 ' H ' ' HG2' ' A' ' 38' ' ' ARG . 75.0 p -89.72 32.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.547 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' HB3' HD21 ' A' ' 100' ' ' ASN . 1.2 tt0 -108.32 109.35 61.66 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.779 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.39 172.3 13.78 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.609 2.206 . . . . 0.0 112.289 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.639 HG23 ' OD1' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -139.04 105.21 7.31 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.892 . . . . 0.0 109.604 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.39 175.28 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.661 2.241 . . . . 0.0 112.569 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 11.4 m -143.22 -166.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.958 . . . . 0.0 109.677 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -49.21 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.09 -65.05 0.67 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 111.184 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.97 99.67 1.83 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.622 -2.431 . . . . 0.0 108.48 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.685 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.55 122.32 0.34 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.7 -31.58 71.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.381 -0.824 . . . . 0.0 110.716 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.696 HG22 ' OG ' ' A' ' 211' ' ' SER . 47.1 t -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.925 -1.11 . . . . 0.0 109.637 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.41 -45.1 4.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.19 4.55 55.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.602 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.2 p30 -82.03 -121.57 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.602 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 mtm-85 -123.19 167.37 13.79 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.371 1.082 . . . . 0.0 108.572 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.6 p -124.09 -17.41 6.22 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.255 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 m -151.76 -167.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.574 -1.328 . . . . 0.0 109.521 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.557 ' N ' HG23 ' A' ' 56' ' ' VAL . 4.6 mt-10 -32.36 120.23 0.41 Allowed Pre-proline 0 C--N 1.295 -1.782 0 O-C-N 121.91 -0.494 . . . . 0.0 110.176 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' VAL . 98.3 Cg_endo -75.57 172.28 63.85 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.87 0.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -116.91 129.78 25.06 Favored Pre-proline 0 C--N 1.28 -2.419 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' O ' ' OG1' ' A' ' 63' ' ' THR . 37.5 Cg_exo -49.67 140.27 29.55 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.057 1.838 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.86 155.86 27.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.34 -9.73 25.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -95.66 135.88 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -1.199 . . . . 0.0 109.91 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -108.61 167.12 10.28 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.729 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -149.35 156.42 42.04 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.386 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.67 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -141.22 -174.65 4.07 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 118' ' ' ARG . 2.5 t -144.58 127.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 119.803 -1.811 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.667 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.6 OUTLIER -156.72 153.85 29.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.701 -1.25 . . . . 0.0 109.853 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.612 ' N ' HG12 ' A' ' 116' ' ' VAL . . . -161.36 -170.08 25.53 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.333 -1.413 . . . . 0.0 112.993 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.776 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -133.65 -93.04 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.906 0.86 . . . . 0.0 110.264 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.702 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -132.46 65.37 0.59 Allowed Glycine 0 N--CA 1.498 2.811 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.702 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.5 t 120.75 170.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 124.16 0.984 . . . . 0.0 109.499 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.562 ' N ' ' SG ' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -120.58 30.13 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.242 -0.911 . . . . 0.0 111.341 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.51 ' C ' HD11 ' A' ' 210' ' ' LEU . 7.2 m0 -88.79 -87.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.404 -1.435 . . . . 0.0 109.005 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -7.37 29.96 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -76.13 -47.54 23.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -1.169 . . . . 0.0 110.28 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.571 ' CD ' ' O ' ' A' ' 77' ' ' GLU . 7.2 tp10 -78.67 -27.8 45.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 82' ' ' VAL . 31.4 ttt-85 -56.23 -34.55 66.44 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.942 -1.098 . . . . 0.0 109.925 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -75.7 17.82 0.28 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 110.294 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 81.3 m-85 -126.35 -41.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.847 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.57 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -74.36 8.77 2.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 109.793 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.0 m -109.54 15.8 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 109.365 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.72 156.83 24.08 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.808 0.813 . . . . 0.0 109.018 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -89.98 140.11 29.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.337 0.589 . . . . 0.0 109.61 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.46 -29.36 8.32 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 120' ' ' VAL . 1.2 t -77.43 123.51 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.401 -1.058 . . . . 0.0 109.301 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.598 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.327 -0.858 . . . . 0.0 108.988 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 89' ' ' THR . 6.4 p -158.43 -162.14 1.08 Allowed 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.596 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.685 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.7 p -160.99 128.36 4.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 108.817 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.598 ' OE1' ' O ' ' A' ' 89' ' ' THR . 4.1 mp0 -130.95 145.78 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.415 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 117' ' ' VAL . 1.1 m -126.76 156.56 37.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -172.09 -128.96 1.09 Allowed Glycine 0 C--N 1.293 -1.831 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.28 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE1' HG21 ' A' ' 106' ' ' VAL . 83.1 m-85 -143.24 160.64 40.09 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.876 -0.779 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -168.71 148.41 4.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.365 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 87.37 30.8 18.25 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.643 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -142.97 173.28 24.17 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.595 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 22.8 p80 -135.88 85.34 2.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -1.204 . . . . 0.0 110.22 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 35' ' ' LEU . 96.4 m -150.02 163.48 38.03 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.057 -1.027 . . . . 0.0 108.393 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.587 ' N ' ' HA2' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -65.18 -76.8 0.07 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.718 0.771 . . . . 0.0 111.423 -177.604 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.639 ' OD1' HG23 ' A' ' 42' ' ' ILE . 6.3 m-80 -121.46 83.17 40.43 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-O 121.504 0.668 . . . . 0.0 110.09 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.46 ' HA ' ' CD ' ' A' ' 105' ' ' GLU . 23.1 Cg_exo -63.15 117.24 4.17 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 123.34 2.693 . . . . 0.0 113.023 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.593 ' H ' ' HG2' ' A' ' 105' ' ' GLU . 4.1 p -109.16 149.77 28.87 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 120.569 -1.332 . . . . 0.0 107.617 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.687 ' CZ ' ' OH ' ' A' ' 155' ' ' TYR . 2.8 t80 -47.68 -34.37 8.06 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.398 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -73.28 -26.49 61.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 110.443 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.643 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -83.53 -57.33 3.28 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 120.565 -1.334 . . . . 0.0 110.142 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.643 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 11.5 m -61.93 -20.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.471 -0.768 . . . . 0.0 111.843 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.565 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.3 p -33.85 -37.84 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.438 -0.789 . . . . 0.0 109.66 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 106' ' ' VAL . 27.0 t -103.97 -115.53 0.22 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.653 -1.28 . . . . 0.0 109.791 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.458 ' N ' ' OG ' ' A' ' 108' ' ' SER . 1.5 mp0 -120.4 9.86 11.06 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.347 0.594 . . . . 0.0 110.236 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.895 ' O ' HD22 ' A' ' 35' ' ' LEU . 5.4 mttt -43.0 -50.96 5.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -122.51 14.13 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.747 -1.221 . . . . 0.0 110.512 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.632 ' O ' ' C14' ' A' ' 21' ' ' MYR . . . 37.2 35.02 0.14 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.643 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.09 168.93 19.1 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.038 -1.272 . . . . 0.0 109.801 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -119.12 114.11 21.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 72' ' ' CYS . 1.9 pp20? -72.86 130.05 39.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.269 -0.895 . . . . 0.0 109.906 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -153.41 -179.39 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.146 -0.971 . . . . 0.0 110.507 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.658 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.3 m -115.94 117.8 56.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.808 0.813 . . . . 0.0 110.2 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.896 HH22 ' N ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -98.24 101.68 13.21 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.664 ' C ' HH22 ' A' ' 118' ' ' ARG . 31.0 m -126.63 123.65 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.896 ' N ' HH22 ' A' ' 118' ' ' ARG . 0.7 OUTLIER -78.27 171.57 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.894 ' CD2' HD21 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -158.08 155.58 29.49 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.356 -1.338 . . . . 0.0 110.957 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -103.4 102.63 30.54 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.822 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' O ' ' A' ' 126' ' ' ILE . 31.7 Cg_exo -43.7 -64.24 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.968 2.445 . . . . 0.0 112.754 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -44.43 -29.96 0.78 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.811 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -92.92 -46.32 7.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 109.769 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 130' ' ' GLU . 2.6 tt -126.07 166.99 21.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.048 -1.032 . . . . 0.0 108.255 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.53 ' N ' ' CG1' ' A' ' 126' ' ' ILE . 6.1 m -99.96 159.33 15.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.66 -1.275 . . . . 0.0 110.721 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 1.077 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 17.4 t80 -66.43 -27.46 67.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.585 ' O ' ' OE1' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -69.67 -16.74 63.41 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' A' ' 126' ' ' ILE . 2.8 mt-10 -73.57 -72.33 0.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 108.992 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.99 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -39.2 -35.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 178.504 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 1.077 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 44.4 mt -76.28 -44.75 35.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' GLU . 2.6 mttm -52.28 -53.56 42.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.94 -1.1 . . . . 0.0 110.117 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.751 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 41.3 t -57.85 -30.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.797 -1.19 . . . . 0.0 108.45 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.709 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 3.0 t80 -73.1 -56.74 4.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.143 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 37.7 m95 -71.57 -54.08 11.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.384 -1.448 . . . . 0.0 110.021 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.485 ' O ' HG21 ' A' ' 225' ' ' VAL . 20.8 tt0 -37.08 -56.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.751 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -103.25 63.8 0.82 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.061 -1.025 . . . . 0.0 109.949 -178.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.776 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 22.5 m80 -158.28 177.21 11.53 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.286 1.041 . . . . 0.0 110.072 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' THR . 1.6 t0 -145.22 80.23 11.18 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 190' ' ' THR . 13.0 Cg_exo -48.09 13.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.545 2.163 . . . . 0.0 113.592 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . 1.049 HG22 HG22 ' A' ' 189' ' ' ILE . 0.4 OUTLIER -122.15 43.29 2.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.808 -1.182 . . . . 0.0 110.318 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.587 ' O ' ' O ' ' A' ' 144' ' ' GLY . 5.3 mt-30 -130.72 78.61 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 109.325 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.43 -116.26 0.0 OUTLIER Glycine 0 N--CA 1.493 2.473 0 CA-C-O 121.905 0.725 . . . . 0.0 112.513 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.97 42.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.795 -0.827 . . . . 0.0 110.353 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -170.9 139.62 1.48 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.24 177.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.615 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -146.93 91.46 2.01 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.128 -1.607 . . . . 0.0 108.424 176.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.46 -129.47 9.83 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -94.69 12.9 26.14 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.652 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.675 ' OD1' ' CE2' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -109.05 112.91 25.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.649 -1.282 . . . . 0.0 109.488 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.483 ' CE2' ' HG3' ' A' ' 146' ' ' ARG . 6.2 m-85 -104.22 113.48 27.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.53 149.42 7.87 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.43 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.598 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -48.87 -45.98 41.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.51 -0.994 . . . . 0.0 109.393 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.814 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 2.1 pm0 -75.38 1.53 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 111.177 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.814 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 21.1 m-85 -102.99 41.58 1.24 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.443 -1.411 . . . . 0.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.618 ' O ' ' O ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -103.45 174.91 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 108.969 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.4 129.37 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -143.74 117.82 9.48 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 115.94 -2.304 . . . . 0.0 112.444 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' ASP . 16.1 t -111.98 133.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.214 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.507 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 53.7 m-85 -130.5 94.41 29.68 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.0 109.192 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.9 170.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.773 2.315 . . . . 0.0 112.063 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.458 HG22 ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -98.0 -21.13 16.99 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 120.941 -1.099 . . . . 0.0 109.633 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 165' ' ' VAL . 4.1 p 173.54 -178.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.086 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.07 -15.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.009 1.385 . . . . 0.0 108.6 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.6 t -55.69 -64.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.672 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.67 HE22 ' HB2' ' A' ' 66' ' ' ALA . 17.1 mt-30 -79.54 -19.32 49.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.682 -0.636 . . . . 0.0 110.932 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.4 ' HG2' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -52.15 -31.23 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.869 -1.145 . . . . 0.0 110.632 -178.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.06 65.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.681 -1.262 . . . . 0.0 109.979 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.433 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.92 -42.94 9.2 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.136 -0.977 . . . . 0.0 110.409 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.11 -57.79 8.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.855 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.4 HD13 ' HG2' ' A' ' 167' ' ' MET . 1.2 mp -52.63 -35.76 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.026 -1.046 . . . . 0.0 109.048 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 -74.51 -45.38 46.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.526 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -56.21 -31.15 63.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -72.17 -52.15 17.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.824 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -73.0 -26.1 61.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 110.317 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 6.2 pt-20 -52.97 -34.53 56.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.687 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -79.65 -28.94 40.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.077 -1.014 . . . . 0.0 109.454 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.704 ' OE1' HG23 ' A' ' 189' ' ' ILE . 15.5 tp60 -74.91 -7.66 54.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -75.49 -41.93 54.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 0.0 108.907 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.454 HG13 ' HE2' ' A' ' 183' ' ' LYS . 73.6 t -88.52 -43.66 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.315 -0.865 . . . . 0.0 109.859 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 186' ' ' PHE . 38.2 mt -56.55 -49.17 75.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.058 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.1 t -55.24 -30.33 59.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.35 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.454 ' HE2' HG13 ' A' ' 180' ' ' VAL . 13.9 pttt -88.26 -6.76 57.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.229 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.417 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.9 m170 -108.43 29.32 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.77 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 27.9 t-20 69.67 68.93 0.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 181' ' ' LEU . 23.4 m-85 -137.14 169.99 16.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.935 . . . . 0.0 109.0 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -119.82 -159.8 11.04 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -58.62 105.77 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.204 1.936 . . . . 0.0 110.774 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 1.049 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -51.19 174.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.175 -0.953 . . . . 0.0 110.048 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 141' ' ' PRO . 4.8 p -137.32 67.73 1.43 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.232 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.9 m -100.6 125.2 46.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.692 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -76.32 113.77 14.26 Favored 'General case' 0 C--N 1.278 -2.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.205 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.47 108.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.87 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.692 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.4 OUTLIER -147.4 153.36 39.52 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -104.16 164.9 11.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.01 39.07 94.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.539 ' O ' ' C ' ' A' ' 198' ' ' VAL . 55.6 mm-40 -96.41 90.99 5.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.68 -1.482 . . . . 0.0 108.974 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.539 ' C ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -32.11 150.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.554 -0.716 . . . . 0.0 109.97 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.491 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 38.3 t80 -96.11 140.02 31.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.458 -0.776 . . . . 0.0 109.325 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 93' ' ' PHE . 7.0 m-85 -130.86 94.81 3.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.351 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -54.12 136.44 42.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 110.428 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.602 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -84.46 -174.94 5.55 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.13 161.12 30.98 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 122.264 1.03 . . . . 0.0 110.059 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -43.31 74.27 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.459 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -60.82 -7.85 2.64 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.425 -0.797 . . . . 0.0 110.119 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.622 ' CE1' ' CB ' ' A' ' 103' ' ' TYR . 50.4 m-70 -104.4 4.01 32.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.985 -1.072 . . . . 0.0 110.65 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.849 ' O ' ' N ' ' A' ' 209' ' ' TYR . 16.7 mm-40 -109.89 -143.83 0.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.144 0.973 . . . . 0.0 110.19 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.677 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -35.49 -4.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.845 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.849 ' N ' ' O ' ' A' ' 207' ' ' GLN . 59.4 t80 -39.75 -42.14 1.21 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 120.757 -1.214 . . . . 0.0 111.015 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 216' ' ' GLY . 6.6 mt -71.08 -20.75 62.32 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.68 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.696 ' OG ' HG22 ' A' ' 50' ' ' VAL . 8.1 t -73.25 -49.07 29.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 0.0 108.946 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.1 0.92 56.31 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.264 -0.897 . . . . 0.0 110.264 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.634 ' OD1' ' CD2' ' A' ' 209' ' ' TYR . 20.8 m120 -132.65 133.42 23.46 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 109.686 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.1 2.1 5.26 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.698 2.266 . . . . 0.0 113.663 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 217' ' ' TYR . 2.9 t0 -62.74 -17.43 60.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.23 . . . . 0.0 109.864 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.673 ' O ' HD13 ' A' ' 210' ' ' LEU . . . 63.88 -62.75 0.05 OUTLIER Glycine 0 C--N 1.296 -1.684 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 215' ' ' ASP . 2.8 p90 171.31 -156.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 109.569 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 3.6 t -159.94 79.51 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.006 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 161.24 174.28 30.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.41 -165.16 1.29 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.234 -1.157 . . . . 0.0 109.858 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.04 -107.87 2.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -128.06 -168.44 12.45 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 225' ' ' VAL . 6.8 t -165.1 -7.63 0.03 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.603 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 223' ' ' THR . . . -67.49 7.27 2.07 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.568 ' H ' ' C ' ' A' ' 223' ' ' THR . 2.3 t -111.41 165.74 6.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.883 -0.775 . . . . 0.0 109.546 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.597 ' O ' HD11 ' A' ' 231' ' ' ILE . 0.3 OUTLIER -44.99 103.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.695 1.236 . . . . 0.0 109.228 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.52 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -73.76 -55.82 3.16 Favored Pre-proline 0 C--N 1.274 -2.693 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.126 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.544 ' CD ' ' H ' ' A' ' 229' ' ' MET . 40.8 Cg_endo -94.08 -36.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.068 2.512 . . . . 0.0 109.834 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.554 ' O ' ' C ' ' A' ' 230' ' ' ALA . 5.0 mtt -54.77 154.14 5.37 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.969 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.554 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.45 134.3 0.06 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.319 0.581 . . . . 0.0 109.966 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.597 HD11 ' O ' ' A' ' 226' ' ' SER . 1.8 mm -133.51 109.93 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.261 -0.899 . . . . 0.0 109.316 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -68.14 117.8 10.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.36 0 O-C-N 121.228 -0.92 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.709 ' C1 ' ' H ' ' A' ' 23' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 22' ' ' GLY . 54.4 m-20 36.07 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -1.146 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.67 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -50.86 -18.96 0.85 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.255 -0.903 . . . . 0.0 109.236 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB2' ' C1 ' ' A' ' 21' ' ' MYR . . . -50.41 -8.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 123.028 1.394 . . . . 0.0 109.624 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.67 ' H ' ' C ' ' A' ' 24' ' ' SER . 22.9 t -46.52 -27.25 1.06 Allowed 'General case' 0 C--N 1.261 -3.282 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.427 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' ' SD ' ' A' ' 145' ' ' MET . 0.9 OUTLIER -97.23 45.07 1.04 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 123.274 1.511 . . . . 0.0 109.888 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.72 ' O ' ' O ' ' A' ' 29' ' ' ILE . 44.6 t -151.99 25.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.263 -3.161 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.72 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -33.95 177.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 123.225 1.488 . . . . 0.0 110.852 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -103.92 121.3 42.82 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.952 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -49.35 -15.59 0.14 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 30' ' ' SER . 11.4 mm-40 -62.17 -62.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.855 . . . . 0.0 109.793 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' ' C ' ' A' ' 34' ' ' ALA . 28.5 tt0 -75.19 -28.39 60.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.707 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -30.97 152.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.781 . . . . 0.0 110.203 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.441 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -50.2 173.0 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.441 ' CD ' ' HB3' ' A' ' 35' ' ' LEU . 12.8 Cg_exo -70.27 -40.44 4.52 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 123.125 2.55 . . . . 0.0 115.726 -176.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' ' C ' ' A' ' 98' ' ' THR . . . 93.28 94.75 1.49 Allowed Glycine 0 N--CA 1.501 2.979 0 C-N-CA 118.115 -1.993 . . . . 0.0 110.319 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 5.2 mmt85 -96.23 -172.61 2.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.703 -1.469 . . . . 0.0 109.343 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 p -124.4 37.22 4.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.93 . . . . 0.0 109.911 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.502 ' CB ' HD21 ' A' ' 100' ' ' ASN . 1.4 tt0 -111.74 92.95 18.54 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.9 -1.125 . . . . 0.0 109.943 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.82 -178.1 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.936 2.424 . . . . 0.0 112.216 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.67 133.96 18.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.26 175.51 11.24 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.608 2.205 . . . . 0.0 112.318 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -147.43 -167.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 45' ' ' THR . 15.1 t -49.21 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.616 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.39 -50.32 71.94 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.173 -0.954 . . . . 0.0 111.068 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 48' ' ' HIS . 27.7 mttm -84.34 99.17 10.45 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.614 -2.434 . . . . 0.0 108.419 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.6 t-80 -32.11 117.88 0.23 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -64.59 -32.46 74.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.318 -0.864 . . . . 0.0 110.665 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 211' ' ' SER . 25.9 t -63.43 -44.1 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 109.379 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -106.37 -45.09 4.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.39 4.53 54.96 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.687 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 27.3 p30 -82.04 -112.71 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.673 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.4 mtt180 -130.09 174.36 9.87 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.653 1.692 . . . . 0.0 110.423 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.8 p -137.95 8.35 2.75 Favored 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.892 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 57' ' ' GLU . 10.9 m -144.98 132.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.687 -1.258 . . . . 0.0 109.519 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.691 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 1.4 pm0 -32.86 151.81 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 CA-C-O 121.809 0.814 . . . . 0.0 110.849 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.4 Cg_endo -78.88 166.28 79.76 Favored 'Cis proline' 0 C--N 1.303 -1.844 0 C-N-CA 121.808 -2.163 . . . . 0.0 111.716 -0.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CE1' HG11 ' A' ' 120' ' ' VAL . 31.8 m-85 -110.26 154.56 42.82 Favored Pre-proline 0 C--N 1.269 -2.907 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.118 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 63' ' ' THR . 44.1 Cg_exo -50.15 132.5 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.3 2.0 . . . . 0.0 112.1 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -48.65 146.69 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.84 46.52 23.17 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -128.93 137.54 51.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -1.121 . . . . 0.0 109.674 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.87 149.51 25.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.702 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -138.86 113.11 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.446 ' HB1' HE22 ' A' ' 166' ' ' GLN . . . -112.09 -167.69 1.22 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG11 ' HD2' ' A' ' 160' ' ' TYR . 7.2 t -141.96 132.06 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.07 -1.644 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 131' ' ' LEU . 91.3 m-85 -123.04 156.16 35.42 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.193 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.674 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -140.44 114.71 0.98 Allowed Glycine 0 C--O 1.207 -1.571 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CD1' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -125.31 -82.47 0.63 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.485 -1.009 . . . . 0.0 109.31 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.624 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -153.27 -163.55 11.84 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.693 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -29.67 104.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.903 . . . . 0.0 108.582 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.786 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -49.44 6.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.787 . . . . 0.0 111.4 -178.189 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.693 ' N ' ' O ' ' A' ' 72' ' ' CYS . 14.5 m0 -72.04 -47.58 50.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.614 -1.304 . . . . 0.0 108.799 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.58 -22.93 27.53 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.721 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.35 -26.87 56.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.618 ' OE2' HG13 ' A' ' 91' ' ' VAL . 8.9 tp10 -84.59 -36.66 21.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.693 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.799 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.7 ttt85 -59.28 -59.17 5.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.606 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.608 ' O ' HG21 ' A' ' 134' ' ' VAL . 18.0 mmtm -56.43 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.944 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.721 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.0 m-85 -120.88 -40.93 2.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.824 -1.173 . . . . 0.0 110.315 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.577 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -87.96 3.74 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.84 -1.163 . . . . 0.0 109.981 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.5 m -94.62 13.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.514 HD11 HG21 ' A' ' 134' ' ' VAL . 75.7 mt -106.56 152.76 23.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.96 0.886 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 8.8 pttm -88.96 145.79 25.3 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.15 -25.37 28.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.593 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -73.29 137.78 22.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.97 . . . . 0.0 108.807 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.687 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -81.41 -41.06 22.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 108.744 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.534 ' HB3' HD21 ' A' ' 53' ' ' ASN . 1.1 p -173.51 -163.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 88' ' ' SER . 60.3 p -158.82 170.78 21.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.581 ' O ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.96 176.49 6.15 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -152.35 162.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.821 -1.174 . . . . 0.0 109.853 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.15 171.22 44.08 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 200' ' ' TYR . 4.1 m-85 -87.55 155.84 19.79 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.473 -1.016 . . . . 0.0 109.499 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -178.96 155.47 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.391 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.8 22.26 14.16 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -154.49 -151.62 5.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.519 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 47.9 p-80 -178.37 107.09 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.691 ' O ' ' O ' ' A' ' 99' ' ' ARG . 1.1 m -152.26 156.04 38.9 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.71 ' O ' ' N ' ' A' ' 101' ' ' PRO . 7.8 ttp180 -40.27 169.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.628 ' C ' ' O ' ' A' ' 99' ' ' ARG . 0.1 OUTLIER -30.71 89.96 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.71 ' N ' ' O ' ' A' ' 99' ' ' ARG . 1.3 Cg_endo -77.15 141.78 21.07 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.052 2.501 . . . . 0.0 112.963 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.549 ' O ' HG22 ' A' ' 106' ' ' VAL . 24.6 p -124.06 170.69 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.116 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.783 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 1.2 t80 -56.92 -43.36 81.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.798 . . . . 0.0 109.325 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -73.35 -27.54 61.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.356 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.4 mm-40 -80.88 -41.37 23.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.777 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 102' ' ' THR . 5.4 m -55.73 -23.99 15.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 120.421 -1.425 . . . . 0.0 108.634 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.667 ' O ' ' N ' ' A' ' 109' ' ' GLU . 23.2 m -59.27 -36.3 75.29 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 110' ' ' LYS . 9.1 m -46.95 -9.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.8 mt-10 65.3 -12.25 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.679 -0.638 . . . . 0.0 109.944 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 108' ' ' SER . 23.8 mttp -77.56 -15.05 59.49 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.063 -1.023 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' GLY . 4.7 p -91.19 -6.61 53.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 109.665 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 36.28 37.28 0.18 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.102 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.58 ' HE2' ' HG2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -82.04 158.13 23.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.596 -1.532 . . . . 0.0 109.974 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -120.83 112.67 19.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.448 -0.783 . . . . 0.0 109.118 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.682 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 74.4 mt-10 -61.54 117.44 5.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.674 HG12 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -125.29 -176.11 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 91' ' ' VAL . 6.7 t -132.68 120.74 42.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.734 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.609 ' HD2' ' CZ ' ' A' ' 199' ' ' PHE . 9.9 ptm180 -97.81 120.95 39.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 119' ' ' VAL . 2.6 m -133.87 129.91 55.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 O-C-N 120.72 -1.237 . . . . 0.0 109.645 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.552 HG11 ' CE1' ' A' ' 59' ' ' PHE . 0.8 OUTLIER -92.32 145.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.717 ' CD2' HD11 ' A' ' 131' ' ' LEU . 4.1 m-85 -129.21 161.16 30.79 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.182 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -121.62 105.19 38.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.591 -0.693 . . . . 0.0 110.382 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 18.7 Cg_exo -43.64 -61.2 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.538 2.825 . . . . 0.0 114.229 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.2 tt0 -26.9 -52.69 0.06 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.361 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 21.05 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 0.0 109.756 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -157.6 162.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.28 -0.888 . . . . 0.0 109.618 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.57 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -128.72 148.3 50.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.894 -1.129 . . . . 0.0 109.653 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.765 ' CE2' HD11 ' A' ' 132' ' ' LEU . 72.8 t80 -54.43 -38.86 66.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.222 -0.924 . . . . 0.0 109.613 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -51.08 -14.36 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.07 -1.019 . . . . 0.0 108.84 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.57 ' HG3' ' H ' ' A' ' 127' ' ' SER . 6.5 mm-40 -73.77 -62.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.882 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.048 HD12 ' H ' ' A' ' 131' ' ' LEU . 2.9 mp -51.69 -34.12 37.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.976 -1.077 . . . . 0.0 108.184 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.765 HD11 ' CE2' ' A' ' 128' ' ' PHE . 39.0 mt -68.67 -50.16 53.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 110.255 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.21 -30.01 70.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.084 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 79' ' ' LYS . 1.2 t -74.04 -40.06 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.884 -1.135 . . . . 0.0 109.633 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.683 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 24.3 t80 -69.26 -43.41 74.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.63 -0.669 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.649 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 82.3 m95 -71.73 -39.69 69.93 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.699 -1.251 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.85 -37.12 59.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 112.88 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 25.3 m-80 -97.78 36.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.639 -1.288 . . . . 0.0 113.27 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.683 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER 177.97 130.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.56 -1.338 . . . . 0.0 110.733 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.606 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -61.54 112.04 5.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.428 ' HB2' HD12 ' A' ' 189' ' ' ILE . 45.6 Cg_endo -74.68 -11.01 22.05 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.161 1.907 . . . . 0.0 112.569 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.494 HG22 HD13 ' A' ' 189' ' ' ILE . 71.4 p -101.2 46.62 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.021 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.622 ' O ' ' O ' ' A' ' 144' ' ' GLY . 2.6 pt20 -114.08 107.29 15.45 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.81 0.814 . . . . 0.0 110.552 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.668 ' HA2' HG21 ' A' ' 190' ' ' THR . . . -39.06 -118.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.578 0 CA-C-O 121.482 0.49 . . . . 0.0 112.157 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.578 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -99.48 44.62 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.258 . . . . 0.0 111.822 -177.135 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.438 ' HB3' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -174.29 159.61 3.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.701 -1.25 . . . . 0.0 109.329 178.421 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.596 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -122.85 145.14 48.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.428 -1.42 . . . . 0.0 110.536 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.543 ' CA ' HD22 ' A' ' 220' ' ' LEU . . . 65.85 -124.19 25.73 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -111.7 26.7 10.37 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.76 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.702 ' OD1' ' N ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -107.88 167.13 10.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.124 . . . . 0.0 108.42 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 151' ' ' PHE . 33.5 m-85 -132.35 111.54 11.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.824 -1.173 . . . . 0.0 109.912 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 172.38 143.61 4.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.449 HG22 ' H ' ' A' ' 153' ' ' THR . 0.1 OUTLIER -74.55 6.2 4.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -1.219 . . . . 0.0 109.147 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.606 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -88.87 -1.22 57.98 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.606 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 29.7 m-85 -136.75 62.55 1.6 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.763 HH22 ' CB ' ' A' ' 192' ' ' ASP . 10.4 mtm105 -107.96 174.74 5.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.599 ' OG ' ' NE2' ' A' ' 139' ' ' HIS . 6.2 t -93.2 107.26 19.1 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.464 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -138.42 123.08 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 118.182 -1.407 . . . . 0.0 111.473 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.693 HG23 ' CG2' ' A' ' 191' ' ' THR . 11.2 t -112.04 127.66 69.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.249 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.494 ' CG ' ' HG3' ' A' ' 197' ' ' GLN . 7.6 m-85 -119.81 89.24 41.47 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.78 174.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.237 2.625 . . . . 0.0 112.608 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -96.24 -33.85 11.85 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.559 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 12.3 t -176.64 -162.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.374 -0.828 . . . . 0.0 109.054 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.559 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -56.93 -15.46 4.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.988 1.375 . . . . 0.0 108.614 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.559 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 3.7 t -55.82 -64.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.749 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.479 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 11.6 mt-30 -79.32 -17.76 53.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.618 -0.676 . . . . 0.0 111.061 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' HD23 ' A' ' 171' ' ' LEU . 3.1 ttm -52.36 -38.05 57.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.761 -1.212 . . . . 0.0 110.218 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.37 -23.49 57.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.862 -1.149 . . . . 0.0 109.688 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.667 ' N ' ' OE2' ' A' ' 168' ' ' GLU . . . -92.88 -42.17 9.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.46 -55.17 23.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.677 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 172' ' ' ARG . 2.5 pp -52.65 -35.55 55.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.055 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.577 ' O ' ' OE2' ' A' ' 176' ' ' GLU . 4.2 mtm180 -74.82 -46.45 36.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.886 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.649 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 70.2 m -56.54 -41.33 76.6 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.446 -0.784 . . . . 0.0 109.546 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.476 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 25.1 ttpp -72.4 -49.99 29.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.63 -25.52 68.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' O ' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -64.74 -53.36 48.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.497 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -78.9 -21.4 47.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.737 -179.669 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.628 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 38.8 tp60 -62.14 -41.0 97.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 0.0 109.656 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -16.0 58.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.939 . . . . 0.0 109.619 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 176' ' ' GLU . 49.7 t -81.55 -54.71 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -75.72 -30.96 59.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 14.5 t -56.89 -38.0 72.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.599 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -79.35 0.77 27.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -108.15 23.81 13.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 70.15 62.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.639 -179.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 228' ' ' PRO . 20.1 m-85 -134.74 168.07 19.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -94.84 -150.58 27.28 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.04 136.72 11.84 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.755 2.303 . . . . 0.0 112.099 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.673 HG22 ' H ' ' A' ' 191' ' ' THR . 2.6 mm -59.14 123.16 10.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.668 HG21 ' HA2' ' A' ' 144' ' ' GLY . 53.2 p -79.41 5.1 13.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.995 . . . . 0.0 110.744 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.693 ' CG2' HG23 ' A' ' 159' ' ' VAL . 31.3 m -43.81 110.94 0.24 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.763 ' CB ' HH22 ' A' ' 156' ' ' ARG . 4.0 t0 -77.14 117.74 18.99 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.945 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.17 123.62 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.68 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -163.54 155.96 17.92 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.366 -0.834 . . . . 0.0 109.089 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.74 167.32 9.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 62.75 66.2 2.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' HG3' ' CG ' ' A' ' 160' ' ' TYR . 78.5 mm-40 -111.3 102.87 11.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -1.199 . . . . 0.0 109.429 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 197' ' ' GLN . 61.9 t -41.67 155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.424 -0.798 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.609 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 22.1 t80 -117.64 151.52 37.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.865 . . . . 0.0 109.505 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -152.01 98.33 2.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.506 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 19.6 m-85 -54.0 136.13 41.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 110.554 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HB1' ' CB ' ' A' ' 206' ' ' HIS . . . -87.27 -177.97 6.09 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.8 pt-20 -75.29 175.56 8.24 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.381 -0.825 . . . . 0.0 109.478 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -52.04 67.03 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.512 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.13 -19.25 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.601 -0.687 . . . . 0.0 109.874 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.786 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 7.2 m-70 -96.99 7.84 45.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 110.327 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.829 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.0 mm-40 -127.0 -142.04 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.308 1.052 . . . . 0.0 110.491 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.615 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -35.46 -3.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.352 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.829 ' N ' ' O ' ' A' ' 207' ' ' GLN . 88.2 t80 -40.85 -43.45 2.05 Favored 'General case' 0 N--CA 1.514 2.761 0 O-C-N 120.431 -1.418 . . . . 0.0 110.431 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.463 ' H ' HD12 ' A' ' 210' ' ' LEU . 4.5 mp -75.87 -13.44 60.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.425 -1.422 . . . . 0.0 110.085 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.737 ' HB2' HG22 ' A' ' 50' ' ' VAL . 79.8 p -57.88 -44.2 86.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 -9.01 54.45 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.538 -0.726 . . . . 0.0 109.498 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 214' ' ' PRO . 12.6 m-80 -137.13 66.8 54.38 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 213' ' ' ASN . 12.3 Cg_exo -67.29 9.59 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.013 2.476 . . . . 0.0 112.237 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.497 ' OD1' ' C ' ' A' ' 215' ' ' ASP . 1.1 p30 -63.07 -18.92 63.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.537 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.62 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.71 85.35 0.05 OUTLIER Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.157 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.703 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 87.2 t80 -48.91 -171.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.314 2.057 . . . . 0.0 109.052 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.703 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 13.2 m -72.29 76.65 1.0 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.661 -1.275 . . . . 0.0 108.852 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.94 17.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.543 HD22 ' CA ' ' A' ' 148' ' ' GLY . 4.8 mp -85.25 -177.54 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -1.212 . . . . 0.0 109.777 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.96 90.61 0.08 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.59 171.22 14.32 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.574 ' OG1' ' OD1' ' A' ' 140' ' ' ASP . 1.6 t -143.5 8.31 1.55 Allowed 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 114.919 -0.64 . . . . 0.0 109.713 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -73.5 23.57 0.99 Allowed Glycine 0 C--N 1.303 -1.294 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 223' ' ' THR . 4.0 p -111.53 163.69 8.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.715 -0.873 . . . . 0.0 109.954 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.52 110.06 22.55 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 122.167 0.984 . . . . 0.0 109.054 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.566 ' CB ' ' CD ' ' A' ' 228' ' ' PRO . 1.3 m -72.37 -72.32 0.21 Allowed Pre-proline 0 C--N 1.279 -2.48 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 72.8 Cg_endo -74.39 -40.7 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.192 1.928 . . . . 0.0 109.828 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.544 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -54.66 153.08 6.22 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.873 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.52 138.23 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.32 0.581 . . . . 0.0 109.789 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.558 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -149.78 118.8 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -68.99 42.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 0.0 109.472 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 121.218 -0.926 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.444 ' H72' ' SD ' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.541 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 22' ' ' GLY . 4.6 m-20 -35.53 107.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -1.112 . . . . 0.0 109.365 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.5 m -67.93 -33.39 74.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 110.078 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -72.96 -10.24 59.58 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 123.282 1.515 . . . . 0.0 109.505 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.536 ' O ' HG21 ' A' ' 153' ' ' THR . 95.3 p -49.4 -65.26 0.6 Allowed 'General case' 0 C--N 1.26 -3.285 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.645 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.794 ' HB2' H142 ' A' ' 21' ' ' MYR . 0.0 OUTLIER -103.81 45.94 0.94 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.63 1.205 . . . . 0.0 111.278 -178.097 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.661 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -143.91 12.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.607 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 179.061 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -36.22 166.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.736 1.255 . . . . 0.0 109.189 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.05 124.66 28.11 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.617 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.14 -26.28 60.28 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.506 -0.746 . . . . 0.0 109.183 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -81.64 -4.67 56.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' LEU . 5.7 mt-10 -98.02 -36.23 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 35' ' ' LEU . . . -35.59 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.653 ' O ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER -40.48 162.41 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 38' ' ' ARG . 60.5 Cg_exo -50.76 -30.67 30.14 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.971 1.781 . . . . 0.0 110.911 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' H ' HD12 ' A' ' 35' ' ' LEU . . . 65.2 -38.8 0.11 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 36' ' ' PRO . 7.9 ttt180 -53.38 121.54 7.83 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.737 -1.449 . . . . 0.0 109.315 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 41' ' ' PRO . 4.4 m -127.89 31.87 5.04 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.656 ' C ' ' O ' ' A' ' 39' ' ' THR . 3.1 tm-20 -8.17 75.44 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.142 0 CA-C-O 121.41 0.624 . . . . 0.0 110.679 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.673 ' N ' ' O ' ' A' ' 39' ' ' THR . 72.2 Cg_endo -90.97 -177.3 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.695 2.93 . . . . 0.0 112.511 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 42' ' ' ILE . 6.8 pt -102.08 149.75 36.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 109.023 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -39.85 164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.92 2.413 . . . . 0.0 112.554 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 202' ' ' ALA . 27.2 m -106.87 -154.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 45' ' ' THR . 9.9 t -80.09 86.79 5.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.231 -0.918 . . . . 0.0 110.14 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.612 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.41 -37.65 70.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.383 -0.823 . . . . 0.0 111.016 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.8 mtmt -93.24 98.86 11.55 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 116.33 -2.148 . . . . 0.0 108.15 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.661 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.14 107.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -30.45 64.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.807 . . . . 0.0 111.133 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 81' ' ' TRP . 13.2 t -66.65 -43.59 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.788 -1.195 . . . . 0.0 109.554 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.38 -42.17 4.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.135 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.06 0.97 48.33 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 46.4 m-20 -72.14 -119.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -127.92 174.17 9.39 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 123.506 1.622 . . . . 0.0 110.103 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.859 ' O ' HG13 ' A' ' 56' ' ' VAL . 10.3 p -150.89 22.13 0.78 Allowed 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.134 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 55' ' ' THR . 2.5 m -167.79 143.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.918 -1.114 . . . . 0.0 109.542 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' A' ' 56' ' ' VAL . 32.6 mt-10 -32.46 142.76 0.16 Allowed Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.442 -0.786 . . . . 0.0 110.462 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 88.4 Cg_endo -77.52 167.1 80.02 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.224 -1.99 . . . . 0.0 111.661 0.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -100.39 132.69 22.12 Favored Pre-proline 0 C--N 1.271 -2.835 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.905 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' O ' ' OG1' ' A' ' 63' ' ' THR . 45.5 Cg_exo -49.51 114.61 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.999 1.799 . . . . 0.0 112.199 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.71 118.39 3.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -8.26 20.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.611 HG22 ' HB3' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -83.12 137.13 34.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.107 . . . . 0.0 109.795 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.77 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.1 tp60 -103.66 155.33 18.64 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.374 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.734 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -161.79 137.27 7.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.276 -1.515 . . . . 0.0 112.434 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.28 -168.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.96 115.02 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.785 -1.822 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 1.5 p90 -163.29 156.04 18.61 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 109.719 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.92 164.16 30.31 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' ' OD1' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -114.8 -88.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -1.111 . . . . 0.0 109.052 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . -125.07 -152.14 8.2 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.681 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.4 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.412 -1.052 . . . . 0.0 108.193 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.729 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -49.45 5.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.361 -0.837 . . . . 0.0 111.665 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.783 ' CZ2' ' CE1' ' A' ' 206' ' ' HIS . 5.1 m0 -69.52 -49.84 50.76 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.277 -1.514 . . . . 0.0 108.549 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.52 -49.65 76.31 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB3' HG21 ' A' ' 117' ' ' VAL . . . -76.13 -27.52 57.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.964 -1.315 . . . . 0.0 110.202 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' OE1' HG22 ' A' ' 91' ' ' VAL . 6.9 tp10 -52.1 -34.85 45.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.907 -1.12 . . . . 0.0 110.153 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 21.7 ttt-85 -106.52 -56.69 2.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.979 -1.076 . . . . 0.0 111.36 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.655 ' O ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -38.69 -17.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 110.262 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 11.6 m-85 -91.52 -42.7 10.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.702 -1.249 . . . . 0.0 110.953 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.54 ' CE3' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -70.91 -4.61 25.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.745 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 79' ' ' LYS . 3.7 m -83.62 14.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.752 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 134' ' ' VAL . 96.4 mt -90.69 164.0 14.3 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -93.19 138.12 31.88 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.451 0.643 . . . . 0.0 110.359 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 123' ' ' PRO . . . 89.65 -19.12 42.67 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.22 137.91 18.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.945 -1.326 . . . . 0.0 109.775 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.571 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -76.73 -40.89 47.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.563 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.3 OUTLIER 177.12 -160.38 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.079 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.553 ' N ' ' OG ' ' A' ' 88' ' ' SER . 70.2 p -160.33 150.97 18.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.547 HE21 ' HD3' ' A' ' 118' ' ' ARG . 1.1 mp0 -144.68 164.43 30.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.583 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.2 OUTLIER -144.53 156.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.061 -1.024 . . . . 0.0 110.008 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 176.29 45.93 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 1.4 m-85 -88.77 164.78 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.356 -1.085 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.677 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.73 174.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.144 -0.973 . . . . 0.0 109.642 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 53.17 46.96 62.03 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -135.87 -152.38 6.36 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 120.945 -1.326 . . . . 0.0 110.381 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.701 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 0.2 OUTLIER -153.29 63.63 0.76 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.535 -0.979 . . . . 0.0 108.856 -179.808 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.653 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.95 142.37 16.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 101' ' ' PRO . 31.0 mtp180 -49.26 177.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 108.548 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.567 ' C ' ' O ' ' A' ' 99' ' ' ARG . 2.6 m120 -33.84 94.92 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.332 -0.855 . . . . 0.0 109.111 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 60.9 Cg_endo -85.62 163.07 10.82 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.81 2.34 . . . . 0.0 112.503 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.589 ' OG1' ' OE1' ' A' ' 105' ' ' GLU . 21.5 p -121.02 170.78 9.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.692 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.777 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 13.6 t80 -60.37 -59.56 5.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.0 110.295 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -55.48 -36.73 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 108.309 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.589 ' OE1' ' OG1' ' A' ' 102' ' ' THR . 0.1 OUTLIER -58.27 -62.01 2.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.258 0.552 . . . . 0.0 110.345 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.033 HG12 ' OG1' ' A' ' 111' ' ' THR . 27.1 m -65.04 -23.98 34.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.264 -0.897 . . . . 0.0 110.856 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.594 ' C ' ' H ' ' A' ' 109' ' ' GLU . 42.9 t -42.13 -44.18 3.57 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.74 ' C ' ' H ' ' A' ' 110' ' ' LYS . 33.2 t -69.42 13.23 0.13 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.24 -0.912 . . . . 0.0 108.735 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER 51.95 -16.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.514 0.726 . . . . 0.0 110.755 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.74 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -45.88 -30.43 1.73 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.67 -0.644 . . . . 0.0 110.186 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 1.033 ' OG1' HG12 ' A' ' 106' ' ' VAL . 48.7 p -84.53 11.77 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.129 . . . . 0.0 109.073 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 24.72 44.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.677 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 2.6 m-70 -83.91 170.83 13.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.492 -1.593 . . . . 0.0 109.214 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB1' ' CB ' ' A' ' 158' ' ' ALA . . . -118.55 114.21 22.46 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.693 ' OE2' ' CG ' ' A' ' 73' ' ' PHE . 1.9 mm-40 -51.19 118.25 3.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -125.21 136.18 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.05 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.561 HG22 ' CG1' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -116.85 125.01 73.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 118' ' ' ARG . 2.7 ptm180 -104.7 116.37 31.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 110.723 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.603 HG13 HD22 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -124.57 114.25 39.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.466 HG12 ' HB3' ' A' ' 65' ' ' MET . 0.7 OUTLIER -95.43 159.51 2.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.041 -1.037 . . . . 0.0 111.698 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.82 ' HB2' HG22 ' A' ' 126' ' ' ILE . 5.7 p90 -138.95 136.61 35.61 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 123.518 1.628 . . . . 0.0 111.592 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.969 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 6.9 ptt-85 -137.16 -1.09 0.03 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.621 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.969 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 56.2 Cg_endo -71.53 -27.75 18.45 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 124.288 3.325 . . . . 0.0 116.838 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 5.1 tt0 72.79 -5.18 1.94 Allowed 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.651 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -105.51 -25.07 12.47 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.892 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -128.4 124.13 61.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.332 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.519 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -132.22 -170.73 2.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.885 -1.135 . . . . 0.0 112.698 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.733 ' N ' ' CE2' ' A' ' 121' ' ' TYR . 60.5 t80 -58.08 -45.39 87.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.569 -0.707 . . . . 0.0 110.497 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' O ' HD23 ' A' ' 132' ' ' LEU . 78.0 mt-10 -46.73 -35.02 5.67 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.73 ' HG3' HD13 ' A' ' 126' ' ' ILE . 17.4 mm-40 -73.77 -63.54 1.19 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.689 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 13.2 mt -34.22 -57.83 0.48 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.786 HD23 ' H ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -76.84 -42.17 41.24 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.403 -1.435 . . . . 0.0 110.996 -178.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.786 ' H ' HD23 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -52.15 -63.07 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.771 -1.205 . . . . 0.0 109.167 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.8 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 t -50.14 -40.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' CZ3' ' A' ' 136' ' ' TRP . 15.8 t80 -56.45 -45.46 80.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.188 -1.57 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.514 ' O ' HG21 ' A' ' 223' ' ' THR . 29.4 m95 -73.49 -41.57 62.93 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.642 -1.286 . . . . 0.0 111.102 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -67.5 -2.45 6.51 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.749 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.8 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -133.76 48.0 2.4 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.937 -1.727 . . . . 0.0 112.096 -178.939 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 1.025 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 176.21 -164.79 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.646 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -129.49 117.63 18.75 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.509 ' HG3' ' CD2' ' A' ' 177' ' ' TYR . 10.7 Cg_endo -67.12 -4.11 10.98 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.554 1.503 . . . . 0.0 111.615 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.608 HG22 HD13 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -101.3 -13.76 17.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.196 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.645 ' CD ' ' H ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -68.02 70.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.633 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -52.05 -118.26 0.01 OUTLIER Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.659 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.62 39.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -1.041 . . . . 0.0 109.334 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -156.52 164.83 37.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.681 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -155.52 89.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.566 -1.334 . . . . 0.0 109.44 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.645 ' H ' ' CD ' ' A' ' 143' ' ' GLN . . . 51.72 -113.65 2.56 Favored Glycine 0 N--CA 1.478 1.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -80.48 3.83 20.24 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.434 -0.883 . . . . 0.0 110.236 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -108.28 146.34 33.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.915 -1.116 . . . . 0.0 108.934 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.61 130.42 32.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.053 -1.029 . . . . 0.0 109.961 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.01 163.34 9.48 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.421 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.575 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 44.8 p -73.72 -10.62 59.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.523 -0.986 . . . . 0.0 109.896 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 16.2 pm0 -87.47 -7.08 58.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.446 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 32.2 m-85 -124.41 60.43 1.15 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.082 -1.011 . . . . 0.0 108.772 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.5 HH12 ' HB ' ' A' ' 153' ' ' THR . 5.4 ptt-85 -112.96 173.67 6.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 118.57 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.468 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . . . -139.62 116.36 10.83 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' A' ' 192' ' ' ASP . 48.4 t -102.19 148.34 7.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.609 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.412 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 91.0 m-85 -139.23 87.36 13.82 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.776 -1.203 . . . . 0.0 108.554 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -46.02 163.15 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.881 2.387 . . . . 0.0 112.243 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.566 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.14 -21.54 13.24 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 120.635 -1.29 . . . . 0.0 110.553 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 162' ' ' THR . 0.8 OUTLIER -176.48 178.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 0.0 108.929 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.31 -16.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 123.007 1.384 . . . . 0.0 108.484 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.558 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.3 t -59.26 -62.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.812 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.925 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.576 ' O ' ' CB ' ' A' ' 170' ' ' ALA . 4.5 mp0 -77.74 -19.4 55.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 110.381 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.5 ttt -54.09 -54.66 36.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.954 -1.092 . . . . 0.0 109.534 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.465 ' OE1' ' N ' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -54.58 -66.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 109.77 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -57.5 -39.33 76.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.869 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.44 -58.54 6.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.6 mp -53.04 -49.5 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -60.87 -48.55 81.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 109.466 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.498 ' HB2' ' NE1' ' A' ' 136' ' ' TRP . 1.0 OUTLIER -55.97 -40.15 72.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.66 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.636 ' HZ2' HD12 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -73.04 -58.2 3.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.607 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.97 -44.56 92.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.913 . . . . 0.0 110.81 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 74.8 mt-10 -53.1 -20.21 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.031 . . . . 0.0 110.451 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.509 ' CD2' ' HG3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -79.49 -40.08 30.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.821 -1.174 . . . . 0.0 110.556 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -52.25 -44.8 65.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.835 -1.166 . . . . 0.0 108.502 179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -30.59 5.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 109.286 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.7 t -87.9 -54.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.278 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.608 HD13 HG22 ' A' ' 142' ' ' THR . 25.3 mt -58.99 -45.55 90.34 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.387 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -23.57 22.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.972 -1.08 . . . . 0.0 109.023 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -88.43 -13.84 39.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.338 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 2.9 m-70 -99.85 11.76 38.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 10.0 t-20 72.0 55.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.73 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.487 ' HE2' ' HG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -119.31 -176.58 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 108.972 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -119.55 -158.13 10.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.561 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.4 Cg_exo -58.63 116.47 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.325 2.017 . . . . 0.0 110.771 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.636 HD12 ' HZ2' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -47.91 -175.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.005 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.633 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 26.8 p -154.67 55.34 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.654 -0.653 . . . . 0.0 110.384 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.614 ' CG2' HG23 ' A' ' 159' ' ' VAL . 32.9 m -99.93 119.05 37.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 17.2 t0 -75.9 111.06 10.88 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.389 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 1.0 OUTLIER -117.33 114.82 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 110.466 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.81 ' HE ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -165.0 -170.16 1.87 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.539 ' OE2' ' C ' ' A' ' 194' ' ' ARG . 9.4 mp0 -145.82 178.66 8.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.309 . . . . 0.0 110.389 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.23 14.91 67.88 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.077 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.81 ' NE2' ' HE ' ' A' ' 194' ' ' ARG . 1.2 mp0 -89.35 126.47 35.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.502 -1.587 . . . . 0.0 109.784 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.31 154.87 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.464 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 6.7 t80 -92.82 124.79 37.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.13 95.09 5.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.285 -0.884 . . . . 0.0 108.975 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -54.41 133.87 45.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.322 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.525 ' O ' HG11 ' A' ' 44' ' ' VAL . . . -84.58 -175.75 5.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.808 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.2 pm0 -74.89 171.5 13.92 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -58.52 -53.84 53.74 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -51.35 -11.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.016 -1.052 . . . . 0.0 111.118 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.783 ' CE1' ' CZ2' ' A' ' 74' ' ' TRP . 12.2 m-70 -101.49 10.27 40.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.709 -1.245 . . . . 0.0 110.335 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.0 mm-40 -131.12 -146.46 0.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.233 1.015 . . . . 0.0 110.009 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.696 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 12.8 mp0 -33.87 -8.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.444 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 11.3 t80 -44.95 -40.52 6.45 Favored 'General case' 0 N--CA 1.515 2.815 0 O-C-N 120.146 -1.596 . . . . 0.0 109.343 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -52.61 -18.43 1.76 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 120.868 -1.145 . . . . 0.0 110.47 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 p -61.39 -39.7 91.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -71.02 -33.07 70.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.306 -0.871 . . . . 0.0 109.687 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 215' ' ' ASP . 5.6 m-80 -134.27 70.0 73.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.441 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HB3' ' NE ' ' A' ' 78' ' ' ARG . 24.3 Cg_exo -60.76 8.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.039 2.492 . . . . 0.0 112.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 213' ' ' ASN . 10.1 t0 -63.37 -18.97 64.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.524 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.79 85.32 0.05 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.512 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.74 92.97 9.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.598 2.199 . . . . 0.0 109.388 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.727 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -169.72 112.74 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 109.491 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -0.33 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.505 3.294 0 CA-C-O 122.464 1.036 . . . . 0.0 112.711 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.78 -173.71 2.76 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.676 -0.896 . . . . 0.0 109.69 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -82.73 -149.04 7.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -153.64 -136.66 2.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' THR . . . . . 1.025 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER 45.26 25.0 0.17 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.286 -1.126 . . . . 0.0 109.131 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -163.12 40.26 0.34 Allowed Glycine 0 C--N 1.302 -1.355 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.651 HG12 ' O ' ' A' ' 225' ' ' VAL . 2.7 t -66.74 96.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -1.159 . . . . 0.0 109.133 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.621 ' H ' ' CB ' ' A' ' 229' ' ' MET . 0.3 OUTLIER -98.41 -153.0 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.11 0.957 . . . . 0.0 109.507 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.574 ' CB ' ' CD ' ' A' ' 228' ' ' PRO . 1.2 m -71.24 -68.27 0.49 Allowed Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 45.9 Cg_endo -68.6 -39.42 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.427 2.084 . . . . 0.0 109.51 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.621 ' CB ' ' H ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -54.35 151.06 7.95 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.745 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.561 ' O ' HG13 ' A' ' 225' ' ' VAL . . . -32.77 131.77 0.16 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.188 0.518 . . . . 0.0 109.817 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 231' ' ' ILE . 1.2 mm -128.0 103.99 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.2 -0.937 . . . . 0.0 109.396 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -23.18 55.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.427 -0.795 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.357 0 O-C-N 121.287 -0.883 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.794 H142 ' HB2' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' OD2' ' OG ' ' A' ' 26' ' ' SER . 19.0 t70 -65.27 65.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -1.189 . . . . 0.0 109.393 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 22' ' ' GLY . 4.4 t -50.85 -19.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.758 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -62.32 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 123.265 1.507 . . . . 0.0 110.694 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.458 ' OG ' ' OD2' ' A' ' 23' ' ' ASP . 59.5 p -47.3 -7.09 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.967 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.677 ' HZ3' ' HB3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -105.46 23.14 14.26 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 124.305 2.002 . . . . 0.0 109.538 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.681 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -156.74 21.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.257 -3.433 0 CA-C-N 112.845 -1.98 . . . . 0.0 105.717 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.635 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.75 168.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.744 1.259 . . . . 0.0 109.539 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.09 124.47 31.8 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.68 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.9 -46.01 78.49 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.761 -0.587 . . . . 0.0 109.576 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.654 ' CD ' ' H ' ' A' ' 32' ' ' GLU . 3.1 pm0 -78.46 15.77 0.93 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.569 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.582 ' O ' ' C ' ' A' ' 34' ' ' ALA . 10.1 tp10 -116.07 -40.6 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.6 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -29.0 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.766 . . . . 0.0 110.108 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -37.58 161.26 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -59.73 -41.98 50.41 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.064 1.842 . . . . 0.0 111.676 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.93 134.54 4.41 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' CG ' ' H ' ' A' ' 39' ' ' THR . 14.5 ttp180 -110.75 177.78 4.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -1.112 . . . . 0.0 109.518 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -124.57 33.52 5.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.586 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.83 98.88 27.2 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.009 . . . . 0.0 109.65 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.78 170.78 15.14 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.726 2.284 . . . . 0.0 112.211 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.43 HD11 ' HE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -139.06 100.56 7.88 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.938 . . . . 0.0 109.639 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.21 168.19 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.595 2.197 . . . . 0.0 112.209 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 204' ' ' ASP . 12.5 m -139.39 170.4 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.167 -0.958 . . . . 0.0 109.675 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 45' ' ' THR . 13.4 t -58.82 103.77 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.356 -0.84 . . . . 0.0 110.231 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.572 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.92 -50.13 73.51 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.359 -0.838 . . . . 0.0 111.479 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.4 pttt -70.74 100.62 1.92 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 115.846 -2.342 . . . . 0.0 108.168 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.604 ' HD1' ' HB ' ' A' ' 50' ' ' VAL . 6.3 t-80 -31.95 125.02 0.28 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.003 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.469 ' ND1' ' O ' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -66.65 -8.08 25.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 110.848 -178.733 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HD1' ' A' ' 48' ' ' HIS . 18.9 t -92.98 -63.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.161 . . . . 0.0 109.805 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -83.56 -42.76 16.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.0 5.5 54.82 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.3 p30 -81.52 -119.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.689 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttp180 -129.54 168.67 16.04 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.989 1.376 . . . . 0.0 108.418 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.685 ' O ' HG13 ' A' ' 56' ' ' VAL . 20.8 p -128.38 30.68 5.14 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.94 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 55' ' ' THR . 7.0 m -161.29 132.58 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-10 -33.78 154.41 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.314 0 CA-C-O 121.899 0.857 . . . . 0.0 110.852 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HD2' ' NH2' ' A' ' 54' ' ' ARG . 96.5 Cg_endo -79.44 166.28 78.52 Favored 'Cis proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.48 -2.3 . . . . 0.0 111.756 -0.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.484 ' CE1' HG11 ' A' ' 120' ' ' VAL . 32.6 m-85 -108.37 154.51 41.39 Favored Pre-proline 0 C--N 1.267 -3.005 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.041 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.51 148.88 10.63 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.33 2.02 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -55.95 132.79 50.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.84 53.91 2.6 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.23 137.1 40.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -1.051 . . . . 0.0 109.44 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' OE1' ' CA ' ' A' ' 64' ' ' GLN . 1.6 tp60 -123.85 125.43 44.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.688 ' SD ' ' NH2' ' A' ' 118' ' ' ARG . 3.5 ptt? -109.63 141.28 42.39 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.621 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.43 -167.29 1.87 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.0 129.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.081 -1.637 . . . . 0.0 109.446 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 1.025 ' O ' HG22 ' A' ' 117' ' ' VAL . 59.1 m-85 -117.82 125.75 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.116 -0.99 . . . . 0.0 108.61 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.13 105.81 1.72 Allowed Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.023 -1.56 . . . . 0.0 110.146 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.723 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -107.86 -88.79 0.47 Allowed 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.449 -1.03 . . . . 0.0 108.666 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' N ' ' OE2' ' A' ' 115' ' ' GLU . . . -146.92 -152.73 5.71 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.812 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -36.42 106.05 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 108.956 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.85 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.419 -0.801 . . . . 0.0 112.307 -178.225 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 1.0 ' O ' HD11 ' A' ' 210' ' ' LEU . 21.1 m0 -67.48 -48.73 66.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.076 -1.64 . . . . 0.0 109.412 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.43 5.42 57.21 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.55 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.726 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.42 -41.86 38.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.276 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.727 ' OE2' HG13 ' A' ' 119' ' ' VAL . 2.6 tp10 -83.39 -14.82 51.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.15 -0.969 . . . . 0.0 111.786 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.842 ' CB ' HD13 ' A' ' 210' ' ' LEU . 15.0 ttp85 -57.52 -73.13 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.807 -1.183 . . . . 0.0 110.965 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 11.9 mttt -61.71 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.726 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.5 m-85 -115.87 -29.95 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.757 -1.215 . . . . 0.0 110.602 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.613 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.0 OUTLIER -104.26 -0.75 27.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.723 -1.236 . . . . 0.0 109.571 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 78' ' ' ARG . 3.7 m -93.3 8.51 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 109.105 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -103.3 -179.03 3.84 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -96.72 156.51 16.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.639 -1.288 . . . . 0.0 111.209 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.72 79.88 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.557 -0.714 . . . . 0.0 111.906 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 86' ' ' VAL . 1.1 t -99.79 129.52 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 120.387 -1.654 . . . . 0.0 110.791 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.584 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.68 -43.8 30.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.53 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t -169.62 -176.74 2.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 1.113 HG22 HG12 ' A' ' 119' ' ' VAL . 7.7 p -148.31 149.53 32.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.097 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.576 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 1.0 OUTLIER -146.71 170.51 16.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.41 -0.806 . . . . 0.0 109.455 -179.564 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.815 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -146.66 167.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . 178.06 156.02 15.61 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 202' ' ' ALA . 0.5 OUTLIER -80.01 160.71 25.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.604 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.648 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.56 -170.11 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 0.0 109.875 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.35 22.41 63.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.745 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -128.44 -164.06 11.46 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.511 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 1.9 p80 -145.57 78.5 1.54 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.38 -1.07 . . . . 0.0 109.708 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.498 ' O ' ' C ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -147.36 135.18 21.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.498 ' C ' ' O ' ' A' ' 98' ' ' THR . 5.9 mtt180 -38.84 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.47 89.5 49.47 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 109.668 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.461 ' HG3' ' HE2' ' A' ' 113' ' ' HIS . 5.1 Cg_exo -70.87 132.81 22.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.834 2.356 . . . . 0.0 110.848 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 21.1 p -124.21 159.43 30.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.845 -1.159 . . . . 0.0 110.614 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 102' ' ' THR . 6.0 t80 -48.41 -38.85 20.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 108.834 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -40.46 64.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.79 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.0 mm-40 -81.75 -30.99 32.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -80.98 -29.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 108.833 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -28.97 64.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.508 -0.745 . . . . 0.0 109.496 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.677 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 51.6 p -62.67 -70.46 0.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.677 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.9 mt-10 140.4 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -48.22 1.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 110.939 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' GLU . 14.4 p -108.25 -7.47 15.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.814 -1.179 . . . . 0.0 109.55 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 43.03 51.0 6.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.745 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 15.4 m-70 -97.27 169.19 9.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.295 . . . . 0.0 108.929 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -124.2 113.08 17.82 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.665 ' OE2' ' N ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -51.7 114.67 1.34 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.959 . . . . 0.0 108.939 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -125.34 157.66 34.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.025 HG22 ' O ' ' A' ' 68' ' ' PHE . 20.6 m -130.14 131.96 65.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.688 ' NH2' ' SD ' ' A' ' 65' ' ' MET . 10.6 ptm180 -103.68 130.34 51.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.738 -1.226 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 1.113 HG12 HG22 ' A' ' 89' ' ' THR . 0.2 OUTLIER -132.86 138.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.61 122.0 63.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.953 ' CZ ' HD22 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -125.41 166.88 15.79 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.472 -177.767 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.505 ' HG2' ' H ' ' A' ' 125' ' ' HIS . 4.5 ttm180 -99.26 114.1 65.29 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.668 -0.645 . . . . 0.0 110.534 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 51.2 Cg_exo -50.85 -42.37 51.78 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.406 2.07 . . . . 0.0 111.785 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -57.28 -23.09 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.299 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.505 ' H ' ' HG2' ' A' ' 122' ' ' ARG . 1.1 m-70 -104.86 -56.02 2.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 108.849 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 3.3 tp -130.25 133.43 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.47 168.53 19.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.16 -0.963 . . . . 0.0 110.42 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.824 ' CE2' HD11 ' A' ' 132' ' ' LEU . 4.0 t80 -69.56 -44.87 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.568 ' HA ' HD12 ' A' ' 132' ' ' LEU . 1.3 pt-20 -47.95 -31.06 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 11.8 mm-40 -57.38 -70.02 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 111.216 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.953 HD22 ' CZ ' ' A' ' 121' ' ' TYR . 8.5 mp -56.31 -27.13 54.55 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.133 -1.604 . . . . 0.0 110.078 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.824 HD11 ' CE2' ' A' ' 128' ' ' PHE . 5.0 mt -55.91 -30.54 61.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.382 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HZ2' ' HB2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -70.63 -52.0 24.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.747 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 9.2 t -49.91 -30.7 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 108.461 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 51.3 t80 -70.79 -46.6 62.58 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.028 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 177' ' ' TYR . 58.2 m95 -72.68 -60.94 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.396 -1.44 . . . . 0.0 110.719 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 14.8 tm-20 -37.93 -56.98 1.07 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.311 -0.868 . . . . 0.0 111.789 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -96.55 61.55 1.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.011 -1.056 . . . . 0.0 110.681 -178.128 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.765 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 13.4 m80 -152.99 -161.81 1.36 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.729 ' OD2' ' NE2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -121.24 178.06 1.31 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' CD ' ' OD2' ' A' ' 140' ' ' ASP . 9.7 Cg_exo -69.09 -83.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.257 1.971 . . . . 0.0 112.005 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -124.83 13.44 8.55 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.378 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.729 ' NE2' ' OD2' ' A' ' 140' ' ' ASP . 2.1 mt-30 -55.45 70.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.008 -1.058 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.79 13.67 51.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.677 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -115.41 2.42 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -1.083 . . . . 0.0 109.296 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' NE ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER 174.98 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.245 -0.909 . . . . 0.0 109.223 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.92 103.11 11.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 119.581 -1.949 . . . . 0.0 108.822 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' NE ' ' A' ' 146' ' ' ARG . . . 67.21 -118.74 10.55 Favored Glycine 0 C--N 1.301 -1.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.79 -33.17 30.99 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-N 114.381 -0.909 . . . . 0.0 112.377 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.705 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 4.5 m-20 -72.19 99.1 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.229 -1.544 . . . . 0.0 110.415 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.655 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 10.5 p90 -92.92 128.83 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.82 177.58 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.21 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -82.87 -0.49 48.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -1.135 . . . . 0.0 109.602 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -100.81 4.33 42.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.113 -0.992 . . . . 0.0 109.308 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.541 ' CG ' ' CB ' ' A' ' 150' ' ' ASP . 29.4 m-85 -124.65 58.41 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 108.74 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -110.18 -177.09 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.514 -0.741 . . . . 0.0 109.347 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 190' ' ' THR . 31.1 t -90.66 128.39 36.61 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -151.01 113.19 4.56 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.715 -1.594 . . . . 0.0 111.553 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.83 HG23 ' CG2' ' A' ' 191' ' ' THR . 5.8 t -113.71 122.33 67.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.0 m-30 -111.03 124.64 32.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 O-C-N 121.583 -0.698 . . . . 0.0 109.328 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.26 176.53 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.767 2.311 . . . . 0.0 112.193 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.96 -23.54 19.54 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 174.33 -162.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.6 -15.57 7.83 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 123.039 1.4 . . . . 0.0 108.549 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.3 t -55.82 -63.46 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.817 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.321 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.441 ' N ' HG12 ' A' ' 165' ' ' VAL . 12.0 mt-30 -78.56 -12.59 60.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.707 . . . . 0.0 111.375 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.676 ' O ' HD12 ' A' ' 171' ' ' LEU . 6.0 ttm -52.6 -44.89 66.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.685 -1.26 . . . . 0.0 109.915 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -75.63 -20.35 58.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 109.759 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.61 -52.78 4.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.006 . . . . 0.0 110.0 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.53 -42.0 63.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 167' ' ' MET . 0.8 OUTLIER -52.73 -31.02 35.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.334 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -74.41 -35.56 63.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 76.8 p -56.68 -46.11 81.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 109.781 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -70.21 -44.36 68.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -72.16 -15.85 61.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 109.876 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 0.9 OUTLIER -78.37 -57.75 3.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.26 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 136' ' ' TRP . 7.7 t80 -67.21 -37.26 83.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 187' ' ' GLY . 14.2 tp60 -62.21 -10.96 12.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -37.89 65.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.57 -37.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.028 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.608 ' C ' ' H ' ' A' ' 183' ' ' LYS . 4.2 mm? -67.58 -48.52 66.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.089 -1.007 . . . . 0.0 109.733 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t -56.04 1.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.965 -1.084 . . . . 0.0 109.213 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 181' ' ' LEU . 21.8 ttpt -78.1 -53.48 7.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 108.971 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.707 ' CE1' ' CE1' ' A' ' 186' ' ' PHE . 0.0 OUTLIER -75.64 7.2 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 18.8 t-20 73.29 64.07 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 109.8 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.707 ' CE1' ' CE1' ' A' ' 184' ' ' HIS . 21.4 m-85 -99.27 174.38 6.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.21 -0.931 . . . . 0.0 108.723 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -77.1 175.6 53.87 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.599 ' O ' ' OG1' ' A' ' 142' ' ' THR . 26.6 Cg_exo -58.95 -175.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.497 2.131 . . . . 0.0 111.617 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 189' ' ' ILE . 1.1 mm -89.41 112.23 24.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.058 -1.027 . . . . 0.0 109.675 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 142' ' ' THR . 2.3 t -78.33 -3.07 41.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 109.444 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.83 ' CG2' HG23 ' A' ' 159' ' ' VAL . 20.6 m -42.95 114.46 0.61 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.601 1.191 . . . . 0.0 108.101 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.664 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 4.1 t70 -76.14 116.94 17.32 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.962 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.81 100.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.851 . . . . 0.0 109.297 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.664 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -154.45 151.74 29.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 109.026 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.755 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -109.55 -175.7 2.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.71 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.06 34.06 48.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -106.95 118.79 37.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.451 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 5.4 p -57.04 159.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.54 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 13.5 t80 -113.7 126.6 55.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' PHE . 6.9 m-85 -127.86 103.12 7.09 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.17 -0.956 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -54.32 137.62 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 111.191 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -88.34 179.59 6.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.533 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 3.4 pt-20 -74.56 171.75 13.25 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.417 -0.802 . . . . 0.0 109.302 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.576 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.99 -47.45 85.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.036 -1.04 . . . . 0.0 108.478 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.533 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -50.08 -25.44 3.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 109.826 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.68 ' O ' HG21 ' A' ' 91' ' ' VAL . 14.5 m-70 -92.67 8.28 39.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.98 . . . . 0.0 109.839 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -127.91 -136.77 0.24 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.834 1.302 . . . . 0.0 110.177 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.613 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 1.4 mp0 -35.01 -4.64 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.196 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.825 ' N ' ' O ' ' A' ' 207' ' ' GLN . 87.6 t80 -41.96 -48.72 4.57 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.616 -1.302 . . . . 0.0 110.537 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 1.0 HD11 ' O ' ' A' ' 74' ' ' TRP . 2.9 mt -50.23 -12.53 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.512 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 209' ' ' TYR . 32.4 t -67.32 -40.36 85.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.219 -0.926 . . . . 0.0 108.921 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.69 -39.7 30.7 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.27 -0.894 . . . . 0.0 109.196 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -119.47 120.37 30.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 216' ' ' GLY . 58.3 Cg_endo -72.68 -50.48 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.074 1.849 . . . . 0.0 112.672 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 217' ' ' TYR . 5.7 p-10 -62.81 -3.52 1.61 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.048 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.499 ' CA ' HD23 ' A' ' 210' ' ' LEU . . . 61.31 -66.68 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 215' ' ' ASP . 38.2 p90 -177.98 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 108.325 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.506 ' N ' ' CD2' ' A' ' 217' ' ' TYR . 10.2 t -73.71 -124.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.039 -1.038 . . . . 0.0 108.676 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.712 ' C ' HD12 ' A' ' 220' ' ' LEU . . . 74.53 -164.8 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 219' ' ' GLY . 5.2 mp -151.33 -175.17 5.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -73.61 -110.78 0.07 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.687 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -135.81 -141.11 4.28 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 119.562 -1.304 . . . . 0.0 109.893 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 139' ' ' HIS . 50.5 p -38.2 -20.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -1.101 . . . . 0.0 109.177 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . 55.64 7.55 1.56 Allowed Glycine 0 N--CA 1.477 1.429 0 N-CA-C 107.221 -2.351 . . . . 0.0 107.221 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.616 ' H ' ' C ' ' A' ' 223' ' ' THR . 0.5 OUTLIER -49.51 158.92 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 121.325 0.583 . . . . 0.0 110.138 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.32 108.75 21.36 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.094 0.95 . . . . 0.0 109.047 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -73.74 -57.46 2.52 Favored Pre-proline 0 C--N 1.279 -2.476 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.282 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.533 ' HD3' ' SG ' ' A' ' 227' ' ' CYS . 41.5 Cg_endo -94.49 -33.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.881 2.388 . . . . 0.0 110.081 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.545 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.2 OUTLIER -55.66 154.57 6.61 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.852 0.834 . . . . 0.0 110.097 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.48 148.99 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.352 0.596 . . . . 0.0 109.862 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 231' ' ' ILE . 1.4 mm -131.12 108.84 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.175 -0.953 . . . . 0.0 109.273 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -68.51 150.02 48.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.86 . . . . 0.0 109.584 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.354 0 O-C-N 121.342 -0.849 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.456 H112 HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' H52' ' A' ' 21' ' ' MYR . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -111.46 41.35 1.9 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -1.121 . . . . 0.0 109.716 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.88 -18.45 0.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.095 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -49.37 -92.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 123.221 1.486 . . . . 0.0 110.832 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.579 ' OG ' HG21 ' A' ' 153' ' ' THR . 28.0 t -45.14 -11.1 0.01 OUTLIER 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.582 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.678 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -90.14 24.73 2.39 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 124.591 2.138 . . . . 0.0 107.803 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -158.41 21.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.256 -3.462 0 CA-C-N 112.902 -1.953 . . . . 0.0 106.397 -178.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.733 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.29 174.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.359 1.552 . . . . 0.0 109.65 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.409 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.8 124.7 25.39 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.112 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.9 86.8 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.24 0.543 . . . . 0.0 109.553 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.565 ' OE2' ' O ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.14 0.67 5.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 tt0 -99.41 -48.47 4.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 108.964 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -30.68 152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.547 0.689 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.652 ' O ' ' CG2' ' A' ' 98' ' ' THR . 4.2 mm? -79.32 169.64 19.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.597 ' C ' ' H ' ' A' ' 38' ' ' ARG . 34.5 Cg_exo -59.33 -42.15 52.05 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.093 1.862 . . . . 0.0 111.974 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 100' ' ' ASN . . . 60.56 -16.89 0.04 OUTLIER Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.028 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.629 ' C ' ' H ' ' A' ' 40' ' ' GLU . 38.8 ttt85 -30.53 154.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.188 -1.184 . . . . 0.0 110.144 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.426 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.3 OUTLIER -58.88 25.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.334 -0.854 . . . . 0.0 110.847 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.629 ' H ' ' C ' ' A' ' 38' ' ' ARG . 2.1 mm-40 -44.34 -52.34 17.11 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.87 -1.144 . . . . 0.0 109.352 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 40' ' ' GLU . 64.7 Cg_endo -79.68 -178.27 4.44 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.844 2.362 . . . . 0.0 112.53 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -136.19 166.6 26.8 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.626 ' O ' HG13 ' A' ' 44' ' ' VAL . 82.9 Cg_exo -44.19 -170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.799 2.333 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 43' ' ' PRO . 31.2 m -162.23 161.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.275 -0.891 . . . . 0.0 110.112 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER 25.55 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.693 -0.629 . . . . 0.0 111.195 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.619 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -87.47 -45.42 10.52 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.099 -1.0 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.5 98.99 10.42 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 115.737 -2.385 . . . . 0.0 108.155 179.332 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.677 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.9 t-80 -32.73 115.89 0.2 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.96 -40.88 90.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 0.0 110.501 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.663 HG22 ' OG ' ' A' ' 211' ' ' SER . 48.5 t -56.67 -49.69 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 109.867 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -99.59 -46.1 5.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.86 4.06 55.77 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.89 -118.7 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 ttt180 -125.36 171.56 10.33 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.097 1.427 . . . . 0.0 108.689 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.619 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.3 p -131.22 12.06 5.05 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.163 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.763 HG12 ' CZ ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -144.78 131.03 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.057 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' VAL . 17.4 mt-10 -34.63 156.51 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 CA-C-O 121.979 0.895 . . . . 0.0 110.818 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -81.44 165.36 74.9 Favored 'Cis proline' 0 C--N 1.3 -1.981 0 C-N-CA 121.466 -2.306 . . . . 0.0 111.992 -0.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 120' ' ' VAL . 28.6 m-85 -112.42 149.61 41.33 Favored Pre-proline 0 C--N 1.267 -3.004 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.765 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' GLU . 10.0 Cg_endo -54.47 140.27 74.46 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.732 2.288 . . . . 0.0 112.195 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 60' ' ' PRO . 4.4 mt-10 -43.47 157.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.23 47.77 42.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.538 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -133.32 135.63 44.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.736 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.538 ' OE1' ' C ' ' A' ' 63' ' ' THR . 3.8 mp0 -123.63 145.82 48.65 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 3.2 ttp -139.57 145.42 38.58 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 109.793 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.61 -170.61 2.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 160' ' ' TYR . 22.9 t -144.17 107.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 119.967 -1.708 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 1.085 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -162.63 162.8 27.24 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.763 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.21 148.15 19.24 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.287 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.701 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 0.8 OUTLIER -85.73 -84.55 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 0.0 108.358 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.715 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.94 75.85 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.715 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 48.3 t 111.13 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -52.58 5.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.574 -1.329 . . . . 0.0 110.797 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.648 ' H ' ' C ' ' A' ' 72' ' ' CYS . 32.6 m0 -89.14 -90.96 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.698 -1.251 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA2' HD13 ' A' ' 210' ' ' LEU . . . -57.18 -6.09 1.85 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.547 ' HB1' ' HG3' ' A' ' 70' ' ' MET . . . -76.48 -70.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -1.13 . . . . 0.0 110.953 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.592 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 13.8 tp10 -51.03 -14.71 0.24 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.682 ' O ' ' N ' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -64.0 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.168 . . . . 0.0 110.341 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' A' ' 78' ' ' ARG . 3.9 mmtt -30.62 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 111.349 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.682 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.3 m-85 -76.25 -42.16 46.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.801 -1.187 . . . . 0.0 111.734 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.538 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -85.56 2.29 45.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.486 -1.383 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -97.4 22.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.978 -1.076 . . . . 0.0 109.526 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.503 HD12 ' OH ' ' A' ' 121' ' ' TYR . 34.4 mt -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 108.993 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -92.91 142.94 26.76 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.364 0.602 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.488 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 101.75 -26.91 22.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -68.74 136.55 26.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.628 -0.925 . . . . 0.0 109.573 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.602 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.61 -44.33 17.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.532 ' HB3' HD21 ' A' ' 53' ' ' ASN . 1.1 p -170.8 -169.58 0.79 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 88' ' ' SER . 75.2 p -158.55 165.48 34.42 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.301 -0.875 . . . . 0.0 109.317 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.592 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.51 169.78 11.8 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.363 -0.836 . . . . 0.0 109.021 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' CG2' ' CD ' ' A' ' 207' ' ' GLN . 4.1 m -129.18 -173.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 170.47 160.7 19.53 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.502 ' CZ ' ' HB1' ' A' ' 202' ' ' ALA . 7.7 m-85 -97.51 154.21 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.956 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . . . -178.6 179.28 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.35 93.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -136.6 -151.31 6.01 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.0 61.28 1.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 0.0 109.344 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.652 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.47 176.89 12.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CE1' ' A' ' 200' ' ' TYR . 99.5 mtt180 -100.83 -77.49 0.54 Allowed 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 37' ' ' GLY . 19.2 m120 -117.28 70.77 6.04 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.377 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HG3' ' NE2' ' A' ' 113' ' ' HIS . 44.0 Cg_endo -71.87 170.53 18.58 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.746 2.297 . . . . 0.0 112.057 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.638 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.4 p -121.06 171.36 8.72 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.562 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -63.52 -59.33 4.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.56 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -58.42 -23.0 56.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 108.392 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.638 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.0 mm-40 -73.02 -56.45 5.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.397 0.618 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.763 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.3 m -65.47 -24.67 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.288 -0.883 . . . . 0.0 111.421 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 12.5 p -55.61 -23.44 27.53 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 110' ' ' LYS . 21.4 t -69.62 5.38 1.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.227 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 107' ' ' CYS . 1.9 tt0 59.61 -6.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.272 -0.893 . . . . 0.0 109.483 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' A' ' 108' ' ' SER . 18.0 mttt -72.52 -29.37 63.53 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 110.713 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.763 ' OG1' HG12 ' A' ' 106' ' ' VAL . 68.7 p -87.47 -6.59 58.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.878 -1.139 . . . . 0.0 110.541 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 35.31 43.84 0.53 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.439 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.5 ' ND1' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.1 163.17 26.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.393 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.444 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . . . -113.49 113.41 25.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 0.0 108.972 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.658 ' CD ' ' N ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -50.12 127.02 15.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.667 HG11 ' CE2' ' A' ' 160' ' ' TYR . 2.6 m -151.1 165.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.085 HG22 ' O ' ' A' ' 68' ' ' PHE . 2.5 m -143.96 149.4 17.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.195 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.766 ' CD ' ' CZ ' ' A' ' 199' ' ' PHE . 10.1 ptm180 -116.84 95.05 4.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.572 HG11 ' CG ' ' A' ' 80' ' ' PHE . 13.6 m -97.06 126.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.927 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.9 t -80.63 140.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.616 ' CG ' HD22 ' A' ' 131' ' ' LEU . 4.5 m-85 -132.05 161.0 34.27 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.079 -1.013 . . . . 0.0 109.224 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.638 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -125.07 109.72 27.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.506 -0.746 . . . . 0.0 110.384 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 124' ' ' GLU . 24.1 Cg_exo -44.43 -61.44 0.58 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.401 2.734 . . . . 0.0 114.493 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 123' ' ' PRO . 38.6 tt0 -25.98 -57.32 0.07 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.402 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.6 22.68 13.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.733 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -157.87 162.94 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.382 -0.824 . . . . 0.0 108.962 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.598 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -125.94 165.61 18.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.44 -1.412 . . . . 0.0 110.942 -179.096 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.567 ' CZ ' ' CD2' ' A' ' 132' ' ' LEU . 38.6 t80 -70.61 -43.8 68.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 108.988 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 5.0 mp0 -48.02 -14.6 0.05 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.891 -1.131 . . . . 0.0 108.086 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -73.67 -69.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.984 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -40.98 -38.7 1.02 Allowed 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.606 -1.308 . . . . 0.0 108.296 179.398 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.567 ' CD2' ' CZ ' ' A' ' 128' ' ' PHE . 4.2 mm? -75.42 -35.13 61.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.525 -0.734 . . . . 0.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 130' ' ' GLU . 0.5 OUTLIER -70.28 -57.68 4.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.964 -1.085 . . . . 0.0 111.256 -178.41 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.682 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.6 OUTLIER -50.42 -35.49 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.081 -1.012 . . . . 0.0 109.767 -178.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 50.7 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.526 -0.734 . . . . 0.0 110.485 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.817 ' O ' HG21 ' A' ' 223' ' ' THR . 90.5 m95 -72.8 -33.19 66.08 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.866 -1.146 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -79.43 -21.52 45.43 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.2 m-80 -121.28 53.69 1.15 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.102 -1.624 . . . . 0.0 113.443 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 223' ' ' THR . 0.2 OUTLIER 172.51 -175.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.186 0.993 . . . . 0.0 110.13 176.564 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 142' ' ' THR . 3.5 t70 -128.3 134.98 26.85 Favored Pre-proline 0 C--N 1.291 -1.959 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.429 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 190' ' ' THR . 72.0 Cg_endo -80.31 -11.15 13.36 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.353 2.035 . . . . 0.0 112.854 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.828 HG22 HG22 ' A' ' 189' ' ' ILE . 1.9 p -104.04 50.23 0.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 109.362 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 190' ' ' THR . 5.6 mm100 -114.64 83.63 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.621 ' CA ' HG21 ' A' ' 190' ' ' THR . . . -38.55 -117.53 0.0 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.922 0.734 . . . . 0.0 112.499 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.671 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 11.0 ptt? -92.87 53.5 2.02 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -1.02 . . . . 0.0 109.507 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' C ' ' O ' ' A' ' 155' ' ' TYR . 28.4 ptt-85 -178.56 154.71 0.79 Allowed 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.701 ' NE2' ' O ' ' A' ' 70' ' ' MET . 6.4 mt-30 -157.18 149.17 22.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.344 -1.473 . . . . 0.0 110.718 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.52 -124.62 3.21 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-O 122.986 1.326 . . . . 0.0 110.66 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -81.54 -35.32 30.43 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.049 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.654 ' OD2' ' SG ' ' A' ' 72' ' ' CYS . 0.0 OUTLIER -87.19 152.2 22.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.316 -1.49 . . . . 0.0 107.92 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.498 ' CB ' ' HB2' ' A' ' 146' ' ' ARG . 8.9 p90 -136.58 154.49 50.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.47 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.671 ' CA ' ' O ' ' A' ' 145' ' ' MET . . . 126.6 178.64 15.4 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 118.48 -1.819 . . . . 0.0 111.642 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.579 HG21 ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -66.76 0.86 2.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.638 -0.919 . . . . 0.0 110.584 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 14.8 pm0 -112.38 16.5 19.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.75 -1.219 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.692 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 28.2 m-85 -146.69 59.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.742 ' HD2' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -114.81 177.05 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 190' ' ' THR . 1.0 OUTLIER -90.44 124.36 34.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 119.867 -1.77 . . . . 0.0 106.455 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.742 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -142.68 111.48 6.35 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.084 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.3 m -113.41 123.98 69.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.253 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.667 ' CE2' HG11 ' A' ' 116' ' ' VAL . 2.4 m-30 -112.7 126.16 28.76 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.75 170.67 17.2 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.146 1.898 . . . . 0.0 112.228 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.541 ' HB ' HE22 ' A' ' 166' ' ' GLN . 0.7 OUTLIER -102.9 -22.19 13.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 120.923 -1.111 . . . . 0.0 110.22 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -176.92 174.59 1.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 108.972 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' ' SD ' ' A' ' 167' ' ' MET . . . -45.49 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 123.081 1.42 . . . . 0.0 108.181 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 163' ' ' SER . 4.9 t -58.06 -62.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.836 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.541 HE22 ' HB ' ' A' ' 162' ' ' THR . 4.6 mp0 -76.68 -12.9 60.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.492 -0.755 . . . . 0.0 110.123 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' A' ' 164' ' ' ALA . 32.3 mtt -53.99 -47.97 70.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 109.971 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.047 -1.033 . . . . 0.0 110.161 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.48 -58.82 2.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 0.0 109.866 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.79 -48.55 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.955 . . . . 0.0 109.852 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -53.06 -42.43 65.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.542 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -68.3 -45.04 74.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.163 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.619 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 8.7 p -56.32 -53.48 56.81 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -55.91 -58.2 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.461 ' N ' ' HD3' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -60.61 -11.4 7.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.539 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 180' ' ' VAL . 1.6 tt0 -75.18 -50.45 16.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 110.007 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 181' ' ' LEU . 1.1 m-85 -79.41 -31.16 42.67 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.062 -1.024 . . . . 0.0 109.797 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 188' ' ' PRO . 21.9 tp60 -63.08 -40.79 98.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -77.82 -26.36 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 176' ' ' GLU . 98.0 t -87.29 -54.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.021 -1.049 . . . . 0.0 110.058 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.511 ' CD2' ' CD2' ' A' ' 177' ' ' TYR . 4.4 mm? -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.4 t -56.22 -35.64 67.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -88.49 9.09 24.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.855 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.462 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 38.5 m-70 -108.41 29.32 7.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.057 -1.027 . . . . 0.0 109.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 5.1 t-20 71.92 16.26 5.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -104.53 174.92 5.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.172 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -125.62 -149.02 7.36 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 178' ' ' GLN . 27.6 Cg_exo -58.75 106.64 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.379 2.053 . . . . 0.0 110.709 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.828 HG22 HG22 ' A' ' 142' ' ' THR . 0.3 OUTLIER -48.08 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 110.409 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 79.4 p -119.95 47.38 1.75 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.396 0.617 . . . . 0.0 109.746 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.2 m -97.94 118.67 35.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.4 t70 -76.08 140.76 42.02 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.42 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.56 93.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.977 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -157.15 153.18 27.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.642 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -119.67 -173.41 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.02 20.76 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 198' ' ' VAL . 61.1 mm-40 -91.63 101.81 14.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.273 . . . . 0.0 109.531 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.611 HG21 ' CZ ' ' A' ' 200' ' ' TYR . 3.0 p -35.95 153.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.766 ' CZ ' ' CD ' ' A' ' 118' ' ' ARG . 68.9 t80 -111.13 131.25 55.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CE1' ' O ' ' A' ' 99' ' ' ARG . 42.1 m-85 -127.26 112.65 15.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 0.0 109.419 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.763 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 16.5 m-85 -53.74 142.69 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.075 . . . . 0.0 110.614 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.515 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -90.77 178.18 6.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.575 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 3.0 mt-10 -73.67 161.13 30.62 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.557 1.17 . . . . 0.0 110.364 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -49.72 73.57 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.531 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.575 ' OH ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -59.47 -3.75 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.087 -1.008 . . . . 0.0 110.777 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.562 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 14.6 m-70 -101.29 -20.91 15.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.823 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -101.2 -134.36 0.3 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.705 1.24 . . . . 0.0 110.504 -178.201 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.538 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 1.3 mp0 -34.88 -2.93 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.442 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.823 ' N ' ' O ' ' A' ' 207' ' ' GLN . 75.9 t80 -41.34 -46.38 3.27 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.191 -1.568 . . . . 0.0 109.952 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.619 ' CD1' ' C ' ' A' ' 74' ' ' TRP . 0.7 OUTLIER -71.34 -13.21 61.8 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.573 -1.329 . . . . 0.0 110.441 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.663 ' OG ' HG22 ' A' ' 50' ' ' VAL . 36.9 t -63.38 -38.68 92.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 108.985 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -72.78 -38.73 67.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.357 -0.84 . . . . 0.0 109.35 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.57 77.42 76.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.063 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.675 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 12.7 Cg_exo -66.73 5.08 0.84 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.99 2.46 . . . . 0.0 112.683 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.95 -19.99 64.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.11 84.46 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.829 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.534 ' CD2' ' O ' ' A' ' 217' ' ' TYR . 78.8 t80 -70.53 83.94 0.6 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 121.108 2.454 . . . . 0.0 109.268 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 43.1 t -168.84 -124.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.966 -1.084 . . . . 0.0 108.803 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.529 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 134.69 153.4 6.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.478 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 75.62 143.15 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -1.106 . . . . 0.0 110.06 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -134.27 -144.43 5.07 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -152.0 -144.3 3.89 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.864 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.3 OUTLIER 41.33 24.34 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.494 -1.004 . . . . 0.0 109.032 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -158.2 37.78 0.52 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.476 HG12 ' O ' ' A' ' 225' ' ' VAL . 11.8 t -103.81 98.63 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -1.173 . . . . 0.0 109.141 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.0 107.43 19.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.278 1.037 . . . . 0.0 109.433 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.529 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.43 -57.65 2.07 Favored Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.576 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.529 ' HD3' ' SG ' ' A' ' 227' ' ' CYS . 41.3 Cg_endo -95.2 -29.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.918 2.412 . . . . 0.0 110.636 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.612 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.5 OUTLIER -55.11 157.18 3.53 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.623 0.725 . . . . 0.0 109.957 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.612 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -18.44 136.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.551 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 233' ' ' LYS . 3.0 tp -153.86 121.46 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.31 -0.869 . . . . 0.0 109.139 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 231' ' ' ILE . 4.5 ttmm -33.75 -32.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.357 -0.84 . . . . 0.0 109.708 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 121.293 -0.879 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.502 ' H52' ' H ' ' A' ' 23' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.676 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.658 ' C ' ' NZ ' ' A' ' 27' ' ' LYS . 1.1 t0 -46.5 84.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -1.189 . . . . 0.0 109.415 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.704 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -50.68 -33.51 22.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.94 -93.89 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 123.403 1.573 . . . . 0.0 111.116 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 m -47.16 -18.38 0.09 Allowed 'General case' 0 C--N 1.257 -3.445 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.793 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.681 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -102.53 22.7 13.09 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 124.412 2.053 . . . . 0.0 109.86 -178.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.771 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -168.16 28.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.665 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -178.788 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.721 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.14 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 123.068 1.413 . . . . 0.0 110.029 -177.812 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -94.9 123.86 38.61 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.344 179.49 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -56.74 -57.87 10.57 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.156 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' OE1' ' O ' ' A' ' 32' ' ' GLU . 1.5 pp20? -53.05 -6.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.952 . . . . 0.0 109.915 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.0 tt0 -112.46 -35.99 5.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.813 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . . . -44.88 -179.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.285 -0.884 . . . . 0.0 109.552 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 mm? -55.24 169.54 0.45 Allowed Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.29 -49.33 3.67 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.791 2.327 . . . . 0.0 113.221 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.643 ' H ' ' N ' ' A' ' 99' ' ' ARG . . . 100.34 87.75 1.97 Allowed Glycine 0 N--CA 1.5 2.932 0 C-N-CA 118.928 -1.605 . . . . 0.0 111.191 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.666 ' NH2' ' OE2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -101.26 -179.27 3.99 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.421 -1.635 . . . . 0.0 109.233 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.2 p -124.16 32.63 5.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.652 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.666 ' OE2' ' NH2' ' A' ' 38' ' ' ARG . 9.1 tt0 -118.52 75.21 12.27 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.155 -0.966 . . . . 0.0 109.48 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.11 -178.45 4.59 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.87 2.38 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -131.8 103.01 14.64 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 42' ' ' ILE . 74.0 Cg_exo -46.27 -166.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.321 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.1 m -150.56 -179.16 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.768 HG23 ' O ' ' A' ' 45' ' ' THR . 9.6 t -34.19 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.773 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.646 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -55.86 -38.75 70.51 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.344 -0.847 . . . . 0.0 111.196 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttp -91.46 98.7 11.84 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 116.15 -2.22 . . . . 0.0 108.678 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.7 t-80 -31.73 110.95 0.08 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -59.82 -30.79 69.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 110.807 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 3.4 t -64.6 -43.4 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.934 -1.104 . . . . 0.0 109.524 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.86 -44.49 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.941 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 104.1 1.73 45.03 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.5 p30 -76.15 -112.05 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.607 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -130.68 175.25 9.17 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 123.806 1.765 . . . . 0.0 110.811 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 6.9 p -149.33 23.35 0.92 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 112.425 -2.17 . . . . 0.0 110.088 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.497 HG22 ' C ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -157.27 132.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 56' ' ' VAL . 12.7 mt-10 -41.48 156.03 0.22 Allowed Pre-proline 0 C--N 1.304 -1.397 0 CA-C-O 121.855 0.836 . . . . 0.0 110.199 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.24 157.12 62.87 Favored 'Cis proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.494 0.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.769 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 18.7 m-85 -104.15 147.91 35.08 Favored Pre-proline 0 C--N 1.279 -2.496 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 11.7 Cg_endo -57.47 134.21 61.94 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.843 2.362 . . . . 0.0 112.423 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -49.34 158.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 64' ' ' GLN . . . 93.91 -35.88 3.98 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -83.03 134.06 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.784 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.57 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 6.2 mp0 -114.98 -175.93 2.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 2.2 ttp -161.35 149.37 15.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.642 -1.286 . . . . 0.0 110.826 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.71 -174.37 2.67 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG12 ' CG1' ' A' ' 116' ' ' VAL . 1.4 t -146.23 106.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.686 -1.884 . . . . 0.0 109.96 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.704 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -140.82 156.39 46.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.963 -1.495 . . . . 0.0 110.359 177.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' CA ' ' OE2' ' A' ' 115' ' ' GLU . . . -132.15 154.18 20.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.738 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -122.81 -91.85 0.55 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.738 ' H ' ' CG ' ' A' ' 70' ' ' MET . . . -134.84 63.76 0.6 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.767 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 48.5 t 109.13 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.575 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -81.43 25.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.363 -1.46 . . . . 0.0 110.873 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.767 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 8.3 m0 -91.6 -72.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.567 -1.333 . . . . 0.0 109.573 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.26 -3.51 65.76 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 117' ' ' VAL . . . -77.09 -32.89 56.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.198 -1.178 . . . . 0.0 109.473 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.629 ' OE2' ' CA ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -83.69 -15.79 47.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.016 -1.052 . . . . 0.0 110.154 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.794 ' O ' HG13 ' A' ' 82' ' ' VAL . 28.0 ttt180 -79.46 -67.6 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 110.027 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.452 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 14.2 mttp -54.89 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.613 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.712 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 19.1 m-85 -120.72 -39.7 2.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.879 -1.138 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.632 ' CZ2' ' OG ' ' A' ' 211' ' ' SER . 0.9 OUTLIER -82.28 -3.98 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.764 -1.21 . . . . 0.0 110.03 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.3 m -83.94 17.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.034 -1.041 . . . . 0.0 109.334 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.71 154.53 22.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 137.26 32.51 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.55 -31.89 5.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.72 136.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.57 -0.959 . . . . 0.0 109.549 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.668 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -71.15 -39.91 71.64 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.915 0.864 . . . . 0.0 108.828 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.697 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 179.63 -160.57 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.608 ' HB ' HG12 ' A' ' 119' ' ' VAL . 63.6 p -157.51 151.16 24.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.033 -1.042 . . . . 0.0 109.801 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.697 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 5.1 mp0 -147.32 167.75 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.753 . . . . 0.0 109.028 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -142.96 168.65 13.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.026 -1.046 . . . . 0.0 109.878 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.414 ' HA2' ' N ' ' A' ' 202' ' ' ALA . . . 177.37 164.07 30.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -80.11 174.29 11.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -1.078 . . . . 0.0 109.192 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.728 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -175.2 177.04 1.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 50.9 22.13 5.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -134.64 -164.1 10.43 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.813 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 57.3 p-80 -173.75 105.34 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.398 -1.06 . . . . 0.0 108.904 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.607 ' O ' ' C ' ' A' ' 99' ' ' ARG . 1.6 m -137.72 148.0 45.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.643 ' N ' ' H ' ' A' ' 37' ' ' GLY . 19.6 tpt180 -33.21 -68.75 0.1 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 19.1 m120 -124.3 95.88 42.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.44 106.0 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.481 2.121 . . . . 0.0 113.224 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 22.0 p -122.08 170.81 9.48 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.94 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.483 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 2.1 t80 -63.45 -58.95 5.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.217 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.544 ' HZ3' ' HB3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -61.58 -22.86 65.57 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.113 -0.992 . . . . 0.0 108.816 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.653 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.1 mm-40 -66.28 -57.54 7.3 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.459 0.647 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 18.7 m -65.45 -24.78 35.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.844 . . . . 0.0 110.808 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.401 ' O ' ' OE1' ' A' ' 109' ' ' GLU . 24.0 t -64.56 -28.47 69.66 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.656 ' C ' ' H ' ' A' ' 110' ' ' LYS . 2.5 t -70.91 2.09 4.75 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.707 ' O ' HG21 ' A' ' 29' ' ' ILE . 4.8 mp0 58.54 -21.6 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.452 -0.78 . . . . 0.0 110.953 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.768 ' O ' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.75 2.25 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.472 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.522 HG22 ' OG1' ' A' ' 98' ' ' THR . 3.1 p -107.73 -29.41 9.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.091 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 62.13 49.06 78.64 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.728 ' ND1' ' N ' ' A' ' 94' ' ' ALA . 1.5 m-70 -97.24 173.5 7.19 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.783 -1.422 . . . . 0.0 109.784 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.37 116.63 18.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.533 ' C ' ' CD ' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -62.36 123.79 19.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.991 -1.068 . . . . 0.0 109.296 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -128.09 140.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.1 -1.0 . . . . 0.0 109.308 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.737 HG21 ' CB ' ' A' ' 76' ' ' ALA . 2.0 t -103.78 107.32 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.769 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -96.58 96.98 9.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.637 1.208 . . . . 0.0 110.386 -177.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.608 HG12 ' HB ' ' A' ' 89' ' ' THR . 20.4 m -112.12 128.03 68.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.903 -1.123 . . . . 0.0 108.675 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -80.29 169.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.879 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.967 ' CD2' HD21 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -156.56 156.27 33.34 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.806 -1.558 . . . . 0.0 111.599 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.67 110.62 35.2 Favored Pre-proline 0 C--N 1.291 -1.958 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.937 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.541 ' O ' ' C ' ' A' ' 124' ' ' GLU . 39.3 Cg_exo -45.32 -63.76 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.068 2.512 . . . . 0.0 113.23 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.2 tp10 -25.69 -43.7 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -127.82 3.76 6.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.707 -1.246 . . . . 0.0 109.898 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 126' ' ' ILE . 0.1 OUTLIER -155.15 104.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.05 0.929 . . . . 0.0 108.964 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.3 m -69.81 169.64 12.64 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.774 0.797 . . . . 0.0 111.871 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.702 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 36.9 t80 -69.39 -27.92 65.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 109.43 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 133' ' ' LYS . 2.5 mt-10 -62.69 -19.77 64.2 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.517 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.59 ' CG ' HD13 ' A' ' 126' ' ' ILE . 3.2 mm-40 -66.63 -72.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.042 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.009 ' H ' HD22 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -42.05 -40.05 2.13 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.702 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 8.3 mp -75.68 -34.89 60.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.77 . . . . 0.0 111.611 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -58.54 -68.91 0.21 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.504 -1.372 . . . . 0.0 110.085 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.618 HG12 ' CZ ' ' A' ' 80' ' ' PHE . 58.5 t -51.3 -22.19 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.253 -0.904 . . . . 0.0 109.208 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 34.7 t80 -73.41 -52.18 14.65 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 111.147 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 58.8 m95 -70.22 -38.72 75.32 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.069 -1.644 . . . . 0.0 111.569 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.48 -43.46 73.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.831 -1.168 . . . . 0.0 111.641 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.477 ' OD1' HG13 ' A' ' 134' ' ' VAL . 31.9 m120 -81.56 59.27 4.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 112.296 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.765 ' CE1' ' O ' ' A' ' 135' ' ' PHE . 46.8 m80 -153.76 -166.59 2.43 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.003 0.906 . . . . 0.0 109.293 176.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -132.87 171.61 8.86 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 140' ' ' ASP . 30.8 Cg_exo -33.5 -103.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.039 1.826 . . . . 0.0 113.334 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.943 HG23 ' O ' ' A' ' 142' ' ' THR . 1.5 t -128.45 57.14 1.6 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.041 -1.037 . . . . 0.0 111.428 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.737 ' OE1' ' N ' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -75.93 84.42 2.85 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.218 -1.551 . . . . 0.0 110.882 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.728 ' CA ' HG21 ' A' ' 190' ' ' THR . . . -39.39 -115.85 0.0 OUTLIER Glycine 0 N--CA 1.491 2.345 0 CA-C-O 122.097 0.832 . . . . 0.0 111.723 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.739 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.27 25.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.743 -0.857 . . . . 0.0 111.691 -176.873 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.536 ' NH2' ' OD1' ' A' ' 149' ' ' ASN . 10.6 ttt-85 -159.54 88.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 119.218 -2.176 . . . . 0.0 112.115 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.692 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -57.66 122.19 12.19 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.992 -1.692 . . . . 0.0 108.954 178.635 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.663 ' H ' ' HG3' ' A' ' 143' ' ' GLN . . . 43.14 -114.96 0.93 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 122.932 1.296 . . . . 0.0 110.197 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.536 ' OD1' ' NH2' ' A' ' 146' ' ' ARG . 3.0 t-20 -95.98 15.81 19.55 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.084 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 8.7 m-20 -101.7 93.39 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.903 -1.123 . . . . 0.0 108.457 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.45 ' HB3' ' HE ' ' A' ' 146' ' ' ARG . 4.8 p90 -75.47 121.83 22.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.381 -0.824 . . . . 0.0 110.875 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 167.13 140.34 2.88 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.119 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.544 HG21 ' HA ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.84 -4.02 47.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -1.197 . . . . 0.0 108.729 179.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.726 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -96.58 -13.2 23.1 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.352 -0.843 . . . . 0.0 110.486 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.611 ' O ' ' O ' ' A' ' 70' ' ' MET . 13.2 m-85 -100.16 -4.72 29.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.864 -1.148 . . . . 0.0 110.98 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.61 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -42.69 177.58 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.842 -1.161 . . . . 0.0 109.492 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.1 t -91.55 124.87 36.04 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -145.55 127.82 15.8 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 116.468 -2.093 . . . . 0.0 112.705 -176.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.551 HG23 ' CG2' ' A' ' 191' ' ' THR . 5.2 t -117.9 129.46 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.097 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -122.27 95.59 47.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.336 -0.852 . . . . 0.0 108.814 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.6 170.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.633 2.222 . . . . 0.0 112.044 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.56 -29.64 14.25 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 120.911 -1.118 . . . . 0.0 109.632 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 165' ' ' VAL . 2.0 m -179.52 -162.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.93 -15.55 9.18 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 123.021 1.391 . . . . 0.0 108.599 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.7 t -55.77 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.883 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.759 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 13.1 mt-30 -78.86 -19.13 52.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 ttp -52.44 -36.19 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.705 -1.247 . . . . 0.0 110.394 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -75.58 -32.55 60.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.795 -1.19 . . . . 0.0 110.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.58 -43.28 9.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.077 -1.014 . . . . 0.0 110.134 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.79 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.697 ' C ' HD12 ' A' ' 171' ' ' LEU . 1.3 pp -52.85 -33.52 50.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.004 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -74.6 -55.54 5.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.82 -39.02 73.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.373 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -65.07 -58.36 6.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 175' ' ' GLU . 0.9 OUTLIER -70.58 -24.19 62.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.933 . . . . 0.0 109.908 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 5.8 mm-40 -53.26 -30.87 40.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -0.91 . . . . 0.0 109.931 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.591 ' CD1' ' CD1' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.47 -45.36 19.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.907 -1.121 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.553 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.5 OUTLIER -54.26 -30.83 51.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -61.83 -44.27 97.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.319 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 181' ' ' LEU . 9.2 p -87.31 -42.2 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.387 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 177' ' ' TYR . 31.8 mt -65.24 -39.4 92.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.111 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.553 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 21.6 p -56.07 -26.56 49.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.987 -1.071 . . . . 0.0 109.401 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -88.3 -9.66 52.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.737 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -108.33 34.93 3.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.873 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 63.36 68.65 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.937 . . . . 0.0 109.799 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -148.08 174.55 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -126.22 -162.24 11.19 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.518 ' HA ' HE22 ' A' ' 178' ' ' GLN . 32.0 Cg_exo -58.07 105.56 0.21 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.993 1.795 . . . . 0.0 110.274 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -47.68 155.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.585 -178.129 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.728 HG21 ' CA ' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -88.57 44.73 1.23 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.338 0.589 . . . . 0.0 111.571 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.551 ' CG2' HG23 ' A' ' 159' ' ' VAL . 19.4 m -84.57 113.78 21.49 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.494 ' OD2' ' CZ ' ' A' ' 194' ' ' ARG . 9.1 t0 -75.54 114.98 14.72 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.986 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.76 97.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 121.925 0.869 . . . . 0.0 109.45 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.669 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -152.62 152.29 31.62 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.644 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 1.0 OUTLIER -111.74 -176.95 3.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 110.197 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.55 30.37 66.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.669 ' NE2' ' O ' ' A' ' 194' ' ' ARG . 1.8 mp0 -95.85 95.16 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.239 . . . . 0.0 109.882 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 197' ' ' GLN . 8.3 p -32.6 154.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 109.711 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.545 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 65.0 t80 -120.63 137.23 54.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.633 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.9 m-85 -139.54 112.84 8.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.167 -0.958 . . . . 0.0 109.787 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.582 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.3 m-85 -54.12 141.67 28.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 110.108 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -90.46 -174.64 4.2 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.03 165.05 25.82 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.749 -0.594 . . . . 0.0 109.704 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.454 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -57.95 -45.14 87.13 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.537 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -55.05 -13.53 1.19 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.697 ' O ' HG21 ' A' ' 91' ' ' VAL . 14.3 m-70 -100.99 5.38 43.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.83 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.3 mm-40 -124.57 -144.18 0.32 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.238 1.018 . . . . 0.0 110.143 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.719 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 11.7 mp0 -34.4 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.188 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.83 ' N ' ' O ' ' A' ' 207' ' ' GLN . 79.5 t80 -43.7 -45.58 7.09 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 120.495 -1.378 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -55.21 -17.3 4.18 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.648 -1.283 . . . . 0.0 110.068 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.632 ' OG ' ' CZ2' ' A' ' 81' ' ' TRP . 13.4 m -73.17 -26.51 61.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.109 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -87.75 -38.92 15.36 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.338 -0.851 . . . . 0.0 109.487 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.4 m-80 -123.42 79.66 53.92 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.63 8.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.954 2.436 . . . . 0.0 112.598 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 213' ' ' ASN . 1.5 t70 -63.44 -19.09 64.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.023 -1.048 . . . . 0.0 110.356 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.98 84.97 0.05 OUTLIER Glycine 0 N--CA 1.503 3.104 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.693 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -83.38 92.68 7.6 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.652 2.226 . . . . 0.0 109.297 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 49.1 t -168.74 -124.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 O-C-N 120.994 -1.066 . . . . 0.0 108.962 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 153.8 151.8 5.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 2.5 tp 75.47 162.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.734 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 157.16 81.59 0.04 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.42 140.83 3.66 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.2 p -75.64 -42.66 50.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.277 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 94.37 -4.13 69.77 Favored Glycine 0 C--N 1.305 -1.194 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.28 115.4 11.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.546 -0.973 . . . . 0.0 109.508 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.0 m -99.02 107.8 20.31 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.094 -1.004 . . . . 0.0 109.571 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.53 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.87 -56.41 2.13 Favored Pre-proline 0 C--N 1.276 -2.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.829 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.559 ' CD ' ' H ' ' A' ' 229' ' ' MET . 27.2 Cg_endo -95.7 -35.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.269 2.646 . . . . 0.0 110.307 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.569 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -54.27 156.13 3.38 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.057 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.569 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -24.74 135.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.423 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.544 ' O ' ' C ' ' A' ' 232' ' ' LYS . 1.0 OUTLIER -133.98 110.72 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.345 -0.847 . . . . 0.0 109.13 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 231' ' ' ILE . 10.1 tttt -34.57 99.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.805 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.333 0 O-C-N 121.344 -0.847 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.492 H122 HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' C ' ' O1 ' ' A' ' 21' ' ' MYR . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.1 m-20 -86.06 134.49 33.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -1.18 . . . . 0.0 109.364 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.79 -32.47 73.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 109.552 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' ILE . . . -75.65 -7.12 53.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 123.222 1.487 . . . . 0.0 109.078 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 23' ' ' ASP . 34.9 t -47.01 -29.84 2.3 Favored 'General case' 0 C--N 1.263 -3.178 0 CA-C-N 113.606 -1.633 . . . . 0.0 110.106 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' C ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -108.6 26.74 10.16 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 123.424 1.583 . . . . 0.0 109.069 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.738 ' O ' ' O ' ' A' ' 29' ' ' ILE . 41.9 t -156.95 24.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.556 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.738 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -35.3 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 123.198 1.475 . . . . 0.0 110.038 -178.049 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -74.63 124.25 26.34 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.966 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HB1' ' NE2' ' A' ' 97' ' ' HIS . . . -64.76 -40.06 94.65 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.83 -0.544 . . . . 0.0 109.692 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.654 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -80.65 12.77 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' ' C ' ' A' ' 34' ' ' ALA . 1.6 tt0 -116.67 -43.25 2.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 109.648 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -33.08 152.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.586 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -37.12 160.56 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.23 -39.02 82.23 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.061 1.84 . . . . 0.0 111.966 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.5 155.51 9.77 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.574 ' NH2' ' OE1' ' A' ' 40' ' ' GLU . 43.0 mmm-85 -120.72 154.72 35.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 109.595 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.6 m -124.37 32.13 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.574 ' OE1' ' NH2' ' A' ' 38' ' ' ARG . 2.5 mt-10 -103.25 142.84 25.4 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.37 166.79 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.283 1.988 . . . . 0.0 112.181 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.644 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.4 OUTLIER -138.99 41.96 0.52 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.693 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.69 ' O ' HG13 ' A' ' 44' ' ' VAL . 35.6 Cg_endo -66.97 164.09 31.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.747 2.298 . . . . 0.0 112.261 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 43' ' ' PRO . 7.0 m -161.2 172.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.227 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.71 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 109.681 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.27 -40.38 74.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 110.911 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.574 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.62 99.72 11.93 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.002 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.643 ' O ' ' N ' ' A' ' 52' ' ' GLY . 6.7 t-80 -31.16 104.19 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -53.97 -26.17 24.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.654 -0.654 . . . . 0.0 110.965 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 2.6 t -70.09 -48.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.84 -1.163 . . . . 0.0 109.448 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -103.56 -41.1 6.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.54 1.98 53.27 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 66.2 m-20 -75.41 -116.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.578 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -131.55 174.39 10.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.657 1.694 . . . . 0.0 110.217 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 16.0 p -145.56 18.98 1.51 Allowed 'General case' 0 C--N 1.264 -3.118 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -165.62 149.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.037 -1.04 . . . . 0.0 109.05 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.55 ' O ' ' O ' ' A' ' 56' ' ' VAL . 16.0 mt-10 -32.33 154.92 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.675 0 CA-C-O 121.885 0.85 . . . . 0.0 110.731 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 84.4 Cg_endo -79.3 165.51 80.62 Favored 'Cis proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.689 -2.213 . . . . 0.0 112.126 -0.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.526 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-30 -115.98 85.68 15.35 Favored Pre-proline 0 C--N 1.27 -2.871 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.16 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.96 170.18 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.974 2.45 . . . . 0.0 112.549 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -75.98 158.32 32.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.4 -38.42 3.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.03 135.04 50.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.602 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 14.9 mp0 -113.32 171.65 7.43 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.735 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -156.9 145.48 19.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.58 -1.325 . . . . 0.0 110.896 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -120.1 -169.36 1.78 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.61 HG12 ' O ' ' A' ' 67' ' ' VAL . 2.7 t -143.02 101.6 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.024 -1.672 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 2.4 p90 -148.38 149.37 31.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.922 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 158' ' ' ALA . . . 179.74 156.25 17.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.613 ' HE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 mtt -145.68 30.72 1.08 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.347 -1.09 . . . . 0.0 108.339 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.588 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -166.6 155.63 26.94 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.924 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.769 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -35.97 116.76 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -45.26 7.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.869 -178.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.769 ' N ' ' O ' ' A' ' 72' ' ' CYS . 24.9 m0 -82.34 -64.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.3 -1.5 . . . . 0.0 109.84 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.09 -26.82 74.38 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.024 -1.047 . . . . 0.0 111.335 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.761 ' CB ' HG21 ' A' ' 117' ' ' VAL . . . -76.94 -29.25 55.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.343 . . . . 0.0 111.526 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.557 ' HB2' HG11 ' A' ' 91' ' ' VAL . 28.2 tt0 -83.88 -13.86 52.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.277 -1.515 . . . . 0.0 110.757 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 80' ' ' PHE . 15.9 ttt180 -69.29 -81.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.132 -0.98 . . . . 0.0 111.137 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 25.2 mtmt -58.76 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.211 -0.931 . . . . 0.0 110.628 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.757 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.1 m-85 -97.9 -38.72 9.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.911 -1.118 . . . . 0.0 109.026 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.593 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.5 p90 -85.17 8.48 18.09 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 82' ' ' VAL . 1.2 m -99.36 18.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.97 167.68 9.62 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.28 162.72 14.5 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.536 -0.727 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.4 5.61 50.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 86' ' ' VAL . 0.9 OUTLIER -90.78 117.45 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -1.063 . . . . 0.0 109.436 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.578 ' OH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -68.45 -36.29 78.81 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.218 1.009 . . . . 0.0 108.753 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.538 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER 177.83 -164.03 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.293 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.663 ' C ' HE21 ' A' ' 90' ' ' GLN . 71.3 p -156.25 144.76 20.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.663 HE21 ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -141.86 166.34 24.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 117' ' ' VAL . 3.0 m -152.41 160.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -179.22 -174.54 45.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 1.6 m-85 -86.32 169.41 12.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.307 -1.114 . . . . 0.0 109.554 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 1.034 ' C ' ' HD1' ' A' ' 113' ' ' HIS . . . -179.58 149.09 0.36 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.005 -1.059 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 76.86 22.24 72.34 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.709 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -100.44 -165.04 28.45 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.69 ' CG ' ' O ' ' A' ' 97' ' ' HIS . 0.1 OUTLIER -140.85 72.02 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.571 -179.979 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.78 175.99 13.17 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.448 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.0 mmp_? -76.26 -78.28 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.422 -0.799 . . . . 0.0 109.047 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -116.18 66.43 3.1 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.88 149.95 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.307 2.004 . . . . 0.0 111.674 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.636 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 17.4 p -120.85 172.62 7.77 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.221 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.712 ' CG ' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -66.41 -59.23 3.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.069 -1.019 . . . . 0.0 109.958 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.712 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -57.93 -23.52 53.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.636 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.2 mm-40 -67.25 -64.95 0.75 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.601 0.715 . . . . 0.0 109.936 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG12 ' CB ' ' A' ' 111' ' ' THR . 34.4 m -71.39 -24.37 23.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.479 -0.763 . . . . 0.0 111.098 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.512 ' C ' ' O ' ' A' ' 106' ' ' VAL . 11.9 t -38.38 -22.9 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.67 ' N ' ' O ' ' A' ' 106' ' ' VAL . 80.2 p -77.8 -80.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.682 ' O ' ' N ' ' A' ' 111' ' ' THR . 0.0 OUTLIER 158.7 -39.62 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.507 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.642 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 1.6 ttmt -46.29 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.911 -0.493 . . . . 0.0 112.215 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.729 ' CB ' HG12 ' A' ' 106' ' ' VAL . 11.1 p -101.33 -19.68 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.449 -1.407 . . . . 0.0 109.193 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 67.16 21.63 72.04 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.075 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 1.034 ' HD1' ' C ' ' A' ' 94' ' ' ALA . 1.4 m-70 -80.15 172.46 13.74 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.258 -1.731 . . . . 0.0 108.174 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.44 112.92 13.69 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.079 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.684 ' OE1' ' CE2' ' A' ' 73' ' ' PHE . 20.8 mm-40 -51.04 112.1 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 94' ' ' ALA . 1.5 m -123.34 138.37 53.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 108.937 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.761 HG21 ' CB ' ' A' ' 76' ' ' ALA . 2.5 t -103.78 113.11 39.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.526 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -96.92 113.84 25.41 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 89' ' ' THR . 6.0 m -132.02 126.57 56.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -86.2 169.41 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.435 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.761 ' CD1' HD11 ' A' ' 131' ' ' LEU . 0.2 OUTLIER -157.4 156.62 32.56 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.651 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -106.66 99.28 24.24 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.918 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 Cg_exo -43.55 -63.91 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.032 2.488 . . . . 0.0 112.917 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.753 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 22.5 mp0 -49.91 -13.14 0.09 Allowed 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.586 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 123' ' ' PRO . 22.1 m-70 -110.86 -46.85 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 130' ' ' GLU . 5.3 tp -128.73 144.18 38.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -75.11 153.1 38.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.864 -1.148 . . . . 0.0 111.192 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 132' ' ' LEU . 41.4 t80 -63.9 -28.7 70.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -52.88 -32.13 43.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 6.5 mm-40 -62.39 -67.85 0.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.761 HD11 ' CD1' ' A' ' 121' ' ' TYR . 17.0 mt -34.05 -49.07 0.34 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.199 -0.938 . . . . 0.0 108.711 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.573 HD11 ' CE2' ' A' ' 128' ' ' PHE . 64.0 mt -76.61 -34.54 58.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 110.69 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' GLU . 31.7 ttmt -57.71 -68.37 0.25 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.885 -1.134 . . . . 0.0 110.449 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.752 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -49.28 -34.17 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 108.985 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.613 ' CZ ' ' HE2' ' A' ' 70' ' ' MET . 26.4 t80 -57.92 -52.67 64.53 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.014 -1.054 . . . . 0.0 111.072 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.58 ' O ' ' CG2' ' A' ' 223' ' ' THR . 85.6 m95 -74.8 -47.45 30.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.159 -1.588 . . . . 0.0 111.236 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.582 ' O ' ' O ' ' A' ' 222' ' ' GLY . 1.3 mm-40 -45.23 -48.83 12.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 111.334 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.752 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.5 p30 -98.51 38.22 1.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 112.554 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 223' ' ' THR . 20.6 m80 -155.44 -155.77 0.59 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.714 -1.241 . . . . 0.0 109.342 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 70' ' ' MET . 2.7 t0 -147.33 132.01 8.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 177' ' ' TYR . 68.9 Cg_endo -73.81 -13.81 24.26 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 121.931 1.754 . . . . 0.0 113.142 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.844 HG22 HG22 ' A' ' 189' ' ' ILE . 3.3 p -122.32 56.63 1.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.743 -1.223 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.662 ' OE1' ' NE2' ' A' ' 147' ' ' GLN . 1.3 pt20 -122.39 77.59 1.42 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.713 -1.242 . . . . 0.0 110.889 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -47.34 -117.64 0.0 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.653 ' O ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -85.19 47.02 1.35 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.338 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 150' ' ' ASP . 1.6 ttm180 -162.16 87.23 0.63 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.583 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.681 ' OE1' ' N ' ' A' ' 148' ' ' GLY . 2.1 tp-100 -84.09 119.94 25.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.181 -1.575 . . . . 0.0 109.381 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . 53.26 -113.45 2.97 Favored Glycine 0 C--N 1.293 -1.844 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.622 ' OD1' ' N ' ' A' ' 149' ' ' ASN . 1.8 p-10 -101.12 22.77 11.8 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 114.18 -1.01 . . . . 0.0 110.023 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -107.61 161.12 15.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.0 109.426 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.528 ' CD2' ' O ' ' A' ' 151' ' ' PHE . 35.0 p90 -136.79 127.07 26.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.1 149.43 5.05 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.956 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 1.2 p -56.06 -52.68 63.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.596 -0.943 . . . . 0.0 109.407 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.636 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 8.9 pm0 -56.55 -11.04 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.669 . . . . 0.0 110.857 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -101.63 49.64 0.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.804 -1.185 . . . . 0.0 109.348 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.672 ' NH1' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -116.54 165.06 13.68 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.635 ' N ' HE21 ' A' ' 143' ' ' GLN . 44.9 p -77.02 128.22 34.09 Favored 'General case' 0 CA--C 1.467 -2.237 0 CA-C-O 122.442 1.115 . . . . 0.0 108.25 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.493 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -137.31 129.49 29.38 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.282 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.625 ' CG1' ' CG2' ' A' ' 191' ' ' THR . 0.2 OUTLIER -139.41 108.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.011 177.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 160' ' ' TYR . 1.1 m-30 -107.08 134.32 19.93 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.56 168.96 17.49 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.364 2.043 . . . . 0.0 111.835 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -19.59 20.59 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.907 -1.12 . . . . 0.0 108.939 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER 179.57 -164.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.7 -15.6 20.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 123.005 1.383 . . . . 0.0 108.421 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.6 t -56.05 -64.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.541 HE22 ' HB2' ' A' ' 66' ' ' ALA . 23.6 mt-30 -79.6 -17.12 54.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.675 -0.641 . . . . 0.0 110.9 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.92 -44.09 66.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.847 -1.158 . . . . 0.0 110.04 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.23 -20.76 59.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.8 -54.3 3.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.76 -44.54 66.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 171' ' ' LEU . 52.4 mt -52.88 -39.65 62.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.642 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -74.52 -51.35 14.96 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 0.0 109.527 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.549 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.8 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.699 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.499 ' HZ3' HD11 ' A' ' 189' ' ' ILE . 6.8 tttp -73.05 -58.16 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.0 110.326 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.35 -27.86 61.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.916 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mm-40 -53.06 -31.32 40.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.961 -1.087 . . . . 0.0 110.129 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -80.22 -33.26 38.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 110.079 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 182' ' ' SER . 0.8 OUTLIER -52.8 -31.96 41.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.013 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.16 -20.39 52.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.804 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.74 -55.88 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.828 -1.17 . . . . 0.0 110.872 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . 7.3 mt -76.22 -19.88 57.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.052 -1.03 . . . . 0.0 110.737 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 2.2 t -55.01 -33.68 62.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.865 -1.147 . . . . 0.0 109.16 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -88.2 1.0 55.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -108.29 32.42 4.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.79 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 69.31 59.49 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 109.939 179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 181' ' ' LEU . 38.4 m-85 -133.81 168.98 17.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.002 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -128.76 -149.0 6.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.65 119.65 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.358 2.039 . . . . 0.0 110.99 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.844 HG22 HG22 ' A' ' 142' ' ' THR . 1.1 pt -57.55 179.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.317 1.056 . . . . 0.0 111.097 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.672 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 1.5 p -139.46 58.39 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.816 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.625 ' CG2' ' CG1' ' A' ' 159' ' ' VAL . 21.7 m -99.55 120.44 39.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.649 ' OD1' ' NE ' ' A' ' 194' ' ' ARG . 15.0 t0 -77.93 122.45 25.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.448 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.426 ' CD1' ' HD3' ' A' ' 174' ' ' LYS . 0.8 OUTLIER -131.45 100.64 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.649 ' NE ' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -151.39 178.38 9.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -129.93 166.28 20.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.13 49.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' A' ' 198' ' ' VAL . 0.4 OUTLIER -89.84 93.97 9.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.079 -1.248 . . . . 0.0 109.425 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 198' ' ' VAL . 7.4 p -41.11 122.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 109.597 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.489 ' CE1' ' HD3' ' A' ' 118' ' ' ARG . 25.4 t80 -77.79 150.39 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.299 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.448 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 6.8 m-85 -149.19 100.53 3.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -53.84 144.07 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -92.02 -170.83 2.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.359 -0.838 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.47 167.3 20.87 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-O 122.801 1.286 . . . . 0.0 110.309 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.612 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -53.8 -43.61 69.48 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.719 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.736 ' CD1' ' O ' ' A' ' 205' ' ' TYR . 0.2 OUTLIER -81.14 13.32 2.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.582 -1.324 . . . . 0.0 109.496 -178.233 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 21.0 m80 -102.71 6.41 39.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.747 -1.221 . . . . 0.0 109.706 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.837 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.4 mm-40 -127.61 -138.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.43 1.11 . . . . 0.0 109.772 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.593 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 18.8 mm-40 -34.15 -4.75 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.936 -1.484 . . . . 0.0 112.282 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.837 ' N ' ' O ' ' A' ' 207' ' ' GLN . 82.0 t80 -42.74 -46.32 5.09 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 120.398 -1.439 . . . . 0.0 109.896 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.649 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.6 OUTLIER -60.43 -17.14 42.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.57 -1.331 . . . . 0.0 110.109 -178.813 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 208' ' ' GLN . 36.6 p -70.53 -47.43 60.43 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 108.643 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -88.85 -7.77 55.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.352 -0.842 . . . . 0.0 110.121 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.66 ' CG ' ' CZ ' ' A' ' 209' ' ' TYR . 5.4 m-80 -129.19 77.15 78.15 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.0 110.102 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.57 10.82 0.92 Allowed 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.511 2.808 . . . . 0.0 112.46 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -61.75 -21.2 64.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.349 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.57 85.81 0.05 OUTLIER Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.46 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 216' ' ' GLY . 9.7 m-85 -47.21 -170.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 120.314 2.057 . . . . 0.0 109.67 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.43 78.32 4.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.914 -1.116 . . . . 0.0 109.745 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 220' ' ' LEU . . . -174.14 143.66 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.594 ' CD1' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 161.19 167.89 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 110.4 131.2 5.97 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.639 ' CA ' ' O ' ' A' ' 139' ' ' HIS . . . -173.43 140.52 5.62 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 139' ' ' HIS . 29.5 p 51.31 15.91 0.35 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.466 -1.02 . . . . 0.0 108.271 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.465 ' N ' ' C ' ' A' ' 222' ' ' GLY . . . -160.73 44.52 0.41 Allowed Glycine 0 C--N 1.303 -1.299 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.71 HG13 ' SG ' ' A' ' 227' ' ' CYS . 91.7 t -83.24 80.85 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.583 -0.951 . . . . 0.0 109.167 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.671 ' O ' ' SD ' ' A' ' 229' ' ' MET . 4.7 m -100.09 23.84 9.4 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.708 1.242 . . . . 0.0 110.223 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.71 ' SG ' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -70.92 -63.28 1.59 Allowed Pre-proline 0 C--N 1.26 -3.299 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.88 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.562 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 42.0 Cg_endo -68.02 -3.24 10.24 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.248 1.965 . . . . 0.0 109.707 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.672 ' O ' ' SD ' ' A' ' 229' ' ' MET . 0.0 OUTLIER -55.37 157.29 3.8 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.916 0.865 . . . . 0.0 110.332 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.86 145.39 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.727 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 231' ' ' ILE . 2.5 mm -127.97 107.16 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.198 -0.939 . . . . 0.0 109.553 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -112.96 97.27 6.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.39 0 O-C-N 121.178 -0.951 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.548 ' H52' ' H ' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 22' ' ' GLY . 2.8 t70 36.16 62.5 0.68 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -1.218 . . . . 0.0 109.367 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.76 -19.8 18.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.33 -0.856 . . . . 0.0 109.865 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.624 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -55.86 -94.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.224 1.488 . . . . 0.0 110.243 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.568 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -47.66 -3.29 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.409 -178.748 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.671 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -104.21 21.77 15.94 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 124.474 2.083 . . . . 0.0 108.468 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.802 HG13 ' O ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -152.71 34.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.256 -3.466 0 CA-C-N 112.725 -2.034 . . . . 0.0 107.208 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' VAL . 1.1 tp -38.6 132.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 122.057 0.932 . . . . 0.0 113.009 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.91 121.43 21.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 122.144 0.973 . . . . 0.0 110.203 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -51.7 -55.36 20.01 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.65 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -53.92 -8.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 2.5 mm-40 -110.61 -36.23 5.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.427 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.91 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 0.0 109.265 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.89 HD21 ' CG ' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -81.3 135.09 50.83 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.207 -0.933 . . . . 0.0 109.141 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -71.76 -26.38 19.31 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.821 2.347 . . . . 0.0 114.242 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.763 ' C ' HD22 ' A' ' 100' ' ' ASN . . . -179.19 158.43 22.48 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.647 HH21 ' C ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -49.56 151.73 1.56 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.031 0.92 . . . . 0.0 111.646 -178.927 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.647 ' C ' HH21 ' A' ' 38' ' ' ARG . 0.2 OUTLIER -124.63 -6.98 7.43 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -171.42 119.15 0.46 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.625 -0.672 . . . . 0.0 109.214 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HB3' ' NH1' ' A' ' 99' ' ' ARG . 74.1 Cg_endo -79.84 148.61 20.01 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.632 2.221 . . . . 0.0 112.777 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.44 87.71 13.23 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.315 -0.866 . . . . 0.0 109.617 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.34 -176.27 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.073 2.515 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 204' ' ' ASP . 15.8 m -147.95 -176.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.927 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.794 HG23 ' O ' ' A' ' 45' ' ' THR . 14.7 t -79.84 104.28 10.31 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.095 -1.003 . . . . 0.0 110.305 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.606 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.94 -29.77 63.42 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.305 -0.872 . . . . 0.0 111.496 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 5.5 pttt -88.52 100.04 12.77 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 115.93 -2.308 . . . . 0.0 108.113 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' A' ' 52' ' ' GLY . 7.2 t-80 -31.64 112.25 0.1 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.796 ' CD2' ' HZ2' ' A' ' 212' ' ' LYS . 13.9 t-80 -50.78 -37.46 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 110.625 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' HG3' ' A' ' 208' ' ' GLN . 18.0 t -72.15 -61.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -77.13 -36.08 55.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.567 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 83.61 0.11 89.79 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 40.5 p30 -78.72 -119.63 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.651 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 29.5 mtt180 -126.46 174.52 8.57 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 123.275 1.512 . . . . 0.0 109.59 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.692 ' C ' HG22 ' A' ' 56' ' ' VAL . 11.7 p -143.42 35.77 1.32 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.87 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.692 HG22 ' C ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -176.56 152.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 0.0 109.098 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -31.67 149.5 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.518 -0.739 . . . . 0.0 110.547 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' NH1' ' A' ' 54' ' ' ARG . 88.4 Cg_endo -79.3 165.94 79.62 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.013 -2.078 . . . . 0.0 112.158 0.065 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.59 129.56 24.25 Favored Pre-proline 0 C--N 1.27 -2.857 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 63' ' ' THR . 46.2 Cg_exo -49.65 148.39 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.083 1.855 . . . . 0.0 112.064 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 158.18 10.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.585 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.55 39.63 75.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -90.2 132.3 35.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -1.147 . . . . 0.0 110.649 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.772 ' NE2' ' CD1' ' A' ' 128' ' ' PHE . 36.7 tp60 -106.16 142.75 35.33 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -161.37 161.81 30.53 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.994 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.77 -167.11 1.77 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 74.5 t -141.78 127.85 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.158 -1.589 . . . . 0.0 108.607 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 1.046 ' O ' HG22 ' A' ' 117' ' ' VAL . 28.1 m-85 -114.87 135.16 54.5 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.835 -1.166 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.38 83.25 0.29 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.635 ' O ' ' O ' ' A' ' 155' ' ' TYR . 2.2 ptp -86.32 -80.99 0.22 Allowed 'General case' 0 C--N 1.282 -2.357 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.843 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 73' ' ' PHE . . . -139.36 -152.2 5.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.781 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -33.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.046 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.686 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -53.51 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 112.039 -177.488 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.781 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 10.9 m0 -70.3 -65.94 0.66 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.742 -1.224 . . . . 0.0 108.562 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.46 -12.07 82.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.68 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.26 -33.88 59.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 109.733 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.566 ' OE2' ' OE1' ' A' ' 208' ' ' GLN . 1.1 tt0 -83.36 -17.09 43.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.832 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -85.93 -52.04 5.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 110.227 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 9.4 mttp -47.91 -4.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.181 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 10.3 m-85 -104.5 -35.39 7.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.0 110.354 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.611 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -88.96 -0.62 57.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.747 -1.22 . . . . 0.0 110.426 -178.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.3 m -88.32 5.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.003 -1.061 . . . . 0.0 110.145 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -116.95 179.33 4.05 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 109.664 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 137.46 37.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.929 -1.107 . . . . 0.0 111.529 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 123' ' ' PRO . . . 124.26 -50.1 0.87 Allowed Glycine 0 C--O 1.202 -1.859 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.763 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.562 HG23 ' CZ ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -53.91 136.85 15.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.715 -1.462 . . . . 0.0 111.582 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.718 ' CD1' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -75.13 -40.76 59.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.694 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 2.0 p -171.92 -174.84 1.38 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 88' ' ' SER . 62.6 p -160.15 128.79 4.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.068 -1.02 . . . . 0.0 109.534 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.694 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 3.0 mp0 -138.46 172.03 13.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.009 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.785 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -132.59 168.19 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -179.45 168.26 38.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -80.0 153.09 29.09 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.351 -1.088 . . . . 0.0 109.138 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.797 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -166.55 175.47 8.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.496 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 53.86 22.4 19.12 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.496 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -102.08 -151.43 23.99 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.516 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 3.7 m-70 -109.81 -41.15 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 109.768 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -154.94 172.83 17.42 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 38' ' ' ARG . 0.3 OUTLIER -81.84 78.3 8.57 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.763 HD22 ' C ' ' A' ' 37' ' ' GLY . 3.2 m120 -115.13 -130.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.324 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.644 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.3 Cg_exo -45.39 -156.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 123.672 2.347 . . . . 0.0 115.092 -175.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.767 ' O ' HG13 ' A' ' 106' ' ' VAL . 29.6 p -126.53 170.66 11.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.231 -0.918 . . . . 0.0 112.046 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.668 ' CD1' ' OE2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -50.21 -43.46 52.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.346 0.594 . . . . 0.0 110.016 179.134 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.562 ' CD ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.05 -34.89 64.22 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.821 -1.174 . . . . 0.0 109.487 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 107' ' ' CYS . 1.7 mm-40 -83.56 -43.7 15.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.81 . . . . 0.0 110.749 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 1.091 HG12 HG21 ' A' ' 111' ' ' THR . 34.5 m -46.33 -21.66 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 120.881 -1.137 . . . . 0.0 109.439 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.487 ' C ' ' O ' ' A' ' 106' ' ' VAL . 10.2 t -36.84 -20.67 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.631 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -79.82 3.91 18.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.062 -1.024 . . . . 0.0 108.865 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.1 mt-10 64.76 3.8 2.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.89 ' CG ' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -72.93 -9.94 59.25 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.025 -1.672 . . . . 0.0 110.467 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . 1.091 HG21 HG12 ' A' ' 106' ' ' VAL . 1.7 p -105.01 -8.34 18.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.653 -1.279 . . . . 0.0 109.705 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 44.36 30.72 2.09 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 7.1 m-70 -81.68 170.01 16.3 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.908 -1.348 . . . . 0.0 109.386 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -129.03 114.33 16.27 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.668 ' OE2' ' CD1' ' A' ' 103' ' ' TYR . 1.6 mm-40 -40.19 120.94 1.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 108.934 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -140.55 162.77 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 110.262 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.046 HG22 ' O ' ' A' ' 68' ' ' PHE . 35.4 m -130.63 127.4 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.484 -0.76 . . . . 0.0 109.216 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -98.38 124.85 43.27 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 119' ' ' VAL . 4.2 m -133.85 125.88 49.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.018 -1.051 . . . . 0.0 108.723 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.718 HG22 ' CD1' ' A' ' 87' ' ' TYR . 1.8 m -96.39 146.55 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.717 -1.239 . . . . 0.0 107.971 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.858 ' CD2' HD22 ' A' ' 131' ' ' LEU . 2.9 m-30 -129.99 147.5 51.74 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.054 0.93 . . . . 0.0 108.661 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.985 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -179.31 27.21 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.985 ' HD3' ' N ' ' A' ' 122' ' ' ARG . 37.9 Cg_exo -73.79 -13.46 24.35 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 N-CA-C 119.436 2.821 . . . . 0.0 119.436 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.87 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.849 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -123.76 2.1 8.81 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.625 HD13 ' CG ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -153.85 132.93 3.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.547 -0.721 . . . . 0.0 109.834 -178.937 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.609 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -103.0 -177.89 3.5 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.04 0.924 . . . . 0.0 112.775 -177.546 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.912 ' HA ' HD21 ' A' ' 131' ' ' LEU . 35.7 t80 -69.82 -40.56 75.82 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.191 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.89 -14.49 47.03 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.805 -1.184 . . . . 0.0 108.809 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.625 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -74.58 -55.94 5.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 111.377 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.963 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.2 OUTLIER -59.99 -34.46 73.36 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 120.597 -1.314 . . . . 0.0 107.862 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 132' ' ' LEU . 1.5 mm? -66.12 -32.49 73.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -70.51 -62.53 1.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.38 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.716 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 25.5 t -49.37 -27.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.16 -0.963 . . . . 0.0 108.979 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.488 ' CE2' HG11 ' A' ' 159' ' ' VAL . 6.7 t80 -71.73 -50.74 27.39 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.794 -1.191 . . . . 0.0 109.889 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.947 ' O ' HG21 ' A' ' 223' ' ' THR . 55.1 m95 -72.4 -37.9 68.57 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.616 -1.303 . . . . 0.0 110.299 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -20.8 64.65 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.9 OUTLIER -131.56 59.48 1.69 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.161 -1.587 . . . . 0.0 111.768 -178.191 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.65 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 170.26 136.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.375 -0.828 . . . . 0.0 109.256 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.28 135.4 72.9 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.451 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 73.8 Cg_endo -75.58 -8.66 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.576 2.184 . . . . 0.0 112.558 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -118.04 56.0 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.228 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 144' ' ' GLY . 6.0 mm100 -118.73 62.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 108.739 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -45.27 -119.29 0.0 OUTLIER Glycine 0 N--CA 1.492 2.422 0 CA-C-O 121.81 0.672 . . . . 0.0 112.414 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.666 ' O ' ' SD ' ' A' ' 145' ' ' MET . 1.5 tmt? -69.84 35.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.507 -0.996 . . . . 0.0 110.648 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 144' ' ' GLY . 4.1 ttm180 -166.32 152.73 9.04 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.023 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.507 HE21 ' HG3' ' A' ' 143' ' ' GLN . 1.2 mm-40 -146.92 100.7 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.439 -1.413 . . . . 0.0 108.39 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 52.03 -119.6 9.23 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.499 ' H ' HD22 ' A' ' 220' ' ' LEU . 1.6 t-20 -81.72 8.86 8.95 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.744 -1.228 . . . . 0.0 110.13 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.36 147.85 29.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.99 -1.069 . . . . 0.0 109.409 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.1 p90 -136.67 129.63 30.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.144 -0.973 . . . . 0.0 110.088 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.5 158.59 7.75 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.415 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.12 -4.6 48.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -1.146 . . . . 0.0 109.65 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.584 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 15.3 pm0 -88.38 3.06 51.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.029 -1.044 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.635 ' O ' ' O ' ' A' ' 70' ' ' MET . 93.2 m-85 -114.9 -12.56 12.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 111.053 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -39.62 172.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.571 -1.331 . . . . 0.0 110.195 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.707 ' OG ' HG23 ' A' ' 190' ' ' THR . 31.5 p -89.11 132.82 34.63 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.456 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -147.64 123.08 10.36 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 117.68 -1.608 . . . . 0.0 111.58 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.677 HG13 ' CG2' ' A' ' 191' ' ' THR . 2.8 m -119.85 130.55 74.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.766 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.483 ' CE2' HG11 ' A' ' 116' ' ' VAL . 10.1 m-30 -112.85 131.66 22.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.105 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.35 169.38 20.17 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.86 2.373 . . . . 0.0 112.624 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.4 OUTLIER -103.14 -6.64 22.0 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.039 -1.038 . . . . 0.0 109.498 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.622 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 166.44 173.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 108.813 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -47.07 -14.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.989 1.376 . . . . 0.0 108.231 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.622 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.3 t -55.54 -61.3 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 170' ' ' ALA . 1.2 mp0 -60.88 -11.62 8.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.557 -0.714 . . . . 0.0 110.378 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttt -51.87 -43.61 63.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 109.919 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.673 ' O ' ' NH1' ' A' ' 172' ' ' ARG . 2.6 tm-20 -75.66 -22.68 56.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -93.06 -56.32 3.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.421 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.96 -58.97 4.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 109.683 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 171' ' ' LEU . 63.2 mt -52.24 -35.68 50.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.08 -1.013 . . . . 0.0 109.244 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.673 ' NH1' ' O ' ' A' ' 168' ' ' GLU . 13.4 ttp-105 -74.52 -55.92 5.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.524 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -56.54 -37.08 70.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.481 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -68.09 -53.15 27.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -73.0 2.21 7.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.66 -56.52 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -27.37 65.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 109.941 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.679 ' NE2' ' OG ' ' A' ' 182' ' ' SER . 0.5 OUTLIER -53.24 -53.85 44.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.171 -0.955 . . . . 0.0 109.666 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -15.55 63.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.89 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.7 t -87.22 -54.2 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 183' ' ' LYS . 35.2 mt -75.26 -45.93 36.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.164 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.679 ' OG ' ' NE2' ' A' ' 178' ' ' GLN . 61.1 m -56.23 -3.05 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 0.0 109.685 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -88.02 -21.29 24.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.306 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.459 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 14.1 m-70 -107.99 14.4 25.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 8.2 t-20 71.92 68.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.21 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.42 173.55 52.99 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.64 174.27 11.99 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.825 2.35 . . . . 0.0 112.245 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 189' ' ' ILE . 0.8 OUTLIER -80.99 116.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.006 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.707 HG23 ' OG ' ' A' ' 157' ' ' SER . 5.2 t -100.37 -5.21 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.002 -1.061 . . . . 0.0 109.544 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.677 ' CG2' HG13 ' A' ' 159' ' ' VAL . 47.0 m -43.6 112.65 0.41 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 7.2 t0 -77.17 132.93 39.03 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.924 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 194' ' ' ARG . 0.8 OUTLIER -133.41 125.66 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.418 -0.801 . . . . 0.0 108.909 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 69.7 mtm-85 -157.11 152.19 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 109.307 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.8 OUTLIER -115.36 -174.51 2.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.53 56.48 8.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -116.25 148.04 40.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -1.213 . . . . 0.0 109.573 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 200' ' ' TYR . 1.3 p -87.7 165.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 55.2 t80 -125.56 132.3 52.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 109.964 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.772 ' CZ ' HG11 ' A' ' 198' ' ' VAL . 35.0 m-85 -128.32 104.39 7.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.822 . . . . 0.0 109.109 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.8 m-85 -54.98 141.48 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 110.572 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.555 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -85.0 -169.3 2.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.574 ' HG3' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -76.0 153.26 36.63 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -56.54 -37.89 71.12 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.083 -1.01 . . . . 0.0 108.318 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.563 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -60.85 -14.55 22.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.635 -0.665 . . . . 0.0 110.635 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.494 ' O ' HG21 ' A' ' 91' ' ' VAL . 20.2 m-70 -99.02 -4.05 33.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.856 -1.152 . . . . 0.0 110.118 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.855 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.1 mt-30 -110.41 -133.07 0.33 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 122.752 1.263 . . . . 0.0 110.568 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -33.63 -5.06 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.887 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.855 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.2 t80 -42.56 -44.43 4.15 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.673 -1.267 . . . . 0.0 109.936 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.625 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -59.23 -17.23 26.34 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.439 -1.413 . . . . 0.0 110.016 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.466 ' OG ' ' ND1' ' A' ' 49' ' ' HIS . 71.1 p -73.26 -31.31 64.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.796 ' HZ2' ' CD2' ' A' ' 49' ' ' HIS . 10.9 mmtm -87.72 -33.91 18.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.866 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.689 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 26.2 m120 -121.71 82.42 41.52 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.46 9.88 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.206 2.604 . . . . 0.0 112.164 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -63.52 -11.92 28.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.13 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.31 85.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.766 -1.206 . . . . 0.0 111.449 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.601 ' O ' ' O ' ' A' ' 216' ' ' GLY . 33.1 t80 -52.31 -158.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.6 2.2 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.581 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 18.1 m -90.3 78.08 6.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.852 -1.155 . . . . 0.0 109.378 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.89 ' O ' HD12 ' A' ' 220' ' ' LEU . . . -88.62 -169.27 44.74 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -152.41 178.96 8.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -1.223 . . . . 0.0 109.673 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -153.98 -162.33 11.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -170.85 -136.53 2.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.947 HG21 ' O ' ' A' ' 136' ' ' TRP . 47.4 p 46.01 21.24 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -1.093 . . . . 0.0 109.436 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -168.12 43.0 0.23 Allowed Glycine 0 C--N 1.3 -1.433 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 225' ' ' VAL . 2.6 p -111.16 81.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -1.158 . . . . 0.0 109.495 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.57 107.59 19.78 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.163 -0.961 . . . . 0.0 109.27 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.18 -57.49 2.25 Favored Pre-proline 0 C--N 1.28 -2.448 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 227' ' ' CYS . 40.0 Cg_endo -95.32 -30.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.866 2.377 . . . . 0.0 110.445 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.552 ' O ' ' C ' ' A' ' 230' ' ' ALA . 4.0 mmm -55.28 155.52 4.95 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.916 0.865 . . . . 0.0 110.216 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.23 142.56 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.307 0.575 . . . . 0.0 109.989 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.562 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -150.11 118.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.3 -0.875 . . . . 0.0 109.228 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -94.73 154.58 17.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.152 -0.967 . . . . 0.0 109.564 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.252 -0.905 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.507 H121 HH22 ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 57.3 151.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -1.181 . . . . 0.0 109.431 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 28' ' ' VAL . 15.5 t -50.37 -18.42 0.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.495 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.55 -93.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.351 1.548 . . . . 0.0 110.94 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 28' ' ' VAL . 6.3 m -46.59 -30.53 2.33 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.638 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.639 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -80.91 22.67 0.6 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 124.221 1.962 . . . . 0.0 109.003 -179.16 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 26' ' ' SER . 29.0 t -148.76 46.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.26 -3.315 0 CA-C-N 112.626 -2.079 . . . . 0.0 106.285 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.18 132.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 122.315 1.055 . . . . 0.0 113.77 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.87 125.55 29.3 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.282 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.961 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -50.41 -27.21 6.0 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.15 3.37 31.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.29 4.55 13.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.617 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.32 178.96 8.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.411 HD13 ' HD3' ' A' ' 36' ' ' PRO . 3.7 mm? -54.07 169.3 0.37 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' HD13 ' A' ' 35' ' ' LEU . 23.9 Cg_exo -63.01 -44.45 15.73 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.123 1.882 . . . . 0.0 112.361 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.3 155.35 7.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.78 145.57 34.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -1.113 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 33.85 5.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.651 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -132.07 94.79 23.22 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.017 . . . . 0.0 109.871 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -53.52 179.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.796 2.331 . . . . 0.0 112.087 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.08 138.5 21.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.157 -0.964 . . . . 0.0 109.706 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 168.37 23.3 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.737 2.291 . . . . 0.0 112.217 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -148.67 -166.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.005 . . . . 0.0 109.586 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.863 HG23 ' O ' ' A' ' 45' ' ' THR . 13.5 t -93.46 94.0 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.02 -45.41 79.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.282 -0.886 . . . . 0.0 111.016 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -83.43 99.94 10.4 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 115.775 -2.37 . . . . 0.0 108.597 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.661 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 15.1 t-80 -30.97 137.01 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.28 -7.47 56.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.267 -0.896 . . . . 0.0 111.139 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 55.1 t -95.51 -55.31 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.828 -1.17 . . . . 0.0 109.967 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -89.98 -43.95 10.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.97 5.37 53.51 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.695 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.37 -117.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.695 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.8 ttp180 -129.2 170.35 13.68 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 123.223 1.487 . . . . 0.0 108.84 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.571 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.6 p -133.56 32.39 3.61 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.544 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.569 HG22 ' C ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -164.71 133.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.214 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.8 pm0 -33.08 148.87 0.06 OUTLIER Pre-proline 0 C--N 1.305 -1.348 0 O-C-N 121.436 -0.79 . . . . 0.0 110.574 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 92.3 Cg_endo -78.03 166.4 80.9 Favored 'Cis proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.866 -2.139 . . . . 0.0 111.545 -0.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.522 ' CE1' HG11 ' A' ' 120' ' ' VAL . 28.6 m-85 -106.32 156.47 36.88 Favored Pre-proline 0 C--N 1.268 -2.973 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.86 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.591 ' CG ' ' CD2' ' A' ' 87' ' ' TYR . 47.8 Cg_exo -49.62 129.28 23.15 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.24 1.96 . . . . 0.0 112.147 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.687 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 1.9 pm0 -43.35 144.31 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.85 . . . . 0.0 109.134 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.34 1.11 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 137.13 28.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -1.06 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.9 tt0 -106.51 136.37 46.41 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.731 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.85 127.9 27.75 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.85 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 -168.79 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 67' ' ' VAL . 43.9 t -143.57 98.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 119.9 -1.75 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -137.52 164.35 28.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.545 178.135 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.58 162.64 33.56 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.971 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.596 ' O ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -115.71 -86.01 0.61 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -132.42 -151.41 6.74 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.784 ' SG ' ' CZ3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -28.58 114.4 0.08 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.521 -0.988 . . . . 0.0 108.992 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -53.0 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.769 -0.582 . . . . 0.0 111.75 -178.316 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.784 ' CZ3' ' SG ' ' A' ' 72' ' ' CYS . 16.1 m0 -84.59 -63.34 1.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.487 -1.383 . . . . 0.0 109.646 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.24 74.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.745 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.04 -38.17 57.48 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.247 -1.149 . . . . 0.0 109.76 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.418 ' OE2' ' CA ' ' A' ' 90' ' ' GLN . 3.6 tt0 -84.5 -14.82 48.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.907 -1.121 . . . . 0.0 110.554 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.71 ' O ' HG13 ' A' ' 82' ' ' VAL . 13.1 ttp180 -76.25 -74.2 0.24 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.025 -1.047 . . . . 0.0 110.556 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.484 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -48.39 -2.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.955 -1.09 . . . . 0.0 110.26 -179.275 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.8 m-85 -108.64 -24.18 11.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.756 ' CH2' HD12 ' A' ' 210' ' ' LEU . 0.1 OUTLIER -104.63 -2.89 24.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.719 -1.238 . . . . 0.0 111.122 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.1 m -97.76 11.54 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.686 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -112.0 178.7 4.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.117 -0.989 . . . . 0.0 109.325 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -98.83 137.53 37.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.0 111.536 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.511 ' HA3' HD12 ' A' ' 126' ' ' ILE . . . 124.28 -33.25 3.88 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -78.61 135.86 25.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.448 -1.031 . . . . 0.0 111.049 -178.783 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.655 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -75.81 -40.24 55.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.71 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.532 ' HB3' HD21 ' A' ' 53' ' ' ASN . 0.9 OUTLIER -174.43 -173.62 0.78 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.593 HG21 ' HB3' ' A' ' 81' ' ' TRP . 39.7 p -144.12 163.01 34.83 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.521 ' OE1' ' OG ' ' A' ' 88' ' ' SER . 1.3 mp0 -154.89 140.03 17.49 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.092 HG12 HG22 ' A' ' 117' ' ' VAL . 3.2 m -127.21 162.79 31.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.951 -1.093 . . . . 0.0 109.521 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.94 177.69 48.13 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.522 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -102.64 168.46 9.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 110.046 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.707 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.19 -170.37 0.17 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 51.25 40.78 45.85 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.738 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -106.05 -158.02 22.15 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.961 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -149.68 58.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.986 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -178.86 7.66 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.02 -1.05 . . . . 0.0 108.335 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 9.3 mmt180 -52.76 -93.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.387 -0.821 . . . . 0.0 108.79 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -123.06 71.99 44.57 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.911 . . . . 0.0 109.286 179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 52.0 Cg_exo -48.85 131.9 25.71 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.495 2.13 . . . . 0.0 111.633 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.64 HG22 ' HG3' ' A' ' 105' ' ' GLU . 1.8 t -121.25 171.3 8.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' ' CB ' ' A' ' 107' ' ' CYS . 40.8 t80 -49.23 -43.71 42.9 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -42.46 92.0 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.599 -0.688 . . . . 0.0 109.399 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.64 ' HG3' HG22 ' A' ' 102' ' ' THR . 2.0 mm-40 -74.77 -54.61 7.03 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.812 -1.18 . . . . 0.0 110.933 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.993 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.0 m -73.09 -25.17 21.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.028 -1.045 . . . . 0.0 111.354 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -38.78 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.69 ' N ' ' O ' ' A' ' 106' ' ' VAL . 84.2 p -76.94 -81.1 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 108' ' ' SER . 0.0 OUTLIER 156.85 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' N ' ' HG2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -53.55 2.79 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 -177.077 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.993 ' OG1' HG12 ' A' ' 106' ' ' VAL . 32.2 p -96.53 -6.14 37.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.25 -1.531 . . . . 0.0 108.961 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 52.92 25.54 23.84 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.829 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.738 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -69.77 159.64 33.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.281 -1.717 . . . . 0.0 109.168 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.642 ' O ' HG13 ' A' ' 116' ' ' VAL . . . -112.38 112.45 24.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.335 -0.853 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.667 ' OE1' ' N ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -48.84 109.0 0.21 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.415 -0.803 . . . . 0.0 108.986 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 114' ' ' ALA . 16.0 m -124.71 137.4 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 91' ' ' VAL . 1.5 t -113.79 123.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.506 HH21 HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -97.82 116.18 29.52 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.313 -0.867 . . . . 0.0 109.342 -179.007 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.8 140.81 47.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.451 -0.781 . . . . 0.0 108.909 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.648 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m -107.26 158.77 7.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.322 -0.862 . . . . 0.0 108.808 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.926 ' CG ' HD22 ' A' ' 131' ' ' LEU . 4.4 m-85 -141.91 155.84 45.5 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.826 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -101.04 106.13 42.79 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.405 -0.81 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 55.3 Cg_exo -47.75 -26.46 6.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.685 2.256 . . . . 0.0 112.5 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.15 -18.6 52.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -121.06 -7.62 9.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.647 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.511 HD12 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -154.1 156.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 110.488 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -108.17 147.68 30.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.715 . . . . 0.0 109.73 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.723 ' CZ ' HD23 ' A' ' 132' ' ' LEU . 2.1 t80 -49.79 -21.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.442 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -63.62 -23.44 67.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.147 -0.97 . . . . 0.0 109.128 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 131' ' ' LEU . 2.5 mt-10 -71.41 -71.53 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.995 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -35.3 -47.87 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.088 -1.007 . . . . 0.0 109.579 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.824 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.8 pp -75.82 -28.93 58.49 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.095 -1.003 . . . . 0.0 111.385 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.729 ' N ' HD12 ' A' ' 132' ' ' LEU . 4.3 mtmt -70.41 -58.16 4.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.671 -1.268 . . . . 0.0 110.312 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.647 ' CG1' ' CE2' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -48.76 -28.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 108.897 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.704 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 38.5 t80 -65.25 -54.8 23.93 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.815 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.557 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 86.8 m95 -71.78 -42.54 67.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.356 -1.465 . . . . 0.0 109.79 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.8 -35.37 22.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.0 111.021 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.564 ' OD1' ' O ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -127.83 72.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.946 -1.096 . . . . 0.0 111.275 -178.242 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 223' ' ' THR . 6.3 m80 -150.6 151.62 32.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.612 ' OD1' ' NE2' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.38 177.77 0.33 Allowed Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.746 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HB3' HD12 ' A' ' 181' ' ' LEU . 3.4 Cg_endo -79.87 -91.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.16 1.907 . . . . 0.0 111.405 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.686 HG22 ' HA ' ' A' ' 189' ' ' ILE . 32.9 p -123.89 54.96 1.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.42 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.597 ' C ' ' H ' ' A' ' 145' ' ' MET . 3.7 mt-30 -101.68 51.46 0.84 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.837 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.685 ' H ' HG21 ' A' ' 190' ' ' THR . . . -61.07 10.13 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.177 -1.487 . . . . 0.0 109.729 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.597 ' H ' ' C ' ' A' ' 143' ' ' GLN . 2.3 ptt? -117.13 13.23 14.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.028 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' GLN . 4.9 tmm_? -178.32 152.68 0.7 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.001 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.612 ' NE2' ' OD1' ' A' ' 140' ' ' ASP . 0.6 OUTLIER -134.53 76.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.409 -1.432 . . . . 0.0 108.8 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.76 -110.37 3.44 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.05 -32.84 39.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 114.453 -0.874 . . . . 0.0 111.901 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 148.39 22.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 109.339 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.91 156.84 47.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.912 -1.118 . . . . 0.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.94 179.47 16.23 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -18.62 37.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -1.184 . . . . 0.0 109.352 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 5.9 pt20 -88.61 4.25 47.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.123 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 67.7 m-85 -122.06 52.37 1.28 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.633 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 70' ' ' MET . 2.4 mtm105 -108.43 -170.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.504 -0.748 . . . . 0.0 109.152 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.72 126.14 35.9 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -133.52 131.84 40.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.443 -1.703 . . . . 0.0 111.104 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.769 HG13 ' CG2' ' A' ' 191' ' ' THR . 1.2 m -135.55 119.0 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.562 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.491 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 2.8 m-30 -116.02 129.76 24.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.73 168.34 22.57 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.381 2.054 . . . . 0.0 112.131 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -20.49 20.09 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.907 -1.121 . . . . 0.0 109.222 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 177.18 -171.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 168' ' ' GLU . . . -53.12 -15.25 0.8 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.995 1.379 . . . . 0.0 108.52 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.52 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.6 t -55.75 -64.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.891 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 18.1 mt-30 -78.74 -20.92 48.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.556 -0.715 . . . . 0.0 110.651 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 12.4 ttp -52.2 -31.96 34.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.54 ' OE1' ' O ' ' A' ' 164' ' ' ALA . 2.8 mp0 -75.35 -36.25 61.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.772 -1.205 . . . . 0.0 109.79 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.566 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.77 -47.33 7.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.086 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.75 -63.15 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.07 -34.69 44.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.974 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -74.93 -35.33 62.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.192 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -59.18 -46.18 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.475 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -72.39 -25.23 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.005 . . . . 0.0 109.744 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 69.5 mt-10 -73.19 -56.82 4.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.664 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.571 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 15.7 pt-20 -53.25 -45.55 68.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.571 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -68.17 -20.54 64.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.631 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.501 HE21 ' HB2' ' A' ' 182' ' ' SER . 43.3 tp60 -74.64 -38.19 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -29.79 52.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.674 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 176' ' ' GLU . 99.2 t -74.38 -54.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.724 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 141' ' ' PRO . 4.5 mm? -64.31 -42.31 96.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.737 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.501 ' HB2' HE21 ' A' ' 178' ' ' GLN . 23.0 t -56.38 -6.22 0.26 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 181' ' ' LEU . 3.8 tttp -88.09 -10.55 49.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.605 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.597 ' O ' ' OD1' ' A' ' 185' ' ' ASN . 0.4 OUTLIER -108.4 35.96 2.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.702 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.597 ' OD1' ' O ' ' A' ' 184' ' ' HIS . 1.0 OUTLIER 72.96 31.01 1.58 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.525 -0.734 . . . . 0.0 110.004 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -105.19 174.65 5.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.18 -147.17 6.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 189' ' ' ILE . 29.6 Cg_exo -58.79 106.29 0.27 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.542 2.161 . . . . 0.0 111.451 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.686 ' HA ' HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.34 -177.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.834 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.685 HG21 ' H ' ' A' ' 144' ' ' GLY . 1.8 p -133.91 68.68 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.691 0.758 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.769 ' CG2' HG13 ' A' ' 159' ' ' VAL . 24.5 m -98.39 119.88 37.84 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.627 ' OD1' ' CZ ' ' A' ' 194' ' ' ARG . 2.0 t70 -75.36 121.04 21.64 Favored 'General case' 0 C--N 1.279 -2.485 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.492 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.55 109.57 14.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.681 HH12 ' C10' ' A' ' 21' ' ' MYR . 1.9 ptp180 -166.75 120.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.709 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 1.9 pm0 -80.81 -179.32 7.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.529 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.49 22.75 61.78 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.491 ' HG3' ' CE2' ' A' ' 160' ' ' TYR . 53.0 mm-40 -93.31 98.29 11.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.612 -1.522 . . . . 0.0 109.516 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.58 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.4 p -42.98 161.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.468 -0.77 . . . . 0.0 109.794 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 41.3 t80 -109.31 131.43 55.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.505 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.408 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 6.8 m-85 -127.54 98.65 5.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.67 131.52 39.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.982 -1.074 . . . . 0.0 110.584 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -83.58 179.14 7.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.0 OUTLIER -74.64 170.57 15.54 Favored 'General case' 0 C--N 1.286 -2.153 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 179.514 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -63.93 -13.43 45.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.897 . . . . 0.0 109.841 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -76.77 -15.75 59.66 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.912 -1.118 . . . . 0.0 110.182 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 74' ' ' TRP . 63.5 m-70 -107.35 8.89 29.94 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.677 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.751 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.7 mm-40 -119.88 -149.98 0.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.822 -1.174 . . . . 0.0 112.087 -177.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.691 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 2.5 mp0 -36.25 -2.49 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.73 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.751 ' N ' ' O ' ' A' ' 207' ' ' GLN . 10.6 p90 -46.79 -34.75 5.54 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 117.373 -1.731 . . . . 0.0 110.705 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.756 HD12 ' CH2' ' A' ' 81' ' ' TRP . 1.7 mt -49.44 -10.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.403 -1.436 . . . . 0.0 110.042 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 209' ' ' TYR . 11.4 p -53.21 -37.02 61.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -84.75 -36.74 21.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.1 66.79 3.09 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.594 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 10.0 Cg_endo -54.9 -39.76 88.77 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.997 2.465 . . . . 0.0 113.16 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.596 ' C ' HH12 ' A' ' 78' ' ' ARG . 29.6 p30 -61.23 -5.6 1.66 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.787 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 218' ' ' CYS . . . 58.99 84.41 0.04 OUTLIER Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.561 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.626 ' OH ' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -48.82 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 121.017 2.408 . . . . 0.0 109.452 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 216' ' ' GLY . 31.4 p -166.12 -125.15 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.769 -1.207 . . . . 0.0 109.143 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.631 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -128.04 -149.94 7.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.564 ' N ' HD23 ' A' ' 220' ' ' LEU . 0.1 OUTLIER -114.23 -175.02 2.59 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.36 -1.083 . . . . 0.0 109.641 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.86 -139.28 0.05 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -153.42 -142.02 3.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.847 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER 33.72 27.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.521 -0.987 . . . . 0.0 109.455 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -79.47 -8.4 87.79 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 226' ' ' SER . 1.3 t -49.55 161.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.847 -0.796 . . . . 0.0 109.507 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.787 ' O ' HD13 ' A' ' 231' ' ' ILE . 0.1 OUTLIER -99.14 108.95 21.69 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.273 1.035 . . . . 0.0 109.202 179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.592 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.1 OUTLIER -73.17 -68.84 0.35 Allowed Pre-proline 0 C--N 1.279 -2.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.154 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.592 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 94.9 Cg_endo -79.65 -35.75 0.73 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.026 1.817 . . . . 0.0 110.122 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.565 ' O ' ' C ' ' A' ' 230' ' ' ALA . 3.9 mmm -55.34 154.16 6.4 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.794 0.807 . . . . 0.0 109.949 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.565 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.31 138.81 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.217 0.532 . . . . 0.0 109.868 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.787 HD13 ' O ' ' A' ' 226' ' ' SER . 2.9 tp -151.52 119.48 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.311 -0.868 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 231' ' ' ILE . 0.2 OUTLIER -35.41 110.74 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 109.551 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.301 0 O-C-N 121.227 -0.921 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.681 ' C10' HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.526 ' C ' ' O ' ' A' ' 22' ' ' GLY . 0.6 OUTLIER 35.96 83.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -1.123 . . . . 0.0 109.275 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.677 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 25.3 m -50.64 -19.42 0.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.077 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -78.04 -94.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 123.199 1.476 . . . . 0.0 110.435 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER -49.1 9.11 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.517 -178.721 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -80.09 21.85 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 124.084 1.897 . . . . 0.0 108.768 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.626 ' H ' ' C ' ' A' ' 26' ' ' SER . 20.1 t -154.13 55.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.261 -3.27 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.452 HG12 ' HB2' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -76.82 135.78 25.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -173.623 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -82.23 131.28 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.151 0.977 . . . . 0.0 110.243 -179.172 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 97' ' ' HIS . . . -45.9 -55.68 6.41 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.494 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -85.03 8.28 18.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.765 -1.209 . . . . 0.0 111.73 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.472 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 3.2 tt0 -117.59 -14.3 10.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.444 -1.41 . . . . 0.0 111.501 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.812 ' C ' HD13 ' A' ' 35' ' ' LEU . . . -67.39 -169.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.541 -1.35 . . . . 0.0 109.45 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.997 ' N ' HD13 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -138.11 61.31 26.67 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.738 ' O ' ' N ' ' A' ' 38' ' ' ARG . 44.3 Cg_endo -89.2 -27.12 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 123.191 2.594 . . . . 0.0 113.198 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . -26.1 81.37 0.0 OUTLIER Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.738 ' N ' ' O ' ' A' ' 36' ' ' PRO . 1.1 ttt85 -139.78 124.88 18.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.048 -1.266 . . . . 0.0 109.548 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -88.13 37.78 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.224 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.08 113.28 29.17 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.935 -1.103 . . . . 0.0 109.707 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -57.7 169.75 2.32 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.167 1.911 . . . . 0.0 112.416 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.591 ' CG2' ' O ' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -139.05 71.34 41.15 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.312 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.75 ' O ' HG13 ' A' ' 44' ' ' VAL . 71.5 Cg_endo -81.37 149.86 17.06 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.06 2.507 . . . . 0.0 112.751 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 43' ' ' PRO . 3.2 m -163.37 158.92 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.416 -0.802 . . . . 0.0 109.493 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.851 HG23 ' O ' ' A' ' 45' ' ' THR . 15.2 t -59.43 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.908 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.586 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.91 -21.79 22.38 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.235 -0.916 . . . . 0.0 110.759 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.6 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.8 OUTLIER -90.93 100.15 13.06 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 116.344 -2.143 . . . . 0.0 108.03 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.631 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 7.8 t-80 -31.48 132.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.633 ' CD2' ' HE2' ' A' ' 212' ' ' LYS . 0.3 OUTLIER -82.72 -11.43 58.32 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.104 -0.998 . . . . 0.0 111.234 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.648 HG22 ' OG ' ' A' ' 211' ' ' SER . 21.9 t -85.6 -36.34 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 108.207 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -45.14 3.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.011 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.11 54.27 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 66.7 m-20 -76.32 -116.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.547 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.89 174.06 10.1 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 123.497 1.617 . . . . 0.0 109.606 177.563 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.762 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.9 p -142.34 38.57 1.56 Allowed 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.07 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 55' ' ' THR . 4.6 m -163.89 138.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.995 -1.066 . . . . 0.0 109.795 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 8.1 pt-20 -71.78 177.33 1.71 Allowed Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 2.9 Cg_exo -49.26 143.62 6.21 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 N-CA-C 116.067 1.526 . . . . 0.0 116.067 -0.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 37.6 m-85 -94.56 110.44 49.04 Favored Pre-proline 0 C--N 1.272 -2.768 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.577 ' O ' ' OG1' ' A' ' 63' ' ' THR . 50.1 Cg_exo -50.38 133.45 36.88 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.331 2.021 . . . . 0.0 112.387 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 60' ' ' PRO . 50.8 mt-10 -43.59 157.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 63' ' ' THR . . . 83.14 32.0 27.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -158.71 137.93 11.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -1.174 . . . . 0.0 109.474 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.663 ' OE1' ' N ' ' A' ' 64' ' ' GLN . 20.6 mp0 -111.55 156.67 21.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.123 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.742 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -140.78 114.62 8.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.965 . . . . 0.0 109.904 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.64 -170.71 1.69 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.93 . . . . 0.0 108.802 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.14 133.55 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.049 -1.657 . . . . 0.0 109.518 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.713 ' CE2' ' O ' ' A' ' 131' ' ' LEU . 25.9 m-85 -126.41 145.22 50.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.828 -1.17 . . . . 0.0 109.293 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.03 108.93 1.72 Allowed Glycine 0 N--CA 1.482 1.715 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.62 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -114.3 -87.84 0.57 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.403 -1.057 . . . . 0.0 108.502 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.569 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -148.19 -152.19 5.63 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.671 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -36.18 104.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.779 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -50.67 7.28 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.679 ' HB3' HD11 ' A' ' 210' ' ' LEU . 37.9 m0 -75.27 -52.23 11.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.656 -1.278 . . . . 0.0 109.417 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' A' ' 218' ' ' CYS . . . -88.8 -26.96 25.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.62 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . -64.85 -45.2 87.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.105 -1.233 . . . . 0.0 110.173 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' OE1' HG13 ' A' ' 91' ' ' VAL . 4.2 tt0 -83.03 -14.77 53.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.126 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.536 ' O ' HG13 ' A' ' 82' ' ' VAL . 51.4 ttp85 -68.6 -36.12 78.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.0 110.067 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -70.49 15.76 0.09 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.0 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 93.2 m-85 -123.73 -42.25 2.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 110.644 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.601 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -68.77 6.88 0.76 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.553 -1.342 . . . . 0.0 109.268 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.5 m -109.53 15.97 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 109.369 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.9 mt -110.84 154.64 23.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.98 138.42 31.5 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.353 0.596 . . . . 0.0 109.561 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.84 -27.35 14.96 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -70.26 137.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.53 -0.982 . . . . 0.0 108.999 179.63 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.549 ' CE1' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -79.94 -46.69 16.27 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.549 ' OG ' ' CE1' ' A' ' 87' ' ' TYR . 1.4 p -165.7 -170.21 1.74 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.631 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 41.4 p -151.16 146.42 26.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 108.989 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.773 HE21 ' HD3' ' A' ' 118' ' ' ARG . 1.1 mp0 -144.59 155.8 43.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 110.13 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -141.05 151.95 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.2 42.82 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.374 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.2 m-85 -80.1 171.68 14.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.951 . . . . 0.0 109.252 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -176.95 168.73 2.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 109.667 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 64.64 20.88 66.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.564 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -93.83 173.72 33.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.731 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 1.2 m-70 -91.66 -111.83 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.544 -1.563 . . . . 0.0 111.404 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.604 ' O ' ' C ' ' A' ' 99' ' ' ARG . 5.9 t -75.98 -172.88 2.12 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.604 ' C ' ' O ' ' A' ' 98' ' ' THR . 0.1 OUTLIER -37.81 139.26 0.32 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.919 ' H ' ' ND2' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -128.38 144.87 53.54 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -172.414 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 100' ' ' ASN . 73.5 Cg_exo -45.68 -147.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 124.133 3.222 . . . . 0.0 112.214 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.543 HG22 ' HG3' ' A' ' 105' ' ' GLU . 1.5 t -125.53 176.1 7.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.971 -1.08 . . . . 0.0 111.514 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.786 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -50.81 -41.1 57.09 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.531 0.682 . . . . 0.0 110.397 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 12.7 tttp -72.59 -33.44 66.72 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.146 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.676 ' C ' ' HZ1' ' A' ' 110' ' ' LYS . 1.9 mm-40 -81.71 -41.2 21.65 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 110.47 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.919 HG12 ' CG2' ' A' ' 111' ' ' THR . 28.3 m -56.29 -23.32 16.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.061 -1.024 . . . . 0.0 109.85 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' A' ' 106' ' ' VAL . 69.0 m -41.66 -15.48 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.687 ' N ' ' O ' ' A' ' 106' ' ' VAL . 35.6 m -102.67 19.81 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 110.006 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER 60.08 -9.38 0.05 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.92 -1.112 . . . . 0.0 109.647 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.679 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -44.67 -14.32 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.739 -0.6 . . . . 0.0 111.691 -178.257 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.919 ' CG2' HG12 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -122.09 -10.0 8.63 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.554 -1.342 . . . . 0.0 111.481 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 60.74 24.87 62.84 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 118.527 -1.796 . . . . 0.0 109.771 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.71 ' HE2' ' CG ' ' A' ' 100' ' ' ASN . 1.8 m-70 -78.83 172.41 13.8 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.992 -1.299 . . . . 0.0 109.274 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -137.25 125.26 22.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.674 ' OE2' ' CZ ' ' A' ' 73' ' ' PHE . 3.5 mt-10 -66.33 119.7 12.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.232 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -125.05 169.74 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.761 ' HA ' HG12 ' A' ' 91' ' ' VAL . 15.8 m -127.13 128.22 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.376 -0.827 . . . . 0.0 109.519 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.773 ' HD3' HE21 ' A' ' 90' ' ' GLN . 8.9 ttm180 -103.48 111.83 24.46 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.551 -0.718 . . . . 0.0 109.886 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.72 112.89 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 65' ' ' MET . 0.8 OUTLIER -98.49 160.72 3.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 108.94 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.53 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 10.5 p90 -141.23 169.5 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.581 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.513 ' C ' ' OE2' ' A' ' 124' ' ' GLU . 60.7 mtp180 -110.05 114.1 56.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' HIS . 38.3 Cg_exo -42.94 -63.97 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.927 2.418 . . . . 0.0 113.022 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.692 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -46.45 -10.67 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 -179.175 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' PRO . 36.1 m80 -126.13 -18.86 4.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.617 -1.302 . . . . 0.0 110.716 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.484 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.59 158.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.873 -1.142 . . . . 0.0 110.212 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.5 p -108.8 153.19 23.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.825 . . . . 0.0 110.369 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' C ' ' N ' ' A' ' 130' ' ' GLU . 25.1 t80 -53.63 -30.1 41.19 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 3.0 mp0 -47.35 -19.26 0.15 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 128' ' ' PHE . 1.5 mm-40 -73.84 -63.02 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.827 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.713 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 7.2 mt -44.74 -45.74 10.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.253 -0.904 . . . . 0.0 108.785 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.891 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.5 pp -75.04 -21.96 58.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.495 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.675 ' N ' HD12 ' A' ' 132' ' ' LEU . 0.4 OUTLIER -69.94 -68.13 0.44 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.736 -1.227 . . . . 0.0 110.057 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.737 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 38.9 t -58.3 -17.22 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.58 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 7.2 t80 -72.45 -60.27 2.31 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.844 -1.16 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.658 ' CB ' ' CE2' ' A' ' 177' ' ' TYR . 94.1 m95 -72.06 -52.84 14.94 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.468 -1.395 . . . . 0.0 110.348 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 136' ' ' TRP . 4.1 tt0 -36.84 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.557 -0.714 . . . . 0.0 111.86 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.737 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.3 OUTLIER -124.0 64.76 1.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.609 -1.307 . . . . 0.0 111.734 -178.458 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.824 ' O ' HG23 ' A' ' 223' ' ' THR . 13.0 m80 -147.95 161.25 41.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.201 -0.937 . . . . 0.0 109.056 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.553 ' HA ' ' H ' ' A' ' 223' ' ' THR . 0.9 OUTLIER -91.77 160.32 36.46 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.086 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 186' ' ' PHE . 79.8 Cg_exo -32.62 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.572 2.181 . . . . 0.0 111.792 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.707 ' OG1' ' N ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -122.21 14.77 10.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.793 -1.192 . . . . 0.0 109.005 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.478 ' OE1' ' CG ' ' A' ' 140' ' ' ASP . 3.5 mt-30 -55.4 71.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.61 10.17 62.84 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.97 15.53 15.14 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 148' ' ' GLY . 4.3 ttm180 179.3 133.62 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.326 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 70' ' ' MET . 2.0 tp60 -109.54 63.67 0.6 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 119.731 -1.856 . . . . 0.0 107.894 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' CD ' ' A' ' 146' ' ' ARG . . . 91.96 -118.07 5.41 Favored Glycine 0 C--N 1.301 -1.413 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -32.75 47.54 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.458 -0.871 . . . . 0.0 111.434 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -76.95 117.46 18.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.28 -1.513 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 35.6 p90 -109.21 131.89 54.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.928 . . . . 0.0 110.716 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.06 164.51 25.9 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.023 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.574 ' OG1' ' OE2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -72.13 -23.42 61.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.589 -0.948 . . . . 0.0 109.629 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.718 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 7.2 pm0 -89.17 3.7 51.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.453 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 22.5 m-85 -112.59 50.03 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 109.37 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 144' ' ' GLY . 1.6 mtm180 -97.37 -178.65 4.23 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 109.236 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 192' ' ' ASP . 3.8 t -93.9 112.95 24.87 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -145.17 123.18 12.06 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 117.866 -1.533 . . . . 0.0 112.036 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 191' ' ' THR . 4.5 t -112.26 127.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.689 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.615 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.5 m-85 -112.88 93.02 22.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.323 -0.86 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -49.12 172.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.838 2.358 . . . . 0.0 112.186 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.516 HG21 ' SD ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -107.44 -44.24 4.35 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.191 -0.943 . . . . 0.0 109.698 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.509 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER -175.12 -178.02 1.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.12 -0.988 . . . . 0.0 109.902 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.18 -24.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 123.252 1.501 . . . . 0.0 108.255 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.649 ' O ' ' CG ' ' A' ' 168' ' ' GLU . 2.5 t -56.43 -53.81 35.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.38 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.472 ' C ' ' H ' ' A' ' 168' ' ' GLU . 3.6 tt0 -78.51 -20.92 49.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.336 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' MET . . . . . 0.674 ' CG ' HD22 ' A' ' 171' ' ' LEU . 22.8 ttm -52.95 -4.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER -73.58 -68.48 0.5 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.845 -1.159 . . . . 0.0 110.583 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -92.74 -42.92 9.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -0.987 . . . . 0.0 111.175 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -51.68 -65.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.968 -1.082 . . . . 0.0 110.169 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.674 HD22 ' CG ' ' A' ' 167' ' ' MET . 0.4 OUTLIER -55.04 -40.14 69.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.045 -1.034 . . . . 0.0 109.431 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -74.26 -24.17 59.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.648 ' N ' ' O ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -67.23 -32.31 73.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.583 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.595 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 8.1 pttm -72.36 -47.14 51.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.997 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CG ' ' A' ' 174' ' ' LYS . 15.3 tt0 -72.86 -30.38 63.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.518 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.639 ' OE2' ' CD2' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -73.22 -40.79 64.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.0 -1.062 . . . . 0.0 110.819 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.658 ' CE2' ' CB ' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -80.12 -25.61 39.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.748 -1.22 . . . . 0.0 110.238 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -74.76 -26.44 59.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 109.912 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 1.4 ttpm? -77.89 -20.04 53.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.22 -54.11 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.76 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.1 mt -66.38 -13.09 60.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.963 . . . . 0.0 109.75 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -59.48 -40.66 87.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -88.04 10.61 18.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.95 . . . . 0.0 109.659 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.516 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 14.3 m170 -104.49 35.11 2.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 68.31 48.55 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.543 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 141' ' ' PRO . 71.7 m-85 -152.5 168.61 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.31 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -117.83 -144.42 7.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -58.66 105.85 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.24 1.96 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.544 ' C ' ' OG1' ' A' ' 142' ' ' THR . 0.5 OUTLIER -47.47 166.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -178.746 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.707 ' N ' ' OG1' ' A' ' 142' ' ' THR . 0.8 OUTLIER -95.06 0.48 54.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.827 -0.546 . . . . 0.0 111.199 -179.117 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.714 HG22 HD11 ' A' ' 193' ' ' ILE . 27.2 m -42.87 108.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.69 -1.256 . . . . 0.0 108.401 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.772 ' O ' HD13 ' A' ' 193' ' ' ILE . 2.2 t70 -76.91 131.8 38.75 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.84 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 192' ' ' ASP . 7.7 mm -131.97 101.38 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.402 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.663 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -143.35 153.54 42.83 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.762 ' CD ' ' H ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -107.02 171.21 7.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.976 -1.077 . . . . 0.0 110.01 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.544 ' C ' ' OE1' ' A' ' 197' ' ' GLN . . . 75.37 43.94 23.5 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.591 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 3.6 mm100 -97.41 97.6 9.24 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.318 -1.107 . . . . 0.0 109.539 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.5 t -48.3 153.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.69 131.88 54.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.407 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' PHE . 4.4 m-85 -131.79 98.35 4.44 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.591 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 16.0 m-85 -54.02 141.49 28.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 110.462 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.559 ' O ' HG11 ' A' ' 44' ' ' VAL . . . -92.87 -176.08 4.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.701 ' OE1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.45 175.11 8.04 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.441 -0.787 . . . . 0.0 109.064 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.701 ' N ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -60.42 -54.83 40.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.867 -1.146 . . . . 0.0 108.77 179.433 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -46.89 -11.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.052 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.786 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 9.1 m-70 -100.75 9.84 41.9 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.12 -0.987 . . . . 0.0 110.777 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.9 mm-40 -130.51 -143.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.402 1.096 . . . . 0.0 110.688 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.754 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 4.4 mp0 -36.59 -2.76 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.072 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 60.3 t80 -41.01 -50.69 3.32 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 120.865 -1.147 . . . . 0.0 112.083 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 74' ' ' TRP . 63.9 mt -65.97 -25.23 67.01 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.115 -1.615 . . . . 0.0 111.221 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.91 -52.06 65.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 108.608 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.636 ' NZ ' ' CB ' ' A' ' 212' ' ' LYS . 7.4 mtmp? -90.34 -12.49 37.54 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 111.096 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.693 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 2.0 m-80 -115.0 95.18 41.08 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.669 -1.269 . . . . 0.0 111.082 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.68 12.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.326 2.684 . . . . 0.0 111.899 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 213' ' ' ASN . 8.1 t0 -60.74 -5.42 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.44 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.33 -47.41 0.13 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.592 -1.289 . . . . 0.0 112.492 177.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.615 ' C ' ' O ' ' A' ' 216' ' ' GLY . 25.9 m-85 -27.22 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 119.382 1.591 . . . . 0.0 109.641 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.759 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 16.6 p -142.24 -127.62 0.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.337 -0.852 . . . . 0.0 109.564 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.759 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -152.66 151.0 22.89 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 mt -104.65 146.25 29.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -1.138 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.4 -162.63 5.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.677 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -155.51 -141.77 3.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 139' ' ' HIS . 1.2 p 47.81 1.39 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.47 -1.017 . . . . 0.0 110.082 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -80.54 11.5 38.83 Favored Glycine 0 C--N 1.306 -1.119 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 225' ' ' VAL . 3.8 p -98.17 119.52 46.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.404 -1.057 . . . . 0.0 109.889 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.447 ' CB ' ' HB3' ' A' ' 229' ' ' MET . 23.5 m -99.41 111.53 23.87 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.609 1.195 . . . . 0.0 108.61 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.615 ' C ' ' H ' ' A' ' 229' ' ' MET . 1.3 m -75.13 -72.4 0.18 Allowed Pre-proline 0 C--N 1.284 -2.276 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.16 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.581 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 19.3 Cg_endo -60.0 2.19 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.221 1.948 . . . . 0.0 109.971 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.615 ' H ' ' C ' ' A' ' 227' ' ' CYS . 0.0 OUTLIER -55.35 157.99 3.42 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.758 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.532 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.97 131.85 0.13 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.711 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.509 HD13 ' HA ' ' A' ' 231' ' ' ILE . 2.0 mm -133.86 110.13 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.27 -0.894 . . . . 0.0 109.284 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.66 -169.95 1.87 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 121.313 -0.867 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.508 ' C8 ' ' NH1' ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -106.44 -141.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -60.89 -34.07 74.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.867 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -65.5 -94.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.915 1.341 . . . . 0.0 110.124 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.664 ' N ' ' OE1' ' A' ' 109' ' ' GLU . 37.1 t -56.92 32.28 0.0 OUTLIER 'General case' 0 C--N 1.259 -3.333 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.939 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.67 ' NZ ' ' OG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -70.39 35.12 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 123.269 1.509 . . . . 0.0 110.773 -178.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.737 HG12 ' O ' ' A' ' 28' ' ' VAL . 0.9 OUTLIER 48.47 70.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 -179.399 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -40.41 120.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 109.219 -3.628 . . . . 0.0 115.301 -169.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.67 ' OG ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.96 121.17 9.92 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.874 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -52.79 -24.7 9.4 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.827 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -73.5 -14.56 61.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.793 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.6 -14.03 14.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.79 ' HB2' ' CE1' ' A' ' 97' ' ' HIS . . . -53.26 146.09 12.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 110.314 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.833 HD12 ' H ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -65.66 166.65 13.88 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.72 -24.14 9.37 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.157 1.905 . . . . 0.0 111.206 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.833 ' H ' HD12 ' A' ' 35' ' ' LEU . . . 95.59 -62.67 1.39 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.675 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.25 125.21 30.04 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.954 -1.321 . . . . 0.0 109.903 -179.191 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 3.6 m -124.73 -5.59 7.52 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 39' ' ' THR . 2.5 mt-10 158.55 151.35 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.664 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 Cg_endo -74.2 134.16 18.89 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.867 2.378 . . . . 0.0 112.187 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 41' ' ' PRO . 14.7 mm -138.12 95.84 10.44 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.146 -0.971 . . . . 0.0 109.729 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.38 168.01 16.91 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.829 2.353 . . . . 0.0 112.174 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' ' 204' ' ' ASP . 29.7 m -129.39 -163.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.14 -0.975 . . . . 0.0 109.68 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.823 HG23 ' O ' ' A' ' 45' ' ' THR . 13.2 t -90.66 102.39 15.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.89 -57.8 10.56 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.367 -0.833 . . . . 0.0 110.915 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -71.23 100.8 2.17 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 115.62 -2.432 . . . . 0.0 108.061 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.711 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 11.4 t-80 -31.63 136.53 0.06 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.478 ' NE2' ' HD2' ' A' ' 212' ' ' LYS . 37.4 t-80 -74.81 -32.32 61.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 111.09 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.482 HG21 ' CG ' ' A' ' 81' ' ' TRP . 64.2 t -70.27 -47.58 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.892 -1.13 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -99.34 -42.72 6.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.062 -1.024 . . . . 0.0 110.789 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.03 2.51 58.17 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 9.9 m120 -75.61 -115.66 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.587 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -134.23 173.44 11.6 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 123.613 1.673 . . . . 0.0 110.106 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 41.3 p -143.72 17.38 1.81 Allowed 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 112.601 -2.091 . . . . 0.0 110.061 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 57' ' ' GLU . 8.6 m -151.96 136.81 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 109.368 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' A' ' 56' ' ' VAL . 8.2 mt-10 -32.4 155.28 0.04 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.971 0.891 . . . . 0.0 110.816 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 89.3 Cg_endo -79.26 165.83 79.98 Favored 'Cis proline' 0 C--N 1.303 -1.865 0 C-N-CA 121.606 -2.248 . . . . 0.0 112.045 -0.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.796 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 2.2 m-30 -112.24 150.31 42.32 Favored Pre-proline 0 C--N 1.269 -2.91 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.21 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' O ' ' OG1' ' A' ' 63' ' ' THR . 36.2 Cg_endo -68.01 109.98 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.727 2.285 . . . . 0.0 112.331 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.84 143.42 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.11 -19.0 50.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -82.78 149.1 27.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -1.134 . . . . 0.0 109.533 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.678 ' OE1' ' N ' ' A' ' 65' ' ' MET . 5.6 tm0? -99.47 146.98 25.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.752 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -139.36 114.27 9.42 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.093 -1.004 . . . . 0.0 109.647 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.98 -167.98 1.63 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 t -142.35 138.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.126 -1.609 . . . . 0.0 109.47 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 1.058 ' O ' HG22 ' A' ' 117' ' ' VAL . 32.9 m-85 -134.63 136.74 43.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.06 111.12 2.21 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.672 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 2.9 mmm -100.01 -89.76 0.33 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.429 -1.042 . . . . 0.0 108.519 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.721 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -161.3 72.49 0.21 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.216 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.721 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 49.0 t 110.52 110.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.561 0.744 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.709 ' HD1' ' HD1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -63.99 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.505 -1.372 . . . . 0.0 110.61 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.796 ' O ' HD21 ' A' ' 210' ' ' LEU . 9.0 m0 -94.89 -70.52 0.71 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.565 -1.334 . . . . 0.0 109.553 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -2.43 65.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB1' ' CG ' ' A' ' 70' ' ' MET . . . -76.34 -37.62 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -1.164 . . . . 0.0 109.796 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.671 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 2.1 pm0 -82.74 -25.75 32.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.267 -0.896 . . . . 0.0 110.479 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.758 ' O ' HG13 ' A' ' 82' ' ' VAL . 6.4 tmm_? -57.94 -56.79 17.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.075 -1.016 . . . . 0.0 110.076 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.0 mttp -43.53 -25.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' CB ' HG11 ' A' ' 119' ' ' VAL . 94.6 m-85 -84.96 -41.75 15.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 111.406 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 81' ' ' TRP . 0.7 OUTLIER -69.55 -5.18 22.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.318 -1.489 . . . . 0.0 109.259 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -97.74 18.58 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.234 -0.916 . . . . 0.0 109.365 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.29 152.2 21.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.972 0.892 . . . . 0.0 109.402 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -90.0 143.27 26.93 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 95.66 -21.44 44.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -75.53 138.02 21.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.838 . . . . 0.0 109.529 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.587 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.8 -47.56 12.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.525 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 1.5 t -167.65 -175.13 2.69 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.631 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.476 HG21 ' N ' ' A' ' 81' ' ' TRP . 20.2 p -149.29 164.38 35.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.803 . . . . 0.0 109.285 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.4 ' HG3' ' NE ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -167.85 162.59 13.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.746 HG12 HG12 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -126.67 176.91 6.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.274 -0.891 . . . . 0.0 109.365 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.53 169.27 37.04 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 202' ' ' ALA . 3.4 m-85 -89.1 161.59 16.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.984 . . . . 0.0 109.99 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.688 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.06 -171.37 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.433 -0.792 . . . . 0.0 109.104 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 54.61 32.1 53.38 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.616 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -139.47 -159.61 8.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.79 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 4.2 p80 -148.77 78.58 1.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.313 -1.11 . . . . 0.0 109.909 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.581 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.86 149.33 21.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.262 -0.898 . . . . 0.0 109.009 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.706 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.1 mmt180 -48.83 -106.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -112.24 83.82 5.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.46 171.18 18.06 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.481 2.121 . . . . 0.0 112.265 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.536 ' OG1' ' HB3' ' A' ' 105' ' ' GLU . 21.2 p -122.27 167.31 13.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.025 -1.047 . . . . 0.0 110.077 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.72 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 2.1 t80 -57.79 -59.33 5.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.586 -0.696 . . . . 0.0 110.144 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -22.06 41.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 108.78 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.556 ' OE2' HD11 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -79.06 -61.46 2.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.653 -0.655 . . . . 0.0 110.596 -179.188 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.702 HG12 ' OG1' ' A' ' 111' ' ' THR . 15.3 m -52.13 -24.68 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.128 -0.982 . . . . 0.0 110.533 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.2 p -52.97 -45.32 67.72 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.695 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 13.6 t -52.23 -6.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.664 ' OE1' ' N ' ' A' ' 26' ' ' SER . 1.9 tt0 65.13 -6.01 0.38 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.585 -0.697 . . . . 0.0 110.359 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' C ' HG21 ' A' ' 29' ' ' ILE . 7.2 tttt -60.98 -23.01 65.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.106 -0.996 . . . . 0.0 109.206 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.702 ' OG1' HG12 ' A' ' 106' ' ' VAL . 25.3 p -94.87 -5.63 44.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.281 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 39.41 47.62 2.85 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.688 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 5.6 m-70 -92.26 170.05 10.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.782 -1.422 . . . . 0.0 109.064 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -123.59 116.1 22.57 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.546 ' C ' ' OE2' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -53.41 143.4 19.25 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.583 -178.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -151.8 174.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.125 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.058 HG22 ' O ' ' A' ' 68' ' ' PHE . 33.9 m -135.32 121.62 32.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.796 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 8.1 ptm180 -96.98 96.9 8.82 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.442 1.115 . . . . 0.0 108.7 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.688 HG11 ' CB ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -103.82 147.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.664 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -114.31 157.25 15.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.664 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 2.8 m-85 -141.89 157.33 45.11 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.243 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.42 ' CD ' ' CG2' ' A' ' 63' ' ' THR . 7.7 mmm180 -109.98 99.55 39.52 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.513 -0.742 . . . . 0.0 109.252 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 125' ' ' HIS . 10.9 Cg_exo -40.32 -67.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.111 2.541 . . . . 0.0 113.906 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -40.94 -12.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.204 -0.935 . . . . 0.0 110.711 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.692 ' N ' ' O ' ' A' ' 123' ' ' PRO . 5.8 m-70 -135.41 6.77 3.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.614 -1.303 . . . . 0.0 109.69 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.582 ' CD1' ' CD ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -156.28 148.31 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.594 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -99.47 151.09 21.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.585 ' CZ ' HD21 ' A' ' 132' ' ' LEU . 41.9 t80 -61.72 -19.88 62.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -61.88 -22.56 65.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 131' ' ' LEU . 3.0 mt-10 -70.15 -70.65 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 110.147 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.025 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.8 OUTLIER -35.19 -50.12 0.51 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.585 HD21 ' CZ ' ' A' ' 128' ' ' PHE . 4.5 mm? -68.05 -54.47 18.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 0.0 111.503 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 137' ' ' GLU . 3.8 tttm -52.04 -57.66 8.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.081 -1.012 . . . . 0.0 111.276 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.555 HG12 ' CZ ' ' A' ' 80' ' ' PHE . 78.8 t -49.83 -33.77 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.132 . . . . 0.0 110.22 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.701 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 23.2 t80 -71.72 -52.33 18.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.831 -1.168 . . . . 0.0 109.923 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.513 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 87.5 m95 -70.42 -32.13 69.6 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.906 -1.121 . . . . 0.0 110.348 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.597 ' O ' ' OG1' ' A' ' 223' ' ' THR . 7.8 tt0 -72.35 -34.83 68.31 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 112.259 -177.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -131.37 73.72 1.56 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.44 -1.412 . . . . 0.0 112.361 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.701 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 2.0 p-80 178.15 129.59 0.06 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.81 -1.181 . . . . 0.0 110.518 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 221' ' ' GLY . 4.8 m-20 -69.09 111.3 8.08 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.451 ' HB3' ' CE1' ' A' ' 139' ' ' HIS . 66.5 Cg_endo -91.34 5.69 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 0.0 113.081 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.814 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -123.14 46.23 2.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 111.049 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.547 ' C ' ' H ' ' A' ' 145' ' ' MET . 44.0 mt-30 -140.39 67.92 1.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 108.999 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' HG21 ' A' ' 190' ' ' THR . . . -65.08 13.0 0.23 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.591 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -115.08 -20.02 10.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.033 -1.275 . . . . 0.0 109.057 178.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.544 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 176.85 163.94 0.47 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.672 ' NE2' ' O ' ' A' ' 70' ' ' MET . 15.3 mt-30 -141.44 159.66 41.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.551 -1.343 . . . . 0.0 110.191 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 147' ' ' GLN . . . 44.23 -120.55 3.44 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 36.9 t30 -111.05 26.11 11.05 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.34 -0.93 . . . . 0.0 110.542 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.573 ' OD2' ' CD1' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -108.18 91.48 3.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.855 -1.153 . . . . 0.0 109.221 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 146' ' ' ARG . 3.7 m-85 -69.14 118.62 12.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 149.8 168.39 15.04 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.138 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER -94.18 9.41 38.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.416 -1.049 . . . . 0.0 109.154 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.725 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 0.7 OUTLIER -93.25 -1.16 56.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.694 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.682 ' CE2' ' OE1' ' A' ' 154' ' ' GLN . 3.3 m-85 -129.99 57.99 1.67 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.024 -1.048 . . . . 0.0 109.879 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.557 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.6 OUTLIER -91.51 -175.63 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 108.913 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.737 ' OG ' HG23 ' A' ' 190' ' ' THR . 13.1 p -94.08 118.89 32.17 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.479 ' HB1' ' NH1' ' A' ' 194' ' ' ARG . . . -147.06 110.72 4.95 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.501 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 192' ' ' ASP . 8.3 t -98.38 131.28 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.739 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.555 ' CE2' HG11 ' A' ' 116' ' ' VAL . 7.8 m-85 -114.01 120.53 38.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.51 173.72 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.574 2.183 . . . . 0.0 113.038 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -94.62 -19.61 20.31 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.227 -0.921 . . . . 0.0 109.215 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 162' ' ' THR . 0.4 OUTLIER 167.69 -163.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.453 -0.779 . . . . 0.0 109.084 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.68 -15.39 11.65 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.952 1.358 . . . . 0.0 108.743 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.76 -62.7 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.638 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.677 HE22 ' NE2' ' A' ' 64' ' ' GLN . 1.4 mp0 -61.44 -12.06 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.524 -0.735 . . . . 0.0 109.823 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.0 ttm -51.94 -34.09 40.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.913 -1.117 . . . . 0.0 110.533 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.37 -38.67 59.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.829 -1.169 . . . . 0.0 110.388 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.552 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.78 -41.52 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.021 -1.049 . . . . 0.0 110.462 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.91 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 171' ' ' LEU . 1.7 mm? -53.04 -36.81 60.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -74.33 -24.06 59.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.92 . . . . 0.0 109.98 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.552 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.62 -50.11 16.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.937 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -36.26 73.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.015 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.05 -49.95 25.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 110.094 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 17.8 pt-20 -59.27 -43.05 92.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.5 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 1.1 m-85 -79.29 -12.2 59.94 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.998 -1.064 . . . . 0.0 109.61 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 178' ' ' GLN . 6.7 tp60 -74.57 -55.13 6.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.594 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.522 ' O ' ' OG ' ' A' ' 182' ' ' SER . 5.7 ttpm? -73.1 -29.49 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.9 -54.37 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.98 . . . . 0.0 109.853 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.17 -5.35 17.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 179' ' ' LYS . 81.4 p -61.62 -67.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.07 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.452 ' N ' ' OG ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -88.64 13.26 12.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.588 ' O ' ' OD1' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -94.83 32.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 0.0 109.542 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.588 ' OD1' ' O ' ' A' ' 184' ' ' HIS . 1.0 OUTLIER 72.87 29.75 1.82 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.669 -0.645 . . . . 0.0 110.324 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.457 ' CD2' ' OD1' ' A' ' 185' ' ' ASN . 7.1 m-85 -137.13 170.9 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.134 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -114.08 -136.76 6.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 189' ' ' ILE . 56.7 Cg_endo -77.45 107.14 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.293 1.995 . . . . 0.0 111.718 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.814 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.05 178.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.737 HG23 ' OG ' ' A' ' 157' ' ' SER . 6.8 t -128.69 -2.27 5.39 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.121 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.601 HG22 HD11 ' A' ' 193' ' ' ILE . 56.8 m -42.91 114.48 0.61 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.659 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 7.0 t0 -87.45 136.34 32.98 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.615 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.601 HD11 HG22 ' A' ' 191' ' ' THR . 4.5 mp -135.53 92.15 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 118.116 -1.434 . . . . 0.0 110.63 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.659 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -134.37 -179.51 5.62 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.634 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 4.3 pt-20 -139.11 -173.04 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.719 -1.238 . . . . 0.0 110.855 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.61 72.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 1.3 mp0 -79.89 128.02 32.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.87 -1.371 . . . . 0.0 109.885 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' A' ' 200' ' ' TYR . 6.7 p -60.55 153.65 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.188 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.619 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 66.7 t80 -117.84 130.29 56.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 109.769 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.706 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 21.0 m-85 -132.29 109.83 10.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.482 -0.761 . . . . 0.0 109.187 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' TYR . . . . . 0.471 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 20.1 m-85 -53.69 131.32 38.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.03 -1.044 . . . . 0.0 111.116 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -82.8 179.28 7.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.491 ' HB3' HG21 ' A' ' 42' ' ' ILE . 8.5 pm0 -75.08 158.68 32.74 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.486 -0.759 . . . . 0.0 108.96 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.781 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -55.4 -39.66 70.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.952 -1.092 . . . . 0.0 108.145 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.51 ' CE1' ' CE2' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -48.83 -19.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.577 -0.702 . . . . 0.0 110.304 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.72 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 10.5 m-70 -100.78 -17.7 16.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.811 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -106.44 -148.49 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.846 0.832 . . . . 0.0 110.357 -177.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.711 ' CG ' ' NE2' ' A' ' 48' ' ' HIS . 4.0 mp0 -35.53 -9.32 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.269 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.811 ' N ' ' O ' ' A' ' 207' ' ' GLN . 1.3 t80 -43.14 -41.87 3.86 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 120.8 -1.188 . . . . 0.0 110.915 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.796 HD21 ' O ' ' A' ' 74' ' ' TRP . 3.7 pp -79.98 -11.92 59.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.693 -1.603 . . . . 0.0 109.6 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 208' ' ' GLN . 91.7 p -55.8 -43.61 77.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 108.843 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.478 ' HD2' ' NE2' ' A' ' 49' ' ' HIS . 6.8 mtmm -65.49 -18.34 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.636 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.9 m-20 -128.24 71.9 79.68 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.004 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.47 9.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.274 2.649 . . . . 0.0 112.704 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.636 ' H ' ' C ' ' A' ' 213' ' ' ASN . 7.3 p30 -63.2 -18.51 63.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.012 -1.055 . . . . 0.0 110.657 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.73 85.47 0.05 OUTLIER Glycine 0 N--CA 1.498 2.79 0 C-N-CA 119.345 -1.407 . . . . 0.0 111.036 178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.743 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 71.4 t80 -45.11 -177.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.321 2.06 . . . . 0.0 109.778 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.743 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 0.7 OUTLIER -72.99 76.86 1.19 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.98 -1.075 . . . . 0.0 109.339 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.4 149.13 17.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.09 -171.78 4.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -1.101 . . . . 0.0 110.0 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 140' ' ' ASP . . . -142.5 -126.99 2.14 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.483 ' O ' ' OG1' ' A' ' 223' ' ' THR . . . -176.8 -134.94 2.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.664 ' CG2' ' H ' ' A' ' 139' ' ' HIS . 10.5 p 62.3 38.25 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -1.043 . . . . 0.0 109.398 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.647 ' O ' ' SD ' ' A' ' 229' ' ' MET . . . -160.59 38.74 0.44 Allowed Glycine 0 C--N 1.301 -1.368 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.85 81.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -1.165 . . . . 0.0 109.211 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.625 ' H ' ' CB ' ' A' ' 229' ' ' MET . 19.6 p -98.45 -154.45 0.46 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.109 0.957 . . . . 0.0 109.807 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.574 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.1 OUTLIER -73.11 -65.55 0.67 Allowed Pre-proline 0 C--N 1.291 -1.97 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.395 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.574 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 42.8 Cg_endo -68.15 -2.22 8.51 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.108 1.872 . . . . 0.0 110.082 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.647 ' SD ' ' O ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -81.01 155.87 26.17 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.877 0.846 . . . . 0.0 109.992 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.22 131.12 0.11 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.209 0.528 . . . . 0.0 109.667 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -152.08 119.43 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.157 -0.964 . . . . 0.0 109.45 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.416 ' N ' HD13 ' A' ' 231' ' ' ILE . 2.1 tptt -56.01 -174.26 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.167 -0.958 . . . . 0.0 109.406 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.382 0 O-C-N 121.266 -0.896 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.481 ' H71' HH22 ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -36.15 134.6 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -1.111 . . . . 0.0 109.167 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 p -68.41 -47.24 67.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 111.192 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.0 -13.09 60.0 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.839 1.304 . . . . 0.0 110.795 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.571 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 2.4 t -63.67 -58.96 5.28 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.831 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.651 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -92.24 25.8 2.79 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 124.152 1.929 . . . . 0.0 109.302 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG12 ' O ' ' A' ' 28' ' ' VAL . 32.1 t -145.61 43.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.258 -3.391 0 CA-C-N 112.883 -1.962 . . . . 0.0 106.331 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.92 133.05 21.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.262 1.03 . . . . 0.0 113.544 -175.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.12 125.41 26.7 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.638 ' HB2' ' CE1' ' A' ' 97' ' ' HIS . . . -48.13 -43.19 30.93 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.654 -0.654 . . . . 0.0 109.433 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -73.34 4.32 4.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' ALA . 15.7 tt0 -111.55 -1.97 15.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -49.66 -168.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 0.0 109.686 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.563 HD13 ' OE1' ' A' ' 105' ' ' GLU . 86.9 mt -83.14 165.63 39.9 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.78 -30.82 93.72 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.237 1.958 . . . . 0.0 112.6 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA2' HH11 ' A' ' 99' ' ' ARG . . . 135.42 143.77 4.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' H ' ' NE ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -69.23 172.83 6.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.12 . . . . 0.0 109.36 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.19 -12.27 7.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.164 -0.96 . . . . 0.0 109.591 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 174.88 115.99 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.132 -0.98 . . . . 0.0 109.435 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.61 163.2 29.6 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.43 2.087 . . . . 0.0 112.299 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.5 OUTLIER -137.57 94.11 12.1 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.474 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' ILE . 54.2 Cg_exo -48.46 -168.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.719 2.279 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.705 HG12 ' N ' ' A' ' 204' ' ' ASP . 26.9 m -136.05 -161.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 45' ' ' THR . 11.8 t -72.75 99.47 2.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -56.19 -49.07 75.09 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.145 -0.972 . . . . 0.0 111.277 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.554 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 mttm -75.35 99.51 4.14 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 115.84 -2.344 . . . . 0.0 108.682 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.7 t-80 -33.03 113.38 0.14 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.477 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.1 t-80 -61.3 -30.86 70.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.365 -0.834 . . . . 0.0 110.83 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.004 HG22 ' OG ' ' A' ' 211' ' ' SER . 26.1 t -65.17 -45.4 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.898 -1.126 . . . . 0.0 109.521 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.03 -45.86 4.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.906 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.53 2.74 47.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.7 p30 -79.33 -116.32 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.1 ttp180 -130.5 170.83 13.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 123.23 1.491 . . . . 0.0 109.057 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.733 ' O ' HG13 ' A' ' 56' ' ' VAL . 21.6 p -134.14 26.84 3.87 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.747 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 55' ' ' THR . 2.9 m -163.48 138.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.796 . . . . 0.0 109.695 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.664 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 2.3 pm0 -33.01 152.3 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.311 -0.868 . . . . 0.0 110.642 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 96.5 Cg_endo -79.28 166.16 79.17 Favored 'Cis proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.7 -0.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -104.02 149.1 36.87 Favored Pre-proline 0 C--N 1.268 -2.965 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 9.6 Cg_endo -54.83 119.47 6.53 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.637 2.225 . . . . 0.0 112.089 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' PRO . 25.1 mt-10 -43.35 117.91 1.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.18 23.94 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -132.93 137.02 46.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.884 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' OE1' ' SD ' ' A' ' 65' ' ' MET . 5.6 mm-40 -104.93 -176.89 3.21 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.761 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -145.11 128.21 16.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.88 -1.138 . . . . 0.0 110.433 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.57 -170.74 2.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.87 146.04 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.146 -1.596 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.739 ' O ' HG22 ' A' ' 117' ' ' VAL . 70.5 m-85 -140.84 126.84 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.671 -1.268 . . . . 0.0 109.961 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.38 107.06 2.76 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.869 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.74 -89.14 0.5 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.515 -0.991 . . . . 0.0 109.715 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.716 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -147.89 167.47 28.81 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.716 ' C ' ' O ' ' A' ' 71' ' ' GLY . 2.1 t -5.82 115.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 117.651 0.725 . . . . 0.0 109.818 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.68 ' HD1' ' HD1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.52 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.22 -0.925 . . . . 0.0 110.764 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.877 ' O ' HD11 ' A' ' 210' ' ' LEU . 0.2 OUTLIER -89.77 -55.61 3.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.752 -1.217 . . . . 0.0 109.153 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 217' ' ' TYR . . . -105.22 2.75 40.41 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.869 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . -76.75 -39.93 50.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.288 . . . . 0.0 110.525 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.671 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 4.6 tt0 -82.65 -14.34 54.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.965 -1.085 . . . . 0.0 110.806 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 20.5 ttt180 -57.91 -72.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.894 -1.129 . . . . 0.0 110.207 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.458 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 12.1 mmtt -44.11 -5.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.748 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 46.7 m-85 -94.43 -41.34 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.734 -1.229 . . . . 0.0 110.978 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -84.99 -0.68 55.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.672 -1.267 . . . . 0.0 110.646 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.17 19.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.977 -1.077 . . . . 0.0 110.051 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -119.73 157.24 28.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.245 -0.91 . . . . 0.0 109.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -93.25 141.59 28.26 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.839 -0.538 . . . . 0.0 109.549 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.04 -29.09 8.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.9 138.61 20.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.468 -1.019 . . . . 0.0 109.865 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.673 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.53 -44.62 28.04 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 89' ' ' THR . 1.1 p -168.17 -162.97 0.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.488 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 88' ' ' SER . 14.1 p -163.82 160.0 21.82 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.394 -0.816 . . . . 0.0 109.126 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.671 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -164.87 171.15 14.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.119 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.66 HG21 ' O ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -141.88 171.84 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 171.39 -175.95 44.78 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' TYR . 2.0 m-85 -96.17 164.88 12.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -1.044 . . . . 0.0 109.614 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -179.31 147.13 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.96 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 88.86 29.02 19.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.752 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -112.18 -156.72 13.26 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.638 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -138.98 54.1 1.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -1.173 . . . . 0.0 109.892 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.731 ' CG2' ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.5 177.15 11.74 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.043 . . . . 0.0 108.262 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.801 ' CD ' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -72.98 -86.64 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.384 -0.822 . . . . 0.0 109.851 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.79 ' H ' ' HE ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -122.79 79.91 49.11 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.869 -1.144 . . . . 0.0 110.051 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HG2' ' CD2' ' A' ' 113' ' ' HIS . 11.4 Cg_exo -67.38 169.28 15.86 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.743 2.295 . . . . 0.0 111.675 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.625 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 16.4 p -117.56 171.11 8.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 109.852 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.618 ' C ' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -63.47 -58.89 5.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 0.0 110.354 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.601 ' CD ' ' O ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -59.22 -22.46 61.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.919 -1.113 . . . . 0.0 108.254 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.625 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.8 mm-40 -72.89 -60.67 2.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.394 0.616 . . . . 0.0 110.977 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 102' ' ' THR . 11.4 m -56.56 -24.66 19.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.402 -0.811 . . . . 0.0 110.997 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.459 ' C ' ' H ' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -49.81 -33.85 17.86 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.253 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 110' ' ' LYS . 1.4 t -63.52 0.12 0.8 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.198 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.571 ' OE2' ' OG ' ' A' ' 26' ' ' SER . 0.8 OUTLIER 63.97 -21.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.251 -0.906 . . . . 0.0 109.87 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.629 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 tttt -57.82 -10.66 1.79 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.278 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.532 ' CB ' HG12 ' A' ' 106' ' ' VAL . 41.3 p -94.08 -38.67 11.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.96 -1.087 . . . . 0.0 110.515 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 72.63 21.2 79.72 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -75.17 161.32 29.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.112 -1.228 . . . . 0.0 110.315 -179.62 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -124.8 113.32 17.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' GLN . 1.9 pp20? -57.26 119.43 6.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.724 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -127.14 170.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.244 -0.91 . . . . 0.0 109.965 179.687 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 68' ' ' PHE . 6.1 m -130.36 125.46 59.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HG3' ' CE1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -96.89 114.49 26.12 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 119' ' ' VAL . 34.9 m -131.78 109.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -75.66 176.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.904 ' CG ' HD21 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -159.94 152.8 21.51 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.38 -1.328 . . . . 0.0 110.391 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 0.485 HH21 ' CG ' ' A' ' 125' ' ' HIS . 1.9 mtp180 -108.7 102.12 46.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.804 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 126' ' ' ILE . 18.3 Cg_exo -41.88 -68.04 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.114 2.542 . . . . 0.0 113.942 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 123' ' ' PRO . 13.3 tt0 -37.97 -33.37 0.08 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.165 -0.96 . . . . 0.0 111.277 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.485 ' CG ' HH21 ' A' ' 122' ' ' ARG . 32.2 m80 -108.39 -0.2 20.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.704 -1.248 . . . . 0.0 109.537 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -155.84 165.55 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.188 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 126' ' ' ILE . 1.4 m -114.03 170.07 8.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.817 -1.177 . . . . 0.0 111.218 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 131' ' ' LEU . 37.5 t80 -69.23 -24.75 64.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.579 -0.701 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.86 -13.02 60.27 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.587 ' HG2' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -75.62 -45.55 36.78 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -77.13 -27.62 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 119.964 -1.71 . . . . 0.0 108.296 178.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.452 HD22 ' CZ ' ' A' ' 68' ' ' PHE . 1.1 mm? -72.62 -57.46 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 110.12 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -52.55 -45.0 66.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 13.3 t -50.1 -37.17 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 0.0 109.29 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.807 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 28.1 t80 -71.44 -47.29 56.74 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.925 -1.109 . . . . 0.0 110.653 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 83.4 m95 -72.18 -14.37 61.79 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.568 -1.332 . . . . 0.0 110.877 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.62 -17.25 19.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.865 -1.147 . . . . 0.0 113.15 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.6 p30 -133.33 63.13 1.64 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 119.983 -1.698 . . . . 0.0 112.861 -177.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.807 ' NE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 p-80 173.17 177.93 0.1 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.615 1.197 . . . . 0.0 110.643 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.631 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -111.56 90.16 11.99 Favored Pre-proline 0 C--N 1.286 -2.154 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.289 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 190' ' ' THR . 33.9 Cg_endo -74.39 -17.39 21.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.501 2.134 . . . . 0.0 112.535 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 190' ' ' THR . 0.3 OUTLIER -89.3 29.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.8 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.631 ' NE2' ' CG ' ' A' ' 140' ' ' ASP . 30.9 mt-30 -129.96 82.64 2.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -37.7 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.496 2.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.28 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.661 ' O ' ' SD ' ' A' ' 145' ' ' MET . 1.8 ppp? -67.25 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -1.142 . . . . 0.0 110.876 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.695 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -152.6 160.43 43.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.057 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.695 ' NE2' ' O ' ' A' ' 146' ' ' ARG . 26.6 mm-40 -153.38 96.52 2.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.413 -1.429 . . . . 0.0 109.044 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.86 -113.94 2.82 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.56 ' H ' HD11 ' A' ' 220' ' ' LEU . 1.8 m-20 -79.29 -32.41 43.54 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.361 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.493 ' HB3' ' CD1' ' A' ' 155' ' ' TYR . 3.6 m-20 -82.63 130.38 35.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.217 -1.552 . . . . 0.0 109.123 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 p90 -128.89 145.62 51.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 0.0 110.028 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 140.41 -165.29 26.1 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -22.43 22.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.447 -1.031 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.596 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 8.7 pm0 -91.83 -5.39 53.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.109 -0.994 . . . . 0.0 108.9 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 103' ' ' TYR . 47.6 m-85 -113.01 61.89 0.64 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.546 HH11 ' CA ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -124.03 168.59 12.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 67.5 p -92.05 141.62 28.41 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.47 ' HA ' ' N ' ' A' ' 192' ' ' ASP . . . -168.17 111.31 0.6 Allowed 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 116.981 -1.888 . . . . 0.0 111.512 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.786 HG23 ' CG2' ' A' ' 191' ' ' THR . 60.2 t -92.41 143.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.051 -1.059 . . . . 0.0 109.18 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -136.14 107.85 9.6 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.05 173.82 12.96 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.556 2.171 . . . . 0.0 112.289 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.6 OUTLIER -89.97 -19.66 24.22 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.184 -0.948 . . . . 0.0 109.009 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.607 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER 167.33 -173.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.329 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.607 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -47.75 -15.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.978 1.371 . . . . 0.0 108.588 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.59 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.7 t -55.17 -65.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.156 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 20.2 mt-30 -78.63 -24.74 45.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.8 ttp -53.51 -41.96 66.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.994 -1.066 . . . . 0.0 110.497 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.26 8.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 110.221 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.07 -36.88 34.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.85 -51.83 59.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LEU . . . . . 0.495 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -52.74 -34.96 55.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.942 . . . . 0.0 109.562 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -34.34 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.425 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -75.41 -36.82 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -67.53 -57.04 7.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.9 . . . . 0.0 110.048 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.91 2.68 6.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -75.87 -52.35 10.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 109.847 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 4.0 m-85 -79.47 -7.46 58.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.502 ' C ' ' CD ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -70.69 -53.92 13.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 179' ' ' LYS . 23.4 tttm -73.22 -15.41 61.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.432 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 176' ' ' GLU . 44.9 t -82.28 -55.5 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 110.274 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 181' ' ' LEU . 4.4 mt -76.37 -27.26 56.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.996 -1.065 . . . . 0.0 109.983 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.4 p -55.99 -14.0 2.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 109.551 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -88.27 -1.04 57.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.446 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 37.3 m-70 -108.26 4.28 24.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.754 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 5.3 t-20 71.77 8.42 6.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.441 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.36 164.43 19.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 108.868 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.794 ' N ' ' CD ' ' A' ' 188' ' ' PRO . . . 92.7 24.64 22.86 Favored Glycine 0 C--N 1.302 -1.324 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.794 ' CD ' ' N ' ' A' ' 187' ' ' GLY . 27.7 Cg_endo -66.06 104.67 0.74 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.64 -1.331 . . . . 0.0 108.64 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.638 ' O ' HD12 ' A' ' 189' ' ' ILE . 1.7 pp -47.01 143.86 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 123.019 1.39 . . . . 0.0 111.386 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 141' ' ' PRO . 69.5 p -121.54 4.75 10.13 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.005 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.786 ' CG2' HG23 ' A' ' 159' ' ' VAL . 72.4 m -42.79 115.45 0.73 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 159' ' ' VAL . 4.0 t0 -75.43 125.13 28.39 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.51 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.21 110.52 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.654 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.524 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 64.8 mtm-85 -146.24 -170.56 3.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.775 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -142.84 166.55 24.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.685 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.47 70.19 1.35 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.431 ' CD ' ' N ' ' A' ' 197' ' ' GLN . 4.3 pm0 -139.16 146.9 41.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.909 -1.348 . . . . 0.0 109.708 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.636 HG23 ' N ' ' A' ' 199' ' ' PHE . 0.7 OUTLIER -98.32 -176.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.087 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.636 ' N ' HG23 ' A' ' 198' ' ' VAL . 46.8 t80 -125.35 130.7 52.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -1.0 . . . . 0.0 109.894 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.702 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 19.9 m-85 -126.67 100.19 6.1 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.331 -0.856 . . . . 0.0 109.212 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.27 136.38 43.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.922 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.462 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -87.69 -169.67 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.7 pt-20 -75.18 167.81 21.2 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 108.915 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.705 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.27 -48.82 80.19 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.987 -1.071 . . . . 0.0 108.692 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.49 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.44 -22.65 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.68 ' HD1' ' HD1' ' A' ' 73' ' ' PHE . 11.8 m-70 -94.0 13.16 23.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.989 -1.069 . . . . 0.0 110.537 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.6 mm-40 -130.32 -141.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.694 1.235 . . . . 0.0 110.899 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.664 ' OE1' ' N ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.03 -2.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.51 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 28.6 t80 -38.41 -42.8 0.77 Allowed 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.595 -1.315 . . . . 0.0 110.496 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 74' ' ' TRP . 9.5 mt -70.47 -25.05 63.0 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.316 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . 1.004 ' OG ' HG22 ' A' ' 50' ' ' VAL . 8.0 t -73.47 -40.5 64.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.077 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.477 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 2.0 mtmm -88.25 -38.05 15.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.318 -0.864 . . . . 0.0 110.034 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 215' ' ' ASP . 1.2 m-80 -101.03 107.65 50.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.14 6.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.766 2.31 . . . . 0.0 113.05 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 213' ' ' ASN . 1.9 t70 -63.14 -16.71 60.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.735 -1.228 . . . . 0.0 109.851 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.84 ' O ' HD22 ' A' ' 210' ' ' LEU . . . 65.59 -68.45 0.11 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.788 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 53.2 t80 171.94 -175.87 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -1.111 . . . . 0.0 109.256 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.788 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 4.5 m -93.08 -125.65 0.1 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.152 -0.968 . . . . 0.0 109.004 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.629 ' O ' ' CG ' ' A' ' 220' ' ' LEU . . . -127.19 148.0 17.21 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.629 ' CG ' ' O ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER 146.92 160.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.47 116.87 1.22 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 139' ' ' HIS . . . 158.03 131.86 1.35 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.434 ' OG1' ' CD ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -115.32 -14.24 11.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.501 -1.0 . . . . 0.0 110.028 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 171.09 54.28 0.04 OUTLIER Glycine 0 C--N 1.306 -1.119 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 227' ' ' CYS . 96.2 t -82.66 135.86 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.355 -1.085 . . . . 0.0 109.346 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.8 t -77.35 23.21 0.21 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.933 1.349 . . . . 0.0 109.409 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.579 ' H ' HG12 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -71.21 -67.53 0.57 Allowed Pre-proline 0 C--N 1.262 -3.207 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.58 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 34.1 Cg_endo -64.51 -6.58 12.32 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.052 1.835 . . . . 0.0 110.184 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.536 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -67.02 154.53 40.95 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.034 0.921 . . . . 0.0 110.155 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -33.67 149.3 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.322 0.582 . . . . 0.0 109.759 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 2.4 mm -135.67 111.16 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.245 -0.91 . . . . 0.0 109.302 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -78.47 158.38 28.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 121.324 -0.86 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 0.477 ' H41' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.632 ' OD1' ' N ' ' A' ' 24' ' ' SER . 45.0 p-10 -46.23 -35.78 5.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -1.193 . . . . 0.0 109.049 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.661 ' C ' ' H ' ' A' ' 26' ' ' SER . 1.8 t -51.09 -18.18 0.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -49.54 -9.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 123.056 1.408 . . . . 0.0 109.523 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.661 ' H ' ' C ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -47.19 -17.91 0.08 Allowed 'General case' 0 C--N 1.262 -3.236 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.127 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.855 ' O ' H122 ' A' ' 21' ' ' MYR . 0.1 OUTLIER -103.14 25.39 9.52 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 123.959 1.838 . . . . 0.0 108.071 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 25' ' ' ALA . 47.9 t -139.66 36.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.19 0 CA-C-N 112.107 -2.315 . . . . 0.0 105.382 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.65 132.07 19.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.765 -175.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.19 124.72 25.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.762 0.791 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -56.06 -22.75 29.43 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.616 -0.678 . . . . 0.0 109.758 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -83.87 -0.76 52.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.559 ' O ' ' NZ ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -112.65 -4.62 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.68 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . . . -61.66 -171.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.808 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.5 mm? -77.33 165.38 52.21 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.44 -44.17 19.41 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.077 1.851 . . . . 0.0 112.15 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' NE ' ' A' ' 38' ' ' ARG . . . 120.48 142.19 6.48 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.709 ' HE ' ' CA ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -109.09 -179.4 3.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -1.162 . . . . 0.0 109.468 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -124.33 0.77 8.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.636 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -97.9 126.4 40.74 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.518 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.97 169.24 20.84 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.492 2.128 . . . . 0.0 112.371 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.633 ' CG1' ' O ' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -139.26 89.72 12.14 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 109.454 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.22 175.24 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.908 2.406 . . . . 0.0 112.558 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 204' ' ' ASP . 16.2 m -138.87 -174.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.668 ' OG1' ' NE2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -59.9 97.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 109.513 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -55.99 -49.19 74.31 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.261 -0.899 . . . . 0.0 111.426 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' O ' ' C ' ' A' ' 48' ' ' HIS . 20.3 mttm -71.03 99.91 1.9 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.906 -2.317 . . . . 0.0 108.241 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.67 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 5.0 t-80 -33.45 101.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.788 ' ND1' ' N ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -53.24 -12.34 0.38 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.341 -0.849 . . . . 0.0 112.077 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 88.2 t -82.49 -50.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.455 -1.403 . . . . 0.0 108.482 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -99.56 -40.41 7.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.523 -0.736 . . . . 0.0 109.768 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.04 2.42 51.76 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 30.2 p30 -77.83 -120.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.715 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 ttm-85 -131.76 167.87 18.78 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 123.286 1.517 . . . . 0.0 109.481 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.886 ' O ' HG13 ' A' ' 56' ' ' VAL . 66.7 p -134.77 34.34 3.17 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.071 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 55' ' ' THR . 2.0 m -168.82 147.21 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 109.49 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 7.6 pt-20 -33.73 145.25 0.15 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 110.057 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.19 161.52 84.8 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.741 -1.774 . . . . 0.0 110.363 0.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 70.8 m-85 -102.37 151.57 38.18 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 59' ' ' PHE . 51.9 Cg_exo -47.6 -178.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.26 1.973 . . . . 0.0 111.983 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.634 ' O ' ' NE ' ' A' ' 122' ' ' ARG . 88.7 mt-10 -79.23 133.73 36.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.68 ' O ' ' NE ' ' A' ' 122' ' ' ARG . . . 49.88 72.01 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.591 ' O ' ' SD ' ' A' ' 65' ' ' MET . 0.8 OUTLIER -90.97 134.36 34.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -1.208 . . . . 0.0 110.105 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.802 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.5 tp60 -97.94 120.41 38.29 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.759 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -133.72 158.59 42.89 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.908 -177.488 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.63 -166.02 2.38 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG11 ' HD2' ' A' ' 160' ' ' TYR . 44.5 t -140.82 115.63 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.084 -1.635 . . . . 0.0 108.595 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 132' ' ' LEU . 72.9 m-85 -111.6 148.66 32.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 110.489 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.79 99.31 0.61 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 2.1 ttt -98.08 -91.07 0.27 Allowed 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.648 -0.913 . . . . 0.0 109.179 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.667 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.4 -149.53 5.99 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.74 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -35.12 104.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.038 . . . . 0.0 108.368 179.103 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CZ ' ' CD ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -54.97 7.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.842 -1.161 . . . . 0.0 111.426 -177.259 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.967 ' O ' HD21 ' A' ' 210' ' ' LEU . 5.9 m0 -74.38 -40.41 62.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.568 -1.332 . . . . 0.0 108.694 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.6 -14.29 25.84 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.814 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.693 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -66.31 -53.5 35.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.668 -1.49 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.635 ' OE2' ' NE2' ' A' ' 208' ' ' GLN . 1.3 tm-20 -82.64 -14.63 54.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.929 . . . . 0.0 110.77 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -58.02 -68.12 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.787 -1.196 . . . . 0.0 109.653 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 82' ' ' VAL . 49.5 mttt -53.36 -5.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.157 -0.965 . . . . 0.0 110.511 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.693 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 11.3 m-85 -90.82 -42.02 10.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.784 -1.197 . . . . 0.0 110.196 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -68.84 -4.79 17.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.712 -1.242 . . . . 0.0 109.323 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 79' ' ' LYS . 2.5 m -97.39 6.74 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.44 HD13 HD11 ' A' ' 126' ' ' ILE . 31.3 mt -85.12 142.41 29.53 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.244 1.021 . . . . 0.0 108.999 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -79.77 131.64 35.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.078 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' C ' ' HG3' ' A' ' 123' ' ' PRO . . . 101.36 -29.19 13.05 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.9 132.97 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.225 -1.162 . . . . 0.0 110.231 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.702 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -79.93 -53.67 6.53 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.516 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 2.3 p -151.73 -176.26 5.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 109.347 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.67 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 82.4 p -157.49 128.6 6.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.38 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.576 ' CD ' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.2 153.03 49.88 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.664 HG23 ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.94 175.54 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 108.903 179.494 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 167.88 177.59 39.29 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.022 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.634 ' N ' ' O ' ' A' ' 200' ' ' TYR . 28.0 m-85 -82.28 166.45 19.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.965 . . . . 0.0 109.395 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.681 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -177.41 -179.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 109.765 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.17 27.37 10.73 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -123.35 -176.82 14.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -135.63 78.16 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.101 . . . . 0.0 109.837 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.4 m -157.07 142.67 17.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 109.196 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -54.06 -84.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.854 . . . . 0.0 109.576 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.459 ' O ' ' CG ' ' A' ' 38' ' ' ARG . 23.7 m120 -118.86 82.69 21.24 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HB2' HG13 ' A' ' 106' ' ' VAL . 72.0 Cg_endo -79.71 161.83 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.847 2.365 . . . . 0.0 112.105 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 106' ' ' VAL . 21.7 p -121.33 169.93 10.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.164 -0.96 . . . . 0.0 109.803 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.47 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 7.8 t80 -56.26 -58.84 6.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -27.05 65.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 109.02 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 102' ' ' THR . 2.0 mt-10 -75.4 -53.27 8.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.726 -0.609 . . . . 0.0 111.159 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 102' ' ' THR . 12.7 m -61.24 -24.3 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.621 ' C ' ' H ' ' A' ' 109' ' ' GLU . 90.7 m -64.65 -38.31 90.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 109.382 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 110' ' ' LYS . 89.3 p -53.8 -0.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.316 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 107' ' ' CYS . 28.8 mt-10 64.89 -5.27 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.559 ' NZ ' ' O ' ' A' ' 33' ' ' GLU . 1.5 mmpt? -66.97 -32.76 74.23 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.178 -0.951 . . . . 0.0 109.67 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.57 ' OG1' HG12 ' A' ' 106' ' ' VAL . 3.7 p -93.51 -0.34 56.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 109.764 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 34.25 55.6 0.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.681 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 1.5 m-70 -93.35 174.54 7.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.907 -1.349 . . . . 0.0 108.813 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.769 ' CB ' HH12 ' A' ' 156' ' ' ARG . . . -129.72 114.97 16.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.66 ' CD ' ' CZ ' ' A' ' 73' ' ' PHE . 3.8 mt-10 -56.44 105.83 0.24 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 94' ' ' ALA . 4.4 m -124.68 159.03 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.134 -0.979 . . . . 0.0 110.499 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.585 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -116.49 122.53 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.645 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.09 97.12 9.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.811 HG21 HD23 ' A' ' 131' ' ' LEU . 1.7 m -100.93 129.4 51.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.78 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.533 HG23 ' OE1' ' A' ' 90' ' ' GLN . 55.1 t -94.79 126.27 47.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.802 ' O ' ' N ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -157.18 142.05 16.89 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.535 -1.266 . . . . 0.0 111.725 -178.784 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ARG . . . . . 1.033 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -165.67 17.15 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 123.612 0.765 . . . . 0.0 110.294 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 1.033 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 7.1 Cg_endo -50.88 -15.68 1.97 Allowed 'Trans proline' 0 C--N 1.294 -2.292 0 C-N-CA 124.189 3.259 . . . . 0.0 115.79 -176.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 1.7 tm-20 70.54 -6.62 1.17 Allowed 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.703 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -111.7 -12.98 13.81 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.33 1.062 . . . . 0.0 108.329 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -152.8 118.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -129.76 -175.4 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.526 -1.359 . . . . 0.0 112.559 -177.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.563 ' CD1' ' C ' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -48.28 -46.54 36.04 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.628 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.673 ' O ' ' CD2' ' A' ' 132' ' ' LEU . 6.0 pt-20 -59.66 -26.57 65.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.502 ' CB ' HD13 ' A' ' 126' ' ' ILE . 9.0 mm-40 -75.31 -66.25 0.79 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.304 -0.872 . . . . 0.0 111.558 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.811 HD23 HG21 ' A' ' 119' ' ' VAL . 9.8 mp -57.41 -23.75 51.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.838 -1.164 . . . . 0.0 113.873 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -75.73 -17.9 59.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 119.843 -1.785 . . . . 0.0 109.556 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.478 ' N ' HD23 ' A' ' 132' ' ' LEU . 7.6 mptt -70.44 -54.54 11.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.697 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 6.6 t -49.66 -40.29 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.349 -0.844 . . . . 0.0 109.046 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.631 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 21.2 t80 -61.08 -41.99 97.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.793 -1.192 . . . . 0.0 110.63 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.71 ' CZ2' ' CA ' ' A' ' 173' ' ' SER . 45.4 m0 -71.51 -50.47 31.04 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.75 -1.219 . . . . 0.0 111.735 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.02 -57.46 12.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 111.73 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.6 OUTLIER -83.3 54.23 2.74 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 112.113 -177.378 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.764 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 20.7 m80 -161.11 176.91 10.81 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.733 ' O ' ' N ' ' A' ' 142' ' ' THR . 0.3 OUTLIER -129.16 70.22 81.54 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 190' ' ' THR . 80.4 Cg_exo -39.39 -0.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.427 2.752 . . . . 0.0 113.627 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -105.88 22.7 15.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.671 -1.268 . . . . 0.0 110.814 -179.639 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.681 ' N ' ' OG1' ' A' ' 190' ' ' THR . 40.3 mt-30 -134.04 78.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 156' ' ' ARG . . . -75.47 12.66 7.34 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.159 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.642 ' O ' ' O ' ' A' ' 152' ' ' GLY . 2.2 ptt? -118.0 -21.82 8.13 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.305 . . . . 0.0 109.911 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' CD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -152.31 168.88 23.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 111.053 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.58 ' OE1' ' O ' ' A' ' 155' ' ' TYR . 5.2 mm100 -120.21 58.77 0.91 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.08 -113.84 3.73 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.823 ' H ' HD11 ' A' ' 220' ' ' LEU . 12.6 t-20 -81.21 11.41 4.28 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 114.771 -0.715 . . . . 0.0 110.874 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.489 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -107.3 87.81 2.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.769 -1.207 . . . . 0.0 109.146 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.453 ' HA ' ' CG ' ' A' ' 146' ' ' ARG . 3.4 m-85 -65.49 115.87 6.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.411 -0.805 . . . . 0.0 110.674 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 166.62 150.78 6.52 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 117.687 -2.197 . . . . 0.0 111.777 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.442 HG21 ' HA ' ' A' ' 27' ' ' LYS . 5.1 p -74.26 -20.23 60.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.701 -0.882 . . . . 0.0 109.325 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.737 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 7.3 pm0 -87.15 -6.69 58.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.58 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 26.4 m-85 -97.11 57.27 1.46 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.108 HH21 ' C13' ' A' ' 21' ' ' MYR . 0.0 OUTLIER -117.63 165.72 13.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.725 -0.61 . . . . 0.0 109.66 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.85 106.03 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -125.21 124.09 40.97 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.06 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.725 HG23 ' CG2' ' A' ' 191' ' ' THR . 10.6 t -113.48 123.27 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.3 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 0.517 ' CG ' ' NE2' ' A' ' 197' ' ' GLN . 3.9 m-30 -118.51 121.53 30.87 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.73 166.25 23.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.462 2.108 . . . . 0.0 112.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.87 1.82 27.14 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 120.796 -1.19 . . . . 0.0 108.793 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER 167.76 170.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 0.0 108.862 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.62 -15.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.04 1.4 . . . . 0.0 108.361 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.5 t -56.05 -64.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.496 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 33.8 mt-30 -78.94 -18.39 53.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.719 -0.613 . . . . 0.0 110.9 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 14.3 ttm -53.16 -46.85 69.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.24 -16.93 60.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 0.0 109.617 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.77 -57.29 2.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.838 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 172' ' ' ARG . . . -52.13 -43.52 64.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.135 -0.978 . . . . 0.0 109.457 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -11.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.246 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 170' ' ' ALA . 75.9 mtt180 -74.78 -39.52 61.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.335 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.71 ' CA ' ' CZ2' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -54.48 -33.1 59.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.055 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.56 -57.44 4.15 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 113.199 -1.819 . . . . 0.0 110.21 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.17 -52.48 12.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 0.0 111.894 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.576 ' O ' ' OE1' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -55.19 -50.64 68.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.921 -1.112 . . . . 0.0 110.742 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.477 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 0.1 OUTLIER -70.99 -13.74 62.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.157 . . . . 0.0 109.907 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.57 ' O ' ' OG ' ' A' ' 182' ' ' SER . 22.0 tp60 -75.01 -48.31 24.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 109.757 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -19.17 55.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 92.7 t -87.23 -52.64 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 181' ' ' LEU . 4.0 mm? -71.95 -44.53 63.43 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.116 -0.99 . . . . 0.0 109.586 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 86.3 p -55.79 -26.59 46.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.016 . . . . 0.0 109.002 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.06 -27.93 21.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.108 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.461 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 1.4 m80 -80.78 15.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.875 . . . . 0.0 109.388 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 17.7 t-20 72.37 48.93 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.937 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.491 ' HE1' ' HG ' ' A' ' 227' ' ' CYS . 0.4 OUTLIER -114.25 -176.72 2.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.0 108.933 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -104.21 -168.94 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.3 Cg_exo -58.81 116.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.519 2.146 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.477 ' C ' HG23 ' A' ' 190' ' ' THR . 0.3 OUTLIER -48.01 176.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 110.145 -179.306 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.681 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 71.2 p -156.98 76.23 0.85 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.597 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' THR . . . . . 0.725 ' CG2' HG23 ' A' ' 159' ' ' VAL . 8.1 m -101.53 122.83 44.54 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.65 ' CG ' HH21 ' A' ' 194' ' ' ARG . 2.1 t0 -81.11 115.98 20.81 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.951 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.69 128.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.386 -0.821 . . . . 0.0 109.396 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.65 HH21 ' CG ' ' A' ' 192' ' ' ASP . 4.7 ptt180 -165.36 173.03 11.58 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.646 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -120.49 -178.66 3.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.909 -1.119 . . . . 0.0 110.431 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 54.89 35.87 59.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.573 ' O ' ' O ' ' A' ' 198' ' ' VAL . 1.8 mp0 -84.11 80.44 9.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.866 -1.373 . . . . 0.0 109.243 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 197' ' ' GLN . 9.8 p -33.31 156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 110.198 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.525 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 65.0 t80 -117.95 138.77 51.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 109.054 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 1.7 m-85 -140.34 113.94 8.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.096 -1.003 . . . . 0.0 109.819 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.66 142.99 21.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -91.26 -168.1 1.97 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.444 -0.785 . . . . 0.0 109.104 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.58 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 2.9 mt-10 -73.38 163.85 27.49 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-O 122.469 1.128 . . . . 0.0 110.372 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.71 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -54.67 -44.26 73.17 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -70.63 4.17 2.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.304 -0.873 . . . . 0.0 110.576 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.499 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 9.4 m-70 -102.99 14.75 31.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.0 OUTLIER -135.74 -150.08 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.971 -1.081 . . . . 0.0 110.178 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.76 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -36.55 -7.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.138 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 2.2 t80 -43.9 -47.09 8.31 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 120.762 -1.211 . . . . 0.0 111.361 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.967 HD21 ' O ' ' A' ' 74' ' ' TRP . 3.6 pp -82.64 -12.26 57.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.0 -1.687 . . . . 0.0 109.947 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.493 ' OG ' HG22 ' A' ' 50' ' ' VAL . 37.3 t -55.83 -50.86 69.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.496 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.2 pttm -70.19 4.9 1.91 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 215' ' ' ASP . 34.6 m120 -142.52 68.01 20.13 Favored Pre-proline 0 N--CA 1.487 1.413 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -48.53 11.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.571 2.848 . . . . 0.0 112.702 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 213' ' ' ASN . 33.9 t70 -61.88 -20.29 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.664 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 60.69 86.15 0.04 OUTLIER Glycine 0 CA--C 1.552 2.371 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.17 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.664 ' O ' ' O ' ' A' ' 216' ' ' GLY . 39.1 t80 -52.11 -150.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 120.538 2.169 . . . . 0.0 109.308 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 49.4 m -71.75 -124.28 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.002 -1.686 . . . . 0.0 109.419 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . 58.72 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.823 HD11 ' H ' ' A' ' 149' ' ' ASN . 0.4 OUTLIER -109.06 -155.74 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.212 . . . . 0.0 109.978 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 138' ' ' ASN . . . -118.73 -73.99 0.44 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . -175.02 134.05 2.63 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.1 t -111.84 7.04 19.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -1.017 . . . . 0.0 109.631 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -75.58 -8.52 84.2 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 226' ' ' SER . 3.2 p -60.37 165.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.827 -0.808 . . . . 0.0 109.852 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 229' ' ' MET . 14.8 m -44.9 106.56 0.08 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 123.173 1.464 . . . . 0.0 109.24 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.58 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.1 OUTLIER -76.32 -66.1 0.39 Allowed Pre-proline 0 C--N 1.278 -2.54 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.994 -179.385 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.58 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 28.0 Cg_endo -64.25 1.29 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.273 1.982 . . . . 0.0 109.779 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.548 ' O ' ' C ' ' A' ' 230' ' ' ALA . 2.2 ptm -54.99 158.63 2.72 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.726 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.83 130.42 0.08 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.0 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.669 ' O ' ' N ' ' A' ' 233' ' ' LYS . 2.0 mm -144.5 115.52 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.193 -0.942 . . . . 0.0 109.273 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 231' ' ' ILE . 4.4 ttpm? -44.51 85.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.517 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.353 0 O-C-N 121.226 -0.921 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 1.108 ' C13' HH21 ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 1.229 ' O ' ' O1 ' ' A' ' 21' ' ' MYR . . . . . . . . 0 N--CA 1.493 2.442 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.438 ' C ' ' N ' ' A' ' 25' ' ' ALA . 17.8 t70 49.03 -80.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -1.13 . . . . 0.0 109.279 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 22' ' ' GLY . 4.8 p -50.24 -16.75 0.35 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 108.917 179.255 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -48.6 -9.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.991 1.377 . . . . 0.0 109.649 -179.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.652 ' H ' ' C ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -47.24 -31.98 4.17 Favored 'General case' 0 C--N 1.259 -3.364 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.346 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.991 ' NZ ' ' H51' ' A' ' 21' ' ' MYR . 0.1 OUTLIER -95.66 25.83 4.34 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 124.305 2.002 . . . . 0.0 108.062 179.491 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 25' ' ' ALA . 40.0 t -142.58 47.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 CA-C-N 112.427 -2.17 . . . . 0.0 105.984 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -64.37 128.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 122.256 1.027 . . . . 0.0 113.128 -175.311 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.05 124.27 30.91 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.908 0.861 . . . . 0.0 110.126 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' CB ' ' NE2' ' A' ' 97' ' ' HIS . . . -49.05 -26.41 2.61 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.14 -22.77 62.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.115 -0.991 . . . . 0.0 110.251 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -116.69 6.95 13.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.2 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -83.17 -165.06 0.98 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.491 -179.665 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.819 ' CB ' HG23 ' A' ' 98' ' ' THR . 0.4 OUTLIER -84.62 171.25 11.45 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.093 -1.004 . . . . 0.0 108.913 -179.528 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.6 -49.4 0.82 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.651 2.234 . . . . 0.0 113.864 -178.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA2' ' N ' ' A' ' 99' ' ' ARG . . . 92.26 114.14 2.07 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.938 -179.443 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.473 ' N ' ' HA ' ' A' ' 99' ' ' ARG . 77.0 mtt180 -100.08 143.56 30.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.875 -1.367 . . . . 0.0 109.445 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.574 ' O ' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -75.36 34.07 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 0.0 109.698 -179.854 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 38' ' ' ARG . 27.5 tp10 -110.68 94.58 20.04 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.883 ' O ' HD13 ' A' ' 42' ' ' ILE . 71.3 Cg_endo -80.83 -178.46 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.802 2.335 . . . . 0.0 112.311 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 41' ' ' PRO . 2.8 mm -132.45 90.71 32.91 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.623 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.93 172.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.803 2.335 . . . . 0.0 112.231 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 17.2 m -151.64 -178.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.49 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.246 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.907 ' O ' HG23 ' A' ' 55' ' ' THR . . . -56.07 -40.61 73.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.482 -0.761 . . . . 0.0 111.052 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttt -74.04 99.23 3.26 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 115.877 -2.329 . . . . 0.0 108.055 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.918 ' CE1' ' HG1' ' A' ' 89' ' ' THR . 4.4 t-80 -34.11 114.07 0.19 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.639 ' CD2' ' HE3' ' A' ' 212' ' ' LYS . 20.9 t-80 -63.05 -31.81 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.657 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.563 HG23 ' HG3' ' A' ' 208' ' ' GLN . 5.3 t -66.71 -38.33 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.936 -1.103 . . . . 0.0 109.484 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -111.08 -44.28 3.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.91 -0.1 51.84 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.74 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 31.9 p30 -77.22 -121.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.74 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.6 ttt180 -131.15 166.88 20.13 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.056 1.408 . . . . 0.0 108.68 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 46' ' ' ALA . 30.5 p -129.03 34.35 4.46 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.421 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' ' 55' ' ' THR . 0.2 OUTLIER -172.63 149.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.037 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -31.63 139.37 0.19 Allowed Pre-proline 0 C--N 1.299 -1.603 0 CA-C-O 121.266 0.555 . . . . 0.0 110.152 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.36 167.26 79.86 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.479 -1.884 . . . . 0.0 111.783 0.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.43 147.3 35.76 Favored Pre-proline 0 C--N 1.271 -2.837 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.34 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 63' ' ' THR . 51.5 Cg_exo -49.39 120.64 5.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.593 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' PRO . 20.3 mm-40 -42.73 118.3 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.799 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 123' ' ' PRO . . . 92.5 44.51 3.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -121.11 142.56 49.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.799 -1.412 . . . . 0.0 110.093 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 65' ' ' MET . 2.2 tm0? -108.53 143.93 36.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.03 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.75 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.8 103.86 5.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.905 -1.122 . . . . 0.0 110.163 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.522 ' HB1' HE22 ' A' ' 166' ' ' GLN . . . -93.08 -169.36 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.027 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 2.2 t -143.62 144.2 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 119.913 -1.742 . . . . 0.0 109.218 179.261 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.495 ' O ' HG12 ' A' ' 116' ' ' VAL . 22.1 m-85 -135.79 143.71 45.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.431 178.797 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.8 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -134.82 90.34 0.24 Allowed Glycine 0 N--CA 1.482 1.761 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.174 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' MET . . . . . 0.918 ' SD ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.93 -74.53 0.61 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -163.59 -156.09 8.53 Favored Glycine 0 C--N 1.3 -1.444 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' CYS . . . . . 0.632 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -23.36 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 122.144 -0.621 . . . . 0.0 109.763 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -53.77 7.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.313 -0.867 . . . . 0.0 111.178 -178.497 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' TRP . . . . . 0.603 ' H ' ' C ' ' A' ' 72' ' ' CYS . 35.9 m0 -68.98 -44.56 72.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.596 -1.315 . . . . 0.0 108.21 179.014 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' SG ' ' A' ' 218' ' ' CYS . . . -98.87 -15.64 33.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.918 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -68.45 -45.07 73.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.939 -1.33 . . . . 0.0 109.85 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.766 ' OE1' HG13 ' A' ' 91' ' ' VAL . 23.5 tt0 -82.66 -20.38 36.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 11.7 ttt-85 -60.54 -46.38 90.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.867 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.45 12.58 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.003 -1.06 . . . . 0.0 110.355 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 37.0 m-85 -124.16 -11.27 7.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 111.136 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' TRP . . . . . 0.521 ' CE2' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -106.83 13.18 28.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.579 -1.326 . . . . 0.0 109.414 179.25 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.8 m -109.26 8.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.089 -1.007 . . . . 0.0 111.238 -178.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.764 ' N ' HD13 ' A' ' 83' ' ' LEU . 0.0 OUTLIER -118.69 166.1 13.17 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.87 -1.144 . . . . 0.0 108.789 179.298 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.541 ' C ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -93.96 144.16 25.71 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 109.459 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.13 -33.69 4.92 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.73 133.77 31.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.639 -0.918 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.698 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -83.38 -45.68 13.43 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 108.747 -179.844 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 55' ' ' THR . 22.9 t -150.01 -166.56 2.58 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.053 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.918 ' HG1' ' CE1' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -169.92 113.7 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.57 ' OE1' ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -126.68 163.79 22.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 109.913 -178.218 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.766 HG13 ' OE1' ' A' ' 77' ' ' GLU . 1.3 m -143.36 150.38 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.069 -1.02 . . . . 0.0 110.457 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . -160.14 178.04 36.36 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 5.4 m-85 -78.73 177.84 8.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.156 -1.202 . . . . 0.0 108.427 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.88 ' HB1' HG13 ' A' ' 198' ' ' VAL . . . -174.39 159.33 3.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.193 -1.567 . . . . 0.0 113.063 -178.053 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.46 20.1 60.83 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.51 -0.744 . . . . 0.0 111.432 178.01 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.736 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -139.0 175.08 21.78 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' HIS . . . . . 0.708 ' H ' ' HD1' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -158.87 95.88 1.32 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.117 -1.226 . . . . 0.0 110.648 -178.631 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.819 HG23 ' CB ' ' A' ' 35' ' ' LEU . 21.0 m -142.3 122.57 13.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 109.681 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.646 ' C ' ' O ' ' A' ' 98' ' ' THR . 1.2 mtp180 10.79 -89.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.862 0.839 . . . . 0.0 109.873 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.569 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m-80 -120.9 90.31 46.64 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 8.8 Cg_exo -68.86 114.66 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.667 2.245 . . . . 0.0 113.358 -177.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.566 ' O ' HG22 ' A' ' 106' ' ' VAL . 19.2 p -121.35 158.9 27.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.639 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.628 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.1 OUTLIER -49.77 -42.13 45.81 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.51 -179.069 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 5.1 tttt -73.06 -27.56 61.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.93 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE1' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -83.14 -41.43 18.52 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.974 -1.079 . . . . 0.0 110.412 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 102' ' ' THR . 6.8 m -57.4 -23.97 20.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.676 -1.265 . . . . 0.0 109.54 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 109' ' ' GLU . 5.8 m -52.92 -43.84 66.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.602 ' C ' ' H ' ' A' ' 110' ' ' LYS . 39.3 m -46.53 -8.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.896 . . . . 0.0 108.83 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.66 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.1 tt0 60.24 -7.78 0.07 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.438 -0.789 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' LYS . . . . . 0.79 ' HB3' HD21 ' A' ' 35' ' ' LEU . 1.1 tttp -79.39 -12.98 59.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.128 -0.983 . . . . 0.0 109.185 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 p -89.6 -19.27 25.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.921 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 55.29 52.43 47.52 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' HIS . . . . . 0.736 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 2.4 m-70 -109.09 171.99 7.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.528 -1.572 . . . . 0.0 109.65 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -139.0 111.98 7.9 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLU . . . . . 0.698 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 mt-10 -54.35 131.48 42.1 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.8 HG12 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -143.02 -170.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 111.804 -178.664 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.2 m -147.5 151.09 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HD3' ' CD1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -121.22 98.4 5.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 108.681 178.57 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.66 HG21 ' CD2' ' A' ' 80' ' ' PHE . 14.4 t -88.05 120.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.86 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 125.75 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 2.5 p90 -130.14 169.88 14.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.582 -1.324 . . . . 0.0 111.065 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -117.43 118.23 35.63 Favored Pre-proline 0 N--CA 1.487 1.398 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.701 ' O ' ' N ' ' A' ' 125' ' ' HIS . 18.4 Cg_exo -42.08 -61.88 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.998 2.465 . . . . 0.0 113.602 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.687 ' OE2' ' CD2' ' A' ' 125' ' ' HIS . 6.8 tm-20 -34.92 -19.36 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.368 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' HIS . . . . . 0.701 ' N ' ' O ' ' A' ' 123' ' ' PRO . 4.2 m170 -134.34 -2.39 2.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.402 -1.436 . . . . 0.0 111.42 -179.024 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.567 HG23 ' CG ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.35 158.74 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.819 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -111.65 170.67 7.98 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.537 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -70.16 -18.72 63.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 24.6 mt-10 -65.15 -23.68 67.18 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.488 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.819 ' CD ' ' H ' ' A' ' 127' ' ' SER . 1.2 pm0 -73.38 -45.28 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.416 -1.714 . . . . 0.0 110.492 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.573 HD13 ' HB ' ' A' ' 119' ' ' VAL . 6.7 mt -64.35 -44.14 92.37 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.884 -1.76 . . . . 0.0 108.941 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 132' ' ' LEU . 0.6 OUTLIER -75.27 -27.16 59.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.042 . . . . 0.0 110.527 -179.233 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 1.4 tmtp? -70.31 -65.68 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.987 -1.071 . . . . 0.0 109.799 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.762 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 37.3 t -49.95 -22.52 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.0 t80 -72.23 -49.91 31.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.197 -0.94 . . . . 0.0 110.593 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.615 ' CG ' ' CE2' ' A' ' 177' ' ' TYR . 66.2 m95 -74.77 -60.56 2.23 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.027 -1.67 . . . . 0.0 110.967 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 136' ' ' TRP . 11.7 tt0 -36.33 -32.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 111.138 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.762 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.5 OUTLIER -131.31 69.66 1.47 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.886 -1.134 . . . . 0.0 110.088 -178.799 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.811 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 4.8 m80 -153.6 142.04 20.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.982 -1.073 . . . . 0.0 110.876 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' ASP . . . . . 0.574 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -106.9 72.18 0.3 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 190' ' ' THR . 57.7 Cg_endo -69.09 -9.14 25.51 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.984 2.456 . . . . 0.0 115.543 -177.434 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.57 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -89.99 16.6 8.01 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.242 -1.536 . . . . 0.0 111.18 -178.668 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 143' ' ' GLN . . . . . 0.574 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -131.06 89.21 2.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.948 -1.095 . . . . 0.0 108.937 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . 0.678 ' O ' ' NH1' ' A' ' 156' ' ' ARG . . . -83.81 20.67 11.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.805 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -113.76 -15.93 12.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.745 -1.444 . . . . 0.0 109.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.509 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 177.6 164.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.407 -0.808 . . . . 0.0 108.857 -179.389 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLN . . . . . 0.566 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 3.3 tp-100 -111.8 132.71 54.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.558 -1.339 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' A' ' 220' ' ' LEU . . . 43.98 -123.59 4.8 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-O 123.317 1.509 . . . . 0.0 111.122 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' ASN . . . . . 0.484 ' H ' HD21 ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.9 -32.92 40.23 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 113.388 -1.406 . . . . 0.0 112.023 -177.58 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 147' ' ' GLN . 42.4 p30 -52.46 164.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.209 -1.557 . . . . 0.0 108.564 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.5 p90 -136.72 119.72 16.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.927 -1.108 . . . . 0.0 109.98 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 153.7 165.88 14.13 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.527 -1.321 . . . . 0.0 109.992 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER -91.03 2.4 56.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -1.125 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 154' ' ' GLN . . . . . 0.631 ' OE1' ' N ' ' A' ' 154' ' ' GLN . 12.2 pm0 -90.2 -0.1 57.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.125 -0.984 . . . . 0.0 108.354 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 36.7 m-85 -123.26 57.16 1.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.436 -0.79 . . . . 0.0 109.768 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.678 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -99.39 -178.58 3.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 108.956 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -93.61 107.75 19.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 176.306 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -137.29 114.85 11.15 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 117.899 -1.521 . . . . 0.0 111.092 -176.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 192' ' ' ASP . 39.6 t -101.4 137.76 27.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.12 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' TYR . . . . . 1.101 ' CG ' HG21 ' A' ' 198' ' ' VAL . 84.4 m-85 -127.15 86.05 59.66 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 108.216 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 160' ' ' TYR . 52.0 Cg_exo -38.35 168.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.089 2.526 . . . . 0.0 112.972 -178.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -102.69 -40.65 6.52 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.144 -0.972 . . . . 0.0 109.534 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.9 OUTLIER -173.25 178.52 2.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 0.0 109.798 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.8 -23.84 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.11 1.433 . . . . 0.0 108.076 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 163' ' ' SER . 2.5 t -56.09 -56.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.863 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 166' ' ' GLN . . . . . 0.522 HE22 ' HB1' ' A' ' 66' ' ' ALA . 2.7 tt0 -78.08 -36.29 48.41 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.483 -178.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.4 ttp -52.67 -11.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 110.782 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -75.57 -53.8 8.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.758 -1.214 . . . . 0.0 110.034 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 169' ' ' ALA . . . . . 0.588 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.73 -47.93 6.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -50.97 -55.72 15.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -0.917 . . . . 0.0 110.083 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.52 -41.23 63.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.051 . . . . 0.0 109.331 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.43 -37.34 63.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.601 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.51 -39.13 72.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 174' ' ' LYS . . . . . 0.793 ' HZ3' ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -72.59 -58.27 3.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.003 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.793 ' N ' ' HZ3' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -57.22 -50.3 73.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.265 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.497 ' CD ' ' C ' ' A' ' 176' ' ' GLU . 0.9 OUTLIER -53.39 -34.99 59.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.976 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 177' ' ' TYR . . . . . 0.615 ' CE2' ' CG ' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -79.75 -35.01 39.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.023 -1.048 . . . . 0.0 109.638 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 178' ' ' GLN . . . . . 0.594 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.5 tp60 -75.13 -33.79 61.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.329 -0.857 . . . . 0.0 109.621 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -73.54 -31.25 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.332 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.06 -51.75 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.09 -39.69 66.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.988 . . . . 0.0 109.574 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 t -56.32 -32.13 64.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -88.01 0.8 55.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 184' ' ' HIS . . . . . 0.762 ' ND1' ' SG ' ' A' ' 227' ' ' CYS . 10.0 m-70 -108.33 35.97 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.677 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 28.9 t-20 68.61 58.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.58 -179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 186' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 184' ' ' HIS . 86.3 m-85 -151.8 168.5 24.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.85 -167.44 19.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HA ' ' NE2' ' A' ' 178' ' ' GLN . 10.8 Cg_endo -58.57 107.69 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.644 1.563 . . . . 0.0 110.53 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.594 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -47.22 168.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 122.21 1.005 . . . . 0.0 110.603 -178.228 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 190' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 141' ' ' PRO . 27.1 p -120.33 58.65 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.485 -179.348 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -100.12 116.11 31.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.654 ' CG ' ' NH1' ' A' ' 194' ' ' ARG . 4.0 t0 -76.51 128.24 34.38 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.551 -178.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 193' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -125.32 99.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -179.364 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 9.8 mtm-85 -135.4 152.57 51.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 195' ' ' GLU . . . . . 0.522 ' OE1' ' N ' ' A' ' 195' ' ' GLU . 1.4 mp0 -129.48 163.77 25.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.504 -1.372 . . . . 0.0 110.752 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 104.65 -22.01 35.15 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' GLN . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' VAL . 0.9 OUTLIER -142.45 -173.9 3.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.054 -1.262 . . . . 0.0 111.747 -178.691 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 198' ' ' VAL . . . . . 1.101 HG21 ' CG ' ' A' ' 160' ' ' TYR . 91.1 t 109.2 74.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.921 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 174.708 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.457 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 3.0 t80 -165.5 126.57 1.92 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 111.134 172.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -156.47 94.9 1.52 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.475 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -49.19 125.85 11.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.783 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 202' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.2 -168.69 2.26 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' GLU . . . . . 0.65 ' OE2' ' CE2' ' A' ' 205' ' ' TYR . 1.4 pt-20 -75.81 -176.51 3.39 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.0 -1.062 . . . . 0.0 108.766 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -50.06 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.831 -1.168 . . . . 0.0 110.662 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 205' ' ' TYR . . . . . 0.788 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -62.66 1.95 0.33 Allowed 'General case' 0 C--N 1.307 -1.283 0 O-C-N 120.877 -1.139 . . . . 0.0 112.144 -178.307 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.71 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 5.0 m-70 -102.04 11.6 38.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.434 -1.416 . . . . 0.0 110.942 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' GLN . . . . . 0.853 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.7 mm-40 -129.53 -141.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.641 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 208' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 89' ' ' THR . 1.0 OUTLIER -37.01 -1.36 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.389 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 209' ' ' TYR . . . . . 0.853 ' N ' ' O ' ' A' ' 207' ' ' GLN . 80.1 t80 -38.45 -42.26 0.73 Allowed 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.014 -1.054 . . . . 0.0 111.457 -178.103 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 210' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.9 OUTLIER -62.21 -47.68 83.37 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.553 -178.467 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.3 t -56.11 -38.24 70.5 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.061 -1.024 . . . . 0.0 108.873 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.639 ' HE3' ' CD2' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -88.28 -21.24 24.56 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 213' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 209' ' ' TYR . 1.4 m-80 -133.4 89.11 33.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.541 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 214' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 216' ' ' GLY . 31.7 Cg_exo -56.92 13.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 123.525 2.817 . . . . 0.0 112.08 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.592 ' H ' ' C ' ' A' ' 213' ' ' ASN . 38.0 t0 -60.92 20.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.937 . . . . 0.0 111.112 -177.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 216' ' ' GLY . . . . . 0.605 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.52 -51.47 0.14 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.868 -1.158 . . . . 0.0 112.199 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 217' ' ' TYR . . . . . 0.605 ' C ' ' O ' ' A' ' 216' ' ' GLY . 27.0 m-85 -22.32 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.905 0 CA-C-N 118.892 1.346 . . . . 0.0 110.121 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 218' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER -151.18 103.01 2.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.441 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 219' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 218' ' ' CYS . . . -36.33 151.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 220' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' A' ' 148' ' ' GLY . 0.4 OUTLIER -63.41 -175.67 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -1.142 . . . . 0.0 109.52 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.65 -67.62 0.8 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 222' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . 156.85 147.05 4.65 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 223' ' ' THR . . . . . 0.574 ' C ' ' N ' ' A' ' 225' ' ' VAL . 0.1 OUTLIER -70.29 -48.62 55.88 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.495 -1.003 . . . . 0.0 109.114 179.974 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 224' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 223' ' ' THR . . . 45.9 21.73 0.66 Allowed Glycine 0 N--CA 1.481 1.666 0 N-CA-C 105.716 -2.953 . . . . 0.0 105.716 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 225' ' ' VAL . . . . . 0.574 ' N ' ' C ' ' A' ' 223' ' ' THR . 0.4 OUTLIER -90.17 131.59 37.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.228 -0.986 . . . . 0.0 110.519 -178.272 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 226' ' ' SER . . . . . 0.68 ' H ' ' CB ' ' A' ' 229' ' ' MET . 48.4 t -98.48 -155.67 0.51 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.236 -0.915 . . . . 0.0 109.186 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 227' ' ' CYS . . . . . 0.762 ' SG ' ' ND1' ' A' ' 184' ' ' HIS . 0.1 OUTLIER -73.8 -66.64 0.49 Allowed Pre-proline 0 C--N 1.291 -1.944 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.382 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 228' ' ' PRO . . . . . 0.583 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 57.4 Cg_endo -70.37 -15.29 34.76 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.263 1.975 . . . . 0.0 110.322 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 229' ' ' MET . . . . . 0.68 ' CB ' ' H ' ' A' ' 226' ' ' SER . 2.8 mmm -55.27 154.76 5.6 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.973 0.892 . . . . 0.0 110.047 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 230' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -32.91 130.24 0.2 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.848 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 231' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 231' ' ' ILE . 1.8 mm -139.66 103.19 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.216 -0.927 . . . . 0.0 109.339 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.41 -78.51 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.472 -0.767 . . . . 0.0 109.428 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.347 0 O-C-N 121.259 -0.901 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 21' ' ' MYR . . . . . 1.229 ' O1 ' ' O ' ' A' ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 t . . . . . 0 CA--C 1.542 0.672 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -57.63 134.64 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.489 1.516 . . . . 0.0 108.946 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.28 122.01 13.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 107.972 173.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.43 -26.12 62.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.702 1.201 . . . . 0.0 111.94 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -68.81 -32.11 71.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.904 2.882 . . . . 0.0 113.07 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -91.46 -14.54 30.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.886 1.674 . . . . 0.0 111.053 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -55.12 155.71 4.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.915 1.286 . . . . 0.0 111.744 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.55 0.978 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.938 174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 pt . . . . . 0 N--CA 1.448 -0.552 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.01 165.48 32.47 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.814 1.676 . . . . 0.0 109.612 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.78 -172.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 125.289 1.436 . . . . 0.0 109.863 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 t -55.24 92.23 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.839 2.055 . . . . 0.0 109.235 165.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.4 89.08 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.836 1.254 . . . . 0.0 110.567 -169.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -81.68 117.21 21.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.087 0.955 . . . . 0.0 108.46 165.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -50.58 115.77 1.63 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.434 2.694 . . . . 0.0 110.521 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -63.27 -25.11 68.16 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.497 1.499 . . . . 0.0 112.985 -170.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.24 -46.31 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.664 1.185 . . . . 0.0 109.994 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.8 m -99.07 -46.9 5.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.881 0.872 . . . . 0.0 111.71 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 -4.62 36.18 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.567 2.032 . . . . 0.0 112.928 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -81.22 -98.36 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.173 1.789 . . . . 0.0 112.487 -172.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 56' ' ' VAL . 24.1 ttm-85 -153.84 153.99 33.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.495 1.518 . . . . 0.0 110.502 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -128.24 11.33 6.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.448 2.699 . . . . 0.0 111.443 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 m -139.5 159.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 119.914 -1.741 . . . . 0.0 107.486 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.72 147.61 70.71 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.371 1.068 . . . . 0.0 111.487 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.31 144.96 79.21 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 119.725 0.938 . . . . 0.0 111.782 2.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -87.57 141.22 31.99 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -52.85 143.47 48.24 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.012 3.142 . . . . 0.0 112.838 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -62.12 133.71 55.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.75 0.82 . . . . 0.0 110.028 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 30.22 30.97 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.9 p -111.49 139.86 46.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 163.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -105.11 157.97 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 165.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.3 143.75 38.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.009 1.723 . . . . 0.0 107.426 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.69 172.69 12.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.019 2.128 . . . . 0.0 106.789 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 50.0 t -133.42 123.47 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -134.75 128.77 33.52 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.996 1.718 . . . . 0.0 109.067 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.11 134.73 10.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 126.552 2.025 . . . . 0.0 108.407 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.4 ptp -128.3 -121.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 105.85 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.51 -154.78 29.78 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 171.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 t -44.06 117.35 1.19 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.769 2.028 . . . . 0.0 111.456 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.436 ' HB2' HG11 ' A' ' 91' ' ' VAL 0.289 0.0 OUTLIER -51.93 -11.59 0.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -176.695 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -53.66 -69.32 0.12 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.898 2.479 . . . . 0.0 114.111 165.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 -15.91 66.46 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.087 -1.008 . . . . 0.0 111.553 -171.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.5 70.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.979 1.711 . . . . 0.0 111.105 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.24 -40.65 81.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.402 1.881 . . . . 0.0 111.817 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -51.28 -52.49 44.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.893 2.077 . . . . 0.0 113.355 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.26 -3.18 12.8 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.777 1.231 . . . . 0.0 114.316 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -102.44 -27.83 12.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.825 -1.083 . . . . 0.0 112.241 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -80.87 -19.57 44.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 121.413 1.915 . . . . 0.0 111.795 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -79.56 -0.21 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 125.703 1.601 . . . . 0.0 112.281 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.9 152.34 22.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.147 1.779 . . . . 0.0 108.948 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -89.97 134.59 34.14 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.9 -13.54 45.52 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.01 0.814 . . . . 0.0 112.514 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 p -72.23 132.09 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 169.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.09 -51.09 11.65 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.1 p -161.48 171.58 17.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.314 1.845 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 p -128.45 153.97 46.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 107.885 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -145.43 160.37 41.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.009 2.124 . . . . 0.0 109.54 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -138.96 154.16 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.14 1.376 . . . . 0.0 111.103 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.86 176.55 40.63 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-O 122.237 0.91 . . . . 0.0 111.519 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.83 136.71 32.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.37 165.38 28.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.778 1.631 . . . . 0.0 107.871 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.34 2.45 79.9 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 119.747 -1.846 . . . . 0.0 114.867 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -115.16 -173.62 17.78 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.753 1.644 . . . . 0.0 110.923 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . 0.261 0.0 OUTLIER -145.42 60.76 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.325 1.45 . . . . 0.0 110.561 -167.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.52 142.35 27.95 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 129.29 3.036 . . . . 0.0 104.887 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 37.8 mtm180 -67.18 -55.56 13.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.297 0.953 . . . . 0.0 112.429 -178.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.273 43.2 m-80 -137.69 70.24 51.77 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 120.314 1.416 . . . . 0.0 112.619 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.79 152.0 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.124 1.883 . . . . 0.0 108.444 171.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.418 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 34.1 p -108.03 175.25 5.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.168 1.387 . . . . 0.0 107.617 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -53.26 -44.75 68.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 111.862 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -72.94 -30.01 63.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.958 1.303 . . . . 0.0 111.395 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 102' ' ' THR . 9.6 mm-40 -77.08 -45.89 25.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.167 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.01 -25.92 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.257 1.39 . . . . 0.0 112.769 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.5 t -56.67 -29.67 62.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.511 1.925 . . . . 0.0 113.262 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.0 p -68.04 -13.44 62.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.618 1.167 . . . . 0.0 112.963 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 79.15 -23.21 0.25 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 130.237 3.415 . . . . 0.0 112.224 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -54.38 -22.73 13.1 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 127.06 2.144 . . . . 0.0 114.629 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.0 p -76.41 -29.83 57.21 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.317 -1.49 . . . . 0.0 111.525 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.19 85.08 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.909 1.718 . . . . 0.0 112.325 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.29 152.11 41.98 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.299 1.549 . . . . 0.0 112.4 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -110.29 129.53 55.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.656 2.382 . . . . 0.0 105.523 165.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -74.11 132.64 42.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.15 151.69 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.704 1.602 . . . . 0.0 110.187 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.3 m -105.2 128.84 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 127.602 2.361 . . . . 0.0 106.159 171.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -107.44 95.18 5.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.778 2.431 . . . . 0.0 104.652 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 131' ' ' LEU . 3.6 m -108.85 126.71 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.56 142.34 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.462 ' HD1' HD11 ' A' ' 131' ' ' LEU . 34.3 p90 -134.0 158.31 43.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.727 1.211 . . . . 0.0 110.086 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -103.97 106.24 52.13 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.876 1.271 . . . . 0.0 108.158 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -35.23 -42.57 0.41 Allowed 'Trans proline' 0 C--N 1.361 1.217 1 C-N-CA 127.391 5.394 . . . . 0.0 118.652 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.83 -25.39 56.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.342 1.857 . . . . 0.0 113.658 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -120.68 -16.02 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.973 1.309 . . . . 0.0 113.341 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.033 1.733 . . . . 0.0 107.681 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.2 p -83.78 169.62 15.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.358 1.435 . . . . 0.0 111.369 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.01 -32.46 72.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.008 1.323 . . . . 0.0 112.028 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -56.54 -27.14 56.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.013 2.125 . . . . 0.0 112.717 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.38 -44.41 65.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.313 1.445 . . . . 0.0 111.373 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 119' ' ' VAL . 36.0 mt -67.33 -42.51 83.46 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.961 0.8 . . . . 0.0 110.398 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.28 -52.96 63.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.654 1.581 . . . . 0.0 110.334 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -52.1 -55.53 20.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.039 1.736 . . . . 0.0 112.805 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.432 HG13 HD21 ' A' ' 138' ' ' ASN . 96.2 t -60.05 -42.02 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.875 0.87 . . . . 0.0 110.927 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -56.08 -56.34 21.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.333 0.969 . . . . 0.0 112.244 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -63.28 -45.11 92.96 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.89 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.66 -24.02 63.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.958 2.103 . . . . 0.0 114.77 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.432 HD21 HG13 ' A' ' 134' ' ' VAL 0.442 12.6 p30 -130.01 47.09 2.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.691 1.196 . . . . 0.0 114.2 -176.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -153.76 158.01 40.31 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.164 -1.398 . . . . 0.0 110.481 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -90.81 115.88 65.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.976 1.716 . . . . 0.0 107.363 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.721 ' HD3' HG23 ' A' ' 223' ' ' THR . 62.7 Cg_endo -82.58 -6.9 11.69 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.416 2.077 . . . . 0.0 114.495 -170.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.2 p -109.45 9.73 25.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.197 1.799 . . . . 0.0 112.128 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -110.57 108.43 18.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.58 -56.58 1.24 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -166.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -90.92 19.01 5.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.409 1.105 . . . . 0.0 112.657 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.0 ttm105 -167.5 148.4 5.45 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.912 2.085 . . . . 0.0 107.302 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -139.44 114.06 9.22 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.546 1.539 . . . . 0.0 107.651 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 45.8 -109.5 0.34 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.7 2.095 . . . . 0.0 113.124 -167.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -85.8 -16.91 37.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.645 1.578 . . . . 0.0 112.112 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.98 122.34 33.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.941 1.296 . . . . 0.0 107.58 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -115.83 139.59 50.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.337 1.455 . . . . 0.0 110.578 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.99 157.04 9.36 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.033 1.778 . . . . 0.0 112.024 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.6 t -58.58 -15.83 13.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.226 2.611 . . . . 0.0 114.618 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -80.46 -18.34 49.01 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.02 -1.05 . . . . 0.0 112.3 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -111.16 66.85 0.63 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -109.95 152.04 26.36 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.63 1.172 . . . . 0.0 108.123 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 p -60.28 118.41 6.37 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.593 1.157 . . . . 0.0 109.093 156.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.18 116.98 6.69 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.528 1.131 . . . . 0.0 110.869 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 76.2 t -111.13 121.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -115.27 114.1 43.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.52 155.67 45.24 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 123.151 2.567 . . . . 0.0 111.412 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.2 m -79.69 -32.67 41.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.037 0.935 . . . . 0.0 111.859 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 87.9 p -171.6 -167.56 0.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.21 1.804 . . . . 0.0 108.954 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.1 -21.96 25.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.105 . . . . 0.0 113.797 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -52.44 -56.67 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.933 2.493 . . . . 0.0 110.899 169.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -86.77 -18.96 29.82 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.915 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.6 ttt -54.89 -36.02 64.72 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.557 1.543 . . . . 0.0 113.303 175.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -67.98 -38.01 82.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.889 0.876 . . . . 0.0 112.142 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.07 -38.98 12.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.678 1.191 . . . . 0.0 111.356 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.47 74.7 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.004 1.722 . . . . 0.0 111.057 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.29 -34.76 79.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.24 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -69.35 -46.89 65.93 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.724 0.809 . . . . 0.0 110.007 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.8 p -59.42 -40.65 87.37 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.252 1.421 . . . . 0.0 112.06 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.07 -63.67 1.11 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.109 2.164 . . . . 0.0 110.596 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.51 -34.75 78.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.597 1.159 . . . . 0.0 113.736 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.03 -48.12 83.02 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.438 1.895 . . . . 0.0 111.714 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -76.68 -25.82 54.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -60.46 -44.06 96.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.734 0.697 . . . . 0.0 110.94 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -64.69 -42.14 95.53 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.744 1.218 . . . . 0.0 112.671 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.26 -42.36 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 119.028 0.831 . . . . 0.0 110.565 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -83.01 -23.61 33.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.432 1.015 . . . . 0.0 113.184 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.5 t -56.86 -33.91 67.3 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.839 1.2 . . . . 0.0 111.351 167.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -79.46 -17.61 53.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -91.95 12.11 22.85 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.481 1.512 . . . . 0.0 111.721 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 76.94 28.89 0.63 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.625 1.97 . . . . 0.0 111.049 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -98.69 169.23 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -103.65 -160.6 24.9 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.441 1.019 . . . . 0.0 110.904 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.24 21.67 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 124.094 3.196 . . . . 0.0 111.903 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.64 149.55 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.845 0.831 . . . . 0.0 109.627 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.6 p -112.59 21.52 15.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.175 1.79 . . . . 0.0 109.951 -171.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -66.72 106.44 1.84 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -69.82 124.59 24.38 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.719 1.208 . . . . 0.0 108.268 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.89 114.66 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -144.92 160.86 40.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 129.212 3.005 . . . . 0.0 106.484 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 161.82 20.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.624 1.969 . . . . 0.0 108.733 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.24 61.9 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.813 -0.555 . . . . 0.0 111.911 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -76.49 120.19 21.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.981 0.912 . . . . 0.0 109.134 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 p -59.92 134.88 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.141 1.777 . . . . 0.0 108.866 168.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -101.01 129.47 46.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -122.18 115.64 22.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -57.39 130.43 46.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.414 1.085 . . . . 0.0 110.294 171.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -76.88 173.5 11.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.136 0.974 . . . . 0.0 109.372 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.66 160.7 22.13 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.772 1.629 . . . . 0.0 110.798 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -55.57 -37.94 68.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.373 2.269 . . . . 0.0 111.976 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -18.89 22.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.262 2.225 . . . . 0.0 114.123 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.405 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 74.9 m-70 -105.28 -6.47 19.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.366 1.467 . . . . 0.0 111.442 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.41 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 76.8 mm-40 -94.91 -130.75 0.15 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.194 2.198 . . . . 0.0 108.952 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -68.79 14.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 132.02 4.128 . . . . 0.0 112.797 -173.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -51.56 -39.43 57.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.118 2.567 . . . . 0.0 112.463 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 210' ' ' LEU . 3.1 mp -84.33 0.45 49.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.68 0.792 . . . . 0.0 112.021 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -76.21 -38.18 56.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.889 -1.132 . . . . 0.0 108.01 166.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -77.51 -34.9 53.93 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.525 1.53 . . . . 0.0 110.107 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -117.7 77.65 11.4 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.246 1.818 . . . . 0.0 109.246 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.37 1.91 4.38 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.605 2.87 . . . . 0.0 114.268 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -39.53 -38.88 0.64 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.46 3.104 . . . . 0.0 113.362 163.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.67 44.1 11.02 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 162.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -36.97 109.84 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.58 2.752 . . . . 0.0 115.413 -161.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 12.1 t 81.92 -65.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.455 2.302 . . . . 0.0 114.704 161.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.25 151.44 46.93 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.648 0.619 . . . . 0.0 114.648 -147.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.02 171.69 14.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.919 1.287 . . . . 0.0 109.576 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -88.58 -164.46 40.33 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 160.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -117.29 -141.04 6.81 Favored Glycine 0 CA--C 1.519 0.319 0 O-C-N 121.375 -1.074 . . . . 0.0 114.855 -159.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.721 HG23 ' HD3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.473 0.702 1 C-N-CA 136.037 5.735 . . . . 0.0 119.923 163.188 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.788 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.61 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -41.34 177.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.76 -178.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -107.67 125.64 51.61 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.509 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -54.01 -17.93 3.08 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.427 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.566 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -82.98 -9.52 59.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.974 -1.079 . . . . 0.0 110.12 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 34' ' ' ALA . 9.4 tp10 -112.32 -28.11 8.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 110.384 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -30.57 148.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.157 -0.965 . . . . 0.0 110.389 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.016 0.436 . . . . 0.0 110.413 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 42' ' ' ILE . 76.6 Cg_exo -48.34 -165.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.787 2.325 . . . . 0.0 111.435 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -160.9 -171.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.891 -1.131 . . . . 0.0 110.281 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -33.9 83.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.554 0.692 . . . . 0.0 111.334 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -64.4 -20.13 65.95 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.441 -0.787 . . . . 0.0 110.271 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -88.49 100.45 13.07 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 116.384 -2.126 . . . . 0.0 107.786 178.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.657 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 6.1 t-80 -30.18 141.21 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.0 -6.96 57.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.468 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 46.9 t -95.43 -63.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -80.55 -44.69 18.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.927 . . . . 0.0 110.214 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.22 55.6 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 33.4 p30 -82.75 -114.87 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 57' ' ' GLU . 1.2 ttm-85 -128.06 170.57 12.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.978 1.37 . . . . 0.0 108.434 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 3.0 p -132.22 17.33 4.52 Favored 'General case' 0 C--N 1.263 -3.169 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.968 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.519 ' O ' ' C ' ' A' ' 57' ' ' GLU . 3.4 m -151.55 -168.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.098 -1.001 . . . . 0.0 109.117 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.683 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 23.7 mm-40 -34.08 153.77 0.05 OUTLIER Pre-proline 0 C--N 1.293 -1.854 0 CA-C-O 121.494 0.664 . . . . 0.0 110.296 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -87.79 155.29 41.94 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.03 -1.654 . . . . 0.0 110.889 0.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-85 -117.53 66.68 5.0 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.28 -176.42 0.84 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.821 2.347 . . . . 0.0 113.049 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.39 158.55 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.94 -41.37 2.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.511 HG23 ' HE ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -97.72 144.2 27.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -1.04 . . . . 0.0 109.231 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.726 HE21 HE21 ' A' ' 166' ' ' GLN . 29.4 tp60 -107.79 147.77 30.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -122.18 128.85 51.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -147.33 -167.38 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.2 t -141.98 140.69 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.081 -1.637 . . . . 0.0 109.379 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 42.0 m-85 -127.92 131.91 49.33 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.668 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -135.89 136.15 8.27 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.233 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -126.25 -94.29 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.514 -0.992 . . . . 0.0 108.998 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.691 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -142.46 71.28 0.4 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.4 t 113.05 149.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.087 0.955 . . . . 0.0 108.776 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.701 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -101.6 20.26 16.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.2 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.698 ' CG ' ' OH ' ' A' ' 209' ' ' TYR . 17.8 m0 -101.56 -65.98 0.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.748 -1.22 . . . . 0.0 109.395 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.523 ' N ' ' OH ' ' A' ' 217' ' ' TYR . . . -68.32 -16.12 68.77 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.714 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -75.29 -58.27 3.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.409 -1.054 . . . . 0.0 110.591 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.544 ' O ' ' CD ' ' A' ' 77' ' ' GLU . 10.5 tp10 -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.253 -0.904 . . . . 0.0 111.473 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 78' ' ' ARG . 13.9 tpt85 -56.52 -53.98 51.23 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.874 -1.142 . . . . 0.0 110.787 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -83.42 18.32 1.86 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.329 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.714 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 4.9 m-85 -103.95 -40.05 6.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.776 -1.203 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.596 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -81.91 -4.36 56.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.848 -1.158 . . . . 0.0 110.108 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -90.4 21.11 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 0.0 109.786 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.662 HD12 HD21 ' A' ' 131' ' ' LEU . 60.6 mt -111.1 165.92 11.5 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.794 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 169.85 10.93 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.16 3.64 38.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -98.89 115.91 40.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.559 -0.965 . . . . 0.0 109.615 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.0 OUTLIER -73.53 -46.64 46.44 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.523 ' C ' HE22 ' A' ' 90' ' ' GLN . 6.9 t -164.37 157.65 17.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.542 -0.724 . . . . 0.0 109.554 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.657 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.1 p -117.26 154.05 31.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.645 ' NE2' ' C ' ' A' ' 89' ' ' THR . 10.9 mp0 -149.24 146.95 27.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.773 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 117' ' ' VAL . 20.6 m -140.56 177.7 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 110.124 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . 156.48 -118.9 0.87 Allowed Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.209 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 5.0 m-85 -125.13 167.78 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.937 . . . . 0.0 109.814 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.673 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.76 -179.62 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.884 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.61 6.61 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.509 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -121.95 -170.56 13.81 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.682 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -144.05 78.55 1.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.548 -0.972 . . . . 0.0 109.917 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.471 HG21 HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -157.52 145.1 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 109.238 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 3.5 ttm-85 -55.17 -80.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.427 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.46 ' ND2' ' HG2' ' A' ' 99' ' ' ARG . 44.5 m-80 -122.83 75.25 47.54 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.054 -1.029 . . . . 0.0 109.668 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.78 151.48 31.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.827 2.351 . . . . 0.0 112.05 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 106' ' ' VAL . 19.1 p -122.0 164.22 18.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.055 -1.028 . . . . 0.0 109.393 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -51.1 -44.35 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.614 -0.678 . . . . 0.0 110.016 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -27.03 62.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.009 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 0.6 OUTLIER -80.98 -38.06 28.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.074 -1.016 . . . . 0.0 110.375 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.9 HG12 ' OG1' ' A' ' 111' ' ' THR . 15.3 m -69.42 -24.03 27.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 120.866 -1.146 . . . . 0.0 110.161 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.624 ' C ' ' H ' ' A' ' 109' ' ' GLU . 94.5 m -45.76 -45.21 14.46 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 110' ' ' LYS . 29.6 t -60.52 5.5 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.85 . . . . 0.0 108.965 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.624 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.9 mt-10 54.82 -0.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.456 -0.778 . . . . 0.0 109.659 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 mmtp -63.84 -19.5 65.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.058 -1.026 . . . . 0.0 109.044 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.9 ' OG1' HG12 ' A' ' 106' ' ' VAL . 31.7 p -98.34 0.72 46.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.418 -0.801 . . . . 0.0 109.373 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 30.99 47.81 0.17 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -84.79 174.7 9.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.709 -1.465 . . . . 0.0 108.367 178.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.765 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -125.52 114.52 18.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.131 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.701 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.1 mm-40 -62.52 111.53 2.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -140.16 -171.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.095 -1.003 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.843 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.1 m -130.32 128.18 63.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.468 0.652 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.602 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -97.95 97.3 8.82 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.485 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -105.8 129.72 58.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.509 -179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.25 132.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.742 ' CD2' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -139.06 156.71 46.98 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.544 0.688 . . . . 0.0 109.695 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.511 ' HE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -95.92 108.28 39.72 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.66 -0.65 . . . . 0.0 110.633 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 15.2 Cg_exo -41.62 -67.47 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.713 2.276 . . . . 0.0 113.169 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.748 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 18.4 mp0 -49.64 -21.3 0.99 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.258 -0.901 . . . . 0.0 109.746 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 122' ' ' ARG . 1.1 m80 -92.37 -33.82 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -0.981 . . . . 0.0 108.981 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.673 HD11 ' CG ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -148.18 141.04 18.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.14 140.81 57.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.955 -1.091 . . . . 0.0 110.088 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.911 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 21.9 t80 -69.42 -33.28 72.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -14.01 61.47 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.673 ' CG ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -74.98 -45.33 42.81 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.473 -0.767 . . . . 0.0 110.454 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.742 HD12 ' CD2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -71.67 -31.02 66.35 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 119.361 -2.087 . . . . 0.0 107.492 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.911 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 1.1 mt -57.01 -21.77 33.31 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -70.34 -52.89 19.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.411 -0.805 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -49.93 -34.82 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.713 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 13.6 t80 -69.01 -53.22 21.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 50.6 m95 -70.44 -55.61 8.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.583 -1.323 . . . . 0.0 109.129 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.517 ' O ' ' OE2' ' A' ' 137' ' ' GLU . 2.2 tm-20 -37.53 -40.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.68 -0.637 . . . . 0.0 111.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 14.0 p30 -125.4 72.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.972 -1.08 . . . . 0.0 110.784 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.713 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 8.4 m80 -157.62 142.18 16.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.122 -0.986 . . . . 0.0 110.593 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.786 ' CG ' HE21 ' A' ' 143' ' ' GLN . 0.7 OUTLIER -105.21 73.02 0.24 Allowed Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.483 ' CD ' ' O ' ' A' ' 139' ' ' HIS . 17.7 Cg_endo -59.53 23.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.736 1.624 . . . . 0.0 112.587 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 189' ' ' ILE . 0.2 OUTLIER -121.95 1.6 9.86 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.135 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.786 HE21 ' CG ' ' A' ' 140' ' ' ASP . 46.2 mt-30 -106.79 92.35 4.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.951 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.594 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -37.97 -113.3 0.0 OUTLIER Glycine 0 N--CA 1.495 2.603 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.331 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.649 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 22.2 ptt? -66.05 41.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.84 0.829 . . . . 0.0 110.963 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.708 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 178.37 145.49 0.13 Allowed 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.897 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 1.3 mt-30 -152.13 155.48 37.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 119.782 -1.824 . . . . 0.0 110.215 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.58 -126.25 3.63 Favored Glycine 0 C--N 1.302 -1.309 0 CA-C-O 122.898 1.277 . . . . 0.0 110.438 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.47 ' HB2' ' H ' ' A' ' 220' ' ' LEU . 0.7 OUTLIER -81.85 -34.57 30.05 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.16 -1.02 . . . . 0.0 112.129 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.475 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -91.84 126.26 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.314 -1.491 . . . . 0.0 108.862 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.43 ' CA ' ' HB2' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -105.81 154.62 20.26 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.054 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.708 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 123.92 172.89 13.78 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.353 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -75.56 -28.15 58.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.285 -1.126 . . . . 0.0 109.82 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.653 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 4.3 pt20 -69.98 -5.74 28.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.885 -1.134 . . . . 0.0 109.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.653 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 23.4 m-85 -131.4 52.08 2.09 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.078 -1.014 . . . . 0.0 109.351 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.801 HH22 HH22 ' A' ' 194' ' ' ARG . 6.8 mtp180 -90.96 176.18 6.7 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.582 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.694 ' OG ' HG23 ' A' ' 191' ' ' THR . 0.2 OUTLIER -91.08 117.66 29.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 175.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -136.99 128.75 28.92 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.99 -175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.578 HG22 ' CZ ' ' A' ' 135' ' ' PHE . 1.4 t -115.89 115.52 49.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -113.2 121.15 38.66 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.7 170.11 13.02 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.575 2.183 . . . . 0.0 112.28 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.716 HG23 ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -90.15 -29.23 18.42 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 120.916 -1.115 . . . . 0.0 109.369 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.48 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 178.48 -162.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.58 -15.83 2.03 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.993 1.378 . . . . 0.0 108.648 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.48 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.8 t -55.92 -64.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.726 HE21 HE21 ' A' ' 64' ' ' GLN . 22.3 mt-30 -79.56 -19.59 49.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.596 -0.69 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.93 -34.87 43.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.26 -28.56 63.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.746 -1.221 . . . . 0.0 109.431 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.76 -45.13 8.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.65 -56.09 17.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 mt -52.87 -37.16 60.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.218 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -55.84 -36.5 67.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.539 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -72.84 -57.81 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.595 ' CG ' ' N ' ' A' ' 176' ' ' GLU . 6.4 pt-20 -63.46 -47.09 83.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.635 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -53.08 -31.98 44.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 109.655 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.506 ' CE2' HD21 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -78.92 -14.92 58.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.527 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.496 ' CD ' ' C ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -74.89 -38.79 61.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.182 -0.949 . . . . 0.0 109.299 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.456 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -78.02 -23.17 48.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.651 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 176' ' ' GLU . 60.3 t -75.59 -54.56 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' HB ' ' A' ' 223' ' ' THR . 4.6 mm? -68.96 -36.46 77.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.629 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.3 p -56.03 -27.8 54.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -88.11 -3.03 58.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.42 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.444 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 11.9 m170 -107.59 35.88 2.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.86 61.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.493 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -152.19 175.04 13.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.9 -141.49 5.01 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.51 105.82 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.239 1.96 . . . . 0.0 111.196 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.714 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -53.24 177.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 2.7 p -143.89 70.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.647 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.694 HG23 ' OG ' ' A' ' 157' ' ' SER . 61.2 m -100.47 160.24 14.51 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH2' ' A' ' 156' ' ' ARG . 21.2 t0 -105.91 106.38 16.86 Favored 'General case' 0 C--N 1.265 -3.067 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.93 114.07 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.415 -0.803 . . . . 0.0 109.054 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.801 HH22 HH22 ' A' ' 156' ' ' ARG . 1.0 OUTLIER -154.68 -170.46 3.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 109.178 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.421 ' HA ' HE22 ' A' ' 197' ' ' GLN . 86.3 mt-10 -119.67 -179.22 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 56.37 54.08 38.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.495 ' H ' ' CD ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.85 92.48 6.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.454 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.42 156.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 118' ' ' ARG . 63.2 t80 -126.05 140.24 52.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.235 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 10.2 m-85 -139.67 103.89 4.79 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.052 -1.03 . . . . 0.0 109.975 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -52.4 132.58 34.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 111.219 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.427 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -88.37 -171.26 3.28 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.662 ' CD ' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.44 174.94 8.22 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.662 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.4 OUTLIER -60.92 -50.49 73.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.733 -1.229 . . . . 0.0 108.088 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.659 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.53 -8.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 109.77 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.571 ' N ' ' O ' ' A' ' 204' ' ' ASP . 8.7 m-70 -103.55 13.62 32.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.066 -1.021 . . . . 0.0 111.446 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.774 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -138.6 -148.0 0.25 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.684 -1.26 . . . . 0.0 111.197 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.753 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 18.7 mp0 -33.49 -3.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.606 -1.179 . . . . 0.0 114.049 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.774 ' N ' ' O ' ' A' ' 207' ' ' GLN . 14.3 p90 -44.83 -33.63 2.0 Favored 'General case' 0 N--CA 1.518 2.941 0 C-N-CA 116.429 -2.108 . . . . 0.0 108.738 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 209' ' ' TYR . 0.4 OUTLIER -51.13 -20.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.769 -1.207 . . . . 0.0 109.947 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 16.2 t -59.88 -35.83 75.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.058 -1.026 . . . . 0.0 108.683 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 214' ' ' PRO . 5.8 mmmt -88.29 -29.8 20.1 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.468 -0.77 . . . . 0.0 109.67 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -119.6 51.07 1.67 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 213' ' ' ASN . 12.0 Cg_endo -60.41 8.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.095 2.53 . . . . 0.0 112.406 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.0 t70 -63.58 -12.48 33.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 110.36 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 62.56 86.67 0.05 OUTLIER Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.657 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.61 ' O ' ' O ' ' A' ' 216' ' ' GLY . 1.5 p90 -44.61 179.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.385 2.093 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.452 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER -72.84 76.71 1.15 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.041 -1.037 . . . . 0.0 108.765 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.36 150.42 17.24 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.47 ' H ' ' HB2' ' A' ' 149' ' ' ASN . 7.6 mt -84.67 -173.38 4.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 165.2 110.48 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 154.0 139.09 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.508 ' HB ' HD11 ' A' ' 181' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.195 -1.179 . . . . 0.0 109.45 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.789 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -41.18 176.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 122.828 1.299 . . . . 0.0 109.669 -178.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -105.27 123.26 47.54 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.423 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.851 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -47.04 -36.18 7.7 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.697 -0.627 . . . . 0.0 109.531 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -54.0 -38.0 64.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.81 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' C ' ' A' ' 34' ' ' ALA . 24.3 tp10 -91.19 -27.87 18.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.573 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -28.24 126.38 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 110.371 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.923 HD23 ' OE1' ' A' ' 105' ' ' GLU . 4.5 mp . . . . . 0 C--N 1.304 -1.412 0 O-C-N 121.567 -0.708 . . . . 0.0 109.715 179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.032 0.444 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' HG13 ' A' ' 44' ' ' VAL . 83.7 Cg_endo -85.0 162.6 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.144 2.563 . . . . 0.0 112.504 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 43' ' ' PRO . 15.7 m -160.7 -176.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.238 -0.914 . . . . 0.0 109.628 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.6 100.12 12.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.598 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.45 -61.31 2.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.261 -0.9 . . . . 0.0 111.414 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.553 ' O ' ' C ' ' A' ' 48' ' ' HIS . 17.3 mttm -70.82 100.76 1.98 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 115.579 -2.448 . . . . 0.0 108.423 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.635 ' HE2' ' HG1' ' A' ' 89' ' ' THR . 5.9 t-80 -32.34 122.88 0.33 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.06 -28.94 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 0.0 111.012 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' ' 81' ' ' TRP . 41.8 t -69.25 -43.78 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.143 . . . . 0.0 110.001 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -106.57 -44.16 4.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 110.306 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.22 2.76 51.25 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 43.9 p30 -79.44 -121.01 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.6 mmt180 -127.81 172.03 11.21 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 123.061 1.41 . . . . 0.0 109.784 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 37.0 p -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.985 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.537 ' O ' ' C ' ' A' ' 57' ' ' GLU . 11.6 m -145.62 132.76 15.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.415 -1.428 . . . . 0.0 109.809 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.6 mm-40 -32.73 149.36 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.504 0 CA-C-O 121.75 0.786 . . . . 0.0 110.538 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.3 Cg_endo -78.34 166.21 80.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.961 -2.1 . . . . 0.0 111.831 -0.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.33 151.68 39.15 Favored Pre-proline 0 C--N 1.269 -2.934 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.289 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.57 ' O ' ' OG1' ' A' ' 63' ' ' THR . 23.9 Cg_endo -64.61 122.94 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.747 2.298 . . . . 0.0 112.162 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.536 ' O ' ' CD ' ' A' ' 61' ' ' GLU . 2.4 pp20? -43.48 143.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 32.41 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -154.77 137.15 14.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.603 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.903 ' NE2' ' H ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -108.11 171.08 7.61 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.582 ' O ' HG21 ' A' ' 162' ' ' THR . 7.4 mtm -128.07 132.54 49.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.99 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.91 -170.75 2.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.683 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 62.0 t -143.58 151.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 119.906 -1.746 . . . . 0.0 109.749 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 36.6 m-85 -147.07 125.93 12.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.982 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -105.68 89.26 0.61 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.541 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -85.89 -75.2 0.38 Allowed 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.626 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -165.74 -161.03 13.85 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.728 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -28.77 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.289 1.045 . . . . 0.0 108.611 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.78 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -59.3 7.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.016 . . . . 0.0 111.183 -177.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.675 ' O ' HD11 ' A' ' 210' ' ' LEU . 6.3 m0 -69.35 -60.83 2.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.0 108.856 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.69 -10.01 58.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . . . -59.7 -58.61 7.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.694 ' OE1' HG13 ' A' ' 91' ' ' VAL . 8.8 pt-20 -76.12 -12.57 60.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.132 -0.98 . . . . 0.0 110.757 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -56.79 -54.97 40.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.603 -1.31 . . . . 0.0 109.623 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HZ3' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -56.43 -0.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 0.0 110.69 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.537 ' CE2' HG11 ' A' ' 134' ' ' VAL . 19.8 m-85 -94.32 -39.57 10.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.744 -1.223 . . . . 0.0 109.851 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.72 ' HB2' HG11 ' A' ' 50' ' ' VAL . 1.3 p90 -77.01 16.74 0.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.85 -1.156 . . . . 0.0 109.318 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 m -117.11 19.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 83' ' ' LEU . 3.9 pp -135.67 161.31 35.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.11 -0.994 . . . . 0.0 109.466 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 150.3 20.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.686 . . . . 0.0 109.984 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 110.44 -29.0 9.48 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -84.36 132.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.791 -0.829 . . . . 0.0 110.143 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.693 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.85 -43.04 31.56 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' CG ' ' A' ' 48' ' ' HIS . 5.5 t -162.25 -165.19 1.16 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.483 0.659 . . . . 0.0 109.796 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.635 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 74.1 p -154.16 143.47 21.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 118' ' ' ARG . 6.7 mp0 -144.64 145.88 31.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 109.854 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.694 HG13 ' OE1' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -128.99 156.6 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.037 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.28 172.84 45.84 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 102' ' ' THR . 3.7 m-85 -79.99 138.37 37.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -1.058 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.779 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -157.72 -170.16 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.926 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.513 ' O ' ' NH2' ' A' ' 194' ' ' ARG . . . 40.83 38.05 1.51 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.581 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -117.71 -154.27 9.83 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.757 -1.437 . . . . 0.0 109.751 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.851 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -151.8 64.68 0.86 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.325 -1.103 . . . . 0.0 109.166 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.635 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.31 -178.48 7.38 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.027 -1.045 . . . . 0.0 108.636 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 14.3 tpp85 -75.12 -107.59 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.449 -0.782 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' CG ' ' A' ' 99' ' ' ARG . 1.2 m-80 -104.9 72.69 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.574 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 38.3 Cg_endo -65.59 157.72 56.99 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.824 2.35 . . . . 0.0 112.521 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 106' ' ' VAL . 23.2 p -122.94 170.43 10.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.414 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 4.3 t80 -55.48 -45.76 76.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -25.89 61.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 0.0 110.033 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.923 ' OE1' HD23 ' A' ' 35' ' ' LEU . 3.5 mm-40 -81.89 -37.66 26.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 102' ' ' THR . 13.5 m -66.31 -23.83 32.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 O-C-N 120.594 -1.317 . . . . 0.0 109.663 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.614 ' C ' ' H ' ' A' ' 109' ' ' GLU . 3.7 t -52.72 -38.93 61.55 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.648 ' OG ' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -52.86 -1.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.23 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.4 tt0 59.65 -6.59 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.253 -0.905 . . . . 0.0 109.65 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.718 ' CB ' HD13 ' A' ' 35' ' ' LEU . 1.6 mmtt -75.98 -24.46 55.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 110.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.448 ' OG1' HG12 ' A' ' 106' ' ' VAL . 31.1 p -84.15 -10.56 57.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 109.378 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 43.26 39.5 4.14 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.672 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -82.42 162.6 22.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.225 . . . . 0.0 109.16 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.869 ' HB2' HH12 ' A' ' 156' ' ' ARG . . . -124.37 113.85 18.74 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.376 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.689 ' OE1' ' CD1' ' A' ' 73' ' ' PHE . 2.4 mm-40 -54.27 116.31 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.779 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -124.66 175.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.03 -1.044 . . . . 0.0 110.88 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.738 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.6 m -133.01 114.92 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -95.87 98.68 10.6 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 80' ' ' PHE . 14.0 m -118.96 122.43 69.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.5 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -83.6 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.903 ' H ' ' NE2' ' A' ' 64' ' ' GLN . 4.7 m-85 -130.18 160.71 32.99 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.845 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 50.6 mtp85 -101.3 105.44 39.64 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.52 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 125' ' ' HIS . 9.4 Cg_exo -40.58 -66.84 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 123.203 2.602 . . . . 0.0 113.877 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.5 tt0 -42.82 -19.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.997 -1.064 . . . . 0.0 109.938 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' A' ' 123' ' ' PRO . 67.5 m-70 -109.97 -7.78 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.999 -1.063 . . . . 0.0 109.852 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.687 HG22 ' CD ' ' A' ' 130' ' ' GLU . 1.2 pt -152.19 -176.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.389 1.09 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.545 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 43.7 t -130.37 152.32 49.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 25.4 t80 -48.33 -19.16 0.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.514 -1.367 . . . . 0.0 109.382 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' C ' ' A' ' 127' ' ' SER . 9.1 mp0 -70.48 -24.54 62.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.352 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.687 ' CD ' HG22 ' A' ' 126' ' ' ILE . 7.1 mt-10 -68.87 -71.77 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.0 109.999 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 121' ' ' TYR . 1.2 mp -35.86 -43.55 0.31 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.326 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 7.5 mp -73.94 -44.98 53.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.446 -0.784 . . . . 0.0 111.519 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -53.19 47.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.795 -1.19 . . . . 0.0 110.343 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.676 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 2.0 t -50.28 -50.64 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CZ ' ' CE1' ' A' ' 139' ' ' HIS . 22.5 t80 -58.0 -44.39 87.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.775 -1.203 . . . . 0.0 111.589 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.583 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 67.7 m95 -70.74 -36.09 72.98 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.772 -1.205 . . . . 0.0 111.702 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -79.21 -13.38 59.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.938 -1.101 . . . . 0.0 112.974 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.0 OUTLIER -133.99 59.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.11 -1.619 . . . . 0.0 112.087 -178.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.798 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 p-80 177.58 134.25 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.027 -1.045 . . . . 0.0 109.833 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.658 ' OD2' ' NE2' ' A' ' 143' ' ' GLN . 1.2 t0 -48.96 107.36 0.75 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.33 -0.857 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -85.98 -2.07 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.735 2.29 . . . . 0.0 113.038 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.55 ' C ' ' OG1' ' A' ' 190' ' ' THR . 40.2 p -121.72 20.55 10.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 110.261 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.69 ' N ' ' OG1' ' A' ' 190' ' ' THR . 7.7 mt-30 -130.94 101.25 5.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.022 -1.049 . . . . 0.0 109.15 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.677 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -96.86 18.74 56.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -18.35 12.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.979 -1.306 . . . . 0.0 109.8 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.649 ' C ' ' CD ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.54 164.59 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.001 -1.062 . . . . 0.0 109.87 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.571 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -99.34 108.36 20.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.589 -1.32 . . . . 0.0 109.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.91 -122.15 28.46 Favored Glycine 0 C--N 1.301 -1.366 0 CA-C-O 123.211 1.451 . . . . 0.0 110.461 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.05 -32.96 39.37 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.461 -1.37 . . . . 0.0 111.964 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.571 ' OD2' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.31 101.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.171 -1.581 . . . . 0.0 108.885 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.691 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 6.5 p90 -82.43 118.44 23.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.578 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 166.15 144.19 4.0 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.531 ' O ' ' OG1' ' A' ' 153' ' ' THR . 0.5 OUTLIER -70.97 14.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -1.23 . . . . 0.0 109.047 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.668 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 9.3 pt20 -102.79 -1.65 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.668 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 22.4 m-85 -132.38 53.09 2.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.815 -1.178 . . . . 0.0 109.633 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.869 HH12 ' HB2' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -100.02 177.41 5.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 110.331 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' OG1' ' A' ' 191' ' ' THR . 11.5 p -92.98 71.41 4.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.548 ' CB ' ' OH ' ' A' ' 160' ' ' TYR . . . -97.38 129.57 44.61 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.631 0.729 . . . . 0.0 110.912 -176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 HG21 ' A' ' 191' ' ' THR . 19.9 m -102.11 146.35 10.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.566 ' CE1' HG11 ' A' ' 116' ' ' VAL . 22.2 m-85 -139.89 115.89 8.07 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 72.3 Cg_endo -77.57 167.37 24.33 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.344 2.029 . . . . 0.0 113.349 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -93.5 -41.73 9.62 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.282 -0.886 . . . . 0.0 109.392 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -171.8 -172.15 0.98 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 109.994 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.8 -25.53 4.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.074 1.416 . . . . 0.0 108.529 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 166' ' ' GLN . 2.5 t -56.01 -58.8 3.82 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.12 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.435 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -78.25 -25.66 46.94 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.086 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -38.6 56.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 0.0 110.657 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.13 -61.62 1.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 110.826 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . . . -93.86 -16.93 23.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.85 -1.156 . . . . 0.0 112.341 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.33 -65.67 0.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.429 -1.419 . . . . 0.0 110.357 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.13 -21.42 61.58 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.875 -1.141 . . . . 0.0 108.247 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.556 ' N ' HD23 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -75.51 -27.98 58.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.438 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.583 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 97.3 p -56.29 -26.91 53.67 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 174' ' ' LYS . 14.4 mtmm -67.73 -58.48 4.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.55 8.56 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.019 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.57 -75.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 110.102 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -58.16 -32.31 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -52.79 -17.97 1.63 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 0.0 109.652 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -68.04 -39.29 83.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.686 ' O ' ' CE1' ' A' ' 184' ' ' HIS . 15.8 m -87.45 -30.88 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.108 -0.995 . . . . 0.0 109.898 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.29 -38.51 60.32 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.133 -0.979 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.9 t -56.56 -24.78 49.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -75.69 -29.84 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.686 ' CE1' ' O ' ' A' ' 180' ' ' VAL . 0.6 OUTLIER -86.0 6.39 28.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.366 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.74 68.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.554 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -115.78 162.62 17.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.82 178.23 48.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.5 157.86 29.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.708 2.272 . . . . 0.0 112.075 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -64.05 125.29 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.166 -0.959 . . . . 0.0 108.686 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.69 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 6.8 p -110.59 54.1 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.548 ' OG1' ' O ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -100.68 159.53 15.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.671 ' CG ' HH12 ' A' ' 194' ' ' ARG . 10.7 t0 -109.29 145.28 36.23 Favored 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.321 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.405 HD13 ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -123.73 156.41 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.671 HH12 ' CG ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -146.82 -166.91 2.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.821 -1.174 . . . . 0.0 111.276 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.807 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.46 159.62 14.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 1.24 ' O ' ' NE2' ' A' ' 197' ' ' GLN . . . 10.97 -79.69 0.0 OUTLIER Glycine 0 C--O 1.17 -3.858 0 N-CA-C 105.261 -3.135 . . . . 0.0 105.261 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 1.24 ' NE2' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 151.15 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 124.048 0.939 . . . . 0.0 110.172 175.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 198' ' ' VAL . 10.0 p -45.78 117.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 117.47 -1.692 . . . . 0.0 106.511 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.51 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 18.6 t80 -102.52 147.53 26.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 111.578 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 7.7 m-85 -153.39 100.75 2.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.482 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 25.6 m-85 -53.08 135.43 37.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.787 -1.196 . . . . 0.0 109.65 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.654 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -86.87 -170.56 3.12 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.257 -0.902 . . . . 0.0 108.9 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -74.39 155.06 38.5 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.473 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -50.6 -43.22 56.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.557 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -54.07 -15.14 1.3 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.624 . . . . 0.0 109.74 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.78 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 8.2 m-70 -100.69 9.35 42.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.605 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.832 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.5 mm-40 -127.98 -145.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.092 0.949 . . . . 0.0 110.119 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.684 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.86 -3.72 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.953 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.832 ' N ' ' O ' ' A' ' 207' ' ' GLN . 86.8 t80 -41.02 -43.22 2.1 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 120.524 -1.36 . . . . 0.0 110.837 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.675 HD11 ' O ' ' A' ' 74' ' ' TRP . 0.8 OUTLIER -65.36 -13.14 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.378 -1.452 . . . . 0.0 109.903 -178.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 208' ' ' GLN . 94.6 p -55.96 -31.09 62.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.08 -1.012 . . . . 0.0 108.656 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -85.62 -36.39 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.456 -0.778 . . . . 0.0 109.0 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -131.98 68.41 80.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' LEU . 52.5 Cg_exo -49.94 8.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.072 2.514 . . . . 0.0 113.298 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 213' ' ' ASN . 0.0 OUTLIER -61.34 -24.8 66.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.49 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 58.88 83.84 0.05 OUTLIER Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.21 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -70.5 88.2 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.902 2.351 . . . . 0.0 108.575 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.587 ' O ' ' O ' ' A' ' 219' ' ' GLY . 18.1 t -169.74 114.32 0.52 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.863 -1.148 . . . . 0.0 109.387 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -39.89 170.09 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.93 -174.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.343 -1.093 . . . . 0.0 110.131 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.575 ' O ' ' C ' ' A' ' 222' ' ' GLY . . . -155.04 -80.88 0.03 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 221' ' ' GLY . . . -27.95 105.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 CA-C-O 123.051 1.362 . . . . 0.0 109.954 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.27 -2.855 0 CA-C-N 113.896 -1.152 . . . . 0.0 109.308 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.716 ' O ' ' O ' ' A' ' 29' ' ' ILE . 47.5 t . . . . . 0 CA--C 1.502 -0.902 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.716 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -36.58 176.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-O 123.141 1.448 . . . . 0.0 110.14 -178.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.434 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.7 124.45 26.03 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.249 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.43 80.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.755 -0.591 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.17 0.88 3.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 mm-40 -107.27 -35.93 6.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 108.963 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.599 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.78 -170.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.665 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 35' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 108.973 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.717 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 120.923 0.392 . . . . 0.0 110.143 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.922 ' O ' HG13 ' A' ' 44' ' ' VAL . 27.2 Cg_endo -64.34 165.91 18.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.636 2.224 . . . . 0.0 111.862 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 43' ' ' PRO . 2.3 m -172.95 172.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.38 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.642 ' O ' HG23 ' A' ' 45' ' ' THR . 7.3 t 9.98 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.509 0.671 . . . . 0.0 110.823 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.703 ' O ' HG23 ' A' ' 55' ' ' THR . . . -69.24 -52.68 25.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 111.394 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.557 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.63 99.66 10.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 115.746 -2.382 . . . . 0.0 108.765 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.775 ' NE2' ' NE2' ' A' ' 208' ' ' GLN . 8.5 t-80 -31.67 141.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.492 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.9 t60 -80.44 -42.51 22.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 110.572 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 211' ' ' SER . 25.8 t -58.1 -37.56 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 110.179 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 t -109.4 -48.69 3.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 110.507 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.04 4.63 55.35 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.6 p30 -81.81 -110.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.68 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 10.1 mtm-85 -129.24 174.88 9.19 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 123.519 1.628 . . . . 0.0 109.855 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 46' ' ' ALA . 63.3 p -132.51 0.35 3.64 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.397 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' GLU . 1.1 m -145.11 132.09 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.507 -1.37 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt-10 -34.03 154.8 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 CA-C-O 121.881 0.848 . . . . 0.0 110.845 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.8 Cg_endo -79.53 166.05 78.82 Favored 'Cis proline' 0 C--N 1.301 -1.969 0 C-N-CA 121.479 -2.301 . . . . 0.0 111.633 -0.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.402 ' CZ ' HG21 ' A' ' 120' ' ' VAL . 35.6 m-85 -111.15 148.92 39.71 Favored Pre-proline 0 C--N 1.266 -3.035 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.0 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 63' ' ' THR . 8.3 Cg_endo -53.28 139.47 63.75 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.929 2.42 . . . . 0.0 112.618 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -45.5 158.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 42.78 66.82 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.544 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 1.2 p -136.7 147.38 46.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.622 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.583 ' OE1' ' CG ' ' A' ' 123' ' ' PRO . 2.1 mp0 -116.79 173.47 6.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.41 -0.806 . . . . 0.0 108.839 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.751 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -154.22 128.67 9.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.983 -1.073 . . . . 0.0 109.841 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.01 -167.6 2.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.1 t -143.22 137.6 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.087 -1.633 . . . . 0.0 109.983 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 1.045 ' O ' HG22 ' A' ' 117' ' ' VAL . 54.5 m-85 -131.76 137.89 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.059 -1.026 . . . . 0.0 110.144 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -122.78 110.26 1.52 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 105.715 -2.954 . . . . 0.0 105.715 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.556 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -107.14 -87.62 0.48 Allowed 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.214 -1.168 . . . . 0.0 110.413 -177.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.717 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.75 74.76 0.2 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.717 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 51.1 t 111.41 82.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.68 ' N ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -55.72 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.623 -1.298 . . . . 0.0 110.734 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.643 ' H ' ' C ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -91.41 -44.41 9.15 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.068 -1.02 . . . . 0.0 109.363 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.51 -3.95 49.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.695 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.24 -35.41 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 109.733 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.628 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 29.4 tt0 -68.17 -15.17 63.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.28 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.593 ' O ' HG13 ' A' ' 82' ' ' VAL . 11.5 ttt180 -60.16 -54.39 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.504 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.507 ' H ' ' HE2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -73.38 25.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.941 -1.099 . . . . 0.0 110.165 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.7 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 6.8 m-85 -126.78 -39.01 2.01 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.482 -0.761 . . . . 0.0 110.125 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.693 ' CE2' ' OG ' ' A' ' 211' ' ' SER . 1.2 p90 -84.74 1.71 45.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.703 -1.248 . . . . 0.0 109.72 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.2 m -104.84 11.66 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.829 HD11 HG21 ' A' ' 134' ' ' VAL . 96.0 mt -99.04 149.49 22.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.07 0.938 . . . . 0.0 109.116 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.579 ' HZ3' ' HA ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -85.82 136.7 33.21 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 107.53 -26.51 17.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -72.3 138.67 21.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.128 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.692 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -78.42 -41.38 33.11 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -175.56 -169.81 0.38 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.568 ' OG1' ' OE2' ' A' ' 77' ' ' GLU . 30.6 p -146.55 167.0 24.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.914 -1.116 . . . . 0.0 110.214 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.628 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -168.66 -178.75 3.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.921 HG12 HG12 ' A' ' 117' ' ' VAL . 1.6 m -156.82 161.03 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.665 -1.272 . . . . 0.0 108.504 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 201' ' ' TYR . . . -167.46 -172.42 34.57 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.199 -1.477 . . . . 0.0 111.934 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 202' ' ' ALA . 1.6 m-85 -104.44 150.29 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.852 -0.793 . . . . 0.0 109.511 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.656 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -177.0 154.22 1.07 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.31 38.56 7.16 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.498 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -129.5 -152.01 7.47 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.038 -1.272 . . . . 0.0 110.111 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.48 55.1 1.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 109.474 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.401 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -157.07 141.62 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.682 ' O ' ' CE2' ' A' ' 200' ' ' TYR . 0.0 OUTLIER -48.96 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 109.438 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.8 m-20 -122.84 86.27 50.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.517 ' CG ' ' NE2' ' A' ' 113' ' ' HIS . 59.4 Cg_endo -78.41 -171.62 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.657 2.238 . . . . 0.0 111.811 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.633 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 23.1 p -121.69 170.5 9.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.048 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.53 -59.09 5.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.39 -0.819 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -61.22 -23.22 65.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 108.822 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.633 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.1 mm-40 -67.81 -60.07 2.81 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.66 0.743 . . . . 0.0 110.322 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.918 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.8 m -64.37 -24.49 35.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.663 -0.648 . . . . 0.0 111.635 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.7 t -53.7 -0.5 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.261 -0.9 . . . . 0.0 109.363 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 110' ' ' LYS . 22.6 p -99.8 11.17 39.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.453 ' O ' HG21 ' A' ' 29' ' ' ILE . 2.5 tt0 59.08 -5.58 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.071 -1.018 . . . . 0.0 109.512 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.4 OUTLIER -70.67 -30.97 67.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 110.371 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.918 ' OG1' HG12 ' A' ' 106' ' ' VAL . 26.7 p -84.98 -18.34 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.929 -1.107 . . . . 0.0 110.28 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.06 14.61 47.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.652 ' CD2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -58.32 158.22 7.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.029 -1.277 . . . . 0.0 109.711 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.542 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -120.36 113.83 20.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.68 ' OE1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.95 135.23 15.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.483 -179.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -151.68 178.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.989 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.045 HG22 ' O ' ' A' ' 68' ' ' PHE . 34.5 m -138.97 147.89 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.201 -0.937 . . . . 0.0 110.688 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.793 ' NH1' ' CZ ' ' A' ' 201' ' ' TYR . 8.9 ptm180 -115.49 95.71 5.29 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.731 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 4.0 m -109.52 113.82 45.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.17 -1.581 . . . . 0.0 108.815 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.0 t -74.49 156.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.161 ' CD2' HD22 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -136.9 160.35 39.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.887 -1.133 . . . . 0.0 110.156 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 59.8 mtp180 -119.46 100.4 49.61 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 125' ' ' HIS . 13.5 Cg_exo -41.71 -61.05 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.235 2.623 . . . . 0.0 113.276 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -38.37 -14.59 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.603 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.695 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -143.8 15.53 1.76 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.718 -1.239 . . . . 0.0 109.49 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -155.19 146.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.869 . . . . 0.0 109.419 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.572 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -107.8 166.79 10.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.244 -0.91 . . . . 0.0 109.37 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 169' ' ' ALA . 37.9 t80 -64.82 -38.83 92.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 133' ' ' LYS . 36.7 mm-40 -53.71 -27.39 27.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 109.086 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 1.0 OUTLIER -66.69 -68.82 0.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.094 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.161 HD22 ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -33.89 -47.55 0.26 Allowed 'General case' 0 C--N 1.316 -0.859 0 O-C-N 120.95 -1.094 . . . . 0.0 108.493 178.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 173' ' ' SER . 11.2 mp -76.1 -41.24 50.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.581 ' O ' ' OE2' ' A' ' 137' ' ' GLU . 2.8 tmmm? -52.56 -39.59 61.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.098 -1.001 . . . . 0.0 111.44 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.829 HG21 HD11 ' A' ' 83' ' ' LEU . 1.1 t -74.84 -39.44 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.722 -1.236 . . . . 0.0 110.098 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 8.0 t80 -65.32 -48.22 73.83 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.375 -0.828 . . . . 0.0 111.211 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.52 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 61.4 m95 -67.04 -34.11 76.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.784 -1.198 . . . . 0.0 111.363 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.672 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -76.95 -33.21 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 113.23 -176.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 41.9 m-80 -96.12 36.09 1.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.323 -1.486 . . . . 0.0 114.483 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.799 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 6.6 p-80 178.53 175.95 0.54 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.393 -1.442 . . . . 0.0 111.981 176.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.85 107.92 57.84 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 20.38 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.187 1.925 . . . . 0.0 112.299 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.73 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -115.7 3.18 13.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.753 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.536 ' O ' ' O ' ' A' ' 146' ' ' ARG . 18.1 mt-30 -101.88 78.26 1.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.069 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 146' ' ' ARG . . . -39.4 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.499 2.855 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.466 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.471 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -66.97 40.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.936 0.874 . . . . 0.0 110.39 -176.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.652 ' CZ ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -161.65 152.54 18.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' A' ' 143' ' ' GLN . 21.0 mm100 -154.92 74.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.281 -1.512 . . . . 0.0 110.05 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 220' ' ' LEU . . . 78.11 -115.71 4.27 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -79.52 -33.45 42.01 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-N 114.517 -0.842 . . . . 0.0 111.624 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.497 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -85.36 129.49 34.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.283 -1.511 . . . . 0.0 109.015 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.446 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 17.6 p90 -127.64 138.39 52.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 154' ' ' GLN . . . 138.58 167.08 10.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.48 ' O ' ' O ' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -72.32 15.16 0.18 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.001 -1.294 . . . . 0.0 108.9 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.598 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 1.4 pt20 -114.32 17.58 17.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 44.2 m-85 -155.48 65.63 0.62 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.703 HH22 ' CG ' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -118.54 -176.03 3.0 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.384 -0.822 . . . . 0.0 109.389 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 t -92.11 140.56 29.51 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.461 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -162.14 118.95 2.06 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.603 -2.039 . . . . 0.0 112.115 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.72 HG13 ' CG2' ' A' ' 191' ' ' THR . 2.2 m -115.72 126.2 73.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.154 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.484 ' CE2' HG11 ' A' ' 116' ' ' VAL . 4.8 m-30 -113.9 119.99 39.87 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.41 170.43 19.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.564 2.176 . . . . 0.0 112.53 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.16 -40.4 8.82 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.209 -0.932 . . . . 0.0 109.592 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 165' ' ' VAL . 43.3 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.114 -0.991 . . . . 0.0 109.923 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 123.154 1.454 . . . . 0.0 108.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 163' ' ' SER . 2.5 t -56.06 -56.46 12.83 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.987 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.227 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.472 HE21 ' HB2' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -78.03 -36.82 48.13 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.965 -178.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 1.5 mtm -52.46 -35.41 52.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 110.815 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -48.29 -55.0 11.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 109.962 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . . . -93.13 -30.84 15.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.017 -1.052 . . . . 0.0 110.582 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.468 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -52.54 -62.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.047 . . . . 0.0 110.014 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mt -52.66 -33.87 49.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 109.642 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.739 ' HB3' HD23 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -56.43 -34.27 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.912 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -72.18 -46.79 54.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.96 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -72.22 -39.67 68.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.045 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.59 -29.45 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.089 -1.007 . . . . 0.0 109.92 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -79.54 -44.15 21.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.886 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.767 ' OE1' HG23 ' A' ' 189' ' ' ILE . 35.8 tp60 -62.19 -5.34 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.592 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -49.64 13.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.89 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.35 -51.81 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 181' ' ' LEU . 4.5 mm? -53.72 -40.82 66.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.835 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 51.0 p -56.38 -27.27 55.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.441 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -88.03 6.34 36.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.554 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.428 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 1.7 m-70 -108.22 35.82 3.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 69.88 36.07 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.48 175.61 5.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.402 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.625 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -133.47 -145.62 5.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 189' ' ' ILE . 30.0 Cg_exo -58.73 106.03 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.402 2.068 . . . . 0.0 111.248 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.767 HG23 ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -48.45 -172.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 21.4 p -151.43 58.57 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.568 -0.707 . . . . 0.0 109.813 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.72 ' CG2' HG13 ' A' ' 159' ' ' VAL . 45.7 m -99.76 128.7 45.84 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.703 ' CG ' HH22 ' A' ' 156' ' ' ARG . 4.9 t70 -75.97 119.42 19.91 Favored 'General case' 0 C--N 1.272 -2.793 0 C-N-CA 119.569 -0.853 . . . . 0.0 109.419 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.421 ' C ' ' CG ' ' A' ' 194' ' ' ARG . 0.6 OUTLIER -119.77 103.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.386 -0.925 . . . . 0.0 109.643 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.661 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -165.33 141.92 5.58 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.654 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -114.95 -177.67 3.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 109.843 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.77 29.75 60.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 198' ' ' VAL . 16.2 mm-40 -104.0 103.64 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.302 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -33.6 154.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.183 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.576 ' CE1' ' HD2' ' A' ' 118' ' ' ARG . 7.7 t80 -128.75 120.23 26.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.682 ' CE2' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.97 126.77 40.29 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.793 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.53 -176.53 3.4 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 116.329 -2.148 . . . . 0.0 114.642 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . . . -95.71 -179.58 4.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 112.185 -2.279 . . . . 0.0 111.478 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.698 ' HA ' HG11 ' A' ' 44' ' ' VAL . 1.3 pt-20 -73.57 -168.16 0.53 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.429 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.74 -14.38 54.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.866 -1.146 . . . . 0.0 110.527 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.651 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -78.53 -14.17 59.48 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.881 -1.137 . . . . 0.0 109.382 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 74' ' ' TRP . 74.2 m-70 -104.68 2.88 30.91 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.109 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.841 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.2 mm-40 -120.51 -138.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.237 1.018 . . . . 0.0 109.938 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.775 ' NE2' ' NE2' ' A' ' 48' ' ' HIS . 1.4 mp0 -34.73 -5.56 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.634 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.841 ' N ' ' O ' ' A' ' 207' ' ' GLN . 64.2 t80 -41.88 -47.48 4.25 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 120.464 -1.398 . . . . 0.0 109.298 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.72 HD22 ' SG ' ' A' ' 218' ' ' CYS . 0.9 OUTLIER -70.63 -28.68 65.01 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.532 -1.355 . . . . 0.0 110.219 -179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.693 ' OG ' ' CE2' ' A' ' 81' ' ' TRP . 0.1 OUTLIER -69.01 -41.83 77.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.923 -1.11 . . . . 0.0 108.22 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -88.91 -19.17 26.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.535 -0.728 . . . . 0.0 109.672 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.766 ' ND2' ' CD1' ' A' ' 209' ' ' TYR . 34.7 m-80 -116.0 89.89 26.27 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.036 . . . . 0.0 110.265 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.1 11.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.249 2.632 . . . . 0.0 112.205 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.1 t0 -61.94 -4.73 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.275 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.617 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 64.05 -44.32 0.09 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.996 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.617 ' C ' ' O ' ' A' ' 216' ' ' GLY . 40.6 m-85 -23.33 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 CA-C-N 119.408 1.604 . . . . 0.0 110.529 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.72 ' SG ' HD22 ' A' ' 210' ' ' LEU . 69.1 m -137.42 -126.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -151.92 -154.84 6.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.715 HD12 ' HA3' ' A' ' 148' ' ' GLY . 20.4 mt -82.82 -175.84 6.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.664 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.13 125.85 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.591 ' H ' ' HA ' ' A' ' 139' ' ' HIS . . . 140.28 167.67 11.1 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 139' ' ' HIS . 11.7 p . . . . . 0 C--N 1.27 -2.889 0 CA-C-N 114.388 -0.906 . . . . 0.0 108.672 179.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.214 -0.799 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.644 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -39.82 175.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.328 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.497 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -99.59 126.97 45.66 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.634 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -47.04 -62.11 1.56 Allowed 'General case' 0 C--N 1.285 -2.233 0 CA-C-O 121.258 0.551 . . . . 0.0 109.904 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -54.72 -3.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' ALA . 3.0 tt0 -108.97 -23.69 11.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.928 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.6 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.98 -167.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.904 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.826 ' CB ' HG23 ' A' ' 98' ' ' THR . 1.7 mm? . . . . . 0 C--N 1.305 -1.352 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.47 167.93 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.909 2.406 . . . . 0.0 112.31 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' ALA . 28.8 m -128.68 -171.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.613 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 44' ' ' VAL . 1.3 t -39.2 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.591 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.72 -27.18 58.65 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.192 -0.943 . . . . 0.0 111.313 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 7.8 ptpt -91.96 98.9 11.86 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 116.243 -2.183 . . . . 0.0 107.873 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.693 ' CG ' ' OG ' ' A' ' 88' ' ' SER . 6.1 t-80 -32.43 121.78 0.33 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -67.09 -34.91 78.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.347 -0.846 . . . . 0.0 111.276 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.601 HG23 ' HG3' ' A' ' 208' ' ' GLN . 21.7 t -70.5 -34.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.887 -1.133 . . . . 0.0 109.725 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -107.73 -42.45 4.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 92.46 0.42 70.03 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.699 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 34.5 p30 -78.17 -119.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.699 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttt-85 -126.3 170.74 11.59 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 123.246 1.498 . . . . 0.0 108.736 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.729 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.3 p -131.95 23.26 4.57 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 55' ' ' THR . 5.6 m -162.11 138.03 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.74 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.3 156.83 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.025 0.917 . . . . 0.0 110.795 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 81.3 Cg_endo -80.07 166.18 77.2 Favored 'Cis proline' 0 C--N 1.301 -1.953 0 C-N-CA 121.471 -2.304 . . . . 0.0 112.157 -0.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.521 ' CE1' HG11 ' A' ' 120' ' ' VAL . 27.2 m-85 -103.27 147.91 34.88 Favored Pre-proline 0 C--N 1.27 -2.89 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.078 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.49 ' O ' ' OG1' ' A' ' 63' ' ' THR . 38.9 Cg_endo -70.29 142.89 46.73 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.827 2.351 . . . . 0.0 112.368 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -46.43 158.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.467 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.26 62.65 5.42 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.54 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.5 OUTLIER -146.02 139.41 26.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -1.116 . . . . 0.0 109.569 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.628 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 1.6 mp0 -109.15 123.58 49.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.649 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -111.78 139.49 47.21 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.08 -169.38 2.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 117' ' ' VAL . 72.2 t -143.94 140.79 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.105 -1.622 . . . . 0.0 109.743 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.896 ' O ' HG22 ' A' ' 117' ' ' VAL . 97.3 m-85 -123.19 155.2 37.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -153.32 94.67 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 118.564 -1.779 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.588 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -92.87 -87.01 0.24 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.621 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -134.97 -158.01 8.22 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.769 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.85 102.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -1.019 . . . . 0.0 108.317 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.657 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -51.95 7.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 111.698 -177.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.769 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 4.7 m0 -69.22 -73.39 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.604 -1.31 . . . . 0.0 109.027 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.9 -14.52 63.37 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . . . -77.03 -53.88 7.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -1.143 . . . . 0.0 110.858 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.71 ' OE2' HG13 ' A' ' 91' ' ' VAL . 7.8 tp10 -48.42 -36.56 15.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.298 -0.876 . . . . 0.0 111.379 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.899 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.5 tmt_? -66.36 -57.95 6.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 0.0 109.941 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -41.18 -10.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.527 -0.733 . . . . 0.0 111.366 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.685 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.7 m-85 -101.91 -40.69 6.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.583 -1.323 . . . . 0.0 111.256 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.622 ' HB3' HG21 ' A' ' 89' ' ' THR . 1.1 p90 -86.69 1.83 50.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.48 -1.387 . . . . 0.0 110.906 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.2 m -83.52 19.99 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.134 . . . . 0.0 109.636 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -129.97 158.57 39.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.662 ' HZ1' ' C ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -91.48 153.43 19.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.576 -0.702 . . . . 0.0 109.742 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -26.63 19.09 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.533 HG23 ' CD2' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -75.34 138.06 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.712 -0.875 . . . . 0.0 109.76 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.691 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -82.74 -41.52 19.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 89' ' ' THR . 11.8 t -156.98 -163.66 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.662 0.744 . . . . 0.0 110.066 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 88' ' ' SER . 3.7 p -168.72 121.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.557 ' C ' ' OE2' ' A' ' 77' ' ' GLU . 5.5 mp0 -136.39 173.63 11.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.963 -1.086 . . . . 0.0 110.707 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.782 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -146.39 157.93 11.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.584 0.707 . . . . 0.0 109.62 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.43 174.5 46.08 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.627 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -85.39 156.13 20.99 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.374 -1.074 . . . . 0.0 109.547 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.8 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -172.72 -170.73 0.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 109.72 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 59.27 21.77 54.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.754 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -160.41 -156.08 8.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.697 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 40.4 p-80 178.91 109.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.416 -1.049 . . . . 0.0 108.983 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.826 HG23 ' CB ' ' A' ' 35' ' ' LEU . 13.9 m -144.45 144.79 31.55 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.612 ' C ' ' O ' ' A' ' 98' ' ' THR . 17.6 mtm-85 -19.83 -85.39 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.747 0.784 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -117.19 90.83 34.97 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 2.8 Cg_exo -73.35 111.1 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.566 2.178 . . . . 0.0 113.329 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.6 p -123.05 163.3 20.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' A' ' 103' ' ' TYR . 0.5 OUTLIER -50.05 -35.95 27.1 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.381 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.629 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 3.9 ttmt -73.7 -31.93 63.67 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.693 -0.63 . . . . 0.0 110.956 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.2 mm-40 -80.99 -47.08 14.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 102' ' ' THR . 30.2 m -67.6 -25.03 32.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 120.608 -1.308 . . . . 0.0 110.342 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.629 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 14.5 p -53.89 -40.62 66.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.673 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 58.1 m -48.51 -66.52 0.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.673 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.6 mt-10 137.82 -25.25 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.259 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' HD22 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -67.06 3.87 1.02 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.542 -177.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.439 ' OG1' HG12 ' A' ' 106' ' ' VAL . 71.0 p -99.91 -25.15 14.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.77 -1.206 . . . . 0.0 109.33 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 66.07 13.26 59.47 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.428 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.754 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.55 159.07 28.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.494 -1.592 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 1.041 ' HB2' ' NH2' ' A' ' 156' ' ' ARG . . . -126.31 117.79 23.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.657 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.5 mm-40 -49.46 112.61 0.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.76 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -124.54 175.29 7.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.382 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 68' ' ' PHE . 33.7 m -132.45 148.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.15 -0.969 . . . . 0.0 110.158 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.502 ' CD ' ' C ' ' A' ' 118' ' ' ARG . 2.0 tpp180 -110.69 107.81 17.49 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.685 HG12 HG22 ' A' ' 89' ' ' THR . 7.5 m -133.66 116.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 108.805 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.538 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.0 OUTLIER -96.95 158.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 131' ' ' LEU . 3.0 m-85 -134.45 155.45 50.32 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.885 -1.134 . . . . 0.0 109.543 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.624 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 1.4 ptm180 -110.37 112.31 57.05 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 125' ' ' HIS . 34.1 Cg_exo -44.48 -63.6 0.32 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 123.177 2.584 . . . . 0.0 113.383 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.755 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 16.9 mp0 -33.17 -21.9 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.737 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.688 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -137.99 6.46 2.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.433 -1.417 . . . . 0.0 110.502 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -155.82 150.41 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 110.043 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.568 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 37.6 t -97.81 147.6 24.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.96 ' CE2' HD11 ' A' ' 132' ' ' LEU . 50.8 t80 -62.51 -21.16 65.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.28 -7.57 47.9 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.568 ' HG3' ' H ' ' A' ' 127' ' ' SER . 9.1 mm-40 -74.46 -70.31 0.41 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.757 -0.59 . . . . 0.0 110.358 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.044 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -51.95 -29.79 21.91 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 120.495 -1.378 . . . . 0.0 108.236 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.96 HD11 ' CE2' ' A' ' 128' ' ' PHE . 47.3 mt -63.68 -57.05 11.23 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.524 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -39.61 94.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.745 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.759 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 3.8 t -50.27 -62.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 109.515 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 6.0 t80 -54.63 -39.09 67.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.457 -1.402 . . . . 0.0 110.078 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.56 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 51.5 m95 -70.75 -36.35 73.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.973 -1.079 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.77 -4.95 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 113.577 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.759 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -122.74 41.71 3.37 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.06 -1.65 . . . . 0.0 111.422 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 173.55 -168.41 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.849 0.833 . . . . 0.0 108.752 177.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -118.25 138.57 25.74 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.449 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 93.3 Cg_endo -81.21 0.99 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.614 2.21 . . . . 0.0 113.285 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.571 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -121.8 47.25 1.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.858 -1.151 . . . . 0.0 110.196 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.574 ' O ' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER -129.9 70.32 1.43 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.129 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.72 ' H ' HG21 ' A' ' 190' ' ' THR . . . -51.59 -118.71 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.626 ' C ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -70.56 40.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.444 -1.033 . . . . 0.0 109.736 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 144' ' ' GLY . 9.4 ttt180 -165.64 85.29 0.35 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.558 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.588 ' OE1' ' O ' ' A' ' 70' ' ' MET . 5.7 tp60 -86.23 117.16 24.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.428 -1.42 . . . . 0.0 109.79 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 46.58 -114.31 1.44 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.533 ' O ' ' CG ' ' A' ' 149' ' ' ASN . 12.8 t30 -92.77 16.71 11.75 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 114.329 -0.936 . . . . 0.0 110.282 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.19 147.15 30.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.114 . . . . 0.0 109.201 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 151' ' ' PHE . 20.2 p90 -130.07 129.42 43.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' NE2' ' A' ' 154' ' ' GLN . . . 147.16 155.06 6.4 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.675 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.1 OUTLIER -79.3 5.1 13.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.361 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.651 ' N ' ' OE1' ' A' ' 154' ' ' GLN . 15.1 pm0 -97.48 -5.75 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.474 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 23.0 m-85 -122.45 61.82 0.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.122 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.041 ' NH2' ' HB2' ' A' ' 114' ' ' ALA . 8.9 ptt-85 -112.23 175.91 5.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -0.842 . . . . 0.0 109.125 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.639 ' HB3' ' HE2' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -89.44 121.0 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -137.18 128.88 28.75 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 118.291 -1.363 . . . . 0.0 110.986 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.781 HG13 ' CG2' ' A' ' 191' ' ' THR . 1.1 m -126.77 120.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.26 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.518 ' CE2' HG11 ' A' ' 116' ' ' VAL . 6.2 m-30 -109.86 126.13 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.14 174.66 9.84 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 123.012 2.474 . . . . 0.0 112.999 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.556 ' OG1' ' OE1' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -99.3 -40.33 7.98 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.469 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -172.97 -162.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 0.0 109.722 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -53.57 -16.64 1.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.921 1.343 . . . . 0.0 108.959 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.469 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.9 t -59.2 -57.54 10.97 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.246 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.556 ' OE1' ' OG1' ' A' ' 162' ' ' THR . 1.3 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.749 -0.594 . . . . 0.0 110.392 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtp -50.92 -44.33 60.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.658 -1.276 . . . . 0.0 109.498 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.69 -19.23 59.27 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.034 -1.041 . . . . 0.0 109.12 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.58 -57.65 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.85 . . . . 0.0 110.616 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.64 -65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.068 -1.02 . . . . 0.0 110.035 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -33.53 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.24 -45.92 44.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.56 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 83.0 p -56.23 -49.45 74.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.388 -0.82 . . . . 0.0 109.826 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.536 ' HZ3' HD12 ' A' ' 189' ' ' ILE . 12.8 tttm -61.8 -53.59 53.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.741 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.02 -6.75 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.849 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.15 -52.17 9.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 110.464 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -11.79 59.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.028 -1.045 . . . . 0.0 110.28 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.517 ' OE1' ' CB ' ' A' ' 182' ' ' SER . 0.2 OUTLIER -70.8 -41.07 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.561 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -77.05 -16.04 59.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.49 -54.62 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 0.0 109.911 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.449 ' CD1' ' CG ' ' A' ' 141' ' ' PRO . 37.2 mt -75.4 -43.68 48.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 110.174 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.517 ' CB ' ' OE1' ' A' ' 178' ' ' GLN . 12.7 t -55.35 -22.1 17.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -88.18 -9.94 51.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 109.008 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.419 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 22.5 m170 -108.28 34.58 3.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.5 OUTLIER 69.79 68.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.965 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -134.73 173.15 12.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -110.75 -168.74 19.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 189' ' ' ILE . 11.1 Cg_endo -58.84 115.1 2.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.761 1.641 . . . . 0.0 110.812 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.571 HG22 HG22 ' A' ' 142' ' ' THR . 0.3 OUTLIER -47.8 179.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.0 110.06 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.72 HG21 ' H ' ' A' ' 144' ' ' GLY . 39.9 p -140.01 59.75 1.57 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.781 ' CG2' HG13 ' A' ' 159' ' ' VAL . 27.1 m -98.04 115.81 28.97 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 194' ' ' ARG . 6.3 t0 -84.72 125.28 32.4 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.953 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.44 148.33 19.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.65 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 3.6 mtm180 -165.44 169.81 15.19 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.522 -0.736 . . . . 0.0 109.128 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.697 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -123.86 170.6 10.41 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.994 -1.067 . . . . 0.0 110.808 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 195' ' ' GLU . . . 22.72 38.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.753 ' H ' ' CD ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -65.32 132.76 49.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.832 -1.393 . . . . 0.0 109.862 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.84 163.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -127.05 141.69 51.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.365 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' A' ' 93' ' ' PHE . 1.6 m-85 -142.56 97.91 3.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.922 . . . . 0.0 109.608 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -54.24 134.64 44.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.38 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.93 -173.16 4.58 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.669 ' CD ' ' H ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -75.33 168.06 20.71 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.636 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.04 -48.97 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.863 -1.148 . . . . 0.0 108.51 179.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.669 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.48 -23.04 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 110.054 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.651 ' O ' HG21 ' A' ' 91' ' ' VAL . 9.5 m-70 -92.3 6.79 45.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.048 -1.032 . . . . 0.0 110.022 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.827 ' O ' ' N ' ' A' ' 209' ' ' TYR . 6.0 mm-40 -122.56 -138.66 0.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.776 1.274 . . . . 0.0 111.024 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.699 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.3 OUTLIER -34.21 -3.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.44 -179.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.827 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.0 t80 -42.68 -43.08 3.72 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 120.563 -1.336 . . . . 0.0 110.464 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.625 HD21 ' O ' ' A' ' 74' ' ' TRP . 2.9 mp -61.17 -12.37 12.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.525 -1.36 . . . . 0.0 109.867 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.5 t -55.78 -29.76 60.2 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 108.545 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -83.92 -35.16 24.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.423 -0.798 . . . . 0.0 108.867 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -136.35 130.65 18.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 216' ' ' GLY . 30.2 Cg_endo -65.37 -56.84 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.921 1.747 . . . . 0.0 113.287 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.617 ' O ' ' N ' ' A' ' 217' ' ' TYR . 0.8 OUTLIER -64.11 2.37 0.56 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.689 -1.257 . . . . 0.0 107.926 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 61.95 -68.43 0.02 OUTLIER Glycine 0 N--CA 1.479 1.507 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' A' ' 215' ' ' ASP . 9.2 t80 -145.95 -150.85 0.35 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.475 -1.015 . . . . 0.0 108.737 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 218' ' ' CYS . 23.8 p -90.3 77.96 6.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.089 -1.007 . . . . 0.0 108.991 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -135.73 -152.05 6.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -169.66 -178.71 3.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -1.208 . . . . 0.0 109.75 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 220' ' ' LEU . . . -104.57 -143.74 12.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.437 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -154.45 -141.94 3.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.421 -1.046 . . . . 0.0 109.662 -179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.215 -0.762 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.652 HG21 ' O ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -42.68 176.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.759 1.266 . . . . 0.0 108.775 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -94.02 128.66 40.5 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.16 179.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 97' ' ' HIS . . . -47.34 -38.5 13.0 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.24 -10.66 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.632 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 34' ' ' ALA . 4.6 tt0 -81.87 -46.48 14.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 111' ' ' THR . . . -37.07 137.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.483 HD23 ' N ' ' A' ' 35' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.935 -1.103 . . . . 0.0 112.28 -179.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.635 ' O ' ' CG1' ' A' ' 42' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.15 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.2 m -148.88 -179.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.542 ' OG1' ' OD1' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -47.9 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.129 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.41 -28.09 58.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.424 -0.797 . . . . 0.0 111.39 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.84 99.27 11.7 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 115.958 -2.297 . . . . 0.0 108.581 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.941 ' CE1' ' HG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.25 126.43 0.27 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.474 ' CD2' ' OG ' ' A' ' 211' ' ' SER . 1.9 t60 -71.41 -29.4 64.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.697 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.855 HG21 ' CG ' ' A' ' 81' ' ' TRP . 21.5 t -69.25 -40.58 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.977 -1.077 . . . . 0.0 110.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -109.37 -42.69 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.158 -0.963 . . . . 0.0 110.335 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.26 3.59 56.58 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 38.4 p30 -79.21 -116.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.0 ttt180 -129.43 169.95 14.3 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 123.221 1.486 . . . . 0.0 108.992 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.75 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.3 p -133.7 34.0 3.45 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.025 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 55' ' ' THR . 4.5 m -163.86 150.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.71 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.3 pm0 -32.2 153.89 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.72 0 CA-C-O 121.932 0.872 . . . . 0.0 110.909 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 98.6 Cg_endo -78.73 166.07 80.52 Favored 'Cis proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.568 -2.263 . . . . 0.0 111.862 0.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.783 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 1.9 m-30 -115.48 132.45 23.11 Favored Pre-proline 0 C--N 1.269 -2.892 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.977 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.536 ' O ' ' OG1' ' A' ' 63' ' ' THR . 47.1 Cg_exo -49.48 115.57 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.002 1.801 . . . . 0.0 112.049 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -43.31 152.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.644 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.583 ' O ' ' CD ' ' A' ' 123' ' ' PRO . . . 79.38 4.38 89.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 1.2 p -90.8 143.51 26.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -1.146 . . . . 0.0 109.694 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mp0 -121.71 125.62 47.03 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.674 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -116.92 115.12 24.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 0.0 110.114 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' ' HE1' ' A' ' 128' ' ' PHE . . . -88.4 -175.98 5.18 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.3 t -146.06 113.83 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 119.724 -1.86 . . . . 0.0 110.11 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 1.107 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.4 p90 -162.71 155.19 19.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.722 -1.236 . . . . 0.0 109.387 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.628 ' HA2' HG13 ' A' ' 117' ' ' VAL . . . -136.04 133.59 6.71 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.297 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.612 ' CG ' ' N ' ' A' ' 71' ' ' GLY . 8.0 ptm -85.05 -50.71 7.21 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -1.013 . . . . 0.0 108.537 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.612 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.58 -154.15 8.2 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.697 ' H ' ' CG ' ' A' ' 150' ' ' ASP . 40.9 t -35.49 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -1.062 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.84 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -58.84 25.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.97 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.745 ' NE1' ' CE1' ' A' ' 209' ' ' TYR . 9.6 t90 -77.9 -60.29 2.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.9 -1.125 . . . . 0.0 108.91 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.67 -3.91 43.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.78 69.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.004 -1.292 . . . . 0.0 109.475 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.664 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 6.7 tt0 -73.63 -13.74 61.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 80' ' ' PHE . 11.1 ttp85 -60.53 -71.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 110.288 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.676 ' O ' HG22 ' A' ' 82' ' ' VAL . 14.7 mtmt -36.32 -22.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.212 -0.93 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.943 ' CD2' HG21 ' A' ' 119' ' ' VAL . 84.3 m-85 -77.98 -41.81 34.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 0.0 110.803 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.855 ' CG ' HG21 ' A' ' 50' ' ' VAL . 1.2 p90 -76.83 8.59 3.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.55 -1.344 . . . . 0.0 109.518 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -102.13 19.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.0 109.851 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 126' ' ' ILE . 45.6 mt -110.97 154.22 24.44 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.029 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -92.67 132.28 37.04 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -27.36 13.46 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -67.18 136.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.378 -1.072 . . . . 0.0 109.309 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.683 ' CE2' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -76.96 -51.49 11.07 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.585 -0.697 . . . . 0.0 109.455 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.683 ' OG ' ' CE2' ' A' ' 87' ' ' TYR . 2.0 p -160.04 -160.49 0.8 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.183 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.941 ' HG1' ' CE1' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -164.11 155.48 16.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.664 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.46 171.69 10.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.989 -1.069 . . . . 0.0 109.737 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.84 HG11 ' HB2' ' A' ' 73' ' ' PHE . 1.8 m -142.98 166.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.955 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.91 173.76 45.15 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 200' ' ' TYR . 5.5 m-85 -80.73 163.27 23.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.271 -1.135 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.631 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.94 139.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.993 -1.067 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 94.66 23.92 19.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.698 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -108.15 178.92 21.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.429 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 1.6 m170 -120.59 58.63 0.93 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.286 -1.126 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.714 HG22 ' H ' ' A' ' 99' ' ' ARG . 2.3 m -157.51 -178.41 7.32 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.88 -1.137 . . . . 0.0 108.724 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.714 ' H ' HG22 ' A' ' 98' ' ' THR . 34.9 mtt180 -76.66 -89.36 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.934 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.516 ' N ' ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -113.43 96.52 40.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.965 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 11.5 Cg_endo -79.93 159.97 24.18 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.257 . . . . 0.0 112.21 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.63 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 9.9 p -114.78 172.51 6.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.19 -0.944 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.603 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -63.88 -59.65 4.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -59.3 -22.95 61.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.094 . . . . 0.0 108.528 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.63 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 8.3 mm-40 -69.78 -56.67 6.52 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.533 0.683 . . . . 0.0 110.471 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 102' ' ' THR . 16.6 m -66.17 -24.74 34.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.498 -0.752 . . . . 0.0 111.368 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.631 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.8 p -57.36 -41.93 81.06 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 35.5 p -51.91 -66.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.3 mt-10 138.62 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -46.8 -27.44 1.22 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.415 -0.803 . . . . 0.0 111.767 -178.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 11.1 p -90.84 -32.6 16.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.564 -1.335 . . . . 0.0 109.941 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 65.76 44.32 92.47 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.698 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 1.2 m-70 -86.2 173.74 9.59 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.674 -1.486 . . . . 0.0 108.778 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -132.38 114.19 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.609 ' OE2' ' CE1' ' A' ' 73' ' ' PHE . 17.0 mt-10 -56.05 123.16 13.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.813 HG11 ' CE2' ' A' ' 160' ' ' TYR . 11.8 m -127.31 150.82 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.416 -0.802 . . . . 0.0 108.979 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.107 HG22 ' O ' ' A' ' 68' ' ' PHE . 3.6 m -111.31 135.31 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.783 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -98.52 98.51 9.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.532 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.943 HG21 ' CD2' ' A' ' 80' ' ' PHE . 49.0 t -103.38 120.75 53.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.449 -0.782 . . . . 0.0 109.222 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.508 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -118.07 144.2 26.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.699 ' CE2' HD11 ' A' ' 131' ' ' LEU . 8.8 p90 -141.39 174.31 10.67 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.087 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -116.03 117.93 38.8 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' HIS . 28.2 Cg_exo -42.09 -62.38 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.879 2.386 . . . . 0.0 113.318 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.759 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 27.3 mp0 -38.94 -14.34 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.153 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' PRO . 11.8 m-70 -133.38 -10.8 2.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.527 -1.358 . . . . 0.0 111.578 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.64 158.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 120.565 -1.335 . . . . 0.0 110.656 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.515 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 1.1 p -109.76 169.53 8.66 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.795 0.807 . . . . 0.0 111.375 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.57 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 41.2 t80 -69.32 -27.85 65.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 22.4 mt-10 -66.4 -8.74 27.67 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 127' ' ' SER . 7.2 mm-40 -72.36 -66.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.827 . . . . 0.0 110.797 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.901 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -57.29 -35.65 70.06 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.61 -1.306 . . . . 0.0 107.98 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 9.3 mp -74.73 -50.4 17.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 3.8 tttt -52.66 -41.37 63.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.865 -1.147 . . . . 0.0 110.272 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.638 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -72.15 -28.5 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.952 -1.093 . . . . 0.0 109.501 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.801 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.3 t80 -71.41 -50.8 28.36 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.732 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.52 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 76.9 m95 -72.03 -46.6 56.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.207 -1.558 . . . . 0.0 110.527 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.56 -42.78 55.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.14 -0.975 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.711 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -119.43 74.3 0.99 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 110.433 -178.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.801 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 12.0 m80 -156.75 -179.92 8.66 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.149 0.976 . . . . 0.0 110.299 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.558 ' HB3' HE21 ' A' ' 143' ' ' GLN . 1.0 OUTLIER -144.26 67.77 15.08 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 140' ' ' ASP . 16.4 Cg_exo -63.51 12.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.681 2.921 . . . . 0.0 113.998 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.607 HG22 HG22 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -121.95 29.15 7.21 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.046 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.667 ' O ' ' CG ' ' A' ' 143' ' ' GLN . 4.8 pt20 -155.61 77.69 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.841 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.699 ' N ' HG21 ' A' ' 190' ' ' THR . . . -70.38 14.71 1.25 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.658 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -108.27 1.46 21.99 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.146 -1.208 . . . . 0.0 108.223 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.461 ' CB ' ' HA ' ' A' ' 151' ' ' PHE . 11.5 ptt180 178.59 -174.18 0.17 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.718 0.771 . . . . 0.0 109.314 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.454 HE22 ' HA ' ' A' ' 139' ' ' HIS . 0.4 OUTLIER -175.1 118.93 0.18 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.721 0.772 . . . . 0.0 109.255 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.88 -120.38 10.53 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.448 ' ND2' ' HA3' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -80.94 -34.02 33.6 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.321 -0.939 . . . . 0.0 112.176 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.697 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 1.5 m-20 -82.48 144.21 30.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.398 -1.439 . . . . 0.0 109.23 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.461 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 38.5 p90 -136.36 144.57 44.66 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.05 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.66 -174.18 18.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.13 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.671 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -74.83 -19.72 60.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.695 -0.886 . . . . 0.0 110.367 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 155' ' ' TYR . 17.5 pm0 -86.52 7.51 25.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.156 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 154' ' ' GLN . 16.3 m-85 -139.65 50.84 1.75 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 0.0 109.59 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 153' ' ' THR . 38.4 mtm-85 -93.52 173.21 7.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.28 -0.888 . . . . 0.0 108.676 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.605 ' OG ' ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -94.28 109.26 21.09 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -133.33 119.28 19.53 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.396 -1.322 . . . . 0.0 109.947 -177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.693 HG23 ' CG2' ' A' ' 191' ' ' THR . 7.9 t -114.5 125.43 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.813 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -119.57 133.51 23.82 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.23 169.03 22.09 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.564 2.176 . . . . 0.0 111.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -19.69 20.17 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 120.729 -1.232 . . . . 0.0 109.146 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 p 177.44 -163.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.74 23.68 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.033 1.397 . . . . 0.0 108.471 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.4 t -56.15 -62.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.496 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 170' ' ' ALA . 17.8 mt-30 -77.81 -11.42 59.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 0.0 111.298 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.42 -45.57 62.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.569 -1.332 . . . . 0.0 109.248 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.71 -17.75 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.87 -55.88 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.0 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.34 -53.77 40.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 171' ' ' LEU . 70.0 mt -52.66 -39.1 61.5 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 108.906 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -58.26 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.429 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.52 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 4.0 p -56.67 -36.23 69.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.253 -0.904 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.471 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 4.2 ttpt -72.61 -46.41 54.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 109.383 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.423 ' N ' ' HE2' ' A' ' 174' ' ' LYS . 1.5 tt0 -71.63 -30.23 65.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 4.1 pt-20 -53.25 -34.02 55.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.526 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.618 ' CD2' HD11 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.28 -30.83 43.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.499 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.4 OUTLIER -66.61 -38.12 86.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 109.466 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -28.28 59.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.1 t -87.48 -54.22 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.618 HD11 ' CD2' ' A' ' 177' ' ' TYR . 3.7 mt -63.97 -45.26 89.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.027 -1.045 . . . . 0.0 109.92 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 87.8 p -54.97 -23.75 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -88.38 -3.56 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.46 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.7 m-70 -108.18 30.82 6.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.1 OUTLIER 72.3 29.74 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 110.25 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -103.54 175.16 5.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.032 -1.042 . . . . 0.0 108.99 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.93 -152.05 8.45 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' A' ' 189' ' ' ILE . 28.0 Cg_exo -58.69 105.74 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.639 2.226 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.607 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.8 -178.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.265 -0.897 . . . . 0.0 110.01 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.699 HG21 ' N ' ' A' ' 144' ' ' GLY . 1.7 t -130.76 -2.04 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.777 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.693 ' CG2' HG23 ' A' ' 159' ' ' VAL . 3.9 m -42.07 113.43 0.44 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.657 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -80.79 114.53 19.74 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.341 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.21 111.93 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.672 ' NH2' ' OH ' ' A' ' 160' ' ' TYR . 55.6 mtm-85 -115.18 -173.23 2.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.02 164.12 33.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.42 23.36 1.98 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.754 ' H ' ' CD ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -83.68 173.23 11.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.62 -1.518 . . . . 0.0 108.919 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.743 ' CG1' ' CE2' ' A' ' 200' ' ' TYR . 1.0 OUTLIER -118.72 160.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.08 . . . . 0.0 110.379 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.511 ' CZ ' ' HG3' ' A' ' 118' ' ' ARG . 47.1 t80 -91.04 149.88 21.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 109.314 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.743 ' CE2' ' CG1' ' A' ' 198' ' ' VAL . 18.6 m-85 -143.83 100.43 3.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 109.8 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -58.54 146.49 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 109.225 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -90.07 -167.22 1.78 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.101 -0.999 . . . . 0.0 108.985 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.719 ' OE2' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -73.84 176.82 6.0 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 109.267 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.719 ' N ' ' OE2' ' A' ' 203' ' ' GLU . 0.3 OUTLIER -61.03 -61.02 2.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.711 ' CD1' ' OE2' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.43 8.62 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.774 -1.204 . . . . 0.0 111.039 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.603 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 6.5 m-70 -104.0 14.8 29.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.766 -1.209 . . . . 0.0 111.04 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.803 ' O ' ' N ' ' A' ' 209' ' ' TYR . 20.0 mm-40 -129.05 -168.35 1.91 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 110.495 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.824 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -38.64 1.15 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.803 ' N ' ' O ' ' A' ' 207' ' ' GLN . 21.1 p90 -38.35 -24.03 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 O-C-N 120.788 -1.195 . . . . 0.0 110.965 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.714 ' CB ' ' HE1' ' A' ' 74' ' ' TRP . 0.2 OUTLIER -79.38 -10.42 59.8 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.267 -1.521 . . . . 0.0 111.81 -176.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.474 ' OG ' ' CD2' ' A' ' 49' ' ' HIS . 83.3 p -54.06 -24.63 17.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.152 -0.968 . . . . 0.0 108.757 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 49' ' ' HIS . 6.4 mmmt -68.39 -18.41 64.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.0 OUTLIER -140.23 73.05 32.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.71 4.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 123.037 2.491 . . . . 0.0 113.079 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.623 ' OD2' ' CE1' ' A' ' 217' ' ' TYR . 38.0 t0 -63.02 -19.5 64.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 110.053 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.56 85.25 0.04 OUTLIER Glycine 0 N--CA 1.504 3.214 0 C-N-CA 120.067 -1.064 . . . . 0.0 111.757 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.623 ' CE1' ' OD2' ' A' ' 215' ' ' ASP . 66.5 m-85 -91.81 81.13 5.21 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 121.002 2.401 . . . . 0.0 109.602 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.572 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.5 OUTLIER -170.83 112.12 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 109.447 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.572 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -37.87 161.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 218' ' ' CYS . 4.6 mp -143.54 -177.97 5.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.12 -1.224 . . . . 0.0 109.775 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 108.47 158.74 19.53 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.501 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -123.79 -167.31 12.74 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 222' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--N 1.269 -2.914 0 CA-C-N 114.511 -0.844 . . . . 0.0 109.219 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 29' ' ' ILE . 36.0 t . . . . . 0 C--O 1.215 -0.742 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -40.08 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.984 1.373 . . . . 0.0 109.773 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.471 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -111.25 125.97 54.38 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HA ' ' ND1' ' A' ' 97' ' ' HIS . . . -46.47 -22.39 0.26 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.25 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 22.3 mp0 -83.97 -7.58 59.37 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.082 -1.011 . . . . 0.0 110.391 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.7 pt-20 -106.3 -14.6 15.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 109.578 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.833 ' HB2' ' NE2' ' A' ' 97' ' ' HIS . . . -45.48 -170.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.597 0.713 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.1 mm? . . . . . 0 C--N 1.307 -1.262 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.174 0.511 . . . . 0.0 109.865 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.736 ' O ' HG13 ' A' ' 44' ' ' VAL . 72.0 Cg_endo -82.38 169.59 13.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.054 2.503 . . . . 0.0 112.334 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' ' 43' ' ' PRO . 5.1 m -162.34 -166.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.834 ' O ' HG23 ' A' ' 45' ' ' THR . 14.1 t -82.31 95.16 7.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.602 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.73 -27.59 59.51 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.26 -0.9 . . . . 0.0 111.424 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.587 ' O ' ' C ' ' A' ' 48' ' ' HIS . 4.5 ptpt -95.42 99.03 11.0 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.588 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.35 114.34 0.13 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -27.81 69.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.0 111.134 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.621 HG11 ' CD1' ' A' ' 81' ' ' TRP . 15.8 t -71.27 -38.98 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.326 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -109.94 -42.74 4.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 110.239 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.14 0.9 55.92 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 24.4 p30 -76.24 -117.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.589 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 41.8 mtm-85 -126.16 174.01 8.82 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.323 1.535 . . . . 0.0 110.121 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.642 ' C ' HG22 ' A' ' 56' ' ' VAL . 2.9 p -147.11 30.78 0.94 Allowed 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.293 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.642 HG22 ' C ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -171.34 134.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.064 -1.023 . . . . 0.0 109.484 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.595 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.28 144.96 0.1 Allowed Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.395 -0.816 . . . . 0.0 110.534 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 90.1 Cg_endo -77.17 166.66 81.71 Favored 'Cis proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.132 -2.028 . . . . 0.0 111.825 -0.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.786 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 92.8 m-85 -106.85 153.31 40.89 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.351 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.545 ' O ' ' OG1' ' A' ' 63' ' ' THR . 32.3 Cg_exo -50.3 161.03 1.25 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.318 2.012 . . . . 0.0 112.22 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.189 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.96 61.53 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -144.9 137.68 26.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -1.117 . . . . 0.0 109.413 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.637 ' CD ' ' H ' ' A' ' 65' ' ' MET . 13.3 tp60 -106.29 157.53 17.53 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 108.811 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.772 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -126.85 137.81 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.618 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -130.07 -171.03 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG21 ' CD ' ' A' ' 197' ' ' GLN . 96.5 t -144.49 150.11 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.156 -1.59 . . . . 0.0 110.093 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 67.1 m-85 -143.21 141.62 31.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.29 -0.881 . . . . 0.0 108.824 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.742 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -137.1 101.61 0.35 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.716 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -109.18 -89.73 0.47 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.46 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.649 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -141.09 -166.46 10.73 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.788 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 1.1 t -25.79 107.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.833 -0.804 . . . . 0.0 109.026 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.798 ' CZ ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.1 6.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 111.893 -177.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.788 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 32.0 m0 -71.66 -40.79 69.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.215 -1.553 . . . . 0.0 107.899 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.8 -23.34 30.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.71 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.0 -21.8 54.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 110.662 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.598 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -84.89 -41.91 15.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.64 -1.288 . . . . 0.0 111.486 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.699 ' O ' HG13 ' A' ' 82' ' ' VAL . 3.9 ttt180 -56.69 -57.84 10.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.758 -1.214 . . . . 0.0 111.309 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.405 ' O ' HG21 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -60.0 25.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.978 -1.076 . . . . 0.0 110.953 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 19.6 m-85 -128.26 -41.78 1.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.94 -1.1 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.621 ' CD1' HG11 ' A' ' 50' ' ' VAL . 1.2 p90 -91.63 -2.7 56.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.645 -1.284 . . . . 0.0 110.341 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 78' ' ' ARG . 3.4 m -83.87 13.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.085 -1.009 . . . . 0.0 109.14 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.404 HD13 ' OE1' ' A' ' 130' ' ' GLU . 43.3 mt -111.68 152.91 27.17 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.915 0.864 . . . . 0.0 109.408 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 136.41 34.17 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.41 -31.43 6.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -72.96 137.65 23.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.554 -0.968 . . . . 0.0 109.118 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.675 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -72.4 -42.42 65.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.671 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -177.67 -171.2 0.3 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.444 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.496 ' OG1' ' CD ' ' A' ' 77' ' ' GLU . 1.1 p -151.44 156.73 41.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.671 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 9.0 mp0 -149.64 158.55 44.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.415 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.598 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.6 OUTLIER -135.85 150.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 108.829 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.23 174.35 42.44 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.646 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.3 m-85 -79.06 146.46 33.26 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.306 -1.114 . . . . 0.0 108.464 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.69 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -145.12 -175.55 4.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.288 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 49.76 21.62 3.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.555 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -91.0 178.31 42.03 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.833 ' NE2' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -137.47 5.28 2.69 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.285 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 1.149 HG22 HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -160.08 147.38 16.36 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 119.918 -1.738 . . . . 0.0 110.899 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.661 ' C ' ' ND2' ' A' ' 100' ' ' ASN . 4.3 mtp85 -72.3 61.51 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 1.149 HD21 HG22 ' A' ' 98' ' ' THR . 0.5 OUTLIER -123.58 -136.2 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 -176.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 100' ' ' ASN . 74.4 Cg_exo -40.42 169.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.137 0 CA-C-N 122.486 1.924 . . . . 0.0 114.562 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.967 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.9 p -123.72 -175.1 3.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.605 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.706 ' CD1' ' CE1' ' A' ' 206' ' ' HIS . 0.3 OUTLIER -47.59 -38.73 15.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 0.0 110.38 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -74.34 -49.46 22.78 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.932 -1.105 . . . . 0.0 111.636 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' C ' ' N ' ' A' ' 107' ' ' CYS . 9.5 mm-40 -84.28 -25.34 29.42 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.038 -1.039 . . . . 0.0 111.24 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 102' ' ' THR . 29.7 m -54.48 -21.52 6.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.494 ' C ' ' O ' ' A' ' 106' ' ' VAL . 1.2 p -37.32 -20.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.869 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 106' ' ' VAL . 79.3 p -75.49 3.36 9.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 108.859 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 106' ' ' VAL . 16.2 mt-10 55.39 3.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.65 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.55 ' O ' ' NE2' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -77.51 -19.69 55.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 110.829 -178.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.745 HG21 HG12 ' A' ' 106' ' ' VAL . 67.8 p -86.22 -6.27 59.02 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.679 -1.263 . . . . 0.0 110.393 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 51.16 16.8 2.18 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.489 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.69 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -73.86 161.55 30.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -1.173 . . . . 0.0 110.763 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -138.74 114.28 9.76 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.688 ' OE1' ' CE1' ' A' ' 155' ' ' TYR . 6.3 mp0 -55.17 130.87 43.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.742 HG12 ' CA ' ' A' ' 69' ' ' GLY . 10.5 m -142.19 -171.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.581 ' HA ' HG12 ' A' ' 91' ' ' VAL . 2.9 t -131.1 118.86 42.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.685 -0.634 . . . . 0.0 110.33 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.786 ' NH1' ' CZ ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.31 103.29 15.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 117' ' ' VAL . 2.1 t -120.69 142.86 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.743 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.682 HG12 ' NH2' ' A' ' 118' ' ' ARG . 1.8 m -107.95 163.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.651 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 3.6 m-85 -141.93 151.55 42.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.906 -1.122 . . . . 0.0 109.412 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -102.02 105.94 44.93 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.877 . . . . 0.0 109.923 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 52.5 Cg_exo -50.04 -23.93 10.03 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.595 2.196 . . . . 0.0 112.345 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -83.61 -21.54 32.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.922 . . . . 0.0 110.317 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -116.29 -12.17 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.781 HD13 ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.47 163.61 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 126' ' ' ILE . 32.8 t -110.6 170.84 7.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.626 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 7.9 t80 -69.54 -19.99 63.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -71.18 -17.45 62.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.581 -1.325 . . . . 0.0 108.171 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.781 ' HG2' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -76.39 -42.35 44.77 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.567 -0.708 . . . . 0.0 110.803 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.618 HD13 ' CB ' ' A' ' 66' ' ' ALA . 1.2 pp -65.53 -48.95 70.72 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.254 -1.529 . . . . 0.0 108.813 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.883 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.4 pp -71.39 -18.8 62.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.929 -1.107 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.736 ' N ' HD12 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.01 -42.62 66.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.735 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -67.04 -38.72 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.147 -0.971 . . . . 0.0 110.321 -178.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.792 ' CE1' ' CE1' ' A' ' 139' ' ' HIS . 5.3 t80 -61.62 -48.49 80.66 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.4 -0.813 . . . . 0.0 110.389 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.731 ' CG ' ' CZ ' ' A' ' 177' ' ' TYR . 90.3 m95 -70.47 -32.44 69.98 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 120.863 -1.148 . . . . 0.0 110.66 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.26 -43.62 41.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 112.562 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 2.8 m-80 -111.48 65.05 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.588 -1.32 . . . . 0.0 112.581 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.792 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.1 OUTLIER 175.67 134.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.195 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.659 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -73.88 114.55 33.66 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.394 -0.816 . . . . 0.0 109.167 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 190' ' ' THR . 72.9 Cg_endo -81.43 -26.79 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.501 2.134 . . . . 0.0 113.053 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.694 HG22 HG22 ' A' ' 189' ' ' ILE . 0.7 OUTLIER -89.13 34.07 0.8 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.904 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.72 ' OE1' ' N ' ' A' ' 148' ' ' GLY . 29.7 mt-30 -129.84 90.79 3.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.081 -1.012 . . . . 0.0 110.808 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.678 ' H ' HG21 ' A' ' 190' ' ' THR . . . -63.57 -117.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.67 40.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.949 . . . . 0.0 109.846 -178.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 144' ' ' GLY . 13.5 ttt-85 -163.58 84.66 0.48 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.288 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.581 ' OE1' ' OE1' ' A' ' 143' ' ' GLN . 6.2 tp-100 -76.53 63.64 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.481 -1.387 . . . . 0.0 109.866 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.72 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 91.6 -121.3 6.31 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -80.52 10.33 4.88 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.217 -0.992 . . . . 0.0 109.515 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.16 154.65 20.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 108.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -136.46 125.42 24.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.984 -1.072 . . . . 0.0 110.477 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 156.46 142.04 3.33 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.12 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.419 ' O ' ' OG1' ' A' ' 153' ' ' THR . 0.1 OUTLIER -72.62 5.0 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -1.102 . . . . 0.0 109.014 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.623 ' NE2' ' CZ ' ' A' ' 155' ' ' TYR . 7.2 pt20 -95.18 -1.47 51.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.199 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.688 ' CE1' ' OE1' ' A' ' 115' ' ' GLU . 38.8 m-85 -129.82 61.11 1.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.326 -0.859 . . . . 0.0 108.993 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.799 ' NH2' HH22 ' A' ' 194' ' ' ARG . 5.8 mtm180 -111.6 177.92 4.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 109.83 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -92.48 119.39 31.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 176.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.627 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -140.4 129.33 23.31 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 118.191 -1.403 . . . . 0.0 111.189 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.741 HG13 ' CG2' ' A' ' 191' ' ' THR . 3.1 m -107.4 127.85 62.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.706 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.627 ' CE1' ' HB1' ' A' ' 158' ' ' ALA . 10.9 m-85 -124.86 107.73 28.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.3 176.08 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.359 2.039 . . . . 0.0 112.802 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.2 -34.2 11.2 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.458 -0.776 . . . . 0.0 109.46 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 p -173.96 -163.21 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.165 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.99 -17.8 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.972 1.368 . . . . 0.0 108.764 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.21 -61.0 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.758 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 170' ' ' ALA . 1.3 tt0 -76.88 -25.75 53.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.69 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.4 ' SD ' ' CD1' ' A' ' 171' ' ' LEU . 1.7 mtt -52.3 -14.47 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.004 -1.06 . . . . 0.0 110.627 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -75.9 -45.55 34.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.754 -1.216 . . . . 0.0 109.638 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -93.03 -47.45 6.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.517 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 166' ' ' GLN . . . -52.71 -65.92 0.47 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.192 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.4 ' CD1' ' SD ' ' A' ' 167' ' ' MET . 0.6 OUTLIER -54.94 -47.59 74.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.521 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -61.25 -38.18 85.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.614 ' OG ' ' NE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -56.33 -32.6 64.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 109.281 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -72.6 -55.99 6.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 110.203 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -70.68 -47.64 58.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.463 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -53.11 -32.89 49.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.025 . . . . 0.0 109.824 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.731 ' CZ ' ' CG ' ' A' ' 136' ' ' TRP . 1.5 m-85 -74.08 -30.58 62.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.538 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.6 mm100 -52.92 -60.77 2.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.961 -1.087 . . . . 0.0 109.478 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -47.79 -22.31 0.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.959 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.25 -53.2 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 109.605 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.1 mt -74.68 -44.88 47.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.873 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.2 t -55.63 -30.85 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.018 -1.051 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -88.34 -3.33 58.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.305 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 43.3 m170 -108.25 35.86 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 186' ' ' PHE . 0.5 OUTLIER 68.23 66.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 185' ' ' ASN . 65.4 m-85 -158.13 168.57 26.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.054 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.2 -158.73 18.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -58.76 107.33 0.33 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.483 2.122 . . . . 0.0 111.193 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.694 HG22 HG22 ' A' ' 142' ' ' THR . 0.4 OUTLIER -46.9 169.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.444 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.678 HG21 ' H ' ' A' ' 144' ' ' GLY . 79.2 p -114.67 58.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.562 0.696 . . . . 0.0 109.446 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.741 ' CG2' HG13 ' A' ' 159' ' ' VAL . 39.8 m -94.45 116.65 29.04 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.628 ' CG ' HH22 ' A' ' 156' ' ' ARG . 32.9 t70 -93.98 138.18 32.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 121.582 0.706 . . . . 0.0 110.505 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.493 HD13 ' CG2' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -111.62 159.73 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.799 HH22 ' NH2' ' A' ' 156' ' ' ARG . 1.5 ttm180 -162.31 -167.65 1.66 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.887 -1.133 . . . . 0.0 110.465 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -103.11 140.37 37.41 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.997 ' O ' ' NE2' ' A' ' 197' ' ' GLN . . . 14.38 -81.21 0.0 OUTLIER Glycine 0 C--O 1.185 -2.964 0 N-CA-C 104.069 -3.613 . . . . 0.0 104.069 -177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.997 ' NE2' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 145.13 115.07 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.127 0.464 . . . . 0.0 111.616 172.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 198' ' ' VAL . 7.7 p -61.12 82.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 119.963 -1.711 . . . . 0.0 106.732 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.677 ' N ' ' O ' ' A' ' 197' ' ' GLN . 11.7 t80 -49.76 147.88 3.41 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.088 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.6 m-85 -151.05 97.31 2.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.492 ' CZ ' ' CG1' ' A' ' 56' ' ' VAL . 25.0 m-85 -53.78 147.84 11.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.994 -1.066 . . . . 0.0 110.76 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.543 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -99.31 177.72 5.11 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.535 ' OE2' ' CD2' ' A' ' 206' ' ' HIS . 1.3 pm0 -74.17 163.12 28.24 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.035 -1.041 . . . . 0.0 109.056 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.646 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -49.56 -51.87 33.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.912 -1.118 . . . . 0.0 108.522 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -46.85 -15.97 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.757 . . . . 0.0 110.189 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.798 ' ND1' ' CZ ' ' A' ' 73' ' ' PHE . 4.7 m-70 -100.75 13.49 34.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 110.684 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.847 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.6 mm-40 -131.87 -138.98 0.2 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.478 1.132 . . . . 0.0 109.989 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.68 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -32.86 -3.65 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.858 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.847 ' N ' ' O ' ' A' ' 207' ' ' GLN . 9.4 t80 -41.7 -43.27 2.81 Favored 'General case' 0 N--CA 1.511 2.624 0 O-C-N 120.171 -1.581 . . . . 0.0 108.699 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.678 HD22 ' HA2' ' A' ' 216' ' ' GLY . 0.2 OUTLIER -53.29 -25.18 13.71 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.627 -1.296 . . . . 0.0 109.538 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 208' ' ' GLN . 29.0 t -55.71 -51.1 68.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.909 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -67.46 -33.45 75.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.197 -0.939 . . . . 0.0 108.506 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 215' ' ' ASP . 24.8 m120 -136.47 76.03 50.06 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.631 ' N ' ' O ' ' A' ' 210' ' ' LEU . 76.8 Cg_exo -45.35 -0.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.942 2.428 . . . . 0.0 112.532 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 213' ' ' ASN . 4.9 t70 -63.95 -16.1 60.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.046 -1.034 . . . . 0.0 110.025 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.678 ' HA2' HD22 ' A' ' 210' ' ' LEU . . . 62.56 -66.68 0.02 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 215' ' ' ASP . 24.8 t80 -159.91 -150.68 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -1.013 . . . . 0.0 109.237 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 8.6 t -79.87 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.105 -0.997 . . . . 0.0 109.685 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 220' ' ' LEU . . . -90.03 -144.05 11.12 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 1.4 tp 76.75 139.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.793 -0.828 . . . . 0.0 109.755 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.31 115.64 0.34 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 148.66 141.64 3.5 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 136' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.285 . . . . 0.0 109.819 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.936 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.205 -1.25 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.936 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 15.4 -179.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-O 123.375 1.559 . . . . 0.0 113.565 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.21 119.89 15.08 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.721 -1.237 . . . . 0.0 110.685 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' A' ' 33' ' ' GLU . . . -59.31 -46.15 89.35 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.596 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.694 ' OE2' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -53.33 -12.73 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 108.994 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.694 ' N ' ' OE2' ' A' ' 32' ' ' GLU . 3.3 tt0 -113.72 -48.42 2.93 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -47.72 163.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.228 -0.92 . . . . 0.0 108.814 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.895 HD22 ' O ' ' A' ' 110' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.585 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.639 HG23 ' OD1' ' A' ' 100' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.39 175.28 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.661 2.241 . . . . 0.0 112.569 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 11.4 m -143.22 -166.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.958 . . . . 0.0 109.677 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -49.21 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.577 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.09 -65.05 0.67 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 111.184 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.97 99.67 1.83 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.622 -2.431 . . . . 0.0 108.48 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.685 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.55 122.32 0.34 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.7 -31.58 71.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.381 -0.824 . . . . 0.0 110.716 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.696 HG22 ' OG ' ' A' ' 211' ' ' SER . 47.1 t -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.925 -1.11 . . . . 0.0 109.637 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.41 -45.1 4.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.19 4.55 55.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.602 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.2 p30 -82.03 -121.57 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.602 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 mtm-85 -123.19 167.37 13.79 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.371 1.082 . . . . 0.0 108.572 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.6 p -124.09 -17.41 6.22 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.255 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 m -151.76 -167.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.574 -1.328 . . . . 0.0 109.521 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.557 ' N ' HG23 ' A' ' 56' ' ' VAL . 4.6 mt-10 -32.36 120.23 0.41 Allowed Pre-proline 0 C--N 1.295 -1.782 0 O-C-N 121.91 -0.494 . . . . 0.0 110.176 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' VAL . 98.3 Cg_endo -75.57 172.28 63.85 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.87 0.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -116.91 129.78 25.06 Favored Pre-proline 0 C--N 1.28 -2.419 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.59 ' O ' ' OG1' ' A' ' 63' ' ' THR . 37.5 Cg_exo -49.67 140.27 29.55 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.057 1.838 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.86 155.86 27.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.34 -9.73 25.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -95.66 135.88 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -1.199 . . . . 0.0 109.91 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -108.61 167.12 10.28 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.729 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -149.35 156.42 42.04 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.386 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.67 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -141.22 -174.65 4.07 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 118' ' ' ARG . 2.5 t -144.58 127.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 119.803 -1.811 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.667 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.6 OUTLIER -156.72 153.85 29.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.701 -1.25 . . . . 0.0 109.853 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.612 ' N ' HG12 ' A' ' 116' ' ' VAL . . . -161.36 -170.08 25.53 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.333 -1.413 . . . . 0.0 112.993 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.776 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -133.65 -93.04 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.906 0.86 . . . . 0.0 110.264 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.702 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -132.46 65.37 0.59 Allowed Glycine 0 N--CA 1.498 2.811 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.702 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.5 t 120.75 170.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 124.16 0.984 . . . . 0.0 109.499 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.562 ' N ' ' SG ' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -120.58 30.13 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.242 -0.911 . . . . 0.0 111.341 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.51 ' CA ' HD11 ' A' ' 210' ' ' LEU . 7.2 m0 -88.79 -87.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.404 -1.435 . . . . 0.0 109.005 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -7.37 29.96 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -76.13 -47.54 23.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -1.169 . . . . 0.0 110.28 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.571 ' O ' ' CD ' ' A' ' 77' ' ' GLU . 7.2 tp10 -78.67 -27.8 45.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 82' ' ' VAL . 31.4 ttt-85 -56.23 -34.55 66.44 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.942 -1.098 . . . . 0.0 109.925 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -75.7 17.82 0.28 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 110.294 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 81.3 m-85 -126.35 -41.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.847 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.57 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -74.36 8.77 2.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 109.793 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.0 m -109.54 15.8 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 109.365 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.72 156.83 24.08 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.808 0.813 . . . . 0.0 109.018 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -89.98 140.11 29.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.337 0.589 . . . . 0.0 109.61 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.46 -29.36 8.32 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 120' ' ' VAL . 1.2 t -77.43 123.51 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.401 -1.058 . . . . 0.0 109.301 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.598 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.327 -0.858 . . . . 0.0 108.988 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 89' ' ' THR . 6.4 p -158.43 -162.14 1.08 Allowed 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.596 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.685 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.7 p -160.99 128.36 4.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 108.817 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.598 ' OE1' ' O ' ' A' ' 89' ' ' THR . 4.1 mp0 -130.95 145.78 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.415 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 117' ' ' VAL . 1.1 m -126.76 156.56 37.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -172.09 -128.96 1.09 Allowed Glycine 0 C--N 1.293 -1.831 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.28 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE1' HG21 ' A' ' 106' ' ' VAL . 83.1 m-85 -143.24 160.64 40.09 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.876 -0.779 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -168.71 148.41 4.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.365 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 87.37 30.8 18.25 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.643 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -142.97 173.28 24.17 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.733 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 29.0 p-80 -135.88 85.34 2.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -1.204 . . . . 0.0 110.22 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 35' ' ' LEU . 96.4 m -150.02 163.48 38.03 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.057 -1.027 . . . . 0.0 108.393 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.548 ' N ' HG22 ' A' ' 98' ' ' THR . 0.1 OUTLIER -65.18 -76.8 0.07 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.718 0.771 . . . . 0.0 111.423 -177.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.639 ' OD1' HG23 ' A' ' 42' ' ' ILE . 6.3 m-80 -121.46 83.17 40.43 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-O 121.504 0.668 . . . . 0.0 110.09 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.46 ' HA ' ' CD ' ' A' ' 105' ' ' GLU . 23.1 Cg_exo -63.15 117.24 4.17 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 123.34 2.693 . . . . 0.0 113.023 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.593 ' H ' ' HG2' ' A' ' 105' ' ' GLU . 4.1 p -109.16 149.77 28.87 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 120.569 -1.332 . . . . 0.0 107.617 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.687 ' CZ ' ' OH ' ' A' ' 155' ' ' TYR . 2.8 t80 -47.68 -34.37 8.06 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.398 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -73.28 -26.49 61.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 110.443 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.643 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -83.53 -57.33 3.28 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 120.565 -1.334 . . . . 0.0 110.142 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.643 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 11.5 m -61.93 -20.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.471 -0.768 . . . . 0.0 111.843 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.565 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.3 p -33.85 -37.84 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.438 -0.789 . . . . 0.0 109.66 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 106' ' ' VAL . 27.0 t -103.97 -115.53 0.22 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.653 -1.28 . . . . 0.0 109.791 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.458 ' N ' ' OG ' ' A' ' 108' ' ' SER . 1.5 mp0 -120.4 9.86 11.06 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.347 0.594 . . . . 0.0 110.236 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.895 ' O ' HD22 ' A' ' 35' ' ' LEU . 5.4 mttt -43.0 -50.96 5.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -122.51 14.13 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.747 -1.221 . . . . 0.0 110.512 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.544 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 37.2 35.02 0.14 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.643 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.09 168.93 19.1 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.038 -1.272 . . . . 0.0 109.801 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -119.12 114.11 21.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 72' ' ' CYS . 1.9 pp20? -72.86 130.05 39.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.269 -0.895 . . . . 0.0 109.906 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -153.41 -179.39 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.146 -0.971 . . . . 0.0 110.507 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.658 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.3 m -115.94 117.8 56.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.808 0.813 . . . . 0.0 110.2 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.896 HH22 ' N ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -98.24 101.68 13.21 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.664 ' C ' HH22 ' A' ' 118' ' ' ARG . 31.0 m -126.63 123.65 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.896 ' N ' HH22 ' A' ' 118' ' ' ARG . 0.7 OUTLIER -78.27 171.57 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.894 ' CD2' HD21 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -158.08 155.58 29.49 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.356 -1.338 . . . . 0.0 110.957 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -103.4 102.63 30.54 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.822 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' O ' ' A' ' 126' ' ' ILE . 31.7 Cg_exo -43.7 -64.24 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.968 2.445 . . . . 0.0 112.754 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -44.43 -29.96 0.78 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.811 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -92.92 -46.32 7.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 109.769 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 130' ' ' GLU . 2.6 tt -126.07 166.99 21.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.048 -1.032 . . . . 0.0 108.255 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.53 ' N ' ' CG1' ' A' ' 126' ' ' ILE . 6.1 m -99.96 159.33 15.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.66 -1.275 . . . . 0.0 110.721 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 1.077 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 17.4 t80 -66.43 -27.46 67.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.585 ' OE1' ' O ' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -69.67 -16.74 63.41 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' A' ' 126' ' ' ILE . 2.8 mt-10 -73.57 -72.33 0.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 108.992 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.99 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -39.2 -35.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 178.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 1.077 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 44.4 mt -76.28 -44.75 35.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' GLU . 2.6 mttm -52.28 -53.56 42.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.94 -1.1 . . . . 0.0 110.117 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.656 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 41.3 t -57.85 -30.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.797 -1.19 . . . . 0.0 108.45 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.709 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 3.0 t80 -73.1 -56.74 4.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.143 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 37.7 m95 -71.57 -54.08 11.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.384 -1.448 . . . . 0.0 110.021 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.444 ' C ' ' O ' ' A' ' 136' ' ' TRP . 20.8 tt0 -37.08 -56.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.717 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 8.3 p30 -103.25 63.8 0.82 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.061 -1.025 . . . . 0.0 109.949 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.776 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 22.5 m80 -158.28 177.21 11.53 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.286 1.041 . . . . 0.0 110.072 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' THR . 1.6 t0 -145.22 80.23 11.18 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 190' ' ' THR . 13.0 Cg_exo -48.09 13.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.545 2.163 . . . . 0.0 113.592 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 1.049 HG22 HG22 ' A' ' 189' ' ' ILE . 0.4 OUTLIER -122.15 43.29 2.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.808 -1.182 . . . . 0.0 110.318 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.587 ' O ' ' O ' ' A' ' 144' ' ' GLY . 5.3 mt-30 -130.72 78.61 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 109.325 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.43 -116.26 0.0 OUTLIER Glycine 0 N--CA 1.493 2.473 0 CA-C-O 121.905 0.725 . . . . 0.0 112.513 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.97 42.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.795 -0.827 . . . . 0.0 110.353 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -170.9 139.62 1.48 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.24 177.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.615 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -146.93 91.46 2.01 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.128 -1.607 . . . . 0.0 108.424 176.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.46 -129.47 9.83 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -94.69 12.9 26.14 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.652 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.675 ' OD1' ' CE2' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -109.05 112.91 25.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.649 -1.282 . . . . 0.0 109.488 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.483 ' CE2' ' HG3' ' A' ' 146' ' ' ARG . 6.2 m-85 -104.22 113.48 27.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.53 149.42 7.87 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.43 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.598 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -48.87 -45.98 41.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.51 -0.994 . . . . 0.0 109.393 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.814 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 2.1 pm0 -75.38 1.53 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 111.177 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.814 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 21.1 m-85 -102.99 41.58 1.24 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.443 -1.411 . . . . 0.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.618 ' O ' ' O ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -103.45 174.91 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 108.969 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.4 129.37 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -143.74 117.82 9.48 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 115.94 -2.304 . . . . 0.0 112.444 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' ASP . 16.1 t -111.98 133.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.214 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.507 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 53.7 m-85 -130.5 94.41 29.68 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.0 109.192 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.9 170.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.773 2.315 . . . . 0.0 112.063 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.458 HG22 ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -98.0 -21.13 16.99 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 120.941 -1.099 . . . . 0.0 109.633 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 165' ' ' VAL . 4.1 p 173.54 -178.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.086 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.07 -15.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.009 1.385 . . . . 0.0 108.6 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.6 t -55.69 -64.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.672 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.67 HE22 ' HB2' ' A' ' 66' ' ' ALA . 17.1 mt-30 -79.54 -19.32 49.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.682 -0.636 . . . . 0.0 110.932 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.4 ' HG2' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -52.15 -31.23 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.869 -1.145 . . . . 0.0 110.632 -178.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.06 65.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.681 -1.262 . . . . 0.0 109.979 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.433 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.92 -42.94 9.2 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.136 -0.977 . . . . 0.0 110.409 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.11 -57.79 8.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.855 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.4 HD13 ' HG2' ' A' ' 167' ' ' MET . 1.2 mp -52.63 -35.76 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.026 -1.046 . . . . 0.0 109.048 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 -74.51 -45.38 46.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.526 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -56.21 -31.15 63.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -72.17 -52.15 17.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.824 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -73.0 -26.1 61.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 110.317 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 6.2 pt-20 -52.97 -34.53 56.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.687 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -79.65 -28.94 40.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.077 -1.014 . . . . 0.0 109.454 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.704 ' OE1' HG23 ' A' ' 189' ' ' ILE . 15.5 tp60 -74.91 -7.66 54.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -75.49 -41.93 54.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 0.0 108.907 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.454 HG13 ' HE2' ' A' ' 183' ' ' LYS . 73.6 t -88.52 -43.66 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.315 -0.865 . . . . 0.0 109.859 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 186' ' ' PHE . 38.2 mt -56.55 -49.17 75.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.058 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.1 t -55.24 -30.33 59.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.35 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.454 ' HE2' HG13 ' A' ' 180' ' ' VAL . 13.9 pttt -88.26 -6.76 57.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.229 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.417 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.9 m170 -108.43 29.32 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.77 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.5 OUTLIER 69.67 68.93 0.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 181' ' ' LEU . 23.4 m-85 -137.14 169.99 16.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.935 . . . . 0.0 109.0 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -119.82 -159.8 11.04 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -58.62 105.77 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.204 1.936 . . . . 0.0 110.774 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 1.049 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -51.19 174.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.175 -0.953 . . . . 0.0 110.048 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 141' ' ' PRO . 4.8 p -137.32 67.73 1.43 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.232 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.9 m -100.6 125.2 46.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.692 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -76.32 113.77 14.26 Favored 'General case' 0 C--N 1.278 -2.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.205 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.47 108.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.87 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.692 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.4 OUTLIER -147.4 153.36 39.52 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -104.16 164.9 11.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.01 39.07 94.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.539 ' O ' ' C ' ' A' ' 198' ' ' VAL . 55.6 mm-40 -96.41 90.99 5.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.68 -1.482 . . . . 0.0 108.974 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.539 ' C ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -32.11 150.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.554 -0.716 . . . . 0.0 109.97 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.491 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 38.3 t80 -96.11 140.02 31.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.458 -0.776 . . . . 0.0 109.325 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 93' ' ' PHE . 7.0 m-85 -130.86 94.81 3.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.351 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -54.12 136.44 42.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 110.428 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.602 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -84.46 -174.94 5.55 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.13 161.12 30.98 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 122.264 1.03 . . . . 0.0 110.059 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -43.31 74.27 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.459 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -60.82 -7.85 2.64 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.425 -0.797 . . . . 0.0 110.119 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.622 ' CE1' ' CB ' ' A' ' 103' ' ' TYR . 50.4 m-70 -104.4 4.01 32.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.985 -1.072 . . . . 0.0 110.65 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.849 ' O ' ' N ' ' A' ' 209' ' ' TYR . 16.7 mm-40 -109.89 -143.83 0.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.144 0.973 . . . . 0.0 110.19 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.677 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -35.49 -4.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.845 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.849 ' N ' ' O ' ' A' ' 207' ' ' GLN . 59.4 t80 -39.75 -42.14 1.21 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 120.757 -1.214 . . . . 0.0 111.015 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 216' ' ' GLY . 6.6 mt -71.08 -20.75 62.32 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.68 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.696 ' OG ' HG22 ' A' ' 50' ' ' VAL . 8.1 t -73.25 -49.07 29.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 0.0 108.946 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.1 0.92 56.31 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.264 -0.897 . . . . 0.0 110.264 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.788 ' ND2' ' CD2' ' A' ' 209' ' ' TYR . 36.3 m-80 -132.65 133.42 23.46 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 109.686 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.1 2.1 5.26 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.698 2.266 . . . . 0.0 113.663 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 217' ' ' TYR . 2.9 t0 -62.74 -17.43 60.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.23 . . . . 0.0 109.864 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.673 ' O ' HD13 ' A' ' 210' ' ' LEU . . . 63.88 -62.75 0.05 OUTLIER Glycine 0 C--N 1.296 -1.684 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 215' ' ' ASP . 2.8 p90 171.31 -156.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 109.569 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 3.6 t -159.94 79.51 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.006 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 161.24 174.28 30.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.41 -165.16 1.29 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.234 -1.157 . . . . 0.0 109.858 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.04 -107.87 2.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -128.06 -168.44 12.45 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 C--N 1.27 -2.89 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.603 -179.843 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.72 ' O ' ' O ' ' A' ' 29' ' ' ILE . 44.6 t . . . . . 0 C--O 1.214 -0.805 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.72 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -33.95 177.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 123.225 1.488 . . . . 0.0 110.852 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -103.92 121.3 42.82 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.952 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -49.35 -15.59 0.14 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 30' ' ' SER . 11.4 mm-40 -62.17 -62.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.855 . . . . 0.0 109.793 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' ' C ' ' A' ' 34' ' ' ALA . 28.5 tt0 -75.19 -28.39 60.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.707 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -30.97 152.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.781 . . . . 0.0 110.203 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 98' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.26 175.51 11.24 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.608 2.205 . . . . 0.0 112.318 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -147.43 -167.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 45' ' ' THR . 15.1 t -49.21 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.616 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.39 -50.32 71.94 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.173 -0.954 . . . . 0.0 111.068 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 48' ' ' HIS . 27.7 mttm -84.34 99.17 10.45 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.614 -2.434 . . . . 0.0 108.419 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.6 t-80 -32.11 117.88 0.23 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -64.59 -32.46 74.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.318 -0.864 . . . . 0.0 110.665 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 211' ' ' SER . 25.9 t -63.43 -44.1 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 109.379 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -106.37 -45.09 4.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.39 4.53 54.96 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.687 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 27.3 p30 -82.04 -112.71 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.673 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.4 mtt180 -130.09 174.36 9.87 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.653 1.692 . . . . 0.0 110.423 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.8 p -137.95 8.35 2.75 Favored 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.892 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 57' ' ' GLU . 10.9 m -144.98 132.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.687 -1.258 . . . . 0.0 109.519 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.691 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.4 pm0 -32.86 151.81 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 CA-C-O 121.809 0.814 . . . . 0.0 110.849 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.4 Cg_endo -78.88 166.28 79.76 Favored 'Cis proline' 0 C--N 1.303 -1.844 0 C-N-CA 121.808 -2.163 . . . . 0.0 111.716 -0.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CE1' HG11 ' A' ' 120' ' ' VAL . 31.8 m-85 -110.26 154.56 42.82 Favored Pre-proline 0 C--N 1.269 -2.907 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.118 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 63' ' ' THR . 44.1 Cg_exo -50.15 132.5 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.3 2.0 . . . . 0.0 112.1 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -48.65 146.69 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.84 46.52 23.17 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -128.93 137.54 51.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -1.121 . . . . 0.0 109.674 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.87 149.51 25.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.702 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -138.86 113.11 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.659 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -112.09 -167.69 1.22 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG11 ' HD2' ' A' ' 160' ' ' TYR . 7.2 t -141.96 132.06 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.07 -1.644 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 131' ' ' LEU . 91.3 m-85 -123.04 156.16 35.42 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.193 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.674 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -140.44 114.71 0.98 Allowed Glycine 0 C--O 1.207 -1.571 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CD1' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -125.31 -82.47 0.63 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.485 -1.009 . . . . 0.0 109.31 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.624 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -153.27 -163.55 11.84 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.693 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -29.67 104.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.903 . . . . 0.0 108.582 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.786 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -49.44 6.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.787 . . . . 0.0 111.4 -178.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.693 ' N ' ' O ' ' A' ' 72' ' ' CYS . 14.5 m0 -72.04 -47.58 50.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.614 -1.304 . . . . 0.0 108.799 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.58 -22.93 27.53 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.721 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.35 -26.87 56.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.618 ' OE2' HG13 ' A' ' 91' ' ' VAL . 8.9 tp10 -84.59 -36.66 21.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.693 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.799 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.7 ttt85 -59.28 -59.17 5.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.606 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.608 ' O ' HG21 ' A' ' 134' ' ' VAL . 18.0 mmtm -56.43 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.944 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.721 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.0 m-85 -120.88 -40.93 2.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.824 -1.173 . . . . 0.0 110.315 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.577 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -87.96 3.74 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.84 -1.163 . . . . 0.0 109.981 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.5 m -94.62 13.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.514 HD11 HG21 ' A' ' 134' ' ' VAL . 75.7 mt -106.56 152.76 23.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.96 0.886 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.527 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 8.8 pttm -88.96 145.79 25.3 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.15 -25.37 28.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.593 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -73.29 137.78 22.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.97 . . . . 0.0 108.807 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.687 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -81.41 -41.06 22.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 108.744 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.534 ' HB3' HD21 ' A' ' 53' ' ' ASN . 1.1 p -173.51 -163.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 88' ' ' SER . 60.3 p -158.82 170.78 21.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.581 ' O ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.96 176.49 6.15 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -152.35 162.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.821 -1.174 . . . . 0.0 109.853 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.15 171.22 44.08 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 200' ' ' TYR . 4.1 m-85 -87.55 155.84 19.79 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.473 -1.016 . . . . 0.0 109.499 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -178.96 155.47 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.391 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.8 22.26 14.16 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.491 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -154.49 -151.62 5.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.519 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 47.9 p-80 -178.37 107.09 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.691 ' O ' ' O ' ' A' ' 99' ' ' ARG . 1.1 m -152.26 156.04 38.9 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.802 ' NE ' HD22 ' A' ' 100' ' ' ASN . 7.8 ttp180 -40.27 169.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.802 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -30.71 89.96 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.71 ' N ' ' O ' ' A' ' 99' ' ' ARG . 1.3 Cg_endo -77.15 141.78 21.07 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.052 2.501 . . . . 0.0 112.963 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.549 ' O ' HG22 ' A' ' 106' ' ' VAL . 24.6 p -124.06 170.69 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.116 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.783 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 1.2 t80 -56.92 -43.36 81.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.798 . . . . 0.0 109.325 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -73.35 -27.54 61.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.356 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.4 mm-40 -80.88 -41.37 23.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.777 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 102' ' ' THR . 5.4 m -55.73 -23.99 15.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 120.421 -1.425 . . . . 0.0 108.634 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.667 ' O ' ' N ' ' A' ' 109' ' ' GLU . 23.2 m -59.27 -36.3 75.29 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 110' ' ' LYS . 9.1 m -46.95 -9.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.8 mt-10 65.3 -12.25 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.679 -0.638 . . . . 0.0 109.944 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 108' ' ' SER . 23.8 mttp -77.56 -15.05 59.49 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.063 -1.023 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' GLY . 4.7 p -91.19 -6.61 53.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 109.665 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 36.28 37.28 0.18 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.102 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.58 ' HE2' ' HG2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -82.04 158.13 23.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.596 -1.532 . . . . 0.0 109.974 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -120.83 112.67 19.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.448 -0.783 . . . . 0.0 109.118 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.682 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 74.4 mt-10 -61.54 117.44 5.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.674 HG12 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -125.29 -176.11 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 91' ' ' VAL . 6.7 t -132.68 120.74 42.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.734 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.609 ' HD2' ' CZ ' ' A' ' 199' ' ' PHE . 9.9 ptm180 -97.81 120.95 39.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 119' ' ' VAL . 2.6 m -133.87 129.91 55.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 O-C-N 120.72 -1.237 . . . . 0.0 109.645 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.552 HG11 ' CE1' ' A' ' 59' ' ' PHE . 0.8 OUTLIER -92.32 145.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.717 ' CD2' HD11 ' A' ' 131' ' ' LEU . 4.1 m-85 -129.21 161.16 30.79 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.182 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -121.62 105.19 38.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.591 -0.693 . . . . 0.0 110.382 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 18.7 Cg_exo -43.64 -61.2 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.538 2.825 . . . . 0.0 114.229 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.2 tt0 -26.9 -52.69 0.06 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.361 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 21.05 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 0.0 109.756 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -157.6 162.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.28 -0.888 . . . . 0.0 109.618 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.57 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -128.72 148.3 50.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.894 -1.129 . . . . 0.0 109.653 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.765 ' CE2' HD11 ' A' ' 132' ' ' LEU . 72.8 t80 -54.43 -38.86 66.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.222 -0.924 . . . . 0.0 109.613 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -51.08 -14.36 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.07 -1.019 . . . . 0.0 108.84 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.57 ' HG3' ' H ' ' A' ' 127' ' ' SER . 6.5 mm-40 -73.77 -62.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.882 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.048 HD12 ' H ' ' A' ' 131' ' ' LEU . 2.9 mp -51.69 -34.12 37.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.976 -1.077 . . . . 0.0 108.184 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.765 HD11 ' CE2' ' A' ' 128' ' ' PHE . 39.0 mt -68.67 -50.16 53.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 110.255 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.21 -30.01 70.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.084 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 79' ' ' LYS . 1.2 t -74.04 -40.06 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.884 -1.135 . . . . 0.0 109.633 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.683 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 24.3 t80 -69.26 -43.41 74.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.63 -0.669 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.649 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 82.3 m95 -71.73 -39.69 69.93 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.699 -1.251 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.85 -37.12 59.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 112.88 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 25.3 m-80 -97.78 36.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.639 -1.288 . . . . 0.0 113.27 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.683 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER 177.97 130.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.56 -1.338 . . . . 0.0 110.733 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.606 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -61.54 112.04 5.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.428 ' HB2' HD12 ' A' ' 189' ' ' ILE . 45.6 Cg_endo -74.68 -11.01 22.05 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.161 1.907 . . . . 0.0 112.569 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.494 HG22 HD13 ' A' ' 189' ' ' ILE . 71.4 p -101.2 46.62 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.021 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.631 HE22 HE21 ' A' ' 147' ' ' GLN . 2.6 pt20 -114.08 107.29 15.45 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.81 0.814 . . . . 0.0 110.552 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.668 ' HA2' HG21 ' A' ' 190' ' ' THR . . . -39.06 -118.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.578 0 CA-C-O 121.482 0.49 . . . . 0.0 112.157 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.578 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -99.48 44.62 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.258 . . . . 0.0 111.822 -177.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.438 ' HB3' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -174.29 159.61 3.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.701 -1.25 . . . . 0.0 109.329 178.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.631 HE21 HE22 ' A' ' 143' ' ' GLN . 0.0 OUTLIER -122.85 145.14 48.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.428 -1.42 . . . . 0.0 110.536 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.543 ' CA ' HD22 ' A' ' 220' ' ' LEU . . . 65.85 -124.19 25.73 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -111.7 26.7 10.37 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.76 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.702 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -107.88 167.13 10.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.124 . . . . 0.0 108.42 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 151' ' ' PHE . 33.5 m-85 -132.35 111.54 11.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.824 -1.173 . . . . 0.0 109.912 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 172.38 143.61 4.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.449 ' H ' HG22 ' A' ' 153' ' ' THR . 0.1 OUTLIER -74.55 6.2 4.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -1.219 . . . . 0.0 109.147 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.667 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 6.8 pt20 -88.87 -1.22 57.98 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.667 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 29.7 m-85 -136.75 62.55 1.6 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.763 HH22 ' CB ' ' A' ' 192' ' ' ASP . 10.4 mtm105 -107.96 174.74 5.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.657 ' OG ' ' NE2' ' A' ' 139' ' ' HIS . 6.2 t -93.2 107.26 19.1 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.464 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -138.42 123.08 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 118.182 -1.407 . . . . 0.0 111.473 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.693 HG23 ' CG2' ' A' ' 191' ' ' THR . 11.2 t -112.04 127.66 69.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.249 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.494 ' CG ' ' HG3' ' A' ' 197' ' ' GLN . 7.6 m-85 -119.81 89.24 41.47 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.78 174.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.237 2.625 . . . . 0.0 112.608 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -96.24 -33.85 11.85 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.559 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 12.3 t -176.64 -162.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.374 -0.828 . . . . 0.0 109.054 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.559 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -56.93 -15.46 4.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.988 1.375 . . . . 0.0 108.614 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.559 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 3.7 t -55.82 -64.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.749 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.659 HE22 ' HB2' ' A' ' 66' ' ' ALA . 14.1 mt-30 -79.32 -17.76 53.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.618 -0.676 . . . . 0.0 111.061 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' HD23 ' A' ' 171' ' ' LEU . 3.1 ttm -52.36 -38.05 57.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.761 -1.212 . . . . 0.0 110.218 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.37 -23.49 57.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.862 -1.149 . . . . 0.0 109.688 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.667 ' N ' ' OE2' ' A' ' 168' ' ' GLU . . . -92.88 -42.17 9.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.46 -55.17 23.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.677 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 172' ' ' ARG . 2.5 pp -52.65 -35.55 55.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.055 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.577 ' O ' ' OE2' ' A' ' 176' ' ' GLU . 4.2 mtm180 -74.82 -46.45 36.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.886 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.649 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 70.2 m -56.54 -41.33 76.6 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.446 -0.784 . . . . 0.0 109.546 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.476 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 25.1 ttpp -72.4 -49.99 29.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.63 -25.52 68.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' O ' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -64.74 -53.36 48.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.497 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -78.9 -21.4 47.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.737 -179.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.628 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 38.8 tp60 -62.14 -41.0 97.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 0.0 109.656 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -16.0 58.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.939 . . . . 0.0 109.619 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 176' ' ' GLU . 49.7 t -81.55 -54.71 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -75.72 -30.96 59.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 14.5 t -56.89 -38.0 72.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.599 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -79.35 0.77 27.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -108.15 23.81 13.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.15 62.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.639 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 20.1 m-85 -134.74 168.07 19.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -94.84 -150.58 27.28 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.04 136.72 11.84 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.755 2.303 . . . . 0.0 112.099 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.673 HG22 ' H ' ' A' ' 191' ' ' THR . 2.6 mm -59.14 123.16 10.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.668 HG21 ' HA2' ' A' ' 144' ' ' GLY . 53.2 p -79.41 5.1 13.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.995 . . . . 0.0 110.744 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.693 ' CG2' HG23 ' A' ' 159' ' ' VAL . 31.3 m -43.81 110.94 0.24 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.763 ' CB ' HH22 ' A' ' 156' ' ' ARG . 4.0 t0 -77.14 117.74 18.99 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.945 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.17 123.62 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.68 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -163.54 155.96 17.92 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.366 -0.834 . . . . 0.0 109.089 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.74 167.32 9.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 62.75 66.2 2.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.494 ' HG3' ' CG ' ' A' ' 160' ' ' TYR . 78.5 mm-40 -111.3 102.87 11.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -1.199 . . . . 0.0 109.429 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 197' ' ' GLN . 61.9 t -41.67 155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.424 -0.798 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.609 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 22.1 t80 -117.64 151.52 37.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.865 . . . . 0.0 109.505 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -152.01 98.33 2.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.506 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 19.6 m-85 -54.0 136.13 41.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 110.554 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HB1' ' CB ' ' A' ' 206' ' ' HIS . . . -87.27 -177.97 6.09 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.8 pt-20 -75.29 175.56 8.24 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.381 -0.825 . . . . 0.0 109.478 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -52.04 67.03 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.512 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.13 -19.25 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.601 -0.687 . . . . 0.0 109.874 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.786 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 7.2 m-70 -96.99 7.84 45.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 110.327 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.829 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.0 mm-40 -127.0 -142.04 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.308 1.052 . . . . 0.0 110.491 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.615 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -35.46 -3.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.352 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.829 ' N ' ' O ' ' A' ' 207' ' ' GLN . 88.2 t80 -40.85 -43.45 2.05 Favored 'General case' 0 N--CA 1.514 2.761 0 O-C-N 120.431 -1.418 . . . . 0.0 110.431 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.463 HD12 ' H ' ' A' ' 210' ' ' LEU . 4.5 mp -75.87 -13.44 60.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.425 -1.422 . . . . 0.0 110.085 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.737 ' HB2' HG22 ' A' ' 50' ' ' VAL . 79.8 p -57.88 -44.2 86.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 -9.01 54.45 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.538 -0.726 . . . . 0.0 109.498 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 214' ' ' PRO . 10.3 m120 -137.13 66.8 54.38 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 213' ' ' ASN . 12.3 Cg_exo -67.29 9.59 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.013 2.476 . . . . 0.0 112.237 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.497 ' C ' ' OD1' ' A' ' 215' ' ' ASP . 1.1 p30 -63.07 -18.92 63.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.537 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.62 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.71 85.35 0.05 OUTLIER Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.157 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.703 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 87.2 t80 -48.91 -171.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.314 2.057 . . . . 0.0 109.052 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.703 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 13.2 m -72.29 76.65 1.0 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.661 -1.275 . . . . 0.0 108.852 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.94 17.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.543 HD22 ' CA ' ' A' ' 148' ' ' GLY . 4.8 mp -85.25 -177.54 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -1.212 . . . . 0.0 109.777 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.96 90.61 0.08 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.59 171.22 14.32 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.574 ' OG1' ' OD1' ' A' ' 140' ' ' ASP . 1.6 t . . . . . 0 C--N 1.27 -2.851 0 CA-C-N 114.919 -0.64 . . . . 0.0 109.713 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.661 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--O 1.214 -0.795 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -36.22 166.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.736 1.255 . . . . 0.0 109.189 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.05 124.66 28.11 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.617 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB1' ' HE1' ' A' ' 97' ' ' HIS . . . -57.14 -26.28 60.28 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.506 -0.746 . . . . 0.0 109.183 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -81.64 -4.67 56.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' LEU . 5.7 mt-10 -98.02 -36.23 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 35' ' ' LEU . . . -35.59 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.653 ' O ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 42' ' ' ILE . 6.8 pt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -39.85 164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.92 2.413 . . . . 0.0 112.554 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 202' ' ' ALA . 27.2 m -106.87 -154.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.733 ' O ' HG23 ' A' ' 45' ' ' THR . 9.9 t -80.09 86.79 5.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.231 -0.918 . . . . 0.0 110.14 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.612 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.41 -37.65 70.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.383 -0.823 . . . . 0.0 111.016 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.8 mtmt -93.24 98.86 11.55 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 116.33 -2.148 . . . . 0.0 108.15 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.661 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.14 107.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -30.45 64.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.807 . . . . 0.0 111.133 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 81' ' ' TRP . 13.2 t -66.65 -43.59 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.788 -1.195 . . . . 0.0 109.554 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.38 -42.17 4.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.135 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.06 0.97 48.33 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 46.4 m-20 -72.14 -119.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.571 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -127.92 174.17 9.39 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 123.506 1.622 . . . . 0.0 110.103 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.859 ' O ' HG13 ' A' ' 56' ' ' VAL . 10.3 p -150.89 22.13 0.78 Allowed 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.134 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 55' ' ' THR . 2.5 m -167.79 143.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.918 -1.114 . . . . 0.0 109.542 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' A' ' 56' ' ' VAL . 32.6 mt-10 -32.46 142.76 0.16 Allowed Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.442 -0.786 . . . . 0.0 110.462 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 88.4 Cg_endo -77.52 167.1 80.02 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.224 -1.99 . . . . 0.0 111.661 0.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -100.39 132.69 22.12 Favored Pre-proline 0 C--N 1.271 -2.835 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.905 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.524 ' O ' ' OG1' ' A' ' 63' ' ' THR . 45.5 Cg_exo -49.51 114.61 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.999 1.799 . . . . 0.0 112.199 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.71 118.39 3.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -8.26 20.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.611 HG22 ' HB3' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -83.12 137.13 34.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.107 . . . . 0.0 109.795 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.77 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.1 tp60 -103.66 155.33 18.64 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.374 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.734 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -161.79 137.27 7.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.276 -1.515 . . . . 0.0 112.434 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.28 -168.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.96 115.02 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.785 -1.822 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 1.5 p90 -163.29 156.04 18.61 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 109.719 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.92 164.16 30.31 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' ' OD1' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -114.8 -88.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -1.111 . . . . 0.0 109.052 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . -125.07 -152.14 8.2 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.681 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.4 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.412 -1.052 . . . . 0.0 108.193 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.729 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -49.45 5.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.361 -0.837 . . . . 0.0 111.665 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.783 ' CZ2' ' CE1' ' A' ' 206' ' ' HIS . 5.1 m0 -69.52 -49.84 50.76 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.277 -1.514 . . . . 0.0 108.549 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.52 -49.65 76.31 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB3' HG21 ' A' ' 117' ' ' VAL . . . -76.13 -27.52 57.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.964 -1.315 . . . . 0.0 110.202 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.575 ' OE1' HG22 ' A' ' 91' ' ' VAL . 6.9 tp10 -52.1 -34.85 45.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.907 -1.12 . . . . 0.0 110.153 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 21.7 ttt-85 -106.52 -56.69 2.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.979 -1.076 . . . . 0.0 111.36 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.655 ' O ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -38.69 -17.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 110.262 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 11.6 m-85 -91.52 -42.7 10.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.702 -1.249 . . . . 0.0 110.953 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.54 ' CE3' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -70.91 -4.61 25.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.745 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 79' ' ' LYS . 3.7 m -83.62 14.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.752 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 134' ' ' VAL . 96.4 mt -90.69 164.0 14.3 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -93.19 138.12 31.88 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.451 0.643 . . . . 0.0 110.359 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 123' ' ' PRO . . . 89.65 -19.12 42.67 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.22 137.91 18.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.945 -1.326 . . . . 0.0 109.775 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.571 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -76.73 -40.89 47.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.676 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 177.12 -160.38 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.079 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.553 ' N ' ' OG ' ' A' ' 88' ' ' SER . 70.2 p -160.33 150.97 18.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.676 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 8.6 mp0 -144.68 164.43 30.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.583 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.2 OUTLIER -144.53 156.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.061 -1.024 . . . . 0.0 110.008 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 176.29 45.93 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 1.4 m-85 -88.77 164.78 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.356 -1.085 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.677 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.73 174.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.144 -0.973 . . . . 0.0 109.642 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 53.17 46.96 62.03 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -135.87 -152.38 6.36 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 120.945 -1.326 . . . . 0.0 110.381 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.701 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 2.5 t-160 -153.29 63.63 0.76 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.535 -0.979 . . . . 0.0 108.856 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.653 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.95 142.37 16.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 101' ' ' PRO . 31.0 mtp180 -49.26 177.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 108.548 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.567 ' C ' ' O ' ' A' ' 99' ' ' ARG . 2.6 m-80 -33.84 94.92 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.332 -0.855 . . . . 0.0 109.111 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 60.9 Cg_endo -85.62 163.07 10.82 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.81 2.34 . . . . 0.0 112.503 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.589 ' OG1' ' OE1' ' A' ' 105' ' ' GLU . 21.5 p -121.02 170.78 9.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.692 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.777 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 13.6 t80 -60.37 -59.56 5.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.0 110.295 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -55.48 -36.73 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 108.309 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.589 ' OE1' ' OG1' ' A' ' 102' ' ' THR . 0.1 OUTLIER -58.27 -62.01 2.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.258 0.552 . . . . 0.0 110.345 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.033 HG12 ' OG1' ' A' ' 111' ' ' THR . 27.1 m -65.04 -23.98 34.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.264 -0.897 . . . . 0.0 110.856 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.594 ' C ' ' H ' ' A' ' 109' ' ' GLU . 42.9 t -42.13 -44.18 3.57 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.74 ' C ' ' H ' ' A' ' 110' ' ' LYS . 33.2 t -69.42 13.23 0.13 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.24 -0.912 . . . . 0.0 108.735 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER 51.95 -16.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.514 0.726 . . . . 0.0 110.755 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.74 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -45.88 -30.43 1.73 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.67 -0.644 . . . . 0.0 110.186 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 1.033 ' OG1' HG12 ' A' ' 106' ' ' VAL . 48.7 p -84.53 11.77 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.129 . . . . 0.0 109.073 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 24.72 44.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.677 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 2.6 m-70 -83.91 170.83 13.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.492 -1.593 . . . . 0.0 109.214 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB1' ' CB ' ' A' ' 158' ' ' ALA . . . -118.55 114.21 22.46 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.693 ' OE2' ' CG ' ' A' ' 73' ' ' PHE . 1.9 mm-40 -51.19 118.25 3.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -125.21 136.18 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.05 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.561 HG22 ' CG1' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -116.85 125.01 73.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 118' ' ' ARG . 2.7 ptm180 -104.7 116.37 31.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 110.723 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.603 HG13 HD22 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -124.57 114.25 39.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.466 HG12 ' HB3' ' A' ' 65' ' ' MET . 0.7 OUTLIER -95.43 159.51 2.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.041 -1.037 . . . . 0.0 111.698 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.82 ' HB2' HG22 ' A' ' 126' ' ' ILE . 5.7 p90 -138.95 136.61 35.61 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 123.518 1.628 . . . . 0.0 111.592 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.969 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 6.9 ptt-85 -137.16 -1.09 0.03 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.621 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.969 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 56.2 Cg_endo -71.53 -27.75 18.45 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 124.288 3.325 . . . . 0.0 116.838 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 5.1 tt0 72.79 -5.18 1.94 Allowed 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.651 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -105.51 -25.07 12.47 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.892 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -128.4 124.13 61.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.519 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -132.22 -170.73 2.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.885 -1.135 . . . . 0.0 112.698 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.733 ' N ' ' CE2' ' A' ' 121' ' ' TYR . 60.5 t80 -58.08 -45.39 87.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.569 -0.707 . . . . 0.0 110.497 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.554 ' O ' HD23 ' A' ' 132' ' ' LEU . 78.0 mt-10 -46.73 -35.02 5.67 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.73 ' HG3' HD13 ' A' ' 126' ' ' ILE . 17.4 mm-40 -73.77 -63.54 1.19 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.689 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 13.2 mt -34.22 -57.83 0.48 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.786 HD23 ' H ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -76.84 -42.17 41.24 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.403 -1.435 . . . . 0.0 110.996 -178.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.786 ' H ' HD23 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -52.15 -63.07 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.771 -1.205 . . . . 0.0 109.167 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.8 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 t -50.14 -40.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' CZ3' ' A' ' 136' ' ' TRP . 15.8 t80 -56.45 -45.46 80.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.188 -1.57 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.514 ' O ' HG21 ' A' ' 223' ' ' THR . 29.4 m95 -73.49 -41.57 62.93 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.642 -1.286 . . . . 0.0 111.102 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -67.5 -2.45 6.51 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.8 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -133.76 48.0 2.4 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.937 -1.727 . . . . 0.0 112.096 -178.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 1.025 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 176.21 -164.79 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.646 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -129.49 117.63 18.75 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.509 ' HG3' ' CD2' ' A' ' 177' ' ' TYR . 10.7 Cg_endo -67.12 -4.11 10.98 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.554 1.503 . . . . 0.0 111.615 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.608 HG22 HD13 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -101.3 -13.76 17.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.196 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.645 ' CD ' ' H ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -68.02 70.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.633 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -52.05 -118.26 0.01 OUTLIER Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.659 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.62 39.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -1.041 . . . . 0.0 109.334 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -156.52 164.83 37.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.681 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -155.52 89.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.566 -1.334 . . . . 0.0 109.44 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.645 ' H ' ' CD ' ' A' ' 143' ' ' GLN . . . 51.72 -113.65 2.56 Favored Glycine 0 N--CA 1.478 1.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -80.48 3.83 20.24 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.434 -0.883 . . . . 0.0 110.236 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -108.28 146.34 33.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.915 -1.116 . . . . 0.0 108.934 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.61 130.42 32.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.053 -1.029 . . . . 0.0 109.961 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.01 163.34 9.48 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.421 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.575 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 44.8 p -73.72 -10.62 59.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.523 -0.986 . . . . 0.0 109.896 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 16.2 pm0 -87.47 -7.08 58.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.446 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 32.2 m-85 -124.41 60.43 1.15 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.082 -1.011 . . . . 0.0 108.772 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.5 HH12 ' HB ' ' A' ' 153' ' ' THR . 5.4 ptt-85 -112.96 173.67 6.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 118.57 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.468 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . . . -139.62 116.36 10.83 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' A' ' 192' ' ' ASP . 48.4 t -102.19 148.34 7.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.609 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.412 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 91.0 m-85 -139.23 87.36 13.82 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.776 -1.203 . . . . 0.0 108.554 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -46.02 163.15 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.881 2.387 . . . . 0.0 112.243 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.566 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.14 -21.54 13.24 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 120.635 -1.29 . . . . 0.0 110.553 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 162' ' ' THR . 0.8 OUTLIER -176.48 178.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 0.0 108.929 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.31 -16.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 123.007 1.384 . . . . 0.0 108.484 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.558 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.3 t -59.26 -62.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.812 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.925 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.576 ' O ' ' CB ' ' A' ' 170' ' ' ALA . 4.5 mp0 -77.74 -19.4 55.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 110.381 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.5 ttt -54.09 -54.66 36.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.954 -1.092 . . . . 0.0 109.534 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -54.58 -66.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 109.77 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -57.5 -39.33 76.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.869 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.44 -58.54 6.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.6 mp -53.04 -49.5 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -60.87 -48.55 81.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 109.466 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.498 ' HB2' ' NE1' ' A' ' 136' ' ' TRP . 1.0 OUTLIER -55.97 -40.15 72.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.66 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.636 ' HZ2' HD12 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -73.04 -58.2 3.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.607 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.97 -44.56 92.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.913 . . . . 0.0 110.81 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 74.8 mt-10 -53.1 -20.21 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.031 . . . . 0.0 110.451 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.509 ' CD2' ' HG3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -79.49 -40.08 30.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.821 -1.174 . . . . 0.0 110.556 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -44.8 65.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.835 -1.166 . . . . 0.0 108.502 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -30.59 5.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 109.286 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.7 t -87.9 -54.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.278 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.608 HD13 HG22 ' A' ' 142' ' ' THR . 25.3 mt -58.99 -45.55 90.34 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.387 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -23.57 22.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.972 -1.08 . . . . 0.0 109.023 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -88.43 -13.84 39.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.338 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 2.9 m-70 -99.85 11.76 38.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 72.0 55.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.73 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.487 ' HE2' ' HG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -119.31 -176.58 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 108.972 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -119.55 -158.13 10.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.561 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.4 Cg_exo -58.63 116.47 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.325 2.017 . . . . 0.0 110.771 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.636 HD12 ' HZ2' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -47.91 -175.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.005 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.633 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 26.8 p -154.67 55.34 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.654 -0.653 . . . . 0.0 110.384 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.614 ' CG2' HG23 ' A' ' 159' ' ' VAL . 32.9 m -99.93 119.05 37.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 17.2 t0 -75.9 111.06 10.88 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.389 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 1.0 OUTLIER -117.33 114.82 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 110.466 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.81 ' HE ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -165.0 -170.16 1.87 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.539 ' OE2' ' C ' ' A' ' 194' ' ' ARG . 9.4 mp0 -145.82 178.66 8.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.309 . . . . 0.0 110.389 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.23 14.91 67.88 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.077 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.81 ' NE2' ' HE ' ' A' ' 194' ' ' ARG . 1.2 mp0 -89.35 126.47 35.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.502 -1.587 . . . . 0.0 109.784 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.31 154.87 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.464 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 6.7 t80 -92.82 124.79 37.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.13 95.09 5.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.285 -0.884 . . . . 0.0 108.975 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -54.41 133.87 45.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.322 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.525 ' O ' HG11 ' A' ' 44' ' ' VAL . . . -84.58 -175.75 5.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.808 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.2 pm0 -74.89 171.5 13.92 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -58.52 -53.84 53.74 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -51.35 -11.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.016 -1.052 . . . . 0.0 111.118 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.783 ' CE1' ' CZ2' ' A' ' 74' ' ' TRP . 12.2 m-70 -101.49 10.27 40.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.709 -1.245 . . . . 0.0 110.335 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.0 mm-40 -131.12 -146.46 0.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.233 1.015 . . . . 0.0 110.009 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.696 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 12.8 mp0 -33.87 -8.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.444 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 11.3 t80 -44.95 -40.52 6.45 Favored 'General case' 0 N--CA 1.515 2.815 0 O-C-N 120.146 -1.596 . . . . 0.0 109.343 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -52.61 -18.43 1.76 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 120.868 -1.145 . . . . 0.0 110.47 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 p -61.39 -39.7 91.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -71.02 -33.07 70.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.306 -0.871 . . . . 0.0 109.687 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 215' ' ' ASP . 5.6 m-80 -134.27 70.0 73.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.441 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HB3' ' NE ' ' A' ' 78' ' ' ARG . 24.3 Cg_exo -60.76 8.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.039 2.492 . . . . 0.0 112.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 213' ' ' ASN . 10.1 t0 -63.37 -18.97 64.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.524 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.79 85.32 0.05 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.512 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.74 92.97 9.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.598 2.199 . . . . 0.0 109.388 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.727 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -169.72 112.74 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 109.491 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -0.33 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.505 3.294 0 CA-C-O 122.464 1.036 . . . . 0.0 112.711 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.78 -173.71 2.76 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.676 -0.896 . . . . 0.0 109.69 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -82.73 -149.04 7.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -153.64 -136.66 2.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 1.025 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER . . . . . 0 N--CA 1.485 1.307 0 O-C-N 121.286 -1.126 . . . . 0.0 109.131 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.681 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.213 -0.822 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.635 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.75 168.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.744 1.259 . . . . 0.0 109.539 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.09 124.47 31.8 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.68 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -55.9 -46.01 78.49 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.761 -0.587 . . . . 0.0 109.576 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.654 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 3.1 pm0 -78.46 15.77 0.93 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.569 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.582 ' O ' ' C ' ' A' ' 34' ' ' ALA . 10.1 tp10 -116.07 -40.6 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.6 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -29.0 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.766 . . . . 0.0 110.108 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.43 HD11 ' HE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.573 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.21 168.19 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.595 2.197 . . . . 0.0 112.209 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 204' ' ' ASP . 12.5 m -139.39 170.4 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.167 -0.958 . . . . 0.0 109.675 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.785 ' O ' HG23 ' A' ' 45' ' ' THR . 13.4 t -58.82 103.77 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.356 -0.84 . . . . 0.0 110.231 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.572 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.92 -50.13 73.51 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.359 -0.838 . . . . 0.0 111.479 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.4 pttt -70.74 100.62 1.92 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 115.846 -2.342 . . . . 0.0 108.168 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.604 ' HD1' ' HB ' ' A' ' 50' ' ' VAL . 6.3 t-80 -31.95 125.02 0.28 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.003 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.469 ' O ' ' ND1' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -66.65 -8.08 25.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 110.848 -178.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HD1' ' A' ' 48' ' ' HIS . 18.9 t -92.98 -63.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.161 . . . . 0.0 109.805 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -83.56 -42.76 16.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.0 5.5 54.82 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.3 p30 -81.52 -119.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.689 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttp180 -129.54 168.67 16.04 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.989 1.376 . . . . 0.0 108.418 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.685 ' O ' HG13 ' A' ' 56' ' ' VAL . 20.8 p -128.38 30.68 5.14 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.94 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 55' ' ' THR . 7.0 m -161.29 132.58 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-10 -33.78 154.41 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.314 0 CA-C-O 121.899 0.857 . . . . 0.0 110.852 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HD2' ' NH2' ' A' ' 54' ' ' ARG . 96.5 Cg_endo -79.44 166.28 78.52 Favored 'Cis proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.48 -2.3 . . . . 0.0 111.756 -0.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.484 ' CE1' HG11 ' A' ' 120' ' ' VAL . 32.6 m-85 -108.37 154.51 41.39 Favored Pre-proline 0 C--N 1.267 -3.005 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.041 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.51 148.88 10.63 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.33 2.02 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -55.95 132.79 50.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.84 53.91 2.6 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.23 137.1 40.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -1.051 . . . . 0.0 109.44 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.532 ' OE1' ' CA ' ' A' ' 64' ' ' GLN . 1.6 tp60 -123.85 125.43 44.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.688 ' SD ' ' NH2' ' A' ' 118' ' ' ARG . 3.5 ptt? -109.63 141.28 42.39 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.621 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.43 -167.29 1.87 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.0 129.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.081 -1.637 . . . . 0.0 109.446 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 1.025 ' O ' HG22 ' A' ' 117' ' ' VAL . 59.1 m-85 -117.82 125.75 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.116 -0.99 . . . . 0.0 108.61 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.13 105.81 1.72 Allowed Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.023 -1.56 . . . . 0.0 110.146 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.723 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -107.86 -88.79 0.47 Allowed 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.449 -1.03 . . . . 0.0 108.666 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.635 ' N ' ' OE2' ' A' ' 115' ' ' GLU . . . -146.92 -152.73 5.71 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.812 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -36.42 106.05 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 108.956 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.85 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.419 -0.801 . . . . 0.0 112.307 -178.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 1.0 ' O ' HD11 ' A' ' 210' ' ' LEU . 21.1 m0 -67.48 -48.73 66.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.076 -1.64 . . . . 0.0 109.412 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.43 5.42 57.21 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.55 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.726 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.42 -41.86 38.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.276 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.727 ' OE2' HG13 ' A' ' 119' ' ' VAL . 2.6 tp10 -83.39 -14.82 51.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.15 -0.969 . . . . 0.0 111.786 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.842 ' CB ' HD13 ' A' ' 210' ' ' LEU . 15.0 ttp85 -57.52 -73.13 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.807 -1.183 . . . . 0.0 110.965 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 11.9 mttt -61.71 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.726 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.5 m-85 -115.87 -29.95 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.757 -1.215 . . . . 0.0 110.602 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.613 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.0 OUTLIER -104.26 -0.75 27.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.723 -1.236 . . . . 0.0 109.571 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 78' ' ' ARG . 3.7 m -93.3 8.51 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 109.105 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -103.3 -179.03 3.84 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -96.72 156.51 16.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.639 -1.288 . . . . 0.0 111.209 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.72 79.88 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.557 -0.714 . . . . 0.0 111.906 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 86' ' ' VAL . 1.1 t -99.79 129.52 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 120.387 -1.654 . . . . 0.0 110.791 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.584 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.68 -43.8 30.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.53 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t -169.62 -176.74 2.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 1.113 HG22 HG12 ' A' ' 119' ' ' VAL . 7.7 p -148.31 149.53 32.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.097 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.576 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 8.8 mp0 -146.71 170.51 16.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.41 -0.806 . . . . 0.0 109.455 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.815 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -146.66 167.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . 178.06 156.02 15.61 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 202' ' ' ALA . 0.5 OUTLIER -80.01 160.71 25.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.604 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.648 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.56 -170.11 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 0.0 109.875 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.35 22.41 63.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.745 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -128.44 -164.06 11.46 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -145.57 78.5 1.54 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.38 -1.07 . . . . 0.0 109.708 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.498 ' O ' ' C ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -147.36 135.18 21.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.651 ' C ' HD22 ' A' ' 100' ' ' ASN . 5.9 mtt180 -38.84 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.651 HD22 ' C ' ' A' ' 99' ' ' ARG . 1.1 m-80 -122.47 89.5 49.47 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 109.668 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.461 ' HG3' ' HE2' ' A' ' 113' ' ' HIS . 5.1 Cg_exo -70.87 132.81 22.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.834 2.356 . . . . 0.0 110.848 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 21.1 p -124.21 159.43 30.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.845 -1.159 . . . . 0.0 110.614 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 102' ' ' THR . 6.0 t80 -48.41 -38.85 20.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 108.834 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -40.46 64.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.79 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.0 mm-40 -81.75 -30.99 32.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -80.98 -29.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 108.833 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -28.97 64.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.508 -0.745 . . . . 0.0 109.496 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.677 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 51.6 p -62.67 -70.46 0.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.677 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.9 mt-10 140.4 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -48.22 1.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 110.939 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' GLU . 14.4 p -108.25 -7.47 15.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.814 -1.179 . . . . 0.0 109.55 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 43.03 51.0 6.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.745 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 15.4 m-70 -97.27 169.19 9.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.295 . . . . 0.0 108.929 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -124.2 113.08 17.82 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.665 ' OE2' ' N ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -51.7 114.67 1.34 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.959 . . . . 0.0 108.939 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -125.34 157.66 34.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.025 HG22 ' O ' ' A' ' 68' ' ' PHE . 20.6 m -130.14 131.96 65.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.688 ' NH2' ' SD ' ' A' ' 65' ' ' MET . 10.6 ptm180 -103.68 130.34 51.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.738 -1.226 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 1.113 HG12 HG22 ' A' ' 89' ' ' THR . 0.2 OUTLIER -132.86 138.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.61 122.0 63.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.953 ' CZ ' HD22 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -125.41 166.88 15.79 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.472 -177.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.505 ' HG2' ' H ' ' A' ' 125' ' ' HIS . 4.5 ttm180 -99.26 114.1 65.29 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.668 -0.645 . . . . 0.0 110.534 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 51.2 Cg_exo -50.85 -42.37 51.78 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.406 2.07 . . . . 0.0 111.785 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -57.28 -23.09 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.299 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.505 ' H ' ' HG2' ' A' ' 122' ' ' ARG . 1.1 m-70 -104.86 -56.02 2.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 108.849 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 3.3 tp -130.25 133.43 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.47 168.53 19.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.16 -0.963 . . . . 0.0 110.42 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.824 ' CE2' HD11 ' A' ' 132' ' ' LEU . 4.0 t80 -69.56 -44.87 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.568 ' HA ' HD12 ' A' ' 132' ' ' LEU . 1.3 pt-20 -47.95 -31.06 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 11.8 mm-40 -57.38 -70.02 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 111.216 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.953 HD22 ' CZ ' ' A' ' 121' ' ' TYR . 8.5 mp -56.31 -27.13 54.55 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.133 -1.604 . . . . 0.0 110.078 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.824 HD11 ' CE2' ' A' ' 128' ' ' PHE . 5.0 mt -55.91 -30.54 61.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.382 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HB2' ' HZ2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -70.63 -52.0 24.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.686 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 9.2 t -49.91 -30.7 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 108.461 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 51.3 t80 -70.79 -46.6 62.58 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.028 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 177' ' ' TYR . 58.2 m95 -72.68 -60.94 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.396 -1.44 . . . . 0.0 110.719 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 14.8 tm-20 -37.93 -56.98 1.07 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.311 -0.868 . . . . 0.0 111.789 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.743 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 4.6 p30 -96.55 61.55 1.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.011 -1.056 . . . . 0.0 110.681 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.765 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 13.4 m80 -152.99 -161.81 1.36 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.669 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -121.24 178.06 1.31 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.41 ' CD ' ' OD2' ' A' ' 140' ' ' ASP . 9.7 Cg_exo -69.09 -83.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.257 1.971 . . . . 0.0 112.005 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -124.83 13.44 8.55 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.378 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 140' ' ' ASP . 2.6 mt-30 -55.45 70.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.008 -1.058 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.79 13.67 51.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.458 ' H ' ' HG3' ' A' ' 145' ' ' MET . 0.0 OUTLIER -115.41 2.42 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -1.083 . . . . 0.0 109.296 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.478 ' NE ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER 174.98 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.245 -0.909 . . . . 0.0 109.223 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.92 103.11 11.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 119.581 -1.949 . . . . 0.0 108.822 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' NE ' ' A' ' 146' ' ' ARG . . . 67.21 -118.74 10.55 Favored Glycine 0 C--N 1.301 -1.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.79 -33.17 30.99 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-N 114.381 -0.909 . . . . 0.0 112.377 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.705 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 4.5 m-20 -72.19 99.1 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.229 -1.544 . . . . 0.0 110.415 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.655 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 10.5 p90 -92.92 128.83 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.82 177.58 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.21 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.418 HG22 ' H ' ' A' ' 153' ' ' THR . 0.1 OUTLIER -82.87 -0.49 48.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -1.135 . . . . 0.0 109.602 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -100.81 4.33 42.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.113 -0.992 . . . . 0.0 109.308 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.541 ' CG ' ' CB ' ' A' ' 150' ' ' ASP . 29.4 m-85 -124.65 58.41 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 108.74 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -110.18 -177.09 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.514 -0.741 . . . . 0.0 109.347 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 190' ' ' THR . 31.1 t -90.66 128.39 36.61 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -151.01 113.19 4.56 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.715 -1.594 . . . . 0.0 111.553 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.83 HG23 ' CG2' ' A' ' 191' ' ' THR . 5.8 t -113.71 122.33 67.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.0 m-30 -111.03 124.64 32.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 O-C-N 121.583 -0.698 . . . . 0.0 109.328 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.26 176.53 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.767 2.311 . . . . 0.0 112.193 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.96 -23.54 19.54 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 174.33 -162.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.6 -15.57 7.83 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 123.039 1.4 . . . . 0.0 108.549 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.3 t -55.82 -63.46 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.817 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.321 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.514 HE22 ' NE2' ' A' ' 64' ' ' GLN . 16.8 mt-30 -78.56 -12.59 60.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.707 . . . . 0.0 111.375 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.676 ' O ' HD12 ' A' ' 171' ' ' LEU . 6.0 ttm -52.6 -44.89 66.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.685 -1.26 . . . . 0.0 109.915 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -75.63 -20.35 58.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 109.759 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.61 -52.78 4.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.006 . . . . 0.0 110.0 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.53 -42.0 63.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 167' ' ' MET . 0.8 OUTLIER -52.73 -31.02 35.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.334 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -74.41 -35.56 63.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 76.8 p -56.68 -46.11 81.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 109.781 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -70.21 -44.36 68.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -72.16 -15.85 61.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 109.876 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 0.9 OUTLIER -78.37 -57.75 3.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.26 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 136' ' ' TRP . 7.7 t80 -67.21 -37.26 83.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 187' ' ' GLY . 14.2 tp60 -62.21 -10.96 12.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -37.89 65.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.57 -37.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.028 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.608 ' C ' ' H ' ' A' ' 183' ' ' LYS . 4.2 mm? -67.58 -48.52 66.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.089 -1.007 . . . . 0.0 109.733 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t -56.04 1.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.965 -1.084 . . . . 0.0 109.213 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 181' ' ' LEU . 21.8 ttpt -78.1 -53.48 7.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 108.971 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.743 ' CD2' ' CE2' ' A' ' 186' ' ' PHE . 0.0 OUTLIER -75.64 7.2 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.4 OUTLIER 73.29 64.07 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 109.8 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.743 ' CE2' ' CD2' ' A' ' 184' ' ' HIS . 21.4 m-85 -99.27 174.38 6.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.21 -0.931 . . . . 0.0 108.723 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -77.1 175.6 53.87 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.599 ' O ' ' OG1' ' A' ' 142' ' ' THR . 26.6 Cg_exo -58.95 -175.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.497 2.131 . . . . 0.0 111.617 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 189' ' ' ILE . 1.1 mm -89.41 112.23 24.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.058 -1.027 . . . . 0.0 109.675 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 142' ' ' THR . 2.3 t -78.33 -3.07 41.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 109.444 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.83 ' CG2' HG23 ' A' ' 159' ' ' VAL . 20.6 m -42.95 114.46 0.61 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.601 1.191 . . . . 0.0 108.101 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.664 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 4.1 t70 -76.14 116.94 17.32 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.962 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.81 100.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.851 . . . . 0.0 109.297 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.664 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -154.45 151.74 29.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 109.026 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.755 ' H ' ' CD ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -109.55 -175.7 2.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.71 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.06 34.06 48.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -106.95 118.79 37.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.451 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 5.4 p -57.04 159.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.54 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 13.5 t80 -113.7 126.6 55.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' PHE . 6.9 m-85 -127.86 103.12 7.09 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.17 -0.956 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -54.32 137.62 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 111.191 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -88.34 179.59 6.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.533 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 3.4 pt-20 -74.56 171.75 13.25 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.417 -0.802 . . . . 0.0 109.302 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.576 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.99 -47.45 85.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.036 -1.04 . . . . 0.0 108.478 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.533 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -50.08 -25.44 3.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 109.826 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.68 ' O ' HG21 ' A' ' 91' ' ' VAL . 14.5 m-70 -92.67 8.28 39.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.98 . . . . 0.0 109.839 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -127.91 -136.77 0.24 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.834 1.302 . . . . 0.0 110.177 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.613 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 1.4 mp0 -35.01 -4.64 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.196 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.825 ' N ' ' O ' ' A' ' 207' ' ' GLN . 87.6 t80 -41.96 -48.72 4.57 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.616 -1.302 . . . . 0.0 110.537 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 1.0 HD11 ' O ' ' A' ' 74' ' ' TRP . 2.9 mt -50.23 -12.53 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.512 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 209' ' ' TYR . 32.4 t -67.32 -40.36 85.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.219 -0.926 . . . . 0.0 108.921 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.69 -39.7 30.7 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.27 -0.894 . . . . 0.0 109.196 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -119.47 120.37 30.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 216' ' ' GLY . 58.3 Cg_endo -72.68 -50.48 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.074 1.849 . . . . 0.0 112.672 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 217' ' ' TYR . 5.7 p-10 -62.81 -3.52 1.61 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.048 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.499 ' CA ' HD23 ' A' ' 210' ' ' LEU . . . 61.31 -66.68 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 215' ' ' ASP . 38.2 p90 -177.98 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 108.325 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.506 ' N ' ' CD2' ' A' ' 217' ' ' TYR . 10.2 t -73.71 -124.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.039 -1.038 . . . . 0.0 108.676 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.712 ' C ' HD12 ' A' ' 220' ' ' LEU . . . 74.53 -164.8 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 219' ' ' GLY . 5.2 mp -151.33 -175.17 5.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -73.61 -110.78 0.07 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -135.81 -141.11 4.28 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 119.562 -1.304 . . . . 0.0 109.893 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 139' ' ' HIS . 50.5 p . . . . . 0 N--CA 1.488 1.434 0 O-C-N 121.329 -1.101 . . . . 0.0 109.177 -179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--O 1.213 -0.824 0 N-CA-C 106.397 -1.705 . . . . 0.0 106.397 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.733 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.29 174.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.359 1.552 . . . . 0.0 109.65 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.409 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.8 124.7 25.39 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.112 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.9 86.8 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.24 0.543 . . . . 0.0 109.553 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.565 ' O ' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.14 0.67 5.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 tt0 -99.41 -48.47 4.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 108.964 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -30.68 152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.547 0.689 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.652 ' O ' ' CG2' ' A' ' 98' ' ' THR . 4.2 mm? . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.626 ' O ' HG13 ' A' ' 44' ' ' VAL . 82.9 Cg_exo -44.19 -170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.799 2.333 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 43' ' ' PRO . 31.2 m -162.23 161.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.275 -0.891 . . . . 0.0 110.112 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER 25.55 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.693 -0.629 . . . . 0.0 111.195 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.619 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -87.47 -45.42 10.52 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.099 -1.0 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.5 98.99 10.42 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 115.737 -2.385 . . . . 0.0 108.155 179.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.677 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.9 t-80 -32.73 115.89 0.2 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.96 -40.88 90.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 0.0 110.501 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.663 HG22 ' OG ' ' A' ' 211' ' ' SER . 48.5 t -56.67 -49.69 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 109.867 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -99.59 -46.1 5.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.86 4.06 55.77 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.89 -118.7 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 ttt180 -125.36 171.56 10.33 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.097 1.427 . . . . 0.0 108.689 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.619 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.3 p -131.22 12.06 5.05 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.163 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.763 HG12 ' CZ ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -144.78 131.03 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.057 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' VAL . 17.4 mt-10 -34.63 156.51 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 CA-C-O 121.979 0.895 . . . . 0.0 110.818 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -81.44 165.36 74.9 Favored 'Cis proline' 0 C--N 1.3 -1.981 0 C-N-CA 121.466 -2.306 . . . . 0.0 111.992 -0.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 120' ' ' VAL . 28.6 m-85 -112.42 149.61 41.33 Favored Pre-proline 0 C--N 1.267 -3.004 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.765 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' GLU . 10.0 Cg_endo -54.47 140.27 74.46 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.732 2.288 . . . . 0.0 112.195 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 60' ' ' PRO . 4.4 mt-10 -43.47 157.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.23 47.77 42.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.538 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -133.32 135.63 44.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.736 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.538 ' OE1' ' C ' ' A' ' 63' ' ' THR . 3.8 mp0 -123.63 145.82 48.65 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 3.2 ttp -139.57 145.42 38.58 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 109.793 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.61 -170.61 2.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 160' ' ' TYR . 22.9 t -144.17 107.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 119.967 -1.708 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 1.085 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -162.63 162.8 27.24 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.763 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.21 148.15 19.24 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.287 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.701 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 0.8 OUTLIER -85.73 -84.55 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 0.0 108.358 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.715 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.94 75.85 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.715 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 48.3 t 111.13 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -52.58 5.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.574 -1.329 . . . . 0.0 110.797 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.648 ' H ' ' C ' ' A' ' 72' ' ' CYS . 32.6 m0 -89.14 -90.96 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.698 -1.251 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA2' HD13 ' A' ' 210' ' ' LEU . . . -57.18 -6.09 1.85 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.547 ' HB1' ' HG3' ' A' ' 70' ' ' MET . . . -76.48 -70.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -1.13 . . . . 0.0 110.953 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.592 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 13.8 tp10 -51.03 -14.71 0.24 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.682 ' O ' ' N ' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -64.0 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.168 . . . . 0.0 110.341 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' A' ' 78' ' ' ARG . 3.9 mmtt -30.62 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 111.349 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.682 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.3 m-85 -76.25 -42.16 46.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.801 -1.187 . . . . 0.0 111.734 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.538 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -85.56 2.29 45.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.486 -1.383 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -97.4 22.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.978 -1.076 . . . . 0.0 109.526 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.503 HD12 ' OH ' ' A' ' 121' ' ' TYR . 34.4 mt -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 108.993 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -92.91 142.94 26.76 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.364 0.602 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.488 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 101.75 -26.91 22.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -68.74 136.55 26.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.628 -0.925 . . . . 0.0 109.573 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.602 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.61 -44.33 17.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.532 ' HB3' HD21 ' A' ' 53' ' ' ASN . 1.1 p -170.8 -169.58 0.79 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 88' ' ' SER . 75.2 p -158.55 165.48 34.42 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.301 -0.875 . . . . 0.0 109.317 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.592 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.51 169.78 11.8 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.363 -0.836 . . . . 0.0 109.021 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.438 ' CG2' ' CD ' ' A' ' 207' ' ' GLN . 4.1 m -129.18 -173.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 170.47 160.7 19.53 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.502 ' CZ ' ' HB1' ' A' ' 202' ' ' ALA . 7.7 m-85 -97.51 154.21 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.956 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . . . -178.6 179.28 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.35 93.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.5 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -136.6 -151.31 6.01 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.0 61.28 1.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 0.0 109.344 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.652 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.47 176.89 12.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CE1' ' A' ' 200' ' ' TYR . 99.5 mtt180 -100.83 -77.49 0.54 Allowed 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 39.3 m-80 -117.28 70.77 6.04 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.377 179.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HG3' ' NE2' ' A' ' 113' ' ' HIS . 44.0 Cg_endo -71.87 170.53 18.58 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.746 2.297 . . . . 0.0 112.057 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.638 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.4 p -121.06 171.36 8.72 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.562 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -63.52 -59.33 4.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.56 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -58.42 -23.0 56.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 108.392 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.638 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.0 mm-40 -73.02 -56.45 5.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.397 0.618 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.763 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.3 m -65.47 -24.67 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.288 -0.883 . . . . 0.0 111.421 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 12.5 p -55.61 -23.44 27.53 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 110' ' ' LYS . 21.4 t -69.62 5.38 1.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.227 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 107' ' ' CYS . 1.9 tt0 59.61 -6.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.272 -0.893 . . . . 0.0 109.483 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' A' ' 108' ' ' SER . 18.0 mttt -72.52 -29.37 63.53 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 110.713 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.763 ' OG1' HG12 ' A' ' 106' ' ' VAL . 68.7 p -87.47 -6.59 58.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.878 -1.139 . . . . 0.0 110.541 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 35.31 43.84 0.53 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.439 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.5 ' ND1' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.1 163.17 26.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.393 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.444 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . . . -113.49 113.41 25.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 0.0 108.972 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.658 ' N ' ' CD ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -50.12 127.02 15.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.667 HG11 ' CE2' ' A' ' 160' ' ' TYR . 2.6 m -151.1 165.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.085 HG22 ' O ' ' A' ' 68' ' ' PHE . 2.5 m -143.96 149.4 17.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.195 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.766 ' CD ' ' CZ ' ' A' ' 199' ' ' PHE . 10.1 ptm180 -116.84 95.05 4.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.572 HG11 ' CG ' ' A' ' 80' ' ' PHE . 13.6 m -97.06 126.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.927 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.9 t -80.63 140.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.616 ' CG ' HD22 ' A' ' 131' ' ' LEU . 4.5 m-85 -132.05 161.0 34.27 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.079 -1.013 . . . . 0.0 109.224 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.638 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -125.07 109.72 27.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.506 -0.746 . . . . 0.0 110.384 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 124' ' ' GLU . 24.1 Cg_exo -44.43 -61.44 0.58 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.401 2.734 . . . . 0.0 114.493 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 123' ' ' PRO . 38.6 tt0 -25.98 -57.32 0.07 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.402 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.6 22.68 13.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.733 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -157.87 162.94 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.382 -0.824 . . . . 0.0 108.962 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.598 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -125.94 165.61 18.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.44 -1.412 . . . . 0.0 110.942 -179.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.567 ' CZ ' ' CD2' ' A' ' 132' ' ' LEU . 38.6 t80 -70.61 -43.8 68.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 108.988 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 5.0 mp0 -48.02 -14.6 0.05 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.891 -1.131 . . . . 0.0 108.086 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -73.67 -69.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.984 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -40.98 -38.7 1.02 Allowed 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.606 -1.308 . . . . 0.0 108.296 179.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.567 ' CD2' ' CZ ' ' A' ' 128' ' ' PHE . 4.2 mm? -75.42 -35.13 61.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.525 -0.734 . . . . 0.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 130' ' ' GLU . 0.5 OUTLIER -70.28 -57.68 4.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.964 -1.085 . . . . 0.0 111.256 -178.41 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.682 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.6 OUTLIER -50.42 -35.49 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.081 -1.012 . . . . 0.0 109.767 -178.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 50.7 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.526 -0.734 . . . . 0.0 110.485 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.817 ' O ' HG21 ' A' ' 223' ' ' THR . 90.5 m95 -72.8 -33.19 66.08 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.866 -1.146 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -79.43 -21.52 45.43 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.2 m-80 -121.28 53.69 1.15 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.102 -1.624 . . . . 0.0 113.443 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 223' ' ' THR . 0.2 OUTLIER 172.51 -175.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.186 0.993 . . . . 0.0 110.13 176.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 142' ' ' THR . 3.5 t70 -128.3 134.98 26.85 Favored Pre-proline 0 C--N 1.291 -1.959 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.429 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 190' ' ' THR . 72.0 Cg_endo -80.31 -11.15 13.36 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.353 2.035 . . . . 0.0 112.854 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.828 HG22 HG22 ' A' ' 189' ' ' ILE . 1.9 p -104.04 50.23 0.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 109.362 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 190' ' ' THR . 5.6 mm100 -114.64 83.63 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.621 ' CA ' HG21 ' A' ' 190' ' ' THR . . . -38.55 -117.53 0.0 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.922 0.734 . . . . 0.0 112.499 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.671 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 11.0 ptt? -92.87 53.5 2.02 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -1.02 . . . . 0.0 109.507 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' C ' ' O ' ' A' ' 155' ' ' TYR . 28.4 ptt-85 -178.56 154.71 0.79 Allowed 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.701 ' NE2' ' O ' ' A' ' 70' ' ' MET . 6.4 mt-30 -157.18 149.17 22.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.344 -1.473 . . . . 0.0 110.718 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.52 -124.62 3.21 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-O 122.986 1.326 . . . . 0.0 110.66 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -81.54 -35.32 30.43 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.049 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.654 ' OD2' ' SG ' ' A' ' 72' ' ' CYS . 0.0 OUTLIER -87.19 152.2 22.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.316 -1.49 . . . . 0.0 107.92 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.498 ' CB ' ' HB2' ' A' ' 146' ' ' ARG . 8.9 p90 -136.58 154.49 50.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.47 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.671 ' CA ' ' O ' ' A' ' 145' ' ' MET . . . 126.6 178.64 15.4 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 118.48 -1.819 . . . . 0.0 111.642 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 113' ' ' HIS . 0.2 OUTLIER -66.76 0.86 2.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.638 -0.919 . . . . 0.0 110.584 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 14.8 pm0 -112.38 16.5 19.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.75 -1.219 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.692 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 28.2 m-85 -146.69 59.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.742 ' HD2' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -114.81 177.05 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 190' ' ' THR . 1.0 OUTLIER -90.44 124.36 34.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 119.867 -1.77 . . . . 0.0 106.455 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.742 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -142.68 111.48 6.35 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.084 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.3 m -113.41 123.98 69.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.253 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.667 ' CE2' HG11 ' A' ' 116' ' ' VAL . 2.4 m-30 -112.7 126.16 28.76 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.75 170.67 17.2 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.146 1.898 . . . . 0.0 112.228 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.541 ' HB ' HE22 ' A' ' 166' ' ' GLN . 0.7 OUTLIER -102.9 -22.19 13.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 120.923 -1.111 . . . . 0.0 110.22 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -176.92 174.59 1.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 108.972 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' ' SD ' ' A' ' 167' ' ' MET . . . -45.49 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 123.081 1.42 . . . . 0.0 108.181 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 163' ' ' SER . 4.9 t -58.06 -62.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.836 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.541 HE22 ' HB ' ' A' ' 162' ' ' THR . 4.6 mp0 -76.68 -12.9 60.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.492 -0.755 . . . . 0.0 110.123 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' A' ' 164' ' ' ALA . 32.3 mtt -53.99 -47.97 70.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 109.971 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.047 -1.033 . . . . 0.0 110.161 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.48 -58.82 2.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 0.0 109.866 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.79 -48.55 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.955 . . . . 0.0 109.852 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -53.06 -42.43 65.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.542 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -68.3 -45.04 74.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.163 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.619 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 8.7 p -56.32 -53.48 56.81 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -55.91 -58.2 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.461 ' N ' ' HD3' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -60.61 -11.4 7.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.539 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 180' ' ' VAL . 1.6 tt0 -75.18 -50.45 16.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 110.007 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 181' ' ' LEU . 1.1 m-85 -79.41 -31.16 42.67 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.062 -1.024 . . . . 0.0 109.797 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 188' ' ' PRO . 21.9 tp60 -63.08 -40.79 98.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -77.82 -26.36 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 176' ' ' GLU . 98.0 t -87.29 -54.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.021 -1.049 . . . . 0.0 110.058 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.511 ' CD2' ' CD2' ' A' ' 177' ' ' TYR . 4.4 mm? -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.4 t -56.22 -35.64 67.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -88.49 9.09 24.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.855 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.462 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 38.5 m-70 -108.41 29.32 7.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.057 -1.027 . . . . 0.0 109.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.92 16.26 5.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -104.53 174.92 5.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.172 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -125.62 -149.02 7.36 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 178' ' ' GLN . 27.6 Cg_exo -58.75 106.64 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.379 2.053 . . . . 0.0 110.709 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.828 HG22 HG22 ' A' ' 142' ' ' THR . 0.3 OUTLIER -48.08 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 110.409 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 79.4 p -119.95 47.38 1.75 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.396 0.617 . . . . 0.0 109.746 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.2 m -97.94 118.67 35.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.4 t70 -76.08 140.76 42.02 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.42 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.56 93.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.977 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -157.15 153.18 27.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.642 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -119.67 -173.41 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.02 20.76 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 198' ' ' VAL . 61.1 mm-40 -91.63 101.81 14.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.273 . . . . 0.0 109.531 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.611 HG21 ' CZ ' ' A' ' 200' ' ' TYR . 3.0 p -35.95 153.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.766 ' CZ ' ' CD ' ' A' ' 118' ' ' ARG . 68.9 t80 -111.13 131.25 55.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CE1' ' O ' ' A' ' 99' ' ' ARG . 42.1 m-85 -127.26 112.65 15.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 0.0 109.419 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.763 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 16.5 m-85 -53.74 142.69 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.075 . . . . 0.0 110.614 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.515 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -90.77 178.18 6.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.575 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 3.0 mt-10 -73.67 161.13 30.62 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.557 1.17 . . . . 0.0 110.364 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -49.72 73.57 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.531 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.575 ' OH ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -59.47 -3.75 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.087 -1.008 . . . . 0.0 110.777 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.562 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 14.6 m-70 -101.29 -20.91 15.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.823 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -101.2 -134.36 0.3 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.705 1.24 . . . . 0.0 110.504 -178.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.538 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 1.3 mp0 -34.88 -2.93 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.442 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.823 ' N ' ' O ' ' A' ' 207' ' ' GLN . 75.9 t80 -41.34 -46.38 3.27 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.191 -1.568 . . . . 0.0 109.952 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.619 ' CD1' ' C ' ' A' ' 74' ' ' TRP . 0.7 OUTLIER -71.34 -13.21 61.8 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.573 -1.329 . . . . 0.0 110.441 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.663 ' OG ' HG22 ' A' ' 50' ' ' VAL . 36.9 t -63.38 -38.68 92.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 108.985 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -72.78 -38.73 67.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.357 -0.84 . . . . 0.0 109.35 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.57 77.42 76.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.063 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.675 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 12.7 Cg_exo -66.73 5.08 0.84 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.99 2.46 . . . . 0.0 112.683 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.95 -19.99 64.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.11 84.46 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.829 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 217' ' ' TYR . 78.8 t80 -70.53 83.94 0.6 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 121.108 2.454 . . . . 0.0 109.268 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 43.1 t -168.84 -124.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.966 -1.084 . . . . 0.0 108.803 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.529 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 134.69 153.4 6.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.478 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 75.62 143.15 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -1.106 . . . . 0.0 110.06 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -134.27 -144.43 5.07 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.449 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -152.0 -144.3 3.89 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.864 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.3 OUTLIER . . . . . 0 C--N 1.301 -1.533 0 O-C-N 121.494 -1.004 . . . . 0.0 109.032 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.771 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.213 -0.84 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.721 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.14 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 123.068 1.413 . . . . 0.0 110.029 -177.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -94.9 123.86 38.61 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.344 179.49 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -56.74 -57.87 10.57 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.156 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.522 ' OE1' ' O ' ' A' ' 32' ' ' GLU . 1.5 pp20? -53.05 -6.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.952 . . . . 0.0 109.915 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.0 tt0 -112.46 -35.99 5.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.813 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . . . -44.88 -179.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.285 -0.884 . . . . 0.0 109.552 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 mm? . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 43' ' ' PRO . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 42' ' ' ILE . 74.0 Cg_exo -46.27 -166.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.321 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.1 m -150.56 -179.16 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.768 ' O ' HG23 ' A' ' 45' ' ' THR . 9.6 t -34.19 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.773 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.646 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -55.86 -38.75 70.51 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.344 -0.847 . . . . 0.0 111.196 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.578 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttp -91.46 98.7 11.84 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 116.15 -2.22 . . . . 0.0 108.678 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.7 t-80 -31.73 110.95 0.08 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -59.82 -30.79 69.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 110.807 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 3.4 t -64.6 -43.4 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.934 -1.104 . . . . 0.0 109.524 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.86 -44.49 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.941 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 104.1 1.73 45.03 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.5 p30 -76.15 -112.05 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.607 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -130.68 175.25 9.17 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 123.806 1.765 . . . . 0.0 110.811 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 6.9 p -149.33 23.35 0.92 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 112.425 -2.17 . . . . 0.0 110.088 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.497 HG22 ' C ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -157.27 132.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 56' ' ' VAL . 12.7 mt-10 -41.48 156.03 0.22 Allowed Pre-proline 0 C--N 1.304 -1.397 0 CA-C-O 121.855 0.836 . . . . 0.0 110.199 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.24 157.12 62.87 Favored 'Cis proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.494 0.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.769 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 18.7 m-85 -104.15 147.91 35.08 Favored Pre-proline 0 C--N 1.279 -2.496 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 11.7 Cg_endo -57.47 134.21 61.94 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.843 2.362 . . . . 0.0 112.423 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -49.34 158.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 64' ' ' GLN . . . 93.91 -35.88 3.98 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -83.03 134.06 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.784 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.57 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 6.2 mp0 -114.98 -175.93 2.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 2.2 ttp -161.35 149.37 15.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.642 -1.286 . . . . 0.0 110.826 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.71 -174.37 2.67 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.54 HG12 ' CG1' ' A' ' 116' ' ' VAL . 1.4 t -146.23 106.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.686 -1.884 . . . . 0.0 109.96 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.704 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -140.82 156.39 46.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.963 -1.495 . . . . 0.0 110.359 177.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.431 ' CA ' ' OE2' ' A' ' 115' ' ' GLU . . . -132.15 154.18 20.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.738 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -122.81 -91.85 0.55 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.738 ' H ' ' CG ' ' A' ' 70' ' ' MET . . . -134.84 63.76 0.6 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.767 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 48.5 t 109.13 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.575 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -81.43 25.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.363 -1.46 . . . . 0.0 110.873 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.767 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 8.3 m0 -91.6 -72.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.567 -1.333 . . . . 0.0 109.573 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.26 -3.51 65.76 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 117' ' ' VAL . . . -77.09 -32.89 56.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.198 -1.178 . . . . 0.0 109.473 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.629 ' OE2' ' CA ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -83.69 -15.79 47.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.016 -1.052 . . . . 0.0 110.154 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.794 ' O ' HG13 ' A' ' 82' ' ' VAL . 28.0 ttt180 -79.46 -67.6 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 110.027 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.452 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 14.2 mttp -54.89 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.613 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.712 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 19.1 m-85 -120.72 -39.7 2.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.879 -1.138 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.632 ' CZ2' ' OG ' ' A' ' 211' ' ' SER . 0.9 OUTLIER -82.28 -3.98 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.764 -1.21 . . . . 0.0 110.03 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.3 m -83.94 17.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.034 -1.041 . . . . 0.0 109.334 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.71 154.53 22.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 137.26 32.51 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.55 -31.89 5.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.72 136.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.57 -0.959 . . . . 0.0 109.549 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.668 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -71.15 -39.91 71.64 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.915 0.864 . . . . 0.0 108.828 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.697 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 179.63 -160.57 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.608 ' HB ' HG12 ' A' ' 119' ' ' VAL . 63.6 p -157.51 151.16 24.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.033 -1.042 . . . . 0.0 109.801 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.697 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 5.1 mp0 -147.32 167.75 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.753 . . . . 0.0 109.028 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -142.96 168.65 13.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.026 -1.046 . . . . 0.0 109.878 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.414 ' HA2' ' N ' ' A' ' 202' ' ' ALA . . . 177.37 164.07 30.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -80.11 174.29 11.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -1.078 . . . . 0.0 109.192 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.728 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -175.2 177.04 1.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 50.9 22.13 5.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.517 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -134.64 -164.1 10.43 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.813 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 57.3 p-80 -173.75 105.34 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.398 -1.06 . . . . 0.0 108.904 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.607 ' O ' ' C ' ' A' ' 99' ' ' ARG . 1.6 m -137.72 148.0 45.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.607 ' C ' ' O ' ' A' ' 98' ' ' THR . 19.6 tpt180 -33.21 -68.75 0.1 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.508 ' ND2' ' HG3' ' A' ' 99' ' ' ARG . 50.5 m-80 -124.3 95.88 42.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.44 106.0 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.481 2.121 . . . . 0.0 113.224 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 22.0 p -122.08 170.81 9.48 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.94 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.483 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 2.1 t80 -63.45 -58.95 5.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.217 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.544 ' HB3' ' HZ3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -61.58 -22.86 65.57 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.113 -0.992 . . . . 0.0 108.816 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.653 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.1 mm-40 -66.28 -57.54 7.3 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.459 0.647 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 18.7 m -65.45 -24.78 35.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.844 . . . . 0.0 110.808 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.401 ' O ' ' OE1' ' A' ' 109' ' ' GLU . 24.0 t -64.56 -28.47 69.66 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.656 ' C ' ' H ' ' A' ' 110' ' ' LYS . 2.5 t -70.91 2.09 4.75 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.707 ' O ' HG21 ' A' ' 29' ' ' ILE . 4.8 mp0 58.54 -21.6 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.452 -0.78 . . . . 0.0 110.953 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.768 ' O ' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.75 2.25 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.522 HG22 ' OG1' ' A' ' 98' ' ' THR . 3.1 p -107.73 -29.41 9.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.091 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 62.13 49.06 78.64 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.728 ' ND1' ' N ' ' A' ' 94' ' ' ALA . 1.5 m-70 -97.24 173.5 7.19 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.783 -1.422 . . . . 0.0 109.784 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.37 116.63 18.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.533 ' CD ' ' C ' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -62.36 123.79 19.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.991 -1.068 . . . . 0.0 109.296 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -128.09 140.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.1 -1.0 . . . . 0.0 109.308 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.737 HG21 ' CB ' ' A' ' 76' ' ' ALA . 2.0 t -103.78 107.32 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.769 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -96.58 96.98 9.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.637 1.208 . . . . 0.0 110.386 -177.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.608 HG12 ' HB ' ' A' ' 89' ' ' THR . 20.4 m -112.12 128.03 68.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.903 -1.123 . . . . 0.0 108.675 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -80.29 169.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.967 ' CD2' HD21 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -156.56 156.27 33.34 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.806 -1.558 . . . . 0.0 111.599 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.67 110.62 35.2 Favored Pre-proline 0 C--N 1.291 -1.958 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.937 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.541 ' O ' ' C ' ' A' ' 124' ' ' GLU . 39.3 Cg_exo -45.32 -63.76 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.068 2.512 . . . . 0.0 113.23 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.2 tp10 -25.69 -43.7 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -127.82 3.76 6.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.707 -1.246 . . . . 0.0 109.898 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -155.15 104.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.05 0.929 . . . . 0.0 108.964 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.3 m -69.81 169.64 12.64 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.774 0.797 . . . . 0.0 111.871 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.702 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 36.9 t80 -69.39 -27.92 65.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 109.43 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 133' ' ' LYS . 2.5 mt-10 -62.69 -19.77 64.2 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.517 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.59 ' CG ' HD13 ' A' ' 126' ' ' ILE . 3.2 mm-40 -66.63 -72.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.042 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.009 HD22 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -42.05 -40.05 2.13 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.702 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 8.3 mp -75.68 -34.89 60.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.77 . . . . 0.0 111.611 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -58.54 -68.91 0.21 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.504 -1.372 . . . . 0.0 110.085 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.627 HG13 ' ND2' ' A' ' 138' ' ' ASN . 58.5 t -51.3 -22.19 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.253 -0.904 . . . . 0.0 109.208 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 34.7 t80 -73.41 -52.18 14.65 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 111.147 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 58.8 m95 -70.22 -38.72 75.32 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.069 -1.644 . . . . 0.0 111.569 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.48 -43.46 73.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.831 -1.168 . . . . 0.0 111.641 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.627 ' ND2' HG13 ' A' ' 134' ' ' VAL . 67.8 m-80 -81.56 59.27 4.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 112.296 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.765 ' CE1' ' O ' ' A' ' 135' ' ' PHE . 46.8 m80 -153.76 -166.59 2.43 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.003 0.906 . . . . 0.0 109.293 176.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -132.87 171.61 8.86 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 140' ' ' ASP . 30.8 Cg_exo -33.5 -103.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.039 1.826 . . . . 0.0 113.334 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.943 ' O ' HG23 ' A' ' 142' ' ' THR . 1.5 t -128.45 57.14 1.6 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.041 -1.037 . . . . 0.0 111.428 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.737 ' N ' ' OE1' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -75.93 84.42 2.85 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.218 -1.551 . . . . 0.0 110.882 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.728 ' CA ' HG21 ' A' ' 190' ' ' THR . . . -39.39 -115.85 0.0 OUTLIER Glycine 0 N--CA 1.491 2.345 0 CA-C-O 122.097 0.832 . . . . 0.0 111.723 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.739 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.27 25.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.743 -0.857 . . . . 0.0 111.691 -176.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.536 ' NH2' ' OD1' ' A' ' 149' ' ' ASN . 10.6 ttt-85 -159.54 88.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 119.218 -2.176 . . . . 0.0 112.115 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.692 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -57.66 122.19 12.19 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.992 -1.692 . . . . 0.0 108.954 178.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.663 ' H ' ' HG3' ' A' ' 143' ' ' GLN . . . 43.14 -114.96 0.93 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 122.932 1.296 . . . . 0.0 110.197 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.536 ' OD1' ' NH2' ' A' ' 146' ' ' ARG . 3.0 t-20 -95.98 15.81 19.55 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.084 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 8.7 m-20 -101.7 93.39 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.903 -1.123 . . . . 0.0 108.457 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.45 ' HB3' ' HE ' ' A' ' 146' ' ' ARG . 4.8 p90 -75.47 121.83 22.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.381 -0.824 . . . . 0.0 110.875 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 167.13 140.34 2.88 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.119 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.84 -4.02 47.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -1.197 . . . . 0.0 108.729 179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.726 ' CD ' ' H ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -96.58 -13.2 23.1 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.352 -0.843 . . . . 0.0 110.486 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.611 ' O ' ' O ' ' A' ' 70' ' ' MET . 13.2 m-85 -100.16 -4.72 29.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.864 -1.148 . . . . 0.0 110.98 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.61 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -42.69 177.58 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.842 -1.161 . . . . 0.0 109.492 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.1 t -91.55 124.87 36.04 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -145.55 127.82 15.8 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 116.468 -2.093 . . . . 0.0 112.705 -176.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.551 HG23 ' CG2' ' A' ' 191' ' ' THR . 5.2 t -117.9 129.46 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.097 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -122.27 95.59 47.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.336 -0.852 . . . . 0.0 108.814 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.6 170.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.633 2.222 . . . . 0.0 112.044 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.56 -29.64 14.25 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 120.911 -1.118 . . . . 0.0 109.632 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 165' ' ' VAL . 2.0 m -179.52 -162.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.93 -15.55 9.18 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 123.021 1.391 . . . . 0.0 108.599 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.7 t -55.77 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.883 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.759 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 16.4 mt-30 -78.86 -19.13 52.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 ttp -52.44 -36.19 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.705 -1.247 . . . . 0.0 110.394 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -75.58 -32.55 60.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.795 -1.19 . . . . 0.0 110.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.58 -43.28 9.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.077 -1.014 . . . . 0.0 110.134 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.79 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.697 HD12 ' C ' ' A' ' 171' ' ' LEU . 1.3 pp -52.85 -33.52 50.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.004 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -74.6 -55.54 5.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.82 -39.02 73.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.373 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -65.07 -58.36 6.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 175' ' ' GLU . 0.9 OUTLIER -70.58 -24.19 62.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.933 . . . . 0.0 109.908 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 5.8 mm-40 -53.26 -30.87 40.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -0.91 . . . . 0.0 109.931 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.591 ' CD1' ' CD1' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.47 -45.36 19.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.907 -1.121 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.72 HE22 ' C ' ' A' ' 187' ' ' GLY . 1.2 tp60 -54.26 -30.83 51.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -61.83 -44.27 97.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.319 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 181' ' ' LEU . 9.2 p -87.31 -42.2 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.387 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 177' ' ' TYR . 31.8 mt -65.24 -39.4 92.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.111 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.553 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 21.6 p -56.07 -26.56 49.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.987 -1.071 . . . . 0.0 109.401 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -88.3 -9.66 52.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.737 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -108.33 34.93 3.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.873 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.36 68.65 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.937 . . . . 0.0 109.799 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -148.08 174.55 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.72 ' C ' HE22 ' A' ' 178' ' ' GLN . . . -126.22 -162.24 11.19 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 189' ' ' ILE . 32.0 Cg_exo -58.07 105.56 0.21 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.993 1.795 . . . . 0.0 110.274 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -47.68 155.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.585 -178.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.728 HG21 ' CA ' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -88.57 44.73 1.23 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.338 0.589 . . . . 0.0 111.571 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.551 ' CG2' HG23 ' A' ' 159' ' ' VAL . 19.4 m -84.57 113.78 21.49 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.494 ' OD2' ' CZ ' ' A' ' 194' ' ' ARG . 9.1 t0 -75.54 114.98 14.72 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.986 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.76 97.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 121.925 0.869 . . . . 0.0 109.45 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.669 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -152.62 152.29 31.62 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.644 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 1.0 OUTLIER -111.74 -176.95 3.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 110.197 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.55 30.37 66.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.669 ' NE2' ' O ' ' A' ' 194' ' ' ARG . 1.8 mp0 -95.85 95.16 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.239 . . . . 0.0 109.882 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 197' ' ' GLN . 8.3 p -32.6 154.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 109.711 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.545 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 65.0 t80 -120.63 137.23 54.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.633 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.9 m-85 -139.54 112.84 8.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.167 -0.958 . . . . 0.0 109.787 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.582 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.3 m-85 -54.12 141.67 28.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 110.108 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -90.46 -174.64 4.2 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.03 165.05 25.82 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.749 -0.594 . . . . 0.0 109.704 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.454 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -57.95 -45.14 87.13 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.537 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -55.05 -13.53 1.19 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.697 ' O ' HG21 ' A' ' 91' ' ' VAL . 14.3 m-70 -100.99 5.38 43.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.83 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.3 mm-40 -124.57 -144.18 0.32 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.238 1.018 . . . . 0.0 110.143 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.719 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 11.7 mp0 -34.4 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.188 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.83 ' N ' ' O ' ' A' ' 207' ' ' GLN . 79.5 t80 -43.7 -45.58 7.09 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 120.495 -1.378 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -55.21 -17.3 4.18 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.648 -1.283 . . . . 0.0 110.068 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.632 ' OG ' ' CZ2' ' A' ' 81' ' ' TRP . 13.4 m -73.17 -26.51 61.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.109 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -87.75 -38.92 15.36 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.338 -0.851 . . . . 0.0 109.487 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.4 m-80 -123.42 79.66 53.92 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.63 8.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.954 2.436 . . . . 0.0 112.598 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 213' ' ' ASN . 1.5 t70 -63.44 -19.09 64.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.023 -1.048 . . . . 0.0 110.356 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.98 84.97 0.05 OUTLIER Glycine 0 N--CA 1.503 3.104 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.693 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -83.38 92.68 7.6 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.652 2.226 . . . . 0.0 109.297 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 49.1 t -168.74 -124.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 O-C-N 120.994 -1.066 . . . . 0.0 108.962 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 153.8 151.8 5.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 2.5 tp 75.47 162.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.734 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 157.16 81.59 0.04 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.42 140.83 3.66 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.277 179.817 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.738 ' O ' ' O ' ' A' ' 29' ' ' ILE . 41.9 t . . . . . 0 CA--C 1.501 -0.942 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.738 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -35.3 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 123.198 1.475 . . . . 0.0 110.038 -178.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -74.63 124.25 26.34 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.966 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.836 ' HB1' ' CE1' ' A' ' 97' ' ' HIS . . . -64.76 -40.06 94.65 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.83 -0.544 . . . . 0.0 109.692 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.654 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -80.65 12.77 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' ' C ' ' A' ' 34' ' ' ALA . 1.6 tt0 -116.67 -43.25 2.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 109.648 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -33.08 152.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.586 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.644 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.69 ' O ' HG13 ' A' ' 44' ' ' VAL . 35.6 Cg_endo -66.97 164.09 31.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.747 2.298 . . . . 0.0 112.261 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 43' ' ' PRO . 7.0 m -161.2 172.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.227 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.71 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 109.681 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.27 -40.38 74.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 110.911 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.574 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.62 99.72 11.93 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.002 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.643 ' O ' ' N ' ' A' ' 52' ' ' GLY . 6.7 t-80 -31.16 104.19 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -53.97 -26.17 24.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.654 -0.654 . . . . 0.0 110.965 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 2.6 t -70.09 -48.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.84 -1.163 . . . . 0.0 109.448 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -103.56 -41.1 6.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.54 1.98 53.27 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 66.2 m-20 -75.41 -116.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.578 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -131.55 174.39 10.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.657 1.694 . . . . 0.0 110.217 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 16.0 p -145.56 18.98 1.51 Allowed 'General case' 0 C--N 1.264 -3.118 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -165.62 149.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.037 -1.04 . . . . 0.0 109.05 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.55 ' O ' ' O ' ' A' ' 56' ' ' VAL . 16.0 mt-10 -32.33 154.92 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.675 0 CA-C-O 121.885 0.85 . . . . 0.0 110.731 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 84.4 Cg_endo -79.3 165.51 80.62 Favored 'Cis proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.689 -2.213 . . . . 0.0 112.126 -0.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.526 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-30 -115.98 85.68 15.35 Favored Pre-proline 0 C--N 1.27 -2.871 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.16 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.96 170.18 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.974 2.45 . . . . 0.0 112.549 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -75.98 158.32 32.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.4 -38.42 3.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.03 135.04 50.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.602 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 14.9 mp0 -113.32 171.65 7.43 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.735 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -156.9 145.48 19.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.58 -1.325 . . . . 0.0 110.896 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -120.1 -169.36 1.78 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.61 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.7 t -143.02 101.6 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.024 -1.672 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 2.4 p90 -148.38 149.37 31.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.922 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 158' ' ' ALA . . . 179.74 156.25 17.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.613 ' HE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 mtt -145.68 30.72 1.08 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.347 -1.09 . . . . 0.0 108.339 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.588 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -166.6 155.63 26.94 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.924 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.769 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -35.97 116.76 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -45.26 7.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.869 -178.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.769 ' N ' ' O ' ' A' ' 72' ' ' CYS . 24.9 m0 -82.34 -64.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.3 -1.5 . . . . 0.0 109.84 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.09 -26.82 74.38 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.024 -1.047 . . . . 0.0 111.335 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.761 ' CB ' HG21 ' A' ' 117' ' ' VAL . . . -76.94 -29.25 55.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.343 . . . . 0.0 111.526 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.557 ' HB2' HG11 ' A' ' 91' ' ' VAL . 28.2 tt0 -83.88 -13.86 52.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.277 -1.515 . . . . 0.0 110.757 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 80' ' ' PHE . 15.9 ttt180 -69.29 -81.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.132 -0.98 . . . . 0.0 111.137 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.509 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 25.2 mtmt -58.76 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.211 -0.931 . . . . 0.0 110.628 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.757 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.1 m-85 -97.9 -38.72 9.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.911 -1.118 . . . . 0.0 109.026 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.593 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.5 p90 -85.17 8.48 18.09 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 m -99.36 18.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.97 167.68 9.62 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.28 162.72 14.5 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.536 -0.727 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.4 5.61 50.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -90.78 117.45 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -1.063 . . . . 0.0 109.436 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.578 ' OH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -68.45 -36.29 78.81 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.218 1.009 . . . . 0.0 108.753 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.538 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER 177.83 -164.03 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.293 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.663 ' C ' HE21 ' A' ' 90' ' ' GLN . 71.3 p -156.25 144.76 20.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.663 HE21 ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -141.86 166.34 24.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 117' ' ' VAL . 3.0 m -152.41 160.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -179.22 -174.54 45.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 1.6 m-85 -86.32 169.41 12.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.307 -1.114 . . . . 0.0 109.554 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 1.034 ' C ' ' HD1' ' A' ' 113' ' ' HIS . . . -179.58 149.09 0.36 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.005 -1.059 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 76.86 22.24 72.34 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.709 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -100.44 -165.04 28.45 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.836 ' CE1' ' HB1' ' A' ' 31' ' ' ALA . 1.7 t-160 -140.85 72.02 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.78 175.99 13.17 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.448 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.0 mmp_? -76.26 -78.28 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.422 -0.799 . . . . 0.0 109.047 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -116.18 66.43 3.1 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.88 149.95 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.307 2.004 . . . . 0.0 111.674 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.636 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 17.4 p -120.85 172.62 7.77 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.221 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.712 ' CG ' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -66.41 -59.23 3.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.069 -1.019 . . . . 0.0 109.958 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.712 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -57.93 -23.52 53.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.636 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.2 mm-40 -67.25 -64.95 0.75 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.601 0.715 . . . . 0.0 109.936 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.729 HG12 ' CB ' ' A' ' 111' ' ' THR . 34.4 m -71.39 -24.37 23.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.479 -0.763 . . . . 0.0 111.098 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.512 ' C ' ' O ' ' A' ' 106' ' ' VAL . 11.9 t -38.38 -22.9 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.67 ' N ' ' O ' ' A' ' 106' ' ' VAL . 80.2 p -77.8 -80.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.682 ' O ' ' N ' ' A' ' 111' ' ' THR . 0.0 OUTLIER 158.7 -39.62 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.642 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 1.6 ttmt -46.29 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.911 -0.493 . . . . 0.0 112.215 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.729 ' CB ' HG12 ' A' ' 106' ' ' VAL . 11.1 p -101.33 -19.68 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.449 -1.407 . . . . 0.0 109.193 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 67.16 21.63 72.04 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.075 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 1.034 ' HD1' ' C ' ' A' ' 94' ' ' ALA . 1.4 m-70 -80.15 172.46 13.74 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.258 -1.731 . . . . 0.0 108.174 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.44 112.92 13.69 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.079 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.684 ' OE1' ' CE2' ' A' ' 73' ' ' PHE . 20.8 mm-40 -51.04 112.1 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 94' ' ' ALA . 1.5 m -123.34 138.37 53.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 108.937 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.761 HG21 ' CB ' ' A' ' 76' ' ' ALA . 2.5 t -103.78 113.11 39.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.526 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -96.92 113.84 25.41 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 89' ' ' THR . 6.0 m -132.02 126.57 56.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -86.2 169.41 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.435 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.761 ' CD1' HD11 ' A' ' 131' ' ' LEU . 0.2 OUTLIER -157.4 156.62 32.56 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.651 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -106.66 99.28 24.24 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.918 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 Cg_exo -43.55 -63.91 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.032 2.488 . . . . 0.0 112.917 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.753 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 22.5 mp0 -49.91 -13.14 0.09 Allowed 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.586 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.442 ' N ' ' C ' ' A' ' 123' ' ' PRO . 22.1 m-70 -110.86 -46.85 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 130' ' ' GLU . 5.3 tp -128.73 144.18 38.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -75.11 153.1 38.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.864 -1.148 . . . . 0.0 111.192 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 132' ' ' LEU . 41.4 t80 -63.9 -28.7 70.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -52.88 -32.13 43.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 6.5 mm-40 -62.39 -67.85 0.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.761 HD11 ' CD1' ' A' ' 121' ' ' TYR . 17.0 mt -34.05 -49.07 0.34 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.199 -0.938 . . . . 0.0 108.711 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.573 HD11 ' CE2' ' A' ' 128' ' ' PHE . 64.0 mt -76.61 -34.54 58.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 110.69 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' GLU . 31.7 ttmt -57.71 -68.37 0.25 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.885 -1.134 . . . . 0.0 110.449 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.752 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -49.28 -34.17 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 108.985 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.613 ' CZ ' ' HE2' ' A' ' 70' ' ' MET . 26.4 t80 -57.92 -52.67 64.53 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.014 -1.054 . . . . 0.0 111.072 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.58 ' O ' ' CG2' ' A' ' 223' ' ' THR . 85.6 m95 -74.8 -47.45 30.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.159 -1.588 . . . . 0.0 111.236 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.582 ' O ' ' O ' ' A' ' 222' ' ' GLY . 1.3 mm-40 -45.23 -48.83 12.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 111.334 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.752 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.5 p30 -98.51 38.22 1.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 112.554 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 223' ' ' THR . 20.6 m80 -155.44 -155.77 0.59 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.714 -1.241 . . . . 0.0 109.342 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 70' ' ' MET . 2.7 t0 -147.33 132.01 8.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 177' ' ' TYR . 68.9 Cg_endo -73.81 -13.81 24.26 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 121.931 1.754 . . . . 0.0 113.142 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.844 HG22 HG22 ' A' ' 189' ' ' ILE . 3.3 p -122.32 56.63 1.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.743 -1.223 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.812 ' NE2' ' NE2' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -122.39 77.59 1.42 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.713 -1.242 . . . . 0.0 110.889 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -47.34 -117.64 0.0 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.653 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -85.19 47.02 1.35 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.338 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 150' ' ' ASP . 1.6 ttm180 -162.16 87.23 0.63 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.583 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.812 ' NE2' ' NE2' ' A' ' 143' ' ' GLN . 2.1 tp-100 -84.09 119.94 25.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.181 -1.575 . . . . 0.0 109.381 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . 53.26 -113.45 2.97 Favored Glycine 0 C--N 1.293 -1.844 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.622 ' OD1' ' N ' ' A' ' 149' ' ' ASN . 1.8 p-10 -101.12 22.77 11.8 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 114.18 -1.01 . . . . 0.0 110.023 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -107.61 161.12 15.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.0 109.426 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 151' ' ' PHE . 35.0 p90 -136.79 127.07 26.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.1 149.43 5.05 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.956 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 1.2 p -56.06 -52.68 63.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.596 -0.943 . . . . 0.0 109.407 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.636 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 8.9 pm0 -56.55 -11.04 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.669 . . . . 0.0 110.857 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -101.63 49.64 0.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.804 -1.185 . . . . 0.0 109.348 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.672 ' NH1' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -116.54 165.06 13.68 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.607 ' OG ' ' O ' ' A' ' 190' ' ' THR . 44.9 p -77.02 128.22 34.09 Favored 'General case' 0 CA--C 1.467 -2.237 0 CA-C-O 122.442 1.115 . . . . 0.0 108.25 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.493 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -137.31 129.49 29.38 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.282 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.625 ' CG1' ' CG2' ' A' ' 191' ' ' THR . 0.2 OUTLIER -139.41 108.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.011 177.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 160' ' ' TYR . 1.1 m-30 -107.08 134.32 19.93 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.56 168.96 17.49 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.364 2.043 . . . . 0.0 111.835 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -19.59 20.59 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.907 -1.12 . . . . 0.0 108.939 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER 179.57 -164.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.7 -15.6 20.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 123.005 1.383 . . . . 0.0 108.421 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.6 t -56.05 -64.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.541 HE22 ' HB2' ' A' ' 66' ' ' ALA . 23.6 mt-30 -79.6 -17.12 54.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.675 -0.641 . . . . 0.0 110.9 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.92 -44.09 66.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.847 -1.158 . . . . 0.0 110.04 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.23 -20.76 59.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.8 -54.3 3.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.76 -44.54 66.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 171' ' ' LEU . 52.4 mt -52.88 -39.65 62.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.642 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -74.52 -51.35 14.96 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 0.0 109.527 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.549 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.8 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.699 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.499 ' HZ3' HD11 ' A' ' 189' ' ' ILE . 6.8 tttp -73.05 -58.16 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.0 110.326 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.35 -27.86 61.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.916 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mm-40 -53.06 -31.32 40.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.961 -1.087 . . . . 0.0 110.129 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -80.22 -33.26 38.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 110.079 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 182' ' ' SER . 0.8 OUTLIER -52.8 -31.96 41.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.013 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.16 -20.39 52.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.804 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.74 -55.88 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.828 -1.17 . . . . 0.0 110.872 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . 7.3 mt -76.22 -19.88 57.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.052 -1.03 . . . . 0.0 110.737 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 2.2 t -55.01 -33.68 62.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.865 -1.147 . . . . 0.0 109.16 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -88.2 1.0 55.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -108.29 32.42 4.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.79 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.31 59.49 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 109.939 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 181' ' ' LEU . 38.4 m-85 -133.81 168.98 17.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.002 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -128.76 -149.0 6.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.65 119.65 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.358 2.039 . . . . 0.0 110.99 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.844 HG22 HG22 ' A' ' 142' ' ' THR . 1.1 pt -57.55 179.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.317 1.056 . . . . 0.0 111.097 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.672 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 1.5 p -139.46 58.39 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.816 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.625 ' CG2' ' CG1' ' A' ' 159' ' ' VAL . 21.7 m -99.55 120.44 39.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.649 ' OD1' ' NE ' ' A' ' 194' ' ' ARG . 15.0 t0 -77.93 122.45 25.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.448 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.426 ' CD1' ' HD3' ' A' ' 174' ' ' LYS . 0.8 OUTLIER -131.45 100.64 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.649 ' NE ' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -151.39 178.38 9.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -129.93 166.28 20.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.13 49.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.513 ' NE2' ' CD2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -89.84 93.97 9.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.079 -1.248 . . . . 0.0 109.425 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 198' ' ' VAL . 7.4 p -41.11 122.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 109.597 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.489 ' CE1' ' HD3' ' A' ' 118' ' ' ARG . 25.4 t80 -77.79 150.39 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.299 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.448 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 6.8 m-85 -149.19 100.53 3.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -53.84 144.07 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -92.02 -170.83 2.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.359 -0.838 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.47 167.3 20.87 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-O 122.801 1.286 . . . . 0.0 110.309 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.612 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -53.8 -43.61 69.48 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.719 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.736 ' O ' ' CD1' ' A' ' 205' ' ' TYR . 0.2 OUTLIER -81.14 13.32 2.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.582 -1.324 . . . . 0.0 109.496 -178.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.549 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 22.7 m-70 -102.71 6.41 39.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.747 -1.221 . . . . 0.0 109.706 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.837 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.4 mm-40 -127.61 -138.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.43 1.11 . . . . 0.0 109.772 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.593 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 18.8 mm-40 -34.15 -4.75 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.936 -1.484 . . . . 0.0 112.282 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.837 ' N ' ' O ' ' A' ' 207' ' ' GLN . 82.0 t80 -42.74 -46.32 5.09 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 120.398 -1.439 . . . . 0.0 109.896 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.649 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.6 OUTLIER -60.43 -17.14 42.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.57 -1.331 . . . . 0.0 110.109 -178.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 208' ' ' GLN . 36.6 p -70.53 -47.43 60.43 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 108.643 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -88.85 -7.77 55.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.352 -0.842 . . . . 0.0 110.121 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.66 ' CG ' ' CZ ' ' A' ' 209' ' ' TYR . 5.4 m-80 -129.19 77.15 78.15 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.0 110.102 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.57 10.82 0.92 Allowed 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.511 2.808 . . . . 0.0 112.46 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -61.75 -21.2 64.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.349 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.57 85.81 0.05 OUTLIER Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.46 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 216' ' ' GLY . 9.7 m-85 -47.21 -170.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 120.314 2.057 . . . . 0.0 109.67 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.43 78.32 4.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.914 -1.116 . . . . 0.0 109.745 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 220' ' ' LEU . . . -174.14 143.66 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.594 ' CD1' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 161.19 167.89 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 110.4 131.2 5.97 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.639 ' CA ' ' O ' ' A' ' 139' ' ' HIS . . . -173.43 140.52 5.62 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 139' ' ' HIS . 29.5 p . . . . . 0 C--N 1.295 -1.798 0 O-C-N 121.466 -1.02 . . . . 0.0 108.271 -179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.802 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.212 -0.899 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' VAL . 1.1 tp -38.6 132.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 122.057 0.932 . . . . 0.0 113.009 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.91 121.43 21.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 122.144 0.973 . . . . 0.0 110.203 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -51.7 -55.36 20.01 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.65 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -53.92 -8.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 2.5 mm-40 -110.61 -36.23 5.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.427 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.91 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 0.0 109.265 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.89 HD21 ' CG ' ' A' ' 110' ' ' LYS . 0.4 OUTLIER . . . . . 0 C--N 1.303 -1.428 0 O-C-N 121.207 -0.933 . . . . 0.0 109.141 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.697 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.34 -176.27 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.073 2.515 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 204' ' ' ASP . 15.8 m -147.95 -176.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.927 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.794 ' O ' HG23 ' A' ' 45' ' ' THR . 14.7 t -79.84 104.28 10.31 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.095 -1.003 . . . . 0.0 110.305 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.606 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.94 -29.77 63.42 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.305 -0.872 . . . . 0.0 111.496 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 5.5 pttt -88.52 100.04 12.77 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 115.93 -2.308 . . . . 0.0 108.113 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' A' ' 52' ' ' GLY . 7.2 t-80 -31.64 112.25 0.1 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.796 ' CD2' ' HZ2' ' A' ' 212' ' ' LYS . 13.9 t-80 -50.78 -37.46 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 110.625 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' HG3' ' A' ' 208' ' ' GLN . 18.0 t -72.15 -61.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -77.13 -36.08 55.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.567 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 83.61 0.11 89.79 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 40.5 p30 -78.72 -119.63 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.651 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 29.5 mtt180 -126.46 174.52 8.57 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 123.275 1.512 . . . . 0.0 109.59 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.692 ' C ' HG22 ' A' ' 56' ' ' VAL . 11.7 p -143.42 35.77 1.32 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.87 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.692 HG22 ' C ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -176.56 152.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 0.0 109.098 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -31.67 149.5 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.518 -0.739 . . . . 0.0 110.547 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' NH1' ' A' ' 54' ' ' ARG . 88.4 Cg_endo -79.3 165.94 79.62 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.013 -2.078 . . . . 0.0 112.158 0.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.59 129.56 24.25 Favored Pre-proline 0 C--N 1.27 -2.857 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 63' ' ' THR . 46.2 Cg_exo -49.65 148.39 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.083 1.855 . . . . 0.0 112.064 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 158.18 10.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.585 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.55 39.63 75.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -90.2 132.3 35.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -1.147 . . . . 0.0 110.649 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.772 ' NE2' ' CD1' ' A' ' 128' ' ' PHE . 36.7 tp60 -106.16 142.75 35.33 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -161.37 161.81 30.53 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.994 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.77 -167.11 1.77 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 74.5 t -141.78 127.85 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.158 -1.589 . . . . 0.0 108.607 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 1.046 ' O ' HG22 ' A' ' 117' ' ' VAL . 28.1 m-85 -114.87 135.16 54.5 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.835 -1.166 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.38 83.25 0.29 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.635 ' O ' ' O ' ' A' ' 155' ' ' TYR . 2.2 ptp -86.32 -80.99 0.22 Allowed 'General case' 0 C--N 1.282 -2.357 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.843 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 73' ' ' PHE . . . -139.36 -152.2 5.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.781 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -33.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.686 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -53.51 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 112.039 -177.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.781 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 10.9 m0 -70.3 -65.94 0.66 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.742 -1.224 . . . . 0.0 108.562 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.46 -12.07 82.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.68 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.26 -33.88 59.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 109.733 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.566 ' OE2' ' OE1' ' A' ' 208' ' ' GLN . 1.1 tt0 -83.36 -17.09 43.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.832 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -85.93 -52.04 5.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 110.227 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 9.4 mttp -47.91 -4.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.181 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 10.3 m-85 -104.5 -35.39 7.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.0 110.354 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.611 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -88.96 -0.62 57.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.747 -1.22 . . . . 0.0 110.426 -178.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.3 m -88.32 5.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.003 -1.061 . . . . 0.0 110.145 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -116.95 179.33 4.05 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 109.664 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 137.46 37.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.929 -1.107 . . . . 0.0 111.529 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 123' ' ' PRO . . . 124.26 -50.1 0.87 Allowed Glycine 0 C--O 1.202 -1.859 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.763 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.562 HG23 ' CZ ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -53.91 136.85 15.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.715 -1.462 . . . . 0.0 111.582 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.718 ' CD1' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -75.13 -40.76 59.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.694 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 2.0 p -171.92 -174.84 1.38 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 88' ' ' SER . 62.6 p -160.15 128.79 4.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.068 -1.02 . . . . 0.0 109.534 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.694 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 3.0 mp0 -138.46 172.03 13.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.009 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.785 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -132.59 168.19 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -179.45 168.26 38.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -80.0 153.09 29.09 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.351 -1.088 . . . . 0.0 109.138 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.797 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -166.55 175.47 8.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.496 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 53.86 22.4 19.12 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.496 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -102.08 -151.43 23.99 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.516 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 3.7 m-70 -109.81 -41.15 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 109.768 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.597 ' HB ' HD21 ' A' ' 100' ' ' ASN . 0.6 OUTLIER -154.94 172.83 17.42 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.685 ' C ' HD22 ' A' ' 100' ' ' ASN . 0.3 OUTLIER -81.84 78.3 8.57 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.792 ' N ' HD22 ' A' ' 100' ' ' ASN . 1.1 m-80 -115.13 -130.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.324 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.644 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.3 Cg_exo -45.39 -156.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 123.672 2.347 . . . . 0.0 115.092 -175.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.767 ' O ' HG13 ' A' ' 106' ' ' VAL . 29.6 p -126.53 170.66 11.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.231 -0.918 . . . . 0.0 112.046 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.668 ' CD1' ' OE2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -50.21 -43.46 52.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.346 0.594 . . . . 0.0 110.016 179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.562 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.05 -34.89 64.22 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.821 -1.174 . . . . 0.0 109.487 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 107' ' ' CYS . 1.7 mm-40 -83.56 -43.7 15.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.81 . . . . 0.0 110.749 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 1.091 HG12 HG21 ' A' ' 111' ' ' THR . 34.5 m -46.33 -21.66 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 120.881 -1.137 . . . . 0.0 109.439 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.487 ' C ' ' O ' ' A' ' 106' ' ' VAL . 10.2 t -36.84 -20.67 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.631 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -79.82 3.91 18.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.062 -1.024 . . . . 0.0 108.865 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.1 mt-10 64.76 3.8 2.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.89 ' CG ' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -72.93 -9.94 59.25 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.025 -1.672 . . . . 0.0 110.467 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 1.091 HG21 HG12 ' A' ' 106' ' ' VAL . 1.7 p -105.01 -8.34 18.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.653 -1.279 . . . . 0.0 109.705 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 44.36 30.72 2.09 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 7.1 m-70 -81.68 170.01 16.3 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.908 -1.348 . . . . 0.0 109.386 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -129.03 114.33 16.27 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.668 ' OE2' ' CD1' ' A' ' 103' ' ' TYR . 1.6 mm-40 -40.19 120.94 1.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 108.934 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.797 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -140.55 162.77 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 110.262 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.046 HG22 ' O ' ' A' ' 68' ' ' PHE . 35.4 m -130.63 127.4 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.484 -0.76 . . . . 0.0 109.216 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -98.38 124.85 43.27 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 119' ' ' VAL . 4.2 m -133.85 125.88 49.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.018 -1.051 . . . . 0.0 108.723 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.718 HG22 ' CD1' ' A' ' 87' ' ' TYR . 1.8 m -96.39 146.55 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.717 -1.239 . . . . 0.0 107.971 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.858 ' CD2' HD22 ' A' ' 131' ' ' LEU . 2.9 m-30 -129.99 147.5 51.74 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.054 0.93 . . . . 0.0 108.661 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.985 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -179.31 27.21 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.985 ' HD3' ' N ' ' A' ' 122' ' ' ARG . 37.9 Cg_exo -73.79 -13.46 24.35 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 N-CA-C 119.436 2.821 . . . . 0.0 119.436 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.87 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.849 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -123.76 2.1 8.81 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.625 HD13 ' CG ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -153.85 132.93 3.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.547 -0.721 . . . . 0.0 109.834 -178.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.609 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -103.0 -177.89 3.5 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.04 0.924 . . . . 0.0 112.775 -177.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.912 ' HA ' HD21 ' A' ' 131' ' ' LEU . 35.7 t80 -69.82 -40.56 75.82 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.191 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.89 -14.49 47.03 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.805 -1.184 . . . . 0.0 108.809 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.625 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -74.58 -55.94 5.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 111.377 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.963 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.2 OUTLIER -59.99 -34.46 73.36 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 120.597 -1.314 . . . . 0.0 107.862 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 132' ' ' LEU . 1.5 mm? -66.12 -32.49 73.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -70.51 -62.53 1.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.38 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.716 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 25.5 t -49.37 -27.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.16 -0.963 . . . . 0.0 108.979 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.488 ' CE2' HG11 ' A' ' 159' ' ' VAL . 6.7 t80 -71.73 -50.74 27.39 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.794 -1.191 . . . . 0.0 109.889 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.947 ' O ' HG21 ' A' ' 223' ' ' THR . 55.1 m95 -72.4 -37.9 68.57 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.616 -1.303 . . . . 0.0 110.299 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -20.8 64.65 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.9 OUTLIER -131.56 59.48 1.69 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.161 -1.587 . . . . 0.0 111.768 -178.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.65 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 170.26 136.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.375 -0.828 . . . . 0.0 109.256 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.28 135.4 72.9 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.451 ' HG2' ' CD1' ' A' ' 181' ' ' LEU . 73.8 Cg_endo -75.58 -8.66 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.576 2.184 . . . . 0.0 112.558 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -118.04 56.0 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.228 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 144' ' ' GLY . 6.0 mm100 -118.73 62.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 108.739 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -45.27 -119.29 0.0 OUTLIER Glycine 0 N--CA 1.492 2.422 0 CA-C-O 121.81 0.672 . . . . 0.0 112.414 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.666 ' SD ' ' O ' ' A' ' 145' ' ' MET . 1.5 tmt? -69.84 35.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.507 -0.996 . . . . 0.0 110.648 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 144' ' ' GLY . 4.1 ttm180 -166.32 152.73 9.04 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.023 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.507 HE21 ' HG3' ' A' ' 143' ' ' GLN . 1.2 mm-40 -146.92 100.7 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.439 -1.413 . . . . 0.0 108.39 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 52.03 -119.6 9.23 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.499 ' H ' HD22 ' A' ' 220' ' ' LEU . 1.6 t-20 -81.72 8.86 8.95 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.744 -1.228 . . . . 0.0 110.13 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.36 147.85 29.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.99 -1.069 . . . . 0.0 109.409 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.1 p90 -136.67 129.63 30.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.144 -0.973 . . . . 0.0 110.088 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.5 158.59 7.75 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.415 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 153' ' ' THR . 0.1 OUTLIER -78.12 -4.6 48.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -1.146 . . . . 0.0 109.65 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.584 ' N ' ' OE1' ' A' ' 154' ' ' GLN . 15.3 pm0 -88.38 3.06 51.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.029 -1.044 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.635 ' O ' ' O ' ' A' ' 70' ' ' MET . 93.2 m-85 -114.9 -12.56 12.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 111.053 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -39.62 172.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.571 -1.331 . . . . 0.0 110.195 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.707 ' OG ' HG23 ' A' ' 190' ' ' THR . 31.5 p -89.11 132.82 34.63 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.456 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -147.64 123.08 10.36 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 117.68 -1.608 . . . . 0.0 111.58 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.677 HG13 ' CG2' ' A' ' 191' ' ' THR . 2.8 m -119.85 130.55 74.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.766 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.483 ' CE2' HG11 ' A' ' 116' ' ' VAL . 10.1 m-30 -112.85 131.66 22.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.105 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.35 169.38 20.17 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.86 2.373 . . . . 0.0 112.624 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.4 OUTLIER -103.14 -6.64 22.0 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.039 -1.038 . . . . 0.0 109.498 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.622 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 166.44 173.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 108.813 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -47.07 -14.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.989 1.376 . . . . 0.0 108.231 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.622 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.3 t -55.54 -61.3 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 170' ' ' ALA . 1.2 mp0 -60.88 -11.62 8.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.557 -0.714 . . . . 0.0 110.378 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttt -51.87 -43.61 63.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 109.919 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.673 ' O ' ' NH1' ' A' ' 172' ' ' ARG . 2.6 tm-20 -75.66 -22.68 56.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -93.06 -56.32 3.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.421 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.96 -58.97 4.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 109.683 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 171' ' ' LEU . 63.2 mt -52.24 -35.68 50.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.08 -1.013 . . . . 0.0 109.244 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.673 ' NH1' ' O ' ' A' ' 168' ' ' GLU . 13.4 ttp-105 -74.52 -55.92 5.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.524 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -56.54 -37.08 70.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.481 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -68.09 -53.15 27.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -73.0 2.21 7.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.66 -56.52 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -27.37 65.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 109.941 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.679 ' NE2' ' OG ' ' A' ' 182' ' ' SER . 0.5 OUTLIER -53.24 -53.85 44.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.171 -0.955 . . . . 0.0 109.666 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -15.55 63.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.89 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.7 t -87.22 -54.2 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 183' ' ' LYS . 35.2 mt -75.26 -45.93 36.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.164 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.679 ' OG ' ' NE2' ' A' ' 178' ' ' GLN . 61.1 m -56.23 -3.05 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 0.0 109.685 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -88.02 -21.29 24.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.306 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.459 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 14.1 m-70 -107.99 14.4 25.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.92 68.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.21 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.42 173.55 52.99 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.64 174.27 11.99 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.825 2.35 . . . . 0.0 112.245 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 189' ' ' ILE . 0.8 OUTLIER -80.99 116.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.006 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.707 HG23 ' OG ' ' A' ' 157' ' ' SER . 5.2 t -100.37 -5.21 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.002 -1.061 . . . . 0.0 109.544 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.677 ' CG2' HG13 ' A' ' 159' ' ' VAL . 47.0 m -43.6 112.65 0.41 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 7.2 t0 -77.17 132.93 39.03 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.924 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 194' ' ' ARG . 0.8 OUTLIER -133.41 125.66 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.418 -0.801 . . . . 0.0 108.909 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 69.7 mtm-85 -157.11 152.19 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 109.307 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.8 OUTLIER -115.36 -174.51 2.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.53 56.48 8.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -116.25 148.04 40.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -1.213 . . . . 0.0 109.573 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 200' ' ' TYR . 1.3 p -87.7 165.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 55.2 t80 -125.56 132.3 52.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 109.964 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.772 ' CZ ' HG11 ' A' ' 198' ' ' VAL . 35.0 m-85 -128.32 104.39 7.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.822 . . . . 0.0 109.109 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.8 m-85 -54.98 141.48 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 110.572 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.555 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -85.0 -169.3 2.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.574 ' HG3' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -76.0 153.26 36.63 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -56.54 -37.89 71.12 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.083 -1.01 . . . . 0.0 108.318 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.563 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -60.85 -14.55 22.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.635 -0.665 . . . . 0.0 110.635 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.494 ' O ' HG21 ' A' ' 91' ' ' VAL . 20.2 m-70 -99.02 -4.05 33.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.856 -1.152 . . . . 0.0 110.118 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.855 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.1 mt-30 -110.41 -133.07 0.33 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 122.752 1.263 . . . . 0.0 110.568 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.669 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -33.63 -5.06 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.887 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.855 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.2 t80 -42.56 -44.43 4.15 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.673 -1.267 . . . . 0.0 109.936 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.625 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -59.23 -17.23 26.34 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.439 -1.413 . . . . 0.0 110.016 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.466 ' OG ' ' ND1' ' A' ' 49' ' ' HIS . 71.1 p -73.26 -31.31 64.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.796 ' HZ2' ' CD2' ' A' ' 49' ' ' HIS . 10.9 mmtm -87.72 -33.91 18.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.866 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.689 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 26.2 m120 -121.71 82.42 41.52 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.46 9.88 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.206 2.604 . . . . 0.0 112.164 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -63.52 -11.92 28.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.13 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.31 85.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.766 -1.206 . . . . 0.0 111.449 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.601 ' O ' ' O ' ' A' ' 216' ' ' GLY . 33.1 t80 -52.31 -158.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.6 2.2 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.581 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 18.1 m -90.3 78.08 6.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.852 -1.155 . . . . 0.0 109.378 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.89 ' O ' HD12 ' A' ' 220' ' ' LEU . . . -88.62 -169.27 44.74 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -152.41 178.96 8.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -1.223 . . . . 0.0 109.673 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -153.98 -162.33 11.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -170.85 -136.53 2.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.947 HG21 ' O ' ' A' ' 136' ' ' TRP . 47.4 p . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.342 -1.093 . . . . 0.0 109.436 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.0 t . . . . . 0 N--CA 1.475 0.811 0 N-CA-C 106.285 -1.746 . . . . 0.0 106.285 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.18 132.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 122.315 1.055 . . . . 0.0 113.77 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.87 125.55 29.3 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.282 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.961 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -50.41 -27.21 6.0 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.15 3.37 31.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.29 4.55 13.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.617 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.32 178.96 8.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.7 mm? . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.399 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 168.37 23.3 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.737 2.291 . . . . 0.0 112.217 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -148.67 -166.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.005 . . . . 0.0 109.586 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.863 ' O ' HG23 ' A' ' 45' ' ' THR . 13.5 t -93.46 94.0 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.02 -45.41 79.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.282 -0.886 . . . . 0.0 111.016 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -83.43 99.94 10.4 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 115.775 -2.37 . . . . 0.0 108.597 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.661 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 15.1 t-80 -30.97 137.01 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.28 -7.47 56.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.267 -0.896 . . . . 0.0 111.139 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 55.1 t -95.51 -55.31 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.828 -1.17 . . . . 0.0 109.967 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -89.98 -43.95 10.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.97 5.37 53.51 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.695 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.37 -117.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.695 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.8 ttp180 -129.2 170.35 13.68 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 123.223 1.487 . . . . 0.0 108.84 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.592 HG22 HE21 ' A' ' 90' ' ' GLN . 4.6 p -133.56 32.39 3.61 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.544 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.569 HG22 ' C ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -164.71 133.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.214 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.8 pm0 -33.08 148.87 0.06 OUTLIER Pre-proline 0 C--N 1.305 -1.348 0 O-C-N 121.436 -0.79 . . . . 0.0 110.574 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 92.3 Cg_endo -78.03 166.4 80.9 Favored 'Cis proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.866 -2.139 . . . . 0.0 111.545 -0.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.522 ' CE1' HG11 ' A' ' 120' ' ' VAL . 28.6 m-85 -106.32 156.47 36.88 Favored Pre-proline 0 C--N 1.268 -2.973 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.86 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.591 ' CG ' ' CD2' ' A' ' 87' ' ' TYR . 47.8 Cg_exo -49.62 129.28 23.15 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.24 1.96 . . . . 0.0 112.147 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.687 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 1.9 pm0 -43.35 144.31 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.85 . . . . 0.0 109.134 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.34 1.11 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 137.13 28.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -1.06 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.9 tt0 -106.51 136.37 46.41 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.731 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.85 127.9 27.75 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.85 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 -168.79 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 67' ' ' VAL . 43.9 t -143.57 98.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 119.9 -1.75 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -137.52 164.35 28.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.545 178.135 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.58 162.64 33.56 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.971 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.596 ' O ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -115.71 -86.01 0.61 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -132.42 -151.41 6.74 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.784 ' SG ' ' CZ3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -28.58 114.4 0.08 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.521 -0.988 . . . . 0.0 108.992 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -53.0 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.769 -0.582 . . . . 0.0 111.75 -178.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.784 ' CZ3' ' SG ' ' A' ' 72' ' ' CYS . 16.1 m0 -84.59 -63.34 1.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.487 -1.383 . . . . 0.0 109.646 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.24 74.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.745 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.04 -38.17 57.48 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.247 -1.149 . . . . 0.0 109.76 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.544 ' CD ' ' NE2' ' A' ' 208' ' ' GLN . 3.6 tt0 -84.5 -14.82 48.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.907 -1.121 . . . . 0.0 110.554 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.71 ' O ' HG13 ' A' ' 82' ' ' VAL . 13.1 ttp180 -76.25 -74.2 0.24 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.025 -1.047 . . . . 0.0 110.556 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.484 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -48.39 -2.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.955 -1.09 . . . . 0.0 110.26 -179.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.8 m-85 -108.64 -24.18 11.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.756 ' CH2' HD12 ' A' ' 210' ' ' LEU . 0.1 OUTLIER -104.63 -2.89 24.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.719 -1.238 . . . . 0.0 111.122 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.1 m -97.76 11.54 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.686 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -112.0 178.7 4.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.117 -0.989 . . . . 0.0 109.325 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -98.83 137.53 37.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.0 111.536 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.511 ' HA3' HD12 ' A' ' 126' ' ' ILE . . . 124.28 -33.25 3.88 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -78.61 135.86 25.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.448 -1.031 . . . . 0.0 111.049 -178.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.655 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -75.81 -40.24 55.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.685 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.9 OUTLIER -174.43 -173.62 0.78 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.593 HG21 ' HB3' ' A' ' 81' ' ' TRP . 39.7 p -144.12 163.01 34.83 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.685 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 12.7 mp0 -154.89 140.03 17.49 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.092 HG12 HG22 ' A' ' 117' ' ' VAL . 3.2 m -127.21 162.79 31.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.951 -1.093 . . . . 0.0 109.521 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.94 177.69 48.13 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.522 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -102.64 168.46 9.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 110.046 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.707 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.19 -170.37 0.17 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 51.25 40.78 45.85 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.738 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -106.05 -158.02 22.15 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.961 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -149.68 58.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.986 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -178.86 7.66 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.02 -1.05 . . . . 0.0 108.335 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.677 ' C ' HD22 ' A' ' 100' ' ' ASN . 9.3 mmt180 -52.76 -93.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.387 -0.821 . . . . 0.0 108.79 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.677 HD22 ' C ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -123.06 71.99 44.57 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.911 . . . . 0.0 109.286 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 52.0 Cg_exo -48.85 131.9 25.71 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.495 2.13 . . . . 0.0 111.633 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.64 HG22 ' HG3' ' A' ' 105' ' ' GLU . 1.8 t -121.25 171.3 8.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' ' CB ' ' A' ' 107' ' ' CYS . 40.8 t80 -49.23 -43.71 42.9 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -42.46 92.0 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.599 -0.688 . . . . 0.0 109.399 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.64 ' HG3' HG22 ' A' ' 102' ' ' THR . 2.0 mm-40 -74.77 -54.61 7.03 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.812 -1.18 . . . . 0.0 110.933 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.993 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.0 m -73.09 -25.17 21.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.028 -1.045 . . . . 0.0 111.354 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -38.78 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.69 ' N ' ' O ' ' A' ' 106' ' ' VAL . 84.2 p -76.94 -81.1 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 108' ' ' SER . 0.0 OUTLIER 156.85 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.452 ' N ' ' HG2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -53.55 2.79 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 -177.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.993 ' OG1' HG12 ' A' ' 106' ' ' VAL . 32.2 p -96.53 -6.14 37.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.25 -1.531 . . . . 0.0 108.961 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 52.92 25.54 23.84 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.829 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.738 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -69.77 159.64 33.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.281 -1.717 . . . . 0.0 109.168 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.642 ' O ' HG13 ' A' ' 116' ' ' VAL . . . -112.38 112.45 24.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.335 -0.853 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.667 ' N ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -48.84 109.0 0.21 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.415 -0.803 . . . . 0.0 108.986 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 114' ' ' ALA . 16.0 m -124.71 137.4 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 91' ' ' VAL . 1.5 t -113.79 123.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.506 HH21 HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -97.82 116.18 29.52 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.313 -0.867 . . . . 0.0 109.342 -179.007 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.8 140.81 47.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.451 -0.781 . . . . 0.0 108.909 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.648 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m -107.26 158.77 7.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.322 -0.862 . . . . 0.0 108.808 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.926 ' CG ' HD22 ' A' ' 131' ' ' LEU . 4.4 m-85 -141.91 155.84 45.5 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.826 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -101.04 106.13 42.79 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.405 -0.81 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 55.3 Cg_exo -47.75 -26.46 6.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.685 2.256 . . . . 0.0 112.5 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.15 -18.6 52.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -121.06 -7.62 9.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.647 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.511 HD12 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -154.1 156.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 110.488 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -108.17 147.68 30.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.715 . . . . 0.0 109.73 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.723 ' CZ ' HD23 ' A' ' 132' ' ' LEU . 2.1 t80 -49.79 -21.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.442 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -63.62 -23.44 67.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.147 -0.97 . . . . 0.0 109.128 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 131' ' ' LEU . 2.5 mt-10 -71.41 -71.53 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.995 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -35.3 -47.87 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.088 -1.007 . . . . 0.0 109.579 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.824 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.8 pp -75.82 -28.93 58.49 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.095 -1.003 . . . . 0.0 111.385 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.729 ' N ' HD12 ' A' ' 132' ' ' LEU . 4.3 mtmt -70.41 -58.16 4.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.671 -1.268 . . . . 0.0 110.312 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.714 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -48.76 -28.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 108.897 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.704 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 38.5 t80 -65.25 -54.8 23.93 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.815 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.557 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 86.8 m95 -71.78 -42.54 67.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.356 -1.465 . . . . 0.0 109.79 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.8 -35.37 22.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.0 111.021 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.714 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 11.4 p30 -127.83 72.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.946 -1.096 . . . . 0.0 111.275 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 223' ' ' THR . 6.3 m80 -150.6 151.62 32.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.612 ' OD1' ' NE2' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.38 177.77 0.33 Allowed Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HB3' HD12 ' A' ' 181' ' ' LEU . 3.4 Cg_endo -79.87 -91.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.16 1.907 . . . . 0.0 111.405 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.686 HG22 ' HA ' ' A' ' 189' ' ' ILE . 32.9 p -123.89 54.96 1.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.42 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.597 ' C ' ' H ' ' A' ' 145' ' ' MET . 3.7 mt-30 -101.68 51.46 0.84 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.837 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.685 ' H ' HG21 ' A' ' 190' ' ' THR . . . -61.07 10.13 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.177 -1.487 . . . . 0.0 109.729 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.597 ' H ' ' C ' ' A' ' 143' ' ' GLN . 2.3 ptt? -117.13 13.23 14.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.028 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' GLN . 4.9 tmm_? -178.32 152.68 0.7 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.001 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.612 ' NE2' ' OD1' ' A' ' 140' ' ' ASP . 0.6 OUTLIER -134.53 76.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.409 -1.432 . . . . 0.0 108.8 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.76 -110.37 3.44 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.05 -32.84 39.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 114.453 -0.874 . . . . 0.0 111.901 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 148.39 22.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 109.339 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.91 156.84 47.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.912 -1.118 . . . . 0.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.94 179.47 16.23 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -18.62 37.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -1.184 . . . . 0.0 109.352 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 5.9 pt20 -88.61 4.25 47.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.123 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 67.7 m-85 -122.06 52.37 1.28 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.633 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 70' ' ' MET . 2.4 mtm105 -108.43 -170.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.504 -0.748 . . . . 0.0 109.152 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.72 126.14 35.9 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -133.52 131.84 40.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.443 -1.703 . . . . 0.0 111.104 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.769 HG13 ' CG2' ' A' ' 191' ' ' THR . 1.2 m -135.55 119.0 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.562 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.491 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 2.8 m-30 -116.02 129.76 24.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.73 168.34 22.57 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.381 2.054 . . . . 0.0 112.131 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -20.49 20.09 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.907 -1.121 . . . . 0.0 109.222 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 177.18 -171.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 168' ' ' GLU . . . -53.12 -15.25 0.8 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.995 1.379 . . . . 0.0 108.52 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.52 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.6 t -55.75 -64.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.891 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 18.1 mt-30 -78.74 -20.92 48.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.556 -0.715 . . . . 0.0 110.651 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 12.4 ttp -52.2 -31.96 34.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.54 ' OE1' ' O ' ' A' ' 164' ' ' ALA . 2.8 mp0 -75.35 -36.25 61.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.772 -1.205 . . . . 0.0 109.79 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.566 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.77 -47.33 7.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.086 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.75 -63.15 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.07 -34.69 44.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.974 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -74.93 -35.33 62.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.192 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -59.18 -46.18 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.475 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -72.39 -25.23 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.005 . . . . 0.0 109.744 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 69.5 mt-10 -73.19 -56.82 4.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.664 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.571 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 15.7 pt-20 -53.25 -45.55 68.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.571 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -68.17 -20.54 64.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.631 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.501 HE21 ' HB2' ' A' ' 182' ' ' SER . 43.3 tp60 -74.64 -38.19 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -29.79 52.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.674 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 176' ' ' GLU . 99.2 t -74.38 -54.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.724 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 141' ' ' PRO . 4.5 mm? -64.31 -42.31 96.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.737 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.501 ' HB2' HE21 ' A' ' 178' ' ' GLN . 23.0 t -56.38 -6.22 0.26 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 181' ' ' LEU . 3.8 tttp -88.09 -10.55 49.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.605 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.747 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.4 OUTLIER -108.4 35.96 2.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.702 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 184' ' ' HIS . 0.0 OUTLIER 72.96 31.01 1.58 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.525 -0.734 . . . . 0.0 110.004 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -105.19 174.65 5.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.18 -147.17 6.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 189' ' ' ILE . 29.6 Cg_exo -58.79 106.29 0.27 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.542 2.161 . . . . 0.0 111.451 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.686 ' HA ' HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.34 -177.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.834 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.685 HG21 ' H ' ' A' ' 144' ' ' GLY . 1.8 p -133.91 68.68 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.691 0.758 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.769 ' CG2' HG13 ' A' ' 159' ' ' VAL . 24.5 m -98.39 119.88 37.84 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.627 ' OD1' ' CZ ' ' A' ' 194' ' ' ARG . 2.0 t70 -75.36 121.04 21.64 Favored 'General case' 0 C--N 1.279 -2.485 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.492 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.55 109.57 14.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.627 ' CZ ' ' OD1' ' A' ' 192' ' ' ASP . 1.9 ptp180 -166.75 120.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.709 ' H ' ' CD ' ' A' ' 195' ' ' GLU . 1.9 pm0 -80.81 -179.32 7.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.529 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.49 22.75 61.78 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.491 ' HG3' ' CE2' ' A' ' 160' ' ' TYR . 53.0 mm-40 -93.31 98.29 11.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.612 -1.522 . . . . 0.0 109.516 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.58 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.4 p -42.98 161.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.468 -0.77 . . . . 0.0 109.794 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 41.3 t80 -109.31 131.43 55.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.505 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.408 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 6.8 m-85 -127.54 98.65 5.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.67 131.52 39.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.982 -1.074 . . . . 0.0 110.584 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -83.58 179.14 7.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.0 OUTLIER -74.64 170.57 15.54 Favored 'General case' 0 C--N 1.286 -2.153 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 179.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -63.93 -13.43 45.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.897 . . . . 0.0 109.841 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -76.77 -15.75 59.66 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.912 -1.118 . . . . 0.0 110.182 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 74' ' ' TRP . 63.5 m-70 -107.35 8.89 29.94 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.677 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.751 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.7 mm-40 -119.88 -149.98 0.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.822 -1.174 . . . . 0.0 112.087 -177.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.691 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 12.2 mp0 -36.25 -2.49 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.73 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.751 ' N ' ' O ' ' A' ' 207' ' ' GLN . 10.6 p90 -46.79 -34.75 5.54 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 117.373 -1.731 . . . . 0.0 110.705 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.756 HD12 ' CH2' ' A' ' 81' ' ' TRP . 1.7 mt -49.44 -10.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.403 -1.436 . . . . 0.0 110.042 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 209' ' ' TYR . 11.4 p -53.21 -37.02 61.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -84.75 -36.74 21.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.1 66.79 3.09 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.594 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 10.0 Cg_endo -54.9 -39.76 88.77 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.997 2.465 . . . . 0.0 113.16 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.596 ' C ' HH12 ' A' ' 78' ' ' ARG . 29.6 p30 -61.23 -5.6 1.66 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.787 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 218' ' ' CYS . . . 58.99 84.41 0.04 OUTLIER Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.561 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.626 ' OH ' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -48.82 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 121.017 2.408 . . . . 0.0 109.452 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 216' ' ' GLY . 31.4 p -166.12 -125.15 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.769 -1.207 . . . . 0.0 109.143 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.631 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -128.04 -149.94 7.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 220' ' ' LEU . 0.1 OUTLIER -114.23 -175.02 2.59 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.36 -1.083 . . . . 0.0 109.641 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.86 -139.28 0.05 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.543 ' O ' ' C ' ' A' ' 223' ' ' THR . . . -153.42 -142.02 3.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.847 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.521 -0.987 . . . . 0.0 109.455 -179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 20.1 t . . . . . 0 CA--C 1.505 -0.77 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.452 HG12 ' HB2' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -76.82 135.78 25.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -173.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -82.23 131.28 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.151 0.977 . . . . 0.0 110.243 -179.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 97' ' ' HIS . . . -45.9 -55.68 6.41 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.494 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -85.03 8.28 18.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.765 -1.209 . . . . 0.0 111.73 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.472 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 3.2 tt0 -117.59 -14.3 10.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.444 -1.41 . . . . 0.0 111.501 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.812 ' C ' HD13 ' A' ' 35' ' ' LEU . . . -67.39 -169.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.541 -1.35 . . . . 0.0 109.45 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.997 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.591 ' CG2' ' O ' ' A' ' 201' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.75 ' O ' HG13 ' A' ' 44' ' ' VAL . 71.5 Cg_endo -81.37 149.86 17.06 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.06 2.507 . . . . 0.0 112.751 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 43' ' ' PRO . 3.2 m -163.37 158.92 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.416 -0.802 . . . . 0.0 109.493 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 45' ' ' THR . 15.2 t -59.43 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.908 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.586 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.91 -21.79 22.38 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.235 -0.916 . . . . 0.0 110.759 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.6 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.8 OUTLIER -90.93 100.15 13.06 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 116.344 -2.143 . . . . 0.0 108.03 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.631 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 7.8 t-80 -31.48 132.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.5 ' CD2' ' HD3' ' A' ' 212' ' ' LYS . 0.1 OUTLIER -82.72 -11.43 58.32 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.104 -0.998 . . . . 0.0 111.234 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.648 HG22 ' OG ' ' A' ' 211' ' ' SER . 21.9 t -85.6 -36.34 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 108.207 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -45.14 3.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.011 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.11 54.27 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 66.7 m-20 -76.32 -116.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.547 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.89 174.06 10.1 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 123.497 1.617 . . . . 0.0 109.606 177.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.762 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.9 p -142.34 38.57 1.56 Allowed 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.07 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 55' ' ' THR . 4.6 m -163.89 138.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.995 -1.066 . . . . 0.0 109.795 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 8.1 pt-20 -71.78 177.33 1.71 Allowed Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 2.9 Cg_exo -49.26 143.62 6.21 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 N-CA-C 116.067 1.526 . . . . 0.0 116.067 -0.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 37.6 m-85 -94.56 110.44 49.04 Favored Pre-proline 0 C--N 1.272 -2.768 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.577 ' O ' ' OG1' ' A' ' 63' ' ' THR . 50.1 Cg_exo -50.38 133.45 36.88 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.331 2.021 . . . . 0.0 112.387 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 60' ' ' PRO . 50.8 mt-10 -43.59 157.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 63' ' ' THR . . . 83.14 32.0 27.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -158.71 137.93 11.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -1.174 . . . . 0.0 109.474 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.663 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 20.6 mp0 -111.55 156.67 21.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.123 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.742 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -140.78 114.62 8.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.965 . . . . 0.0 109.904 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.64 -170.71 1.69 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.93 . . . . 0.0 108.802 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.14 133.55 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.049 -1.657 . . . . 0.0 109.518 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.713 ' CE2' ' O ' ' A' ' 131' ' ' LEU . 25.9 m-85 -126.41 145.22 50.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.828 -1.17 . . . . 0.0 109.293 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.03 108.93 1.72 Allowed Glycine 0 N--CA 1.482 1.715 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.62 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -114.3 -87.84 0.57 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.403 -1.057 . . . . 0.0 108.502 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.569 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -148.19 -152.19 5.63 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.671 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -36.18 104.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.779 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -50.67 7.28 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.679 ' HB3' HD11 ' A' ' 210' ' ' LEU . 37.9 m0 -75.27 -52.23 11.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.656 -1.278 . . . . 0.0 109.417 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' A' ' 218' ' ' CYS . . . -88.8 -26.96 25.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.62 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . -64.85 -45.2 87.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.105 -1.233 . . . . 0.0 110.173 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.486 ' OE1' HG13 ' A' ' 91' ' ' VAL . 4.2 tt0 -83.03 -14.77 53.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.126 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.536 ' O ' HG13 ' A' ' 82' ' ' VAL . 51.4 ttp85 -68.6 -36.12 78.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.0 110.067 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -70.49 15.76 0.09 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.0 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 93.2 m-85 -123.73 -42.25 2.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 110.644 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.601 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -68.77 6.88 0.76 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.553 -1.342 . . . . 0.0 109.268 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.5 m -109.53 15.97 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 109.369 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.9 mt -110.84 154.64 23.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.98 138.42 31.5 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.353 0.596 . . . . 0.0 109.561 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.84 -27.35 14.96 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -70.26 137.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.53 -0.982 . . . . 0.0 108.999 179.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.547 ' OH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -79.94 -46.69 16.27 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.672 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 1.4 p -165.7 -170.21 1.74 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.631 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 41.4 p -151.16 146.42 26.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 108.989 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.672 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 6.8 mp0 -144.59 155.8 43.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 110.13 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -141.05 151.95 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.2 42.82 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.374 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.2 m-85 -80.1 171.68 14.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.951 . . . . 0.0 109.252 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -176.95 168.73 2.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 109.667 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 64.64 20.88 66.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.564 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -93.83 173.72 33.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.731 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 1.2 m-70 -91.66 -111.83 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.544 -1.563 . . . . 0.0 111.404 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.604 ' O ' ' C ' ' A' ' 99' ' ' ARG . 5.9 t -75.98 -172.88 2.12 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.604 ' C ' ' O ' ' A' ' 98' ' ' THR . 0.1 OUTLIER -37.81 139.26 0.32 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.919 ' H ' ' ND2' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -128.38 144.87 53.54 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -172.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 100' ' ' ASN . 73.5 Cg_exo -45.68 -147.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 124.133 3.222 . . . . 0.0 112.214 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.543 HG22 ' HG3' ' A' ' 105' ' ' GLU . 1.5 t -125.53 176.1 7.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.971 -1.08 . . . . 0.0 111.514 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.786 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -50.81 -41.1 57.09 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.531 0.682 . . . . 0.0 110.397 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 12.7 tttp -72.59 -33.44 66.72 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.146 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.676 ' C ' ' HZ1' ' A' ' 110' ' ' LYS . 1.9 mm-40 -81.71 -41.2 21.65 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 110.47 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.919 HG12 ' CG2' ' A' ' 111' ' ' THR . 28.3 m -56.29 -23.32 16.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.061 -1.024 . . . . 0.0 109.85 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' A' ' 106' ' ' VAL . 69.0 m -41.66 -15.48 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.687 ' N ' ' O ' ' A' ' 106' ' ' VAL . 35.6 m -102.67 19.81 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 110.006 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER 60.08 -9.38 0.05 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.92 -1.112 . . . . 0.0 109.647 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.679 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -44.67 -14.32 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.739 -0.6 . . . . 0.0 111.691 -178.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.919 ' CG2' HG12 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -122.09 -10.0 8.63 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.554 -1.342 . . . . 0.0 111.481 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 60.74 24.87 62.84 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 118.527 -1.796 . . . . 0.0 109.771 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.71 ' HE2' ' CG ' ' A' ' 100' ' ' ASN . 1.8 m-70 -78.83 172.41 13.8 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.992 -1.299 . . . . 0.0 109.274 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -137.25 125.26 22.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.674 ' OE2' ' CZ ' ' A' ' 73' ' ' PHE . 3.5 mt-10 -66.33 119.7 12.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.232 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -125.05 169.74 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.761 ' HA ' HG12 ' A' ' 91' ' ' VAL . 15.8 m -127.13 128.22 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.376 -0.827 . . . . 0.0 109.519 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 90' ' ' GLN . 8.9 ttm180 -103.48 111.83 24.46 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.551 -0.718 . . . . 0.0 109.886 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.72 112.89 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 65' ' ' MET . 0.8 OUTLIER -98.49 160.72 3.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 108.94 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 10.5 p90 -141.23 169.5 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.581 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.513 ' C ' ' OE2' ' A' ' 124' ' ' GLU . 60.7 mtp180 -110.05 114.1 56.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' HIS . 38.3 Cg_exo -42.94 -63.97 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.927 2.418 . . . . 0.0 113.022 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.692 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -46.45 -10.67 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 -179.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' PRO . 36.1 m80 -126.13 -18.86 4.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.617 -1.302 . . . . 0.0 110.716 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.484 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.59 158.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.873 -1.142 . . . . 0.0 110.212 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.5 p -108.8 153.19 23.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.825 . . . . 0.0 110.369 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.488 ' C ' ' N ' ' A' ' 130' ' ' GLU . 25.1 t80 -53.63 -30.1 41.19 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 3.0 mp0 -47.35 -19.26 0.15 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 128' ' ' PHE . 1.5 mm-40 -73.84 -63.02 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.827 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.713 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 7.2 mt -44.74 -45.74 10.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.253 -0.904 . . . . 0.0 108.785 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.891 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.5 pp -75.04 -21.96 58.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.495 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.675 ' N ' HD12 ' A' ' 132' ' ' LEU . 0.4 OUTLIER -69.94 -68.13 0.44 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.736 -1.227 . . . . 0.0 110.057 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.727 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 38.9 t -58.3 -17.22 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.58 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 7.2 t80 -72.45 -60.27 2.31 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.844 -1.16 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.658 ' CB ' ' CE2' ' A' ' 177' ' ' TYR . 94.1 m95 -72.06 -52.84 14.94 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.468 -1.395 . . . . 0.0 110.348 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 136' ' ' TRP . 4.1 tt0 -36.84 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.557 -0.714 . . . . 0.0 111.86 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.727 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.7 p30 -124.0 64.76 1.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.609 -1.307 . . . . 0.0 111.734 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.824 ' O ' HG23 ' A' ' 223' ' ' THR . 13.0 m80 -147.95 161.25 41.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.201 -0.937 . . . . 0.0 109.056 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.669 ' CG ' HE22 ' A' ' 143' ' ' GLN . 0.9 OUTLIER -91.77 160.32 36.46 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 186' ' ' PHE . 79.8 Cg_exo -32.62 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.572 2.181 . . . . 0.0 111.792 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.707 ' OG1' ' N ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -122.21 14.77 10.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.793 -1.192 . . . . 0.0 109.005 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.669 HE22 ' CG ' ' A' ' 140' ' ' ASP . 3.5 mt-30 -55.4 71.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.61 10.17 62.84 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.97 15.53 15.14 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 148' ' ' GLY . 4.3 ttm180 179.3 133.62 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.326 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 70' ' ' MET . 2.0 tp60 -109.54 63.67 0.6 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 119.731 -1.856 . . . . 0.0 107.894 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' CD ' ' A' ' 146' ' ' ARG . . . 91.96 -118.07 5.41 Favored Glycine 0 C--N 1.301 -1.413 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -32.75 47.54 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.458 -0.871 . . . . 0.0 111.434 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -76.95 117.46 18.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.28 -1.513 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 35.6 p90 -109.21 131.89 54.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.928 . . . . 0.0 110.716 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.06 164.51 25.9 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.023 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.574 ' OG1' ' OE2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -72.13 -23.42 61.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.589 -0.948 . . . . 0.0 109.629 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.718 ' CD ' ' H ' ' A' ' 154' ' ' GLN . 7.2 pm0 -89.17 3.7 51.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.453 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 22.5 m-85 -112.59 50.03 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 109.37 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 144' ' ' GLY . 1.6 mtm180 -97.37 -178.65 4.23 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 109.236 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 192' ' ' ASP . 3.8 t -93.9 112.95 24.87 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -145.17 123.18 12.06 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 117.866 -1.533 . . . . 0.0 112.036 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 191' ' ' THR . 4.5 t -112.26 127.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.689 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.615 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.5 m-85 -112.88 93.02 22.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.323 -0.86 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -49.12 172.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.838 2.358 . . . . 0.0 112.186 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.516 HG21 ' SD ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -107.44 -44.24 4.35 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.191 -0.943 . . . . 0.0 109.698 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.509 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER -175.12 -178.02 1.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.12 -0.988 . . . . 0.0 109.902 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.18 -24.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 123.252 1.501 . . . . 0.0 108.255 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.649 ' O ' ' CG ' ' A' ' 168' ' ' GLU . 2.5 t -56.43 -53.81 35.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.38 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.472 ' C ' ' H ' ' A' ' 168' ' ' GLU . 0.4 OUTLIER -78.51 -20.92 49.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.336 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . 0.674 ' CG ' HD22 ' A' ' 171' ' ' LEU . 22.8 ttm -52.95 -4.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER -73.58 -68.48 0.5 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.845 -1.159 . . . . 0.0 110.583 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -92.74 -42.92 9.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -0.987 . . . . 0.0 111.175 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -51.68 -65.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.968 -1.082 . . . . 0.0 110.169 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.674 HD22 ' CG ' ' A' ' 167' ' ' MET . 0.4 OUTLIER -55.04 -40.14 69.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.045 -1.034 . . . . 0.0 109.431 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -74.26 -24.17 59.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.648 ' N ' ' O ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -67.23 -32.31 73.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.583 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.595 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 8.1 pttm -72.36 -47.14 51.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.997 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CG ' ' A' ' 174' ' ' LYS . 15.3 tt0 -72.86 -30.38 63.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.518 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.639 ' OE2' ' CD2' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -73.22 -40.79 64.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.0 -1.062 . . . . 0.0 110.819 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.658 ' CE2' ' CB ' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -80.12 -25.61 39.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.748 -1.22 . . . . 0.0 110.238 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -74.76 -26.44 59.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 109.912 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 1.4 ttpm? -77.89 -20.04 53.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.22 -54.11 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.76 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.1 mt -66.38 -13.09 60.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.963 . . . . 0.0 109.75 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -59.48 -40.66 87.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -88.04 10.61 18.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.95 . . . . 0.0 109.659 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.516 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 14.3 m170 -104.49 35.11 2.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.31 48.55 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.543 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 141' ' ' PRO . 71.7 m-85 -152.5 168.61 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.31 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -117.83 -144.42 7.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -58.66 105.85 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.24 1.96 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.544 ' C ' ' OG1' ' A' ' 142' ' ' THR . 0.5 OUTLIER -47.47 166.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -178.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.707 ' N ' ' OG1' ' A' ' 142' ' ' THR . 0.8 OUTLIER -95.06 0.48 54.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.827 -0.546 . . . . 0.0 111.199 -179.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.714 HG22 HD11 ' A' ' 193' ' ' ILE . 27.2 m -42.87 108.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.69 -1.256 . . . . 0.0 108.401 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.772 ' O ' HD13 ' A' ' 193' ' ' ILE . 2.2 t70 -76.91 131.8 38.75 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.84 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 192' ' ' ASP . 7.7 mm -131.97 101.38 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.402 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.663 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -143.35 153.54 42.83 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.762 ' H ' ' CD ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -107.02 171.21 7.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.976 -1.077 . . . . 0.0 110.01 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.544 ' C ' ' OE1' ' A' ' 197' ' ' GLN . . . 75.37 43.94 23.5 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.591 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 3.6 mm100 -97.41 97.6 9.24 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.318 -1.107 . . . . 0.0 109.539 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.5 t -48.3 153.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.69 131.88 54.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.407 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' PHE . 4.4 m-85 -131.79 98.35 4.44 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.591 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 16.0 m-85 -54.02 141.49 28.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 110.462 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.559 ' O ' HG11 ' A' ' 44' ' ' VAL . . . -92.87 -176.08 4.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.701 ' OE1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.45 175.11 8.04 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.441 -0.787 . . . . 0.0 109.064 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.701 ' N ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -60.42 -54.83 40.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.867 -1.146 . . . . 0.0 108.77 179.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -46.89 -11.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.052 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.786 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 9.1 m-70 -100.75 9.84 41.9 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.12 -0.987 . . . . 0.0 110.777 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.9 mm-40 -130.51 -143.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.402 1.096 . . . . 0.0 110.688 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.754 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 16.4 mp0 -36.59 -2.76 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.072 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 60.3 t80 -41.01 -50.69 3.32 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 120.865 -1.147 . . . . 0.0 112.083 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 74' ' ' TRP . 63.9 mt -65.97 -25.23 67.01 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.115 -1.615 . . . . 0.0 111.221 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.91 -52.06 65.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 108.608 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.636 ' CB ' ' NZ ' ' A' ' 212' ' ' LYS . 7.4 mtmp? -90.34 -12.49 37.54 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 111.096 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.693 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 2.0 m-80 -115.0 95.18 41.08 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.669 -1.269 . . . . 0.0 111.082 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.68 12.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.326 2.684 . . . . 0.0 111.899 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 213' ' ' ASN . 8.1 t0 -60.74 -5.42 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.44 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.33 -47.41 0.13 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.592 -1.289 . . . . 0.0 112.492 177.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.615 ' C ' ' O ' ' A' ' 216' ' ' GLY . 25.9 m-85 -27.22 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 119.382 1.591 . . . . 0.0 109.641 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.759 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 16.6 p -142.24 -127.62 0.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.337 -0.852 . . . . 0.0 109.564 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.759 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -152.66 151.0 22.89 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 mt -104.65 146.25 29.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -1.138 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.4 -162.63 5.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -155.51 -141.77 3.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 139' ' ' HIS . 1.2 p . . . . . 0 C--N 1.304 -1.376 0 O-C-N 121.47 -1.017 . . . . 0.0 110.082 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.737 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.9 OUTLIER . . . . . 0 CA--C 1.473 -2.005 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.486 HG21 ' C ' ' A' ' 110' ' ' LYS . 0.2 OUTLIER -40.41 120.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 109.219 -3.628 . . . . 0.0 115.301 -169.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -57.96 121.17 9.92 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.874 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -52.79 -24.7 9.4 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.827 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.631 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -73.5 -14.56 61.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.793 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.6 -14.03 14.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.79 ' HB2' ' CE1' ' A' ' 97' ' ' HIS . . . -53.26 146.09 12.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 110.314 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.556 HD11 ' OE2' ' A' ' 105' ' ' GLU . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.491 HG21 ' HB3' ' A' ' 203' ' ' GLU . 14.7 mm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.38 168.01 16.91 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.829 2.353 . . . . 0.0 112.174 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' ' 204' ' ' ASP . 29.7 m -129.39 -163.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.14 -0.975 . . . . 0.0 109.68 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.823 ' O ' HG23 ' A' ' 45' ' ' THR . 13.2 t -90.66 102.39 15.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.57 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.89 -57.8 10.56 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.367 -0.833 . . . . 0.0 110.915 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -71.23 100.8 2.17 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 115.62 -2.432 . . . . 0.0 108.061 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.711 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 11.4 t-80 -31.63 136.53 0.06 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.478 ' NE2' ' HD2' ' A' ' 212' ' ' LYS . 37.4 t-80 -74.81 -32.32 61.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 111.09 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.482 HG21 ' CG ' ' A' ' 81' ' ' TRP . 64.2 t -70.27 -47.58 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.892 -1.13 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -99.34 -42.72 6.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.062 -1.024 . . . . 0.0 110.789 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.03 2.51 58.17 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 70.9 m-20 -75.61 -115.66 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.587 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -134.23 173.44 11.6 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 123.613 1.673 . . . . 0.0 110.106 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 41.3 p -143.72 17.38 1.81 Allowed 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 112.601 -2.091 . . . . 0.0 110.061 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 57' ' ' GLU . 8.6 m -151.96 136.81 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 109.368 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' A' ' 56' ' ' VAL . 8.2 mt-10 -32.4 155.28 0.04 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.971 0.891 . . . . 0.0 110.816 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 89.3 Cg_endo -79.26 165.83 79.98 Favored 'Cis proline' 0 C--N 1.303 -1.865 0 C-N-CA 121.606 -2.248 . . . . 0.0 112.045 -0.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.796 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 2.2 m-30 -112.24 150.31 42.32 Favored Pre-proline 0 C--N 1.269 -2.91 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.21 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' O ' ' OG1' ' A' ' 63' ' ' THR . 36.2 Cg_endo -68.01 109.98 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.727 2.285 . . . . 0.0 112.331 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.84 143.42 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.11 -19.0 50.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -82.78 149.1 27.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -1.134 . . . . 0.0 109.533 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.678 ' OE1' ' N ' ' A' ' 65' ' ' MET . 5.6 tm0? -99.47 146.98 25.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.752 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -139.36 114.27 9.42 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.093 -1.004 . . . . 0.0 109.647 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.98 -167.98 1.63 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 t -142.35 138.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.126 -1.609 . . . . 0.0 109.47 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 1.058 ' O ' HG22 ' A' ' 117' ' ' VAL . 32.9 m-85 -134.63 136.74 43.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.06 111.12 2.21 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.672 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 2.9 mmm -100.01 -89.76 0.33 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.429 -1.042 . . . . 0.0 108.519 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.721 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -161.3 72.49 0.21 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.216 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.721 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 49.0 t 110.52 110.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.561 0.744 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.6 ' CD1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -63.99 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.505 -1.372 . . . . 0.0 110.61 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.796 ' O ' HD21 ' A' ' 210' ' ' LEU . 9.0 m0 -94.89 -70.52 0.71 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.565 -1.334 . . . . 0.0 109.553 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -2.43 65.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB1' ' CG ' ' A' ' 70' ' ' MET . . . -76.34 -37.62 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -1.164 . . . . 0.0 109.796 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.671 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 2.1 pm0 -82.74 -25.75 32.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.267 -0.896 . . . . 0.0 110.479 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.758 ' O ' HG13 ' A' ' 82' ' ' VAL . 6.4 tmm_? -57.94 -56.79 17.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.075 -1.016 . . . . 0.0 110.076 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.555 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.0 mttp -43.53 -25.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' CB ' HG11 ' A' ' 119' ' ' VAL . 94.6 m-85 -84.96 -41.75 15.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 111.406 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 81' ' ' TRP . 0.7 OUTLIER -69.55 -5.18 22.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.318 -1.489 . . . . 0.0 109.259 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -97.74 18.58 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.234 -0.916 . . . . 0.0 109.365 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.29 152.2 21.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.972 0.892 . . . . 0.0 109.402 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -90.0 143.27 26.93 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 95.66 -21.44 44.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -75.53 138.02 21.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.838 . . . . 0.0 109.529 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.587 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.8 -47.56 12.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.525 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 1.5 t -167.65 -175.13 2.69 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.631 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.476 HG21 ' N ' ' A' ' 81' ' ' TRP . 20.2 p -149.29 164.38 35.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.803 . . . . 0.0 109.285 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.4 ' HG3' ' NE ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -167.85 162.59 13.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.746 HG12 HG12 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -126.67 176.91 6.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.274 -0.891 . . . . 0.0 109.365 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.53 169.27 37.04 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 202' ' ' ALA . 3.4 m-85 -89.1 161.59 16.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.984 . . . . 0.0 109.99 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.688 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.06 -171.37 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.433 -0.792 . . . . 0.0 109.104 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 54.61 32.1 53.38 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.616 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -139.47 -159.61 8.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.79 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 4.2 p80 -148.77 78.58 1.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.313 -1.11 . . . . 0.0 109.909 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.581 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.86 149.33 21.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.262 -0.898 . . . . 0.0 109.009 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.706 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.1 mmt180 -48.83 -106.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -112.24 83.82 5.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.46 171.18 18.06 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.481 2.121 . . . . 0.0 112.265 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.536 ' OG1' ' HB3' ' A' ' 105' ' ' GLU . 21.2 p -122.27 167.31 13.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.025 -1.047 . . . . 0.0 110.077 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.72 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 2.1 t80 -57.79 -59.33 5.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.586 -0.696 . . . . 0.0 110.144 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -22.06 41.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 108.78 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.556 ' OE2' HD11 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -79.06 -61.46 2.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.653 -0.655 . . . . 0.0 110.596 -179.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.702 HG12 ' OG1' ' A' ' 111' ' ' THR . 15.3 m -52.13 -24.68 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.128 -0.982 . . . . 0.0 110.533 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.2 p -52.97 -45.32 67.72 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.695 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 13.6 t -52.23 -6.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.596 ' H ' ' C ' ' A' ' 107' ' ' CYS . 1.9 tt0 65.13 -6.01 0.38 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.585 -0.697 . . . . 0.0 110.359 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.486 ' C ' HG21 ' A' ' 29' ' ' ILE . 7.2 tttt -60.98 -23.01 65.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.106 -0.996 . . . . 0.0 109.206 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.702 ' OG1' HG12 ' A' ' 106' ' ' VAL . 25.3 p -94.87 -5.63 44.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.281 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 39.41 47.62 2.85 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.688 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 5.6 m-70 -92.26 170.05 10.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.782 -1.422 . . . . 0.0 109.064 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -123.59 116.1 22.57 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.546 ' OE2' ' C ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -53.41 143.4 19.25 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.583 -178.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -151.8 174.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.125 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 1.058 HG22 ' O ' ' A' ' 68' ' ' PHE . 33.9 m -135.32 121.62 32.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.796 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 8.1 ptm180 -96.98 96.9 8.82 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.442 1.115 . . . . 0.0 108.7 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.688 HG11 ' CB ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -103.82 147.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.664 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -114.31 157.25 15.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.664 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 2.8 m-85 -141.89 157.33 45.11 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.243 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.42 ' CD ' ' CG2' ' A' ' 63' ' ' THR . 7.7 mmm180 -109.98 99.55 39.52 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.513 -0.742 . . . . 0.0 109.252 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 125' ' ' HIS . 10.9 Cg_exo -40.32 -67.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.111 2.541 . . . . 0.0 113.906 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -40.94 -12.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.204 -0.935 . . . . 0.0 110.711 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.692 ' N ' ' O ' ' A' ' 123' ' ' PRO . 5.8 m-70 -135.41 6.77 3.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.614 -1.303 . . . . 0.0 109.69 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.582 ' CD1' ' CD ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -156.28 148.31 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.594 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -99.47 151.09 21.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.585 ' CZ ' HD21 ' A' ' 132' ' ' LEU . 41.9 t80 -61.72 -19.88 62.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -61.88 -22.56 65.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 131' ' ' LEU . 3.0 mt-10 -70.15 -70.65 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 110.147 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.025 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.8 OUTLIER -35.19 -50.12 0.51 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.585 HD21 ' CZ ' ' A' ' 128' ' ' PHE . 4.5 mm? -68.05 -54.47 18.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 0.0 111.503 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 137' ' ' GLU . 3.8 tttm -52.04 -57.66 8.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.081 -1.012 . . . . 0.0 111.276 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.555 HG12 ' CZ ' ' A' ' 80' ' ' PHE . 78.8 t -49.83 -33.77 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.132 . . . . 0.0 110.22 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.701 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 23.2 t80 -71.72 -52.33 18.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.831 -1.168 . . . . 0.0 109.923 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.513 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 87.5 m95 -70.42 -32.13 69.6 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.906 -1.121 . . . . 0.0 110.348 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.597 ' O ' ' OG1' ' A' ' 223' ' ' THR . 7.8 tt0 -72.35 -34.83 68.31 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 112.259 -177.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.37 73.72 1.56 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.44 -1.412 . . . . 0.0 112.361 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.701 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 2.0 p-80 178.15 129.59 0.06 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.81 -1.181 . . . . 0.0 110.518 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 221' ' ' GLY . 4.8 m-20 -69.09 111.3 8.08 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.451 ' HB3' ' CE1' ' A' ' 139' ' ' HIS . 66.5 Cg_endo -91.34 5.69 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 0.0 113.081 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.814 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -123.14 46.23 2.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 111.049 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.547 ' C ' ' H ' ' A' ' 145' ' ' MET . 23.5 mt-30 -140.39 67.92 1.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 108.999 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' HG21 ' A' ' 190' ' ' THR . . . -65.08 13.0 0.23 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.591 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -115.08 -20.02 10.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.033 -1.275 . . . . 0.0 109.057 178.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.544 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 176.85 163.94 0.47 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.672 ' NE2' ' O ' ' A' ' 70' ' ' MET . 15.3 mt-30 -141.44 159.66 41.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.551 -1.343 . . . . 0.0 110.191 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 147' ' ' GLN . . . 44.23 -120.55 3.44 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 36.9 t30 -111.05 26.11 11.05 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.34 -0.93 . . . . 0.0 110.542 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.573 ' OD2' ' CD1' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -108.18 91.48 3.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.855 -1.153 . . . . 0.0 109.221 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 146' ' ' ARG . 3.7 m-85 -69.14 118.62 12.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 149.8 168.39 15.04 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.138 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER -94.18 9.41 38.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.416 -1.049 . . . . 0.0 109.154 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.725 ' CD ' ' H ' ' A' ' 154' ' ' GLN . 0.7 OUTLIER -93.25 -1.16 56.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.694 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.682 ' CE2' ' OE1' ' A' ' 154' ' ' GLN . 3.3 m-85 -129.99 57.99 1.67 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.024 -1.048 . . . . 0.0 109.879 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.557 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.6 OUTLIER -91.51 -175.63 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 108.913 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.737 ' OG ' HG23 ' A' ' 190' ' ' THR . 13.1 p -94.08 118.89 32.17 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.479 ' HB1' ' NH1' ' A' ' 194' ' ' ARG . . . -147.06 110.72 4.95 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.501 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 192' ' ' ASP . 8.3 t -98.38 131.28 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.739 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.555 ' CE2' HG11 ' A' ' 116' ' ' VAL . 7.8 m-85 -114.01 120.53 38.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.51 173.72 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.574 2.183 . . . . 0.0 113.038 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -94.62 -19.61 20.31 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.227 -0.921 . . . . 0.0 109.215 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 162' ' ' THR . 0.4 OUTLIER 167.69 -163.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.453 -0.779 . . . . 0.0 109.084 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.68 -15.39 11.65 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.952 1.358 . . . . 0.0 108.743 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.76 -62.7 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.638 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.677 HE22 ' NE2' ' A' ' 64' ' ' GLN . 1.4 mp0 -61.44 -12.06 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.524 -0.735 . . . . 0.0 109.823 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.0 ttm -51.94 -34.09 40.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.913 -1.117 . . . . 0.0 110.533 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.37 -38.67 59.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.829 -1.169 . . . . 0.0 110.388 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.552 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.78 -41.52 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.021 -1.049 . . . . 0.0 110.462 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.91 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 171' ' ' LEU . 1.7 mm? -53.04 -36.81 60.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -74.33 -24.06 59.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.92 . . . . 0.0 109.98 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.552 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.62 -50.11 16.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.937 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -36.26 73.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.015 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.05 -49.95 25.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 110.094 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 17.8 pt-20 -59.27 -43.05 92.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.5 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 1.1 m-85 -79.29 -12.2 59.94 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.998 -1.064 . . . . 0.0 109.61 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 178' ' ' GLN . 6.7 tp60 -74.57 -55.13 6.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.594 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.522 ' O ' ' OG ' ' A' ' 182' ' ' SER . 5.7 ttpm? -73.1 -29.49 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.9 -54.37 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.98 . . . . 0.0 109.853 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.17 -5.35 17.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 179' ' ' LYS . 81.4 p -61.62 -67.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.07 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.452 ' N ' ' OG ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -88.64 13.26 12.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.738 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -94.83 32.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 0.0 109.542 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.756 HD22 ' C ' ' A' ' 185' ' ' ASN . 0.0 OUTLIER 72.87 29.75 1.82 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.669 -0.645 . . . . 0.0 110.324 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.603 ' CD2' ' ND2' ' A' ' 185' ' ' ASN . 7.1 m-85 -137.13 170.9 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.134 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -114.08 -136.76 6.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 189' ' ' ILE . 56.7 Cg_endo -77.45 107.14 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.293 1.995 . . . . 0.0 111.718 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.814 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.05 178.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.737 HG23 ' OG ' ' A' ' 157' ' ' SER . 6.8 t -128.69 -2.27 5.39 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.121 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.601 HG22 HD11 ' A' ' 193' ' ' ILE . 56.8 m -42.91 114.48 0.61 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.659 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 7.0 t0 -87.45 136.34 32.98 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.615 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.601 HD11 HG22 ' A' ' 191' ' ' THR . 4.5 mp -135.53 92.15 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 118.116 -1.434 . . . . 0.0 110.63 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.659 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -134.37 -179.51 5.62 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.583 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 4.3 pt-20 -139.11 -173.04 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.719 -1.238 . . . . 0.0 110.855 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.61 72.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 1.3 mp0 -79.89 128.02 32.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.87 -1.371 . . . . 0.0 109.885 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' A' ' 200' ' ' TYR . 6.7 p -60.55 153.65 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.188 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.619 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 66.7 t80 -117.84 130.29 56.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 109.769 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.706 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 21.0 m-85 -132.29 109.83 10.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.482 -0.761 . . . . 0.0 109.187 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . 0.471 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 20.1 m-85 -53.69 131.32 38.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.03 -1.044 . . . . 0.0 111.116 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -82.8 179.28 7.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.491 ' HB3' HG21 ' A' ' 42' ' ' ILE . 8.5 pm0 -75.08 158.68 32.74 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.486 -0.759 . . . . 0.0 108.96 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.781 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -55.4 -39.66 70.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.952 -1.092 . . . . 0.0 108.145 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.51 ' CE1' ' CE2' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -48.83 -19.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.577 -0.702 . . . . 0.0 110.304 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.72 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 10.5 m-70 -100.78 -17.7 16.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.811 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -106.44 -148.49 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.846 0.832 . . . . 0.0 110.357 -177.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.711 ' CG ' ' NE2' ' A' ' 48' ' ' HIS . 18.5 mp0 -35.53 -9.32 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.269 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.811 ' N ' ' O ' ' A' ' 207' ' ' GLN . 1.3 t80 -43.14 -41.87 3.86 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 120.8 -1.188 . . . . 0.0 110.915 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.796 HD21 ' O ' ' A' ' 74' ' ' TRP . 3.7 pp -79.98 -11.92 59.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.693 -1.603 . . . . 0.0 109.6 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 208' ' ' GLN . 91.7 p -55.8 -43.61 77.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 108.843 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.478 ' HD2' ' NE2' ' A' ' 49' ' ' HIS . 6.8 mtmm -65.49 -18.34 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.636 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.9 m-20 -128.24 71.9 79.68 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.004 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.47 9.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.274 2.649 . . . . 0.0 112.704 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.636 ' H ' ' C ' ' A' ' 213' ' ' ASN . 7.3 p30 -63.2 -18.51 63.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.012 -1.055 . . . . 0.0 110.657 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.73 85.47 0.05 OUTLIER Glycine 0 N--CA 1.498 2.79 0 C-N-CA 119.345 -1.407 . . . . 0.0 111.036 178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.743 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 71.4 t80 -45.11 -177.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.321 2.06 . . . . 0.0 109.778 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.743 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 0.7 OUTLIER -72.99 76.86 1.19 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.98 -1.075 . . . . 0.0 109.339 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.4 149.13 17.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.09 -171.78 4.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -1.101 . . . . 0.0 110.0 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 140' ' ' ASP . . . -142.5 -126.99 2.14 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.483 ' O ' ' OG1' ' A' ' 223' ' ' THR . . . -176.8 -134.94 2.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.664 ' CG2' ' H ' ' A' ' 139' ' ' HIS . 10.5 p . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.428 -1.043 . . . . 0.0 109.398 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 28' ' ' VAL . 32.1 t . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.92 133.05 21.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.262 1.03 . . . . 0.0 113.544 -175.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.12 125.41 26.7 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.638 ' HB2' ' CE1' ' A' ' 97' ' ' HIS . . . -48.13 -43.19 30.93 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.654 -0.654 . . . . 0.0 109.433 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -73.34 4.32 4.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' ALA . 15.7 tt0 -111.55 -1.97 15.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -49.66 -168.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 0.0 109.686 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.563 HD13 ' OE1' ' A' ' 105' ' ' GLU . 86.9 mt . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' ILE . 54.2 Cg_exo -48.46 -168.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.719 2.279 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.705 HG12 ' N ' ' A' ' 204' ' ' ASP . 26.9 m -136.05 -161.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 45' ' ' THR . 11.8 t -72.75 99.47 2.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -56.19 -49.07 75.09 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.145 -0.972 . . . . 0.0 111.277 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.554 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 mttm -75.35 99.51 4.14 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 115.84 -2.344 . . . . 0.0 108.682 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.7 t-80 -33.03 113.38 0.14 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.477 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.1 t-80 -61.3 -30.86 70.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.365 -0.834 . . . . 0.0 110.83 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.004 HG22 ' OG ' ' A' ' 211' ' ' SER . 26.1 t -65.17 -45.4 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.898 -1.126 . . . . 0.0 109.521 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.03 -45.86 4.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.906 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.53 2.74 47.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.7 p30 -79.33 -116.32 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.1 ttp180 -130.5 170.83 13.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 123.23 1.491 . . . . 0.0 109.057 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.733 ' O ' HG13 ' A' ' 56' ' ' VAL . 21.6 p -134.14 26.84 3.87 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.747 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 55' ' ' THR . 2.9 m -163.48 138.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.796 . . . . 0.0 109.695 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 2.3 pm0 -33.01 152.3 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.311 -0.868 . . . . 0.0 110.642 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 96.5 Cg_endo -79.28 166.16 79.17 Favored 'Cis proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.7 -0.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -104.02 149.1 36.87 Favored Pre-proline 0 C--N 1.268 -2.965 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 9.6 Cg_endo -54.83 119.47 6.53 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.637 2.225 . . . . 0.0 112.089 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' PRO . 25.1 mt-10 -43.35 117.91 1.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.18 23.94 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -132.93 137.02 46.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.884 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.415 ' OE1' ' SD ' ' A' ' 65' ' ' MET . 5.6 mm-40 -104.93 -176.89 3.21 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.761 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -145.11 128.21 16.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.88 -1.138 . . . . 0.0 110.433 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.57 -170.74 2.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.87 146.04 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.146 -1.596 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.739 ' O ' HG22 ' A' ' 117' ' ' VAL . 70.5 m-85 -140.84 126.84 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.671 -1.268 . . . . 0.0 109.961 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.38 107.06 2.76 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.869 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.74 -89.14 0.5 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.515 -0.991 . . . . 0.0 109.715 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.716 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -147.89 167.47 28.81 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.716 ' C ' ' O ' ' A' ' 71' ' ' GLY . 2.1 t -5.82 115.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 117.651 0.725 . . . . 0.0 109.818 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.68 ' HD1' ' HD1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.52 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.22 -0.925 . . . . 0.0 110.764 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.877 ' O ' HD11 ' A' ' 210' ' ' LEU . 0.2 OUTLIER -89.77 -55.61 3.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.752 -1.217 . . . . 0.0 109.153 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 217' ' ' TYR . . . -105.22 2.75 40.41 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.869 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . -76.75 -39.93 50.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.288 . . . . 0.0 110.525 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.671 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 4.6 tt0 -82.65 -14.34 54.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.965 -1.085 . . . . 0.0 110.806 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 20.5 ttt180 -57.91 -72.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.894 -1.129 . . . . 0.0 110.207 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.458 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 12.1 mmtt -44.11 -5.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.748 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 46.7 m-85 -94.43 -41.34 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.734 -1.229 . . . . 0.0 110.978 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -84.99 -0.68 55.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.672 -1.267 . . . . 0.0 110.646 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.17 19.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.977 -1.077 . . . . 0.0 110.051 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -119.73 157.24 28.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.245 -0.91 . . . . 0.0 109.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -93.25 141.59 28.26 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.839 -0.538 . . . . 0.0 109.549 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.04 -29.09 8.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.9 138.61 20.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.468 -1.019 . . . . 0.0 109.865 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.673 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.53 -44.62 28.04 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 89' ' ' THR . 1.1 p -168.17 -162.97 0.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.488 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 88' ' ' SER . 14.1 p -163.82 160.0 21.82 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.394 -0.816 . . . . 0.0 109.126 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.671 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -164.87 171.15 14.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.119 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.66 HG21 ' O ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -141.88 171.84 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 171.39 -175.95 44.78 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' TYR . 2.0 m-85 -96.17 164.88 12.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -1.044 . . . . 0.0 109.614 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -179.31 147.13 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.96 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 88.86 29.02 19.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.752 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -112.18 -156.72 13.26 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.638 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -138.98 54.1 1.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -1.173 . . . . 0.0 109.892 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.731 ' CG2' ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.5 177.15 11.74 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.043 . . . . 0.0 108.262 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.801 ' CD ' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -72.98 -86.64 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.384 -0.822 . . . . 0.0 109.851 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.79 ' H ' ' HE ' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -122.79 79.91 49.11 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.869 -1.144 . . . . 0.0 110.051 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HG2' ' CD2' ' A' ' 113' ' ' HIS . 11.4 Cg_exo -67.38 169.28 15.86 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.743 2.295 . . . . 0.0 111.675 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.625 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 16.4 p -117.56 171.11 8.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 109.852 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.618 ' C ' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -63.47 -58.89 5.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 0.0 110.354 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.601 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -59.22 -22.46 61.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.919 -1.113 . . . . 0.0 108.254 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.625 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.8 mm-40 -72.89 -60.67 2.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.394 0.616 . . . . 0.0 110.977 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 102' ' ' THR . 11.4 m -56.56 -24.66 19.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.402 -0.811 . . . . 0.0 110.997 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.459 ' C ' ' H ' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -49.81 -33.85 17.86 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.253 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 110' ' ' LYS . 1.4 t -63.52 0.12 0.8 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.198 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.459 ' H ' ' C ' ' A' ' 107' ' ' CYS . 0.8 OUTLIER 63.97 -21.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.251 -0.906 . . . . 0.0 109.87 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.629 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 tttt -57.82 -10.66 1.79 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.278 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.532 ' CB ' HG12 ' A' ' 106' ' ' VAL . 41.3 p -94.08 -38.67 11.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.96 -1.087 . . . . 0.0 110.515 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 72.63 21.2 79.72 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -75.17 161.32 29.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.112 -1.228 . . . . 0.0 110.315 -179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -124.8 113.32 17.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' GLN . 1.9 pp20? -57.26 119.43 6.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.724 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -127.14 170.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.244 -0.91 . . . . 0.0 109.965 179.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 68' ' ' PHE . 6.1 m -130.36 125.46 59.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HG3' ' CE1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -96.89 114.49 26.12 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.683 ' O ' HG23 ' A' ' 119' ' ' VAL . 34.9 m -131.78 109.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -75.66 176.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.904 ' CG ' HD21 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -159.94 152.8 21.51 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.38 -1.328 . . . . 0.0 110.391 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 0.485 HH21 ' CG ' ' A' ' 125' ' ' HIS . 1.9 mtp180 -108.7 102.12 46.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.804 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 126' ' ' ILE . 18.3 Cg_exo -41.88 -68.04 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.114 2.542 . . . . 0.0 113.942 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 123' ' ' PRO . 13.3 tt0 -37.97 -33.37 0.08 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.165 -0.96 . . . . 0.0 111.277 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.485 ' CG ' HH21 ' A' ' 122' ' ' ARG . 32.2 m80 -108.39 -0.2 20.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.704 -1.248 . . . . 0.0 109.537 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -155.84 165.55 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.188 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 126' ' ' ILE . 1.4 m -114.03 170.07 8.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.817 -1.177 . . . . 0.0 111.218 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 131' ' ' LEU . 37.5 t80 -69.23 -24.75 64.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.579 -0.701 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.86 -13.02 60.27 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.587 ' HG2' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -75.62 -45.55 36.78 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -77.13 -27.62 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 119.964 -1.71 . . . . 0.0 108.296 178.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.452 HD22 ' CZ ' ' A' ' 68' ' ' PHE . 1.1 mm? -72.62 -57.46 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 110.12 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -52.55 -45.0 66.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 13.3 t -50.1 -37.17 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 0.0 109.29 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.807 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 28.1 t80 -71.44 -47.29 56.74 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.925 -1.109 . . . . 0.0 110.653 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 83.4 m95 -72.18 -14.37 61.79 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.568 -1.332 . . . . 0.0 110.877 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.62 -17.25 19.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.865 -1.147 . . . . 0.0 113.15 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.6 p30 -133.33 63.13 1.64 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 119.983 -1.698 . . . . 0.0 112.861 -177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.807 ' NE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 p-80 173.17 177.93 0.1 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.615 1.197 . . . . 0.0 110.643 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.631 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -111.56 90.16 11.99 Favored Pre-proline 0 C--N 1.286 -2.154 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.289 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 190' ' ' THR . 33.9 Cg_endo -74.39 -17.39 21.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.501 2.134 . . . . 0.0 112.535 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 190' ' ' THR . 0.3 OUTLIER -89.3 29.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.8 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.631 ' NE2' ' CG ' ' A' ' 140' ' ' ASP . 30.9 mt-30 -129.96 82.64 2.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -37.7 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.496 2.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.28 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 145' ' ' MET . 1.8 ppp? -67.25 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -1.142 . . . . 0.0 110.876 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.594 ' O ' ' O ' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -152.6 160.43 43.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.057 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.585 ' OE1' ' O ' ' A' ' 146' ' ' ARG . 14.3 mm100 -153.38 96.52 2.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.413 -1.429 . . . . 0.0 109.044 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.86 -113.94 2.82 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.56 ' H ' HD11 ' A' ' 220' ' ' LEU . 1.8 m-20 -79.29 -32.41 43.54 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.361 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.493 ' HB3' ' CD1' ' A' ' 155' ' ' TYR . 3.6 m-20 -82.63 130.38 35.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.217 -1.552 . . . . 0.0 109.123 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 p90 -128.89 145.62 51.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 0.0 110.028 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 140.41 -165.29 26.1 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -22.43 22.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.447 -1.031 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.596 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 8.7 pm0 -91.83 -5.39 53.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.109 -0.994 . . . . 0.0 108.9 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 103' ' ' TYR . 47.6 m-85 -113.01 61.89 0.64 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.546 HH11 ' CA ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -124.03 168.59 12.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 67.5 p -92.05 141.62 28.41 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.47 ' HA ' ' N ' ' A' ' 192' ' ' ASP . . . -168.17 111.31 0.6 Allowed 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 116.981 -1.888 . . . . 0.0 111.512 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.786 HG23 ' CG2' ' A' ' 191' ' ' THR . 60.2 t -92.41 143.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.051 -1.059 . . . . 0.0 109.18 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -136.14 107.85 9.6 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.05 173.82 12.96 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.556 2.171 . . . . 0.0 112.289 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.6 OUTLIER -89.97 -19.66 24.22 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.184 -0.948 . . . . 0.0 109.009 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.607 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER 167.33 -173.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.329 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.607 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -47.75 -15.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.978 1.371 . . . . 0.0 108.588 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.59 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.7 t -55.17 -65.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.156 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 20.2 mt-30 -78.63 -24.74 45.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.8 ttp -53.51 -41.96 66.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.994 -1.066 . . . . 0.0 110.497 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.26 8.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 110.221 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.07 -36.88 34.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.85 -51.83 59.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . 0.495 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -52.74 -34.96 55.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.942 . . . . 0.0 109.562 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -34.34 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.425 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -75.41 -36.82 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -67.53 -57.04 7.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.9 . . . . 0.0 110.048 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.91 2.68 6.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -75.87 -52.35 10.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 109.847 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 4.0 m-85 -79.47 -7.46 58.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.502 ' CD ' ' C ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -70.69 -53.92 13.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 179' ' ' LYS . 23.4 tttm -73.22 -15.41 61.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.432 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 176' ' ' GLU . 44.9 t -82.28 -55.5 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 110.274 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 181' ' ' LEU . 4.4 mt -76.37 -27.26 56.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.996 -1.065 . . . . 0.0 109.983 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.4 p -55.99 -14.0 2.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 109.551 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -88.27 -1.04 57.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.446 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 37.3 m-70 -108.26 4.28 24.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.754 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.77 8.42 6.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.441 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.36 164.43 19.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 108.868 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.794 ' N ' ' CD ' ' A' ' 188' ' ' PRO . . . 92.7 24.64 22.86 Favored Glycine 0 C--N 1.302 -1.324 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.794 ' CD ' ' N ' ' A' ' 187' ' ' GLY . 27.7 Cg_endo -66.06 104.67 0.74 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.64 -1.331 . . . . 0.0 108.64 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.638 ' O ' HD12 ' A' ' 189' ' ' ILE . 1.7 pp -47.01 143.86 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 123.019 1.39 . . . . 0.0 111.386 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 141' ' ' PRO . 69.5 p -121.54 4.75 10.13 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.005 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.786 ' CG2' HG23 ' A' ' 159' ' ' VAL . 72.4 m -42.79 115.45 0.73 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 159' ' ' VAL . 4.0 t0 -75.43 125.13 28.39 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.51 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.21 110.52 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.654 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.524 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 64.8 mtm-85 -146.24 -170.56 3.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.775 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.531 ' HA ' HE22 ' A' ' 197' ' ' GLN . 27.6 mt-10 -142.84 166.55 24.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.685 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.47 70.19 1.35 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.531 HE22 ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -139.16 146.9 41.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.909 -1.348 . . . . 0.0 109.708 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.636 HG23 ' N ' ' A' ' 199' ' ' PHE . 0.7 OUTLIER -98.32 -176.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.087 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.636 ' N ' HG23 ' A' ' 198' ' ' VAL . 46.8 t80 -125.35 130.7 52.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -1.0 . . . . 0.0 109.894 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.702 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 19.9 m-85 -126.67 100.19 6.1 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.331 -0.856 . . . . 0.0 109.212 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.27 136.38 43.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.922 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.462 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -87.69 -169.67 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.7 pt-20 -75.18 167.81 21.2 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 108.915 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.705 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.27 -48.82 80.19 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.987 -1.071 . . . . 0.0 108.692 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.49 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.44 -22.65 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.68 ' HD1' ' HD1' ' A' ' 73' ' ' PHE . 11.8 m-70 -94.0 13.16 23.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.989 -1.069 . . . . 0.0 110.537 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.6 mm-40 -130.32 -141.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.694 1.235 . . . . 0.0 110.899 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.664 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.03 -2.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.51 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 28.6 t80 -38.41 -42.8 0.77 Allowed 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.595 -1.315 . . . . 0.0 110.496 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 74' ' ' TRP . 9.5 mt -70.47 -25.05 63.0 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.316 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 1.004 ' OG ' HG22 ' A' ' 50' ' ' VAL . 8.0 t -73.47 -40.5 64.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.077 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.477 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 2.0 mtmm -88.25 -38.05 15.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.318 -0.864 . . . . 0.0 110.034 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 215' ' ' ASP . 1.2 m-80 -101.03 107.65 50.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.14 6.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.766 2.31 . . . . 0.0 113.05 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 213' ' ' ASN . 1.9 t70 -63.14 -16.71 60.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.735 -1.228 . . . . 0.0 109.851 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.84 ' O ' HD22 ' A' ' 210' ' ' LEU . . . 65.59 -68.45 0.11 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.788 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 53.2 t80 171.94 -175.87 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -1.111 . . . . 0.0 109.256 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.788 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 4.5 m -93.08 -125.65 0.1 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.152 -0.968 . . . . 0.0 109.004 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.629 ' O ' ' CG ' ' A' ' 220' ' ' LEU . . . -127.19 148.0 17.21 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.629 ' CG ' ' O ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER 146.92 160.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.47 116.87 1.22 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 139' ' ' HIS . . . 158.03 131.86 1.35 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.434 ' OG1' ' CD ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.501 -1.0 . . . . 0.0 110.028 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.534 ' O ' HG12 ' A' ' 28' ' ' VAL . 47.9 t . . . . . 0 N--CA 1.485 1.305 0 N-CA-C 105.382 -2.081 . . . . 0.0 105.382 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.65 132.07 19.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.765 -175.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.19 124.72 25.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.762 0.791 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -56.06 -22.75 29.43 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.616 -0.678 . . . . 0.0 109.758 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -83.87 -0.76 52.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.559 ' O ' ' NZ ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -112.65 -4.62 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.68 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . . . -61.66 -171.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.808 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.5 mm? . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.633 ' O ' ' CG1' ' A' ' 42' ' ' ILE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.22 175.24 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.908 2.406 . . . . 0.0 112.558 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 204' ' ' ASP . 16.2 m -138.87 -174.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.668 ' OG1' ' NE2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -59.9 97.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 109.513 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -55.99 -49.19 74.31 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.261 -0.899 . . . . 0.0 111.426 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.534 ' O ' ' C ' ' A' ' 48' ' ' HIS . 20.3 mttm -71.03 99.91 1.9 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.906 -2.317 . . . . 0.0 108.241 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.67 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 5.0 t-80 -33.45 101.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.788 ' N ' ' ND1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -53.24 -12.34 0.38 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.341 -0.849 . . . . 0.0 112.077 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 88.2 t -82.49 -50.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.455 -1.403 . . . . 0.0 108.482 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -99.56 -40.41 7.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.523 -0.736 . . . . 0.0 109.768 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.04 2.42 51.76 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 30.2 p30 -77.83 -120.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.715 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 ttm-85 -131.76 167.87 18.78 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 123.286 1.517 . . . . 0.0 109.481 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.886 ' O ' HG13 ' A' ' 56' ' ' VAL . 66.7 p -134.77 34.34 3.17 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.071 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 55' ' ' THR . 2.0 m -168.82 147.21 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 109.49 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 7.6 pt-20 -33.73 145.25 0.15 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 110.057 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.19 161.52 84.8 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.741 -1.774 . . . . 0.0 110.363 0.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 70.8 m-85 -102.37 151.57 38.18 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 59' ' ' PHE . 51.9 Cg_exo -47.6 -178.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.26 1.973 . . . . 0.0 111.983 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.634 ' O ' ' NE ' ' A' ' 122' ' ' ARG . 88.7 mt-10 -79.23 133.73 36.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.68 ' O ' ' NE ' ' A' ' 122' ' ' ARG . . . 49.88 72.01 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.591 ' O ' ' SD ' ' A' ' 65' ' ' MET . 0.8 OUTLIER -90.97 134.36 34.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -1.208 . . . . 0.0 110.105 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.802 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.5 tp60 -97.94 120.41 38.29 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.759 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -133.72 158.59 42.89 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.908 -177.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.63 -166.02 2.38 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG11 ' HD2' ' A' ' 160' ' ' TYR . 44.5 t -140.82 115.63 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.084 -1.635 . . . . 0.0 108.595 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 132' ' ' LEU . 72.9 m-85 -111.6 148.66 32.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 110.489 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.79 99.31 0.61 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 2.1 ttt -98.08 -91.07 0.27 Allowed 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.648 -0.913 . . . . 0.0 109.179 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.667 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.4 -149.53 5.99 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.74 ' SG ' ' O ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -35.12 104.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.038 . . . . 0.0 108.368 179.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CZ ' ' CD ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -54.97 7.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.842 -1.161 . . . . 0.0 111.426 -177.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.967 ' O ' HD21 ' A' ' 210' ' ' LEU . 5.9 m0 -74.38 -40.41 62.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.568 -1.332 . . . . 0.0 108.694 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.6 -14.29 25.84 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.814 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.693 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -66.31 -53.5 35.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.668 -1.49 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.635 ' OE2' ' NE2' ' A' ' 208' ' ' GLN . 1.3 tm-20 -82.64 -14.63 54.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.929 . . . . 0.0 110.77 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.476 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -58.02 -68.12 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.787 -1.196 . . . . 0.0 109.653 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 82' ' ' VAL . 49.5 mttt -53.36 -5.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.157 -0.965 . . . . 0.0 110.511 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.693 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 11.3 m-85 -90.82 -42.02 10.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.784 -1.197 . . . . 0.0 110.196 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -68.84 -4.79 17.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.712 -1.242 . . . . 0.0 109.323 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 79' ' ' LYS . 2.5 m -97.39 6.74 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.44 HD13 HD11 ' A' ' 126' ' ' ILE . 31.3 mt -85.12 142.41 29.53 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.244 1.021 . . . . 0.0 108.999 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -79.77 131.64 35.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.078 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . 0.499 ' C ' ' HG3' ' A' ' 123' ' ' PRO . . . 101.36 -29.19 13.05 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.9 132.97 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.225 -1.162 . . . . 0.0 110.231 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.702 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -79.93 -53.67 6.53 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.516 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 2.3 p -151.73 -176.26 5.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 109.347 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.67 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 82.4 p -157.49 128.6 6.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.38 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.576 ' CD ' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.2 153.03 49.88 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.664 HG23 ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.94 175.54 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 108.903 179.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 167.88 177.59 39.29 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.022 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.634 ' N ' ' O ' ' A' ' 200' ' ' TYR . 28.0 m-85 -82.28 166.45 19.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.965 . . . . 0.0 109.395 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.681 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -177.41 -179.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 109.765 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.17 27.37 10.73 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -123.35 -176.82 14.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -135.63 78.16 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.101 . . . . 0.0 109.837 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.4 m -157.07 142.67 17.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 109.196 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -54.06 -84.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.854 . . . . 0.0 109.576 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.481 ' ND2' ' HG2' ' A' ' 99' ' ' ARG . 55.9 m-80 -118.86 82.69 21.24 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HB2' HG13 ' A' ' 106' ' ' VAL . 72.0 Cg_endo -79.71 161.83 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.847 2.365 . . . . 0.0 112.105 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 106' ' ' VAL . 21.7 p -121.33 169.93 10.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.164 -0.96 . . . . 0.0 109.803 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.47 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 7.8 t80 -56.26 -58.84 6.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -27.05 65.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 109.02 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 102' ' ' THR . 2.0 mt-10 -75.4 -53.27 8.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.726 -0.609 . . . . 0.0 111.159 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 102' ' ' THR . 12.7 m -61.24 -24.3 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.621 ' C ' ' H ' ' A' ' 109' ' ' GLU . 90.7 m -64.65 -38.31 90.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 109.382 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 110' ' ' LYS . 89.3 p -53.8 -0.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.316 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 107' ' ' CYS . 28.8 mt-10 64.89 -5.27 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.559 ' NZ ' ' O ' ' A' ' 33' ' ' GLU . 1.5 mmpt? -66.97 -32.76 74.23 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.178 -0.951 . . . . 0.0 109.67 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.57 ' OG1' HG12 ' A' ' 106' ' ' VAL . 3.7 p -93.51 -0.34 56.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 109.764 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 34.25 55.6 0.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.681 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 1.5 m-70 -93.35 174.54 7.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.907 -1.349 . . . . 0.0 108.813 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.769 ' CB ' HH12 ' A' ' 156' ' ' ARG . . . -129.72 114.97 16.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.66 ' CD ' ' CZ ' ' A' ' 73' ' ' PHE . 3.8 mt-10 -56.44 105.83 0.24 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 94' ' ' ALA . 4.4 m -124.68 159.03 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.134 -0.979 . . . . 0.0 110.499 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.585 ' CG2' ' O ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -116.49 122.53 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.645 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.09 97.12 9.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.811 HG21 HD23 ' A' ' 131' ' ' LEU . 1.7 m -100.93 129.4 51.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.78 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.533 HG23 ' OE1' ' A' ' 90' ' ' GLN . 55.1 t -94.79 126.27 47.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.802 ' O ' ' N ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -157.18 142.05 16.89 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.535 -1.266 . . . . 0.0 111.725 -178.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . 1.033 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -165.67 17.15 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 123.612 0.765 . . . . 0.0 110.294 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 1.033 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 7.1 Cg_endo -50.88 -15.68 1.97 Allowed 'Trans proline' 0 C--N 1.294 -2.292 0 C-N-CA 124.189 3.259 . . . . 0.0 115.79 -176.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 1.7 tm-20 70.54 -6.62 1.17 Allowed 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.703 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -111.7 -12.98 13.81 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.33 1.062 . . . . 0.0 108.329 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -152.8 118.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -129.76 -175.4 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.526 -1.359 . . . . 0.0 112.559 -177.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.563 ' C ' ' CD1' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -48.28 -46.54 36.04 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.673 ' O ' ' CD2' ' A' ' 132' ' ' LEU . 6.0 pt-20 -59.66 -26.57 65.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.502 ' CB ' HD13 ' A' ' 126' ' ' ILE . 9.0 mm-40 -75.31 -66.25 0.79 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.304 -0.872 . . . . 0.0 111.558 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.811 HD23 HG21 ' A' ' 119' ' ' VAL . 9.8 mp -57.41 -23.75 51.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.838 -1.164 . . . . 0.0 113.873 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -75.73 -17.9 59.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 119.843 -1.785 . . . . 0.0 109.556 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.478 ' N ' HD23 ' A' ' 132' ' ' LEU . 7.6 mptt -70.44 -54.54 11.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.697 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 6.6 t -49.66 -40.29 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.349 -0.844 . . . . 0.0 109.046 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.631 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 21.2 t80 -61.08 -41.99 97.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.793 -1.192 . . . . 0.0 110.63 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.71 ' CZ2' ' CA ' ' A' ' 173' ' ' SER . 45.4 m0 -71.51 -50.47 31.04 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.75 -1.219 . . . . 0.0 111.735 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.02 -57.46 12.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 111.73 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.6 OUTLIER -83.3 54.23 2.74 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 112.113 -177.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.764 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 20.7 m80 -161.11 176.91 10.81 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.75 ' CG ' HE21 ' A' ' 143' ' ' GLN . 0.3 OUTLIER -129.16 70.22 81.54 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 190' ' ' THR . 80.4 Cg_exo -39.39 -0.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.427 2.752 . . . . 0.0 113.627 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -105.88 22.7 15.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.671 -1.268 . . . . 0.0 110.814 -179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.75 HE21 ' CG ' ' A' ' 140' ' ' ASP . 33.4 mt-30 -134.04 78.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 156' ' ' ARG . . . -75.47 12.66 7.34 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.159 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.642 ' O ' ' O ' ' A' ' 152' ' ' GLY . 2.2 ptt? -118.0 -21.82 8.13 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.305 . . . . 0.0 109.911 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.548 ' CD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -152.31 168.88 23.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 111.053 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.58 ' OE1' ' O ' ' A' ' 155' ' ' TYR . 5.2 mm100 -120.21 58.77 0.91 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.08 -113.84 3.73 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.823 ' H ' HD11 ' A' ' 220' ' ' LEU . 12.6 t-20 -81.21 11.41 4.28 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 114.771 -0.715 . . . . 0.0 110.874 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.489 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -107.3 87.81 2.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.769 -1.207 . . . . 0.0 109.146 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.453 ' HA ' ' CG ' ' A' ' 146' ' ' ARG . 3.4 m-85 -65.49 115.87 6.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.411 -0.805 . . . . 0.0 110.674 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 166.62 150.78 6.52 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 117.687 -2.197 . . . . 0.0 111.777 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 5.1 p -74.26 -20.23 60.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.701 -0.882 . . . . 0.0 109.325 179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.737 ' CD ' ' H ' ' A' ' 154' ' ' GLN . 7.3 pm0 -87.15 -6.69 58.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.58 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 26.4 m-85 -97.11 57.27 1.46 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.769 HH12 ' CB ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -117.63 165.72 13.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.725 -0.61 . . . . 0.0 109.66 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.85 106.03 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -125.21 124.09 40.97 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.06 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.725 HG23 ' CG2' ' A' ' 191' ' ' THR . 10.6 t -113.48 123.27 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.3 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 0.517 ' CG ' ' NE2' ' A' ' 197' ' ' GLN . 3.9 m-30 -118.51 121.53 30.87 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.73 166.25 23.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.462 2.108 . . . . 0.0 112.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.87 1.82 27.14 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 120.796 -1.19 . . . . 0.0 108.793 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER 167.76 170.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 0.0 108.862 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.62 -15.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.04 1.4 . . . . 0.0 108.361 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.5 t -56.05 -64.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . 0.496 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 33.8 mt-30 -78.94 -18.39 53.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.719 -0.613 . . . . 0.0 110.9 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 14.3 ttm -53.16 -46.85 69.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.24 -16.93 60.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 0.0 109.617 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.77 -57.29 2.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.838 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 172' ' ' ARG . . . -52.13 -43.52 64.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.135 -0.978 . . . . 0.0 109.457 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -11.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.246 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 170' ' ' ALA . 75.9 mtt180 -74.78 -39.52 61.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.335 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.71 ' CA ' ' CZ2' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -54.48 -33.1 59.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.56 -57.44 4.15 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 113.199 -1.819 . . . . 0.0 110.21 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.17 -52.48 12.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 0.0 111.894 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -55.19 -50.64 68.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.921 -1.112 . . . . 0.0 110.742 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.477 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 0.1 OUTLIER -70.99 -13.74 62.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.157 . . . . 0.0 109.907 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.57 ' O ' ' OG ' ' A' ' 182' ' ' SER . 22.0 tp60 -75.01 -48.31 24.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 109.757 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -19.17 55.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . 0.563 ' O ' ' CD2' ' A' ' 184' ' ' HIS . 92.7 t -87.23 -52.64 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 181' ' ' LEU . 4.0 mm? -71.95 -44.53 63.43 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.116 -0.99 . . . . 0.0 109.586 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 86.3 p -55.79 -26.59 46.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.016 . . . . 0.0 109.002 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.06 -27.93 21.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.108 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 180' ' ' VAL . 12.5 m170 -80.78 15.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.875 . . . . 0.0 109.388 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.3 OUTLIER 72.37 48.93 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.937 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.4 ' CG ' HD12 ' A' ' 181' ' ' LEU . 0.4 OUTLIER -114.25 -176.72 2.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.0 108.933 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -104.21 -168.94 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.3 Cg_exo -58.81 116.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.519 2.146 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.477 ' C ' HG23 ' A' ' 190' ' ' THR . 0.3 OUTLIER -48.01 176.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 110.145 -179.306 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.681 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 71.2 p -156.98 76.23 0.85 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.597 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . 0.725 ' CG2' HG23 ' A' ' 159' ' ' VAL . 8.1 m -101.53 122.83 44.54 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.65 ' CG ' HH21 ' A' ' 194' ' ' ARG . 2.1 t0 -81.11 115.98 20.81 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.951 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.69 128.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.386 -0.821 . . . . 0.0 109.396 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.65 HH21 ' CG ' ' A' ' 192' ' ' ASP . 4.7 ptt180 -165.36 173.03 11.58 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.646 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -120.49 -178.66 3.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.909 -1.119 . . . . 0.0 110.431 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 54.89 35.87 59.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.573 ' O ' ' O ' ' A' ' 198' ' ' VAL . 1.8 mp0 -84.11 80.44 9.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.866 -1.373 . . . . 0.0 109.243 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 197' ' ' GLN . 9.8 p -33.31 156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 110.198 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.525 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 65.0 t80 -117.95 138.77 51.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 109.054 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 1.7 m-85 -140.34 113.94 8.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.096 -1.003 . . . . 0.0 109.819 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.66 142.99 21.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -91.26 -168.1 1.97 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.444 -0.785 . . . . 0.0 109.104 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.58 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 2.9 mt-10 -73.38 163.85 27.49 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-O 122.469 1.128 . . . . 0.0 110.372 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.71 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -54.67 -44.26 73.17 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -70.63 4.17 2.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.304 -0.873 . . . . 0.0 110.576 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.499 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 9.4 m-70 -102.99 14.75 31.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.0 OUTLIER -135.74 -150.08 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.971 -1.081 . . . . 0.0 110.178 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.76 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -36.55 -7.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.138 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 2.2 t80 -43.9 -47.09 8.31 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 120.762 -1.211 . . . . 0.0 111.361 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.967 HD21 ' O ' ' A' ' 74' ' ' TRP . 3.6 pp -82.64 -12.26 57.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.0 -1.687 . . . . 0.0 109.947 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.493 ' OG ' HG22 ' A' ' 50' ' ' VAL . 37.3 t -55.83 -50.86 69.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.496 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.498 ' HE2' HD21 ' A' ' 213' ' ' ASN . 1.2 pttm -70.19 4.9 1.91 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 215' ' ' ASP . 75.9 m-20 -142.52 68.01 20.13 Favored Pre-proline 0 N--CA 1.487 1.413 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -48.53 11.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.571 2.848 . . . . 0.0 112.702 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 213' ' ' ASN . 33.9 t70 -61.88 -20.29 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.664 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 60.69 86.15 0.04 OUTLIER Glycine 0 CA--C 1.552 2.371 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.17 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.664 ' O ' ' O ' ' A' ' 216' ' ' GLY . 39.1 t80 -52.11 -150.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 120.538 2.169 . . . . 0.0 109.308 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 49.4 m -71.75 -124.28 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.002 -1.686 . . . . 0.0 109.419 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . 58.72 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.823 HD11 ' H ' ' A' ' 149' ' ' ASN . 0.4 OUTLIER -109.06 -155.74 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.212 . . . . 0.0 109.978 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 138' ' ' ASN . . . -118.73 -73.99 0.44 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . -175.02 134.05 2.63 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.471 -1.017 . . . . 0.0 109.631 179.956 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 28' ' ' VAL . 40.0 t . . . . . 0 N--CA 1.482 1.154 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -64.37 128.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 122.256 1.027 . . . . 0.0 113.128 -175.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.05 124.27 30.91 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.908 0.861 . . . . 0.0 110.126 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' CB ' ' NE2' ' A' ' 97' ' ' HIS . . . -49.05 -26.41 2.61 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.14 -22.77 62.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.115 -0.991 . . . . 0.0 110.251 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -116.69 6.95 13.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.2 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -83.17 -165.06 0.98 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.491 -179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.819 ' CB ' HG23 ' A' ' 98' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.487 1.396 0 O-C-N 121.093 -1.004 . . . . 0.0 108.913 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 N--CA 1.491 1.616 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.93 172.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.803 2.335 . . . . 0.0 112.231 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 17.2 m -151.64 -178.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.49 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.246 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.907 ' O ' HG23 ' A' ' 55' ' ' THR . . . -56.07 -40.61 73.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.482 -0.761 . . . . 0.0 111.052 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttt -74.04 99.23 3.26 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 115.877 -2.329 . . . . 0.0 108.055 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.918 ' CE1' ' HG1' ' A' ' 89' ' ' THR . 4.4 t-80 -34.11 114.07 0.19 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' HIS . . . . . 0.634 ' CG ' ' CE ' ' A' ' 212' ' ' LYS . 63.7 t60 -63.05 -31.81 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.657 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.563 HG23 ' HG3' ' A' ' 208' ' ' GLN . 5.3 t -66.71 -38.33 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.936 -1.103 . . . . 0.0 109.484 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -111.08 -44.28 3.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.91 -0.1 51.84 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.74 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 31.9 p30 -77.22 -121.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.74 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.6 ttt180 -131.15 166.88 20.13 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.056 1.408 . . . . 0.0 108.68 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 46' ' ' ALA . 30.5 p -129.03 34.35 4.46 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' ' 55' ' ' THR . 0.2 OUTLIER -172.63 149.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.037 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -31.63 139.37 0.19 Allowed Pre-proline 0 C--N 1.299 -1.603 0 CA-C-O 121.266 0.555 . . . . 0.0 110.152 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.36 167.26 79.86 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.479 -1.884 . . . . 0.0 111.783 0.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.43 147.3 35.76 Favored Pre-proline 0 C--N 1.271 -2.837 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.34 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 63' ' ' THR . 51.5 Cg_exo -49.39 120.64 5.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.593 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' PRO . 20.3 mm-40 -42.73 118.3 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.799 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 123' ' ' PRO . . . 92.5 44.51 3.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -121.11 142.56 49.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.799 -1.412 . . . . 0.0 110.093 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 65' ' ' MET . 2.2 tm0? -108.53 143.93 36.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.75 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.8 103.86 5.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.905 -1.122 . . . . 0.0 110.163 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.08 -169.36 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 2.2 t -143.62 144.2 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 119.913 -1.742 . . . . 0.0 109.218 179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.495 ' O ' HG12 ' A' ' 116' ' ' VAL . 22.1 m-85 -135.79 143.71 45.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.431 178.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.8 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -134.82 90.34 0.24 Allowed Glycine 0 N--CA 1.482 1.761 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.174 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' MET . . . . . 0.918 ' SD ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.93 -74.53 0.61 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -163.59 -156.09 8.53 Favored Glycine 0 C--N 1.3 -1.444 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' CYS . . . . . 0.632 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -23.36 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 122.144 -0.621 . . . . 0.0 109.763 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -53.77 7.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.313 -0.867 . . . . 0.0 111.178 -178.497 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' TRP . . . . . 0.603 ' H ' ' C ' ' A' ' 72' ' ' CYS . 35.9 m0 -68.98 -44.56 72.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.596 -1.315 . . . . 0.0 108.21 179.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' SG ' ' A' ' 218' ' ' CYS . . . -98.87 -15.64 33.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.918 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -68.45 -45.07 73.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.939 -1.33 . . . . 0.0 109.85 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . 0.766 ' OE1' HG13 ' A' ' 91' ' ' VAL . 23.5 tt0 -82.66 -20.38 36.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 11.7 ttt-85 -60.54 -46.38 90.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.867 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.45 12.58 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.003 -1.06 . . . . 0.0 110.355 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 37.0 m-85 -124.16 -11.27 7.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 111.136 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' TRP . . . . . 0.521 ' CE2' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -106.83 13.18 28.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.579 -1.326 . . . . 0.0 109.414 179.25 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.8 m -109.26 8.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.089 -1.007 . . . . 0.0 111.238 -178.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -118.69 166.1 13.17 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.87 -1.144 . . . . 0.0 108.789 179.298 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.541 ' C ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -93.96 144.16 25.71 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 109.459 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.13 -33.69 4.92 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.73 133.77 31.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.639 -0.918 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.698 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -83.38 -45.68 13.43 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 108.747 -179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 55' ' ' THR . 22.9 t -150.01 -166.56 2.58 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.053 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.918 ' HG1' ' CE1' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -169.92 113.7 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.57 ' OE1' ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -126.68 163.79 22.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 109.913 -178.218 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.766 HG13 ' OE1' ' A' ' 77' ' ' GLU . 1.3 m -143.36 150.38 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.069 -1.02 . . . . 0.0 110.457 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . -160.14 178.04 36.36 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 5.4 m-85 -78.73 177.84 8.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.156 -1.202 . . . . 0.0 108.427 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.88 ' HB1' HG13 ' A' ' 198' ' ' VAL . . . -174.39 159.33 3.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.193 -1.567 . . . . 0.0 113.063 -178.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.46 20.1 60.83 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.51 -0.744 . . . . 0.0 111.432 178.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.736 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -139.0 175.08 21.78 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . 0.708 ' H ' ' HD1' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -158.87 95.88 1.32 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.117 -1.226 . . . . 0.0 110.648 -178.631 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' THR . . . . . 0.819 HG23 ' CB ' ' A' ' 35' ' ' LEU . 21.0 m -142.3 122.57 13.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 109.681 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ARG . . . . . 0.646 ' C ' ' O ' ' A' ' 98' ' ' THR . 1.2 mtp180 10.79 -89.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.862 0.839 . . . . 0.0 109.873 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.569 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m-80 -120.9 90.31 46.64 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 8.8 Cg_exo -68.86 114.66 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.667 2.245 . . . . 0.0 113.358 -177.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.566 ' O ' HG22 ' A' ' 106' ' ' VAL . 19.2 p -121.35 158.9 27.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.639 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' TYR . . . . . 0.628 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.1 OUTLIER -49.77 -42.13 45.81 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.51 -179.069 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 5.1 tttt -73.06 -27.56 61.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.93 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE1' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -83.14 -41.43 18.52 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.974 -1.079 . . . . 0.0 110.412 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 102' ' ' THR . 6.8 m -57.4 -23.97 20.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.676 -1.265 . . . . 0.0 109.54 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 109' ' ' GLU . 5.8 m -52.92 -43.84 66.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.602 ' C ' ' H ' ' A' ' 110' ' ' LYS . 39.3 m -46.53 -8.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.896 . . . . 0.0 108.83 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.66 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.1 tt0 60.24 -7.78 0.07 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.438 -0.789 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' LYS . . . . . 0.79 ' HB3' HD21 ' A' ' 35' ' ' LEU . 1.1 tttp -79.39 -12.98 59.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.128 -0.983 . . . . 0.0 109.185 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 p -89.6 -19.27 25.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.921 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 55.29 52.43 47.52 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' HIS . . . . . 0.736 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 2.4 m-70 -109.09 171.99 7.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.528 -1.572 . . . . 0.0 109.65 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -139.0 111.98 7.9 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLU . . . . . 0.698 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 mt-10 -54.35 131.48 42.1 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.8 HG12 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -143.02 -170.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 111.804 -178.664 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.2 m -147.5 151.09 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HD3' ' CD1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -121.22 98.4 5.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 108.681 178.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.66 HG21 ' CD2' ' A' ' 80' ' ' PHE . 14.4 t -88.05 120.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.86 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 125.75 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.519 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 2.5 p90 -130.14 169.88 14.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.582 -1.324 . . . . 0.0 111.065 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -117.43 118.23 35.63 Favored Pre-proline 0 N--CA 1.487 1.398 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.701 ' O ' ' N ' ' A' ' 125' ' ' HIS . 18.4 Cg_exo -42.08 -61.88 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.998 2.465 . . . . 0.0 113.602 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.687 ' OE2' ' CD2' ' A' ' 125' ' ' HIS . 6.8 tm-20 -34.92 -19.36 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.368 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' HIS . . . . . 0.701 ' N ' ' O ' ' A' ' 123' ' ' PRO . 4.2 m170 -134.34 -2.39 2.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.402 -1.436 . . . . 0.0 111.42 -179.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.567 HG23 ' CG ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.35 158.74 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' SER . . . . . 0.819 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -111.65 170.67 7.98 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.537 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -70.16 -18.72 63.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 24.6 mt-10 -65.15 -23.68 67.18 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.488 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.819 ' CD ' ' H ' ' A' ' 127' ' ' SER . 1.2 pm0 -73.38 -45.28 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.416 -1.714 . . . . 0.0 110.492 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' LEU . . . . . 0.573 HD13 ' HB ' ' A' ' 119' ' ' VAL . 6.7 mt -64.35 -44.14 92.37 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.884 -1.76 . . . . 0.0 108.941 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 132' ' ' LEU . 0.6 OUTLIER -75.27 -27.16 59.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.042 . . . . 0.0 110.527 -179.233 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 1.4 tmtp? -70.31 -65.68 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.987 -1.071 . . . . 0.0 109.799 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.735 HG12 ' CZ ' ' A' ' 80' ' ' PHE . 37.3 t -49.95 -22.52 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.0 t80 -72.23 -49.91 31.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.197 -0.94 . . . . 0.0 110.593 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.615 ' CG ' ' CE2' ' A' ' 177' ' ' TYR . 66.2 m95 -74.77 -60.56 2.23 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.027 -1.67 . . . . 0.0 110.967 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 136' ' ' TRP . 11.7 tt0 -36.33 -32.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 111.138 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 12.0 p30 -131.31 69.66 1.47 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.886 -1.134 . . . . 0.0 110.088 -178.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.811 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 4.8 m80 -153.6 142.04 20.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.982 -1.073 . . . . 0.0 110.876 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' ASP . . . . . 0.574 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -106.9 72.18 0.3 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 190' ' ' THR . 57.7 Cg_endo -69.09 -9.14 25.51 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.984 2.456 . . . . 0.0 115.543 -177.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.57 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -89.99 16.6 8.01 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.242 -1.536 . . . . 0.0 111.18 -178.668 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' GLN . . . . . 0.574 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -131.06 89.21 2.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.948 -1.095 . . . . 0.0 108.937 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . 0.678 ' O ' ' NH1' ' A' ' 156' ' ' ARG . . . -83.81 20.67 11.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.805 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -113.76 -15.93 12.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.745 -1.444 . . . . 0.0 109.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' ARG . . . . . 0.509 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 177.6 164.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.407 -0.808 . . . . 0.0 108.857 -179.389 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLN . . . . . 0.566 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 3.3 tp-100 -111.8 132.71 54.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.558 -1.339 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' A' ' 220' ' ' LEU . . . 43.98 -123.59 4.8 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-O 123.317 1.509 . . . . 0.0 111.122 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' ASN . . . . . 0.484 ' H ' HD21 ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.9 -32.92 40.23 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 113.388 -1.406 . . . . 0.0 112.023 -177.58 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 147' ' ' GLN . 42.4 p30 -52.46 164.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.209 -1.557 . . . . 0.0 108.564 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.5 p90 -136.72 119.72 16.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.927 -1.108 . . . . 0.0 109.98 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 153.7 165.88 14.13 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.527 -1.321 . . . . 0.0 109.992 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER -91.03 2.4 56.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -1.125 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' GLN . . . . . 0.631 ' N ' ' OE1' ' A' ' 154' ' ' GLN . 12.2 pm0 -90.2 -0.1 57.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.125 -0.984 . . . . 0.0 108.354 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 36.7 m-85 -123.26 57.16 1.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.436 -0.79 . . . . 0.0 109.768 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.678 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -99.39 -178.58 3.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 108.956 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -93.61 107.75 19.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 176.306 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -137.29 114.85 11.15 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 117.899 -1.521 . . . . 0.0 111.092 -176.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 192' ' ' ASP . 39.6 t -101.4 137.76 27.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.12 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' TYR . . . . . 1.101 ' CG ' HG21 ' A' ' 198' ' ' VAL . 84.4 m-85 -127.15 86.05 59.66 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 108.216 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 160' ' ' TYR . 52.0 Cg_exo -38.35 168.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.089 2.526 . . . . 0.0 112.972 -178.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -102.69 -40.65 6.52 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.144 -0.972 . . . . 0.0 109.534 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.9 OUTLIER -173.25 178.52 2.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 0.0 109.798 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.8 -23.84 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.11 1.433 . . . . 0.0 108.076 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 163' ' ' SER . 2.5 t -56.09 -56.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.863 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.08 -36.29 48.41 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.483 -178.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.4 ttp -52.67 -11.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 110.782 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -75.57 -53.8 8.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.758 -1.214 . . . . 0.0 110.034 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . 0.588 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.73 -47.93 6.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -50.97 -55.72 15.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -0.917 . . . . 0.0 110.083 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.52 -41.23 63.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.051 . . . . 0.0 109.331 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.43 -37.34 63.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' SER . . . . . 0.601 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.51 -39.13 72.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' LYS . . . . . 0.793 ' HZ3' ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -72.59 -58.27 3.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.003 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.793 ' N ' ' HZ3' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -57.22 -50.3 73.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.265 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.497 ' CD ' ' C ' ' A' ' 176' ' ' GLU . 0.9 OUTLIER -53.39 -34.99 59.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.976 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' TYR . . . . . 0.615 ' CE2' ' CG ' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -79.75 -35.01 39.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.023 -1.048 . . . . 0.0 109.638 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . 0.594 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.5 tp60 -75.13 -33.79 61.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.329 -0.857 . . . . 0.0 109.621 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -73.54 -31.25 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.332 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.06 -51.75 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.09 -39.69 66.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.988 . . . . 0.0 109.574 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 t -56.32 -32.13 64.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -88.01 0.8 55.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 184' ' ' HIS . . . . . 0.532 ' O ' ' CE2' ' A' ' 186' ' ' PHE . 10.0 m-70 -108.33 35.97 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.677 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.61 58.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.58 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 186' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 184' ' ' HIS . 86.3 m-85 -151.8 168.5 24.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.85 -167.44 19.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HA ' ' NE2' ' A' ' 178' ' ' GLN . 10.8 Cg_endo -58.57 107.69 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.644 1.563 . . . . 0.0 110.53 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 189' ' ' ILE . . . . . 0.594 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -47.22 168.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 122.21 1.005 . . . . 0.0 110.603 -178.228 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 190' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 141' ' ' PRO . 27.1 p -120.33 58.65 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.485 -179.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -100.12 116.11 31.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 192' ' ' ASP . . . . . 0.654 ' CG ' ' NH1' ' A' ' 194' ' ' ARG . 4.0 t0 -76.51 128.24 34.38 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.551 -178.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -125.32 99.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -179.364 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 194' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 9.8 mtm-85 -135.4 152.57 51.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 195' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 195' ' ' GLU . 1.4 mp0 -129.48 163.77 25.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.504 -1.372 . . . . 0.0 110.752 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 104.65 -22.01 35.15 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' GLN . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' VAL . 0.9 OUTLIER -142.45 -173.9 3.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.054 -1.262 . . . . 0.0 111.747 -178.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' VAL . . . . . 1.101 HG21 ' CG ' ' A' ' 160' ' ' TYR . 91.1 t 109.2 74.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.921 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 174.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.457 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 3.0 t80 -165.5 126.57 1.92 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 111.134 172.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -156.47 94.9 1.52 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -49.19 125.85 11.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.783 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.2 -168.69 2.26 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' GLU . . . . . 0.65 ' OE2' ' CE2' ' A' ' 205' ' ' TYR . 1.4 pt-20 -75.81 -176.51 3.39 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.0 -1.062 . . . . 0.0 108.766 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -50.06 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.831 -1.168 . . . . 0.0 110.662 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' TYR . . . . . 0.788 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -62.66 1.95 0.33 Allowed 'General case' 0 C--N 1.307 -1.283 0 O-C-N 120.877 -1.139 . . . . 0.0 112.144 -178.307 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.71 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 5.0 m-70 -102.04 11.6 38.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.434 -1.416 . . . . 0.0 110.942 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' GLN . . . . . 0.853 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.7 mm-40 -129.53 -141.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.641 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 89' ' ' THR . 1.0 OUTLIER -37.01 -1.36 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.389 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' TYR . . . . . 0.853 ' N ' ' O ' ' A' ' 207' ' ' GLN . 80.1 t80 -38.45 -42.26 0.73 Allowed 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.014 -1.054 . . . . 0.0 111.457 -178.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.9 OUTLIER -62.21 -47.68 83.37 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.553 -178.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.3 t -56.11 -38.24 70.5 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.061 -1.024 . . . . 0.0 108.873 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.634 ' CE ' ' CG ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -88.28 -21.24 24.56 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 209' ' ' TYR . 1.4 m-80 -133.4 89.11 33.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.541 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 216' ' ' GLY . 31.7 Cg_exo -56.92 13.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 123.525 2.817 . . . . 0.0 112.08 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.592 ' H ' ' C ' ' A' ' 213' ' ' ASN . 38.0 t0 -60.92 20.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.937 . . . . 0.0 111.112 -177.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' GLY . . . . . 0.605 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.52 -51.47 0.14 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.868 -1.158 . . . . 0.0 112.199 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' TYR . . . . . 0.605 ' C ' ' O ' ' A' ' 216' ' ' GLY . 27.0 m-85 -22.32 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.905 0 CA-C-N 118.892 1.346 . . . . 0.0 110.121 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER -151.18 103.01 2.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.441 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 218' ' ' CYS . . . -36.33 151.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' A' ' 148' ' ' GLY . 0.4 OUTLIER -63.41 -175.67 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -1.142 . . . . 0.0 109.52 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.65 -67.62 0.8 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . 156.85 147.05 4.65 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' THR . . . . . 0.418 HG23 ' H ' ' A' ' 223' ' ' THR . 0.1 OUTLIER . . . . . 0 C--N 1.296 -1.724 0 O-C-N 121.495 -1.003 . . . . 0.0 109.114 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.629 0 N-CA-C 106.281 -2.728 . . . . 0.0 106.281 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 58.14 39.87 25.6 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 120.0 1.9 . . . . 0.0 109.321 -163.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.3 t -57.37 -38.25 73.91 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.143 2.177 . . . . 0.0 111.306 -162.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -33.95 -42.7 0.13 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.129 2.971 . . . . 0.0 116.16 161.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.7 t -76.95 -20.19 56.44 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.309 1.044 . . . . 0.0 111.848 -175.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.45 -37.22 8.53 Favored 'General case' 0 C--N 1.348 0.539 0 CA-C-N 119.361 0.982 . . . . 0.0 110.57 171.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 t -91.78 51.06 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.672 0 C-N-CA 125.847 1.659 . . . . 0.0 107.378 171.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.42 HD11 ' HB2' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -57.63 134.64 22.13 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 125.489 1.516 . . . . 0.0 108.946 179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -60.28 122.01 13.44 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.803 1.241 . . . . 0.0 107.972 173.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.43 -26.12 62.94 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.702 1.201 . . . . 0.0 111.94 -179.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -68.81 -32.11 71.58 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 128.904 2.882 . . . . 0.0 113.07 171.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.5 tp10 -91.46 -14.54 30.33 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.886 1.674 . . . . 0.0 111.053 -177.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -55.12 155.71 4.54 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 124.915 1.286 . . . . 0.0 111.744 174.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.08 150.9 13.9 Favored Pre-proline 0 CA--C 1.55 0.978 0 CA-C-O 118.468 -0.777 . . . . 0.0 109.938 174.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.28 -35.8 44.98 Favored 'Trans proline' 0 C--N 1.352 0.743 0 C-N-CA 123.221 2.614 . . . . 0.0 114.612 -177.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.484 ' HA3' ' H ' ' A' ' 99' ' ' ARG . . . 104.65 130.3 6.77 Favored Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 105.707 -2.957 . . . . 0.0 105.707 -168.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -90.08 157.62 17.69 Favored 'General case' 0 CA--C 1.548 0.877 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 169.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.2 m -109.93 16.63 21.82 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 120.111 -1.618 . . . . 0.0 109.656 177.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -98.16 102.07 12.93 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 126.498 1.919 . . . . 0.0 107.439 -174.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -76.19 161.93 34.66 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 121.987 1.791 . . . . 0.0 109.42 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 pt -130.75 94.14 29.67 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -72.01 165.48 32.47 Favored 'Trans proline' 0 C--N 1.356 0.926 0 C-N-CA 121.814 1.676 . . . . 0.0 109.612 169.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.6 m -125.78 -172.28 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 C-N-CA 125.289 1.436 . . . . 0.0 109.863 -175.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.3 t -55.24 92.23 0.01 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.839 2.055 . . . . 0.0 109.235 165.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.71 -38.4 89.08 Favored 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.836 1.254 . . . . 0.0 110.567 -169.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -81.68 117.21 21.83 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.087 0.955 . . . . 0.0 108.46 165.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 14.5 t-80 -50.58 115.77 1.63 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 128.434 2.694 . . . . 0.0 110.521 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 27.4 t60 -63.27 -25.11 68.16 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 120.497 1.499 . . . . 0.0 112.985 -170.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 2.1 t -75.24 -46.31 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.914 0 C-N-CA 124.664 1.185 . . . . 0.0 109.994 179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 31.8 m -99.07 -46.9 5.42 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.881 0.872 . . . . 0.0 111.71 -172.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 106.92 -4.62 36.18 Favored Glycine 0 CA--C 1.537 1.439 0 C-N-CA 126.567 2.032 . . . . 0.0 112.928 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -81.22 -98.36 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.173 1.789 . . . . 0.0 112.487 -172.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.426 ' HG2' ' H ' ' A' ' 56' ' ' VAL . 24.1 ttm-85 -153.84 153.99 33.12 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.495 1.518 . . . . 0.0 110.502 -175.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.0 p -128.24 11.33 6.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 128.448 2.699 . . . . 0.0 111.443 177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.426 ' H ' ' HG2' ' A' ' 54' ' ' ARG . 8.1 m -139.5 159.69 28.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 O-C-N 119.914 -1.741 . . . . 0.0 107.486 -176.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -58.72 147.61 70.71 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 124.371 1.068 . . . . 0.0 111.487 176.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.31 144.96 79.21 Favored 'Cis proline' 0 CA--C 1.537 0.658 0 CA-C-N 119.725 0.938 . . . . 0.0 111.782 2.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -87.57 141.22 31.99 Favored Pre-proline 0 CA--C 1.544 0.719 0 N-CA-C 107.467 -1.308 . . . . 0.0 107.467 171.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -52.85 143.47 48.24 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 124.012 3.142 . . . . 0.0 112.838 176.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -62.12 133.71 55.61 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 123.75 0.82 . . . . 0.0 110.028 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.41 30.22 30.97 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 110.61 -0.996 . . . . 0.0 110.61 -174.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.9 p -111.49 139.86 46.57 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 163.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -105.11 157.97 16.9 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.187 -1.782 . . . . 0.0 106.187 165.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.3 143.75 38.02 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 126.009 1.723 . . . . 0.0 107.426 177.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -137.69 172.69 12.58 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 127.019 2.128 . . . . 0.0 106.789 174.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 50.0 t -133.42 123.47 46.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 -175.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -134.75 128.77 33.52 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 125.996 1.718 . . . . 0.0 109.067 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -119.11 134.73 10.93 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 126.552 2.025 . . . . 0.0 108.407 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . . . . . . . . . 14.4 ptp -128.3 -121.96 0.23 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 126.882 2.073 . . . . 0.0 105.85 175.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.51 -154.78 29.78 Favored Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 171.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . . . . . . . . . 38.0 t -44.06 117.35 1.19 Allowed 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.769 2.028 . . . . 0.0 111.456 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.436 ' HB2' HG11 ' A' ' 91' ' ' VAL 0.289 0.0 OUTLIER -51.93 -11.59 0.17 Allowed 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 116.684 2.105 . . . . 0.0 116.684 -176.695 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . . . . . . . . . 24.7 m0 -53.66 -69.32 0.12 Allowed 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 127.898 2.479 . . . . 0.0 114.111 165.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.92 -15.91 66.46 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 121.087 -1.008 . . . . 0.0 111.553 -171.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.16 -46.5 70.58 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.979 1.711 . . . . 0.0 111.105 174.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -68.24 -40.65 81.92 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.402 1.881 . . . . 0.0 111.817 -176.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -51.28 -52.49 44.61 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 126.893 2.077 . . . . 0.0 113.355 -176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -69.26 -3.18 12.8 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.777 1.231 . . . . 0.0 114.316 -175.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -102.44 -27.83 12.57 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-O 117.825 -1.083 . . . . 0.0 112.241 174.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -80.87 -19.57 44.19 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 121.413 1.915 . . . . 0.0 111.795 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.8 m -79.56 -0.21 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.884 0 C-N-CA 125.703 1.601 . . . . 0.0 112.281 -178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 53.7 mt -86.9 152.34 22.52 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.147 1.779 . . . . 0.0 108.948 176.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.1 tppp? -89.97 134.59 34.14 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 172.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 105.9 -13.54 45.52 Favored Glycine 0 CA--C 1.53 1.003 0 C-N-CA 124.01 0.814 . . . . 0.0 112.514 175.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.1 p -72.23 132.09 33.84 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 169.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 75.8 t80 -77.09 -51.09 11.65 Favored 'General case' 0 CA--C 1.538 0.487 0 N-CA-C 107.575 -1.268 . . . . 0.0 107.575 176.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 79.1 p -161.48 171.58 17.89 Favored 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 126.314 1.845 . . . . 0.0 110.136 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 43.9 p -128.45 153.97 46.56 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.781 1.632 . . . . 0.0 107.885 174.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 5.6 mp0 -145.43 160.37 41.68 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 127.009 2.124 . . . . 0.0 109.54 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -138.96 154.16 25.69 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 125.14 1.376 . . . . 0.0 111.103 177.402 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -164.86 176.55 40.63 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-O 122.237 0.91 . . . . 0.0 111.519 -177.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -90.83 136.71 32.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 104.812 -2.292 . . . . 0.0 104.812 166.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -145.37 165.38 28.65 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.778 1.631 . . . . 0.0 107.871 171.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.34 2.45 79.9 Favored Glycine 0 CA--C 1.533 1.195 0 O-C-N 119.747 -1.846 . . . . 0.0 114.867 171.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -115.16 -173.62 17.78 Favored Glycine 0 CA--C 1.525 0.715 0 C-N-CA 125.753 1.644 . . . . 0.0 110.923 -174.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . 0.261 0.0 OUTLIER -145.42 60.76 1.29 Allowed 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.325 1.45 . . . . 0.0 110.561 -167.132 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -146.52 142.35 27.95 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 129.29 3.036 . . . . 0.0 104.887 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.484 ' H ' ' HA3' ' A' ' 37' ' ' GLY . 37.8 mtm180 -67.18 -55.56 13.59 Favored 'General case' 0 CA--C 1.549 0.909 0 CA-C-N 119.297 0.953 . . . . 0.0 112.429 -178.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . 0.273 43.2 m-80 -137.69 70.24 51.77 Favored Pre-proline 0 N--CA 1.481 1.088 0 CA-C-N 120.314 1.416 . . . . 0.0 112.619 177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -75.79 152.0 36.7 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 122.124 1.883 . . . . 0.0 108.444 171.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.418 ' H ' ' HB2' ' A' ' 105' ' ' GLU . 34.1 p -108.03 175.25 5.54 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.168 1.387 . . . . 0.0 107.617 173.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -53.26 -44.75 68.43 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.975 1.71 . . . . 0.0 111.862 176.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -72.94 -30.01 63.55 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.958 1.303 . . . . 0.0 111.395 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.418 ' HB2' ' H ' ' A' ' 102' ' ' THR . 9.6 mm-40 -77.08 -45.89 25.49 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.167 175.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.01 -25.92 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.257 1.39 . . . . 0.0 112.769 176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.5 t -56.67 -29.67 62.57 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 126.511 1.925 . . . . 0.0 113.262 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.0 p -68.04 -13.44 62.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.618 1.167 . . . . 0.0 112.963 175.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 79.15 -23.21 0.25 Allowed 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 130.237 3.415 . . . . 0.0 112.224 -174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -54.38 -22.73 13.1 Favored 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 127.06 2.144 . . . . 0.0 114.629 -173.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 51.0 p -76.41 -29.83 57.21 Favored 'General case' 0 CA--C 1.545 0.784 0 O-C-N 120.317 -1.49 . . . . 0.0 111.525 176.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 75.83 9.19 85.08 Favored Glycine 0 CA--C 1.531 1.085 0 C-N-CA 125.909 1.718 . . . . 0.0 112.325 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -64.29 152.11 41.98 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-N 119.299 1.549 . . . . 0.0 112.4 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -110.29 129.53 55.72 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 127.656 2.382 . . . . 0.0 105.523 165.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -74.11 132.64 42.47 Favored 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.2 m -137.15 151.69 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.704 1.602 . . . . 0.0 110.187 -176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.445 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.3 m -105.2 128.84 58.77 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 C-N-CA 127.602 2.361 . . . . 0.0 106.159 171.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 32.1 ttt180 -107.44 95.18 5.52 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 127.778 2.431 . . . . 0.0 104.652 176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.515 HG23 HD13 ' A' ' 131' ' ' LEU . 3.6 m -108.85 126.71 65.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 105.815 -1.921 . . . . 0.0 105.815 -174.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 2.7 m -107.56 142.34 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.462 ' HD1' HD11 ' A' ' 131' ' ' LEU . 34.3 p90 -134.0 158.31 43.85 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 124.727 1.211 . . . . 0.0 110.086 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -103.97 106.24 52.13 Favored Pre-proline 0 CA--C 1.551 1.001 0 C-N-CA 124.876 1.271 . . . . 0.0 108.158 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -35.23 -42.57 0.41 Allowed 'Trans proline' 0 C--N 1.361 1.217 1 C-N-CA 127.391 5.394 . . . . 0.0 118.652 174.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.83 -25.39 56.06 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.342 1.857 . . . . 0.0 113.658 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -120.68 -16.02 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.973 1.309 . . . . 0.0 113.341 -174.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.18 135.62 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 126.033 1.733 . . . . 0.0 107.681 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 98.2 p -83.78 169.62 15.01 Favored 'General case' 0 CA--C 1.548 0.885 0 CA-C-N 120.358 1.435 . . . . 0.0 111.369 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -61.01 -32.46 72.05 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 125.008 1.323 . . . . 0.0 112.028 176.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -56.54 -27.14 56.91 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.013 2.125 . . . . 0.0 112.717 177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.1 mm-40 -71.38 -44.41 65.01 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.313 1.445 . . . . 0.0 111.373 -177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.515 HD13 HG23 ' A' ' 119' ' ' VAL . 36.0 mt -67.33 -42.51 83.46 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.961 0.8 . . . . 0.0 110.398 178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 27.6 mt -58.28 -52.96 63.41 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.654 1.581 . . . . 0.0 110.334 173.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -52.1 -55.53 20.17 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.039 1.736 . . . . 0.0 112.805 176.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.432 HG13 HD21 ' A' ' 138' ' ' ASN . 96.2 t -60.05 -42.02 88.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 C-N-CA 123.875 0.87 . . . . 0.0 110.927 178.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -56.08 -56.34 21.98 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 119.333 0.969 . . . . 0.0 112.244 170.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . . . . . . . . . 93.2 m95 -63.28 -45.11 92.96 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 117.9 -1.048 . . . . 0.0 112.89 -176.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -69.66 -24.02 63.56 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 126.958 2.103 . . . . 0.0 114.77 -174.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.432 HD21 HG13 ' A' ' 134' ' ' VAL 0.442 12.6 p30 -130.01 47.09 2.55 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.691 1.196 . . . . 0.0 114.2 -176.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -153.76 158.01 40.31 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.164 -1.398 . . . . 0.0 110.481 167.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -90.81 115.88 65.2 Favored Pre-proline 0 CA--C 1.546 0.79 0 CA-C-N 120.976 1.716 . . . . 0.0 107.363 172.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.721 ' HD3' HG23 ' A' ' 223' ' ' THR . 62.7 Cg_endo -82.58 -6.9 11.69 Favored 'Trans proline' 0 CA--C 1.535 0.56 0 C-N-CA 122.416 2.077 . . . . 0.0 114.495 -170.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 32.2 p -109.45 9.73 25.43 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.197 1.799 . . . . 0.0 112.128 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -110.57 108.43 18.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 107.095 -1.446 . . . . 0.0 107.095 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -95.58 -56.58 1.24 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -166.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 26.9 ptt? -90.92 19.01 5.93 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 118.409 1.105 . . . . 0.0 112.657 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 39.0 ttm105 -167.5 148.4 5.45 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 126.912 2.085 . . . . 0.0 107.302 -174.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 49.6 mm-40 -139.44 114.06 9.22 Favored 'General case' 0 C--N 1.333 -0.138 0 C-N-CA 125.546 1.539 . . . . 0.0 107.651 172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 45.8 -109.5 0.34 Allowed Glycine 0 CA--C 1.534 1.251 0 C-N-CA 126.7 2.095 . . . . 0.0 113.124 -167.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -85.8 -16.91 37.26 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 125.645 1.578 . . . . 0.0 112.112 -177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -90.98 122.34 33.57 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.941 1.296 . . . . 0.0 107.58 -175.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -115.83 139.59 50.04 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.337 1.455 . . . . 0.0 110.578 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 126.99 157.04 9.36 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 126.033 1.778 . . . . 0.0 112.024 -177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.6 t -58.58 -15.83 13.13 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 128.226 2.611 . . . . 0.0 114.618 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . . . . . . . . . 17.4 pm0 -80.46 -18.34 49.01 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.02 -1.05 . . . . 0.0 112.3 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 42.4 m-85 -111.16 66.85 0.63 Allowed 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -177.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . . . . . . . . . 4.9 mtp85 -109.95 152.04 26.36 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.63 1.172 . . . . 0.0 108.123 176.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.9 p -60.28 118.41 6.37 Favored 'General case' 0 CA--C 1.551 0.995 0 C-N-CA 124.593 1.157 . . . . 0.0 109.093 156.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -148.18 116.98 6.69 Favored 'General case' 0 C--O 1.224 -0.262 0 C-N-CA 124.528 1.131 . . . . 0.0 110.869 -174.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 76.2 t -111.13 121.76 64.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -115.27 114.1 43.22 Favored Pre-proline 0 CA--C 1.541 0.598 0 N-CA-C 107.321 -1.363 . . . . 0.0 107.321 173.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -74.52 155.67 45.24 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 123.151 2.567 . . . . 0.0 111.412 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 44.2 m -79.69 -32.67 41.4 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 124.037 0.935 . . . . 0.0 111.859 -178.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 87.9 p -171.6 -167.56 0.52 Allowed 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.21 1.804 . . . . 0.0 108.954 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -56.1 -21.96 25.32 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 126.964 2.105 . . . . 0.0 113.797 171.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 53.5 t -52.44 -56.67 6.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 127.933 2.493 . . . . 0.0 110.899 169.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -86.77 -18.96 29.82 Favored 'General case' 0 C--O 1.221 -0.402 0 CA-C-O 118.076 -0.964 . . . . 0.0 110.915 -174.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 25.6 ttt -54.89 -36.02 64.72 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 125.557 1.543 . . . . 0.0 113.303 175.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 81.3 mt-10 -67.98 -38.01 82.18 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.889 0.876 . . . . 0.0 112.142 176.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -91.07 -38.98 12.44 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.678 1.191 . . . . 0.0 111.356 -175.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -67.8 -45.47 74.7 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.004 1.722 . . . . 0.0 111.057 -175.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 96.0 mt -65.29 -34.76 79.1 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.155 0.982 . . . . 0.0 111.24 174.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 20.1 ttt85 -69.35 -46.89 65.93 Favored 'General case' 0 C--O 1.222 -0.39 0 C-N-CA 123.724 0.809 . . . . 0.0 110.007 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 8.8 p -59.42 -40.65 87.37 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 125.252 1.421 . . . . 0.0 112.06 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 61.4 tttm -56.07 -63.67 1.11 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 127.109 2.164 . . . . 0.0 110.596 169.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.51 -34.75 78.47 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.597 1.159 . . . . 0.0 113.736 -176.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -60.03 -48.12 83.02 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 126.438 1.895 . . . . 0.0 111.714 177.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -76.68 -25.82 54.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 178.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -60.46 -44.06 96.24 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.734 0.697 . . . . 0.0 110.94 168.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -64.69 -42.14 95.53 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.744 1.218 . . . . 0.0 112.671 -177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 13.1 m -75.26 -42.36 43.96 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 CA-C-N 119.028 0.831 . . . . 0.0 110.565 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 95.4 mt -83.01 -23.61 33.2 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 119.432 1.015 . . . . 0.0 113.184 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 48.5 t -56.86 -33.91 67.3 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 119.839 1.2 . . . . 0.0 111.351 167.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -79.46 -17.61 53.86 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.607 1.563 . . . . 0.0 112.019 177.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -91.95 12.11 22.85 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.481 1.512 . . . . 0.0 111.721 178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 76.94 28.89 0.63 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 126.625 1.97 . . . . 0.0 111.049 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -98.69 169.23 9.63 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 107.685 -1.228 . . . . 0.0 107.685 172.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -103.65 -160.6 24.9 Favored Glycine 0 CA--C 1.533 1.196 0 C-N-CA 124.441 1.019 . . . . 0.0 110.904 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -51.41 127.24 21.67 Favored 'Trans proline' 0 C--N 1.353 0.796 0 C-N-CA 124.094 3.196 . . . . 0.0 111.903 173.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 17.4 pt -65.64 149.55 11.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 121.845 0.831 . . . . 0.0 109.627 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . . . . . . . . . 57.6 p -112.59 21.52 15.54 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 126.175 1.79 . . . . 0.0 109.951 -171.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 86.7 m -66.72 106.44 1.84 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 50.0 m-20 -69.82 124.59 24.38 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 124.719 1.208 . . . . 0.0 108.268 177.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 2.4 mt -125.89 114.66 39.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 106.422 -1.695 . . . . 0.0 106.422 175.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . . . . . . . . . 83.9 mtm-85 -144.92 160.86 40.64 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 129.212 3.005 . . . . 0.0 106.484 177.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -119.61 161.82 20.01 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.624 1.969 . . . . 0.0 108.733 172.314 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 84.82 18.24 61.9 Favored Glycine 0 CA--C 1.529 0.966 0 O-C-N 121.813 -0.555 . . . . 0.0 111.911 172.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 10.4 mp0 -76.49 120.19 21.37 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.981 0.912 . . . . 0.0 109.134 -179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 13.7 p -59.92 134.88 25.02 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 C-N-CA 126.141 1.777 . . . . 0.0 108.866 168.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 38.7 t80 -101.01 129.47 46.85 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 175.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -122.18 115.64 22.77 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 170.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -57.39 130.43 46.23 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.414 1.085 . . . . 0.0 110.294 171.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . . . . . . . . . . . -76.88 173.5 11.65 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.136 0.974 . . . . 0.0 109.372 172.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.66 160.7 22.13 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 125.772 1.629 . . . . 0.0 110.798 174.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -55.57 -37.94 68.7 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 127.373 2.269 . . . . 0.0 111.976 -176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -57.65 -18.89 22.9 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.262 2.225 . . . . 0.0 114.123 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.405 ' HB3' ' CE1' ' A' ' 73' ' ' PHE . 74.9 m-70 -105.28 -6.47 19.66 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.366 1.467 . . . . 0.0 111.442 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.41 ' HA ' ' CG2' ' A' ' 91' ' ' VAL . 76.8 mm-40 -94.91 -130.75 0.15 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.194 2.198 . . . . 0.0 108.952 178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . . . . . . . . . 40.2 mm-40 -68.79 14.4 0.08 Allowed 'General case' 0 CA--C 1.537 0.479 1 C-N-CA 132.02 4.128 . . . . 0.0 112.797 -173.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -51.56 -39.43 57.79 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 128.118 2.567 . . . . 0.0 112.463 177.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.452 HD12 ' H ' ' A' ' 210' ' ' LEU . 3.1 mp -84.33 0.45 49.13 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.68 0.792 . . . . 0.0 112.021 -179.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 23.1 t -76.21 -38.18 56.81 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.889 -1.132 . . . . 0.0 108.01 166.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -77.51 -34.9 53.93 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.525 1.53 . . . . 0.0 110.107 175.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -117.7 77.65 11.4 Favored Pre-proline 0 CA--C 1.541 0.624 0 C-N-CA 126.246 1.818 . . . . 0.0 109.246 -179.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.37 1.91 4.38 Favored 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 123.605 2.87 . . . . 0.0 114.268 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -39.53 -38.88 0.64 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 129.46 3.104 . . . . 0.0 113.362 163.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 78.67 44.1 11.02 Favored Glycine 0 C--N 1.343 0.924 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 162.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 44.2 t80 -36.97 109.84 0.1 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.58 2.752 . . . . 0.0 115.413 -161.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 12.1 t 81.92 -65.51 0.12 Allowed 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 127.455 2.302 . . . . 0.0 114.704 161.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -72.25 151.44 46.93 Favored Glycine 0 CA--C 1.53 1.007 0 N-CA-C 114.648 0.619 . . . . 0.0 114.648 -147.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -77.02 171.69 14.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 124.919 1.287 . . . . 0.0 109.576 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -88.58 -164.46 40.33 Favored Glycine 0 CA--C 1.536 1.347 0 N-CA-C 107.899 -2.08 . . . . 0.0 107.899 160.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -117.29 -141.04 6.81 Favored Glycine 0 CA--C 1.519 0.319 0 O-C-N 121.375 -1.074 . . . . 0.0 114.855 -159.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.721 HG23 ' HD3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER 0.56 -35.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.702 1 C-N-CA 136.037 5.735 . . . . 0.0 119.923 163.188 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -77.41 0.71 68.12 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 126.788 2.137 . . . . 0.0 112.436 -155.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 8.9 m -49.28 71.04 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 127.048 2.139 . . . . 0.0 113.274 141.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 66.4 m -78.83 151.5 31.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 104.72 -2.326 . . . . 0.0 104.72 127.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . . . . . . . . 1.058 27.4 p 98.07 -109.78 0.0 OUTLIER Pre-proline 0 CA--C 1.548 0.89 1 C-N-CA 135.798 5.639 . . . . 0.0 113.74 -12.629 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -50.63 -19.76 5.5 Favored 'Trans proline' 0 CA--C 1.549 1.275 0 C-N-CA 124.251 3.301 . . . . 0.0 118.112 173.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . . . . . . . . . 60.2 ttp -143.36 148.05 35.62 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 127.397 2.279 . . . . 0.0 107.635 178.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . . . . . . . . 0.265 . . 85.59 -14.23 0.57 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 128.8 2.84 . . . . 0.0 115.098 170.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.3 mp -103.2 132.81 48.64 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.833 0 C-N-CA 127.623 2.369 . . . . 0.0 106.051 178.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . 0.256 36.4 ttmt 72.88 -113.28 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.552 1 C-N-CA 132.517 4.327 . . . . 0.0 112.026 -9.558 . . . . . . . . 3 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.4 2.777 0 CA-C-N 113.195 -1.82 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.676 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.535 ' C ' ' O ' ' A' ' 22' ' ' GLY . 39.3 m-20 36.0 -89.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.22 -1.164 . . . . 0.0 109.317 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.676 ' N ' ' O ' ' A' ' 22' ' ' GLY . 1.6 m -50.62 -18.23 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.248 -0.907 . . . . 0.0 109.031 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.619 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -49.95 -7.68 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 123.011 1.386 . . . . 0.0 109.751 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.673 ' H ' ' C ' ' A' ' 24' ' ' SER . 40.9 t -46.37 -9.26 0.01 OUTLIER 'General case' 0 C--N 1.262 -3.227 0 CA-C-N 114.002 -1.454 . . . . 0.0 109.445 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.619 ' N ' ' O ' ' A' ' 25' ' ' ALA . 1.8 pttt -114.91 54.88 0.77 Allowed 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 123.416 1.579 . . . . 0.0 108.753 179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.695 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -155.55 21.67 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.259 -3.362 0 N-CA-C 104.217 -2.512 . . . . 0.0 104.217 -178.488 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.61 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -41.34 177.06 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 CA-C-N 113.858 -1.519 . . . . 0.0 109.76 -178.074 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.482 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -107.67 125.64 51.61 Favored 'General case' 0 C--N 1.278 -2.514 0 CA-C-N 114.938 -1.028 . . . . 0.0 108.509 179.118 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.682 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -54.01 -17.93 3.08 Favored 'General case' 0 C--N 1.282 -2.344 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.427 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.566 ' N ' ' OE1' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -82.98 -9.52 59.24 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.974 -1.079 . . . . 0.0 110.12 -179.536 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.545 ' O ' ' C ' ' A' ' 34' ' ' ALA . 9.4 tp10 -112.32 -28.11 8.04 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.079 -1.013 . . . . 0.0 110.384 -179.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -30.57 148.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.157 -0.965 . . . . 0.0 110.389 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.569 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -37.78 161.39 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.796 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_exo -60.18 -41.81 48.22 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.026 1.817 . . . . 0.0 111.747 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 126.1 137.11 4.58 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.16 165.78 12.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -1.124 . . . . 0.0 109.435 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.43 ' HA ' ' ND2' ' A' ' 100' ' ' ASN . 2.2 m -124.94 33.55 5.17 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.94 . . . . 0.0 109.706 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -118.05 74.24 10.13 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.013 -1.054 . . . . 0.0 110.11 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -77.09 130.94 11.56 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 122.907 2.404 . . . . 0.0 111.581 179.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.529 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.7 OUTLIER -139.27 92.23 10.72 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.947 -1.096 . . . . 0.0 110.413 -179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.529 ' O ' ' O ' ' A' ' 42' ' ' ILE . 76.6 Cg_exo -48.34 -165.98 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.787 2.325 . . . . 0.0 111.435 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.664 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.0 OUTLIER -160.9 -171.14 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.891 -1.131 . . . . 0.0 110.281 178.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.469 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.2 OUTLIER -33.9 83.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.554 0.692 . . . . 0.0 111.334 -178.67 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.664 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -64.4 -20.13 65.95 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.441 -0.787 . . . . 0.0 110.271 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -88.49 100.45 13.07 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 116.384 -2.126 . . . . 0.0 107.786 178.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.657 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 6.1 t-80 -30.18 141.21 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.93 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -79.0 -6.96 57.63 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.313 -0.867 . . . . 0.0 110.464 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.468 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 46.9 t -95.43 -63.68 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.704 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -80.55 -44.69 18.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.218 -0.927 . . . . 0.0 110.214 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.9 7.22 55.6 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 109.273 -1.531 . . . . 0.0 109.273 -179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.681 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 33.4 p30 -82.75 -114.87 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.683 ' NE ' ' O ' ' A' ' 57' ' ' GLU . 1.2 ttm-85 -128.06 170.57 12.76 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 122.978 1.37 . . . . 0.0 108.434 178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.588 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 3.0 p -132.22 17.33 4.52 Favored 'General case' 0 C--N 1.263 -3.169 0 CA-C-N 113.928 -1.487 . . . . 0.0 108.968 178.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.519 ' O ' ' C ' ' A' ' 57' ' ' GLU . 3.4 m -151.55 -168.47 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 121.098 -1.001 . . . . 0.0 109.117 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.683 ' O ' ' NE ' ' A' ' 54' ' ' ARG . 23.7 mm-40 -34.08 153.77 0.05 OUTLIER Pre-proline 0 C--N 1.293 -1.854 0 CA-C-O 121.494 0.664 . . . . 0.0 110.296 -179.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -87.79 155.29 41.94 Favored 'Cis proline' 0 C--N 1.306 -1.67 0 C-N-CA 123.03 -1.654 . . . . 0.0 110.889 0.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-85 -117.53 66.68 5.0 Favored Pre-proline 0 C--N 1.283 -2.302 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 179.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -67.28 -176.42 0.84 Allowed 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.821 2.347 . . . . 0.0 113.049 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -69.39 158.55 34.88 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.513 -0.742 . . . . 0.0 109.702 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 107.94 -41.37 2.23 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 108.998 -1.641 . . . . 0.0 108.998 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.511 HG23 ' HE ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -97.72 144.2 27.59 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.432 -1.04 . . . . 0.0 109.231 179.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.726 HE21 HE21 ' A' ' 166' ' ' GLN . 29.4 tp60 -107.79 147.77 30.4 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.716 ' O ' HG23 ' A' ' 162' ' ' THR . 0.0 OUTLIER -122.18 128.85 51.7 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.205 -0.934 . . . . 0.0 109.365 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.571 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -147.33 -167.38 2.77 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.2 t -141.98 140.69 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 O-C-N 120.081 -1.637 . . . . 0.0 109.379 179.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 42.0 m-85 -127.92 131.91 49.33 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 178.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.668 ' HA3' HG12 ' A' ' 116' ' ' VAL . . . -135.89 136.15 8.27 Favored Glycine 0 N--CA 1.491 2.343 0 C-N-CA 118.819 -1.658 . . . . 0.0 110.233 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -126.25 -94.29 0.47 Allowed 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.514 -0.992 . . . . 0.0 108.998 179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.691 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -142.46 71.28 0.4 Allowed Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.933 -2.067 . . . . 0.0 107.933 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.691 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.4 t 113.05 149.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.463 0 C-N-CA 124.087 0.955 . . . . 0.0 108.776 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.701 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.1 OUTLIER -101.6 20.26 16.47 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.563 -1.255 . . . . 0.0 111.2 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.698 ' CG ' ' OH ' ' A' ' 209' ' ' TYR . 17.8 m0 -101.56 -65.98 0.94 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.748 -1.22 . . . . 0.0 109.395 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.523 ' N ' ' OH ' ' A' ' 217' ' ' TYR . . . -68.32 -16.12 68.77 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.821 -1.712 . . . . 0.0 108.821 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.714 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -75.29 -58.27 3.39 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.409 -1.054 . . . . 0.0 110.591 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.544 ' O ' ' CD ' ' A' ' 77' ' ' GLU . 10.5 tp10 -65.19 -14.72 61.3 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.253 -0.904 . . . . 0.0 111.473 -178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.418 HH11 ' HG3' ' A' ' 78' ' ' ARG . 13.9 tpt85 -56.52 -53.98 51.23 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 120.874 -1.142 . . . . 0.0 110.787 -178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.9 mmtm -83.42 18.32 1.86 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.93 -1.106 . . . . 0.0 111.329 -178.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.714 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 4.9 m-85 -103.95 -40.05 6.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.776 -1.203 . . . . 0.0 110.331 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.596 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -81.91 -4.36 56.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.848 -1.158 . . . . 0.0 110.108 -179.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.678 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -90.4 21.11 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.059 -1.025 . . . . 0.0 109.786 -179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.662 HD12 HD21 ' A' ' 131' ' ' LEU . 60.6 mt -111.1 165.92 11.5 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 108.794 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.75 169.85 10.93 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 121.519 0.676 . . . . 0.0 110.115 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.16 3.64 38.66 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.551 ' O ' HG12 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -98.89 115.91 40.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.559 -0.965 . . . . 0.0 109.615 -179.635 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.51 ' CE2' ' HB3' ' A' ' 88' ' ' SER . 0.0 OUTLIER -73.53 -46.64 46.44 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 179.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.523 ' C ' HE22 ' A' ' 90' ' ' GLN . 6.9 t -164.37 157.65 17.74 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.542 -0.724 . . . . 0.0 109.554 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.657 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.1 p -117.26 154.05 31.85 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.645 ' NE2' ' C ' ' A' ' 89' ' ' THR . 10.9 mp0 -149.24 146.95 27.85 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.145 -0.972 . . . . 0.0 109.773 -178.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.843 HG12 ' HA ' ' A' ' 117' ' ' VAL . 20.6 m -140.56 177.7 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.215 -0.928 . . . . 0.0 110.124 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.456 ' O ' ' CE2' ' A' ' 73' ' ' PHE . . . 156.48 -118.9 0.87 Allowed Glycine 0 N--CA 1.483 1.822 0 C-N-CA 119.746 -1.216 . . . . 0.0 110.209 179.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 5.0 m-85 -125.13 167.78 14.32 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.608 -0.937 . . . . 0.0 109.814 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.673 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.76 -179.62 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 0.0 109.884 -179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 45.77 36.61 6.61 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.509 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -121.95 -170.56 13.81 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.682 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -144.05 78.55 1.59 Allowed 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.548 -0.972 . . . . 0.0 109.917 -179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.471 HG21 HG22 ' A' ' 111' ' ' THR . 0.0 OUTLIER -157.52 145.1 18.68 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.047 -1.033 . . . . 0.0 109.238 179.825 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 3.5 ttm-85 -55.17 -80.35 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 109.427 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.46 ' ND2' ' HG2' ' A' ' 99' ' ' ARG . 44.5 m-80 -122.83 75.25 47.54 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.054 -1.029 . . . . 0.0 109.668 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -76.78 151.48 31.78 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.827 2.351 . . . . 0.0 112.05 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.547 ' O ' HG22 ' A' ' 106' ' ' VAL . 19.1 p -122.0 164.22 18.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.055 -1.028 . . . . 0.0 109.393 179.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -51.1 -44.35 61.27 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.614 -0.678 . . . . 0.0 110.016 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -72.34 -27.03 62.15 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.151 -0.968 . . . . 0.0 110.009 -179.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.413 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 0.6 OUTLIER -80.98 -38.06 28.23 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.074 -1.016 . . . . 0.0 110.375 -179.345 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.9 HG12 ' OG1' ' A' ' 111' ' ' THR . 15.3 m -69.42 -24.03 27.08 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 120.866 -1.146 . . . . 0.0 110.161 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.624 ' C ' ' H ' ' A' ' 109' ' ' GLU . 94.5 m -45.76 -45.21 14.46 Favored 'General case' 0 C--N 1.296 -1.718 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 110' ' ' LYS . 29.6 t -60.52 5.5 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.339 -0.85 . . . . 0.0 108.965 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.624 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.9 mt-10 54.82 -0.04 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.456 -0.778 . . . . 0.0 109.659 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 mmtp -63.84 -19.5 65.08 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.058 -1.026 . . . . 0.0 109.044 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.9 ' OG1' HG12 ' A' ' 106' ' ' VAL . 31.7 p -98.34 0.72 46.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.418 -0.801 . . . . 0.0 109.373 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 30.99 47.81 0.17 Allowed Glycine 0 N--CA 1.488 2.155 0 C-N-CA 120.19 -1.005 . . . . 0.0 110.739 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -84.79 174.7 9.67 Favored 'General case' 0 N--CA 1.505 2.299 0 O-C-N 120.709 -1.465 . . . . 0.0 108.367 178.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.765 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -125.52 114.52 18.87 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.752 -0.779 . . . . 0.0 109.131 179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.701 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.1 mm-40 -62.52 111.53 2.08 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.765 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -140.16 -171.96 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.095 -1.003 . . . . 0.0 110.962 -178.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.843 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.1 m -130.32 128.18 63.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 CA-C-O 121.468 0.652 . . . . 0.0 109.754 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.602 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -97.95 97.3 8.82 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.485 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -105.8 129.72 58.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.63 0 O-C-N 121.342 -0.849 . . . . 0.0 109.509 -179.057 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.519 HG11 ' CZ ' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -108.25 132.28 56.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.343 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.742 ' CD2' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -139.06 156.71 46.98 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.544 0.688 . . . . 0.0 109.695 -178.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.511 ' HE ' HG23 ' A' ' 63' ' ' THR . 0.0 OUTLIER -95.92 108.28 39.72 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 121.66 -0.65 . . . . 0.0 110.633 -178.481 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 15.2 Cg_exo -41.62 -67.47 0.12 Allowed 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.713 2.276 . . . . 0.0 113.169 178.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.748 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 18.4 mp0 -49.64 -21.3 0.99 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.258 -0.901 . . . . 0.0 109.746 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 122' ' ' ARG . 1.1 m80 -92.37 -33.82 14.42 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.13 -0.981 . . . . 0.0 108.981 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.673 HD11 ' CG ' ' A' ' 130' ' ' GLU . 1.0 OUTLIER -148.18 141.04 18.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 N-CA-C 107.035 -1.469 . . . . 0.0 107.035 179.263 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.14 140.81 57.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.955 -1.091 . . . . 0.0 110.088 -179.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.911 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 21.9 t80 -69.42 -33.28 72.75 Favored 'General case' 0 N--CA 1.498 1.966 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.222 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -14.01 61.47 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.673 ' CG ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -74.98 -45.33 42.81 Favored 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.473 -0.767 . . . . 0.0 110.454 -179.0 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.742 HD12 ' CD2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -71.67 -31.02 66.35 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 119.361 -2.087 . . . . 0.0 107.492 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.911 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 1.1 mt -57.01 -21.77 33.31 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.445 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -70.34 -52.89 19.33 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.411 -0.805 . . . . 0.0 109.9 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.5 OUTLIER -49.93 -34.82 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.713 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 13.6 t80 -69.01 -53.22 21.67 Favored 'General case' 0 C--N 1.293 -1.888 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 50.6 m95 -70.44 -55.61 8.6 Favored 'General case' 0 N--CA 1.505 2.303 0 O-C-N 120.583 -1.323 . . . . 0.0 109.129 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.517 ' O ' ' OE2' ' A' ' 137' ' ' GLU . 2.2 tm-20 -37.53 -40.18 0.37 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.68 -0.637 . . . . 0.0 111.202 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 14.0 p30 -125.4 72.09 1.24 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.972 -1.08 . . . . 0.0 110.784 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.713 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 8.4 m80 -157.62 142.18 16.41 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.122 -0.986 . . . . 0.0 110.593 179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.786 ' CG ' HE21 ' A' ' 143' ' ' GLN . 0.7 OUTLIER -105.21 73.02 0.24 Allowed Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 106.916 -1.513 . . . . 0.0 106.916 176.636 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.483 ' CD ' ' O ' ' A' ' 139' ' ' HIS . 17.7 Cg_endo -59.53 23.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 121.736 1.624 . . . . 0.0 112.587 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 189' ' ' ILE . 0.2 OUTLIER -121.95 1.6 9.86 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 118.543 -1.263 . . . . 0.0 111.135 -179.819 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.786 HE21 ' CG ' ' A' ' 140' ' ' ASP . 46.2 mt-30 -106.79 92.35 4.06 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.753 -1.217 . . . . 0.0 108.951 178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.594 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -37.97 -113.3 0.0 OUTLIER Glycine 0 N--CA 1.495 2.603 0 CA-C-N 115.564 -0.744 . . . . 0.0 113.331 -178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.649 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 22.2 ptt? -66.05 41.78 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.84 0.829 . . . . 0.0 110.963 -175.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.708 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 178.37 145.49 0.13 Allowed 'General case' 0 C--N 1.29 -2.015 0 C-N-CA 119.711 -0.796 . . . . 0.0 108.897 178.671 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 1.3 mt-30 -152.13 155.48 37.94 Favored 'General case' 0 N--CA 1.502 2.148 0 O-C-N 119.782 -1.824 . . . . 0.0 110.215 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.58 -126.25 3.63 Favored Glycine 0 C--N 1.302 -1.309 0 CA-C-O 122.898 1.277 . . . . 0.0 110.438 178.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.47 ' HB2' ' H ' ' A' ' 220' ' ' LEU . 0.7 OUTLIER -81.85 -34.57 30.05 Favored 'General case' 0 C--N 1.279 -2.48 0 CA-C-N 114.16 -1.02 . . . . 0.0 112.129 -178.511 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.475 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 1.0 OUTLIER -91.84 126.26 36.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.314 -1.491 . . . . 0.0 108.862 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.43 ' CA ' ' HB2' ' A' ' 146' ' ' ARG . 0.2 OUTLIER -105.81 154.62 20.26 Favored 'General case' 0 C--N 1.303 -1.454 0 C-N-CA 119.443 -0.903 . . . . 0.0 110.054 -179.265 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.708 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 123.92 172.89 13.78 Favored Glycine 0 N--CA 1.497 2.74 0 C-N-CA 119.399 -1.381 . . . . 0.0 110.353 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -75.56 -28.15 58.9 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.285 -1.126 . . . . 0.0 109.82 -179.847 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.653 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 4.3 pt20 -69.98 -5.74 28.47 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.885 -1.134 . . . . 0.0 109.448 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.653 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 23.4 m-85 -131.4 52.08 2.09 Favored 'General case' 0 N--CA 1.484 1.266 0 O-C-N 121.078 -1.014 . . . . 0.0 109.351 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.801 HH22 HH22 ' A' ' 194' ' ' ARG . 6.8 mtp180 -90.96 176.18 6.7 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.142 -0.974 . . . . 0.0 109.582 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.694 ' OG ' HG23 ' A' ' 191' ' ' THR . 0.2 OUTLIER -91.08 117.66 29.78 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 103.383 -2.821 . . . . 0.0 103.383 175.733 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -136.99 128.75 28.92 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.863 -1.535 . . . . 0.0 111.99 -175.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.578 HG22 ' CZ ' ' A' ' 135' ' ' PHE . 1.4 t -115.89 115.52 49.49 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 177.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -113.2 121.15 38.66 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 121.38 -0.825 . . . . 0.0 109.299 -179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -82.7 170.11 13.02 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 C-N-CA 122.575 2.183 . . . . 0.0 112.28 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.716 HG23 ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -90.15 -29.23 18.42 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 120.916 -1.115 . . . . 0.0 109.369 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.48 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 178.48 -162.38 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 -179.744 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -54.58 -15.83 2.03 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-O 122.993 1.378 . . . . 0.0 108.648 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.48 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.8 t -55.92 -64.79 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.863 0 CA-C-N 114.096 -1.411 . . . . 0.0 109.666 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.726 HE21 HE21 ' A' ' 64' ' ' GLN . 22.3 mt-30 -79.56 -19.59 49.09 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.596 -0.69 . . . . 0.0 110.651 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttp -51.93 -34.87 43.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.874 -1.141 . . . . 0.0 110.407 -179.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -72.26 -28.56 63.21 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.746 -1.221 . . . . 0.0 109.431 179.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.473 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.76 -45.13 8.17 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.76 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.65 -56.09 17.88 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.214 -0.929 . . . . 0.0 109.553 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.3 mt -52.87 -37.16 60.11 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.164 -0.96 . . . . 0.0 109.218 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.26 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.306 -0.871 . . . . 0.0 109.422 179.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -55.84 -36.5 67.59 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.283 -0.886 . . . . 0.0 109.539 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.8 tttm -72.84 -57.81 3.8 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.147 -0.971 . . . . 0.0 110.223 -179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.595 ' CG ' ' N ' ' A' ' 176' ' ' GLU . 6.4 pt-20 -63.46 -47.09 83.27 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.217 -0.927 . . . . 0.0 110.427 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.635 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -53.08 -31.98 44.69 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.056 -1.028 . . . . 0.0 109.655 -179.442 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.506 ' CE2' HD21 ' A' ' 181' ' ' LEU . 0.6 OUTLIER -78.92 -14.92 58.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.283 -0.886 . . . . 0.0 109.527 -179.76 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.496 ' CD ' ' C ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -74.89 -38.79 61.79 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.182 -0.949 . . . . 0.0 109.299 -179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.456 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 0.1 OUTLIER -78.02 -23.17 48.34 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.265 -0.897 . . . . 0.0 109.651 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.635 HG23 ' O ' ' A' ' 176' ' ' GLU . 60.3 t -75.59 -54.56 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -0.961 . . . . 0.0 109.712 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.508 HD11 ' HB ' ' A' ' 223' ' ' THR . 4.6 mm? -68.96 -36.46 77.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.889 . . . . 0.0 109.629 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 88.3 p -56.03 -27.8 54.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.941 . . . . 0.0 109.276 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 14.4 mttt -88.11 -3.03 58.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.279 -0.888 . . . . 0.0 109.42 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.444 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 11.9 m170 -107.59 35.88 2.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.578 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.444 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.86 61.66 0.14 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.213 -0.93 . . . . 0.0 109.493 -179.933 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -152.19 175.04 13.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.285 -0.884 . . . . 0.0 109.308 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.9 -141.49 5.01 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -58.51 105.82 0.24 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.239 1.96 . . . . 0.0 111.196 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.714 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -53.24 177.15 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.221 -0.925 . . . . 0.0 110.354 -179.042 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.594 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 2.7 p -143.89 70.76 1.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 120.07 -0.652 . . . . 0.0 110.647 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.694 HG23 ' OG ' ' A' ' 157' ' ' SER . 61.2 m -100.47 160.24 14.51 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 105.243 -2.132 . . . . 0.0 105.243 177.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH2' ' A' ' 156' ' ' ARG . 21.2 t0 -105.91 106.38 16.86 Favored 'General case' 0 C--N 1.265 -3.067 0 C-N-CA 119.609 -0.836 . . . . 0.0 110.007 -179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -121.93 114.07 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.415 -0.803 . . . . 0.0 109.054 179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.801 HH22 HH22 ' A' ' 156' ' ' ARG . 1.0 OUTLIER -154.68 -170.46 3.53 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.381 -0.824 . . . . 0.0 109.178 -179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.421 ' HA ' HE22 ' A' ' 197' ' ' GLN . 86.3 mt-10 -119.67 -179.22 3.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.481 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 56.37 54.08 38.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.495 ' H ' ' CD ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.85 92.48 6.54 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.249 -1.148 . . . . 0.0 109.454 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 9.8 p -60.42 156.55 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.274 -0.891 . . . . 0.0 109.553 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.513 ' CZ ' ' HB2' ' A' ' 118' ' ' ARG . 63.2 t80 -126.05 140.24 52.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.342 -0.849 . . . . 0.0 109.235 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 10.2 m-85 -139.67 103.89 4.79 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.052 -1.03 . . . . 0.0 109.975 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -52.4 132.58 34.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -0.896 . . . . 0.0 111.219 -179.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.427 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -88.37 -171.26 3.28 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.662 ' CD ' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.44 174.94 8.22 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.662 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.4 OUTLIER -60.92 -50.49 73.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.733 -1.229 . . . . 0.0 108.088 178.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.659 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.53 -8.46 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.615 -0.678 . . . . 0.0 109.77 179.463 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.571 ' N ' ' O ' ' A' ' 204' ' ' ASP . 8.7 m-70 -103.55 13.62 32.98 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.066 -1.021 . . . . 0.0 111.446 -179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.774 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -138.6 -148.0 0.25 Allowed 'General case' 0 N--CA 1.501 2.101 0 O-C-N 120.684 -1.26 . . . . 0.0 111.197 -177.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.753 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 18.7 mp0 -33.49 -3.83 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.986 0 CA-C-N 114.606 -1.179 . . . . 0.0 114.049 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.774 ' N ' ' O ' ' A' ' 207' ' ' GLN . 14.3 p90 -44.83 -33.63 2.0 Favored 'General case' 0 N--CA 1.518 2.941 0 C-N-CA 116.429 -2.108 . . . . 0.0 108.738 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 209' ' ' TYR . 0.4 OUTLIER -51.13 -20.03 1.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.769 -1.207 . . . . 0.0 109.947 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 16.2 t -59.88 -35.83 75.66 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.058 -1.026 . . . . 0.0 108.683 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.443 ' C ' ' CD ' ' A' ' 214' ' ' PRO . 5.8 mmmt -88.29 -29.8 20.1 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.468 -0.77 . . . . 0.0 109.67 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.523 ' N ' ' CD ' ' A' ' 214' ' ' PRO . 0.7 OUTLIER -119.6 51.07 1.67 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.178 -0.951 . . . . 0.0 109.734 -179.873 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 213' ' ' ASN . 12.0 Cg_endo -60.41 8.95 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.826 0 C-N-CA 123.095 2.53 . . . . 0.0 112.406 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.5 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.0 t70 -63.58 -12.48 33.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -0.897 . . . . 0.0 110.36 -178.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.61 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 62.56 86.67 0.05 OUTLIER Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.34 -1.409 . . . . 0.0 110.657 178.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.61 ' O ' ' O ' ' A' ' 216' ' ' GLY . 1.5 p90 -44.61 179.05 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 CA-C-N 120.385 2.093 . . . . 0.0 109.612 -179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.452 ' O ' ' ND2' ' A' ' 149' ' ' ASN . 0.1 OUTLIER -72.84 76.71 1.15 Allowed 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.041 -1.037 . . . . 0.0 108.765 179.916 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -109.36 150.42 17.24 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.47 ' H ' ' HB2' ' A' ' 149' ' ' ASN . 7.6 mt -84.67 -173.38 4.69 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -1.12 . . . . 0.0 109.562 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 165.2 110.48 0.23 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.401 -1.48 . . . . 0.0 109.401 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 154.0 139.09 2.77 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.508 ' HB ' HD11 ' A' ' 181' ' ' LEU . 0.9 OUTLIER -81.33 37.06 0.44 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.195 -1.179 . . . . 0.0 109.45 179.955 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 72.25 13.67 76.74 Favored Glycine 0 C--N 1.302 -1.312 0 N-CA-C 108.77 -1.732 . . . . 0.0 108.77 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.836 HG22 ' HG3' ' A' ' 229' ' ' MET . 0.8 OUTLIER -49.89 101.4 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.746 -0.855 . . . . 0.0 109.061 179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.689 ' O ' ' SD ' ' A' ' 229' ' ' MET . 47.9 t -99.76 -153.11 0.43 Allowed 'General case' 0 C--N 1.307 -1.254 0 O-C-N 120.729 -1.232 . . . . 0.0 110.429 -178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.586 ' O ' ' SD ' ' A' ' 229' ' ' MET . 0.0 OUTLIER -76.59 -55.88 1.52 Allowed Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 178.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.473 ' HD3' ' SG ' ' A' ' 227' ' ' CYS . 84.3 Cg_exo -50.37 -24.74 12.5 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.413 2.075 . . . . 0.0 109.477 178.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.836 ' HG3' HG22 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -51.63 161.19 0.54 Allowed 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 113.193 -1.821 . . . . 0.0 110.351 -179.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.555 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.3 130.25 0.08 Allowed 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.967 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.463 HG12 ' SD ' ' A' ' 229' ' ' MET . 1.5 mm -142.58 114.43 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 O-C-N 121.205 -0.934 . . . . 0.0 109.39 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -79.13 136.1 37.03 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.0 109.491 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.346 0 O-C-N 121.271 -0.893 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.474 ' C1 ' ' HB2' ' A' ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.651 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.491 2.315 0 N-CA-C 109.466 -1.454 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 59.38 -69.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.309 -1.112 . . . . 0.0 109.445 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.674 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -50.79 -18.58 0.76 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.251 -0.906 . . . . 0.0 109.367 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.672 ' N ' ' O1 ' ' A' ' 21' ' ' MYR . . . -49.89 -9.02 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 123.018 1.39 . . . . 0.0 109.53 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.674 ' H ' ' C ' ' A' ' 24' ' ' SER . 2.3 p -47.46 -6.29 0.01 OUTLIER 'General case' 0 C--N 1.261 -3.26 0 CA-C-N 113.884 -1.507 . . . . 0.0 109.595 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.626 ' N ' ' O ' ' A' ' 25' ' ' ALA . 0.8 OUTLIER -122.3 40.38 3.67 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.984 1.373 . . . . 0.0 109.561 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -161.51 22.48 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.256 -3.469 0 N-CA-C 105.25 -2.13 . . . . 0.0 105.25 -178.022 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.628 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -41.18 176.13 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-O 122.828 1.299 . . . . 0.0 109.669 -178.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.473 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -105.27 123.26 47.54 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-N 114.714 -1.13 . . . . 0.0 109.423 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.851 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -47.04 -36.18 7.7 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.697 -0.627 . . . . 0.0 109.531 179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -54.0 -38.0 64.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.196 -0.94 . . . . 0.0 109.81 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.578 ' O ' ' C ' ' A' ' 34' ' ' ALA . 24.3 tp10 -91.19 -27.87 18.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.895 . . . . 0.0 109.573 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.578 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -28.24 126.38 0.09 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.59 -0.694 . . . . 0.0 110.371 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.923 HD23 ' OE1' ' A' ' 105' ' ' GLU . 4.5 mp -41.61 171.95 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.412 0 O-C-N 121.567 -0.708 . . . . 0.0 109.715 179.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.588 ' O ' HG22 ' A' ' 98' ' ' THR . 24.7 Cg_exo -61.48 -50.06 6.32 Favored 'Trans proline' 0 N--CA 1.491 1.355 0 C-N-CA 122.267 1.978 . . . . 0.0 111.114 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.428 ' O ' ' HA ' ' A' ' 101' ' ' PRO . . . 112.39 -64.38 0.27 Allowed Glycine 0 N--CA 1.489 2.175 0 C-N-CA 119.916 -1.135 . . . . 0.0 110.741 178.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.456 ' HD2' ' N ' ' A' ' 40' ' ' GLU . 5.4 tmm_? -64.79 122.54 17.14 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.57 -1.547 . . . . 0.0 109.973 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.535 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -126.66 -12.21 6.07 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 178.254 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.535 ' CB ' ' O ' ' A' ' 39' ' ' THR . 2.9 mt-10 156.87 165.67 0.02 OUTLIER Pre-proline 0 N--CA 1.495 1.812 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.66 170.91 0.17 Allowed 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.632 2.222 . . . . 0.0 112.281 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -139.55 78.18 27.09 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.023 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.659 ' O ' HG13 ' A' ' 44' ' ' VAL . 83.7 Cg_endo -85.0 162.6 11.72 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 C-N-CA 123.144 2.563 . . . . 0.0 112.504 179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.659 HG13 ' O ' ' A' ' 43' ' ' PRO . 15.7 m -160.7 -176.85 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.238 -0.914 . . . . 0.0 109.628 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -86.6 100.12 12.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.136 -0.977 . . . . 0.0 110.281 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.598 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.45 -61.31 2.5 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 121.261 -0.9 . . . . 0.0 111.414 -179.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.553 ' O ' ' C ' ' A' ' 48' ' ' HIS . 17.3 mttm -70.82 100.76 1.98 Allowed 'General case' 0 C--N 1.287 -2.148 0 C-N-CA 115.579 -2.448 . . . . 0.0 108.423 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.635 ' HE2' ' HG1' ' A' ' 89' ' ' THR . 5.9 t-80 -32.34 122.88 0.33 Allowed 'General case' 0 C--N 1.292 -1.933 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -68.06 -28.94 67.81 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.47 -0.769 . . . . 0.0 111.012 -178.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.72 HG11 ' HB2' ' A' ' 81' ' ' TRP . 41.8 t -69.25 -43.78 81.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.872 -1.143 . . . . 0.0 110.001 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -106.57 -44.16 4.55 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.0 110.306 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.22 2.76 51.25 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.693 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 43.9 p30 -79.44 -121.01 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.359 -1.719 . . . . 0.0 106.359 178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.6 mmt180 -127.81 172.03 11.21 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 123.061 1.41 . . . . 0.0 109.784 178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.598 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 37.0 p -138.55 9.63 2.67 Favored 'General case' 0 C--N 1.271 -2.834 0 CA-C-N 113.854 -1.521 . . . . 0.0 110.985 178.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.537 ' O ' ' C ' ' A' ' 57' ' ' GLU . 11.6 m -145.62 132.76 15.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.415 -1.428 . . . . 0.0 109.809 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.6 mm-40 -32.73 149.36 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.504 0 CA-C-O 121.75 0.786 . . . . 0.0 110.538 -179.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.435 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.3 Cg_endo -78.34 166.21 80.85 Favored 'Cis proline' 0 C--N 1.306 -1.696 0 C-N-CA 121.961 -2.1 . . . . 0.0 111.831 -0.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.33 151.68 39.15 Favored Pre-proline 0 C--N 1.269 -2.934 0 CA-C-N 114.355 -1.293 . . . . 0.0 109.289 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.57 ' O ' ' OG1' ' A' ' 63' ' ' THR . 23.9 Cg_endo -64.61 122.94 10.98 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 C-N-CA 122.747 2.298 . . . . 0.0 112.162 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.536 ' O ' ' CD ' ' A' ' 61' ' ' GLU . 2.4 pp20? -43.48 143.82 0.86 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.31 32.41 7.8 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -154.77 137.15 14.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.308 -1.113 . . . . 0.0 109.603 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.903 ' NE2' ' H ' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -108.11 171.08 7.61 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.582 ' O ' HG21 ' A' ' 162' ' ' THR . 7.4 mtm -128.07 132.54 49.03 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.925 -1.109 . . . . 0.0 109.99 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -130.91 -170.75 2.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.683 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 62.0 t -143.58 151.27 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 119.906 -1.746 . . . . 0.0 109.749 -179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.683 ' CD1' ' O ' ' A' ' 67' ' ' VAL . 36.6 m-85 -147.07 125.93 12.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.097 -1.002 . . . . 0.0 109.982 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -105.68 89.26 0.61 Allowed Glycine 0 N--CA 1.484 1.87 0 N-CA-C 109.187 -1.565 . . . . 0.0 109.187 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.541 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -85.89 -75.2 0.38 Allowed 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.626 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -165.74 -161.03 13.85 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 107.755 -2.138 . . . . 0.0 107.755 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.728 ' O ' ' SG ' ' A' ' 72' ' ' CYS . 0.5 OUTLIER -28.77 107.83 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 CA-C-N 118.289 1.045 . . . . 0.0 108.611 179.241 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.78 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -59.3 7.28 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.075 -1.016 . . . . 0.0 111.183 -177.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.675 ' O ' HD11 ' A' ' 210' ' ' LEU . 6.3 m0 -69.35 -60.83 2.08 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.746 -1.221 . . . . 0.0 108.856 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.69 -10.01 58.2 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.874 -1.291 . . . . 0.0 109.874 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.556 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . . . -59.7 -58.61 7.85 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.188 -1.183 . . . . 0.0 110.273 -179.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.694 ' OE1' HG13 ' A' ' 91' ' ' VAL . 8.8 pt-20 -76.12 -12.57 60.13 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.132 -0.98 . . . . 0.0 110.757 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -56.79 -54.97 40.2 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.603 -1.31 . . . . 0.0 109.623 -179.401 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.461 ' HZ3' ' HB2' ' A' ' 79' ' ' LYS . 0.1 OUTLIER -56.43 -0.79 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.141 -0.975 . . . . 0.0 110.69 -179.239 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.537 ' CE2' HG11 ' A' ' 134' ' ' VAL . 19.8 m-85 -94.32 -39.57 10.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.744 -1.223 . . . . 0.0 109.851 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.72 ' HB2' HG11 ' A' ' 50' ' ' VAL . 1.3 p90 -77.01 16.74 0.51 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.85 -1.156 . . . . 0.0 109.318 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.604 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 m -117.11 19.58 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.163 -0.961 . . . . 0.0 110.139 -178.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.446 HD12 ' C ' ' A' ' 83' ' ' LEU . 3.9 pp -135.67 161.31 35.89 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.11 -0.994 . . . . 0.0 109.466 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -93.03 150.3 20.63 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.603 -0.686 . . . . 0.0 109.984 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.468 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 110.44 -29.0 9.48 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 108.213 -1.955 . . . . 0.0 108.213 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -84.36 132.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 O-C-N 121.791 -0.829 . . . . 0.0 110.143 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.693 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.85 -43.04 31.56 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.639 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.51 ' OG ' ' CG ' ' A' ' 48' ' ' HIS . 5.5 t -162.25 -165.19 1.16 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-O 121.483 0.659 . . . . 0.0 109.796 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.635 ' HG1' ' HE2' ' A' ' 48' ' ' HIS . 74.1 p -154.16 143.47 21.38 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.519 ' O ' ' N ' ' A' ' 118' ' ' ARG . 6.7 mp0 -144.64 145.88 31.99 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.174 -0.954 . . . . 0.0 109.854 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.694 HG13 ' OE1' ' A' ' 77' ' ' GLU . 0.1 OUTLIER -128.99 156.6 41.73 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.277 -0.889 . . . . 0.0 109.037 179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -175.28 172.84 45.84 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 102' ' ' THR . 3.7 m-85 -79.99 138.37 37.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.401 -1.058 . . . . 0.0 109.059 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.779 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -157.72 -170.16 3.1 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.045 -1.035 . . . . 0.0 109.926 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.513 ' O ' ' NH2' ' A' ' 194' ' ' ARG . . . 40.83 38.05 1.51 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.581 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -117.71 -154.27 9.83 Favored Glycine 0 N--CA 1.496 2.659 0 O-C-N 120.757 -1.437 . . . . 0.0 109.751 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.851 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -151.8 64.68 0.86 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.325 -1.103 . . . . 0.0 109.166 -179.328 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.635 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.31 -178.48 7.38 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.027 -1.045 . . . . 0.0 108.636 -179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.689 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 14.3 tpp85 -75.12 -107.59 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.768 0 O-C-N 121.449 -0.782 . . . . 0.0 109.318 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.466 ' ND2' ' CG ' ' A' ' 99' ' ' ARG . 1.2 m-80 -104.9 72.69 0.22 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.445 179.645 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.574 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 38.3 Cg_endo -65.59 157.72 56.99 Favored 'Trans proline' 0 N--CA 1.496 1.642 0 C-N-CA 122.824 2.35 . . . . 0.0 112.521 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.556 ' O ' HG22 ' A' ' 106' ' ' VAL . 23.2 p -122.94 170.43 10.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.244 -0.91 . . . . 0.0 109.438 179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.414 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 4.3 t80 -55.48 -45.76 76.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.592 -0.692 . . . . 0.0 109.975 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.49 -25.89 61.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 0.0 110.033 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.923 ' OE1' HD23 ' A' ' 35' ' ' LEU . 3.5 mm-40 -81.89 -37.66 26.53 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.104 -0.997 . . . . 0.0 110.544 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.556 HG22 ' O ' ' A' ' 102' ' ' THR . 13.5 m -66.31 -23.83 32.41 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.218 0 O-C-N 120.594 -1.317 . . . . 0.0 109.663 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.614 ' C ' ' H ' ' A' ' 109' ' ' GLU . 3.7 t -52.72 -38.93 61.55 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.521 -0.737 . . . . 0.0 109.58 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.648 ' OG ' HD22 ' A' ' 35' ' ' LEU . 0.1 OUTLIER -52.86 -1.49 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.169 -0.957 . . . . 0.0 109.23 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.614 ' H ' ' C ' ' A' ' 107' ' ' CYS . 2.4 tt0 59.65 -6.59 0.07 Allowed 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.253 -0.905 . . . . 0.0 109.65 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.718 ' CB ' HD13 ' A' ' 35' ' ' LEU . 1.6 mmtt -75.98 -24.46 55.37 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.382 -0.824 . . . . 0.0 110.163 -179.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.448 ' OG1' HG12 ' A' ' 106' ' ' VAL . 31.1 p -84.15 -10.56 57.66 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.828 -1.17 . . . . 0.0 109.378 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.437 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 43.26 39.5 4.14 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.672 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -82.42 162.6 22.08 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -1.225 . . . . 0.0 109.16 179.908 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.869 ' HB2' HH12 ' A' ' 156' ' ' ARG . . . -124.37 113.85 18.74 Favored 'General case' 0 N--CA 1.49 1.575 0 C-N-CA 119.572 -0.851 . . . . 0.0 109.376 179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.689 ' OE1' ' CD1' ' A' ' 73' ' ' PHE . 2.4 mm-40 -54.27 116.31 2.55 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 179.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.779 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -124.66 175.82 6.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.03 -1.044 . . . . 0.0 110.88 -178.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.738 ' O ' HG23 ' A' ' 117' ' ' VAL . 3.6 m -133.01 114.92 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.55 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 90' ' ' GLN . 0.2 OUTLIER -95.87 98.68 10.6 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.657 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.501 HG21 ' CD2' ' A' ' 80' ' ' PHE . 14.0 m -118.96 122.43 69.32 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 C-N-CA 120.045 -0.662 . . . . 0.0 109.5 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -83.6 155.75 3.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.903 ' H ' ' NE2' ' A' ' 64' ' ' GLN . 4.7 m-85 -130.18 160.71 32.99 Favored 'General case' 0 N--CA 1.504 2.233 0 C-N-CA 119.062 -1.055 . . . . 0.0 108.845 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.468 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 50.6 mtp85 -101.3 105.44 39.64 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.531 -0.731 . . . . 0.0 110.52 -179.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.547 ' O ' ' N ' ' A' ' 125' ' ' HIS . 9.4 Cg_exo -40.58 -66.84 0.13 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 123.203 2.602 . . . . 0.0 113.877 178.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.425 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.5 tt0 -42.82 -19.31 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.997 -1.064 . . . . 0.0 109.938 -179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.547 ' N ' ' O ' ' A' ' 123' ' ' PRO . 67.5 m-70 -109.97 -7.78 14.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.999 -1.063 . . . . 0.0 109.852 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.687 HG22 ' CD ' ' A' ' 130' ' ' GLU . 1.2 pt -152.19 -176.85 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-O 122.389 1.09 . . . . 0.0 110.989 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.545 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 43.7 t -130.37 152.32 49.91 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 177.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.647 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 25.4 t80 -48.33 -19.16 0.27 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.514 -1.367 . . . . 0.0 109.382 -179.54 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.439 ' N ' ' C ' ' A' ' 127' ' ' SER . 9.1 mp0 -70.48 -24.54 62.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.352 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.687 ' CD ' HG22 ' A' ' 126' ' ' ILE . 7.1 mt-10 -68.87 -71.77 0.21 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.0 109.999 -179.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.69 HD21 ' HB2' ' A' ' 121' ' ' TYR . 1.2 mp -35.86 -43.55 0.31 Allowed 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.326 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.647 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 7.5 mp -73.94 -44.98 53.15 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.446 -0.784 . . . . 0.0 111.519 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.26 -53.19 47.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.795 -1.19 . . . . 0.0 110.343 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.676 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 2.0 t -50.28 -50.64 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.177 -0.952 . . . . 0.0 110.227 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.798 ' CZ ' ' CE1' ' A' ' 139' ' ' HIS . 22.5 t80 -58.0 -44.39 87.18 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.775 -1.203 . . . . 0.0 111.589 -178.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.583 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 67.7 m95 -70.74 -36.09 72.98 Favored 'General case' 0 N--CA 1.507 2.422 0 O-C-N 120.772 -1.205 . . . . 0.0 111.702 -178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -79.21 -13.38 59.73 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.938 -1.101 . . . . 0.0 112.974 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.676 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.0 OUTLIER -133.99 59.63 1.73 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.11 -1.619 . . . . 0.0 112.087 -178.31 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.798 ' CE1' ' CZ ' ' A' ' 135' ' ' PHE . 1.3 p-80 177.58 134.25 0.07 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.027 -1.045 . . . . 0.0 109.833 178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.658 ' OD2' ' NE2' ' A' ' 143' ' ' GLN . 1.2 t0 -48.96 107.36 0.75 Allowed Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.33 -0.857 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -85.98 -2.07 8.79 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.735 2.29 . . . . 0.0 113.038 -179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.55 ' C ' ' OG1' ' A' ' 190' ' ' THR . 40.2 p -121.72 20.55 10.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.986 -1.071 . . . . 0.0 110.261 -179.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.69 ' N ' ' OG1' ' A' ' 190' ' ' THR . 7.7 mt-30 -130.94 101.25 5.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.022 -1.049 . . . . 0.0 109.15 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.677 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -96.86 18.74 56.98 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.321 -1.112 . . . . 0.0 110.321 -179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.26 -18.35 12.1 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.979 -1.306 . . . . 0.0 109.8 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.649 ' C ' ' CD ' ' A' ' 146' ' ' ARG . 0.0 OUTLIER 179.54 164.59 1.03 Allowed 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.001 -1.062 . . . . 0.0 109.87 -179.214 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.571 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -99.34 108.36 20.86 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.589 -1.32 . . . . 0.0 109.999 179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 57.91 -122.15 28.46 Favored Glycine 0 C--N 1.301 -1.366 0 CA-C-O 123.211 1.451 . . . . 0.0 110.461 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -80.05 -32.96 39.37 Favored 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 113.461 -1.37 . . . . 0.0 111.964 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.571 ' OD2' ' O ' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.31 101.71 0.18 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.171 -1.581 . . . . 0.0 108.885 -179.961 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.691 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 6.5 p90 -82.43 118.44 23.21 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.328 -0.857 . . . . 0.0 110.368 -179.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.578 ' H ' ' HB2' ' A' ' 146' ' ' ARG . . . 166.15 144.19 4.0 Favored Glycine 0 N--CA 1.494 2.55 0 N-CA-C 110.015 -1.234 . . . . 0.0 110.015 179.412 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.531 ' O ' ' OG1' ' A' ' 153' ' ' THR . 0.5 OUTLIER -70.97 14.54 0.14 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.109 -1.23 . . . . 0.0 109.047 179.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.668 ' CD ' ' CZ ' ' A' ' 155' ' ' TYR . 9.3 pt20 -102.79 -1.65 29.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.285 -0.884 . . . . 0.0 110.383 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.668 ' CZ ' ' CD ' ' A' ' 154' ' ' GLN . 22.4 m-85 -132.38 53.09 2.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.815 -1.178 . . . . 0.0 109.633 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.869 HH12 ' HB2' ' A' ' 114' ' ' ALA . 0.4 OUTLIER -100.02 177.41 5.1 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.131 -0.981 . . . . 0.0 110.331 -179.171 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.548 ' O ' ' OG1' ' A' ' 191' ' ' THR . 11.5 p -92.98 71.41 4.67 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 177.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.548 ' CB ' ' OH ' ' A' ' 160' ' ' TYR . . . -97.38 129.57 44.61 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 121.631 0.729 . . . . 0.0 110.912 -176.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.531 HG13 HG21 ' A' ' 191' ' ' THR . 19.9 m -102.11 146.35 10.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.566 ' CE1' HG11 ' A' ' 116' ' ' VAL . 22.2 m-85 -139.89 115.89 8.07 Favored Pre-proline 0 C--N 1.295 -1.773 0 N-CA-C 107.659 -1.238 . . . . 0.0 107.659 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.524 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 72.3 Cg_endo -77.57 167.37 24.33 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.344 2.029 . . . . 0.0 113.349 -178.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.582 HG21 ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -93.5 -41.73 9.62 Favored 'General case' 0 C--N 1.315 -0.915 0 O-C-N 121.282 -0.886 . . . . 0.0 109.392 179.501 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.446 ' OG ' ' C ' ' A' ' 162' ' ' THR . 0.9 OUTLIER -171.8 -172.15 0.98 Allowed 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.225 -0.922 . . . . 0.0 109.994 -179.836 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.8 -25.53 4.56 Favored 'General case' 0 N--CA 1.491 1.59 0 CA-C-O 123.074 1.416 . . . . 0.0 108.529 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.435 HG12 ' N ' ' A' ' 166' ' ' GLN . 2.5 t -56.01 -58.8 3.82 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.074 0 CA-C-N 113.798 -1.546 . . . . 0.0 109.12 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.435 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -78.25 -25.66 46.94 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.086 -0.961 . . . . 0.0 111.086 -178.692 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.77 -38.6 56.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.28 -0.887 . . . . 0.0 110.657 -178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 -48.13 -61.62 1.89 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.889 -1.132 . . . . 0.0 110.826 -179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.56 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . . . -93.86 -16.93 23.59 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 120.85 -1.156 . . . . 0.0 112.341 -178.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.33 -65.67 0.52 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.429 -1.419 . . . . 0.0 110.357 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.571 HD23 ' C ' ' A' ' 171' ' ' LEU . 0.0 OUTLIER -60.13 -21.42 61.58 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 120.875 -1.141 . . . . 0.0 108.247 179.82 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.556 ' N ' HD23 ' A' ' 171' ' ' LEU . 0.3 OUTLIER -75.51 -27.98 58.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.398 -0.814 . . . . 0.0 109.438 178.825 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.583 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 97.3 p -56.29 -26.91 53.67 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.248 -0.908 . . . . 0.0 109.79 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 174' ' ' LYS . 14.4 mtmm -67.73 -58.48 4.56 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.113 -0.992 . . . . 0.0 109.825 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -73.55 8.56 1.77 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.172 -0.955 . . . . 0.0 110.019 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -78.57 -75.75 0.22 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.117 -0.99 . . . . 0.0 110.102 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.434 ' O ' HG22 ' A' ' 180' ' ' VAL . 0.2 OUTLIER -58.16 -32.31 68.07 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.303 -0.873 . . . . 0.0 110.222 -179.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 20.8 tp60 -52.79 -17.97 1.63 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -0.963 . . . . 0.0 109.652 -179.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 3.1 ttmm -68.04 -39.29 83.09 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.635 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.686 ' O ' ' CE1' ' A' ' 184' ' ' HIS . 15.8 m -87.45 -30.88 5.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.108 -0.995 . . . . 0.0 109.898 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 40.1 mt -75.29 -38.51 60.32 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.133 -0.979 . . . . 0.0 109.62 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 36.9 t -56.56 -24.78 49.56 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.896 . . . . 0.0 109.527 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.9 mtpt -75.69 -29.84 59.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.453 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.708 ' CD2' ' SD ' ' A' ' 229' ' ' MET . 0.6 OUTLIER -86.0 6.39 28.95 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.311 -0.868 . . . . 0.0 109.366 179.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.427 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.74 68.66 0.15 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.356 -0.84 . . . . 0.0 109.554 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -115.78 162.62 17.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.267 -0.896 . . . . 0.0 109.435 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.82 178.23 48.77 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -59.5 157.86 29.86 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 122.708 2.272 . . . . 0.0 112.075 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.533 HD13 ' HA ' ' A' ' 189' ' ' ILE . 0.4 OUTLIER -64.05 125.29 20.47 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 O-C-N 121.166 -0.959 . . . . 0.0 108.686 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.69 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 6.8 p -110.59 54.1 0.68 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.17 -0.956 . . . . 0.0 109.685 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.548 ' OG1' ' O ' ' A' ' 157' ' ' SER . 0.8 OUTLIER -100.68 159.53 15.09 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 106.695 -1.595 . . . . 0.0 106.695 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.671 ' CG ' HH12 ' A' ' 194' ' ' ARG . 10.7 t0 -109.29 145.28 36.23 Favored 'General case' 0 C--N 1.26 -3.306 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.321 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.405 HD13 ' CG2' ' A' ' 159' ' ' VAL . 0.8 OUTLIER -123.73 156.41 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.671 HH12 ' CG ' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -146.82 -166.91 2.62 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.821 -1.174 . . . . 0.0 111.276 -178.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.807 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -95.46 159.62 14.91 Favored 'General case' 0 CA--C 1.473 -1.986 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 178.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 1.24 ' O ' ' NE2' ' A' ' 197' ' ' GLN . . . 10.97 -79.69 0.0 OUTLIER Glycine 0 C--O 1.17 -3.858 0 N-CA-C 105.261 -3.135 . . . . 0.0 105.261 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 1.24 ' NE2' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 151.15 88.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 C-N-CA 124.048 0.939 . . . . 0.0 110.172 175.625 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.64 HG13 ' O ' ' A' ' 198' ' ' VAL . 10.0 p -45.78 117.8 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 117.47 -1.692 . . . . 0.0 106.511 177.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.51 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 18.6 t80 -102.52 147.53 26.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.073 -1.017 . . . . 0.0 111.578 -177.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.689 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 7.7 m-85 -153.39 100.75 2.46 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.482 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 25.6 m-85 -53.08 135.43 37.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.787 -1.196 . . . . 0.0 109.65 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.654 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -86.87 -170.56 3.12 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.257 -0.902 . . . . 0.0 108.9 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 11.3 mp0 -74.39 155.06 38.5 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 121.542 -0.724 . . . . 0.0 109.52 179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.473 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -50.6 -43.22 56.67 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.496 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.557 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -54.07 -15.14 1.3 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.702 -0.624 . . . . 0.0 109.74 179.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.78 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 8.2 m-70 -100.69 9.35 42.56 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.142 -0.974 . . . . 0.0 110.605 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.832 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.5 mm-40 -127.98 -145.87 0.32 Allowed 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 122.092 0.949 . . . . 0.0 110.119 -178.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.684 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.86 -3.72 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.285 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.953 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.832 ' N ' ' O ' ' A' ' 207' ' ' GLN . 86.8 t80 -41.02 -43.22 2.1 Favored 'General case' 0 N--CA 1.517 2.88 0 O-C-N 120.524 -1.36 . . . . 0.0 110.837 -179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.675 HD11 ' O ' ' A' ' 74' ' ' TRP . 0.8 OUTLIER -65.36 -13.14 57.89 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.378 -1.452 . . . . 0.0 109.903 -178.234 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.418 ' N ' ' O ' ' A' ' 208' ' ' GLN . 94.6 p -55.96 -31.09 62.66 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.08 -1.012 . . . . 0.0 108.656 179.243 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.9 mmtp -85.62 -36.39 20.38 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 121.456 -0.778 . . . . 0.0 109.0 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.593 ' O ' ' N ' ' A' ' 215' ' ' ASP . 0.1 OUTLIER -131.98 68.41 80.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.408 ' N ' ' O ' ' A' ' 210' ' ' LEU . 52.5 Cg_exo -49.94 8.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 123.072 2.514 . . . . 0.0 113.298 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.593 ' N ' ' O ' ' A' ' 213' ' ' ASN . 0.0 OUTLIER -61.34 -24.8 66.71 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.618 -1.233 . . . . 0.0 109.49 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 58.88 83.84 0.05 OUTLIER Glycine 0 N--CA 1.499 2.889 0 C-N-CA 120.385 -0.912 . . . . 0.0 112.21 177.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 91.0 t80 -70.5 88.2 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 120.902 2.351 . . . . 0.0 108.575 178.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.587 ' O ' ' O ' ' A' ' 219' ' ' GLY . 18.1 t -169.74 114.32 0.52 Allowed 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.863 -1.148 . . . . 0.0 109.387 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -39.89 170.09 0.01 OUTLIER Glycine 0 N--CA 1.492 2.391 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 2.5 pp -61.93 -174.84 0.06 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.343 -1.093 . . . . 0.0 110.131 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.575 ' O ' ' C ' ' A' ' 222' ' ' GLY . . . -155.04 -80.88 0.03 OUTLIER Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.575 ' C ' ' O ' ' A' ' 221' ' ' GLY . . . -27.95 105.99 0.01 OUTLIER Glycine 0 N--CA 1.49 2.292 0 CA-C-O 123.051 1.362 . . . . 0.0 109.954 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.619 ' C ' ' H ' ' A' ' 225' ' ' VAL . 0.8 OUTLIER -126.91 21.19 6.93 Favored 'General case' 0 C--N 1.27 -2.855 0 CA-C-N 113.896 -1.152 . . . . 0.0 109.308 179.76 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -69.33 14.29 0.95 Allowed Glycine 0 N--CA 1.474 1.198 0 N-CA-C 108.506 -1.837 . . . . 0.0 108.506 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.726 HG13 ' O ' ' A' ' 230' ' ' ALA . 1.5 t -100.86 120.77 50.83 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.887 -0.772 . . . . 0.0 109.575 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.677 ' H ' ' CB ' ' A' ' 229' ' ' MET . 0.7 OUTLIER -98.62 -153.66 0.44 Allowed 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 122.061 0.934 . . . . 0.0 109.776 -179.986 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.575 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -72.53 -63.9 1.06 Allowed Pre-proline 0 C--N 1.291 -1.966 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.568 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.575 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 56.5 Cg_endo -70.55 -36.65 8.38 Favored 'Trans proline' 0 N--CA 1.492 1.439 0 C-N-CA 122.37 2.047 . . . . 0.0 109.447 178.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.708 ' SD ' ' CD2' ' A' ' 184' ' ' HIS . 0.0 OUTLIER -53.7 153.61 4.35 Favored 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.416 -1.266 . . . . 0.0 109.756 179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.726 ' O ' HG13 ' A' ' 225' ' ' VAL . . . -29.29 130.85 0.07 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 121.139 0.495 . . . . 0.0 109.989 -179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 1.6 mm -138.33 112.47 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.263 -0.898 . . . . 0.0 109.407 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 14.7 ttpp -71.54 110.76 6.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.297 -0.877 . . . . 0.0 109.467 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.375 0 O-C-N 121.268 -0.895 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.672 ' O1 ' ' N ' ' A' ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.383 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.587 ' O ' ' O ' ' A' ' 22' ' ' GLY . 8.4 t0 43.79 100.13 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.3 -1.118 . . . . 0.0 109.185 -179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 p -66.78 -27.01 67.24 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.233 -0.917 . . . . 0.0 110.222 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.57 ' O ' ' N ' ' A' ' 29' ' ' ILE . . . -77.63 -12.42 59.97 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 122.895 1.331 . . . . 0.0 109.931 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.809 ' O ' HG21 ' A' ' 153' ' ' THR . 29.8 t -49.46 -48.87 47.31 Favored 'General case' 0 C--N 1.261 -3.281 0 CA-C-N 114.072 -1.422 . . . . 0.0 110.695 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.867 ' O ' H142 ' A' ' 21' ' ' MYR . 0.0 OUTLIER -115.95 27.5 9.24 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-O 123.446 1.594 . . . . 0.0 109.796 -178.934 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.716 ' O ' ' O ' ' A' ' 29' ' ' ILE . 47.5 t -152.19 22.7 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.557 0 N-CA-C 104.269 -2.493 . . . . 0.0 104.269 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.716 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -36.58 176.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 CA-C-O 123.141 1.448 . . . . 0.0 110.14 -178.341 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.434 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -73.7 124.45 26.03 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.768 -1.105 . . . . 0.0 110.249 -179.839 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.79 -43.43 80.87 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.755 -0.591 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -68.17 0.88 3.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.306 -0.871 . . . . 0.0 109.767 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.599 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 mm-40 -107.27 -35.93 6.67 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.272 -0.892 . . . . 0.0 108.963 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.599 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.78 -170.17 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.401 -0.812 . . . . 0.0 109.665 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' N ' ' CD2' ' A' ' 35' ' ' LEU . 4.2 mm? -82.68 165.76 39.98 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.225 -0.922 . . . . 0.0 108.973 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -62.59 -45.29 14.6 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.129 1.886 . . . . 0.0 111.987 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.411 ' HA2' HG22 ' A' ' 98' ' ' THR . . . 126.09 153.86 8.51 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.751 -1.339 . . . . 0.0 109.751 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 36.7 mtt-85 -147.41 149.52 32.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -1.106 . . . . 0.0 109.469 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.493 ' HA ' HD22 ' A' ' 100' ' ' ASN . 13.6 p -122.72 -13.4 7.93 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.251 -0.905 . . . . 0.0 109.398 179.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -49.61 149.46 4.26 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -64.86 151.74 84.66 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 C-N-CA 122.855 2.37 . . . . 0.0 112.13 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.717 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -137.83 35.59 0.26 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.164 -0.96 . . . . 0.0 110.143 -179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.922 ' O ' HG13 ' A' ' 44' ' ' VAL . 27.2 Cg_endo -64.34 165.91 18.61 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 C-N-CA 122.636 2.224 . . . . 0.0 111.862 179.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.922 HG13 ' O ' ' A' ' 43' ' ' PRO . 2.3 m -172.95 172.89 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.441 -0.787 . . . . 0.0 109.38 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.642 ' O ' HG23 ' A' ' 45' ' ' THR . 7.3 t 9.98 80.99 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-O 121.509 0.671 . . . . 0.0 110.823 -179.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.703 ' O ' HG23 ' A' ' 55' ' ' THR . . . -69.24 -52.68 25.24 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.576 -0.702 . . . . 0.0 111.394 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.557 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.63 99.66 10.93 Favored 'General case' 0 C--N 1.285 -2.199 0 C-N-CA 115.746 -2.382 . . . . 0.0 108.765 -179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.775 ' NE2' ' NE2' ' A' ' 208' ' ' GLN . 8.5 t-80 -31.67 141.34 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.492 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.9 t60 -80.44 -42.51 22.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.989 -1.07 . . . . 0.0 110.572 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.453 ' CG2' ' OG ' ' A' ' 211' ' ' SER . 25.8 t -58.1 -37.56 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -0.966 . . . . 0.0 110.179 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.4 t -109.4 -48.69 3.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.182 -0.949 . . . . 0.0 110.507 -179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.04 4.63 55.35 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.191 -1.564 . . . . 0.0 109.191 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.692 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.6 p30 -81.81 -110.38 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.68 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 10.1 mtm-85 -129.24 174.88 9.19 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 123.519 1.628 . . . . 0.0 109.855 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.703 HG23 ' O ' ' A' ' 46' ' ' ALA . 63.3 p -132.51 0.35 3.64 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 112.939 -1.937 . . . . 0.0 111.397 178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.499 ' O ' ' C ' ' A' ' 57' ' ' GLU . 1.1 m -145.11 132.09 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 120.507 -1.37 . . . . 0.0 110.01 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.5 mt-10 -34.03 154.8 0.05 OUTLIER Pre-proline 0 C--N 1.301 -1.526 0 CA-C-O 121.881 0.848 . . . . 0.0 110.845 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.425 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.8 Cg_endo -79.53 166.05 78.82 Favored 'Cis proline' 0 C--N 1.301 -1.969 0 C-N-CA 121.479 -2.301 . . . . 0.0 111.633 -0.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.402 ' CZ ' HG21 ' A' ' 120' ' ' VAL . 35.6 m-85 -111.15 148.92 39.71 Favored Pre-proline 0 C--N 1.266 -3.035 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.0 179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.482 ' O ' ' OG1' ' A' ' 63' ' ' THR . 8.3 Cg_endo -53.28 139.47 63.75 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.929 2.42 . . . . 0.0 112.618 -179.179 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -45.5 158.35 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.377 -0.827 . . . . 0.0 109.435 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.08 42.78 66.82 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.072 -1.611 . . . . 0.0 109.072 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.544 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 1.2 p -136.7 147.38 46.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -1.072 . . . . 0.0 109.622 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.583 ' OE1' ' CG ' ' A' ' 123' ' ' PRO . 2.1 mp0 -116.79 173.47 6.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.41 -0.806 . . . . 0.0 108.839 179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.751 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -154.22 128.67 9.18 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.983 -1.073 . . . . 0.0 109.841 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.01 -167.6 2.33 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 35.1 t -143.22 137.6 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 120.087 -1.633 . . . . 0.0 109.983 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 1.045 ' O ' HG22 ' A' ' 117' ' ' VAL . 54.5 m-85 -131.76 137.89 48.38 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.059 -1.026 . . . . 0.0 110.144 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -122.78 110.26 1.52 Allowed Glycine 0 N--CA 1.479 1.545 0 N-CA-C 105.715 -2.954 . . . . 0.0 105.715 176.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.556 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -107.14 -87.62 0.48 Allowed 'General case' 0 C--N 1.292 -1.921 0 O-C-N 121.214 -1.168 . . . . 0.0 110.413 -177.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.717 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.75 74.76 0.2 Allowed Glycine 0 N--CA 1.496 2.699 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.717 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 51.1 t 111.41 82.24 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.68 ' N ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -55.72 7.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.623 -1.298 . . . . 0.0 110.734 -178.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.643 ' H ' ' C ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -91.41 -44.41 9.15 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.068 -1.02 . . . . 0.0 109.363 179.196 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -102.51 -3.95 49.87 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.695 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.24 -35.41 59.01 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.167 -1.196 . . . . 0.0 109.733 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.628 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 29.4 tt0 -68.17 -15.17 63.47 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.267 -0.896 . . . . 0.0 110.28 -179.307 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.593 ' O ' HG13 ' A' ' 82' ' ' VAL . 11.5 ttt180 -60.16 -54.39 46.41 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.108 -0.995 . . . . 0.0 110.504 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.507 ' H ' ' HE2' ' A' ' 79' ' ' LYS . 0.2 OUTLIER -73.38 25.99 0.07 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.941 -1.099 . . . . 0.0 110.165 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.7 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 6.8 m-85 -126.78 -39.01 2.01 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.482 -0.761 . . . . 0.0 110.125 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.693 ' CE2' ' OG ' ' A' ' 211' ' ' SER . 1.2 p90 -84.74 1.71 45.38 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.703 -1.248 . . . . 0.0 109.72 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.2 m -104.84 11.66 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.047 -1.033 . . . . 0.0 109.595 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.829 HD11 HG21 ' A' ' 134' ' ' VAL . 96.0 mt -99.04 149.49 22.95 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 122.07 0.938 . . . . 0.0 109.116 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.579 ' HZ3' ' HA ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -85.82 136.7 33.21 Favored 'General case' 0 C--N 1.287 -2.113 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 -179.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.427 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 107.53 -26.51 17.95 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 108.632 -1.787 . . . . 0.0 108.632 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -72.3 138.67 21.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.375 -1.074 . . . . 0.0 109.128 179.734 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.692 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -78.42 -41.38 33.11 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.516 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -175.56 -169.81 0.38 Allowed 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 177.985 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.568 ' OG1' ' OE2' ' A' ' 77' ' ' GLU . 30.6 p -146.55 167.0 24.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.914 -1.116 . . . . 0.0 110.214 -179.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.628 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -168.66 -178.75 3.55 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.921 HG12 HG12 ' A' ' 117' ' ' VAL . 1.6 m -156.82 161.03 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.32 0 O-C-N 120.665 -1.272 . . . . 0.0 108.504 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.521 ' HA3' ' HA ' ' A' ' 201' ' ' TYR . . . -167.46 -172.42 34.57 Favored Glycine 0 N--CA 1.483 1.824 0 C-N-CA 119.199 -1.477 . . . . 0.0 111.934 -177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.654 ' CZ ' ' HB2' ' A' ' 202' ' ' ALA . 1.6 m-85 -104.44 150.29 24.68 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.852 -0.793 . . . . 0.0 109.511 179.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.656 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -177.0 154.22 1.07 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.126 -0.984 . . . . 0.0 110.045 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 88.31 38.56 7.16 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.946 -1.262 . . . . 0.0 109.946 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.498 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -129.5 -152.01 7.47 Favored Glycine 0 N--CA 1.493 2.487 0 O-C-N 121.038 -1.272 . . . . 0.0 110.111 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -132.48 55.1 1.9 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -1.017 . . . . 0.0 109.474 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.411 HG22 ' HA2' ' A' ' 37' ' ' GLY . 0.2 OUTLIER -157.07 141.62 16.68 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.222 -0.924 . . . . 0.0 109.429 -179.978 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.682 ' O ' ' CE2' ' A' ' 200' ' ' TYR . 0.0 OUTLIER -48.96 -93.13 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.293 -0.879 . . . . 0.0 109.438 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.493 HD22 ' HA ' ' A' ' 39' ' ' THR . 10.8 m-20 -122.84 86.27 50.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.243 -0.91 . . . . 0.0 109.866 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.517 ' CG ' ' NE2' ' A' ' 113' ' ' HIS . 59.4 Cg_endo -78.41 -171.62 1.27 Allowed 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.657 2.238 . . . . 0.0 111.811 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.633 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 23.1 p -121.69 170.5 9.67 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.024 -1.048 . . . . 0.0 110.157 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -62.53 -59.09 5.43 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.39 -0.819 . . . . 0.0 110.302 -179.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.7 mtpt -61.22 -23.22 65.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 108.822 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.633 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.1 mm-40 -67.81 -60.07 2.81 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.66 0.743 . . . . 0.0 110.322 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.918 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.8 m -64.37 -24.49 35.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 O-C-N 121.663 -0.648 . . . . 0.0 111.635 -178.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 4.7 t -53.7 -0.5 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.876 0 O-C-N 121.261 -0.9 . . . . 0.0 109.363 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 110' ' ' LYS . 22.6 p -99.8 11.17 39.93 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.292 -0.88 . . . . 0.0 109.6 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.453 ' O ' HG21 ' A' ' 29' ' ' ILE . 2.5 tt0 59.08 -5.58 0.06 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.071 -1.018 . . . . 0.0 109.512 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.625 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.4 OUTLIER -70.67 -30.97 67.71 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.412 -0.805 . . . . 0.0 110.371 -179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.918 ' OG1' HG12 ' A' ' 106' ' ' VAL . 26.7 p -84.98 -18.34 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.929 -1.107 . . . . 0.0 110.28 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 62.06 14.61 47.01 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.652 ' CD2' HG11 ' A' ' 106' ' ' VAL . 0.3 OUTLIER -58.32 158.22 7.56 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.029 -1.277 . . . . 0.0 109.711 179.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.542 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -120.36 113.83 20.94 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.68 ' OE1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.95 135.23 15.96 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.174 -0.954 . . . . 0.0 109.483 -179.28 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.656 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.1 OUTLIER -151.68 178.73 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.363 -0.836 . . . . 0.0 108.989 179.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.045 HG22 ' O ' ' A' ' 68' ' ' PHE . 34.5 m -138.97 147.89 24.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.201 -0.937 . . . . 0.0 110.688 -179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.793 ' NH1' ' CZ ' ' A' ' 201' ' ' TYR . 8.9 ptm180 -115.49 95.71 5.29 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.731 ' O ' ' CE1' ' A' ' 121' ' ' TYR . 4.0 m -109.52 113.82 45.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.768 0 O-C-N 120.17 -1.581 . . . . 0.0 108.815 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.456 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.0 t -74.49 156.75 6.29 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.161 ' CD2' HD22 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -136.9 160.35 39.14 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.887 -1.133 . . . . 0.0 110.156 -179.833 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.427 ' CG ' ' O ' ' A' ' 85' ' ' GLY . 59.8 mtp180 -119.46 100.4 49.61 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 125' ' ' HIS . 13.5 Cg_exo -41.71 -61.05 0.56 Allowed 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 123.235 2.623 . . . . 0.0 113.276 -179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.434 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -38.37 -14.59 0.01 OUTLIER 'General case' 0 C--N 1.285 -2.21 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.603 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.695 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -143.8 15.53 1.76 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.718 -1.239 . . . . 0.0 109.49 179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.476 HG21 ' HB3' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -155.19 146.26 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.31 -0.869 . . . . 0.0 109.419 179.605 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.572 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -107.8 166.79 10.44 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.244 -0.91 . . . . 0.0 109.37 179.828 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.457 ' CE2' ' HB3' ' A' ' 169' ' ' ALA . 37.9 t80 -64.82 -38.83 92.3 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.996 -1.065 . . . . 0.0 109.36 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.421 ' O ' ' N ' ' A' ' 133' ' ' LYS . 36.7 mm-40 -53.71 -27.39 27.82 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.0 109.086 179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 1.0 OUTLIER -66.69 -68.82 0.35 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.292 -0.88 . . . . 0.0 109.094 179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.161 HD22 ' CD2' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -33.89 -47.55 0.26 Allowed 'General case' 0 C--N 1.316 -0.859 0 O-C-N 120.95 -1.094 . . . . 0.0 108.493 178.932 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.739 HD23 ' HB3' ' A' ' 173' ' ' SER . 11.2 mp -76.1 -41.24 50.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 111.243 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.581 ' O ' ' OE2' ' A' ' 137' ' ' GLU . 2.8 tmmm? -52.56 -39.59 61.66 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.098 -1.001 . . . . 0.0 111.44 -178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.829 HG21 HD11 ' A' ' 83' ' ' LEU . 1.1 t -74.84 -39.44 45.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.722 -1.236 . . . . 0.0 110.098 -178.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.799 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 8.0 t80 -65.32 -48.22 73.83 Favored 'General case' 0 C--N 1.293 -1.89 0 O-C-N 121.375 -0.828 . . . . 0.0 111.211 -178.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.52 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 61.4 m95 -67.04 -34.11 76.98 Favored 'General case' 0 N--CA 1.508 2.447 0 O-C-N 120.784 -1.198 . . . . 0.0 111.363 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.672 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.0 OUTLIER -76.95 -33.21 57.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.113 -0.992 . . . . 0.0 113.23 -176.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.674 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 41.9 m-80 -96.12 36.09 1.36 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.323 -1.486 . . . . 0.0 114.483 -175.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.799 ' NE2' ' CE1' ' A' ' 135' ' ' PHE . 6.6 p-80 178.53 175.95 0.54 Allowed 'General case' 0 N--CA 1.503 2.203 0 O-C-N 120.393 -1.442 . . . . 0.0 111.981 176.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -110.85 107.92 57.84 Favored Pre-proline 0 C--N 1.292 -1.921 0 CA-C-N 114.08 -1.418 . . . . 0.0 108.579 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.48 20.38 0.77 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.187 1.925 . . . . 0.0 112.299 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.73 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -115.7 3.18 13.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.257 -0.902 . . . . 0.0 109.753 179.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.536 ' O ' ' O ' ' A' ' 146' ' ' ARG . 18.1 mt-30 -101.88 78.26 1.79 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.121 -0.987 . . . . 0.0 109.069 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.534 ' C ' ' H ' ' A' ' 146' ' ' ARG . . . -39.4 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.499 2.855 0 CA-C-N 115.827 -0.624 . . . . 0.0 113.466 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.471 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.1 OUTLIER -66.97 40.23 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 CA-C-O 121.936 0.874 . . . . 0.0 110.39 -176.67 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.652 ' CZ ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER -161.65 152.54 18.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.165 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.521 ' OE1' ' O ' ' A' ' 143' ' ' GLN . 21.0 mm100 -154.92 74.82 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.281 -1.512 . . . . 0.0 110.05 178.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 220' ' ' LEU . . . 78.11 -115.71 4.27 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -79.52 -33.45 42.01 Favored 'General case' 0 C--N 1.274 -2.716 0 CA-C-N 114.517 -0.842 . . . . 0.0 111.624 -178.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.497 ' HB3' ' CD2' ' A' ' 155' ' ' TYR . 0.7 OUTLIER -85.36 129.49 34.8 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.283 -1.511 . . . . 0.0 109.015 179.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.446 ' HB3' ' NH1' ' A' ' 146' ' ' ARG . 17.6 p90 -127.64 138.39 52.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.07 -1.019 . . . . 0.0 110.383 -179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.523 ' C ' ' H ' ' A' ' 154' ' ' GLN . . . 138.58 167.08 10.86 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.809 HG21 ' O ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -72.32 15.16 0.18 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.001 -1.294 . . . . 0.0 108.9 179.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.598 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 1.4 pt20 -114.32 17.58 17.45 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.598 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 44.2 m-85 -155.48 65.63 0.62 Allowed 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.703 HH22 ' CG ' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -118.54 -176.03 3.0 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.384 -0.822 . . . . 0.0 109.389 -179.829 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.6 t -92.11 140.56 29.51 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 104.323 -2.473 . . . . 0.0 104.323 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.461 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -162.14 118.95 2.06 Favored 'General case' 0 C--N 1.282 -2.362 0 C-N-CA 116.603 -2.039 . . . . 0.0 112.115 -177.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.72 HG13 ' CG2' ' A' ' 191' ' ' THR . 2.2 m -115.72 126.2 73.17 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.731 0 C-N-CA 118.935 -1.106 . . . . 0.0 109.154 177.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.484 ' CE2' HG11 ' A' ' 116' ' ' VAL . 4.8 m-30 -113.9 119.99 39.87 Favored Pre-proline 0 N--CA 1.493 1.675 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -76.41 170.43 19.99 Favored 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.564 2.176 . . . . 0.0 112.53 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.16 -40.4 8.82 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 121.209 -0.932 . . . . 0.0 109.592 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.451 ' C ' ' N ' ' A' ' 165' ' ' VAL . 43.3 t -175.38 -173.86 0.68 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.114 -0.991 . . . . 0.0 109.923 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -50.35 -24.56 3.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 123.154 1.454 . . . . 0.0 108.422 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.451 ' N ' ' C ' ' A' ' 163' ' ' SER . 2.5 t -56.06 -56.46 12.83 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.987 0 CA-C-N 113.727 -1.578 . . . . 0.0 109.227 179.1 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.472 HE21 ' HB2' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -78.03 -36.82 48.13 Favored 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.965 -178.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.434 ' HA ' ' HB3' ' A' ' 170' ' ' ALA . 1.5 mtm -52.46 -35.41 52.46 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.202 -0.936 . . . . 0.0 110.815 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -48.29 -55.0 11.72 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.817 -1.177 . . . . 0.0 109.962 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.457 ' HB3' ' CE2' ' A' ' 128' ' ' PHE . . . -93.13 -30.84 15.04 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.017 -1.052 . . . . 0.0 110.582 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.468 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -52.54 -62.32 1.72 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.026 -1.047 . . . . 0.0 110.014 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.6 mt -52.66 -33.87 49.05 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.164 -0.96 . . . . 0.0 109.922 -179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 3.2 ttt180 -74.17 -40.12 62.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.161 -0.962 . . . . 0.0 109.642 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.739 ' HB3' HD23 ' A' ' 132' ' ' LEU . 0.1 OUTLIER -56.43 -34.27 66.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.333 -0.854 . . . . 0.0 109.912 -179.765 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -72.18 -46.79 54.88 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.179 -0.951 . . . . 0.0 109.96 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -72.22 -39.67 68.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.205 -0.934 . . . . 0.0 110.045 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -56.59 -29.45 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.089 -1.007 . . . . 0.0 109.92 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.492 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -79.54 -44.15 21.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.067 -1.02 . . . . 0.0 109.886 -179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.767 ' OE1' HG23 ' A' ' 189' ' ' ILE . 35.8 tp60 -62.19 -5.34 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.236 -0.915 . . . . 0.0 109.592 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.87 -49.64 13.84 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.152 -0.968 . . . . 0.0 109.89 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 14.4 t -87.35 -51.81 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.173 -0.954 . . . . 0.0 110.304 -179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.411 ' HA ' HD13 ' A' ' 181' ' ' LEU . 4.5 mm? -53.72 -40.82 66.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.103 -0.998 . . . . 0.0 109.835 -179.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 51.0 p -56.38 -27.27 55.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.086 -1.009 . . . . 0.0 109.441 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.434 ' HD2' ' N ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -88.03 6.34 36.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.213 -0.929 . . . . 0.0 109.554 -179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.428 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 1.7 m-70 -108.22 35.82 3.02 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.22 -0.925 . . . . 0.0 109.568 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.428 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 69.88 36.07 2.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.477 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -115.48 175.61 5.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.402 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.625 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -133.47 -145.62 5.38 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.58 ' O ' ' O ' ' A' ' 189' ' ' ILE . 30.0 Cg_exo -58.73 106.03 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 C-N-CA 122.402 2.068 . . . . 0.0 111.248 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.767 HG23 ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -48.45 -172.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.0 109.959 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.492 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 21.4 p -151.43 58.57 0.89 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.568 -0.707 . . . . 0.0 109.813 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.72 ' CG2' HG13 ' A' ' 159' ' ' VAL . 45.7 m -99.76 128.7 45.84 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.703 ' CG ' HH22 ' A' ' 156' ' ' ARG . 4.9 t70 -75.97 119.42 19.91 Favored 'General case' 0 C--N 1.272 -2.793 0 C-N-CA 119.569 -0.853 . . . . 0.0 109.419 -178.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.421 ' C ' ' CG ' ' A' ' 194' ' ' ARG . 0.6 OUTLIER -119.77 103.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 C-N-CA 119.386 -0.925 . . . . 0.0 109.643 -179.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.661 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -165.33 141.92 5.58 Favored 'General case' 0 C--N 1.296 -1.76 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.654 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -114.95 -177.67 3.18 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.027 -1.046 . . . . 0.0 109.843 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 74.77 29.75 60.74 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.903 -1.279 . . . . 0.0 109.903 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.577 ' O ' ' O ' ' A' ' 198' ' ' VAL . 16.2 mm-40 -104.0 103.64 13.49 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.987 -1.302 . . . . 0.0 108.977 179.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.577 ' O ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -33.6 154.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.461 -0.774 . . . . 0.0 109.183 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.576 ' CE1' ' HD2' ' A' ' 118' ' ' ARG . 7.7 t80 -128.75 120.23 26.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.02 -1.05 . . . . 0.0 110.579 -178.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.682 ' CE2' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -128.97 126.77 40.29 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.793 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -98.53 -176.53 3.4 Favored 'General case' 0 C--N 1.31 -1.116 0 C-N-CA 116.329 -2.148 . . . . 0.0 114.642 -177.849 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.654 ' HB2' ' CZ ' ' A' ' 93' ' ' PHE . . . -95.71 -179.58 4.78 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 112.185 -2.279 . . . . 0.0 111.478 -176.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.698 ' HA ' HG11 ' A' ' 44' ' ' VAL . 1.3 pt-20 -73.57 -168.16 0.53 Allowed 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.429 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.74 -14.38 54.62 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.866 -1.146 . . . . 0.0 110.527 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.651 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -78.53 -14.17 59.48 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 120.881 -1.137 . . . . 0.0 109.382 -179.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.487 ' HA ' ' CD1' ' A' ' 74' ' ' TRP . 74.2 m-70 -104.68 2.88 30.91 Favored 'General case' 0 C--N 1.303 -1.423 0 C-N-CA 119.33 -0.948 . . . . 0.0 110.109 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.841 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.2 mm-40 -120.51 -138.14 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 122.237 1.018 . . . . 0.0 109.938 -177.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.775 ' NE2' ' NE2' ' A' ' 48' ' ' HIS . 1.4 mp0 -34.73 -5.56 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.193 0 CA-C-N 114.301 -1.318 . . . . 0.0 111.634 -179.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.841 ' N ' ' O ' ' A' ' 207' ' ' GLN . 64.2 t80 -41.88 -47.48 4.25 Favored 'General case' 0 N--CA 1.511 2.591 0 O-C-N 120.464 -1.398 . . . . 0.0 109.298 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.72 HD22 ' SG ' ' A' ' 218' ' ' CYS . 0.9 OUTLIER -70.63 -28.68 65.01 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.532 -1.355 . . . . 0.0 110.219 -179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.693 ' OG ' ' CE2' ' A' ' 81' ' ' TRP . 0.1 OUTLIER -69.01 -41.83 77.26 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 120.923 -1.11 . . . . 0.0 108.22 178.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.492 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 0.6 OUTLIER -88.91 -19.17 26.14 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.535 -0.728 . . . . 0.0 109.672 179.587 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.766 ' ND2' ' CD1' ' A' ' 209' ' ' TYR . 34.7 m-80 -116.0 89.89 26.27 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.043 -1.036 . . . . 0.0 110.265 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_exo -54.1 11.94 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 123.249 2.632 . . . . 0.0 112.205 179.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.62 ' H ' ' C ' ' A' ' 213' ' ' ASN . 9.1 t0 -61.94 -4.73 1.71 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.144 -0.973 . . . . 0.0 110.275 -178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.617 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 64.05 -44.32 0.09 OUTLIER Glycine 0 N--CA 1.486 2.032 0 C-N-CA 119.968 -1.11 . . . . 0.0 112.996 177.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.617 ' C ' ' O ' ' A' ' 216' ' ' GLY . 40.6 m-85 -23.33 102.75 0.02 OUTLIER 'General case' 0 N--CA 1.52 3.029 0 CA-C-N 119.408 1.604 . . . . 0.0 110.529 -178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.72 ' SG ' HD22 ' A' ' 210' ' ' LEU . 69.1 m -137.42 -126.76 0.13 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 109.419 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -151.92 -154.84 6.76 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.417 -1.473 . . . . 0.0 109.417 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.715 HD12 ' HA3' ' A' ' 148' ' ' GLY . 20.4 mt -82.82 -175.84 6.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.231 -1.158 . . . . 0.0 109.664 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 179.13 125.85 0.97 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.591 ' H ' ' HA ' ' A' ' 139' ' ' HIS . . . 140.28 167.67 11.1 Favored Glycine 0 C--N 1.306 -1.109 0 N-CA-C 108.674 -1.77 . . . . 0.0 108.674 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.501 HG22 ' O ' ' A' ' 139' ' ' HIS . 11.7 p -101.34 -21.29 14.89 Favored 'General case' 0 C--N 1.27 -2.889 0 CA-C-N 114.388 -0.906 . . . . 0.0 108.672 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 173.85 -53.69 0.15 Allowed Glycine 0 C--N 1.303 -1.269 0 N-CA-C 108.954 -1.659 . . . . 0.0 108.954 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.589 HG12 ' N ' ' A' ' 226' ' ' SER . 68.6 t -72.23 166.15 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.476 -1.014 . . . . 0.0 109.191 179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.605 ' OG ' HD13 ' A' ' 231' ' ' ILE . 0.2 OUTLIER -98.54 107.58 20.07 Favored 'General case' 0 C--N 1.305 -1.344 0 CA-C-O 122.248 1.023 . . . . 0.0 109.265 179.706 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.484 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.07 -57.47 2.32 Favored Pre-proline 0 C--N 1.281 -2.38 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.342 179.511 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.513 ' CD ' ' H ' ' A' ' 229' ' ' MET . 42.9 Cg_endo -94.23 -33.09 0.05 OUTLIER 'Trans proline' 0 C--N 1.315 -1.215 0 C-N-CA 122.885 2.39 . . . . 0.0 110.116 178.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.561 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.8 OUTLIER -55.28 154.91 5.45 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.784 0.802 . . . . 0.0 109.854 179.66 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.561 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.87 128.27 0.14 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-O 121.137 0.494 . . . . 0.0 109.811 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.664 ' O ' ' N ' ' A' ' 233' ' ' LYS . 3.4 tp -157.58 122.1 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.073 0 O-C-N 121.106 -0.996 . . . . 0.0 109.346 -179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 231' ' ' ILE . 4.2 ttpm? -42.61 86.97 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.192 -0.943 . . . . 0.0 109.437 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.664 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.369 0 O-C-N 121.201 -0.937 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.867 H142 ' O ' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.57 ' O ' ' CB ' ' A' ' 25' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 22' ' ' GLY . 2.0 t70 -45.08 -53.55 7.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.103 -1.233 . . . . 0.0 109.176 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.646 ' C ' ' H ' ' A' ' 26' ' ' SER . 3.5 m -50.94 -18.42 0.77 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.312 -0.868 . . . . 0.0 109.191 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.578 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -49.62 -9.5 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 123.037 1.399 . . . . 0.0 109.482 -179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.646 ' H ' ' C ' ' A' ' 24' ' ' SER . 1.9 t -47.63 -8.92 0.02 OUTLIER 'General case' 0 C--N 1.261 -3.246 0 CA-C-N 113.836 -1.529 . . . . 0.0 109.638 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' N ' ' O ' ' A' ' 25' ' ' ALA . 1.2 ptpp? -124.08 41.25 3.54 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 123.051 1.405 . . . . 0.0 109.472 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.688 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -160.19 21.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.258 -3.376 0 N-CA-C 104.739 -2.319 . . . . 0.0 104.739 -178.218 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.644 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -39.82 175.57 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.328 -178.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.497 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -99.59 126.97 45.66 Favored 'General case' 0 C--N 1.277 -2.577 0 CA-C-N 115.191 -0.913 . . . . 0.0 108.634 178.983 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.527 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -47.04 -62.11 1.56 Allowed 'General case' 0 C--N 1.285 -2.233 0 CA-C-O 121.258 0.551 . . . . 0.0 109.904 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -54.72 -3.3 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.101 -1.0 . . . . 0.0 110.017 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.6 ' O ' ' O ' ' A' ' 34' ' ' ALA . 3.0 tt0 -108.97 -23.69 11.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.14 -0.975 . . . . 0.0 109.928 -179.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.6 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.98 -167.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.258 -0.901 . . . . 0.0 109.904 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.826 ' CB ' HG23 ' A' ' 98' ' ' THR . 1.7 mm? -72.24 174.51 4.12 Favored Pre-proline 0 C--N 1.305 -1.352 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.431 ' CD ' ' HB3' ' A' ' 35' ' ' LEU . 18.8 Cg_exo -66.91 -46.39 3.35 Favored 'Trans proline' 0 N--CA 1.5 1.853 0 C-N-CA 122.796 2.33 . . . . 0.0 114.279 -177.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.452 ' HA2' ' C ' ' A' ' 98' ' ' THR . . . 101.4 106.25 2.91 Favored Glycine 0 N--CA 1.498 2.794 0 C-N-CA 118.855 -1.64 . . . . 0.0 110.409 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.545 ' N ' ' HA ' ' A' ' 99' ' ' ARG . 4.4 tpt180 -99.12 157.55 16.28 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.048 -1.266 . . . . 0.0 109.325 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.512 ' O ' ' C ' ' A' ' 40' ' ' GLU . 0.6 OUTLIER -84.84 -28.66 25.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.959 . . . . 0.0 109.559 -179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.512 ' C ' ' O ' ' A' ' 39' ' ' THR . 1.9 tt0 -36.46 100.53 0.2 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.574 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.439 ' N ' ' O ' ' A' ' 39' ' ' THR . 69.7 Cg_endo -80.66 160.76 21.91 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.574 2.183 . . . . 0.0 112.265 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -138.96 84.02 17.71 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -80.47 167.93 18.66 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 122.909 2.406 . . . . 0.0 112.31 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' ALA . 28.8 m -128.68 -171.85 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.274 -0.891 . . . . 0.0 109.613 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.466 ' C ' ' O ' ' A' ' 44' ' ' VAL . 1.3 t -39.2 97.41 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.332 -0.855 . . . . 0.0 109.706 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.591 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.72 -27.18 58.65 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.192 -0.943 . . . . 0.0 111.313 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.577 ' O ' ' C ' ' A' ' 48' ' ' HIS . 7.8 ptpt -91.96 98.9 11.86 Favored 'General case' 0 C--N 1.289 -2.035 0 C-N-CA 116.243 -2.183 . . . . 0.0 107.873 178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.693 ' CG ' ' OG ' ' A' ' 88' ' ' SER . 6.1 t-80 -32.43 121.78 0.33 Allowed 'General case' 0 C--N 1.295 -1.782 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.69 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -67.09 -34.91 78.65 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.347 -0.846 . . . . 0.0 111.276 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.601 HG23 ' HG3' ' A' ' 208' ' ' GLN . 21.7 t -70.5 -34.8 59.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 120.887 -1.133 . . . . 0.0 109.725 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.1 t -107.73 -42.45 4.73 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.372 -0.83 . . . . 0.0 110.146 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.668 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 92.46 0.42 70.03 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.126 -1.59 . . . . 0.0 109.126 -179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.699 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 34.5 p30 -78.17 -119.73 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.267 -1.753 . . . . 0.0 106.267 178.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.699 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttt-85 -126.3 170.74 11.59 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-O 123.246 1.498 . . . . 0.0 108.736 178.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.729 ' O ' HG13 ' A' ' 56' ' ' VAL . 1.3 p -131.95 23.26 4.57 Favored 'General case' 0 C--N 1.261 -3.252 0 CA-C-N 113.613 -1.631 . . . . 0.0 109.07 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 55' ' ' THR . 5.6 m -162.11 138.03 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.74 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.3 156.83 0.03 OUTLIER Pre-proline 0 C--N 1.304 -1.391 0 CA-C-O 122.025 0.917 . . . . 0.0 110.795 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.411 ' HA ' ' CB ' ' A' ' 57' ' ' GLU . 81.3 Cg_endo -80.07 166.18 77.2 Favored 'Cis proline' 0 C--N 1.301 -1.953 0 C-N-CA 121.471 -2.304 . . . . 0.0 112.157 -0.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.521 ' CE1' HG11 ' A' ' 120' ' ' VAL . 27.2 m-85 -103.27 147.91 34.88 Favored Pre-proline 0 C--N 1.27 -2.89 0 CA-C-N 114.236 -1.347 . . . . 0.0 109.078 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.49 ' O ' ' OG1' ' A' ' 63' ' ' THR . 38.9 Cg_endo -70.29 142.89 46.73 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.827 2.351 . . . . 0.0 112.368 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -46.43 158.23 0.12 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.356 -0.84 . . . . 0.0 109.467 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 62.26 62.65 5.42 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.54 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.5 OUTLIER -146.02 139.41 26.08 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -1.116 . . . . 0.0 109.569 -179.764 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.628 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 1.6 mp0 -109.15 123.58 49.44 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.649 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -111.78 139.49 47.21 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.279 -0.888 . . . . 0.0 109.704 -178.932 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -163.08 -169.38 2.0 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.507 HG13 ' O ' ' A' ' 117' ' ' VAL . 72.2 t -143.94 140.79 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 120.105 -1.622 . . . . 0.0 109.743 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.896 ' O ' HG22 ' A' ' 117' ' ' VAL . 97.3 m-85 -123.19 155.2 37.57 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.506 ' O ' ' O ' ' A' ' 156' ' ' ARG . . . -153.32 94.67 0.15 Allowed Glycine 0 N--CA 1.483 1.816 0 C-N-CA 118.564 -1.779 . . . . 0.0 109.948 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.588 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -92.87 -87.01 0.24 Allowed 'General case' 0 C--N 1.287 -2.139 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 178.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.621 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -134.97 -158.01 8.22 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 108.4 -1.88 . . . . 0.0 108.4 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.769 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.85 102.4 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.468 -1.019 . . . . 0.0 108.317 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.657 ' CZ ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -51.95 7.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.38 -0.825 . . . . 0.0 111.698 -177.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.769 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 4.7 m0 -69.22 -73.39 0.15 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.604 -1.31 . . . . 0.0 109.027 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -66.9 -14.52 63.37 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 73' ' ' PHE . . . -77.03 -53.88 7.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -1.143 . . . . 0.0 110.858 -179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.71 ' OE2' HG13 ' A' ' 91' ' ' VAL . 7.8 tp10 -48.42 -36.56 15.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.298 -0.876 . . . . 0.0 111.379 -178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.899 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.5 tmt_? -66.36 -57.95 6.34 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.78 -1.2 . . . . 0.0 109.941 -179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' HD3' ' H ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -41.18 -10.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.527 -0.733 . . . . 0.0 111.366 -179.128 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.685 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.7 m-85 -101.91 -40.69 6.78 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.583 -1.323 . . . . 0.0 111.256 -179.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.622 ' HB3' HG21 ' A' ' 89' ' ' THR . 1.1 p90 -86.69 1.83 50.63 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.48 -1.387 . . . . 0.0 110.906 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.2 m -83.52 19.99 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.885 -1.134 . . . . 0.0 109.636 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 83' ' ' LEU . 0.6 OUTLIER -129.97 158.57 39.19 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.448 -0.782 . . . . 0.0 109.132 179.65 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.662 ' HZ1' ' C ' ' A' ' 83' ' ' LEU . 0.1 OUTLIER -91.48 153.43 19.82 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.576 -0.702 . . . . 0.0 109.742 -179.53 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 106.68 -26.63 19.09 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 108.547 -1.821 . . . . 0.0 108.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.533 HG23 ' CD2' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -75.34 138.06 21.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.712 -0.875 . . . . 0.0 109.76 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.691 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -82.74 -41.52 19.14 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.607 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.852 ' O ' HG23 ' A' ' 89' ' ' THR . 11.8 t -156.98 -163.66 1.45 Allowed 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.662 0.744 . . . . 0.0 110.066 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.852 HG23 ' O ' ' A' ' 88' ' ' SER . 3.7 p -168.72 121.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.788 -1.189 . . . . 0.0 107.788 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.557 ' C ' ' OE2' ' A' ' 77' ' ' GLU . 5.5 mp0 -136.39 173.63 11.5 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.963 -1.086 . . . . 0.0 110.707 -178.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.782 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -146.39 157.93 11.29 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 CA-C-O 121.584 0.707 . . . . 0.0 109.62 -179.587 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.43 174.5 46.08 Favored Glycine 0 N--CA 1.484 1.835 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.627 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 0.7 OUTLIER -85.39 156.13 20.99 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.374 -1.074 . . . . 0.0 109.547 -179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.8 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -172.72 -170.73 0.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 0.0 109.72 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 59.27 21.77 54.38 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.754 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -160.41 -156.08 8.04 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.186 -1.566 . . . . 0.0 109.186 179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.697 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 40.4 p-80 178.91 109.34 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.416 -1.049 . . . . 0.0 108.983 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.826 HG23 ' CB ' ' A' ' 35' ' ' LEU . 13.9 m -144.45 144.79 31.55 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.243 -0.911 . . . . 0.0 109.219 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.612 ' C ' ' O ' ' A' ' 98' ' ' THR . 17.6 mtm-85 -19.83 -85.39 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 CA-C-O 121.747 0.784 . . . . 0.0 109.637 -179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.1 m-80 -117.19 90.83 34.97 Favored Pre-proline 0 C--N 1.298 -1.655 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 178.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.627 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 2.8 Cg_exo -73.35 111.1 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.566 2.178 . . . . 0.0 113.329 -177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.484 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.6 p -123.05 163.3 20.74 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.635 ' CD1' ' O ' ' A' ' 103' ' ' TYR . 0.5 OUTLIER -50.05 -35.95 27.1 Favored 'General case' 0 C--N 1.296 -1.751 0 C-N-CA 119.168 -1.013 . . . . 0.0 108.381 179.348 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.629 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 3.9 ttmt -73.7 -31.93 63.67 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.693 -0.63 . . . . 0.0 110.956 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.484 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 1.2 mm-40 -80.99 -47.08 14.12 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.496 -1.378 . . . . 0.0 111.222 -178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 102' ' ' THR . 30.2 m -67.6 -25.03 32.02 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 120.608 -1.308 . . . . 0.0 110.342 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.629 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 14.5 p -53.89 -40.62 66.76 Favored 'General case' 0 C--N 1.292 -1.912 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.673 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 58.1 m -48.51 -66.52 0.39 Allowed 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 178.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.673 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.6 mt-10 137.82 -25.25 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.259 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.515 ' O ' HD22 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -67.06 3.87 1.02 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.202 -0.936 . . . . 0.0 111.542 -177.532 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.439 ' OG1' HG12 ' A' ' 106' ' ' VAL . 71.0 p -99.91 -25.15 14.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.77 -1.206 . . . . 0.0 109.33 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.606 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 66.07 13.26 59.47 Favored Glycine 0 N--CA 1.488 2.105 0 C-N-CA 119.808 -1.187 . . . . 0.0 110.428 -179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.754 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -78.55 159.07 28.35 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.494 -1.592 . . . . 0.0 109.809 -179.725 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 1.041 ' HB2' ' NH2' ' A' ' 156' ' ' ARG . . . -126.31 117.79 23.73 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.657 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 2.5 mm-40 -49.46 112.61 0.67 Allowed 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 119.125 -1.03 . . . . 0.0 108.76 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.8 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.2 OUTLIER -124.54 175.29 7.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.346 -0.846 . . . . 0.0 109.382 -179.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.896 HG22 ' O ' ' A' ' 68' ' ' PHE . 33.7 m -132.45 148.84 31.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.15 -0.969 . . . . 0.0 110.158 -179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.502 ' CD ' ' C ' ' A' ' 118' ' ' ARG . 2.0 tpp180 -110.69 107.81 17.49 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.685 HG12 HG22 ' A' ' 89' ' ' THR . 7.5 m -133.66 116.2 23.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 O-C-N 121.193 -0.942 . . . . 0.0 108.805 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.538 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.0 OUTLIER -96.95 158.23 3.2 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.634 ' CZ ' ' HB3' ' A' ' 131' ' ' LEU . 3.0 m-85 -134.45 155.45 50.32 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.885 -1.134 . . . . 0.0 109.543 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.624 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 1.4 ptm180 -110.37 112.31 57.05 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.191 -0.943 . . . . 0.0 110.721 -178.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.688 ' O ' ' N ' ' A' ' 125' ' ' HIS . 34.1 Cg_exo -44.48 -63.6 0.32 Allowed 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 123.177 2.584 . . . . 0.0 113.383 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.755 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 16.9 mp0 -33.17 -21.9 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.737 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.688 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -137.99 6.46 2.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.433 -1.417 . . . . 0.0 110.502 -179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.501 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -155.82 150.41 10.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.0 110.043 179.904 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.568 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 37.6 t -97.81 147.6 24.24 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.242 -0.911 . . . . 0.0 109.552 179.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.96 ' CE2' HD11 ' A' ' 132' ' ' LEU . 50.8 t80 -62.51 -21.16 65.31 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.068 -1.02 . . . . 0.0 109.507 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -71.28 -7.57 47.9 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.568 ' HG3' ' H ' ' A' ' 127' ' ' SER . 9.1 mm-40 -74.46 -70.31 0.41 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.757 -0.59 . . . . 0.0 110.358 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.044 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -51.95 -29.79 21.91 Favored 'General case' 0 C--N 1.313 -0.994 0 O-C-N 120.495 -1.378 . . . . 0.0 108.236 179.636 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.96 HD11 ' CE2' ' A' ' 128' ' ' PHE . 47.3 mt -63.68 -57.05 11.23 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 119.67 -0.812 . . . . 0.0 109.524 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -62.47 -39.61 94.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.261 -0.899 . . . . 0.0 109.745 -179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.759 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 3.8 t -50.27 -62.31 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.208 -0.933 . . . . 0.0 109.515 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.623 ' CE1' ' NE2' ' A' ' 139' ' ' HIS . 6.0 t80 -54.63 -39.09 67.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.457 -1.402 . . . . 0.0 110.078 -179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.56 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 51.5 m95 -70.75 -36.35 73.08 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 120.973 -1.079 . . . . 0.0 110.83 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -83.77 -4.95 59.05 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.146 -0.971 . . . . 0.0 113.577 -176.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.759 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -122.74 41.71 3.37 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.06 -1.65 . . . . 0.0 111.422 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.855 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 173.55 -168.41 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.955 0 CA-C-O 121.849 0.833 . . . . 0.0 108.752 177.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.542 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.1 OUTLIER -118.25 138.57 25.74 Favored Pre-proline 0 C--N 1.288 -2.067 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.449 ' CG ' ' CD1' ' A' ' 181' ' ' LEU . 93.3 Cg_endo -81.21 0.99 9.62 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.614 2.21 . . . . 0.0 113.285 -179.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.571 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -121.8 47.25 1.91 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.858 -1.151 . . . . 0.0 110.196 -179.692 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.574 ' O ' ' O ' ' A' ' 144' ' ' GLY . 0.0 OUTLIER -129.9 70.32 1.43 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.893 -1.129 . . . . 0.0 109.606 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.72 ' H ' HG21 ' A' ' 190' ' ' THR . . . -51.59 -118.71 0.01 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.626 ' C ' ' SD ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -70.56 40.05 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.444 -1.033 . . . . 0.0 109.736 -178.737 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.482 ' H ' ' C ' ' A' ' 144' ' ' GLY . 9.4 ttt180 -165.64 85.29 0.35 Allowed 'General case' 0 N--CA 1.501 2.1 0 C-N-CA 119.696 -0.802 . . . . 0.0 110.558 179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.588 ' OE1' ' O ' ' A' ' 70' ' ' MET . 5.7 tp60 -86.23 117.16 24.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.428 -1.42 . . . . 0.0 109.79 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 46.58 -114.31 1.44 Allowed Glycine 0 N--CA 1.479 1.512 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 179.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.533 ' O ' ' CG ' ' A' ' 149' ' ' ASN . 12.8 t30 -92.77 16.71 11.75 Favored 'General case' 0 C--N 1.272 -2.8 0 CA-C-N 114.329 -0.936 . . . . 0.0 110.282 -179.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -107.19 147.15 30.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.917 -1.114 . . . . 0.0 109.201 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.49 ' O ' ' CG ' ' A' ' 151' ' ' PHE . 20.2 p90 -130.07 129.42 43.59 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.143 -0.973 . . . . 0.0 109.792 -179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' NE2' ' A' ' 154' ' ' GLN . . . 147.16 155.06 6.4 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.675 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.1 OUTLIER -79.3 5.1 13.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.273 -1.134 . . . . 0.0 109.361 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.651 ' N ' ' OE1' ' A' ' 154' ' ' GLN . 15.1 pm0 -97.48 -5.75 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.243 -0.91 . . . . 0.0 109.958 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.474 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 23.0 m-85 -122.45 61.82 0.98 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.904 -1.122 . . . . 0.0 109.055 179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.041 ' NH2' ' HB2' ' A' ' 114' ' ' ALA . 8.9 ptt-85 -112.23 175.91 5.24 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.352 -0.842 . . . . 0.0 109.125 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.639 ' HB3' ' HE2' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -89.44 121.0 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 105.177 -2.156 . . . . 0.0 105.177 178.358 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.48 ' N ' ' O ' ' A' ' 69' ' ' GLY . . . -137.18 128.88 28.75 Favored 'General case' 0 C--N 1.287 -2.151 0 C-N-CA 118.291 -1.363 . . . . 0.0 110.986 -176.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.781 HG13 ' CG2' ' A' ' 191' ' ' THR . 1.1 m -126.77 120.01 54.83 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.715 0 C-N-CA 118.554 -1.258 . . . . 0.0 109.26 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.518 ' CE2' HG11 ' A' ' 116' ' ' VAL . 6.2 m-30 -109.86 126.13 29.72 Favored Pre-proline 0 N--CA 1.491 1.601 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -82.14 174.66 9.84 Favored 'Trans proline' 0 N--CA 1.496 1.672 0 C-N-CA 123.012 2.474 . . . . 0.0 112.999 -178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.556 ' OG1' ' OE1' ' A' ' 166' ' ' GLN . 0.0 OUTLIER -99.3 -40.33 7.98 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 121.315 -0.866 . . . . 0.0 109.875 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.469 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.5 OUTLIER -172.97 -162.42 0.17 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.273 -0.892 . . . . 0.0 109.722 -179.693 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -53.57 -16.64 1.63 Allowed 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.921 1.343 . . . . 0.0 108.959 -179.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.469 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.9 t -59.2 -57.54 10.97 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.892 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.246 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.556 ' OE1' ' OG1' ' A' ' 162' ' ' THR . 1.3 mp0 -77.34 -11.21 59.81 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.749 -0.594 . . . . 0.0 110.392 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 2.1 mtp -50.92 -44.33 60.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.658 -1.276 . . . . 0.0 109.498 -178.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -75.69 -19.23 59.27 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.034 -1.041 . . . . 0.0 109.12 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.58 -57.65 2.52 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.341 -0.85 . . . . 0.0 110.616 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.494 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.64 -65.03 0.63 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.068 -1.02 . . . . 0.0 110.035 -179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -51.86 -33.53 36.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 0.0 109.486 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -74.24 -45.92 44.88 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.202 -0.936 . . . . 0.0 109.358 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.56 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 83.0 p -56.23 -49.45 74.09 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.388 -0.82 . . . . 0.0 109.826 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.536 ' HZ3' HD12 ' A' ' 189' ' ' ILE . 12.8 tttm -61.8 -53.59 53.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.214 -0.929 . . . . 0.0 109.741 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -70.02 -6.75 35.7 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.849 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -78.15 -52.17 9.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.146 -0.971 . . . . 0.0 110.464 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -79.22 -11.79 59.96 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.028 -1.045 . . . . 0.0 110.28 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.517 ' OE1' ' CB ' ' A' ' 182' ' ' SER . 0.2 OUTLIER -70.8 -41.07 72.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.112 -0.993 . . . . 0.0 109.561 -179.727 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 14.9 tttp -77.05 -16.04 59.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.215 -0.928 . . . . 0.0 109.884 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 99.1 t -87.49 -54.62 7.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.108 -0.995 . . . . 0.0 109.911 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.449 ' CD1' ' CG ' ' A' ' 141' ' ' PRO . 37.2 mt -75.4 -43.68 48.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.127 -0.983 . . . . 0.0 110.174 -179.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.517 ' CB ' ' OE1' ' A' ' 178' ' ' GLN . 12.7 t -55.35 -22.1 17.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.313 -179.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.6 tppt? -88.18 -9.94 51.48 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 109.008 179.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.419 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 22.5 m170 -108.28 34.58 3.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.599 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.419 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.5 OUTLIER 69.79 68.95 0.24 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.965 179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -134.73 173.15 12.01 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.258 -0.901 . . . . 0.0 109.334 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -110.75 -168.74 19.23 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.774 -1.73 . . . . 0.0 108.774 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.513 ' O ' ' O ' ' A' ' 189' ' ' ILE . 11.1 Cg_endo -58.84 115.1 2.31 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.761 1.641 . . . . 0.0 110.812 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.571 HG22 HG22 ' A' ' 142' ' ' THR . 0.3 OUTLIER -47.8 179.4 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.29 -0.881 . . . . 0.0 110.06 -178.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.72 HG21 ' H ' ' A' ' 144' ' ' GLY . 39.9 p -140.01 59.75 1.57 Allowed 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.154 -179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.781 ' CG2' HG13 ' A' ' 159' ' ' VAL . 27.1 m -98.04 115.81 28.97 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 106.598 -1.63 . . . . 0.0 106.598 178.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.65 ' OD2' ' NH2' ' A' ' 194' ' ' ARG . 6.3 t0 -84.72 125.28 32.4 Favored 'General case' 0 C--N 1.281 -2.384 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.953 -178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 5.5 mt -116.44 148.33 19.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.65 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 3.6 mtm180 -165.44 169.81 15.19 Favored 'General case' 0 C--N 1.296 -1.729 0 O-C-N 121.522 -0.736 . . . . 0.0 109.128 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.697 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -123.86 170.6 10.41 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 120.994 -1.067 . . . . 0.0 110.808 -179.887 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.578 ' C ' ' O ' ' A' ' 195' ' ' GLU . . . 22.72 38.94 0.01 OUTLIER Glycine 0 N--CA 1.495 2.594 0 N-CA-C 110.889 -0.884 . . . . 0.0 110.889 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.753 ' H ' ' CD ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -65.32 132.76 49.84 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.832 -1.393 . . . . 0.0 109.862 -179.761 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 1.2 p -51.84 163.21 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.522 -0.736 . . . . 0.0 109.669 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -127.05 141.69 51.72 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.258 -0.901 . . . . 0.0 109.365 -179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.563 ' O ' ' N ' ' A' ' 93' ' ' PHE . 1.6 m-85 -142.56 97.91 3.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.224 -0.922 . . . . 0.0 109.608 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -54.24 134.64 44.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 0.0 110.38 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.483 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.93 -173.16 4.58 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.669 ' CD ' ' H ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -75.33 168.06 20.71 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.288 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.636 ' N ' ' CD ' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.04 -48.97 78.48 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.863 -1.148 . . . . 0.0 108.51 179.135 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.669 ' H ' ' CD ' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.48 -23.04 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.351 -0.843 . . . . 0.0 110.054 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.651 ' O ' HG21 ' A' ' 91' ' ' VAL . 9.5 m-70 -92.3 6.79 45.5 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.048 -1.032 . . . . 0.0 110.022 -178.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.827 ' O ' ' N ' ' A' ' 209' ' ' TYR . 6.0 mm-40 -122.56 -138.66 0.31 Allowed 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 122.776 1.274 . . . . 0.0 111.024 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.699 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.3 OUTLIER -34.21 -3.89 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 CA-C-N 113.273 -1.785 . . . . 0.0 112.44 -179.072 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.827 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.0 t80 -42.68 -43.08 3.72 Favored 'General case' 0 N--CA 1.516 2.845 0 O-C-N 120.563 -1.336 . . . . 0.0 110.464 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.625 HD21 ' O ' ' A' ' 74' ' ' TRP . 2.9 mp -61.17 -12.37 12.47 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 120.525 -1.36 . . . . 0.0 109.867 -178.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 17.5 t -55.78 -29.76 60.2 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.114 -0.991 . . . . 0.0 108.545 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.0 mmtm -83.92 -35.16 24.25 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.423 -0.798 . . . . 0.0 108.867 179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -136.35 130.65 18.24 Favored Pre-proline 0 N--CA 1.489 1.502 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.546 ' C ' ' H ' ' A' ' 216' ' ' GLY . 30.2 Cg_endo -65.37 -56.84 0.31 Allowed 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 121.921 1.747 . . . . 0.0 113.287 -179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.617 ' O ' ' N ' ' A' ' 217' ' ' TYR . 0.8 OUTLIER -64.11 2.37 0.56 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.689 -1.257 . . . . 0.0 107.926 179.38 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.546 ' H ' ' C ' ' A' ' 214' ' ' PRO . . . 61.95 -68.43 0.02 OUTLIER Glycine 0 N--CA 1.479 1.507 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 179.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.617 ' N ' ' O ' ' A' ' 215' ' ' ASP . 9.2 t80 -145.95 -150.85 0.35 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.475 -1.015 . . . . 0.0 108.737 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.644 ' SG ' ' O ' ' A' ' 218' ' ' CYS . 23.8 p -90.3 77.96 6.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.089 -1.007 . . . . 0.0 108.991 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -135.73 -152.05 6.31 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.491 HD23 ' C ' ' A' ' 220' ' ' LEU . 0.6 OUTLIER -169.66 -178.71 3.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -1.208 . . . . 0.0 109.75 -179.879 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.415 ' N ' ' HG ' ' A' ' 220' ' ' LEU . . . -104.57 -143.74 12.49 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.687 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -154.45 -141.94 3.35 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.855 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.2 OUTLIER 40.88 15.25 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.421 -1.046 . . . . 0.0 109.662 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -86.87 14.22 57.19 Favored Glycine 0 C--N 1.299 -1.482 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.828 ' O ' HG13 ' A' ' 225' ' ' VAL . 9.2 p -111.59 97.42 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.333 -1.099 . . . . 0.0 109.825 -179.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.645 ' H ' ' CB ' ' A' ' 229' ' ' MET . 3.0 p -98.63 -153.9 0.45 Allowed 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.183 -0.948 . . . . 0.0 109.496 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.512 ' CB ' ' CD ' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -72.47 -67.72 0.47 Allowed Pre-proline 0 C--N 1.291 -1.965 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.525 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.512 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 34.9 Cg_endo -65.21 -37.42 31.91 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 122.308 2.005 . . . . 0.0 109.532 178.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.645 ' CB ' ' H ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -53.6 152.75 4.83 Favored 'General case' 0 C--N 1.292 -1.932 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.717 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 225' ' ' VAL . . . -29.12 133.54 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.303 0.573 . . . . 0.0 110.125 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.478 ' O ' HG22 ' A' ' 231' ' ' ILE . 2.7 mm -129.96 108.46 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.254 -0.904 . . . . 0.0 109.246 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.451 ' HD2' ' N ' ' A' ' 233' ' ' LYS . 0.0 OUTLIER -89.75 -152.65 0.26 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 109.39 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.451 ' N ' ' HD2' ' A' ' 232' ' ' LYS . . . . . . . . 0 C--N 1.306 -1.307 0 O-C-N 121.143 -0.973 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.479 H121 ' NH1' ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.503 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.49 2.274 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -67.71 61.57 0.07 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.237 -1.155 . . . . 0.0 109.381 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.503 ' N ' ' O ' ' A' ' 22' ' ' GLY . 2.5 m -50.56 -18.51 0.69 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.362 -0.836 . . . . 0.0 109.555 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.485 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -70.02 -93.47 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 123.366 1.555 . . . . 0.0 111.069 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.423 ' O ' ' CG2' ' A' ' 29' ' ' ILE . 19.0 m -46.42 -11.49 0.02 OUTLIER 'General case' 0 C--N 1.256 -3.483 0 CA-C-N 113.329 -1.76 . . . . 0.0 111.619 -177.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.687 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 1.7 ttpt -106.12 25.03 11.5 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 124.595 2.141 . . . . 0.0 109.492 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.685 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -157.45 21.1 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.253 -3.59 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 -179.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.652 HG21 ' O ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -42.68 176.23 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 CA-C-O 122.759 1.266 . . . . 0.0 108.775 -178.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.492 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -94.02 128.66 40.5 Favored 'General case' 0 C--N 1.27 -2.88 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.16 179.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.429 ' HB1' ' HB3' ' A' ' 97' ' ' HIS . . . -47.34 -38.5 13.0 Favored 'General case' 0 C--N 1.288 -2.093 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -62.24 -10.66 11.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.338 -0.851 . . . . 0.0 109.632 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.513 ' O ' ' C ' ' A' ' 34' ' ' ALA . 4.6 tt0 -81.87 -46.48 14.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 109.142 179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 111' ' ' THR . . . -37.07 137.36 0.35 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.227 -0.921 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.777 ' N ' ' CD ' ' A' ' 36' ' ' PRO . 0.5 OUTLIER -131.88 14.03 0.05 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 120.935 -1.103 . . . . 0.0 112.28 -179.113 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.777 ' CD ' ' N ' ' A' ' 35' ' ' LEU . 11.0 Cg_endo -64.97 -28.7 57.86 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 121.329 1.353 . . . . 0.0 111.745 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.605 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . 17.31 89.42 0.01 OUTLIER Glycine 0 N--CA 1.498 2.778 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.421 ' HG3' HH11 ' A' ' 38' ' ' ARG . 0.0 OUTLIER -116.6 177.7 4.6 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.181 -1.188 . . . . 0.0 109.503 179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.98 -21.75 5.02 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -0.897 . . . . 0.0 109.526 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.573 ' CD ' ' N ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -148.25 149.36 31.89 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.0 109.488 -179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -72.47 -178.2 3.21 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.771 2.314 . . . . 0.0 112.194 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.635 ' O ' ' CG1' ' A' ' 42' ' ' ILE . 0.6 OUTLIER -135.54 97.9 12.64 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.185 -0.947 . . . . 0.0 109.431 -179.945 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.15 179.44 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.639 2.226 . . . . 0.0 112.358 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.2 m -148.88 -179.26 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.317 -0.865 . . . . 0.0 109.35 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.542 ' OG1' ' OD1' ' A' ' 204' ' ' ASP . 0.2 OUTLIER -47.9 84.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.168 -0.957 . . . . 0.0 109.129 179.841 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.671 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.41 -28.09 58.34 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.424 -0.797 . . . . 0.0 111.39 -178.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.552 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.84 99.27 11.7 Favored 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 115.958 -2.297 . . . . 0.0 108.581 179.181 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.941 ' CE1' ' HG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.25 126.43 0.27 Allowed 'General case' 0 C--N 1.292 -1.895 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 179.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.474 ' CD2' ' OG ' ' A' ' 211' ' ' SER . 1.9 t60 -71.41 -29.4 64.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.287 -0.883 . . . . 0.0 110.697 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.855 HG21 ' CG ' ' A' ' 81' ' ' TRP . 21.5 t -69.25 -40.58 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.977 -1.077 . . . . 0.0 110.015 -179.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.2 m -109.37 -42.69 4.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.158 -0.963 . . . . 0.0 110.335 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.26 3.59 56.58 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.311 -1.516 . . . . 0.0 109.311 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 38.4 p30 -79.21 -116.6 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 178.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.0 ttt180 -129.43 169.95 14.3 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 123.221 1.486 . . . . 0.0 108.992 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.75 ' O ' HG13 ' A' ' 56' ' ' VAL . 3.3 p -133.7 34.0 3.45 Favored 'General case' 0 C--N 1.264 -3.15 0 CA-C-N 113.543 -1.662 . . . . 0.0 108.025 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 55' ' ' THR . 4.5 m -163.86 150.34 2.99 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.71 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.3 pm0 -32.2 153.89 0.04 OUTLIER Pre-proline 0 C--N 1.296 -1.72 0 CA-C-O 121.932 0.872 . . . . 0.0 110.909 -178.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 98.6 Cg_endo -78.73 166.07 80.52 Favored 'Cis proline' 0 C--N 1.304 -1.798 0 C-N-CA 121.568 -2.263 . . . . 0.0 111.862 0.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.783 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 1.9 m-30 -115.48 132.45 23.11 Favored Pre-proline 0 C--N 1.269 -2.892 0 CA-C-N 114.342 -1.299 . . . . 0.0 108.977 -179.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.536 ' O ' ' OG1' ' A' ' 63' ' ' THR . 47.1 Cg_exo -49.48 115.57 1.84 Allowed 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 122.002 1.801 . . . . 0.0 112.049 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 60' ' ' PRO . 0.0 OUTLIER -43.31 152.98 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.238 -0.914 . . . . 0.0 109.644 -179.863 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.583 ' O ' ' CD ' ' A' ' 123' ' ' PRO . . . 79.38 4.38 89.05 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.536 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 1.2 p -90.8 143.51 26.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -1.146 . . . . 0.0 109.694 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.498 ' HB2' ' CZ ' ' A' ' 121' ' ' TYR . 3.4 mp0 -121.71 125.62 47.03 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.674 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -116.92 115.12 24.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.134 -0.979 . . . . 0.0 110.114 -179.353 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB2' ' HE1' ' A' ' 128' ' ' PHE . . . -88.4 -175.98 5.18 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 179.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 71.3 t -146.06 113.83 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 119.724 -1.86 . . . . 0.0 110.11 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 1.107 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.4 p90 -162.71 155.19 19.02 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.722 -1.236 . . . . 0.0 109.387 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.628 ' HA2' HG13 ' A' ' 117' ' ' VAL . . . -136.04 133.59 6.71 Favored Glycine 0 N--CA 1.485 1.94 0 C-N-CA 119.33 -1.414 . . . . 0.0 110.297 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.612 ' CG ' ' N ' ' A' ' 71' ' ' GLY . 8.0 ptm -85.05 -50.71 7.21 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.478 -1.013 . . . . 0.0 108.537 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.612 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.58 -154.15 8.2 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 108.012 -2.035 . . . . 0.0 108.012 179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.697 ' H ' ' CG ' ' A' ' 150' ' ' ASP . 40.9 t -35.49 103.59 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.394 -1.062 . . . . 0.0 108.314 178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.84 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -58.84 25.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.261 -0.9 . . . . 0.0 110.97 -178.365 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.745 ' NE1' ' CE1' ' A' ' 209' ' ' TYR . 9.6 t90 -77.9 -60.29 2.43 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 120.9 -1.125 . . . . 0.0 108.91 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -104.67 -3.91 43.01 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.79 -42.78 69.89 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.004 -1.292 . . . . 0.0 109.475 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.664 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 6.7 tt0 -73.63 -13.74 61.05 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.401 -0.812 . . . . 0.0 109.916 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.674 ' O ' ' N ' ' A' ' 80' ' ' PHE . 11.1 ttp85 -60.53 -71.32 0.14 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.133 -0.979 . . . . 0.0 110.288 -179.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.676 ' O ' HG22 ' A' ' 82' ' ' VAL . 14.7 mtmt -36.32 -22.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.212 -0.93 . . . . 0.0 110.578 -179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.943 ' CD2' HG21 ' A' ' 119' ' ' VAL . 84.3 m-85 -77.98 -41.81 34.84 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.003 -1.061 . . . . 0.0 110.803 -178.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.855 ' CG ' HG21 ' A' ' 50' ' ' VAL . 1.2 p90 -76.83 8.59 3.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.55 -1.344 . . . . 0.0 109.518 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.676 HG22 ' O ' ' A' ' 79' ' ' LYS . 0.9 OUTLIER -102.13 19.67 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -0.914 . . . . 0.0 109.851 -179.385 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 126' ' ' ILE . 45.6 mt -110.97 154.22 24.44 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.272 -0.893 . . . . 0.0 109.029 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -92.67 132.28 37.04 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 108.72 -27.36 13.46 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.021 -1.631 . . . . 0.0 109.021 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -67.18 136.38 26.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 O-C-N 121.378 -1.072 . . . . 0.0 109.309 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.683 ' CE2' ' OG ' ' A' ' 88' ' ' SER . 0.0 OUTLIER -76.96 -51.49 11.07 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.585 -0.697 . . . . 0.0 109.455 179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.683 ' OG ' ' CE2' ' A' ' 87' ' ' TYR . 2.0 p -160.04 -160.49 0.8 Allowed 'General case' 0 C--N 1.3 -1.583 0 C-N-CA 119.74 -0.784 . . . . 0.0 110.183 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.941 ' HG1' ' CE1' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -164.11 155.48 16.05 Favored 'General case' 0 C--N 1.303 -1.439 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.664 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.46 171.69 10.24 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.989 -1.069 . . . . 0.0 109.737 -179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.84 HG11 ' HB2' ' A' ' 73' ' ' PHE . 1.8 m -142.98 166.65 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.955 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -171.91 173.76 45.15 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.654 ' N ' ' O ' ' A' ' 200' ' ' TYR . 5.5 m-85 -80.73 163.27 23.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.271 -1.135 . . . . 0.0 109.252 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.631 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.94 139.53 0.13 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.993 -1.067 . . . . 0.0 110.213 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 94.66 23.92 19.65 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.698 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -108.15 178.92 21.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.429 ' HB3' ' HB1' ' A' ' 31' ' ' ALA . 1.6 m170 -120.59 58.63 0.93 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.286 -1.126 . . . . 0.0 110.006 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.714 HG22 ' H ' ' A' ' 99' ' ' ARG . 2.3 m -157.51 -178.41 7.32 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 120.88 -1.137 . . . . 0.0 108.724 179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.714 ' H ' HG22 ' A' ' 98' ' ' THR . 34.9 mtt180 -76.66 -89.36 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.809 0 O-C-N 121.613 -0.679 . . . . 0.0 109.934 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.516 ' N ' ' ND2' ' A' ' 100' ' ' ASN . 0.2 OUTLIER -113.43 96.52 40.17 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.214 -0.929 . . . . 0.0 109.965 -179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.538 ' CG ' ' CD2' ' A' ' 113' ' ' HIS . 11.5 Cg_endo -79.93 159.97 24.18 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.686 2.257 . . . . 0.0 112.21 179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.63 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 9.9 p -114.78 172.51 6.99 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.19 -0.944 . . . . 0.0 109.852 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.603 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 0.5 OUTLIER -63.88 -59.65 4.25 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.171 -0.956 . . . . 0.0 110.337 -179.025 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 2.0 mttm -59.3 -22.95 61.99 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.949 -1.094 . . . . 0.0 108.528 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.63 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 8.3 mm-40 -69.78 -56.67 6.52 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.533 0.683 . . . . 0.0 110.471 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 102' ' ' THR . 16.6 m -66.17 -24.74 34.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.498 -0.752 . . . . 0.0 111.368 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.631 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.8 p -57.36 -41.93 81.06 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 121.254 -0.904 . . . . 0.0 109.486 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.675 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 35.5 p -51.91 -66.56 0.36 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.363 -0.836 . . . . 0.0 109.359 179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.675 ' CG ' ' O ' ' A' ' 108' ' ' SER . 11.3 mt-10 138.62 -27.79 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.4 ' HD3' HD21 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -46.8 -27.44 1.22 Allowed 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.415 -0.803 . . . . 0.0 111.767 -178.612 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 34' ' ' ALA . 11.1 p -90.84 -32.6 16.0 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.564 -1.335 . . . . 0.0 109.941 -179.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.545 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 65.76 44.32 92.47 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.698 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 1.2 m-70 -86.2 173.74 9.59 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.674 -1.486 . . . . 0.0 108.778 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.568 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -132.38 114.19 14.07 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.609 ' OE2' ' CE1' ' A' ' 73' ' ' PHE . 17.0 mt-10 -56.05 123.16 13.49 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.403 -179.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.813 HG11 ' CE2' ' A' ' 160' ' ' TYR . 11.8 m -127.31 150.82 33.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.416 -0.802 . . . . 0.0 108.979 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.107 HG22 ' O ' ' A' ' 68' ' ' PHE . 3.6 m -111.31 135.31 50.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 O-C-N 121.081 -1.012 . . . . 0.0 109.336 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.783 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -98.52 98.51 9.69 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.532 -178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.943 HG21 ' CD2' ' A' ' 80' ' ' PHE . 49.0 t -103.38 120.75 53.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.449 -0.782 . . . . 0.0 109.222 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.508 ' O ' HG22 ' A' ' 86' ' ' VAL . 0.2 OUTLIER -118.07 144.2 26.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.699 ' CE2' HD11 ' A' ' 131' ' ' LEU . 8.8 p90 -141.39 174.31 10.67 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 119.226 -0.99 . . . . 0.0 111.087 -178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 70.4 mtp180 -116.03 117.93 38.8 Favored Pre-proline 0 N--CA 1.488 1.438 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.676 ' O ' ' N ' ' A' ' 125' ' ' HIS . 28.2 Cg_exo -42.09 -62.38 0.42 Allowed 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.879 2.386 . . . . 0.0 113.318 -179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.759 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 27.3 mp0 -38.94 -14.34 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 115.69 -0.687 . . . . 0.0 111.153 -178.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.676 ' N ' ' O ' ' A' ' 123' ' ' PRO . 11.8 m-70 -133.38 -10.8 2.85 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.527 -1.358 . . . . 0.0 111.578 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.64 158.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 120.565 -1.335 . . . . 0.0 110.656 -179.633 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.515 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 1.1 p -109.76 169.53 8.66 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 121.795 0.807 . . . . 0.0 111.375 -179.023 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.57 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 41.2 t80 -69.32 -27.85 65.74 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.587 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 22.4 mt-10 -66.4 -8.74 27.67 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.515 ' HG3' ' H ' ' A' ' 127' ' ' SER . 7.2 mm-40 -72.36 -66.23 0.68 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.376 -0.827 . . . . 0.0 110.797 -179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.901 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -57.29 -35.65 70.06 Favored 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.61 -1.306 . . . . 0.0 107.98 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.57 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 9.3 mp -74.73 -50.4 17.57 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.321 -0.862 . . . . 0.0 110.892 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.587 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 3.8 tttt -52.66 -41.37 63.74 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.865 -1.147 . . . . 0.0 110.272 -178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.638 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -72.15 -28.5 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.952 -1.093 . . . . 0.0 109.501 -179.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.801 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.3 t80 -71.41 -50.8 28.36 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 120.264 -0.574 . . . . 0.0 110.732 -179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.52 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 76.9 m95 -72.03 -46.6 56.47 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 120.207 -1.558 . . . . 0.0 110.527 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -50.56 -42.78 55.9 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.14 -0.975 . . . . 0.0 110.894 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.711 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -119.43 74.3 0.99 Allowed 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.116 -0.99 . . . . 0.0 110.433 -178.215 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.801 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 12.0 m80 -156.75 -179.92 8.66 Favored 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 122.149 0.976 . . . . 0.0 110.299 178.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.558 ' HB3' HE21 ' A' ' 143' ' ' GLN . 1.0 OUTLIER -144.26 67.77 15.08 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 178.668 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.481 ' HD3' ' N ' ' A' ' 140' ' ' ASP . 16.4 Cg_exo -63.51 12.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.302 -1.903 0 C-N-CA 123.681 2.921 . . . . 0.0 113.998 -177.132 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.607 HG22 HG22 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -121.95 29.15 7.21 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.805 -1.158 . . . . 0.0 111.046 -179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.667 ' O ' ' CG ' ' A' ' 143' ' ' GLN . 4.8 pt20 -155.61 77.69 0.98 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.042 -1.036 . . . . 0.0 108.841 178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.699 ' N ' HG21 ' A' ' 190' ' ' THR . . . -70.38 14.71 1.25 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 110.178 -1.169 . . . . 0.0 110.178 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.658 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.5 OUTLIER -108.27 1.46 21.99 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.146 -1.208 . . . . 0.0 108.223 179.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.461 ' CB ' ' HA ' ' A' ' 151' ' ' PHE . 11.5 ptt180 178.59 -174.18 0.17 Allowed 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.718 0.771 . . . . 0.0 109.314 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.454 HE22 ' HA ' ' A' ' 139' ' ' HIS . 0.4 OUTLIER -175.1 118.93 0.18 Allowed 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.721 0.772 . . . . 0.0 109.255 179.067 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.88 -120.38 10.53 Favored Glycine 0 C--N 1.3 -1.456 0 N-CA-C 109.751 -1.34 . . . . 0.0 109.751 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.448 ' ND2' ' HA3' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -80.94 -34.02 33.6 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.321 -0.939 . . . . 0.0 112.176 -178.322 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.697 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 1.5 m-20 -82.48 144.21 30.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.398 -1.439 . . . . 0.0 109.23 -179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.461 ' HA ' ' CB ' ' A' ' 146' ' ' ARG . 38.5 p90 -136.36 144.57 44.66 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.758 -1.177 . . . . 0.0 111.05 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 127.66 -174.18 18.59 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 118.771 -1.681 . . . . 0.0 111.13 179.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.671 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 0.5 OUTLIER -74.83 -19.72 60.06 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.695 -0.886 . . . . 0.0 110.367 -179.549 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 155' ' ' TYR . 17.5 pm0 -86.52 7.51 25.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.931 -1.106 . . . . 0.0 110.156 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 154' ' ' GLN . 16.3 m-85 -139.65 50.84 1.75 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 0.0 109.59 179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.671 ' NH1' ' O ' ' A' ' 153' ' ' THR . 38.4 mtm-85 -93.52 173.21 7.81 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.28 -0.888 . . . . 0.0 108.676 179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.605 ' OG ' ' CG2' ' A' ' 190' ' ' THR . 0.1 OUTLIER -94.28 109.26 21.09 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 105.373 -2.084 . . . . 0.0 105.373 177.271 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.451 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -133.33 119.28 19.53 Favored 'General case' 0 C--N 1.29 -2.02 0 C-N-CA 118.396 -1.322 . . . . 0.0 109.947 -177.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.693 HG23 ' CG2' ' A' ' 191' ' ' THR . 7.9 t -114.5 125.43 71.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 C-N-CA 118.941 -1.104 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.813 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -119.57 133.51 23.82 Favored Pre-proline 0 N--CA 1.492 1.647 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.23 169.03 22.09 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.564 2.176 . . . . 0.0 111.649 179.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.72 -19.69 20.17 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 120.729 -1.232 . . . . 0.0 109.146 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 12.0 p 177.44 -163.23 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.88 -15.74 23.68 Favored 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.033 1.397 . . . . 0.0 108.471 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.424 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.4 t -56.15 -62.97 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.827 0 CA-C-N 113.889 -1.505 . . . . 0.0 110.496 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.465 ' O ' ' N ' ' A' ' 170' ' ' ALA . 17.8 mt-30 -77.81 -11.42 59.88 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.465 -0.772 . . . . 0.0 111.298 -178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -51.42 -45.57 62.63 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.569 -1.332 . . . . 0.0 109.248 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.71 -17.75 59.83 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.073 -1.017 . . . . 0.0 109.219 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.87 -55.88 3.2 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.234 -0.916 . . . . 0.0 110.0 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.465 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.34 -53.77 40.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 0.0 109.386 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.417 HD23 ' HA ' ' A' ' 171' ' ' LEU . 70.0 mt -52.66 -39.1 61.5 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.131 -0.981 . . . . 0.0 108.906 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.31 -58.26 3.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.29 -0.881 . . . . 0.0 109.429 179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.52 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 4.0 p -56.67 -36.23 69.35 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.253 -0.904 . . . . 0.0 109.415 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.471 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 4.2 ttpt -72.61 -46.41 54.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.137 -0.977 . . . . 0.0 109.383 179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.423 ' N ' ' HE2' ' A' ' 174' ' ' LYS . 1.5 tt0 -71.63 -30.23 65.54 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.291 -0.881 . . . . 0.0 109.957 -179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.455 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 4.1 pt-20 -53.25 -34.02 55.43 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.072 -1.017 . . . . 0.0 109.526 -179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.618 ' CD2' HD11 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.28 -30.83 43.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.217 -0.927 . . . . 0.0 109.524 -179.971 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.499 ' O ' ' OG ' ' A' ' 182' ' ' SER . 0.4 OUTLIER -66.61 -38.12 86.32 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.316 -0.865 . . . . 0.0 109.466 -179.896 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -28.28 59.42 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.188 -0.945 . . . . 0.0 109.482 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 96.1 t -87.48 -54.22 8.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 0.0 109.88 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.618 HD11 ' CD2' ' A' ' 177' ' ' TYR . 3.7 mt -63.97 -45.26 89.87 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.027 -1.045 . . . . 0.0 109.92 -179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 87.8 p -54.97 -23.75 20.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.892 -1.13 . . . . 0.0 108.965 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.2 tptt -88.38 -3.56 58.82 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.46 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.7 m-70 -108.18 30.82 6.05 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.363 -0.835 . . . . 0.0 109.708 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.46 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.1 OUTLIER 72.3 29.74 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.242 -0.911 . . . . 0.0 110.25 179.628 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -103.54 175.16 5.57 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.032 -1.042 . . . . 0.0 108.99 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -122.93 -152.05 8.45 Favored Glycine 0 N--CA 1.493 2.433 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.508 ' O ' ' O ' ' A' ' 189' ' ' ILE . 28.0 Cg_exo -58.69 105.74 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 C-N-CA 122.639 2.226 . . . . 0.0 111.423 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.607 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.8 -178.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.265 -0.897 . . . . 0.0 110.01 -179.279 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.699 HG21 ' N ' ' A' ' 144' ' ' GLY . 1.7 t -130.76 -2.04 4.2 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.528 -0.732 . . . . 0.0 110.777 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.693 ' CG2' HG23 ' A' ' 159' ' ' VAL . 3.9 m -42.07 113.43 0.44 Allowed 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.657 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -80.79 114.53 19.74 Favored 'General case' 0 C--N 1.278 -2.51 0 CA-C-N 115.459 -0.792 . . . . 0.0 110.341 -178.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.21 111.93 36.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.672 ' NH2' ' OH ' ' A' ' 160' ' ' TYR . 55.6 mtm-85 -115.18 -173.23 2.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.244 -0.91 . . . . 0.0 110.016 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -146.02 164.12 33.08 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.401 -0.812 . . . . 0.0 109.586 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.42 23.36 1.98 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.931 -0.867 . . . . 0.0 110.931 179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.754 ' H ' ' CD ' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -83.68 173.23 11.53 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.62 -1.518 . . . . 0.0 108.919 179.292 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.743 ' CG1' ' CE2' ' A' ' 200' ' ' TYR . 1.0 OUTLIER -118.72 160.43 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 120.971 -1.08 . . . . 0.0 110.379 -179.078 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.511 ' CZ ' ' HG3' ' A' ' 118' ' ' ARG . 47.1 t80 -91.04 149.88 21.65 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.556 -0.715 . . . . 0.0 109.314 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.743 ' CE2' ' CG1' ' A' ' 198' ' ' VAL . 18.6 m-85 -143.83 100.43 3.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 109.8 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -58.54 146.49 35.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 109.225 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.478 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -90.07 -167.22 1.78 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.101 -0.999 . . . . 0.0 108.985 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.719 ' OE2' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -73.84 176.82 6.0 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.428 -0.795 . . . . 0.0 109.267 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.719 ' N ' ' OE2' ' A' ' 203' ' ' GLU . 0.3 OUTLIER -61.03 -61.02 2.87 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.168 -0.957 . . . . 0.0 109.618 179.577 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.711 ' CD1' ' OE2' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -58.43 8.62 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.145 0 O-C-N 120.774 -1.204 . . . . 0.0 111.039 -179.46 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.603 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 6.5 m-70 -104.0 14.8 29.94 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.766 -1.209 . . . . 0.0 111.04 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.803 ' O ' ' N ' ' A' ' 209' ' ' TYR . 20.0 mm-40 -129.05 -168.35 1.91 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.726 -1.234 . . . . 0.0 110.495 -177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.824 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -38.64 1.15 0.0 OUTLIER 'General case' 0 N--CA 1.512 2.647 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -179.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.803 ' N ' ' O ' ' A' ' 207' ' ' GLN . 21.1 p90 -38.35 -24.03 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.819 0 O-C-N 120.788 -1.195 . . . . 0.0 110.965 -177.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.714 ' CB ' ' HE1' ' A' ' 74' ' ' TRP . 0.2 OUTLIER -79.38 -10.42 59.8 Favored 'General case' 0 C--N 1.293 -1.875 0 O-C-N 120.267 -1.521 . . . . 0.0 111.81 -176.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.474 ' OG ' ' CD2' ' A' ' 49' ' ' HIS . 83.3 p -54.06 -24.63 17.97 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.152 -0.968 . . . . 0.0 108.757 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.472 ' HG2' ' CE1' ' A' ' 49' ' ' HIS . 6.4 mmmt -68.39 -18.41 64.45 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.523 ' C ' ' H ' ' A' ' 215' ' ' ASP . 0.0 OUTLIER -140.23 73.05 32.05 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -51.71 4.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 123.037 2.491 . . . . 0.0 113.079 -179.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.623 ' OD2' ' CE1' ' A' ' 217' ' ' TYR . 38.0 t0 -63.02 -19.5 64.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.897 -1.127 . . . . 0.0 110.053 -179.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.56 85.25 0.04 OUTLIER Glycine 0 N--CA 1.504 3.214 0 C-N-CA 120.067 -1.064 . . . . 0.0 111.757 177.65 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.623 ' CE1' ' OD2' ' A' ' 215' ' ' ASP . 66.5 m-85 -91.81 81.13 5.21 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 121.002 2.401 . . . . 0.0 109.602 179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.572 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.5 OUTLIER -170.83 112.12 0.39 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.9 -1.125 . . . . 0.0 109.447 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.572 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -37.87 161.08 0.01 OUTLIER Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.034 -1.626 . . . . 0.0 109.034 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.545 ' CD1' ' O ' ' A' ' 218' ' ' CYS . 4.6 mp -143.54 -177.97 5.66 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.12 -1.224 . . . . 0.0 109.775 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 108.47 158.74 19.53 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.667 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -123.79 -167.31 12.74 Favored Glycine 0 C--N 1.304 -1.201 0 N-CA-C 108.515 -1.834 . . . . 0.0 108.515 179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.501 ' C ' ' O ' ' A' ' 222' ' ' GLY . 0.0 OUTLIER -34.95 -25.74 0.01 OUTLIER 'General case' 0 C--N 1.269 -2.914 0 CA-C-N 114.511 -0.844 . . . . 0.0 109.219 -179.969 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . 79.59 17.03 76.54 Favored Glycine 0 C--N 1.305 -1.158 0 N-CA-C 108.689 -1.764 . . . . 0.0 108.689 179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.638 ' C ' ' H ' ' A' ' 227' ' ' CYS . 3.2 p -53.58 166.16 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.809 -0.819 . . . . 0.0 109.627 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 5.6 m -66.94 25.14 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.312 1.053 . . . . 0.0 111.437 -178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.638 ' H ' ' C ' ' A' ' 225' ' ' VAL . 1.3 m -69.87 -71.29 0.29 Allowed Pre-proline 0 C--N 1.259 -3.368 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.867 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.569 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 21.7 Cg_endo -62.78 -0.51 2.06 Favored 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.833 1.689 . . . . 0.0 110.074 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.66 ' SD ' ' O ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -58.0 155.52 10.71 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-O 121.8 0.81 . . . . 0.0 110.262 -179.929 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.66 ' O ' ' SD ' ' A' ' 229' ' ' MET . . . -30.43 136.01 0.04 OUTLIER 'General case' 0 C--N 1.297 -1.715 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.792 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.582 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 2.5 tp -147.3 117.43 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.208 -0.932 . . . . 0.0 109.394 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 18.2 tttm -69.76 -26.84 64.49 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.22 -0.925 . . . . 0.0 109.479 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.195 -0.941 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.597 ' O1 ' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.495 0 N-CA-C 109.26 -1.536 . . . . 0.0 109.26 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.483 ' CG ' ' N ' ' A' ' 24' ' ' SER . 3.5 p-10 -48.11 -45.03 32.45 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.082 -1.246 . . . . 0.0 108.666 179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.665 ' C ' ' H ' ' A' ' 26' ' ' SER . 2.5 m -50.81 -15.97 0.35 Allowed 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.603 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -47.74 -9.5 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 CA-C-O 122.852 1.31 . . . . 0.0 109.935 -178.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.665 ' H ' ' C ' ' A' ' 24' ' ' SER . 0.3 OUTLIER -47.19 -17.05 0.05 Allowed 'General case' 0 C--N 1.262 -3.237 0 CA-C-N 114.321 -1.309 . . . . 0.0 108.103 179.549 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.641 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -109.34 24.9 12.45 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 124.15 1.929 . . . . 0.0 109.2 -179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.624 ' O ' ' O ' ' A' ' 29' ' ' ILE . 36.0 t -155.68 21.96 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.266 -3.045 0 N-CA-C 105.275 -2.121 . . . . 0.0 105.275 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.624 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -40.08 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.984 1.373 . . . . 0.0 109.773 -178.025 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.471 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.6 OUTLIER -111.25 125.97 54.38 Favored 'General case' 0 C--N 1.271 -2.84 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 177.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.418 ' HA ' ' ND1' ' A' ' 97' ' ' HIS . . . -46.47 -22.39 0.26 Allowed 'General case' 0 C--N 1.276 -2.616 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.25 -179.013 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.582 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 22.3 mp0 -83.97 -7.58 59.37 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.082 -1.011 . . . . 0.0 110.391 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.618 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.7 pt-20 -106.3 -14.6 15.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.014 -1.054 . . . . 0.0 109.578 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.833 ' HB2' ' NE2' ' A' ' 97' ' ' HIS . . . -45.48 -170.86 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.597 0.713 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.498 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.1 mm? -70.34 165.06 48.08 Favored Pre-proline 0 C--N 1.307 -1.262 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 179.576 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_exo -66.85 -56.07 0.28 Allowed 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.256 1.971 . . . . 0.0 112.404 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.584 ' N ' ' OD1' ' A' ' 100' ' ' ASN . . . 160.07 143.0 3.53 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 40' ' ' GLU . 9.2 ttm180 -149.83 128.21 12.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.358 -1.084 . . . . 0.0 109.267 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.474 HG22 ' O ' ' A' ' 39' ' ' THR . 17.7 m -66.33 35.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.073 -1.017 . . . . 0.0 109.301 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 38' ' ' ARG . 1.6 tt0 -63.12 112.57 7.14 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.11 -0.994 . . . . 0.0 110.128 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -86.33 143.66 7.73 Favored 'Trans proline' 0 C--N 1.313 -1.291 0 C-N-CA 122.806 2.337 . . . . 0.0 112.187 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mt -129.86 84.08 61.97 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.093 -1.004 . . . . 0.0 109.865 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.736 ' O ' HG13 ' A' ' 44' ' ' VAL . 72.0 Cg_endo -82.38 169.59 13.92 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 123.054 2.503 . . . . 0.0 112.334 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.736 HG13 ' O ' ' A' ' 43' ' ' PRO . 5.1 m -162.34 -166.73 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.172 -0.955 . . . . 0.0 109.595 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.834 ' O ' HG23 ' A' ' 45' ' ' THR . 14.1 t -82.31 95.16 7.52 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.218 -0.926 . . . . 0.0 110.233 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.602 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.73 -27.59 59.51 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.26 -0.9 . . . . 0.0 111.424 -179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.587 ' O ' ' C ' ' A' ' 48' ' ' HIS . 4.5 ptpt -95.42 99.03 11.0 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 116.407 -2.117 . . . . 0.0 108.588 178.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.67 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.35 114.34 0.13 Allowed 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -64.0 -27.81 69.38 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.401 -0.812 . . . . 0.0 111.134 -178.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.621 HG11 ' CD1' ' A' ' 81' ' ' TRP . 15.8 t -71.27 -38.98 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.865 -1.147 . . . . 0.0 109.326 -179.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 20.4 t -109.94 -42.74 4.15 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.562 -0.711 . . . . 0.0 110.239 -179.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.67 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.14 0.9 55.92 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.304 -1.518 . . . . 0.0 109.304 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 24.4 p30 -76.24 -117.59 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.589 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 41.8 mtm-85 -126.16 174.01 8.82 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 123.323 1.535 . . . . 0.0 110.121 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.642 ' C ' HG22 ' A' ' 56' ' ' VAL . 2.9 p -147.11 30.78 0.94 Allowed 'General case' 0 C--N 1.273 -2.761 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.293 178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.642 HG22 ' C ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -171.34 134.72 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.064 -1.023 . . . . 0.0 109.484 179.927 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.595 ' N ' ' OE1' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -32.28 144.96 0.1 Allowed Pre-proline 0 C--N 1.307 -1.276 0 O-C-N 121.395 -0.816 . . . . 0.0 110.534 -179.306 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 90.1 Cg_endo -77.17 166.66 81.71 Favored 'Cis proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.132 -2.028 . . . . 0.0 111.825 -0.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.786 ' CZ ' ' NH1' ' A' ' 118' ' ' ARG . 92.8 m-85 -106.85 153.31 40.89 Favored Pre-proline 0 C--N 1.269 -2.918 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.351 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.545 ' O ' ' OG1' ' A' ' 63' ' ' THR . 32.3 Cg_exo -50.3 161.03 1.25 Allowed 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.318 2.012 . . . . 0.0 112.22 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -79.44 155.02 28.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.189 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 61.14 50.96 61.53 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.545 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -144.9 137.68 26.4 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -1.117 . . . . 0.0 109.413 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.637 ' CD ' ' H ' ' A' ' 65' ' ' MET . 13.3 tp60 -106.29 157.53 17.53 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 108.811 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.772 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -126.85 137.81 53.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.24 -0.912 . . . . 0.0 109.925 179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.618 ' CB ' HD13 ' A' ' 131' ' ' LEU . . . -130.07 -171.03 2.43 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG21 ' CD ' ' A' ' 197' ' ' GLN . 96.5 t -144.49 150.11 16.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.156 -1.59 . . . . 0.0 110.093 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.496 ' CD1' ' HB2' ' A' ' 135' ' ' PHE . 67.1 m-85 -143.21 141.62 31.16 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.29 -0.881 . . . . 0.0 108.824 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.742 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -137.1 101.61 0.35 Allowed Glycine 0 N--CA 1.48 1.595 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.716 ' N ' ' SD ' ' A' ' 70' ' ' MET . 0.0 OUTLIER -109.18 -89.73 0.47 Allowed 'General case' 0 C--N 1.293 -1.877 0 C-N-CA 119.533 -0.867 . . . . 0.0 109.46 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.649 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -141.09 -166.46 10.73 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 108.696 -1.762 . . . . 0.0 108.696 179.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.788 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 1.1 t -25.79 107.24 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.833 -0.804 . . . . 0.0 109.026 179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.798 ' CZ ' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.1 6.83 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.362 -0.836 . . . . 0.0 111.893 -177.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.788 ' CD2' ' SG ' ' A' ' 72' ' ' CYS . 32.0 m0 -71.66 -40.79 69.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.215 -1.553 . . . . 0.0 107.899 178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -90.8 -23.34 30.75 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.251 -1.539 . . . . 0.0 109.251 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.71 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.0 -21.8 54.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.32 -1.106 . . . . 0.0 110.662 -179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.598 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -84.89 -41.91 15.53 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 120.64 -1.288 . . . . 0.0 111.486 -178.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.699 ' O ' HG13 ' A' ' 82' ' ' VAL . 3.9 ttt180 -56.69 -57.84 10.68 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.758 -1.214 . . . . 0.0 111.309 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.405 ' O ' HG21 ' A' ' 134' ' ' VAL . 0.1 OUTLIER -60.0 25.77 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.978 -1.076 . . . . 0.0 110.953 -178.574 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 19.6 m-85 -128.26 -41.78 1.55 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.94 -1.1 . . . . 0.0 110.844 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.621 ' CD1' HG11 ' A' ' 50' ' ' VAL . 1.2 p90 -91.63 -2.7 56.98 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.645 -1.284 . . . . 0.0 110.341 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.699 HG13 ' O ' ' A' ' 78' ' ' ARG . 3.4 m -83.87 13.93 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.085 -1.009 . . . . 0.0 109.14 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.404 HD13 ' OE1' ' A' ' 130' ' ' GLU . 43.3 mt -111.68 152.91 27.17 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.915 0.864 . . . . 0.0 109.408 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.86 136.41 34.17 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.636 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.41 -31.43 6.19 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 108.826 -1.71 . . . . 0.0 108.826 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -72.96 137.65 23.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.554 -0.968 . . . . 0.0 109.118 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.675 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -72.4 -42.42 65.18 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.463 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.671 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 1.0 OUTLIER -177.67 -171.2 0.3 Allowed 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 120.176 -0.61 . . . . 0.0 109.444 179.571 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.496 ' OG1' ' CD ' ' A' ' 77' ' ' GLU . 1.1 p -151.44 156.73 41.24 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.383 -0.823 . . . . 0.0 109.273 179.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.671 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 9.0 mp0 -149.64 158.55 44.28 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.417 -0.802 . . . . 0.0 109.415 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.598 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.6 OUTLIER -135.85 150.88 28.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.176 -0.952 . . . . 0.0 108.829 178.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -167.23 174.35 42.44 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 109.028 -1.629 . . . . 0.0 109.028 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.646 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.3 m-85 -79.06 146.46 33.26 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.306 -1.114 . . . . 0.0 108.464 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.69 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -145.12 -175.55 4.74 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.142 -0.974 . . . . 0.0 109.288 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 49.76 21.62 3.65 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.555 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -91.0 178.31 42.03 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 108.42 -1.872 . . . . 0.0 108.42 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.833 ' NE2' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -137.47 5.28 2.69 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 118.032 -1.467 . . . . 0.0 113.285 -179.167 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 1.149 HG22 HD21 ' A' ' 100' ' ' ASN . 1.0 OUTLIER -160.08 147.38 16.36 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 119.918 -1.738 . . . . 0.0 110.899 179.898 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.661 ' C ' ' ND2' ' A' ' 100' ' ' ASN . 4.3 mtp85 -72.3 61.51 0.47 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 1.149 HD21 HG22 ' A' ' 98' ' ' THR . 0.5 OUTLIER -123.58 -136.2 0.0 OUTLIER Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.356 -0.84 . . . . 0.0 109.885 -176.931 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.612 ' CD ' ' CB ' ' A' ' 100' ' ' ASN . 74.4 Cg_exo -40.42 169.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.487 1.137 0 CA-C-N 122.486 1.924 . . . . 0.0 114.562 -178.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.967 ' O ' HG13 ' A' ' 106' ' ' VAL . 8.9 p -123.72 -175.1 3.13 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.605 -177.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.706 ' CD1' ' CE1' ' A' ' 206' ' ' HIS . 0.3 OUTLIER -47.59 -38.73 15.06 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.436 -1.415 . . . . 0.0 110.38 -179.261 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.2 tttt -74.34 -49.46 22.78 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 120.932 -1.105 . . . . 0.0 111.636 -178.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' C ' ' N ' ' A' ' 107' ' ' CYS . 9.5 mm-40 -84.28 -25.34 29.42 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.038 -1.039 . . . . 0.0 111.24 -177.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 102' ' ' THR . 29.7 m -54.48 -21.52 6.93 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 107.008 -1.478 . . . . 0.0 107.008 178.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.494 ' C ' ' O ' ' A' ' 106' ' ' VAL . 1.2 p -37.32 -20.8 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.784 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.869 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.701 ' N ' ' O ' ' A' ' 106' ' ' VAL . 79.3 p -75.49 3.36 9.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.22 -0.925 . . . . 0.0 108.859 179.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.661 ' N ' ' O ' ' A' ' 106' ' ' VAL . 16.2 mt-10 55.39 3.99 0.09 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.534 -0.729 . . . . 0.0 110.65 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.55 ' O ' ' NE2' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -77.51 -19.69 55.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.852 -1.155 . . . . 0.0 110.829 -178.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.745 HG21 HG12 ' A' ' 106' ' ' VAL . 67.8 p -86.22 -6.27 59.02 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.679 -1.263 . . . . 0.0 110.393 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 51.16 16.8 2.18 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 118.997 -1.573 . . . . 0.0 109.489 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.69 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -73.86 161.55 30.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.205 -1.173 . . . . 0.0 110.763 -179.187 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.509 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -138.74 114.28 9.76 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 179.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.688 ' OE1' ' CE1' ' A' ' 155' ' ' TYR . 6.3 mp0 -55.17 130.87 43.73 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.193 -179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.742 HG12 ' CA ' ' A' ' 69' ' ' GLY . 10.5 m -142.19 -171.24 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.031 -1.043 . . . . 0.0 110.978 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.581 ' HA ' HG12 ' A' ' 91' ' ' VAL . 2.9 t -131.1 118.86 42.82 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 O-C-N 121.685 -0.634 . . . . 0.0 110.33 -178.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.786 ' NH1' ' CZ ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.31 103.29 15.19 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.44 HG22 HG12 ' A' ' 117' ' ' VAL . 2.1 t -120.69 142.86 34.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.502 -0.749 . . . . 0.0 110.743 -177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.682 HG12 ' NH2' ' A' ' 118' ' ' ARG . 1.8 m -107.95 163.26 5.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.099 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.651 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 3.6 m-85 -141.93 151.55 42.7 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.906 -1.122 . . . . 0.0 109.412 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -102.02 105.94 44.93 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.298 -0.877 . . . . 0.0 109.923 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 52.5 Cg_exo -50.04 -23.93 10.03 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.595 2.196 . . . . 0.0 112.345 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -83.61 -21.54 32.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.224 -0.922 . . . . 0.0 110.317 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 16.2 m80 -116.29 -12.17 11.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.781 HD13 ' HG2' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.47 163.61 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.292 -0.88 . . . . 0.0 110.33 -179.814 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.425 ' N ' HG23 ' A' ' 126' ' ' ILE . 32.8 t -110.6 170.84 7.83 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.305 -0.872 . . . . 0.0 110.826 -178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.626 ' O ' ' CD1' ' A' ' 128' ' ' PHE . 7.9 t80 -69.54 -19.99 63.69 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.49 -0.756 . . . . 0.0 109.52 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -71.18 -17.45 62.53 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.581 -1.325 . . . . 0.0 108.171 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.781 ' HG2' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -76.39 -42.35 44.77 Favored 'General case' 0 C--N 1.308 -1.208 0 O-C-N 121.567 -0.708 . . . . 0.0 110.803 -179.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.618 HD13 ' CB ' ' A' ' 66' ' ' ALA . 1.2 pp -65.53 -48.95 70.72 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 120.254 -1.529 . . . . 0.0 108.813 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.883 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.4 pp -71.39 -18.8 62.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.929 -1.107 . . . . 0.0 110.212 -179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.736 ' N ' HD12 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.01 -42.62 66.21 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.0 110.723 -179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.735 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 1.0 OUTLIER -67.04 -38.72 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.147 -0.971 . . . . 0.0 110.321 -178.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.792 ' CE1' ' CE1' ' A' ' 139' ' ' HIS . 5.3 t80 -61.62 -48.49 80.66 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 121.4 -0.813 . . . . 0.0 110.389 -178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.731 ' CG ' ' CZ ' ' A' ' 177' ' ' TYR . 90.3 m95 -70.47 -32.44 69.98 Favored 'General case' 0 N--CA 1.509 2.511 0 O-C-N 120.863 -1.148 . . . . 0.0 110.66 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -76.26 -43.62 41.02 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.308 -0.87 . . . . 0.0 112.562 -177.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.405 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 2.8 m-80 -111.48 65.05 0.62 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.588 -1.32 . . . . 0.0 112.581 -176.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.792 ' CE1' ' CE1' ' A' ' 135' ' ' PHE . 0.1 OUTLIER 175.67 134.26 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.098 -1.001 . . . . 0.0 110.195 177.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.659 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.2 OUTLIER -73.88 114.55 33.66 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.394 -0.816 . . . . 0.0 109.167 179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.408 ' O ' ' OG1' ' A' ' 190' ' ' THR . 72.9 Cg_endo -81.43 -26.79 3.08 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.501 2.134 . . . . 0.0 113.053 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.694 HG22 HG22 ' A' ' 189' ' ' ILE . 0.7 OUTLIER -89.13 34.07 0.8 Allowed 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.063 -1.023 . . . . 0.0 109.904 -179.748 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.72 ' OE1' ' N ' ' A' ' 148' ' ' GLY . 29.7 mt-30 -129.84 90.79 3.03 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.081 -1.012 . . . . 0.0 110.808 -179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.678 ' H ' HG21 ' A' ' 190' ' ' THR . . . -63.57 -117.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.541 -1.023 . . . . 0.0 110.541 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.472 ' SD ' ' H71' ' A' ' 21' ' ' MYR . 0.0 OUTLIER -69.67 40.33 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.586 -0.949 . . . . 0.0 109.846 -178.832 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.485 ' H ' ' C ' ' A' ' 144' ' ' GLY . 13.5 ttt-85 -163.58 84.66 0.48 Allowed 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 119.53 -0.868 . . . . 0.0 110.288 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.581 ' OE1' ' OE1' ' A' ' 143' ' ' GLN . 6.2 tp-100 -76.53 63.64 2.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.481 -1.387 . . . . 0.0 109.866 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.72 ' N ' ' OE1' ' A' ' 143' ' ' GLN . . . 91.6 -121.3 6.31 Favored Glycine 0 N--CA 1.476 1.33 0 N-CA-C 109.127 -1.589 . . . . 0.0 109.127 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -80.52 10.33 4.88 Favored 'General case' 0 C--N 1.269 -2.917 0 CA-C-N 114.217 -0.992 . . . . 0.0 109.515 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.16 154.65 20.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.242 -0.911 . . . . 0.0 108.64 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -136.46 125.42 24.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.984 -1.072 . . . . 0.0 110.477 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.58 ' HA2' ' HZ1' ' A' ' 27' ' ' LYS . . . 156.46 142.04 3.33 Favored Glycine 0 N--CA 1.492 2.408 0 C-N-CA 119.661 -1.257 . . . . 0.0 110.12 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.603 ' N ' ' NZ ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -72.62 5.0 3.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.327 -1.102 . . . . 0.0 109.014 179.508 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.623 ' NE2' ' CZ ' ' A' ' 155' ' ' TYR . 7.2 pt20 -95.18 -1.47 51.72 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.327 -0.858 . . . . 0.0 109.199 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.688 ' CE1' ' OE1' ' A' ' 115' ' ' GLU . 38.8 m-85 -129.82 61.11 1.57 Allowed 'General case' 0 N--CA 1.485 1.294 0 O-C-N 121.326 -0.859 . . . . 0.0 108.993 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.799 ' NH2' HH22 ' A' ' 194' ' ' ARG . 5.8 mtm180 -111.6 177.92 4.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.307 -0.871 . . . . 0.0 109.83 -179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.543 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -92.48 119.39 31.93 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 104.487 -2.412 . . . . 0.0 104.487 176.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.627 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -140.4 129.33 23.31 Favored 'General case' 0 C--N 1.286 -2.185 0 C-N-CA 118.191 -1.403 . . . . 0.0 111.189 -176.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.741 HG13 ' CG2' ' A' ' 191' ' ' THR . 3.1 m -107.4 127.85 62.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 C-N-CA 118.675 -1.21 . . . . 0.0 108.706 177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.627 ' CE1' ' HB1' ' A' ' 158' ' ' ALA . 10.9 m-85 -124.86 107.73 28.52 Favored Pre-proline 0 C--N 1.295 -1.78 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -77.3 176.08 10.53 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.359 2.039 . . . . 0.0 112.802 -179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.2 -34.2 11.2 Favored 'General case' 0 C--N 1.306 -1.293 0 O-C-N 121.458 -0.776 . . . . 0.0 109.46 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.0 p -173.96 -163.21 0.16 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.414 -0.804 . . . . 0.0 109.165 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -61.99 -17.8 58.34 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-O 122.972 1.368 . . . . 0.0 108.764 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t -61.21 -61.0 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.835 0 CA-C-N 114.095 -1.411 . . . . 0.0 109.758 179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.445 ' HG2' ' HB2' ' A' ' 170' ' ' ALA . 1.3 tt0 -76.88 -25.75 53.42 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.69 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.4 ' SD ' ' CD1' ' A' ' 171' ' ' LEU . 1.7 mtt -52.3 -14.47 0.46 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.004 -1.06 . . . . 0.0 110.627 -178.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -75.9 -45.55 34.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.754 -1.216 . . . . 0.0 109.638 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.484 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -93.03 -47.45 6.98 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 0.0 110.517 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.445 ' HB2' ' HG2' ' A' ' 166' ' ' GLN . . . -52.71 -65.92 0.47 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.027 -1.046 . . . . 0.0 110.192 -178.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.4 ' CD1' ' SD ' ' A' ' 167' ' ' MET . 0.6 OUTLIER -54.94 -47.59 74.27 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.112 -0.993 . . . . 0.0 109.521 -179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -61.25 -38.18 85.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.175 -0.953 . . . . 0.0 109.386 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.614 ' OG ' ' NE1' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -56.33 -32.6 64.82 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.263 -0.898 . . . . 0.0 109.281 179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 25.4 tttm -72.6 -55.99 6.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.284 -0.885 . . . . 0.0 110.203 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -70.68 -47.64 58.85 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.232 -0.917 . . . . 0.0 110.463 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -53.11 -32.89 49.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.059 -1.025 . . . . 0.0 109.824 -179.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.731 ' CZ ' ' CG ' ' A' ' 136' ' ' TRP . 1.5 m-85 -74.08 -30.58 62.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -0.908 . . . . 0.0 110.002 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.538 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.6 mm100 -52.92 -60.77 2.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.961 -1.087 . . . . 0.0 109.478 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 17.4 ttmm -47.79 -22.31 0.52 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.881 . . . . 0.0 109.959 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.25 -53.2 10.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.122 -0.986 . . . . 0.0 109.605 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 38.1 mt -74.68 -44.88 47.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.26 -0.9 . . . . 0.0 109.873 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 43.2 t -55.63 -30.85 61.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.018 -1.051 . . . . 0.0 109.423 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -88.34 -3.33 58.86 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.305 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.408 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 43.3 m170 -108.25 35.86 3.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.303 -0.873 . . . . 0.0 109.759 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.461 ' O ' ' CG ' ' A' ' 186' ' ' PHE . 0.5 OUTLIER 68.23 66.88 0.33 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.239 -0.913 . . . . 0.0 109.604 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.461 ' CG ' ' O ' ' A' ' 185' ' ' ASN . 65.4 m-85 -158.13 168.57 26.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.312 -0.868 . . . . 0.0 109.054 179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.2 -158.73 18.56 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.284 -1.526 . . . . 0.0 109.284 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_exo -58.76 107.33 0.33 Allowed 'Trans proline' 0 C--N 1.303 -1.829 0 C-N-CA 122.483 2.122 . . . . 0.0 111.193 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.694 HG22 HG22 ' A' ' 142' ' ' THR . 0.4 OUTLIER -46.9 169.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.914 . . . . 0.0 110.444 -178.685 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.678 HG21 ' H ' ' A' ' 144' ' ' GLY . 79.2 p -114.67 58.25 0.7 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.562 0.696 . . . . 0.0 109.446 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.741 ' CG2' HG13 ' A' ' 159' ' ' VAL . 39.8 m -94.45 116.65 29.04 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 179.18 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.628 ' CG ' HH22 ' A' ' 156' ' ' ARG . 32.9 t70 -93.98 138.18 32.38 Favored 'General case' 0 C--N 1.279 -2.47 0 CA-C-O 121.582 0.706 . . . . 0.0 110.505 -178.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.493 HD13 ' CG2' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -111.62 159.73 11.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 N-CA-C 107.786 -1.191 . . . . 0.0 107.786 178.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.799 HH22 ' NH2' ' A' ' 156' ' ' ARG . 1.5 ttm180 -162.31 -167.65 1.66 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.887 -1.133 . . . . 0.0 110.465 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.787 ' O ' ' N ' ' A' ' 197' ' ' GLN . 0.7 OUTLIER -103.11 140.37 37.41 Favored 'General case' 0 CA--C 1.477 -1.864 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 178.678 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.997 ' O ' ' NE2' ' A' ' 197' ' ' GLN . . . 14.38 -81.21 0.0 OUTLIER Glycine 0 C--O 1.185 -2.964 0 N-CA-C 104.069 -3.613 . . . . 0.0 104.069 -177.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.997 ' NE2' ' O ' ' A' ' 196' ' ' GLY . 0.0 OUTLIER 145.13 115.07 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.289 0 CA-C-N 117.127 0.464 . . . . 0.0 111.616 172.606 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.707 HG13 ' O ' ' A' ' 198' ' ' VAL . 7.7 p -61.12 82.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 119.963 -1.711 . . . . 0.0 106.732 177.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.677 ' N ' ' O ' ' A' ' 197' ' ' GLN . 11.7 t80 -49.76 147.88 3.41 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 114.833 -1.076 . . . . 0.0 112.088 -177.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.646 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.6 m-85 -151.05 97.31 2.44 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.492 ' CZ ' ' CG1' ' A' ' 56' ' ' VAL . 25.0 m-85 -53.78 147.84 11.1 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.994 -1.066 . . . . 0.0 110.76 -178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.543 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -99.31 177.72 5.11 Favored 'General case' 0 C--N 1.31 -1.141 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.535 ' OE2' ' CD2' ' A' ' 206' ' ' HIS . 1.3 pm0 -74.17 163.12 28.24 Favored 'General case' 0 C--N 1.287 -2.116 0 O-C-N 121.035 -1.041 . . . . 0.0 109.056 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.646 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -49.56 -51.87 33.95 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.912 -1.118 . . . . 0.0 108.522 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -46.85 -15.97 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.757 . . . . 0.0 110.189 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.798 ' ND1' ' CZ ' ' A' ' 73' ' ' PHE . 4.7 m-70 -100.75 13.49 34.75 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.036 -1.04 . . . . 0.0 110.684 -178.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.847 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.6 mm-40 -131.87 -138.98 0.2 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 122.478 1.132 . . . . 0.0 109.989 -178.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.68 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -32.86 -3.65 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.27 0 CA-C-N 113.704 -1.589 . . . . 0.0 112.858 -179.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.847 ' N ' ' O ' ' A' ' 207' ' ' GLN . 9.4 t80 -41.7 -43.27 2.81 Favored 'General case' 0 N--CA 1.511 2.624 0 O-C-N 120.171 -1.581 . . . . 0.0 108.699 179.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.678 HD22 ' HA2' ' A' ' 216' ' ' GLY . 0.2 OUTLIER -53.29 -25.18 13.71 Favored 'General case' 0 C--N 1.313 -0.98 0 O-C-N 120.627 -1.296 . . . . 0.0 109.538 -179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.532 ' N ' ' O ' ' A' ' 208' ' ' GLN . 29.0 t -55.71 -51.1 68.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.111 -0.993 . . . . 0.0 108.909 179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 11.0 mtmm -67.46 -33.45 75.16 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.197 -0.939 . . . . 0.0 108.506 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.64 ' O ' ' N ' ' A' ' 215' ' ' ASP . 24.8 m120 -136.47 76.03 50.06 Favored Pre-proline 0 N--CA 1.487 1.405 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.631 ' N ' ' O ' ' A' ' 210' ' ' LEU . 76.8 Cg_exo -45.35 -0.41 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.942 2.428 . . . . 0.0 112.532 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.64 ' N ' ' O ' ' A' ' 213' ' ' ASN . 4.9 t70 -63.95 -16.1 60.72 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.046 -1.034 . . . . 0.0 110.025 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.678 ' HA2' HD22 ' A' ' 210' ' ' LEU . . . 62.56 -66.68 0.02 OUTLIER Glycine 0 N--CA 1.479 1.56 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.592 ' N ' ' O ' ' A' ' 215' ' ' ASP . 24.8 t80 -159.91 -150.68 0.23 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -1.013 . . . . 0.0 109.237 -179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.526 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 8.6 t -79.87 -124.79 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.105 -0.997 . . . . 0.0 109.685 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.495 ' O ' ' CB ' ' A' ' 220' ' ' LEU . . . -90.03 -144.05 11.12 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 1.4 tp 76.75 139.78 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.793 -0.828 . . . . 0.0 109.755 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 163.31 115.64 0.34 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 148.66 141.64 3.5 Favored Glycine 0 N--CA 1.495 2.567 0 N-CA-C 108.962 -1.655 . . . . 0.0 108.962 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 136' ' ' TRP . 0.4 OUTLIER -103.98 -19.96 14.04 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.016 -1.285 . . . . 0.0 109.819 -179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 176.98 49.18 0.06 OUTLIER Glycine 0 C--N 1.305 -1.18 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.669 ' O ' HG12 ' A' ' 225' ' ' VAL . 2.2 t -55.24 97.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.284 -1.127 . . . . 0.0 109.078 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.642 ' H ' ' CB ' ' A' ' 229' ' ' MET . 1.3 p -98.5 -152.48 0.41 Allowed 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 121.965 0.888 . . . . 0.0 109.835 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.538 ' N ' ' OG ' ' A' ' 226' ' ' SER . 0.1 OUTLIER -71.3 -70.11 0.33 Allowed Pre-proline 0 N--CA 1.504 2.231 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.518 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 30.4 Cg_endo -64.52 -40.07 25.4 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.1 1.866 . . . . 0.0 109.412 178.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.642 ' CB ' ' H ' ' A' ' 226' ' ' SER . 2.9 mmm -54.12 151.78 6.7 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 114.739 -1.118 . . . . 0.0 109.56 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.638 ' O ' HG13 ' A' ' 225' ' ' VAL . . . -30.85 129.52 0.12 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.903 -0.498 . . . . 0.0 109.882 -179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.628 ' CG1' ' O ' ' A' ' 226' ' ' SER . 1.7 mm -142.8 114.74 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.115 -0.991 . . . . 0.0 109.446 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 11.6 tttt -93.14 10.86 29.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.505 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.341 0 O-C-N 121.246 -0.909 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.478 ' C13' ' OG1' ' A' ' 153' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.709 ' H ' ' C1 ' ' A' ' 21' ' ' MYR . 11.4 p30 -162.24 83.23 0.56 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -1.143 . . . . 0.0 109.501 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.624 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -51.01 -24.28 3.62 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.315 -0.866 . . . . 0.0 109.378 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -55.49 -6.89 0.2 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 123.106 1.431 . . . . 0.0 109.057 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.624 ' H ' ' C ' ' A' ' 24' ' ' SER . 14.9 t -46.74 -9.18 0.02 OUTLIER 'General case' 0 C--N 1.262 -3.23 0 CA-C-N 113.672 -1.604 . . . . 0.0 110.004 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 25' ' ' ALA . 7.9 pttm -83.48 24.84 0.8 Allowed 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 124.033 1.873 . . . . 0.0 108.58 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.936 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -164.55 13.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.253 -3.611 0 CA-C-N 112.037 -2.347 . . . . 0.0 105.842 -178.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.936 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER 15.4 -179.08 0.0 OUTLIER 'Isoleucine or valine' 0 C--O 1.207 -1.14 0 CA-C-O 123.375 1.559 . . . . 0.0 113.565 179.697 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.21 119.89 15.08 Favored 'General case' 0 C--N 1.279 -2.468 0 O-C-N 120.721 -1.237 . . . . 0.0 110.685 -177.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' C ' ' N ' ' A' ' 33' ' ' GLU . . . -59.31 -46.15 89.35 Favored 'General case' 0 C--N 1.292 -1.893 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.596 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.694 ' OE2' ' N ' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -53.33 -12.73 0.45 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.153 -0.967 . . . . 0.0 108.994 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.694 ' N ' ' OE2' ' A' ' 32' ' ' GLU . 3.3 tt0 -113.72 -48.42 2.93 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' HD11 ' A' ' 29' ' ' ILE . . . -47.72 163.86 0.05 Allowed 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.228 -0.92 . . . . 0.0 108.814 179.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.895 HD22 ' O ' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -85.68 173.95 6.29 Favored Pre-proline 0 C--N 1.301 -1.532 0 O-C-N 121.319 -0.863 . . . . 0.0 109.585 -179.213 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.444 ' CD ' ' HB3' ' A' ' 35' ' ' LEU . 5.9 Cg_exo -77.59 -63.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.498 1.775 0 C-N-CA 123.156 2.57 . . . . 0.0 114.924 -177.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.587 ' HA2' ' N ' ' A' ' 99' ' ' ARG . . . 119.22 110.37 2.37 Favored Glycine 0 N--CA 1.498 2.787 0 C-N-CA 119.317 -1.42 . . . . 0.0 110.722 -178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.556 ' H ' ' CB ' ' A' ' 99' ' ' ARG . 1.5 ttm180 -106.72 169.9 8.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.813 -1.404 . . . . 0.0 109.152 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.449 ' H ' ' HG2' ' A' ' 38' ' ' ARG . 75.0 p -89.72 32.89 0.86 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -0.961 . . . . 0.0 109.547 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.506 ' HB3' HD21 ' A' ' 100' ' ' ASN . 1.2 tt0 -108.32 109.35 61.66 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.26 -0.9 . . . . 0.0 109.779 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -80.39 172.3 13.78 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.609 2.206 . . . . 0.0 112.289 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.639 HG23 ' OD1' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -139.04 105.21 7.31 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.274 -0.892 . . . . 0.0 109.604 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -80.39 175.28 10.37 Favored 'Trans proline' 0 C--N 1.311 -1.413 0 C-N-CA 122.661 2.241 . . . . 0.0 112.569 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.602 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 11.4 m -143.22 -166.53 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.166 -0.958 . . . . 0.0 109.677 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 45' ' ' THR . 1.0 OUTLIER -49.21 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.204 -0.935 . . . . 0.0 109.847 -179.857 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.577 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.09 -65.05 0.67 Allowed 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 111.184 -179.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -70.97 99.67 1.83 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.622 -2.431 . . . . 0.0 108.48 -179.127 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.685 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 4.6 t-80 -32.55 122.32 0.34 Allowed 'General case' 0 C--N 1.291 -1.958 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.7 -31.58 71.64 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.381 -0.824 . . . . 0.0 110.716 -178.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.696 HG22 ' OG ' ' A' ' 211' ' ' SER . 47.1 t -65.71 -44.02 93.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.925 -1.11 . . . . 0.0 109.637 -179.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.41 -45.1 4.55 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.274 -0.891 . . . . 0.0 109.954 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.597 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.19 4.55 55.19 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.602 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.2 p30 -82.03 -121.57 0.02 OUTLIER 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 106.195 -1.779 . . . . 0.0 106.195 178.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.602 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 mtm-85 -123.19 167.37 13.79 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 122.371 1.082 . . . . 0.0 108.572 178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.6 p -124.09 -17.41 6.22 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.255 178.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 58' ' ' PRO . 1.4 m -151.76 -167.92 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.574 -1.328 . . . . 0.0 109.521 -178.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.557 ' N ' HG23 ' A' ' 56' ' ' VAL . 4.6 mt-10 -32.36 120.23 0.41 Allowed Pre-proline 0 C--N 1.295 -1.782 0 O-C-N 121.91 -0.494 . . . . 0.0 110.176 -179.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.573 ' O ' ' O ' ' A' ' 56' ' ' VAL . 98.3 Cg_endo -75.57 172.28 63.85 Favored 'Cis proline' 0 C--N 1.313 -1.328 0 C-N-CA 123.52 -1.45 . . . . 0.0 111.87 0.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -116.91 129.78 25.06 Favored Pre-proline 0 C--N 1.28 -2.419 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.59 ' O ' ' OG1' ' A' ' 63' ' ' THR . 37.5 Cg_exo -49.67 140.27 29.55 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.057 1.838 . . . . 0.0 112.335 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -79.86 155.86 27.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.252 -0.905 . . . . 0.0 109.541 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 77.34 -9.73 25.87 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.59 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -95.66 135.88 36.79 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.162 -1.199 . . . . 0.0 109.91 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 5.7 mt-30 -108.61 167.12 10.28 Favored 'General case' 0 C--N 1.298 -1.649 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.729 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -149.35 156.42 42.04 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 118.368 -1.333 . . . . 0.0 111.386 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.67 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -141.22 -174.65 4.07 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 178.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.513 HG22 ' HG2' ' A' ' 118' ' ' ARG . 2.5 t -144.58 127.06 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 119.803 -1.811 . . . . 0.0 109.666 179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.667 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.6 OUTLIER -156.72 153.85 29.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.701 -1.25 . . . . 0.0 109.853 177.479 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.612 ' N ' HG12 ' A' ' 116' ' ' VAL . . . -161.36 -170.08 25.53 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.333 -1.413 . . . . 0.0 112.993 -178.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.776 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -133.65 -93.04 0.33 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.906 0.86 . . . . 0.0 110.264 -179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.702 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -132.46 65.37 0.59 Allowed Glycine 0 N--CA 1.498 2.811 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.702 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 42.5 t 120.75 170.64 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 C-N-CA 124.16 0.984 . . . . 0.0 109.499 -179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.562 ' N ' ' SG ' ' A' ' 72' ' ' CYS . 0.1 OUTLIER -120.58 30.13 7.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.242 -0.911 . . . . 0.0 111.341 -179.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.51 ' CA ' HD11 ' A' ' 210' ' ' LEU . 7.2 m0 -88.79 -87.44 0.16 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.404 -1.435 . . . . 0.0 109.005 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -64.98 -7.37 29.96 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.469 ' HA ' ' CE ' ' A' ' 70' ' ' MET . . . -76.13 -47.54 23.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.213 -1.169 . . . . 0.0 110.28 -179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.571 ' O ' ' CD ' ' A' ' 77' ' ' GLU . 7.2 tp10 -78.67 -27.8 45.25 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.014 -1.054 . . . . 0.0 110.188 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.542 ' O ' HG13 ' A' ' 82' ' ' VAL . 31.4 ttt-85 -56.23 -34.55 66.44 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.942 -1.098 . . . . 0.0 109.925 -179.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 14.9 mtmm -75.7 17.82 0.28 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.151 -0.968 . . . . 0.0 110.294 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.631 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 81.3 m-85 -126.35 -41.16 1.91 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.089 -1.007 . . . . 0.0 110.847 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.57 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -74.36 8.77 2.01 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.564 -1.335 . . . . 0.0 109.793 -179.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.0 m -109.54 15.8 7.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.254 -0.904 . . . . 0.0 109.365 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 45.6 mt -114.72 156.83 24.08 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.808 0.813 . . . . 0.0 109.018 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 4.1 mttm -89.98 140.11 29.95 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 121.337 0.589 . . . . 0.0 109.61 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.46 -29.36 8.32 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 120' ' ' VAL . 1.2 t -77.43 123.51 34.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.401 -1.058 . . . . 0.0 109.301 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.598 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -68.03 -42.92 79.87 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.327 -0.858 . . . . 0.0 108.988 179.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.549 ' O ' HG23 ' A' ' 89' ' ' THR . 6.4 p -158.43 -162.14 1.08 Allowed 'General case' 0 C--N 1.296 -1.747 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.596 179.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.685 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 43.7 p -160.99 128.36 4.2 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.362 -0.836 . . . . 0.0 108.817 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.598 ' OE1' ' O ' ' A' ' 89' ' ' THR . 4.1 mp0 -130.95 145.78 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.144 -0.973 . . . . 0.0 110.415 -179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.658 HG12 ' HA ' ' A' ' 117' ' ' VAL . 1.1 m -126.76 156.56 37.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.341 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 178.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.486 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -172.09 -128.96 1.09 Allowed Glycine 0 C--N 1.293 -1.831 0 C-N-CA 119.021 -1.562 . . . . 0.0 110.28 -179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.609 ' CE1' HG21 ' A' ' 106' ' ' VAL . 83.1 m-85 -143.24 160.64 40.09 Favored 'General case' 0 C--N 1.296 -1.75 0 O-C-N 121.876 -0.779 . . . . 0.0 109.4 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.6 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -168.71 148.41 4.36 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.365 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 87.37 30.8 18.25 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.029 -1.228 . . . . 0.0 110.029 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.643 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -142.97 173.28 24.17 Favored Glycine 0 N--CA 1.494 2.543 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.733 ' CD2' ' O ' ' A' ' 97' ' ' HIS . 29.0 p-80 -135.88 85.34 2.15 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.154 -1.204 . . . . 0.0 110.22 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 35' ' ' LEU . 96.4 m -150.02 163.48 38.03 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.057 -1.027 . . . . 0.0 108.393 178.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.587 ' N ' ' HA2' ' A' ' 37' ' ' GLY . 0.1 OUTLIER -65.18 -76.8 0.07 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.718 0.771 . . . . 0.0 111.423 -177.604 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.639 ' OD1' HG23 ' A' ' 42' ' ' ILE . 6.3 m-80 -121.46 83.17 40.43 Favored Pre-proline 0 C--N 1.295 -1.796 0 CA-C-O 121.504 0.668 . . . . 0.0 110.09 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.46 ' HA ' ' CD ' ' A' ' 105' ' ' GLU . 23.1 Cg_exo -63.15 117.24 4.17 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 C-N-CA 123.34 2.693 . . . . 0.0 113.023 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.593 ' H ' ' HG2' ' A' ' 105' ' ' GLU . 4.1 p -109.16 149.77 28.87 Favored 'General case' 0 N--CA 1.484 1.236 0 O-C-N 120.569 -1.332 . . . . 0.0 107.617 178.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.687 ' CZ ' ' OH ' ' A' ' 155' ' ' TYR . 2.8 t80 -47.68 -34.37 8.06 Favored 'General case' 0 C--N 1.296 -1.745 0 C-N-CA 119.067 -1.053 . . . . 0.0 108.398 -178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.463 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -73.28 -26.49 61.11 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.527 -0.733 . . . . 0.0 110.443 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.643 ' HG3' ' N ' ' A' ' 106' ' ' VAL . 0.0 OUTLIER -83.53 -57.33 3.28 Favored 'General case' 0 C--N 1.314 -0.942 0 O-C-N 120.565 -1.334 . . . . 0.0 110.142 -178.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.643 ' N ' ' HG3' ' A' ' 105' ' ' GLU . 11.5 m -61.93 -20.96 24.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.471 -0.768 . . . . 0.0 111.843 -178.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.565 ' C ' ' O ' ' A' ' 106' ' ' VAL . 9.3 p -33.85 -37.84 0.05 OUTLIER 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.438 -0.789 . . . . 0.0 109.66 -178.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.488 ' N ' ' O ' ' A' ' 106' ' ' VAL . 27.0 t -103.97 -115.53 0.22 Allowed 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.653 -1.28 . . . . 0.0 109.791 178.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.458 ' N ' ' OG ' ' A' ' 108' ' ' SER . 1.5 mp0 -120.4 9.86 11.06 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-O 121.347 0.594 . . . . 0.0 110.236 -179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.895 ' O ' HD22 ' A' ' 35' ' ' LEU . 5.4 mttt -43.0 -50.96 5.84 Favored 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.494 -0.754 . . . . 0.0 109.935 -178.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.544 ' O ' ' C ' ' A' ' 112' ' ' GLY . 0.6 OUTLIER -122.51 14.13 10.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.747 -1.221 . . . . 0.0 110.512 179.663 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.632 ' O ' ' C14' ' A' ' 21' ' ' MYR . . . 37.2 35.02 0.14 Allowed Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.643 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.09 168.93 19.1 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.038 -1.272 . . . . 0.0 109.801 -179.701 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.6 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -119.12 114.11 21.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CD ' ' H ' ' A' ' 72' ' ' CYS . 1.9 pp20? -72.86 130.05 39.54 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.269 -0.895 . . . . 0.0 109.906 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.612 HG12 ' N ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -153.41 -179.39 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.146 -0.971 . . . . 0.0 110.507 -179.974 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.658 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.3 m -115.94 117.8 56.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.367 0 CA-C-O 121.808 0.813 . . . . 0.0 110.2 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.896 HH22 ' N ' ' A' ' 120' ' ' VAL . 0.0 OUTLIER -98.24 101.68 13.21 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.919 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.664 ' C ' HH22 ' A' ' 118' ' ' ARG . 31.0 m -126.63 123.65 63.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.896 ' N ' HH22 ' A' ' 118' ' ' ARG . 0.7 OUTLIER -78.27 171.57 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 179.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.894 ' CD2' HD21 ' A' ' 131' ' ' LEU . 0.3 OUTLIER -158.08 155.58 29.49 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 118.356 -1.338 . . . . 0.0 110.957 179.612 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 82.9 mtt180 -103.4 102.63 30.54 Favored Pre-proline 0 C--N 1.294 -1.817 0 CA-C-N 115.533 -0.758 . . . . 0.0 109.822 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.559 ' O ' ' O ' ' A' ' 126' ' ' ILE . 31.7 Cg_exo -43.7 -64.24 0.27 Allowed 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.968 2.445 . . . . 0.0 112.754 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -44.43 -29.96 0.78 Allowed 'General case' 0 C--N 1.287 -2.131 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.811 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -92.92 -46.32 7.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.07 -1.019 . . . . 0.0 109.769 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.777 HD11 ' HB3' ' A' ' 130' ' ' GLU . 2.6 tt -126.07 166.99 21.24 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 O-C-N 121.048 -1.032 . . . . 0.0 108.255 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.53 ' N ' ' CG1' ' A' ' 126' ' ' ILE . 6.1 m -99.96 159.33 15.16 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.66 -1.275 . . . . 0.0 110.721 -178.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 1.077 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 17.4 t80 -66.43 -27.46 67.85 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.585 ' OE1' ' O ' ' A' ' 129' ' ' GLU . 0.8 OUTLIER -69.67 -16.74 63.41 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.777 ' HB3' HD11 ' A' ' 126' ' ' ILE . 2.8 mt-10 -73.57 -72.33 0.27 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 108.992 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.99 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -39.2 -35.69 0.26 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.46 -1.4 . . . . 0.0 107.998 178.504 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 1.077 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 44.4 mt -76.28 -44.75 35.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.261 -0.899 . . . . 0.0 110.607 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.465 ' N ' ' O ' ' A' ' 129' ' ' GLU . 2.6 mttm -52.28 -53.56 42.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.94 -1.1 . . . . 0.0 110.117 -178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.656 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 41.3 t -57.85 -30.34 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.797 -1.19 . . . . 0.0 108.45 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.709 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 3.0 t80 -73.1 -56.74 4.69 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.275 -0.891 . . . . 0.0 110.143 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.526 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 37.7 m95 -71.57 -54.08 11.65 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 120.384 -1.448 . . . . 0.0 110.021 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.485 ' O ' HG21 ' A' ' 225' ' ' VAL . 20.8 tt0 -37.08 -56.05 0.92 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.52 -0.737 . . . . 0.0 111.099 -178.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.717 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 8.3 p30 -103.25 63.8 0.82 Allowed 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.061 -1.025 . . . . 0.0 109.949 -178.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.776 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 22.5 m80 -158.28 177.21 11.53 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.286 1.041 . . . . 0.0 110.072 178.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.685 ' O ' ' N ' ' A' ' 142' ' ' THR . 1.6 t0 -145.22 80.23 11.18 Favored Pre-proline 0 C--N 1.297 -1.685 0 N-CA-C 106.154 -1.795 . . . . 0.0 106.154 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.595 ' O ' ' N ' ' A' ' 190' ' ' THR . 13.0 Cg_exo -48.09 13.66 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.545 2.163 . . . . 0.0 113.592 -176.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 1.049 HG22 HG22 ' A' ' 189' ' ' ILE . 0.4 OUTLIER -122.15 43.29 2.91 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.808 -1.182 . . . . 0.0 110.318 -179.769 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.587 ' O ' ' O ' ' A' ' 144' ' ' GLY . 5.3 mt-30 -130.72 78.61 1.85 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.859 -1.151 . . . . 0.0 109.325 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.587 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -39.43 -116.26 0.0 OUTLIER Glycine 0 N--CA 1.493 2.473 0 CA-C-O 121.905 0.725 . . . . 0.0 112.513 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.97 42.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.795 -0.827 . . . . 0.0 110.353 -177.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.509 ' O ' ' CB ' ' A' ' 143' ' ' GLN . 0.9 OUTLIER -170.9 139.62 1.48 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 119.107 -1.037 . . . . 0.0 111.24 177.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.615 ' HB3' ' N ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -146.93 91.46 2.01 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.128 -1.607 . . . . 0.0 108.424 176.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 91.46 -129.47 9.83 Favored Glycine 0 C--N 1.3 -1.447 0 N-CA-C 108.037 -2.025 . . . . 0.0 108.037 -179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -94.69 12.9 26.14 Favored 'General case' 0 C--N 1.268 -2.937 0 CA-C-N 114.734 -0.733 . . . . 0.0 110.652 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.675 ' OD1' ' CE2' ' A' ' 155' ' ' TYR . 0.3 OUTLIER -109.05 112.91 25.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.649 -1.282 . . . . 0.0 109.488 179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.483 ' CE2' ' HG3' ' A' ' 146' ' ' ARG . 6.2 m-85 -104.22 113.48 27.06 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.06 -1.025 . . . . 0.0 110.126 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 177.53 149.42 7.87 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.679 -1.248 . . . . 0.0 110.43 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.598 ' O ' ' CD ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -48.87 -45.98 41.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.51 -0.994 . . . . 0.0 109.393 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.814 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 2.1 pm0 -75.38 1.53 13.66 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.397 -0.814 . . . . 0.0 111.177 -178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.814 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 21.1 m-85 -102.99 41.58 1.24 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.443 -1.411 . . . . 0.0 110.122 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.618 ' O ' ' O ' ' A' ' 70' ' ' MET . 0.4 OUTLIER -103.45 174.91 5.66 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.886 -1.134 . . . . 0.0 108.969 179.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.4 129.37 34.4 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 103.778 -2.675 . . . . 0.0 103.778 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.509 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -143.74 117.82 9.48 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 115.94 -2.304 . . . . 0.0 112.444 -176.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.414 ' N ' ' O ' ' A' ' 192' ' ' ASP . 16.1 t -111.98 133.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 C-N-CA 119.457 -0.897 . . . . 0.0 110.214 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.507 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 53.7 m-85 -130.5 94.41 29.68 Favored Pre-proline 0 N--CA 1.497 1.877 0 O-C-N 121.433 -0.792 . . . . 0.0 109.192 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -47.9 170.47 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.529 0 C-N-CA 122.773 2.315 . . . . 0.0 112.063 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.458 HG22 ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -98.0 -21.13 16.99 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 120.941 -1.099 . . . . 0.0 109.633 -179.831 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.635 ' O ' ' N ' ' A' ' 165' ' ' VAL . 4.1 p 173.54 -178.95 0.09 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.086 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.442 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.07 -15.06 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 123.009 1.385 . . . . 0.0 108.6 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.635 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.6 t -55.69 -64.85 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.894 0 CA-C-N 113.93 -1.486 . . . . 0.0 109.672 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.67 HE22 ' HB2' ' A' ' 66' ' ' ALA . 17.1 mt-30 -79.54 -19.32 49.82 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.682 -0.636 . . . . 0.0 110.932 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.4 ' HG2' HD13 ' A' ' 171' ' ' LEU . 0.0 OUTLIER -52.15 -31.23 30.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.869 -1.145 . . . . 0.0 110.632 -178.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -71.98 -43.06 65.76 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.681 -1.262 . . . . 0.0 109.979 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.433 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.92 -42.94 9.2 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.136 -0.977 . . . . 0.0 110.409 -179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.501 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.11 -57.79 8.52 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.169 -0.957 . . . . 0.0 109.855 -179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.4 HD13 ' HG2' ' A' ' 167' ' ' MET . 1.2 mp -52.63 -35.76 55.28 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.026 -1.046 . . . . 0.0 109.048 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 7.0 mtm-85 -74.51 -45.38 46.19 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.297 -0.877 . . . . 0.0 109.457 179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.526 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -56.21 -31.15 63.21 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.913 . . . . 0.0 109.508 -179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 8.6 tttm -72.17 -52.15 17.95 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.256 -0.902 . . . . 0.0 109.824 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -73.0 -26.1 61.22 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.238 -0.914 . . . . 0.0 110.317 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.401 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 6.2 pt-20 -52.97 -34.53 56.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.036 -1.04 . . . . 0.0 109.687 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.493 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -79.65 -28.94 40.8 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.077 -1.014 . . . . 0.0 109.454 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.704 ' OE1' HG23 ' A' ' 189' ' ' ILE . 15.5 tp60 -74.91 -7.66 54.19 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.901 . . . . 0.0 109.881 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -75.49 -41.93 54.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.08 -1.013 . . . . 0.0 108.907 179.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.454 HG13 ' HE2' ' A' ' 183' ' ' LYS . 73.6 t -88.52 -43.66 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.315 -0.865 . . . . 0.0 109.859 179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 186' ' ' PHE . 38.2 mt -56.55 -49.17 75.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.157 -0.964 . . . . 0.0 110.058 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 32.1 t -55.24 -30.33 59.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.081 -1.012 . . . . 0.0 109.35 -179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.454 ' HE2' HG13 ' A' ' 180' ' ' VAL . 13.9 pttt -88.26 -6.76 57.6 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.229 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.417 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 3.9 m170 -108.43 29.32 7.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.218 -0.927 . . . . 0.0 109.77 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.417 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.5 OUTLIER 69.67 68.93 0.24 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 110.066 179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 181' ' ' LEU . 23.4 m-85 -137.14 169.99 16.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.935 . . . . 0.0 109.0 179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.469 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -119.82 -159.8 11.04 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_exo -58.62 105.77 0.24 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 C-N-CA 122.204 1.936 . . . . 0.0 110.774 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 1.049 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -51.19 174.74 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 121.175 -0.953 . . . . 0.0 110.048 -178.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.595 ' N ' ' O ' ' A' ' 141' ' ' PRO . 4.8 p -137.32 67.73 1.43 Allowed 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.232 -179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 37.9 m -100.6 125.2 46.97 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 177.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.692 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.8 t70 -76.32 113.77 14.26 Favored 'General case' 0 C--N 1.278 -2.532 0 O-C-N 121.354 -0.841 . . . . 0.0 109.205 -178.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -131.47 108.38 14.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 C-N-CA 118.888 -1.125 . . . . 0.0 109.87 179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.692 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.4 OUTLIER -147.4 153.36 39.52 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 179.708 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -104.16 164.9 11.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.807 -1.183 . . . . 0.0 110.098 -179.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.01 39.07 94.65 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.539 ' O ' ' C ' ' A' ' 198' ' ' VAL . 55.6 mm-40 -96.41 90.99 5.61 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.68 -1.482 . . . . 0.0 108.974 179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.539 ' C ' ' O ' ' A' ' 197' ' ' GLN . 2.0 p -32.11 150.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.554 -0.716 . . . . 0.0 109.97 -179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.491 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 38.3 t80 -96.11 140.02 31.44 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.458 -0.776 . . . . 0.0 109.325 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.566 ' O ' ' N ' ' A' ' 93' ' ' PHE . 7.0 m-85 -130.86 94.81 3.69 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.227 -0.92 . . . . 0.0 109.351 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -54.12 136.44 42.13 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.417 -0.802 . . . . 0.0 110.428 -179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.602 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -84.46 -174.94 5.55 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -73.13 161.12 30.98 Favored 'General case' 0 N--CA 1.509 2.524 0 CA-C-O 122.264 1.03 . . . . 0.0 110.059 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -55.19 -43.31 74.27 Favored 'General case' 0 C--N 1.291 -1.977 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.459 179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -60.82 -7.85 2.64 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.425 -0.797 . . . . 0.0 110.119 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.622 ' CE1' ' CB ' ' A' ' 103' ' ' TYR . 50.4 m-70 -104.4 4.01 32.92 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.985 -1.072 . . . . 0.0 110.65 -178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.849 ' O ' ' N ' ' A' ' 209' ' ' TYR . 16.7 mm-40 -109.89 -143.83 0.39 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-O 122.144 0.973 . . . . 0.0 110.19 -178.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.677 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -35.49 -4.0 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.845 -179.649 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.849 ' N ' ' O ' ' A' ' 207' ' ' GLN . 59.4 t80 -39.75 -42.14 1.21 Allowed 'General case' 0 N--CA 1.518 2.968 0 O-C-N 120.757 -1.214 . . . . 0.0 111.015 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.673 HD13 ' O ' ' A' ' 216' ' ' GLY . 6.6 mt -71.08 -20.75 62.32 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 118.275 -1.37 . . . . 0.0 109.68 -178.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.696 ' OG ' HG22 ' A' ' 50' ' ' VAL . 8.1 t -73.25 -49.07 29.81 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.195 -0.941 . . . . 0.0 108.946 179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.1 0.92 56.31 Favored 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.264 -0.897 . . . . 0.0 110.264 -179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.788 ' ND2' ' CD2' ' A' ' 209' ' ' TYR . 36.3 m-80 -132.65 133.42 23.46 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 120.904 -1.122 . . . . 0.0 109.686 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -72.1 2.1 5.26 Favored 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.698 2.266 . . . . 0.0 113.663 -179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.545 ' O ' ' N ' ' A' ' 217' ' ' TYR . 2.9 t0 -62.74 -17.43 60.86 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.733 -1.23 . . . . 0.0 109.864 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.673 ' O ' HD13 ' A' ' 210' ' ' LEU . . . 63.88 -62.75 0.05 OUTLIER Glycine 0 C--N 1.296 -1.684 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 178.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.545 ' N ' ' O ' ' A' ' 215' ' ' ASP . 2.8 p90 171.31 -156.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -1.186 . . . . 0.0 109.569 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 3.6 t -159.94 79.51 0.69 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.391 -0.818 . . . . 0.0 109.006 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . 161.24 174.28 30.9 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 14.5 mt -92.41 -165.16 1.29 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.234 -1.157 . . . . 0.0 109.858 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -113.04 -107.87 2.86 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . -128.06 -168.44 12.45 Favored Glycine 0 C--O 1.215 -1.088 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 225' ' ' VAL . 6.8 t -165.1 -7.63 0.03 OUTLIER 'General case' 0 C--N 1.27 -2.89 0 CA-C-N 114.501 -0.849 . . . . 0.0 109.603 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.421 ' H ' ' H ' ' A' ' 223' ' ' THR . . . -67.49 7.27 2.07 Favored Glycine 0 C--N 1.305 -1.159 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.568 ' H ' ' C ' ' A' ' 223' ' ' THR . 2.3 t -111.41 165.74 6.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.883 -0.775 . . . . 0.0 109.546 -179.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.597 ' O ' HD11 ' A' ' 231' ' ' ILE . 0.3 OUTLIER -44.99 103.91 0.04 OUTLIER 'General case' 0 C--N 1.305 -1.359 0 CA-C-O 122.695 1.236 . . . . 0.0 109.228 -179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.52 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -73.76 -55.82 3.16 Favored Pre-proline 0 C--N 1.274 -2.693 0 CA-C-N 114.659 -1.155 . . . . 0.0 109.126 179.493 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.544 ' CD ' ' H ' ' A' ' 229' ' ' MET . 40.8 Cg_endo -94.08 -36.01 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.322 0 C-N-CA 123.068 2.512 . . . . 0.0 109.834 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.554 ' O ' ' C ' ' A' ' 230' ' ' ALA . 5.0 mtt -54.77 154.14 5.37 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.972 -1.013 . . . . 0.0 109.969 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.554 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.45 134.3 0.06 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-O 121.319 0.581 . . . . 0.0 109.966 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.597 HD11 ' O ' ' A' ' 226' ' ' SER . 1.8 mm -133.51 109.93 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.261 -0.899 . . . . 0.0 109.316 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -68.14 117.8 10.45 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.442 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.36 0 O-C-N 121.228 -0.92 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.709 ' C1 ' ' H ' ' A' ' 23' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.669 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.451 -1.46 . . . . 0.0 109.451 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 22' ' ' GLY . 54.4 m-20 36.07 -89.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.252 -1.146 . . . . 0.0 109.387 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.67 ' C ' ' H ' ' A' ' 26' ' ' SER . 0.1 OUTLIER -50.86 -18.96 0.85 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.255 -0.903 . . . . 0.0 109.236 179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.434 ' HB2' ' C1 ' ' A' ' 21' ' ' MYR . . . -50.41 -8.11 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 123.028 1.394 . . . . 0.0 109.624 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.67 ' H ' ' C ' ' A' ' 24' ' ' SER . 22.9 t -46.52 -27.25 1.06 Allowed 'General case' 0 C--N 1.261 -3.282 0 CA-C-N 113.888 -1.505 . . . . 0.0 109.427 -179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HE2' ' SD ' ' A' ' 145' ' ' MET . 0.9 OUTLIER -97.23 45.07 1.04 Allowed 'General case' 0 C--N 1.303 -1.433 0 CA-C-O 123.274 1.511 . . . . 0.0 109.888 -179.915 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.72 ' O ' ' O ' ' A' ' 29' ' ' ILE . 44.6 t -151.99 25.8 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.263 -3.161 0 N-CA-C 104.213 -2.514 . . . . 0.0 104.213 -179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.72 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -33.95 177.09 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-O 123.225 1.488 . . . . 0.0 110.852 -178.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.44 ' C ' ' N ' ' A' ' 32' ' ' GLU . 0.7 OUTLIER -103.92 121.3 42.82 Favored 'General case' 0 C--N 1.278 -2.511 0 CA-C-N 114.66 -1.155 . . . . 0.0 108.952 179.017 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.519 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -49.35 -15.59 0.14 Allowed 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.44 ' N ' ' C ' ' A' ' 30' ' ' SER . 11.4 mm-40 -62.17 -62.86 1.48 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.333 -0.855 . . . . 0.0 109.793 -179.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.562 ' O ' ' C ' ' A' ' 34' ' ' ALA . 28.5 tt0 -75.19 -28.39 60.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.256 -0.903 . . . . 0.0 109.707 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.562 ' C ' ' O ' ' A' ' 33' ' ' GLU . . . -30.97 152.05 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.451 -0.781 . . . . 0.0 110.203 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.441 ' HB3' ' CD ' ' A' ' 36' ' ' PRO . 0.2 OUTLIER -50.2 173.0 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.649 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 179.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.441 ' CD ' ' HB3' ' A' ' 35' ' ' LEU . 12.8 Cg_exo -70.27 -40.44 4.52 Favored 'Trans proline' 0 N--CA 1.502 1.983 0 C-N-CA 123.125 2.55 . . . . 0.0 115.726 -176.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.536 ' HA2' ' C ' ' A' ' 98' ' ' THR . . . 93.28 94.75 1.49 Allowed Glycine 0 N--CA 1.501 2.979 0 C-N-CA 118.115 -1.993 . . . . 0.0 110.319 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.566 ' HB2' ' H ' ' A' ' 100' ' ' ASN . 5.2 mmt85 -96.23 -172.61 2.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.703 -1.469 . . . . 0.0 109.343 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 p -124.4 37.22 4.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.213 -0.93 . . . . 0.0 109.911 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -111.74 92.95 18.54 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 120.9 -1.125 . . . . 0.0 109.943 -179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.82 -178.1 3.72 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.936 2.424 . . . . 0.0 112.216 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.67 133.96 18.11 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.138 -0.976 . . . . 0.0 109.461 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -77.26 175.51 11.24 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.608 2.205 . . . . 0.0 112.318 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' O ' ' N ' ' A' ' 46' ' ' ALA . 0.9 OUTLIER -147.43 -167.94 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 0.0 109.536 179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.816 ' O ' HG23 ' A' ' 45' ' ' THR . 15.1 t -49.21 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.218 -0.926 . . . . 0.0 109.669 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.616 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.39 -50.32 71.94 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.173 -0.954 . . . . 0.0 111.068 -178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.543 ' O ' ' C ' ' A' ' 48' ' ' HIS . 27.7 mttm -84.34 99.17 10.45 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 115.614 -2.434 . . . . 0.0 108.419 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.6 t-80 -32.11 117.88 0.23 Allowed 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -64.59 -32.46 74.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.318 -0.864 . . . . 0.0 110.665 -178.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.737 HG22 ' HB2' ' A' ' 211' ' ' SER . 25.9 t -63.43 -44.1 98.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.958 -1.089 . . . . 0.0 109.379 -179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -106.37 -45.09 4.36 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.362 -0.836 . . . . 0.0 109.985 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 100.39 4.53 54.96 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.204 -1.558 . . . . 0.0 109.204 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.687 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 27.3 p30 -82.04 -112.71 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.673 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 4.4 mtt180 -130.09 174.36 9.87 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.653 1.692 . . . . 0.0 110.423 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.616 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 7.8 p -137.95 8.35 2.75 Favored 'General case' 0 C--N 1.266 -3.042 0 CA-C-N 112.789 -2.005 . . . . 0.0 110.892 178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.536 ' O ' ' C ' ' A' ' 57' ' ' GLU . 10.9 m -144.98 132.68 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 120.687 -1.258 . . . . 0.0 109.519 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.691 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 1.4 pm0 -32.86 151.81 0.04 OUTLIER Pre-proline 0 C--N 1.303 -1.454 0 CA-C-O 121.809 0.814 . . . . 0.0 110.849 -179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.434 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 97.4 Cg_endo -78.88 166.28 79.76 Favored 'Cis proline' 0 C--N 1.303 -1.844 0 C-N-CA 121.808 -2.163 . . . . 0.0 111.716 -0.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CE1' HG11 ' A' ' 120' ' ' VAL . 31.8 m-85 -110.26 154.56 42.82 Favored Pre-proline 0 C--N 1.269 -2.907 0 CA-C-N 114.403 -1.271 . . . . 0.0 109.118 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.42 ' O ' ' OG1' ' A' ' 63' ' ' THR . 44.1 Cg_exo -50.15 132.5 33.56 Favored 'Trans proline' 0 C--N 1.31 -1.493 0 C-N-CA 122.3 2.0 . . . . 0.0 112.1 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -48.65 146.69 2.92 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 109.361 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 73.84 46.52 23.17 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.42 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.7 OUTLIER -128.93 137.54 51.47 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.295 -1.121 . . . . 0.0 109.674 -179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -104.87 149.51 25.62 Favored 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 179.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.702 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -138.86 113.11 8.74 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.143 -0.973 . . . . 0.0 109.808 -179.862 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.659 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -112.09 -167.69 1.22 Allowed 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG11 ' HD2' ' A' ' 160' ' ' TYR . 7.2 t -141.96 132.06 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.07 -1.644 . . . . 0.0 108.998 179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.508 ' CE1' ' HB3' ' A' ' 131' ' ' LEU . 91.3 m-85 -123.04 156.16 35.42 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.094 -1.004 . . . . 0.0 109.193 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.674 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -140.44 114.71 0.98 Allowed Glycine 0 C--O 1.207 -1.571 0 N-CA-C 107.811 -2.116 . . . . 0.0 107.811 179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.572 ' SD ' ' CD1' ' A' ' 135' ' ' PHE . 0.3 OUTLIER -125.31 -82.47 0.63 Allowed 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.485 -1.009 . . . . 0.0 109.31 -179.333 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.624 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -153.27 -163.55 11.84 Favored Glycine 0 N--CA 1.484 1.874 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.693 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -29.67 104.32 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.665 -0.903 . . . . 0.0 108.582 179.583 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.786 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -49.44 6.98 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.44 -0.787 . . . . 0.0 111.4 -178.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.693 ' N ' ' O ' ' A' ' 72' ' ' CYS . 14.5 m0 -72.04 -47.58 50.68 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.614 -1.304 . . . . 0.0 108.799 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -92.58 -22.93 27.53 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.721 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.35 -26.87 56.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.305 -1.115 . . . . 0.0 109.791 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.618 ' OE2' HG13 ' A' ' 91' ' ' VAL . 8.9 tp10 -84.59 -36.66 21.91 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.063 -1.023 . . . . 0.0 110.693 -179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.799 ' O ' HG13 ' A' ' 82' ' ' VAL . 1.7 ttt85 -59.28 -59.17 5.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.038 -1.039 . . . . 0.0 110.606 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.608 ' O ' HG21 ' A' ' 134' ' ' VAL . 18.0 mmtm -56.43 16.79 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.17 -0.956 . . . . 0.0 110.944 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.721 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.0 m-85 -120.88 -40.93 2.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.824 -1.173 . . . . 0.0 110.315 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.577 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.3 p90 -87.96 3.74 47.57 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.84 -1.163 . . . . 0.0 109.981 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.5 m -94.62 13.11 3.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.187 -0.946 . . . . 0.0 109.498 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.514 HD11 HG21 ' A' ' 134' ' ' VAL . 75.7 mt -106.56 152.76 23.28 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.96 0.886 . . . . 0.0 109.135 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 8.8 pttm -88.96 145.79 25.3 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 101.15 -25.37 28.53 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 108.066 -2.014 . . . . 0.0 108.066 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.593 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -73.29 137.78 22.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.97 . . . . 0.0 108.807 179.434 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.687 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -81.41 -41.06 22.45 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.361 -0.837 . . . . 0.0 108.744 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.534 ' HB3' HD21 ' A' ' 53' ' ' ASN . 1.1 p -173.51 -163.42 0.18 Allowed 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 119.896 -0.722 . . . . 0.0 109.484 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.509 ' CG2' ' O ' ' A' ' 88' ' ' SER . 60.3 p -158.82 170.78 21.36 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.0 109.382 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.581 ' O ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.96 176.49 6.15 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.69 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -152.35 162.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 120.821 -1.174 . . . . 0.0 109.853 -179.161 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -172.15 171.22 44.08 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.263 -1.535 . . . . 0.0 109.263 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.572 ' N ' ' O ' ' A' ' 200' ' ' TYR . 4.1 m-85 -87.55 155.84 19.79 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.473 -1.016 . . . . 0.0 109.499 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.574 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -178.96 155.47 0.76 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.391 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 98.8 22.26 14.16 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.491 ' CA ' ' ND1' ' A' ' 113' ' ' HIS . . . -154.49 -151.62 5.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.001 -1.64 . . . . 0.0 109.001 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.519 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 47.9 p-80 -178.37 107.09 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.272 -1.134 . . . . 0.0 109.557 -179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.691 ' O ' ' O ' ' A' ' 99' ' ' ARG . 1.1 m -152.26 156.04 38.9 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.802 ' NE ' HD22 ' A' ' 100' ' ' ASN . 7.8 ttp180 -40.27 169.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.742 0 N-CA-C 106.809 -1.552 . . . . 0.0 106.809 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.802 HD22 ' NE ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -30.71 89.96 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.106 -0.996 . . . . 0.0 108.854 -179.445 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.71 ' N ' ' O ' ' A' ' 99' ' ' ARG . 1.3 Cg_endo -77.15 141.78 21.07 Favored 'Trans proline' 0 C--N 1.315 -1.219 0 C-N-CA 123.052 2.501 . . . . 0.0 112.963 -178.021 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.549 ' O ' HG22 ' A' ' 106' ' ' VAL . 24.6 p -124.06 170.69 10.42 Favored 'General case' 0 N--CA 1.49 1.541 0 C-N-CA 119.801 -0.76 . . . . 0.0 109.116 178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.783 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 1.2 t80 -56.92 -43.36 81.36 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.424 -0.798 . . . . 0.0 109.325 179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 4.9 mmtp -73.35 -27.54 61.56 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.249 -0.907 . . . . 0.0 110.356 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.433 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.4 mm-40 -80.88 -41.37 23.19 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.908 -1.12 . . . . 0.0 110.777 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.549 HG22 ' O ' ' A' ' 102' ' ' THR . 5.4 m -55.73 -23.99 15.79 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.216 0 O-C-N 120.421 -1.425 . . . . 0.0 108.634 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.667 ' O ' ' N ' ' A' ' 109' ' ' GLU . 23.2 m -59.27 -36.3 75.29 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 108.409 -0.96 . . . . 0.0 108.409 179.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.54 ' C ' ' H ' ' A' ' 110' ' ' LYS . 9.1 m -46.95 -9.16 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.667 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.8 mt-10 65.3 -12.25 0.15 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.679 -0.638 . . . . 0.0 109.944 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.54 ' H ' ' C ' ' A' ' 108' ' ' SER . 23.8 mttp -77.56 -15.05 59.49 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.063 -1.023 . . . . 0.0 109.547 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.537 ' O ' ' C ' ' A' ' 112' ' ' GLY . 4.7 p -91.19 -6.61 53.19 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.054 -1.029 . . . . 0.0 109.665 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.537 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 36.28 37.28 0.18 Allowed Glycine 0 N--CA 1.487 2.084 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.102 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.58 ' HE2' ' HG2' ' A' ' 101' ' ' PRO . 0.3 OUTLIER -82.04 158.13 23.91 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.596 -1.532 . . . . 0.0 109.974 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.574 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -120.83 112.67 19.1 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.448 -0.783 . . . . 0.0 109.118 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.682 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 74.4 mt-10 -61.54 117.44 5.73 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.283 -0.886 . . . . 0.0 108.649 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.674 HG12 ' CA ' ' A' ' 69' ' ' GLY . 0.0 OUTLIER -125.29 -176.11 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.069 -1.019 . . . . 0.0 110.578 -179.257 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.786 HG13 HG13 ' A' ' 91' ' ' VAL . 6.7 t -132.68 120.74 42.96 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.734 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.609 ' HD2' ' CZ ' ' A' ' 199' ' ' PHE . 9.9 ptm180 -97.81 120.95 39.12 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 106.561 -1.644 . . . . 0.0 106.561 177.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.461 ' O ' HG23 ' A' ' 119' ' ' VAL . 2.6 m -133.87 129.91 55.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 O-C-N 120.72 -1.237 . . . . 0.0 109.645 -178.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.552 HG11 ' CE1' ' A' ' 59' ' ' PHE . 0.8 OUTLIER -92.32 145.34 7.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 106.994 -1.484 . . . . 0.0 106.994 178.678 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.717 ' CD2' HD11 ' A' ' 131' ' ' LEU . 4.1 m-85 -129.21 161.16 30.79 Favored 'General case' 0 N--CA 1.509 2.486 0 C-N-CA 119.446 -0.902 . . . . 0.0 109.182 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 1.8 mtp180 -121.62 105.19 38.82 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 121.591 -0.693 . . . . 0.0 110.382 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 18.7 Cg_exo -43.64 -61.2 0.6 Allowed 'Trans proline' 0 N--CA 1.496 1.647 0 C-N-CA 123.538 2.825 . . . . 0.0 114.229 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 123' ' ' PRO . 1.2 tt0 -26.9 -52.69 0.06 Allowed 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.361 -178.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -115.83 21.05 14.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.038 -1.039 . . . . 0.0 109.756 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 84' ' ' LYS . 0.2 OUTLIER -157.6 162.5 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 O-C-N 121.28 -0.888 . . . . 0.0 109.618 -179.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.57 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.9 OUTLIER -128.72 148.3 50.83 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.894 -1.129 . . . . 0.0 109.653 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.765 ' CE2' HD11 ' A' ' 132' ' ' LEU . 72.8 t80 -54.43 -38.86 66.78 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.222 -0.924 . . . . 0.0 109.613 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -51.08 -14.36 0.23 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.07 -1.019 . . . . 0.0 108.84 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.57 ' HG3' ' H ' ' A' ' 127' ' ' SER . 6.5 mm-40 -73.77 -62.1 1.61 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.366 -0.834 . . . . 0.0 109.882 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.048 HD12 ' H ' ' A' ' 131' ' ' LEU . 2.9 mp -51.69 -34.12 37.16 Favored 'General case' 0 C--N 1.308 -1.227 0 O-C-N 120.976 -1.077 . . . . 0.0 108.184 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.765 HD11 ' CE2' ' A' ' 128' ' ' PHE . 39.0 mt -68.67 -50.16 53.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 110.255 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -62.21 -30.01 70.78 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.244 -0.91 . . . . 0.0 111.084 -178.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.608 HG21 ' O ' ' A' ' 79' ' ' LYS . 1.2 t -74.04 -40.06 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 120.884 -1.135 . . . . 0.0 109.633 -179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.683 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 24.3 t80 -69.26 -43.41 74.0 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.63 -0.669 . . . . 0.0 110.957 -178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.649 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 82.3 m95 -71.73 -39.69 69.93 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 120.699 -1.251 . . . . 0.0 111.01 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 -75.85 -37.12 59.29 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.267 -0.896 . . . . 0.0 112.88 -177.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.565 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 25.3 m-80 -97.78 36.52 1.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.639 -1.288 . . . . 0.0 113.27 -176.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.683 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 0.3 OUTLIER 177.97 130.19 0.06 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.56 -1.338 . . . . 0.0 110.733 178.175 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.606 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -61.54 112.04 5.36 Favored Pre-proline 0 N--CA 1.492 1.658 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.134 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.428 ' HB2' HD12 ' A' ' 189' ' ' ILE . 45.6 Cg_endo -74.68 -11.01 22.05 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.161 1.907 . . . . 0.0 112.569 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.494 HG22 HD13 ' A' ' 189' ' ' ILE . 71.4 p -101.2 46.62 0.93 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.26 -0.9 . . . . 0.0 109.021 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.631 HE22 HE21 ' A' ' 147' ' ' GLN . 2.6 pt20 -114.08 107.29 15.45 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.81 0.814 . . . . 0.0 110.552 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.668 ' HA2' HG21 ' A' ' 190' ' ' THR . . . -39.06 -118.22 0.0 OUTLIER Glycine 0 N--CA 1.495 2.578 0 CA-C-O 121.482 0.49 . . . . 0.0 112.157 -179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.578 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.4 OUTLIER -99.48 44.62 1.02 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.061 -1.258 . . . . 0.0 111.822 -177.135 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.438 ' HB3' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -174.29 159.61 3.15 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 120.701 -1.25 . . . . 0.0 109.329 178.421 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.631 HE21 HE22 ' A' ' 143' ' ' GLN . 0.0 OUTLIER -122.85 145.14 48.71 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.428 -1.42 . . . . 0.0 110.536 -179.653 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.543 ' CA ' HD22 ' A' ' 220' ' ' LEU . . . 65.85 -124.19 25.73 Favored Glycine 0 C--N 1.307 -1.057 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -111.7 26.7 10.37 Favored 'General case' 0 C--N 1.274 -2.704 0 CA-C-N 114.301 -0.949 . . . . 0.0 110.76 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.702 ' N ' ' OD1' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -107.88 167.13 10.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.901 -1.124 . . . . 0.0 108.42 179.631 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 151' ' ' PHE . 33.5 m-85 -132.35 111.54 11.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.824 -1.173 . . . . 0.0 109.912 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.578 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 172.38 143.61 4.21 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.449 ' H ' HG22 ' A' ' 153' ' ' THR . 0.1 OUTLIER -74.55 6.2 4.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.128 -1.219 . . . . 0.0 109.147 179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.667 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 6.8 pt20 -88.87 -1.22 57.98 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.667 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 29.7 m-85 -136.75 62.55 1.6 Allowed 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 179.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.763 HH22 ' CB ' ' A' ' 192' ' ' ASP . 10.4 mtm105 -107.96 174.74 5.74 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.171 -0.955 . . . . 0.0 110.438 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.657 ' OG ' ' NE2' ' A' ' 139' ' ' HIS . 6.2 t -93.2 107.26 19.1 Favored 'General case' 0 N--CA 1.496 1.875 0 N-CA-C 104.024 -2.584 . . . . 0.0 104.024 176.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.464 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -138.42 123.08 18.63 Favored 'General case' 0 C--N 1.286 -2.153 0 C-N-CA 118.182 -1.407 . . . . 0.0 111.473 -176.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.693 HG23 ' CG2' ' A' ' 191' ' ' THR . 11.2 t -112.04 127.66 69.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 C-N-CA 119.27 -0.972 . . . . 0.0 109.249 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.494 ' CG ' ' HG3' ' A' ' 197' ' ' GLN . 7.6 m-85 -119.81 89.24 41.47 Favored Pre-proline 0 N--CA 1.494 1.742 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -46.78 174.01 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 123.237 2.625 . . . . 0.0 112.608 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.436 ' CG2' ' O ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -96.24 -33.85 11.85 Favored 'General case' 0 C--N 1.309 -1.173 0 O-C-N 121.232 -0.917 . . . . 0.0 109.479 179.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.559 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 12.3 t -176.64 -162.59 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.374 -0.828 . . . . 0.0 109.054 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.559 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -56.93 -15.46 4.95 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 122.988 1.375 . . . . 0.0 108.614 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.559 ' O ' ' OE2' ' A' ' 168' ' ' GLU . 3.7 t -55.82 -64.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.904 0 CA-C-N 113.96 -1.473 . . . . 0.0 109.749 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.659 HE22 ' HB2' ' A' ' 66' ' ' ALA . 14.1 mt-30 -79.32 -17.76 53.91 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.618 -0.676 . . . . 0.0 111.061 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.417 ' O ' HD23 ' A' ' 171' ' ' LEU . 3.1 ttm -52.36 -38.05 57.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.761 -1.212 . . . . 0.0 110.218 -179.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.667 ' OE2' ' N ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.37 -23.49 57.15 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.862 -1.149 . . . . 0.0 109.688 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.667 ' N ' ' OE2' ' A' ' 168' ' ' GLU . . . -92.88 -42.17 9.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.149 -0.969 . . . . 0.0 109.749 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.46 -55.17 23.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.291 -0.881 . . . . 0.0 109.677 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.471 ' HG ' ' N ' ' A' ' 172' ' ' ARG . 2.5 pp -52.65 -35.55 55.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.055 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.577 ' O ' ' OE2' ' A' ' 176' ' ' GLU . 4.2 mtm180 -74.82 -46.45 36.64 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 0.0 108.886 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.649 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 70.2 m -56.54 -41.33 76.6 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.446 -0.784 . . . . 0.0 109.546 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.476 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 25.1 ttpp -72.4 -49.99 29.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.759 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -63.63 -25.52 68.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.222 -0.923 . . . . 0.0 109.841 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.577 ' OE2' ' O ' ' A' ' 172' ' ' ARG . 0.3 OUTLIER -64.74 -53.36 48.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.178 -0.951 . . . . 0.0 109.878 -179.767 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.497 ' CE1' ' HB3' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -78.9 -21.4 47.43 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.145 -0.972 . . . . 0.0 109.737 -179.669 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.628 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 38.8 tp60 -62.14 -41.0 97.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.186 -0.946 . . . . 0.0 109.656 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.57 -16.0 58.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.939 . . . . 0.0 109.619 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 176' ' ' GLU . 49.7 t -81.55 -54.71 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.959 . . . . 0.0 109.594 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 35.4 mt -75.72 -30.96 59.45 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.573 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.486 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 14.5 t -56.89 -38.0 72.17 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.869 . . . . 0.0 109.599 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 33.1 mttp -79.35 0.77 27.68 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.249 -0.907 . . . . 0.0 109.478 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -108.15 23.81 13.93 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.445 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.15 62.61 0.23 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.403 -0.811 . . . . 0.0 109.639 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.48 ' CZ ' ' HD2' ' A' ' 228' ' ' PRO . 20.1 m-85 -134.74 168.07 19.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.154 -0.966 . . . . 0.0 109.349 179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -94.84 -150.58 27.28 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -80.04 136.72 11.84 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.755 2.303 . . . . 0.0 112.099 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.673 HG22 ' H ' ' A' ' 191' ' ' THR . 2.6 mm -59.14 123.16 10.87 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 O-C-N 121.207 -0.933 . . . . 0.0 110.468 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.668 HG21 ' HA2' ' A' ' 144' ' ' GLY . 53.2 p -79.41 5.1 13.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.109 -0.995 . . . . 0.0 110.744 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.693 ' CG2' HG23 ' A' ' 159' ' ' VAL . 31.3 m -43.81 110.94 0.24 Allowed 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.763 ' CB ' HH22 ' A' ' 156' ' ' ARG . 4.0 t0 -77.14 117.74 18.99 Favored 'General case' 0 C--N 1.277 -2.567 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.945 -178.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -117.17 123.62 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.68 ' NH2' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -163.54 155.96 17.92 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.366 -0.834 . . . . 0.0 109.089 -179.098 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 10.0 mt-10 -105.74 167.32 9.85 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.1 -1.0 . . . . 0.0 109.625 179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 62.75 66.2 2.71 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.164 -1.174 . . . . 0.0 110.164 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.494 ' HG3' ' CG ' ' A' ' 160' ' ' TYR . 78.5 mm-40 -111.3 102.87 11.23 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.161 -1.199 . . . . 0.0 109.429 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 197' ' ' GLN . 61.9 t -41.67 155.02 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.424 -0.798 . . . . 0.0 109.692 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.609 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 22.1 t80 -117.64 151.52 37.04 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.317 -0.865 . . . . 0.0 109.505 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.572 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.6 OUTLIER -152.01 98.33 2.43 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.506 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 19.6 m-85 -54.0 136.13 41.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.106 -0.996 . . . . 0.0 110.554 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.465 ' HB1' ' CB ' ' A' ' 206' ' ' HIS . . . -87.27 -177.97 6.09 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.512 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.8 pt-20 -75.29 175.56 8.24 Favored 'General case' 0 C--N 1.29 -1.987 0 O-C-N 121.381 -0.825 . . . . 0.0 109.478 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -60.14 -52.04 67.03 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.512 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -48.13 -19.25 0.26 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.601 -0.687 . . . . 0.0 109.874 179.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.786 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 7.2 m-70 -96.99 7.84 45.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.127 -0.983 . . . . 0.0 110.327 -178.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.829 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.0 mm-40 -127.0 -142.04 0.28 Allowed 'General case' 0 N--CA 1.491 1.618 0 CA-C-O 122.308 1.052 . . . . 0.0 110.491 -178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.615 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -35.46 -3.38 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.245 0 CA-C-N 114.199 -1.364 . . . . 0.0 112.352 -179.356 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.829 ' N ' ' O ' ' A' ' 207' ' ' GLN . 88.2 t80 -40.85 -43.45 2.05 Favored 'General case' 0 N--CA 1.514 2.761 0 O-C-N 120.431 -1.418 . . . . 0.0 110.431 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.463 HD12 ' H ' ' A' ' 210' ' ' LEU . 4.5 mp -75.87 -13.44 60.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.425 -1.422 . . . . 0.0 110.085 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.737 ' HB2' HG22 ' A' ' 50' ' ' VAL . 79.8 p -57.88 -44.2 86.53 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 178.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 -9.01 54.45 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.538 -0.726 . . . . 0.0 109.498 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.443 ' N ' ' HD3' ' A' ' 214' ' ' PRO . 10.3 m120 -137.13 66.8 54.38 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.191 -0.943 . . . . 0.0 109.707 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.443 ' HD3' ' N ' ' A' ' 213' ' ' ASN . 12.3 Cg_exo -67.29 9.59 0.3 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 123.013 2.476 . . . . 0.0 112.237 179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.497 ' C ' ' OD1' ' A' ' 215' ' ' ASP . 1.1 p30 -63.07 -18.92 63.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.133 -0.98 . . . . 0.0 110.537 -178.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.62 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.71 85.35 0.05 OUTLIER Glycine 0 N--CA 1.498 2.828 0 C-N-CA 119.652 -1.261 . . . . 0.0 111.157 178.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.703 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 87.2 t80 -48.91 -171.87 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 120.314 2.057 . . . . 0.0 109.052 179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.703 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 13.2 m -72.29 76.65 1.0 Allowed 'General case' 0 C--N 1.307 -1.273 0 O-C-N 120.661 -1.275 . . . . 0.0 108.852 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.47 157.94 17.13 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.543 HD22 ' CA ' ' A' ' 148' ' ' GLY . 4.8 mp -85.25 -177.54 6.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.14 -1.212 . . . . 0.0 109.777 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 162.96 90.61 0.08 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.59 171.22 14.32 Favored Glycine 0 C--N 1.304 -1.2 0 N-CA-C 108.038 -2.025 . . . . 0.0 108.038 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.574 ' OG1' ' OD1' ' A' ' 140' ' ' ASP . 1.6 t -143.5 8.31 1.55 Allowed 'General case' 0 C--N 1.27 -2.851 0 CA-C-N 114.919 -0.64 . . . . 0.0 109.713 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -73.5 23.57 0.99 Allowed Glycine 0 C--N 1.303 -1.294 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.554 ' H ' ' C ' ' A' ' 223' ' ' THR . 4.0 p -111.53 163.69 8.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.715 -0.873 . . . . 0.0 109.954 -178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.52 110.06 22.55 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-O 122.167 0.984 . . . . 0.0 109.054 179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.566 ' CB ' ' CD ' ' A' ' 228' ' ' PRO . 1.3 m -72.37 -72.32 0.21 Allowed Pre-proline 0 C--N 1.279 -2.48 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 72.8 Cg_endo -74.39 -40.7 1.07 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.192 1.928 . . . . 0.0 109.828 177.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.544 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -54.66 153.08 6.22 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.873 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.544 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.52 138.23 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.32 0.581 . . . . 0.0 109.789 -179.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.558 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -149.78 118.8 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.279 -0.888 . . . . 0.0 109.305 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 6.4 tttm -68.99 42.47 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.168 -0.957 . . . . 0.0 109.472 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.49 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 121.218 -0.926 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.444 ' H72' ' SD ' ' A' ' 145' ' ' MET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.541 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.541 ' C ' ' O ' ' A' ' 22' ' ' GLY . 4.6 m-20 -35.53 107.98 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.31 -1.112 . . . . 0.0 109.365 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.5 m -67.93 -33.39 74.59 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.33 -0.856 . . . . 0.0 110.078 -179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.409 ' HA ' HG12 ' A' ' 28' ' ' VAL . . . -72.96 -10.24 59.58 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 123.282 1.515 . . . . 0.0 109.505 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.536 ' O ' HG21 ' A' ' 153' ' ' THR . 95.3 p -49.4 -65.26 0.6 Allowed 'General case' 0 C--N 1.26 -3.285 0 CA-C-N 113.345 -1.752 . . . . 0.0 111.645 -178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.794 ' HB2' H142 ' A' ' 21' ' ' MYR . 0.0 OUTLIER -103.81 45.94 0.94 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.63 1.205 . . . . 0.0 111.278 -178.097 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.661 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -143.91 12.03 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.253 -3.607 0 N-CA-C 104.431 -2.433 . . . . 0.0 104.431 179.061 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.661 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.0 OUTLIER -36.22 166.68 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.183 0 CA-C-O 122.736 1.255 . . . . 0.0 109.189 -178.981 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -77.05 124.66 28.11 Favored 'General case' 0 C--N 1.273 -2.756 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.617 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.603 ' HB1' ' HE1' ' A' ' 97' ' ' HIS . . . -57.14 -26.28 60.28 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.506 -0.746 . . . . 0.0 109.183 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -81.64 -4.67 56.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.27 -0.894 . . . . 0.0 109.34 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.528 ' O ' ' N ' ' A' ' 35' ' ' LEU . 5.7 mt-10 -98.02 -36.23 10.18 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.322 -0.861 . . . . 0.0 109.266 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' O ' ' O ' ' A' ' 35' ' ' LEU . . . -35.59 96.83 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.279 -0.888 . . . . 0.0 109.404 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.653 ' O ' ' CG2' ' A' ' 98' ' ' THR . 0.5 OUTLIER -40.48 162.41 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.627 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 38' ' ' ARG . 60.5 Cg_exo -50.76 -30.67 30.14 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 121.971 1.781 . . . . 0.0 110.911 -179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.565 ' H ' HD12 ' A' ' 35' ' ' LEU . . . 65.2 -38.8 0.11 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 178.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 36' ' ' PRO . 7.9 ttt180 -53.38 121.54 7.83 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.737 -1.449 . . . . 0.0 109.315 -178.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.673 ' O ' ' N ' ' A' ' 41' ' ' PRO . 4.4 m -127.89 31.87 5.04 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 178.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.656 ' C ' ' O ' ' A' ' 39' ' ' THR . 3.1 tm-20 -8.17 75.44 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.142 0 CA-C-O 121.41 0.624 . . . . 0.0 110.679 -178.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.673 ' N ' ' O ' ' A' ' 39' ' ' THR . 72.2 Cg_endo -90.97 -177.3 1.08 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.695 2.93 . . . . 0.0 112.511 -179.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 42' ' ' ILE . 6.8 pt -102.08 149.75 36.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.296 -0.877 . . . . 0.0 109.023 179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -39.85 164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.92 2.413 . . . . 0.0 112.554 -179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG11 ' O ' ' A' ' 202' ' ' ALA . 27.2 m -106.87 -154.19 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.21 -0.931 . . . . 0.0 109.436 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.733 ' O ' HG23 ' A' ' 45' ' ' THR . 9.9 t -80.09 86.79 5.5 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.231 -0.918 . . . . 0.0 110.14 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.612 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.41 -37.65 70.48 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.383 -0.823 . . . . 0.0 111.016 -179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.586 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.8 mtmt -93.24 98.86 11.55 Favored 'General case' 0 C--N 1.287 -2.135 0 C-N-CA 116.33 -2.148 . . . . 0.0 108.15 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.661 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.4 t-80 -31.14 107.98 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -57.27 -30.45 64.68 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.408 -0.807 . . . . 0.0 111.133 -178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.531 HG21 ' CE2' ' A' ' 81' ' ' TRP . 13.2 t -66.65 -43.59 90.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.788 -1.195 . . . . 0.0 109.554 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.38 -42.17 4.66 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.275 -0.891 . . . . 0.0 110.135 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.661 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.06 0.97 48.33 Favored Glycine 0 N--CA 1.485 1.956 0 N-CA-C 109.088 -1.605 . . . . 0.0 109.088 -179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 46.4 m-20 -72.14 -119.86 0.0 OUTLIER 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 178.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.571 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -127.92 174.17 9.39 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-O 123.506 1.622 . . . . 0.0 110.103 178.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.859 ' O ' HG13 ' A' ' 56' ' ' VAL . 10.3 p -150.89 22.13 0.78 Allowed 'General case' 0 C--N 1.268 -2.975 0 CA-C-N 112.889 -1.96 . . . . 0.0 110.134 178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 55' ' ' THR . 2.5 m -167.79 143.12 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.918 -1.114 . . . . 0.0 109.542 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.531 ' C ' ' O ' ' A' ' 56' ' ' VAL . 32.6 mt-10 -32.46 142.76 0.16 Allowed Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.442 -0.786 . . . . 0.0 110.462 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.4 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 88.4 Cg_endo -77.52 167.1 80.02 Favored 'Cis proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.224 -1.99 . . . . 0.0 111.661 0.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -100.39 132.69 22.12 Favored Pre-proline 0 C--N 1.271 -2.835 0 CA-C-N 114.599 -1.182 . . . . 0.0 108.905 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.524 ' O ' ' OG1' ' A' ' 63' ' ' THR . 45.5 Cg_exo -49.51 114.61 1.4 Allowed 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 121.999 1.799 . . . . 0.0 112.199 179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.71 118.39 3.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.289 -0.882 . . . . 0.0 109.483 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 115.41 -8.26 20.35 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.322 -1.511 . . . . 0.0 109.322 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.611 HG22 ' HB3' ' A' ' 122' ' ' ARG . 0.7 OUTLIER -83.12 137.13 34.21 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.107 . . . . 0.0 109.795 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.77 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.1 tp60 -103.66 155.33 18.64 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 118.519 -1.272 . . . . 0.0 108.374 179.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.734 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -161.79 137.27 7.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.276 -1.515 . . . . 0.0 112.434 -179.458 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -112.28 -168.99 1.39 Allowed 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 177.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 94.9 t -143.96 115.02 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 119.785 -1.822 . . . . 0.0 110.906 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.689 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 1.5 p90 -163.29 156.04 18.61 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.015 -1.053 . . . . 0.0 109.719 178.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -151.92 164.16 30.31 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.499 ' CE ' ' OD1' ' A' ' 138' ' ' ASN . 0.0 OUTLIER -114.8 -88.48 0.57 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.312 -1.111 . . . . 0.0 109.052 179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . -125.07 -152.14 8.2 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.119 -1.992 . . . . 0.0 108.119 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.681 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -31.4 99.17 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.412 -1.052 . . . . 0.0 108.193 179.256 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.729 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -49.45 5.76 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.361 -0.837 . . . . 0.0 111.665 -177.476 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.783 ' CZ2' ' CE1' ' A' ' 206' ' ' HIS . 5.1 m0 -69.52 -49.84 50.76 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 120.277 -1.514 . . . . 0.0 108.549 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.52 -49.65 76.31 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 110.384 -1.086 . . . . 0.0 110.384 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB3' HG21 ' A' ' 117' ' ' VAL . . . -76.13 -27.52 57.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.964 -1.315 . . . . 0.0 110.202 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.575 ' OE1' HG22 ' A' ' 91' ' ' VAL . 6.9 tp10 -52.1 -34.85 45.85 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.907 -1.12 . . . . 0.0 110.153 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 21.7 ttt-85 -106.52 -56.69 2.16 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.979 -1.076 . . . . 0.0 111.36 -178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.655 ' O ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -38.69 -17.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.928 . . . . 0.0 110.262 -178.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 11.6 m-85 -91.52 -42.7 10.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.702 -1.249 . . . . 0.0 110.953 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.54 ' CE3' ' HA ' ' A' ' 78' ' ' ARG . 0.8 OUTLIER -70.91 -4.61 25.35 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.441 -1.304 . . . . 0.0 109.745 -179.335 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.655 HG22 ' O ' ' A' ' 79' ' ' LYS . 3.7 m -83.62 14.14 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 0.0 108.752 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.411 HD11 HG21 ' A' ' 134' ' ' VAL . 96.4 mt -90.69 164.0 14.3 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -93.19 138.12 31.88 Favored 'General case' 0 C--N 1.286 -2.173 0 CA-C-O 121.451 0.643 . . . . 0.0 110.359 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.461 ' CA ' ' HB3' ' A' ' 123' ' ' PRO . . . 89.65 -19.12 42.67 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 110.218 -1.153 . . . . 0.0 110.218 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.22 137.91 18.7 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 O-C-N 120.945 -1.326 . . . . 0.0 109.775 -178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.571 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -76.73 -40.89 47.05 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 178.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.676 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 177.12 -160.38 0.02 OUTLIER 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.079 179.773 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.553 ' N ' ' OG ' ' A' ' 88' ' ' SER . 70.2 p -160.33 150.97 18.58 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.377 -0.827 . . . . 0.0 109.218 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.676 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 8.6 mp0 -144.68 164.43 30.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.583 ' O ' ' NE2' ' A' ' 207' ' ' GLN . 0.2 OUTLIER -144.53 156.48 14.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.061 -1.024 . . . . 0.0 110.008 -179.667 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -173.19 176.29 45.93 Favored Glycine 0 N--CA 1.487 2.088 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 1.4 m-85 -88.77 164.78 15.09 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.356 -1.085 . . . . 0.0 109.818 -179.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.677 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.73 174.7 0.92 Allowed 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.144 -0.973 . . . . 0.0 109.642 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 53.17 46.96 62.03 Favored Glycine 0 N--CA 1.493 2.471 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.524 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -135.87 -152.38 6.36 Favored Glycine 0 N--CA 1.493 2.497 0 O-C-N 120.945 -1.326 . . . . 0.0 110.381 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.701 ' O ' ' CG ' ' A' ' 97' ' ' HIS . 2.5 t-160 -153.29 63.63 0.76 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.535 -0.979 . . . . 0.0 108.856 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.653 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.2 OUTLIER -157.95 142.37 16.14 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 -179.61 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.592 ' O ' ' N ' ' A' ' 101' ' ' PRO . 31.0 mtp180 -49.26 177.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 108.548 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.567 ' C ' ' O ' ' A' ' 99' ' ' ARG . 2.6 m-80 -33.84 94.92 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.332 -0.855 . . . . 0.0 109.111 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 60.9 Cg_endo -85.62 163.07 10.82 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.81 2.34 . . . . 0.0 112.503 -178.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.589 ' OG1' ' OE1' ' A' ' 105' ' ' GLU . 21.5 p -121.02 170.78 9.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.692 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.777 ' CG ' ' CE1' ' A' ' 206' ' ' HIS . 13.6 t80 -60.37 -59.56 5.2 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.321 -0.862 . . . . 0.0 110.295 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.7 tmtp? -55.48 -36.73 66.94 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.057 -1.027 . . . . 0.0 108.309 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.589 ' OE1' ' OG1' ' A' ' 102' ' ' THR . 0.1 OUTLIER -58.27 -62.01 2.15 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-O 121.258 0.552 . . . . 0.0 110.345 179.445 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.033 HG12 ' OG1' ' A' ' 111' ' ' THR . 27.1 m -65.04 -23.98 34.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.264 -0.897 . . . . 0.0 110.856 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.594 ' C ' ' H ' ' A' ' 109' ' ' GLU . 42.9 t -42.13 -44.18 3.57 Favored 'General case' 0 C--N 1.291 -1.944 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.74 ' C ' ' H ' ' A' ' 110' ' ' LYS . 33.2 t -69.42 13.23 0.13 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.24 -0.912 . . . . 0.0 108.735 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.686 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.0 OUTLIER 51.95 -16.24 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 C-N-CA 123.514 0.726 . . . . 0.0 110.755 179.268 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.74 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.3 OUTLIER -45.88 -30.43 1.73 Allowed 'General case' 0 C--N 1.292 -1.893 0 O-C-N 121.67 -0.644 . . . . 0.0 110.186 -179.4 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 1.033 ' OG1' HG12 ' A' ' 106' ' ' VAL . 48.7 p -84.53 11.77 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.894 -1.129 . . . . 0.0 109.073 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.558 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 24.72 44.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.322 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.677 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 2.6 m-70 -83.91 170.83 13.63 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.492 -1.593 . . . . 0.0 109.214 179.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.468 ' HB1' ' CB ' ' A' ' 158' ' ' ALA . . . -118.55 114.21 22.46 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.693 ' OE2' ' CG ' ' A' ' 73' ' ' PHE . 1.9 mm-40 -51.19 118.25 3.11 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.39 -0.819 . . . . 0.0 109.784 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.589 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.8 OUTLIER -125.21 136.18 61.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.05 179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.561 HG22 ' CG1' ' A' ' 91' ' ' VAL . 0.9 OUTLIER -116.85 125.01 73.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 108.015 -1.105 . . . . 0.0 108.015 179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 118' ' ' ARG . 2.7 ptm180 -104.7 116.37 31.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 110.723 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.603 HG13 HD22 ' A' ' 131' ' ' LEU . 0.7 OUTLIER -124.57 114.25 39.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 178.223 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.466 HG12 ' HB3' ' A' ' 65' ' ' MET . 0.7 OUTLIER -95.43 159.51 2.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.041 -1.037 . . . . 0.0 111.698 -177.11 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.82 ' HB2' HG22 ' A' ' 126' ' ' ILE . 5.7 p90 -138.95 136.61 35.61 Favored 'General case' 0 C--O 1.207 -1.166 0 CA-C-O 123.518 1.628 . . . . 0.0 111.592 178.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.969 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 6.9 ptt-85 -137.16 -1.09 0.03 OUTLIER Pre-proline 0 C--N 1.28 -2.445 0 CA-C-N 113.286 -1.779 . . . . 0.0 111.621 179.056 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.969 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 56.2 Cg_endo -71.53 -27.75 18.45 Favored 'Trans proline' 0 C--N 1.302 -1.897 0 C-N-CA 124.288 3.325 . . . . 0.0 116.838 -176.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 5.1 tt0 72.79 -5.18 1.94 Allowed 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 103.532 -2.766 . . . . 0.0 103.532 -172.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.651 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -105.51 -25.07 12.47 Favored 'General case' 0 N--CA 1.507 2.376 0 N-CA-C 107.737 -1.209 . . . . 0.0 107.737 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.892 ' H ' ' HG2' ' A' ' 123' ' ' PRO . 0.3 OUTLIER -128.4 124.13 61.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 105.403 -2.073 . . . . 0.0 105.403 177.332 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.519 ' H ' ' HG3' ' A' ' 130' ' ' GLU . 0.7 OUTLIER -132.22 -170.73 2.48 Favored 'General case' 0 N--CA 1.503 2.209 0 O-C-N 120.885 -1.135 . . . . 0.0 112.698 -176.145 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.733 ' N ' ' CE2' ' A' ' 121' ' ' TYR . 60.5 t80 -58.08 -45.39 87.24 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.569 -0.707 . . . . 0.0 110.497 -179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.554 ' O ' HD23 ' A' ' 132' ' ' LEU . 78.0 mt-10 -46.73 -35.02 5.67 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 179.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.73 ' HG3' HD13 ' A' ' 126' ' ' ILE . 17.4 mm-40 -73.77 -63.54 1.19 Allowed 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 178.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.689 ' O ' ' CZ ' ' A' ' 68' ' ' PHE . 13.2 mt -34.22 -57.83 0.48 Allowed 'General case' 0 N--CA 1.485 1.277 0 O-C-N 121.223 -0.923 . . . . 0.0 110.522 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.786 HD23 ' H ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -76.84 -42.17 41.24 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.403 -1.435 . . . . 0.0 110.996 -178.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.786 ' H ' HD23 ' A' ' 132' ' ' LEU . 0.0 OUTLIER -52.15 -63.07 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.771 -1.205 . . . . 0.0 109.167 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.8 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 14.3 t -50.14 -40.06 16.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE2' ' CZ3' ' A' ' 136' ' ' TRP . 15.8 t80 -56.45 -45.46 80.81 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 120.188 -1.57 . . . . 0.0 109.982 -179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.514 ' O ' HG21 ' A' ' 223' ' ' THR . 29.4 m95 -73.49 -41.57 62.93 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.642 -1.286 . . . . 0.0 111.102 179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.64 ' N ' ' OE1' ' A' ' 137' ' ' GLU . 0.9 OUTLIER -67.5 -2.45 6.51 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 -175.749 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.8 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.2 OUTLIER -133.76 48.0 2.4 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 119.937 -1.727 . . . . 0.0 112.096 -178.939 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 1.025 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 176.21 -164.79 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 177.708 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.646 ' N ' ' CG ' ' A' ' 139' ' ' HIS . 0.5 OUTLIER -129.49 117.63 18.75 Favored Pre-proline 0 C--N 1.292 -1.912 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.21 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.509 ' HG3' ' CD2' ' A' ' 177' ' ' TYR . 10.7 Cg_endo -67.12 -4.11 10.98 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.554 1.503 . . . . 0.0 111.615 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.608 HG22 HD13 ' A' ' 181' ' ' LEU . 0.1 OUTLIER -101.3 -13.76 17.92 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.424 -0.797 . . . . 0.0 109.196 179.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.645 ' CD ' ' H ' ' A' ' 148' ' ' GLY . 0.3 OUTLIER -68.02 70.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.405 -0.809 . . . . 0.0 109.111 179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.633 ' N ' ' OG1' ' A' ' 190' ' ' THR . . . -52.05 -118.26 0.01 OUTLIER Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.982 -0.847 . . . . 0.0 110.982 -179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.659 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.62 39.33 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.43 -1.041 . . . . 0.0 109.334 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.569 ' H ' ' C ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -156.52 164.83 37.76 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.175 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.681 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.5 OUTLIER -155.52 89.55 1.19 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.566 -1.334 . . . . 0.0 109.44 -179.662 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.645 ' H ' ' CD ' ' A' ' 143' ' ' GLN . . . 51.72 -113.65 2.56 Favored Glycine 0 N--CA 1.478 1.481 0 N-CA-C 109.089 -1.604 . . . . 0.0 109.089 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -80.48 3.83 20.24 Favored 'General case' 0 C--N 1.271 -2.816 0 CA-C-N 114.434 -0.883 . . . . 0.0 110.236 -179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -108.28 146.34 33.03 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.915 -1.116 . . . . 0.0 108.934 179.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -136.61 130.42 32.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.053 -1.029 . . . . 0.0 109.961 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 141.01 163.34 9.48 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.515 -1.326 . . . . 0.0 110.421 179.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.575 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 44.8 p -73.72 -10.62 59.87 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.523 -0.986 . . . . 0.0 109.896 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.53 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 16.2 pm0 -87.47 -7.08 58.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.0 -1.062 . . . . 0.0 109.884 -179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.446 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 32.2 m-85 -124.41 60.43 1.15 Allowed 'General case' 0 N--CA 1.485 1.314 0 O-C-N 121.082 -1.011 . . . . 0.0 108.772 178.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.5 HH12 ' HB ' ' A' ' 153' ' ' THR . 5.4 ptt-85 -112.96 173.67 6.27 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.439 -0.788 . . . . 0.0 109.602 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.79 118.57 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 105.508 -2.034 . . . . 0.0 105.508 178.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.468 ' CB ' ' HB1' ' A' ' 114' ' ' ALA . . . -139.62 116.36 10.83 Favored 'General case' 0 C--N 1.288 -2.08 0 C-N-CA 118.057 -1.457 . . . . 0.0 110.865 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.662 ' N ' ' O ' ' A' ' 192' ' ' ASP . 48.4 t -102.19 148.34 7.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 C-N-CA 119.299 -0.96 . . . . 0.0 109.609 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.412 ' OH ' ' CB ' ' A' ' 114' ' ' ALA . 91.0 m-85 -139.23 87.36 13.82 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 120.776 -1.203 . . . . 0.0 108.554 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_exo -46.02 163.15 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.881 2.387 . . . . 0.0 112.243 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.566 ' O ' ' OG ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.14 -21.54 13.24 Favored 'General case' 0 C--N 1.316 -0.882 0 O-C-N 120.635 -1.29 . . . . 0.0 110.553 -179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 162' ' ' THR . 0.8 OUTLIER -176.48 178.54 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.87 -1.144 . . . . 0.0 108.929 179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -48.31 -16.15 0.09 Allowed 'General case' 0 N--CA 1.488 1.453 0 CA-C-O 123.007 1.384 . . . . 0.0 108.484 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.558 ' N ' ' C ' ' A' ' 163' ' ' SER . 5.3 t -59.26 -62.07 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.812 0 CA-C-N 114.03 -1.441 . . . . 0.0 109.925 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.576 ' O ' ' CB ' ' A' ' 170' ' ' ALA . 4.5 mp0 -77.74 -19.4 55.23 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.512 -0.742 . . . . 0.0 110.381 -179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.5 ttt -54.09 -54.66 36.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.954 -1.092 . . . . 0.0 109.534 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.465 ' N ' ' OE1' ' A' ' 168' ' ' GLU . 0.1 OUTLIER -54.58 -66.83 0.33 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.212 -0.93 . . . . 0.0 109.77 -179.913 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.447 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -57.5 -39.33 76.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.216 -0.927 . . . . 0.0 109.869 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.44 -58.54 6.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.319 -0.863 . . . . 0.0 109.642 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 5.6 mp -53.04 -49.5 66.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.263 -0.898 . . . . 0.0 109.782 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.403 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -60.87 -48.55 81.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.141 -0.975 . . . . 0.0 109.466 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.498 ' HB2' ' NE1' ' A' ' 136' ' ' TRP . 1.0 OUTLIER -55.97 -40.15 72.85 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.354 -0.841 . . . . 0.0 109.66 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.636 ' HZ2' HD12 ' A' ' 189' ' ' ILE . 0.0 OUTLIER -73.04 -58.2 3.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.342 -0.848 . . . . 0.0 110.607 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -63.97 -44.56 92.38 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.24 -0.913 . . . . 0.0 110.81 -178.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.403 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 74.8 mt-10 -53.1 -20.21 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.051 -1.031 . . . . 0.0 110.451 -179.028 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.509 ' CD2' ' HG3' ' A' ' 141' ' ' PRO . 0.2 OUTLIER -79.49 -40.08 30.58 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.821 -1.174 . . . . 0.0 110.556 -179.282 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.25 -44.8 65.09 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.835 -1.166 . . . . 0.0 108.502 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.78 -30.59 5.84 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.131 -0.981 . . . . 0.0 109.286 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 3.7 t -87.9 -54.33 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.308 -0.87 . . . . 0.0 110.278 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.608 HD13 HG22 ' A' ' 142' ' ' THR . 25.3 mt -58.99 -45.55 90.34 Favored 'General case' 0 N--CA 1.485 1.278 0 O-C-N 121.129 -0.982 . . . . 0.0 110.387 -179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -55.2 -23.57 22.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.972 -1.08 . . . . 0.0 109.023 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 2.5 tppt? -88.43 -13.84 39.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.365 -0.834 . . . . 0.0 109.338 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.443 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 2.9 m-70 -99.85 11.76 38.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.286 -0.884 . . . . 0.0 109.625 -179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.443 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 72.0 55.45 0.18 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.73 179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.487 ' HE2' ' HG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -119.31 -176.58 3.17 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.244 -0.91 . . . . 0.0 108.972 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -119.55 -158.13 10.53 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.128 -1.589 . . . . 0.0 109.128 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.561 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.4 Cg_exo -58.63 116.47 3.27 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 122.325 2.017 . . . . 0.0 110.771 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.636 HD12 ' HZ2' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -47.91 -175.96 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.286 -0.884 . . . . 0.0 110.005 -178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.633 ' OG1' ' N ' ' A' ' 144' ' ' GLY . 26.8 p -154.67 55.34 0.68 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.654 -0.653 . . . . 0.0 110.384 -179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.614 ' CG2' HG23 ' A' ' 159' ' ' VAL . 32.9 m -99.93 119.05 37.62 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 106.054 -1.832 . . . . 0.0 106.054 177.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 17.2 t0 -75.9 111.06 10.88 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.389 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.466 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 1.0 OUTLIER -117.33 114.82 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.263 -0.898 . . . . 0.0 110.466 -179.602 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.81 ' HE ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -165.0 -170.16 1.87 Allowed 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 179.504 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.539 ' OE2' ' C ' ' A' ' 194' ' ' ARG . 9.4 mp0 -145.82 178.66 8.01 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.606 -1.309 . . . . 0.0 110.389 -179.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.23 14.91 67.88 Favored Glycine 0 N--CA 1.489 2.201 0 C-N-CA 120.342 -0.932 . . . . 0.0 111.077 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.81 ' NE2' ' HE ' ' A' ' 194' ' ' ARG . 1.2 mp0 -89.35 126.47 35.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.502 -1.587 . . . . 0.0 109.784 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 49.0 t -70.31 154.87 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.218 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.464 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 6.7 t80 -92.82 124.79 37.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.244 -0.91 . . . . 0.0 109.769 -179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -115.13 95.09 5.02 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.285 -0.884 . . . . 0.0 108.975 179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -54.41 133.87 45.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.181 -0.949 . . . . 0.0 110.322 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.525 ' O ' HG11 ' A' ' 44' ' ' VAL . . . -84.58 -175.75 5.92 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.808 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.2 pm0 -74.89 171.5 13.92 Favored 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -58.52 -53.84 53.74 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.022 -1.049 . . . . 0.0 110.221 179.974 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -51.35 -11.02 0.1 Allowed 'General case' 0 C--N 1.309 -1.193 0 O-C-N 121.016 -1.052 . . . . 0.0 111.118 -179.174 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.783 ' CE1' ' CZ2' ' A' ' 74' ' ' TRP . 12.2 m-70 -101.49 10.27 40.55 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.709 -1.245 . . . . 0.0 110.335 179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.0 mm-40 -131.12 -146.46 0.3 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-O 122.233 1.015 . . . . 0.0 110.009 -178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.696 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 12.8 mp0 -33.87 -8.62 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.444 -179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 11.3 t80 -44.95 -40.52 6.45 Favored 'General case' 0 N--CA 1.515 2.815 0 O-C-N 120.146 -1.596 . . . . 0.0 109.343 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -52.61 -18.43 1.76 Allowed 'General case' 0 C--N 1.309 -1.178 0 O-C-N 120.868 -1.145 . . . . 0.0 110.47 -179.3 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 1.2 p -61.39 -39.7 91.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.111 -0.993 . . . . 0.0 109.196 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -71.02 -33.07 70.0 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.306 -0.871 . . . . 0.0 109.687 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.446 ' C ' ' H ' ' A' ' 215' ' ' ASP . 5.6 m-80 -134.27 70.0 73.48 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.217 -0.927 . . . . 0.0 109.441 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.453 ' HB3' ' NE ' ' A' ' 78' ' ' ARG . 24.3 Cg_exo -60.76 8.63 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 123.039 2.492 . . . . 0.0 112.618 -179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 213' ' ' ASN . 10.1 t0 -63.37 -18.97 64.24 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.012 -1.055 . . . . 0.0 110.524 -179.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.79 85.32 0.05 OUTLIER Glycine 0 N--CA 1.502 3.069 0 C-N-CA 119.936 -1.126 . . . . 0.0 111.512 177.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.74 92.97 9.3 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 120.598 2.199 . . . . 0.0 109.388 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.727 ' O ' ' O ' ' A' ' 219' ' ' GLY . 0.6 OUTLIER -169.72 112.74 0.49 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.042 -1.036 . . . . 0.0 109.491 -179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.727 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . -0.33 -133.53 0.0 OUTLIER Glycine 0 N--CA 1.505 3.294 0 CA-C-O 122.464 1.036 . . . . 0.0 112.711 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -122.78 -173.71 2.76 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.676 -0.896 . . . . 0.0 109.69 -178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -82.73 -149.04 7.87 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -153.64 -136.66 2.34 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 1.025 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.9 OUTLIER 45.26 25.0 0.17 Allowed 'General case' 0 N--CA 1.485 1.307 0 O-C-N 121.286 -1.126 . . . . 0.0 109.131 -179.862 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -163.12 40.26 0.34 Allowed Glycine 0 C--N 1.302 -1.355 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.651 ' O ' HG12 ' A' ' 225' ' ' VAL . 2.7 t -66.74 96.08 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.229 -1.159 . . . . 0.0 109.133 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.621 ' H ' ' CB ' ' A' ' 229' ' ' MET . 0.3 OUTLIER -98.41 -153.0 0.42 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.11 0.957 . . . . 0.0 109.507 -179.83 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.574 ' CB ' ' CD ' ' A' ' 228' ' ' PRO . 1.2 m -71.24 -68.27 0.49 Allowed Pre-proline 0 C--N 1.289 -2.039 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.574 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 45.9 Cg_endo -68.6 -39.42 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.427 2.084 . . . . 0.0 109.51 178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.621 ' CB ' ' H ' ' A' ' 226' ' ' SER . 0.0 OUTLIER -54.35 151.06 7.95 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.745 179.436 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.561 ' O ' HG13 ' A' ' 225' ' ' VAL . . . -32.77 131.77 0.16 Allowed 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.188 0.518 . . . . 0.0 109.817 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.542 HG22 ' O ' ' A' ' 231' ' ' ILE . 1.2 mm -128.0 103.99 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.2 -0.937 . . . . 0.0 109.396 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.86 -23.18 55.65 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.427 -0.795 . . . . 0.0 109.592 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.357 0 O-C-N 121.287 -0.883 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.794 H142 ' HB2' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.549 ' O ' ' N ' ' A' ' 24' ' ' SER . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.458 ' OD2' ' OG ' ' A' ' 26' ' ' SER . 19.0 t70 -65.27 65.06 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.179 -1.189 . . . . 0.0 109.393 179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 22' ' ' GLY . 4.4 t -50.85 -19.22 0.92 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.321 -0.862 . . . . 0.0 109.758 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.55 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -62.32 -94.3 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 123.265 1.507 . . . . 0.0 110.694 -179.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.458 ' OG ' ' OD2' ' A' ' 23' ' ' ASP . 59.5 p -47.3 -7.09 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 113.409 -1.723 . . . . 0.0 110.967 -178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.677 ' HZ3' ' HB3' ' A' ' 145' ' ' MET . 0.1 OUTLIER -105.46 23.14 14.26 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 124.305 2.002 . . . . 0.0 109.538 -179.104 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.681 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -156.74 21.2 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.257 -3.433 0 CA-C-N 112.845 -1.98 . . . . 0.0 105.717 -179.681 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.635 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.75 168.18 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 CA-C-O 122.744 1.259 . . . . 0.0 109.539 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.09 124.47 31.8 Favored 'General case' 0 C--N 1.275 -2.631 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.68 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.479 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -55.9 -46.01 78.49 Favored 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.761 -0.587 . . . . 0.0 109.576 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.654 ' H ' ' CD ' ' A' ' 32' ' ' GLU . 3.1 pm0 -78.46 15.77 0.93 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.569 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.582 ' O ' ' C ' ' A' ' 34' ' ' ALA . 10.1 tp10 -116.07 -40.6 3.27 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.217 -0.927 . . . . 0.0 109.661 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.6 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -29.0 149.35 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.475 -0.766 . . . . 0.0 110.108 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -37.58 161.26 0.06 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.961 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -59.73 -41.98 50.41 Favored 'Trans proline' 0 N--CA 1.492 1.431 0 C-N-CA 122.064 1.842 . . . . 0.0 111.676 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 122.93 134.54 4.41 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.512 ' CG ' ' H ' ' A' ' 39' ' ' THR . 14.5 ttp180 -110.75 177.78 4.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.309 -1.112 . . . . 0.0 109.518 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.512 ' H ' ' CG ' ' A' ' 38' ' ' ARG . 0.2 OUTLIER -124.57 33.52 5.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.217 -0.927 . . . . 0.0 109.586 -179.904 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.83 98.88 27.2 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.085 -1.009 . . . . 0.0 109.65 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -80.78 170.78 15.14 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.726 2.284 . . . . 0.0 112.211 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.43 HD11 ' HE2' ' A' ' 93' ' ' PHE . 0.0 OUTLIER -139.06 100.56 7.88 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.198 -0.938 . . . . 0.0 109.639 -179.949 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -80.21 168.19 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.595 2.197 . . . . 0.0 112.209 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG12 ' N ' ' A' ' 204' ' ' ASP . 12.5 m -139.39 170.4 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.167 -0.958 . . . . 0.0 109.675 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.785 ' O ' HG23 ' A' ' 45' ' ' THR . 13.4 t -58.82 103.77 0.19 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.356 -0.84 . . . . 0.0 110.231 -179.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.572 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.92 -50.13 73.51 Favored 'General case' 0 C--N 1.307 -1.259 0 O-C-N 121.359 -0.838 . . . . 0.0 111.479 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.558 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.4 pttt -70.74 100.62 1.92 Allowed 'General case' 0 C--N 1.29 -1.982 0 C-N-CA 115.846 -2.342 . . . . 0.0 108.168 -179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.604 ' HD1' ' HB ' ' A' ' 50' ' ' VAL . 6.3 t-80 -31.95 125.02 0.28 Allowed 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.003 179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.469 ' O ' ' ND1' ' A' ' 49' ' ' HIS . 0.8 OUTLIER -66.65 -8.08 25.08 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.416 -0.802 . . . . 0.0 110.848 -178.733 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.604 ' HB ' ' HD1' ' A' ' 48' ' ' HIS . 18.9 t -92.98 -63.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 120.843 -1.161 . . . . 0.0 109.805 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -83.56 -42.76 16.43 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.2 -0.937 . . . . 0.0 110.264 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.0 5.5 54.82 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.689 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 39.3 p30 -81.52 -119.02 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 178.348 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.689 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.9 ttp180 -129.54 168.67 16.04 Favored 'General case' 0 C--N 1.292 -1.905 0 CA-C-O 122.989 1.376 . . . . 0.0 108.418 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.685 ' O ' HG13 ' A' ' 56' ' ' VAL . 20.8 p -128.38 30.68 5.14 Favored 'General case' 0 C--N 1.26 -3.304 0 CA-C-N 113.926 -1.488 . . . . 0.0 108.94 178.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.685 HG13 ' O ' ' A' ' 55' ' ' THR . 7.0 m -161.29 132.58 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.303 -0.873 . . . . 0.0 110.016 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.52 ' C ' ' O ' ' A' ' 56' ' ' VAL . 13.6 mt-10 -33.78 154.41 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.314 0 CA-C-O 121.899 0.857 . . . . 0.0 110.852 -179.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HD2' ' NH2' ' A' ' 54' ' ' ARG . 96.5 Cg_endo -79.44 166.28 78.52 Favored 'Cis proline' 0 C--N 1.302 -1.893 0 C-N-CA 121.48 -2.3 . . . . 0.0 111.756 -0.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.484 ' CE1' HG11 ' A' ' 120' ' ' VAL . 32.6 m-85 -108.37 154.51 41.39 Favored Pre-proline 0 C--N 1.267 -3.005 0 CA-C-N 114.465 -1.243 . . . . 0.0 109.041 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -49.51 148.88 10.63 Favored 'Trans proline' 0 N--CA 1.492 1.434 0 C-N-CA 122.33 2.02 . . . . 0.0 112.468 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -55.95 132.79 50.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.363 -0.836 . . . . 0.0 109.113 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.84 53.91 2.6 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.216 -1.554 . . . . 0.0 109.216 -179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.23 137.1 40.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.413 -1.051 . . . . 0.0 109.44 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.532 ' OE1' ' CA ' ' A' ' 64' ' ' GLN . 1.6 tp60 -123.85 125.43 44.64 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.688 ' SD ' ' NH2' ' A' ' 118' ' ' ARG . 3.5 ptt? -109.63 141.28 42.39 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 119.125 -1.03 . . . . 0.0 110.621 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.43 -167.29 1.87 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 179.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.7 t -142.0 129.74 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.081 -1.637 . . . . 0.0 109.446 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 1.025 ' O ' HG22 ' A' ' 117' ' ' VAL . 59.1 m-85 -117.82 125.75 51.14 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.116 -0.99 . . . . 0.0 108.61 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -113.13 105.81 1.72 Allowed Glycine 0 N--CA 1.485 1.942 0 C-N-CA 119.023 -1.56 . . . . 0.0 110.146 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.723 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 0.0 OUTLIER -107.86 -88.79 0.47 Allowed 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.449 -1.03 . . . . 0.0 108.666 178.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.635 ' N ' ' OE2' ' A' ' 115' ' ' GLU . . . -146.92 -152.73 5.71 Favored Glycine 0 N--CA 1.484 1.84 0 N-CA-C 108.098 -2.001 . . . . 0.0 108.098 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.812 ' SG ' ' CD2' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -36.42 106.05 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 108.956 179.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.667 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -48.85 7.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.419 -0.801 . . . . 0.0 112.307 -178.225 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 1.0 ' O ' HD11 ' A' ' 210' ' ' LEU . 21.1 m0 -67.48 -48.73 66.3 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 120.076 -1.64 . . . . 0.0 109.412 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -100.43 5.42 57.21 Favored Glycine 0 N--CA 1.494 2.564 0 C-N-CA 119.749 -1.215 . . . . 0.0 110.55 -179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.726 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -77.42 -41.86 38.3 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.031 -1.276 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.727 ' OE2' HG13 ' A' ' 119' ' ' VAL . 2.6 tp10 -83.39 -14.82 51.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.15 -0.969 . . . . 0.0 111.786 -177.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.842 ' CB ' HD13 ' A' ' 210' ' ' LEU . 15.0 ttp85 -57.52 -73.13 0.07 Allowed 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.807 -1.183 . . . . 0.0 110.965 -178.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.476 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 11.9 mttt -61.71 17.07 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.157 -0.964 . . . . 0.0 111.444 -178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.726 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 10.5 m-85 -115.87 -29.95 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.757 -1.215 . . . . 0.0 110.602 -179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.613 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.0 OUTLIER -104.26 -0.75 27.97 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.723 -1.236 . . . . 0.0 109.571 179.425 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.713 HG13 ' O ' ' A' ' 78' ' ' ARG . 3.7 m -93.3 8.51 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.222 -0.924 . . . . 0.0 109.105 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.642 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -103.3 -179.03 3.84 Favored 'General case' 0 C--N 1.293 -1.855 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.332 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.1 tttm -96.72 156.51 16.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.639 -1.288 . . . . 0.0 111.209 -178.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 85.6 8.72 79.88 Favored Glycine 0 N--CA 1.493 2.473 0 O-C-N 121.557 -0.714 . . . . 0.0 111.906 177.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.411 ' O ' HG12 ' A' ' 86' ' ' VAL . 1.1 t -99.79 129.52 50.28 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 120.387 -1.654 . . . . 0.0 110.791 -179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.584 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.68 -43.8 30.05 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 178.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.53 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 1.3 t -169.62 -176.74 2.51 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 1.113 HG22 HG12 ' A' ' 119' ' ' VAL . 7.7 p -148.31 149.53 32.0 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.094 -1.004 . . . . 0.0 109.097 179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.576 ' O ' ' OE1' ' A' ' 77' ' ' GLU . 8.8 mp0 -146.71 170.51 16.83 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.41 -0.806 . . . . 0.0 109.455 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.815 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -146.66 167.47 6.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 179.537 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.452 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . 178.06 156.02 15.61 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 -179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.556 ' CE1' ' HB2' ' A' ' 202' ' ' ALA . 0.5 OUTLIER -80.01 160.71 25.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.604 -0.939 . . . . 0.0 109.459 179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.648 ' C ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.56 -170.11 0.15 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 0.0 109.875 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.35 22.41 63.29 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.745 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -128.44 -164.06 11.46 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.479 ' CE1' ' HA ' ' A' ' 31' ' ' ALA . 0.6 OUTLIER -145.57 78.5 1.54 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.38 -1.07 . . . . 0.0 109.708 -179.415 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.498 ' O ' ' C ' ' A' ' 99' ' ' ARG . 0.2 OUTLIER -147.36 135.18 21.17 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.162 -0.961 . . . . 0.0 109.368 179.857 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.651 ' C ' HD22 ' A' ' 100' ' ' ASN . 5.9 mtt180 -38.84 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -0.896 . . . . 0.0 109.439 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.651 HD22 ' C ' ' A' ' 99' ' ' ARG . 1.1 m-80 -122.47 89.5 49.47 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.168 -0.957 . . . . 0.0 109.668 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.461 ' HG3' ' HE2' ' A' ' 113' ' ' HIS . 5.1 Cg_exo -70.87 132.81 22.25 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 C-N-CA 122.834 2.356 . . . . 0.0 110.848 179.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.481 ' O ' ' HB ' ' A' ' 106' ' ' VAL . 21.1 p -124.21 159.43 30.15 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.845 -1.159 . . . . 0.0 110.614 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.402 ' C ' ' O ' ' A' ' 102' ' ' THR . 6.0 t80 -48.41 -38.85 20.7 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 121.17 -0.956 . . . . 0.0 108.834 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -73.46 -40.46 64.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.284 -0.885 . . . . 0.0 109.79 179.374 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.424 ' HB2' ' OG1' ' A' ' 102' ' ' THR . 3.0 mm-40 -81.75 -30.99 32.17 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.189 -0.944 . . . . 0.0 110.474 -179.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.481 ' HB ' ' O ' ' A' ' 102' ' ' THR . 0.9 OUTLIER -80.98 -29.04 11.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 108.833 -179.491 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -57.74 -28.97 64.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.508 -0.745 . . . . 0.0 109.496 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.677 ' O ' ' CG ' ' A' ' 109' ' ' GLU . 51.6 p -62.67 -70.46 0.2 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.274 -0.891 . . . . 0.0 109.364 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.677 ' CG ' ' O ' ' A' ' 108' ' ' SER . 2.9 mt-10 140.4 -29.53 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.6 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -48.22 1.4 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.35 -0.844 . . . . 0.0 110.939 -179.293 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.667 ' N ' ' O ' ' A' ' 109' ' ' GLU . 14.4 p -108.25 -7.47 15.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.814 -1.179 . . . . 0.0 109.55 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.51 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 43.03 51.0 6.11 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 110.125 -1.19 . . . . 0.0 110.125 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.745 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 15.4 m-70 -97.27 169.19 9.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.998 -1.295 . . . . 0.0 108.929 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.464 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -124.2 113.08 17.82 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.665 ' OE2' ' N ' ' A' ' 70' ' ' MET . 0.5 OUTLIER -51.7 114.67 1.34 Allowed 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.301 -0.959 . . . . 0.0 108.939 -179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.538 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.1 OUTLIER -125.34 157.66 34.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 -179.61 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.025 HG22 ' O ' ' A' ' 68' ' ' PHE . 20.6 m -130.14 131.96 65.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.688 ' NH2' ' SD ' ' A' ' 65' ' ' MET . 10.6 ptm180 -103.68 130.34 51.14 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.738 -1.226 . . . . 0.0 109.414 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 1.113 HG12 HG22 ' A' ' 89' ' ' THR . 0.2 OUTLIER -132.86 138.93 50.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.767 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 179.133 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.484 HG11 ' CE1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -123.61 122.0 63.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 179.688 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.953 ' CZ ' HD22 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -125.41 166.88 15.79 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.472 -177.767 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.505 ' HG2' ' H ' ' A' ' 125' ' ' HIS . 4.5 ttm180 -99.26 114.1 65.29 Favored Pre-proline 0 C--N 1.298 -1.656 0 O-C-N 121.668 -0.645 . . . . 0.0 110.534 -178.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 51.2 Cg_exo -50.85 -42.37 51.78 Favored 'Trans proline' 0 N--CA 1.492 1.426 0 C-N-CA 122.406 2.07 . . . . 0.0 111.785 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -57.28 -23.09 46.15 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.299 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.505 ' H ' ' HG2' ' A' ' 122' ' ' ARG . 1.1 m-70 -104.86 -56.02 2.24 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.298 -0.876 . . . . 0.0 108.849 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.423 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 3.3 tp -130.25 133.43 64.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.47 168.53 19.66 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.16 -0.963 . . . . 0.0 110.42 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.824 ' CE2' HD11 ' A' ' 132' ' ' LEU . 4.0 t80 -69.56 -44.87 70.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.377 -0.827 . . . . 0.0 109.253 179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.568 ' HA ' HD12 ' A' ' 132' ' ' LEU . 1.3 pt-20 -47.95 -31.06 4.79 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.214 -0.929 . . . . 0.0 109.199 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.462 ' N ' ' HG3' ' A' ' 129' ' ' GLU . 11.8 mm-40 -57.38 -70.02 0.14 Allowed 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.553 -0.717 . . . . 0.0 111.216 -178.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.953 HD22 ' CZ ' ' A' ' 121' ' ' TYR . 8.5 mp -56.31 -27.13 54.55 Favored 'General case' 0 N--CA 1.48 1.059 0 O-C-N 120.133 -1.604 . . . . 0.0 110.078 -178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.824 HD11 ' CE2' ' A' ' 128' ' ' PHE . 5.0 mt -55.91 -30.54 61.75 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 118.655 -1.218 . . . . 0.0 108.382 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.463 ' HB2' ' HZ2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -70.63 -52.0 24.27 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.686 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 9.2 t -49.91 -30.7 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.189 -0.945 . . . . 0.0 108.461 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 51.3 t80 -70.79 -46.6 62.58 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.028 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.499 ' HB3' ' CD1' ' A' ' 177' ' ' TYR . 58.2 m95 -72.68 -60.94 1.99 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.396 -1.44 . . . . 0.0 110.719 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.419 ' C ' ' O ' ' A' ' 136' ' ' TRP . 14.8 tm-20 -37.93 -56.98 1.07 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.311 -0.868 . . . . 0.0 111.789 -178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.743 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 4.6 p30 -96.55 61.55 1.95 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.011 -1.056 . . . . 0.0 110.681 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.765 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 13.4 m80 -152.99 -161.81 1.36 Allowed 'General case' 0 N--CA 1.505 2.289 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.669 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -121.24 178.06 1.31 Allowed Pre-proline 0 C--N 1.302 -1.483 0 O-C-N 121.137 -0.977 . . . . 0.0 109.001 -179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.41 ' CD ' ' OD2' ' A' ' 140' ' ' ASP . 9.7 Cg_exo -69.09 -83.34 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.257 1.971 . . . . 0.0 112.005 -179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.707 ' O ' ' N ' ' A' ' 144' ' ' GLY . 0.5 OUTLIER -124.83 13.44 8.55 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.378 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.669 ' NE2' ' CG ' ' A' ' 140' ' ' ASP . 2.6 mt-30 -55.45 70.49 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.008 -1.058 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.707 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.79 13.67 51.96 Favored Glycine 0 N--CA 1.486 1.993 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.677 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -115.41 2.42 13.92 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -1.083 . . . . 0.0 109.296 179.565 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.478 ' NE ' ' O ' ' A' ' 148' ' ' GLY . 0.0 OUTLIER 174.98 129.24 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.245 -0.909 . . . . 0.0 109.223 179.393 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.92 103.11 11.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 119.581 -1.949 . . . . 0.0 108.822 178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.478 ' O ' ' NE ' ' A' ' 146' ' ' ARG . . . 67.21 -118.74 10.55 Favored Glycine 0 C--N 1.301 -1.38 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -81.79 -33.17 30.99 Favored 'General case' 0 C--N 1.272 -2.778 0 CA-C-N 114.381 -0.909 . . . . 0.0 112.377 -178.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.705 ' CG ' ' H ' ' A' ' 72' ' ' CYS . 4.5 m-20 -72.19 99.1 2.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.229 -1.544 . . . . 0.0 110.415 -178.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.655 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 10.5 p90 -92.92 128.83 38.92 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.372 -0.83 . . . . 0.0 110.06 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 152.82 177.58 26.57 Favored Glycine 0 N--CA 1.495 2.585 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.21 179.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.53 HG21 ' HA ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -82.87 -0.49 48.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -1.135 . . . . 0.0 109.602 179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.438 ' HG3' ' CE1' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -100.81 4.33 42.8 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.113 -0.992 . . . . 0.0 109.308 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.541 ' CG ' ' CB ' ' A' ' 150' ' ' ASP . 29.4 m-85 -124.65 58.41 1.23 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 108.74 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.452 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.1 OUTLIER -110.18 -177.09 3.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.514 -0.741 . . . . 0.0 109.347 -179.593 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.408 ' HB3' HG23 ' A' ' 190' ' ' THR . 31.1 t -90.66 128.39 36.61 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 177.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.459 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -151.01 113.19 4.56 Favored 'General case' 0 C--N 1.293 -1.87 0 C-N-CA 117.715 -1.594 . . . . 0.0 111.553 -177.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.83 HG23 ' CG2' ' A' ' 191' ' ' THR . 5.8 t -113.71 122.33 67.62 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.745 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.0 m-30 -111.03 124.64 32.39 Favored Pre-proline 0 C--N 1.293 -1.878 0 O-C-N 121.583 -0.698 . . . . 0.0 109.328 -179.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -80.26 176.53 9.17 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 122.767 2.311 . . . . 0.0 112.193 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.96 -23.54 19.54 Favored 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.29 -0.881 . . . . 0.0 109.175 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 174.33 -162.59 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.326 -0.859 . . . . 0.0 109.112 -179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.6 -15.57 7.83 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 123.039 1.4 . . . . 0.0 108.549 179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.441 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.3 t -55.82 -63.46 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.817 0 CA-C-N 113.954 -1.475 . . . . 0.0 110.321 -179.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.514 HE22 ' NE2' ' A' ' 64' ' ' GLN . 16.8 mt-30 -78.56 -12.59 60.02 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.568 -0.707 . . . . 0.0 111.375 -178.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.676 ' O ' HD12 ' A' ' 171' ' ' LEU . 6.0 ttm -52.6 -44.89 66.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.685 -1.26 . . . . 0.0 109.915 -179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -75.63 -20.35 58.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.05 -1.031 . . . . 0.0 109.759 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.61 -52.78 4.47 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.09 -1.006 . . . . 0.0 110.0 -179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.53 -42.0 63.99 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 0.0 109.693 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 167' ' ' MET . 0.8 OUTLIER -52.73 -31.02 35.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.334 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 25.3 mtm180 -74.41 -35.56 63.44 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.224 -0.923 . . . . 0.0 109.589 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.488 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 76.8 p -56.68 -46.11 81.34 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.205 -0.934 . . . . 0.0 109.781 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.467 ' HG3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -70.21 -44.36 68.79 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.17 -0.956 . . . . 0.0 109.813 -179.763 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.467 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 0.2 OUTLIER -72.16 -15.85 61.97 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.243 -0.91 . . . . 0.0 109.876 -179.622 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 177' ' ' TYR . 0.9 OUTLIER -78.37 -57.75 3.61 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.116 -0.99 . . . . 0.0 109.26 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.499 ' CD1' ' HB3' ' A' ' 136' ' ' TRP . 7.7 t80 -67.21 -37.26 83.33 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.289 -0.882 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.435 ' NE2' ' O ' ' A' ' 187' ' ' GLY . 14.2 tp60 -62.21 -10.96 12.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.33 -37.89 65.97 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.149 -0.969 . . . . 0.0 109.335 179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 48.1 t -87.57 -37.16 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 110.028 -179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.608 ' C ' ' H ' ' A' ' 183' ' ' LYS . 4.2 mm? -67.58 -48.52 66.64 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.089 -1.007 . . . . 0.0 109.733 -179.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 9.0 t -56.04 1.28 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.965 -1.084 . . . . 0.0 109.213 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.608 ' H ' ' C ' ' A' ' 181' ' ' LEU . 21.8 ttpt -78.1 -53.48 7.34 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 0.0 108.971 179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.743 ' CD2' ' CE2' ' A' ' 186' ' ' PHE . 0.0 OUTLIER -75.64 7.2 3.95 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.371 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.467 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.4 OUTLIER 73.29 64.07 0.1 Allowed 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.48 -0.763 . . . . 0.0 109.8 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.743 ' CE2' ' CD2' ' A' ' 184' ' ' HIS . 21.4 m-85 -99.27 174.38 6.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.21 -0.931 . . . . 0.0 108.723 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.435 ' O ' ' NE2' ' A' ' 178' ' ' GLN . . . -77.1 175.6 53.87 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.234 -1.547 . . . . 0.0 109.234 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.599 ' O ' ' OG1' ' A' ' 142' ' ' THR . 26.6 Cg_exo -58.95 -175.74 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.497 2.131 . . . . 0.0 111.617 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 189' ' ' ILE . 1.1 mm -89.41 112.23 24.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.058 -1.027 . . . . 0.0 109.675 -179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.549 ' N ' ' OG1' ' A' ' 142' ' ' THR . 2.3 t -78.33 -3.07 41.2 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.997 -1.064 . . . . 0.0 109.444 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.83 ' CG2' HG23 ' A' ' 159' ' ' VAL . 20.6 m -42.95 114.46 0.61 Allowed 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 122.601 1.191 . . . . 0.0 108.101 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.664 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 4.1 t70 -76.14 116.94 17.32 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.962 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -121.81 100.27 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.339 -0.851 . . . . 0.0 109.297 179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.664 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -154.45 151.74 29.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.517 -0.74 . . . . 0.0 109.026 -179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.755 ' H ' ' CD ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -109.55 -175.7 2.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.71 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.06 34.06 48.17 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 53.1 mm-40 -106.95 118.79 37.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.634 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.451 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 5.4 p -57.04 159.31 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.292 -0.88 . . . . 0.0 109.695 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.54 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 13.5 t80 -113.7 126.6 55.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.329 -0.857 . . . . 0.0 109.306 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.529 ' O ' ' N ' ' A' ' 93' ' ' PHE . 6.9 m-85 -127.86 103.12 7.09 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.17 -0.956 . . . . 0.0 109.316 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -54.32 137.62 41.2 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.373 -0.83 . . . . 0.0 111.191 -179.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.556 ' HB2' ' CE1' ' A' ' 93' ' ' PHE . . . -88.34 179.59 6.31 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.533 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 3.4 pt-20 -74.56 171.75 13.25 Favored 'General case' 0 C--N 1.288 -2.092 0 O-C-N 121.417 -0.802 . . . . 0.0 109.302 179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.576 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.99 -47.45 85.76 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.036 -1.04 . . . . 0.0 108.478 179.363 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.533 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -50.08 -25.44 3.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.426 -0.796 . . . . 0.0 109.826 179.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.68 ' O ' HG21 ' A' ' 91' ' ' VAL . 14.5 m-70 -92.67 8.28 39.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.98 . . . . 0.0 109.839 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.825 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.3 mm-40 -127.91 -136.77 0.24 Allowed 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.834 1.302 . . . . 0.0 110.177 -178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.613 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 1.4 mp0 -35.01 -4.64 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.402 0 CA-C-N 113.288 -1.778 . . . . 0.0 112.196 -179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.825 ' N ' ' O ' ' A' ' 207' ' ' GLN . 87.6 t80 -41.96 -48.72 4.57 Favored 'General case' 0 N--CA 1.519 3.009 0 O-C-N 120.616 -1.302 . . . . 0.0 110.537 -179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 1.0 HD11 ' O ' ' A' ' 74' ' ' TRP . 2.9 mt -50.23 -12.53 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.487 -1.383 . . . . 0.0 109.512 -178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.486 ' N ' ' O ' ' A' ' 209' ' ' TYR . 32.4 t -67.32 -40.36 85.96 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.219 -0.926 . . . . 0.0 108.921 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 44.9 mttm -79.69 -39.7 30.7 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 121.27 -0.894 . . . . 0.0 109.196 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 42.3 m-80 -119.47 120.37 30.86 Favored Pre-proline 0 N--CA 1.49 1.554 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.443 ' C ' ' H ' ' A' ' 216' ' ' GLY . 58.3 Cg_endo -72.68 -50.48 0.22 Allowed 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.074 1.849 . . . . 0.0 112.672 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 217' ' ' TYR . 5.7 p-10 -62.81 -3.52 1.61 Allowed 'General case' 0 C--N 1.294 -1.818 0 C-N-CA 118.613 -1.235 . . . . 0.0 108.048 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.499 ' CA ' HD23 ' A' ' 210' ' ' LEU . . . 61.31 -66.68 0.01 OUTLIER Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.628 ' N ' ' O ' ' A' ' 215' ' ' ASP . 38.2 p90 -177.98 -150.47 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.495 -1.003 . . . . 0.0 108.325 -179.373 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.506 ' N ' ' CD2' ' A' ' 217' ' ' TYR . 10.2 t -73.71 -124.4 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.039 -1.038 . . . . 0.0 108.676 179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.712 ' C ' HD12 ' A' ' 220' ' ' LEU . . . 74.53 -164.8 54.7 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.712 HD12 ' C ' ' A' ' 219' ' ' GLY . 5.2 mp -151.33 -175.17 5.07 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.23 -1.159 . . . . 0.0 109.616 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -73.61 -110.78 0.07 OUTLIER Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.687 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -135.81 -141.11 4.28 Favored Glycine 0 N--CA 1.502 3.039 0 C-N-CA 119.562 -1.304 . . . . 0.0 109.893 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.695 ' N ' ' O ' ' A' ' 139' ' ' HIS . 50.5 p -38.2 -20.64 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.329 -1.101 . . . . 0.0 109.177 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.687 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . 55.64 7.55 1.56 Allowed Glycine 0 N--CA 1.477 1.429 0 N-CA-C 107.221 -2.351 . . . . 0.0 107.221 -179.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.616 ' H ' ' C ' ' A' ' 223' ' ' THR . 0.5 OUTLIER -49.51 158.92 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.696 0 CA-C-O 121.325 0.583 . . . . 0.0 110.138 179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.32 108.75 21.36 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-O 122.094 0.95 . . . . 0.0 109.047 179.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.533 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -73.74 -57.46 2.52 Favored Pre-proline 0 C--N 1.279 -2.476 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.282 179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.533 ' HD3' ' SG ' ' A' ' 227' ' ' CYS . 41.5 Cg_endo -94.49 -33.27 0.05 OUTLIER 'Trans proline' 0 C--N 1.314 -1.28 0 C-N-CA 122.881 2.388 . . . . 0.0 110.081 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.545 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.2 OUTLIER -55.66 154.57 6.61 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.852 0.834 . . . . 0.0 110.097 179.72 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.545 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.48 148.99 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.352 0.596 . . . . 0.0 109.862 -179.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.441 HG22 ' O ' ' A' ' 231' ' ' ILE . 1.4 mm -131.12 108.84 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.175 -0.953 . . . . 0.0 109.273 179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 5.2 ttmm -68.51 150.02 48.56 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.323 -0.86 . . . . 0.0 109.584 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.354 0 O-C-N 121.342 -0.849 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.456 H112 HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.466 ' N ' ' H52' ' A' ' 21' ' ' MYR . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.621 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 0.0 OUTLIER -111.46 41.35 1.9 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.294 -1.121 . . . . 0.0 109.716 -179.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.88 -18.45 0.76 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 109.095 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.564 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -49.37 -92.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 123.221 1.486 . . . . 0.0 110.832 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.579 ' OG ' HG21 ' A' ' 153' ' ' THR . 28.0 t -45.14 -11.1 0.01 OUTLIER 'General case' 0 C--N 1.255 -3.506 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.582 -177.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.678 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -90.14 24.73 2.39 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 124.591 2.138 . . . . 0.0 107.803 179.613 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.733 ' O ' ' O ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -158.41 21.01 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.256 -3.462 0 CA-C-N 112.902 -1.953 . . . . 0.0 106.397 -178.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.733 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.29 174.65 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.188 0 CA-C-O 123.359 1.552 . . . . 0.0 109.65 -178.536 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.409 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -71.8 124.7 25.39 Favored 'General case' 0 C--N 1.27 -2.868 0 CA-C-N 114.293 -1.321 . . . . 0.0 110.112 179.745 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -60.76 -38.9 86.8 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-O 121.24 0.543 . . . . 0.0 109.553 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.565 ' O ' ' OE2' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -70.14 0.67 5.78 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.667 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 1.1 tt0 -99.41 -48.47 4.78 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.263 -0.898 . . . . 0.0 108.964 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -30.68 152.23 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 CA-C-O 121.547 0.689 . . . . 0.0 109.988 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.652 ' O ' ' CG2' ' A' ' 98' ' ' THR . 4.2 mm? -79.32 169.64 19.54 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.597 ' C ' ' H ' ' A' ' 38' ' ' ARG . 34.5 Cg_exo -59.33 -42.15 52.05 Favored 'Trans proline' 0 N--CA 1.496 1.637 0 C-N-CA 122.093 1.862 . . . . 0.0 111.974 -179.222 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 100' ' ' ASN . . . 60.56 -16.89 0.04 OUTLIER Glycine 0 N--CA 1.494 2.533 0 C-N-CA 120.089 -1.053 . . . . 0.0 111.028 179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.629 ' C ' ' H ' ' A' ' 40' ' ' GLU . 38.8 ttt85 -30.53 154.83 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.431 0 O-C-N 121.188 -1.184 . . . . 0.0 110.144 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.474 HG23 ' ND2' ' A' ' 100' ' ' ASN . 0.3 OUTLIER -58.88 25.72 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.334 -0.854 . . . . 0.0 110.847 -179.299 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.629 ' H ' ' C ' ' A' ' 38' ' ' ARG . 2.1 mm-40 -44.34 -52.34 17.11 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.87 -1.144 . . . . 0.0 109.352 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.487 ' HD2' ' N ' ' A' ' 40' ' ' GLU . 64.7 Cg_endo -79.68 -178.27 4.44 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.844 2.362 . . . . 0.0 112.53 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.577 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.0 OUTLIER -136.19 166.6 26.8 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.252 -0.905 . . . . 0.0 109.473 -179.845 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.626 ' O ' HG13 ' A' ' 44' ' ' VAL . 82.9 Cg_exo -44.19 -170.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.799 2.333 . . . . 0.0 112.284 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.626 HG13 ' O ' ' A' ' 43' ' ' PRO . 31.2 m -162.23 161.35 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.275 -0.891 . . . . 0.0 110.112 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 44' ' ' VAL . 0.0 OUTLIER 25.55 88.61 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.693 -0.629 . . . . 0.0 111.195 179.866 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.619 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -87.47 -45.42 10.52 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 121.099 -1.0 . . . . 0.0 110.871 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.561 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -84.5 98.99 10.42 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 115.737 -2.385 . . . . 0.0 108.155 179.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.677 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.9 t-80 -32.73 115.89 0.2 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -59.96 -40.88 90.55 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 0.0 110.501 -179.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.663 HG22 ' OG ' ' A' ' 211' ' ' SER . 48.5 t -56.67 -49.69 77.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.016 -1.052 . . . . 0.0 109.867 -179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 42.0 t -99.59 -46.1 5.57 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.935 . . . . 0.0 110.148 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 99.86 4.06 55.77 Favored Glycine 0 N--CA 1.484 1.863 0 N-CA-C 108.989 -1.644 . . . . 0.0 108.989 -179.497 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.679 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.89 -118.7 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 106.249 -1.76 . . . . 0.0 106.249 178.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.679 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 1.7 ttt180 -125.36 171.56 10.33 Favored 'General case' 0 C--N 1.296 -1.746 0 CA-C-O 123.097 1.427 . . . . 0.0 108.689 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.619 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 4.3 p -131.22 12.06 5.05 Favored 'General case' 0 C--N 1.263 -3.188 0 CA-C-N 113.974 -1.467 . . . . 0.0 109.163 178.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.763 HG12 ' CZ ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -144.78 131.03 15.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 C-N-CA 119.35 -0.94 . . . . 0.0 110.057 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.503 ' C ' ' O ' ' A' ' 56' ' ' VAL . 17.4 mt-10 -34.63 156.51 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.531 0 CA-C-O 121.979 0.895 . . . . 0.0 110.818 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -81.44 165.36 74.9 Favored 'Cis proline' 0 C--N 1.3 -1.981 0 C-N-CA 121.466 -2.306 . . . . 0.0 111.992 -0.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CZ ' HG21 ' A' ' 120' ' ' VAL . 28.6 m-85 -112.42 149.61 41.33 Favored Pre-proline 0 C--N 1.267 -3.004 0 CA-C-N 114.128 -1.396 . . . . 0.0 108.765 179.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.427 ' O ' ' C ' ' A' ' 61' ' ' GLU . 10.0 Cg_endo -54.47 140.27 74.46 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 C-N-CA 122.732 2.288 . . . . 0.0 112.195 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 60' ' ' PRO . 4.4 mt-10 -43.47 157.98 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.252 -0.905 . . . . 0.0 109.359 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.23 47.77 42.58 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.538 ' C ' ' OE1' ' A' ' 64' ' ' GLN . 0.9 OUTLIER -133.32 135.63 44.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.308 -1.113 . . . . 0.0 109.736 -179.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.538 ' OE1' ' C ' ' A' ' 63' ' ' THR . 3.8 mp0 -123.63 145.82 48.65 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.46 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 3.2 ttp -139.57 145.42 38.58 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.047 -1.033 . . . . 0.0 109.793 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -124.61 -170.61 2.18 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 160' ' ' TYR . 22.9 t -144.17 107.5 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 119.967 -1.708 . . . . 0.0 110.127 179.745 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 1.085 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -162.63 162.8 27.24 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.976 -1.077 . . . . 0.0 108.763 178.374 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -133.21 148.15 19.24 Favored Glycine 0 N--CA 1.487 2.06 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.287 -179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.701 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 0.8 OUTLIER -85.73 -84.55 0.16 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.445 -1.032 . . . . 0.0 108.358 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.715 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -160.94 75.85 0.19 Allowed Glycine 0 N--CA 1.496 2.673 0 N-CA-C 108.841 -1.704 . . . . 0.0 108.841 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.715 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 48.3 t 111.13 113.22 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.499 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -52.58 5.96 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.936 0 O-C-N 120.574 -1.329 . . . . 0.0 110.797 -179.185 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.648 ' H ' ' C ' ' A' ' 72' ' ' CYS . 32.6 m0 -89.14 -90.96 0.13 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.698 -1.251 . . . . 0.0 109.799 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA2' HD13 ' A' ' 210' ' ' LEU . . . -57.18 -6.09 1.85 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.547 ' HB1' ' HG3' ' A' ' 70' ' ' MET . . . -76.48 -70.09 0.47 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.279 -1.13 . . . . 0.0 110.953 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.592 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 13.8 tp10 -51.03 -14.71 0.24 Allowed 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.436 -0.79 . . . . 0.0 111.721 -178.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.682 ' O ' ' N ' ' A' ' 80' ' ' PHE . 0.3 OUTLIER -64.0 -81.41 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.168 . . . . 0.0 110.341 -179.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.529 ' C ' ' O ' ' A' ' 78' ' ' ARG . 3.9 mmtt -30.62 -28.92 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.456 -0.777 . . . . 0.0 111.349 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.682 ' N ' ' O ' ' A' ' 78' ' ' ARG . 97.3 m-85 -76.25 -42.16 46.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.801 -1.187 . . . . 0.0 111.734 -178.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.538 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -85.56 2.29 45.53 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.486 -1.383 . . . . 0.0 110.719 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.658 ' O ' HG23 ' A' ' 82' ' ' VAL . 0.9 OUTLIER -97.4 22.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.978 -1.076 . . . . 0.0 109.526 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.503 HD12 ' OH ' ' A' ' 121' ' ' TYR . 34.4 mt -115.16 158.46 22.2 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.42 -0.8 . . . . 0.0 108.993 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -92.91 142.94 26.76 Favored 'General case' 0 C--N 1.293 -1.872 0 CA-C-O 121.364 0.602 . . . . 0.0 110.005 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.488 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 101.75 -26.91 22.75 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.36 -1.896 . . . . 0.0 108.36 -179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.547 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -68.74 136.55 26.16 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.628 -0.925 . . . . 0.0 109.573 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.602 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.61 -44.33 17.37 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.532 ' HB3' HD21 ' A' ' 53' ' ' ASN . 1.1 p -170.8 -169.58 0.79 Allowed 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.488 ' CG2' ' O ' ' A' ' 88' ' ' SER . 75.2 p -158.55 165.48 34.42 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.301 -0.875 . . . . 0.0 109.317 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.592 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -167.51 169.78 11.8 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.363 -0.836 . . . . 0.0 109.021 179.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.438 ' CG2' ' CD ' ' A' ' 207' ' ' GLN . 4.1 m -129.18 -173.9 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.253 -0.904 . . . . 0.0 109.168 -179.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.494 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 170.47 160.7 19.53 Favored Glycine 0 N--CA 1.487 2.055 0 C-N-CA 119.231 -1.461 . . . . 0.0 109.943 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.502 ' CZ ' ' HB1' ' A' ' 202' ' ' ALA . 7.7 m-85 -97.51 154.21 17.65 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.575 -0.956 . . . . 0.0 109.518 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.42 ' HA ' ' CE1' ' A' ' 113' ' ' HIS . . . -178.6 179.28 0.75 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.254 -0.904 . . . . 0.0 109.462 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 66.25 38.35 93.7 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.5 ' HA3' ' ND1' ' A' ' 113' ' ' HIS . . . -136.6 -151.31 6.01 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -126.0 61.28 1.27 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.427 -1.043 . . . . 0.0 109.344 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.652 ' CG2' ' O ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -157.47 176.89 12.06 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.11 -0.994 . . . . 0.0 108.731 -179.833 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CE1' ' A' ' 200' ' ' TYR . 99.5 mtt180 -100.83 -77.49 0.54 Allowed 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' A' ' 37' ' ' GLY . 39.3 m-80 -117.28 70.77 6.04 Favored Pre-proline 0 C--N 1.301 -1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.377 179.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.487 ' HG3' ' NE2' ' A' ' 113' ' ' HIS . 44.0 Cg_endo -71.87 170.53 18.58 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.746 2.297 . . . . 0.0 112.057 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.638 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 20.4 p -121.06 171.36 8.72 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 119.313 -0.955 . . . . 0.0 110.052 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.562 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.4 OUTLIER -63.52 -59.33 4.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.249 -0.907 . . . . 0.0 110.14 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.56 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -58.42 -23.0 56.19 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.054 -1.029 . . . . 0.0 108.392 179.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.638 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.0 mm-40 -73.02 -56.45 5.11 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.397 0.618 . . . . 0.0 110.585 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.763 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.3 m -65.47 -24.67 35.22 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 O-C-N 121.288 -0.883 . . . . 0.0 111.421 -178.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.56 ' SG ' ' O ' ' A' ' 104' ' ' LYS . 12.5 p -55.61 -23.44 27.53 Favored 'General case' 0 C--N 1.294 -1.808 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.609 ' C ' ' H ' ' A' ' 110' ' ' LYS . 21.4 t -69.62 5.38 1.45 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.35 -0.844 . . . . 0.0 109.227 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.4 ' H ' ' C ' ' A' ' 107' ' ' CYS . 1.9 tt0 59.61 -6.14 0.07 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.272 -0.893 . . . . 0.0 109.483 179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.609 ' H ' ' C ' ' A' ' 108' ' ' SER . 18.0 mttt -72.52 -29.37 63.53 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.361 -0.837 . . . . 0.0 110.713 -179.135 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.763 ' OG1' HG12 ' A' ' 106' ' ' VAL . 68.7 p -87.47 -6.59 58.33 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.878 -1.139 . . . . 0.0 110.541 -179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 35.31 43.84 0.53 Allowed Glycine 0 N--CA 1.491 2.362 0 C-N-CA 119.959 -1.115 . . . . 0.0 110.439 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.5 ' ND1' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -78.1 163.17 26.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.831 -1.393 . . . . 0.0 109.999 179.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.444 ' HB3' ' OH ' ' A' ' 160' ' ' TYR . . . -113.49 113.41 25.11 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.263 -0.898 . . . . 0.0 108.972 179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.658 ' N ' ' CD ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -50.12 127.02 15.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.311 -0.868 . . . . 0.0 109.67 -179.941 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.667 HG11 ' CE2' ' A' ' 160' ' ' TYR . 2.6 m -151.1 165.8 2.24 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.085 HG22 ' O ' ' A' ' 68' ' ' PHE . 2.5 m -143.96 149.4 17.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.154 -1.019 . . . . 0.0 110.195 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.766 ' CD ' ' CZ ' ' A' ' 199' ' ' PHE . 10.1 ptm180 -116.84 95.05 4.84 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.572 HG11 ' CG ' ' A' ' 80' ' ' PHE . 13.6 m -97.06 126.04 49.94 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 C-N-CA 119.292 -0.963 . . . . 0.0 108.927 -179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.547 ' O ' HG22 ' A' ' 86' ' ' VAL . 3.9 t -80.63 140.74 16.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.616 ' CG ' HD22 ' A' ' 131' ' ' LEU . 4.5 m-85 -132.05 161.0 34.27 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.079 -1.013 . . . . 0.0 109.224 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.638 ' O ' ' CG ' ' A' ' 122' ' ' ARG . 0.0 OUTLIER -125.07 109.72 27.32 Favored Pre-proline 0 C--N 1.303 -1.439 0 O-C-N 121.506 -0.746 . . . . 0.0 110.384 -179.195 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.529 ' O ' ' C ' ' A' ' 124' ' ' GLU . 24.1 Cg_exo -44.43 -61.44 0.58 Allowed 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 123.401 2.734 . . . . 0.0 114.493 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.529 ' C ' ' O ' ' A' ' 123' ' ' PRO . 38.6 tt0 -25.98 -57.32 0.07 Allowed 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.402 -178.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -113.6 22.68 13.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.157 -0.964 . . . . 0.0 109.733 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -157.87 162.94 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 O-C-N 121.382 -0.824 . . . . 0.0 108.962 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.598 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -125.94 165.61 18.43 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 120.44 -1.412 . . . . 0.0 110.942 -179.096 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.567 ' CZ ' ' CD2' ' A' ' 132' ' ' LEU . 38.6 t80 -70.61 -43.8 68.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.204 -0.935 . . . . 0.0 108.988 179.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 129' ' ' GLU . 5.0 mp0 -48.02 -14.6 0.05 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 120.891 -1.131 . . . . 0.0 108.086 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.598 ' HG2' ' H ' ' A' ' 127' ' ' SER . 0.0 OUTLIER -73.67 -69.98 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.677 -0.639 . . . . 0.0 109.798 -179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.984 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -40.98 -38.7 1.02 Allowed 'General case' 0 N--CA 1.482 1.164 0 O-C-N 120.606 -1.308 . . . . 0.0 108.296 179.398 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.567 ' CD2' ' CZ ' ' A' ' 128' ' ' PHE . 4.2 mm? -75.42 -35.13 61.04 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.525 -0.734 . . . . 0.0 110.972 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.439 ' N ' ' O ' ' A' ' 130' ' ' GLU . 0.5 OUTLIER -70.28 -57.68 4.61 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.964 -1.085 . . . . 0.0 111.256 -178.41 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.682 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.6 OUTLIER -50.42 -35.49 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.081 -1.012 . . . . 0.0 109.767 -178.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.786 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 50.7 t80 -62.58 -42.63 99.67 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 121.526 -0.734 . . . . 0.0 110.485 -179.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.817 ' O ' HG21 ' A' ' 223' ' ' THR . 90.5 m95 -72.8 -33.19 66.08 Favored 'General case' 0 N--CA 1.507 2.403 0 O-C-N 120.866 -1.146 . . . . 0.0 111.358 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 10.8 tt0 -79.43 -21.52 45.43 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.682 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.2 m-80 -121.28 53.69 1.15 Allowed 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.102 -1.624 . . . . 0.0 113.443 -176.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.864 ' O ' HG23 ' A' ' 223' ' ' THR . 0.2 OUTLIER 172.51 -175.39 0.05 Allowed 'General case' 0 N--CA 1.504 2.268 0 CA-C-O 122.186 0.993 . . . . 0.0 110.13 176.564 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 142' ' ' THR . 3.5 t70 -128.3 134.98 26.85 Favored Pre-proline 0 C--N 1.291 -1.959 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.429 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.555 ' O ' ' N ' ' A' ' 190' ' ' THR . 72.0 Cg_endo -80.31 -11.15 13.36 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.353 2.035 . . . . 0.0 112.854 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.828 HG22 HG22 ' A' ' 189' ' ' ILE . 1.9 p -104.04 50.23 0.8 Allowed 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.132 -0.98 . . . . 0.0 109.362 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.696 ' N ' ' OG1' ' A' ' 190' ' ' THR . 5.6 mm100 -114.64 83.63 1.92 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.215 -0.928 . . . . 0.0 109.913 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.621 ' CA ' HG21 ' A' ' 190' ' ' THR . . . -38.55 -117.53 0.0 OUTLIER Glycine 0 N--CA 1.495 2.597 0 CA-C-O 121.922 0.734 . . . . 0.0 112.499 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.671 ' O ' ' CA ' ' A' ' 152' ' ' GLY . 11.0 ptt? -92.87 53.5 2.02 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.466 -1.02 . . . . 0.0 109.507 -177.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' C ' ' O ' ' A' ' 155' ' ' TYR . 28.4 ptt-85 -178.56 154.71 0.79 Allowed 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 179.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.701 ' NE2' ' O ' ' A' ' 70' ' ' MET . 6.4 mt-30 -157.18 149.17 22.63 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.344 -1.473 . . . . 0.0 110.718 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 41.52 -124.62 3.21 Favored Glycine 0 C--N 1.302 -1.358 0 CA-C-O 122.986 1.326 . . . . 0.0 110.66 178.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -81.54 -35.32 30.43 Favored 'General case' 0 C--N 1.28 -2.424 0 CA-C-N 114.046 -1.077 . . . . 0.0 112.049 -178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.654 ' OD2' ' SG ' ' A' ' 72' ' ' CYS . 0.0 OUTLIER -87.19 152.2 22.52 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 120.316 -1.49 . . . . 0.0 107.92 179.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.498 ' CB ' ' HB2' ' A' ' 146' ' ' ARG . 8.9 p90 -136.58 154.49 50.67 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 118.319 -1.352 . . . . 0.0 111.47 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.671 ' CA ' ' O ' ' A' ' 145' ' ' MET . . . 126.6 178.64 15.4 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 118.48 -1.819 . . . . 0.0 111.642 178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.579 HG21 ' OG ' ' A' ' 26' ' ' SER . 0.2 OUTLIER -66.76 0.86 2.1 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.638 -0.919 . . . . 0.0 110.584 -179.319 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.692 ' O ' ' CD1' ' A' ' 155' ' ' TYR . 14.8 pm0 -112.38 16.5 19.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.75 -1.219 . . . . 0.0 109.635 -179.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.692 ' CD1' ' O ' ' A' ' 154' ' ' GLN . 28.2 m-85 -146.69 59.57 1.2 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.742 ' HD2' ' HB2' ' A' ' 158' ' ' ALA . 0.0 OUTLIER -114.81 177.05 4.79 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 190' ' ' THR . 1.0 OUTLIER -90.44 124.36 34.9 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 119.867 -1.77 . . . . 0.0 106.455 179.542 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.742 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -142.68 111.48 6.35 Favored 'General case' 0 C--N 1.289 -2.026 0 C-N-CA 118.359 -1.336 . . . . 0.0 110.084 -178.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.581 ' O ' HG23 ' A' ' 159' ' ' VAL . 1.3 m -113.41 123.98 69.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 118.696 -1.202 . . . . 0.0 110.253 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.667 ' CE2' HG11 ' A' ' 116' ' ' VAL . 2.4 m-30 -112.7 126.16 28.76 Favored Pre-proline 0 N--CA 1.492 1.671 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -70.75 170.67 17.2 Favored 'Trans proline' 0 N--CA 1.493 1.496 0 C-N-CA 122.146 1.898 . . . . 0.0 112.228 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.541 ' HB ' HE22 ' A' ' 166' ' ' GLN . 0.7 OUTLIER -102.9 -22.19 13.88 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 120.923 -1.111 . . . . 0.0 110.22 -179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.656 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -176.92 174.59 1.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.842 -1.161 . . . . 0.0 108.972 179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' ' SD ' ' A' ' 167' ' ' MET . . . -45.49 -15.85 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 CA-C-O 123.081 1.42 . . . . 0.0 108.181 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.656 ' N ' ' O ' ' A' ' 163' ' ' SER . 4.9 t -58.06 -62.27 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.78 0 CA-C-N 113.849 -1.523 . . . . 0.0 109.836 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.541 HE22 ' HB ' ' A' ' 162' ' ' THR . 4.6 mp0 -76.68 -12.9 60.07 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.492 -0.755 . . . . 0.0 110.123 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.488 ' SD ' ' HA ' ' A' ' 164' ' ' ALA . 32.3 mtt -53.99 -47.97 70.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 109.971 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 6.7 tm-20 -75.27 -18.18 60.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.047 -1.033 . . . . 0.0 110.161 -179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.48 -58.82 2.24 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 0.0 109.866 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.79 -48.55 66.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.173 -0.955 . . . . 0.0 109.852 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -53.06 -42.43 65.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.117 -0.989 . . . . 0.0 109.542 -179.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 11.6 tpp180 -68.3 -45.04 74.1 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.155 -0.966 . . . . 0.0 109.163 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.619 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 8.7 p -56.32 -53.48 56.81 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.297 -0.877 . . . . 0.0 109.848 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.461 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.0 OUTLIER -55.91 -58.2 8.87 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.923 . . . . 0.0 110.027 -179.397 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.461 ' N ' ' HD3' ' A' ' 174' ' ' LYS . 1.0 OUTLIER -60.61 -11.4 7.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.098 -1.001 . . . . 0.0 109.539 -179.699 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 180' ' ' VAL . 1.6 tt0 -75.18 -50.45 16.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.87 . . . . 0.0 110.007 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.511 ' CD2' ' CD2' ' A' ' 181' ' ' LEU . 1.1 m-85 -79.41 -31.16 42.67 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.062 -1.024 . . . . 0.0 109.797 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 188' ' ' PRO . 21.9 tp60 -63.08 -40.79 98.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.819 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -77.82 -26.36 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.175 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 176' ' ' GLU . 98.0 t -87.29 -54.29 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.021 -1.049 . . . . 0.0 110.058 -179.521 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.511 ' CD2' ' CD2' ' A' ' 177' ' ' TYR . 4.4 mm? -59.96 -24.53 64.47 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.22 -0.925 . . . . 0.0 109.827 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 15.4 t -56.22 -35.64 67.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.239 -0.913 . . . . 0.0 109.685 -179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -88.49 9.09 24.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.148 -0.97 . . . . 0.0 109.855 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.462 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 38.5 m-70 -108.41 29.32 7.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.057 -1.027 . . . . 0.0 109.806 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.462 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.92 16.26 5.53 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.119 -0.988 . . . . 0.0 109.704 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -104.53 174.92 5.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.184 -0.948 . . . . 0.0 109.172 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -125.62 -149.02 7.36 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.407 ' HA ' ' OE1' ' A' ' 178' ' ' GLN . 27.6 Cg_exo -58.75 106.64 0.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.379 2.053 . . . . 0.0 110.709 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.828 HG22 HG22 ' A' ' 142' ' ' THR . 0.3 OUTLIER -48.08 170.27 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.182 -0.949 . . . . 0.0 110.409 -178.817 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.696 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 79.4 p -119.95 47.38 1.75 Allowed 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 121.396 0.617 . . . . 0.0 109.746 179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 54.2 m -97.94 118.67 35.05 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 105.821 -1.918 . . . . 0.0 105.821 178.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 1.4 t70 -76.08 140.76 42.02 Favored 'General case' 0 C--N 1.279 -2.469 0 C-N-CA 119.32 -0.952 . . . . 0.0 110.42 -177.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -135.56 93.42 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 C-N-CA 119.571 -0.852 . . . . 0.0 108.977 178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -157.15 153.18 27.3 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -179.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.642 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -119.67 -173.41 2.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.102 -0.999 . . . . 0.0 109.811 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 73.02 20.76 80.1 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.987 -1.245 . . . . 0.0 109.987 179.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.527 ' O ' ' C ' ' A' ' 198' ' ' VAL . 61.1 mm-40 -91.63 101.81 14.44 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.036 -1.273 . . . . 0.0 109.531 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.611 HG21 ' CZ ' ' A' ' 200' ' ' TYR . 3.0 p -35.95 153.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.202 -0.937 . . . . 0.0 109.274 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.766 ' CZ ' ' CD ' ' A' ' 118' ' ' ARG . 68.9 t80 -111.13 131.25 55.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.169 -0.957 . . . . 0.0 110.273 -179.27 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CE1' ' O ' ' A' ' 99' ' ' ARG . 42.1 m-85 -127.26 112.65 15.33 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.492 -0.755 . . . . 0.0 109.419 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.763 ' CZ ' HG12 ' A' ' 56' ' ' VAL . 16.5 m-85 -53.74 142.69 22.77 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.981 -1.075 . . . . 0.0 110.614 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.515 ' O ' HG21 ' A' ' 44' ' ' VAL . . . -90.77 178.18 6.12 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.575 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 3.0 mt-10 -73.67 161.13 30.62 Favored 'General case' 0 N--CA 1.509 2.488 0 CA-C-O 122.557 1.17 . . . . 0.0 110.364 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.36 -49.72 73.57 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.531 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.575 ' OH ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -59.47 -3.75 0.5 Allowed 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.087 -1.008 . . . . 0.0 110.777 -179.55 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.562 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 14.6 m-70 -101.29 -20.91 15.02 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.855 -1.153 . . . . 0.0 109.944 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.823 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.5 OUTLIER -101.2 -134.36 0.3 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.705 1.24 . . . . 0.0 110.504 -178.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.538 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 1.3 mp0 -34.88 -2.93 0.0 OUTLIER 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 113.392 -1.731 . . . . 0.0 112.442 -179.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.823 ' N ' ' O ' ' A' ' 207' ' ' GLN . 75.9 t80 -41.34 -46.38 3.27 Favored 'General case' 0 N--CA 1.513 2.688 0 O-C-N 120.191 -1.568 . . . . 0.0 109.952 -179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.619 ' CD1' ' C ' ' A' ' 74' ' ' TRP . 0.7 OUTLIER -71.34 -13.21 61.8 Favored 'General case' 0 C--N 1.307 -1.24 0 O-C-N 120.573 -1.329 . . . . 0.0 110.441 -178.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.663 ' OG ' HG22 ' A' ' 50' ' ' VAL . 36.9 t -63.38 -38.68 92.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.215 -0.928 . . . . 0.0 108.985 179.196 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -72.78 -38.73 67.18 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.357 -0.84 . . . . 0.0 109.35 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -127.57 77.42 76.02 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.299 -0.876 . . . . 0.0 109.063 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.675 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 12.7 Cg_exo -66.73 5.08 0.84 Allowed 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.99 2.46 . . . . 0.0 112.683 -179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -62.95 -19.99 64.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.937 -1.102 . . . . 0.0 109.976 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 59.11 84.46 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 C-N-CA 120.209 -0.996 . . . . 0.0 111.829 177.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.534 ' O ' ' CD2' ' A' ' 217' ' ' TYR . 78.8 t80 -70.53 83.94 0.6 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 121.108 2.454 . . . . 0.0 109.268 179.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.529 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 43.1 t -168.84 -124.94 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.316 0 O-C-N 120.966 -1.084 . . . . 0.0 108.803 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.529 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 134.69 153.4 6.84 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.478 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 75.62 143.15 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.32 -1.106 . . . . 0.0 110.06 179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -134.27 -144.43 5.07 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.542 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -152.0 -144.3 3.89 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.864 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.3 OUTLIER 41.33 24.34 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.494 -1.004 . . . . 0.0 109.032 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -158.2 37.78 0.52 Allowed Glycine 0 C--N 1.299 -1.486 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.476 ' O ' HG12 ' A' ' 225' ' ' VAL . 11.8 t -103.81 98.63 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.206 -1.173 . . . . 0.0 109.141 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.0 107.43 19.86 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 122.278 1.037 . . . . 0.0 109.433 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.529 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.43 -57.65 2.07 Favored Pre-proline 0 C--N 1.281 -2.398 0 CA-C-N 115.593 -0.731 . . . . 0.0 109.576 179.413 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.529 ' HD3' ' SG ' ' A' ' 227' ' ' CYS . 41.3 Cg_endo -95.2 -29.35 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 122.918 2.412 . . . . 0.0 110.636 179.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.612 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.5 OUTLIER -55.11 157.18 3.53 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-O 121.623 0.725 . . . . 0.0 109.957 -179.897 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.612 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -18.44 136.56 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.551 -179.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.592 ' O ' ' N ' ' A' ' 233' ' ' LYS . 3.0 tp -153.86 121.46 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 121.31 -0.869 . . . . 0.0 109.139 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.555 ' C ' ' O ' ' A' ' 231' ' ' ILE . 4.5 ttmm -33.75 -32.0 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.357 -0.84 . . . . 0.0 109.708 -179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.592 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.338 0 O-C-N 121.293 -0.879 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.502 ' H52' ' H ' ' A' ' 23' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.676 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . 0 N--CA 1.492 2.405 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.658 ' C ' ' NZ ' ' A' ' 27' ' ' LYS . 1.1 t0 -46.5 84.76 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -1.189 . . . . 0.0 109.415 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.704 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -50.68 -33.51 22.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 -179.722 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -49.94 -93.89 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 123.403 1.573 . . . . 0.0 111.116 -179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 10.3 m -47.16 -18.38 0.09 Allowed 'General case' 0 C--N 1.257 -3.445 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.793 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.681 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -102.53 22.7 13.09 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-O 124.412 2.053 . . . . 0.0 109.86 -178.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.771 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -168.16 28.91 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.252 -3.665 0 N-CA-C 105.028 -2.212 . . . . 0.0 105.028 -178.788 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.721 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -37.14 175.73 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 CA-C-O 123.068 1.413 . . . . 0.0 110.029 -177.812 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.448 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -94.9 123.86 38.61 Favored 'General case' 0 C--N 1.275 -2.644 0 CA-C-N 114.807 -1.088 . . . . 0.0 109.344 179.49 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' C ' ' H ' ' A' ' 33' ' ' GLU . . . -56.74 -57.87 10.57 Favored 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.799 -0.563 . . . . 0.0 110.156 -179.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.522 ' OE1' ' O ' ' A' ' 32' ' ' GLU . 1.5 pp20? -53.05 -6.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.176 -0.952 . . . . 0.0 109.915 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 5.0 tt0 -112.46 -35.99 5.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.274 -0.891 . . . . 0.0 109.686 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.813 ' HB3' ' NE2' ' A' ' 97' ' ' HIS . . . -44.88 -179.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.285 -0.884 . . . . 0.0 109.552 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.451 ' CD2' ' HB3' ' A' ' 110' ' ' LYS . 4.2 mm? -55.24 169.54 0.45 Allowed Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -64.29 -49.33 3.67 Favored 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.791 2.327 . . . . 0.0 113.221 -178.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.643 ' H ' ' N ' ' A' ' 99' ' ' ARG . . . 100.34 87.75 1.97 Allowed Glycine 0 N--CA 1.5 2.932 0 C-N-CA 118.928 -1.605 . . . . 0.0 111.191 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.666 ' NH2' ' OE2' ' A' ' 40' ' ' GLU . 0.2 OUTLIER -101.26 -179.27 3.99 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 120.421 -1.635 . . . . 0.0 109.233 178.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.2 p -124.16 32.63 5.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.259 -0.901 . . . . 0.0 109.652 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.666 ' OE2' ' NH2' ' A' ' 38' ' ' ARG . 9.1 tt0 -118.52 75.21 12.27 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.155 -0.966 . . . . 0.0 109.48 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.11 -178.45 4.59 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.87 2.38 . . . . 0.0 112.414 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.567 ' O ' ' O ' ' A' ' 43' ' ' PRO . 1.0 OUTLIER -131.8 103.01 14.64 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.218 -0.926 . . . . 0.0 109.479 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.567 ' O ' ' O ' ' A' ' 42' ' ' ILE . 74.0 Cg_exo -46.27 -166.99 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.616 2.211 . . . . 0.0 112.321 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.646 ' O ' ' N ' ' A' ' 46' ' ' ALA . 16.1 m -150.56 -179.16 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.44 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.768 ' O ' HG23 ' A' ' 45' ' ' THR . 9.6 t -34.19 89.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.326 -0.859 . . . . 0.0 109.773 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.646 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -55.86 -38.75 70.51 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.344 -0.847 . . . . 0.0 111.196 -178.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.578 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttp -91.46 98.7 11.84 Favored 'General case' 0 C--N 1.288 -2.073 0 C-N-CA 116.15 -2.22 . . . . 0.0 108.678 179.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.667 ' O ' ' N ' ' A' ' 52' ' ' GLY . 5.7 t-80 -31.73 110.95 0.08 Allowed 'General case' 0 N--CA 1.499 2.005 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -59.82 -30.79 69.17 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.354 -0.841 . . . . 0.0 110.807 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 3.4 t -64.6 -43.4 96.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.934 -1.104 . . . . 0.0 109.524 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -108.86 -44.49 4.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 0.0 109.941 -179.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.667 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 104.1 1.73 45.03 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.668 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 22.5 p30 -76.15 -112.05 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.607 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 0.7 OUTLIER -130.68 175.25 9.17 Favored 'General case' 0 C--N 1.296 -1.722 0 CA-C-O 123.806 1.765 . . . . 0.0 110.811 178.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.605 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 6.9 p -149.33 23.35 0.92 Allowed 'General case' 0 C--N 1.269 -2.912 0 CA-C-N 112.425 -2.17 . . . . 0.0 110.088 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.497 HG22 ' C ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -157.27 132.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.844 -1.16 . . . . 0.0 109.86 179.924 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.44 ' C ' ' O ' ' A' ' 56' ' ' VAL . 12.7 mt-10 -41.48 156.03 0.22 Allowed Pre-proline 0 C--N 1.304 -1.397 0 CA-C-O 121.855 0.836 . . . . 0.0 110.199 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_endo -85.24 157.12 62.87 Favored 'Cis proline' 0 C--N 1.302 -1.911 0 C-N-CA 122.345 -1.94 . . . . 0.0 110.494 0.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.769 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 18.7 m-85 -104.15 147.91 35.08 Favored Pre-proline 0 C--N 1.279 -2.496 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 11.7 Cg_endo -57.47 134.21 61.94 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 C-N-CA 122.843 2.362 . . . . 0.0 112.423 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -49.34 158.17 0.42 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.272 -0.893 . . . . 0.0 109.344 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.48 ' O ' ' OE1' ' A' ' 64' ' ' GLN . . . 93.91 -35.88 3.98 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -83.03 134.06 35.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -1.142 . . . . 0.0 109.784 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.57 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 6.2 mp0 -114.98 -175.93 2.79 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.463 ' SD ' ' HB2' ' A' ' 118' ' ' ARG . 2.2 ttp -161.35 149.37 15.42 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 120.642 -1.286 . . . . 0.0 110.826 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -118.71 -174.37 2.67 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.54 HG12 ' CG1' ' A' ' 116' ' ' VAL . 1.4 t -146.23 106.89 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 119.686 -1.884 . . . . 0.0 109.96 179.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.704 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.4 OUTLIER -140.82 156.39 46.15 Favored 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 117.963 -1.495 . . . . 0.0 110.359 177.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.431 ' CA ' ' OE2' ' A' ' 115' ' ' GLU . . . -132.15 154.18 20.89 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 -178.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.738 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -122.81 -91.85 0.55 Allowed 'General case' 0 C--N 1.309 -1.153 0 O-C-N 121.075 -1.25 . . . . 0.0 109.764 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.738 ' H ' ' CG ' ' A' ' 70' ' ' MET . . . -134.84 63.76 0.6 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.767 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 48.5 t 109.13 136.25 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.258 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 -179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.575 ' HB2' HG11 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -81.43 25.9 0.49 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.363 -1.46 . . . . 0.0 110.873 179.904 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.767 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 8.3 m0 -91.6 -72.51 0.58 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.567 -1.333 . . . . 0.0 109.573 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.26 -3.51 65.76 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.737 ' CB ' HG21 ' A' ' 117' ' ' VAL . . . -77.09 -32.89 56.96 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.198 -1.178 . . . . 0.0 109.473 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.629 ' OE2' ' CA ' ' A' ' 90' ' ' GLN . 0.4 OUTLIER -83.69 -15.79 47.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.016 -1.052 . . . . 0.0 110.154 -179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.794 ' O ' HG13 ' A' ' 82' ' ' VAL . 28.0 ttt180 -79.46 -67.6 0.74 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.972 -1.08 . . . . 0.0 110.027 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.452 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 14.2 mttp -54.89 13.3 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.237 -0.914 . . . . 0.0 110.613 -179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.712 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 19.1 m-85 -120.72 -39.7 2.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.879 -1.138 . . . . 0.0 110.135 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.632 ' CZ2' ' OG ' ' A' ' 211' ' ' SER . 0.9 OUTLIER -82.28 -3.98 56.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.764 -1.21 . . . . 0.0 110.03 -179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.794 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.3 m -83.94 17.41 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.034 -1.041 . . . . 0.0 109.334 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 61.9 mt -109.71 154.53 22.75 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 179.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.46 137.26 32.51 Favored 'General case' 0 C--N 1.29 -2.015 0 CA-C-O 121.342 0.591 . . . . 0.0 109.543 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.55 -31.89 5.95 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 108.68 -1.768 . . . . 0.0 108.68 -179.757 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.72 136.26 25.97 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.57 -0.959 . . . . 0.0 109.549 179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.668 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -71.15 -39.91 71.64 Favored 'General case' 0 C--N 1.299 -1.621 0 CA-C-O 121.915 0.864 . . . . 0.0 108.828 179.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.697 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.3 OUTLIER 179.63 -160.57 0.03 OUTLIER 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 179.921 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.608 ' HB ' HG12 ' A' ' 119' ' ' VAL . 63.6 p -157.51 151.16 24.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.033 -1.042 . . . . 0.0 109.801 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.697 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 5.1 mp0 -147.32 167.75 23.52 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.496 -0.753 . . . . 0.0 109.028 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.697 HG21 ' O ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -142.96 168.65 13.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.026 -1.046 . . . . 0.0 109.878 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.414 ' HA2' ' N ' ' A' ' 202' ' ' ALA . . . 177.37 164.07 30.36 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.493 ' CE2' ' HA ' ' A' ' 202' ' ' ALA . 1.9 m-85 -80.11 174.29 11.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.367 -1.078 . . . . 0.0 109.192 179.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.728 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -175.2 177.04 1.96 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.08 -1.012 . . . . 0.0 109.894 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 50.9 22.13 5.79 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 110.244 -1.142 . . . . 0.0 110.244 179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.517 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -134.64 -164.1 10.43 Favored Glycine 0 N--CA 1.495 2.628 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.813 ' NE2' ' HB3' ' A' ' 34' ' ' ALA . 57.3 p-80 -173.75 105.34 0.12 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.398 -1.06 . . . . 0.0 108.904 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.607 ' O ' ' C ' ' A' ' 99' ' ' ARG . 1.6 m -137.72 148.0 45.26 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.643 ' N ' ' H ' ' A' ' 37' ' ' GLY . 19.6 tpt180 -33.21 -68.75 0.1 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.508 ' ND2' ' HG3' ' A' ' 99' ' ' ARG . 50.5 m-80 -124.3 95.88 42.69 Favored Pre-proline 0 C--N 1.296 -1.75 0 N-CA-C 107.459 -1.311 . . . . 0.0 107.459 178.025 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -51.44 106.0 0.12 Allowed 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.481 2.121 . . . . 0.0 113.224 -177.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.653 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 22.0 p -122.08 170.81 9.48 Favored 'General case' 0 N--CA 1.496 1.855 0 C-N-CA 119.456 -0.898 . . . . 0.0 109.94 179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.483 ' HB2' ' CE1' ' A' ' 206' ' ' HIS . 2.1 t80 -63.45 -58.95 5.4 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.239 -0.913 . . . . 0.0 110.217 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.544 ' HB3' ' HZ3' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -61.58 -22.86 65.57 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.113 -0.992 . . . . 0.0 108.816 -179.986 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.653 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.1 mm-40 -66.28 -57.54 7.3 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.459 0.647 . . . . 0.0 110.635 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.447 ' HA ' ' OG1' ' A' ' 111' ' ' THR . 18.7 m -65.45 -24.78 35.47 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.349 -0.844 . . . . 0.0 110.808 -178.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.401 ' O ' ' OE1' ' A' ' 109' ' ' GLU . 24.0 t -64.56 -28.47 69.66 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.656 ' C ' ' H ' ' A' ' 110' ' ' LYS . 2.5 t -70.91 2.09 4.75 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.707 ' O ' HG21 ' A' ' 29' ' ' ILE . 4.8 mp0 58.54 -21.6 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.452 -0.78 . . . . 0.0 110.953 179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.768 ' O ' ' HB1' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -65.75 2.25 1.07 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.868 -1.145 . . . . 0.0 109.528 -179.472 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.522 HG22 ' OG1' ' A' ' 98' ' ' THR . 3.1 p -107.73 -29.41 9.13 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.128 -0.982 . . . . 0.0 109.091 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.597 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 62.13 49.06 78.64 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 120.206 -0.997 . . . . 0.0 110.706 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.728 ' ND1' ' N ' ' A' ' 94' ' ' ALA . 1.5 m-70 -97.24 173.5 7.19 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.783 -1.422 . . . . 0.0 109.784 179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.586 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.37 116.63 18.55 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.533 ' CD ' ' C ' ' A' ' 115' ' ' GLU . 0.4 OUTLIER -62.36 123.79 19.18 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 120.991 -1.068 . . . . 0.0 109.296 -179.451 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.1 OUTLIER -128.09 140.96 47.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.1 -1.0 . . . . 0.0 109.308 179.762 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.737 HG21 ' CB ' ' A' ' 76' ' ' ALA . 2.0 t -103.78 107.32 22.0 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 107.0 -1.481 . . . . 0.0 107.0 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.769 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.1 OUTLIER -96.58 96.98 9.03 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 122.637 1.208 . . . . 0.0 110.386 -177.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.608 HG12 ' HB ' ' A' ' 89' ' ' THR . 20.4 m -112.12 128.03 68.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 O-C-N 120.903 -1.123 . . . . 0.0 108.675 179.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.447 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -80.29 169.09 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.879 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.967 ' CD2' HD21 ' A' ' 131' ' ' LEU . 0.4 OUTLIER -156.56 156.27 33.34 Favored 'General case' 0 C--N 1.294 -1.822 0 C-N-CA 117.806 -1.558 . . . . 0.0 111.599 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -120.67 110.62 35.2 Favored Pre-proline 0 C--N 1.291 -1.958 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.937 -178.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.541 ' O ' ' C ' ' A' ' 124' ' ' GLU . 39.3 Cg_exo -45.32 -63.76 0.31 Allowed 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 123.068 2.512 . . . . 0.0 113.23 178.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.541 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.2 tp10 -25.69 -43.7 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.434 -178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.52 ' N ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -127.82 3.76 6.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.707 -1.246 . . . . 0.0 109.898 -178.681 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 126' ' ' ILE . 0.1 OUTLIER -155.15 104.12 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 CA-C-O 122.05 0.929 . . . . 0.0 108.964 179.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 3.3 m -69.81 169.64 12.64 Favored 'General case' 0 N--CA 1.499 1.986 0 CA-C-O 121.774 0.797 . . . . 0.0 111.871 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.702 ' CZ ' HD11 ' A' ' 132' ' ' LEU . 36.9 t80 -69.39 -27.92 65.72 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.672 -0.642 . . . . 0.0 109.43 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.613 ' O ' ' N ' ' A' ' 133' ' ' LYS . 2.5 mt-10 -62.69 -19.77 64.2 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.377 -0.929 . . . . 0.0 108.517 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.59 ' CG ' HD13 ' A' ' 126' ' ' ILE . 3.2 mm-40 -66.63 -72.24 0.17 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 0.0 110.042 -179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.009 HD22 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -42.05 -40.05 2.13 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 179.146 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.702 HD11 ' CZ ' ' A' ' 128' ' ' PHE . 8.3 mp -75.68 -34.89 60.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.467 -0.77 . . . . 0.0 111.611 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.613 ' N ' ' O ' ' A' ' 129' ' ' GLU . 0.0 OUTLIER -58.54 -68.91 0.21 Allowed 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.504 -1.372 . . . . 0.0 110.085 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.627 HG13 ' ND2' ' A' ' 138' ' ' ASN . 58.5 t -51.3 -22.19 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.253 -0.904 . . . . 0.0 109.208 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.765 ' O ' ' CE1' ' A' ' 139' ' ' HIS . 34.7 t80 -73.41 -52.18 14.65 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.106 -0.996 . . . . 0.0 111.147 -179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 58.8 m95 -70.22 -38.72 75.32 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.069 -1.644 . . . . 0.0 111.569 -178.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.48 -43.46 73.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.831 -1.168 . . . . 0.0 111.641 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.627 ' ND2' HG13 ' A' ' 134' ' ' VAL . 67.8 m-80 -81.56 59.27 4.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.084 -1.01 . . . . 0.0 112.296 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.765 ' CE1' ' O ' ' A' ' 135' ' ' PHE . 46.8 m80 -153.76 -166.59 2.43 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-O 122.003 0.906 . . . . 0.0 109.293 176.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.615 ' OD1' ' N ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -132.87 171.61 8.86 Favored Pre-proline 0 C--N 1.297 -1.686 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.489 ' O ' ' O ' ' A' ' 140' ' ' ASP . 30.8 Cg_exo -33.5 -103.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.3 -1.976 0 C-N-CA 122.039 1.826 . . . . 0.0 113.334 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.943 ' O ' HG23 ' A' ' 142' ' ' THR . 1.5 t -128.45 57.14 1.6 Allowed 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.041 -1.037 . . . . 0.0 111.428 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.737 ' N ' ' OE1' ' A' ' 143' ' ' GLN . 0.0 OUTLIER -75.93 84.42 2.85 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.218 -1.551 . . . . 0.0 110.882 -178.938 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.728 ' CA ' HG21 ' A' ' 190' ' ' THR . . . -39.39 -115.85 0.0 OUTLIER Glycine 0 N--CA 1.491 2.345 0 CA-C-O 122.097 0.832 . . . . 0.0 111.723 178.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.739 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -68.27 25.06 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.743 -0.857 . . . . 0.0 111.691 -176.873 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.536 ' NH2' ' OD1' ' A' ' 149' ' ' ASN . 10.6 ttt-85 -159.54 88.17 0.85 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 119.218 -2.176 . . . . 0.0 112.115 179.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.692 ' OE1' ' N ' ' A' ' 71' ' ' GLY . 0.3 OUTLIER -57.66 122.19 12.19 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 119.992 -1.692 . . . . 0.0 108.954 178.635 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.663 ' H ' ' HG3' ' A' ' 143' ' ' GLN . . . 43.14 -114.96 0.93 Allowed Glycine 0 N--CA 1.479 1.518 0 CA-C-O 122.932 1.296 . . . . 0.0 110.197 178.562 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.536 ' OD1' ' NH2' ' A' ' 146' ' ' ARG . 3.0 t-20 -95.98 15.81 19.55 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 114.104 -1.048 . . . . 0.0 111.084 -178.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 146' ' ' ARG . 8.7 m-20 -101.7 93.39 5.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.903 -1.123 . . . . 0.0 108.457 179.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.45 ' HB3' ' HE ' ' A' ' 146' ' ' ARG . 4.8 p90 -75.47 121.83 22.92 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.381 -0.824 . . . . 0.0 110.875 -178.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 167.13 140.34 2.88 Favored Glycine 0 N--CA 1.495 2.575 0 C-N-CA 119.67 -1.252 . . . . 0.0 110.119 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.544 HG21 ' HA ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.84 -4.02 47.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.165 -1.197 . . . . 0.0 108.729 179.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.726 ' CD ' ' H ' ' A' ' 154' ' ' GLN . 0.0 OUTLIER -96.58 -13.2 23.1 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.352 -0.843 . . . . 0.0 110.486 -179.838 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.611 ' O ' ' O ' ' A' ' 70' ' ' MET . 13.2 m-85 -100.16 -4.72 29.03 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.864 -1.148 . . . . 0.0 110.98 -179.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.61 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -42.69 177.58 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.842 -1.161 . . . . 0.0 109.492 179.82 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.1 t -91.55 124.87 36.04 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 105.096 -2.187 . . . . 0.0 105.096 177.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.479 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -145.55 127.82 15.8 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 116.468 -2.093 . . . . 0.0 112.705 -176.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.551 HG23 ' CG2' ' A' ' 191' ' ' THR . 5.2 t -117.9 129.46 74.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.097 178.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.538 ' CE2' HG11 ' A' ' 116' ' ' VAL . 3.3 m-85 -122.27 95.59 47.02 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.336 -0.852 . . . . 0.0 108.814 178.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -46.6 170.97 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.633 2.222 . . . . 0.0 112.044 -179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -95.56 -29.64 14.25 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 120.911 -1.118 . . . . 0.0 109.632 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.425 ' C ' ' N ' ' A' ' 165' ' ' VAL . 2.0 m -179.52 -162.57 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.93 -15.55 9.18 Favored 'General case' 0 N--CA 1.489 1.481 0 CA-C-O 123.021 1.391 . . . . 0.0 108.599 179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.431 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.7 t -55.77 -64.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.883 0 CA-C-N 113.98 -1.464 . . . . 0.0 109.759 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 16.4 mt-30 -78.86 -19.13 52.72 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.592 -0.693 . . . . 0.0 110.815 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.9 ttp -52.44 -36.19 53.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.705 -1.247 . . . . 0.0 110.394 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -75.58 -32.55 60.41 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.795 -1.19 . . . . 0.0 110.084 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.58 -43.28 9.21 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.077 -1.014 . . . . 0.0 110.134 -179.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.45 -51.79 57.41 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.521 -179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.697 HD12 ' C ' ' A' ' 171' ' ' LEU . 1.3 pp -52.85 -33.52 50.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.011 . . . . 0.0 109.004 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.507 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -74.6 -55.54 5.79 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.82 -39.02 73.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.373 179.866 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.452 ' HD3' ' N ' ' A' ' 175' ' ' GLU . 0.4 OUTLIER -65.07 -58.36 6.26 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 110.095 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.462 ' OE1' ' O ' ' A' ' 175' ' ' GLU . 0.9 OUTLIER -70.58 -24.19 62.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.206 -0.933 . . . . 0.0 109.908 -179.476 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.507 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 5.8 mm-40 -53.26 -30.87 40.73 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.244 -0.91 . . . . 0.0 109.931 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.591 ' CD1' ' CD1' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -79.47 -45.36 19.52 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.907 -1.121 . . . . 0.0 109.402 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.72 HE22 ' C ' ' A' ' 187' ' ' GLY . 1.2 tp60 -54.26 -30.83 51.94 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.206 -0.934 . . . . 0.0 109.451 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 7.2 tttp -61.83 -44.27 97.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 110.319 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.507 HG13 ' N ' ' A' ' 181' ' ' LEU . 9.2 p -87.31 -42.2 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.984 -1.073 . . . . 0.0 110.387 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.591 ' CD1' ' CD1' ' A' ' 177' ' ' TYR . 31.8 mt -65.24 -39.4 92.66 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.034 -1.041 . . . . 0.0 110.111 -179.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.553 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 21.6 p -56.07 -26.56 49.94 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.987 -1.071 . . . . 0.0 109.401 -179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 54.0 tttt -88.3 -9.66 52.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.231 -0.918 . . . . 0.0 109.737 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 49.8 m-70 -108.33 34.93 3.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.12 -0.987 . . . . 0.0 109.873 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 63.36 68.65 0.6 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.202 -0.937 . . . . 0.0 109.799 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 37.4 m-85 -148.08 174.55 11.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.268 179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.72 ' C ' HE22 ' A' ' 178' ' ' GLN . . . -126.22 -162.24 11.19 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 179.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.408 ' O ' ' C ' ' A' ' 189' ' ' ILE . 32.0 Cg_exo -58.07 105.56 0.21 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 121.993 1.795 . . . . 0.0 110.274 179.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.459 HG22 ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -47.68 155.39 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 C-N-CA 118.894 -1.123 . . . . 0.0 109.585 -178.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.728 HG21 ' CA ' ' A' ' 144' ' ' GLY . 0.6 OUTLIER -88.57 44.73 1.23 Allowed 'General case' 0 C--N 1.295 -1.782 0 CA-C-O 121.338 0.589 . . . . 0.0 111.571 -178.378 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.551 ' CG2' HG23 ' A' ' 159' ' ' VAL . 19.4 m -84.57 113.78 21.49 Favored 'General case' 0 C--N 1.295 -1.789 0 N-CA-C 106.184 -1.784 . . . . 0.0 106.184 177.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.494 ' OD2' ' CZ ' ' A' ' 194' ' ' ARG . 9.1 t0 -75.54 114.98 14.72 Favored 'General case' 0 C--N 1.281 -2.397 0 C-N-CA 119.111 -1.035 . . . . 0.0 109.986 -177.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -118.76 97.19 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 CA-C-O 121.925 0.869 . . . . 0.0 109.45 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.669 ' O ' ' NE2' ' A' ' 197' ' ' GLN . 0.0 OUTLIER -152.62 152.29 31.62 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.701 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.644 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 1.0 OUTLIER -111.74 -176.95 3.06 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 110.197 -179.501 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 71.55 30.37 66.67 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.669 ' NE2' ' O ' ' A' ' 194' ' ' ARG . 1.8 mp0 -95.85 95.16 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.094 -1.239 . . . . 0.0 109.882 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.586 ' O ' ' O ' ' A' ' 197' ' ' GLN . 8.3 p -32.6 154.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.372 -0.83 . . . . 0.0 109.711 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.545 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 65.0 t80 -120.63 137.23 54.55 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.187 -0.946 . . . . 0.0 109.633 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.432 ' O ' ' N ' ' A' ' 93' ' ' PHE . 2.9 m-85 -139.54 112.84 8.25 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.167 -0.958 . . . . 0.0 109.787 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.582 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.3 m-85 -54.12 141.67 28.09 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.111 -0.993 . . . . 0.0 110.108 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.493 ' HA ' ' CE2' ' A' ' 93' ' ' PHE . . . -90.46 -174.64 4.2 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.37 -0.831 . . . . 0.0 109.001 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -74.03 165.05 25.82 Favored 'General case' 0 C--N 1.293 -1.851 0 O-C-N 121.749 -0.594 . . . . 0.0 109.704 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.454 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -57.95 -45.14 87.13 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.537 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -55.05 -13.53 1.19 Allowed 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.636 -0.665 . . . . 0.0 109.443 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.697 ' O ' HG21 ' A' ' 91' ' ' VAL . 14.3 m-70 -100.99 5.38 43.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.281 -0.887 . . . . 0.0 110.571 -178.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.83 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.3 mm-40 -124.57 -144.18 0.32 Allowed 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 122.238 1.018 . . . . 0.0 110.143 -178.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.719 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 11.7 mp0 -34.4 -5.4 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.342 -1.299 . . . . 0.0 112.188 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.83 ' N ' ' O ' ' A' ' 207' ' ' GLN . 79.5 t80 -43.7 -45.58 7.09 Favored 'General case' 0 N--CA 1.515 2.8 0 O-C-N 120.495 -1.378 . . . . 0.0 109.861 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.644 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.4 OUTLIER -55.21 -17.3 4.18 Favored 'General case' 0 C--N 1.31 -1.147 0 O-C-N 120.648 -1.283 . . . . 0.0 110.068 -179.117 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.632 ' OG ' ' CZ2' ' A' ' 81' ' ' TRP . 13.4 m -73.17 -26.51 61.21 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.171 -0.956 . . . . 0.0 109.109 179.289 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -87.75 -38.92 15.36 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.338 -0.851 . . . . 0.0 109.487 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.442 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.4 m-80 -123.42 79.66 53.92 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -61.63 8.3 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.954 2.436 . . . . 0.0 112.598 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.442 ' H ' ' C ' ' A' ' 213' ' ' ASN . 1.5 t70 -63.44 -19.09 64.41 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.023 -1.048 . . . . 0.0 110.356 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . . . . . . . . . . . 60.98 84.97 0.05 OUTLIER Glycine 0 N--CA 1.503 3.104 0 C-N-CA 120.013 -1.089 . . . . 0.0 111.693 177.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . . . . . . . . . 56.9 t80 -83.38 92.68 7.6 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 120.652 2.226 . . . . 0.0 109.297 179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.557 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 49.1 t -168.74 -124.99 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 O-C-N 120.994 -1.066 . . . . 0.0 108.962 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.557 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . 153.8 151.8 5.87 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.495 ' CB ' ' O ' ' A' ' 219' ' ' GLY . 2.5 tp 75.47 162.43 0.25 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.259 -1.142 . . . . 0.0 109.734 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 157.16 81.59 0.04 OUTLIER Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.372 -1.491 . . . . 0.0 109.372 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . . . . . . . . . . . 144.42 140.83 3.66 Favored Glycine 0 N--CA 1.496 2.683 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 1.2 p -75.64 -42.66 50.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.192 -1.181 . . . . 0.0 109.277 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 94.37 -4.13 69.77 Favored Glycine 0 C--N 1.305 -1.194 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 42.1 t -71.28 115.4 11.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.546 -0.973 . . . . 0.0 109.508 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 4.0 m -99.02 107.8 20.31 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.094 -1.004 . . . . 0.0 109.571 179.59 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.53 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.87 -56.41 2.13 Favored Pre-proline 0 C--N 1.276 -2.594 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.829 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.559 ' CD ' ' H ' ' A' ' 229' ' ' MET . 27.2 Cg_endo -95.7 -35.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.247 0 C-N-CA 123.269 2.646 . . . . 0.0 110.307 178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.569 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -54.27 156.13 3.38 Favored 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 115.137 -0.938 . . . . 0.0 110.057 -179.806 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.569 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -24.74 135.35 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.423 -179.497 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.544 ' O ' ' C ' ' A' ' 232' ' ' LYS . 1.0 OUTLIER -133.98 110.72 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.345 -0.847 . . . . 0.0 109.13 179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.544 ' C ' ' O ' ' A' ' 231' ' ' ILE . 10.1 tttt -34.57 99.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.411 -0.805 . . . . 0.0 109.591 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.478 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.333 0 O-C-N 121.344 -0.847 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.492 H122 HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.481 ' C ' ' O1 ' ' A' ' 21' ' ' MYR . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.471 ' O ' ' CB ' ' A' ' 26' ' ' SER . 1.1 m-20 -86.06 134.49 33.83 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.193 -1.18 . . . . 0.0 109.364 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.79 -32.47 73.05 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 109.552 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 29' ' ' ILE . . . -75.65 -7.12 53.5 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-O 123.222 1.487 . . . . 0.0 109.078 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.471 ' CB ' ' O ' ' A' ' 23' ' ' ASP . 34.9 t -47.01 -29.84 2.3 Favored 'General case' 0 C--N 1.263 -3.178 0 CA-C-N 113.606 -1.633 . . . . 0.0 110.106 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.513 ' C ' HG23 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -108.6 26.74 10.16 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-O 123.424 1.583 . . . . 0.0 109.069 179.555 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.738 ' O ' ' O ' ' A' ' 29' ' ' ILE . 41.9 t -156.95 24.78 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.254 -3.556 0 N-CA-C 104.503 -2.406 . . . . 0.0 104.503 -178.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.738 ' O ' ' O ' ' A' ' 28' ' ' VAL . 0.1 OUTLIER -35.3 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.252 0 CA-C-O 123.198 1.475 . . . . 0.0 110.038 -178.049 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 29' ' ' ILE . 0.0 OUTLIER -74.63 124.25 26.34 Favored 'General case' 0 C--N 1.275 -2.645 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.966 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.836 ' HB1' ' CE1' ' A' ' 97' ' ' HIS . . . -64.76 -40.06 94.65 Favored 'General case' 0 C--N 1.298 -1.637 0 O-C-N 121.83 -0.544 . . . . 0.0 109.692 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.654 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 0.0 OUTLIER -80.65 12.77 2.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.271 -0.893 . . . . 0.0 109.381 -179.877 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.57 ' O ' ' C ' ' A' ' 34' ' ' ALA . 1.6 tt0 -116.67 -43.25 2.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.314 -0.866 . . . . 0.0 109.648 -179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.642 ' CB ' ' O ' ' A' ' 110' ' ' LYS . . . -33.08 152.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.586 179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.59 ' O ' ' O ' ' A' ' 34' ' ' ALA . 0.2 OUTLIER -37.12 160.56 0.05 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -179.906 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -59.23 -39.02 82.23 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.061 1.84 . . . . 0.0 111.966 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.5 155.51 9.77 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.574 ' NH2' ' OE1' ' A' ' 40' ' ' GLU . 43.0 mmm-85 -120.72 154.72 35.22 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -1.124 . . . . 0.0 109.595 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.47 ' HA ' HD22 ' A' ' 100' ' ' ASN . 6.6 m -124.37 32.13 5.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.261 -0.899 . . . . 0.0 109.488 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.574 ' OE1' ' NH2' ' A' ' 38' ' ' ARG . 2.5 mt-10 -103.25 142.84 25.4 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.148 -0.97 . . . . 0.0 109.564 -179.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -48.37 166.79 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.283 1.988 . . . . 0.0 112.181 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.644 ' N ' ' CD ' ' A' ' 43' ' ' PRO . 0.4 OUTLIER -138.99 41.96 0.52 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 109.693 179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.69 ' O ' HG13 ' A' ' 44' ' ' VAL . 35.6 Cg_endo -66.97 164.09 31.22 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.747 2.298 . . . . 0.0 112.261 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.69 HG13 ' O ' ' A' ' 43' ' ' PRO . 7.0 m -161.2 172.29 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.227 179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -48.71 85.53 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.951 . . . . 0.0 109.681 -179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.625 ' N ' ' O ' ' A' ' 44' ' ' VAL . . . -56.27 -40.38 74.16 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.395 -0.816 . . . . 0.0 110.911 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.574 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -86.62 99.72 11.93 Favored 'General case' 0 C--N 1.286 -2.195 0 C-N-CA 115.992 -2.283 . . . . 0.0 108.002 179.056 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.643 ' O ' ' N ' ' A' ' 52' ' ' GLY . 6.7 t-80 -31.16 104.19 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -53.97 -26.17 24.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.654 -0.654 . . . . 0.0 110.965 -178.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.497 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 2.6 t -70.09 -48.06 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.84 -1.163 . . . . 0.0 109.448 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.4 m -103.56 -41.1 6.07 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 109.631 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.643 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.54 1.98 53.27 Favored Glycine 0 N--CA 1.487 2.043 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 66.2 m-20 -75.41 -116.67 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.578 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.0 OUTLIER -131.55 174.39 10.15 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 123.657 1.694 . . . . 0.0 110.217 178.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.61 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 16.0 p -145.56 18.98 1.51 Allowed 'General case' 0 C--N 1.264 -3.118 0 CA-C-N 112.597 -2.092 . . . . 0.0 109.914 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -165.62 149.85 2.04 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.037 -1.04 . . . . 0.0 109.05 -179.805 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.55 ' O ' ' O ' ' A' ' 56' ' ' VAL . 16.0 mt-10 -32.33 154.92 0.04 OUTLIER Pre-proline 0 C--N 1.297 -1.675 0 CA-C-O 121.885 0.85 . . . . 0.0 110.731 -179.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.422 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 84.4 Cg_endo -79.3 165.51 80.62 Favored 'Cis proline' 0 C--N 1.303 -1.845 0 C-N-CA 121.689 -2.213 . . . . 0.0 112.126 -0.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.526 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 1.7 m-30 -115.98 85.68 15.35 Favored Pre-proline 0 C--N 1.27 -2.871 0 CA-C-N 114.087 -1.415 . . . . 0.0 109.16 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -50.96 170.18 0.15 Allowed 'Trans proline' 0 C--N 1.306 -1.689 0 C-N-CA 122.974 2.45 . . . . 0.0 112.549 -179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -75.98 158.32 32.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.369 -0.832 . . . . 0.0 109.505 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 108.4 -38.42 3.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.176 -1.569 . . . . 0.0 109.176 -179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -108.03 135.04 50.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.419 -1.048 . . . . 0.0 109.625 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.602 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 14.9 mp0 -113.32 171.65 7.43 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.735 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -156.9 145.48 19.8 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.58 -1.325 . . . . 0.0 110.896 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HB2' HE22 ' A' ' 166' ' ' GLN . . . -120.1 -169.36 1.78 Allowed 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.61 ' O ' HG12 ' A' ' 67' ' ' VAL . 2.7 t -143.02 101.6 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 120.024 -1.672 . . . . 0.0 109.757 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.642 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 2.4 p90 -148.38 149.37 31.64 Favored 'General case' 0 N--CA 1.488 1.452 0 C-N-CA 118.383 -1.327 . . . . 0.0 110.922 179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.43 ' O ' ' N ' ' A' ' 158' ' ' ALA . . . 179.74 156.25 17.31 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.613 ' HE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 mtt -145.68 30.72 1.08 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 121.347 -1.09 . . . . 0.0 108.339 178.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.588 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -166.6 155.63 26.94 Favored Glycine 0 N--CA 1.481 1.662 0 C-N-CA 118.731 -1.7 . . . . 0.0 110.924 -179.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.769 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.0 OUTLIER -35.97 116.76 0.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.468 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.755 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -45.26 7.37 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.869 -178.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.769 ' N ' ' O ' ' A' ' 72' ' ' CYS . 24.9 m0 -82.34 -64.94 1.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.3 -1.5 . . . . 0.0 109.84 179.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.09 -26.82 74.38 Favored Glycine 0 N--CA 1.492 2.43 0 O-C-N 121.024 -1.047 . . . . 0.0 111.335 -178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.761 ' CB ' HG21 ' A' ' 117' ' ' VAL . . . -76.94 -29.25 55.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.343 . . . . 0.0 111.526 -178.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.557 ' HB2' HG11 ' A' ' 91' ' ' VAL . 28.2 tt0 -83.88 -13.86 52.56 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.277 -1.515 . . . . 0.0 110.757 -179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 80' ' ' PHE . 15.9 ttt180 -69.29 -81.24 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.132 -0.98 . . . . 0.0 111.137 -178.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.509 ' N ' ' CG ' ' A' ' 78' ' ' ARG . 25.2 mtmt -58.76 12.67 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.211 -0.931 . . . . 0.0 110.628 -178.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.757 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.1 m-85 -97.9 -38.72 9.31 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.911 -1.118 . . . . 0.0 109.026 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.593 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.5 p90 -85.17 8.48 18.09 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.476 -0.89 . . . . 0.0 109.445 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.554 ' O ' HG23 ' A' ' 82' ' ' VAL . 1.2 m -99.36 18.87 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.363 -0.836 . . . . 0.0 109.329 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 50.9 mt -103.97 167.68 9.62 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -91.28 162.72 14.5 Favored 'General case' 0 C--N 1.29 -1.997 0 O-C-N 121.536 -0.727 . . . . 0.0 109.761 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.4 5.61 50.36 Favored Glycine 0 N--CA 1.488 2.123 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.51 ' O ' HG12 ' A' ' 86' ' ' VAL . 0.9 OUTLIER -90.78 117.45 34.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.392 -1.063 . . . . 0.0 109.436 179.967 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.578 ' OH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -68.45 -36.29 78.81 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 122.218 1.009 . . . . 0.0 108.753 179.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.538 ' N ' ' CD1' ' A' ' 87' ' ' TYR . 0.5 OUTLIER 177.83 -164.03 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.293 179.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.663 ' C ' HE21 ' A' ' 90' ' ' GLN . 71.3 p -156.25 144.76 20.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.215 -0.928 . . . . 0.0 109.477 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.663 HE21 ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -141.86 166.34 24.98 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.621 HG12 ' HA ' ' A' ' 117' ' ' VAL . 3.0 m -152.41 160.31 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.026 -1.046 . . . . 0.0 110.455 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -179.22 -174.54 45.42 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 -179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.415 ' O ' ' HB2' ' A' ' 94' ' ' ALA . 1.6 m-85 -86.32 169.41 12.98 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.307 -1.114 . . . . 0.0 109.554 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 1.034 ' C ' ' HD1' ' A' ' 113' ' ' HIS . . . -179.58 149.09 0.36 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.005 -1.059 . . . . 0.0 110.242 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 76.86 22.24 72.34 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.142 -1.183 . . . . 0.0 110.142 179.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.709 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -100.44 -165.04 28.45 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.746 -1.342 . . . . 0.0 109.746 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.836 ' CE1' ' HB1' ' A' ' 31' ' ' ALA . 1.7 t-160 -140.85 72.02 1.38 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.23 -1.159 . . . . 0.0 109.571 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -157.78 175.99 13.17 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.448 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.0 mmp_? -76.26 -78.28 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.422 -0.799 . . . . 0.0 109.047 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.47 HD22 ' HA ' ' A' ' 39' ' ' THR . 26.3 m-80 -116.18 66.43 3.1 Favored Pre-proline 0 N--CA 1.489 1.494 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -48.88 149.95 7.17 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.307 2.004 . . . . 0.0 111.674 -179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.636 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 17.4 p -120.85 172.62 7.77 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 119.226 -0.99 . . . . 0.0 110.221 -179.388 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.712 ' CG ' ' N ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -66.41 -59.23 3.87 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.069 -1.019 . . . . 0.0 109.958 -179.188 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.712 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -57.93 -23.52 53.85 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 107.84 -1.17 . . . . 0.0 107.84 179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.636 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 4.2 mm-40 -67.25 -64.95 0.75 Allowed 'General case' 0 C--N 1.3 -1.576 0 CA-C-O 121.601 0.715 . . . . 0.0 109.936 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG12 ' CB ' ' A' ' 111' ' ' THR . 34.4 m -71.39 -24.37 23.76 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 O-C-N 121.479 -0.763 . . . . 0.0 111.098 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.512 ' C ' ' O ' ' A' ' 106' ' ' VAL . 11.9 t -38.38 -22.9 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.022 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.67 ' N ' ' O ' ' A' ' 106' ' ' VAL . 80.2 p -77.8 -80.6 0.1 Allowed 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.682 ' O ' ' N ' ' A' ' 111' ' ' THR . 0.0 OUTLIER 158.7 -39.62 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 107.318 -1.364 . . . . 0.0 107.318 -179.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.642 ' O ' ' CB ' ' A' ' 34' ' ' ALA . 1.6 ttmt -46.29 2.55 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 O-C-N 121.911 -0.493 . . . . 0.0 112.215 -178.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.729 ' CB ' HG12 ' A' ' 106' ' ' VAL . 11.1 p -101.33 -19.68 15.53 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.449 -1.407 . . . . 0.0 109.193 179.64 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 67.16 21.63 72.04 Favored Glycine 0 N--CA 1.486 1.994 0 C-N-CA 120.211 -0.995 . . . . 0.0 111.075 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 1.034 ' HD1' ' C ' ' A' ' 94' ' ' ALA . 1.4 m-70 -80.15 172.46 13.74 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.258 -1.731 . . . . 0.0 108.174 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -130.44 112.92 13.69 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 119.719 -0.792 . . . . 0.0 109.079 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.684 ' OE1' ' CE2' ' A' ' 73' ' ' PHE . 20.8 mm-40 -51.04 112.1 0.66 Allowed 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.557 HG21 ' HB3' ' A' ' 94' ' ' ALA . 1.5 m -123.34 138.37 53.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.71 0 O-C-N 121.453 -0.779 . . . . 0.0 108.937 -179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.761 HG21 ' CB ' ' A' ' 76' ' ' ALA . 2.5 t -103.78 113.11 39.75 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.694 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.526 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 0.5 OUTLIER -96.92 113.84 25.41 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.127 -0.983 . . . . 0.0 109.916 -178.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.612 HG12 ' HB ' ' A' ' 89' ' ' THR . 6.0 m -132.02 126.57 56.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.44 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -86.2 169.41 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 118.804 -1.158 . . . . 0.0 108.435 -179.831 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.761 ' CD1' HD11 ' A' ' 131' ' ' LEU . 0.2 OUTLIER -157.4 156.62 32.56 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.651 -179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -106.66 99.28 24.24 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.918 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.475 ' HG3' ' CZ ' ' A' ' 121' ' ' TYR . 37.9 Cg_exo -43.55 -63.91 0.29 Allowed 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 123.032 2.488 . . . . 0.0 112.917 179.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.753 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 22.5 mp0 -49.91 -13.14 0.09 Allowed 'General case' 0 C--N 1.286 -2.171 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.586 -179.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.442 ' N ' ' C ' ' A' ' 123' ' ' PRO . 22.1 m-70 -110.86 -46.85 3.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.135 -0.978 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.571 HD11 ' HG3' ' A' ' 130' ' ' GLU . 5.3 tp -128.73 144.18 38.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.178 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 2.5 m -75.11 153.1 38.46 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.864 -1.148 . . . . 0.0 111.192 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 132' ' ' LEU . 41.4 t80 -63.9 -28.7 70.01 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.534 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -52.88 -32.13 43.33 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 179.117 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.59 ' O ' ' C ' ' A' ' 131' ' ' LEU . 6.5 mm-40 -62.39 -67.85 0.38 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.761 HD11 ' CD1' ' A' ' 121' ' ' TYR . 17.0 mt -34.05 -49.07 0.34 Allowed 'General case' 0 C--N 1.31 -1.118 0 O-C-N 121.199 -0.938 . . . . 0.0 108.711 178.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.573 HD11 ' CE2' ' A' ' 128' ' ' PHE . 64.0 mt -76.61 -34.54 58.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.133 -0.979 . . . . 0.0 110.69 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.534 ' N ' ' O ' ' A' ' 129' ' ' GLU . 31.7 ttmt -57.71 -68.37 0.25 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.885 -1.134 . . . . 0.0 110.449 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.752 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -49.28 -34.17 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.209 -0.932 . . . . 0.0 108.985 -179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.613 ' CZ ' ' HE2' ' A' ' 70' ' ' MET . 26.4 t80 -57.92 -52.67 64.53 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 121.014 -1.054 . . . . 0.0 111.072 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.58 ' O ' ' CG2' ' A' ' 223' ' ' THR . 85.6 m95 -74.8 -47.45 30.71 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.159 -1.588 . . . . 0.0 111.236 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.582 ' O ' ' O ' ' A' ' 222' ' ' GLY . 1.3 mm-40 -45.23 -48.83 12.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.056 -1.027 . . . . 0.0 111.334 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.752 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 2.5 p30 -98.51 38.22 1.38 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.036 -1.04 . . . . 0.0 112.554 -177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.68 ' O ' ' N ' ' A' ' 223' ' ' THR . 20.6 m80 -155.44 -155.77 0.59 Allowed 'General case' 0 N--CA 1.502 2.147 0 O-C-N 120.714 -1.241 . . . . 0.0 109.342 176.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.492 ' O ' ' SD ' ' A' ' 70' ' ' MET . 2.7 t0 -147.33 132.01 8.82 Favored Pre-proline 0 C--N 1.302 -1.498 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 -179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.447 ' HG3' ' CD1' ' A' ' 177' ' ' TYR . 68.9 Cg_endo -73.81 -13.81 24.26 Favored 'Trans proline' 0 C--N 1.299 -2.062 0 C-N-CA 121.931 1.754 . . . . 0.0 113.142 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.844 HG22 HG22 ' A' ' 189' ' ' ILE . 3.3 p -122.32 56.63 1.1 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.743 -1.223 . . . . 0.0 110.131 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.812 ' NE2' ' NE2' ' A' ' 147' ' ' GLN . 0.1 OUTLIER -122.39 77.59 1.42 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.713 -1.242 . . . . 0.0 110.889 -179.685 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.608 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -47.34 -117.64 0.0 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.904 -0.878 . . . . 0.0 110.904 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.653 ' SD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -85.19 47.02 1.35 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.204 -1.174 . . . . 0.0 109.338 -178.998 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.423 ' CG ' ' O ' ' A' ' 150' ' ' ASP . 1.6 ttm180 -162.16 87.23 0.63 Allowed 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 119.127 -1.029 . . . . 0.0 111.583 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.812 ' NE2' ' NE2' ' A' ' 143' ' ' GLN . 2.1 tp-100 -84.09 119.94 25.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.181 -1.575 . . . . 0.0 109.381 178.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.681 ' N ' ' OE1' ' A' ' 147' ' ' GLN . . . 53.26 -113.45 2.97 Favored Glycine 0 C--N 1.293 -1.844 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.622 ' OD1' ' N ' ' A' ' 149' ' ' ASN . 1.8 p-10 -101.12 22.77 11.8 Favored 'General case' 0 C--N 1.272 -2.796 0 CA-C-N 114.18 -1.01 . . . . 0.0 110.023 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 146' ' ' ARG . 0.8 OUTLIER -107.61 161.12 15.15 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.0 109.426 179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.528 ' O ' ' CD2' ' A' ' 151' ' ' PHE . 35.0 p90 -136.79 127.07 26.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.103 -0.998 . . . . 0.0 110.31 -179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 151.1 149.43 5.05 Favored Glycine 0 N--CA 1.495 2.59 0 C-N-CA 119.393 -1.384 . . . . 0.0 110.956 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.564 ' H ' ' HB2' ' A' ' 109' ' ' GLU . 1.2 p -56.06 -52.68 63.41 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.596 -0.943 . . . . 0.0 109.407 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.636 ' O ' ' CG ' ' A' ' 115' ' ' GLU . 8.9 pm0 -56.55 -11.04 1.12 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.629 -0.669 . . . . 0.0 110.857 -178.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -101.63 49.64 0.86 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.804 -1.185 . . . . 0.0 109.348 179.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.672 ' NH1' ' O ' ' A' ' 190' ' ' THR . 0.0 OUTLIER -116.54 165.06 13.68 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.607 ' OG ' ' O ' ' A' ' 190' ' ' THR . 44.9 p -77.02 128.22 34.09 Favored 'General case' 0 CA--C 1.467 -2.237 0 CA-C-O 122.442 1.115 . . . . 0.0 108.25 -179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.493 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -137.31 129.49 29.38 Favored 'General case' 0 C--N 1.276 -2.591 0 C-N-CA 117.272 -1.771 . . . . 0.0 111.282 -177.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.625 ' CG1' ' CG2' ' A' ' 191' ' ' THR . 0.2 OUTLIER -139.41 108.1 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.066 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.011 177.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.552 ' N ' ' CD1' ' A' ' 160' ' ' TYR . 1.1 m-30 -107.08 134.32 19.93 Favored Pre-proline 0 C--N 1.3 -1.551 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -80.56 168.96 17.49 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.364 2.043 . . . . 0.0 111.835 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.23 -19.59 20.59 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 120.907 -1.12 . . . . 0.0 108.939 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.416 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER 179.57 -164.29 0.05 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 -179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -59.7 -15.6 20.91 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-O 123.005 1.383 . . . . 0.0 108.421 179.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.432 HG12 ' N ' ' A' ' 166' ' ' GLN . 3.6 t -56.05 -64.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.888 0 CA-C-N 113.961 -1.472 . . . . 0.0 110.104 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.541 HE22 ' HB2' ' A' ' 66' ' ' ALA . 23.6 mt-30 -79.6 -17.12 54.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.675 -0.641 . . . . 0.0 110.9 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -52.92 -44.09 66.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.847 -1.158 . . . . 0.0 110.04 -179.179 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -75.23 -20.76 59.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.976 -1.078 . . . . 0.0 109.705 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.8 -54.3 3.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.202 -0.936 . . . . 0.0 109.773 -179.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.424 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -52.76 -44.54 66.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.627 -179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.431 ' HA ' HD23 ' A' ' 171' ' ' LEU . 52.4 mt -52.88 -39.65 62.81 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.159 -0.963 . . . . 0.0 109.189 179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.642 ' O ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -74.52 -51.35 14.96 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.304 -0.873 . . . . 0.0 109.527 179.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.549 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.8 OUTLIER -55.8 -36.11 67.06 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.225 -0.922 . . . . 0.0 109.699 -179.786 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.499 ' HZ3' HD11 ' A' ' 189' ' ' ILE . 6.8 tttp -73.05 -58.16 3.51 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.151 -0.968 . . . . 0.0 110.326 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -73.35 -27.86 61.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.192 -0.942 . . . . 0.0 110.916 -178.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.642 ' CG ' ' O ' ' A' ' 172' ' ' ARG . 3.5 mm-40 -53.06 -31.32 40.96 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.961 -1.087 . . . . 0.0 110.129 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.452 ' CE2' ' HB3' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -80.22 -33.26 38.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.087 -1.008 . . . . 0.0 110.079 -179.422 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.498 ' O ' ' CB ' ' A' ' 182' ' ' SER . 0.8 OUTLIER -52.8 -31.96 41.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 110.013 -179.518 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 64.2 tttt -78.16 -20.39 52.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.118 -0.989 . . . . 0.0 110.804 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 93.6 t -87.74 -55.88 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 120.828 -1.17 . . . . 0.0 110.872 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.452 ' HB3' ' CD1' ' A' ' 186' ' ' PHE . 7.3 mt -76.22 -19.88 57.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.052 -1.03 . . . . 0.0 110.737 -178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.498 ' CB ' ' O ' ' A' ' 178' ' ' GLN . 2.2 t -55.01 -33.68 62.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.865 -1.147 . . . . 0.0 109.16 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -88.2 1.0 55.43 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 16.5 m-70 -108.29 32.42 4.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -0.893 . . . . 0.0 109.79 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 69.31 59.49 0.32 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.245 -0.909 . . . . 0.0 109.939 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.452 ' CD1' ' HB3' ' A' ' 181' ' ' LEU . 38.4 m-85 -133.81 168.98 17.76 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.203 -0.936 . . . . 0.0 109.002 179.509 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -128.76 -149.0 6.81 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -58.65 119.65 7.03 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.358 2.039 . . . . 0.0 110.99 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.844 HG22 HG22 ' A' ' 142' ' ' THR . 1.1 pt -57.55 179.76 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 122.317 1.056 . . . . 0.0 111.097 -178.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.672 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 1.5 p -139.46 58.39 1.62 Allowed 'General case' 0 N--CA 1.494 1.762 0 CA-C-N 115.353 -0.84 . . . . 0.0 108.816 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.625 ' CG2' ' CG1' ' A' ' 159' ' ' VAL . 21.7 m -99.55 120.44 39.65 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.649 ' OD1' ' NE ' ' A' ' 194' ' ' ARG . 15.0 t0 -77.93 122.45 25.52 Favored 'General case' 0 C--N 1.283 -2.291 0 C-N-CA 118.507 -1.277 . . . . 0.0 110.448 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.426 ' CD1' ' HD3' ' A' ' 174' ' ' LYS . 0.8 OUTLIER -131.45 100.64 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.282 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.649 ' NE ' ' OD1' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -151.39 178.38 9.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.225 -0.922 . . . . 0.0 109.362 -179.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.5 mt-10 -129.93 166.28 20.35 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.177 -0.952 . . . . 0.0 109.606 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.37 33.13 49.47 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.513 ' NE2' ' CD2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -89.84 93.97 9.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.079 -1.248 . . . . 0.0 109.425 179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 198' ' ' VAL . 7.4 p -41.11 122.25 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.216 -0.927 . . . . 0.0 109.597 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.489 ' CE1' ' HD3' ' A' ' 118' ' ' ARG . 25.4 t80 -77.79 150.39 34.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.275 -0.891 . . . . 0.0 109.299 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.448 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 6.8 m-85 -149.19 100.53 3.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.25 -0.906 . . . . 0.0 109.395 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -53.84 144.07 19.45 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.245 -0.909 . . . . 0.0 109.615 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.505 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -92.02 -170.83 2.66 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.359 -0.838 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -72.47 167.3 20.87 Favored 'General case' 0 N--CA 1.51 2.552 0 CA-C-O 122.801 1.286 . . . . 0.0 110.309 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.612 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -53.8 -43.61 69.48 Favored 'General case' 0 C--N 1.282 -2.361 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.719 -178.68 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.736 ' O ' ' CD1' ' A' ' 205' ' ' TYR . 0.2 OUTLIER -81.14 13.32 2.87 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 120.582 -1.324 . . . . 0.0 109.496 -178.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.549 ' CE1' ' CG ' ' A' ' 103' ' ' TYR . 22.7 m-70 -102.71 6.41 39.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.747 -1.221 . . . . 0.0 109.706 -179.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.837 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.4 mm-40 -127.61 -138.46 0.25 Allowed 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 122.43 1.11 . . . . 0.0 109.772 -177.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.593 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 18.8 mm-40 -34.15 -4.75 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.271 0 CA-C-N 113.936 -1.484 . . . . 0.0 112.282 -179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.837 ' N ' ' O ' ' A' ' 207' ' ' GLN . 82.0 t80 -42.74 -46.32 5.09 Favored 'General case' 0 N--CA 1.516 2.833 0 O-C-N 120.398 -1.439 . . . . 0.0 109.896 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.649 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.6 OUTLIER -60.43 -17.14 42.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.57 -1.331 . . . . 0.0 110.109 -178.813 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.43 ' N ' ' O ' ' A' ' 208' ' ' GLN . 36.6 p -70.53 -47.43 60.43 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.088 -1.008 . . . . 0.0 108.643 179.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mmmt -88.85 -7.77 55.53 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.352 -0.842 . . . . 0.0 110.121 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.66 ' CG ' ' CZ ' ' A' ' 209' ' ' TYR . 5.4 m-80 -129.19 77.15 78.15 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 0.0 110.102 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -72.57 10.82 0.92 Allowed 'Trans proline' 0 C--N 1.303 -1.821 0 C-N-CA 123.511 2.808 . . . . 0.0 112.46 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -61.75 -21.2 64.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 0.0 110.349 -178.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.57 85.81 0.05 OUTLIER Glycine 0 N--CA 1.498 2.831 0 C-N-CA 119.694 -1.241 . . . . 0.0 111.46 177.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.646 ' O ' ' O ' ' A' ' 216' ' ' GLY . 9.7 m-85 -47.21 -170.9 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 120.314 2.057 . . . . 0.0 109.67 179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . . . . . . . . . 7.3 m -93.43 78.32 4.41 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.914 -1.116 . . . . 0.0 109.745 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.594 ' O ' ' CD1' ' A' ' 220' ' ' LEU . . . -174.14 143.66 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.594 ' CD1' ' O ' ' A' ' 219' ' ' GLY . 0.9 OUTLIER 161.19 167.89 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 179.782 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 110.4 131.2 5.97 Favored Glycine 0 N--CA 1.493 2.443 0 N-CA-C 110.077 -1.209 . . . . 0.0 110.077 179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.639 ' CA ' ' O ' ' A' ' 139' ' ' HIS . . . -173.43 140.52 5.62 Favored Glycine 0 N--CA 1.48 1.617 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.68 ' N ' ' O ' ' A' ' 139' ' ' HIS . 29.5 p 51.31 15.91 0.35 Allowed 'General case' 0 C--N 1.295 -1.798 0 O-C-N 121.466 -1.02 . . . . 0.0 108.271 -179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.465 ' N ' ' C ' ' A' ' 222' ' ' GLY . . . -160.73 44.52 0.41 Allowed Glycine 0 C--N 1.303 -1.299 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.71 HG13 ' SG ' ' A' ' 227' ' ' CYS . 91.7 t -83.24 80.85 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.583 -0.951 . . . . 0.0 109.167 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.671 ' O ' ' SD ' ' A' ' 229' ' ' MET . 4.7 m -100.09 23.84 9.4 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 122.708 1.242 . . . . 0.0 110.223 -179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.71 ' SG ' HG13 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -70.92 -63.28 1.59 Allowed Pre-proline 0 C--N 1.26 -3.299 0 CA-C-N 114.639 -1.164 . . . . 0.0 109.88 -179.36 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.562 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 42.0 Cg_endo -68.02 -3.24 10.24 Favored 'Trans proline' 0 C--N 1.31 -1.488 0 C-N-CA 122.248 1.965 . . . . 0.0 109.707 178.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.672 ' O ' ' SD ' ' A' ' 229' ' ' MET . 0.0 OUTLIER -55.37 157.29 3.8 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.916 0.865 . . . . 0.0 110.332 -179.73 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.55 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.86 145.39 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.727 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.4 ' O ' HG22 ' A' ' 231' ' ' ILE . 2.5 mm -127.97 107.16 15.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.198 -0.939 . . . . 0.0 109.553 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 28.2 ttpt -112.96 97.27 6.43 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.39 0 O-C-N 121.178 -0.951 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.548 H102 HG22 ' A' ' 153' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 22' ' ' GLY . 2.8 t70 36.16 62.5 0.68 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.129 -1.218 . . . . 0.0 109.367 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -56.76 -19.8 18.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.33 -0.856 . . . . 0.0 109.865 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.624 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -55.86 -94.57 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 CA-C-O 123.224 1.488 . . . . 0.0 110.243 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.568 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -47.66 -3.29 0.01 OUTLIER 'General case' 0 C--N 1.257 -3.432 0 CA-C-N 113.62 -1.627 . . . . 0.0 110.409 -178.748 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.671 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -104.21 21.77 15.94 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 124.474 2.083 . . . . 0.0 108.468 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.802 ' O ' HG13 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -152.71 34.34 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.256 -3.466 0 CA-C-N 112.725 -2.034 . . . . 0.0 107.208 -179.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 28' ' ' VAL . 1.1 tp -38.6 132.62 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.287 -2.112 0 CA-C-O 122.057 0.932 . . . . 0.0 113.009 -176.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.91 121.43 21.88 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-O 122.144 0.973 . . . . 0.0 110.203 -178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.516 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -51.7 -55.36 20.01 Favored 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.65 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -53.92 -8.02 0.15 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.273 -0.892 . . . . 0.0 109.75 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' O ' ' O ' ' A' ' 34' ' ' ALA . 2.5 mm-40 -110.61 -36.23 5.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.427 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.572 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -48.91 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.239 -0.913 . . . . 0.0 109.265 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.89 HD21 ' CG ' ' A' ' 110' ' ' LYS . 0.4 OUTLIER -81.3 135.09 50.83 Favored Pre-proline 0 C--N 1.303 -1.428 0 O-C-N 121.207 -0.933 . . . . 0.0 109.141 -179.831 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -71.76 -26.38 19.31 Favored 'Trans proline' 0 N--CA 1.497 1.704 0 C-N-CA 122.821 2.347 . . . . 0.0 114.242 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.613 ' O ' ' OD1' ' A' ' 100' ' ' ASN . . . -179.19 158.43 22.48 Favored Glycine 0 N--CA 1.487 2.046 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -179.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.647 HH21 ' C ' ' A' ' 39' ' ' THR . 0.0 OUTLIER -49.56 151.73 1.56 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 122.031 0.92 . . . . 0.0 111.646 -178.927 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.647 ' C ' HH21 ' A' ' 38' ' ' ARG . 0.2 OUTLIER -124.63 -6.98 7.43 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 178.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -171.42 119.15 0.46 Allowed Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.625 -0.672 . . . . 0.0 109.214 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.453 ' HB3' ' NH1' ' A' ' 99' ' ' ARG . 74.1 Cg_endo -79.84 148.61 20.01 Favored 'Trans proline' 0 N--CA 1.493 1.443 0 C-N-CA 122.632 2.221 . . . . 0.0 112.777 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.44 87.71 13.23 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.315 -0.866 . . . . 0.0 109.617 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -65.34 -176.27 0.5 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 123.073 2.515 . . . . 0.0 112.471 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.583 HG12 ' N ' ' A' ' 204' ' ' ASP . 15.8 m -147.95 -176.07 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.216 -0.927 . . . . 0.0 109.47 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.794 ' O ' HG23 ' A' ' 45' ' ' THR . 14.7 t -79.84 104.28 10.31 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.095 -1.003 . . . . 0.0 110.305 -179.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.606 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.94 -29.77 63.42 Favored 'General case' 0 C--N 1.308 -1.214 0 O-C-N 121.305 -0.872 . . . . 0.0 111.496 -179.226 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 5.5 pttt -88.52 100.04 12.77 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 115.93 -2.308 . . . . 0.0 108.113 178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.599 ' O ' ' N ' ' A' ' 52' ' ' GLY . 7.2 t-80 -31.64 112.25 0.1 Allowed 'General case' 0 C--N 1.294 -1.825 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.796 ' CD2' ' HZ2' ' A' ' 212' ' ' LYS . 13.9 t-80 -50.78 -37.46 42.41 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.535 -0.728 . . . . 0.0 110.625 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.51 HG23 ' HG3' ' A' ' 208' ' ' GLN . 18.0 t -72.15 -61.67 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.071 -1.018 . . . . 0.0 110.345 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -77.13 -36.08 55.69 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 0.0 110.567 -178.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.599 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 83.61 0.11 89.79 Favored Glycine 0 N--CA 1.484 1.853 0 N-CA-C 108.563 -1.815 . . . . 0.0 108.563 -179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 87' ' ' TYR . 40.5 p30 -78.72 -119.63 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 106.183 -1.784 . . . . 0.0 106.183 178.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.651 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 29.5 mtt180 -126.46 174.52 8.57 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 123.275 1.512 . . . . 0.0 109.59 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.692 ' C ' HG22 ' A' ' 56' ' ' VAL . 11.7 p -143.42 35.77 1.32 Allowed 'General case' 0 C--N 1.268 -2.949 0 CA-C-N 113.584 -1.644 . . . . 0.0 109.87 178.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.692 HG22 ' C ' ' A' ' 55' ' ' THR . 0.0 OUTLIER -176.56 152.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 0.0 109.098 -179.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.544 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -31.67 149.5 0.04 OUTLIER Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.518 -0.739 . . . . 0.0 110.547 -179.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.454 ' HD2' ' NH1' ' A' ' 54' ' ' ARG . 88.4 Cg_endo -79.3 165.94 79.62 Favored 'Cis proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.013 -2.078 . . . . 0.0 112.158 0.065 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -106.59 129.56 24.25 Favored Pre-proline 0 C--N 1.27 -2.857 0 CA-C-N 114.125 -1.398 . . . . 0.0 108.927 179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.809 ' O ' HG23 ' A' ' 63' ' ' THR . 46.2 Cg_exo -49.65 148.39 11.89 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.083 1.855 . . . . 0.0 112.064 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.76 158.18 10.82 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.252 -0.905 . . . . 0.0 109.585 -179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 55.55 39.63 75.37 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.809 HG23 ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -90.2 132.3 35.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.25 -1.147 . . . . 0.0 110.649 -179.851 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.772 ' NE2' ' CD1' ' A' ' 128' ' ' PHE . 36.7 tp60 -106.16 142.75 35.33 Favored 'General case' 0 C--N 1.293 -1.89 0 N-CA-C 106.139 -1.8 . . . . 0.0 106.139 176.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . . . . . . . . . 10.7 ptt? -161.37 161.81 30.53 Favored 'General case' 0 C--N 1.288 -2.087 0 C-N-CA 118.147 -1.421 . . . . 0.0 110.994 -178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -160.77 -167.11 1.77 Allowed 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.433 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 74.5 t -141.78 127.85 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 120.158 -1.589 . . . . 0.0 108.607 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 1.046 ' O ' HG22 ' A' ' 117' ' ' VAL . 28.1 m-85 -114.87 135.16 54.5 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.835 -1.166 . . . . 0.0 109.36 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -134.38 83.25 0.29 Allowed Glycine 0 N--CA 1.485 1.951 0 N-CA-C 108.779 -1.728 . . . . 0.0 108.779 179.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.635 ' O ' ' O ' ' A' ' 155' ' ' TYR . 2.2 ptp -86.32 -80.99 0.22 Allowed 'General case' 0 C--N 1.282 -2.357 0 C-N-CA 120.256 -0.577 . . . . 0.0 109.843 -179.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.686 ' O ' ' N ' ' A' ' 73' ' ' PHE . . . -139.36 -152.2 5.84 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 108.125 -1.99 . . . . 0.0 108.125 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.781 ' SG ' ' CE3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -33.76 92.31 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 179.046 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.686 ' N ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -53.51 10.58 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.47 -0.769 . . . . 0.0 112.039 -177.488 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.781 ' CE3' ' SG ' ' A' ' 72' ' ' CYS . 10.9 m0 -70.3 -65.94 0.66 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.742 -1.224 . . . . 0.0 108.562 179.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.46 -12.07 82.36 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.68 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.26 -33.88 59.14 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 109.733 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.566 ' OE2' ' OE1' ' A' ' 208' ' ' GLN . 1.1 tt0 -83.36 -17.09 43.57 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.267 -0.895 . . . . 0.0 110.231 -179.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.832 ' O ' HG13 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -85.93 -52.04 5.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.999 -1.063 . . . . 0.0 110.227 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.433 ' N ' ' HD3' ' A' ' 78' ' ' ARG . 9.4 mttp -47.91 -4.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.105 -0.997 . . . . 0.0 110.181 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 10.3 m-85 -104.5 -35.39 7.9 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.0 110.354 -179.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.611 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 0.5 OUTLIER -88.96 -0.62 57.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.747 -1.22 . . . . 0.0 110.426 -178.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.832 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.3 m -88.32 5.96 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.003 -1.061 . . . . 0.0 110.145 -179.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.679 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -116.95 179.33 4.05 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.22 -0.925 . . . . 0.0 109.664 -178.895 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.14 137.46 37.62 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.929 -1.107 . . . . 0.0 111.529 -178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.689 ' O ' ' CG ' ' A' ' 123' ' ' PRO . . . 124.26 -50.1 0.87 Allowed Glycine 0 C--O 1.202 -1.859 0 C-N-CA 120.154 -1.022 . . . . 0.0 110.763 177.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.562 HG23 ' CZ ' ' A' ' 121' ' ' TYR . 0.5 OUTLIER -53.91 136.85 15.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 O-C-N 120.715 -1.462 . . . . 0.0 111.582 -178.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.718 ' CD1' HG22 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -75.13 -40.76 59.49 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 177.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.694 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 2.0 p -171.92 -174.84 1.38 Allowed 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 178.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 88' ' ' SER . 62.6 p -160.15 128.79 4.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.068 -1.02 . . . . 0.0 109.534 -179.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.694 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 3.0 mp0 -138.46 172.03 13.5 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 110.009 -179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.785 ' CG1' HG12 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -132.59 168.19 24.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.478 -0.764 . . . . 0.0 109.234 -179.427 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . -179.45 168.26 38.73 Favored Glycine 0 N--CA 1.485 1.919 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 0.5 OUTLIER -80.0 153.09 29.09 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.351 -1.088 . . . . 0.0 109.138 179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.797 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -166.55 175.47 8.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.962 . . . . 0.0 109.496 -179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 53.86 22.4 19.12 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.496 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -102.08 -151.43 23.99 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.516 ' CE1' ' CB ' ' A' ' 31' ' ' ALA . 3.7 m-70 -109.81 -41.15 4.59 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 109.768 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.597 ' HB ' HD21 ' A' ' 100' ' ' ASN . 0.6 OUTLIER -154.94 172.83 17.42 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.685 ' C ' HD22 ' A' ' 100' ' ' ASN . 0.3 OUTLIER -81.84 78.3 8.57 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.823 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.792 ' N ' HD22 ' A' ' 100' ' ' ASN . 1.1 m-80 -115.13 -130.07 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.488 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.324 -177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.644 ' O ' ' O ' ' A' ' 100' ' ' ASN . 6.3 Cg_exo -45.39 -156.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.493 1.49 0 CA-C-N 123.672 2.347 . . . . 0.0 115.092 -175.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.767 ' O ' HG13 ' A' ' 106' ' ' VAL . 29.6 p -126.53 170.66 11.8 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.231 -0.918 . . . . 0.0 112.046 -176.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.668 ' CD1' ' OE2' ' A' ' 115' ' ' GLU . 0.8 OUTLIER -50.21 -43.46 52.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.346 0.594 . . . . 0.0 110.016 179.134 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.562 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -74.05 -34.89 64.22 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.821 -1.174 . . . . 0.0 109.487 -179.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.471 ' C ' ' N ' ' A' ' 107' ' ' CYS . 1.7 mm-40 -83.56 -43.7 15.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.403 -0.81 . . . . 0.0 110.749 -178.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 1.091 HG12 HG21 ' A' ' 111' ' ' THR . 34.5 m -46.33 -21.66 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.273 0 O-C-N 120.881 -1.137 . . . . 0.0 109.439 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.487 ' C ' ' O ' ' A' ' 106' ' ' VAL . 10.2 t -36.84 -20.67 0.01 OUTLIER 'General case' 0 C--N 1.29 -2.018 0 C-N-CA 120.396 -0.521 . . . . 0.0 109.631 -178.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.703 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -79.82 3.91 18.15 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.062 -1.024 . . . . 0.0 108.865 179.165 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.68 ' N ' ' O ' ' A' ' 106' ' ' VAL . 1.1 mt-10 64.76 3.8 2.15 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 177.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.89 ' CG ' HD21 ' A' ' 35' ' ' LEU . 0.0 OUTLIER -72.93 -9.94 59.25 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.025 -1.672 . . . . 0.0 110.467 -179.175 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 1.091 HG21 HG12 ' A' ' 106' ' ' VAL . 1.7 p -105.01 -8.34 18.6 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.653 -1.279 . . . . 0.0 109.705 178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.518 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 44.36 30.72 2.09 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.673 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 7.1 m-70 -81.68 170.01 16.3 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 120.908 -1.348 . . . . 0.0 109.386 179.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.554 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -129.03 114.33 16.27 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.668 ' OE2' ' CD1' ' A' ' 103' ' ' TYR . 1.6 mm-40 -40.19 120.94 1.27 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.148 -0.97 . . . . 0.0 108.934 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.797 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.3 OUTLIER -140.55 162.77 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.073 -1.017 . . . . 0.0 110.262 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.046 HG22 ' O ' ' A' ' 68' ' ' PHE . 35.4 m -130.63 127.4 61.99 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.484 -0.76 . . . . 0.0 109.216 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.675 ' NH1' ' OH ' ' A' ' 201' ' ' TYR . 0.0 OUTLIER -98.38 124.85 43.27 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.101 -0.999 . . . . 0.0 109.697 -179.66 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.457 ' O ' HG23 ' A' ' 119' ' ' VAL . 4.2 m -133.85 125.88 49.81 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.911 0 O-C-N 121.018 -1.051 . . . . 0.0 108.723 178.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.718 HG22 ' CD1' ' A' ' 87' ' ' TYR . 1.8 m -96.39 146.55 7.13 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 120.717 -1.239 . . . . 0.0 107.971 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.858 ' CD2' HD22 ' A' ' 131' ' ' LEU . 2.9 m-30 -129.99 147.5 51.74 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-O 122.054 0.93 . . . . 0.0 108.661 -178.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.985 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -179.31 27.21 0.0 OUTLIER Pre-proline 0 C--N 1.288 -2.08 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.985 ' HD3' ' N ' ' A' ' 122' ' ' ARG . 37.9 Cg_exo -73.79 -13.46 24.35 Favored 'Trans proline' 0 C--N 1.296 -2.208 0 N-CA-C 119.436 2.821 . . . . 0.0 119.436 -170.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 56.87 -3.03 0.04 OUTLIER 'General case' 0 C--N 1.272 -2.778 0 N-CA-C 104.508 -2.404 . . . . 0.0 104.508 -174.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.849 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.4 OUTLIER -123.76 2.1 8.81 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.625 HD13 ' CG ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -153.85 132.93 3.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 121.547 -0.721 . . . . 0.0 109.834 -178.937 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.609 ' H ' ' HG2' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -103.0 -177.89 3.5 Favored 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 122.04 0.924 . . . . 0.0 112.775 -177.546 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.912 ' HA ' HD21 ' A' ' 131' ' ' LEU . 35.7 t80 -69.82 -40.56 75.82 Favored 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.191 -179.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -62.89 -14.49 47.03 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 120.805 -1.184 . . . . 0.0 108.809 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.625 ' CG ' HD13 ' A' ' 126' ' ' ILE . 0.4 OUTLIER -74.58 -55.94 5.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 111.377 -179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.963 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.2 OUTLIER -59.99 -34.46 73.36 Favored 'General case' 0 C--N 1.31 -1.143 0 O-C-N 120.597 -1.314 . . . . 0.0 107.862 -179.706 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.43 ' HA ' HD22 ' A' ' 132' ' ' LEU . 1.5 mm? -66.12 -32.49 73.97 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.135 178.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -70.51 -62.53 1.35 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.0 110.38 -179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.716 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 25.5 t -49.37 -27.42 2.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.16 -0.963 . . . . 0.0 108.979 -179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.488 ' CE2' HG11 ' A' ' 159' ' ' VAL . 6.7 t80 -71.73 -50.74 27.39 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.794 -1.191 . . . . 0.0 109.889 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.947 ' O ' HG21 ' A' ' 223' ' ' THR . 55.1 m95 -72.4 -37.9 68.57 Favored 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.616 -1.303 . . . . 0.0 110.299 179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.27 -20.8 64.65 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -176.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.716 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.9 OUTLIER -131.56 59.48 1.69 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 120.161 -1.587 . . . . 0.0 111.768 -178.191 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.65 ' O ' HG23 ' A' ' 223' ' ' THR . 0.0 OUTLIER 170.26 136.38 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.375 -0.828 . . . . 0.0 109.256 178.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.28 135.4 72.9 Favored Pre-proline 0 C--N 1.298 -1.631 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.451 ' HG2' ' CD1' ' A' ' 181' ' ' LEU . 73.8 Cg_endo -75.58 -8.66 19.56 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.576 2.184 . . . . 0.0 112.558 -179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.54 ' O ' ' OG1' ' A' ' 142' ' ' THR . 0.6 OUTLIER -118.04 56.0 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.188 -0.945 . . . . 0.0 110.228 -179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.563 ' O ' ' O ' ' A' ' 144' ' ' GLY . 6.0 mm100 -118.73 62.63 0.78 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.164 -0.96 . . . . 0.0 108.739 179.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.563 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -45.27 -119.29 0.0 OUTLIER Glycine 0 N--CA 1.492 2.422 0 CA-C-O 121.81 0.672 . . . . 0.0 112.414 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.666 ' SD ' ' O ' ' A' ' 145' ' ' MET . 1.5 tmt? -69.84 35.97 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.507 -0.996 . . . . 0.0 110.648 -177.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.459 ' H ' ' C ' ' A' ' 144' ' ' GLY . 4.1 ttm180 -166.32 152.73 9.04 Favored 'General case' 0 C--N 1.299 -1.599 0 C-N-CA 119.004 -1.078 . . . . 0.0 110.023 179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.507 HE21 ' HG3' ' A' ' 143' ' ' GLN . 1.2 mm-40 -146.92 100.7 3.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.439 -1.413 . . . . 0.0 108.39 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 52.03 -119.6 9.23 Favored Glycine 0 C--N 1.298 -1.543 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 -179.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.499 ' H ' HD22 ' A' ' 220' ' ' LEU . 1.6 t-20 -81.72 8.86 8.95 Favored 'General case' 0 C--N 1.265 -3.101 0 CA-C-N 113.744 -1.228 . . . . 0.0 110.13 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -107.36 147.85 29.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.99 -1.069 . . . . 0.0 109.409 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.424 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.1 p90 -136.67 129.63 30.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.144 -0.973 . . . . 0.0 110.088 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 145.5 158.59 7.75 Favored Glycine 0 N--CA 1.495 2.616 0 C-N-CA 119.493 -1.337 . . . . 0.0 110.415 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.574 HG21 ' HA ' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -78.12 -4.6 48.24 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.251 -1.146 . . . . 0.0 109.65 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.584 ' N ' ' OE1' ' A' ' 154' ' ' GLN . 15.3 pm0 -88.38 3.06 51.21 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.029 -1.044 . . . . 0.0 109.507 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.635 ' O ' ' O ' ' A' ' 70' ' ' MET . 93.2 m-85 -114.9 -12.56 12.04 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.217 -0.927 . . . . 0.0 111.053 -179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.599 ' O ' ' O ' ' A' ' 155' ' ' TYR . 0.0 OUTLIER -39.62 172.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.331 0 O-C-N 120.571 -1.331 . . . . 0.0 110.195 -179.329 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.707 ' OG ' HG23 ' A' ' 190' ' ' THR . 31.5 p -89.11 132.82 34.63 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 105.312 -2.107 . . . . 0.0 105.312 178.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.456 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -147.64 123.08 10.36 Favored 'General case' 0 C--N 1.289 -2.061 0 C-N-CA 117.68 -1.608 . . . . 0.0 111.58 -177.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.677 HG13 ' CG2' ' A' ' 191' ' ' THR . 2.8 m -119.85 130.55 74.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.687 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.766 178.169 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.483 ' CE2' HG11 ' A' ' 116' ' ' VAL . 10.1 m-30 -112.85 131.66 22.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.0 109.105 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.35 169.38 20.17 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 122.86 2.373 . . . . 0.0 112.624 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.475 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.4 OUTLIER -103.14 -6.64 22.0 Favored 'General case' 0 C--N 1.311 -1.07 0 O-C-N 121.039 -1.038 . . . . 0.0 109.498 179.516 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.622 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER 166.44 173.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.261 -0.9 . . . . 0.0 108.813 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -47.07 -14.91 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.989 1.376 . . . . 0.0 108.231 179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.622 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.3 t -55.54 -61.3 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.797 0 CA-C-N 113.925 -1.489 . . . . 0.0 110.113 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.446 ' O ' ' N ' ' A' ' 170' ' ' ALA . 1.2 mp0 -60.88 -11.62 8.45 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.557 -0.714 . . . . 0.0 110.378 -179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 1.8 ttt -51.87 -43.61 63.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.99 -1.069 . . . . 0.0 109.919 -178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.673 ' O ' ' NH1' ' A' ' 172' ' ' ARG . 2.6 tm-20 -75.66 -22.68 56.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.949 -1.094 . . . . 0.0 109.937 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.451 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -93.06 -56.32 3.02 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.076 -1.015 . . . . 0.0 110.421 -179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.446 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.96 -58.97 4.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.079 -1.013 . . . . 0.0 109.683 -179.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 171' ' ' LEU . 63.2 mt -52.24 -35.68 50.33 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.08 -1.013 . . . . 0.0 109.244 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.673 ' NH1' ' O ' ' A' ' 168' ' ' GLU . 13.4 ttp-105 -74.52 -55.92 5.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.241 -0.912 . . . . 0.0 109.568 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.524 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -56.54 -37.08 70.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.171 -0.956 . . . . 0.0 109.481 -179.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 10.1 tttm -68.09 -53.15 27.55 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.129 -0.982 . . . . 0.0 109.695 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -73.0 2.21 7.4 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.221 -0.924 . . . . 0.0 110.086 -179.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -78.66 -56.52 4.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 109.546 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -68.93 -27.37 65.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.233 -0.917 . . . . 0.0 109.941 -179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.679 ' NE2' ' OG ' ' A' ' 182' ' ' SER . 0.5 OUTLIER -53.24 -53.85 44.78 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.171 -0.955 . . . . 0.0 109.666 -179.766 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.15 -15.55 63.78 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.89 -179.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 70.7 t -87.22 -54.2 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.125 -0.985 . . . . 0.0 110.062 -179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.49 ' C ' ' H ' ' A' ' 183' ' ' LYS . 35.2 mt -75.26 -45.93 36.86 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.124 -0.985 . . . . 0.0 110.164 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.679 ' OG ' ' NE2' ' A' ' 178' ' ' GLN . 61.1 m -56.23 -3.05 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.043 -1.036 . . . . 0.0 109.685 -179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.49 ' H ' ' C ' ' A' ' 181' ' ' LEU . 0.1 OUTLIER -88.02 -21.29 24.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.202 -0.936 . . . . 0.0 109.306 179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.459 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 14.1 m-70 -107.99 14.4 25.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.324 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.459 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.92 68.67 0.15 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -0.899 . . . . 0.0 109.422 -179.939 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -116.11 -177.21 3.11 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.216 -0.927 . . . . 0.0 109.42 179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -75.42 173.55 52.99 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.943 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -72.64 174.27 11.99 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.825 2.35 . . . . 0.0 112.245 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.52 ' O ' HG22 ' A' ' 189' ' ' ILE . 0.8 OUTLIER -80.99 116.25 24.97 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 121.28 -0.888 . . . . 0.0 109.006 -179.838 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.707 HG23 ' OG ' ' A' ' 157' ' ' SER . 5.2 t -100.37 -5.21 27.63 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.002 -1.061 . . . . 0.0 109.544 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.677 ' CG2' HG13 ' A' ' 159' ' ' VAL . 47.0 m -43.6 112.65 0.41 Allowed 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 178.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.681 ' OD1' ' NH1' ' A' ' 194' ' ' ARG . 7.2 t0 -77.17 132.93 39.03 Favored 'General case' 0 C--N 1.275 -2.65 0 CA-C-N 115.136 -0.938 . . . . 0.0 109.924 -178.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.438 ' O ' ' CG ' ' A' ' 194' ' ' ARG . 0.8 OUTLIER -133.41 125.66 50.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.418 -0.801 . . . . 0.0 108.909 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.681 ' NH1' ' OD1' ' A' ' 192' ' ' ASP . 69.7 mtm-85 -157.11 152.19 26.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.495 -0.753 . . . . 0.0 109.307 -179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.643 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.8 OUTLIER -115.36 -174.51 2.52 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.204 -0.935 . . . . 0.0 109.584 179.693 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 47.53 56.48 8.29 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.688 -1.365 . . . . 0.0 109.688 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . . . . . . . . . 77.5 mm-40 -116.25 148.04 40.87 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.138 -1.213 . . . . 0.0 109.573 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.772 HG11 ' CZ ' ' A' ' 200' ' ' TYR . 1.3 p -87.7 165.72 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.338 -0.852 . . . . 0.0 109.258 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.456 ' CE1' ' HB3' ' A' ' 118' ' ' ARG . 55.2 t80 -125.56 132.3 52.59 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.108 -0.995 . . . . 0.0 109.964 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.772 ' CZ ' HG11 ' A' ' 198' ' ' VAL . 35.0 m-85 -128.32 104.39 7.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.384 -0.822 . . . . 0.0 109.109 179.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.675 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 23.8 m-85 -54.98 141.48 33.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 0.0 110.572 -179.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.555 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -85.0 -169.3 2.58 Favored 'General case' 0 C--N 1.304 -1.398 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.574 ' HG3' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -76.0 153.26 36.63 Favored 'General case' 0 C--N 1.296 -1.761 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.583 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.7 OUTLIER -56.54 -37.89 71.12 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.083 -1.01 . . . . 0.0 108.318 179.016 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.563 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.1 OUTLIER -60.85 -14.55 22.71 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.635 -0.665 . . . . 0.0 110.635 179.757 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.494 ' O ' HG21 ' A' ' 91' ' ' VAL . 20.2 m-70 -99.02 -4.05 33.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.856 -1.152 . . . . 0.0 110.118 -178.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.855 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.1 mt-30 -110.41 -133.07 0.33 Allowed 'General case' 0 C--N 1.299 -1.6 0 CA-C-O 122.752 1.263 . . . . 0.0 110.568 -178.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.669 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.1 OUTLIER -33.63 -5.06 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 113.265 -1.789 . . . . 0.0 111.887 -179.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.855 ' N ' ' O ' ' A' ' 207' ' ' GLN . 76.2 t80 -42.56 -44.43 4.15 Favored 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.673 -1.267 . . . . 0.0 109.936 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.625 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.5 OUTLIER -59.23 -17.23 26.34 Favored 'General case' 0 C--N 1.312 -1.032 0 O-C-N 120.439 -1.413 . . . . 0.0 110.016 -178.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.466 ' OG ' ' ND1' ' A' ' 49' ' ' HIS . 71.1 p -73.26 -31.31 64.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.262 179.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.796 ' HZ2' ' CD2' ' A' ' 49' ' ' HIS . 10.9 mmtm -87.72 -33.91 18.55 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.339 -0.851 . . . . 0.0 109.866 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.689 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 26.2 m120 -121.71 82.42 41.52 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.0 109.901 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -71.46 9.88 0.86 Allowed 'Trans proline' 0 C--N 1.304 -1.809 0 C-N-CA 123.206 2.604 . . . . 0.0 112.164 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 35.8 p-10 -63.52 -11.92 28.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.165 -0.959 . . . . 0.0 110.13 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.31 85.15 0.05 OUTLIER Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.766 -1.206 . . . . 0.0 111.449 177.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.601 ' O ' ' O ' ' A' ' 216' ' ' GLY . 33.1 t80 -52.31 -158.64 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 120.6 2.2 . . . . 0.0 109.565 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.581 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 18.1 m -90.3 78.08 6.54 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.852 -1.155 . . . . 0.0 109.378 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.89 ' O ' HD12 ' A' ' 220' ' ' LEU . . . -88.62 -169.27 44.74 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.266 -1.533 . . . . 0.0 109.266 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.89 HD12 ' O ' ' A' ' 219' ' ' GLY . 0.7 OUTLIER -152.41 178.96 8.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -1.223 . . . . 0.0 109.673 179.978 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -153.98 -162.33 11.03 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.441 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -170.85 -136.53 2.11 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.947 HG21 ' O ' ' A' ' 136' ' ' TRP . 47.4 p 46.01 21.24 0.09 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.342 -1.093 . . . . 0.0 109.436 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -168.12 43.0 0.23 Allowed Glycine 0 C--N 1.3 -1.433 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.557 HG22 ' O ' ' A' ' 225' ' ' VAL . 2.6 p -111.16 81.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.232 -1.158 . . . . 0.0 109.495 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.57 107.59 19.78 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.163 -0.961 . . . . 0.0 109.27 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.527 ' SG ' ' HD3' ' A' ' 228' ' ' PRO . 0.0 OUTLIER -74.18 -57.49 2.25 Favored Pre-proline 0 C--N 1.28 -2.448 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 179.472 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.527 ' HD3' ' SG ' ' A' ' 227' ' ' CYS . 40.0 Cg_endo -95.32 -30.8 0.06 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.866 2.377 . . . . 0.0 110.445 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.552 ' O ' ' C ' ' A' ' 230' ' ' ALA . 4.0 mmm -55.28 155.52 4.95 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-O 121.916 0.865 . . . . 0.0 110.216 -179.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.552 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.23 142.56 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.307 0.575 . . . . 0.0 109.989 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.562 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -150.11 118.64 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.044 0 O-C-N 121.3 -0.875 . . . . 0.0 109.228 179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.5 tttp -94.73 154.58 17.24 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.152 -0.967 . . . . 0.0 109.564 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.361 0 O-C-N 121.252 -0.905 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.507 H121 HH22 ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.517 ' O ' ' O ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.576 ' OD1' ' N ' ' A' ' 23' ' ' ASP . 0.8 OUTLIER 57.3 151.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.193 -1.181 . . . . 0.0 109.431 -179.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.537 ' O ' ' CG2' ' A' ' 28' ' ' VAL . 15.5 t -50.37 -18.42 0.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.495 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.55 -93.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 123.351 1.548 . . . . 0.0 110.94 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.597 ' C ' ' H ' ' A' ' 28' ' ' VAL . 6.3 m -46.59 -30.53 2.33 Favored 'General case' 0 C--N 1.256 -3.469 0 CA-C-N 113.314 -1.766 . . . . 0.0 111.638 -177.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.639 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -80.91 22.67 0.6 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-O 124.221 1.962 . . . . 0.0 109.003 -179.16 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 26' ' ' SER . 29.0 t -148.76 46.19 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.26 -3.315 0 CA-C-N 112.626 -2.079 . . . . 0.0 106.285 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -62.18 132.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-O 122.315 1.055 . . . . 0.0 113.77 -175.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.87 125.55 29.3 Favored 'General case' 0 C--N 1.31 -1.13 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.282 -179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.961 ' HB2' ' ND1' ' A' ' 97' ' ' HIS . . . -50.41 -27.21 6.0 Favored 'General case' 0 C--N 1.295 -1.772 0 O-C-N 121.547 -0.721 . . . . 0.0 109.69 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -83.15 3.37 31.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.635 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -116.29 4.55 13.49 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.617 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.32 178.96 8.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.403 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.411 HD13 ' HD3' ' A' ' 36' ' ' PRO . 3.7 mm? -54.07 169.3 0.37 Allowed Pre-proline 0 N--CA 1.492 1.631 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.411 ' HD3' HD13 ' A' ' 35' ' ' LEU . 23.9 Cg_exo -63.01 -44.45 15.73 Favored 'Trans proline' 0 N--CA 1.495 1.603 0 C-N-CA 122.123 1.882 . . . . 0.0 112.361 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 134.3 155.35 7.51 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -141.78 145.57 34.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -1.113 . . . . 0.0 109.524 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -124.67 33.85 5.13 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.177 -0.952 . . . . 0.0 109.651 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -132.07 94.79 23.22 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.072 -1.017 . . . . 0.0 109.871 -179.751 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -53.52 179.82 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.796 2.331 . . . . 0.0 112.087 179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -139.08 138.5 21.1 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.157 -0.964 . . . . 0.0 109.706 -179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -77.16 168.37 23.3 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.737 2.291 . . . . 0.0 112.217 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 202' ' ' ALA . 0.0 OUTLIER -148.67 -166.6 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.091 -1.005 . . . . 0.0 109.586 179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.863 ' O ' HG23 ' A' ' 45' ' ' THR . 13.5 t -93.46 94.0 8.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.156 -0.965 . . . . 0.0 109.73 -179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.571 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -56.02 -45.41 79.13 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.282 -0.886 . . . . 0.0 111.016 -179.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -83.43 99.94 10.4 Favored 'General case' 0 C--N 1.288 -2.095 0 C-N-CA 115.775 -2.37 . . . . 0.0 108.597 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.661 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 15.1 t-80 -30.97 137.01 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.7 t-80 -77.28 -7.47 56.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.267 -0.896 . . . . 0.0 111.139 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.472 ' HB ' ' ND1' ' A' ' 48' ' ' HIS . 55.1 t -95.51 -55.31 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.828 -1.17 . . . . 0.0 109.967 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -89.98 -43.95 10.2 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.929 . . . . 0.0 110.524 -179.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 100.97 5.37 53.51 Favored Glycine 0 N--CA 1.485 1.936 0 N-CA-C 109.246 -1.541 . . . . 0.0 109.246 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.695 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.2 p30 -80.37 -117.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 106.592 -1.632 . . . . 0.0 106.592 178.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.695 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 3.8 ttp180 -129.2 170.35 13.68 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-O 123.223 1.487 . . . . 0.0 108.84 178.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.592 HG22 HE21 ' A' ' 90' ' ' GLN . 4.6 p -133.56 32.39 3.61 Favored 'General case' 0 C--N 1.262 -3.226 0 CA-C-N 113.603 -1.635 . . . . 0.0 108.544 178.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.569 HG22 ' C ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -164.71 133.38 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 C-N-CA 119.247 -0.981 . . . . 0.0 110.214 -179.728 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.539 ' C ' ' O ' ' A' ' 56' ' ' VAL . 2.8 pm0 -33.08 148.87 0.06 OUTLIER Pre-proline 0 C--N 1.305 -1.348 0 O-C-N 121.436 -0.79 . . . . 0.0 110.574 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.431 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 92.3 Cg_endo -78.03 166.4 80.9 Favored 'Cis proline' 0 C--N 1.305 -1.762 0 C-N-CA 121.866 -2.139 . . . . 0.0 111.545 -0.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.522 ' CE1' HG11 ' A' ' 120' ' ' VAL . 28.6 m-85 -106.32 156.47 36.88 Favored Pre-proline 0 C--N 1.268 -2.973 0 CA-C-N 114.588 -1.187 . . . . 0.0 108.86 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.591 ' CG ' ' CD2' ' A' ' 87' ' ' TYR . 47.8 Cg_exo -49.62 129.28 23.15 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.24 1.96 . . . . 0.0 112.147 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.687 ' H ' ' CD ' ' A' ' 61' ' ' GLU . 1.9 pm0 -43.35 144.31 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.339 -0.85 . . . . 0.0 109.134 179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 64.72 70.34 1.11 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.252 -1.539 . . . . 0.0 109.252 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.41 137.13 28.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.398 -1.06 . . . . 0.0 109.383 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.485 ' O ' ' N ' ' A' ' 121' ' ' TYR . 4.9 tt0 -106.51 136.37 46.41 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.731 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.85 127.9 27.75 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.217 -0.927 . . . . 0.0 109.85 -179.795 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -115.52 -168.79 1.46 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 179.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 67' ' ' VAL . 43.9 t -143.57 98.15 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 119.9 -1.75 . . . . 0.0 110.599 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.468 ' CZ ' ' O ' ' A' ' 131' ' ' LEU . 0.1 OUTLIER -137.52 164.35 28.93 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.545 178.135 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -160.58 162.64 33.56 Favored Glycine 0 N--CA 1.487 2.047 0 C-N-CA 118.757 -1.687 . . . . 0.0 111.971 -178.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.596 ' O ' ' O ' ' A' ' 156' ' ' ARG . 0.0 OUTLIER -115.71 -86.01 0.61 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.609 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -132.42 -151.41 6.74 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 107.888 -2.085 . . . . 0.0 107.888 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.784 ' SG ' ' CZ3' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -28.58 114.4 0.08 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.521 -0.988 . . . . 0.0 108.992 179.478 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.648 ' CD1' ' N ' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -53.0 18.82 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.769 -0.582 . . . . 0.0 111.75 -178.316 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.784 ' CZ3' ' SG ' ' A' ' 72' ' ' CYS . 16.1 m0 -84.59 -63.34 1.35 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.487 -1.383 . . . . 0.0 109.646 179.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.57 -13.24 74.38 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.745 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -76.04 -38.17 57.48 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.247 -1.149 . . . . 0.0 109.76 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.544 ' CD ' ' NE2' ' A' ' 208' ' ' GLN . 3.6 tt0 -84.5 -14.82 48.0 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.907 -1.121 . . . . 0.0 110.554 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.71 ' O ' HG13 ' A' ' 82' ' ' VAL . 13.1 ttp180 -76.25 -74.2 0.24 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.025 -1.047 . . . . 0.0 110.556 -178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.484 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -48.39 -2.9 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.955 -1.09 . . . . 0.0 110.26 -179.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.745 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 3.8 m-85 -108.64 -24.18 11.47 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.221 -0.924 . . . . 0.0 110.375 -179.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.756 ' CH2' HD12 ' A' ' 210' ' ' LEU . 0.1 OUTLIER -104.63 -2.89 24.46 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.719 -1.238 . . . . 0.0 111.122 -179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.71 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.1 m -97.76 11.54 5.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 120.771 -1.206 . . . . 0.0 110.686 -178.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.669 HD12 ' C ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -112.0 178.7 4.23 Favored 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.117 -0.989 . . . . 0.0 109.325 -179.23 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 5.9 tptt -98.83 137.53 37.28 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.835 -1.166 . . . . 0.0 111.536 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.511 ' HA3' HD12 ' A' ' 126' ' ' ILE . . . 124.28 -33.25 3.88 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -78.61 135.86 25.09 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.722 0 O-C-N 121.448 -1.031 . . . . 0.0 111.049 -178.783 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.655 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -75.81 -40.24 55.37 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 177.71 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.685 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 0.9 OUTLIER -174.43 -173.62 0.78 Allowed 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.312 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.593 HG21 ' HB3' ' A' ' 81' ' ' TRP . 39.7 p -144.12 163.01 34.83 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.447 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.685 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 12.7 mp0 -154.89 140.03 17.49 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.092 HG12 HG22 ' A' ' 117' ' ' VAL . 3.2 m -127.21 162.79 31.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 120.951 -1.093 . . . . 0.0 109.521 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 179.94 177.69 48.13 Favored Glycine 0 N--CA 1.482 1.746 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.522 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 0.1 OUTLIER -102.64 168.46 9.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.286 -1.126 . . . . 0.0 110.046 -179.816 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.707 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.19 -170.37 0.17 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.205 -0.934 . . . . 0.0 109.689 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 51.25 40.78 45.85 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.738 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -106.05 -158.02 22.15 Favored Glycine 0 N--CA 1.498 2.801 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.961 ' ND1' ' HB2' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -149.68 58.45 0.99 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.328 -1.101 . . . . 0.0 109.986 -179.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -157.5 -178.86 7.66 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.02 -1.05 . . . . 0.0 108.335 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.677 ' C ' HD22 ' A' ' 100' ' ' ASN . 9.3 mmt180 -52.76 -93.6 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.857 0 O-C-N 121.387 -0.821 . . . . 0.0 108.79 179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.677 HD22 ' C ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -123.06 71.99 44.57 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.243 -0.911 . . . . 0.0 109.286 179.31 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.501 ' HB2' ' CD2' ' A' ' 113' ' ' HIS . 52.0 Cg_exo -48.85 131.9 25.71 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 122.495 2.13 . . . . 0.0 111.633 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.64 HG22 ' HG3' ' A' ' 105' ' ' GLU . 1.8 t -121.25 171.3 8.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 0.0 109.534 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.58 ' O ' ' CB ' ' A' ' 107' ' ' CYS . 40.8 t80 -49.23 -43.71 42.9 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -42.46 92.0 Favored 'General case' 0 C--N 1.297 -1.692 0 O-C-N 121.599 -0.688 . . . . 0.0 109.399 179.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.64 ' HG3' HG22 ' A' ' 102' ' ' THR . 2.0 mm-40 -74.77 -54.61 7.03 Favored 'General case' 0 C--N 1.312 -1.048 0 O-C-N 120.812 -1.18 . . . . 0.0 110.933 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.993 HG12 ' OG1' ' A' ' 111' ' ' THR . 17.0 m -73.09 -25.17 21.43 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 O-C-N 121.028 -1.045 . . . . 0.0 111.354 -178.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.58 ' CB ' ' O ' ' A' ' 103' ' ' TYR . 0.0 OUTLIER -38.78 -23.94 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.721 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.69 ' N ' ' O ' ' A' ' 106' ' ' VAL . 84.2 p -76.94 -81.1 0.09 Allowed 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 107.799 -1.186 . . . . 0.0 107.799 177.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.601 ' HB3' ' O ' ' A' ' 108' ' ' SER . 0.0 OUTLIER 156.85 -36.3 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.939 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.452 ' N ' ' HG2' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -53.55 2.79 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.024 0 O-C-N 121.359 -0.838 . . . . 0.0 113.065 -177.077 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.993 ' OG1' HG12 ' A' ' 106' ' ' VAL . 32.2 p -96.53 -6.14 37.73 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.25 -1.531 . . . . 0.0 108.961 179.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 52.92 25.54 23.84 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.829 179.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.738 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -69.77 159.64 33.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.281 -1.717 . . . . 0.0 109.168 179.307 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.642 ' O ' HG13 ' A' ' 116' ' ' VAL . . . -112.38 112.45 24.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.335 -0.853 . . . . 0.0 109.062 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.667 ' N ' ' OE1' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -48.84 109.0 0.21 Allowed 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.415 -0.803 . . . . 0.0 108.986 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.642 HG13 ' O ' ' A' ' 114' ' ' ALA . 16.0 m -124.71 137.4 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.258 -0.901 . . . . 0.0 109.364 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.092 HG22 HG12 ' A' ' 91' ' ' VAL . 1.5 t -113.79 123.37 69.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.506 HH21 HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -97.82 116.18 29.52 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.313 -0.867 . . . . 0.0 109.342 -179.007 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.425 HG12 ' CB ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -131.8 140.81 47.22 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 O-C-N 121.451 -0.781 . . . . 0.0 108.909 179.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.648 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.4 m -107.26 158.77 7.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 O-C-N 121.322 -0.862 . . . . 0.0 108.808 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.926 ' CG ' HD22 ' A' ' 131' ' ' LEU . 4.4 m-85 -141.91 155.84 45.5 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.483 -0.887 . . . . 0.0 109.826 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -101.04 106.13 42.79 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.405 -0.81 . . . . 0.0 110.13 -179.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 126' ' ' ILE . 55.3 Cg_exo -47.75 -26.46 6.95 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.685 2.256 . . . . 0.0 112.5 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 -79.15 -18.6 52.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.248 -0.907 . . . . 0.0 110.188 -179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . . . . . . . . . 67.4 m-70 -121.06 -7.62 9.4 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.025 -1.047 . . . . 0.0 109.647 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.511 HD12 ' HA3' ' A' ' 85' ' ' GLY . 0.1 OUTLIER -154.1 156.74 4.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.433 0 O-C-N 121.226 -0.921 . . . . 0.0 110.488 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 33.0 t -108.17 147.68 30.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.557 -0.715 . . . . 0.0 109.73 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.723 ' CZ ' HD23 ' A' ' 132' ' ' LEU . 2.1 t80 -49.79 -21.07 0.99 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 109.442 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -63.62 -23.44 67.38 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.147 -0.97 . . . . 0.0 109.128 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.548 ' O ' ' C ' ' A' ' 131' ' ' LEU . 2.5 mt-10 -71.41 -71.53 0.26 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.092 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.995 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -35.3 -47.87 0.44 Allowed 'General case' 0 N--CA 1.485 1.298 0 O-C-N 121.088 -1.007 . . . . 0.0 109.579 -179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.824 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.8 pp -75.82 -28.93 58.49 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.095 -1.003 . . . . 0.0 111.385 -179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.729 ' N ' HD12 ' A' ' 132' ' ' LEU . 4.3 mtmt -70.41 -58.16 4.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 120.671 -1.268 . . . . 0.0 110.312 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.714 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 0.4 OUTLIER -48.76 -28.55 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.24 -0.913 . . . . 0.0 108.897 -179.505 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.704 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 38.5 t80 -65.25 -54.8 23.93 Favored 'General case' 0 C--N 1.289 -2.045 0 C-N-CA 119.664 -0.814 . . . . 0.0 109.815 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.557 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 86.8 m95 -71.78 -42.54 67.02 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.356 -1.465 . . . . 0.0 109.79 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -49.8 -35.37 22.49 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.0 111.021 -178.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.714 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 11.4 p30 -127.83 72.4 1.4 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.946 -1.096 . . . . 0.0 111.275 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.847 ' O ' HG23 ' A' ' 223' ' ' THR . 6.3 m80 -150.6 151.62 32.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.284 -0.885 . . . . 0.0 109.611 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.612 ' OD1' ' NE2' ' A' ' 147' ' ' GLN . 0.0 OUTLIER -61.38 177.77 0.33 Allowed Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.174 -1.047 . . . . 0.0 108.174 178.746 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HB3' HD12 ' A' ' 181' ' ' LEU . 3.4 Cg_endo -79.87 -91.81 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.16 1.907 . . . . 0.0 111.405 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.686 HG22 ' HA ' ' A' ' 189' ' ' ILE . 32.9 p -123.89 54.96 1.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.305 -0.872 . . . . 0.0 109.42 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.597 ' C ' ' H ' ' A' ' 145' ' ' MET . 3.7 mt-30 -101.68 51.46 0.84 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -0.872 . . . . 0.0 109.837 -179.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.685 ' H ' HG21 ' A' ' 190' ' ' THR . . . -61.07 10.13 0.06 OUTLIER Glycine 0 N--CA 1.488 2.146 0 C-N-CA 119.177 -1.487 . . . . 0.0 109.729 -179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.597 ' H ' ' C ' ' A' ' 143' ' ' GLN . 2.3 ptt? -117.13 13.23 14.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.01 -1.288 . . . . 0.0 109.028 178.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.487 ' HD2' ' N ' ' A' ' 147' ' ' GLN . 4.9 tmm_? -178.32 152.68 0.7 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.491 -0.755 . . . . 0.0 109.001 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.612 ' NE2' ' OD1' ' A' ' 140' ' ' ASP . 0.6 OUTLIER -134.53 76.58 1.65 Allowed 'General case' 0 N--CA 1.482 1.149 0 O-C-N 120.409 -1.432 . . . . 0.0 108.8 179.354 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 66.76 -110.37 3.44 Favored Glycine 0 C--N 1.298 -1.549 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -80.05 -32.84 39.38 Favored 'General case' 0 C--N 1.273 -2.727 0 CA-C-N 114.453 -0.874 . . . . 0.0 111.901 -178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -91.52 148.39 22.32 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.171 -1.581 . . . . 0.0 109.339 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . . . . . . . . . 14.2 p90 -136.91 156.84 47.95 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.912 -1.118 . . . . 0.0 111.173 -179.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 131.94 179.47 16.23 Favored Glycine 0 N--CA 1.495 2.593 0 N-CA-C 110.008 -1.237 . . . . 0.0 110.008 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.7 -18.62 37.34 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.187 -1.184 . . . . 0.0 109.352 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.499 ' NE2' ' CE2' ' A' ' 155' ' ' TYR . 5.9 pt20 -88.61 4.25 47.66 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.232 -0.917 . . . . 0.0 109.123 179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.499 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 67.7 m-85 -122.06 52.37 1.28 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.337 -0.852 . . . . 0.0 109.633 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.596 ' O ' ' O ' ' A' ' 70' ' ' MET . 2.4 mtm105 -108.43 -170.69 1.72 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.504 -0.748 . . . . 0.0 109.152 179.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.72 126.14 35.9 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 105.04 -2.207 . . . . 0.0 105.04 177.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.474 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -133.52 131.84 40.26 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 117.443 -1.703 . . . . 0.0 111.104 -177.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.769 HG13 ' CG2' ' A' ' 191' ' ' THR . 1.2 m -135.55 119.0 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 118.884 -1.126 . . . . 0.0 109.562 178.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.491 ' CE2' ' HG3' ' A' ' 197' ' ' GLN . 2.8 m-30 -116.02 129.76 24.94 Favored Pre-proline 0 N--CA 1.494 1.745 0 N-CA-C 108.067 -1.086 . . . . 0.0 108.067 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -77.73 168.34 22.57 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.381 2.054 . . . . 0.0 112.131 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.72 -20.49 20.09 Favored 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.907 -1.121 . . . . 0.0 109.222 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.52 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER 177.18 -171.04 0.09 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 -179.922 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.54 ' O ' ' OE1' ' A' ' 168' ' ' GLU . . . -53.12 -15.25 0.8 Allowed 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 122.995 1.379 . . . . 0.0 108.52 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.52 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.6 t -55.75 -64.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.891 0 CA-C-N 113.996 -1.456 . . . . 0.0 109.891 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.47 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 18.1 mt-30 -78.74 -20.92 48.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.556 -0.715 . . . . 0.0 110.651 -179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 12.4 ttp -52.2 -31.96 34.16 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.982 -1.074 . . . . 0.0 110.514 -178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.54 ' OE1' ' O ' ' A' ' 164' ' ' ALA . 2.8 mp0 -75.35 -36.25 61.01 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.772 -1.205 . . . . 0.0 109.79 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.566 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.77 -47.33 7.11 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.153 -0.967 . . . . 0.0 110.086 -179.545 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.445 ' N ' ' O ' ' A' ' 166' ' ' GLN . . . -51.75 -63.15 1.23 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.214 -0.929 . . . . 0.0 109.546 -179.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.07 -34.69 44.85 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.046 -1.034 . . . . 0.0 108.974 179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 19.9 ttm-85 -74.93 -35.33 62.18 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -0.902 . . . . 0.0 109.192 179.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.566 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.9 OUTLIER -59.18 -46.18 89.09 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.395 -0.816 . . . . 0.0 109.92 -179.806 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.475 ' HA ' ' CH2' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -72.39 -25.23 61.43 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.091 -1.005 . . . . 0.0 109.744 -179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.447 ' N ' ' HG3' ' A' ' 174' ' ' LYS . 69.5 mt-10 -73.19 -56.82 4.58 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.208 -0.932 . . . . 0.0 109.664 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.571 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 15.7 pt-20 -53.25 -45.55 68.81 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.699 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.571 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -68.17 -20.54 64.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.201 -0.937 . . . . 0.0 109.631 -179.813 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.501 HE21 ' HB2' ' A' ' 182' ' ' SER . 43.3 tp60 -74.64 -38.19 62.56 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -77.56 -29.79 52.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.163 -0.96 . . . . 0.0 109.674 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 176' ' ' GLU . 99.2 t -74.38 -54.09 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 109.724 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.487 HD12 ' HB3' ' A' ' 141' ' ' PRO . 4.5 mm? -64.31 -42.31 96.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.22 -0.925 . . . . 0.0 109.737 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.501 ' HB2' HE21 ' A' ' 178' ' ' GLN . 23.0 t -56.38 -6.22 0.26 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.149 -0.969 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.454 ' H ' ' C ' ' A' ' 181' ' ' LEU . 3.8 tttp -88.09 -10.55 49.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.94 . . . . 0.0 109.605 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.747 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.4 OUTLIER -108.4 35.96 2.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.27 -0.894 . . . . 0.0 109.702 -179.835 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.747 ' ND2' ' O ' ' A' ' 184' ' ' HIS . 0.0 OUTLIER 72.96 31.01 1.58 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.525 -0.734 . . . . 0.0 110.004 -179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -105.19 174.65 5.79 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.314 -0.866 . . . . 0.0 109.52 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -129.18 -147.17 6.28 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 189' ' ' ILE . 29.6 Cg_exo -58.79 106.29 0.27 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.542 2.161 . . . . 0.0 111.451 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.686 ' HA ' HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.34 -177.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.244 -0.91 . . . . 0.0 109.834 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.685 HG21 ' H ' ' A' ' 144' ' ' GLY . 1.8 p -133.91 68.68 1.48 Allowed 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.691 0.758 . . . . 0.0 110.275 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.769 ' CG2' HG13 ' A' ' 159' ' ' VAL . 24.5 m -98.39 119.88 37.84 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 177.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.627 ' OD1' ' CZ ' ' A' ' 194' ' ' ARG . 2.0 t70 -75.36 121.04 21.64 Favored 'General case' 0 C--N 1.279 -2.485 0 C-N-CA 119.999 -0.681 . . . . 0.0 109.492 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -132.55 109.57 14.86 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 C-N-CA 119.12 -1.032 . . . . 0.0 110.472 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.681 HH12 ' C10' ' A' ' 21' ' ' MYR . 1.9 ptp180 -166.75 120.73 1.05 Allowed 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.709 ' H ' ' CD ' ' A' ' 195' ' ' GLU . 1.9 pm0 -80.81 -179.32 7.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.986 -1.071 . . . . 0.0 110.529 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.49 22.75 61.78 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 110.665 -0.974 . . . . 0.0 110.665 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.491 ' HG3' ' CE2' ' A' ' 160' ' ' TYR . 53.0 mm-40 -93.31 98.29 11.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.612 -1.522 . . . . 0.0 109.516 179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.58 ' O ' ' HB1' ' A' ' 94' ' ' ALA . 1.4 p -42.98 161.38 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.468 -0.77 . . . . 0.0 109.794 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.415 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 41.3 t80 -109.31 131.43 55.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.344 -0.848 . . . . 0.0 109.505 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.408 ' HB3' ' CE2' ' A' ' 93' ' ' PHE . 6.8 m-85 -127.54 98.65 5.3 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.25 -0.906 . . . . 0.0 109.504 -179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.67 131.52 39.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.982 -1.074 . . . . 0.0 110.584 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.523 ' O ' ' CG1' ' A' ' 44' ' ' VAL . . . -83.58 179.14 7.7 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 178.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 203' ' ' GLU . 1.0 OUTLIER -74.64 170.57 15.54 Favored 'General case' 0 C--N 1.286 -2.153 0 O-C-N 121.655 -0.653 . . . . 0.0 109.479 179.514 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.481 ' O ' ' OD1' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -63.93 -13.43 45.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.264 -0.897 . . . . 0.0 109.841 179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.551 ' O ' ' CD2' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -76.77 -15.75 59.66 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.912 -1.118 . . . . 0.0 110.182 -179.288 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 74' ' ' TRP . 63.5 m-70 -107.35 8.89 29.94 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.001 -1.079 . . . . 0.0 111.677 -177.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.751 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.7 mm-40 -119.88 -149.98 0.45 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.822 -1.174 . . . . 0.0 112.087 -177.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.691 ' HA ' ' CZ3' ' A' ' 81' ' ' TRP . 12.2 mp0 -36.25 -2.49 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.255 0 CA-C-N 114.45 -1.25 . . . . 0.0 113.73 -178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.751 ' N ' ' O ' ' A' ' 207' ' ' GLN . 10.6 p90 -46.79 -34.75 5.54 Favored 'General case' 0 N--CA 1.523 3.218 0 C-N-CA 117.373 -1.731 . . . . 0.0 110.705 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.756 HD12 ' CH2' ' A' ' 81' ' ' TRP . 1.7 mt -49.44 -10.21 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.177 0 O-C-N 120.403 -1.436 . . . . 0.0 110.042 -177.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' O ' ' A' ' 209' ' ' TYR . 11.4 p -53.21 -37.02 61.63 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 179.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 10.9 mttp -84.75 -36.74 21.55 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.1 66.79 3.09 Favored Pre-proline 0 N--CA 1.491 1.586 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.594 ' O ' ' NH1' ' A' ' 78' ' ' ARG . 10.0 Cg_endo -54.9 -39.76 88.77 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.997 2.465 . . . . 0.0 113.16 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.596 ' C ' HH12 ' A' ' 78' ' ' ARG . 29.6 p30 -61.23 -5.6 1.66 Allowed 'General case' 0 C--N 1.286 -2.168 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.787 -179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.665 ' O ' ' N ' ' A' ' 218' ' ' CYS . . . 58.99 84.41 0.04 OUTLIER Glycine 0 N--CA 1.49 2.298 0 C-N-CA 119.655 -1.259 . . . . 0.0 111.561 177.317 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.626 ' OH ' ' CE1' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -48.82 86.48 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 121.017 2.408 . . . . 0.0 109.452 179.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.665 ' N ' ' O ' ' A' ' 216' ' ' GLY . 31.4 p -166.12 -125.15 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.218 0 O-C-N 120.769 -1.207 . . . . 0.0 109.143 -179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.631 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -128.04 -149.94 7.18 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.564 HD23 ' N ' ' A' ' 220' ' ' LEU . 0.1 OUTLIER -114.23 -175.02 2.59 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.36 -1.083 . . . . 0.0 109.641 -179.752 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -66.86 -139.28 0.05 OUTLIER Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.684 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -153.42 -142.02 3.38 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.847 HG23 ' O ' ' A' ' 139' ' ' HIS . 0.8 OUTLIER 33.72 27.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.521 -0.987 . . . . 0.0 109.455 -179.768 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.684 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -79.47 -8.4 87.79 Favored Glycine 0 C--N 1.305 -1.184 0 N-CA-C 108.646 -1.782 . . . . 0.0 108.646 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.467 ' CG1' ' N ' ' A' ' 226' ' ' SER . 1.3 t -49.55 161.25 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.847 -0.796 . . . . 0.0 109.507 -179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.787 ' O ' HD13 ' A' ' 231' ' ' ILE . 0.1 OUTLIER -99.14 108.95 21.69 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.273 1.035 . . . . 0.0 109.202 179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.592 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.1 OUTLIER -73.17 -68.84 0.35 Allowed Pre-proline 0 C--N 1.279 -2.46 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.154 179.456 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.592 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 94.9 Cg_endo -79.65 -35.75 0.73 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.026 1.817 . . . . 0.0 110.122 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.565 ' O ' ' C ' ' A' ' 230' ' ' ALA . 3.9 mmm -55.34 154.16 6.4 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-O 121.794 0.807 . . . . 0.0 109.949 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.565 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -30.31 138.81 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.664 0 CA-C-O 121.217 0.532 . . . . 0.0 109.868 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.787 HD13 ' O ' ' A' ' 226' ' ' SER . 2.9 tp -151.52 119.48 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.994 0 O-C-N 121.311 -0.868 . . . . 0.0 109.339 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.517 ' C ' ' O ' ' A' ' 231' ' ' ILE . 0.2 OUTLIER -35.41 110.74 0.11 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 109.551 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.301 0 O-C-N 121.227 -0.921 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.681 ' C10' HH12 ' A' ' 194' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.526 ' C ' ' O ' ' A' ' 22' ' ' GLY . 0.6 OUTLIER 35.96 83.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -1.123 . . . . 0.0 109.275 -179.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.677 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 25.3 m -50.64 -19.42 0.91 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.362 -0.836 . . . . 0.0 110.077 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.692 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -78.04 -94.72 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-O 123.199 1.476 . . . . 0.0 110.435 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 28' ' ' VAL . 0.8 OUTLIER -49.1 9.11 0.0 OUTLIER 'General case' 0 C--N 1.258 -3.4 0 CA-C-N 113.453 -1.703 . . . . 0.0 111.517 -178.721 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.692 ' N ' ' O ' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -80.09 21.85 0.55 Allowed 'General case' 0 N--CA 1.492 1.651 0 CA-C-O 124.084 1.897 . . . . 0.0 108.768 -179.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.626 ' H ' ' C ' ' A' ' 26' ' ' SER . 20.1 t -154.13 55.08 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.261 -3.27 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.452 HG12 ' HB2' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -76.82 135.78 25.95 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 -173.623 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.472 ' OG ' ' CB ' ' A' ' 33' ' ' GLU . 0.1 OUTLIER -82.23 131.28 35.23 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-O 122.151 0.977 . . . . 0.0 110.243 -179.172 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.634 ' O ' ' CD2' ' A' ' 97' ' ' HIS . . . -45.9 -55.68 6.41 Favored 'General case' 0 C--N 1.293 -1.884 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.494 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 69.0 mm-40 -85.03 8.28 18.4 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.765 -1.209 . . . . 0.0 111.73 -178.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.472 ' CB ' ' OG ' ' A' ' 30' ' ' SER . 3.2 tt0 -117.59 -14.3 10.25 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.444 -1.41 . . . . 0.0 111.501 -179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.812 ' C ' HD13 ' A' ' 35' ' ' LEU . . . -67.39 -169.07 0.09 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.541 -1.35 . . . . 0.0 109.45 -179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.997 HD13 ' N ' ' A' ' 35' ' ' LEU . 0.0 OUTLIER -138.11 61.31 26.67 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.178 -0.951 . . . . 0.0 110.348 -179.594 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.738 ' O ' ' N ' ' A' ' 38' ' ' ARG . 44.3 Cg_endo -89.2 -27.12 0.39 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 C-N-CA 123.191 2.594 . . . . 0.0 113.198 -179.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.592 ' C ' ' O ' ' A' ' 36' ' ' PRO . . . -26.1 81.37 0.0 OUTLIER Glycine 0 N--CA 1.495 2.628 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.738 ' N ' ' O ' ' A' ' 36' ' ' PRO . 1.1 ttt85 -139.78 124.88 18.72 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.048 -1.266 . . . . 0.0 109.548 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 m -88.13 37.78 0.82 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.314 -0.866 . . . . 0.0 110.224 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -77.08 113.28 29.17 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.935 -1.103 . . . . 0.0 109.707 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -57.7 169.75 2.32 Favored 'Trans proline' 0 N--CA 1.494 1.532 0 C-N-CA 122.167 1.911 . . . . 0.0 112.416 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.591 ' CG2' ' O ' ' A' ' 201' ' ' TYR . 0.1 OUTLIER -139.05 71.34 41.15 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.331 -0.856 . . . . 0.0 109.312 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.75 ' O ' HG13 ' A' ' 44' ' ' VAL . 71.5 Cg_endo -81.37 149.86 17.06 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 123.06 2.507 . . . . 0.0 112.751 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.75 HG13 ' O ' ' A' ' 43' ' ' PRO . 3.2 m -163.37 158.92 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.416 -0.802 . . . . 0.0 109.493 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.851 ' O ' HG23 ' A' ' 45' ' ' THR . 15.2 t -59.43 95.53 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.248 -0.908 . . . . 0.0 109.821 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.586 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.91 -21.79 22.38 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.235 -0.916 . . . . 0.0 110.759 -179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.6 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.8 OUTLIER -90.93 100.15 13.06 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 116.344 -2.143 . . . . 0.0 108.03 178.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.631 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 7.8 t-80 -31.48 132.31 0.1 Allowed 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.5 ' CD2' ' HD3' ' A' ' 212' ' ' LYS . 0.1 OUTLIER -82.72 -11.43 58.32 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.104 -0.998 . . . . 0.0 111.234 -177.141 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.648 HG22 ' OG ' ' A' ' 211' ' ' SER . 21.9 t -85.6 -36.34 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.764 -1.21 . . . . 0.0 108.207 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -110.05 -45.14 3.65 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.619 -0.676 . . . . 0.0 110.011 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 101.22 3.11 54.27 Favored Glycine 0 N--CA 1.486 2.023 0 N-CA-C 109.217 -1.553 . . . . 0.0 109.217 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 66.7 m-20 -76.32 -116.83 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 106.889 -1.523 . . . . 0.0 106.889 178.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.547 ' C ' ' OH ' ' A' ' 87' ' ' TYR . 0.1 OUTLIER -129.89 174.06 10.1 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 123.497 1.617 . . . . 0.0 109.606 177.563 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.762 ' O ' HG13 ' A' ' 56' ' ' VAL . 6.9 p -142.34 38.57 1.56 Allowed 'General case' 0 C--N 1.263 -3.17 0 CA-C-N 112.928 -1.942 . . . . 0.0 110.07 179.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 55' ' ' THR . 4.6 m -163.89 138.7 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.995 -1.066 . . . . 0.0 109.795 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.48 ' HA ' ' C ' ' A' ' 58' ' ' PRO . 8.1 pt-20 -71.78 177.33 1.71 Allowed Pre-proline 0 N--CA 1.489 1.523 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.48 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 2.9 Cg_exo -49.26 143.62 6.21 Favored 'Cis proline' 0 N--CA 1.496 1.622 0 N-CA-C 116.067 1.526 . . . . 0.0 116.067 -0.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.474 ' CE2' ' HB3' ' A' ' 57' ' ' GLU . 37.6 m-85 -94.56 110.44 49.04 Favored Pre-proline 0 C--N 1.272 -2.768 0 CA-C-N 112.435 -2.166 . . . . 0.0 109.089 179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.577 ' O ' ' OG1' ' A' ' 63' ' ' THR . 50.1 Cg_exo -50.38 133.45 36.88 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.331 2.021 . . . . 0.0 112.387 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.412 ' C ' ' O ' ' A' ' 60' ' ' PRO . 50.8 mt-10 -43.59 157.64 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -0.909 . . . . 0.0 109.656 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.542 ' O ' HG23 ' A' ' 63' ' ' THR . . . 83.14 32.0 27.08 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.577 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.8 OUTLIER -158.71 137.93 11.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -1.174 . . . . 0.0 109.474 -179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.663 ' N ' ' OE1' ' A' ' 64' ' ' GLN . 20.6 mp0 -111.55 156.67 21.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.296 -0.878 . . . . 0.0 109.123 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.742 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -140.78 114.62 8.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.157 -0.965 . . . . 0.0 109.904 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -110.64 -170.71 1.69 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.213 -0.93 . . . . 0.0 108.802 179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 63.6 t -144.14 133.55 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.049 -1.657 . . . . 0.0 109.518 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.713 ' CE2' ' O ' ' A' ' 131' ' ' LEU . 25.9 m-85 -126.41 145.22 50.56 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.828 -1.17 . . . . 0.0 109.293 178.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -118.03 108.93 1.72 Allowed Glycine 0 N--CA 1.482 1.715 0 N-CA-C 108.981 -1.648 . . . . 0.0 108.981 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.62 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.1 OUTLIER -114.3 -87.84 0.57 Allowed 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.403 -1.057 . . . . 0.0 108.502 179.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.569 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -148.19 -152.19 5.63 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 108.034 -2.026 . . . . 0.0 108.034 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.671 ' O ' ' N ' ' A' ' 74' ' ' TRP . 0.1 OUTLIER -36.18 104.13 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.069 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.779 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -50.67 7.28 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.175 -0.953 . . . . 0.0 111.316 -178.143 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.679 ' HB3' HD11 ' A' ' 210' ' ' LEU . 37.9 m0 -75.27 -52.23 11.35 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.656 -1.278 . . . . 0.0 109.417 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.427 ' CA ' ' HB2' ' A' ' 218' ' ' CYS . . . -88.8 -26.96 25.47 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 110.349 -1.1 . . . . 0.0 110.349 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.62 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . -64.85 -45.2 87.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.105 -1.233 . . . . 0.0 110.173 -179.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.486 ' OE1' HG13 ' A' ' 91' ' ' VAL . 4.2 tt0 -83.03 -14.77 53.27 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.001 -1.062 . . . . 0.0 110.126 -179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.536 ' O ' HG13 ' A' ' 82' ' ' VAL . 51.4 ttp85 -68.6 -36.12 78.27 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.0 110.067 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -70.49 15.76 0.09 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.0 -179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.648 ' CZ ' ' CG1' ' A' ' 134' ' ' VAL . 93.2 m-85 -123.73 -42.25 2.2 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.113 -0.992 . . . . 0.0 110.644 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.601 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.1 p90 -68.77 6.88 0.76 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.553 -1.342 . . . . 0.0 109.268 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 78' ' ' ARG . 1.5 m -109.53 15.97 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.441 -0.787 . . . . 0.0 109.369 -179.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.9 mt -110.84 154.64 23.71 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.267 -0.896 . . . . 0.0 109.225 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.98 138.42 31.5 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-O 121.353 0.596 . . . . 0.0 109.561 -179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 107.84 -27.35 14.96 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 108.709 -1.756 . . . . 0.0 108.709 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -70.26 137.56 23.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.53 -0.982 . . . . 0.0 108.999 179.63 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.547 ' OH ' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -79.94 -46.69 16.27 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.666 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.672 ' OG ' ' NE2' ' A' ' 90' ' ' GLN . 1.4 p -165.7 -170.21 1.74 Allowed 'General case' 0 C--N 1.298 -1.649 0 C-N-CA 120.066 -0.654 . . . . 0.0 109.718 179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.631 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 41.4 p -151.16 146.42 26.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.35 -0.844 . . . . 0.0 108.989 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.672 ' NE2' ' OG ' ' A' ' 88' ' ' SER . 6.8 mp0 -144.59 155.8 43.82 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.137 -0.977 . . . . 0.0 110.13 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.761 HG12 ' HA ' ' A' ' 117' ' ' VAL . 0.1 OUTLIER -141.05 151.95 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.2 42.82 Favored Glycine 0 N--CA 1.489 2.191 0 C-N-CA 119.475 -1.345 . . . . 0.0 110.374 -179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.611 ' N ' ' O ' ' A' ' 200' ' ' TYR . 1.2 m-85 -80.1 171.68 14.77 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.584 -0.951 . . . . 0.0 109.252 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.67 ' O ' ' N ' ' A' ' 114' ' ' ALA . . . -176.95 168.73 2.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.188 -0.945 . . . . 0.0 109.667 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 64.64 20.88 66.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 110.061 -1.215 . . . . 0.0 110.061 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.564 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -93.83 173.72 33.77 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 107.288 -2.325 . . . . 0.0 107.288 178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.731 ' CD2' ' HB3' ' A' ' 34' ' ' ALA . 1.2 m-70 -91.66 -111.83 0.09 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.544 -1.563 . . . . 0.0 111.404 -178.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.604 ' O ' ' C ' ' A' ' 99' ' ' ARG . 5.9 t -75.98 -172.88 2.12 Favored 'General case' 0 C--N 1.31 -1.122 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.604 ' C ' ' O ' ' A' ' 98' ' ' THR . 0.1 OUTLIER -37.81 139.26 0.32 Allowed 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 -179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.919 ' H ' ' ND2' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -128.38 144.87 53.54 Favored Pre-proline 0 C--N 1.287 -2.128 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -172.414 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.619 ' O ' ' O ' ' A' ' 100' ' ' ASN . 73.5 Cg_exo -45.68 -147.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.314 -1.27 0 C-N-CA 124.133 3.222 . . . . 0.0 112.214 173.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.543 HG22 ' HG3' ' A' ' 105' ' ' GLU . 1.5 t -125.53 176.1 7.08 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 120.971 -1.08 . . . . 0.0 111.514 -178.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.786 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 0.1 OUTLIER -50.81 -41.1 57.09 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 121.531 0.682 . . . . 0.0 110.397 -179.935 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.543 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 12.7 tttp -72.59 -33.44 66.72 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.417 -0.802 . . . . 0.0 110.146 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.676 ' C ' ' HZ1' ' A' ' 110' ' ' LYS . 1.9 mm-40 -81.71 -41.2 21.65 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 120.827 -1.171 . . . . 0.0 110.47 -179.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.919 HG12 ' CG2' ' A' ' 111' ' ' THR . 28.3 m -56.29 -23.32 16.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.061 -1.024 . . . . 0.0 109.85 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.464 ' C ' ' O ' ' A' ' 106' ' ' VAL . 69.0 m -41.66 -15.48 0.01 OUTLIER 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.687 ' N ' ' O ' ' A' ' 106' ' ' VAL . 35.6 m -102.67 19.81 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.434 -0.791 . . . . 0.0 110.006 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER 60.08 -9.38 0.05 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.92 -1.112 . . . . 0.0 109.647 179.324 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.679 ' H ' ' C ' ' A' ' 108' ' ' SER . 0.0 OUTLIER -44.67 -14.32 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.818 0 O-C-N 121.739 -0.6 . . . . 0.0 111.691 -178.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.919 ' CG2' HG12 ' A' ' 106' ' ' VAL . 1.0 OUTLIER -122.09 -10.0 8.63 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.554 -1.342 . . . . 0.0 111.481 179.103 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.577 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 60.74 24.87 62.84 Favored Glycine 0 N--CA 1.484 1.879 0 C-N-CA 118.527 -1.796 . . . . 0.0 109.771 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.71 ' HE2' ' CG ' ' A' ' 100' ' ' ASN . 1.8 m-70 -78.83 172.41 13.8 Favored 'General case' 0 N--CA 1.507 2.4 0 O-C-N 120.992 -1.299 . . . . 0.0 109.274 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.67 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -137.25 125.26 22.81 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.674 ' OE2' ' CZ ' ' A' ' 73' ' ' PHE . 3.5 mt-10 -66.33 119.7 12.02 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.151 -0.968 . . . . 0.0 109.232 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 160' ' ' TYR . 0.0 OUTLIER -125.05 169.74 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.271 -0.893 . . . . 0.0 109.633 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.761 ' HA ' HG12 ' A' ' 91' ' ' VAL . 15.8 m -127.13 128.22 70.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.376 -0.827 . . . . 0.0 109.519 179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' A' ' 90' ' ' GLN . 8.9 ttm180 -103.48 111.83 24.46 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.551 -0.718 . . . . 0.0 109.886 -179.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -131.72 112.89 21.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.21 -0.931 . . . . 0.0 109.417 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.518 HG12 ' HB3' ' A' ' 65' ' ' MET . 0.8 OUTLIER -98.49 160.72 3.12 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.213 -0.929 . . . . 0.0 108.94 179.699 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.53 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 10.5 p90 -141.23 169.5 17.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.926 -1.109 . . . . 0.0 110.581 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.513 ' C ' ' OE2' ' A' ' 124' ' ' GLU . 60.7 mtp180 -110.05 114.1 56.35 Favored Pre-proline 0 N--CA 1.489 1.497 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.53 ' O ' ' N ' ' A' ' 125' ' ' HIS . 38.3 Cg_exo -42.94 -63.97 0.29 Allowed 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.927 2.418 . . . . 0.0 113.022 -179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.692 ' H ' ' CD ' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -46.45 -10.67 0.02 OUTLIER 'General case' 0 C--N 1.284 -2.25 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.82 -179.175 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.53 ' N ' ' O ' ' A' ' 123' ' ' PRO . 36.1 m80 -126.13 -18.86 4.89 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.617 -1.302 . . . . 0.0 110.716 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.484 HG22 ' CD1' ' A' ' 121' ' ' TYR . 0.1 OUTLIER -154.59 158.32 3.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 O-C-N 120.873 -1.142 . . . . 0.0 110.212 -179.526 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 88.5 p -108.8 153.19 23.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.381 -0.825 . . . . 0.0 110.369 -179.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.488 ' C ' ' N ' ' A' ' 130' ' ' GLU . 25.1 t80 -53.63 -30.1 41.19 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.437 ' HA ' ' CD2' ' A' ' 132' ' ' LEU . 3.0 mp0 -47.35 -19.26 0.15 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.488 ' N ' ' C ' ' A' ' 128' ' ' PHE . 1.5 mm-40 -73.84 -63.02 1.3 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 119.886 -0.725 . . . . 0.0 109.827 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.713 ' O ' ' CE2' ' A' ' 68' ' ' PHE . 7.2 mt -44.74 -45.74 10.08 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.253 -0.904 . . . . 0.0 108.785 -179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.891 HD12 ' C ' ' A' ' 132' ' ' LEU . 2.5 pp -75.04 -21.96 58.72 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.879 -1.138 . . . . 0.0 110.495 -179.622 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.675 ' N ' HD12 ' A' ' 132' ' ' LEU . 0.4 OUTLIER -69.94 -68.13 0.44 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.736 -1.227 . . . . 0.0 110.057 -179.595 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.727 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 38.9 t -58.3 -17.22 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.205 -0.934 . . . . 0.0 109.64 -179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.58 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 7.2 t80 -72.45 -60.27 2.31 Favored 'General case' 0 C--N 1.294 -1.835 0 O-C-N 120.844 -1.16 . . . . 0.0 110.374 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.658 ' CB ' ' CE2' ' A' ' 177' ' ' TYR . 94.1 m95 -72.06 -52.84 14.94 Favored 'General case' 0 N--CA 1.503 2.2 0 O-C-N 120.468 -1.395 . . . . 0.0 110.348 -179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' A' ' 136' ' ' TRP . 4.1 tt0 -36.84 -28.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.557 -0.714 . . . . 0.0 111.86 -177.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.727 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.7 p30 -124.0 64.76 1.05 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.609 -1.307 . . . . 0.0 111.734 -178.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.824 ' O ' HG23 ' A' ' 223' ' ' THR . 13.0 m80 -147.95 161.25 41.71 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.201 -0.937 . . . . 0.0 109.056 178.159 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.669 ' CG ' HE22 ' A' ' 143' ' ' GLN . 0.9 OUTLIER -91.77 160.32 36.46 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 186' ' ' PHE . 79.8 Cg_exo -32.62 -92.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.789 0 C-N-CA 122.572 2.181 . . . . 0.0 111.792 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.707 ' OG1' ' N ' ' A' ' 190' ' ' THR . 0.7 OUTLIER -122.21 14.77 10.56 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.793 -1.192 . . . . 0.0 109.005 179.241 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.669 HE22 ' CG ' ' A' ' 140' ' ' ASP . 3.5 mt-30 -55.4 71.41 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.335 -0.853 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.691 ' N ' ' O ' ' A' ' 142' ' ' THR . . . -84.61 10.17 62.84 Favored Glycine 0 N--CA 1.485 1.959 0 N-CA-C 108.55 -1.82 . . . . 0.0 108.55 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.97 15.53 15.14 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 148' ' ' GLY . 4.3 ttm180 179.3 133.62 0.09 Allowed 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.57 -0.852 . . . . 0.0 109.326 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.601 ' OE1' ' O ' ' A' ' 70' ' ' MET . 2.0 tp60 -109.54 63.67 0.6 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 119.731 -1.856 . . . . 0.0 107.894 178.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.448 ' O ' ' CD ' ' A' ' 146' ' ' ARG . . . 91.96 -118.07 5.41 Favored Glycine 0 C--N 1.301 -1.413 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 -178.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -78.63 -32.75 47.54 Favored 'General case' 0 C--N 1.267 -3.008 0 CA-C-N 114.458 -0.871 . . . . 0.0 111.434 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 146' ' ' ARG . 0.0 OUTLIER -76.95 117.46 18.56 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.28 -1.513 . . . . 0.0 109.304 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 35.6 p90 -109.21 131.89 54.64 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.928 . . . . 0.0 110.716 -179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . 170.06 164.51 25.9 Favored Glycine 0 N--CA 1.495 2.609 0 C-N-CA 119.318 -1.42 . . . . 0.0 111.023 179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.574 ' OG1' ' OE2' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -72.13 -23.42 61.3 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.589 -0.948 . . . . 0.0 109.629 179.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.718 ' CD ' ' H ' ' A' ' 154' ' ' GLN . 7.2 pm0 -89.17 3.7 51.04 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.255 -0.903 . . . . 0.0 110.2 -178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.453 ' CE2' ' NE2' ' A' ' 154' ' ' GLN . 22.5 m-85 -112.59 50.03 0.89 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.12 -0.987 . . . . 0.0 109.37 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.517 ' CG ' ' O ' ' A' ' 144' ' ' GLY . 1.6 mtm180 -97.37 -178.65 4.23 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.554 -0.716 . . . . 0.0 109.236 179.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.543 ' O ' ' N ' ' A' ' 192' ' ' ASP . 3.8 t -93.9 112.95 24.87 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 104.016 -2.587 . . . . 0.0 104.016 176.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.487 ' HA ' ' H ' ' A' ' 192' ' ' ASP . . . -145.17 123.18 12.06 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 117.866 -1.533 . . . . 0.0 112.036 -175.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' A' ' 191' ' ' THR . 4.5 t -112.26 127.98 69.16 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.708 0 C-N-CA 119.411 -0.916 . . . . 0.0 108.689 177.692 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.615 ' CE2' HG11 ' A' ' 116' ' ' VAL . 11.5 m-85 -112.88 93.02 22.55 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.323 -0.86 . . . . 0.0 109.404 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -49.12 172.91 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.838 2.358 . . . . 0.0 112.186 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.516 HG21 ' SD ' ' A' ' 65' ' ' MET . 0.2 OUTLIER -107.44 -44.24 4.35 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.191 -0.943 . . . . 0.0 109.698 179.942 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.509 ' C ' ' N ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER -175.12 -178.02 1.14 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.12 -0.988 . . . . 0.0 109.902 -179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.429 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -46.18 -24.79 0.5 Allowed 'General case' 0 N--CA 1.491 1.602 0 CA-C-O 123.252 1.501 . . . . 0.0 108.255 -179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.649 ' O ' ' CG ' ' A' ' 168' ' ' GLU . 2.5 t -56.43 -53.81 35.87 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.972 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.38 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.472 ' C ' ' H ' ' A' ' 168' ' ' GLU . 0.4 OUTLIER -78.51 -20.92 49.72 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.336 -178.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . 0.674 ' CG ' HD22 ' A' ' 171' ' ' LEU . 22.8 ttm -52.95 -4.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.061 -1.024 . . . . 0.0 110.731 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . 0.649 ' CG ' ' O ' ' A' ' 165' ' ' VAL . 0.4 OUTLIER -73.58 -68.48 0.5 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.845 -1.159 . . . . 0.0 110.583 -179.542 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.648 ' O ' ' N ' ' A' ' 173' ' ' SER . . . -92.74 -42.92 9.32 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.121 -0.987 . . . . 0.0 111.175 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -51.68 -65.6 0.53 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.968 -1.082 . . . . 0.0 110.169 -178.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.674 HD22 ' CG ' ' A' ' 167' ' ' MET . 0.4 OUTLIER -55.04 -40.14 69.95 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.045 -1.034 . . . . 0.0 109.431 -179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 23.6 ttt85 -74.26 -24.17 59.24 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.648 ' N ' ' O ' ' A' ' 169' ' ' ALA . 0.1 OUTLIER -67.23 -32.31 73.26 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.145 -0.972 . . . . 0.0 109.583 -179.855 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.595 ' CG ' ' N ' ' A' ' 175' ' ' GLU . 8.1 pttm -72.36 -47.14 51.85 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.127 -0.983 . . . . 0.0 109.997 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.595 ' N ' ' CG ' ' A' ' 174' ' ' LYS . 15.3 tt0 -72.86 -30.38 63.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.151 -0.968 . . . . 0.0 110.518 -179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.639 ' OE2' ' CD2' ' A' ' 177' ' ' TYR . 0.7 OUTLIER -73.22 -40.79 64.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.0 -1.062 . . . . 0.0 110.819 -179.052 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.658 ' CE2' ' CB ' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -80.12 -25.61 39.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.748 -1.22 . . . . 0.0 110.238 -179.305 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.461 ' HG3' ' N ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -74.76 -26.44 59.77 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.106 -0.996 . . . . 0.0 109.912 -179.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 178' ' ' GLN . 1.4 ttpm? -77.89 -20.04 53.66 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.257 -0.902 . . . . 0.0 109.548 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.22 -54.11 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -0.9 . . . . 0.0 109.76 -179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 34.1 mt -66.38 -13.09 60.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.16 -0.963 . . . . 0.0 109.75 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.414 ' OG ' ' C ' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -59.48 -40.66 87.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 0.0 109.556 -179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 23.2 mttt -88.04 10.61 18.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.95 . . . . 0.0 109.659 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.516 ' O ' ' CD2' ' A' ' 186' ' ' PHE . 14.3 m170 -104.49 35.11 2.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.226 -0.921 . . . . 0.0 109.42 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.31 48.55 0.88 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.543 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 141' ' ' PRO . 71.7 m-85 -152.5 168.61 24.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 109.31 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -117.83 -144.42 7.67 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -58.66 105.85 0.25 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.24 1.96 . . . . 0.0 110.999 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.544 ' C ' ' OG1' ' A' ' 142' ' ' THR . 0.5 OUTLIER -47.47 166.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.243 -0.911 . . . . 0.0 110.426 -178.746 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.707 ' N ' ' OG1' ' A' ' 142' ' ' THR . 0.8 OUTLIER -95.06 0.48 54.47 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.827 -0.546 . . . . 0.0 111.199 -179.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.714 HG22 HD11 ' A' ' 193' ' ' ILE . 27.2 m -42.87 108.54 0.1 Allowed 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.69 -1.256 . . . . 0.0 108.401 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.772 ' O ' HD13 ' A' ' 193' ' ' ILE . 2.2 t70 -76.91 131.8 38.75 Favored 'General case' 0 C--N 1.281 -2.407 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.84 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.772 HD13 ' O ' ' A' ' 192' ' ' ASP . 7.7 mm -131.97 101.38 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.297 -0.877 . . . . 0.0 109.402 179.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.663 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.3 OUTLIER -143.35 153.54 42.83 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.762 ' H ' ' CD ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -107.02 171.21 7.5 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.976 -1.077 . . . . 0.0 110.01 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.544 ' C ' ' OE1' ' A' ' 197' ' ' GLN . . . 75.37 43.94 23.5 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.591 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 3.6 mm100 -97.41 97.6 9.24 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.318 -1.107 . . . . 0.0 109.539 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . . . . . . . . . 57.5 t -48.3 153.68 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.277 -0.889 . . . . 0.0 109.538 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -109.69 131.88 54.66 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.328 -0.857 . . . . 0.0 109.407 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.611 ' O ' ' N ' ' A' ' 93' ' ' PHE . 4.4 m-85 -131.79 98.35 4.44 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.257 -0.902 . . . . 0.0 109.38 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.591 ' O ' ' CG2' ' A' ' 42' ' ' ILE . 16.0 m-85 -54.02 141.49 28.11 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.331 -0.856 . . . . 0.0 110.462 -179.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.559 ' O ' HG11 ' A' ' 44' ' ' VAL . . . -92.87 -176.08 4.1 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.237 -1.024 . . . . 0.0 108.237 178.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.701 ' OE1' ' N ' ' A' ' 204' ' ' ASP . 0.0 OUTLIER -74.45 175.11 8.04 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 121.441 -0.787 . . . . 0.0 109.064 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.701 ' N ' ' OE1' ' A' ' 203' ' ' GLU . 0.0 OUTLIER -60.42 -54.83 40.87 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.867 -1.146 . . . . 0.0 108.77 179.433 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.573 ' CE1' ' CE1' ' A' ' 209' ' ' TYR . 0.3 OUTLIER -46.89 -11.15 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.316 -0.865 . . . . 0.0 110.052 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.786 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 9.1 m-70 -100.75 9.84 41.9 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.12 -0.987 . . . . 0.0 110.777 -178.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 3.9 mm-40 -130.51 -143.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.532 0 CA-C-O 122.402 1.096 . . . . 0.0 110.688 -178.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.754 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 16.4 mp0 -36.59 -2.76 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 CA-C-N 114.071 -1.422 . . . . 0.0 112.072 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 60.3 t80 -41.01 -50.69 3.32 Favored 'General case' 0 N--CA 1.518 2.958 0 O-C-N 120.865 -1.147 . . . . 0.0 112.083 -177.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 74' ' ' TRP . 63.9 mt -65.97 -25.23 67.01 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.115 -1.615 . . . . 0.0 111.221 -177.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.648 ' OG ' HG22 ' A' ' 50' ' ' VAL . 0.3 OUTLIER -55.91 -52.06 65.45 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.731 -1.231 . . . . 0.0 108.608 179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.636 ' CB ' ' NZ ' ' A' ' 212' ' ' LYS . 7.4 mtmp? -90.34 -12.49 37.54 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.424 -0.798 . . . . 0.0 111.096 -179.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.693 ' OD1' ' CZ ' ' A' ' 209' ' ' TYR . 2.0 m-80 -115.0 95.18 41.08 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.669 -1.269 . . . . 0.0 111.082 -178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.68 12.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 123.326 2.684 . . . . 0.0 111.899 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.578 ' H ' ' C ' ' A' ' 213' ' ' ASN . 8.1 t0 -60.74 -5.42 1.28 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.0 110.44 -178.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.615 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.33 -47.41 0.13 Allowed Glycine 0 N--CA 1.494 2.548 0 C-N-CA 119.592 -1.289 . . . . 0.0 112.492 177.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.615 ' C ' ' O ' ' A' ' 216' ' ' GLY . 25.9 m-85 -27.22 92.57 0.01 OUTLIER 'General case' 0 N--CA 1.514 2.73 0 CA-C-N 119.382 1.591 . . . . 0.0 109.641 -179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.759 ' SG ' ' N ' ' A' ' 219' ' ' GLY . 16.6 p -142.24 -127.62 0.09 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.337 -0.852 . . . . 0.0 109.564 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.759 ' N ' ' SG ' ' A' ' 218' ' ' CYS . . . -152.66 151.0 22.89 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 5.1 mt -104.65 146.25 29.2 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.265 -1.138 . . . . 0.0 109.847 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -71.4 -162.63 5.2 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.243 -1.543 . . . . 0.0 109.243 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.677 ' O ' ' N ' ' A' ' 224' ' ' GLY . . . -155.51 -141.77 3.29 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.824 HG23 ' O ' ' A' ' 139' ' ' HIS . 1.2 p 47.81 1.39 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.47 -1.017 . . . . 0.0 110.082 -179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.677 ' N ' ' O ' ' A' ' 222' ' ' GLY . . . -80.54 11.5 38.83 Favored Glycine 0 C--N 1.306 -1.119 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.642 ' O ' HG13 ' A' ' 225' ' ' VAL . 3.8 p -98.17 119.52 46.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.404 -1.057 . . . . 0.0 109.889 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.447 ' CB ' ' HB3' ' A' ' 229' ' ' MET . 23.5 m -99.41 111.53 23.87 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 122.609 1.195 . . . . 0.0 108.61 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.615 ' C ' ' H ' ' A' ' 229' ' ' MET . 1.3 m -75.13 -72.4 0.18 Allowed Pre-proline 0 C--N 1.284 -2.276 0 CA-C-N 114.875 -1.057 . . . . 0.0 111.16 -178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.581 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 19.3 Cg_endo -60.0 2.19 0.36 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.221 1.948 . . . . 0.0 109.971 -179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.615 ' H ' ' C ' ' A' ' 227' ' ' CYS . 0.0 OUTLIER -55.35 157.99 3.42 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.997 -1.001 . . . . 0.0 110.758 -179.688 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.532 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.97 131.85 0.13 Allowed 'General case' 0 C--N 1.295 -1.803 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.711 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.509 ' HA ' HD13 ' A' ' 231' ' ' ILE . 2.0 mm -133.86 110.13 13.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.27 -0.894 . . . . 0.0 109.284 179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.66 -169.95 1.87 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.379 -0.826 . . . . 0.0 109.459 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.332 0 O-C-N 121.313 -0.867 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.508 ' C8 ' ' NH1' ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -106.44 -141.48 0.37 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.277 -1.131 . . . . 0.0 109.456 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.7 m -60.89 -34.07 74.08 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.312 -0.867 . . . . 0.0 109.493 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.65 ' O ' ' N ' ' A' ' 27' ' ' LYS . . . -65.5 -94.59 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.915 1.341 . . . . 0.0 110.124 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.664 ' N ' ' OE1' ' A' ' 109' ' ' GLU . 37.1 t -56.92 32.28 0.0 OUTLIER 'General case' 0 C--N 1.259 -3.333 0 CA-C-N 113.627 -1.624 . . . . 0.0 110.939 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.67 ' NZ ' ' OG ' ' A' ' 30' ' ' SER . 0.0 OUTLIER -70.39 35.12 0.04 OUTLIER 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 123.269 1.509 . . . . 0.0 110.773 -178.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.737 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.9 OUTLIER 48.47 70.87 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.261 -3.263 0 N-CA-C 101.289 -3.597 . . . . 0.0 101.289 -179.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.503 HD12 ' O ' ' A' ' 25' ' ' ALA . 0.2 OUTLIER -40.41 120.36 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.269 -2.908 0 CA-C-N 109.219 -3.628 . . . . 0.0 115.301 -169.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.67 ' OG ' ' NZ ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -57.96 121.17 9.92 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.776 -1.557 . . . . 0.0 109.874 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.486 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -52.79 -24.7 9.4 Favored 'General case' 0 C--N 1.291 -1.967 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.827 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.631 ' CD ' ' N ' ' A' ' 32' ' ' GLU . 0.1 OUTLIER -73.5 -14.56 61.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 109.793 -179.749 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -107.6 -14.03 14.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.203 -0.936 . . . . 0.0 109.718 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.79 ' HB2' ' CE1' ' A' ' 97' ' ' HIS . . . -53.26 146.09 12.62 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.233 -0.917 . . . . 0.0 110.314 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.833 HD12 ' H ' ' A' ' 37' ' ' GLY . 0.7 OUTLIER -65.66 166.65 13.88 Favored Pre-proline 0 N--CA 1.491 1.595 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_exo -49.72 -24.14 9.37 Favored 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 122.157 1.905 . . . . 0.0 111.206 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.833 ' H ' HD12 ' A' ' 35' ' ' LEU . . . 95.59 -62.67 1.39 Allowed Glycine 0 N--CA 1.492 2.376 0 C-N-CA 120.083 -1.056 . . . . 0.0 110.675 178.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.484 ' HB2' HD22 ' A' ' 100' ' ' ASN . 0.0 OUTLIER -81.25 125.21 30.04 Favored 'General case' 0 N--CA 1.485 1.297 0 O-C-N 120.954 -1.321 . . . . 0.0 109.903 -179.191 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 40' ' ' GLU . 3.6 m -124.73 -5.59 7.52 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.53 ' CB ' ' O ' ' A' ' 39' ' ' THR . 2.5 mt-10 158.55 151.35 0.01 OUTLIER Pre-proline 0 N--CA 1.49 1.544 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.664 ' O ' HD13 ' A' ' 42' ' ' ILE . 57.0 Cg_endo -74.2 134.16 18.89 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 C-N-CA 122.867 2.378 . . . . 0.0 112.187 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.664 HD13 ' O ' ' A' ' 41' ' ' PRO . 14.7 mm -138.12 95.84 10.44 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.146 -0.971 . . . . 0.0 109.729 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -81.38 168.01 16.91 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.829 2.353 . . . . 0.0 112.174 179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.781 HG12 ' N ' ' A' ' 204' ' ' ASP . 29.7 m -129.39 -163.55 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.14 -0.975 . . . . 0.0 109.68 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.823 ' O ' HG23 ' A' ' 45' ' ' THR . 13.2 t -90.66 102.39 15.14 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 0.0 109.849 -179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.57 ' O ' ' OG1' ' A' ' 55' ' ' THR . . . -55.89 -57.8 10.56 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.367 -0.833 . . . . 0.0 110.915 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' O ' ' C ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -71.23 100.8 2.17 Favored 'General case' 0 C--N 1.285 -2.225 0 C-N-CA 115.62 -2.432 . . . . 0.0 108.061 -179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.711 ' NE2' ' CG ' ' A' ' 208' ' ' GLN . 11.4 t-80 -31.63 136.53 0.06 Allowed 'General case' 0 C--N 1.295 -1.774 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.478 ' NE2' ' HD2' ' A' ' 212' ' ' LYS . 37.4 t-80 -74.81 -32.32 61.95 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.348 -0.845 . . . . 0.0 111.09 -178.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.482 HG21 ' CG ' ' A' ' 81' ' ' TRP . 64.2 t -70.27 -47.58 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.892 -1.13 . . . . 0.0 110.448 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.3 t -99.34 -42.72 6.86 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.062 -1.024 . . . . 0.0 110.789 -178.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . 98.03 2.51 58.17 Favored Glycine 0 N--CA 1.485 1.933 0 N-CA-C 108.26 -1.936 . . . . 0.0 108.26 -178.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 47' ' ' LYS . 70.9 m-20 -75.61 -115.66 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.587 ' O ' ' OH ' ' A' ' 87' ' ' TYR . 0.8 OUTLIER -134.23 173.44 11.6 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 123.613 1.673 . . . . 0.0 110.106 177.814 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.57 ' OG1' ' O ' ' A' ' 46' ' ' ALA . 41.3 p -143.72 17.38 1.81 Allowed 'General case' 0 C--N 1.265 -3.105 0 CA-C-N 112.601 -2.091 . . . . 0.0 110.061 178.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.559 ' O ' ' O ' ' A' ' 57' ' ' GLU . 8.6 m -151.96 136.81 10.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 120.969 -1.082 . . . . 0.0 109.368 -179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.559 ' O ' ' O ' ' A' ' 56' ' ' VAL . 8.2 mt-10 -32.4 155.28 0.04 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 CA-C-O 121.971 0.891 . . . . 0.0 110.816 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 89.3 Cg_endo -79.26 165.83 79.98 Favored 'Cis proline' 0 C--N 1.303 -1.865 0 C-N-CA 121.606 -2.248 . . . . 0.0 112.045 -0.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.796 ' CZ ' ' NH2' ' A' ' 118' ' ' ARG . 2.2 m-30 -112.24 150.31 42.32 Favored Pre-proline 0 C--N 1.269 -2.91 0 CA-C-N 114.287 -1.324 . . . . 0.0 109.21 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' O ' ' OG1' ' A' ' 63' ' ' THR . 36.2 Cg_endo -68.01 109.98 2.07 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.727 2.285 . . . . 0.0 112.331 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -46.84 143.42 2.87 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.179 -0.951 . . . . 0.0 109.489 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 102.11 -19.0 50.63 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -82.78 149.1 27.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.272 -1.134 . . . . 0.0 109.533 179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.678 ' OE1' ' N ' ' A' ' 65' ' ' MET . 5.6 tm0? -99.47 146.98 25.77 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.752 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -139.36 114.27 9.42 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.093 -1.004 . . . . 0.0 109.647 -179.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -121.98 -167.98 1.63 Allowed 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.206 -1.035 . . . . 0.0 108.206 179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.9 t -142.35 138.98 29.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 O-C-N 120.126 -1.609 . . . . 0.0 109.47 179.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 1.058 ' O ' HG22 ' A' ' 117' ' ' VAL . 32.9 m-85 -134.63 136.74 43.1 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.19 -0.944 . . . . 0.0 110.224 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -117.06 111.12 2.21 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 178.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.672 ' O ' ' NE2' ' A' ' 147' ' ' GLN . 2.9 mmm -100.01 -89.76 0.33 Allowed 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.429 -1.042 . . . . 0.0 108.519 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.721 ' O ' ' CB ' ' A' ' 72' ' ' CYS . . . -161.3 72.49 0.21 Allowed Glycine 0 N--CA 1.497 2.706 0 C-N-CA 119.669 -1.253 . . . . 0.0 110.216 179.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.721 ' CB ' ' O ' ' A' ' 71' ' ' GLY . 49.0 t 110.52 110.29 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 123.561 0.744 . . . . 0.0 109.29 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.6 ' CD1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -63.99 27.83 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.505 -1.372 . . . . 0.0 110.61 -179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.796 ' O ' HD21 ' A' ' 210' ' ' LEU . 9.0 m0 -94.89 -70.52 0.71 Allowed 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.565 -1.334 . . . . 0.0 109.553 179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -93.69 -2.43 65.12 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.41 ' HB1' ' CG ' ' A' ' 70' ' ' MET . . . -76.34 -37.62 57.07 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.222 -1.164 . . . . 0.0 109.796 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.671 ' N ' ' OE1' ' A' ' 77' ' ' GLU . 2.1 pm0 -82.74 -25.75 32.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.267 -0.896 . . . . 0.0 110.479 -179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.758 ' O ' HG13 ' A' ' 82' ' ' VAL . 6.4 tmm_? -57.94 -56.79 17.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.075 -1.016 . . . . 0.0 110.076 -179.084 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.555 ' O ' HG22 ' A' ' 82' ' ' VAL . 13.0 mttp -43.53 -25.02 0.13 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.286 -0.884 . . . . 0.0 110.098 -179.648 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' CB ' HG11 ' A' ' 119' ' ' VAL . 94.6 m-85 -84.96 -41.75 15.58 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.151 -0.968 . . . . 0.0 111.406 -178.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.523 ' C ' ' CD1' ' A' ' 81' ' ' TRP . 0.7 OUTLIER -69.55 -5.18 22.6 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.318 -1.489 . . . . 0.0 109.259 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.758 HG13 ' O ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -97.74 18.58 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.234 -0.916 . . . . 0.0 109.365 179.368 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 57.1 mt -102.29 152.2 21.34 Favored 'General case' 0 C--N 1.301 -1.515 0 CA-C-O 121.972 0.892 . . . . 0.0 109.402 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -90.0 143.27 26.93 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.411 ' O ' ' CG ' ' A' ' 122' ' ' ARG . . . 95.66 -21.44 44.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 107.864 -2.094 . . . . 0.0 107.864 -179.22 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 120' ' ' VAL . 0.4 OUTLIER -75.53 138.02 21.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 O-C-N 121.775 -0.838 . . . . 0.0 109.529 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.587 ' OH ' ' O ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -81.8 -47.56 12.71 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.29 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.525 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 1.5 t -167.65 -175.13 2.69 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 120.074 -0.65 . . . . 0.0 109.631 179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.476 HG21 ' N ' ' A' ' 81' ' ' TRP . 20.2 p -149.29 164.38 35.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.416 -0.803 . . . . 0.0 109.285 179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.4 ' HG3' ' NE ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -167.85 162.59 13.73 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.316 -0.865 . . . . 0.0 109.163 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.746 HG12 HG12 ' A' ' 117' ' ' VAL . 0.9 OUTLIER -126.67 176.91 6.1 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.274 -0.891 . . . . 0.0 109.365 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 175.53 169.27 37.04 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 109.621 -1.391 . . . . 0.0 109.621 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.502 ' CZ ' ' HA ' ' A' ' 202' ' ' ALA . 3.4 m-85 -89.1 161.59 16.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.528 -0.984 . . . . 0.0 109.99 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.688 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -179.06 -171.37 0.21 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.433 -0.792 . . . . 0.0 109.104 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 54.61 32.1 53.38 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.616 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -139.47 -159.61 8.05 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.424 -1.471 . . . . 0.0 109.424 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.79 ' CE1' ' HB2' ' A' ' 34' ' ' ALA . 4.2 p80 -148.77 78.58 1.41 Allowed 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.313 -1.11 . . . . 0.0 109.909 -179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.581 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.86 149.33 21.55 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.262 -0.898 . . . . 0.0 109.009 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.706 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 10.1 mmt180 -48.83 -106.79 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.471 -0.768 . . . . 0.0 109.319 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.484 HD22 ' HB2' ' A' ' 38' ' ' ARG . 0.6 OUTLIER -112.24 83.82 5.46 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 109.321 179.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.46 171.18 18.06 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.481 2.121 . . . . 0.0 112.265 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.536 ' OG1' ' HB3' ' A' ' 105' ' ' GLU . 21.2 p -122.27 167.31 13.39 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.025 -1.047 . . . . 0.0 110.077 179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.72 ' CD2' ' NE2' ' A' ' 206' ' ' HIS . 2.1 t80 -57.79 -59.33 5.39 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.586 -0.696 . . . . 0.0 110.144 -179.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -57.48 -22.06 41.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.19 -0.944 . . . . 0.0 108.78 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.556 ' OE2' HD11 ' A' ' 35' ' ' LEU . 0.8 OUTLIER -79.06 -61.46 2.01 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.653 -0.655 . . . . 0.0 110.596 -179.188 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.702 HG12 ' OG1' ' A' ' 111' ' ' THR . 15.3 m -52.13 -24.68 5.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.128 -0.982 . . . . 0.0 110.533 -178.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 108' ' ' SER . 1.2 p -52.97 -45.32 67.72 Favored 'General case' 0 C--N 1.296 -1.732 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.695 ' N ' ' SG ' ' A' ' 107' ' ' CYS . 13.6 t -52.23 -6.33 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.191 -1.041 . . . . 0.0 108.191 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.664 ' OE1' ' N ' ' A' ' 26' ' ' SER . 1.9 tt0 65.13 -6.01 0.38 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.585 -0.697 . . . . 0.0 110.359 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.486 ' C ' HG21 ' A' ' 29' ' ' ILE . 7.2 tttt -60.98 -23.01 65.04 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.106 -0.996 . . . . 0.0 109.206 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.702 ' OG1' HG12 ' A' ' 106' ' ' VAL . 25.3 p -94.87 -5.63 44.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.191 -0.943 . . . . 0.0 109.281 179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.475 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 39.41 47.62 2.85 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.688 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 5.6 m-70 -92.26 170.05 10.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.782 -1.422 . . . . 0.0 109.064 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.558 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -123.59 116.1 22.57 Favored 'General case' 0 C--N 1.296 -1.734 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 178.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.546 ' OE2' ' C ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -53.41 143.4 19.25 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.583 -178.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 114' ' ' ALA . 0.0 OUTLIER -151.8 174.59 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 110.125 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.058 HG22 ' O ' ' A' ' 68' ' ' PHE . 33.9 m -135.32 121.62 32.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.796 ' NH2' ' CZ ' ' A' ' 59' ' ' PHE . 8.1 ptm180 -96.98 96.9 8.82 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-O 122.442 1.115 . . . . 0.0 108.7 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.688 HG11 ' CB ' ' A' ' 80' ' ' PHE . 0.0 OUTLIER -103.82 147.26 10.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.78 0 O-C-N 121.141 -0.974 . . . . 0.0 109.4 -178.963 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.664 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 0.4 OUTLIER -114.31 157.25 15.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.664 ' CD1' ' C ' ' A' ' 120' ' ' VAL . 2.8 m-85 -141.89 157.33 45.11 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 118.96 -1.096 . . . . 0.0 110.243 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.42 ' CD ' ' CG2' ' A' ' 63' ' ' THR . 7.7 mmm180 -109.98 99.55 39.52 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.513 -0.742 . . . . 0.0 109.252 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.692 ' O ' ' N ' ' A' ' 125' ' ' HIS . 10.9 Cg_exo -40.32 -67.41 0.12 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 123.111 2.541 . . . . 0.0 113.906 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.401 ' C ' ' O ' ' A' ' 123' ' ' PRO . 9.6 tt0 -40.94 -12.01 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.204 -0.935 . . . . 0.0 110.711 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.692 ' N ' ' O ' ' A' ' 123' ' ' PRO . 5.8 m-70 -135.41 6.77 3.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.614 -1.303 . . . . 0.0 109.69 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.582 ' CD1' ' CD ' ' A' ' 130' ' ' GLU . 0.2 OUTLIER -156.28 148.31 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 109.594 -179.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.6 t -99.47 151.09 21.51 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.229 -0.919 . . . . 0.0 110.255 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.585 ' CZ ' HD21 ' A' ' 132' ' ' LEU . 41.9 t80 -61.72 -19.88 62.89 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.207 -0.933 . . . . 0.0 109.127 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -61.88 -22.56 65.65 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.348 -0.845 . . . . 0.0 108.843 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.599 ' O ' ' C ' ' A' ' 131' ' ' LEU . 3.0 mt-10 -70.15 -70.65 0.28 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.117 -0.99 . . . . 0.0 110.147 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.025 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.8 OUTLIER -35.19 -50.12 0.51 Allowed 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 179.483 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.585 HD21 ' CZ ' ' A' ' 128' ' ' PHE . 4.5 mm? -68.05 -54.47 18.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 0.0 111.503 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 137' ' ' GLU . 3.8 tttm -52.04 -57.66 8.85 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.081 -1.012 . . . . 0.0 111.276 -178.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.555 HG12 ' CZ ' ' A' ' 80' ' ' PHE . 78.8 t -49.83 -33.77 8.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.888 -1.132 . . . . 0.0 110.22 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.701 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 23.2 t80 -71.72 -52.33 18.3 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.831 -1.168 . . . . 0.0 109.923 -179.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.513 ' HE1' ' HB3' ' A' ' 173' ' ' SER . 87.5 m95 -70.42 -32.13 69.6 Favored 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.906 -1.121 . . . . 0.0 110.348 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.597 ' O ' ' OG1' ' A' ' 223' ' ' THR . 7.8 tt0 -72.35 -34.83 68.31 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.572 -0.705 . . . . 0.0 112.259 -177.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -131.37 73.72 1.56 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.44 -1.412 . . . . 0.0 112.361 -176.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.701 ' ND1' ' O ' ' A' ' 135' ' ' PHE . 2.0 p-80 178.15 129.59 0.06 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.81 -1.181 . . . . 0.0 110.518 178.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 221' ' ' GLY . 4.8 m-20 -69.09 111.3 8.08 Favored Pre-proline 0 N--CA 1.492 1.66 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.451 ' HB3' ' CE1' ' A' ' 139' ' ' HIS . 66.5 Cg_endo -91.34 5.69 3.83 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.396 2.064 . . . . 0.0 113.081 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.814 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -123.14 46.23 2.23 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.749 -1.22 . . . . 0.0 111.049 -179.084 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.547 ' C ' ' H ' ' A' ' 145' ' ' MET . 23.5 mt-30 -140.39 67.92 1.36 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.984 -1.072 . . . . 0.0 108.999 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.468 ' N ' HG21 ' A' ' 190' ' ' THR . . . -65.08 13.0 0.23 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.021 -1.232 . . . . 0.0 110.021 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.591 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -115.08 -20.02 10.63 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.033 -1.275 . . . . 0.0 109.057 178.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.544 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 176.85 163.94 0.47 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.672 ' NE2' ' O ' ' A' ' 70' ' ' MET . 15.3 mt-30 -141.44 159.66 41.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.551 -1.343 . . . . 0.0 110.191 179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.409 ' C ' ' O ' ' A' ' 147' ' ' GLN . . . 44.23 -120.55 3.44 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.441 ' O ' ' OD1' ' A' ' 149' ' ' ASN . 36.9 t30 -111.05 26.11 11.05 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 114.34 -0.93 . . . . 0.0 110.542 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.573 ' OD2' ' CD1' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -108.18 91.48 3.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.855 -1.153 . . . . 0.0 109.221 179.773 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 146' ' ' ARG . 3.7 m-85 -69.14 118.62 12.27 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.249 -0.907 . . . . 0.0 109.481 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.591 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 149.8 168.39 15.04 Favored Glycine 0 N--CA 1.492 2.425 0 C-N-CA 119.708 -1.234 . . . . 0.0 110.138 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.631 ' O ' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER -94.18 9.41 38.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.416 -1.049 . . . . 0.0 109.154 179.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.725 ' CD ' ' H ' ' A' ' 154' ' ' GLN . 0.7 OUTLIER -93.25 -1.16 56.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.249 -0.907 . . . . 0.0 109.694 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.682 ' CE2' ' OE1' ' A' ' 154' ' ' GLN . 3.3 m-85 -129.99 57.99 1.67 Allowed 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.024 -1.048 . . . . 0.0 109.879 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.557 ' C ' ' OE1' ' A' ' 147' ' ' GLN . 0.6 OUTLIER -91.51 -175.63 4.27 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.309 -0.869 . . . . 0.0 108.913 179.478 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.737 ' OG ' HG23 ' A' ' 190' ' ' THR . 13.1 p -94.08 118.89 32.17 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.479 ' HB1' ' NH1' ' A' ' 194' ' ' ARG . . . -147.06 110.72 4.95 Favored 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.501 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.605 ' N ' ' O ' ' A' ' 192' ' ' ASP . 8.3 t -98.38 131.28 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 118.769 -1.172 . . . . 0.0 110.739 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.555 ' CE2' HG11 ' A' ' 116' ' ' VAL . 7.8 m-85 -114.01 120.53 38.58 Favored Pre-proline 0 N--CA 1.492 1.638 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -73.51 173.72 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.646 0 C-N-CA 122.574 2.183 . . . . 0.0 113.038 -178.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.446 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -94.62 -19.61 20.31 Favored 'General case' 0 C--N 1.311 -1.072 0 O-C-N 121.227 -0.921 . . . . 0.0 109.215 179.822 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.446 ' CB ' ' O ' ' A' ' 162' ' ' THR . 0.4 OUTLIER 167.69 -163.77 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.453 -0.779 . . . . 0.0 109.084 -179.947 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -58.68 -15.39 11.65 Favored 'General case' 0 N--CA 1.49 1.548 0 CA-C-O 122.952 1.358 . . . . 0.0 108.743 179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 5.9 t -55.76 -62.7 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.823 0 CA-C-N 114.157 -1.383 . . . . 0.0 109.638 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.677 HE22 ' NE2' ' A' ' 64' ' ' GLN . 1.4 mp0 -61.44 -12.06 13.1 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.524 -0.735 . . . . 0.0 109.823 -179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.0 ttm -51.94 -34.09 40.38 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.913 -1.117 . . . . 0.0 110.533 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -75.37 -38.67 59.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.829 -1.169 . . . . 0.0 110.388 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.552 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.78 -41.52 10.07 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.021 -1.049 . . . . 0.0 110.462 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -52.18 -62.09 1.85 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.135 -0.978 . . . . 0.0 109.91 -179.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.403 HD22 ' HA ' ' A' ' 171' ' ' LEU . 1.7 mm? -53.04 -36.81 60.97 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.242 -0.911 . . . . 0.0 109.886 -179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 12.4 ttm180 -74.33 -24.06 59.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.227 -0.92 . . . . 0.0 109.98 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.552 ' OG ' ' O ' ' A' ' 169' ' ' ALA . 0.0 OUTLIER -75.62 -50.11 16.47 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.137 -0.977 . . . . 0.0 109.937 -179.599 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -70.44 -36.26 73.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.075 -1.015 . . . . 0.0 109.904 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -73.05 -49.95 25.79 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.166 -0.959 . . . . 0.0 110.094 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.5 ' CG ' ' N ' ' A' ' 177' ' ' TYR . 17.8 pt-20 -59.27 -43.05 92.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.214 -0.929 . . . . 0.0 110.072 -179.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.5 ' N ' ' CG ' ' A' ' 176' ' ' GLU . 1.1 m-85 -79.29 -12.2 59.94 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 120.998 -1.064 . . . . 0.0 109.61 -179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.406 HE21 ' C ' ' A' ' 178' ' ' GLN . 6.7 tp60 -74.57 -55.13 6.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.298 -0.876 . . . . 0.0 109.594 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.522 ' O ' ' OG ' ' A' ' 182' ' ' SER . 5.7 ttpm? -73.1 -29.49 62.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.0 110.055 -179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 6.9 t -65.9 -54.37 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.133 -0.98 . . . . 0.0 109.853 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 37.2 mt -68.17 -5.35 17.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.189 -0.944 . . . . 0.0 109.744 -179.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 179' ' ' LYS . 81.4 p -61.62 -67.84 0.37 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.168 -0.958 . . . . 0.0 110.07 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.452 ' N ' ' OG ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -88.64 13.26 12.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.22 -0.925 . . . . 0.0 110.238 -179.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.738 ' O ' ' ND2' ' A' ' 185' ' ' ASN . 0.2 OUTLIER -94.83 32.38 1.65 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 0.0 109.542 -179.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.756 HD22 ' C ' ' A' ' 185' ' ' ASN . 0.0 OUTLIER 72.87 29.75 1.82 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.669 -0.645 . . . . 0.0 110.324 179.703 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.603 ' CD2' ' ND2' ' A' ' 185' ' ' ASN . 7.1 m-85 -137.13 170.9 15.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.134 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -114.08 -136.76 6.39 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.239 -1.544 . . . . 0.0 109.239 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 189' ' ' ILE . 56.7 Cg_endo -77.45 107.14 2.34 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.293 1.995 . . . . 0.0 111.718 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.814 HG22 HG22 ' A' ' 142' ' ' THR . 0.2 OUTLIER -48.05 178.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 -179.363 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.737 HG23 ' OG ' ' A' ' 157' ' ' SER . 6.8 t -128.69 -2.27 5.39 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 120.063 -0.655 . . . . 0.0 110.121 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.601 HG22 HD11 ' A' ' 193' ' ' ILE . 56.8 m -42.91 114.48 0.61 Allowed 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 179.14 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.659 ' OD2' ' NH1' ' A' ' 194' ' ' ARG . 7.0 t0 -87.45 136.34 32.98 Favored 'General case' 0 C--N 1.277 -2.57 0 CA-C-N 115.157 -0.929 . . . . 0.0 108.615 -179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.601 HD11 HG22 ' A' ' 191' ' ' THR . 4.5 mp -135.53 92.15 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 118.116 -1.434 . . . . 0.0 110.63 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.659 ' NH1' ' OD2' ' A' ' 192' ' ' ASP . 0.0 OUTLIER -134.37 -179.51 5.62 Favored 'General case' 0 C--N 1.29 -1.98 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 178.634 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.583 ' O ' ' OE1' ' A' ' 197' ' ' GLN . 4.3 pt-20 -139.11 -173.04 3.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.719 -1.238 . . . . 0.0 110.855 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.92 23.61 72.74 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 110.042 -1.223 . . . . 0.0 110.042 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.583 ' OE1' ' O ' ' A' ' 195' ' ' GLU . 1.3 mp0 -79.89 128.02 32.95 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.87 -1.371 . . . . 0.0 109.885 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.443 HG21 ' CE2' ' A' ' 200' ' ' TYR . 6.7 p -60.55 153.65 4.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.344 -0.848 . . . . 0.0 109.188 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.619 ' CZ ' ' HD2' ' A' ' 118' ' ' ARG . 66.7 t80 -117.84 130.29 56.18 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.189 -0.944 . . . . 0.0 109.769 -179.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.706 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 21.0 m-85 -132.29 109.83 10.17 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.482 -0.761 . . . . 0.0 109.187 -179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . 0.471 ' OH ' ' NH1' ' A' ' 118' ' ' ARG . 20.1 m-85 -53.69 131.32 38.95 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.03 -1.044 . . . . 0.0 111.116 -179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.502 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -82.8 179.28 7.82 Favored 'General case' 0 C--N 1.302 -1.472 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.491 ' HB3' HG21 ' A' ' 42' ' ' ILE . 8.5 pm0 -75.08 158.68 32.74 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.486 -0.759 . . . . 0.0 108.96 179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.781 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -55.4 -39.66 70.47 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.952 -1.092 . . . . 0.0 108.145 179.004 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.51 ' CE1' ' CE2' ' A' ' 209' ' ' TYR . 0.2 OUTLIER -48.83 -19.46 0.38 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.577 -0.702 . . . . 0.0 110.304 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.72 ' NE2' ' CD2' ' A' ' 103' ' ' TYR . 10.5 m-70 -100.78 -17.7 16.79 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.958 -1.089 . . . . 0.0 110.91 -178.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.811 ' O ' ' N ' ' A' ' 209' ' ' TYR . 0.1 OUTLIER -106.44 -148.49 0.41 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 121.846 0.832 . . . . 0.0 110.357 -177.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.711 ' CG ' ' NE2' ' A' ' 48' ' ' HIS . 18.5 mp0 -35.53 -9.32 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.276 0 CA-C-N 115.213 -0.903 . . . . 0.0 111.269 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.811 ' N ' ' O ' ' A' ' 207' ' ' GLN . 1.3 t80 -43.14 -41.87 3.86 Favored 'General case' 0 N--CA 1.512 2.632 0 O-C-N 120.8 -1.188 . . . . 0.0 110.915 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.796 HD21 ' O ' ' A' ' 74' ' ' TRP . 3.7 pp -79.98 -11.92 59.75 Favored 'General case' 0 N--CA 1.491 1.611 0 C-N-CA 117.693 -1.603 . . . . 0.0 109.6 -178.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.499 ' OG ' ' O ' ' A' ' 208' ' ' GLN . 91.7 p -55.8 -43.61 77.03 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.303 -0.873 . . . . 0.0 108.843 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.478 ' HD2' ' NE2' ' A' ' 49' ' ' HIS . 6.8 mtmm -65.49 -18.34 65.25 Favored 'General case' 0 N--CA 1.487 1.376 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.636 ' C ' ' H ' ' A' ' 215' ' ' ASP . 2.9 m-20 -128.24 71.9 79.68 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.511 -0.743 . . . . 0.0 109.004 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -49.47 9.88 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.722 0 C-N-CA 123.274 2.649 . . . . 0.0 112.704 -179.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.636 ' H ' ' C ' ' A' ' 213' ' ' ASN . 7.3 p30 -63.2 -18.51 63.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.012 -1.055 . . . . 0.0 110.657 -178.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.634 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 61.73 85.47 0.05 OUTLIER Glycine 0 N--CA 1.498 2.79 0 C-N-CA 119.345 -1.407 . . . . 0.0 111.036 178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.743 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 71.4 t80 -45.11 -177.83 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.321 2.06 . . . . 0.0 109.778 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.743 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 0.7 OUTLIER -72.99 76.86 1.19 Allowed 'General case' 0 N--CA 1.486 1.338 0 O-C-N 120.98 -1.075 . . . . 0.0 109.339 -179.659 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . . . . . . . . . . . -122.4 149.13 17.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.195 -1.562 . . . . 0.0 109.195 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -152.09 -171.78 4.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.329 -1.101 . . . . 0.0 110.0 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 140' ' ' ASP . . . -142.5 -126.99 2.14 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.483 ' O ' ' OG1' ' A' ' 223' ' ' THR . . . -176.8 -134.94 2.07 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.625 -1.39 . . . . 0.0 109.625 -179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.664 ' CG2' ' H ' ' A' ' 139' ' ' HIS . 10.5 p 62.3 38.25 13.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.428 -1.043 . . . . 0.0 109.398 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.647 ' O ' ' SD ' ' A' ' 229' ' ' MET . . . -160.59 38.74 0.44 Allowed Glycine 0 C--N 1.301 -1.368 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . . . . . . . . . 59.9 t -110.85 81.98 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -1.165 . . . . 0.0 109.211 179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.625 ' H ' ' CB ' ' A' ' 229' ' ' MET . 19.6 p -98.45 -154.45 0.46 Allowed 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.109 0.957 . . . . 0.0 109.807 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.574 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.1 OUTLIER -73.11 -65.55 0.67 Allowed Pre-proline 0 C--N 1.291 -1.97 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.395 -179.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.574 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 42.8 Cg_endo -68.15 -2.22 8.51 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.108 1.872 . . . . 0.0 110.082 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.647 ' SD ' ' O ' ' A' ' 224' ' ' GLY . 0.0 OUTLIER -81.01 155.87 26.17 Favored 'General case' 0 C--N 1.297 -1.675 0 CA-C-O 121.877 0.846 . . . . 0.0 109.992 -179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -31.22 131.12 0.11 Allowed 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.209 0.528 . . . . 0.0 109.667 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.553 ' CG2' ' O ' ' A' ' 231' ' ' ILE . 0.4 OUTLIER -152.08 119.43 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.157 -0.964 . . . . 0.0 109.45 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.416 ' N ' HD13 ' A' ' 231' ' ' ILE . 2.1 tptt -56.01 -174.26 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.167 -0.958 . . . . 0.0 109.406 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.304 -1.382 0 O-C-N 121.266 -0.896 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.481 ' H71' HH22 ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.537 ' O ' ' C ' ' A' ' 23' ' ' ASP . . . . . . . . 0 N--CA 1.492 2.378 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.537 ' C ' ' O ' ' A' ' 22' ' ' GLY . 0.4 OUTLIER -36.15 134.6 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.311 -1.111 . . . . 0.0 109.167 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.6 p -68.41 -47.24 67.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.333 -0.854 . . . . 0.0 111.192 -178.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.0 -13.09 60.0 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-O 122.839 1.304 . . . . 0.0 110.795 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.571 ' OG ' ' OE2' ' A' ' 109' ' ' GLU . 2.4 t -63.67 -58.96 5.28 Favored 'General case' 0 C--N 1.257 -3.453 0 CA-C-N 114.331 -1.304 . . . . 0.0 110.831 -178.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.651 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -92.24 25.8 2.79 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 124.152 1.929 . . . . 0.0 109.302 -178.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.43 ' O ' HG12 ' A' ' 28' ' ' VAL . 32.1 t -145.61 43.69 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.258 -3.391 0 CA-C-N 112.883 -1.962 . . . . 0.0 106.331 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.92 133.05 21.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 CA-C-O 122.262 1.03 . . . . 0.0 113.544 -175.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.12 125.41 26.7 Favored 'General case' 0 C--N 1.31 -1.137 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.718 -179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.638 ' HB2' ' CE1' ' A' ' 97' ' ' HIS . . . -48.13 -43.19 30.93 Favored 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.654 -0.654 . . . . 0.0 109.433 179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 61.4 mm-40 -73.34 4.32 4.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.267 -0.896 . . . . 0.0 109.541 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.583 ' O ' ' O ' ' A' ' 34' ' ' ALA . 15.7 tt0 -111.55 -1.97 15.63 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.239 -0.913 . . . . 0.0 109.148 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.583 ' O ' ' O ' ' A' ' 33' ' ' GLU . . . -49.66 -168.94 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.417 -0.802 . . . . 0.0 109.686 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.563 HD13 ' OE1' ' A' ' 105' ' ' GLU . 86.9 mt -83.14 165.63 39.9 Favored Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -58.78 -30.82 93.72 Favored 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 122.237 1.958 . . . . 0.0 112.6 -178.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.494 ' HA2' HH11 ' A' ' 99' ' ' ARG . . . 135.42 143.77 4.81 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.56 ' H ' ' NE ' ' A' ' 99' ' ' ARG . 1.0 OUTLIER -69.23 172.83 6.35 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.297 -1.12 . . . . 0.0 109.36 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.19 -12.27 7.4 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.164 -0.96 . . . . 0.0 109.591 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 174.88 115.99 0.11 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.132 -0.98 . . . . 0.0 109.435 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.61 163.2 29.6 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.43 2.087 . . . . 0.0 112.299 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.483 ' O ' ' O ' ' A' ' 43' ' ' PRO . 0.5 OUTLIER -137.57 94.11 12.1 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.278 -0.889 . . . . 0.0 109.474 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.483 ' O ' ' O ' ' A' ' 42' ' ' ILE . 54.2 Cg_exo -48.46 -168.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.719 2.279 . . . . 0.0 112.37 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.705 HG12 ' N ' ' A' ' 204' ' ' ASP . 26.9 m -136.05 -161.67 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.257 -0.902 . . . . 0.0 109.465 -179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 45' ' ' THR . 11.8 t -72.75 99.47 2.62 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.178 -0.951 . . . . 0.0 109.842 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.547 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -56.19 -49.07 75.09 Favored 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.145 -0.972 . . . . 0.0 111.277 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.554 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 mttm -75.35 99.51 4.14 Favored 'General case' 0 C--N 1.291 -1.97 0 C-N-CA 115.84 -2.344 . . . . 0.0 108.682 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.63 ' O ' ' N ' ' A' ' 52' ' ' GLY . 4.7 t-80 -33.03 113.38 0.14 Allowed 'General case' 0 C--N 1.294 -1.829 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.477 ' CG ' ' HD2' ' A' ' 212' ' ' LYS . 16.1 t-80 -61.3 -30.86 70.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.365 -0.834 . . . . 0.0 110.83 -178.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.004 HG22 ' OG ' ' A' ' 211' ' ' SER . 26.1 t -65.17 -45.4 94.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.898 -1.126 . . . . 0.0 109.521 -179.586 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.3 m -105.03 -45.86 4.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.334 -0.854 . . . . 0.0 109.906 -179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.63 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 103.53 2.74 47.11 Favored Glycine 0 N--CA 1.486 1.999 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.676 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 28.7 p30 -79.33 -116.32 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 106.516 -1.661 . . . . 0.0 106.516 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.676 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.1 ttp180 -130.5 170.83 13.71 Favored 'General case' 0 C--N 1.294 -1.809 0 CA-C-O 123.23 1.491 . . . . 0.0 109.057 178.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.733 ' O ' HG13 ' A' ' 56' ' ' VAL . 21.6 p -134.14 26.84 3.87 Favored 'General case' 0 C--N 1.264 -3.146 0 CA-C-N 113.674 -1.603 . . . . 0.0 108.747 178.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.733 HG13 ' O ' ' A' ' 55' ' ' THR . 2.9 m -163.48 138.68 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.427 -0.796 . . . . 0.0 109.695 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.664 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 2.3 pm0 -33.01 152.3 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.352 0 O-C-N 121.311 -0.868 . . . . 0.0 110.642 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 57' ' ' GLU . 96.5 Cg_endo -79.28 166.16 79.17 Favored 'Cis proline' 0 C--N 1.302 -1.879 0 C-N-CA 121.648 -2.23 . . . . 0.0 111.7 -0.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -104.02 149.1 36.87 Favored Pre-proline 0 C--N 1.268 -2.965 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.989 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.575 ' O ' ' OG1' ' A' ' 63' ' ' THR . 9.6 Cg_endo -54.83 119.47 6.53 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.637 2.225 . . . . 0.0 112.089 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 60' ' ' PRO . 25.1 mt-10 -43.35 117.91 1.22 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.287 -0.883 . . . . 0.0 109.536 -179.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 111.18 23.94 5.6 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.575 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.6 OUTLIER -132.93 137.02 46.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.19 -1.182 . . . . 0.0 109.884 179.912 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.415 ' OE1' ' SD ' ' A' ' 65' ' ' MET . 5.6 mm-40 -104.93 -176.89 3.21 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.087 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.761 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -145.11 128.21 16.6 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.88 -1.138 . . . . 0.0 110.433 -179.578 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.57 -170.74 2.0 Allowed 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.0 t -144.87 146.04 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.146 -1.596 . . . . 0.0 109.715 179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.739 ' O ' HG22 ' A' ' 117' ' ' VAL . 70.5 m-85 -140.84 126.84 19.42 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.671 -1.268 . . . . 0.0 109.961 178.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -105.38 107.06 2.76 Favored Glycine 0 N--CA 1.482 1.706 0 N-CA-C 107.267 -2.333 . . . . 0.0 107.267 177.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.869 ' SD ' ' HB1' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -110.74 -89.14 0.5 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.515 -0.991 . . . . 0.0 109.715 -178.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.716 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -147.89 167.47 28.81 Favored Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.716 ' C ' ' O ' ' A' ' 71' ' ' GLY . 2.1 t -5.82 115.62 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 117.651 0.725 . . . . 0.0 109.818 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.68 ' HD1' ' HD1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -57.52 27.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.22 -0.925 . . . . 0.0 110.764 -178.634 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.877 ' O ' HD11 ' A' ' 210' ' ' LEU . 0.2 OUTLIER -89.77 -55.61 3.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.752 -1.217 . . . . 0.0 109.153 179.361 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.429 ' HA3' ' CD1' ' A' ' 217' ' ' TYR . . . -105.22 2.75 40.41 Favored Glycine 0 N--CA 1.495 2.584 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.869 ' HB1' ' SD ' ' A' ' 70' ' ' MET . . . -76.75 -39.93 50.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.011 -1.288 . . . . 0.0 110.525 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.671 ' OE2' ' N ' ' A' ' 90' ' ' GLN . 4.6 tt0 -82.65 -14.34 54.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.965 -1.085 . . . . 0.0 110.806 -178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.688 ' O ' ' N ' ' A' ' 80' ' ' PHE . 20.5 ttt180 -57.91 -72.8 0.08 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.894 -1.129 . . . . 0.0 110.207 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.458 ' N ' ' HG2' ' A' ' 78' ' ' ARG . 12.1 mmtt -44.11 -5.04 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.504 -0.748 . . . . 0.0 111.226 -178.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.688 ' N ' ' O ' ' A' ' 78' ' ' ARG . 46.7 m-85 -94.43 -41.34 9.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.734 -1.229 . . . . 0.0 110.978 -179.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.559 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -84.99 -0.68 55.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.672 -1.267 . . . . 0.0 110.646 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 78' ' ' ARG . 0.9 OUTLIER -92.17 19.73 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 120.977 -1.077 . . . . 0.0 110.051 -179.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.0 mt -119.73 157.24 28.97 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.245 -0.91 . . . . 0.0 109.377 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 2.4 mtpt -93.25 141.59 28.26 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.839 -0.538 . . . . 0.0 109.549 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 112.04 -29.09 8.69 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 -179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.9 138.61 20.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.468 -1.019 . . . . 0.0 109.865 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.673 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -77.53 -44.62 28.04 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 179.454 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.733 ' O ' HG23 ' A' ' 89' ' ' THR . 1.1 p -168.17 -162.97 0.44 Allowed 'General case' 0 C--N 1.292 -1.903 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.488 179.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 88' ' ' SER . 14.1 p -163.82 160.0 21.82 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.394 -0.816 . . . . 0.0 109.126 -179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.671 ' N ' ' OE2' ' A' ' 77' ' ' GLU . 0.0 OUTLIER -164.87 171.15 14.49 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.119 179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.66 HG21 ' O ' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -141.88 171.84 10.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.225 -0.922 . . . . 0.0 109.387 -179.774 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.462 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 171.39 -175.95 44.78 Favored Glycine 0 N--CA 1.487 2.093 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.425 ' N ' ' O ' ' A' ' 200' ' ' TYR . 2.0 m-85 -96.17 164.88 12.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.426 -1.044 . . . . 0.0 109.614 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.581 ' HB3' HG21 ' A' ' 116' ' ' VAL . . . -179.31 147.13 0.31 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.163 -0.96 . . . . 0.0 109.936 179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 88.86 29.02 19.51 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.527 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.752 ' N ' ' ND1' ' A' ' 113' ' ' HIS . . . -112.18 -156.72 13.26 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.638 ' CE1' ' HB2' ' A' ' 31' ' ' ALA . 0.2 OUTLIER -138.98 54.1 1.74 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -1.173 . . . . 0.0 109.892 -179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.731 ' CG2' ' NH1' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -157.5 177.15 11.74 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.032 -1.043 . . . . 0.0 108.262 179.537 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.801 ' CD ' ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -72.98 -86.64 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.384 -0.822 . . . . 0.0 109.851 -179.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.79 ' H ' ' HE ' ' A' ' 99' ' ' ARG . 0.7 OUTLIER -122.79 79.91 49.11 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.869 -1.144 . . . . 0.0 110.051 -179.776 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.453 ' HG2' ' CD2' ' A' ' 113' ' ' HIS . 11.4 Cg_exo -67.38 169.28 15.86 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.743 2.295 . . . . 0.0 111.675 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.625 ' OG1' ' CG ' ' A' ' 105' ' ' GLU . 16.4 p -117.56 171.11 8.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.044 -1.035 . . . . 0.0 109.852 179.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.618 ' C ' ' CD1' ' A' ' 103' ' ' TYR . 0.2 OUTLIER -63.47 -58.89 5.58 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.244 -0.91 . . . . 0.0 110.354 -178.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.601 ' O ' ' CD ' ' A' ' 104' ' ' LYS . 0.0 OUTLIER -59.22 -22.46 61.09 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.919 -1.113 . . . . 0.0 108.254 179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.625 ' CG ' ' OG1' ' A' ' 102' ' ' THR . 2.8 mm-40 -72.89 -60.67 2.12 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.394 0.616 . . . . 0.0 110.977 -179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.533 HG22 ' O ' ' A' ' 102' ' ' THR . 11.4 m -56.56 -24.66 19.5 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.402 -0.811 . . . . 0.0 110.997 -178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.459 ' C ' ' H ' ' A' ' 109' ' ' GLU . 0.5 OUTLIER -49.81 -33.85 17.86 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.253 179.759 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.629 ' C ' ' H ' ' A' ' 110' ' ' LYS . 1.4 t -63.52 0.12 0.8 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.317 -0.864 . . . . 0.0 109.198 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.571 ' OE2' ' OG ' ' A' ' 26' ' ' SER . 0.8 OUTLIER 63.97 -21.29 0.07 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.251 -0.906 . . . . 0.0 109.87 179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.629 ' H ' ' C ' ' A' ' 108' ' ' SER . 2.3 tttt -57.82 -10.66 1.79 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.212 -0.93 . . . . 0.0 110.278 -179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.532 ' CB ' HG12 ' A' ' 106' ' ' VAL . 41.3 p -94.08 -38.67 11.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.96 -1.087 . . . . 0.0 110.515 -179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.582 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 72.63 21.2 79.72 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.752 ' ND1' ' N ' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -75.17 161.32 29.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.112 -1.228 . . . . 0.0 110.315 -179.62 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.413 ' O ' HG22 ' A' ' 116' ' ' VAL . . . -124.8 113.32 17.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.577 ' CG ' ' O ' ' A' ' 154' ' ' GLN . 1.9 pp20? -57.26 119.43 6.39 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.15 -0.969 . . . . 0.0 109.724 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.581 HG21 ' HB3' ' A' ' 94' ' ' ALA . 0.0 OUTLIER -127.14 170.87 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.244 -0.91 . . . . 0.0 109.965 179.687 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.739 HG22 ' O ' ' A' ' 68' ' ' PHE . 6.1 m -130.36 125.46 59.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HG3' ' CE1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -96.89 114.49 26.12 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.174 -0.954 . . . . 0.0 109.45 -179.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.683 ' O ' HG23 ' A' ' 119' ' ' VAL . 34.9 m -131.78 109.79 16.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.577 HG23 ' N ' ' A' ' 121' ' ' TYR . 0.6 OUTLIER -75.66 176.2 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.904 ' CG ' HD21 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -159.94 152.8 21.51 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 118.38 -1.328 . . . . 0.0 110.391 179.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 0.485 HH21 ' CG ' ' A' ' 125' ' ' HIS . 1.9 mtp180 -108.7 102.12 46.5 Favored Pre-proline 0 N--CA 1.494 1.74 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.804 -178.39 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.587 ' O ' ' O ' ' A' ' 126' ' ' ILE . 18.3 Cg_exo -41.88 -68.04 0.11 Allowed 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 123.114 2.542 . . . . 0.0 113.942 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.446 ' C ' ' O ' ' A' ' 123' ' ' PRO . 13.3 tt0 -37.97 -33.37 0.08 Allowed 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.165 -0.96 . . . . 0.0 111.277 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.485 ' CG ' HH21 ' A' ' 122' ' ' ARG . 32.2 m80 -108.39 -0.2 20.75 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.704 -1.248 . . . . 0.0 109.537 -179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.587 ' O ' ' O ' ' A' ' 123' ' ' PRO . 0.1 OUTLIER -155.84 165.55 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.188 -179.377 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.421 ' N ' HG23 ' A' ' 126' ' ' ILE . 1.4 m -114.03 170.07 8.55 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.817 -1.177 . . . . 0.0 111.218 -178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.542 ' HA ' HD11 ' A' ' 131' ' ' LEU . 37.5 t80 -69.23 -24.75 64.05 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.579 -0.701 . . . . 0.0 109.414 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -75.86 -13.02 60.27 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.316 -0.865 . . . . 0.0 109.134 179.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.587 ' HG2' HD13 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -75.62 -45.55 36.78 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 121.183 -0.948 . . . . 0.0 110.199 -179.354 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 1.07 HD12 ' H ' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -77.13 -27.62 54.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 119.964 -1.71 . . . . 0.0 108.296 178.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.452 HD22 ' CZ ' ' A' ' 68' ' ' PHE . 1.1 mm? -72.62 -57.46 4.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.524 -0.735 . . . . 0.0 110.12 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -52.55 -45.0 66.17 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.212 -0.93 . . . . 0.0 110.308 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.698 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 13.3 t -50.1 -37.17 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 0.0 109.29 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.807 ' CZ ' ' NE2' ' A' ' 139' ' ' HIS . 28.1 t80 -71.44 -47.29 56.74 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.925 -1.109 . . . . 0.0 110.653 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.516 ' HE1' ' HB2' ' A' ' 173' ' ' SER . 83.4 m95 -72.18 -14.37 61.79 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 120.568 -1.332 . . . . 0.0 110.877 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.62 -17.25 19.62 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.865 -1.147 . . . . 0.0 113.15 -176.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.698 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 1.6 p30 -133.33 63.13 1.64 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 119.983 -1.698 . . . . 0.0 112.861 -177.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.807 ' NE2' ' CZ ' ' A' ' 135' ' ' PHE . 1.7 p-80 173.17 177.93 0.1 Allowed 'General case' 0 N--CA 1.504 2.23 0 CA-C-O 122.615 1.197 . . . . 0.0 110.643 176.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.631 ' CG ' ' NE2' ' A' ' 143' ' ' GLN . 0.4 OUTLIER -111.56 90.16 11.99 Favored Pre-proline 0 C--N 1.286 -2.154 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.289 179.811 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.581 ' O ' ' N ' ' A' ' 190' ' ' THR . 33.9 Cg_endo -74.39 -17.39 21.25 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.501 2.134 . . . . 0.0 112.535 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.492 ' HA ' HG23 ' A' ' 190' ' ' THR . 0.3 OUTLIER -89.3 29.71 1.06 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.976 . . . . 0.0 109.8 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.631 ' NE2' ' CG ' ' A' ' 140' ' ' ASP . 30.9 mt-30 -129.96 82.64 2.08 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.599 ' O ' ' O ' ' A' ' 143' ' ' GLN . . . -37.7 -116.25 0.0 OUTLIER Glycine 0 N--CA 1.496 2.656 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.28 -178.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.661 ' SD ' ' O ' ' A' ' 145' ' ' MET . 1.8 ppp? -67.25 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.258 -1.142 . . . . 0.0 110.876 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.594 ' O ' ' O ' ' A' ' 143' ' ' GLN . 0.1 OUTLIER -152.6 160.43 43.2 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.057 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.585 ' OE1' ' O ' ' A' ' 146' ' ' ARG . 14.3 mm100 -153.38 96.52 2.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.413 -1.429 . . . . 0.0 109.044 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 51.86 -113.94 2.82 Favored Glycine 0 N--CA 1.477 1.4 0 N-CA-C 109.365 -1.494 . . . . 0.0 109.365 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.56 ' H ' HD11 ' A' ' 220' ' ' LEU . 1.8 m-20 -79.29 -32.41 43.54 Favored 'General case' 0 C--N 1.271 -2.823 0 CA-C-N 114.547 -0.826 . . . . 0.0 111.361 -178.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.493 ' HB3' ' CD1' ' A' ' 155' ' ' TYR . 3.6 m-20 -82.63 130.38 35.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.217 -1.552 . . . . 0.0 109.123 179.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.434 ' HB2' ' CZ ' ' A' ' 146' ' ' ARG . 32.3 p90 -128.89 145.62 51.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.079 -1.013 . . . . 0.0 110.028 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 140.41 -165.29 26.1 Favored Glycine 0 N--CA 1.495 2.608 0 C-N-CA 119.296 -1.431 . . . . 0.0 110.817 179.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.31 -22.43 22.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.447 -1.031 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.596 ' H ' ' CD ' ' A' ' 154' ' ' GLN . 8.7 pm0 -91.83 -5.39 53.48 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.109 -0.994 . . . . 0.0 108.9 179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.547 ' OH ' ' CE1' ' A' ' 103' ' ' TYR . 47.6 m-85 -113.01 61.89 0.64 Allowed 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.546 HH11 ' CA ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -124.03 168.59 12.64 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.526 -0.734 . . . . 0.0 109.295 179.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 67.5 p -92.05 141.62 28.41 Favored 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.47 ' HA ' ' N ' ' A' ' 192' ' ' ASP . . . -168.17 111.31 0.6 Allowed 'General case' 0 C--N 1.282 -2.364 0 C-N-CA 116.981 -1.888 . . . . 0.0 111.512 -178.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.786 HG23 ' CG2' ' A' ' 191' ' ' THR . 60.2 t -92.41 143.73 10.77 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.986 0 C-N-CA 119.051 -1.059 . . . . 0.0 109.18 178.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -136.14 107.85 9.6 Favored Pre-proline 0 N--CA 1.494 1.743 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -79.05 173.82 12.96 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.556 2.171 . . . . 0.0 112.289 -179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.448 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.6 OUTLIER -89.97 -19.66 24.22 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.184 -0.948 . . . . 0.0 109.009 179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.607 ' OG ' ' N ' ' A' ' 164' ' ' ALA . 0.9 OUTLIER 167.33 -173.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.24 -0.913 . . . . 0.0 109.329 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.607 ' N ' ' OG ' ' A' ' 163' ' ' SER . . . -47.75 -15.32 0.06 Allowed 'General case' 0 N--CA 1.488 1.442 0 CA-C-O 122.978 1.371 . . . . 0.0 108.588 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.59 ' N ' ' C ' ' A' ' 163' ' ' SER . 3.7 t -55.17 -65.27 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.855 0 CA-C-N 114.101 -1.409 . . . . 0.0 109.156 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.475 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 20.2 mt-30 -78.63 -24.74 45.14 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.702 -0.624 . . . . 0.0 110.411 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 3.8 ttp -53.51 -41.96 66.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.994 -1.066 . . . . 0.0 110.497 -179.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -55.1 -58.26 8.36 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.023 -1.048 . . . . 0.0 110.221 -179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.07 -36.88 34.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.111 -0.993 . . . . 0.0 110.206 -179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 166' ' ' GLN . . . -52.85 -51.83 59.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.22 -0.925 . . . . 0.0 109.726 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . 0.495 ' O ' HD13 ' A' ' 171' ' ' LEU . 0.1 OUTLIER -52.74 -34.96 55.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.194 -0.942 . . . . 0.0 109.562 -179.91 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.19 -34.34 77.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.208 -0.933 . . . . 0.0 109.425 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.516 ' HB2' ' HE1' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -75.41 -36.82 60.75 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.34 -0.85 . . . . 0.0 109.412 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 7.8 ttpt -67.53 -57.04 7.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.9 . . . . 0.0 110.048 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -72.91 2.68 6.38 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.216 -0.927 . . . . 0.0 110.317 -179.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 180' ' ' VAL . 0.3 OUTLIER -75.87 -52.35 10.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.094 -1.004 . . . . 0.0 109.847 -179.808 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.422 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 4.0 m-85 -79.47 -7.46 58.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.027 -1.045 . . . . 0.0 110.263 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.502 ' CD ' ' C ' ' A' ' 178' ' ' GLN . 0.0 OUTLIER -70.69 -53.92 13.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.122 -0.986 . . . . 0.0 109.956 -179.701 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.414 ' O ' ' CG ' ' A' ' 179' ' ' LYS . 23.4 tttm -73.22 -15.41 61.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.277 -0.89 . . . . 0.0 110.432 -179.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 176' ' ' GLU . 44.9 t -82.28 -55.5 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.904 -1.122 . . . . 0.0 110.274 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.495 ' N ' HD23 ' A' ' 181' ' ' LEU . 4.4 mt -76.37 -27.26 56.33 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 120.996 -1.065 . . . . 0.0 109.983 -179.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 44.4 p -55.99 -14.0 2.27 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.085 -1.009 . . . . 0.0 109.551 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.4 tttm -88.27 -1.04 57.79 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 0.0 109.642 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.446 ' O ' ' CB ' ' A' ' 185' ' ' ASN . 37.3 m-70 -108.26 4.28 24.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.176 -0.953 . . . . 0.0 109.754 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.446 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.2 OUTLIER 71.77 8.42 6.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.972 . . . . 0.0 109.441 -179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -165.36 164.43 19.74 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.274 -0.892 . . . . 0.0 108.868 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.794 ' N ' ' CD ' ' A' ' 188' ' ' PRO . . . 92.7 24.64 22.86 Favored Glycine 0 C--N 1.302 -1.324 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.436 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.794 ' CD ' ' N ' ' A' ' 187' ' ' GLY . 27.7 Cg_endo -66.06 104.67 0.74 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 N-CA-C 108.64 -1.331 . . . . 0.0 108.64 178.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.638 ' O ' HD12 ' A' ' 189' ' ' ILE . 1.7 pp -47.01 143.86 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-O 123.019 1.39 . . . . 0.0 111.386 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.581 ' N ' ' O ' ' A' ' 141' ' ' PRO . 69.5 p -121.54 4.75 10.13 Favored 'General case' 0 C--N 1.285 -2.234 0 CA-C-N 114.109 -1.405 . . . . 0.0 110.005 179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.786 ' CG2' HG23 ' A' ' 159' ' ' VAL . 72.4 m -42.79 115.45 0.73 Allowed 'General case' 0 C--N 1.307 -1.245 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 179.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 159' ' ' VAL . 4.0 t0 -75.43 125.13 28.39 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.51 -178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -120.21 110.52 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.461 -0.775 . . . . 0.0 109.654 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.524 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 64.8 mtm-85 -146.24 -170.56 3.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.459 -0.775 . . . . 0.0 109.146 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.531 ' HA ' HE22 ' A' ' 197' ' ' GLN . 27.6 mt-10 -142.84 166.55 24.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.195 -0.941 . . . . 0.0 109.685 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.47 70.19 1.35 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.531 HE22 ' HA ' ' A' ' 195' ' ' GLU . 0.0 OUTLIER -139.16 146.9 41.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.909 -1.348 . . . . 0.0 109.708 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.636 HG23 ' N ' ' A' ' 199' ' ' PHE . 0.7 OUTLIER -98.32 -176.1 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.087 179.794 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.636 ' N ' HG23 ' A' ' 198' ' ' VAL . 46.8 t80 -125.35 130.7 52.47 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.101 -1.0 . . . . 0.0 109.894 -179.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.702 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 19.9 m-85 -126.67 100.19 6.1 Favored 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.331 -0.856 . . . . 0.0 109.212 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -54.27 136.38 43.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.922 -179.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.462 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -87.69 -169.67 2.69 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 178.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.49 ' HG3' ' H ' ' A' ' 205' ' ' TYR . 2.7 pt-20 -75.18 167.81 21.2 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.133 -0.979 . . . . 0.0 108.915 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.705 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -59.27 -48.82 80.19 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.987 -1.071 . . . . 0.0 108.692 179.086 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.49 ' H ' ' HG3' ' A' ' 203' ' ' GLU . 0.2 OUTLIER -47.44 -22.65 0.48 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.582 -0.699 . . . . 0.0 110.443 179.648 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.68 ' HD1' ' HD1' ' A' ' 73' ' ' PHE . 11.8 m-70 -94.0 13.16 23.75 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.989 -1.069 . . . . 0.0 110.537 -178.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.817 ' O ' ' N ' ' A' ' 209' ' ' TYR . 2.6 mm-40 -130.32 -141.01 0.23 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.694 1.235 . . . . 0.0 110.899 -177.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.664 ' N ' ' OE1' ' A' ' 208' ' ' GLN . 0.2 OUTLIER -35.03 -2.93 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.36 0 CA-C-N 113.519 -1.673 . . . . 0.0 112.51 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.817 ' N ' ' O ' ' A' ' 207' ' ' GLN . 28.6 t80 -38.41 -42.8 0.77 Allowed 'General case' 0 N--CA 1.516 2.861 0 O-C-N 120.595 -1.315 . . . . 0.0 110.496 -179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.877 HD11 ' O ' ' A' ' 74' ' ' TRP . 9.5 mt -70.47 -25.05 63.0 Favored 'General case' 0 N--CA 1.496 1.856 0 C-N-CA 118.085 -1.446 . . . . 0.0 109.316 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 1.004 ' OG ' HG22 ' A' ' 50' ' ' VAL . 8.0 t -73.47 -40.5 64.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.252 -0.905 . . . . 0.0 109.077 179.176 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.477 ' HD2' ' CG ' ' A' ' 49' ' ' HIS . 2.0 mtmm -88.25 -38.05 15.56 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.318 -0.864 . . . . 0.0 110.034 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.6 ' O ' ' N ' ' A' ' 215' ' ' ASP . 1.2 m-80 -101.03 107.65 50.89 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.18 -0.95 . . . . 0.0 109.499 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -49.14 6.95 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.433 0 C-N-CA 122.766 2.31 . . . . 0.0 113.05 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 213' ' ' ASN . 1.9 t70 -63.14 -16.71 60.93 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.735 -1.228 . . . . 0.0 109.851 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.84 ' O ' HD22 ' A' ' 210' ' ' LEU . . . 65.59 -68.45 0.11 Allowed Glycine 0 N--CA 1.486 2.021 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.788 ' CG ' ' N ' ' A' ' 218' ' ' CYS . 53.2 t80 171.94 -175.87 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.312 -1.111 . . . . 0.0 109.256 -179.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.788 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 4.5 m -93.08 -125.65 0.1 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.152 -0.968 . . . . 0.0 109.004 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.629 ' O ' ' CG ' ' A' ' 220' ' ' LEU . . . -127.19 148.0 17.21 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.66 -1.376 . . . . 0.0 109.66 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.629 ' CG ' ' O ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER 146.92 160.49 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 -179.582 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . 142.47 116.87 1.22 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.914 -1.274 . . . . 0.0 109.914 179.768 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.576 ' O ' ' O ' ' A' ' 139' ' ' HIS . . . 158.03 131.86 1.35 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.434 ' OG1' ' CD ' ' A' ' 141' ' ' PRO . 0.4 OUTLIER -115.32 -14.24 11.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.501 -1.0 . . . . 0.0 110.028 -179.869 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . 171.09 54.28 0.04 OUTLIER Glycine 0 C--N 1.306 -1.119 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.579 HG12 ' H ' ' A' ' 227' ' ' CYS . 96.2 t -82.66 135.86 24.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.587 0 O-C-N 121.355 -1.085 . . . . 0.0 109.346 -179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . . . . . . . . . 1.8 t -77.35 23.21 0.21 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 122.933 1.349 . . . . 0.0 109.409 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.579 ' H ' HG12 ' A' ' 225' ' ' VAL . 0.0 OUTLIER -71.21 -67.53 0.57 Allowed Pre-proline 0 C--N 1.262 -3.207 0 CA-C-N 114.123 -1.399 . . . . 0.0 109.58 -179.809 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.504 ' CD ' ' CB ' ' A' ' 227' ' ' CYS . 34.1 Cg_endo -64.51 -6.58 12.32 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.052 1.835 . . . . 0.0 110.184 178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.536 ' O ' ' C ' ' A' ' 230' ' ' ALA . 0.0 OUTLIER -67.02 154.53 40.95 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 122.034 0.921 . . . . 0.0 110.155 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.536 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -33.67 149.3 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.748 0 CA-C-O 121.322 0.582 . . . . 0.0 109.759 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . . . . . . . . . 2.4 mm -135.67 111.16 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.245 -0.91 . . . . 0.0 109.302 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 3.3 tttm -78.47 158.38 28.65 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 109.498 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.306 -1.323 0 O-C-N 121.324 -0.86 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 0.477 ' H41' ' NZ ' ' A' ' 27' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.632 ' OD1' ' N ' ' A' ' 24' ' ' SER . 45.0 p-10 -46.23 -35.78 5.51 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.172 -1.193 . . . . 0.0 109.049 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.661 ' C ' ' H ' ' A' ' 26' ' ' SER . 1.8 t -51.09 -18.18 0.79 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.583 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -49.54 -9.4 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 123.056 1.408 . . . . 0.0 109.523 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.661 ' H ' ' C ' ' A' ' 24' ' ' SER . 0.2 OUTLIER -47.19 -17.91 0.08 Allowed 'General case' 0 C--N 1.262 -3.236 0 CA-C-N 114.003 -1.453 . . . . 0.0 109.127 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.855 ' O ' H122 ' A' ' 21' ' ' MYR . 0.1 OUTLIER -103.14 25.39 9.52 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 123.959 1.838 . . . . 0.0 108.071 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 25' ' ' ALA . 47.9 t -139.66 36.12 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.19 0 CA-C-N 112.107 -2.315 . . . . 0.0 105.382 179.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -55.65 132.07 19.14 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 CA-C-N 114.642 -1.163 . . . . 0.0 113.765 -175.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.19 124.72 25.62 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-O 121.762 0.791 . . . . 0.0 109.519 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 97' ' ' HIS . . . -56.06 -22.75 29.43 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.616 -0.678 . . . . 0.0 109.758 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -83.87 -0.76 52.58 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -0.883 . . . . 0.0 109.782 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.559 ' O ' ' NZ ' ' A' ' 110' ' ' LYS . 0.3 OUTLIER -112.65 -4.62 14.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.218 -0.926 . . . . 0.0 109.68 -179.899 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.559 ' HB2' ' CD2' ' A' ' 97' ' ' HIS . . . -61.66 -171.26 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.214 -0.929 . . . . 0.0 109.808 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 35' ' ' LEU . 4.5 mm? -77.33 165.38 52.21 Favored Pre-proline 0 N--CA 1.489 1.503 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -62.44 -44.17 19.41 Favored 'Trans proline' 0 N--CA 1.495 1.56 0 C-N-CA 122.077 1.851 . . . . 0.0 112.15 -179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' C ' ' NE ' ' A' ' 38' ' ' ARG . . . 120.48 142.19 6.48 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.709 ' HE ' ' CA ' ' A' ' 38' ' ' ARG . 0.0 OUTLIER -109.09 -179.4 3.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.225 -1.162 . . . . 0.0 109.468 -179.966 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -124.33 0.77 8.36 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.636 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 7.8 mt-10 -97.9 126.4 40.74 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.244 -0.91 . . . . 0.0 109.518 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -77.97 169.24 20.84 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.492 2.128 . . . . 0.0 112.371 -179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.633 ' O ' ' CG1' ' A' ' 42' ' ' ILE . 0.5 OUTLIER -139.26 89.72 12.14 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.225 -0.922 . . . . 0.0 109.454 179.828 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -82.22 175.24 9.27 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.908 2.406 . . . . 0.0 112.558 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.71 HG12 ' N ' ' A' ' 204' ' ' ASP . 16.2 m -138.87 -174.39 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.397 -0.814 . . . . 0.0 109.263 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.668 ' OG1' ' NE2' ' A' ' 49' ' ' HIS . 0.2 OUTLIER -59.9 97.61 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.098 -1.002 . . . . 0.0 109.513 -179.92 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.461 ' HA ' ' OG1' ' A' ' 55' ' ' THR . . . -55.99 -49.19 74.31 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.261 -0.899 . . . . 0.0 111.426 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.534 ' O ' ' C ' ' A' ' 48' ' ' HIS . 20.3 mttm -71.03 99.91 1.9 Allowed 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 115.906 -2.317 . . . . 0.0 108.241 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.67 ' NE2' ' OG1' ' A' ' 89' ' ' THR . 5.0 t-80 -33.45 101.19 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.788 ' N ' ' ND1' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -53.24 -12.34 0.38 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.341 -0.849 . . . . 0.0 112.077 -178.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.52 ' HB ' ' CE1' ' A' ' 48' ' ' HIS . 88.2 t -82.49 -50.86 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.455 -1.403 . . . . 0.0 108.482 179.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.4 t -99.56 -40.41 7.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.523 -0.736 . . . . 0.0 109.768 179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.514 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 102.04 2.42 51.76 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.715 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 30.2 p30 -77.83 -120.92 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 178.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.715 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.3 ttm-85 -131.76 167.87 18.78 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-O 123.286 1.517 . . . . 0.0 109.481 178.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.886 ' O ' HG13 ' A' ' 56' ' ' VAL . 66.7 p -134.77 34.34 3.17 Favored 'General case' 0 C--N 1.264 -3.111 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.071 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.886 HG13 ' O ' ' A' ' 55' ' ' THR . 2.0 m -168.82 147.21 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.398 -0.814 . . . . 0.0 109.49 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.537 ' C ' ' O ' ' A' ' 56' ' ' VAL . 7.6 pt-20 -33.73 145.25 0.15 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.503 -0.748 . . . . 0.0 110.057 -179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -80.19 161.52 84.8 Favored 'Cis proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.741 -1.774 . . . . 0.0 110.363 0.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.645 ' CE2' ' NH2' ' A' ' 118' ' ' ARG . 70.8 m-85 -102.37 151.57 38.18 Favored Pre-proline 0 C--N 1.279 -2.493 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 59' ' ' PHE . 51.9 Cg_exo -47.6 -178.5 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.26 1.973 . . . . 0.0 111.983 179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.634 ' O ' ' NE ' ' A' ' 122' ' ' ARG . 88.7 mt-10 -79.23 133.73 36.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.176 -0.952 . . . . 0.0 110.591 -178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.68 ' O ' ' NE ' ' A' ' 122' ' ' ARG . . . 49.88 72.01 0.54 Allowed Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.367 -1.093 . . . . 0.0 110.367 179.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.591 ' O ' ' SD ' ' A' ' 65' ' ' MET . 0.8 OUTLIER -90.97 134.36 34.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -1.208 . . . . 0.0 110.105 179.323 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.802 ' N ' ' O ' ' A' ' 121' ' ' TYR . 1.5 tp60 -97.94 120.41 38.29 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 105.532 -2.025 . . . . 0.0 105.532 177.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.759 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -133.72 158.59 42.89 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.894 -1.122 . . . . 0.0 110.908 -177.488 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -146.63 -166.02 2.38 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 179.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG11 ' HD2' ' A' ' 160' ' ' TYR . 44.5 t -140.82 115.63 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 120.084 -1.635 . . . . 0.0 108.595 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 132' ' ' LEU . 72.9 m-85 -111.6 148.66 32.83 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.132 -0.98 . . . . 0.0 110.489 -179.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -123.79 99.31 0.61 Allowed Glycine 0 N--CA 1.481 1.69 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.764 ' SD ' ' CE1' ' A' ' 139' ' ' HIS . 2.1 ttt -98.08 -91.07 0.27 Allowed 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.648 -0.913 . . . . 0.0 109.179 -177.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.667 ' N ' ' CG ' ' A' ' 70' ' ' MET . . . -166.4 -149.53 5.99 Favored Glycine 0 C--N 1.29 -1.983 0 N-CA-C 107.365 -2.294 . . . . 0.0 107.365 -179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.74 ' SG ' ' O ' ' A' ' 72' ' ' CYS . 0.4 OUTLIER -35.12 104.12 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.436 -1.038 . . . . 0.0 108.368 179.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.66 ' CZ ' ' CD ' ' A' ' 115' ' ' GLU . 0.0 OUTLIER -54.97 7.4 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.842 -1.161 . . . . 0.0 111.426 -177.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.967 ' O ' HD21 ' A' ' 210' ' ' LEU . 5.9 m0 -74.38 -40.41 62.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.568 -1.332 . . . . 0.0 108.694 179.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -103.6 -14.29 25.84 Favored Glycine 0 N--CA 1.491 2.338 0 C-N-CA 120.061 -1.066 . . . . 0.0 110.814 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.693 ' O ' ' CD1' ' A' ' 80' ' ' PHE . . . -66.31 -53.5 35.79 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 120.668 -1.49 . . . . 0.0 110.819 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.635 ' OE2' ' NE2' ' A' ' 208' ' ' GLN . 1.3 tm-20 -82.64 -14.63 54.37 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.213 -0.929 . . . . 0.0 110.77 -178.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.476 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 0.0 OUTLIER -58.02 -68.12 0.28 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.787 -1.196 . . . . 0.0 109.653 -179.827 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.599 ' O ' HG22 ' A' ' 82' ' ' VAL . 49.5 mttt -53.36 -5.66 0.06 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.157 -0.965 . . . . 0.0 110.511 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.693 ' CD1' ' O ' ' A' ' 76' ' ' ALA . 11.3 m-85 -90.82 -42.02 10.88 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.784 -1.197 . . . . 0.0 110.196 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.544 ' CZ3' ' HA ' ' A' ' 208' ' ' GLN . 1.2 p90 -68.84 -4.79 17.59 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.712 -1.242 . . . . 0.0 109.323 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 79' ' ' LYS . 2.5 m -97.39 6.74 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.576 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.44 HD13 HD11 ' A' ' 126' ' ' ILE . 31.3 mt -85.12 142.41 29.53 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-O 122.244 1.021 . . . . 0.0 108.999 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.4 ' O ' ' CG ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -79.77 131.64 35.96 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.078 -179.347 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . 0.499 ' C ' ' HG3' ' A' ' 123' ' ' PRO . . . 101.36 -29.19 13.05 Favored Glycine 0 N--CA 1.481 1.69 0 N-CA-C 110.344 -1.102 . . . . 0.0 110.344 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.9 132.97 21.43 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 121.225 -1.162 . . . . 0.0 110.231 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.702 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -79.93 -53.67 6.53 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.514 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.516 ' N ' ' CD2' ' A' ' 87' ' ' TYR . 2.3 p -151.73 -176.26 5.55 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.87 -1.144 . . . . 0.0 109.347 178.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.67 ' OG1' ' NE2' ' A' ' 48' ' ' HIS . 82.4 p -157.49 128.6 6.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.554 -0.716 . . . . 0.0 109.38 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.576 ' CD ' ' N ' ' A' ' 90' ' ' GLN . 0.0 OUTLIER -131.2 153.03 49.88 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.301 -0.874 . . . . 0.0 109.513 179.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.664 HG23 ' OE1' ' A' ' 207' ' ' GLN . 0.0 OUTLIER -123.94 175.54 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.378 -0.826 . . . . 0.0 108.903 179.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.438 ' HA2' ' HB2' ' A' ' 202' ' ' ALA . . . 167.88 177.59 39.29 Favored Glycine 0 N--CA 1.487 2.064 0 C-N-CA 119.358 -1.401 . . . . 0.0 110.022 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.634 ' N ' ' O ' ' A' ' 200' ' ' TYR . 28.0 m-85 -82.28 166.45 19.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.559 -0.965 . . . . 0.0 109.395 179.758 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.681 ' O ' ' ND1' ' A' ' 113' ' ' HIS . . . -177.41 -179.22 0.83 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.21 -0.931 . . . . 0.0 109.765 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 50.17 27.37 10.73 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.479 ' HA3' ' CG ' ' A' ' 113' ' ' HIS . . . -123.35 -176.82 14.92 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.559 ' CD2' ' HB2' ' A' ' 34' ' ' ALA . 0.6 OUTLIER -135.63 78.16 1.71 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -1.101 . . . . 0.0 109.837 -179.752 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 21.4 m -157.07 142.67 17.53 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.157 -0.964 . . . . 0.0 109.196 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.696 ' O ' ' CZ ' ' A' ' 200' ' ' TYR . 0.1 OUTLIER -54.06 -84.77 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.333 -0.854 . . . . 0.0 109.576 -179.907 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.481 ' ND2' ' HG2' ' A' ' 99' ' ' ARG . 55.9 m-80 -118.86 82.69 21.24 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.125 -0.984 . . . . 0.0 109.665 -179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.413 ' HB2' HG13 ' A' ' 106' ' ' VAL . 72.0 Cg_endo -79.71 161.83 24.48 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 122.847 2.365 . . . . 0.0 112.105 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 106' ' ' VAL . 21.7 p -121.33 169.93 10.11 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.164 -0.96 . . . . 0.0 109.803 179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.47 ' CE1' ' SG ' ' A' ' 107' ' ' CYS . 7.8 t80 -56.26 -58.84 6.28 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.684 -0.635 . . . . 0.0 110.986 -179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.11 -27.05 65.23 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.825 -1.172 . . . . 0.0 109.02 -179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.488 ' HB2' ' H ' ' A' ' 102' ' ' THR . 2.0 mt-10 -75.4 -53.27 8.98 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.726 -0.609 . . . . 0.0 111.159 -179.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 102' ' ' THR . 12.7 m -61.24 -24.3 32.9 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 O-C-N 120.733 -1.23 . . . . 0.0 110.617 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.621 ' C ' ' H ' ' A' ' 109' ' ' GLU . 90.7 m -64.65 -38.31 90.57 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.337 -0.852 . . . . 0.0 109.382 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.495 ' C ' ' H ' ' A' ' 110' ' ' LYS . 89.3 p -53.8 -0.7 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.245 -0.909 . . . . 0.0 109.316 179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.621 ' H ' ' C ' ' A' ' 107' ' ' CYS . 28.8 mt-10 64.89 -5.27 0.4 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.31 -0.869 . . . . 0.0 109.49 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.559 ' NZ ' ' O ' ' A' ' 33' ' ' GLU . 1.5 mmpt? -66.97 -32.76 74.23 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.178 -0.951 . . . . 0.0 109.67 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.57 ' OG1' HG12 ' A' ' 106' ' ' VAL . 3.7 p -93.51 -0.34 56.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.174 -0.954 . . . . 0.0 109.764 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.549 ' C ' ' O ' ' A' ' 111' ' ' THR . . . 34.25 55.6 0.73 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 110.157 -1.177 . . . . 0.0 110.157 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.681 ' ND1' ' O ' ' A' ' 94' ' ' ALA . 1.5 m-70 -93.35 174.54 7.15 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 120.907 -1.349 . . . . 0.0 108.813 179.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.769 ' CB ' HH12 ' A' ' 156' ' ' ARG . . . -129.72 114.97 16.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.531 -0.73 . . . . 0.0 109.601 -179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.66 ' CD ' ' CZ ' ' A' ' 73' ' ' PHE . 3.8 mt-10 -56.44 105.83 0.24 Allowed 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.461 HG21 ' HB3' ' A' ' 94' ' ' ALA . 4.4 m -124.68 159.03 31.53 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 O-C-N 121.134 -0.979 . . . . 0.0 110.499 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.585 ' CG2' ' O ' ' A' ' 117' ' ' VAL . 0.9 OUTLIER -116.49 122.53 70.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.601 -0.687 . . . . 0.0 109.422 179.978 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.645 ' NH2' ' CE2' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -96.09 97.12 9.32 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 179.162 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.811 HG21 HD23 ' A' ' 131' ' ' LEU . 1.7 m -100.93 129.4 51.92 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.626 0 C-N-CA 119.641 -0.824 . . . . 0.0 109.78 -178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.533 HG23 ' OE1' ' A' ' 90' ' ' GLN . 55.1 t -94.79 126.27 47.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.606 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.802 ' O ' ' N ' ' A' ' 64' ' ' GLN . 0.1 OUTLIER -157.18 142.05 16.89 Favored 'General case' 0 C--O 1.2 -1.53 0 C-N-CA 118.535 -1.266 . . . . 0.0 111.725 -178.784 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . 1.033 ' H ' ' CD ' ' A' ' 123' ' ' PRO . 0.8 OUTLIER -165.67 17.15 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.596 0 C-N-CA 123.612 0.765 . . . . 0.0 110.294 179.787 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 1.033 ' CD ' ' H ' ' A' ' 122' ' ' ARG . 7.1 Cg_endo -50.88 -15.68 1.97 Allowed 'Trans proline' 0 C--N 1.294 -2.292 0 C-N-CA 124.189 3.259 . . . . 0.0 115.79 -176.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.513 ' CB ' ' O ' ' A' ' 123' ' ' PRO . 1.7 tm-20 70.54 -6.62 1.17 Allowed 'General case' 0 C--N 1.271 -2.813 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -172.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.703 ' H ' ' C ' ' A' ' 123' ' ' PRO . 0.2 OUTLIER -111.7 -12.98 13.81 Favored 'General case' 0 N--CA 1.506 2.356 0 CA-C-O 122.33 1.062 . . . . 0.0 108.329 179.034 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.683 HD12 HD11 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -152.8 118.56 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 N-CA-C 107.221 -1.4 . . . . 0.0 107.221 -179.563 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 128' ' ' PHE . 0.0 OUTLIER -129.76 -175.4 3.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 120.526 -1.359 . . . . 0.0 112.559 -177.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.563 ' C ' ' CD1' ' A' ' 128' ' ' PHE . 1.0 OUTLIER -48.28 -46.54 36.04 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.019 -179.628 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.673 ' O ' ' CD2' ' A' ' 132' ' ' LEU . 6.0 pt-20 -59.66 -26.57 65.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.03 -1.044 . . . . 0.0 109.714 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.502 ' CB ' HD13 ' A' ' 126' ' ' ILE . 9.0 mm-40 -75.31 -66.25 0.79 Allowed 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.304 -0.872 . . . . 0.0 111.558 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.811 HD23 HG21 ' A' ' 119' ' ' VAL . 9.8 mp -57.41 -23.75 51.29 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.838 -1.164 . . . . 0.0 113.873 -176.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.673 ' CD2' ' O ' ' A' ' 129' ' ' GLU . 0.6 OUTLIER -75.73 -17.9 59.76 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 119.843 -1.785 . . . . 0.0 109.556 -179.494 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.478 ' N ' HD23 ' A' ' 132' ' ' LEU . 7.6 mptt -70.44 -54.54 11.95 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.113 -0.992 . . . . 0.0 109.439 179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.697 ' O ' ' ND2' ' A' ' 138' ' ' ASN . 6.6 t -49.66 -40.29 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.349 -0.844 . . . . 0.0 109.046 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.631 ' O ' ' ND1' ' A' ' 139' ' ' HIS . 21.2 t80 -61.08 -41.99 97.67 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.793 -1.192 . . . . 0.0 110.63 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.71 ' CZ2' ' CA ' ' A' ' 173' ' ' SER . 45.4 m0 -71.51 -50.47 31.04 Favored 'General case' 0 N--CA 1.511 2.594 0 O-C-N 120.75 -1.219 . . . . 0.0 111.735 -179.046 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -57.02 -57.46 12.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.004 -1.06 . . . . 0.0 111.73 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.697 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 0.6 OUTLIER -83.3 54.23 2.74 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.169 -0.957 . . . . 0.0 112.113 -177.378 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.764 ' CE1' ' SD ' ' A' ' 70' ' ' MET . 20.7 m80 -161.11 176.91 10.81 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-O 122.531 1.158 . . . . 0.0 109.661 177.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.75 ' CG ' HE21 ' A' ' 143' ' ' GLN . 0.3 OUTLIER -129.16 70.22 81.54 Favored Pre-proline 0 C--N 1.294 -1.83 0 N-CA-C 105.753 -1.944 . . . . 0.0 105.753 176.734 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 190' ' ' THR . 80.4 Cg_exo -39.39 -0.91 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.427 2.752 . . . . 0.0 113.627 -177.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.733 ' N ' ' O ' ' A' ' 140' ' ' ASP . 0.0 OUTLIER -105.88 22.7 15.17 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.671 -1.268 . . . . 0.0 110.814 -179.639 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.75 HE21 ' CG ' ' A' ' 140' ' ' ASP . 33.4 mt-30 -134.04 78.32 1.75 Allowed 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 177.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 156' ' ' ARG . . . -75.47 12.66 7.34 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 119.528 -1.32 . . . . 0.0 110.159 -178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.642 ' O ' ' O ' ' A' ' 152' ' ' GLY . 2.2 ptt? -118.0 -21.82 8.13 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.982 -1.305 . . . . 0.0 109.911 178.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.548 ' CD ' ' O ' ' A' ' 145' ' ' MET . 0.0 OUTLIER -152.31 168.88 23.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.213 -0.929 . . . . 0.0 111.053 -178.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.58 ' OE1' ' O ' ' A' ' 155' ' ' TYR . 5.2 mm100 -120.21 58.77 0.91 Allowed 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 176.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 82.08 -113.84 3.73 Favored Glycine 0 N--CA 1.478 1.488 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.823 ' H ' HD11 ' A' ' 220' ' ' LEU . 12.6 t-20 -81.21 11.41 4.28 Favored 'General case' 0 C--N 1.272 -2.767 0 CA-C-N 114.771 -0.715 . . . . 0.0 110.874 -178.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.489 ' HB3' ' CG ' ' A' ' 155' ' ' TYR . 0.5 OUTLIER -107.3 87.81 2.59 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.769 -1.207 . . . . 0.0 109.146 179.492 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.453 ' HA ' ' CG ' ' A' ' 146' ' ' ARG . 3.4 m-85 -65.49 115.87 6.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.411 -0.805 . . . . 0.0 110.674 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.642 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 166.62 150.78 6.52 Favored Glycine 0 N--CA 1.499 2.852 0 C-N-CA 117.687 -2.197 . . . . 0.0 111.777 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.442 HG21 ' HA ' ' A' ' 27' ' ' LYS . 5.1 p -74.26 -20.23 60.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.701 -0.882 . . . . 0.0 109.325 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.737 ' CD ' ' H ' ' A' ' 154' ' ' GLN . 7.3 pm0 -87.15 -6.69 58.55 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 0.0 109.134 -179.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.58 ' O ' ' OE1' ' A' ' 147' ' ' GLN . 26.4 m-85 -97.11 57.27 1.46 Allowed 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 179.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.108 HH21 ' C13' ' A' ' 21' ' ' MYR . 0.0 OUTLIER -117.63 165.72 13.25 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.725 -0.61 . . . . 0.0 109.66 -179.869 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.85 106.03 18.2 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 104.436 -2.431 . . . . 0.0 104.436 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.475 ' HB1' ' CE1' ' A' ' 160' ' ' TYR . . . -125.21 124.09 40.97 Favored 'General case' 0 C--N 1.281 -2.386 0 C-N-CA 118.94 -1.104 . . . . 0.0 111.06 -176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.725 HG23 ' CG2' ' A' ' 191' ' ' THR . 10.6 t -113.48 123.27 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 C-N-CA 118.729 -1.188 . . . . 0.0 110.3 179.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 0.517 ' CG ' ' NE2' ' A' ' 197' ' ' GLN . 3.9 m-30 -118.51 121.53 30.87 Favored Pre-proline 0 N--CA 1.493 1.704 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 178.337 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -78.73 166.25 23.82 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.462 2.108 . . . . 0.0 112.223 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 163' ' ' SER . 0.7 OUTLIER -105.87 1.82 27.14 Favored 'General case' 0 C--N 1.313 -0.982 0 O-C-N 120.796 -1.19 . . . . 0.0 108.793 179.283 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.643 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER 167.76 170.78 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.793 . . . . 0.0 108.862 179.979 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.62 -15.86 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 123.04 1.4 . . . . 0.0 108.361 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.643 ' N ' ' O ' ' A' ' 163' ' ' SER . 3.5 t -56.05 -64.0 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.861 0 CA-C-N 113.981 -1.463 . . . . 0.0 109.926 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . 0.496 ' HG2' ' CZ ' ' A' ' 128' ' ' PHE . 33.8 mt-30 -78.94 -18.39 53.86 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.719 -0.613 . . . . 0.0 110.9 -178.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 14.3 ttm -53.16 -46.85 69.07 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.022 -1.049 . . . . 0.0 109.82 -179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -75.24 -16.93 60.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.046 -1.034 . . . . 0.0 109.617 179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -92.77 -57.29 2.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.228 -0.92 . . . . 0.0 109.838 -179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . 0.432 ' C ' ' N ' ' A' ' 172' ' ' ARG . . . -52.13 -43.52 64.04 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.135 -0.978 . . . . 0.0 109.457 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -53.1 -11.99 0.31 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.142 -0.974 . . . . 0.0 109.246 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . 0.432 ' N ' ' C ' ' A' ' 170' ' ' ALA . 75.9 mtt180 -74.78 -39.52 61.69 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.159 -0.963 . . . . 0.0 109.335 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.71 ' CA ' ' CZ2' ' A' ' 136' ' ' TRP . 0.9 OUTLIER -54.48 -33.1 59.12 Favored 'General case' 0 N--CA 1.499 2.022 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 178.055 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.56 -57.44 4.15 Favored 'General case' 0 C--N 1.275 -2.652 0 CA-C-N 113.199 -1.819 . . . . 0.0 110.21 -179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -74.17 -52.48 12.34 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.208 -0.933 . . . . 0.0 111.894 -178.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.576 ' OE1' ' O ' ' A' ' 176' ' ' GLU . 0.0 OUTLIER -55.19 -50.64 68.84 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.921 -1.112 . . . . 0.0 110.742 -178.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.477 ' N ' ' HG3' ' A' ' 176' ' ' GLU . 0.1 OUTLIER -70.99 -13.74 62.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.85 -1.157 . . . . 0.0 109.907 -179.174 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.57 ' O ' ' OG ' ' A' ' 182' ' ' SER . 22.0 tp60 -75.01 -48.31 24.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 0.0 109.757 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.62 -19.17 55.95 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.058 -1.026 . . . . 0.0 110.378 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . 0.563 ' O ' ' CD2' ' A' ' 184' ' ' HIS . 92.7 t -87.23 -52.64 11.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.884 -1.135 . . . . 0.0 109.956 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.529 ' N ' HD22 ' A' ' 181' ' ' LEU . 4.0 mm? -71.95 -44.53 63.43 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.116 -0.99 . . . . 0.0 109.586 -179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 178' ' ' GLN . 86.3 p -55.79 -26.59 46.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.075 -1.016 . . . . 0.0 109.002 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -88.06 -27.93 21.67 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.326 -0.859 . . . . 0.0 109.108 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 180' ' ' VAL . 12.5 m170 -80.78 15.35 1.79 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.875 . . . . 0.0 109.388 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . 0.461 ' CB ' ' O ' ' A' ' 184' ' ' HIS . 0.3 OUTLIER 72.37 48.93 0.22 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.318 -0.864 . . . . 0.0 109.937 179.69 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.491 ' HE1' ' HG ' ' A' ' 227' ' ' CYS . 0.4 OUTLIER -114.25 -176.72 2.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.075 -1.016 . . . . 0.0 108.933 179.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -104.21 -168.94 24.93 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.458 ' O ' ' O ' ' A' ' 189' ' ' ILE . 27.3 Cg_exo -58.81 116.12 3.03 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.519 2.146 . . . . 0.0 111.279 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.477 ' C ' HG23 ' A' ' 190' ' ' THR . 0.3 OUTLIER -48.01 176.81 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 O-C-N 121.232 -0.917 . . . . 0.0 110.145 -179.306 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.681 ' OG1' ' N ' ' A' ' 143' ' ' GLN . 71.2 p -156.98 76.23 0.85 Allowed 'General case' 0 N--CA 1.497 1.894 0 C-N-CA 119.758 -0.777 . . . . 0.0 111.597 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . 0.725 ' CG2' HG23 ' A' ' 159' ' ' VAL . 8.1 m -101.53 122.83 44.54 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.65 ' CG ' HH21 ' A' ' 194' ' ' ARG . 2.1 t0 -81.11 115.98 20.81 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.951 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 1.3 mt -119.69 128.06 75.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.386 -0.821 . . . . 0.0 109.396 179.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.65 HH21 ' CG ' ' A' ' 192' ' ' ASP . 4.7 ptt180 -165.36 173.03 11.58 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.646 ' CD ' ' N ' ' A' ' 195' ' ' GLU . 0.9 OUTLIER -120.49 -178.66 3.75 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.909 -1.119 . . . . 0.0 110.431 -179.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 54.89 35.87 59.28 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 110.571 -1.012 . . . . 0.0 110.571 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.573 ' O ' ' O ' ' A' ' 198' ' ' VAL . 1.8 mp0 -84.11 80.44 9.18 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.866 -1.373 . . . . 0.0 109.243 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 0.573 ' O ' ' O ' ' A' ' 197' ' ' GLN . 9.8 p -33.31 156.81 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.517 -0.739 . . . . 0.0 110.198 -179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.525 ' CE1' ' HG3' ' A' ' 118' ' ' ARG . 65.0 t80 -117.95 138.77 51.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.438 -0.789 . . . . 0.0 109.054 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.696 ' CZ ' ' O ' ' A' ' 99' ' ' ARG . 1.7 m-85 -140.34 113.94 8.72 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.096 -1.003 . . . . 0.0 109.819 -179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -53.66 142.99 21.47 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.318 -0.864 . . . . 0.0 109.892 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.438 ' HB2' ' HA2' ' A' ' 92' ' ' GLY . . . -91.26 -168.1 1.97 Allowed 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.444 -0.785 . . . . 0.0 109.104 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.58 ' OE1' ' OH ' ' A' ' 205' ' ' TYR . 2.9 mt-10 -73.38 163.85 27.49 Favored 'General case' 0 N--CA 1.512 2.625 0 CA-C-O 122.469 1.128 . . . . 0.0 110.372 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.71 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -54.67 -44.26 73.17 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-N 115.343 -0.844 . . . . 0.0 108.892 179.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -70.63 4.17 2.62 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.304 -0.873 . . . . 0.0 110.576 -179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.499 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 9.4 m-70 -102.99 14.75 31.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.932 -1.105 . . . . 0.0 110.577 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.789 ' O ' ' N ' ' A' ' 209' ' ' TYR . 1.0 OUTLIER -135.74 -150.08 0.36 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.971 -1.081 . . . . 0.0 110.178 -178.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.76 ' CD ' ' H ' ' A' ' 208' ' ' GLN . 0.0 OUTLIER -36.55 -7.92 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.334 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.138 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.789 ' N ' ' O ' ' A' ' 207' ' ' GLN . 2.2 t80 -43.9 -47.09 8.31 Favored 'General case' 0 N--CA 1.51 2.534 0 O-C-N 120.762 -1.211 . . . . 0.0 111.361 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.967 HD21 ' O ' ' A' ' 74' ' ' TRP . 3.6 pp -82.64 -12.26 57.78 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.0 -1.687 . . . . 0.0 109.947 -178.512 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.493 ' OG ' HG22 ' A' ' 50' ' ' VAL . 37.3 t -55.83 -50.86 69.39 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.188 -0.945 . . . . 0.0 108.496 179.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.498 ' HE2' HD21 ' A' ' 213' ' ' ASN . 1.2 pttm -70.19 4.9 1.91 Allowed 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 178.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.664 ' O ' ' N ' ' A' ' 215' ' ' ASP . 75.9 m-20 -142.52 68.01 20.13 Favored Pre-proline 0 N--CA 1.487 1.413 0 N-CA-C 108.879 -0.786 . . . . 0.0 108.879 179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -48.53 11.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 C-N-CA 123.571 2.848 . . . . 0.0 112.702 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.664 ' N ' ' O ' ' A' ' 213' ' ' ASN . 33.9 t70 -61.88 -20.29 63.57 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.073 -1.017 . . . . 0.0 110.393 -178.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.664 ' O ' ' O ' ' A' ' 217' ' ' TYR . . . 60.69 86.15 0.04 OUTLIER Glycine 0 CA--C 1.552 2.371 0 C-N-CA 119.194 -1.479 . . . . 0.0 111.17 177.358 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.664 ' O ' ' O ' ' A' ' 216' ' ' GLY . 39.1 t80 -52.11 -150.76 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.185 0 CA-C-N 120.538 2.169 . . . . 0.0 109.308 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.65 ' N ' ' CG ' ' A' ' 217' ' ' TYR . 49.4 m -71.75 -124.28 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.26 0 O-C-N 120.002 -1.686 . . . . 0.0 109.419 -179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 218' ' ' CYS . . . 58.72 151.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.306 0 N-CA-C 108.892 -1.683 . . . . 0.0 108.892 -179.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.823 HD11 ' H ' ' A' ' 149' ' ' ASN . 0.4 OUTLIER -109.06 -155.74 0.57 Allowed 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.14 -1.212 . . . . 0.0 109.978 -179.705 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.58 ' O ' ' O ' ' A' ' 138' ' ' ASN . . . -118.73 -73.99 0.44 Allowed Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.47 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . -175.02 134.05 2.63 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . . . . . . . . . 10.1 t -111.84 7.04 19.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.471 -1.017 . . . . 0.0 109.631 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . . . . . . . . . . . -75.58 -8.52 84.2 Favored Glycine 0 C--N 1.305 -1.153 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 226' ' ' SER . 3.2 p -60.37 165.76 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 O-C-N 121.827 -0.808 . . . . 0.0 109.852 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.458 ' CB ' ' HB3' ' A' ' 229' ' ' MET . 14.8 m -44.9 106.56 0.08 Allowed 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 123.173 1.464 . . . . 0.0 109.24 -179.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.58 ' SG ' ' CD ' ' A' ' 228' ' ' PRO . 0.1 OUTLIER -76.32 -66.1 0.39 Allowed Pre-proline 0 C--N 1.278 -2.54 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.994 -179.385 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.58 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 28.0 Cg_endo -64.25 1.29 1.68 Allowed 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.273 1.982 . . . . 0.0 109.779 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.548 ' O ' ' C ' ' A' ' 230' ' ' ALA . 2.2 ptm -54.99 158.63 2.72 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.726 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.548 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -29.83 130.42 0.08 Allowed 'General case' 0 C--N 1.296 -1.742 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.0 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.669 ' O ' ' N ' ' A' ' 233' ' ' LYS . 2.0 mm -144.5 115.52 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.193 -0.942 . . . . 0.0 109.273 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 231' ' ' ILE . 4.4 ttpm? -44.51 85.69 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.0 109.517 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.669 ' N ' ' O ' ' A' ' 231' ' ' ILE . . . . . . . . 0 C--N 1.305 -1.353 0 O-C-N 121.226 -0.921 . . . . 0.0 . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 1.108 ' C13' HH21 ' A' ' 156' ' ' ARG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 1.229 ' O ' ' O1 ' ' A' ' 21' ' ' MYR . . . . . . . . 0 N--CA 1.493 2.442 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.438 ' C ' ' N ' ' A' ' 25' ' ' ALA . 17.8 t70 49.03 -80.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.279 -1.13 . . . . 0.0 109.279 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 22' ' ' GLY . 4.8 p -50.24 -16.75 0.35 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.374 -0.829 . . . . 0.0 108.917 179.255 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.62 ' O ' ' N ' ' A' ' 28' ' ' VAL . . . -48.6 -9.62 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 122.991 1.377 . . . . 0.0 109.649 -179.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.652 ' H ' ' C ' ' A' ' 24' ' ' SER . 0.6 OUTLIER -47.24 -31.98 4.17 Favored 'General case' 0 C--N 1.259 -3.364 0 CA-C-N 114.26 -1.336 . . . . 0.0 108.346 179.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.991 ' NZ ' ' H51' ' A' ' 21' ' ' MYR . 0.1 OUTLIER -95.66 25.83 4.34 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 124.305 2.002 . . . . 0.0 108.062 179.491 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 25' ' ' ALA . 40.0 t -142.58 47.87 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.263 -3.195 0 CA-C-N 112.427 -2.17 . . . . 0.0 105.984 179.534 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.412 HD13 ' O ' ' A' ' 109' ' ' GLU . 0.0 OUTLIER -64.37 128.81 27.46 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 122.256 1.027 . . . . 0.0 113.128 -175.311 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.05 124.27 30.91 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 121.908 0.861 . . . . 0.0 110.126 -178.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' CB ' ' NE2' ' A' ' 97' ' ' HIS . . . -49.05 -26.41 2.61 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.915 -0.491 . . . . 0.0 110.193 -179.86 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.14 -22.77 62.96 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.115 -0.991 . . . . 0.0 110.251 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -116.69 6.95 13.39 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.2 -179.943 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.4 ' CB ' ' CE1' ' A' ' 97' ' ' HIS . . . -83.17 -165.06 0.98 Allowed 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.428 -0.795 . . . . 0.0 109.491 -179.665 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.819 ' CB ' HG23 ' A' ' 98' ' ' THR . 0.4 OUTLIER -84.62 171.25 11.45 Favored Pre-proline 0 N--CA 1.487 1.396 0 O-C-N 121.093 -1.004 . . . . 0.0 108.913 -179.528 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_exo -68.6 -49.4 0.82 Allowed 'Trans proline' 0 N--CA 1.497 1.718 0 C-N-CA 122.651 2.234 . . . . 0.0 113.864 -178.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA2' ' N ' ' A' ' 99' ' ' ARG . . . 92.26 114.14 2.07 Favored Glycine 0 N--CA 1.494 2.503 0 C-N-CA 119.318 -1.42 . . . . 0.0 109.938 -179.443 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.473 ' N ' ' HA ' ' A' ' 99' ' ' ARG . 77.0 mtt180 -100.08 143.56 30.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.875 -1.367 . . . . 0.0 109.445 179.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.574 ' O ' ' OG1' ' A' ' 39' ' ' THR . 0.0 OUTLIER -75.36 34.07 0.11 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 0.0 109.698 -179.854 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 38' ' ' ARG . 27.5 tp10 -110.68 94.58 20.04 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.089 -1.007 . . . . 0.0 109.631 -179.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.883 ' O ' HD13 ' A' ' 42' ' ' ILE . 71.3 Cg_endo -80.83 -178.46 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.802 2.335 . . . . 0.0 112.311 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.883 HD13 ' O ' ' A' ' 41' ' ' PRO . 2.8 mm -132.45 90.71 32.91 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.199 -0.938 . . . . 0.0 109.623 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -50.93 172.81 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.716 0 C-N-CA 122.803 2.335 . . . . 0.0 112.231 179.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.671 ' O ' ' N ' ' A' ' 46' ' ' ALA . 17.2 m -151.64 -178.26 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -0.93 . . . . 0.0 109.448 -179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -47.49 84.88 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.245 -0.909 . . . . 0.0 109.246 179.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.907 ' O ' HG23 ' A' ' 55' ' ' THR . . . -56.07 -40.61 73.85 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.482 -0.761 . . . . 0.0 111.052 -178.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.544 ' O ' ' C ' ' A' ' 48' ' ' HIS . 3.7 pttt -74.04 99.23 3.26 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 115.877 -2.329 . . . . 0.0 108.055 179.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.918 ' CE1' ' HG1' ' A' ' 89' ' ' THR . 4.4 t-80 -34.11 114.07 0.19 Allowed 'General case' 0 C--N 1.292 -1.892 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.383 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.634 ' CG ' ' CE ' ' A' ' 212' ' ' LYS . 63.7 t60 -63.05 -31.81 73.03 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 0.0 110.657 -178.784 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.563 HG23 ' HG3' ' A' ' 208' ' ' GLN . 5.3 t -66.71 -38.33 81.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.936 -1.103 . . . . 0.0 109.484 -179.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 1.1 m -111.08 -44.28 3.61 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.229 -0.919 . . . . 0.0 110.451 -179.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.666 ' N ' ' O ' ' A' ' 48' ' ' HIS . . . 101.91 -0.1 51.84 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.878 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.74 ' OD1' ' N ' ' A' ' 54' ' ' ARG . 31.9 p30 -77.22 -121.0 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 106.821 -1.548 . . . . 0.0 106.821 178.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.74 ' N ' ' OD1' ' A' ' 53' ' ' ASN . 2.6 ttt180 -131.15 166.88 20.13 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-O 123.056 1.408 . . . . 0.0 108.68 177.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.907 HG23 ' O ' ' A' ' 46' ' ' ALA . 30.5 p -129.03 34.35 4.46 Favored 'General case' 0 C--N 1.262 -3.211 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.501 178.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.635 HG12 ' C ' ' A' ' 55' ' ' THR . 0.2 OUTLIER -172.63 149.34 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 C-N-CA 119.136 -1.025 . . . . 0.0 110.037 -179.508 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.528 ' C ' ' O ' ' A' ' 56' ' ' VAL . 0.7 OUTLIER -31.63 139.37 0.19 Allowed Pre-proline 0 C--N 1.299 -1.603 0 CA-C-O 121.266 0.555 . . . . 0.0 110.152 -179.195 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -77.36 167.26 79.86 Favored 'Cis proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.479 -1.884 . . . . 0.0 111.783 0.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -109.43 147.3 35.76 Favored Pre-proline 0 C--N 1.271 -2.837 0 CA-C-N 114.538 -1.21 . . . . 0.0 108.34 179.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.514 ' O ' ' OG1' ' A' ' 63' ' ' THR . 51.5 Cg_exo -49.39 120.64 5.94 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.904 1.736 . . . . 0.0 111.593 179.432 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.42 ' C ' ' O ' ' A' ' 60' ' ' PRO . 20.3 mm-40 -42.73 118.3 1.21 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 109.799 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.412 ' O ' ' HD2' ' A' ' 123' ' ' PRO . . . 92.5 44.51 3.98 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.514 ' OG1' ' O ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -121.11 142.56 49.74 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.799 -1.412 . . . . 0.0 110.093 -179.681 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.669 ' OE1' ' N ' ' A' ' 65' ' ' MET . 2.2 tm0? -108.53 143.93 36.89 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 179.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.75 ' N ' ' SD ' ' A' ' 65' ' ' MET . 0.0 OUTLIER -136.8 103.86 5.32 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.905 -1.122 . . . . 0.0 110.163 -179.306 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -93.08 -169.36 2.14 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 179.027 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.492 ' O ' ' CD1' ' A' ' 68' ' ' PHE . 2.2 t -143.62 144.2 23.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 O-C-N 119.913 -1.742 . . . . 0.0 109.218 179.261 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.495 ' O ' HG12 ' A' ' 116' ' ' VAL . 22.1 m-85 -135.79 143.71 45.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.095 -1.003 . . . . 0.0 109.431 178.797 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.8 ' CA ' HG12 ' A' ' 116' ' ' VAL . . . -134.82 90.34 0.24 Allowed Glycine 0 N--CA 1.482 1.761 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.174 -179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' MET . . . . . 0.918 ' SD ' ' HB2' ' A' ' 76' ' ' ALA . 0.0 OUTLIER -100.93 -74.53 0.61 Allowed 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 178.72 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.632 ' O ' ' C ' ' A' ' 72' ' ' CYS . . . -163.59 -156.09 8.53 Favored Glycine 0 C--N 1.3 -1.444 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' CYS . . . . . 0.632 ' C ' ' O ' ' A' ' 71' ' ' GLY . 0.0 OUTLIER -23.36 91.38 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 122.144 -0.621 . . . . 0.0 109.763 -179.933 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.71 ' CE1' ' ND1' ' A' ' 206' ' ' HIS . 0.0 OUTLIER -53.77 7.26 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.313 -0.867 . . . . 0.0 111.178 -178.497 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' TRP . . . . . 0.603 ' H ' ' C ' ' A' ' 72' ' ' CYS . 35.9 m0 -68.98 -44.56 72.64 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.596 -1.315 . . . . 0.0 108.21 179.014 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.477 ' HA3' ' SG ' ' A' ' 218' ' ' CYS . . . -98.87 -15.64 33.19 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.15 -1.18 . . . . 0.0 110.15 179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.918 ' HB2' ' SD ' ' A' ' 70' ' ' MET . . . -68.45 -45.07 73.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.939 -1.33 . . . . 0.0 109.85 -179.648 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.766 ' OE1' HG13 ' A' ' 91' ' ' VAL . 23.5 tt0 -82.66 -20.38 36.36 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.129 -0.982 . . . . 0.0 110.425 -179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.521 ' HA ' ' CE2' ' A' ' 81' ' ' TRP . 11.7 ttt-85 -60.54 -46.38 90.39 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.083 -1.01 . . . . 0.0 110.867 -179.098 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -67.45 12.58 0.09 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.003 -1.06 . . . . 0.0 110.355 -178.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 37.0 m-85 -124.16 -11.27 7.53 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.062 -1.024 . . . . 0.0 111.136 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' TRP . . . . . 0.521 ' CE2' ' HA ' ' A' ' 78' ' ' ARG . 0.7 OUTLIER -106.83 13.18 28.15 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.579 -1.326 . . . . 0.0 109.414 179.25 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.49 HG13 ' O ' ' A' ' 78' ' ' ARG . 2.8 m -109.26 8.93 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.089 -1.007 . . . . 0.0 111.238 -178.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 83' ' ' LEU . 0.0 OUTLIER -118.69 166.1 13.17 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.87 -1.144 . . . . 0.0 108.789 179.298 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.541 ' C ' ' CD ' ' A' ' 84' ' ' LYS . 0.0 OUTLIER -93.96 144.16 25.71 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.468 -0.77 . . . . 0.0 109.459 -179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.13 -33.69 4.92 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 108.283 -1.927 . . . . 0.0 108.283 -179.85 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -72.73 133.77 31.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.639 -0.918 . . . . 0.0 108.728 179.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.698 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -83.38 -45.68 13.43 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.359 -0.838 . . . . 0.0 108.747 -179.844 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.529 ' OG ' HG22 ' A' ' 55' ' ' THR . 22.9 t -150.01 -166.56 2.58 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.416 -0.803 . . . . 0.0 110.053 179.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.918 ' HG1' ' CE1' ' A' ' 48' ' ' HIS . 0.0 OUTLIER -169.92 113.7 0.49 Allowed 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.57 ' OE1' ' C ' ' A' ' 89' ' ' THR . 0.0 OUTLIER -126.68 163.79 22.7 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.139 -0.976 . . . . 0.0 109.913 -178.218 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.766 HG13 ' OE1' ' A' ' 77' ' ' GLU . 1.3 m -143.36 150.38 17.56 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 121.069 -1.02 . . . . 0.0 110.457 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 200' ' ' TYR . . . -160.14 178.04 36.36 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.695 ' CE2' ' O ' ' A' ' 101' ' ' PRO . 5.4 m-85 -78.73 177.84 8.34 Favored 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.156 -1.202 . . . . 0.0 108.427 179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.88 ' HB1' HG13 ' A' ' 198' ' ' VAL . . . -174.39 159.33 3.03 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.193 -1.567 . . . . 0.0 113.063 -178.053 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 112' ' ' GLY . . . 62.46 20.1 60.83 Favored Glycine 0 N--CA 1.492 2.418 0 O-C-N 121.51 -0.744 . . . . 0.0 111.432 178.01 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.736 ' H ' ' CE1' ' A' ' 113' ' ' HIS . . . -139.0 175.08 21.78 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 178.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . 0.708 ' H ' ' HD1' ' A' ' 97' ' ' HIS . 0.0 OUTLIER -158.87 95.88 1.32 Allowed 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.117 -1.226 . . . . 0.0 110.648 -178.631 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.819 HG23 ' CB ' ' A' ' 35' ' ' LEU . 21.0 m -142.3 122.57 13.89 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 109.681 179.095 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.646 ' C ' ' O ' ' A' ' 98' ' ' THR . 1.2 mtp180 10.79 -89.58 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 121.862 0.839 . . . . 0.0 109.873 -179.649 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.569 ' O ' ' OE1' ' A' ' 105' ' ' GLU . 12.4 m-80 -120.9 90.31 46.64 Favored Pre-proline 0 C--N 1.299 -1.595 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 178.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' PRO . . . . . 0.695 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 8.8 Cg_exo -68.86 114.66 3.63 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.667 2.245 . . . . 0.0 113.358 -177.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.566 ' O ' HG22 ' A' ' 106' ' ' VAL . 19.2 p -121.35 158.9 27.22 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 119.101 -1.039 . . . . 0.0 108.639 178.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.628 ' O ' ' SG ' ' A' ' 107' ' ' CYS . 0.1 OUTLIER -49.77 -42.13 45.81 Favored 'General case' 0 C--N 1.298 -1.658 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.51 -179.069 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' N ' ' CG ' ' A' ' 103' ' ' TYR . 5.1 tttt -73.06 -27.56 61.81 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.93 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.569 ' OE1' ' O ' ' A' ' 100' ' ' ASN . 0.0 OUTLIER -83.14 -41.43 18.52 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.974 -1.079 . . . . 0.0 110.412 -179.238 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.566 HG22 ' O ' ' A' ' 102' ' ' THR . 6.8 m -57.4 -23.97 20.62 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.244 0 O-C-N 120.676 -1.265 . . . . 0.0 109.54 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.66 ' O ' ' N ' ' A' ' 109' ' ' GLU . 5.8 m -52.92 -43.84 66.54 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 179.7 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.602 ' C ' ' H ' ' A' ' 110' ' ' LYS . 39.3 m -46.53 -8.95 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.267 -0.896 . . . . 0.0 108.83 179.453 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.66 ' N ' ' O ' ' A' ' 107' ' ' CYS . 2.1 tt0 60.24 -7.78 0.07 Allowed 'General case' 0 N--CA 1.485 1.32 0 O-C-N 121.438 -0.789 . . . . 0.0 109.705 179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' LYS . . . . . 0.79 ' HB3' HD21 ' A' ' 35' ' ' LEU . 1.1 tttp -79.39 -12.98 59.9 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.128 -0.983 . . . . 0.0 109.185 -179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.7 p -89.6 -19.27 25.14 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.15 -0.969 . . . . 0.0 108.921 178.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.628 ' O ' ' O ' ' A' ' 95' ' ' GLY . . . 55.29 52.43 47.52 Favored Glycine 0 N--CA 1.489 2.219 0 C-N-CA 120.127 -1.035 . . . . 0.0 110.623 -179.951 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' HIS . . . . . 0.736 ' CE1' ' H ' ' A' ' 96' ' ' GLY . 2.4 m-70 -109.09 171.99 7.11 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.528 -1.572 . . . . 0.0 109.65 179.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.542 ' N ' ' O ' ' A' ' 94' ' ' ALA . . . -139.0 111.98 7.9 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.832 -0.803 . . . . 0.0 108.832 178.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . 0.698 ' OE1' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 mt-10 -54.35 131.48 42.1 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.8 HG12 ' CA ' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -143.02 -170.61 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 120.972 -1.08 . . . . 0.0 111.804 -178.664 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.489 ' HA ' HG12 ' A' ' 91' ' ' VAL . 1.2 m -147.5 151.09 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 121.274 0.559 . . . . 0.0 110.129 -179.083 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.457 ' HD3' ' CD1' ' A' ' 199' ' ' PHE . 0.0 OUTLIER -121.22 98.4 5.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 108.681 178.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.66 HG21 ' CD2' ' A' ' 80' ' ' PHE . 14.4 t -88.05 120.85 37.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.486 0 O-C-N 121.151 -0.968 . . . . 0.0 109.86 -179.568 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 20.4 t -103.46 125.75 57.96 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.544 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.519 ' CD1' ' C ' ' A' ' 121' ' ' TYR . 2.5 p90 -130.14 169.88 14.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.582 -1.324 . . . . 0.0 111.065 179.749 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ARG . . . . . . . . . . . . . 10.2 mtp85 -117.43 118.23 35.63 Favored Pre-proline 0 N--CA 1.487 1.398 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 178.565 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.701 ' O ' ' N ' ' A' ' 125' ' ' HIS . 18.4 Cg_exo -42.08 -61.88 0.48 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.998 2.465 . . . . 0.0 113.602 -179.372 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.687 ' OE2' ' CD2' ' A' ' 125' ' ' HIS . 6.8 tm-20 -34.92 -19.36 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.281 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.368 -178.912 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' HIS . . . . . 0.701 ' N ' ' O ' ' A' ' 123' ' ' PRO . 4.2 m170 -134.34 -2.39 2.79 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 120.402 -1.436 . . . . 0.0 111.42 -179.024 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.567 HG23 ' CG ' ' A' ' 130' ' ' GLU . 0.1 OUTLIER -154.35 158.74 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.724 -1.235 . . . . 0.0 110.889 -179.916 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.819 ' H ' ' CD ' ' A' ' 130' ' ' GLU . 0.0 OUTLIER -111.65 170.67 7.98 Favored 'General case' 0 N--CA 1.496 1.865 0 C-N-CA 119.62 -0.832 . . . . 0.0 110.537 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -70.16 -18.72 63.22 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 178.617 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 133' ' ' LYS . 24.6 mt-10 -65.15 -23.68 67.18 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.428 -0.509 . . . . 0.0 110.488 -179.73 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.819 ' CD ' ' H ' ' A' ' 127' ' ' SER . 1.2 pm0 -73.38 -45.28 55.84 Favored 'General case' 0 N--CA 1.497 1.924 0 C-N-CA 117.416 -1.714 . . . . 0.0 110.492 -179.211 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.573 HD13 ' HB ' ' A' ' 119' ' ' VAL . 6.7 mt -64.35 -44.14 92.37 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 119.884 -1.76 . . . . 0.0 108.941 179.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 132' ' ' LEU . 0.6 OUTLIER -75.27 -27.16 59.31 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.032 -1.042 . . . . 0.0 110.527 -179.233 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.54 ' CB ' ' O ' ' A' ' 129' ' ' GLU . 1.4 tmtp? -70.31 -65.68 0.7 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.987 -1.071 . . . . 0.0 109.799 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.735 HG12 ' CZ ' ' A' ' 80' ' ' PHE . 37.3 t -49.95 -22.52 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.22 -0.925 . . . . 0.0 109.297 -179.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.811 ' CE1' ' CD2' ' A' ' 139' ' ' HIS . 66.0 t80 -72.23 -49.91 31.5 Favored 'General case' 0 C--N 1.297 -1.685 0 O-C-N 121.197 -0.94 . . . . 0.0 110.593 -179.463 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.615 ' CG ' ' CE2' ' A' ' 177' ' ' TYR . 66.2 m95 -74.77 -60.56 2.23 Favored 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.027 -1.67 . . . . 0.0 110.967 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.453 ' C ' ' O ' ' A' ' 136' ' ' TRP . 11.7 tt0 -36.33 -32.47 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.444 -0.785 . . . . 0.0 111.138 -178.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.69 ' ND2' ' O ' ' A' ' 134' ' ' VAL . 12.0 p30 -131.31 69.66 1.47 Allowed 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.886 -1.134 . . . . 0.0 110.088 -178.799 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.811 ' CD2' ' CE1' ' A' ' 135' ' ' PHE . 4.8 m80 -153.6 142.04 20.69 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.982 -1.073 . . . . 0.0 110.876 179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . 0.574 ' O ' ' OE1' ' A' ' 143' ' ' GLN . 0.6 OUTLIER -106.9 72.18 0.3 Allowed Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 178.396 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.708 ' O ' ' N ' ' A' ' 190' ' ' THR . 57.7 Cg_endo -69.09 -9.14 25.51 Favored 'Trans proline' 0 N--CA 1.497 1.691 0 C-N-CA 122.984 2.456 . . . . 0.0 115.543 -177.434 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.57 HG22 HG22 ' A' ' 189' ' ' ILE . 0.1 OUTLIER -89.99 16.6 8.01 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 120.242 -1.536 . . . . 0.0 111.18 -178.668 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' GLN . . . . . 0.574 ' OE1' ' O ' ' A' ' 140' ' ' ASP . 0.2 OUTLIER -131.06 89.21 2.7 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 120.948 -1.095 . . . . 0.0 108.937 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . 0.678 ' O ' ' NH1' ' A' ' 156' ' ' ARG . . . -83.81 20.67 11.34 Favored Glycine 0 N--CA 1.49 2.253 0 C-N-CA 120.145 -1.026 . . . . 0.0 110.805 -178.967 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' MET . . . . . 0.593 ' O ' ' O ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER -113.76 -15.93 12.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.745 -1.444 . . . . 0.0 109.552 179.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.509 ' HB2' ' H ' ' A' ' 152' ' ' GLY . 0.0 OUTLIER 177.6 164.83 0.62 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.407 -0.808 . . . . 0.0 108.857 -179.389 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLN . . . . . 0.566 ' O ' ' OD1' ' A' ' 150' ' ' ASP . 3.3 tp-100 -111.8 132.71 54.49 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.558 -1.339 . . . . 0.0 110.871 -179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . 0.488 ' HA3' HD21 ' A' ' 220' ' ' LEU . . . 43.98 -123.59 4.8 Favored Glycine 0 N--CA 1.474 1.185 0 CA-C-O 123.317 1.509 . . . . 0.0 111.122 178.8 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' ASN . . . . . 0.484 ' H ' HD21 ' A' ' 220' ' ' LEU . 0.9 OUTLIER -79.9 -32.92 40.23 Favored 'General case' 0 C--N 1.272 -2.802 0 CA-C-N 113.388 -1.406 . . . . 0.0 112.023 -177.58 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.566 ' OD1' ' O ' ' A' ' 147' ' ' GLN . 42.4 p30 -52.46 164.92 0.29 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.209 -1.557 . . . . 0.0 108.564 -179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.44 ' CD1' ' O ' ' A' ' 151' ' ' PHE . 8.5 p90 -136.72 119.72 16.46 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.927 -1.108 . . . . 0.0 109.98 -179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.593 ' O ' ' O ' ' A' ' 145' ' ' MET . . . 153.7 165.88 14.13 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.527 -1.321 . . . . 0.0 109.992 179.543 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.529 ' O ' HG23 ' A' ' 153' ' ' THR . 0.4 OUTLIER -91.03 2.4 56.34 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -1.125 . . . . 0.0 109.356 179.662 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' GLN . . . . . 0.631 ' N ' ' OE1' ' A' ' 154' ' ' GLN . 12.2 pm0 -90.2 -0.1 57.45 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.125 -0.984 . . . . 0.0 108.354 178.803 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.479 ' CD2' ' HG2' ' A' ' 154' ' ' GLN . 36.7 m-85 -123.26 57.16 1.16 Allowed 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.436 -0.79 . . . . 0.0 109.768 179.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.678 ' NH1' ' O ' ' A' ' 144' ' ' GLY . 0.2 OUTLIER -99.39 -178.58 3.95 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.832 . . . . 0.0 108.956 179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.523 ' OG ' ' O ' ' A' ' 190' ' ' THR . 0.1 OUTLIER -93.61 107.75 19.57 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 104.086 -2.561 . . . . 0.0 104.086 176.306 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.47 ' CB ' ' HB3' ' A' ' 192' ' ' ASP . . . -137.29 114.85 11.15 Favored 'General case' 0 C--N 1.289 -2.031 0 C-N-CA 117.899 -1.521 . . . . 0.0 111.092 -176.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 192' ' ' ASP . 39.6 t -101.4 137.76 27.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 C-N-CA 119.286 -0.966 . . . . 0.0 109.12 178.909 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' TYR . . . . . 1.101 ' CG ' HG21 ' A' ' 198' ' ' VAL . 84.4 m-85 -127.15 86.05 59.66 Favored Pre-proline 0 C--N 1.301 -1.52 0 O-C-N 120.95 -1.094 . . . . 0.0 108.216 178.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 160' ' ' TYR . 52.0 Cg_exo -38.35 168.3 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 123.089 2.526 . . . . 0.0 112.972 -178.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' THR . . . . . 0.493 HG21 ' O ' ' A' ' 65' ' ' MET . 0.1 OUTLIER -102.69 -40.65 6.52 Favored 'General case' 0 C--N 1.312 -1.062 0 O-C-N 121.144 -0.972 . . . . 0.0 109.534 179.817 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.502 ' O ' ' N ' ' A' ' 165' ' ' VAL . 0.9 OUTLIER -173.25 178.52 2.4 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.103 -0.998 . . . . 0.0 109.798 -179.961 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 163' ' ' SER . . . -45.8 -23.84 0.31 Allowed 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 123.11 1.433 . . . . 0.0 108.076 179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 163' ' ' SER . 2.5 t -56.09 -56.07 15.01 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.934 0 CA-C-N 113.696 -1.593 . . . . 0.0 108.863 178.968 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.08 -36.29 48.41 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.483 -178.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' MET . . . . . . . . . . . . . 4.4 ttp -52.67 -11.4 0.21 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.312 -0.868 . . . . 0.0 110.782 -179.072 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -75.57 -53.8 8.03 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.758 -1.214 . . . . 0.0 110.034 -179.82 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . 0.588 ' O ' ' OG ' ' A' ' 173' ' ' SER . . . -92.73 -47.93 6.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.138 -0.976 . . . . 0.0 110.5 -179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' ALA . . . . . . . . . . . . . . . -50.97 -55.72 15.91 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -0.917 . . . . 0.0 110.083 -179.005 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' LEU . . . . . . . . . . . . . 2.9 tp -52.52 -41.23 63.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.018 -1.051 . . . . 0.0 109.331 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -74.43 -37.34 63.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 109.674 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.601 ' HB3' ' HE1' ' A' ' 136' ' ' TRP . 0.7 OUTLIER -56.51 -39.13 72.79 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 0.0 109.854 -179.811 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' LYS . . . . . 0.793 ' HZ3' ' N ' ' A' ' 175' ' ' GLU . 0.5 OUTLIER -72.59 -58.27 3.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.176 -0.953 . . . . 0.0 110.003 -179.783 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.793 ' N ' ' HZ3' ' A' ' 174' ' ' LYS . 0.9 OUTLIER -57.22 -50.3 73.3 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.26 -0.9 . . . . 0.0 109.991 -179.265 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.497 ' CD ' ' C ' ' A' ' 176' ' ' GLU . 0.9 OUTLIER -53.39 -34.99 59.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.947 . . . . 0.0 109.976 -179.555 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' TYR . . . . . 0.615 ' CE2' ' CG ' ' A' ' 136' ' ' TRP . 0.5 OUTLIER -79.75 -35.01 39.39 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.023 -1.048 . . . . 0.0 109.638 -179.744 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . 0.594 ' OE1' ' CG1' ' A' ' 189' ' ' ILE . 4.5 tp60 -75.13 -33.79 61.59 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.329 -0.857 . . . . 0.0 109.621 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -73.54 -31.25 63.56 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.332 179.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' VAL . . . . . . . . . . . . . 10.9 t -87.06 -51.75 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 109.522 179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 28.1 mt -54.09 -39.69 66.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.12 -0.988 . . . . 0.0 109.574 -179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 18.7 t -56.32 -32.13 64.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.179 -0.951 . . . . 0.0 109.548 -179.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.3 ttmt -88.01 0.8 55.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.519 -179.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . 0.762 ' ND1' ' SG ' ' A' ' 227' ' ' CYS . 10.0 m-70 -108.33 35.97 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.218 -0.926 . . . . 0.0 109.677 -179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 68.61 58.7 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.29 -0.882 . . . . 0.0 109.58 -179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 186' ' ' PHE . . . . . 0.532 ' CE2' ' O ' ' A' ' 184' ' ' HIS . 86.3 m-85 -151.8 168.5 24.88 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.4 -0.813 . . . . 0.0 109.267 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.85 -167.44 19.92 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 179.934 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' PRO . . . . . 0.474 ' HA ' ' NE2' ' A' ' 178' ' ' GLN . 10.8 Cg_endo -58.57 107.69 0.35 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 121.644 1.563 . . . . 0.0 110.53 179.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.594 ' CG1' ' OE1' ' A' ' 178' ' ' GLN . 0.4 OUTLIER -47.22 168.34 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 CA-C-O 122.21 1.005 . . . . 0.0 110.603 -178.228 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' THR . . . . . 0.708 ' N ' ' O ' ' A' ' 141' ' ' PRO . 27.1 p -120.33 58.65 0.92 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.485 -179.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' THR . . . . . . . . . . . . . 45.6 m -100.12 116.11 31.37 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.948 -1.501 . . . . 0.0 106.948 178.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.654 ' CG ' ' NH1' ' A' ' 194' ' ' ARG . 4.0 t0 -76.51 128.24 34.38 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 119.328 -0.949 . . . . 0.0 109.551 -178.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . 0.442 ' HA ' ' O ' ' A' ' 159' ' ' VAL . 0.7 OUTLIER -125.32 99.47 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.132 -0.98 . . . . 0.0 110.189 -179.364 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.654 ' NH1' ' CG ' ' A' ' 192' ' ' ASP . 9.8 mtm-85 -135.4 152.57 51.54 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.166 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 195' ' ' GLU . 1.4 mp0 -129.48 163.77 25.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.504 -1.372 . . . . 0.0 110.752 -179.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 104.65 -22.01 35.15 Favored Glycine 0 N--CA 1.48 1.614 0 N-CA-C 109.883 -1.287 . . . . 0.0 109.883 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' GLN . . . . . 0.641 ' O ' ' CB ' ' A' ' 198' ' ' VAL . 0.9 OUTLIER -142.45 -173.9 3.98 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.054 -1.262 . . . . 0.0 111.747 -178.691 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' VAL . . . . . 1.101 HG21 ' CG ' ' A' ' 160' ' ' TYR . 91.1 t 109.2 74.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.517 2.921 0 N-CA-C 116.67 2.1 . . . . 0.0 116.67 174.708 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.457 ' CD1' ' HD3' ' A' ' 118' ' ' ARG . 3.0 t80 -165.5 126.57 1.92 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.457 -0.777 . . . . 0.0 111.134 172.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' TYR . . . . . 0.551 ' O ' ' N ' ' A' ' 93' ' ' PHE . 0.3 OUTLIER -156.47 94.9 1.52 Allowed 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.475 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -49.19 125.85 11.6 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.196 -0.94 . . . . 0.0 110.783 -178.546 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' ALA . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 93' ' ' PHE . . . -84.2 -168.69 2.26 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 178.617 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' GLU . . . . . 0.65 ' OE2' ' CE2' ' A' ' 205' ' ' TYR . 1.4 pt-20 -75.81 -176.51 3.39 Favored 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.0 -1.062 . . . . 0.0 108.766 179.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -64.1 -50.06 69.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.831 -1.168 . . . . 0.0 110.662 -179.415 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' TYR . . . . . 0.788 ' CD1' ' N ' ' A' ' 205' ' ' TYR . 0.0 OUTLIER -62.66 1.95 0.33 Allowed 'General case' 0 C--N 1.307 -1.283 0 O-C-N 120.877 -1.139 . . . . 0.0 112.144 -178.307 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.71 ' ND1' ' CE1' ' A' ' 73' ' ' PHE . 5.0 m-70 -102.04 11.6 38.18 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.434 -1.416 . . . . 0.0 110.942 -179.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' GLN . . . . . 0.853 ' O ' ' N ' ' A' ' 209' ' ' TYR . 4.7 mm-40 -129.53 -141.18 0.24 Allowed 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.15 0.976 . . . . 0.0 109.641 -178.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' GLN . . . . . 0.688 ' NE2' ' O ' ' A' ' 89' ' ' THR . 1.0 OUTLIER -37.01 -1.36 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.463 0 CA-C-N 114.423 -1.262 . . . . 0.0 111.389 178.972 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' TYR . . . . . 0.853 ' N ' ' O ' ' A' ' 207' ' ' GLN . 80.1 t80 -38.45 -42.26 0.73 Allowed 'General case' 0 N--CA 1.516 2.835 0 O-C-N 121.014 -1.054 . . . . 0.0 111.457 -178.103 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' LEU . . . . . 0.431 ' CD1' ' O ' ' A' ' 74' ' ' TRP . 0.9 OUTLIER -62.21 -47.68 83.37 Favored 'General case' 0 N--CA 1.499 2.013 0 C-N-CA 117.274 -1.77 . . . . 0.0 109.553 -178.467 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 45.3 t -56.11 -38.24 70.5 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.061 -1.024 . . . . 0.0 108.873 179.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.634 ' CE ' ' CG ' ' A' ' 49' ' ' HIS . 0.0 OUTLIER -88.28 -21.24 24.56 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.295 -0.878 . . . . 0.0 109.9 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' ASN . . . . . 0.619 ' N ' ' O ' ' A' ' 209' ' ' TYR . 1.4 m-80 -133.4 89.11 33.01 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.095 -1.003 . . . . 0.0 110.541 -179.243 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' PRO . . . . . 0.603 ' C ' ' H ' ' A' ' 216' ' ' GLY . 31.7 Cg_exo -56.92 13.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.816 0 C-N-CA 123.525 2.817 . . . . 0.0 112.08 178.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.592 ' H ' ' C ' ' A' ' 213' ' ' ASN . 38.0 t0 -60.92 20.75 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.2 -0.937 . . . . 0.0 111.112 -177.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' GLY . . . . . 0.605 ' O ' ' C ' ' A' ' 217' ' ' TYR . . . 65.52 -51.47 0.14 Allowed Glycine 0 N--CA 1.496 2.677 0 C-N-CA 119.868 -1.158 . . . . 0.0 112.199 177.706 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' TYR . . . . . 0.605 ' C ' ' O ' ' A' ' 216' ' ' GLY . 27.0 m-85 -22.32 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.905 0 CA-C-N 118.892 1.346 . . . . 0.0 110.121 -179.191 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' CYS . . . . . 0.538 ' O ' ' C ' ' A' ' 219' ' ' GLY . 0.0 OUTLIER -151.18 103.01 2.99 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.449 -0.782 . . . . 0.0 109.441 -179.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' GLY . . . . . 0.538 ' C ' ' O ' ' A' ' 218' ' ' CYS . . . -36.33 151.01 0.02 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.336 -1.506 . . . . 0.0 109.336 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' LEU . . . . . 0.488 HD21 ' HA3' ' A' ' 148' ' ' GLY . 0.4 OUTLIER -63.41 -175.67 0.12 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -1.142 . . . . 0.0 109.52 -180.0 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -101.65 -67.62 0.8 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.291 -1.524 . . . . 0.0 109.291 179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' GLY . . . . . 0.5 ' HA3' ' N ' ' A' ' 139' ' ' HIS . . . 156.85 147.05 4.65 Favored Glycine 0 N--CA 1.483 1.781 0 N-CA-C 108.833 -1.707 . . . . 0.0 108.833 179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' THR . . . . . 0.574 ' C ' ' N ' ' A' ' 225' ' ' VAL . 0.1 OUTLIER -70.29 -48.62 55.88 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.495 -1.003 . . . . 0.0 109.114 179.974 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' GLY . . . . . 0.488 ' C ' ' O ' ' A' ' 223' ' ' THR . . . 45.9 21.73 0.66 Allowed Glycine 0 N--CA 1.481 1.666 0 N-CA-C 105.716 -2.953 . . . . 0.0 105.716 -178.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' VAL . . . . . 0.574 ' N ' ' C ' ' A' ' 223' ' ' THR . 0.4 OUTLIER -90.17 131.59 37.0 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 CA-C-N 114.228 -0.986 . . . . 0.0 110.519 -178.272 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' SER . . . . . 0.68 ' H ' ' CB ' ' A' ' 229' ' ' MET . 48.4 t -98.48 -155.67 0.51 Allowed 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.236 -0.915 . . . . 0.0 109.186 179.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' CYS . . . . . 0.762 ' SG ' ' ND1' ' A' ' 184' ' ' HIS . 0.1 OUTLIER -73.8 -66.64 0.49 Allowed Pre-proline 0 C--N 1.291 -1.944 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.382 -179.835 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' PRO . . . . . 0.583 ' CD ' ' SG ' ' A' ' 227' ' ' CYS . 57.4 Cg_endo -70.37 -15.29 34.76 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.263 1.975 . . . . 0.0 110.322 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' MET . . . . . 0.68 ' CB ' ' H ' ' A' ' 226' ' ' SER . 2.8 mmm -55.27 154.76 5.6 Favored 'General case' 0 C--N 1.299 -1.603 0 CA-C-O 121.973 0.892 . . . . 0.0 110.047 -180.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' ALA . . . . . 0.512 ' C ' ' O ' ' A' ' 229' ' ' MET . . . -32.91 130.24 0.2 Allowed 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.848 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 231' ' ' ILE . 1.8 mm -139.66 103.19 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.216 -0.927 . . . . 0.0 109.339 179.903 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -117.41 -78.51 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.472 -0.767 . . . . 0.0 109.428 -179.883 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . . . . . . . . 0 C--N 1.305 -1.347 0 O-C-N 121.259 -0.901 . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' MYR . . . . . 1.229 ' O1 ' ' O ' ' A' ' 22' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_